C10530	STY	Therapeutic or Preventive Procedure		NCI
C10530	PT	Doxorubicin/Thiotepa		NCI
C10530	SY	DOX/TSPA		NCI
C10530	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10530	RO	chemotherapy regimen has component Doxorubicin	NCI
C10530	RO	chemotherapy regimen has component Thiotepa	NCI
C11376	STY	Therapeutic or Preventive Procedure		NCI
C11376	PT	Cisplatin/Docetaxel/Fluorouracil		NCI
C11376	SY	CDDP/5-FU/TXT		NCI
C11376	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11376	RO	chemotherapy regimen has component Cisplatin	NCI
C11376	RO	chemotherapy regimen has component Fluorouracil	NCI
C11376	RO	chemotherapy regimen has component Docetaxel	NCI
C11914	STY	Therapeutic or Preventive Procedure		NCI
C11914	PT	Detox-B Adjuvant/Verteporfin		NCI
C11914	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11914	RO	chemotherapy regimen has component Verteporfin	NCI
C11914	RO	chemotherapy regimen has component Detox-B Adjuvant	NCI
C10524	STY	Therapeutic or Preventive Procedure		NCI
C10524	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Interleukin-3/Leucovorin Calcium		NCI
C10524	SY	CF/CTX/DOX/5-FU/IL-3		NCI
C10524	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10524	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10524	RO	chemotherapy regimen has component Doxorubicin	NCI
C10524	RO	chemotherapy regimen has component Fluorouracil	NCI
C10524	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10524	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C9925	STY	Therapeutic or Preventive Procedure		NCI
C9925	PT	Cyclophosphamide/Doxorubicin/Tamoxifen		NCI
C9925	SY	ACT		NCI
C9925	SY	CTX/DOX/TMX		NCI
C9925	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9925	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9925	RO	chemotherapy regimen has component Doxorubicin	NCI
C9925	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C9515	STY	Therapeutic or Preventive Procedure		NCI
C9515	PT	Doxorubicin/Fluorouracil/Methotrexate		NCI
C9515	SY	DOX/5-FU/MTX		NCI
C9515	SY	FAMTX		NCI
C9515	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9515	RO	chemotherapy regimen has component Doxorubicin	NCI
C9515	RO	chemotherapy regimen has component Fluorouracil	NCI
C9515	RO	chemotherapy regimen has component Methotrexate	NCI
C11241	STY	Therapeutic or Preventive Procedure		NCI
C11241	PT	Bleomycin/Cyclophosphamide/Idarubicin/Methylprednisolone/Methotrexate/Vincristine		NCI
C11241	SY	BLEO/CTX/IDA/MEPRDL/MTX/VCR		NCI
C11241	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11241	RO	chemotherapy regimen has component Bleomycin	NCI
C11241	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11241	RO	chemotherapy regimen has component Idarubicin	NCI
C11241	RO	chemotherapy regimen has component Methotrexate	NCI
C11241	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11241	RO	chemotherapy regimen has component Vincristine	NCI
C10275	STY	Therapeutic or Preventive Procedure		NCI
C10275	PT	Cyclophosphamide/Doxorubicin/Etoposide/Lomustine/Vincristine		NCI
C10275	SY	CCNU/CTX/DOX/VCR/VP-16		NCI
C10275	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10275	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10275	RO	chemotherapy regimen has component Doxorubicin	NCI
C10275	RO	chemotherapy regimen has component Etoposide	NCI
C10275	RO	chemotherapy regimen has component Lomustine	NCI
C10275	RO	chemotherapy regimen has component Vincristine	NCI
C11487	STY	Therapeutic or Preventive Procedure		NCI
C11487	PT	Cyclophosphamide/Pentostatin		NCI
C11487	SY	CTX/DCF		NCI
C11487	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11487	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11487	RO	chemotherapy regimen has component Pentostatin	NCI
C9980	STY	Therapeutic or Preventive Procedure		NCI
C9980	PT	Fluorouracil/Leucovorin Calcium/Semustine		NCI
C9980	SY	CF/5-FU/MeCCNU		NCI
C9980	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9980	RO	chemotherapy regimen has component Fluorouracil	NCI
C9980	RO	chemotherapy regimen has component Semustine	NCI
C9980	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10608	STY	Therapeutic or Preventive Procedure		NCI
C10608	PT	Carboplatin/Cytarabine/Idarubicin		NCI
C10608	SY	ARA-C/CBDCA/IDA		NCI
C10608	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10608	RO	chemotherapy regimen has component Cytarabine	NCI
C10608	RO	chemotherapy regimen has component Idarubicin	NCI
C10608	RO	chemotherapy regimen has component Carboplatin	NCI
C37746	STY	Therapeutic or Preventive Procedure		NCI
C37746	PT	Docetaxel/Leuprolide/Testosterone		NCI
C37746	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37746	RO	chemotherapy regimen has component Testosterone	NCI
C37746	RO	chemotherapy regimen has component Docetaxel	NCI
C37746	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C136414	STY	Therapeutic or Preventive Procedure		NCI
C136414	PT	EPOCH-O Regimen		NCI
C136414	SY	O-EPOCH Regimen		NCI
C136414	SY	EPOCH Plus Ofatumumab		NCI
C136414	SY	Etoposide-Prednisone-Oncovin-Cyclophosphamide-Hydroxydaunorubicin-Ofatumumab Regimen		NCI
C136414	SY	EPOCH-O		NCI
C136414	SY	Dose-Adjusted Etoposide-Prednisone- Vincristine-Cyclophosphamide-Ofatumumab		NCI
C136414	SY	O-EPOCH		NCI
C136414	SY	EPOCH Plus Arzerra		NCI
C136414	SY	Dose-adjusted Etoposide/Vincristine/Doxorubicin/Cyclophosphamide/Prednisone Plus Ofatumumab Regimen		NCI
C136414	SY	DA EPOCH-O		NCI
C136414	SY	Dose-adjusted EPOCH-Ofatumumab		NCI
C136414	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C136414	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C136414	RO	chemotherapy regimen has component Etoposide	NCI
C136414	RO	chemotherapy regimen has component Prednisone	NCI
C136414	RO	chemotherapy regimen has component Vincristine	NCI
C136414	RO	chemotherapy regimen has component Doxorubicin Hydrochloride	NCI
C136414	RO	chemotherapy regimen has component Ofatumumab	NCI
C11486	STY	Therapeutic or Preventive Procedure		NCI
C11486	PT	Clarithromycin/Omeprazole/Tinidazole		NCI
C11486	SY	CLARITH/OMEP/TDZ		NCI
C11486	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11486	RO	chemotherapy regimen has component Omeprazole	NCI
C11486	RO	chemotherapy regimen has component Tinidazole	NCI
C11486	RO	chemotherapy regimen has component Clarithromycin	NCI
C10568	STY	Therapeutic or Preventive Procedure		NCI
C10568	PT	Asparaginase/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine		NCI
C10568	SY	ARA-C/MP/MTX/PEG-ASP/VCR		NCI
C10568	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10568	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10568	RO	chemotherapy regimen has component Asparaginase	NCI
C10568	RO	chemotherapy regimen has component Methotrexate	NCI
C10568	RO	chemotherapy regimen has component Vincristine	NCI
C10568	RO	chemotherapy regimen has component Pegaspargase	NCI
C11036	STY	Therapeutic or Preventive Procedure		NCI
C11036	PT	Interferon Alfa/Interleukin-2/Monoclonal Antibody R24		NCI
C11036	SY	IFN-A/IL-2/MOAB R24		NCI
C11036	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11036	RO	chemotherapy regimen has component Monoclonal Antibody R24	NCI
C11036	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11036	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C63448	STY	Therapeutic or Preventive Procedure		NCI
C63448	PT	CODOX-M/IVAC Regimen		NCI
C63448	SY	CODOX-M/IVAC		NCI
C63448	SY	Cyclophosphamide-Oncovin-Doxorubicin-Methotrexate/Ifosfamide, VePesid, AraC Regimen		NCI
C63448	SY	CODOX-M Alternating with IVAC		NCI
C63448	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63448	RO	chemotherapy regimen has component Mesna	NCI
C63448	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63448	RO	chemotherapy regimen has component Cytarabine	NCI
C63448	RO	chemotherapy regimen has component Doxorubicin	NCI
C63448	RO	chemotherapy regimen has component Etoposide	NCI
C63448	RO	chemotherapy regimen has component Ifosfamide	NCI
C63448	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C63448	RO	chemotherapy regimen has component Methotrexate	NCI
C63448	RO	chemotherapy regimen has component Vincristine	NCI
C63448	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63448	RO	regimen has accepted use for disease AIDS-Related Non-Hodgkin Lymphoma	NCI
C61007	STY	Classification		NCI
C61007	PT	Agent Combination Indexed in Open Clinical Trials		NCI
C61007	CHD	Agent Combination	NCI
C61007	PAR	Bleomycin/Dacarbazine/Doxorubicin/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Methotrexate/Vincristine	NCI
C61007	PAR	Bleomycin/Cisplatin/Etoposide	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Vincristine	NCI
C61007	PAR	Carmustine/Cyclophosphamide/Etoposide	NCI
C61007	PAR	Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone	NCI
C61007	PAR	Cytarabine/Daunorubicin/Thioguanine	NCI
C61007	PAR	Cytarabine/Daunorubicin/Prednisone/Thioguanine/Vincristine	NCI
C61007	PAR	Cisplatin/Cytarabine/Dexamethasone	NCI
C61007	PAR	Cisplatin/Cytarabine/Dexamethasone/Etoposide	NCI
C61007	PAR	Etoposide/Ifosfamide/Methotrexate	NCI
C61007	PAR	Cisplatin/Doxorubicin/Methotrexate/Vinblastine	NCI
C61007	PAR	Cisplatin/Doxorubicin/Mitomycin	NCI
C61007	PAR	Cytarabine/Mitoxantrone	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Prednisone/Procarbazine/Vincristine	NCI
C61007	PAR	Lomustine/Procarbazine/Vincristine	NCI
C61007	PAR	Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61007	PAR	Asparaginase/Daunorubicin/Prednisone/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Dactinomycin/Vincristine	NCI
C61007	PAR	Dexamethasone/Doxorubicin/Vincristine	NCI
C61007	PAR	Cisplatin/Etoposide/Ifosfamide	NCI
C61007	PAR	Cisplatin/Etoposide	NCI
C61007	PAR	Dactinomycin/Ifosfamide/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Etoposide	NCI
C61007	PAR	Cyclophosphamide/Epirubicin/Vincristine/Prednisone	NCI
C61007	PAR	Carboplatin/Cyclophosphamide/Thiotepa	NCI
C61007	PAR	Asparaginase/Cyclophosphamide/Doxorubicin/Prednisolone/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Etoposide/Methotrexate/Vincristine	NCI
C61007	PAR	Sargramostim/Thiotepa	NCI
C61007	PAR	Cisplatin/Cyclophosphamide/Vindesine	NCI
C61007	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine	NCI
C61007	PAR	Cytarabine/Etoposide/Idarubicin	NCI
C61007	PAR	Cyclophosphamide/Etoposide/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Thiotepa	NCI
C61007	PAR	Cisplatin/Mitomycin	NCI
C61007	PAR	Busulfan/Cyclophosphamide	NCI
C61007	PAR	Bleomycin/Carboplatin	NCI
C61007	PAR	Fluorouracil/Leucovorin Calcium	NCI
C61007	PAR	Carboplatin/Cisplatin	NCI
C61007	PAR	Asparaginase/Cytarabine	NCI
C61007	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Methotrexate/Thioguanine/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Etoposide/Methotrexate	NCI
C61007	PAR	Cyproterone/Goserelin	NCI
C61007	PAR	Goserelin/Nilutamide	NCI
C61007	PAR	Flutamide/Goserelin	NCI
C61007	PAR	Asparaginase/Daunorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate	NCI
C61007	PAR	Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61007	PAR	Cytarabine/Idarubicin	NCI
C61007	PAR	Prednisone/Vincristine	NCI
C61007	PAR	Etoposide/Ifosfamide/Vincristine	NCI
C61007	PAR	Buserelin/Cyproterone	NCI
C61007	PAR	Etoposide/Mitoxantrone	NCI
C61007	PAR	Asparaginase/Dexamethasone/Doxorubicin/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Cytarabine/Mercaptopurine	NCI
C61007	PAR	Cytarabine/Mercaptopurine/Methotrexate	NCI
C61007	PAR	Carboplatin/Cyclophosphamide/Etoposide	NCI
C61007	PAR	Cyclophosphamide/Interleukin-2/Tumor Necrosis Factor	NCI
C61007	PAR	Cytarabine/Etoposide/Ifosfamide	NCI
C61007	PAR	Cisplatin/Fluorouracil/Vincristine	NCI
C61007	PAR	Etoposide/Melphalan	NCI
C61007	PAR	Cisplatin/Doxorubicin	NCI
C61007	PAR	Bleomycin/Cyclophosphamide/Etoposide/Prednisone/Procarbazine	NCI
C61007	PAR	Carmustine/Dacarbazine/Hydroxyurea	NCI
C61007	PAR	Carmustine/Dacarbazine/Hydroxyurea/Vincristine	NCI
C61007	PAR	Cisplatin/Cyclophosphamide/Etoposide/Interleukin-2	NCI
C61007	PAR	Cyclophosphamide/Fluoxymesterone/Mitolactol/Prednisone/Tamoxifen	NCI
C61007	PAR	BCG/Cyclophosphamide/Doxorubicin/Tegafur	NCI
C61007	PAR	Fluorouracil/Mitomycin	NCI
C61007	PAR	Mercaptopurine/Methotrexate/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Dexrazoxane/Doxorubicin/Vincristine	NCI
C61007	PAR	Floxuridine/Leucovorin Calcium	NCI
C61007	PAR	Doxorubicin/Fluorouracil/Mitomycin/Triazinate	NCI
C61007	PAR	Asparaginase/Cytarabine/Sargramostim	NCI
C61007	PAR	Cisplatin/Cyclophosphamide/Vincristine	NCI
C61007	PAR	Buthionine Sulfoximine/Melphalan	NCI
C61007	PAR	Busulfan/Melphalan	NCI
C61007	PAR	Cyclophosphamide/Prednisone	NCI
C61007	PAR	Mercaptopurine/Methotrexate/Prednisolone/Vincristine	NCI
C61007	PAR	Cisplatin/Fluorouracil	NCI
C61007	PAR	Bleomycin/Fluorouracil/Methotrexate/Vincristine	NCI
C61007	PAR	Etoposide/Ifosfamide	NCI
C61007	PAR	Methotrexate/Vinblastine	NCI
C61007	PAR	Carboplatin/Vincristine	NCI
C61007	PAR	Carboplatin/Ifosfamide	NCI
C61007	PAR	Dacarbazine/Doxorubicin/Ifosfamide	NCI
C61007	PAR	Bleomycin/Idoxuridine	NCI
C61007	PAR	Cytarabine/Hydrocortisone/Methotrexate	NCI
C61007	PAR	Carboplatin/Cyclophosphamide/Sargramostim/Thiotepa	NCI
C61007	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Leucovorin Calcium/Sargramostim	NCI
C61007	PAR	Cisplatin/Paclitaxel	NCI
C61007	PAR	Cytarabine/Etoposide	NCI
C61007	PAR	Interleukin-2/Lymphokine-Activated Killer Cells	NCI
C61007	PAR	Cyclophosphamide/Cytarabine	NCI
C61007	PAR	Mercaptopurine/Methotrexate	NCI
C61007	PAR	Cyclophosphamide/Etoposide	NCI
C61007	PAR	Cisplatin/Cyclophosphamide/Etoposide	NCI
C61007	PAR	Cisplatin/Cyclophosphamide/Etoposide/Lomustine/Vincristine	NCI
C61007	PAR	Cisplatin/Cyclophosphamide/Etoposide/Vincristine	NCI
C61007	PAR	Cytarabine/Daunorubicin	NCI
C61007	PAR	Doxorubicin/Fluorouracil	NCI
C61007	PAR	Cytarabine/Methotrexate	NCI
C61007	PAR	Cisplatin/Epirubicin	NCI
C61007	PAR	Carboplatin/Etoposide	NCI
C61007	PAR	Interleukin-2/Tumor Infiltrating Lymphocytes	NCI
C61007	PAR	Etoposide/Thiotepa	NCI
C61007	PAR	Cisplatin/Doxorubicin/Etoposide/Fluorouracil/Mitomycin	NCI
C61007	PAR	Cyclophosphamide/Vincristine	NCI
C61007	PAR	Dactinomycin/Vincristine	NCI
C61007	PAR	Dactinomycin/Doxorubicin/Vincristine	NCI
C61007	PAR	Amifostine/Cisplatin	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Filgrastim	NCI
C61007	PAR	Cisplatin/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Daunorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Thioguanine	NCI
C61007	PAR	Interleukin-2/Monoclonal Antibody Lym-1	NCI
C61007	PAR	Cytarabine/Fludarabine	NCI
C61007	PAR	Cyclophosphamide/Diethylstilbestrol/Fluorouracil	NCI
C61007	PAR	Carboplatin/Doxorubicin	NCI
C61007	PAR	Cisplatin/Lomustine/Vincristine	NCI
C61007	PAR	Daunorubicin/Dexamethasone/Vincristine	NCI
C61007	PAR	Flutamide/Leuprolide	NCI
C61007	PAR	Fluorouracil/L-Leucovorin	NCI
C61007	PAR	Carboplatin/Etoposide/Melphalan	NCI
C61007	PAR	Floxuridine/Fluorouracil	NCI
C61007	PAR	Carmustine/Etoposide/Thiotepa	NCI
C61007	PAR	Etoposide/Idarubicin/Methotrexate	NCI
C61007	PAR	Dipyridamole/Fluorouracil/PALA	NCI
C61007	PAR	Dexamethasone/Doxorubicin/Quinine/Verapamil/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Filgrastim/Prednisone/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Fludarabine	NCI
C61007	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Filgrastim	NCI
C61007	PAR	Carboplatin/Cytarabine/Dexamethasone	NCI
C61007	PAR	Cyclophosphamide/Filgrastim	NCI
C61007	PAR	Filgrastim/Topotecan	NCI
C61007	PAR	Cytarabine/Pegaspargase	NCI
C61007	PAR	Fluorouracil/Leucovorin Calcium/Trimetrexate Glucuronate	NCI
C61007	PAR	Dexamethasone/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine	NCI
C61007	PAR	Dexamethasone/Mercaptopurine/Methotrexate/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Dactinomycin/Doxorubicin/Filgrastim/Vincristine	NCI
C61007	PAR	Doxorubicin/Filgrastim	NCI
C61007	PAR	Bromocriptine/Flutamide	NCI
C61007	PAR	Busulfan/Etoposide	NCI
C61007	PAR	Cyclophosphamide/Daunorubicin/Dexamethasone/Methotrexate/Pegaspargase/Vincristine	NCI
C61007	PAR	Cytarabine/Tretinoin	NCI
C61007	PAR	Interleukin-3/Melphalan	NCI
C61007	PAR	Dexrazoxane/Doxorubicin	NCI
C61007	PAR	Leucovorin Calcium/Mercaptopurine/Methotrexate	NCI
C61007	PAR	Fluorouracil/Leucovorin Calcium/Mitomycin	NCI
C61007	PAR	Dexamethasone/Floxuridine/Leucovorin Calcium	NCI
C61007	PAR	Cyclosporine/Cytarabine/Daunorubicin	NCI
C61007	PAR	Cisplatin/Topotecan	NCI
C61007	PAR	Cyclophosphamide/Paclitaxel	NCI
C61007	PAR	Carboplatin/Paclitaxel	NCI
C61007	PAR	Melphalan/Methylprednisolone	NCI
C61007	PAR	Cytarabine/Mercaptopurine	NCI
C61007	PAR	Asparaginase/Cytarabine/Dexamethasone/Etoposide	NCI
C61007	PAR	Ifosfamide/Paclitaxel	NCI
C61007	PAR	Cyclophosphamide/Epirubicin	NCI
C61007	PAR	Bicalutamide/Leuprolide	NCI
C61007	PAR	Bicalutamide/Goserelin	NCI
C61007	PAR	Cytarabine/Dexamethasone/Etoposide/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Cytarabine/Daunorubicin/Thioguanine	NCI
C61007	PAR	Methotrexate/Zidovudine	NCI
C61007	PAR	Cytarabine/Mercaptopurine/Methotrexate/Teniposide/Thioguanine	NCI
C61007	PAR	Carboplatin/Thiotepa	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Paclitaxel	NCI
C61007	PAR	Cyclophosphamide/Topotecan	NCI
C61007	PAR	Cyclophosphamide/Methotrexate	NCI
C61007	PAR	Hydroxyurea/Tretinoin	NCI
C61007	PAR	Cisplatin/Vinorelbine	NCI
C61007	PAR	Asparaginase/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Toremifene	NCI
C61007	PAR	Cytarabine/Dexamethasone/Etoposide/Ifosfamide/Methotrexate	NCI
C61007	PAR	Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate	NCI
C61007	PAR	Cyclophosphamide/Dexamethasone	NCI
C61007	PAR	Carboplatin/Filgrastim/Topotecan	NCI
C61007	PAR	Fluorouracil/Irinotecan/Leucovorin Calcium	NCI
C61007	PAR	Cytarabine/Doxorubicin/Prednisone/Thioguanine/Vincristine	NCI
C61007	PAR	Ciprofloxacin/Cisplatin/Etoposide	NCI
C61007	PAR	Cytarabine/Milodistim/Mitoxantrone	NCI
C61007	PAR	Cyclosporine/Methotrexate	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Prednisone	NCI
C61007	PAR	Chlorambucil/Prednisolone/Procarbazine/Vinblastine	NCI
C61007	PAR	Cisplatin/Cyclophosphamide/Etoposide/Filgrastim	NCI
C61007	PAR	Cytarabine/Filgrastim/Idarubicin/Interleukin-6	NCI
C61007	PAR	Carboplatin/Etoposide/Filgrastim/Ifosfamide/Paclitaxel	NCI
C61007	PAR	Carboplatin/Etoposide/Vincristine	NCI
C61007	PAR	Goserelin/Tamoxifen	NCI
C61007	PAR	Monoclonal Antibody 3F8/Sargramostim	NCI
C61007	PAR	Carmustine/O6-Benzylguanine	NCI
C61007	PAR	Cyclophosphamide/Didanosine/Doxorubicin/Etoposide	NCI
C61007	PAR	Antineoplaston A10/Antineoplaston AS2-1	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Methylprednisolone/Vincristine	NCI
C61007	PAR	Cisplatin/Doxorubicin/Paclitaxel	NCI
C61007	PAR	Cisplatin/Doxorubicin/Filgrastim/Paclitaxel	NCI
C61007	PAR	Cisplatin/Tirapazamine	NCI
C61007	PAR	Cisplatin/Epirubicin/Fluorouracil	NCI
C61007	PAR	Carmustine/Mitolactol	NCI
C61007	PAR	Cisplatin/Safingol	NCI
C61007	PAR	Cisplatin/Irinotecan	NCI
C61007	PAR	Cisplatin/Docetaxel	NCI
C61007	PAR	Bleomycin/Cisplatin/Cyclophosphamide/Etoposide	NCI
C61007	PAR	Carmustine/Temozolomide	NCI
C61007	PAR	Carbogen/Niacinamide	NCI
C61007	PAR	Daunorubicin/Pegaspargase/Prednisone/Vincristine	NCI
C61007	PAR	Melphalan/Prednisone	NCI
C61007	PAR	Cytarabine/Etoposide/Mitoxantrone	NCI
C61007	PAR	Carboplatin/Doxorubicin/Etoposide	NCI
C61007	PAR	Bleomycin/Doxorubicin/Etoposide/Mechlorethamine/Prednisone/Vinblastine/Vincristine	NCI
C61007	PAR	Cisplatin/Doxorubicin/Methotrexate	NCI
C61007	PAR	Fluorouracil/Interferon Alfa	NCI
C61007	PAR	Interferon Alfa/Tamoxifen	NCI
C61007	PAR	Interferon Alfa/Piroxicam	NCI
C61007	PAR	Carmustine/Cyclophosphamide/Interferon Alfa/Melphalan/Prednisone/Vincristine	NCI
C61007	PAR	Fluorouracil/Interferon Alfa/Interleukin-2	NCI
C61007	PAR	Cytarabine/Interferon Alfa	NCI
C61007	PAR	Cisplatin/Fluorouracil/Interferon Alfa	NCI
C61007	PAR	Chlorambucil/Interferon Alfa	NCI
C61007	PAR	Interferon Alfa/Tretinoin	NCI
C61007	PAR	Cisplatin/Dacarbazine/Interferon Alfa/interleukin-2/Vinblastine	NCI
C61007	PAR	Filgrastim/Fluorouracil/Hydroxyurea/Interferon Alfa	NCI
C61007	PAR	interleukin-2/Monoclonal Antibody OKT3	NCI
C61007	PAR	Cyclophosphamide/Filgrastim/Paclitaxel	NCI
C61007	PAR	Cyclophosphamide/Paclitaxel/Sargramostim	NCI
C61007	PAR	Cyclosporine/Methylprednisolone	NCI
C61007	PAR	Dexamethasone/Pegaspargase/Vincristine	NCI
C61007	PAR	Carmustine/Cytarabine/Etoposide/Melphalan	NCI
C61007	PAR	Docetaxel/Filgrastim/Vinorelbine	NCI
C61007	PAR	QS21/Tyrosinase Peptide	NCI
C61007	PAR	Interleukin-2/Melatonin	NCI
C61007	PAR	Paclitaxel/Vinorelbine	NCI
C61007	PAR	Cisplatin/Gemcitabine	NCI
C61007	PAR	Carboplatin/Lobradimil	NCI
C61007	PAR	Doxorubicin/Losoxantrone	NCI
C61007	PAR	Cyclosporine/Prednisone	NCI
C61007	PAR	Methotrexate/Pegaspargase/Vincristine	NCI
C61007	PAR	Estramustine/Strontium Chloride Sr 89/Vinblastine	NCI
C61007	PAR	Cyclosporine/Interferon Gamma/Interleukin-2	NCI
C61007	PAR	Cyclophosphamide/Dexamethasone/Etoposide/Mercaptopurine/Methotrexate/Vincristine	NCI
C61007	PAR	Paclitaxel/Trastuzumab	NCI
C61007	PAR	Carboplatin/Paclitaxel/Topotecan	NCI
C61007	PAR	Prednisone/Tacrolimus	NCI
C61007	PAR	Octreotide Pamoate/Tamoxifen	NCI
C61007	PAR	Docetaxel/Epirubicin	NCI
C61007	PAR	Cyclosporine/Methotrexate/Sirolimus	NCI
C61007	PAR	Interferon Gamma/Interleukin-1-Beta/Interleukin-2/Sargramostim/Tumor Necrosis Factor	NCI
C61007	PAR	Cyclophosphamide/Indomethacin/Zinc Sulfate	NCI
C61007	PAR	Bryostatin 1/Vincristine	NCI
C61007	PAR	Methotrexate/Tacrolimus	NCI
C61007	PAR	Cisplatin/Mitomycin/Vincristine	NCI
C61007	PAR	Dexamethasone/Fludarabine/Mitoxantrone	NCI
C61007	PAR	Anti-thymocyte Globulin/Melphalan	NCI
C61007	PAR	Carmustine/Cisplatin/Filgrastim/Thiotepa	NCI
C61007	PAR	Carmustine/Irinotecan	NCI
C61007	PAR	Flavopiridol/Paclitaxel	NCI
C61007	PAR	Carboplatin/Estramustine/Paclitaxel	NCI
C61007	PAR	Amifostine/Cisplatin/Paclitaxel	NCI
C61007	PAR	Amifostine/Carboplatin/Paclitaxel	NCI
C61007	PAR	Doxorubicin HCl Liposome/VX-853	NCI
C61007	PAR	Doxorubicin/Etoposide/Ifosfamide	NCI
C61007	PAR	Anti-thymocyte Globulin/Cyclophosphamide	NCI
C61007	PAR	Doxorubicin/Estramustine/Ketoconazole/Vinblastine	NCI
C61007	PAR	Docetaxel/Estramustine	NCI
C61007	PAR	Doxorubicin/Gemcitabine	NCI
C61007	PAR	Gemcitabine/Irinotecan	NCI
C61007	PAR	Cyclosporine/Mycophenolate Mofetil	NCI
C61007	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-2/MART-1 Antigen/Tyrosinase Peptide	NCI
C61007	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Sargramostim/Tyrosinase Peptide	NCI
C61007	PAR	Buserelin/Flutamide	NCI
C61007	PAR	Buserelin/Nilutamide	NCI
C61007	PAR	Bicalutamide/Buserelin	NCI
C61007	PAR	Leuprolide/Nilutamide	NCI
C61007	PAR	Cetuximab/Cisplatin	NCI
C61007	PAR	Docetaxel/Fluorouracil	NCI
C61007	PAR	Dexamethasone/Granisetron	NCI
C61007	PAR	Leucovorin Calcium/Methotrexate/Vincristine	NCI
C61007	PAR	Mitoxantrone/Prednisone	NCI
C61007	PAR	Cytarabine/Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vincristine	NCI
C61007	PAR	Fludarabine/Rituximab	NCI
C61007	PAR	Mycophenolate Mofetil/Tacrolimus	NCI
C61007	PAR	Cisplatin/Docetaxel/Fluorouracil	NCI
C61007	PAR	Cyproterone/Luteinizing Hormone-Releasing Factor	NCI
C61007	PAR	Cyclophosphamide/Tirapazamine	NCI
C61007	PAR	Amifostine/Carboplatin/Filgrastim/Paclitaxel	NCI
C61007	PAR	Busulfan/Cyclophosphamide/Anti-Thymocyte Globulin	NCI
C61007	PAR	Cyclophosphamide/Methylprednisolone	NCI
C61007	PAR	Carboplatin/Thalidomide	NCI
C61007	PAR	Cisplatin/Pemetrexed Disodium	NCI
C61007	PAR	Carboplatin/Gemcitabine/Paclitaxel	NCI
C61007	PAR	Fluorouracil/Paclitaxel	NCI
C61007	PAR	Anti-Thymocyte Globulin/Busulfan/Melphalan	NCI
C61007	PAR	Busulfan/Melphalan/Methylprednisolone	NCI
C61007	PAR	Cyclophosphamide/Docetaxel/Doxorubicin	NCI
C61007	PAR	Ethinyl Estradiol/Norgestrel	NCI
C61007	PAR	Carmustine/Melphalan	NCI
C61007	PAR	Gemcitabine/Paclitaxel	NCI
C61007	PAR	Gemcitabine/Vinorelbine	NCI
C61007	PAR	BAY 12-9566/Fluorouracil/Leucovorin Calcium	NCI
C61007	PAR	Irinotecan/Oxaliplatin	NCI
C61007	PAR	Anti-Thymocyte Globulin/Cyclophosphamide/Fludarabine	NCI
C61007	PAR	Carboplatin/Docetaxel	NCI
C61007	PAR	Carboplatin/Gemcitabine	NCI
C61007	PAR	Filgrastim/Sargramostim	NCI
C61007	PAR	Cyclophosphamide/Rituximab	NCI
C61007	PAR	Bleomycin/Cisplatin/Etoposide/Paclitaxel	NCI
C61007	PAR	Antineoplaston A10/Methotrexate	NCI
C61007	PAR	Interferon Alfa/Tretinoin Liposome	NCI
C61007	PAR	Dexamethasone/Rituximab	NCI
C61007	PAR	Interferon Alfa/Interleukin-2 Liposome/Polyvalent Melanoma Vaccine	NCI
C61007	PAR	Methotrexate/Methylprednisolone	NCI
C61007	PAR	Cisplatin/Flavopiridol	NCI
C61007	PAR	Gemcitabine/Tipifarnib	NCI
C61007	PAR	Cytarabine/Hydrocortisone/Leucovorin Calcium/Methotrexate	NCI
C61007	PAR	Capecitabine/Docetaxel	NCI
C61007	PAR	Flutamide/Triptorelin	NCI
C61007	PAR	Docetaxel/Gemcitabine	NCI
C61007	PAR	Carboplatin/Paclitaxel/PSC 833	NCI
C61007	PAR	Fluorouracil/Oxaliplatin	NCI
C61007	PAR	Methotrexate/Prednisolone	NCI
C61007	PAR	Dexamethasone/Methotrexate	NCI
C61007	PAR	Asparaginase/Daunorubicin/Dexamethasone/Methotrexate/Vincristine	NCI
C61007	PAR	Asparaginase/Cyclophosphamide/Daunorubicin/Dexamethasone/Methotrexate/Vincristine	NCI
C61007	PAR	Asparaginase/Cyclophosphamide/Daunorubicin/Methotrexate/Prednisolone/Vincristine	NCI
C61007	PAR	Asparaginase/Cytarabine/Mercaptopurine/Methotrexate	NCI
C61007	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine	NCI
C61007	PAR	Asparaginase/Leucovorin Calcium/Mercaptopurine/Methotrexate	NCI
C61007	PAR	Asparaginase/Cyclophosphamide/Daunorubicin/Dexamethasone/Leucovorin Calcium/Methotrexate/Thioguanine/Vindesine	NCI
C61007	PAR	Asparaginase/Cytarabine/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine	NCI
C61007	PAR	Asparaginase/Cytarabine/Dexamethasone/Etoposide/Mitoxantrone	NCI
C61007	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Mercaptopurine/Methotrexate/Thioguanine/Vincristine/Vindesine	NCI
C61007	PAR	Isotretinoin/Temozolomide	NCI
C61007	PAR	Carboplatin/Cyclophosphamide/Vincristine	NCI
C61007	PAR	QS21/TF(c)-KLH Conjugate Vaccine	NCI
C61007	PAR	Capecitabine/Vinorelbine	NCI
C61007	PAR	Fludarabine/Melphalan	NCI
C61007	PAR	Docetaxel/Irinotecan	NCI
C61007	PAR	Methotrexate/Prednisone	NCI
C61007	PAR	Anti-thymocyte globulin/Cyclophosphamide/Methylprednisolone	NCI
C61007	PAR	Irinotecan/Vincristine	NCI
C61007	PAR	Cisplatin/Dexrazoxane/Doxorubicin	NCI
C61007	PAR	Doxorubicin/Ranpirnase	NCI
C61007	PAR	Capecitabine/Oxaliplatin	NCI
C61007	PAR	Carboplatin/Paclitaxel/Thalidomide	NCI
C61007	PAR	Autologous Tumor Cell Vaccine/Sargramostim	NCI
C61007	PAR	Bryostatin 1/Interleukin-2	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Vincristine	NCI
C61007	PAR	MART-1 antigen/Montanide ISA-51	NCI
C61007	PAR	Dexamethasone/Floxuridine/Leucovorin Calcium/SCH-58500	NCI
C61007	PAR	gp100 Antigen/Interleukin-2/Montanide ISA-51	NCI
C61007	PAR	gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide	NCI
C61007	PAR	Oxaliplatin/Paclitaxel	NCI
C61007	PAR	Bicalutamide/Goserelin/Mitoxantrone/Prednisone	NCI
C61007	PAR	Autologous Tumor Cell Vaccine/Keyhole Limpet Hemocyanin/Sargramostim	NCI
C61007	PAR	Rituximab/Yttrium Y 90 ibritumomab tiuxetan	NCI
C61007	PAR	gp100 Antigen/Interleukin-2/Montanide ISA-51/Tumor Infiltrating Lymphocytes	NCI
C61007	PAR	Anti-thymocyte globulin/Cyclosporine	NCI
C61007	PAR	Asparaginase/cyclophosphamide/cytarabine/daunorubicin/dexamethasone/methotrexate/thioguanine/vincristine	NCI
C61007	PAR	Asparaginase/cyclophosphamide/cytarabine/daunorubicin/methotrexate/prednisone/vincristine	NCI
C61007	PAR	Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Prednisone	NCI
C61007	PAR	Asparaginase/cytarabine/daunorubicin/methotrexate/prednisone/vincristine	NCI
C61007	PAR	Dactinomycin/Melphalan	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Rituximab/Vincristine	NCI
C61007	PAR	Docetaxel/Thalidomide	NCI
C61007	PAR	Tariquidar/Vinorelbine	NCI
C61007	PAR	Montanide ISA-51/PR1 leukemia peptide vaccine/Sargramostim	NCI
C61007	PAR	Carboplatin/Paclitaxel/Tirapazamine	NCI
C61007	PAR	Carboplatin/Etoposide/Ifosfamide/Rituximab	NCI
C61007	PAR	Cisplatin/Cytarabine/Dexamethasone/Rituximab	NCI
C61007	PAR	Carmustine/Efaproxiral	NCI
C61007	PAR	Interferon Alfa/Isotretinoin/Paclitaxel	NCI
C61007	PAR	Temozolomide/Thalidomide	NCI
C61007	PAR	Bleomycin/Cyclophosphamide/Etoposide/Mitoxantrone/Prednisolone/Vincristine	NCI
C61007	PAR	O6-benzylguanine/Temozolomide	NCI
C61007	PAR	Leucovorin Calcium/Methotrexate	NCI
C61007	PAR	Gemcitabine/Pemetrexed Disodium	NCI
C61007	PAR	Arsenic trioxide/Ascorbic acid	NCI
C61007	PAR	Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine	NCI
C61007	PAR	Interferon Alfa/Thalidomide	NCI
C61007	PAR	Lomustine/Temozolomide	NCI
C61007	PAR	Cyclophosphamide/Cytarabine/Topotecan	NCI
C61007	PAR	Cisplatin/Gemcitabine/Paclitaxel	NCI
C61007	PAR	Carmustine/Cisplatin/Dacarbazine/Tamoxifen	NCI
C61007	PAR	Dexamethasone/Idarubicin	NCI
C61007	PAR	Carboplatin/Temozolomide/Vincristine	NCI
C61007	PAR	Chlorambucil/Dexamethasone/Mitoxantrone	NCI
C61007	PAR	Fluorouracil/Irinotecan	NCI
C61007	PAR	Doxorubicin/Hydrocortisone/Methotrexate	NCI
C61007	PAR	Cytarabine/Dexamethasone/Etoposide/Ifosfamide/Methotrexate/Vinblastine	NCI
C61007	PAR	Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vinblastine	NCI
C61007	PAR	Autologous Lymphocytes/Interleukin-2	NCI
C61007	PAR	Capecitabine/Irinotecan/Oxaliplatin	NCI
C61007	PAR	Prednisone/Thalidomide	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Iodine I 131 Tositumomab/Prednisone/Vincristine	NCI
C61007	PAR	Bortezomib/Fluorouracil/Leucovorin Calcium	NCI
C61007	PAR	Flavopiridol/Gemcitabine	NCI
C61007	PAR	Dexamethasone/Floxuridine	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Rituximab/Vincristine	NCI
C61007	PAR	Anti-thymocyte globulin/fludarabine/melphalan	NCI
C61007	PAR	Imatinib Mesylate/Interferon Alfa	NCI
C61007	PAR	Carboplatin/Irinotecan	NCI
C61007	PAR	Calcitriol/Dexamethasone	NCI
C61007	PAR	Fludarabine/Thalidomide	NCI
C61007	PAR	Carboplatin/Etoposide Phosphate/Ifosfamide	NCI
C61007	PAR	Autologous Dendritic Cells/Autologous Tumor Cell Vaccine/Sargramostim	NCI
C61007	PAR	Bevacizumab/Capecitabine	NCI
C61007	PAR	Cisplatin/UCN-01	NCI
C61007	PAR	Sulindac/Thalidomide	NCI
C61007	PAR	Cisplatin/Dexamethasone/Gemcitabine	NCI
C61007	PAR	Carboplatin/Methotrexate/Vinblastine	NCI
C61007	PAR	Docetaxel/Filgrastim/Gemcitabine	NCI
C61007	PAR	Bismuth Bi213 Monoclonal Antibody M195/Cytarabine/Filgrastim	NCI
C61007	PAR	Leucovorin Calcium/Mercaptopurine/Methotrexate/Prednisolone/Vincristine	NCI
C61007	PAR	Cytarabine/Daunorubicin/Dexamethasone/Prednisolone/Thioguanine/Vincristine	NCI
C61007	PAR	Methotrexate/Prednisolone/Prednisone	NCI
C61007	PAR	Asparaginase/cytarabine/daunorubicin/dexamethasone/methotrexate/prednisolone/vincristine	NCI
C61007	PAR	Leucovorin Calcium/Mercaptopurine/Methotrexate/Prednisolone	NCI
C61007	PAR	Keyhole Limpet Hemocyanin/Sargramostim	NCI
C61007	PAR	Carboplatin/IM-862/Paclitaxel	NCI
C61007	PAR	Doxorubicin/Etoposide/Ifosfamide/Vincristine	NCI
C61007	PAR	Cetuximab/Fluorouracil/Irinotecan/Leucovorin Calcium	NCI
C61007	PAR	Interleukin-2/Monoclonal Antibody Ch14.18	NCI
C61007	PAR	Autologous Lymphocytes/Interleukin-2/Sargramostim	NCI
C61007	PAR	Fluorouracil/Irinotecan/Leucovorin Calcium/SU5416	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Prednisone/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Prednisone/Rituximab/Vincristine	NCI
C61007	PAR	Carboplatin/Docetaxel/Trastuzumab	NCI
C61007	PAR	Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Methotrexate/Pegaspargase/Thioguanine/Vincristine	NCI
C61007	PAR	EGFR Antisense DNA/Sargramostim	NCI
C61007	PAR	EGFR Antisense DNA/Keyhole Limpet Hemocyanin	NCI
C61007	PAR	Calcium Gluconate/Cholecalciferol/Zoledronate	NCI
C61007	PAR	Etoposide/Ifosfamide/Imatinib Mesylate/Methotrexate	NCI
C61007	PAR	Cyclophosphamide/Daunorubicin/Dexamethasone/Imatinib Mesylate/Methotrexate/Pegaspargase/Vincristine	NCI
C61007	PAR	Asparaginase/Cytarabine/Imatinib mesylate	NCI
C61007	PAR	Cyclophosphamide/Dexamethasone/Etoposide/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine	NCI
C61007	PAR	Dexamethasone/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine	NCI
C61007	PAR	Bortezomib/Doxorubicin	NCI
C61007	PAR	Bevacizumab/Cytarabine/Idarubicin	NCI
C61007	PAR	Cytarabine/Fludarabine/Isotretinoin	NCI
C61007	PAR	Doxorubicin/Strontium Chloride Sr 89	NCI
C61007	PAR	Cisplatin/Etoposide/Ifosfamide/Prednisolone	NCI
C61007	PAR	Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/MART-1 antigen/Montanide ISA-51/tyrosinase peptide	NCI
C61007	PAR	Docetaxel/Ifosfamide	NCI
C61007	PAR	Bevacizumab/Fluorouracil/Leucovorin Calcium/Oxaliplatin	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Tirapazamine	NCI
C61007	PAR	Bevacizumab/Interferon Alfa	NCI
C61007	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vinblastine/Vincristine	NCI
C61007	PAR	Temozolomide/Vinorelbine	NCI
C61007	PAR	Erlotinib/Gemcitabine	NCI
C61007	PAR	Isotretinoin/Monoclonal antibody Ch14.18/Sargramostim	NCI
C61007	PAR	Interleukin-2/Isotretinoin/Monoclonal Antibody Ch14.18	NCI
C61007	PAR	Cytarabine/dexamethasone/methotrexate/pegaspargase/vincristine	NCI
C61007	PAR	Bevacizumab/Cisplatin/Gemcitabine	NCI
C61007	PAR	Docetaxel/Estramustine/Thalidomide	NCI
C61007	PAR	Alemtuzumab/Fludarabine/Melphalan	NCI
C61007	PAR	Autologous Dendritic Cells/Fowlpox-CEA-TRICOM Vaccine	NCI
C61007	PAR	Bevacizumab/Docetaxel	NCI
C61007	PAR	Multivitamins/Soy Protein Isolate	NCI
C61007	PAR	Anti-CD3 x Anti-HER-2-Neu Bispecific Monoclonal Antibody/Autologous Lymphocytes/Interleukin-2/Sargramostim	NCI
C61007	PAR	Busulfan/Fludarabine	NCI
C61007	PAR	Carboplatin/Cetuximab/Gemcitabine	NCI
C61007	PAR	Carboplatin/Erlotinib/Paclitaxel	NCI
C61007	PAR	Bevacizumab/Paclitaxel	NCI
C61007	PAR	Cytarabine/Imatinib Mesylate	NCI
C61007	PAR	Cyclophosphamide/Doxorubicin/Filgrastim/Prednisone/Rituximab/Vincristine	NCI
C61007	PAR	Bortezomib/Carboplatin/Paclitaxel	NCI
C61007	PAR	Dexamethasone/Doxorubicin	NCI
C61007	PAR	Cyclophosphamide/Dexamethasone/Doxorubicin	NCI
C61007	PAR	Anti-thymocyte globulin/Cyclophosphamide/Fludarabine/methylprednisolone	NCI
C61007	PAR	Capecitabine/Gemcitabine	NCI
C61007	PAR	Celecoxib/Docetaxel	NCI
C61007	PAR	Isotretinoin/Monoclonal antibody Ch14.18	NCI
C61007	PAR	Cisplatin/Erlotinib	NCI
C61007	PAR	Bortezomib/Paclitaxel	NCI
C61007	PAR	Irinotecan/UCN-01	NCI
C61007	PAR	Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/Montanide ISA-51	NCI
C61007	PAR	Goserelin/Raloxifene	NCI
C61007	PAR	Dalteparin/Gemcitabine	NCI
C61007	PAR	Autologous Lymphocytes/gp100 Antigen/Interleukin-2/Montanide ISA-51	NCI
C61007	PAR	Asparaginase/Leucovorin Calcium/Methotrexate	NCI
C61007	PAR	Allogeneic lymphocytes/Interleukin-2	NCI
C61007	PAR	Fowlpox Virus Vaccine/gp100 Antigen/Interleukin-2	NCI
C61007	PAR	Alemtuzumab/Cyclophosphamide/Fludarabine	NCI
C61007	PAR	Cisplatin/Gefitinib	NCI
C61007	PAR	Erlotinib/Trastuzumab	NCI
C61007	PAR	Celecoxib/Eflornithine	NCI
C61007	PAR	Dexamethasone/Thalidomide	NCI
C61007	PAR	Cyclophosphamide/Pentostatin/Rituximab	NCI
C61007	PAR	Cytarabine/Daunorubicin/Oblimersen	NCI
C61007	PAR	Docetaxel/Ketoconazole	NCI
C61007	PAR	Cytarabine/Dexamethasone/Etoposide/Filgrastim/Ifosfamide/Leucovorin Calcium/Methotrexate/Rituximab/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Filgrastim/Leucovorin Calcium/Methotrexate/Rituximab/Vincristine	NCI
C61007	PAR	Cyclophosphamide/Epirubicin/Paclitaxel	NCI
C61007	PAR	Fowlpox-CEA-TRICOM Vaccine/Sargramostim	NCI
C61007	PAR	Ad5CMV-p53 gene/Cisplatin/Fluorouracil	NCI
C61007	PAR	Ad5CMV-p53 gene/Docetaxel	NCI
C61007	PAR	Fowlpox-CEA-TRICOM Vaccine/Sargramostim/Vaccinia-CEA-TRICOM Vaccine	NCI
C61007	PAR	Cyclophosphamide/Dexamethasone/Doxorubicin/Rituximab/Vincristine	NCI
C61007	PAR	Cytarabine/Leucovorin Calcium/Methotrexate/Rituximab	NCI
C61007	PAR	Docetaxel/Filgrastim/Trastuzumab/Vinorelbine	NCI
C61007	PAR	Decitabine/FR901228	NCI
C61007	PAR	Asparaginase/Cytarabine/Dexamethasone/Doxorubicin/methotrexate/thioguanine/vincristine	NCI
C61007	PAR	Lycopene/Multivitamins	NCI
C61007	PAR	Cyclophosphamide/Cytarabine/Thioguanine	NCI
C61007	PAR	Fowlpox-CEA-TRICOM Vaccine/Fowlpox-Sargramostim	NCI
C61007	PAR	Doxorubicin/Tariquidar	NCI
C61007	PAR	Tositumomab and Iodine I 131 Tositumomab	NCI
C61007	PAR	dHER2 Vaccine+AS15 Adjuvant	NCI
C10282	STY	Therapeutic or Preventive Procedure		NCI
C10282	PT	Altretamine/Etoposide/Methotrexate		NCI
C10282	SY	VHM		NCI
C10282	SY	HMM/MTX/VP-16		NCI
C10282	SY	MVH		NCI
C10282	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10282	RO	chemotherapy regimen has component Etoposide	NCI
C10282	RO	chemotherapy regimen has component Altretamine	NCI
C10282	RO	chemotherapy regimen has component Methotrexate	NCI
C37855	STY	Therapeutic or Preventive Procedure		NCI
C37855	PT	Selenium/Soy Protein Isolate/Vitamin E		NCI
C37855	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37855	RO	chemotherapy regimen has component Selenium	NCI
C37855	RO	chemotherapy regimen has component Vitamin E Compound	NCI
C37855	RO	chemotherapy regimen has component Soy Protein Isolate	NCI
C10518	STY	Therapeutic or Preventive Procedure		NCI
C10518	PT	Bleomycin/Cisplatin/Etoposide/Filgrastim		NCI
C10518	SY	BLEO/CDDP/G-CSF/VP-16		NCI
C10518	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10518	RO	chemotherapy regimen has component Bleomycin	NCI
C10518	RO	chemotherapy regimen has component Cisplatin	NCI
C10518	RO	chemotherapy regimen has component Etoposide	NCI
C10518	RO	chemotherapy regimen has component Filgrastim	NCI
C11114	STY	Therapeutic or Preventive Procedure		NCI
C11114	PT	Interleukin-2/Melatonin		NCI
C11114	SY	IL-2/MLT		NCI
C11114	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11114	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11114	RO	chemotherapy regimen has component Therapeutic Melatonin	NCI
C11650	STY	Therapeutic or Preventive Procedure		NCI
C11650	PT	Fluorouracil/UCN-01		NCI
C11650	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11650	RO	chemotherapy regimen has component Fluorouracil	NCI
C11650	RO	chemotherapy regimen has component 7-Hydroxystaurosporine	NCI
C9778	STY	Therapeutic or Preventive Procedure		NCI
C9778	PT	Etoposide/Vincristine		NCI
C9778	SY	VCR/VP-16		NCI
C9778	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9778	RO	chemotherapy regimen has component Etoposide	NCI
C9778	RO	chemotherapy regimen has component Vincristine	NCI
C9899	STY	Therapeutic or Preventive Procedure		NCI
C9899	PT	Carmustine/Cisplatin/Dacarbazine/Interleukin-2/Tamoxifen		NCI
C9899	SY	BCNU/CDDP/DTIC/IL-2/TMX		NCI
C9899	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9899	RO	chemotherapy regimen has component Carmustine	NCI
C9899	RO	chemotherapy regimen has component Cisplatin	NCI
C9899	RO	chemotherapy regimen has component Dacarbazine	NCI
C9899	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C9899	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C154326	STY	Therapeutic or Preventive Procedure		NCI
C154326	PT	Encorafenib/Binimetinib Regimen		NCI
C154326	SY	Binimetinib/Encorafenib		NCI
C154326	SY	Encorafenib/Binimetinib		NCI
C154326	SY	Encorafenib Plus Binimetinib		NCI
C154326	SY	Encorafenib-Binimetinib		NCI
C154326	SY	Binimetinib/Encorafenib Regimen		NCI
C154326	SY	Encorafenib + Binimetinib		NCI
C154326	CHD	Chemotherapy Regimen Used to Treat Melanoma	NCI
C154326	RO	chemotherapy regimen has component Binimetinib	NCI
C154326	RO	chemotherapy regimen has component Encorafenib	NCI
C11099	STY	Therapeutic or Preventive Procedure		NCI
C11099	PT	Busulfan/Dexamethasone/Thiotepa		NCI
C11099	SY	BU/DM/TSPA		NCI
C11099	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11099	RO	chemotherapy regimen has component Busulfan	NCI
C11099	RO	chemotherapy regimen has component Dexamethasone	NCI
C11099	RO	chemotherapy regimen has component Thiotepa	NCI
C10206	STY	Therapeutic or Preventive Procedure		NCI
C10206	PT	Carboplatin/Cyclophosphamide/Sargramostim/Thiotepa		NCI
C10206	SY	CBDCA/CTX/GM-CSF/TSPA		NCI
C10206	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10206	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10206	RO	chemotherapy regimen has component Thiotepa	NCI
C10206	RO	chemotherapy regimen has component Carboplatin	NCI
C10206	RO	chemotherapy regimen has component Sargramostim	NCI
C10333	STY	Therapeutic or Preventive Procedure		NCI
C10333	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Tamoxifen		NCI
C10333	SY	CTX/DOX/5-FU/TMX		NCI
C10333	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10333	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10333	RO	chemotherapy regimen has component Doxorubicin	NCI
C10333	RO	chemotherapy regimen has component Fluorouracil	NCI
C10333	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C63386	STY	Therapeutic or Preventive Procedure		NCI
C63386	PT	Cyclophosphamide-Etoposide-Vincristine Regimen		NCI
C63386	SY	CEV		NCI
C63386	SY	CEV Regimen		NCI
C63386	SY	Cytoxan-Etoposide-Vincristine Regimen		NCI
C63386	CHD	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C63386	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63386	RO	chemotherapy regimen has component Etoposide	NCI
C63386	RO	chemotherapy regimen has component Vincristine	NCI
C63386	RO	regimen has accepted use for disease Lung Small Cell Carcinoma	NCI
C10386	STY	Therapeutic or Preventive Procedure		NCI
C10386	PT	Ethacrynic Acid/Melphalan		NCI
C10386	SY	EA/L-PAM		NCI
C10386	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10386	RO	chemotherapy regimen has component Ethacrynic Acid	NCI
C10386	RO	chemotherapy regimen has component Melphalan	NCI
C11176	STY	Therapeutic or Preventive Procedure		NCI
C11176	PT	Carmustine/Interferon Alfa/Tamoxifen		NCI
C11176	SY	BCNU/IFN-A/TMX		NCI
C11176	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11176	RO	chemotherapy regimen has component Carmustine	NCI
C11176	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11176	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C12130	STY	Therapeutic or Preventive Procedure		NCI
C12130	PT	Montanide ISA-51/PSA prostate cancer vaccine		NCI
C12130	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12130	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C12130	RO	chemotherapy regimen has component PSA Prostate Cancer Vaccine	NCI
C10821	STY	Therapeutic or Preventive Procedure		NCI
C10821	PT	Cytarabine/Topotecan		NCI
C10821	SY	ARA-C/TOPO		NCI
C10821	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10821	RO	chemotherapy regimen has component Cytarabine	NCI
C10821	RO	chemotherapy regimen has component Topotecan	NCI
C9920	STY	Therapeutic or Preventive Procedure		NCI
C9920	PT	Interleukin-2/Interleukin-4		NCI
C9920	SY	IL-2/IL-4		NCI
C9920	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9920	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9920	RO	chemotherapy regimen has component Binetrakin	NCI
C11591	STY	Therapeutic or Preventive Procedure		NCI
C11591	PT	Allovectin-7/Dacarbazine		NCI
C11591	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11591	RO	chemotherapy regimen has component Dacarbazine	NCI
C11591	RO	chemotherapy regimen has component Allovectin-7	NCI
C11776	STY	Therapeutic or Preventive Procedure		NCI
C11776	PT	Cisplatin/Cytarabine/Dexamethasone/Rituximab		NCI
C11776	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11776	RO	chemotherapy regimen has component Cisplatin	NCI
C11776	RO	chemotherapy regimen has component Cytarabine	NCI
C11776	RO	chemotherapy regimen has component Dexamethasone	NCI
C11776	RO	chemotherapy regimen has component Rituximab	NCI
C11101	STY	Therapeutic or Preventive Procedure		NCI
C11101	PT	Dexamethasone/Doxorubicin/Pegaspargase/Vincristine		NCI
C11101	SY	DM/DOX/PEG-ASP/VCR		NCI
C11101	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11101	RO	chemotherapy regimen has component Dexamethasone	NCI
C11101	RO	chemotherapy regimen has component Doxorubicin	NCI
C11101	RO	chemotherapy regimen has component Vincristine	NCI
C11101	RO	chemotherapy regimen has component Pegaspargase	NCI
C10883	STY	Therapeutic or Preventive Procedure		NCI
C10883	PT	Carboplatin/Etoposide/Filgrastim/Ifosfamide/Paclitaxel		NCI
C10883	SY	CBDCA/G-CSF/IFF/TAX/VP-16		NCI
C10883	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10883	RO	chemotherapy regimen has component Etoposide	NCI
C10883	RO	chemotherapy regimen has component Ifosfamide	NCI
C10883	RO	chemotherapy regimen has component Carboplatin	NCI
C10883	RO	chemotherapy regimen has component Paclitaxel	NCI
C10883	RO	chemotherapy regimen has component Filgrastim	NCI
C63384	STY	Therapeutic or Preventive Procedure		NCI
C63384	PT	PET Regimen		NCI
C63384	SY	Platinol-Etoposide-Taxol Regimen		NCI
C63384	CHD	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C63384	RO	chemotherapy regimen has component Cisplatin	NCI
C63384	RO	chemotherapy regimen has component Etoposide	NCI
C63384	RO	chemotherapy regimen has component Paclitaxel	NCI
C63384	RO	regimen has accepted use for disease Lung Small Cell Carcinoma	NCI
C9632	STY	Therapeutic or Preventive Procedure		NCI
C9632	PT	Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Methotrexate/Prednisone/Vincristine		NCI
C9632	SY	ARA-C/BLEO/CTX/DOX/MTX/PRED/VCR/VP-16		NCI
C9632	SY	PROMACE-CytaBOM		NCI
C9632	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9632	RO	chemotherapy regimen has component Bleomycin	NCI
C9632	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9632	RO	chemotherapy regimen has component Cytarabine	NCI
C9632	RO	chemotherapy regimen has component Doxorubicin	NCI
C9632	RO	chemotherapy regimen has component Etoposide	NCI
C9632	RO	chemotherapy regimen has component Methotrexate	NCI
C9632	RO	chemotherapy regimen has component Prednisone	NCI
C9632	RO	chemotherapy regimen has component Vincristine	NCI
C10513	STY	Therapeutic or Preventive Procedure		NCI
C10513	PT	Cisplatin/Filgrastim/Fluorouracil/Hydroxyurea		NCI
C10513	SY	CDDP/5-FU/G-CSF/HU		NCI
C10513	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10513	RO	chemotherapy regimen has component Cisplatin	NCI
C10513	RO	chemotherapy regimen has component Fluorouracil	NCI
C10513	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10513	RO	chemotherapy regimen has component Filgrastim	NCI
C11282	STY	Therapeutic or Preventive Procedure		NCI
C11282	PT	Epoetin Alfa/Fluorouracil/Hydroxyurea/Paclitaxel		NCI
C11282	SY	EPO/5-FU/HU/TAX		NCI
C11282	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11282	RO	chemotherapy regimen has component Fluorouracil	NCI
C11282	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11282	RO	chemotherapy regimen has component Paclitaxel	NCI
C11282	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C156377	STY	Therapeutic or Preventive Procedure		NCI
C156377	PT	Abemaciclib/Letrozole Regimen		NCI
C156377	SY	Letrozole-Abemaciclib		NCI
C156377	SY	Letrozole/Abemaciclib Regimen		NCI
C156377	SY	Abemaciclib-Letrozole		NCI
C156377	SY	Verzenio/Femara		NCI
C156377	SY	Abemaciclib/Letrozole		NCI
C156377	SY	Letrozole/Abemaciclib		NCI
C156377	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156377	RO	chemotherapy regimen has component Letrozole	NCI
C156377	RO	chemotherapy regimen has component Abemaciclib	NCI
C11131	STY	Therapeutic or Preventive Procedure		NCI
C11131	PT	Cyclophosphamide/Etoposide/Mitoxantrone		NCI
C11131	SY	CTX/DHAD/VP-16		NCI
C11131	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11131	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11131	RO	chemotherapy regimen has component Etoposide	NCI
C11131	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C138047	STY	Therapeutic or Preventive Procedure		NCI
C138047	PT	Docetaxel/Carboplatin/Trastuzumab/Pertuzumab Regimen		NCI
C138047	SY	TCH + P		NCI
C138047	SY	TCH Plus Pertuzumab Regimen		NCI
C138047	SY	TCH + Pertuzumab		NCI
C138047	SY	Taxotere-Carboplatin-Herceptin-Perjeta		NCI
C138047	SY	Taxotere-Carboplatin-Herceptin-Pertuzumab		NCI
C138047	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C10410	STY	Therapeutic or Preventive Procedure		NCI
C10410	PT	Cisplatin/Cyclophosphamide/Interleukin-2		NCI
C10410	SY	CDDP/CTX/IL-2		NCI
C10410	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10410	RO	chemotherapy regimen has component Cisplatin	NCI
C10410	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10410	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11566	STY	Therapeutic or Preventive Procedure		NCI
C11566	PT	Cyclophosphamide/Doxorubicin/Monoclonal Antibody HER2		NCI
C11566	SY	CTX/DOX/MOAB HER2		NCI
C11566	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11566	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11566	RO	chemotherapy regimen has component Doxorubicin	NCI
C11566	RO	chemotherapy regimen has component Trastuzumab	NCI
C29471	STY	Therapeutic or Preventive Procedure		NCI
C29471	PT	Aminoglutethimide/Hydrocortisone/Suramin		NCI
C29471	SY	Suramin/AGT/HC		NCI
C29471	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C29471	RO	chemotherapy regimen has component Aminoglutethimide	NCI
C29471	RO	chemotherapy regimen has component Cortisol	NCI
C29471	RO	chemotherapy regimen has component Suramin	NCI
C11124	STY	Therapeutic or Preventive Procedure		NCI
C11124	PT	Asparaginase/Cytarabine/Methotrexate		NCI
C11124	SY	ARA-C/ASP/MTX		NCI
C11124	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11124	RO	chemotherapy regimen has component Asparaginase	NCI
C11124	RO	chemotherapy regimen has component Cytarabine	NCI
C11124	RO	chemotherapy regimen has component Methotrexate	NCI
C11635	STY	Therapeutic or Preventive Procedure		NCI
C11635	PT	Capecitabine/Oxaliplatin		NCI
C11635	SY	XELOX		NCI
C11635	SY	Xeloda/Oxalipaltin		NCI
C11635	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11635	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11635	RO	chemotherapy regimen has component Capecitabine	NCI
C10623	STY	Therapeutic or Preventive Procedure		NCI
C10623	PT	Cyclophosphamide/Interleukin-1-Alpha		NCI
C10623	SY	CTX/IL-1A		NCI
C10623	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10623	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10623	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C136262	STY	Therapeutic or Preventive Procedure		NCI
C136262	PT	Bendamustine/Lenalidomide/Dexamethasone Regimen		NCI
C136262	SY	Bendamustine/Lenalidomide/Dexamethasone		NCI
C136262	SY	Bendamustine-Lenalidomide-Dexamethasone Regimen		NCI
C136262	SY	BRD		NCI
C136262	SY	Treanda/Revlimid/Dexamethasone		NCI
C136262	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136262	RO	chemotherapy regimen has component Dexamethasone	NCI
C136262	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136262	RO	chemotherapy regimen has component Bendamustine Hydrochloride	NCI
C136262	RO	chemotherapy regimen has component Lenalidomide	NCI
C11654	STY	Therapeutic or Preventive Procedure		NCI
C11654	PT	MART-1 antigen/Montanide ISA-51		NCI
C11654	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11654	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11654	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C9516	STY	Therapeutic or Preventive Procedure		NCI
C9516	PT	Amsacrine/Cytarabine/Prednisone/Vincristine		NCI
C9516	SY	AMSA-OAP		NCI
C9516	SY	AMSA/ARA-C/PRED/VCR		NCI
C9516	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9516	RO	chemotherapy regimen has component Amsacrine	NCI
C9516	RO	chemotherapy regimen has component Cytarabine	NCI
C9516	RO	chemotherapy regimen has component Prednisone	NCI
C9516	RO	chemotherapy regimen has component Vincristine	NCI
C12066	STY	Therapeutic or Preventive Procedure		NCI
C12066	PT	Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/MART-1 antigen/Montanide ISA-51/tyrosinase peptide		NCI
C12066	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12066	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C12066	RO	chemotherapy regimen has component gp100 Antigen	NCI
C12066	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C12066	RO	chemotherapy regimen has component Ipilimumab	NCI
C12066	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10525	STY	Therapeutic or Preventive Procedure		NCI
C10525	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Interleukin-3/Leucovorin Calcium/Sargramostim		NCI
C10525	SY	Cyclophosphamide/Doxorubicin/Fluorouracil/Interleukin-3/Leucovorincalcium/Sargramostim		NCI
C10525	SY	CF/CTX/DOX/5-FU/GM-CSF/IL-3		NCI
C10525	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10525	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10525	RO	chemotherapy regimen has component Doxorubicin	NCI
C10525	RO	chemotherapy regimen has component Fluorouracil	NCI
C10525	RO	chemotherapy regimen has component Sargramostim	NCI
C10525	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10525	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C37458	STY	Therapeutic or Preventive Procedure		NCI
C37458	PT	Ad5CMV-p53 Gene/Docetaxel/Doxorubicin		NCI
C37458	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37458	RO	chemotherapy regimen has component Doxorubicin	NCI
C37458	RO	chemotherapy regimen has component Docetaxel	NCI
C37458	RO	chemotherapy regimen has component Ad5CMV-p53 Gene	NCI
C11206	STY	Therapeutic or Preventive Procedure		NCI
C11206	PT	Pegaspargase/Vincristine		NCI
C11206	SY	PEG-ASP/VCR		NCI
C11206	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11206	RO	chemotherapy regimen has component Vincristine	NCI
C11206	RO	chemotherapy regimen has component Pegaspargase	NCI
C154213	STY	Therapeutic or Preventive Procedure		NCI
C154213	PT	CHOP Plus Obinutuzumab Regimen		NCI
C154213	SY	CHOP + Obinutuzumab		NCI
C154213	SY	Obinutuzumab/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine		NCI
C154213	SY	Obinutuzumab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone		NCI
C154213	SY	GCHOP		NCI
C154213	SY	Obinutuzumab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone Regimen		NCI
C154213	SY	Obinutuzumab Plus Cyclophosphamide/Doxorubicin/Vincristine/Prednisone		NCI
C154213	SY	Obinutuzumab-Cyclophosphamide-Doxorubicin-Prednisone-Vincristine		NCI
C154213	SY	G-CHOP		NCI
C154213	SY	CHOP Plus Obinutuzumab		NCI
C154213	SY	CHOP + Obinutuzumab Regimen		NCI
C154213	SY	CHOP-Obinutuzumab Regimen		NCI
C154213	SY	Gazyva Plus CHOP		NCI
C154213	SY	Obinutuzumab-Cyclophosphamide-Doxorubicin-Prednisone-Vincristine Regimen		NCI
C154213	SY	Obinutuzumab/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine Regimen		NCI
C154213	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C154213	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C154213	RO	chemotherapy regimen has component Doxorubicin	NCI
C154213	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C154213	RO	chemotherapy regimen has component Prednisone	NCI
C154213	RO	chemotherapy regimen has component Vincristine	NCI
C154213	RO	chemotherapy regimen has component Obinutuzumab	NCI
C10920	STY	Therapeutic or Preventive Procedure		NCI
C10920	PT	Dexamethasone/Methotrexate/Procarbazine/Vincristine		NCI
C10920	SY	DM/MTX/PCB/VCR		NCI
C10920	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10920	RO	chemotherapy regimen has component Dexamethasone	NCI
C10920	RO	chemotherapy regimen has component Methotrexate	NCI
C10920	RO	chemotherapy regimen has component Vincristine	NCI
C10920	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10097	STY	Therapeutic or Preventive Procedure		NCI
C10097	PT	Carmustine/Cisplatin/Cyclophosphamide/Cytarabine/Hydroxyurea/Methylprednisolone/Procarbazine/Vincristine		NCI
C10097	SY	ARA-C/BCNU/CDDP/CTX/HU/MePRDL/PCB/VCR		NCI
C10097	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10097	RO	chemotherapy regimen has component Carmustine	NCI
C10097	RO	chemotherapy regimen has component Cisplatin	NCI
C10097	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10097	RO	chemotherapy regimen has component Cytarabine	NCI
C10097	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10097	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10097	RO	chemotherapy regimen has component Vincristine	NCI
C10097	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10315	STY	Therapeutic or Preventive Procedure		NCI
C10315	PT	Dactinomycin/Doxorubicin/Vincristine		NCI
C10315	SY	DACT/DOX/VCR		NCI
C10315	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10315	RO	chemotherapy regimen has component Dactinomycin	NCI
C10315	RO	chemotherapy regimen has component Doxorubicin	NCI
C10315	RO	chemotherapy regimen has component Vincristine	NCI
C10727	STY	Therapeutic or Preventive Procedure		NCI
C10727	PT	Floxuridine/Leucovorin Calcium/PALA		NCI
C10727	SY	CF/FUDR/PALA		NCI
C10727	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10727	RO	chemotherapy regimen has component Floxuridine	NCI
C10727	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C10727	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10213	STY	Therapeutic or Preventive Procedure		NCI
C10213	PT	Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate/Vincristine		NCI
C10213	SY	ARA-C/ASP/CTX/MTX/VCR		NCI
C10213	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10213	RO	chemotherapy regimen has component Asparaginase	NCI
C10213	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10213	RO	chemotherapy regimen has component Cytarabine	NCI
C10213	RO	chemotherapy regimen has component Methotrexate	NCI
C10213	RO	chemotherapy regimen has component Vincristine	NCI
C37825	STY	Therapeutic or Preventive Procedure		NCI
C37825	PT	Lonafarnib/Paclitaxel/Trastuzumab		NCI
C37825	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37825	RO	chemotherapy regimen has component Paclitaxel	NCI
C37825	RO	chemotherapy regimen has component Trastuzumab	NCI
C37825	RO	chemotherapy regimen has component Lonafarnib	NCI
C63453	STY	Therapeutic or Preventive Procedure		NCI
C63453	PT	CNOP Regimen		NCI
C63453	SY	Cytoxan-Novantrone-Oncovin-Prednisone Regimen		NCI
C63453	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63453	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63453	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C63453	RO	chemotherapy regimen has component Prednisone	NCI
C63453	RO	chemotherapy regimen has component Vincristine	NCI
C63453	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10080	STY	Therapeutic or Preventive Procedure		NCI
C10080	PT	Cytarabine/Doxorubicin/Mercaptopurine/Prednisone/Vincristine		NCI
C10080	SY	ARA-C/DOX/MP/PRED/VCR		NCI
C10080	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10080	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10080	RO	chemotherapy regimen has component Cytarabine	NCI
C10080	RO	chemotherapy regimen has component Doxorubicin	NCI
C10080	RO	chemotherapy regimen has component Prednisone	NCI
C10080	RO	chemotherapy regimen has component Vincristine	NCI
C11992	STY	Therapeutic or Preventive Procedure		NCI
C11992	PT	Cyclophosphamide/Cytarabine/Dexamethasone/Mercaptopurine/Methotrexate		NCI
C11992	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11992	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11992	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11992	RO	chemotherapy regimen has component Cytarabine	NCI
C11992	RO	chemotherapy regimen has component Dexamethasone	NCI
C11992	RO	chemotherapy regimen has component Methotrexate	NCI
C11771	STY	Therapeutic or Preventive Procedure		NCI
C11771	PT	Asparaginase/cyclophosphamide/cytarabine/daunorubicin/thioguanine		NCI
C11771	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11771	RO	chemotherapy regimen has component Asparaginase	NCI
C11771	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11771	RO	chemotherapy regimen has component Cytarabine	NCI
C11771	RO	chemotherapy regimen has component Thioguanine	NCI
C11771	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37572	STY	Therapeutic or Preventive Procedure		NCI
C37572	PT	Bortezomib/Fludarabine		NCI
C37572	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37572	RO	chemotherapy regimen has component Fludarabine	NCI
C37572	RO	chemotherapy regimen has component Bortezomib	NCI
C10676	STY	Therapeutic or Preventive Procedure		NCI
C10676	PT	Melphalan/Methylprednisolone		NCI
C10676	SY	L-PAM/MePRDL		NCI
C10676	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10676	RO	chemotherapy regimen has component Melphalan	NCI
C10676	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10946	STY	Therapeutic or Preventive Procedure		NCI
C10946	PT	Carmustine/Mitolactol		NCI
C10946	SY	BCNU/DBD		NCI
C10946	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10946	RO	chemotherapy regimen has component Carmustine	NCI
C10946	RO	chemotherapy regimen has component Mitolactol	NCI
C10348	STY	Therapeutic or Preventive Procedure		NCI
C10348	PT	Fluorouracil/Methotrexate/Tamoxifen/Thiotepa		NCI
C10348	SY	5-FU/MTX/TMX/TSPA		NCI
C10348	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10348	RO	chemotherapy regimen has component Fluorouracil	NCI
C10348	RO	chemotherapy regimen has component Methotrexate	NCI
C10348	RO	chemotherapy regimen has component Thiotepa	NCI
C10348	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10823	STY	Therapeutic or Preventive Procedure		NCI
C10823	PT	Cisplatin/Etoposide/Paclitaxel		NCI
C10823	SY	CDDP/TAX/VP-16		NCI
C10823	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10823	RO	chemotherapy regimen has component Cisplatin	NCI
C10823	RO	chemotherapy regimen has component Etoposide	NCI
C10823	RO	chemotherapy regimen has component Paclitaxel	NCI
C11590	STY	Therapeutic or Preventive Procedure		NCI
C11590	PT	ALVAC-hB7.1/Canarypox-hIL-12 Melanoma Vaccine		NCI
C11590	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11590	RO	chemotherapy regimen has component Canarypox-hIL-12 Melanoma Vaccine	NCI
C11590	RO	chemotherapy regimen has component ALVAC-hB7.1	NCI
C63443	STY	Therapeutic or Preventive Procedure		NCI
C63443	PT	Chemotherapy Regimen Used to Treat Chronic Lymphocytic Leukemia		NCI
C63443	CHD	Chemotherapy Regimen	NCI
C63443	PAR	CVP Regimen	NCI
C63443	PAR	FCR Regimen	NCI
C63443	PAR	FC Regimen	NCI
C63443	PAR	FP Regimen	NCI
C63443	PAR	PC Regimen	NCI
C63443	PAR	RF Regimen	NCI
C63443	PAR	Chlorambucil-Prednisone Regimen	NCI
C63443	PAR	Chlorambucil/Rituximab Regimen	NCI
C9673	STY	Therapeutic or Preventive Procedure		NCI
C9673	PT	Bleomycin/Cyclophosphamide/Dexamethasone/Methotrexate/Mitoxantrone/Vincristine		NCI
C9673	SY	BLEO/CTX/DHAD/DM/MTX/VCR		NCI
C9673	SY	M-BNCOD		NCI
C9673	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9673	RO	chemotherapy regimen has component Bleomycin	NCI
C9673	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9673	RO	chemotherapy regimen has component Dexamethasone	NCI
C9673	RO	chemotherapy regimen has component Methotrexate	NCI
C9673	RO	chemotherapy regimen has component Vincristine	NCI
C9673	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9783	STY	Therapeutic or Preventive Procedure		NCI
C9783	PT	Carmustine/Cisplatin/Cyclophosphamide		NCI
C9783	SY	STAMP I		NCI
C9783	SY	BCNU/CDDP/CTX		NCI
C9783	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9783	RO	chemotherapy regimen has component Carmustine	NCI
C9783	RO	chemotherapy regimen has component Cisplatin	NCI
C9783	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C125601	STY	Therapeutic or Preventive Procedure		NCI
C125601	PT	Carboplatin/Etoposide/Melphalan Regimen		NCI
C125601	SY	CEM Regimen		NCI
C125601	SY	CEM		NCI
C125601	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C125601	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C125601	RO	regimen has accepted use for disease Chronic Lymphocytic Leukemia	NCI
C125601	RO	chemotherapy regimen has component Prednisone	NCI
C125601	RO	chemotherapy regimen has component Vincristine	NCI
C125601	RO	regimen has accepted use for disease Indolent Adult Non-Hodgkin Lymphoma	NCI
C10490	STY	Therapeutic or Preventive Procedure		NCI
C10490	PT	Filgrastim/Fluorouracil/Leucovorin Calcium		NCI
C10490	SY	CF/5-FU/G-CSF		NCI
C10490	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10490	RO	chemotherapy regimen has component Fluorouracil	NCI
C10490	RO	chemotherapy regimen has component Filgrastim	NCI
C10490	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9558	STY	Therapeutic or Preventive Procedure		NCI
C9558	PT	Cyclophosphamide/Cytarabine/Prednisone/Vincristine		NCI
C9558	SY	VPCA		NCI
C9558	SY	ARA-C/CTX/PRED/VCR		NCI
C9558	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9558	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9558	RO	chemotherapy regimen has component Cytarabine	NCI
C9558	RO	chemotherapy regimen has component Prednisone	NCI
C9558	RO	chemotherapy regimen has component Vincristine	NCI
C11304	STY	Therapeutic or Preventive Procedure		NCI
C11304	PT	Oltipraz/Vitamin A		NCI
C11304	SY	OPZ/VIT-A		NCI
C11304	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11304	RO	chemotherapy regimen has component Oltipraz	NCI
C11304	RO	chemotherapy regimen has component Vitamin A Compound	NCI
C136264	STY	Therapeutic or Preventive Procedure		NCI
C136264	PT	Carfilzomib/Lenalidomide/Dexamethasone Regimen		NCI
C136264	SY	Kyprolis/Revlimid/Dexamethasone		NCI
C136264	SY	Carfilzomib-Lenalidomide-Dexamethasone		NCI
C136264	SY	Carfilzomib/Lenalidomide/Dexamethasone		NCI
C136264	SY	Carfilzomib-Lenalidomide-Dexamethasone Regimen		NCI
C136264	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136264	RO	chemotherapy regimen has component Dexamethasone	NCI
C136264	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136264	RO	chemotherapy regimen has component Lenalidomide	NCI
C136264	RO	chemotherapy regimen has component Carfilzomib	NCI
C11950	STY	Therapeutic or Preventive Procedure		NCI
C11950	PT	IDEC-In2B8/Rituximab/Yttrium Y 90 Ibritumomab Tiuxetan		NCI
C11950	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11950	RO	chemotherapy regimen has component Rituximab	NCI
C11950	RO	chemotherapy regimen has component Indium In-111 Ibritumomab Tiuxetan	NCI
C11950	RO	chemotherapy regimen has component Yttrium Y-90 Ibritumomab Tiuxetan	NCI
C9677	STY	Therapeutic or Preventive Procedure		NCI
C9677	PT	Cyclophosphamide/Cytarabine/Thioguanine		NCI
C9677	SY	ARA-C/CTX/TG		NCI
C9677	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9677	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9677	RO	chemotherapy regimen has component Cytarabine	NCI
C9677	RO	chemotherapy regimen has component Thioguanine	NCI
C63631	STY	Therapeutic or Preventive Procedure		NCI
C63631	PT	Docetaxel-Carboplatin Regimen		NCI
C63631	SY	Docetaxel/Carboplatin		NCI
C63631	SY	Docetaxel-Carboplatin		NCI
C63631	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63631	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C63631	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C63631	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63631	RO	chemotherapy regimen has component Carboplatin	NCI
C63631	RO	chemotherapy regimen has component Docetaxel	NCI
C63631	RO	regimen has accepted use for disease Ovarian Carcinoma	NCI
C11725	STY	Therapeutic or Preventive Procedure		NCI
C11725	PT	Fluorouracil/Leucovorin Calcium/Triacetyluridine		NCI
C11725	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11725	RO	chemotherapy regimen has component Fluorouracil	NCI
C11725	RO	chemotherapy regimen has component Uridine Triacetate	NCI
C11725	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11358	STY	Therapeutic or Preventive Procedure		NCI
C11358	PT	ALVAC-CEA Vaccine/Sargramostim		NCI
C11358	SY	ALVAC-CEA/GM-CSF		NCI
C11358	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11358	RO	chemotherapy regimen has component Sargramostim	NCI
C11358	RO	chemotherapy regimen has component ALVAC-CEA Vaccine	NCI
C63436	STY	Therapeutic or Preventive Procedure		NCI
C63436	PT	PCH Regimen		NCI
C63436	SY	Paclitaxel-Carboplatin-Herceptin Regimen		NCI
C63436	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63436	RO	chemotherapy regimen has component Carboplatin	NCI
C63436	RO	chemotherapy regimen has component Paclitaxel	NCI
C63436	RO	chemotherapy regimen has component Trastuzumab	NCI
C63436	RO	regimen has accepted use for disease HER2 Positive Breast Carcinoma	NCI
C37469	STY	Therapeutic or Preventive Procedure		NCI
C37469	PT	Cisplatin/Doxorubicin Hydrochloride Liposome/Paclitaxel		NCI
C37469	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37469	RO	chemotherapy regimen has component Cisplatin	NCI
C37469	RO	chemotherapy regimen has component Paclitaxel	NCI
C37469	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C10356	STY	Therapeutic or Preventive Procedure		NCI
C10356	PT	Cisplatin/Fluorouracil/Leucovorin Calcium/Mitomycin		NCI
C10356	SY	CDDP/CF/5-FU/MITO		NCI
C10356	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10356	RO	chemotherapy regimen has component Mitomycin	NCI
C10356	RO	chemotherapy regimen has component Cisplatin	NCI
C10356	RO	chemotherapy regimen has component Fluorouracil	NCI
C10356	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11698	STY	Therapeutic or Preventive Procedure		NCI
C11698	PT	Oxaliplatin/Paclitaxel		NCI
C11698	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11698	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11698	RO	chemotherapy regimen has component Paclitaxel	NCI
C10886	STY	Therapeutic or Preventive Procedure		NCI
C10886	PT	Cyclophosphamide/Mitoxantrone/Prednisolone/Vincristine		NCI
C10886	SY	CTX/DHAD/PRDL/VCR		NCI
C10886	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10886	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10886	RO	chemotherapy regimen has component Prednisolone	NCI
C10886	RO	chemotherapy regimen has component Vincristine	NCI
C10886	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10370	STY	Therapeutic or Preventive Procedure		NCI
C10370	PT	Cisplatin/Dacarbazine/Tamoxifen		NCI
C10370	SY	CDDP/DTIC/TMX		NCI
C10370	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10370	RO	chemotherapy regimen has component Cisplatin	NCI
C10370	RO	chemotherapy regimen has component Dacarbazine	NCI
C10370	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11841	STY	Therapeutic or Preventive Procedure		NCI
C11841	PT	Fluorouracil/IM-862		NCI
C11841	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11841	RO	chemotherapy regimen has component Fluorouracil	NCI
C11841	RO	chemotherapy regimen has component Oglufanide Disodium	NCI
C37497	STY	Therapeutic or Preventive Procedure		NCI
C37497	PT	BCG/NY-ESO-1 Peptide Vaccine		NCI
C37497	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37497	RO	chemotherapy regimen has component BCG Vaccine	NCI
C37497	RO	chemotherapy regimen has component NY-ESO-1 Peptide Vaccine	NCI
C10190	STY	Therapeutic or Preventive Procedure		NCI
C10190	PT	Cyclophosphamide/Lomustine/Melphalan/Prednisolone/Vincristine		NCI
C10190	SY	CCVMP		NCI
C10190	SY	CCNU/CTX/L-PAM/PRDL/VCR		NCI
C10190	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10190	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10190	RO	chemotherapy regimen has component Lomustine	NCI
C10190	RO	chemotherapy regimen has component Melphalan	NCI
C10190	RO	chemotherapy regimen has component Prednisolone	NCI
C10190	RO	chemotherapy regimen has component Vincristine	NCI
C12042	STY	Therapeutic or Preventive Procedure		NCI
C12042	PT	Dexamethasone/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine		NCI
C12042	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12042	RO	chemotherapy regimen has component Mercaptopurine	NCI
C12042	RO	chemotherapy regimen has component Dexamethasone	NCI
C12042	RO	chemotherapy regimen has component Methotrexate	NCI
C12042	RO	chemotherapy regimen has component Vincristine	NCI
C12042	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C10873	STY	Therapeutic or Preventive Procedure		NCI
C10873	PT	Cyclophosphamide/Topotecan/Vincristine		NCI
C10873	SY	CTX/TOPO/VCR		NCI
C10873	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10873	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10873	RO	chemotherapy regimen has component Vincristine	NCI
C10873	RO	chemotherapy regimen has component Topotecan	NCI
C11934	STY	Therapeutic or Preventive Procedure		NCI
C11934	PT	Carboplatin/Irinotecan		NCI
C11934	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11934	RO	chemotherapy regimen has component Carboplatin	NCI
C11934	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C9618	STY	Therapeutic or Preventive Procedure		NCI
C9618	PT	Mechlorethamine/Procarbazine/Vincristine		NCI
C9618	SY	NM/PCB/VCR		NCI
C9618	SY	MOP		NCI
C9618	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9618	RO	chemotherapy regimen has component Vincristine	NCI
C9618	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9618	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C67211	STY	Therapeutic or Preventive Procedure		NCI
C67211	PT	LNH-92 Regimen		NCI
C67211	CHD	Chemotherapy Regimen Used to Treat Childhood Non-Hodgkin's Lymphoma	NCI
C67211	RO	chemotherapy regimen has component Asparaginase	NCI
C67211	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67211	RO	chemotherapy regimen has component Cytarabine	NCI
C67211	RO	chemotherapy regimen has component Daunorubicin	NCI
C67211	RO	chemotherapy regimen has component Dexamethasone	NCI
C67211	RO	chemotherapy regimen has component Methotrexate	NCI
C67211	RO	chemotherapy regimen has component Thioguanine	NCI
C67211	RO	chemotherapy regimen has component Vincristine	NCI
C67211	RO	regimen has accepted use for disease Childhood Anaplastic Large Cell Lymphoma	NCI
C9658	STY	Therapeutic or Preventive Procedure		NCI
C9658	PT	Cyclophosphamide/Doxorubicin/Methotrexate/Prednisolone/Vincristine		NCI
C9658	SY	CTX/DOX/MTX/PRDL/VCR		NCI
C9658	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9658	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9658	RO	chemotherapy regimen has component Doxorubicin	NCI
C9658	RO	chemotherapy regimen has component Methotrexate	NCI
C9658	RO	chemotherapy regimen has component Prednisolone	NCI
C9658	RO	chemotherapy regimen has component Vincristine	NCI
C9637	STY	Therapeutic or Preventive Procedure		NCI
C9637	PT	Bleomycin/Doxorubicin/Lomustine/Streptozocin		NCI
C9637	SY	CABS		NCI
C9637	SY	BLEO/CCNU/DOX/SZC		NCI
C9637	SY	SCAB		NCI
C9637	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9637	RO	chemotherapy regimen has component Bleomycin	NCI
C9637	RO	chemotherapy regimen has component Doxorubicin	NCI
C9637	RO	chemotherapy regimen has component Lomustine	NCI
C9637	RO	chemotherapy regimen has component Streptozocin	NCI
C11212	STY	Therapeutic or Preventive Procedure		NCI
C11212	PT	Dronabinol/Megestrol		NCI
C11212	SY	MEG/THC		NCI
C11212	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11212	RO	chemotherapy regimen has component Megestrol	NCI
C11212	RO	chemotherapy regimen has component Dronabinol	NCI
C11705	STY	Therapeutic or Preventive Procedure		NCI
C11705	PT	gp100 Antigen/Interleukin-2/Montanide ISA-51/Tumor Infiltrating Lymphocytes		NCI
C11705	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11705	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11705	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11705	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C11705	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37726	STY	Therapeutic or Preventive Procedure		NCI
C37726	PT	Daunorubicin/Dexamethasone/Pegaspargase/Vincristine		NCI
C37726	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37726	RO	chemotherapy regimen has component Dexamethasone	NCI
C37726	RO	chemotherapy regimen has component Vincristine	NCI
C37726	RO	chemotherapy regimen has component Pegaspargase	NCI
C37726	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9981	STY	Therapeutic or Preventive Procedure		NCI
C9981	PT	Fluorouracil/Levamisole		NCI
C9981	SY	5FU/Levamisole		NCI
C9981	SY	5-FU/LEV		NCI
C9981	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9981	RO	chemotherapy regimen has component Fluorouracil	NCI
C9981	RO	chemotherapy regimen has component Levamisole Hydrochloride	NCI
C154325	STY	Therapeutic or Preventive Procedure		NCI
C154325	PT	Dabrafenib/Trametinib Regimen		NCI
C154325	SY	Dabrafenib/Trametinib		NCI
C154325	SY	Dabrafenib-Trametinib Regimen		NCI
C154325	SY	Dabrafenib + Trametinib		NCI
C154325	SY	Dabrafenib Plus Trametinib		NCI
C154325	CHD	Chemotherapy Regimen Used to Treat Melanoma	NCI
C154325	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C154325	RO	chemotherapy regimen has component Trametinib	NCI
C154325	RO	chemotherapy regimen has component Dabrafenib	NCI
C11529	STY	Therapeutic or Preventive Procedure		NCI
C11529	PT	Dexamethasone/Methotrexate		NCI
C11529	SY	DM/MTX		NCI
C11529	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11529	RO	chemotherapy regimen has component Dexamethasone	NCI
C11529	RO	chemotherapy regimen has component Methotrexate	NCI
C10020	STY	Therapeutic or Preventive Procedure		NCI
C10020	PT	Fluorouracil/Methotrexate/Mitolactol/Prednisone		NCI
C10020	SY	DBD/5-FU/MTX/PRED		NCI
C10020	SY	DMFP		NCI
C10020	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10020	RO	chemotherapy regimen has component Fluorouracil	NCI
C10020	RO	chemotherapy regimen has component Methotrexate	NCI
C10020	RO	chemotherapy regimen has component Mitolactol	NCI
C10020	RO	chemotherapy regimen has component Prednisone	NCI
C10634	STY	Therapeutic or Preventive Procedure		NCI
C10634	PT	Cyclophosphamide/Doxorubicin/Interleukin-3/Prednisone/Vincristine/Zidovudine		NCI
C10634	SY	CTX/DOX/IL-3/PRED/VCR/ZDV		NCI
C10634	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10634	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10634	RO	chemotherapy regimen has component Doxorubicin	NCI
C10634	RO	chemotherapy regimen has component Prednisone	NCI
C10634	RO	chemotherapy regimen has component Vincristine	NCI
C10634	RO	chemotherapy regimen has component Zidovudine	NCI
C10634	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C11167	STY	Therapeutic or Preventive Procedure		NCI
C11167	PT	Cytarabine/Hydroxyurea/Interferon Alfa		NCI
C11167	SY	ARA-C/HU/IFN-A		NCI
C11167	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11167	RO	chemotherapy regimen has component Cytarabine	NCI
C11167	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11167	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11286	STY	Therapeutic or Preventive Procedure		NCI
C11286	PT	Amifostine/Cisplatin/Paclitaxel		NCI
C11286	SY	CDDP/TAX/WR-2721		NCI
C11286	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11286	RO	chemotherapy regimen has component Cisplatin	NCI
C11286	RO	chemotherapy regimen has component Amifostine	NCI
C11286	RO	chemotherapy regimen has component Paclitaxel	NCI
C11675	STY	Therapeutic or Preventive Procedure		NCI
C11675	PT	Montanide ISA-51/Tyrosinase-Related Protein-1		NCI
C11675	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11675	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11675	RO	chemotherapy regimen has component Recombinant Tyrosinase-Related Protein-1	NCI
C9622	STY	Therapeutic or Preventive Procedure		NCI
C9622	PT	Mechlorethamine/Prednisone/Procarbazine/Vinblastine/Vincristine		NCI
C9622	SY	NM/PCB/PRED/VBL/VCR		NCI
C9622	SY	MVVPP		NCI
C9622	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9622	RO	chemotherapy regimen has component Prednisone	NCI
C9622	RO	chemotherapy regimen has component Vinblastine	NCI
C9622	RO	chemotherapy regimen has component Vincristine	NCI
C9622	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9622	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C10949	STY	Therapeutic or Preventive Procedure		NCI
C10949	PT	Carboplatin/Cyclophosphamide/Filgrastim/Paclitaxel		NCI
C10949	SY	CBDCA/CTX/G-CSF/TAX		NCI
C10949	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10949	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10949	RO	chemotherapy regimen has component Carboplatin	NCI
C10949	RO	chemotherapy regimen has component Paclitaxel	NCI
C10949	RO	chemotherapy regimen has component Filgrastim	NCI
C11991	STY	Therapeutic or Preventive Procedure		NCI
C11991	PT	Cyclophosphamide/cytarabine/mercaptopurine/methotrexate/prednisolone		NCI
C11991	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11991	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11991	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11991	RO	chemotherapy regimen has component Cytarabine	NCI
C11991	RO	chemotherapy regimen has component Methotrexate	NCI
C11991	RO	chemotherapy regimen has component Prednisolone	NCI
C154215	STY	Therapeutic or Preventive Procedure		NCI
C154215	PT	R-CDOP Regimen		NCI
C154215	SY	Rituximab-Cyclophosphamide-Liposomal Doxorubicin-Vincristine-Prednisone Regimen		NCI
C154215	SY	Rituximab-Cyclophosphamide-Liposomal Doxorubicin-Vincristine-Prednisone		NCI
C154215	SY	RCDOP		NCI
C154215	SY	Rituximab-Cyclophosphamide-Doxil-Oncovin-Prednisone Regimen		NCI
C154215	SY	Rituximab/Cyclophosphamide/Liposomal Doxorubicin/Vincristine/Prednisone		NCI
C154215	SY	R-CDOP		NCI
C154215	SY	Rituximab/Cyclophosphamide/Liposomal Doxorubicin/Vincristine/Prednisone Regimen		NCI
C154215	SY	Rituximab/Cyclophosphamide/Doxil/Oncovin/Prednisone Regimen		NCI
C154215	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C154215	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C154215	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C154215	RO	chemotherapy regimen has component Prednisone	NCI
C154215	RO	chemotherapy regimen has component Vincristine	NCI
C154215	RO	chemotherapy regimen has component Rituximab	NCI
C154215	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C9680	STY	Therapeutic or Preventive Procedure		NCI
C9680	PT	Cisplatin/Etoposide/Methotrexate		NCI
C9680	SY	CDDP/MTX/VP-16		NCI
C9680	SY	MEP		NCI
C9680	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9680	RO	chemotherapy regimen has component Cisplatin	NCI
C9680	RO	chemotherapy regimen has component Etoposide	NCI
C9680	RO	chemotherapy regimen has component Methotrexate	NCI
C63607	STY	Therapeutic or Preventive Procedure		NCI
C63607	PT	IFL-Bevacizumab Regimen		NCI
C63607	SY	Irinotecan-Fluorouracil-Leucovorin-Bevacizumab Regimen		NCI
C63607	SY	IFL-Avastin Regimen		NCI
C63607	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63607	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63607	RO	chemotherapy regimen has component Fluorouracil	NCI
C63607	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C63607	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63607	RO	chemotherapy regimen has component Bevacizumab	NCI
C37528	STY	Therapeutic or Preventive Procedure		NCI
C37528	PT	Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody/Sargramostim		NCI
C37528	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37528	RO	chemotherapy regimen has component Sargramostim	NCI
C37528	RO	chemotherapy regimen has component Ipilimumab	NCI
C11669	STY	Therapeutic or Preventive Procedure		NCI
C11669	PT	Montanide ISA-51/Tyrosinase peptide		NCI
C11669	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11669	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11669	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11276	STY	Therapeutic or Preventive Procedure		NCI
C11276	PT	Interferon Alfa/Ritonavir/Stavudine		NCI
C11276	SY	d4T/IFN-A/RIT		NCI
C11276	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11276	RO	chemotherapy regimen has component Stavudine	NCI
C11276	RO	chemotherapy regimen has component Ritonavir	NCI
C11276	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37639	STY	Therapeutic or Preventive Procedure		NCI
C37639	PT	Cetuximab/Cisplatin		NCI
C37639	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37639	RO	chemotherapy regimen has component Cisplatin	NCI
C37639	RO	chemotherapy regimen has component Cetuximab	NCI
C10351	STY	Therapeutic or Preventive Procedure		NCI
C10351	PT	Cyclophosphamide/Interleukin-2/Lymphokine-Activated Killer Cells		NCI
C10351	SY	CTX/IL-2/LAK		NCI
C10351	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10351	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10351	RO	chemotherapy regimen has component Lymphokine-Activated Killer Cells	NCI
C10351	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10777	STY	Therapeutic or Preventive Procedure		NCI
C10777	PT	Filgrastim/Paclitaxel/Topotecan		NCI
C10777	SY	G-CSF/TAX/TOPO		NCI
C10777	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10777	RO	chemotherapy regimen has component Paclitaxel	NCI
C10777	RO	chemotherapy regimen has component Topotecan	NCI
C10777	RO	chemotherapy regimen has component Filgrastim	NCI
C37507	STY	Therapeutic or Preventive Procedure		NCI
C37507	PT	NY-ESO-1 Protein Vaccine Plus Montanide ISA-51 VG		NCI
C37507	SY	NY-ESO-1 Protein Vaccine Emulsified In Montanide ISA-51 VG		NCI
C37507	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37507	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C37507	RO	chemotherapy regimen has component NY-ESO-1 Peptide Vaccine	NCI
C37507	RO	concept in subset CTRP Terminology	NCI
C37507	RO	concept in subset CTRP Agent Terminology	NCI
C9588	STY	Therapeutic or Preventive Procedure		NCI
C9588	PT	Cyclophosphamide/Doxorubicin/Etoposide/Vincristine		NCI
C9588	SY	CAPO		NCI
C9588	SY	CAVE		NCI
C9588	SY	EVAC		NCI
C9588	SY	VCAV		NCI
C9588	SY	CTX/DOX/VCR/VP-16		NCI
C9588	SY	VOCA		NCI
C9588	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9588	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9588	RO	chemotherapy regimen has component Doxorubicin	NCI
C9588	RO	chemotherapy regimen has component Etoposide	NCI
C9588	RO	chemotherapy regimen has component Vincristine	NCI
C63455	STY	Therapeutic or Preventive Procedure		NCI
C63455	PT	HyperCVAD Regimen		NCI
C63455	SY	Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone Regimen		NCI
C63455	SY	HyperCVAD		NCI
C63455	SY	Hyper-CVAD Regimen		NCI
C63455	CHD	Chemotherapy Regimen Used to Treat Acute Lymphoblastic Leukemia	NCI
C63455	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63455	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63455	RO	chemotherapy regimen has component Dexamethasone	NCI
C63455	RO	chemotherapy regimen has component Doxorubicin	NCI
C63455	RO	chemotherapy regimen has component Vincristine	NCI
C63455	RO	regimen has accepted use for disease Adult Burkitt Lymphoma	NCI
C63455	RO	regimen has accepted use for disease Adult Burkitt Leukemia	NCI
C10888	STY	Therapeutic or Preventive Procedure		NCI
C10888	PT	Cisplatin/Filgrastim/Topotecan		NCI
C10888	SY	CDDP/G-CSF/TOPO		NCI
C10888	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10888	RO	chemotherapy regimen has component Cisplatin	NCI
C10888	RO	chemotherapy regimen has component Topotecan	NCI
C10888	RO	chemotherapy regimen has component Filgrastim	NCI
C140111	STY	Therapeutic or Preventive Procedure		NCI
C140111	PT	R-BAC Regimen		NCI
C140111	SY	R-BAC		NCI
C140111	SY	Rituximab/Bendamustine/Ara-C		NCI
C140111	SY	Rituximab-Bendamustine-Cytarabine		NCI
C140111	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140111	RO	chemotherapy regimen has component Cytarabine	NCI
C140111	RO	chemotherapy regimen has component Rituximab	NCI
C140111	RO	chemotherapy regimen has component Bendamustine	NCI
C10257	STY	Therapeutic or Preventive Procedure		NCI
C10257	PT	Mercaptopurine/Prednisone/Vincristine		NCI
C10257	SY	MP/PRED/VCR		NCI
C10257	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10257	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10257	RO	chemotherapy regimen has component Prednisone	NCI
C10257	RO	chemotherapy regimen has component Vincristine	NCI
C10207	STY	Therapeutic or Preventive Procedure		NCI
C10207	PT	Asparaginase/Cytarabine/Methotrexate/Vincristine		NCI
C10207	SY	ARA-C/ASP/MTX/VCR		NCI
C10207	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10207	RO	chemotherapy regimen has component Asparaginase	NCI
C10207	RO	chemotherapy regimen has component Cytarabine	NCI
C10207	RO	chemotherapy regimen has component Methotrexate	NCI
C10207	RO	chemotherapy regimen has component Vincristine	NCI
C37665	STY	Therapeutic or Preventive Procedure		NCI
C37665	PT	Cisplatin/Imatinib Mesylate/Irinotecan		NCI
C37665	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37665	RO	chemotherapy regimen has component Cisplatin	NCI
C37665	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37665	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C67170	STY	Therapeutic or Preventive Procedure		NCI
C67170	PT	OEPA-COPP Regimen		NCI
C67170	SY	OEPA-COPP		NCI
C67170	SY	Oncovin-Etoposide-Prednisone-Adriamycin/Cyclophosphamide-Oncovin-Prednisone-Procarbazine Regimen		NCI
C67170	SY	GPOH-HD 95 Regimen		NCI
C67170	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67170	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67170	RO	chemotherapy regimen has component Doxorubicin	NCI
C67170	RO	chemotherapy regimen has component Etoposide	NCI
C67170	RO	chemotherapy regimen has component Prednisone	NCI
C67170	RO	chemotherapy regimen has component Vincristine	NCI
C67170	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C67170	RO	regimen has accepted use for disease Childhood Hodgkin Lymphoma	NCI
C37526	STY	Therapeutic or Preventive Procedure		NCI
C37526	PT	Anastrozole/Gefitinib		NCI
C37526	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37526	RO	chemotherapy regimen has component Anastrozole	NCI
C37526	RO	chemotherapy regimen has component Gefitinib	NCI
C10258	STY	Therapeutic or Preventive Procedure		NCI
C10258	PT	Fludarabine/Prednisone		NCI
C10258	SY	FAMP/PRED		NCI
C10258	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10258	RO	chemotherapy regimen has component Prednisone	NCI
C10258	RO	chemotherapy regimen has component Fludarabine	NCI
C11513	STY	Therapeutic or Preventive Procedure		NCI
C11513	PT	Carboplatin/Temozolomide		NCI
C11513	SY	CBDCA/TMZ		NCI
C11513	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11513	RO	chemotherapy regimen has component Temozolomide	NCI
C11513	RO	chemotherapy regimen has component Carboplatin	NCI
C9850	STY	Therapeutic or Preventive Procedure		NCI
C9850	PT	Buserelin/Cyproterone		NCI
C9850	SY	BSRL/CPTR		NCI
C9850	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9850	RO	chemotherapy regimen has component Buserelin	NCI
C9850	RO	chemotherapy regimen has component Cyproterone	NCI
C12110	STY	Therapeutic or Preventive Procedure		NCI
C12110	PT	Cytarabine/Gemtuzumab Ozogamicin/Mitoxantrone		NCI
C12110	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12110	RO	chemotherapy regimen has component Cytarabine	NCI
C12110	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C12110	RO	chemotherapy regimen has component Gemtuzumab Ozogamicin	NCI
C12105	STY	Therapeutic or Preventive Procedure		NCI
C12105	PT	Bevacizumab/Paclitaxel		NCI
C12105	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12105	RO	chemotherapy regimen has component Paclitaxel	NCI
C12105	RO	chemotherapy regimen has component Bevacizumab	NCI
C10855	STY	Therapeutic or Preventive Procedure		NCI
C10855	PT	Paclitaxel/PSC 833		NCI
C10855	SY	PSC 833/TAX		NCI
C10855	SY	PSC/Paclitaxel		NCI
C10855	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10855	RO	chemotherapy regimen has component Paclitaxel	NCI
C10855	RO	chemotherapy regimen has component Valspodar	NCI
C10208	STY	Therapeutic or Preventive Procedure		NCI
C10208	PT	Thiotepa/Vinblastine		NCI
C10208	SY	TSPA/VBL		NCI
C10208	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10208	RO	chemotherapy regimen has component Thiotepa	NCI
C10208	RO	chemotherapy regimen has component Vinblastine	NCI
C63620	STY	Therapeutic or Preventive Procedure		NCI
C63620	PT	LMB-86 Regimen		NCI
C63620	SY	LMB-89 Group C		NCI
C63620	CHD	Chemotherapy Regimen Used to Treat Acute Lymphoblastic Leukemia	NCI
C63620	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63620	RO	chemotherapy regimen has component Cytarabine	NCI
C63620	RO	chemotherapy regimen has component Doxorubicin	NCI
C63620	RO	chemotherapy regimen has component Etoposide	NCI
C63620	RO	chemotherapy regimen has component Methotrexate	NCI
C63620	RO	chemotherapy regimen has component Prednisone	NCI
C63620	RO	chemotherapy regimen has component Vincristine	NCI
C63620	RO	regimen has accepted use for disease Adult Burkitt Lymphoma	NCI
C63620	RO	regimen has accepted use for disease Adult Burkitt Leukemia	NCI
C67202	STY	Therapeutic or Preventive Procedure		NCI
C67202	PT	Ifosfamide-Vinorelbine Regimen		NCI
C67202	SY	Ifosfamide-Vinorelbine		NCI
C67202	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C67202	RO	chemotherapy regimen has component Ifosfamide	NCI
C67202	RO	chemotherapy regimen has component Vinorelbine	NCI
C12186	STY	Therapeutic or Preventive Procedure		NCI
C12186	PT	Irinotecan/Thalidomide		NCI
C12186	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12186	RO	chemotherapy regimen has component Thalidomide	NCI
C12186	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11159	STY	Therapeutic or Preventive Procedure		NCI
C11159	PT	Cimetidine/Tumor Infiltrating Lymphocytes		NCI
C11159	SY	cimetidine/TIL		NCI
C11159	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11159	RO	chemotherapy regimen has component Cimetidine	NCI
C11159	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C11984	STY	Therapeutic or Preventive Procedure		NCI
C11984	PT	Bevacizumab/Docetaxel/Estramustine		NCI
C11984	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11984	RO	chemotherapy regimen has component Estramustine	NCI
C11984	RO	chemotherapy regimen has component Docetaxel	NCI
C11984	RO	chemotherapy regimen has component Bevacizumab	NCI
C9996	STY	Therapeutic or Preventive Procedure		NCI
C9996	PT	Daunorubicin/Etoposide/Prednisone/Teniposide/Thioguanine/Vincristine		NCI
C9996	SY	DNR/PRED/TG/VCR/VM-26/VP-16		NCI
C9996	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9996	RO	chemotherapy regimen has component Etoposide	NCI
C9996	RO	chemotherapy regimen has component Prednisone	NCI
C9996	RO	chemotherapy regimen has component Teniposide	NCI
C9996	RO	chemotherapy regimen has component Thioguanine	NCI
C9996	RO	chemotherapy regimen has component Vincristine	NCI
C9996	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10367	STY	Therapeutic or Preventive Procedure		NCI
C10367	PT	Interleukin-2/Lymphokine-Activated Killer Cells/Monoclonal Antibody R24		NCI
C10367	SY	IL-2/LAK/MOAB R24		NCI
C10367	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10367	RO	chemotherapy regimen has component Lymphokine-Activated Killer Cells	NCI
C10367	RO	chemotherapy regimen has component Monoclonal Antibody R24	NCI
C10367	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9641	STY	Therapeutic or Preventive Procedure		NCI
C9641	PT	Bleomycin/Chlorambucil/Cisplatin/Cyclophosphamide/Dactinomycin/Vinblastine		NCI
C9641	SY	BLEO/CDDP/CLB/CTX/DACT/VBL		NCI
C9641	SY	VAB-III		NCI
C9641	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9641	RO	chemotherapy regimen has component Bleomycin	NCI
C9641	RO	chemotherapy regimen has component Chlorambucil	NCI
C9641	RO	chemotherapy regimen has component Cisplatin	NCI
C9641	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9641	RO	chemotherapy regimen has component Dactinomycin	NCI
C9641	RO	chemotherapy regimen has component Vinblastine	NCI
C37658	STY	Therapeutic or Preventive Procedure		NCI
C37658	PT	Cisplatin/Fluorouracil/Paclitaxel/Pegfilgrastim		NCI
C37658	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37658	RO	chemotherapy regimen has component Cisplatin	NCI
C37658	RO	chemotherapy regimen has component Fluorouracil	NCI
C37658	RO	chemotherapy regimen has component Paclitaxel	NCI
C37658	RO	chemotherapy regimen has component Pegfilgrastim	NCI
C11688	STY	Therapeutic or Preventive Procedure		NCI
C11688	PT	E7(86-93) Lipopeptide/HPV-16 E7(12-20) Peptide Vaccine/Montanide ISA-51		NCI
C11688	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11688	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11688	RO	chemotherapy regimen has component HPV 16 E7:86-93 Peptide Vaccine	NCI
C11688	RO	chemotherapy regimen has component HPV 16 E7:12-20 Peptide Vaccine	NCI
C11602	STY	Therapeutic or Preventive Procedure		NCI
C11602	STY	Organic Chemical		NCI
C11602	PT	XELIRI Regimen		NCI
C11602	SY	CapIri		NCI
C11602	SY	Capecitabine/Irinotecan Regimen		NCI
C11602	SY	Xeloda/Camptosar Regimen		NCI
C11602	SY	XelIri		NCI
C11602	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C11602	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11602	RO	chemotherapy regimen has component Capecitabine	NCI
C63525	STY	Therapeutic or Preventive Procedure		NCI
C63525	PT	CVD Regimen		NCI
C63525	SY	Cisplatin-Vinblastine-DTIC Regimen		NCI
C63525	SY	Cisplatin-Vinblastine-Dacarbazine Regimen		NCI
C63525	CHD	Chemotherapy Regimen Used to Treat Melanoma	NCI
C63525	RO	chemotherapy regimen has component Cisplatin	NCI
C63525	RO	chemotherapy regimen has component Dacarbazine	NCI
C63525	RO	regimen has accepted use for disease Melanoma	NCI
C63525	RO	chemotherapy regimen has component Vinblastine	NCI
C11226	STY	Therapeutic or Preventive Procedure		NCI
C11226	PT	Cyclophosphamide/Indomethacin/Zinc Sulfate		NCI
C11226	SY	CTX/indomethacin/zinc sulfate		NCI
C11226	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11226	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11226	RO	chemotherapy regimen has component Indomethacin	NCI
C11226	RO	chemotherapy regimen has component Zinc Sulfate	NCI
C11749	STY	Therapeutic or Preventive Procedure		NCI
C11749	PT	Cytarabine/Fludarabine/Oblimersen		NCI
C11749	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11749	RO	chemotherapy regimen has component Cytarabine	NCI
C11749	RO	chemotherapy regimen has component Fludarabine	NCI
C11749	RO	chemotherapy regimen has component Oblimersen	NCI
C63618	STY	Therapeutic or Preventive Procedure		NCI
C63618	PT	Linker Regimen		NCI
C63618	CHD	Chemotherapy Regimen Used to Treat Acute Lymphoblastic Leukemia	NCI
C63618	RO	chemotherapy regimen has component Asparaginase	NCI
C63618	RO	chemotherapy regimen has component Cytarabine	NCI
C63618	RO	chemotherapy regimen has component Daunorubicin	NCI
C63618	RO	chemotherapy regimen has component Methotrexate	NCI
C63618	RO	chemotherapy regimen has component Prednisone	NCI
C63618	RO	chemotherapy regimen has component Teniposide	NCI
C63618	RO	chemotherapy regimen has component Vincristine	NCI
C63618	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63618	RO	regimen has accepted use for disease Adult Acute Lymphoblastic Leukemia	NCI
C156378	STY	Therapeutic or Preventive Procedure		NCI
C156378	PT	Abemaciclib/Exemestane Regimen		NCI
C156378	SY	Exemestane/Abemaciclib Regimen		NCI
C156378	SY	Exemestane-Abemaciclib		NCI
C156378	SY	Exemestane/Abemaciclib		NCI
C156378	SY	Abemaciclib/Exemestane		NCI
C156378	SY	Abemaciclib-Exemestane		NCI
C156378	SY	Aromasin/Verzenio		NCI
C156378	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156378	RO	chemotherapy regimen has component Exemestane	NCI
C156378	RO	chemotherapy regimen has component Abemaciclib	NCI
C9836	STY	Therapeutic or Preventive Procedure		NCI
C9836	PT	Asparaginase/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine		NCI
C9836	SY	ASP/CTX/DOX/PRED/VCR		NCI
C9836	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9836	RO	chemotherapy regimen has component Asparaginase	NCI
C9836	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9836	RO	chemotherapy regimen has component Doxorubicin	NCI
C9836	RO	chemotherapy regimen has component Prednisone	NCI
C9836	RO	chemotherapy regimen has component Vincristine	NCI
C67484	STY	Therapeutic or Preventive Procedure		NCI
C67484	PT	AIE Regimen		NCI
C67484	SY	Cytarabine-Idarubicin-Etoposide Regimen		NCI
C67484	SY	MRC AML10 Study-AIE Regimen		NCI
C67484	SY	AraC-Idarubicin-Etoposide Regimen		NCI
C67484	CHD	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia	NCI
C67484	RO	chemotherapy regimen has component Cytarabine	NCI
C67484	RO	chemotherapy regimen has component Etoposide	NCI
C67484	RO	chemotherapy regimen has component Idarubicin	NCI
C67484	RO	regimen has accepted use for disease Childhood Acute Myeloid Leukemia	NCI
C10430	STY	Therapeutic or Preventive Procedure		NCI
C10430	PT	Cisplatin/Dihydro-5-Azacytidine		NCI
C10430	SY	CDDP/DHAC		NCI
C10430	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10430	RO	chemotherapy regimen has component Cisplatin	NCI
C10430	RO	chemotherapy regimen has component Dihydro-5-Azacytidine	NCI
C37685	STY	Therapeutic or Preventive Procedure		NCI
C37685	PT	Cyclophosphamide/Doxorubicin/Prednisolone/Rituximab/Vincristine		NCI
C37685	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37685	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37685	RO	chemotherapy regimen has component Doxorubicin	NCI
C37685	RO	chemotherapy regimen has component Prednisolone	NCI
C37685	RO	chemotherapy regimen has component Vincristine	NCI
C37685	RO	chemotherapy regimen has component Rituximab	NCI
C12182	STY	Therapeutic or Preventive Procedure		NCI
C12182	PT	Cyclophosphamide/Pentostatin/Rituximab		NCI
C12182	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12182	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12182	RO	chemotherapy regimen has component Pentostatin	NCI
C12182	RO	chemotherapy regimen has component Rituximab	NCI
C37729	STY	Therapeutic or Preventive Procedure		NCI
C37729	PT	Dexamethasone/Doxorubicin/Thalidomide/Vincristine		NCI
C37729	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37729	RO	chemotherapy regimen has component Dexamethasone	NCI
C37729	RO	chemotherapy regimen has component Doxorubicin	NCI
C37729	RO	chemotherapy regimen has component Thalidomide	NCI
C37729	RO	chemotherapy regimen has component Vincristine	NCI
C9578	STY	Therapeutic or Preventive Procedure		NCI
C9578	PT	Cytarabine/Daunorubicin/Prednisone/Thioguanine/Vincristine		NCI
C9578	SY	ARA-C/DNR/PRED/TG/VCR		NCI
C9578	SY	DATVP		NCI
C9578	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9578	RO	chemotherapy regimen has component Cytarabine	NCI
C9578	RO	chemotherapy regimen has component Prednisone	NCI
C9578	RO	chemotherapy regimen has component Thioguanine	NCI
C9578	RO	chemotherapy regimen has component Vincristine	NCI
C9578	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10232	STY	Therapeutic or Preventive Procedure		NCI
C10232	PT	Fluorouracil/Interleukin-1-Beta		NCI
C10232	SY	5-FU/IL-1B		NCI
C10232	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10232	RO	chemotherapy regimen has component Fluorouracil	NCI
C10232	RO	chemotherapy regimen has component Recombinant Interleukin-1-beta	NCI
C10255	STY	Therapeutic or Preventive Procedure		NCI
C10255	PT	Fluorouracil/Semustine		NCI
C10255	SY	5-FU/MeCCNU		NCI
C10255	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10255	RO	chemotherapy regimen has component Fluorouracil	NCI
C10255	RO	chemotherapy regimen has component Semustine	NCI
C12145	STY	Therapeutic or Preventive Procedure		NCI
C12145	PT	Asparaginase/Leucovorin Calcium/Methotrexate		NCI
C12145	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12145	RO	chemotherapy regimen has component Asparaginase	NCI
C12145	RO	chemotherapy regimen has component Methotrexate	NCI
C12145	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11656	STY	Therapeutic or Preventive Procedure		NCI
C11656	PT	Montanide ISA-51/Peptide 946-tetanus peptide conjugate melanoma vaccine		NCI
C11656	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11656	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11656	RO	chemotherapy regimen has component Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine	NCI
C10800	STY	Therapeutic or Preventive Procedure		NCI
C10800	PT	Doxorubicin/Etoposide/Mitotane/Vincristine		NCI
C10800	SY	MAVE		NCI
C10800	SY	DDD/DOX/VCR/VP-16		NCI
C10800	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10800	RO	chemotherapy regimen has component Doxorubicin	NCI
C10800	RO	chemotherapy regimen has component Etoposide	NCI
C10800	RO	chemotherapy regimen has component Mitotane	NCI
C10800	RO	chemotherapy regimen has component Vincristine	NCI
C10872	STY	Therapeutic or Preventive Procedure		NCI
C10872	PT	Carboplatin/Etoposide/Filgrastim/Ifosfamide/Interleukin-6		NCI
C10872	SY	CBDCA/G-CSF/IFF/IL-6/VP-16		NCI
C10872	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10872	RO	chemotherapy regimen has component Etoposide	NCI
C10872	RO	chemotherapy regimen has component Ifosfamide	NCI
C10872	RO	chemotherapy regimen has component Carboplatin	NCI
C10872	RO	chemotherapy regimen has component Filgrastim	NCI
C10872	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C64789	STY	Therapeutic or Preventive Procedure		NCI
C64789	PT	POMB/ACE Regimen		NCI
C64789	SY	Platinol-Oncovin-Methotrexate-Bleomycin/Actinomycin-Cytoxan-Etoposide Regimen		NCI
C64789	CHD	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm	NCI
C64789	RO	chemotherapy regimen has component Bleomycin	NCI
C64789	RO	chemotherapy regimen has component Cisplatin	NCI
C64789	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C64789	RO	chemotherapy regimen has component Dactinomycin	NCI
C64789	RO	chemotherapy regimen has component Etoposide	NCI
C64789	RO	chemotherapy regimen has component Methotrexate	NCI
C64789	RO	chemotherapy regimen has component Vincristine	NCI
C64789	RO	regimen has accepted use for disease Malignant Testicular Germ Cell Tumor	NCI
C11440	STY	Therapeutic or Preventive Procedure		NCI
C11440	PT	Carmustine/Gemcitabine/Melphalan		NCI
C11440	SY	BCNU/dFdC/L-PAM		NCI
C11440	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11440	RO	chemotherapy regimen has component Carmustine	NCI
C11440	RO	chemotherapy regimen has component Melphalan	NCI
C11440	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10456	STY	Therapeutic or Preventive Procedure		NCI
C10456	PT	Cisplatin/Doxorubicin/Filgrastim/Methotrexate/Vinblastine		NCI
C10456	SY	CDDP/DOX/G-CSF/MTX/VBL		NCI
C10456	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10456	RO	chemotherapy regimen has component Cisplatin	NCI
C10456	RO	chemotherapy regimen has component Doxorubicin	NCI
C10456	RO	chemotherapy regimen has component Methotrexate	NCI
C10456	RO	chemotherapy regimen has component Vinblastine	NCI
C10456	RO	chemotherapy regimen has component Filgrastim	NCI
C10481	STY	Therapeutic or Preventive Procedure		NCI
C10481	PT	Interleukin-2/PEG-Interleukin-2		NCI
C10481	SY	IL-2/PEG-IL-2		NCI
C10481	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10481	RO	chemotherapy regimen has component PEG-interleukin-2	NCI
C10481	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9840	STY	Therapeutic or Preventive Procedure		NCI
C9840	PT	Aminoglutethimide/Megestrol		NCI
C9840	SY	AGT/MEG		NCI
C9840	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9840	RO	chemotherapy regimen has component Aminoglutethimide	NCI
C9840	RO	chemotherapy regimen has component Megestrol	NCI
C9722	STY	Therapeutic or Preventive Procedure		NCI
C9722	PT	Amsacrine/Cytarabine/Etoposide		NCI
C9722	SY	AMSA/ARA-C/VP-16		NCI
C9722	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9722	RO	chemotherapy regimen has component Amsacrine	NCI
C9722	RO	chemotherapy regimen has component Cytarabine	NCI
C9722	RO	chemotherapy regimen has component Etoposide	NCI
C9876	STY	Therapeutic or Preventive Procedure		NCI
C9876	PT	Cytarabine/Mercaptopurine/Methotrexate		NCI
C9876	SY	ARA-C/MP/MTX		NCI
C9876	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9876	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9876	RO	chemotherapy regimen has component Cytarabine	NCI
C9876	RO	chemotherapy regimen has component Methotrexate	NCI
C11043	STY	Therapeutic or Preventive Procedure		NCI
C11043	PT	Carboplatin/Etoposide/Interferon Alfa/Mitoxantrone		NCI
C11043	SY	CBDCA/DHAD/IFN-A/VP-16		NCI
C11043	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11043	RO	chemotherapy regimen has component Etoposide	NCI
C11043	RO	chemotherapy regimen has component Carboplatin	NCI
C11043	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11043	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11928	STY	Therapeutic or Preventive Procedure		NCI
C11928	PT	Selenium/vitamin E		NCI
C11928	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11928	RO	chemotherapy regimen has component Selenium	NCI
C11928	RO	chemotherapy regimen has component Vitamin E Compound	NCI
C10817	STY	Therapeutic or Preventive Procedure		NCI
C10817	PT	Floxuridine/Hydroxyurea/Leucovorin Calcium		NCI
C10817	SY	CF/FUDR/HU		NCI
C10817	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10817	RO	chemotherapy regimen has component Floxuridine	NCI
C10817	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10817	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10508	STY	Therapeutic or Preventive Procedure		NCI
C10508	PT	Carboplatin/Dacarbazine/Tamoxifen		NCI
C10508	SY	CBDCA/DTIC/TMX		NCI
C10508	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10508	RO	chemotherapy regimen has component Dacarbazine	NCI
C10508	RO	chemotherapy regimen has component Carboplatin	NCI
C10508	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C9720	STY	Therapeutic or Preventive Procedure		NCI
C9720	PT	Cisplatin/Cytarabine/Etoposide/Methylprednisolone		NCI
C9720	SY	ARA-C/CDDP/MePRDL/VP-16		NCI
C9720	SY	E-SHAP		NCI
C9720	SY	ESHAP		NCI
C9720	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9720	RO	chemotherapy regimen has component Cisplatin	NCI
C9720	RO	chemotherapy regimen has component Cytarabine	NCI
C9720	RO	chemotherapy regimen has component Etoposide	NCI
C9720	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11574	STY	Therapeutic or Preventive Procedure		NCI
C11574	PT	Monoclonal Antibody HER2/Paclitaxel		NCI
C11574	SY	MOAB HER2/TAX		NCI
C11574	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11574	RO	chemotherapy regimen has component Paclitaxel	NCI
C11574	RO	chemotherapy regimen has component Trastuzumab	NCI
C9663	STY	Therapeutic or Preventive Procedure		NCI
C9663	PT	Etoposide/Methotrexate/Vincristine		NCI
C9663	SY	MTX/VCR/VP-16		NCI
C9663	SY	VMV		NCI
C9663	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9663	RO	chemotherapy regimen has component Etoposide	NCI
C9663	RO	chemotherapy regimen has component Methotrexate	NCI
C9663	RO	chemotherapy regimen has component Vincristine	NCI
C11655	STY	Therapeutic or Preventive Procedure		NCI
C11655	PT	Montanide ISA-51/Peptide 946 melanoma vaccine		NCI
C11655	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11655	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11655	RO	chemotherapy regimen has component Peptide 946 Melanoma Vaccine	NCI
C150707	STY	Therapeutic or Preventive Procedure		NCI
C150707	PT	Cisplatin/Docetaxel/Cetuximab Regimen		NCI
C150707	SY	Cisplatin/Docetaxel/Cetuximab		NCI
C150707	SY	Taxotere/Platinol/Erbitux		NCI
C150707	SY	Cisplatin-Docetaxel-Cetuximab Regimen		NCI
C150707	SY	TPE		NCI
C150707	SY	TPEx		NCI
C150707	SY	Cisplatin-Docetaxel-Cetuximab		NCI
C150707	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C150707	RO	chemotherapy regimen has component Cisplatin	NCI
C150707	RO	chemotherapy regimen has component Docetaxel	NCI
C150707	RO	chemotherapy regimen has component Cetuximab	NCI
C150707	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C11062	STY	Therapeutic or Preventive Procedure		NCI
C11062	PT	Cisplatin/Dacarbazine/Interferon Alfa/Tamoxifen		NCI
C11062	SY	CDDP/DTIC/IFN-A/TMX		NCI
C11062	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11062	RO	chemotherapy regimen has component Cisplatin	NCI
C11062	RO	chemotherapy regimen has component Dacarbazine	NCI
C11062	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11062	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10814	STY	Therapeutic or Preventive Procedure		NCI
C10814	PT	Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate		NCI
C10814	SY	CTX/DM/DOX/MTX		NCI
C10814	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10814	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10814	RO	chemotherapy regimen has component Dexamethasone	NCI
C10814	RO	chemotherapy regimen has component Doxorubicin	NCI
C10814	RO	chemotherapy regimen has component Methotrexate	NCI
C138039	STY	Therapeutic or Preventive Procedure		NCI
C138039	PT	FEC Followed by Pertuzumab/Trastuzumab/Paclitaxel Regimen		NCI
C138039	SY	Fluorouracil/Epirubicin/Cyclophosphamide Followed by Pertuzumab/Trastuzumab/Paclitaxel		NCI
C138039	SY	Fluorouracil/Epirubicin/Cyclophosphamide Followed by Pertuzumab + Trastuzumab + Paclitaxel		NCI
C138039	SY	FEC Followed by Pertuzumab + Trastuzumab + Paclitaxel		NCI
C138039	SY	FEC Followed by Paclitaxel/Trastuzumab/Pertuzumab		NCI
C138039	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138039	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138039	RO	chemotherapy regimen has component Fluorouracil	NCI
C138039	RO	chemotherapy regimen has component Paclitaxel	NCI
C138039	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C138039	RO	chemotherapy regimen has component Trastuzumab	NCI
C10649	STY	Therapeutic or Preventive Procedure		NCI
C10649	PT	Cyclosporine/Etoposide/Mitoxantrone		NCI
C10649	SY	CYSP/DHAD/VP-16		NCI
C10649	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10649	RO	chemotherapy regimen has component Cyclosporine	NCI
C10649	RO	chemotherapy regimen has component Etoposide	NCI
C10649	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11413	STY	Therapeutic or Preventive Procedure		NCI
C11413	PT	Carboplatin/Doxorubicin HCl Liposome/Paclitaxel		NCI
C11413	SY	CBDCA/LipoDox/TAX		NCI
C11413	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11413	RO	chemotherapy regimen has component Carboplatin	NCI
C11413	RO	chemotherapy regimen has component Paclitaxel	NCI
C11413	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C10249	STY	Therapeutic or Preventive Procedure		NCI
C10249	PT	Fluorouracil/Methotrexate/PALA		NCI
C10249	SY	5-FU/MTX/PALA		NCI
C10249	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10249	RO	chemotherapy regimen has component Fluorouracil	NCI
C10249	RO	chemotherapy regimen has component Methotrexate	NCI
C10249	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C10381	STY	Therapeutic or Preventive Procedure		NCI
C10381	PT	Mechlorethamine/Vincristine		NCI
C10381	SY	NM/VCR		NCI
C10381	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10381	RO	chemotherapy regimen has component Vincristine	NCI
C10381	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C10436	STY	Therapeutic or Preventive Procedure		NCI
C10436	PT	Amifostine/Carboplatin/Cisplatin		NCI
C10436	SY	CBDCA/CDDP/WR-2721		NCI
C10436	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10436	RO	chemotherapy regimen has component Cisplatin	NCI
C10436	RO	chemotherapy regimen has component Amifostine	NCI
C10436	RO	chemotherapy regimen has component Carboplatin	NCI
C11118	STY	Therapeutic or Preventive Procedure		NCI
C11118	PT	Carboplatin/RMP-7		NCI
C11118	SY	CBDCA/RMP-7		NCI
C11118	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11118	RO	chemotherapy regimen has component Carboplatin	NCI
C11118	RO	chemotherapy regimen has component Labradimil	NCI
C10627	STY	Therapeutic or Preventive Procedure		NCI
C10627	PT	Interleukin-2/Interleukin-4/Tumor Infiltrating Lymphocytes		NCI
C10627	SY	IL-2/IL-4/TIL		NCI
C10627	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10627	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C10627	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10627	RO	chemotherapy regimen has component Binetrakin	NCI
C37717	STY	Therapeutic or Preventive Procedure		NCI
C37717	PT	Cytarabine/Irinotecan		NCI
C37717	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37717	RO	chemotherapy regimen has component Cytarabine	NCI
C37717	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C10455	STY	Therapeutic or Preventive Procedure		NCI
C10455	PT	Bleomycin/Cisplatin/Etoposide/Ifosfamide		NCI
C10455	SY	BLEO/CDDP/IFF/VP-16		NCI
C10455	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10455	RO	chemotherapy regimen has component Bleomycin	NCI
C10455	RO	chemotherapy regimen has component Cisplatin	NCI
C10455	RO	chemotherapy regimen has component Etoposide	NCI
C10455	RO	chemotherapy regimen has component Ifosfamide	NCI
C10802	STY	Therapeutic or Preventive Procedure		NCI
C10802	PT	Carmustine/Dacarbazine/Thymidine		NCI
C10802	SY	BCNU/DTIC/TDR		NCI
C10802	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10802	RO	chemotherapy regimen has component Carmustine	NCI
C10802	RO	chemotherapy regimen has component Dacarbazine	NCI
C10802	RO	chemotherapy regimen has component Thymidine	NCI
C11020	STY	Therapeutic or Preventive Procedure		NCI
C11020	PT	Cisplatin/Etoposide/Interferon Alfa		NCI
C11020	SY	CDDP/IFN-A/VP-16		NCI
C11020	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11020	RO	chemotherapy regimen has component Cisplatin	NCI
C11020	RO	chemotherapy regimen has component Etoposide	NCI
C11020	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10196	STY	Therapeutic or Preventive Procedure		NCI
C10196	PT	Cyclophosphamide/Doxorubicin/Etoposide/Interleukin-2		NCI
C10196	SY	LACE		NCI
C10196	SY	CTX/DOX/IL-2/VP-16		NCI
C10196	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10196	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10196	RO	chemotherapy regimen has component Doxorubicin	NCI
C10196	RO	chemotherapy regimen has component Etoposide	NCI
C10196	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11564	STY	Therapeutic or Preventive Procedure		NCI
C11564	PT	Detox-B Adjuvant/Keyhole Limpet Hemocyanin/Sialyl Tn Antigen		NCI
C11564	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11564	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C11564	RO	chemotherapy regimen has component Sialyl Tn Antigen	NCI
C11564	RO	chemotherapy regimen has component Detox-B Adjuvant	NCI
C67197	STY	Therapeutic or Preventive Procedure		NCI
C67197	PT	NHL-BFM-90 Regimen		NCI
C67197	SY	BFM-90 Regimen		NCI
C67197	CHD	Chemotherapy Regimen Used to Treat Childhood Non-Hodgkin's Lymphoma	NCI
C67197	RO	chemotherapy regimen has component Mercaptopurine	NCI
C67197	RO	chemotherapy regimen has component Asparaginase	NCI
C67197	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67197	RO	chemotherapy regimen has component Cytarabine	NCI
C67197	RO	chemotherapy regimen has component Daunorubicin	NCI
C67197	RO	chemotherapy regimen has component Dexamethasone	NCI
C67197	RO	chemotherapy regimen has component Doxorubicin	NCI
C67197	RO	chemotherapy regimen has component Methotrexate	NCI
C67197	RO	chemotherapy regimen has component Prednisone	NCI
C67197	RO	chemotherapy regimen has component Thioguanine	NCI
C67197	RO	chemotherapy regimen has component Vincristine	NCI
C67197	RO	regimen has accepted use for disease Childhood Burkitt Lymphoma	NCI
C67197	RO	regimen has accepted use for disease Childhood Lymphoblastic Lymphoma	NCI
C67197	RO	regimen has accepted use for disease Childhood Anaplastic Large Cell Lymphoma	NCI
C67197	RO	regimen has accepted use for disease Childhood Diffuse Large B-Cell Lymphoma	NCI
C11489	STY	Therapeutic or Preventive Procedure		NCI
C11489	PT	Asparaginase/Dexamethasone/Mercaptopurine/Vincristine		NCI
C11489	SY	ASP/DM/MP/VCR		NCI
C11489	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11489	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11489	RO	chemotherapy regimen has component Asparaginase	NCI
C11489	RO	chemotherapy regimen has component Dexamethasone	NCI
C11489	RO	chemotherapy regimen has component Vincristine	NCI
C10826	STY	Therapeutic or Preventive Procedure		NCI
C10826	PT	Doxorubicin/Methotrexate		NCI
C10826	SY	DOX/MTX		NCI
C10826	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10826	RO	chemotherapy regimen has component Doxorubicin	NCI
C10826	RO	chemotherapy regimen has component Methotrexate	NCI
C10439	STY	Therapeutic or Preventive Procedure		NCI
C10439	PT	Cisplatin/Cytarabine/Dexamethasone/Etoposide/Sargramostim		NCI
C10439	SY	ARA-C/CDDP/DM/GM-CSF/VP-16		NCI
C10439	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10439	RO	chemotherapy regimen has component Cisplatin	NCI
C10439	RO	chemotherapy regimen has component Cytarabine	NCI
C10439	RO	chemotherapy regimen has component Dexamethasone	NCI
C10439	RO	chemotherapy regimen has component Etoposide	NCI
C10439	RO	chemotherapy regimen has component Sargramostim	NCI
C10242	STY	Therapeutic or Preventive Procedure		NCI
C10242	PT	Etoposide/Mitomycin		NCI
C10242	SY	MITO/VP-16		NCI
C10242	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10242	RO	chemotherapy regimen has component Mitomycin	NCI
C10242	RO	chemotherapy regimen has component Etoposide	NCI
C11948	STY	Therapeutic or Preventive Procedure		NCI
C11948	PT	Autologous Tumor Cell Vaccine/Interleukin-2		NCI
C11948	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11948	RO	chemotherapy regimen has component Autologous Tumor Cell Vaccine	NCI
C11948	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11340	STY	Therapeutic or Preventive Procedure		NCI
C11340	PT	Carboplatin/Etoposide/Fluorouracil		NCI
C11340	SY	CBDCA/5-FU/VP-16		NCI
C11340	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11340	RO	chemotherapy regimen has component Etoposide	NCI
C11340	RO	chemotherapy regimen has component Fluorouracil	NCI
C11340	RO	chemotherapy regimen has component Carboplatin	NCI
C10506	STY	Therapeutic or Preventive Procedure		NCI
C10506	PT	Carboplatin/Cytarabine/Dexamethasone/Sargramostim		NCI
C10506	SY	ARA-C/CBDCA/DM/GM-CSF		NCI
C10506	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10506	RO	chemotherapy regimen has component Cytarabine	NCI
C10506	RO	chemotherapy regimen has component Dexamethasone	NCI
C10506	RO	chemotherapy regimen has component Carboplatin	NCI
C10506	RO	chemotherapy regimen has component Sargramostim	NCI
C63502	STY	Therapeutic or Preventive Procedure		NCI
C63502	PT	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma		NCI
C63502	SY	Chemotherapy Regimen Used to Treat Pancreatic Cancer		NCI
C63502	CHD	Chemotherapy Regimen	NCI
C63502	PAR	Folfirinox Regimen	NCI
C63502	PAR	Gemcitabine-Oxaliplatin Regimen	NCI
C63502	PAR	FAM Regimen	NCI
C63502	PAR	GEM-CAP Regimen	NCI
C63502	PAR	GTX Regimen	NCI
C63502	PAR	Gemcitabine-Cisplatin Regimen	NCI
C63502	PAR	Gemcitabine-Erlotinib Regimen	NCI
C63502	PAR	Gemcitabine-Irinotecan Regimen	NCI
C63502	PAR	OFF Regimen	NCI
C63502	PAR	GNP Regimen	NCI
C10306	STY	Therapeutic or Preventive Procedure		NCI
C10306	PT	Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Prednisone/Teniposide		NCI
C10306	SY	ARA-C/ASP/MP/MTX/PRED/VM-26		NCI
C10306	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10306	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10306	RO	chemotherapy regimen has component Asparaginase	NCI
C10306	RO	chemotherapy regimen has component Cytarabine	NCI
C10306	RO	chemotherapy regimen has component Methotrexate	NCI
C10306	RO	chemotherapy regimen has component Prednisone	NCI
C10306	RO	chemotherapy regimen has component Teniposide	NCI
C11957	STY	Therapeutic or Preventive Procedure		NCI
C11957	PT	Docetaxel/Filgrastim/XR9576		NCI
C11957	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11957	RO	chemotherapy regimen has component Filgrastim	NCI
C11957	RO	chemotherapy regimen has component Docetaxel	NCI
C11957	RO	chemotherapy regimen has component Tariquidar	NCI
C9959	STY	Therapeutic or Preventive Procedure		NCI
C9959	PT	Bleomycin/Mechlorethamine/Prednisone/Procarbazine/Vincristine		NCI
C9959	SY	BLEO-MOPP		NCI
C9959	SY	BLEO/NM/PCB/PRED/VCR		NCI
C9959	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9959	RO	chemotherapy regimen has component Bleomycin	NCI
C9959	RO	chemotherapy regimen has component Prednisone	NCI
C9959	RO	chemotherapy regimen has component Vincristine	NCI
C9959	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9959	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C10039	STY	Therapeutic or Preventive Procedure		NCI
C10039	PT	Amifostine/Cisplatin/Monoclonal Antibody R24		NCI
C10039	SY	CDDP/MOAB R24/WR-2721		NCI
C10039	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10039	RO	chemotherapy regimen has component Cisplatin	NCI
C10039	RO	chemotherapy regimen has component Amifostine	NCI
C10039	RO	chemotherapy regimen has component Monoclonal Antibody R24	NCI
C37588	STY	Therapeutic or Preventive Procedure		NCI
C37588	PT	Capecitabine/Celecoxib/Irinotecan		NCI
C37588	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37588	RO	chemotherapy regimen has component Celecoxib	NCI
C37588	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37588	RO	chemotherapy regimen has component Capecitabine	NCI
C10761	STY	Therapeutic or Preventive Procedure		NCI
C10761	PT	Doxorubicin/Hydroxyurea		NCI
C10761	SY	DOX/HU		NCI
C10761	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10761	RO	chemotherapy regimen has component Doxorubicin	NCI
C10761	RO	chemotherapy regimen has component Hydroxyurea	NCI
C63727	STY	Therapeutic or Preventive Procedure		NCI
C63727	PT	PFL Regimen		NCI
C63727	SY	Platinol-Fluorouracil-Leucovorin Regimen		NCI
C63727	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C63727	RO	chemotherapy regimen has component Cisplatin	NCI
C63727	RO	chemotherapy regimen has component Fluorouracil	NCI
C63727	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63727	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C9901	STY	Therapeutic or Preventive Procedure		NCI
C9901	PT	Medroxyprogesterone/Tamoxifen		NCI
C9901	SY	MPA/TMX		NCI
C9901	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9901	RO	chemotherapy regimen has component Medroxyprogesterone	NCI
C9901	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10354	STY	Therapeutic or Preventive Procedure		NCI
C10354	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Goserelin		NCI
C10354	SY	CTX/DOX/5-FU/ZDX		NCI
C10354	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10354	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10354	RO	chemotherapy regimen has component Doxorubicin	NCI
C10354	RO	chemotherapy regimen has component Fluorouracil	NCI
C10354	RO	chemotherapy regimen has component Goserelin	NCI
C10467	STY	Therapeutic or Preventive Procedure		NCI
C10467	PT	Asparaginase/Cytarabine/Methotrexate/Prednisone/Vincristine		NCI
C10467	SY	ARA-C/ASP/MTX/PRED/VCR		NCI
C10467	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10467	RO	chemotherapy regimen has component Asparaginase	NCI
C10467	RO	chemotherapy regimen has component Cytarabine	NCI
C10467	RO	chemotherapy regimen has component Methotrexate	NCI
C10467	RO	chemotherapy regimen has component Prednisone	NCI
C10467	RO	chemotherapy regimen has component Vincristine	NCI
C10140	STY	Therapeutic or Preventive Procedure		NCI
C10140	PT	Cytarabine/Daunorubicin/Etoposide/Thioguanine		NCI
C10140	SY	V-TAD		NCI
C10140	SY	ARA-C/DNR/TG/VP-16		NCI
C10140	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10140	RO	chemotherapy regimen has component Cytarabine	NCI
C10140	RO	chemotherapy regimen has component Etoposide	NCI
C10140	RO	chemotherapy regimen has component Thioguanine	NCI
C10140	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C12080	STY	Therapeutic or Preventive Procedure		NCI
C12080	PT	Conjugated Estrogens/Medroxyprogesterone		NCI
C12080	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12080	RO	chemotherapy regimen has component Estrogens, Conjugated	NCI
C12080	RO	chemotherapy regimen has component Medroxyprogesterone	NCI
C11163	STY	Therapeutic or Preventive Procedure		NCI
C11163	PT	Cytarabine/Etoposide/Methotrexate/Pegaspargase/Prednisone/Thioguanine/Vincristine		NCI
C11163	SY	ARA-C/MTX/PEG-ASP/PRED/TG/VCR/VP-16		NCI
C11163	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11163	RO	chemotherapy regimen has component Cytarabine	NCI
C11163	RO	chemotherapy regimen has component Etoposide	NCI
C11163	RO	chemotherapy regimen has component Methotrexate	NCI
C11163	RO	chemotherapy regimen has component Prednisone	NCI
C11163	RO	chemotherapy regimen has component Thioguanine	NCI
C11163	RO	chemotherapy regimen has component Vincristine	NCI
C11163	RO	chemotherapy regimen has component Pegaspargase	NCI
C11496	STY	Therapeutic or Preventive Procedure		NCI
C11496	PT	Asparaginase/Mercaptopurine/Methotrexate/Vincristine		NCI
C11496	SY	ASP/MP/MTX/VCR		NCI
C11496	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11496	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11496	RO	chemotherapy regimen has component Asparaginase	NCI
C11496	RO	chemotherapy regimen has component Methotrexate	NCI
C11496	RO	chemotherapy regimen has component Vincristine	NCI
C10706	STY	Therapeutic or Preventive Procedure		NCI
C10706	PT	Carboplatin/Cisplatin/Cyclophosphamide/Etoposide		NCI
C10706	SY	CBDCA/CDDP/CTX/VP-16		NCI
C10706	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10706	RO	chemotherapy regimen has component Cisplatin	NCI
C10706	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10706	RO	chemotherapy regimen has component Etoposide	NCI
C10706	RO	chemotherapy regimen has component Carboplatin	NCI
C10279	STY	Therapeutic or Preventive Procedure		NCI
C10279	PT	Doxorubicin/Fluorouracil/Mitomycin/Vincristine		NCI
C10279	SY	VFAM		NCI
C10279	SY	DOX/5-FU/MITO/VCR		NCI
C10279	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10279	RO	chemotherapy regimen has component Mitomycin	NCI
C10279	RO	chemotherapy regimen has component Doxorubicin	NCI
C10279	RO	chemotherapy regimen has component Fluorouracil	NCI
C10279	RO	chemotherapy regimen has component Vincristine	NCI
C10487	STY	Therapeutic or Preventive Procedure		NCI
C10487	PT	Cyclophosphamide/Doxorubicin/Filgrastim/Prednisone/Vincristine		NCI
C10487	SY	CTX/DOX/G-CSF/PRED/VCR		NCI
C10487	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10487	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10487	RO	chemotherapy regimen has component Doxorubicin	NCI
C10487	RO	chemotherapy regimen has component Prednisone	NCI
C10487	RO	chemotherapy regimen has component Vincristine	NCI
C10487	RO	chemotherapy regimen has component Filgrastim	NCI
C15593	STY	Therapeutic or Preventive Procedure		NCI
C15593	PT	gp100 Antigen/Interleukin-2		NCI
C15593	SY	gp100/IL-2		NCI
C15593	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15593	RO	chemotherapy regimen has component gp100 Antigen	NCI
C15593	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C138054	STY	Therapeutic or Preventive Procedure		NCI
C138054	PT	TC Regimen		NCI
C138054	SY	Taxotere/Cytoxan		NCI
C138054	SY	Docetaxel/Cyclophosphamide Regimen		NCI
C138054	SY	Docetaxel/Cyclophosphamide		NCI
C138054	SY	Docetaxel-Cyclophosphamide		NCI
C138054	SY	Docetaxel + Cyclophosphamide		NCI
C138054	SY	TC		NCI
C138054	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138054	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138054	RO	chemotherapy regimen has component Docetaxel	NCI
C37675	STY	Therapeutic or Preventive Procedure		NCI
C37675	PT	Cyclophosphamide/Cytarabine/Dexamethasone/Etoposide Phosphate/Methotrexate		NCI
C37675	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37675	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37675	RO	chemotherapy regimen has component Cytarabine	NCI
C37675	RO	chemotherapy regimen has component Dexamethasone	NCI
C37675	RO	chemotherapy regimen has component Methotrexate	NCI
C37675	RO	chemotherapy regimen has component Etoposide Phosphate	NCI
C10325	STY	Therapeutic or Preventive Procedure		NCI
C10325	PT	Cisplatin/Vincristine		NCI
C10325	SY	CDDP/VCR		NCI
C10325	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10325	RO	chemotherapy regimen has component Cisplatin	NCI
C10325	RO	chemotherapy regimen has component Vincristine	NCI
C9894	STY	Therapeutic or Preventive Procedure		NCI
C9894	PT	Cytarabine/Etoposide/Ifosfamide		NCI
C9894	SY	ARA-C/IFF/VP-16		NCI
C9894	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9894	RO	chemotherapy regimen has component Cytarabine	NCI
C9894	RO	chemotherapy regimen has component Etoposide	NCI
C9894	RO	chemotherapy regimen has component Ifosfamide	NCI
C37827	STY	Therapeutic or Preventive Procedure		NCI
C37827	PT	Melanoma Helper Peptide Vaccine/Montanide ISA-51/Multi-Epitope Melanoma Peptide Vaccine/Sargramostim		NCI
C37827	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37827	RO	chemotherapy regimen has component Sargramostim	NCI
C37827	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C37827	RO	chemotherapy regimen has component Multi-epitope Melanoma Peptide Vaccine	NCI
C37827	RO	chemotherapy regimen has component Melanoma Helper Peptide Vaccine	NCI
C37533	STY	Therapeutic or Preventive Procedure		NCI
C37533	PT	Arsenic Trioxide/Imatinib Mesylate		NCI
C37533	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37533	RO	chemotherapy regimen has component Arsenic Trioxide	NCI
C37533	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C11427	STY	Therapeutic or Preventive Procedure		NCI
C11427	PT	Cyclophosphamide/Daunorubicin/Prednisone/Vincristine		NCI
C11427	SY	CTX/DNR/PRED/VCR		NCI
C11427	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11427	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11427	RO	chemotherapy regimen has component Prednisone	NCI
C11427	RO	chemotherapy regimen has component Vincristine	NCI
C11427	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37776	STY	Therapeutic or Preventive Procedure		NCI
C37776	PT	Flavopiridol/Fluorouracil/Irinotecan/Leucovorin Calcium		NCI
C37776	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37776	RO	chemotherapy regimen has component Fluorouracil	NCI
C37776	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37776	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37776	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C11158	STY	Therapeutic or Preventive Procedure		NCI
C11158	PT	Carboplatin/Filgrastim		NCI
C11158	SY	CBDCA/G-CSF		NCI
C11158	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11158	RO	chemotherapy regimen has component Carboplatin	NCI
C11158	RO	chemotherapy regimen has component Filgrastim	NCI
C9794	STY	Therapeutic or Preventive Procedure		NCI
C9794	PT	Cisplatin/Mitolactol		NCI
C9794	SY	CDDP/DBD		NCI
C9794	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9794	RO	chemotherapy regimen has component Cisplatin	NCI
C9794	RO	chemotherapy regimen has component Mitolactol	NCI
C11052	STY	Therapeutic or Preventive Procedure		NCI
C11052	PT	Bleomycin/Cisplatin/Ifosfamide/Interferon Alfa		NCI
C11052	SY	BLEO/CDDP/IFF/IFN-A		NCI
C11052	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11052	RO	chemotherapy regimen has component Bleomycin	NCI
C11052	RO	chemotherapy regimen has component Cisplatin	NCI
C11052	RO	chemotherapy regimen has component Ifosfamide	NCI
C11052	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C129579	STY	Therapeutic or Preventive Procedure		NCI
C129579	PT	Carboplatin-Etoposide-Vincristine Regimen		NCI
C129579	SY	CEV		NCI
C129579	SY	Carboplatin/Etoposide/Vincristine Regimen		NCI
C129579	SY	CEV Regimen		NCI
C129579	CHD	Chemotherapy Regimen Used to Treat Retinoblastoma	NCI
C129579	RO	chemotherapy regimen has component Etoposide	NCI
C129579	RO	chemotherapy regimen has component Vincristine	NCI
C129579	RO	chemotherapy regimen has component Carboplatin	NCI
C10387	STY	Therapeutic or Preventive Procedure		NCI
C10387	PT	Cyclophosphamide/Diethylstilbestrol/Fluorouracil		NCI
C10387	SY	CTX/DES/5-FU		NCI
C10387	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10387	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10387	RO	chemotherapy regimen has component Diethylstilbestrol	NCI
C10387	RO	chemotherapy regimen has component Fluorouracil	NCI
C9923	STY	Therapeutic or Preventive Procedure		NCI
C9923	PT	Asparaginase/Cyclophosphamide/Prednisone/Vincristine		NCI
C9923	SY	ASP/CTX/PRED/VCR		NCI
C9923	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9923	RO	chemotherapy regimen has component Asparaginase	NCI
C9923	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9923	RO	chemotherapy regimen has component Prednisone	NCI
C9923	RO	chemotherapy regimen has component Vincristine	NCI
C11597	STY	Therapeutic or Preventive Procedure		NCI
C11597	PT	Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Tyrosinase Peptide		NCI
C11597	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11597	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11597	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11597	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C11597	RO	chemotherapy regimen has component Flu Matrix Peptide p58-66	NCI
C11597	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11518	STY	Therapeutic or Preventive Procedure		NCI
C11518	PT	Interferon Alfa/Toremifene		NCI
C11518	SY	IFN-A/TOR		NCI
C11518	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11518	RO	chemotherapy regimen has component Toremifene	NCI
C11518	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10151	STY	Therapeutic or Preventive Procedure		NCI
C10151	PT	Doxorubicin/Melphalan/Teniposide		NCI
C10151	SY	MAV		NCI
C10151	SY	DOX/L-PAM/VM-26		NCI
C10151	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10151	RO	chemotherapy regimen has component Doxorubicin	NCI
C10151	RO	chemotherapy regimen has component Melphalan	NCI
C10151	RO	chemotherapy regimen has component Teniposide	NCI
C10629	STY	Therapeutic or Preventive Procedure		NCI
C10629	PT	Edatrexate/Ifosfamide		NCI
C10629	SY	EDAM/IFF		NCI
C10629	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10629	RO	chemotherapy regimen has component Ifosfamide	NCI
C10629	RO	chemotherapy regimen has component Edatrexate	NCI
C10655	STY	Therapeutic or Preventive Procedure		NCI
C10655	PT	Cyclophosphamide/Paclitaxel		NCI
C10655	SY	CTX/TAX		NCI
C10655	SY	Paclitaxel/Cyclophosphamide		NCI
C10655	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10655	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10655	RO	chemotherapy regimen has component Paclitaxel	NCI
C134622	STY	Therapeutic or Preventive Procedure		NCI
C134622	PT	Cisplatin-Methotrexate Regimen		NCI
C134622	SY	Cisplatin/Methotrexate Regimen		NCI
C134622	CHD	Chemotherapy Regimen Used to Treat Bladder Carcinoma	NCI
C134622	RO	chemotherapy regimen has component Cisplatin	NCI
C134622	RO	chemotherapy regimen has component Methotrexate	NCI
C37672	STY	Pharmacologic Substance		NCI
C37672	PT	Coenzyme Q10/Vitamin E		NCI
C37672	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37672	RO	chemotherapy regimen has component Vitamin E Compound	NCI
C37672	RO	chemotherapy regimen has component Coenzyme Q10	NCI
C15560	STY	Therapeutic or Preventive Procedure		NCI
C15560	PT	Interleukin-3/Thiotepa		NCI
C15560	SY	IL-3/TSPA		NCI
C15560	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15560	RO	chemotherapy regimen has component Thiotepa	NCI
C15560	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C9561	STY	Therapeutic or Preventive Procedure		NCI
C9561	PT	Cyclophosphamide/Fluorouracil/Methotrexate/Vincristine		NCI
C9561	SY	COMF		NCI
C9561	SY	CTX/5-FU/MTX/VCR		NCI
C9561	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9561	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9561	RO	chemotherapy regimen has component Fluorouracil	NCI
C9561	RO	chemotherapy regimen has component Methotrexate	NCI
C9561	RO	chemotherapy regimen has component Vincristine	NCI
C9614	STY	Therapeutic or Preventive Procedure		NCI
C9614	PT	Fluorouracil/Leucovorin Calcium/Methotrexate		NCI
C9614	SY	MLF		NCI
C9614	SY	CF/5-FU/MTX		NCI
C9614	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9614	RO	chemotherapy regimen has component Fluorouracil	NCI
C9614	RO	chemotherapy regimen has component Methotrexate	NCI
C9614	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63376	STY	Therapeutic or Preventive Procedure		NCI
C63376	PT	chlVPP Regimen		NCI
C63376	SY	Chlorambucil-Vinblastine-Procarbazine-Prednisone Regimen		NCI
C63376	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63376	RO	chemotherapy regimen has component Chlorambucil	NCI
C63376	RO	chemotherapy regimen has component Prednisone	NCI
C63376	RO	chemotherapy regimen has component Vinblastine	NCI
C63376	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C63376	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C11220	STY	Therapeutic or Preventive Procedure		NCI
C11220	PT	Cisplatin/Doxorubicin/Ifosfamide/Mitomycin/Sargramostim		NCI
C11220	SY	CDDP/DOX/GM-CSF/IFF/MITO		NCI
C11220	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11220	RO	chemotherapy regimen has component Mitomycin	NCI
C11220	RO	chemotherapy regimen has component Cisplatin	NCI
C11220	RO	chemotherapy regimen has component Doxorubicin	NCI
C11220	RO	chemotherapy regimen has component Ifosfamide	NCI
C11220	RO	chemotherapy regimen has component Sargramostim	NCI
C11447	STY	Therapeutic or Preventive Procedure		NCI
C11447	PT	Incomplete Freund's Adjuvant/Von Hippel-Lindau Peptide Vaccine		NCI
C11447	SY	IFA/VHL peptide		NCI
C11447	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11447	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11447	RO	chemotherapy regimen has component Von Hippel-Lindau Peptide Vaccine	NCI
C9577	STY	Therapeutic or Preventive Procedure		NCI
C9577	PT	Cytarabine/Daunorubicin/Thioguanine		NCI
C9577	SY	ARA-C/DNR/TG		NCI
C9577	SY	TAD		NCI
C9577	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9577	RO	chemotherapy regimen has component Cytarabine	NCI
C9577	RO	chemotherapy regimen has component Thioguanine	NCI
C9577	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9982	STY	Therapeutic or Preventive Procedure		NCI
C9982	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Sargramostim/Vincristine		NCI
C9982	SY	CTX/DOX/5-FU/GM-CSF/MTX/VCR		NCI
C9982	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9982	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9982	RO	chemotherapy regimen has component Doxorubicin	NCI
C9982	RO	chemotherapy regimen has component Fluorouracil	NCI
C9982	RO	chemotherapy regimen has component Methotrexate	NCI
C9982	RO	chemotherapy regimen has component Vincristine	NCI
C9982	RO	chemotherapy regimen has component Sargramostim	NCI
C9978	STY	Therapeutic or Preventive Procedure		NCI
C9978	PT	Cyclophosphamide/Doxorubicin/Lomustine		NCI
C9978	SY	CAC		NCI
C9978	SY	CCNU/CTX/DOX		NCI
C9978	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9978	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9978	RO	chemotherapy regimen has component Doxorubicin	NCI
C9978	RO	chemotherapy regimen has component Lomustine	NCI
C138049	STY	Therapeutic or Preventive Procedure		NCI
C138049	PT	Carboplatin/Gemcitabine Regimen		NCI
C138049	SY	Carboplatin-Gemcitabine		NCI
C138049	SY	Carboplatin + Gemcitabine Regimen		NCI
C138049	SY	Carboplatin/Gemcitabine		NCI
C138049	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C154270	STY	Therapeutic or Preventive Procedure		NCI
C154270	PT	Lenvatinib/Everolimus Regimen		NCI
C154270	SY	Everolimus/Lenvatinib		NCI
C154270	SY	Lenvatinib-Everolimus		NCI
C154270	SY	Lenvatinib + Everolimus		NCI
C154270	SY	Lenvatinib Plus Everolimus		NCI
C154270	SY	Lenvatinib/Everolimus		NCI
C154270	CHD	Chemotherapy Regimen Used to Treat Malignant Renal Neoplasm	NCI
C154270	RO	chemotherapy regimen has component Everolimus	NCI
C154270	RO	chemotherapy regimen has component Lenvatinib	NCI
C10612	STY	Therapeutic or Preventive Procedure		NCI
C10612	PT	Asparaginase/Daunorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C10612	SY	ASP/DNR/MP/MTX/PRED/VCR		NCI
C10612	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10612	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10612	RO	chemotherapy regimen has component Asparaginase	NCI
C10612	RO	chemotherapy regimen has component Methotrexate	NCI
C10612	RO	chemotherapy regimen has component Prednisone	NCI
C10612	RO	chemotherapy regimen has component Vincristine	NCI
C10612	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10357	STY	Therapeutic or Preventive Procedure		NCI
C10357	PT	Asparaginase/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine		NCI
C10357	SY	ARA-C/ASP/CTX/TG/VCR		NCI
C10357	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10357	RO	chemotherapy regimen has component Asparaginase	NCI
C10357	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10357	RO	chemotherapy regimen has component Cytarabine	NCI
C10357	RO	chemotherapy regimen has component Thioguanine	NCI
C10357	RO	chemotherapy regimen has component Vincristine	NCI
C10806	STY	Therapeutic or Preventive Procedure		NCI
C10806	PT	Hydroxyurea/Tretinoin		NCI
C10806	SY	ATRA/HU		NCI
C10806	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10806	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10806	RO	chemotherapy regimen has component Tretinoin	NCI
C10392	STY	Therapeutic or Preventive Procedure		NCI
C10392	PT	Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Pentamidine/Sargramostim/Vincristine/Zidovudine		NCI
C10392	SY	CTX/DOX/GM-CSF/MTX/PAD/VCR/VP-16/ZDV		NCI
C10392	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10392	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10392	RO	chemotherapy regimen has component Doxorubicin	NCI
C10392	RO	chemotherapy regimen has component Etoposide	NCI
C10392	RO	chemotherapy regimen has component Methotrexate	NCI
C10392	RO	chemotherapy regimen has component Pentamidine	NCI
C10392	RO	chemotherapy regimen has component Vincristine	NCI
C10392	RO	chemotherapy regimen has component Zidovudine	NCI
C10392	RO	chemotherapy regimen has component Sargramostim	NCI
C15594	STY	Therapeutic or Preventive Procedure		NCI
C15594	PT	Interleukin-2/Monoclonal Antibody HuG1-M195		NCI
C15594	SY	IL-2/MOAB HuM195		NCI
C15594	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15594	RO	chemotherapy regimen has component Lintuzumab	NCI
C15594	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11619	STY	Therapeutic or Preventive Procedure		NCI
C11619	PT	CRL 1005/gp100 Antigen/Incomplete Freund's Adjuvant/Tyrosinase Peptide		NCI
C11619	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11619	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11619	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11619	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11619	RO	chemotherapy regimen has component CRL 1005	NCI
C10446	STY	Therapeutic or Preventive Procedure		NCI
C10446	PT	Filgrastim/Paclitaxel		NCI
C10446	SY	G-CSF/TAX		NCI
C10446	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10446	RO	chemotherapy regimen has component Paclitaxel	NCI
C10446	RO	chemotherapy regimen has component Filgrastim	NCI
C9635	STY	Therapeutic or Preventive Procedure		NCI
C9635	PT	Bleomycin/Cisplatin/Etoposide/Vinblastine		NCI
C9635	SY	BLEO/CDDP/VBL/VP-16		NCI
C9635	SY	PVBV		NCI
C9635	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9635	RO	chemotherapy regimen has component Bleomycin	NCI
C9635	RO	chemotherapy regimen has component Cisplatin	NCI
C9635	RO	chemotherapy regimen has component Etoposide	NCI
C9635	RO	chemotherapy regimen has component Vinblastine	NCI
C67514	STY	Therapeutic or Preventive Procedure		NCI
C67514	PT	APE/Gestational Trophoblastic Tumor Regimen		NCI
C67514	CHD	Chemotherapy Regimen Used to Treat Gestational Trophoblastic Tumor	NCI
C67514	RO	chemotherapy regimen has component Cisplatin	NCI
C67514	RO	chemotherapy regimen has component Dactinomycin	NCI
C67514	RO	chemotherapy regimen has component Etoposide	NCI
C11426	STY	Therapeutic or Preventive Procedure		NCI
C11426	PT	Cyclophosphamide/Doxorubicin HCl Liposome/Prednisone/Vincristine		NCI
C11426	SY	CTX/LipoDox/PRED/VCR		NCI
C11426	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11426	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11426	RO	chemotherapy regimen has component Prednisone	NCI
C11426	RO	chemotherapy regimen has component Vincristine	NCI
C11426	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C37593	STY	Therapeutic or Preventive Procedure		NCI
C37593	PT	Captopril/Tissue Plasminogen Activator		NCI
C37593	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37593	RO	chemotherapy regimen has component Captopril	NCI
C37593	RO	chemotherapy regimen has component Alteplase	NCI
C15590	STY	Therapeutic or Preventive Procedure		NCI
C15590	PT	Monoclonal Antibody 3F8/Sargramostim		NCI
C15590	SY	GM-CSF/MOAB 3F8		NCI
C15590	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C15590	RO	chemotherapy regimen has component Sargramostim	NCI
C15590	RO	chemotherapy regimen has component Monoclonal Antibody 3F8	NCI
C9719	STY	Therapeutic or Preventive Procedure		NCI
C9719	PT	Cisplatin/Doxorubicin/Vincristine		NCI
C9719	SY	APO		NCI
C9719	SY	CDDP/DOX/VCR		NCI
C9719	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9719	RO	chemotherapy regimen has component Cisplatin	NCI
C9719	RO	chemotherapy regimen has component Doxorubicin	NCI
C9719	RO	chemotherapy regimen has component Vincristine	NCI
C11112	STY	Therapeutic or Preventive Procedure		NCI
C11112	PT	Mercaptopurine/Methotrexate/Tretinoin		NCI
C11112	SY	ATRA/MP/MTX		NCI
C11112	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11112	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11112	RO	chemotherapy regimen has component Methotrexate	NCI
C11112	RO	chemotherapy regimen has component Tretinoin	NCI
C11112	RO	subset includes concept Mononucleotide Marker Name	NCI
C11112	RO	subset includes concept Pentanucleotide Marker Name	NCI
C11112	RO	subset includes concept Software Name	NCI
C11112	RO	subset includes concept Internal Orifice Area	NCI
C11112	RO	subset includes concept Dinucleotide Marker Name	NCI
C11112	RO	subset includes concept Magnetic Field Strength	NCI
C11547	STY	Therapeutic or Preventive Procedure		NCI
C11547	PT	Carboplatin/Paclitaxel/SCH-58500		NCI
C11547	SY	CBDCA/SCH-58500/TAX		NCI
C11547	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11547	RO	chemotherapy regimen has component Carboplatin	NCI
C11547	RO	chemotherapy regimen has component Paclitaxel	NCI
C11547	RO	chemotherapy regimen has component Recombinant Adenovirus-p53 SCH-58500	NCI
C9562	STY	Therapeutic or Preventive Procedure		NCI
C9562	PT	Cyclophosphamide/Methotrexate/Prednisone/Vincristine		NCI
C9562	SY	M-COP		NCI
C9562	SY	CTX/MTX/PRED/VCR		NCI
C9562	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9562	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9562	RO	chemotherapy regimen has component Methotrexate	NCI
C9562	RO	chemotherapy regimen has component Prednisone	NCI
C9562	RO	chemotherapy regimen has component Vincristine	NCI
C10520	STY	Therapeutic or Preventive Procedure		NCI
C10520	PT	Bleomycin/Cisplatin/Etoposide/Filgrastim/Ifosfamide		NCI
C10520	SY	BLEO/CDDP/G-CSF/IFF/VP-16		NCI
C10520	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10520	RO	chemotherapy regimen has component Bleomycin	NCI
C10520	RO	chemotherapy regimen has component Cisplatin	NCI
C10520	RO	chemotherapy regimen has component Etoposide	NCI
C10520	RO	chemotherapy regimen has component Ifosfamide	NCI
C10520	RO	chemotherapy regimen has component Filgrastim	NCI
C10523	STY	Therapeutic or Preventive Procedure		NCI
C10523	PT	Interferon Gamma/Macrophage Colony-Stimulating Factor		NCI
C10523	SY	IFN-G/M-CSF		NCI
C10523	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10523	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C10523	RO	chemotherapy regimen has component Recombinant Macrophage Colony-Stimulating Factor	NCI
C11918	STY	Therapeutic or Preventive Procedure		NCI
C11918	PT	Cyclosporine/Paclitaxel/Yttrium Y 90 Monoclonal Antibody Lym-1		NCI
C11918	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11918	RO	chemotherapy regimen has component Cyclosporine	NCI
C11918	RO	chemotherapy regimen has component Paclitaxel	NCI
C11918	RO	chemotherapy regimen has component Y 90 Monoclonal Antibody Lym-1	NCI
C136257	STY	Therapeutic or Preventive Procedure		NCI
C136257	PT	Infusional Fluorouracil/Leucovorin/Bevacizumab Regimen		NCI
C136257	SY	Infusional 5-FU/LV Plus Bevacizumab		NCI
C136257	SY	Infusional Fluorouracil/Leucovorin/Avastin		NCI
C136257	SY	Infusional Fluorouracil/Leucovorin Plus Avastin		NCI
C136257	SY	Infusional Fluorouracil/leucovorin Plus Bevacizumab		NCI
C136257	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136257	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136257	RO	chemotherapy regimen has component Fluorouracil	NCI
C136257	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C136257	RO	chemotherapy regimen has component Bevacizumab	NCI
C10089	STY	Therapeutic or Preventive Procedure		NCI
C10089	PT	Cisplatin/Cyclophosphamide/Cytarabine/Hydroxyurea/Lomustine/Methylprednisolone/Procarbazine/Vincristine		NCI
C10089	SY	ARA-C/CCNU/CDDP/CTX/HU/MePRDL/PCB/VCR		NCI
C10089	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10089	RO	chemotherapy regimen has component Cisplatin	NCI
C10089	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10089	RO	chemotherapy regimen has component Cytarabine	NCI
C10089	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10089	RO	chemotherapy regimen has component Lomustine	NCI
C10089	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10089	RO	chemotherapy regimen has component Vincristine	NCI
C10089	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9661	STY	Therapeutic or Preventive Procedure		NCI
C9661	PT	Cyclophosphamide/Melphalan/Prednisone/Vincristine		NCI
C9661	SY	CTX/L-PAM/PRED/VCR		NCI
C9661	SY	VCMP		NCI
C9661	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9661	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9661	RO	chemotherapy regimen has component Melphalan	NCI
C9661	RO	chemotherapy regimen has component Prednisone	NCI
C9661	RO	chemotherapy regimen has component Vincristine	NCI
C10960	STY	Therapeutic or Preventive Procedure		NCI
C10960	PT	Interleukin-2/MART-1 Antigen		NCI
C10960	SY	IL-2/MART-1		NCI
C10960	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10960	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10960	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11221	STY	Therapeutic or Preventive Procedure		NCI
C11221	PT	Doxorubicin/DPPE		NCI
C11221	SY	DOX/DPPE		NCI
C11221	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11221	RO	chemotherapy regimen has component Doxorubicin	NCI
C11221	RO	chemotherapy regimen has component Tesmilifene Hydrochloride	NCI
C9703	STY	Therapeutic or Preventive Procedure		NCI
C9703	PT	Fluorouracil/Methotrexate/Thiotepa		NCI
C9703	SY	5-FU/MTX/TSPA		NCI
C9703	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9703	RO	chemotherapy regimen has component Fluorouracil	NCI
C9703	RO	chemotherapy regimen has component Methotrexate	NCI
C9703	RO	chemotherapy regimen has component Thiotepa	NCI
C37596	STY	Therapeutic or Preventive Procedure		NCI
C37596	PT	Carboplatin/Celecoxib/Paclitaxel		NCI
C37596	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37596	RO	chemotherapy regimen has component Carboplatin	NCI
C37596	RO	chemotherapy regimen has component Paclitaxel	NCI
C37596	RO	chemotherapy regimen has component Celecoxib	NCI
C37601	STY	Therapeutic or Preventive Procedure		NCI
C37601	PT	Carboplatin/Cyclophosphamide/Etoposide Phosphate		NCI
C37601	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37601	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37601	RO	chemotherapy regimen has component Etoposide Phosphate	NCI
C37601	RO	chemotherapy regimen has component Carboplatin	NCI
C37536	STY	Therapeutic or Preventive Procedure		NCI
C37536	PT	Autologous Dendritic Cells/CD40-Ligand		NCI
C37536	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37536	RO	chemotherapy regimen has component Therapeutic Autologous Dendritic Cells	NCI
C37536	RO	chemotherapy regimen has component Recombinant CD40-Ligand	NCI
C10349	STY	Therapeutic or Preventive Procedure		NCI
C10349	PT	Cisplatin/Etoposide/Sargramostim		NCI
C10349	SY	CDDP/GM-CSF/VP-16		NCI
C10349	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10349	RO	chemotherapy regimen has component Cisplatin	NCI
C10349	RO	chemotherapy regimen has component Etoposide	NCI
C10349	RO	chemotherapy regimen has component Sargramostim	NCI
C12174	STY	Therapeutic or Preventive Procedure		NCI
C12174	PT	Isotretinoin/Sargramostim		NCI
C12174	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12174	RO	chemotherapy regimen has component Isotretinoin	NCI
C12174	RO	chemotherapy regimen has component Sargramostim	NCI
C37806	STY	Therapeutic or Preventive Procedure		NCI
C37806	PT	Gemcitabine/Suramin		NCI
C37806	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37806	RO	chemotherapy regimen has component Suramin	NCI
C37806	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C9987	STY	Therapeutic or Preventive Procedure		NCI
C9987	PT	Cyclophosphamide/Doxorubicin/Etoposide/Sargramostim		NCI
C9987	SY	CTX/DOX/GM-CSF/VP-16		NCI
C9987	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9987	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9987	RO	chemotherapy regimen has component Doxorubicin	NCI
C9987	RO	chemotherapy regimen has component Etoposide	NCI
C9987	RO	chemotherapy regimen has component Sargramostim	NCI
C15579	STY	Therapeutic or Preventive Procedure		NCI
C15579	PT	Interleukin-2/Tumor Necrosis Factor Receptor IgG Chimera		NCI
C15579	SY	IL-2/TNFR:Fc		NCI
C15579	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15579	RO	chemotherapy regimen has component Etanercept	NCI
C15579	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11995	STY	Therapeutic or Preventive Procedure		NCI
C11995	PT	Carboplatin/ISIS 3521/Paclitaxel		NCI
C11995	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11995	RO	chemotherapy regimen has component Carboplatin	NCI
C11995	RO	chemotherapy regimen has component Paclitaxel	NCI
C11995	RO	chemotherapy regimen has component ISIS 3521	NCI
C9947	STY	Therapeutic or Preventive Procedure		NCI
C9947	PT	Bleomycin/Cyclophosphamide/Etoposide/Prednisone/Procarbazine		NCI
C9947	SY	B-CEPP		NCI
C9947	SY	BLEO/CTX/PCB/PRED/VP-16		NCI
C9947	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9947	RO	chemotherapy regimen has component Bleomycin	NCI
C9947	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9947	RO	chemotherapy regimen has component Etoposide	NCI
C9947	RO	chemotherapy regimen has component Prednisone	NCI
C9947	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11222	STY	Therapeutic or Preventive Procedure		NCI
C11222	PT	Dacarbazine/Doxorubicin/Ifosfamide/Vincristine		NCI
C11222	SY	DOX/DTIC/IFF/VCR		NCI
C11222	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11222	RO	chemotherapy regimen has component Dacarbazine	NCI
C11222	RO	chemotherapy regimen has component Doxorubicin	NCI
C11222	RO	chemotherapy regimen has component Ifosfamide	NCI
C11222	RO	chemotherapy regimen has component Vincristine	NCI
C140099	STY	Therapeutic or Preventive Procedure		NCI
C140099	PT	R-ESHAP Regimen		NCI
C140099	SY	Rituximab-Etoposide-Solu-Medrol-High-dose Ara-C-Platinol		NCI
C140099	SY	R-ESHAP		NCI
C140099	SY	Rituximab-Etoposide-Methylprednisolone-High-dose Cytarabine-Cisplatin		NCI
C140099	SY	Etoposide/Methylprednisolone/High-dose Cytarabine/Cisplatin		NCI
C140099	SY	Rituximab/Etoposide/Solumedrol/High-dose Cytarabine/Cisplatin		NCI
C140099	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C140099	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140099	RO	chemotherapy regimen has component Cisplatin	NCI
C140099	RO	chemotherapy regimen has component Cytarabine	NCI
C140099	RO	chemotherapy regimen has component Etoposide	NCI
C140099	RO	chemotherapy regimen has component Methylprednisolone	NCI
C140099	RO	chemotherapy regimen has component Rituximab	NCI
C11945	STY	Therapeutic or Preventive Procedure		NCI
C11945	PT	Bevacizumab/Capecitabine		NCI
C11945	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11945	RO	chemotherapy regimen has component Capecitabine	NCI
C11945	RO	chemotherapy regimen has component Bevacizumab	NCI
C9893	STY	Therapeutic or Preventive Procedure		NCI
C9893	PT	Cyclophosphamide/Doxorubicin/Methotrexate/Sargramostim/Vincristine		NCI
C9893	SY	CTX/DOX/GM-CSF/MTX/VCR		NCI
C9893	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9893	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9893	RO	chemotherapy regimen has component Doxorubicin	NCI
C9893	RO	chemotherapy regimen has component Methotrexate	NCI
C9893	RO	chemotherapy regimen has component Vincristine	NCI
C9893	RO	chemotherapy regimen has component Sargramostim	NCI
C11888	STY	Therapeutic or Preventive Procedure		NCI
C11888	PT	Etoposide/Ifosfamide/Topotecan		NCI
C11888	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11888	RO	chemotherapy regimen has component Etoposide	NCI
C11888	RO	chemotherapy regimen has component Ifosfamide	NCI
C11888	RO	chemotherapy regimen has component Topotecan	NCI
C10998	STY	Therapeutic or Preventive Procedure		NCI
C10998	PT	Fluorouracil/Interferon Alfa/PALA		NCI
C10998	SY	5-FU/IFN-A/PALA		NCI
C10998	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10998	RO	chemotherapy regimen has component Fluorouracil	NCI
C10998	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C10998	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11429	STY	Therapeutic or Preventive Procedure		NCI
C11429	PT	Carmustine/Melphalan		NCI
C11429	SY	BCNU/L-PAM		NCI
C11429	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11429	RO	chemotherapy regimen has component Carmustine	NCI
C11429	RO	chemotherapy regimen has component Melphalan	NCI
C11111	STY	Therapeutic or Preventive Procedure		NCI
C11111	PT	Interferon Alfa/Interleukin-2/Paclitaxel		NCI
C11111	SY	IFN-A/IL-2/TAX		NCI
C11111	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11111	RO	chemotherapy regimen has component Paclitaxel	NCI
C11111	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11111	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11497	STY	Therapeutic or Preventive Procedure		NCI
C11497	PT	Cytarabine/Mercaptopurine/Methotrexate/Prednisone		NCI
C11497	SY	ARA-C/MP/MTX/PRED		NCI
C11497	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11497	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11497	RO	chemotherapy regimen has component Cytarabine	NCI
C11497	RO	chemotherapy regimen has component Methotrexate	NCI
C11497	RO	chemotherapy regimen has component Prednisone	NCI
C11584	STY	Therapeutic or Preventive Procedure		NCI
C11584	PT	AG3340/Mitoxantrone/Prednisone		NCI
C11584	SY	AG3340/DHAD/PRED		NCI
C11584	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11584	RO	chemotherapy regimen has component Prednisone	NCI
C11584	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11584	RO	chemotherapy regimen has component Prinomastat	NCI
C10713	STY	Therapeutic or Preventive Procedure		NCI
C10713	PT	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Mercaptopurine/Methotrexate/Vincristine		NCI
C10713	SY	ARA-C/ASP/CTX/DM/MP/MTX/VCR		NCI
C10713	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10713	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10713	RO	chemotherapy regimen has component Asparaginase	NCI
C10713	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10713	RO	chemotherapy regimen has component Cytarabine	NCI
C10713	RO	chemotherapy regimen has component Dexamethasone	NCI
C10713	RO	chemotherapy regimen has component Methotrexate	NCI
C10713	RO	chemotherapy regimen has component Vincristine	NCI
C11507	STY	Therapeutic or Preventive Procedure		NCI
C11507	PT	Irinotecan/Mitomycin		NCI
C11507	SY	CPT-11/MITO		NCI
C11507	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11507	RO	chemotherapy regimen has component Mitomycin	NCI
C11507	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C10592	STY	Therapeutic or Preventive Procedure		NCI
C10592	PT	Hexamethylene Bisacetamide/Tretinoin		NCI
C10592	SY	ATRA/HMBA		NCI
C10592	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10592	RO	chemotherapy regimen has component Tretinoin	NCI
C10592	RO	chemotherapy regimen has component Hexamethylene Bisacetamide	NCI
C11202	STY	Therapeutic or Preventive Procedure		NCI
C11202	PT	Dexamethasone/Etoposide/Ifosfamide/Pegaspargase/Vincristine		NCI
C11202	SY	DM/IFF/PEG-ASP/VCR/VP-16		NCI
C11202	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11202	RO	chemotherapy regimen has component Dexamethasone	NCI
C11202	RO	chemotherapy regimen has component Etoposide	NCI
C11202	RO	chemotherapy regimen has component Ifosfamide	NCI
C11202	RO	chemotherapy regimen has component Vincristine	NCI
C11202	RO	chemotherapy regimen has component Pegaspargase	NCI
C11344	STY	Therapeutic or Preventive Procedure		NCI
C11344	PT	Bleomycin/Cyclophosphamide/Dexrazoxane/Doxorubicin/Etoposide/Prednisone/Vincristine		NCI
C11344	SY	ADR-529/BLEO/CTX/DOX/PRED/VCR/VP-16		NCI
C11344	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11344	RO	chemotherapy regimen has component Bleomycin	NCI
C11344	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11344	RO	chemotherapy regimen has component Doxorubicin	NCI
C11344	RO	chemotherapy regimen has component Etoposide	NCI
C11344	RO	chemotherapy regimen has component Prednisone	NCI
C11344	RO	chemotherapy regimen has component Vincristine	NCI
C11344	RO	chemotherapy regimen has component Dexrazoxane	NCI
C10774	STY	Therapeutic or Preventive Procedure		NCI
C10774	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Leucovorin Calcium/Milodistim		NCI
C10774	SY	CF/CTX/DOX/5-FU/PIXY321		NCI
C10774	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10774	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10774	RO	chemotherapy regimen has component Doxorubicin	NCI
C10774	RO	chemotherapy regimen has component Fluorouracil	NCI
C10774	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10774	RO	chemotherapy regimen has component Milodistim	NCI
C10579	STY	Therapeutic or Preventive Procedure		NCI
C10579	PT	Doxorubicin/Filgrastim/Mercaptopurine/Prednisone/Vincristine		NCI
C10579	SY	DOX/G-CSF/MP/PRED/VCR		NCI
C10579	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10579	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10579	RO	chemotherapy regimen has component Doxorubicin	NCI
C10579	RO	chemotherapy regimen has component Prednisone	NCI
C10579	RO	chemotherapy regimen has component Vincristine	NCI
C10579	RO	chemotherapy regimen has component Filgrastim	NCI
C9591	STY	Therapeutic or Preventive Procedure		NCI
C9591	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Tegafur		NCI
C9591	SY	CDDP/CTX/DOX/FT		NCI
C9591	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9591	RO	chemotherapy regimen has component Cisplatin	NCI
C9591	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9591	RO	chemotherapy regimen has component Doxorubicin	NCI
C9591	RO	chemotherapy regimen has component Tegafur	NCI
C11539	STY	Therapeutic or Preventive Procedure		NCI
C11539	PT	Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Mercaptopurine/Methotrexate/Thioguanine/Vincristine/Vindesine		NCI
C11539	SY	ARA-C/ASP/CTX/DAVA/DM/DNR/MP/MTX/TG/VCR		NCI
C11539	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11539	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11539	RO	chemotherapy regimen has component Asparaginase	NCI
C11539	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11539	RO	chemotherapy regimen has component Cytarabine	NCI
C11539	RO	chemotherapy regimen has component Dexamethasone	NCI
C11539	RO	chemotherapy regimen has component Methotrexate	NCI
C11539	RO	chemotherapy regimen has component Thioguanine	NCI
C11539	RO	chemotherapy regimen has component Vincristine	NCI
C11539	RO	chemotherapy regimen has component Vindesine	NCI
C11539	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11393	STY	Therapeutic or Preventive Procedure		NCI
C11393	PT	Cyclophosphamide/DPPE		NCI
C11393	SY	CTX/DPPE		NCI
C11393	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11393	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11393	RO	chemotherapy regimen has component Tesmilifene Hydrochloride	NCI
C12191	STY	Therapeutic or Preventive Procedure		NCI
C12191	PT	Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Filgrastim/Leucovorin Calcium/Methotrexate/Rituximab/Vincristine		NCI
C12191	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12191	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12191	RO	chemotherapy regimen has component Cytarabine	NCI
C12191	RO	chemotherapy regimen has component Dexamethasone	NCI
C12191	RO	chemotherapy regimen has component Doxorubicin	NCI
C12191	RO	chemotherapy regimen has component Methotrexate	NCI
C12191	RO	chemotherapy regimen has component Vincristine	NCI
C12191	RO	chemotherapy regimen has component Filgrastim	NCI
C12191	RO	chemotherapy regimen has component Rituximab	NCI
C12191	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10557	STY	Therapeutic or Preventive Procedure		NCI
C10557	PT	Cyclophosphamide/Doxorubicin/Etoposide/Medroxyprogesterone/Quinine		NCI
C10557	SY	CTX/DOX/MPA/QUIN/VP-16		NCI
C10557	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10557	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10557	RO	chemotherapy regimen has component Doxorubicin	NCI
C10557	RO	chemotherapy regimen has component Etoposide	NCI
C10557	RO	chemotherapy regimen has component Medroxyprogesterone	NCI
C10557	RO	chemotherapy regimen has component Quinine	NCI
C9965	STY	Therapeutic or Preventive Procedure		NCI
C9965	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Triazinate		NCI
C9965	SY	CDDP/CTX/DOX/TZT		NCI
C9965	SY	T-CAP		NCI
C9965	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9965	RO	chemotherapy regimen has component Cisplatin	NCI
C9965	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9965	RO	chemotherapy regimen has component Doxorubicin	NCI
C9965	RO	chemotherapy regimen has component Triazinate	NCI
C11626	STY	Therapeutic or Preventive Procedure		NCI
C11626	PT	Detoxpc/Lung Tumor Associated Antigen		NCI
C11626	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11626	RO	chemotherapy regimen has component DetoxPC	NCI
C11626	RO	chemotherapy regimen has component Lung Tumor Associated Antigen	NCI
C9843	STY	Therapeutic or Preventive Procedure		NCI
C9843	PT	Carmustine/Cisplatin		NCI
C9843	SY	BCNU/CDDP		NCI
C9843	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9843	RO	chemotherapy regimen has component Carmustine	NCI
C9843	RO	chemotherapy regimen has component Cisplatin	NCI
C11188	STY	Therapeutic or Preventive Procedure		NCI
C11188	PT	Fluorouracil/Phenylbutyrate		NCI
C11188	SY	5-FU/PBA		NCI
C11188	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11188	RO	chemotherapy regimen has component Fluorouracil	NCI
C11188	RO	chemotherapy regimen has component Sodium Phenylbutyrate	NCI
C63761	STY	Therapeutic or Preventive Procedure		NCI
C63761	PT	Vinorelbine-Carboplatin Regimen		NCI
C63761	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63761	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63761	RO	chemotherapy regimen has component Vinorelbine	NCI
C63761	RO	chemotherapy regimen has component Carboplatin	NCI
C10908	STY	Therapeutic or Preventive Procedure		NCI
C10908	PT	Filgrastim/Gallium Nitrate/Paclitaxel		NCI
C10908	SY	GAN/G-CSF/TAX		NCI
C10908	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10908	RO	chemotherapy regimen has component Gallium Nitrate	NCI
C10908	RO	chemotherapy regimen has component Paclitaxel	NCI
C10908	RO	chemotherapy regimen has component Filgrastim	NCI
C9541	STY	Therapeutic or Preventive Procedure		NCI
C9541	PT	Carmustine/Cyclophosphamide/Etoposide		NCI
C9541	SY	BCNU/CTX/VP-16		NCI
C9541	SY	CBV		NCI
C9541	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9541	RO	chemotherapy regimen has component Carmustine	NCI
C9541	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9541	RO	chemotherapy regimen has component Etoposide	NCI
C11542	STY	Therapeutic or Preventive Procedure		NCI
C11542	PT	Amifostine/Bleomycin/Cisplatin/Etoposide		NCI
C11542	SY	BLEO/CDDP/VP-16/WR-2721		NCI
C11542	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11542	RO	chemotherapy regimen has component Bleomycin	NCI
C11542	RO	chemotherapy regimen has component Cisplatin	NCI
C11542	RO	chemotherapy regimen has component Amifostine	NCI
C11542	RO	chemotherapy regimen has component Etoposide	NCI
C37563	STY	Therapeutic or Preventive Procedure		NCI
C37563	PT	Boronophenylalanine-Fructose Complex/Sodium Borocaptate		NCI
C37563	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37563	RO	chemotherapy regimen has component Sodium Borocaptate	NCI
C37563	RO	chemotherapy regimen has component Boronophenylalanine-Fructose Complex	NCI
C12203	STY	Therapeutic or Preventive Procedure		NCI
C12203	PT	Cyclophosphamide/Dexamethasone/Doxorubicin/Rituximab/Vincristine		NCI
C12203	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12203	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12203	RO	chemotherapy regimen has component Dexamethasone	NCI
C12203	RO	chemotherapy regimen has component Doxorubicin	NCI
C12203	RO	chemotherapy regimen has component Vincristine	NCI
C12203	RO	chemotherapy regimen has component Rituximab	NCI
C9951	STY	Therapeutic or Preventive Procedure		NCI
C9951	PT	Carmustine/Dacarbazine/Hydroxyurea		NCI
C9951	SY	BCNU/DTIC/HU		NCI
C9951	SY	BHD		NCI
C9951	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9951	RO	chemotherapy regimen has component Carmustine	NCI
C9951	RO	chemotherapy regimen has component Dacarbazine	NCI
C9951	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10484	STY	Therapeutic or Preventive Procedure		NCI
C10484	PT	Cyclophosphamide/Dexamethasone/Vincristine		NCI
C10484	SY	CTX/DM/VCR		NCI
C10484	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10484	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10484	RO	chemotherapy regimen has component Dexamethasone	NCI
C10484	RO	chemotherapy regimen has component Vincristine	NCI
C10214	STY	Therapeutic or Preventive Procedure		NCI
C10214	PT	Cyclophosphamide/Fluorouracil/Fluoxymesterone/Methotrexate		NCI
C10214	SY	CMFH		NCI
C10214	SY	CTX/5-FU/FXM/MTX		NCI
C10214	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10214	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10214	RO	chemotherapy regimen has component Fluorouracil	NCI
C10214	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C10214	RO	chemotherapy regimen has component Methotrexate	NCI
C11129	STY	Therapeutic or Preventive Procedure		NCI
C11129	PT	Dexrazoxane/Doxorubicin/Filgrastim/Paclitaxel		NCI
C11129	SY	ADR-529/DOX/G-CSF/TAX		NCI
C11129	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11129	RO	chemotherapy regimen has component Doxorubicin	NCI
C11129	RO	chemotherapy regimen has component Dexrazoxane	NCI
C11129	RO	chemotherapy regimen has component Paclitaxel	NCI
C11129	RO	chemotherapy regimen has component Filgrastim	NCI
C11939	STY	Therapeutic or Preventive Procedure		NCI
C11939	PT	Calcitriol/Dexamethasone		NCI
C11939	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11939	RO	chemotherapy regimen has component Calcitriol	NCI
C11939	RO	chemotherapy regimen has component Dexamethasone	NCI
C12007	STY	Therapeutic or Preventive Procedure		NCI
C12007	PT	Monoclonal antibody Ch14.18/Sargramostim		NCI
C12007	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12007	RO	chemotherapy regimen has component Sargramostim	NCI
C12007	RO	chemotherapy regimen has component Dinutuximab	NCI
C15480	STY	Therapeutic or Preventive Procedure		NCI
C15480	PT	Sargramostim/Zidovudine		NCI
C15480	SY	GM-CSF/ZDV		NCI
C15480	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15480	RO	chemotherapy regimen has component Zidovudine	NCI
C15480	RO	chemotherapy regimen has component Sargramostim	NCI
C136256	STY	Therapeutic or Preventive Procedure		NCI
C136256	PT	Infusional Fluorouracil/Leucovorin Regimen		NCI
C136256	SY	Infusional 5-FU/LV		NCI
C136256	SY	Infusional 5-FU/Leucovorin		NCI
C136256	SY	Infusional Fluorouracil/Leucovorin		NCI
C136256	SY	Infusional Fluorouracil/Folinic Acid		NCI
C136256	SY	Infusional 5-FU/LV Regimen		NCI
C136256	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136256	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136256	RO	chemotherapy regimen has component Fluorouracil	NCI
C136256	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9970	STY	Therapeutic or Preventive Procedure		NCI
C9970	PT	Doxorubicin/Mercaptopurine/Prednisone/Vincristine		NCI
C9970	SY	BOMB		NCI
C9970	SY	DOX/MP/PRED/VCR		NCI
C9970	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9970	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9970	RO	chemotherapy regimen has component Doxorubicin	NCI
C9970	RO	chemotherapy regimen has component Prednisone	NCI
C9970	RO	chemotherapy regimen has component Vincristine	NCI
C11764	STY	Therapeutic or Preventive Procedure		NCI
C11764	PT	Folfirinox Regimen		NCI
C11764	SY	Fluorouracil/irinotecan/leucovorin calcium/oxaliplatin		NCI
C11764	SY	Fluorouracil with Irinotecan Hydrochloride, Leucovorin Calcium and Oxaliplatin		NCI
C11764	CHD	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C11764	RO	chemotherapy regimen has component Fluorouracil	NCI
C11764	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11764	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11764	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11764	RO	concept in subset CTRP Terminology	NCI
C11764	RO	concept in subset CTRP Agent Terminology	NCI
C63437	STY	Therapeutic or Preventive Procedure		NCI
C63437	PT	ABV Regimen		NCI
C63437	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63437	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C63437	RO	chemotherapy regimen has component Bleomycin	NCI
C63437	RO	chemotherapy regimen has component Doxorubicin	NCI
C63437	RO	chemotherapy regimen has component Vinblastine	NCI
C63437	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C63437	RO	regimen has accepted use for disease AIDS-Related Kaposi Sarcoma	NCI
C10656	STY	Therapeutic or Preventive Procedure		NCI
C10656	PT	Estramustine/Vinblastine		NCI
C10656	SY	EM/VBL		NCI
C10656	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10656	RO	chemotherapy regimen has component Estramustine	NCI
C10656	RO	chemotherapy regimen has component Vinblastine	NCI
C9896	STY	Therapeutic or Preventive Procedure		NCI
C9896	PT	Bleomycin/Doxorubicin/Vincristine/Zidovudine		NCI
C9896	SY	BLEO/DOX/VCR/ZDV		NCI
C9896	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9896	RO	chemotherapy regimen has component Bleomycin	NCI
C9896	RO	chemotherapy regimen has component Doxorubicin	NCI
C9896	RO	chemotherapy regimen has component Vincristine	NCI
C9896	RO	chemotherapy regimen has component Zidovudine	NCI
C10900	STY	Therapeutic or Preventive Procedure		NCI
C10900	PT	Cyclophosphamide/Doxorubicin/Leuprolide/Tamoxifen		NCI
C10900	SY	CTX/DOX/LEUP/TMX		NCI
C10900	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10900	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10900	RO	chemotherapy regimen has component Doxorubicin	NCI
C10900	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10900	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C11959	STY	Therapeutic or Preventive Procedure		NCI
C11959	PT	Trastuzumab/Vinorelbine		NCI
C11959	SY	Vinorelbine + Trastuzumab		NCI
C11959	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11959	RO	chemotherapy regimen has component Vinorelbine	NCI
C11959	RO	chemotherapy regimen has component Trastuzumab	NCI
C15527	STY	Therapeutic or Preventive Procedure		NCI
C15527	PT	Interleukin-2/Sargramostim		NCI
C15527	SY	GM-CSF/IL-2		NCI
C15527	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15527	RO	chemotherapy regimen has component Sargramostim	NCI
C15527	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10707	STY	Therapeutic or Preventive Procedure		NCI
C10707	PT	Leuprolide/Suramin		NCI
C10707	SY	LEUP/SUR		NCI
C10707	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10707	RO	chemotherapy regimen has component Suramin	NCI
C10707	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C11842	STY	Therapeutic or Preventive Procedure		NCI
C11842	PT	IM-862/Irinotecan		NCI
C11842	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11842	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11842	RO	chemotherapy regimen has component Oglufanide Disodium	NCI
C10833	STY	Therapeutic or Preventive Procedure		NCI
C10833	PT	Cisplatin/Dexamethasone/Doxorubicin/Floxuridine/Leucovorin Calcium		NCI
C10833	SY	CDDP/CF/DM/DOX/FUDR		NCI
C10833	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10833	RO	chemotherapy regimen has component Cisplatin	NCI
C10833	RO	chemotherapy regimen has component Dexamethasone	NCI
C10833	RO	chemotherapy regimen has component Doxorubicin	NCI
C10833	RO	chemotherapy regimen has component Floxuridine	NCI
C10833	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10572	STY	Therapeutic or Preventive Procedure		NCI
C10572	PT	Asparaginase/Dexamethasone/Mercaptopurine/Methotrexate/Vincristine		NCI
C10572	SY	ASP/DM/MP/MTX/VCR		NCI
C10572	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10572	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10572	RO	chemotherapy regimen has component Asparaginase	NCI
C10572	RO	chemotherapy regimen has component Dexamethasone	NCI
C10572	RO	chemotherapy regimen has component Methotrexate	NCI
C10572	RO	chemotherapy regimen has component Vincristine	NCI
C9567	STY	Therapeutic or Preventive Procedure		NCI
C9567	PT	COPP Regimen		NCI
C9567	SY	Cyclophosphamide/Prednisone/Procarbazine/Vincristine		NCI
C9567	SY	COPP		NCI
C9567	SY	Cytoxan-Oncovin-Procarbazine-Prednisone Regimen		NCI
C9567	SY	CTX/PCB/PRED/VCR		NCI
C9567	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C9567	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C9567	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9567	RO	chemotherapy regimen has component Prednisone	NCI
C9567	RO	chemotherapy regimen has component Vincristine	NCI
C9567	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9567	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C9567	RO	regimen has accepted use for disease Indolent Adult Non-Hodgkin Lymphoma	NCI
C11119	STY	Therapeutic or Preventive Procedure		NCI
C11119	PT	Epirubicin/Vinorelbine		NCI
C11119	SY	EPI/VNB		NCI
C11119	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11119	RO	chemotherapy regimen has component Vinorelbine	NCI
C11119	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C136253	STY	Therapeutic or Preventive Procedure		NCI
C136253	PT	FOLFOXIRI/Bevacizumab Regimen		NCI
C136253	SY	FOLFOXIRI-Avastin Regimen		NCI
C136253	SY	Leucovorin/Fluorouracil/Oxaliplatin/Irinotecan/Bevacizumab		NCI
C136253	SY	FOLFOXIRI-Bevacizumab Regimen		NCI
C136253	SY	FOLFOXIRI Plus Bevacizumab		NCI
C136253	SY	Folinic Acid/Fluorouracil/Oxaliplatin/Irinotecan Plus Bevacizumab		NCI
C136253	SY	FOLFOXIRI/Avastin Regimen		NCI
C136253	SY	Leucovorin-Fluorouracil-Oxaliplatin-Irinotecan Plus Avastin		NCI
C136253	SY	FOLFOXIRI Plus Avastin		NCI
C136253	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136253	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136253	RO	chemotherapy regimen has component Fluorouracil	NCI
C136253	RO	chemotherapy regimen has component Oxaliplatin	NCI
C136253	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C136253	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C136253	RO	chemotherapy regimen has component Bevacizumab	NCI
C9526	STY	Therapeutic or Preventive Procedure		NCI
C9526	PT	Bleomycin/Cisplatin/Etoposide		NCI
C9526	SY	PVP-16B		NCI
C9526	SY	BLEO/CDDP/VP-16		NCI
C9526	SY	PEB		NCI
C9526	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9526	RO	chemotherapy regimen has component Bleomycin	NCI
C9526	RO	chemotherapy regimen has component Cisplatin	NCI
C9526	RO	chemotherapy regimen has component Etoposide	NCI
C10202	STY	Therapeutic or Preventive Procedure		NCI
C10202	PT	Etoposide/Tumor Necrosis Factor		NCI
C10202	SY	TNF/VP-16		NCI
C10202	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10202	RO	chemotherapy regimen has component Etoposide	NCI
C10202	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C11023	STY	Therapeutic or Preventive Procedure		NCI
C11023	PT	Carmustine/Cisplatin/Dacarbazine/Interferon Alfa/Tamoxifen		NCI
C11023	SY	BCNU/CDDP/DTIC/IFN-A/TMX		NCI
C11023	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11023	RO	chemotherapy regimen has component Carmustine	NCI
C11023	RO	chemotherapy regimen has component Cisplatin	NCI
C11023	RO	chemotherapy regimen has component Dacarbazine	NCI
C11023	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11023	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37506	STY	Therapeutic or Preventive Procedure		NCI
C37506	PT	IDEC-114 Monoclonal Antibody/Rituximab		NCI
C37506	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37506	RO	chemotherapy regimen has component Rituximab	NCI
C37506	RO	chemotherapy regimen has component Galiximab	NCI
C11125	STY	Therapeutic or Preventive Procedure		NCI
C11125	PT	Daunorubicin/Dexamethasone		NCI
C11125	SY	DM/DNR		NCI
C11125	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11125	RO	chemotherapy regimen has component Dexamethasone	NCI
C11125	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10904	STY	Therapeutic or Preventive Procedure		NCI
C10904	PT	Dexamethasone/Dexniguldipine/Doxorubicin/Prednisone/Vincristine		NCI
C10904	SY	DM/DNIG/DOX/PRED/VCR		NCI
C10904	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10904	RO	chemotherapy regimen has component Dexamethasone	NCI
C10904	RO	chemotherapy regimen has component Doxorubicin	NCI
C10904	RO	chemotherapy regimen has component Prednisone	NCI
C10904	RO	chemotherapy regimen has component Vincristine	NCI
C10904	RO	chemotherapy regimen has component Dexniguldipine	NCI
C72672	STY	Therapeutic or Preventive Procedure		NCI
C72672	PT	Tositumomab and Iodine I 131 Tositumomab		NCI
C72672	SY	Bexxar Therapeutic Regimen		NCI
C72672	SY	Bexxar Therapy		NCI
C72672	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C72672	RO	chemotherapy regimen has component Iodine I 131 Tositumomab	NCI
C72672	RO	chemotherapy regimen has component Tositumomab	NCI
C72672	RO	concept in subset CTRP Terminology	NCI
C72672	RO	concept in subset CTRP Agent Terminology	NCI
C10365	STY	Therapeutic or Preventive Procedure		NCI
C10365	PT	Carboplatin/Cyclophosphamide/Mitoxantrone		NCI
C10365	SY	CBDCA/CTX/DHAD		NCI
C10365	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10365	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10365	RO	chemotherapy regimen has component Carboplatin	NCI
C10365	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11195	STY	Therapeutic or Preventive Procedure		NCI
C11195	PT	Carboplatin/9-cis-Retinoic Acid		NCI
C11195	SY	CBDCA/9-CRA		NCI
C11195	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11195	RO	chemotherapy regimen has component Carboplatin	NCI
C11195	RO	chemotherapy regimen has component Alitretinoin	NCI
C11422	STY	Therapeutic or Preventive Procedure		NCI
C11422	PT	Interleukin-2/Rituximab		NCI
C11422	SY	IL-2/MOAB IDEC-C2B8		NCI
C11422	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11422	RO	chemotherapy regimen has component Rituximab	NCI
C11422	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10913	STY	Therapeutic or Preventive Procedure		NCI
C10913	PT	Cisplatin/Cytarabine/Dexamethasone/Idarubicin		NCI
C10913	SY	ARA-C/CDDP/DM/IDA		NCI
C10913	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10913	RO	chemotherapy regimen has component Cisplatin	NCI
C10913	RO	chemotherapy regimen has component Cytarabine	NCI
C10913	RO	chemotherapy regimen has component Dexamethasone	NCI
C10913	RO	chemotherapy regimen has component Idarubicin	NCI
C10619	STY	Therapeutic or Preventive Procedure		NCI
C10619	PT	Cisplatin/Doxorubicin/Edatrexate/Vinblastine		NCI
C10619	SY	CDDP/DOX/EDAM/VBL		NCI
C10619	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10619	RO	chemotherapy regimen has component Cisplatin	NCI
C10619	RO	chemotherapy regimen has component Doxorubicin	NCI
C10619	RO	chemotherapy regimen has component Vinblastine	NCI
C10619	RO	chemotherapy regimen has component Edatrexate	NCI
C63435	STY	Therapeutic or Preventive Procedure		NCI
C63435	PT	TAC Regimen		NCI
C63435	SY	Taxotere-Adriamycin-Cytoxan Regimen		NCI
C63435	SY	TAC		NCI
C63435	SY	Docetaxel/Doxorubicin/Cyclophosphamide		NCI
C63435	SY	Docetaxel/Doxorubicin/Cyclophosphamide Regimen		NCI
C63435	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63435	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63435	RO	chemotherapy regimen has component Doxorubicin	NCI
C63435	RO	chemotherapy regimen has component Docetaxel	NCI
C63435	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C10881	STY	Therapeutic or Preventive Procedure		NCI
C10881	PT	Cytarabine/Etoposide/Filgrastim/Interleukin-6/Mitoxantrone		NCI
C10881	SY	ARA-C/DHAD/G-CSF/IL-6/VP-16		NCI
C10881	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10881	RO	chemotherapy regimen has component Cytarabine	NCI
C10881	RO	chemotherapy regimen has component Etoposide	NCI
C10881	RO	chemotherapy regimen has component Filgrastim	NCI
C10881	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10881	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C156246	STY	Therapeutic or Preventive Procedure		NCI
C156246	PT	R-CHOP Plus Methotrexate Regimen		NCI
C156246	SY	CHOP-R Plus Methotrexate		NCI
C156246	SY	Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Rituximab/Vincristine Regimen		NCI
C156246	SY	Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone-Methotrexate Regimen		NCI
C156246	SY	R-CHOP Plus MTX		NCI
C156246	SY	Methotrexate Plus R-CHOP		NCI
C156246	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C156246	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C156246	RO	chemotherapy regimen has component Doxorubicin	NCI
C156246	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C156246	RO	chemotherapy regimen has component Methotrexate	NCI
C156246	RO	chemotherapy regimen has component Prednisone	NCI
C156246	RO	chemotherapy regimen has component Vincristine	NCI
C156246	RO	chemotherapy regimen has component Rituximab	NCI
C156246	RO	regimen has accepted use for disease Mantle Cell Lymphoma	NCI
C11307	STY	Therapeutic or Preventive Procedure		NCI
C11307	PT	Bryostatin 1/Cytarabine		NCI
C11307	SY	ARA-C/BRYO		NCI
C11307	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11307	RO	chemotherapy regimen has component Cytarabine	NCI
C11307	RO	chemotherapy regimen has component Bryostatin 1	NCI
C11048	STY	Therapeutic or Preventive Procedure		NCI
C11048	PT	Allopurinol/Fluorouracil/Interferon Alfa		NCI
C11048	SY	ALLO/5-FU/IFN-A		NCI
C11048	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11048	RO	chemotherapy regimen has component Allopurinol	NCI
C11048	RO	chemotherapy regimen has component Fluorouracil	NCI
C11048	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9949	STY	Therapeutic or Preventive Procedure		NCI
C9949	PT	Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine		NCI
C9949	SY	ARA-C/CTX/DM/DOX/TG/VCR		NCI
C9949	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9949	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9949	RO	chemotherapy regimen has component Cytarabine	NCI
C9949	RO	chemotherapy regimen has component Dexamethasone	NCI
C9949	RO	chemotherapy regimen has component Doxorubicin	NCI
C9949	RO	chemotherapy regimen has component Thioguanine	NCI
C9949	RO	chemotherapy regimen has component Vincristine	NCI
C12101	STY	Therapeutic or Preventive Procedure		NCI
C12101	PT	ALVAC-CEA-B7.1 vaccine/Fluorouracil/Irinotecan/Leucovorin calcium/Tetanus toxoid		NCI
C12101	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12101	RO	chemotherapy regimen has component Fluorouracil	NCI
C12101	RO	chemotherapy regimen has component Tetanus Toxoid Vaccine	NCI
C12101	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C12101	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12101	RO	chemotherapy regimen has component ALVAC-CEA B7.1 Vaccine	NCI
C11641	STY	Therapeutic or Preventive Procedure		NCI
C11641	PT	Tamoxifen/Trastuzumab		NCI
C11641	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11641	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11641	RO	chemotherapy regimen has component Trastuzumab	NCI
C10108	STY	Therapeutic or Preventive Procedure		NCI
C10108	PT	Methotrexate/Prednisone/Procarbazine/Vincristine		NCI
C10108	SY	MTX/PCB/PRED/VCR		NCI
C10108	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10108	RO	chemotherapy regimen has component Methotrexate	NCI
C10108	RO	chemotherapy regimen has component Prednisone	NCI
C10108	RO	chemotherapy regimen has component Vincristine	NCI
C10108	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9650	STY	Therapeutic or Preventive Procedure		NCI
C9650	PT	Doxorubicin/Etoposide/Vincristine		NCI
C9650	SY	DOX/VCR/VP-16		NCI
C9650	SY	VAV		NCI
C9650	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9650	RO	chemotherapy regimen has component Doxorubicin	NCI
C9650	RO	chemotherapy regimen has component Etoposide	NCI
C9650	RO	chemotherapy regimen has component Vincristine	NCI
C142859	STY	Therapeutic or Preventive Procedure		NCI
C142859	PT	Letrozole/Palbociclib Regimen		NCI
C142859	SY	Letrozole/Palbociclib		NCI
C142859	SY	Letrozole-Palbociclib		NCI
C142859	SY	Femara/Ibrance		NCI
C142859	SY	Palbociclib + Letrozole		NCI
C142859	SY	Letrozole + Palbociclib		NCI
C142859	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C142859	RO	chemotherapy regimen has component Letrozole	NCI
C142859	RO	chemotherapy regimen has component Palbociclib	NCI
C142859	RO	concept in subset CTRP Terminology	NCI
C142859	RO	concept in subset CTRP Agent Terminology	NCI
C11732	STY	Therapeutic or Preventive Procedure		NCI
C11732	PT	Asparaginase/cytarabine/daunorubicin/methotrexate/prednisone/vincristine		NCI
C11732	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11732	RO	chemotherapy regimen has component Asparaginase	NCI
C11732	RO	chemotherapy regimen has component Cytarabine	NCI
C11732	RO	chemotherapy regimen has component Methotrexate	NCI
C11732	RO	chemotherapy regimen has component Prednisone	NCI
C11732	RO	chemotherapy regimen has component Vincristine	NCI
C11732	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11543	STY	Therapeutic or Preventive Procedure		NCI
C11543	PT	Piperacillin/Tazobactam/Vancomycin		NCI
C11543	SY	PIPER/TAZO/VANCO		NCI
C11543	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11543	RO	chemotherapy regimen has component Vancomycin	NCI
C11543	RO	chemotherapy regimen has component Piperacillin Sodium	NCI
C11543	RO	chemotherapy regimen has component Tazobactam Sodium	NCI
C11745	STY	Therapeutic or Preventive Procedure		NCI
C11745	PT	Amifostine/Cisplatin/Irinotecan		NCI
C11745	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11745	RO	chemotherapy regimen has component Cisplatin	NCI
C11745	RO	chemotherapy regimen has component Amifostine	NCI
C11745	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C63466	STY	Therapeutic or Preventive Procedure		NCI
C63466	PT	Thalidomide-Rituximab Regimen		NCI
C63466	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63466	RO	chemotherapy regimen has component Thalidomide	NCI
C63466	RO	chemotherapy regimen has component Rituximab	NCI
C63466	RO	regimen has accepted use for disease Recurrent Mantle Cell Lymphoma	NCI
C63466	RO	regimen has accepted use for disease Refractory Mantle Cell Lymphoma	NCI
C99697	STY	Therapeutic or Preventive Procedure		NCI
C99697	PT	F-MACHOP Regimen		NCI
C99697	SY	5-Fluorouracil-Methotrexate-Leucovorin-Cytarabine-Cyclophosphamide-Doxorubicin-Vincristine-Prednisone Regimen		NCI
C99697	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C99697	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C99697	RO	chemotherapy regimen has component Cytarabine	NCI
C99697	RO	chemotherapy regimen has component Doxorubicin	NCI
C99697	RO	chemotherapy regimen has component Fluorouracil	NCI
C99697	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C99697	RO	chemotherapy regimen has component Methotrexate	NCI
C99697	RO	chemotherapy regimen has component Prednisone	NCI
C99697	RO	chemotherapy regimen has component Vincristine	NCI
C99697	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10794	STY	Therapeutic or Preventive Procedure		NCI
C10794	PT	Asparaginase/Daunorubicin/Prednisolone/Vindesine		NCI
C10794	SY	ASP/DAVA/DNR/PRDL		NCI
C10794	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10794	RO	chemotherapy regimen has component Asparaginase	NCI
C10794	RO	chemotherapy regimen has component Prednisolone	NCI
C10794	RO	chemotherapy regimen has component Vindesine	NCI
C10794	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C12006	STY	Therapeutic or Preventive Procedure		NCI
C12006	PT	Cetuximab/Fluorouracil/Irinotecan/Leucovorin Calcium		NCI
C12006	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12006	RO	chemotherapy regimen has component Fluorouracil	NCI
C12006	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C12006	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12006	RO	chemotherapy regimen has component Cetuximab	NCI
C10417	STY	Therapeutic or Preventive Procedure		NCI
C10417	PT	Carboplatin/Cytarabine/Etoposide		NCI
C10417	SY	ARA-C/CBDCA/VP-16		NCI
C10417	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10417	RO	chemotherapy regimen has component Cytarabine	NCI
C10417	RO	chemotherapy regimen has component Etoposide	NCI
C10417	RO	chemotherapy regimen has component Carboplatin	NCI
C12069	STY	Therapeutic or Preventive Procedure		NCI
C12069	PT	Apolizumab/Rituximab		NCI
C12069	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12069	RO	chemotherapy regimen has component Rituximab	NCI
C12069	RO	chemotherapy regimen has component Apolizumab	NCI
C9725	STY	Therapeutic or Preventive Procedure		NCI
C9725	PT	Altretamine/Mitomycin/Vinblastine		NCI
C9725	SY	HMVlb		NCI
C9725	SY	HMM/MITO/VBL		NCI
C9725	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9725	RO	chemotherapy regimen has component Mitomycin	NCI
C9725	RO	chemotherapy regimen has component Altretamine	NCI
C9725	RO	chemotherapy regimen has component Vinblastine	NCI
C63520	STY	Therapeutic or Preventive Procedure		NCI
C63520	PT	Cisplatin-Doxorubicin-Paclitaxel Regimen		NCI
C63520	CHD	Chemotherapy Regimen Used to Treat Endometrial Carcinoma	NCI
C63520	RO	regimen has accepted use for disease Endometrial Carcinoma	NCI
C37748	STY	Therapeutic or Preventive Procedure		NCI
C37748	PT	Docetaxel/Tariquidar		NCI
C37748	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37748	RO	chemotherapy regimen has component Docetaxel	NCI
C37748	RO	chemotherapy regimen has component Tariquidar	NCI
C10144	STY	Therapeutic or Preventive Procedure		NCI
C10144	PT	Trifluoperazine/Vinblastine		NCI
C10144	SY	TFPZ/VBL		NCI
C10144	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10144	RO	chemotherapy regimen has component Vinblastine	NCI
C10144	RO	chemotherapy regimen has component Trifluoperazine Hydrochloride	NCI
C10049	STY	Therapeutic or Preventive Procedure		NCI
C10049	PT	Carmustine/Cyclophosphamide/Thiotepa/Vincristine		NCI
C10049	SY	BCNU/CTX/TSPA/VCR		NCI
C10049	SY	BTOC		NCI
C10049	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10049	RO	chemotherapy regimen has component Carmustine	NCI
C10049	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10049	RO	chemotherapy regimen has component Thiotepa	NCI
C10049	RO	chemotherapy regimen has component Vincristine	NCI
C11126	STY	Therapeutic or Preventive Procedure		NCI
C11126	PT	Fluorouracil/Octreotide Pamoate		NCI
C11126	SY	5-FU/SMS 201-995 pa		NCI
C11126	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11126	RO	chemotherapy regimen has component Fluorouracil	NCI
C11126	RO	chemotherapy regimen has component Octreotide Pamoate	NCI
C10157	STY	Therapeutic or Preventive Procedure		NCI
C10157	PT	Altretamine/Carboplatin/Cyclophosphamide/Doxorubicin		NCI
C10157	SY	CHAC-1		NCI
C10157	SY	CBDCA/CTX/DOX/HMM		NCI
C10157	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10157	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10157	RO	chemotherapy regimen has component Doxorubicin	NCI
C10157	RO	chemotherapy regimen has component Altretamine	NCI
C10157	RO	chemotherapy regimen has component Carboplatin	NCI
C11238	STY	Therapeutic or Preventive Procedure		NCI
C11238	PT	Cisplatin/Filgrastim/Paclitaxel/Topotecan		NCI
C11238	SY	CDDP/G-CSF/TAX/TOPO		NCI
C11238	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11238	RO	chemotherapy regimen has component Cisplatin	NCI
C11238	RO	chemotherapy regimen has component Paclitaxel	NCI
C11238	RO	chemotherapy regimen has component Topotecan	NCI
C11238	RO	chemotherapy regimen has component Filgrastim	NCI
C37477	STY	Therapeutic or Preventive Procedure		NCI
C37477	PT	Docetaxel/Vitaxin-2		NCI
C37477	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37477	RO	chemotherapy regimen has component Docetaxel	NCI
C37477	RO	chemotherapy regimen has component Vitaxin-2	NCI
C11880	STY	Therapeutic or Preventive Procedure		NCI
C11880	PT	Celecoxib/Trastuzumab		NCI
C11880	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11880	RO	chemotherapy regimen has component Celecoxib	NCI
C11880	RO	chemotherapy regimen has component Trastuzumab	NCI
C10280	STY	Therapeutic or Preventive Procedure		NCI
C10280	PT	Doxorubicin/Fluorouracil/Semustine		NCI
C10280	SY	DOX/5-FU/MeCCNU		NCI
C10280	SY	MEFA		NCI
C10280	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10280	RO	chemotherapy regimen has component Doxorubicin	NCI
C10280	RO	chemotherapy regimen has component Fluorouracil	NCI
C10280	RO	chemotherapy regimen has component Semustine	NCI
C9510	STY	Therapeutic or Preventive Procedure		NCI
C9510	PT	Cyclophosphamide/Doxorubicin		NCI
C9510	SY	CTX/DOX		NCI
C9510	SY	ACe		NCI
C9510	SY	Doxorubicin/Cyclophosphamide		NCI
C9510	SY	CA		NCI
C9510	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9510	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9510	RO	chemotherapy regimen has component Doxorubicin	NCI
C37700	STY	Therapeutic or Preventive Procedure		NCI
C37700	PT	Cyclophosphamide/Prednisone/Rasburicase/Vincristine		NCI
C37700	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37700	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37700	RO	chemotherapy regimen has component Prednisone	NCI
C37700	RO	chemotherapy regimen has component Vincristine	NCI
C37700	RO	chemotherapy regimen has component Rasburicase	NCI
C11563	STY	Therapeutic or Preventive Procedure		NCI
C11563	PT	Doxorubicin/Ifosfamide/Methotrexate/Muramyl Tripeptide Phosphatidylethanolamine Liposome		NCI
C11563	SY	DOX/IFF/MTP-PE Liposome/MTX		NCI
C11563	SY	Doxorubicin/Ifosfamide/Methotrexate/Muramyl Tripeptide Phosphatidylethanolamine		NCI
C11563	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11563	RO	chemotherapy regimen has component Doxorubicin	NCI
C11563	RO	chemotherapy regimen has component Ifosfamide	NCI
C11563	RO	chemotherapy regimen has component Methotrexate	NCI
C11563	RO	chemotherapy regimen has component Mifamurtide	NCI
C12109	STY	Therapeutic or Preventive Procedure		NCI
C12109	PT	Bevacizumab/Gemcitabine		NCI
C12109	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12109	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12109	RO	chemotherapy regimen has component Bevacizumab	NCI
C10402	STY	Therapeutic or Preventive Procedure		NCI
C10402	PT	Cisplatin/Etoposide/Hydrazine Sulfate		NCI
C10402	SY	CDDP/HDZ/VP-16		NCI
C10402	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10402	RO	chemotherapy regimen has component Cisplatin	NCI
C10402	RO	chemotherapy regimen has component Etoposide	NCI
C10402	RO	chemotherapy regimen has component Hydrazine Sulfate	NCI
C11336	STY	Therapeutic or Preventive Procedure		NCI
C11336	PT	Buserelin/Nilutamide		NCI
C11336	SY	ANAN/BSRL		NCI
C11336	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11336	RO	chemotherapy regimen has component Buserelin	NCI
C11336	RO	chemotherapy regimen has component Nilutamide	NCI
C9600	STY	Therapeutic or Preventive Procedure		NCI
C9600	PT	Cisplatin/Doxorubicin/Ifosfamide		NCI
C9600	SY	PIA		NCI
C9600	SY	CDDP/DOX/IFF		NCI
C9600	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9600	RO	chemotherapy regimen has component Cisplatin	NCI
C9600	RO	chemotherapy regimen has component Doxorubicin	NCI
C9600	RO	chemotherapy regimen has component Ifosfamide	NCI
C10536	STY	Therapeutic or Preventive Procedure		NCI
C10536	PT	Cyclophosphamide/Dexamethasone/Doxorubicin/Quinine/Verapamil/Vincristine		NCI
C10536	SY	CTX/DM/DOX/QUIN/VCR/VPAM		NCI
C10536	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10536	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10536	RO	chemotherapy regimen has component Dexamethasone	NCI
C10536	RO	chemotherapy regimen has component Doxorubicin	NCI
C10536	RO	chemotherapy regimen has component Quinine	NCI
C10536	RO	chemotherapy regimen has component Verapamil	NCI
C10536	RO	chemotherapy regimen has component Vincristine	NCI
C10331	STY	Therapeutic or Preventive Procedure		NCI
C10331	PT	Cyclophosphamide/Interleukin-2/Tumor Infiltrating Lymphocytes		NCI
C10331	SY	CTX/IL-2/TIL		NCI
C10331	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10331	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10331	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C10331	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10472	STY	Therapeutic or Preventive Procedure		NCI
C10472	PT	Fluoxymesterone/Tamoxifen		NCI
C10472	SY	FXM/TMX		NCI
C10472	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10472	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C10472	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C12061	STY	Therapeutic or Preventive Procedure		NCI
C12061	PT	Cisplatin/Doxorubicin/Etoposide/Ifosfamide/Methotrexate/Trastuzumab		NCI
C12061	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12061	RO	chemotherapy regimen has component Cisplatin	NCI
C12061	RO	chemotherapy regimen has component Doxorubicin	NCI
C12061	RO	chemotherapy regimen has component Etoposide	NCI
C12061	RO	chemotherapy regimen has component Ifosfamide	NCI
C12061	RO	chemotherapy regimen has component Methotrexate	NCI
C12061	RO	chemotherapy regimen has component Trastuzumab	NCI
C10152	STY	Therapeutic or Preventive Procedure		NCI
C10152	PT	Etoposide/Ifosfamide/Vindesine		NCI
C10152	SY	DAVA/IFF/VP-16		NCI
C10152	SY	VPIV		NCI
C10152	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10152	RO	chemotherapy regimen has component Etoposide	NCI
C10152	RO	chemotherapy regimen has component Ifosfamide	NCI
C10152	RO	chemotherapy regimen has component Vindesine	NCI
C9708	STY	Therapeutic or Preventive Procedure		NCI
C9708	PT	Mitoxantrone/Prednisone/Procarbazine/Vincristine		NCI
C9708	SY	DHAD/PCB/PRED/VCR		NCI
C9708	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9708	RO	chemotherapy regimen has component Prednisone	NCI
C9708	RO	chemotherapy regimen has component Vincristine	NCI
C9708	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9708	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37554	STY	Therapeutic or Preventive Procedure		NCI
C37554	PT	Bevacizumab/Cetuximab/Irinotecan		NCI
C37554	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37554	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37554	RO	chemotherapy regimen has component Bevacizumab	NCI
C37554	RO	chemotherapy regimen has component Cetuximab	NCI
C11758	STY	Therapeutic or Preventive Procedure		NCI
C11758	PT	Anti-thymocyte globulin/methylprednisolone/tacrolimus		NCI
C11758	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11758	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11758	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11758	RO	chemotherapy regimen has component Tacrolimus	NCI
C12107	STY	Therapeutic or Preventive Procedure		NCI
C12107	PT	Cytarabine/Imatinib Mesylate		NCI
C12107	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12107	RO	chemotherapy regimen has component Cytarabine	NCI
C12107	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C9927	STY	Therapeutic or Preventive Procedure		NCI
C9927	PT	Doxorubicin/Ifosfamide/Vincristine		NCI
C9927	SY	DOX/IFF/VCR		NCI
C9927	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9927	RO	chemotherapy regimen has component Doxorubicin	NCI
C9927	RO	chemotherapy regimen has component Ifosfamide	NCI
C9927	RO	chemotherapy regimen has component Vincristine	NCI
C11320	STY	Therapeutic or Preventive Procedure		NCI
C11320	PT	gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Sargramostim/Tyrosinase Peptide		NCI
C11320	SY	GM-CSF/GP100/IFA/MART-1/TYRP		NCI
C11320	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11320	RO	chemotherapy regimen has component Sargramostim	NCI
C11320	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11320	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11320	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11320	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10890	STY	Therapeutic or Preventive Procedure		NCI
C10890	PT	Cisplatin/Epoetin Alfa/Etoposide/Filgrastim/Ifosfamide		NCI
C10890	SY	CDDP/EPO/G-CSF/IFF/VP-16		NCI
C10890	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10890	RO	chemotherapy regimen has component Cisplatin	NCI
C10890	RO	chemotherapy regimen has component Etoposide	NCI
C10890	RO	chemotherapy regimen has component Ifosfamide	NCI
C10890	RO	chemotherapy regimen has component Filgrastim	NCI
C10890	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C9795	STY	Therapeutic or Preventive Procedure		NCI
C9795	PT	Asparaginase/Cytarabine		NCI
C9795	SY	ARA-C/ASP		NCI
C9795	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9795	RO	chemotherapy regimen has component Asparaginase	NCI
C9795	RO	chemotherapy regimen has component Cytarabine	NCI
C10340	STY	Therapeutic or Preventive Procedure		NCI
C10340	PT	Etoposide/Ifosfamide/Mitoxantrone		NCI
C10340	SY	DHAD/IFF/VP-16		NCI
C10340	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10340	RO	chemotherapy regimen has component Etoposide	NCI
C10340	RO	chemotherapy regimen has component Ifosfamide	NCI
C10340	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37622	STY	Therapeutic or Preventive Procedure		NCI
C37622	PT	Carboplatin/Polyglutamate Paclitaxel		NCI
C37622	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37622	RO	chemotherapy regimen has component Carboplatin	NCI
C37622	RO	chemotherapy regimen has component Paclitaxel Poliglumex	NCI
C10561	STY	Therapeutic or Preventive Procedure		NCI
C10561	PT	Fluorouracil/Idoxuridine/Leucovorin Calcium/PALA		NCI
C10561	SY	CF/5-FU/IUDR/PALA		NCI
C10561	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10561	RO	chemotherapy regimen has component Fluorouracil	NCI
C10561	RO	chemotherapy regimen has component Idoxuridine	NCI
C10561	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C10561	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37519	STY	Therapeutic or Preventive Procedure		NCI
C37519	PT	Allogeneic Lymphocytes/Cyclosporine		NCI
C37519	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37519	RO	chemotherapy regimen has component Cyclosporine	NCI
C37519	RO	chemotherapy regimen has component Therapeutic Allogeneic Lymphocytes	NCI
C9672	STY	Therapeutic or Preventive Procedure		NCI
C9672	PT	Epirubicin/Fluorouracil/Mitomycin		NCI
C9672	SY	EPI/5-FU/MITO		NCI
C9672	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9672	RO	chemotherapy regimen has component Mitomycin	NCI
C9672	RO	chemotherapy regimen has component Fluorouracil	NCI
C9672	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C10559	STY	Therapeutic or Preventive Procedure		NCI
C10559	PT	Carboplatin/Diethyldithiocarbamate		NCI
C10559	SY	CBDCA/DTC		NCI
C10559	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10559	RO	chemotherapy regimen has component Ditiocarb	NCI
C10559	RO	chemotherapy regimen has component Carboplatin	NCI
C11151	STY	Therapeutic or Preventive Procedure		NCI
C11151	PT	Cyclophosphamide/Cytarabine/Methylprednisolone		NCI
C11151	SY	ARA-C/CTX/MePRDL		NCI
C11151	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11151	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11151	RO	chemotherapy regimen has component Cytarabine	NCI
C11151	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11860	STY	Therapeutic or Preventive Procedure		NCI
C11860	PT	Arginine butyrate/Ganciclovir		NCI
C11860	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11860	RO	chemotherapy regimen has component Ganciclovir	NCI
C11860	RO	chemotherapy regimen has component Arginine Butyrate	NCI
C63459	STY	Therapeutic or Preventive Procedure		NCI
C63459	PT	PCR Regimen		NCI
C63459	SY	Pentostatin-Cyclophosphamide-Rituximab Regimen		NCI
C63459	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63459	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63459	RO	chemotherapy regimen has component Pentostatin	NCI
C63459	RO	chemotherapy regimen has component Rituximab	NCI
C63459	RO	regimen has accepted use for disease Recurrent Mantle Cell Lymphoma	NCI
C63459	RO	regimen has accepted use for disease Refractory Mantle Cell Lymphoma	NCI
C11697	STY	Therapeutic or Preventive Procedure		NCI
C11697	PT	Estramustine/Paclitaxel/Vinorelbine		NCI
C11697	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11697	RO	chemotherapy regimen has component Estramustine	NCI
C11697	RO	chemotherapy regimen has component Vinorelbine	NCI
C11697	RO	chemotherapy regimen has component Paclitaxel	NCI
C11623	STY	Therapeutic or Preventive Procedure		NCI
C11623	PT	Leflunomide/Mitoxantrone		NCI
C11623	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11623	RO	chemotherapy regimen has component Leflunomide	NCI
C11623	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9715	STY	Therapeutic or Preventive Procedure		NCI
C9715	PT	Cisplatin/Cyclophosphamide/Mitoxantrone		NCI
C9715	SY	CDDP/CTX/DHAD		NCI
C9715	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9715	RO	chemotherapy regimen has component Cisplatin	NCI
C9715	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9715	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9664	STY	Therapeutic or Preventive Procedure		NCI
C9664	PT	Prednisolone/Vincristine		NCI
C9664	SY	VP		NCI
C9664	SY	PRDL/VCR		NCI
C9664	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9664	RO	chemotherapy regimen has component Prednisolone	NCI
C9664	RO	chemotherapy regimen has component Vincristine	NCI
C11310	STY	Therapeutic or Preventive Procedure		NCI
C11310	PT	Bryostatin 1/Cisplatin		NCI
C11310	SY	BRYO/CDDP		NCI
C11310	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11310	RO	chemotherapy regimen has component Cisplatin	NCI
C11310	RO	chemotherapy regimen has component Bryostatin 1	NCI
C10123	STY	Therapeutic or Preventive Procedure		NCI
C10123	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Misonidazole		NCI
C10123	SY	M-CAP		NCI
C10123	SY	CDDP/CTX/DOX/MNI		NCI
C10123	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10123	RO	chemotherapy regimen has component Cisplatin	NCI
C10123	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10123	RO	chemotherapy regimen has component Doxorubicin	NCI
C10123	RO	chemotherapy regimen has component Misonidazole	NCI
C11722	STY	Therapeutic or Preventive Procedure		NCI
C11722	PT	Alum adjuvant/Monoclonal antibody 4B5 anti-idiotype vaccine		NCI
C11722	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11722	RO	chemotherapy regimen has component Monoclonal Antibody 4B5 Anti-Idiotype Vaccine	NCI
C11722	RO	chemotherapy regimen has component Aluminum Sulfate Anhydrous	NCI
C37557	STY	Therapeutic or Preventive Procedure		NCI
C37557	PT	Bevacizumab/Erlotinib		NCI
C37557	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37557	RO	chemotherapy regimen has component Bevacizumab	NCI
C37557	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C15627	STY	Therapeutic or Preventive Procedure		NCI
C15627	PT	Interferon Alfa/Monoclonal Antibody CC49/Paclitaxel		NCI
C15627	SY	IFN-A/MOAB CC49/TAX		NCI
C15627	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15627	RO	chemotherapy regimen has component Paclitaxel	NCI
C15627	RO	chemotherapy regimen has component Minretumomab	NCI
C15627	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10863	STY	Therapeutic or Preventive Procedure		NCI
C10863	PT	Cytarabine/Mitoxantrone/Sargramostim		NCI
C10863	SY	ARA-C/DHAD/GM-CSF		NCI
C10863	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10863	RO	chemotherapy regimen has component Cytarabine	NCI
C10863	RO	chemotherapy regimen has component Sargramostim	NCI
C10863	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11965	STY	Therapeutic or Preventive Procedure		NCI
C11965	PT	Bismuth Bi213 Monoclonal Antibody M195/Cytarabine/Filgrastim		NCI
C11965	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11965	RO	chemotherapy regimen has component Cytarabine	NCI
C11965	RO	chemotherapy regimen has component Filgrastim	NCI
C11965	RO	chemotherapy regimen has component Bismuth Bi213 Monoclonal Antibody M195	NCI
C11193	STY	Therapeutic or Preventive Procedure		NCI
C11193	PT	Cytarabine/Deoxycytidine		NCI
C11193	SY	ARA-C/dC		NCI
C11193	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11193	RO	chemotherapy regimen has component Cytarabine	NCI
C11193	RO	chemotherapy regimen has component Deoxycytidine	NCI
C10937	STY	Therapeutic or Preventive Procedure		NCI
C10937	PT	Cisplatin/Epirubicin/Fluorouracil		NCI
C10937	SY	CDDP/EPI/5-FU		NCI
C10937	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10937	RO	chemotherapy regimen has component Cisplatin	NCI
C10937	RO	chemotherapy regimen has component Fluorouracil	NCI
C10937	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C10443	STY	Therapeutic or Preventive Procedure		NCI
C10443	PT	Cyclophosphamide/Dexverapamil/Doxorubicin/Etoposide/Prednisone/Vincristine		NCI
C10443	SY	CTX/DOX/PRED/R-VPAM/VCR/VP-16		NCI
C10443	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10443	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10443	RO	chemotherapy regimen has component Doxorubicin	NCI
C10443	RO	chemotherapy regimen has component Etoposide	NCI
C10443	RO	chemotherapy regimen has component Prednisone	NCI
C10443	RO	chemotherapy regimen has component Vincristine	NCI
C10443	RO	chemotherapy regimen has component Dexverapamil	NCI
C9805	STY	Therapeutic or Preventive Procedure		NCI
C9805	PT	Flutamide/Goserelin		NCI
C9805	SY	FLUT/ZDX		NCI
C9805	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9805	RO	chemotherapy regimen has component Flutamide	NCI
C9805	RO	chemotherapy regimen has component Goserelin	NCI
C37567	STY	Therapeutic or Preventive Procedure		NCI
C37567	PT	Bortezomib/Carboplatin/Paclitaxel		NCI
C37567	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37567	RO	chemotherapy regimen has component Carboplatin	NCI
C37567	RO	chemotherapy regimen has component Paclitaxel	NCI
C37567	RO	chemotherapy regimen has component Bortezomib	NCI
C140103	STY	Therapeutic or Preventive Procedure		NCI
C140103	PT	R-HD-MTX/ARA-C Regimen		NCI
C140103	SY	Rituximab/HD-Methotrexate/Cytarabine		NCI
C140103	SY	Rituximab-HD-MTX/ARA-C		NCI
C140103	SY	Rituximab Plus HD MTX Plus HD AraC		NCI
C140103	SY	Rituximab-High-dose Methotrexate-High-dose Cytarabine		NCI
C140103	SY	R-HD-MTX/ARA-C		NCI
C140103	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140103	RO	chemotherapy regimen has component Cytarabine	NCI
C140103	RO	chemotherapy regimen has component Methotrexate	NCI
C140103	RO	chemotherapy regimen has component Rituximab	NCI
C11369	STY	Therapeutic or Preventive Procedure		NCI
C11369	PT	Cytarabine/Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vincristine		NCI
C11369	SY	ARA-C/CTX/DM/DOX/MTX/VCR		NCI
C11369	SY	Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Methotrexate/Vincristine		NCI
C11369	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11369	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11369	RO	chemotherapy regimen has component Cytarabine	NCI
C11369	RO	chemotherapy regimen has component Dexamethasone	NCI
C11369	RO	chemotherapy regimen has component Doxorubicin	NCI
C11369	RO	chemotherapy regimen has component Methotrexate	NCI
C11369	RO	chemotherapy regimen has component Vincristine	NCI
C9862	STY	Therapeutic or Preventive Procedure		NCI
C9862	PT	Diaziquone/Etoposide		NCI
C9862	SY	AZQ/VP-16		NCI
C9862	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9862	RO	chemotherapy regimen has component Etoposide	NCI
C9862	RO	chemotherapy regimen has component Diaziquone	NCI
C37810	STY	Therapeutic or Preventive Procedure		NCI
C37810	PT	Imatinib Mesylate/PEG-Interferon Alfa-2a		NCI
C37810	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37810	RO	chemotherapy regimen has component Peginterferon Alfa-2a	NCI
C37810	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C10694	STY	Therapeutic or Preventive Procedure		NCI
C10694	PT	Cisplatin/Estramustine/Etoposide		NCI
C10694	SY	CDDP/EM/VP-16		NCI
C10694	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10694	RO	chemotherapy regimen has component Cisplatin	NCI
C10694	RO	chemotherapy regimen has component Estramustine	NCI
C10694	RO	chemotherapy regimen has component Etoposide	NCI
C11704	STY	Therapeutic or Preventive Procedure		NCI
C11704	PT	LY335979/Vinorelbine		NCI
C11704	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11704	RO	chemotherapy regimen has component Vinorelbine	NCI
C11704	RO	chemotherapy regimen has component Zosuquidar Trihydrochloride	NCI
C37791	STY	Therapeutic or Preventive Procedure		NCI
C37791	PT	Fowlpox-PSA-TRICOM Vaccine/Sargramostim/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine		NCI
C37791	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37791	RO	chemotherapy regimen has component Sargramostim	NCI
C37791	RO	chemotherapy regimen has component Fowlpox-PSA-TRICOM Vaccine	NCI
C37791	RO	chemotherapy regimen has component Rilimogene Galvacirepvec	NCI
C9848	STY	Therapeutic or Preventive Procedure		NCI
C9848	PT	Amsacrine/Cytarabine/Daunorubicin		NCI
C9848	SY	AMSA/ARA-C/DNR		NCI
C9848	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9848	RO	chemotherapy regimen has component Amsacrine	NCI
C9848	RO	chemotherapy regimen has component Cytarabine	NCI
C9848	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9974	STY	Therapeutic or Preventive Procedure		NCI
C9974	PT	Amiodarone/Doxorubicin		NCI
C9974	SY	amiodarone/DOX		NCI
C9974	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9974	RO	chemotherapy regimen has component Doxorubicin	NCI
C9974	RO	chemotherapy regimen has component Amiodarone Hydrochloride	NCI
C10369	STY	Therapeutic or Preventive Procedure		NCI
C10369	PT	Dacarbazine/Interleukin-2		NCI
C10369	SY	DTIC/IL-2		NCI
C10369	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10369	RO	chemotherapy regimen has component Dacarbazine	NCI
C10369	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C136282	STY	Therapeutic or Preventive Procedure		NCI
C136282	PT	Bevacizumab/Cisplatin/Pemetrexed Regimen		NCI
C136282	SY	Bevacizumab-Cisplatin-Pemetrexed		NCI
C136282	SY	Bevacizumab/Cisplatin/Pemetrexed		NCI
C136282	SY	Bevacizumab-Cisplatin-Pemetrexed Regimen		NCI
C136282	SY	Avastin/Cisplatin/Pemetrexed		NCI
C136282	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C136282	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C136282	RO	chemotherapy regimen has component Cisplatin	NCI
C136282	RO	chemotherapy regimen has component Bevacizumab	NCI
C136282	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C11288	STY	Therapeutic or Preventive Procedure		NCI
C11288	PT	Amifostine/Topotecan		NCI
C11288	SY	TOPO/WR-2721		NCI
C11288	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11288	RO	chemotherapy regimen has component Amifostine	NCI
C11288	RO	chemotherapy regimen has component Topotecan	NCI
C138051	STY	Therapeutic or Preventive Procedure		NCI
C138051	PT	Paclitaxel/Trastuzumab Regimen		NCI
C138051	SY	Paclitaxel/Trastuzumab		NCI
C138051	SY	Paclitaxel-Trastuzumab		NCI
C138051	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138051	RO	chemotherapy regimen has component Paclitaxel	NCI
C138051	RO	chemotherapy regimen has component Trastuzumab	NCI
C37811	STY	Therapeutic or Preventive Procedure		NCI
C37811	PT	Imatinib Mesylate/Oblimersen		NCI
C37811	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37811	RO	chemotherapy regimen has component Oblimersen	NCI
C37811	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C11290	STY	Therapeutic or Preventive Procedure		NCI
C11290	PT	Amifostine/Cisplatin/Fluorouracil		NCI
C11290	SY	CDDP/5-FU/WR-2721		NCI
C11290	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11290	RO	chemotherapy regimen has component Cisplatin	NCI
C11290	RO	chemotherapy regimen has component Amifostine	NCI
C11290	RO	chemotherapy regimen has component Fluorouracil	NCI
C10464	STY	Therapeutic or Preventive Procedure		NCI
C10464	PT	Cisplatin/Cyclophosphamide/Leuprolide		NCI
C10464	SY	CDDP/CTX/LEUP		NCI
C10464	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10464	RO	chemotherapy regimen has component Cisplatin	NCI
C10464	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10464	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C37721	STY	Therapeutic or Preventive Procedure		NCI
C37721	PT	Dacarbazine/Interleukin-2/Temozolomide		NCI
C37721	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37721	RO	chemotherapy regimen has component Dacarbazine	NCI
C37721	RO	chemotherapy regimen has component Temozolomide	NCI
C37721	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10790	STY	Therapeutic or Preventive Procedure		NCI
C10790	PT	Busulfan/Ciprofloxacin/Cyclophosphamide/Pentoxifylline		NCI
C10790	SY	BU/CPFX/CTX/PTX		NCI
C10790	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10790	RO	chemotherapy regimen has component Busulfan	NCI
C10790	RO	chemotherapy regimen has component Ciprofloxacin	NCI
C10790	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10790	RO	chemotherapy regimen has component Pentoxifylline	NCI
C11012	STY	Therapeutic or Preventive Procedure		NCI
C11012	PT	Interferon Alfa/Mercaptopurine/Methotrexate		NCI
C11012	SY	IFN-A/MP/MTX		NCI
C11012	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11012	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11012	RO	chemotherapy regimen has component Methotrexate	NCI
C11012	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9735	STY	Therapeutic or Preventive Procedure		NCI
C9735	PT	Ifosfamide/Cyclophosphamide/Etoposide		NCI
C9735	SY	CTX/IFF/VP-16		NCI
C9735	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9735	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9735	RO	chemotherapy regimen has component Etoposide	NCI
C9735	RO	chemotherapy regimen has component Ifosfamide	NCI
C37710	STY	Therapeutic or Preventive Procedure		NCI
C37710	PT	Cytarabine/Daunorubicin/Methotrexate/Pegaspargase/Prednisone/Vincristine		NCI
C37710	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37710	RO	chemotherapy regimen has component Cytarabine	NCI
C37710	RO	chemotherapy regimen has component Methotrexate	NCI
C37710	RO	chemotherapy regimen has component Prednisone	NCI
C37710	RO	chemotherapy regimen has component Vincristine	NCI
C37710	RO	chemotherapy regimen has component Pegaspargase	NCI
C37710	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11994	STY	Therapeutic or Preventive Procedure		NCI
C11994	PT	Keyhole Limpet Hemocyanin/Sargramostim		NCI
C11994	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11994	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C11994	RO	chemotherapy regimen has component Sargramostim	NCI
C11179	STY	Therapeutic or Preventive Procedure		NCI
C11179	PT	Dacarbazine/Doxorubicin/Ifosfamide/Mesna		NCI
C11179	SY	DOX/DTIC/IFF/mesna		NCI
C11179	SY	MAID		NCI
C11179	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11179	RO	chemotherapy regimen has component Mesna	NCI
C11179	RO	chemotherapy regimen has component Dacarbazine	NCI
C11179	RO	chemotherapy regimen has component Doxorubicin	NCI
C11179	RO	chemotherapy regimen has component Ifosfamide	NCI
C37740	STY	Therapeutic or Preventive Procedure		NCI
C37740	PT	Docetaxel/Epirubicin/Pegfilgrastim		NCI
C37740	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37740	RO	chemotherapy regimen has component Docetaxel	NCI
C37740	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C37740	RO	chemotherapy regimen has component Pegfilgrastim	NCI
C37793	STY	Therapeutic or Preventive Procedure		NCI
C37793	PT	Fowlpox-Sargramostim Vaccine/Fowlpox-TRICOM Vaccine		NCI
C37793	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37793	RO	chemotherapy regimen has component Recombinant Fowlpox-TRICOM Vaccine	NCI
C37793	RO	chemotherapy regimen has component Recombinant Fowlpox GM-CSF Vaccine Adjuvant	NCI
C10082	STY	Therapeutic or Preventive Procedure		NCI
C10082	PT	Bleomycin/Cisplatin/Doxorubicin		NCI
C10082	SY	BLEO/CDDP/DOX		NCI
C10082	SY	ABCX		NCI
C10082	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10082	RO	chemotherapy regimen has component Bleomycin	NCI
C10082	RO	chemotherapy regimen has component Cisplatin	NCI
C10082	RO	chemotherapy regimen has component Doxorubicin	NCI
C10695	STY	Therapeutic or Preventive Procedure		NCI
C10695	PT	Cisplatin/Decitabine		NCI
C10695	SY	CDDP/DAC		NCI
C10695	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10695	RO	chemotherapy regimen has component Cisplatin	NCI
C10695	RO	chemotherapy regimen has component Decitabine	NCI
C11018	STY	Therapeutic or Preventive Procedure		NCI
C11018	PT	Interferon Alfa/Poly ICLC		NCI
C11018	SY	IFN-A/Poly ICLC		NCI
C11018	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11018	RO	chemotherapy regimen has component Poly ICLC	NCI
C11018	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10322	STY	Therapeutic or Preventive Procedure		NCI
C10322	PT	Carmustine/Cyclophosphamide/Etoposide/Filgrastim		NCI
C10322	SY	BCNU/CTX/G-CSF/VP-16		NCI
C10322	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10322	RO	chemotherapy regimen has component Carmustine	NCI
C10322	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10322	RO	chemotherapy regimen has component Etoposide	NCI
C10322	RO	chemotherapy regimen has component Filgrastim	NCI
C11534	STY	Therapeutic or Preventive Procedure		NCI
C11534	PT	Cytarabine/Methotrexate/Thioguanine		NCI
C11534	SY	ARA-C/MTX/TG		NCI
C11534	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11534	RO	chemotherapy regimen has component Cytarabine	NCI
C11534	RO	chemotherapy regimen has component Methotrexate	NCI
C11534	RO	chemotherapy regimen has component Thioguanine	NCI
C11585	STY	Therapeutic or Preventive Procedure		NCI
C11585	PT	QS21/Tn(c)-KLH Conjugate Vaccine		NCI
C11585	SY	QS21/Tn(c)-KLH		NCI
C11585	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11585	RO	chemotherapy regimen has component QS21	NCI
C11585	RO	chemotherapy regimen has component Tn(c)-KLH Conjugate Vaccine	NCI
C10491	STY	Therapeutic or Preventive Procedure		NCI
C10491	PT	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine		NCI
C10491	SY	ARA-C/ASP/CTX/DM/DOX/TG/VCR		NCI
C10491	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10491	RO	chemotherapy regimen has component Asparaginase	NCI
C10491	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10491	RO	chemotherapy regimen has component Cytarabine	NCI
C10491	RO	chemotherapy regimen has component Dexamethasone	NCI
C10491	RO	chemotherapy regimen has component Doxorubicin	NCI
C10491	RO	chemotherapy regimen has component Thioguanine	NCI
C10491	RO	chemotherapy regimen has component Vincristine	NCI
C63794	STY	Therapeutic or Preventive Procedure		NCI
C63794	PT	VIP Regimen		NCI
C63794	SY	VP16-Ifosfamide-Platinol Regimen		NCI
C63794	SY	Etoposide-Ifosfamide-Cisplatin Regimen		NCI
C63794	SY	VePesid-Ifosfamide-Platinol Regimen		NCI
C63794	SY	VIP		NCI
C63794	CHD	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm	NCI
C63794	RO	chemotherapy regimen has component Cisplatin	NCI
C63794	RO	chemotherapy regimen has component Etoposide	NCI
C63794	RO	chemotherapy regimen has component Ifosfamide	NCI
C63794	RO	regimen has accepted use for disease Malignant Testicular Germ Cell Tumor	NCI
C64786	STY	Therapeutic or Preventive Procedure		NCI
C64786	PT	ELF Regimen		NCI
C64786	SY	Etoposide/Fluorouracil/Leucovorin		NCI
C64786	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C64786	RO	chemotherapy regimen has component Etoposide	NCI
C64786	RO	chemotherapy regimen has component Fluorouracil	NCI
C64786	RO	regimen has accepted use for disease Gastric Carcinoma	NCI
C64786	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C67515	STY	Therapeutic or Preventive Procedure		NCI
C67515	PT	PEBA Regimen		NCI
C67515	SY	PEBA		NCI
C67515	SY	Platinol-Etoposide-Bleomycin-Adriamycin Regimen		NCI
C67515	CHD	Chemotherapy Regimen Used to Treat Gestational Trophoblastic Tumor	NCI
C67515	RO	chemotherapy regimen has component Bleomycin	NCI
C67515	RO	chemotherapy regimen has component Cisplatin	NCI
C67515	RO	chemotherapy regimen has component Doxorubicin	NCI
C67515	RO	chemotherapy regimen has component Etoposide	NCI
C67515	RO	regimen has accepted use for disease Gestational Trophoblastic Tumor	NCI
C9999	STY	Therapeutic or Preventive Procedure		NCI
C9999	PT	Cyclophosphamide/Fluorouracil/Fluoxymesterone/Methotrexate/Prednisone/Tamoxifen		NCI
C9999	SY	CTX/5-FU/FXM/MTX/PRED/TMX		NCI
C9999	SY	CMF(P)TH		NCI
C9999	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9999	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9999	RO	chemotherapy regimen has component Fluorouracil	NCI
C9999	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C9999	RO	chemotherapy regimen has component Methotrexate	NCI
C9999	RO	chemotherapy regimen has component Prednisone	NCI
C9999	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10014	STY	Therapeutic or Preventive Procedure		NCI
C10014	PT	Fluoxymesterone/Mitolactol/Mitoxantrone/Tamoxifen		NCI
C10014	SY	D(DHAD)TH		NCI
C10014	SY	DBD/DHAD/FXM/TMX		NCI
C10014	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10014	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C10014	RO	chemotherapy regimen has component Mitolactol	NCI
C10014	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10014	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9512	STY	Therapeutic or Preventive Procedure		NCI
C9512	PT	Melphalan/Thiotepa		NCI
C9512	SY	MELT		NCI
C9512	SY	L-PAM/TSPA		NCI
C9512	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9512	RO	chemotherapy regimen has component Melphalan	NCI
C9512	RO	chemotherapy regimen has component Thiotepa	NCI
C9726	STY	Therapeutic or Preventive Procedure		NCI
C9726	PT	Doxorubicin/Fluorouracil/Leucovorin Calcium		NCI
C9726	SY	CF/DOX/5-FU		NCI
C9726	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9726	RO	chemotherapy regimen has component Doxorubicin	NCI
C9726	RO	chemotherapy regimen has component Fluorouracil	NCI
C9726	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12068	STY	Therapeutic or Preventive Procedure		NCI
C12068	PT	Carboplatin/Temozolomide/Thiotepa		NCI
C12068	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12068	RO	chemotherapy regimen has component Thiotepa	NCI
C12068	RO	chemotherapy regimen has component Temozolomide	NCI
C12068	RO	chemotherapy regimen has component Carboplatin	NCI
C37565	STY	Therapeutic or Preventive Procedure		NCI
C37565	PT	Bortezomib/Carboplatin/Etoposide		NCI
C37565	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37565	RO	chemotherapy regimen has component Etoposide	NCI
C37565	RO	chemotherapy regimen has component Carboplatin	NCI
C37565	RO	chemotherapy regimen has component Bortezomib	NCI
C10519	STY	Therapeutic or Preventive Procedure		NCI
C10519	PT	Bleomycin/Cisplatin/Filgrastim/Vincristine		NCI
C10519	SY	BLEO/CDDP/G-CSF/VCR		NCI
C10519	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10519	RO	chemotherapy regimen has component Bleomycin	NCI
C10519	RO	chemotherapy regimen has component Cisplatin	NCI
C10519	RO	chemotherapy regimen has component Vincristine	NCI
C10519	RO	chemotherapy regimen has component Filgrastim	NCI
C10419	STY	Therapeutic or Preventive Procedure		NCI
C10419	PT	Carboplatin/Cisplatin/Doxorubicin/Methotrexate/Vinblastine		NCI
C10419	SY	CBDCA/CDDP/DOX/MTX/VBL		NCI
C10419	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10419	RO	chemotherapy regimen has component Cisplatin	NCI
C10419	RO	chemotherapy regimen has component Doxorubicin	NCI
C10419	RO	chemotherapy regimen has component Methotrexate	NCI
C10419	RO	chemotherapy regimen has component Vinblastine	NCI
C10419	RO	chemotherapy regimen has component Carboplatin	NCI
C11546	STY	Therapeutic or Preventive Procedure		NCI
C11546	PT	Cyclosporine/Interferon Alfa/Sargramostim		NCI
C11546	SY	CYSP/GM-CSF/IFN-A		NCI
C11546	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11546	RO	chemotherapy regimen has component Cyclosporine	NCI
C11546	RO	chemotherapy regimen has component Sargramostim	NCI
C11546	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10076	STY	Therapeutic or Preventive Procedure		NCI
C10076	PT	Doxorubicin/Fluorouracil/Triazinate		NCI
C10076	SY	FAT		NCI
C10076	SY	DOX/5-FU/TZT		NCI
C10076	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10076	RO	chemotherapy regimen has component Doxorubicin	NCI
C10076	RO	chemotherapy regimen has component Fluorouracil	NCI
C10076	RO	chemotherapy regimen has component Triazinate	NCI
C9955	STY	Therapeutic or Preventive Procedure		NCI
C9955	PT	Interferon Beta/Zidovudine		NCI
C9955	SY	IFN-B/ZDV		NCI
C9955	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9955	RO	chemotherapy regimen has component Zidovudine	NCI
C9955	RO	chemotherapy regimen has component Recombinant Interferon Beta	NCI
C11707	STY	Therapeutic or Preventive Procedure		NCI
C11707	PT	Cisplatin/Cytarabine/Etoposide/Ifosfamide/Yttrium Y 90 Humanized Epratuzumab		NCI
C11707	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11707	RO	chemotherapy regimen has component Cisplatin	NCI
C11707	RO	chemotherapy regimen has component Cytarabine	NCI
C11707	RO	chemotherapy regimen has component Etoposide	NCI
C11707	RO	chemotherapy regimen has component Ifosfamide	NCI
C11707	RO	chemotherapy regimen has component Yttrium Y-90 Epratuzumab Tetraxetan	NCI
C148284	STY	Therapeutic or Preventive Procedure		NCI
C148284	PT	VAC/VI Regimen		NCI
C148284	SY	VAC Alternating with VI		NCI
C148284	SY	Vincristine/Dactinomycin/Cyclophosphamide Alternating With Vincristine/Irinotecan		NCI
C148284	SY	Vincristine/Actinomycin-D/Cyclophosphamide Alternating with Vincristine/Irinotecan		NCI
C148284	SY	Vincristine/Actinomycin-D/Cyclophosphamide-Vincristine/Irinotecan		NCI
C148284	SY	VAC/VI		NCI
C148284	SY	VAC Plus VI		NCI
C148284	SY	VAC-VI		NCI
C148284	SY	Vincristine/Dactinomycin/Cyclophosphamide-Vincristine/Irinotecan		NCI
C148284	CHD	Chemotherapy Regimen Used to Treat Childhood Rhabdomyosarcoma	NCI
C148284	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C148284	RO	chemotherapy regimen has component Dactinomycin	NCI
C148284	RO	chemotherapy regimen has component Vincristine	NCI
C148284	RO	chemotherapy regimen has component Irinotecan	NCI
C10686	STY	Therapeutic or Preventive Procedure		NCI
C10686	PT	Cyclosporine/Paclitaxel		NCI
C10686	SY	CYSP/TAX		NCI
C10686	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10686	RO	chemotherapy regimen has component Cyclosporine	NCI
C10686	RO	chemotherapy regimen has component Paclitaxel	NCI
C82410	STY	Therapeutic or Preventive Procedure		NCI
C82410	PT	Cyclophosphamide/Epirubicin/Vincristine/Prednisone		NCI
C82410	SY	CEOP Regimen		NCI
C82410	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C82410	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C82410	RO	chemotherapy regimen has component Prednisone	NCI
C82410	RO	chemotherapy regimen has component Vincristine	NCI
C82410	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11812	STY	Therapeutic or Preventive Procedure		NCI
C11812	PT	Cyclosporine/Filgrastim/Methylprednisolone/Monoclonal Antibody Okt3		NCI
C11812	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11812	RO	chemotherapy regimen has component Cyclosporine	NCI
C11812	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11812	RO	chemotherapy regimen has component Muromonab-CD3	NCI
C11812	RO	chemotherapy regimen has component Filgrastim	NCI
C11904	STY	Therapeutic or Preventive Procedure		NCI
C11904	PT	Flavopiridol/irinotecan		NCI
C11904	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11904	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11904	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C10997	STY	Therapeutic or Preventive Procedure		NCI
C10997	PT	Cyclophosphamide/Doxorubicin/Interferon Alfa/Prednisone/Vincristine		NCI
C10997	SY	CTX/DOX/IFN-A/PRED/VCR		NCI
C10997	SY	I-COPA		NCI
C10997	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10997	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10997	RO	chemotherapy regimen has component Doxorubicin	NCI
C10997	RO	chemotherapy regimen has component Prednisone	NCI
C10997	RO	chemotherapy regimen has component Vincristine	NCI
C10997	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10009	STY	Therapeutic or Preventive Procedure		NCI
C10009	PT	Prednisolone/Tamoxifen		NCI
C10009	SY	PRDL/TMX		NCI
C10009	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10009	RO	chemotherapy regimen has component Prednisolone	NCI
C10009	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11094	STY	Therapeutic or Preventive Procedure		NCI
C11094	PT	Human Chorionic Gonadotropin/Staphage Lysate		NCI
C11094	SY	HCG/SPL		NCI
C11094	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11094	RO	chemotherapy regimen has component Staphage Lysate	NCI
C11094	RO	chemotherapy regimen has component Recombinant Human Chorionic Gonadotropin	NCI
C11960	STY	Therapeutic or Preventive Procedure		NCI
C11960	PT	Topotecan/ZD9331		NCI
C11960	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11960	RO	chemotherapy regimen has component Topotecan	NCI
C11960	RO	chemotherapy regimen has component Plevitrexed	NCI
C10985	STY	Therapeutic or Preventive Procedure		NCI
C10985	PT	Cyclophosphamide/Interferon Alfa/Interleukin-2		NCI
C10985	SY	CTX/IFN-A/IL-2		NCI
C10985	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10985	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10985	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10985	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10646	STY	Therapeutic or Preventive Procedure		NCI
C10646	PT	Etoposide/Topotecan		NCI
C10646	SY	TOPO/VP-16		NCI
C10646	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10646	RO	chemotherapy regimen has component Etoposide	NCI
C10646	RO	chemotherapy regimen has component Topotecan	NCI
C11667	STY	Therapeutic or Preventive Procedure		NCI
C11667	PT	Cyclosporine/Irinotecan/Phenobarbital		NCI
C11667	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11667	RO	chemotherapy regimen has component Cyclosporine	NCI
C11667	RO	chemotherapy regimen has component Phenobarbital	NCI
C11667	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37742	STY	Therapeutic or Preventive Procedure		NCI
C37742	PT	Docetaxel/Estramustine/Exisulind		NCI
C37742	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37742	RO	chemotherapy regimen has component Estramustine	NCI
C37742	RO	chemotherapy regimen has component Exisulind	NCI
C37742	RO	chemotherapy regimen has component Docetaxel	NCI
C10010	STY	Therapeutic or Preventive Procedure		NCI
C10010	PT	Asparaginase/Cyclophosphamide/Methotrexate/Prednisone/Vincristine/Zorubicin		NCI
C10010	SY	CROPAM		NCI
C10010	SY	ASP/CTX/MTX/PRED/RBZ/VCR		NCI
C10010	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10010	RO	chemotherapy regimen has component Asparaginase	NCI
C10010	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10010	RO	chemotherapy regimen has component Methotrexate	NCI
C10010	RO	chemotherapy regimen has component Prednisone	NCI
C10010	RO	chemotherapy regimen has component Vincristine	NCI
C10010	RO	chemotherapy regimen has component Zorubicin Hydrochloride	NCI
C11982	STY	Therapeutic or Preventive Procedure		NCI
C11982	PT	Doxorubicin Hcl Liposome/ZD0473		NCI
C11982	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11982	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C11982	RO	chemotherapy regimen has component Picoplatin	NCI
C11435	STY	Therapeutic or Preventive Procedure		NCI
C11435	PT	BAY 12-9566/Doxorubicin		NCI
C11435	SY	BAY 12-9566/DOX		NCI
C11435	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11435	RO	chemotherapy regimen has component Doxorubicin	NCI
C11435	RO	chemotherapy regimen has component Tanomastat	NCI
C37654	STY	Therapeutic or Preventive Procedure		NCI
C37654	PT	Cisplatin/Filgrastim/Fluorouracil/Paclitaxel		NCI
C37654	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37654	RO	chemotherapy regimen has component Cisplatin	NCI
C37654	RO	chemotherapy regimen has component Fluorouracil	NCI
C37654	RO	chemotherapy regimen has component Paclitaxel	NCI
C37654	RO	chemotherapy regimen has component Filgrastim	NCI
C37481	STY	Therapeutic or Preventive Procedure		NCI
C37481	PT	Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/NY-ESO-B/QS21/Tyrosinase Peptide		NCI
C37481	SY	Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Melan-A/NY-ESO-B/QS21/Tyrosinase Peptide		NCI
C37481	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37481	RO	chemotherapy regimen has component QS21	NCI
C37481	RO	chemotherapy regimen has component gp100 Antigen	NCI
C37481	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C37481	RO	chemotherapy regimen has component NY-ESO-B	NCI
C37481	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C37481	RO	chemotherapy regimen has component Flu Matrix Peptide p58-66	NCI
C37481	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C9630	STY	Therapeutic or Preventive Procedure		NCI
C9630	PT	Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C9630	SY	MP/MTX/PRED/VCR		NCI
C9630	SY	POMP-24		NCI
C9630	SY	MMVP		NCI
C9630	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9630	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9630	RO	chemotherapy regimen has component Methotrexate	NCI
C9630	RO	chemotherapy regimen has component Prednisone	NCI
C9630	RO	chemotherapy regimen has component Vincristine	NCI
C10418	STY	Therapeutic or Preventive Procedure		NCI
C10418	PT	Fluorouracil/Hydroxyurea/Idoxuridine		NCI
C10418	SY	5-FU/HU/IUDR		NCI
C10418	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10418	RO	chemotherapy regimen has component Fluorouracil	NCI
C10418	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10418	RO	chemotherapy regimen has component Idoxuridine	NCI
C10431	STY	Therapeutic or Preventive Procedure		NCI
C10431	PT	Interleukin-2/Monoclonal Antibody 14G2A		NCI
C10431	SY	IL-2/MOAB 14G2A		NCI
C10431	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10431	RO	chemotherapy regimen has component Monoclonal Antibody 14G2A	NCI
C10431	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9688	STY	Therapeutic or Preventive Procedure		NCI
C9688	PT	Cisplatin/Etoposide/Fluorouracil		NCI
C9688	SY	CDDP/5-FU/VP-16		NCI
C9688	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9688	RO	chemotherapy regimen has component Cisplatin	NCI
C9688	RO	chemotherapy regimen has component Etoposide	NCI
C9688	RO	chemotherapy regimen has component Fluorouracil	NCI
C10314	STY	Therapeutic or Preventive Procedure		NCI
C10314	PT	Dactinomycin/Vincristine		NCI
C10314	SY	DACT/VCR		NCI
C10314	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10314	RO	chemotherapy regimen has component Dactinomycin	NCI
C10314	RO	chemotherapy regimen has component Vincristine	NCI
C11080	STY	Therapeutic or Preventive Procedure		NCI
C11080	PT	Cyclophosphamide/Interleukin-2/Monoclonal Antibody OKT3		NCI
C11080	SY	CTX/IL-2/MOAB OKT3		NCI
C11080	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11080	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11080	RO	chemotherapy regimen has component Muromonab-CD3	NCI
C11080	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11987	STY	Therapeutic or Preventive Procedure		NCI
C11987	PT	Asparaginase/cytarabine/dexamethasone/vincristine		NCI
C11987	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11987	RO	chemotherapy regimen has component Asparaginase	NCI
C11987	RO	chemotherapy regimen has component Cytarabine	NCI
C11987	RO	chemotherapy regimen has component Dexamethasone	NCI
C11987	RO	chemotherapy regimen has component Vincristine	NCI
C156308	STY	Therapeutic or Preventive Procedure		NCI
C156308	PT	Letrozole/Trastuzumab Regimen		NCI
C156308	SY	Letrozole/Herceptin		NCI
C156308	SY	Trastuzumab/Letrozole Regimen		NCI
C156308	SY	Trastuzumab/Letrozole		NCI
C156308	SY	Letrozole/Trastuzumab		NCI
C156308	SY	Letrozole-Trastuzumab		NCI
C156308	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156308	RO	chemotherapy regimen has component Letrozole	NCI
C156308	RO	chemotherapy regimen has component Trastuzumab	NCI
C11643	STY	Therapeutic or Preventive Procedure		NCI
C11643	PT	Irinotecan/Trastuzumab		NCI
C11643	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11643	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11643	RO	chemotherapy regimen has component Trastuzumab	NCI
C11781	STY	Therapeutic or Preventive Procedure		NCI
C11781	PT	RAS Peptide Cancer Vaccine/Sargramostim		NCI
C11781	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11781	RO	chemotherapy regimen has component Sargramostim	NCI
C11781	RO	chemotherapy regimen has component RAS Peptide Cancer Vaccine	NCI
C11502	STY	Therapeutic or Preventive Procedure		NCI
C11502	PT	Gemcitabine/R115777		NCI
C11502	SY	dFdC/R115777		NCI
C11502	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11502	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11502	RO	chemotherapy regimen has component Tipifarnib	NCI
C11024	STY	Therapeutic or Preventive Procedure		NCI
C11024	PT	Floxuridine/Fluorouracil/Interferon Alfa/Leucovorin Calcium		NCI
C11024	SY	CF/5-FU/FUDR/IFN-A		NCI
C11024	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11024	RO	chemotherapy regimen has component Floxuridine	NCI
C11024	RO	chemotherapy regimen has component Fluorouracil	NCI
C11024	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11024	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C140094	STY	Therapeutic or Preventive Procedure		NCI
C140094	PT	BR Regimen		NCI
C140094	SY	BR		NCI
C140094	SY	Bendamustine/Rituximab		NCI
C140094	SY	Bendamustine-Rituximab		NCI
C140094	SY	Bendamustine Plus Rituximab		NCI
C140094	SY	B-R Regimen		NCI
C140094	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C140094	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140094	RO	chemotherapy regimen has component Rituximab	NCI
C140094	RO	chemotherapy regimen has component Bendamustine	NCI
C11454	STY	Therapeutic or Preventive Procedure		NCI
C11454	PT	Dexamethasone/Methotrexate/Thioguanine/Vincristine		NCI
C11454	SY	DM/MTX/TG/VCR		NCI
C11454	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11454	RO	chemotherapy regimen has component Dexamethasone	NCI
C11454	RO	chemotherapy regimen has component Methotrexate	NCI
C11454	RO	chemotherapy regimen has component Thioguanine	NCI
C11454	RO	chemotherapy regimen has component Vincristine	NCI
C10385	STY	Therapeutic or Preventive Procedure		NCI
C10385	PT	Cytarabine/Daunorubicin/Sargramostim		NCI
C10385	SY	ARA-C/DNR/GM-CSF		NCI
C10385	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10385	RO	chemotherapy regimen has component Cytarabine	NCI
C10385	RO	chemotherapy regimen has component Sargramostim	NCI
C10385	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37766	STY	Therapeutic or Preventive Procedure		NCI
C37766	PT	Erlotinib/Paclitaxel/Trastuzumab		NCI
C37766	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37766	RO	chemotherapy regimen has component Paclitaxel	NCI
C37766	RO	chemotherapy regimen has component Trastuzumab	NCI
C37766	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C9933	STY	Therapeutic or Preventive Procedure		NCI
C9933	PT	Chlorambucil/Dacarbazine/Dactinomycin/Doxorubicin/Methotrexate/Vincristine		NCI
C9933	SY	ALOMAD		NCI
C9933	SY	CLB/DACT/DOX/DTIC/MTX/VCR		NCI
C9933	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9933	RO	chemotherapy regimen has component Chlorambucil	NCI
C9933	RO	chemotherapy regimen has component Dacarbazine	NCI
C9933	RO	chemotherapy regimen has component Dactinomycin	NCI
C9933	RO	chemotherapy regimen has component Doxorubicin	NCI
C9933	RO	chemotherapy regimen has component Methotrexate	NCI
C9933	RO	chemotherapy regimen has component Vincristine	NCI
C11049	STY	Therapeutic or Preventive Procedure		NCI
C11049	PT	Interferon Alfa/Tretinoin		NCI
C11049	SY	ATRA/IFN-A		NCI
C11049	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11049	RO	chemotherapy regimen has component Tretinoin	NCI
C11049	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9507	STY	Therapeutic or Preventive Procedure		NCI
C9507	PT	Cytarabine/Doxorubicin		NCI
C9507	SY	ARA-C/DOX		NCI
C9507	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9507	RO	chemotherapy regimen has component Cytarabine	NCI
C9507	RO	chemotherapy regimen has component Doxorubicin	NCI
C10628	STY	Therapeutic or Preventive Procedure		NCI
C10628	PT	Cytarabine/Tretinoin		NCI
C10628	SY	ARA-C/ATRA		NCI
C10628	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10628	RO	chemotherapy regimen has component Cytarabine	NCI
C10628	RO	chemotherapy regimen has component Tretinoin	NCI
C11388	STY	Therapeutic or Preventive Procedure		NCI
C11388	PT	Cytarabine/Daunorubicin/Interleukin-11/Sargramostim		NCI
C11388	SY	ARA-C/DNR/GM-CSF/IL-11		NCI
C11388	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11388	RO	chemotherapy regimen has component Cytarabine	NCI
C11388	RO	chemotherapy regimen has component Sargramostim	NCI
C11388	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11388	RO	chemotherapy regimen has component Oprelvekin	NCI
C11482	STY	Therapeutic or Preventive Procedure		NCI
C11482	PT	Cyclophosphamide/Theratope STn-KLH Vaccine		NCI
C11482	SY	CTX/THERATOPE		NCI
C11482	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11482	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11482	RO	chemotherapy regimen has component Sialyl Tn-KLH Vaccine	NCI
C10746	STY	Therapeutic or Preventive Procedure		NCI
C10746	PT	Dexamethasone/Doxorubicin/Prednisone/Quinine/Vincristine		NCI
C10746	SY	DM/DOX/PRED/QUIN/VCR		NCI
C10746	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10746	RO	chemotherapy regimen has component Dexamethasone	NCI
C10746	RO	chemotherapy regimen has component Doxorubicin	NCI
C10746	RO	chemotherapy regimen has component Prednisone	NCI
C10746	RO	chemotherapy regimen has component Quinine	NCI
C10746	RO	chemotherapy regimen has component Vincristine	NCI
C11967	STY	Therapeutic or Preventive Procedure		NCI
C11967	PT	Dacarbazine/Oblimersen		NCI
C11967	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11967	RO	chemotherapy regimen has component Dacarbazine	NCI
C11967	RO	chemotherapy regimen has component Oblimersen	NCI
C37651	STY	Therapeutic or Preventive Procedure		NCI
C37651	PT	Cisplatin/Etoposide/Irinotecan		NCI
C37651	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37651	RO	chemotherapy regimen has component Cisplatin	NCI
C37651	RO	chemotherapy regimen has component Etoposide	NCI
C37651	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C12188	STY	Therapeutic or Preventive Procedure		NCI
C12188	PT	Docetaxel/Sulindac		NCI
C12188	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12188	RO	chemotherapy regimen has component Sulindac	NCI
C12188	RO	chemotherapy regimen has component Docetaxel	NCI
C11714	STY	Therapeutic or Preventive Procedure		NCI
C11714	PT	Cyclophosphamide/Cytarabine/Fludarabine		NCI
C11714	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11714	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11714	RO	chemotherapy regimen has component Cytarabine	NCI
C11714	RO	chemotherapy regimen has component Fludarabine	NCI
C11354	STY	Therapeutic or Preventive Procedure		NCI
C11354	PT	Peptide 946 Melanoma Vaccine/QS21		NCI
C11354	SY	p946/QS21		NCI
C11354	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11354	RO	chemotherapy regimen has component QS21	NCI
C11354	RO	chemotherapy regimen has component Peptide 946 Melanoma Vaccine	NCI
C10611	STY	Therapeutic or Preventive Procedure		NCI
C10611	PT	Ifosfamide/Muramyl Tripeptide Phosphatidylethanolamine Liposome		NCI
C10611	SY	IFF/MTP-PE Liposome		NCI
C10611	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10611	RO	chemotherapy regimen has component Ifosfamide	NCI
C10611	RO	chemotherapy regimen has component Mifamurtide	NCI
C10996	STY	Therapeutic or Preventive Procedure		NCI
C10996	PT	Cisplatin/Interferon Alfa/interleukin-2		NCI
C10996	SY	CDDP/IFN-A/IL-2		NCI
C10996	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10996	RO	chemotherapy regimen has component Cisplatin	NCI
C10996	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10996	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10813	STY	Therapeutic or Preventive Procedure		NCI
C10813	PT	Cytarabine/Dexamethasone/Etoposide/Ifosfamide/Methotrexate		NCI
C10813	SY	ARA-C/DM/IFF/MTX/VP-16		NCI
C10813	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10813	RO	chemotherapy regimen has component Cytarabine	NCI
C10813	RO	chemotherapy regimen has component Dexamethasone	NCI
C10813	RO	chemotherapy regimen has component Etoposide	NCI
C10813	RO	chemotherapy regimen has component Ifosfamide	NCI
C10813	RO	chemotherapy regimen has component Methotrexate	NCI
C10250	STY	Therapeutic or Preventive Procedure		NCI
C10250	PT	Carboplatin/Vinblastine		NCI
C10250	SY	CBDCA/VBL		NCI
C10250	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10250	RO	chemotherapy regimen has component Vinblastine	NCI
C10250	RO	chemotherapy regimen has component Carboplatin	NCI
C10100	STY	Therapeutic or Preventive Procedure		NCI
C10100	PT	Cyclophosphamide/Fluorouracil/Methotrexate/Tamoxifen		NCI
C10100	SY	CMFT		NCI
C10100	SY	CTX/5-FU/MTX/TMX		NCI
C10100	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10100	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10100	RO	chemotherapy regimen has component Fluorouracil	NCI
C10100	RO	chemotherapy regimen has component Methotrexate	NCI
C10100	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C136265	STY	Therapeutic or Preventive Procedure		NCI
C136265	PT	Carfilzomib/Dexamethasone Regimen		NCI
C136265	SY	Carfilzomib/Dexamethasone		NCI
C136265	SY	Carfilzomib-Dexamethasone Regimen		NCI
C136265	SY	Kyprolis/Dexamethasone		NCI
C136265	SY	Carfilzomib-Dexamethasone		NCI
C136265	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136265	RO	chemotherapy regimen has component Dexamethasone	NCI
C136265	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136265	RO	chemotherapy regimen has component Carfilzomib	NCI
C11503	STY	Therapeutic or Preventive Procedure		NCI
C11503	PT	Amifostine/Carboplatin/Etoposide/Ifosfamide		NCI
C11503	SY	CBDCA/IFF/VP-16/WR-2721		NCI
C11503	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11503	RO	chemotherapy regimen has component Amifostine	NCI
C11503	RO	chemotherapy regimen has component Etoposide	NCI
C11503	RO	chemotherapy regimen has component Ifosfamide	NCI
C11503	RO	chemotherapy regimen has component Carboplatin	NCI
C10617	STY	Therapeutic or Preventive Procedure		NCI
C10617	PT	Dexamethasone/Mercaptopurine/Vincristine		NCI
C10617	SY	DM/MP/VCR		NCI
C10617	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10617	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10617	RO	chemotherapy regimen has component Dexamethasone	NCI
C10617	RO	chemotherapy regimen has component Vincristine	NCI
C10550	STY	Therapeutic or Preventive Procedure		NCI
C10550	PT	Asparaginase/Cyclophosphamide/Daunorubicin/Filgrastim/Prednisone/Vincristine		NCI
C10550	SY	ASP/CTX/DNR/G-CSF/PRED/VCR		NCI
C10550	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10550	RO	chemotherapy regimen has component Asparaginase	NCI
C10550	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10550	RO	chemotherapy regimen has component Prednisone	NCI
C10550	RO	chemotherapy regimen has component Vincristine	NCI
C10550	RO	chemotherapy regimen has component Filgrastim	NCI
C10550	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9921	STY	Therapeutic or Preventive Procedure		NCI
C9921	PT	Carmustine/Thymidine		NCI
C9921	SY	BCNU/TDR		NCI
C9921	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9921	RO	chemotherapy regimen has component Carmustine	NCI
C9921	RO	chemotherapy regimen has component Thymidine	NCI
C10121	STY	Therapeutic or Preventive Procedure		NCI
C10121	PT	Cyclophosphamide/Cytarabine/Etoposide/Methotrexate/Prednisone/Vincristine		NCI
C10121	SY	MOPLACE		NCI
C10121	SY	ARA-C/CTX/MTX/PRED/VCR/VP-16		NCI
C10121	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10121	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10121	RO	chemotherapy regimen has component Cytarabine	NCI
C10121	RO	chemotherapy regimen has component Etoposide	NCI
C10121	RO	chemotherapy regimen has component Methotrexate	NCI
C10121	RO	chemotherapy regimen has component Prednisone	NCI
C10121	RO	chemotherapy regimen has component Vincristine	NCI
C136252	STY	Therapeutic or Preventive Procedure		NCI
C136252	PT	FOLFOXIRI		NCI
C136252	SY	Leucovorin/Fluorouracil/Oxaliplatin/Irinotecan		NCI
C136252	SY	Folinic Acid/Fluorouracil/Oxaliplatin/Irinotecan		NCI
C136252	SY	Leucovorin-Fluorouracil-Oxaliplatin-Irinotecan		NCI
C136252	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136252	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136252	RO	chemotherapy regimen has component Fluorouracil	NCI
C136252	RO	chemotherapy regimen has component Oxaliplatin	NCI
C136252	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C136252	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11691	STY	Therapeutic or Preventive Procedure		NCI
C11691	PT	gp100 Antigen/MART-1 Antigen/Tyrosinase Peptide		NCI
C11691	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11691	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11691	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11691	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C9905	STY	Therapeutic or Preventive Procedure		NCI
C9905	PT	Asparaginase/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine		NCI
C9905	SY	ARA-C/ASP/DM/DOX/TG/VCR		NCI
C9905	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9905	RO	chemotherapy regimen has component Asparaginase	NCI
C9905	RO	chemotherapy regimen has component Cytarabine	NCI
C9905	RO	chemotherapy regimen has component Dexamethasone	NCI
C9905	RO	chemotherapy regimen has component Doxorubicin	NCI
C9905	RO	chemotherapy regimen has component Thioguanine	NCI
C9905	RO	chemotherapy regimen has component Vincristine	NCI
C64839	STY	Therapeutic or Preventive Procedure		NCI
C64839	PT	VMCP-VBAP Regimen		NCI
C64839	SY	Vincristine-Melphalan-Cytoxan-Prednisone (VMCP)/Vincristine-BCNU-Adriamycin-Prednisone (VBAP) Regimen		NCI
C64839	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C64839	RO	chemotherapy regimen has component Carmustine	NCI
C64839	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C64839	RO	chemotherapy regimen has component Doxorubicin	NCI
C64839	RO	chemotherapy regimen has component Melphalan	NCI
C64839	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C64839	RO	chemotherapy regimen has component Prednisone	NCI
C64839	RO	chemotherapy regimen has component Vincristine	NCI
C10599	STY	Therapeutic or Preventive Procedure		NCI
C10599	PT	Busulfan/Etoposide		NCI
C10599	SY	BU/VP-16		NCI
C10599	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10599	RO	chemotherapy regimen has component Busulfan	NCI
C10599	RO	chemotherapy regimen has component Etoposide	NCI
C9514	STY	Therapeutic or Preventive Procedure		NCI
C9514	PT	Cytarabine/Doxorubicin/Prednisone/Vincristine		NCI
C9514	SY	HOAP		NCI
C9514	SY	POCA		NCI
C9514	SY	ARA-C/DOX/PRED/VCR		NCI
C9514	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9514	RO	chemotherapy regimen has component Cytarabine	NCI
C9514	RO	chemotherapy regimen has component Doxorubicin	NCI
C9514	RO	chemotherapy regimen has component Prednisone	NCI
C9514	RO	chemotherapy regimen has component Vincristine	NCI
C9716	STY	Therapeutic or Preventive Procedure		NCI
C9716	PT	Melphalan/Prednisone		NCI
C9716	SY	MP		NCI
C9716	SY	L-PAM/PRED		NCI
C9716	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9716	RO	chemotherapy regimen has component Melphalan	NCI
C9716	RO	chemotherapy regimen has component Prednisone	NCI
C11058	STY	Therapeutic or Preventive Procedure		NCI
C11058	PT	Carmustine/Doxorubicin/Interferon Alfa/Prednisone/Vincristine		NCI
C11058	SY	BCNU/DOX/IFN-A/PRED/VCR		NCI
C11058	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11058	RO	chemotherapy regimen has component Carmustine	NCI
C11058	RO	chemotherapy regimen has component Doxorubicin	NCI
C11058	RO	chemotherapy regimen has component Prednisone	NCI
C11058	RO	chemotherapy regimen has component Vincristine	NCI
C11058	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10940	STY	Therapeutic or Preventive Procedure		NCI
C10940	PT	CI-980/Filgrastim		NCI
C10940	SY	CI-980/G-CSF		NCI
C10940	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10940	RO	chemotherapy regimen has component Filgrastim	NCI
C10940	RO	chemotherapy regimen has component Mivobulin Isethionate	NCI
C10135	STY	Therapeutic or Preventive Procedure		NCI
C10135	PT	Cytarabine/Filgrastim		NCI
C10135	SY	ARA-C/G-CSF		NCI
C10135	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10135	RO	chemotherapy regimen has component Cytarabine	NCI
C10135	RO	chemotherapy regimen has component Filgrastim	NCI
C11392	STY	Therapeutic or Preventive Procedure		NCI
C11392	PT	Finasteride/Flutamide		NCI
C11392	SY	FLUT/MK-906		NCI
C11392	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11392	RO	chemotherapy regimen has component Flutamide	NCI
C11392	RO	chemotherapy regimen has component Finasteride	NCI
C10916	STY	Therapeutic or Preventive Procedure		NCI
C10916	PT	Carboplatin/Milodistim/Paclitaxel		NCI
C10916	SY	CBDCA/PIXY321/TAX		NCI
C10916	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10916	RO	chemotherapy regimen has component Carboplatin	NCI
C10916	RO	chemotherapy regimen has component Paclitaxel	NCI
C10916	RO	chemotherapy regimen has component Milodistim	NCI
C11877	STY	Therapeutic or Preventive Procedure		NCI
C11877	PT	Denileukin Diftitox/Dexamethasone		NCI
C11877	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11877	RO	chemotherapy regimen has component Dexamethasone	NCI
C11877	RO	chemotherapy regimen has component Denileukin Diftitox	NCI
C11979	STY	Therapeutic or Preventive Procedure		NCI
C11979	PT	506U78/Mercaptopurine/Methotrexate		NCI
C11979	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11979	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11979	RO	chemotherapy regimen has component Methotrexate	NCI
C11979	RO	chemotherapy regimen has component Nelarabine	NCI
C11856	STY	Therapeutic or Preventive Procedure		NCI
C11856	PT	Capecitabine/Paclitaxel/Trastuzumab		NCI
C11856	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11856	RO	chemotherapy regimen has component Paclitaxel	NCI
C11856	RO	chemotherapy regimen has component Capecitabine	NCI
C11856	RO	chemotherapy regimen has component Trastuzumab	NCI
C9986	STY	Therapeutic or Preventive Procedure		NCI
C9986	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Sargramostim		NCI
C9986	SY	CDDP/CTX/DOX/GM-CSF/VP-16		NCI
C9986	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9986	RO	chemotherapy regimen has component Cisplatin	NCI
C9986	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9986	RO	chemotherapy regimen has component Doxorubicin	NCI
C9986	RO	chemotherapy regimen has component Etoposide	NCI
C9986	RO	chemotherapy regimen has component Sargramostim	NCI
C9910	STY	Therapeutic or Preventive Procedure		NCI
C9910	PT	Doxorubicin/Ifosfamide/Prednisone/Vincristine		NCI
C9910	SY	IHOP		NCI
C9910	SY	DOX/IFF/PRED/VCR		NCI
C9910	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9910	RO	chemotherapy regimen has component Doxorubicin	NCI
C9910	RO	chemotherapy regimen has component Ifosfamide	NCI
C9910	RO	chemotherapy regimen has component Prednisone	NCI
C9910	RO	chemotherapy regimen has component Vincristine	NCI
C37617	STY	Therapeutic or Preventive Procedure		NCI
C37617	PT	Carboplatin/Monoclonal Antibody ABX-EGF/Paclitaxel		NCI
C37617	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37617	RO	chemotherapy regimen has component Carboplatin	NCI
C37617	RO	chemotherapy regimen has component Paclitaxel	NCI
C37617	RO	chemotherapy regimen has component Panitumumab	NCI
C126792	STY	Therapeutic or Preventive Procedure		NCI
C126792	PT	Busulfan/Melphalan Regimen		NCI
C126792	SY	BuMel Regimen		NCI
C126792	SY	BuMel		NCI
C126792	SY	Busulfan-Melphalan Regimen		NCI
C126792	CHD	Chemotherapy Regimen	NCI
C126792	RO	chemotherapy regimen has component Busulfan	NCI
C126792	RO	chemotherapy regimen has component Melphalan	NCI
C11199	STY	Therapeutic or Preventive Procedure		NCI
C11199	PT	Carboplatin/Cyclosporine/Dipyridamole/Etoposide/Prochlorperazine		NCI
C11199	SY	CBDCA/CYSP/DP/PCPZ/VP-16		NCI
C11199	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11199	RO	chemotherapy regimen has component Cyclosporine	NCI
C11199	RO	chemotherapy regimen has component Dipyridamole	NCI
C11199	RO	chemotherapy regimen has component Etoposide	NCI
C11199	RO	chemotherapy regimen has component Prochlorperazine	NCI
C11199	RO	chemotherapy regimen has component Carboplatin	NCI
C10677	STY	Therapeutic or Preventive Procedure		NCI
C10677	PT	Cytarabine/Mercaptopurine		NCI
C10677	SY	ARA-C/MP		NCI
C10677	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10677	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10677	RO	chemotherapy regimen has component Cytarabine	NCI
C9936	STY	Therapeutic or Preventive Procedure		NCI
C9936	PT	Prednisone/Procarbazine/Vincristine		NCI
C9936	SY	PCB/PRED/VCR		NCI
C9936	SY	OPP		NCI
C9936	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9936	RO	chemotherapy regimen has component Prednisone	NCI
C9936	RO	chemotherapy regimen has component Vincristine	NCI
C9936	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10470	STY	Therapeutic or Preventive Procedure		NCI
C10470	PT	Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Methotrexate/Prednisone/Thioguanine/Vincristine		NCI
C10470	SY	ARA-C/ASP/CTX/DNR/MTX/PRED/TG/VCR		NCI
C10470	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10470	RO	chemotherapy regimen has component Asparaginase	NCI
C10470	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10470	RO	chemotherapy regimen has component Cytarabine	NCI
C10470	RO	chemotherapy regimen has component Methotrexate	NCI
C10470	RO	chemotherapy regimen has component Prednisone	NCI
C10470	RO	chemotherapy regimen has component Thioguanine	NCI
C10470	RO	chemotherapy regimen has component Vincristine	NCI
C10470	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11601	STY	Therapeutic or Preventive Procedure		NCI
C11601	PT	QS21/TF(c)-KLH Conjugate Vaccine		NCI
C11601	SY	QS21/TF(c)-KLH		NCI
C11601	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11601	RO	chemotherapy regimen has component QS21	NCI
C11601	RO	chemotherapy regimen has component TF(c)-KLH Conjugate Vaccine	NCI
C11969	STY	Therapeutic or Preventive Procedure		NCI
C11969	PT	GPI-0100/MUC-2-Globo H-KLH Conjugate Vaccine		NCI
C11969	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11969	RO	chemotherapy regimen has component GPI-0100	NCI
C11969	RO	chemotherapy regimen has component MUC-2-Globo H-KLH Conjugate Vaccine	NCI
C11237	STY	Therapeutic or Preventive Procedure		NCI
C11237	PT	Irinotecan/Raltitrexed		NCI
C11237	SY	CPT-11/ICI D1694		NCI
C11237	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11237	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11237	RO	chemotherapy regimen has component Raltitrexed	NCI
C10698	STY	Therapeutic or Preventive Procedure		NCI
C10698	PT	Cyclophosphamide/Epirubicin		NCI
C10698	SY	CTX/EPI		NCI
C10698	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10698	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10698	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C9882	STY	Therapeutic or Preventive Procedure		NCI
C9882	PT	Cyclophosphamide/Diaziquone		NCI
C9882	SY	AZQ/CTX		NCI
C9882	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9882	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9882	RO	chemotherapy regimen has component Diaziquone	NCI
C63685	STY	Therapeutic or Preventive Procedure		NCI
C63685	PT	GEM-CAP Regimen		NCI
C63685	SY	Gemcitabine-Capecitabine Regimen		NCI
C63685	CHD	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C63685	RO	regimen has accepted use for disease Pancreatic Carcinoma	NCI
C63685	RO	chemotherapy regimen has component Capecitabine	NCI
C63685	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11802	STY	Therapeutic or Preventive Procedure		NCI
C11802	PT	Cytarabine/Filgrastim/Fludarabine		NCI
C11802	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11802	RO	chemotherapy regimen has component Cytarabine	NCI
C11802	RO	chemotherapy regimen has component Fludarabine	NCI
C11802	RO	chemotherapy regimen has component Filgrastim	NCI
C9584	STY	Therapeutic or Preventive Procedure		NCI
C9584	PT	Doxorubicin/Procarbazine/Prednisone/Vincristine		NCI
C9584	SY	DOX/PCB/PRED/VCR		NCI
C9584	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9584	RO	chemotherapy regimen has component Doxorubicin	NCI
C9584	RO	chemotherapy regimen has component Prednisone	NCI
C9584	RO	chemotherapy regimen has component Vincristine	NCI
C9584	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9889	STY	Therapeutic or Preventive Procedure		NCI
C9889	PT	Cytarabine/Doxorubicin/Thioguanine		NCI
C9889	SY	ARA-C/DOX/TG		NCI
C9889	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9889	RO	chemotherapy regimen has component Cytarabine	NCI
C9889	RO	chemotherapy regimen has component Doxorubicin	NCI
C9889	RO	chemotherapy regimen has component Thioguanine	NCI
C10671	STY	Therapeutic or Preventive Procedure		NCI
C10671	PT	Chlorambucil/Cladribine		NCI
C10671	SY	2-CdA/CLB		NCI
C10671	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10671	RO	chemotherapy regimen has component Chlorambucil	NCI
C10671	RO	chemotherapy regimen has component Cladribine	NCI
C10237	STY	Therapeutic or Preventive Procedure		NCI
C10237	PT	Cyclophosphamide/Interleukin-2		NCI
C10237	SY	CTX/IL-2		NCI
C10237	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10237	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10237	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10922	STY	Therapeutic or Preventive Procedure		NCI
C10922	PT	Cisplatin/Pyrazoloacridine		NCI
C10922	SY	CDDP/PZA		NCI
C10922	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10922	RO	chemotherapy regimen has component Cisplatin	NCI
C10922	RO	chemotherapy regimen has component Pyrazoloacridine	NCI
C10252	STY	Therapeutic or Preventive Procedure		NCI
C10252	PT	Cyclophosphamide/Cytarabine		NCI
C10252	SY	ARA-C/CTX		NCI
C10252	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10252	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10252	RO	chemotherapy regimen has component Cytarabine	NCI
C11505	STY	Therapeutic or Preventive Procedure		NCI
C11505	PT	Dextromethorphan/Morphine		NCI
C11505	SY	DEX/MORPH		NCI
C11505	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11505	RO	chemotherapy regimen has component Morphine Sulfate	NCI
C11505	RO	chemotherapy regimen has component Dextromethorphan Hydrobromide	NCI
C63594	STY	Therapeutic or Preventive Procedure		NCI
C63594	PT	IFL Regimen		NCI
C63594	SY	IFL-Modified Saltz Regimen		NCI
C63594	SY	Irinotecan/Fluorouracil/Leucovorin		NCI
C63594	SY	Irinotecan-Fluorouracil-Leucovorin Regimen		NCI
C63594	SY	IFL-Saltz Regimen		NCI
C63594	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63594	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63594	RO	chemotherapy regimen has component Fluorouracil	NCI
C63594	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C63594	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10326	STY	Therapeutic or Preventive Procedure		NCI
C10326	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine		NCI
C10326	SY	CDDP/CTX/DOX/MTX/VCR/VP-16		NCI
C10326	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10326	RO	chemotherapy regimen has component Cisplatin	NCI
C10326	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10326	RO	chemotherapy regimen has component Doxorubicin	NCI
C10326	RO	chemotherapy regimen has component Etoposide	NCI
C10326	RO	chemotherapy regimen has component Methotrexate	NCI
C10326	RO	chemotherapy regimen has component Vincristine	NCI
C9738	STY	Therapeutic or Preventive Procedure		NCI
C9738	PT	Doxorubicin/Vincristine/VX-710		NCI
C9738	SY	DOX/VCR/VX-710		NCI
C9738	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9738	RO	chemotherapy regimen has component Doxorubicin	NCI
C9738	RO	chemotherapy regimen has component Vincristine	NCI
C9738	RO	chemotherapy regimen has component Biricodar Dicitrate	NCI
C10578	STY	Therapeutic or Preventive Procedure		NCI
C10578	PT	Asparaginase/Filgrastim/Teniposide		NCI
C10578	SY	ARA-C/G-CSF/VM-26		NCI
C10578	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10578	RO	chemotherapy regimen has component Asparaginase	NCI
C10578	RO	chemotherapy regimen has component Teniposide	NCI
C10578	RO	chemotherapy regimen has component Filgrastim	NCI
C9989	STY	Therapeutic or Preventive Procedure		NCI
C9989	PT	Prednisone/Sargramostim/Vincristine		NCI
C9989	SY	GM-CSF/PRED/VCR		NCI
C9989	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9989	RO	chemotherapy regimen has component Prednisone	NCI
C9989	RO	chemotherapy regimen has component Vincristine	NCI
C9989	RO	chemotherapy regimen has component Sargramostim	NCI
C11398	STY	Therapeutic or Preventive Procedure		NCI
C11398	PT	Docetaxel/Doxorubicin HCl Liposome		NCI
C11398	SY	LipoDox/TXT		NCI
C11398	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11398	RO	chemotherapy regimen has component Docetaxel	NCI
C11398	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C63511	STY	Therapeutic or Preventive Procedure		NCI
C63511	PT	MAID Regimen		NCI
C63511	SY	Mesna-Adriamycin-Ifosfamide-Dacarbazine Regimen		NCI
C63511	SY	Mesna-Adriamycin-Ifosfamide-DTIC Regimen		NCI
C63511	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C63511	RO	chemotherapy regimen has component Mesna	NCI
C63511	RO	chemotherapy regimen has component Dacarbazine	NCI
C63511	RO	chemotherapy regimen has component Doxorubicin	NCI
C63511	RO	chemotherapy regimen has component Ifosfamide	NCI
C63511	RO	regimen has accepted use for disease Soft Tissue Sarcoma	NCI
C11723	STY	Therapeutic or Preventive Procedure		NCI
C11723	PT	Monoclonal antibody 4B5 anti-idiotype vaccine/Sargramostim		NCI
C11723	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11723	RO	chemotherapy regimen has component Sargramostim	NCI
C11723	RO	chemotherapy regimen has component Monoclonal Antibody 4B5 Anti-Idiotype Vaccine	NCI
C9935	STY	Therapeutic or Preventive Procedure		NCI
C9935	PT	Cisplatin/Dianhydrogalactitol/Doxorubicin/Vincristine		NCI
C9935	SY	ODAP		NCI
C9935	SY	CDDP/DAG/DOX/VCR		NCI
C9935	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9935	RO	chemotherapy regimen has component Cisplatin	NCI
C9935	RO	chemotherapy regimen has component Dianhydrogalactitol	NCI
C9935	RO	chemotherapy regimen has component Doxorubicin	NCI
C9935	RO	chemotherapy regimen has component Vincristine	NCI
C10090	STY	Therapeutic or Preventive Procedure		NCI
C10090	PT	Doxorubicin/Methotrexate/Vinblastine		NCI
C10090	SY	AVM		NCI
C10090	SY	DOX/MTX/VBL		NCI
C10090	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10090	RO	chemotherapy regimen has component Doxorubicin	NCI
C10090	RO	chemotherapy regimen has component Methotrexate	NCI
C10090	RO	chemotherapy regimen has component Vinblastine	NCI
C64837	STY	Therapeutic or Preventive Procedure		NCI
C64837	PT	VBMCP Regimen		NCI
C64837	SY	Vincristine-BCNU-Melphalan-Cytoxan-Prednisone Regimen		NCI
C64837	SY	M2 Protocol		NCI
C64837	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C64837	RO	chemotherapy regimen has component Carmustine	NCI
C64837	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C64837	RO	chemotherapy regimen has component Melphalan	NCI
C64837	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C64837	RO	chemotherapy regimen has component Prednisone	NCI
C64837	RO	chemotherapy regimen has component Vincristine	NCI
C11139	STY	Therapeutic or Preventive Procedure		NCI
C11139	PT	Cyclosporine/Cytarabine/Daunorubicin/Etoposide		NCI
C11139	SY	ARA-C/CYSP/DNR/VP-16		NCI
C11139	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11139	RO	chemotherapy regimen has component Cyclosporine	NCI
C11139	RO	chemotherapy regimen has component Cytarabine	NCI
C11139	RO	chemotherapy regimen has component Etoposide	NCI
C11139	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C138034	STY	Therapeutic or Preventive Procedure		NCI
C138034	PT	Docetaxel/Cyclophosphamide/Trastuzumab Regimen		NCI
C138034	SY	Docetaxel/Cyclophosphamide + Trastuzumab		NCI
C138034	SY	Docetaxel + Cyclophosphamide + Trastuzumab		NCI
C138034	SY	Docetaxel/Cyclophosphamide Plus Trastuzumab		NCI
C138034	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C10299	STY	Therapeutic or Preventive Procedure		NCI
C10299	PT	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Vincristine		NCI
C10299	SY	ARA-C/ASP/CTX/DM/DOX/VCR		NCI
C10299	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10299	RO	chemotherapy regimen has component Asparaginase	NCI
C10299	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10299	RO	chemotherapy regimen has component Cytarabine	NCI
C10299	RO	chemotherapy regimen has component Dexamethasone	NCI
C10299	RO	chemotherapy regimen has component Doxorubicin	NCI
C10299	RO	chemotherapy regimen has component Vincristine	NCI
C37479	STY	Therapeutic or Preventive Procedure		NCI
C37479	PT	Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3 /MART-1 Antigen/NY-ESO-B/QS21/Tyrosinase Peptide		NCI
C37479	SY	Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3 /MART-1 Antigen/Melan-A/NY-ESO-B/QS21/Tyrosinase Peptide		NCI
C37479	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37479	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C37479	RO	chemotherapy regimen has component QS21	NCI
C37479	RO	chemotherapy regimen has component gp100 Antigen	NCI
C37479	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C37479	RO	chemotherapy regimen has component NY-ESO-B	NCI
C37479	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C37479	RO	chemotherapy regimen has component Flu Matrix Peptide p58-66	NCI
C37479	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C12062	STY	Therapeutic or Preventive Procedure		NCI
C12062	PT	Cisplatin/Etoposide/Ifosfamide/Prednisolone		NCI
C12062	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12062	RO	chemotherapy regimen has component Cisplatin	NCI
C12062	RO	chemotherapy regimen has component Etoposide	NCI
C12062	RO	chemotherapy regimen has component Ifosfamide	NCI
C12062	RO	chemotherapy regimen has component Prednisolone	NCI
C10745	STY	Therapeutic or Preventive Procedure		NCI
C10745	PT	Cyclophosphamide/Procarbazine/Vincristine		NCI
C10745	SY	CTX/PCB/VCR		NCI
C10745	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10745	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10745	RO	chemotherapy regimen has component Vincristine	NCI
C10745	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C37768	STY	Therapeutic or Preventive Procedure		NCI
C37768	PT	Estradiol/Zoledronate		NCI
C37768	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37768	RO	chemotherapy regimen has component Estradiol	NCI
C37768	RO	chemotherapy regimen has component Zoledronic Acid	NCI
C37640	STY	Therapeutic or Preventive Procedure		NCI
C37640	PT	Cetuximab/Docetaxel/Irinotecan		NCI
C37640	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37640	RO	chemotherapy regimen has component Docetaxel	NCI
C37640	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37640	RO	chemotherapy regimen has component Cetuximab	NCI
C9652	STY	Therapeutic or Preventive Procedure		NCI
C9652	PT	Carmustine/Dexamethasone/Doxorubicin/Melphalan/Vincristine		NCI
C9652	SY	VBAMDex		NCI
C9652	SY	BCNU/DM/DOX/L-PAM/VCR		NCI
C9652	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9652	RO	chemotherapy regimen has component Carmustine	NCI
C9652	RO	chemotherapy regimen has component Dexamethasone	NCI
C9652	RO	chemotherapy regimen has component Doxorubicin	NCI
C9652	RO	chemotherapy regimen has component Melphalan	NCI
C9652	RO	chemotherapy regimen has component Vincristine	NCI
C10308	STY	Therapeutic or Preventive Procedure		NCI
C10308	PT	Doxorubicin/Quinidine		NCI
C10308	SY	DOX/QND		NCI
C10308	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10308	RO	chemotherapy regimen has component Doxorubicin	NCI
C10308	RO	chemotherapy regimen has component Quinidine	NCI
C10217	STY	Therapeutic or Preventive Procedure		NCI
C10217	PT	Bleomycin/Carmustine/Etoposide/Methotrexate/Prednisone		NCI
C10217	SY	BCNU/BLEO/MTX/PRED/VP-16		NCI
C10217	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10217	RO	chemotherapy regimen has component Bleomycin	NCI
C10217	RO	chemotherapy regimen has component Carmustine	NCI
C10217	RO	chemotherapy regimen has component Etoposide	NCI
C10217	RO	chemotherapy regimen has component Methotrexate	NCI
C10217	RO	chemotherapy regimen has component Prednisone	NCI
C11200	STY	Therapeutic or Preventive Procedure		NCI
C11200	PT	Carboplatin/Cyclosporine/Interferon Alfa		NCI
C11200	SY	CBDCA/CYSP/IFN-A		NCI
C11200	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11200	RO	chemotherapy regimen has component Cyclosporine	NCI
C11200	RO	chemotherapy regimen has component Carboplatin	NCI
C11200	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37853	STY	Therapeutic or Preventive Procedure		NCI
C37853	PT	Sargramostim/Vaccinia-CEA-TRICOM Vaccine		NCI
C37853	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37853	RO	chemotherapy regimen has component Sargramostim	NCI
C37853	RO	chemotherapy regimen has component Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine	NCI
C10375	STY	Therapeutic or Preventive Procedure		NCI
C10375	PT	Busulfan/Cytarabine/Etoposide		NCI
C10375	SY	ARA-C/BU/VP-16		NCI
C10375	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10375	RO	chemotherapy regimen has component Busulfan	NCI
C10375	RO	chemotherapy regimen has component Cytarabine	NCI
C10375	RO	chemotherapy regimen has component Etoposide	NCI
C11301	STY	Therapeutic or Preventive Procedure		NCI
C11301	PT	Amifostine/Ciprofloxacin/Pentoxifylline		NCI
C11301	SY	CPFX/PTX/WR-2721		NCI
C11301	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11301	RO	chemotherapy regimen has component Ciprofloxacin	NCI
C11301	RO	chemotherapy regimen has component Amifostine	NCI
C11301	RO	chemotherapy regimen has component Pentoxifylline	NCI
C11442	STY	Therapeutic or Preventive Procedure		NCI
C11442	PT	Irinotecan/Oxaliplatin		NCI
C11442	SY	CPT-11/L-OHP		NCI
C11442	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11442	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11442	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11122	STY	Therapeutic or Preventive Procedure		NCI
C11122	PT	Doxorubicin/Losoxantrone		NCI
C11122	SY	DOX/DuP-941		NCI
C11122	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11122	RO	chemotherapy regimen has component Doxorubicin	NCI
C11122	RO	chemotherapy regimen has component Losoxantrone	NCI
C12198	STY	Therapeutic or Preventive Procedure		NCI
C12198	PT	Fowlpox-CEA-TRICOM Vaccine/Fowlpox-Sargramostim		NCI
C12198	SY	Fowlpox-CEA-TRICOM Vaccine/Fowlpox-Sargramostim Vaccine		NCI
C12198	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12198	RO	chemotherapy regimen has component Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine	NCI
C12198	RO	chemotherapy regimen has component Recombinant Fowlpox GM-CSF Vaccine Adjuvant	NCI
C11679	STY	Therapeutic or Preventive Procedure		NCI
C11679	PT	gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide		NCI
C11679	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11679	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11679	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11679	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11679	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10593	STY	Therapeutic or Preventive Procedure		NCI
C10593	PT	Bromocriptine/Flutamide		NCI
C10593	SY	BRCR/FLUT		NCI
C10593	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10593	RO	chemotherapy regimen has component Flutamide	NCI
C10593	RO	chemotherapy regimen has component Bromocriptine Mesylate	NCI
C11664	STY	Therapeutic or Preventive Procedure		NCI
C11664	PT	Interleukin-2/Montanide ISA-51/Von Hippel-Lindau Peptide Vaccine		NCI
C11664	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11664	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11664	RO	chemotherapy regimen has component Von Hippel-Lindau Peptide Vaccine	NCI
C11664	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C67229	STY	Therapeutic or Preventive Procedure		NCI
C67229	PT	Chemotherapy Regimen Used to Treat Ewing's Family of Tumors		NCI
C67229	SY	Chemotherapy Used to Treat Ewing's Sarcoma Peripheral Primitive Neuroectodermal Tumor		NCI
C67229	SY	Chemotherapy Regimen Used to Treat Peripheral Primitive Neuroectodermal Tumor		NCI
C67229	SY	Chemotherapy Regimen Used to Treat PNET		NCI
C67229	SY	Chemotherapy Regimen Used to Treat Ewing's Sarcoma		NCI
C67229	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C67229	PAR	VIT Regimen	NCI
C67229	PAR	Cyclophosphamide-Topotecan Regimen	NCI
C67229	PAR	VAdriaC-IE Regimen	NCI
C67229	PAR	VAdriaC Regimen	NCI
C10077	STY	Therapeutic or Preventive Procedure		NCI
C10077	PT	Interferon Gamma/Levamisole		NCI
C10077	SY	IFN-G/LEV		NCI
C10077	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10077	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C10077	RO	chemotherapy regimen has component Levamisole Hydrochloride	NCI
C157051	STY	Therapeutic or Preventive Procedure		NCI
C157051	PT	Ipilimumab/Talimogene Laherparepvec Regimen		NCI
C157051	SY	Talimogene Laherparepvec/ Ipilimumab		NCI
C157051	SY	Yervoy/Imlygic		NCI
C157051	SY	Ipilimumab/Talimogene Laherparepvec		NCI
C157051	CHD	Chemotherapy Regimen Used to Treat Melanoma	NCI
C11405	STY	Therapeutic or Preventive Procedure		NCI
C11405	PT	gp100 Antigen/Incomplete Freund's Adjuvant/Tyrosinase Peptide		NCI
C11405	SY	gp100/IFA/TYRP		NCI
C11405	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11405	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11405	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11405	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C37460	STY	Therapeutic or Preventive Procedure		NCI
C37460	PT	Autologous Dendritic Cells/Keyhole Limpet Hemocyanin/MAGE-3/Melan-A/Survivin Antigen		NCI
C37460	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37460	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C37460	RO	chemotherapy regimen has component Survivin Antigen	NCI
C37460	RO	chemotherapy regimen has component Therapeutic Autologous Dendritic Cells	NCI
C37460	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C37460	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11096	STY	Therapeutic or Preventive Procedure		NCI
C11096	PT	Dexamethasone/Melphalan		NCI
C11096	SY	DM/L-PAM		NCI
C11096	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11096	RO	chemotherapy regimen has component Dexamethasone	NCI
C11096	RO	chemotherapy regimen has component Melphalan	NCI
C10192	STY	Therapeutic or Preventive Procedure		NCI
C10192	PT	Carboplatin/Ifosfamide		NCI
C10192	SY	CBDCA/IFF		NCI
C10192	SY	IMP		NCI
C10192	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10192	RO	chemotherapy regimen has component Ifosfamide	NCI
C10192	RO	chemotherapy regimen has component Carboplatin	NCI
C10669	STY	Therapeutic or Preventive Procedure		NCI
C10669	PT	Paclitaxel/Topotecan		NCI
C10669	SY	TAX/TOPO		NCI
C10669	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10669	RO	chemotherapy regimen has component Paclitaxel	NCI
C10669	RO	chemotherapy regimen has component Topotecan	NCI
C10560	STY	Therapeutic or Preventive Procedure		NCI
C10560	PT	Levamisole/Tamoxifen		NCI
C10560	SY	LEV/TMX		NCI
C10560	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10560	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10560	RO	chemotherapy regimen has component Levamisole Hydrochloride	NCI
C48388	STY	Pharmacologic Substance		NCI
C48388	STY	Organic Chemical		NCI
C48388	PT	Everolimus/Gefitinib		NCI
C48388	SY	RAD/ZD 1839		NCI
C48388	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C48388	RO	chemotherapy regimen has component Everolimus	NCI
C48388	RO	chemotherapy regimen has component Gefitinib	NCI
C9984	STY	Therapeutic or Preventive Procedure		NCI
C9984	PT	Lomustine/Prednisone/Vincristine		NCI
C9984	SY	CCNU/PRED/VCR		NCI
C9984	SY	CCNU-OP		NCI
C9984	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9984	RO	chemotherapy regimen has component Lomustine	NCI
C9984	RO	chemotherapy regimen has component Prednisone	NCI
C9984	RO	chemotherapy regimen has component Vincristine	NCI
C10057	STY	Therapeutic or Preventive Procedure		NCI
C10057	PT	Fenretinide/Tamoxifen		NCI
C10057	SY	HPR/TMX		NCI
C10057	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10057	RO	chemotherapy regimen has component Fenretinide	NCI
C10057	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11805	STY	Therapeutic or Preventive Procedure		NCI
C11805	PT	Temozolomide/Thalidomide		NCI
C11805	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11805	RO	chemotherapy regimen has component Thalidomide	NCI
C11805	RO	chemotherapy regimen has component Temozolomide	NCI
C10822	STY	Therapeutic or Preventive Procedure		NCI
C10822	PT	Cyclophosphamide/Doxorubicin/Filgrastim/Fluorouracil/Leucovorin Calcium		NCI
C10822	SY	CF/CTX/DOX/5-FU/G-CSF		NCI
C10822	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10822	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10822	RO	chemotherapy regimen has component Doxorubicin	NCI
C10822	RO	chemotherapy regimen has component Fluorouracil	NCI
C10822	RO	chemotherapy regimen has component Filgrastim	NCI
C10822	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11932	STY	Therapeutic or Preventive Procedure		NCI
C11932	PT	Daunorubicin/Imatinib Mesylate/Prednisone/Vincristine		NCI
C11932	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11932	RO	chemotherapy regimen has component Prednisone	NCI
C11932	RO	chemotherapy regimen has component Vincristine	NCI
C11932	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11932	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C10113	STY	Therapeutic or Preventive Procedure		NCI
C10113	PT	Conjugated Estrogens/Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Tamoxifen		NCI
C10113	SY	CTX/DOX/EST/5-FU/MTX/TMX		NCI
C10113	SY	CAMFTP		NCI
C10113	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10113	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10113	RO	chemotherapy regimen has component Doxorubicin	NCI
C10113	RO	chemotherapy regimen has component Estrogens, Conjugated	NCI
C10113	RO	chemotherapy regimen has component Fluorouracil	NCI
C10113	RO	chemotherapy regimen has component Methotrexate	NCI
C10113	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C9628	STY	Therapeutic or Preventive Procedure		NCI
C9628	PT	Cisplatin/Fluorouracil/Leucovorin Calcium		NCI
C9628	SY	CDDP/CF/5-FU		NCI
C9628	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9628	RO	chemotherapy regimen has component Cisplatin	NCI
C9628	RO	chemotherapy regimen has component Fluorouracil	NCI
C9628	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10957	STY	Therapeutic or Preventive Procedure		NCI
C10957	PT	Cisplatin/Cyclophosphamide/Filgrastim/Paclitaxel		NCI
C10957	SY	CDDP/CTX/G-CSF/TAX		NCI
C10957	SY	Cisplatin/Pacli/Cyclo/GCSF		NCI
C10957	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10957	RO	chemotherapy regimen has component Cisplatin	NCI
C10957	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10957	RO	chemotherapy regimen has component Paclitaxel	NCI
C10957	RO	chemotherapy regimen has component Filgrastim	NCI
C37517	STY	Therapeutic or Preventive Procedure		NCI
C37517	PT	Alemtuzumab/Fludarabine		NCI
C37517	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37517	RO	chemotherapy regimen has component Fludarabine	NCI
C37517	RO	chemotherapy regimen has component Alemtuzumab	NCI
C10391	STY	Therapeutic or Preventive Procedure		NCI
C10391	PT	Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Sargramostim/Vincristine		NCI
C10391	SY	CTX/DOX/GM-CSF/MTX/VCR/VP-16		NCI
C10391	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10391	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10391	RO	chemotherapy regimen has component Doxorubicin	NCI
C10391	RO	chemotherapy regimen has component Etoposide	NCI
C10391	RO	chemotherapy regimen has component Methotrexate	NCI
C10391	RO	chemotherapy regimen has component Vincristine	NCI
C10391	RO	chemotherapy regimen has component Sargramostim	NCI
C64841	STY	Therapeutic or Preventive Procedure		NCI
C64841	PT	Estramustine-Etoposide Regimen		NCI
C64841	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C64841	RO	chemotherapy regimen has component Estramustine	NCI
C64841	RO	chemotherapy regimen has component Etoposide	NCI
C64841	RO	regimen has accepted use for disease Metastatic Prostate Carcinoma	NCI
C11324	STY	Therapeutic or Preventive Procedure		NCI
C11324	PT	gp100 Antigen/Incomplete Freund's Adjuvant/Sargramostim		NCI
C11324	SY	GM-CSF/gp100/IFA		NCI
C11324	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11324	RO	chemotherapy regimen has component Sargramostim	NCI
C11324	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11324	RO	chemotherapy regimen has component gp100 Antigen	NCI
C9852	STY	Therapeutic or Preventive Procedure		NCI
C9852	PT	Doxorubicin/Ifosfamide/Sargramostim		NCI
C9852	SY	DOX/GM-CSF/IFF		NCI
C9852	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9852	RO	chemotherapy regimen has component Doxorubicin	NCI
C9852	RO	chemotherapy regimen has component Ifosfamide	NCI
C9852	RO	chemotherapy regimen has component Sargramostim	NCI
C10605	STY	Therapeutic or Preventive Procedure		NCI
C10605	PT	Indomethacin/Interleukin-1-Alpha/Etoposide		NCI
C10605	SY	IL-1A/Indomethacin/VP-16		NCI
C10605	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10605	RO	chemotherapy regimen has component Etoposide	NCI
C10605	RO	chemotherapy regimen has component Indomethacin	NCI
C10605	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C37480	STY	Therapeutic or Preventive Procedure		NCI
C37480	PT	Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3/MART-1 Antigen/NY-ESO-B/Tyrosinase Peptide		NCI
C37480	SY	Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3/MART-1 Antigen/Melan-A/NY-ESO-B/Tyrosinase Peptide		NCI
C37480	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37480	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C37480	RO	chemotherapy regimen has component gp100 Antigen	NCI
C37480	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C37480	RO	chemotherapy regimen has component NY-ESO-B	NCI
C37480	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C37480	RO	chemotherapy regimen has component Flu Matrix Peptide p58-66	NCI
C37480	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10725	STY	Therapeutic or Preventive Procedure		NCI
C10725	PT	Fluorouracil/Gallium Nitrate		NCI
C10725	SY	5-FU/GAN		NCI
C10725	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10725	RO	chemotherapy regimen has component Fluorouracil	NCI
C10725	RO	chemotherapy regimen has component Gallium Nitrate	NCI
C11492	STY	Therapeutic or Preventive Procedure		NCI
C11492	PT	Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Mercaptopurine/Methotrexate/Thioguanine/Vincristine		NCI
C11492	SY	ARA-C/ASP/CTX/DM/DNR/MP/MTX/TG/VCR		NCI
C11492	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11492	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11492	RO	chemotherapy regimen has component Asparaginase	NCI
C11492	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11492	RO	chemotherapy regimen has component Cytarabine	NCI
C11492	RO	chemotherapy regimen has component Dexamethasone	NCI
C11492	RO	chemotherapy regimen has component Methotrexate	NCI
C11492	RO	chemotherapy regimen has component Thioguanine	NCI
C11492	RO	chemotherapy regimen has component Vincristine	NCI
C11492	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11005	STY	Therapeutic or Preventive Procedure		NCI
C11005	PT	Cisplatin/Interferon Alfa		NCI
C11005	SY	CDDP/IFN-A		NCI
C11005	SY	Cisplatin/Interferon		NCI
C11005	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11005	RO	chemotherapy regimen has component Cisplatin	NCI
C11005	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C67192	STY	Therapeutic or Preventive Procedure		NCI
C67192	PT	Chemotherapy Regimen Used to Treat Childhood Non-Hodgkin's Lymphoma		NCI
C67192	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C67192	PAR	APO Regimen	NCI
C67192	PAR	DECAL Regimen	NCI
C67192	PAR	HM89 Regimen	NCI
C67192	PAR	HM91 Regimen	NCI
C67192	PAR	LMB-89 Regimen	NCI
C67192	PAR	LNH-92 Regimen	NCI
C67192	PAR	NHL-BFM-90 Regimen	NCI
C67192	PAR	NHL-BFM-95 Regimen	NCI
C9913	STY	Therapeutic or Preventive Procedure		NCI
C9913	PT	Altretamine/Carmustine/Mitomycin		NCI
C9913	SY	MiCH		NCI
C9913	SY	BCNU/HMM/MITO		NCI
C9913	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9913	RO	chemotherapy regimen has component Mitomycin	NCI
C9913	RO	chemotherapy regimen has component Carmustine	NCI
C9913	RO	chemotherapy regimen has component Altretamine	NCI
C136245	STY	Therapeutic or Preventive Procedure		NCI
C136245	PT	Capecitabine/Panitumumab Regimen		NCI
C136245	SY	Capecitabine/Panitumumab		NCI
C136245	SY	Xeloda-Vectibix Regimen		NCI
C136245	SY	Capecitabine-Panitumumab		NCI
C136245	SY	Capecitabine-Panitumumab Regimen		NCI
C136245	SY	Xeloda/Vectibix Regimen		NCI
C136245	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136245	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136245	RO	chemotherapy regimen has component Capecitabine	NCI
C136245	RO	chemotherapy regimen has component Panitumumab	NCI
C9740	STY	Therapeutic or Preventive Procedure		NCI
C9740	PT	Docetaxol/Vinblastine		NCI
C9740	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9740	RO	chemotherapy regimen has component Vinblastine	NCI
C9740	RO	chemotherapy regimen has component Docetaxel	NCI
C9595	STY	Therapeutic or Preventive Procedure		NCI
C9595	PT	FEC Regimen		NCI
C9595	SY	FEC		NCI
C9595	SY	Fluorouracil/Epirubicin/Intravenous Cyclophosphamide		NCI
C9595	SY	Fluorouracil/Epirubicin/IV Cyclophosphamide		NCI
C9595	SY	FEC 100		NCI
C9595	SY	IV Cyclophosphamide/Epirubicin/Fluorouracil		NCI
C9595	SY	CTX/EPI/5-FU		NCI
C9595	SY	Fluorouracil-Epirubicin-IV Cytoxan Regimen		NCI
C9595	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C9595	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9595	RO	chemotherapy regimen has component Fluorouracil	NCI
C9595	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C9595	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C11109	STY	Therapeutic or Preventive Procedure		NCI
C11109	PT	Cyclophosphamide/Daunorubicin/Dexamethasone/Vincristine		NCI
C11109	SY	CTX/DM/DNR/VCR		NCI
C11109	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11109	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11109	RO	chemotherapy regimen has component Dexamethasone	NCI
C11109	RO	chemotherapy regimen has component Vincristine	NCI
C11109	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C64792	STY	Therapeutic or Preventive Procedure		NCI
C64792	PT	VIM-D Regimen		NCI
C64792	SY	VP-16-Ifosfamide-Mitoxantrone-Dexamethasone Regimen		NCI
C64792	SY	VP-16/Ifosfamide/Mitoxantrone/Dexamethasone		NCI
C64792	SY	VIMD Regimen		NCI
C64792	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C64792	RO	chemotherapy regimen has component Dexamethasone	NCI
C64792	RO	chemotherapy regimen has component Etoposide	NCI
C64792	RO	chemotherapy regimen has component Ifosfamide	NCI
C64792	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C64792	RO	regimen has accepted use for disease Refractory Hodgkin Lymphoma	NCI
C11971	STY	Therapeutic or Preventive Procedure		NCI
C11971	PT	Leucovorin Calcium/Mercaptopurine/Methotrexate/Prednisolone/Vincristine		NCI
C11971	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11971	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11971	RO	chemotherapy regimen has component Methotrexate	NCI
C11971	RO	chemotherapy regimen has component Prednisolone	NCI
C11971	RO	chemotherapy regimen has component Vincristine	NCI
C11971	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37634	STY	Therapeutic or Preventive Procedure		NCI
C37634	PT	Celecoxib/Fluorouracil/Leucovorin Calcium/Oxaliplatin		NCI
C37634	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37634	RO	chemotherapy regimen has component Fluorouracil	NCI
C37634	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37634	RO	chemotherapy regimen has component Celecoxib	NCI
C37634	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10058	STY	Therapeutic or Preventive Procedure		NCI
C10058	PT	Altretamine/Cisplatin/Cyclophosphamide/Fluorouracil		NCI
C10058	SY	CHEX-UP		NCI
C10058	SY	CDDP/CTX/5-FU/HMM		NCI
C10058	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10058	RO	chemotherapy regimen has component Cisplatin	NCI
C10058	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10058	RO	chemotherapy regimen has component Fluorouracil	NCI
C10058	RO	chemotherapy regimen has component Altretamine	NCI
C9744	STY	Therapeutic or Preventive Procedure		NCI
C9744	PT	Doxifluridine/L-Leucovorin		NCI
C9744	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9744	RO	chemotherapy regimen has component Doxifluridine	NCI
C9744	RO	chemotherapy regimen has component Levoleucovorin	NCI
C9542	STY	Therapeutic or Preventive Procedure		NCI
C9542	PT	Cyclophosphamide/Lomustine/Methotrexate/Vincristine		NCI
C9542	SY	CyMOC		NCI
C9542	SY	CCNU/CTX/MTX/VCR		NCI
C9542	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9542	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9542	RO	chemotherapy regimen has component Lomustine	NCI
C9542	RO	chemotherapy regimen has component Methotrexate	NCI
C9542	RO	chemotherapy regimen has component Vincristine	NCI
C12053	STY	Therapeutic or Preventive Procedure		NCI
C12053	PT	Probenecid/10-Propargyl-10-Deazaaminopterin		NCI
C12053	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12053	RO	chemotherapy regimen has component Probenecid	NCI
C12053	RO	chemotherapy regimen has component Pralatrexate	NCI
C11910	STY	Therapeutic or Preventive Procedure		NCI
C11910	PT	Fluorouracil/Leucovorin Calcium/PS-341		NCI
C11910	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11910	RO	chemotherapy regimen has component Fluorouracil	NCI
C11910	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11910	RO	chemotherapy regimen has component Bortezomib	NCI
C11051	STY	Therapeutic or Preventive Procedure		NCI
C11051	PT	Bleomycin/Doxorubicin/Vincristine/zalcitabine		NCI
C11051	SY	BLEO/ddC/DOX/VCR		NCI
C11051	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11051	RO	chemotherapy regimen has component Bleomycin	NCI
C11051	RO	chemotherapy regimen has component Zalcitabine	NCI
C11051	RO	chemotherapy regimen has component Doxorubicin	NCI
C11051	RO	chemotherapy regimen has component Vincristine	NCI
C67511	STY	Therapeutic or Preventive Procedure		NCI
C67511	PT	EMA-CO Regimen		NCI
C67511	SY	Etoposide-Methotrexate-Actinomycin-D-Cyclophosphamide-Oncovin Regimen		NCI
C67511	SY	EMA-CO		NCI
C67511	SY	EMA/CO Regimen		NCI
C67511	SY	Etoposide/Methotrexate/Actinomycin-D/Cyclophosphamide/Vincristine Regimen		NCI
C67511	CHD	Chemotherapy Regimen Used to Treat Gestational Trophoblastic Tumor	NCI
C67511	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67511	RO	chemotherapy regimen has component Dactinomycin	NCI
C67511	RO	chemotherapy regimen has component Etoposide	NCI
C67511	RO	chemotherapy regimen has component Methotrexate	NCI
C67511	RO	chemotherapy regimen has component Vincristine	NCI
C67511	RO	regimen has accepted use for disease Gestational Trophoblastic Tumor	NCI
C11953	STY	Therapeutic or Preventive Procedure		NCI
C11953	PT	PEG-Interferon Alfa-2b/Temozolomide		NCI
C11953	SY	PEG-IFNA2b/TMZ		NCI
C11953	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11953	RO	chemotherapy regimen has component Temozolomide	NCI
C11953	RO	chemotherapy regimen has component Peginterferon Alfa-2b	NCI
C11827	STY	Therapeutic or Preventive Procedure		NCI
C11827	PT	Dexamethasone/SU5416		NCI
C11827	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11827	RO	chemotherapy regimen has component Dexamethasone	NCI
C11827	RO	chemotherapy regimen has component Semaxanib	NCI
C12002	STY	Therapeutic or Preventive Procedure		NCI
C12002	PT	Carboplatin/Etoposide Phosphate/Melphalan		NCI
C12002	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12002	RO	chemotherapy regimen has component Melphalan	NCI
C12002	RO	chemotherapy regimen has component Etoposide Phosphate	NCI
C12002	RO	chemotherapy regimen has component Carboplatin	NCI
C11522	STY	Therapeutic or Preventive Procedure		NCI
C11522	PT	Amifostine/Carboplatin/Cyclophosphamide/Thiotepa		NCI
C11522	SY	CBDCA/CTX/TSPA/WR-2721		NCI
C11522	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11522	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11522	RO	chemotherapy regimen has component Amifostine	NCI
C11522	RO	chemotherapy regimen has component Thiotepa	NCI
C11522	RO	chemotherapy regimen has component Carboplatin	NCI
C37818	STY	Therapeutic or Preventive Procedure		NCI
C37818	PT	Interferon Gamma/Voriconazole		NCI
C37818	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37818	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C37818	RO	chemotherapy regimen has component Voriconazole	NCI
C10736	STY	Therapeutic or Preventive Procedure		NCI
C10736	PT	Daunorubicin/Methylprednisolone/Vincristine		NCI
C10736	SY	DNR/MePRDL/VCR		NCI
C10736	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10736	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10736	RO	chemotherapy regimen has component Vincristine	NCI
C10736	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37649	STY	Therapeutic or Preventive Procedure		NCI
C37649	PT	Cisplatin/Edotecarin		NCI
C37649	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37649	RO	chemotherapy regimen has component Cisplatin	NCI
C37649	RO	chemotherapy regimen has component Edotecarin	NCI
C10330	STY	Therapeutic or Preventive Procedure		NCI
C10330	PT	Melphalan/Misonidazole		NCI
C10330	SY	L-PAM/MNI		NCI
C10330	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10330	RO	chemotherapy regimen has component Melphalan	NCI
C10330	RO	chemotherapy regimen has component Misonidazole	NCI
C10652	STY	Therapeutic or Preventive Procedure		NCI
C10652	PT	Cisplatin/Cytarabine/Hydroxyurea		NCI
C10652	SY	ARA-C/CDDP/HU		NCI
C10652	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10652	RO	chemotherapy regimen has component Cisplatin	NCI
C10652	RO	chemotherapy regimen has component Cytarabine	NCI
C10652	RO	chemotherapy regimen has component Hydroxyurea	NCI
C156261	STY	Therapeutic or Preventive Procedure		NCI
C156261	PT	Cyclophosphamide/Vincristine/Dacarbazine Regimen		NCI
C156261	SY	CVD		NCI
C156261	SY	Cyclophosphamide/Vincristine/Dacarbazine		NCI
C156261	SY	Cytoxan/Vincristine/Dacarbazine		NCI
C156261	SY	Cyclophosphamide-Vincristine-Dacarbazine		NCI
C156261	CHD	Chemotherapy Regimen Used to Treat Malignant Neuroendocrine and Adrenal Neoplasm	NCI
C156261	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C156261	RO	chemotherapy regimen has component Dacarbazine	NCI
C156261	RO	chemotherapy regimen has component Vincristine	NCI
C10722	STY	Therapeutic or Preventive Procedure		NCI
C10722	PT	Thioguanine/Tiazofurin		NCI
C10722	SY	TCAR/TG		NCI
C10722	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10722	RO	chemotherapy regimen has component Thioguanine	NCI
C10722	RO	chemotherapy regimen has component Tiazofurin	NCI
C136279	STY	Therapeutic or Preventive Procedure		NCI
C136279	PT	Pomalidomide/Carfilzomib/Dexamethasone Regimen		NCI
C136279	SY	Pomalidomide/Kyprolis/Dexamethasone		NCI
C136279	SY	Pomalidomide-Carfilzomib-Dexamethasone		NCI
C136279	SY	CPD		NCI
C136279	SY	Pomalidomide-Carfilzomib-Dexamethasone Regimen		NCI
C136279	SY	Pomalidomide/Carfilzomib/Dexamethasone		NCI
C136279	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136279	RO	chemotherapy regimen has component Dexamethasone	NCI
C136279	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136279	RO	chemotherapy regimen has component Carfilzomib	NCI
C136279	RO	chemotherapy regimen has component Pomalidomide	NCI
C9538	STY	Therapeutic or Preventive Procedure		NCI
C9538	PT	Cyclophosphamide/Doxorubicin/Methotrexate/Procarbazine		NCI
C9538	SY	CTX/DOX/MTX/PCB		NCI
C9538	SY	CAMP Protocol		NCI
C9538	SY	CAMP		NCI
C9538	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9538	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9538	RO	chemotherapy regimen has component Doxorubicin	NCI
C9538	RO	chemotherapy regimen has component Methotrexate	NCI
C9538	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10807	STY	Therapeutic or Preventive Procedure		NCI
C10807	PT	Cisplatin/Vinorelbine		NCI
C10807	SY	CDDP/VNB		NCI
C10807	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10807	RO	chemotherapy regimen has component Cisplatin	NCI
C10807	RO	chemotherapy regimen has component Vinorelbine	NCI
C128248	STY	Therapeutic or Preventive Procedure		NCI
C128248	PT	PEB Regimen		NCI
C128248	SY	Cisplatin-Etoposide-Bleomycin Regimen		NCI
C128248	SY	Pediatric BEP Regimen		NCI
C128248	SY	Pediatric PEB Regimen		NCI
C128248	SY	Cisplatin/Etoposide/Bleomycin		NCI
C128248	SY	Pediatric PEB		NCI
C128248	SY	PEB		NCI
C128248	SY	Platinol-Etoposide-Bleomycin Regimen		NCI
C128248	CHD	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm	NCI
C128248	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C128248	RO	chemotherapy regimen has component Bleomycin	NCI
C128248	RO	chemotherapy regimen has component Cisplatin	NCI
C128248	RO	chemotherapy regimen has component Etoposide	NCI
C128248	RO	regimen has accepted use for disease Childhood Testicular Germ Cell Tumor	NCI
C128248	RO	regimen has accepted use for disease Childhood Ovarian Germ Cell Tumor	NCI
C128248	RO	regimen has accepted use for disease Malignant Testicular Germ Cell Tumor	NCI
C128248	RO	regimen has accepted use for disease Ovarian Carcinoma	NCI
C37530	STY	Therapeutic or Preventive Procedure		NCI
C37530	PT	Anti-Thymocyte Globulin/Busulfan/Cyclophosphamide/Methylprednisolone		NCI
C37530	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37530	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C37530	RO	chemotherapy regimen has component Busulfan	NCI
C37530	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37530	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11373	STY	Therapeutic or Preventive Procedure		NCI
C11373	PT	Carboxyamidotriazole/Ketoconazole		NCI
C11373	SY	CAI/KCZ		NCI
C11373	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11373	RO	chemotherapy regimen has component Ketoconazole	NCI
C11373	RO	chemotherapy regimen has component Carboxyamidotriazole	NCI
C9963	STY	Therapeutic or Preventive Procedure		NCI
C9963	PT	Carmustine/Methotrexate/Procarbazine		NCI
C9963	SY	BMP		NCI
C9963	SY	BCNU/MTX/PCB		NCI
C9963	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9963	RO	chemotherapy regimen has component Carmustine	NCI
C9963	RO	chemotherapy regimen has component Methotrexate	NCI
C9963	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C156247	STY	Therapeutic or Preventive Procedure		NCI
C156247	PT	Megestrol/Tamoxifen Regimen		NCI
C156247	SY	Tamoxifen-Megace		NCI
C156247	SY	Tamoxifen/Megace Regimen		NCI
C156247	SY	Megace/Tamoxifen Regimen		NCI
C156247	SY	Tamoxifen/Megestrol Regimen		NCI
C156247	SY	Megestrol Acetate/Tamoxifen Regimen		NCI
C156247	SY	Tamoxifen-Megestrol Acetate		NCI
C156247	CHD	Chemotherapy Regimen Used to Treat Endometrial Carcinoma	NCI
C156247	RO	regimen has accepted use for disease Endometrial Carcinoma	NCI
C10753	STY	Therapeutic or Preventive Procedure		NCI
C10753	PT	Filgrastim/Methotrexate/Paclitaxel		NCI
C10753	SY	G-CSF/MTX/TAX		NCI
C10753	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10753	RO	chemotherapy regimen has component Methotrexate	NCI
C10753	RO	chemotherapy regimen has component Paclitaxel	NCI
C10753	RO	chemotherapy regimen has component Filgrastim	NCI
C10728	STY	Therapeutic or Preventive Procedure		NCI
C10728	PT	Cytarabine/Dexamethasone/Etoposide/Vincristine		NCI
C10728	SY	ARA-C/DM/VCR/VP-16		NCI
C10728	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10728	RO	chemotherapy regimen has component Cytarabine	NCI
C10728	RO	chemotherapy regimen has component Dexamethasone	NCI
C10728	RO	chemotherapy regimen has component Etoposide	NCI
C10728	RO	chemotherapy regimen has component Vincristine	NCI
C37736	STY	Therapeutic or Preventive Procedure		NCI
C37736	PT	Docetaxel/GTI-2040		NCI
C37736	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37736	RO	chemotherapy regimen has component Docetaxel	NCI
C37736	RO	chemotherapy regimen has component GTI-2040	NCI
C15624	STY	Therapeutic or Preventive Procedure		NCI
C15624	PT	9-cis-Retinoic Acid/Interferon Alfa		NCI
C15624	SY	9-CRA/IFN-A		NCI
C15624	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15624	RO	chemotherapy regimen has component Alitretinoin	NCI
C15624	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9666	STY	Therapeutic or Preventive Procedure		NCI
C9666	PT	Bleomycin/Dacarbazine/Doxorubicin/Lomustine/Prednisone		NCI
C9666	SY	AB-DIC		NCI
C9666	SY	BLEO/CCNU/DOX/DTIC/PRED		NCI
C9666	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9666	RO	chemotherapy regimen has component Bleomycin	NCI
C9666	RO	chemotherapy regimen has component Dacarbazine	NCI
C9666	RO	chemotherapy regimen has component Doxorubicin	NCI
C9666	RO	chemotherapy regimen has component Lomustine	NCI
C9666	RO	chemotherapy regimen has component Prednisone	NCI
C10173	STY	Therapeutic or Preventive Procedure		NCI
C10173	PT	Bleomycin/Cyclophosphamide/Cytarabine/Prednisone/Vincristine		NCI
C10173	SY	COAP-BLEO		NCI
C10173	SY	ARA-C/BLEO/CTX/PRED/VCR		NCI
C10173	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10173	RO	chemotherapy regimen has component Bleomycin	NCI
C10173	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10173	RO	chemotherapy regimen has component Cytarabine	NCI
C10173	RO	chemotherapy regimen has component Prednisone	NCI
C10173	RO	chemotherapy regimen has component Vincristine	NCI
C63498	STY	Therapeutic or Preventive Procedure		NCI
C63498	PT	VAD Regimen		NCI
C63498	SY	Vincristine-Adriamycin-Dexamethasone Regimen		NCI
C63498	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C63498	RO	chemotherapy regimen has component Dexamethasone	NCI
C63498	RO	chemotherapy regimen has component Doxorubicin	NCI
C63498	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C63498	RO	chemotherapy regimen has component Vincristine	NCI
C37687	STY	Therapeutic or Preventive Procedure		NCI
C37687	PT	Cyclophosphamide/Doxorubicin/Trastuzumab		NCI
C37687	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37687	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37687	RO	chemotherapy regimen has component Doxorubicin	NCI
C37687	RO	chemotherapy regimen has component Trastuzumab	NCI
C11137	STY	Therapeutic or Preventive Procedure		NCI
C11137	PT	Etoposide/Ifosfamide/Mesna/Mitoxantrone		NCI
C11137	SY	DHAD/IFF/mesna/VP-16		NCI
C11137	SY	MINE		NCI
C11137	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11137	RO	chemotherapy regimen has component Mesna	NCI
C11137	RO	chemotherapy regimen has component Etoposide	NCI
C11137	RO	chemotherapy regimen has component Ifosfamide	NCI
C11137	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C12197	STY	Therapeutic or Preventive Procedure		NCI
C12197	PT	Fowlpox-CEA-TRICOM Vaccine/Sargramostim		NCI
C12197	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12197	RO	chemotherapy regimen has component Sargramostim	NCI
C12197	RO	chemotherapy regimen has component Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine	NCI
C10877	STY	Therapeutic or Preventive Procedure		NCI
C10877	PT	Mitoxantrone/Paclitaxel		NCI
C10877	SY	DHAD/TAX		NCI
C10877	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10877	RO	chemotherapy regimen has component Paclitaxel	NCI
C10877	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37544	STY	Therapeutic or Preventive Procedure		NCI
C37544	PT	Autologous Tumor Cell Vaccine/CD40-Ligand/Interleukin-2 Gene		NCI
C37544	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37544	RO	chemotherapy regimen has component Autologous Tumor Cell Vaccine	NCI
C37544	RO	chemotherapy regimen has component Interleukin-2 Gene	NCI
C37544	RO	chemotherapy regimen has component Recombinant CD40-Ligand	NCI
C10320	STY	Therapeutic or Preventive Procedure		NCI
C10320	PT	Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Sargramostim/Vincristine		NCI
C10320	SY	BLEO/CTX/DM/DOX/GM-CSF/MTX/VCR		NCI
C10320	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10320	RO	chemotherapy regimen has component Bleomycin	NCI
C10320	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10320	RO	chemotherapy regimen has component Dexamethasone	NCI
C10320	RO	chemotherapy regimen has component Doxorubicin	NCI
C10320	RO	chemotherapy regimen has component Methotrexate	NCI
C10320	RO	chemotherapy regimen has component Vincristine	NCI
C10320	RO	chemotherapy regimen has component Sargramostim	NCI
C11833	STY	Therapeutic or Preventive Procedure		NCI
C11833	PT	Gemcitabine/SU5416		NCI
C11833	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11833	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11833	RO	chemotherapy regimen has component Semaxanib	NCI
C10733	STY	Therapeutic or Preventive Procedure		NCI
C10733	PT	Floxuridine/Mitomycin		NCI
C10733	SY	FUDR/MITO		NCI
C10733	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10733	RO	chemotherapy regimen has component Mitomycin	NCI
C10733	RO	chemotherapy regimen has component Floxuridine	NCI
C10435	STY	Therapeutic or Preventive Procedure		NCI
C10435	PT	Cimetidine/Cyclophosphamide/Indomethacin/Interleukin-2		NCI
C10435	SY	cimetidine/CTX/IL-2/Indomethacin		NCI
C10435	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10435	RO	chemotherapy regimen has component Cimetidine	NCI
C10435	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10435	RO	chemotherapy regimen has component Indomethacin	NCI
C10435	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12166	STY	Therapeutic or Preventive Procedure		NCI
C12166	PT	Interferon Alfa/Temozolomide		NCI
C12166	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12166	RO	chemotherapy regimen has component Temozolomide	NCI
C12166	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11003	STY	Therapeutic or Preventive Procedure		NCI
C11003	PT	Interferon Alfa/Piroxicam		NCI
C11003	SY	IFN-A/PXM		NCI
C11003	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11003	RO	chemotherapy regimen has component Piroxicam	NCI
C11003	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11183	STY	Therapeutic or Preventive Procedure		NCI
C11183	PT	Carboplatin/Paclitaxel/Topotecan		NCI
C11183	SY	CBDCA/TAX/TOPO		NCI
C11183	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11183	RO	chemotherapy regimen has component Carboplatin	NCI
C11183	RO	chemotherapy regimen has component Paclitaxel	NCI
C11183	RO	chemotherapy regimen has component Topotecan	NCI
C9576	STY	Therapeutic or Preventive Procedure		NCI
C9576	PT	Cyclophosphamide/Dacarbazine/Doxorubicin/Vincristine		NCI
C9576	SY	CY-VA-DIC		NCI
C9576	SY	CTX/DOX/DTIC/VCR		NCI
C9576	SY	VAdrC-D		NCI
C9576	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9576	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9576	RO	chemotherapy regimen has component Dacarbazine	NCI
C9576	RO	chemotherapy regimen has component Doxorubicin	NCI
C9576	RO	chemotherapy regimen has component Vincristine	NCI
C37844	STY	Therapeutic or Preventive Procedure		NCI
C37844	PT	Paclitaxel/Trastuzumab		NCI
C37844	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37844	RO	chemotherapy regimen has component Paclitaxel	NCI
C37844	RO	chemotherapy regimen has component Trastuzumab	NCI
C11794	STY	Therapeutic or Preventive Procedure		NCI
C11794	PT	Cisplatin/Mitomycin/Tretinoin/Vinorelbine		NCI
C11794	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11794	RO	chemotherapy regimen has component Mitomycin	NCI
C11794	RO	chemotherapy regimen has component Cisplatin	NCI
C11794	RO	chemotherapy regimen has component Tretinoin	NCI
C11794	RO	chemotherapy regimen has component Vinorelbine	NCI
C10095	STY	Therapeutic or Preventive Procedure		NCI
C10095	PT	Altretamine/Cisplatin		NCI
C10095	SY	CDDP/HMM		NCI
C10095	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10095	RO	chemotherapy regimen has component Cisplatin	NCI
C10095	RO	chemotherapy regimen has component Altretamine	NCI
C10302	STY	Therapeutic or Preventive Procedure		NCI
C10302	PT	Daunorubicin/Dexamethasone/Ifosfamide/Methotrexate/Thioguanine/Vindesine		NCI
C10302	SY	DAVA/DM/DNR/IFF/MTX/TG		NCI
C10302	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10302	RO	chemotherapy regimen has component Dexamethasone	NCI
C10302	RO	chemotherapy regimen has component Ifosfamide	NCI
C10302	RO	chemotherapy regimen has component Methotrexate	NCI
C10302	RO	chemotherapy regimen has component Thioguanine	NCI
C10302	RO	chemotherapy regimen has component Vindesine	NCI
C10302	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C63688	STY	Therapeutic or Preventive Procedure		NCI
C63688	PT	CyVADIC Regimen		NCI
C63688	SY	Cyclophosphamide-Vincristine-Adriamycin-DTIC Regimen		NCI
C63688	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C63688	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63688	RO	chemotherapy regimen has component Dacarbazine	NCI
C63688	RO	chemotherapy regimen has component Doxorubicin	NCI
C63688	RO	chemotherapy regimen has component Vincristine	NCI
C63688	RO	regimen has accepted use for disease Soft Tissue Sarcoma	NCI
C11491	STY	Therapeutic or Preventive Procedure		NCI
C11491	PT	Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine		NCI
C11491	SY	CF/DM/MP/MTX/VCR		NCI
C11491	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11491	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11491	RO	chemotherapy regimen has component Dexamethasone	NCI
C11491	RO	chemotherapy regimen has component Methotrexate	NCI
C11491	RO	chemotherapy regimen has component Vincristine	NCI
C11491	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11709	STY	Therapeutic or Preventive Procedure		NCI
C11709	PT	Keyhole Limpet Hemocyanin/MUC-1 Antigen/QS21		NCI
C11709	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11709	RO	chemotherapy regimen has component MUC-1 Antigen	NCI
C11709	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C11709	RO	chemotherapy regimen has component QS21	NCI
C11494	STY	Therapeutic or Preventive Procedure		NCI
C11494	PT	Interferon Alfa/Interleukin-2 Liposome/Polyvalent Melanoma Vaccine		NCI
C11494	SY	IFN-A/IL-2 LIPO/POLYMELVAC		NCI
C11494	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11494	RO	chemotherapy regimen has component Interleukin-2 Liposome	NCI
C11494	RO	chemotherapy regimen has component Polyvalent Melanoma Vaccine	NCI
C11494	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10636	STY	Therapeutic or Preventive Procedure		NCI
C10636	PT	Doxorubicin/Vinorelbine		NCI
C10636	SY	DOX/VNB		NCI
C10636	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10636	RO	chemotherapy regimen has component Doxorubicin	NCI
C10636	RO	chemotherapy regimen has component Vinorelbine	NCI
C10372	STY	Therapeutic or Preventive Procedure		NCI
C10372	PT	Cyclophosphamide/Interleukin-2/Monoclonal Antibody R24		NCI
C10372	SY	CTX/IL-2/MOAB R24		NCI
C10372	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10372	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10372	RO	chemotherapy regimen has component Monoclonal Antibody R24	NCI
C10372	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11414	STY	Therapeutic or Preventive Procedure		NCI
C11414	PT	Carboplatin/Gemcitabine/Paclitaxel		NCI
C11414	SY	CBDCA/dFdC/TAX		NCI
C11414	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11414	RO	chemotherapy regimen has component Carboplatin	NCI
C11414	RO	chemotherapy regimen has component Paclitaxel	NCI
C11414	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63608	STY	Therapeutic or Preventive Procedure		NCI
C63608	PT	FOLFIRI-Bevacizumab Regimen		NCI
C63608	SY	Folinic Acid-Fluorouracil-Irinotecan-Bevacizumab Regimen		NCI
C63608	SY	FOLFIRI-Avastin Regimen		NCI
C63608	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63608	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63608	RO	chemotherapy regimen has component Fluorouracil	NCI
C63608	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C63608	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63608	RO	chemotherapy regimen has component Bevacizumab	NCI
C63608	RO	concept in subset CTRP Terminology	NCI
C63608	RO	concept in subset CTRP Agent Terminology	NCI
C10664	STY	Therapeutic or Preventive Procedure		NCI
C10664	PT	Etoposide/Paclitaxel		NCI
C10664	SY	TAX/VP-16		NCI
C10664	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10664	RO	chemotherapy regimen has component Etoposide	NCI
C10664	RO	chemotherapy regimen has component Paclitaxel	NCI
C12199	STY	Therapeutic or Preventive Procedure		NCI
C12199	PT	Ad5CMV-p53 gene/Cisplatin/Fluorouracil		NCI
C12199	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12199	RO	chemotherapy regimen has component Cisplatin	NCI
C12199	RO	chemotherapy regimen has component Fluorouracil	NCI
C12199	RO	chemotherapy regimen has component Ad5CMV-p53 Gene	NCI
C11339	STY	Therapeutic or Preventive Procedure		NCI
C11339	PT	Histamine Dihydrochloride/Interleukin-2		NCI
C11339	SY	HIST/IL-2		NCI
C11339	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11339	RO	chemotherapy regimen has component Histamine Dihydrochloride	NCI
C11339	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10115	STY	Therapeutic or Preventive Procedure		NCI
C10115	PT	Doxorubicin/Fluorouracil/Methotrexate/Mitomycin		NCI
C10115	SY	M-FAM		NCI
C10115	SY	DOX/5-FU/MITO/MTX		NCI
C10115	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10115	RO	chemotherapy regimen has component Mitomycin	NCI
C10115	RO	chemotherapy regimen has component Doxorubicin	NCI
C10115	RO	chemotherapy regimen has component Fluorouracil	NCI
C10115	RO	chemotherapy regimen has component Methotrexate	NCI
C10545	STY	Therapeutic or Preventive Procedure		NCI
C10545	PT	Dipyridamole/Etoposide/Ketoconazole/Metronidazole/Tamoxifen		NCI
C10545	SY	DP/KCZ/METRO/TMX/VP-16		NCI
C10545	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10545	RO	chemotherapy regimen has component Dipyridamole	NCI
C10545	RO	chemotherapy regimen has component Etoposide	NCI
C10545	RO	chemotherapy regimen has component Ketoconazole	NCI
C10545	RO	chemotherapy regimen has component Metronidazole	NCI
C10545	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10461	STY	Therapeutic or Preventive Procedure		NCI
C10461	PT	Fluorouracil/Interleukin-2/Leucovorin Calcium/Lymphokine-Activated Killer Cells		NCI
C10461	SY	CF/5-FU/IL-2/LAK		NCI
C10461	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10461	RO	chemotherapy regimen has component Fluorouracil	NCI
C10461	RO	chemotherapy regimen has component Lymphokine-Activated Killer Cells	NCI
C10461	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10461	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11399	STY	Therapeutic or Preventive Procedure		NCI
C11399	PT	Carboplatin/Lomustine/Procarbazine/Vincristine		NCI
C11399	SY	CBDCA/CCNU/PCB/VCR		NCI
C11399	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11399	RO	chemotherapy regimen has component Lomustine	NCI
C11399	RO	chemotherapy regimen has component Vincristine	NCI
C11399	RO	chemotherapy regimen has component Carboplatin	NCI
C11399	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11763	STY	Therapeutic or Preventive Procedure		NCI
C11763	PT	Cisplatin/Cyclophosphamide/Etoposide/Mafosfamide/Vincristine		NCI
C11763	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11763	RO	chemotherapy regimen has component Cisplatin	NCI
C11763	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11763	RO	chemotherapy regimen has component Etoposide	NCI
C11763	RO	chemotherapy regimen has component Vincristine	NCI
C11763	RO	chemotherapy regimen has component Mafosfamide	NCI
C63729	STY	Therapeutic or Preventive Procedure		NCI
C63729	PT	BV Regimen		NCI
C63729	SY	Bleomycin-Vincristine Regimen		NCI
C63729	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C63729	RO	chemotherapy regimen has component Bleomycin	NCI
C63729	RO	chemotherapy regimen has component Vincristine	NCI
C63729	RO	regimen has accepted use for disease AIDS-Related Kaposi Sarcoma	NCI
C10463	STY	Therapeutic or Preventive Procedure		NCI
C10463	PT	Carboplatin/Etoposide/Ifosfamide/Sargramostim		NCI
C10463	SY	CBDCA/GM-CSF/IFF/VP-16		NCI
C10463	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10463	RO	chemotherapy regimen has component Etoposide	NCI
C10463	RO	chemotherapy regimen has component Ifosfamide	NCI
C10463	RO	chemotherapy regimen has component Carboplatin	NCI
C10463	RO	chemotherapy regimen has component Sargramostim	NCI
C37631	STY	Therapeutic or Preventive Procedure		NCI
C37631	PT	Celecoxib/Exemestane		NCI
C37631	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37631	RO	chemotherapy regimen has component Celecoxib	NCI
C37631	RO	chemotherapy regimen has component Exemestane	NCI
C11300	STY	Therapeutic or Preventive Procedure		NCI
C11300	PT	Doxorubicin/Estramustine/Ketoconazole/Vinblastine		NCI
C11300	SY	DOX/EM/KCZ/VBL		NCI
C11300	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11300	RO	chemotherapy regimen has component Doxorubicin	NCI
C11300	RO	chemotherapy regimen has component Estramustine	NCI
C11300	RO	chemotherapy regimen has component Ketoconazole	NCI
C11300	RO	chemotherapy regimen has component Vinblastine	NCI
C11703	STY	Therapeutic or Preventive Procedure		NCI
C11703	PT	Rituximab/Yttrium Y 90 ibritumomab tiuxetan		NCI
C11703	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11703	RO	chemotherapy regimen has component Rituximab	NCI
C11703	RO	chemotherapy regimen has component Yttrium Y-90 Ibritumomab Tiuxetan	NCI
C10025	STY	Therapeutic or Preventive Procedure		NCI
C10025	PT	Asparaginase/Cytarabine/Doxorubicin/Prednisone/Vincristine		NCI
C10025	SY	LAPOCA		NCI
C10025	SY	ARA-C/ASP/DOX/PRED/VCR		NCI
C10025	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10025	RO	chemotherapy regimen has component Asparaginase	NCI
C10025	RO	chemotherapy regimen has component Cytarabine	NCI
C10025	RO	chemotherapy regimen has component Doxorubicin	NCI
C10025	RO	chemotherapy regimen has component Prednisone	NCI
C10025	RO	chemotherapy regimen has component Vincristine	NCI
C10781	STY	Therapeutic or Preventive Procedure		NCI
C10781	PT	Cisplatin/Etoposide/Filgrastim/Ifosfamide/Interleukin-3		NCI
C10781	SY	CDDP/G-CSF/IFF/IL-3/VP-16		NCI
C10781	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10781	RO	chemotherapy regimen has component Cisplatin	NCI
C10781	RO	chemotherapy regimen has component Etoposide	NCI
C10781	RO	chemotherapy regimen has component Ifosfamide	NCI
C10781	RO	chemotherapy regimen has component Filgrastim	NCI
C10781	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C9559	STY	Therapeutic or Preventive Procedure		NCI
C9559	PT	Bleomycin/Cisplatin/Vincristine		NCI
C9559	SY	COB		NCI
C9559	SY	BLEO/CDDP/VCR		NCI
C9559	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9559	RO	chemotherapy regimen has component Bleomycin	NCI
C9559	RO	chemotherapy regimen has component Cisplatin	NCI
C9559	RO	chemotherapy regimen has component Vincristine	NCI
C64836	STY	Therapeutic or Preventive Procedure		NCI
C64836	PT	MPB Regimen		NCI
C64836	SY	Melphalan-Prednisone-Bortezomib Regimen		NCI
C64836	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C64836	RO	chemotherapy regimen has component Melphalan	NCI
C64836	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C64836	RO	chemotherapy regimen has component Prednisone	NCI
C64836	RO	chemotherapy regimen has component Bortezomib	NCI
C11923	STY	Therapeutic or Preventive Procedure		NCI
C11923	PT	Filgrastim/Melphalan		NCI
C11923	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11923	RO	chemotherapy regimen has component Melphalan	NCI
C11923	RO	chemotherapy regimen has component Filgrastim	NCI
C11207	STY	Therapeutic or Preventive Procedure		NCI
C11207	PT	Carboplatin/Ifosfamide/Paclitaxel		NCI
C11207	SY	CBDCA/IFF/TAX		NCI
C11207	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11207	RO	chemotherapy regimen has component Ifosfamide	NCI
C11207	RO	chemotherapy regimen has component Carboplatin	NCI
C11207	RO	chemotherapy regimen has component Paclitaxel	NCI
C10198	STY	Therapeutic or Preventive Procedure		NCI
C10198	PT	Epirubicin/Prednisone/Vincristine		NCI
C10198	SY	EPI/PRED/VCR		NCI
C10198	SY	EOP		NCI
C10198	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10198	RO	chemotherapy regimen has component Prednisone	NCI
C10198	RO	chemotherapy regimen has component Vincristine	NCI
C10198	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11432	STY	Therapeutic or Preventive Procedure		NCI
C11432	PT	Gemcitabine/Vinorelbine		NCI
C11432	SY	dFdC/VNB		NCI
C11432	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11432	RO	chemotherapy regimen has component Vinorelbine	NCI
C11432	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C67231	STY	Therapeutic or Preventive Procedure		NCI
C67231	PT	VAdriaC Regimen		NCI
C67231	SY	VAdriaC		NCI
C67231	SY	Vincristine-Adriamycin-Cyclophosphamide Regimen		NCI
C67231	CHD	Chemotherapy Regimen Used to Treat Ewing's Family of Tumors	NCI
C67231	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67231	RO	chemotherapy regimen has component Doxorubicin	NCI
C67231	RO	chemotherapy regimen has component Vincristine	NCI
C10138	STY	Therapeutic or Preventive Procedure		NCI
C10138	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Vincristine		NCI
C10138	SY	MACOP-B		NCI
C10138	SY	BLEO/CTX/DOX/MTX/PRED/VCR		NCI
C10138	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10138	RO	chemotherapy regimen has component Bleomycin	NCI
C10138	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10138	RO	chemotherapy regimen has component Doxorubicin	NCI
C10138	RO	chemotherapy regimen has component Methotrexate	NCI
C10138	RO	chemotherapy regimen has component Prednisone	NCI
C10138	RO	chemotherapy regimen has component Vincristine	NCI
C12194	STY	Therapeutic or Preventive Procedure		NCI
C12194	PT	Gemcitabine/UCN-01		NCI
C12194	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12194	RO	chemotherapy regimen has component 7-Hydroxystaurosporine	NCI
C12194	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11666	STY	Therapeutic or Preventive Procedure		NCI
C11666	PT	gp100 Antigen/Interleukin-2/Montanide ISA-51		NCI
C11666	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11666	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11666	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11666	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11913	STY	Therapeutic or Preventive Procedure		NCI
C11913	PT	Doxorubicin/Octreotide		NCI
C11913	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11913	RO	chemotherapy regimen has component Doxorubicin	NCI
C11913	RO	chemotherapy regimen has component Octreotide	NCI
C136280	STY	Therapeutic or Preventive Procedure		NCI
C136280	PT	Pomalidomide/Cyclophosphamide/Dexamethasone Regimen		NCI
C136280	SY	PCD		NCI
C136280	SY	Pomalidomide/Cyclophosphamide/Dexamethasone		NCI
C136280	SY	Pomalidomide-Cyclophosphamide-Dexamethasone Regimen		NCI
C136280	SY	Pomalidomide-Cyclophosphamide-Dexamethasone		NCI
C136280	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136280	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C136280	RO	chemotherapy regimen has component Dexamethasone	NCI
C136280	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136280	RO	chemotherapy regimen has component Pomalidomide	NCI
C10358	STY	Therapeutic or Preventive Procedure		NCI
C10358	PT	Interferon Gamma/Sargramostim		NCI
C10358	SY	GM-CSF/IFN-G		NCI
C10358	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10358	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C10358	RO	chemotherapy regimen has component Sargramostim	NCI
C10865	STY	Therapeutic or Preventive Procedure		NCI
C10865	PT	Aminocamptothecin/Filgrastim		NCI
C10865	SY	9-AC/G-CSF		NCI
C10865	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10865	RO	chemotherapy regimen has component Filgrastim	NCI
C10865	RO	chemotherapy regimen has component Aminocamptothecin	NCI
C37732	STY	Therapeutic or Preventive Procedure		NCI
C37732	PT	Dexamethasone/Idarubicin/Imatinib Mesylate/Pegaspargase/Vincristine		NCI
C37732	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37732	RO	chemotherapy regimen has component Dexamethasone	NCI
C37732	RO	chemotherapy regimen has component Idarubicin	NCI
C37732	RO	chemotherapy regimen has component Vincristine	NCI
C37732	RO	chemotherapy regimen has component Pegaspargase	NCI
C37732	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C9833	STY	Therapeutic or Preventive Procedure		NCI
C9833	PT	Cyclophosphamide/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C9833	SY	CTX/DOX/MP/MTX/PRED/VCR		NCI
C9833	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9833	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9833	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9833	RO	chemotherapy regimen has component Doxorubicin	NCI
C9833	RO	chemotherapy regimen has component Methotrexate	NCI
C9833	RO	chemotherapy regimen has component Prednisone	NCI
C9833	RO	chemotherapy regimen has component Vincristine	NCI
C10750	STY	Therapeutic or Preventive Procedure		NCI
C10750	PT	Beta Carotene/Vitamin A		NCI
C10750	SY	beta carotene/VIT-A		NCI
C10750	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10750	RO	chemotherapy regimen has component Beta-Carotene	NCI
C10750	RO	chemotherapy regimen has component Vitamin A Compound	NCI
C12078	STY	Therapeutic or Preventive Procedure		NCI
C12078	PT	Temozolomide/Vinorelbine		NCI
C12078	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12078	RO	chemotherapy regimen has component Temozolomide	NCI
C12078	RO	chemotherapy regimen has component Vinorelbine	NCI
C15588	STY	Therapeutic or Preventive Procedure		NCI
C15588	PT	interleukin-6/sargramostim		NCI
C15588	SY	GM-CSF/IL-6		NCI
C15588	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15588	RO	chemotherapy regimen has component Sargramostim	NCI
C15588	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C11353	STY	Therapeutic or Preventive Procedure		NCI
C11353	PT	Interleukin-2/Sargramostim/Vinblastine		NCI
C11353	SY	GM-CSF/IL-2/VBL		NCI
C11353	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11353	RO	chemotherapy regimen has component Vinblastine	NCI
C11353	RO	chemotherapy regimen has component Sargramostim	NCI
C11353	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37616	STY	Therapeutic or Preventive Procedure		NCI
C37616	PT	Carboplatin/Lobradimil		NCI
C37616	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37616	RO	chemotherapy regimen has component Carboplatin	NCI
C37616	RO	chemotherapy regimen has component Labradimil	NCI
C156302	STY	Therapeutic or Preventive Procedure		NCI
C156302	PT	Everolimus/Tamoxifen Regimen		NCI
C156302	SY	Tamoxifen/Everolimus		NCI
C156302	SY	Everolimus/Tamoxifen		NCI
C156302	SY	Everolimus-Tamoxifen		NCI
C156302	SY	Tamoxifen/Everolimus Regimen		NCI
C156302	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156302	RO	chemotherapy regimen has component Tamoxifen	NCI
C156302	RO	chemotherapy regimen has component Everolimus	NCI
C11911	STY	Therapeutic or Preventive Procedure		NCI
C11911	PT	Carboplatin/Paclitaxel/Suramin		NCI
C11911	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11911	RO	chemotherapy regimen has component Suramin	NCI
C11911	RO	chemotherapy regimen has component Carboplatin	NCI
C11911	RO	chemotherapy regimen has component Paclitaxel	NCI
C9573	STY	Therapeutic or Preventive Procedure		NCI
C9573	PT	CVP Regimen		NCI
C9573	SY	Cyclophosphamide-Vincristine-Prednisone Regimen		NCI
C9573	SY	VCP		NCI
C9573	SY	Cyclophosphamide/Prednisone/Vincristine		NCI
C9573	SY	CTX/PRED/VCR		NCI
C9573	SY	CVP		NCI
C9573	CHD	Chemotherapy Regimen Used to Treat Chronic Lymphocytic Leukemia	NCI
C9573	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C9573	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9573	RO	regimen has accepted use for disease Chronic Lymphocytic Leukemia	NCI
C9573	RO	chemotherapy regimen has component Prednisone	NCI
C9573	RO	chemotherapy regimen has component Vincristine	NCI
C9573	RO	regimen has accepted use for disease Indolent Adult Non-Hodgkin Lymphoma	NCI
C138036	STY	Therapeutic or Preventive Procedure		NCI
C138036	PT	Dose-dense AC Followed by Paclitaxel/Trastuzumab Regimen		NCI
C138036	SY	Dose-dense Adriamycin/Cytoxan Followed by Paclitaxel/Trastuzumab		NCI
C138036	SY	Dose-dense Doxorubicin/Cyclophosphamide Followed by Paclitaxel/Trastuzumab		NCI
C138036	SY	Dose-dense AC Followed by Paclitaxel/Trastuzumab		NCI
C138036	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138036	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138036	RO	chemotherapy regimen has component Doxorubicin	NCI
C138036	RO	chemotherapy regimen has component Paclitaxel	NCI
C138036	RO	chemotherapy regimen has component Trastuzumab	NCI
C63789	STY	Therapeutic or Preventive Procedure		NCI
C63789	PT	Gemcitabine-Liposomal Doxorubicin Regimen		NCI
C63789	SY	Gemcitabine-Doxil Regimen		NCI
C63789	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C63789	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63789	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C63789	RO	regimen has accepted use for disease Ovarian Carcinoma	NCI
C10532	STY	Therapeutic or Preventive Procedure		NCI
C10532	PT	Cisplatin/Doxorubicin/Methotrexate/Sargramostim/Vinblastine		NCI
C10532	SY	CDDP/DOX/GM-CSF/MTX/VBL		NCI
C10532	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10532	RO	chemotherapy regimen has component Cisplatin	NCI
C10532	RO	chemotherapy regimen has component Doxorubicin	NCI
C10532	RO	chemotherapy regimen has component Methotrexate	NCI
C10532	RO	chemotherapy regimen has component Vinblastine	NCI
C10532	RO	chemotherapy regimen has component Sargramostim	NCI
C12070	STY	Therapeutic or Preventive Procedure		NCI
C12070	PT	Bevacizumab/Fluorouracil/Leucovorin Calcium/Oxaliplatin		NCI
C12070	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12070	RO	chemotherapy regimen has component Fluorouracil	NCI
C12070	RO	chemotherapy regimen has component Oxaliplatin	NCI
C12070	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12070	RO	chemotherapy regimen has component Bevacizumab	NCI
C11946	STY	Therapeutic or Preventive Procedure		NCI
C11946	PT	Doxorubicin Hcl Liposome/Interleukin-12		NCI
C11946	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11946	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C11946	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C10037	STY	Therapeutic or Preventive Procedure		NCI
C10037	PT	Dacarbazine/Zorubicin		NCI
C10037	SY	DTIC/RBZ		NCI
C10037	SY	RUBIDIC		NCI
C10037	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10037	RO	chemotherapy regimen has component Dacarbazine	NCI
C10037	RO	chemotherapy regimen has component Zorubicin Hydrochloride	NCI
C10106	STY	Therapeutic or Preventive Procedure		NCI
C10106	PT	Cytarabine/Etoposide/Prednisone/Teniposide		NCI
C10106	SY	ARA-C/PRED/VM-26/VP-16		NCI
C10106	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10106	RO	chemotherapy regimen has component Cytarabine	NCI
C10106	RO	chemotherapy regimen has component Etoposide	NCI
C10106	RO	chemotherapy regimen has component Prednisone	NCI
C10106	RO	chemotherapy regimen has component Teniposide	NCI
C10062	STY	Therapeutic or Preventive Procedure		NCI
C10062	PT	Cyclophosphamide/Doxorubicin/Melphalan/Methotrexate/Vincristine		NCI
C10062	SY	COMPADRI-V		NCI
C10062	SY	CTX/DOX/L-PAM/MTX/VCR		NCI
C10062	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10062	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10062	RO	chemotherapy regimen has component Doxorubicin	NCI
C10062	RO	chemotherapy regimen has component Melphalan	NCI
C10062	RO	chemotherapy regimen has component Methotrexate	NCI
C10062	RO	chemotherapy regimen has component Vincristine	NCI
C12012	STY	Therapeutic or Preventive Procedure		NCI
C12012	PT	Docetaxel/Exisulind		NCI
C12012	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12012	RO	chemotherapy regimen has component Exisulind	NCI
C12012	RO	chemotherapy regimen has component Docetaxel	NCI
C10776	STY	Therapeutic or Preventive Procedure		NCI
C10776	PT	Filgrastim/Pyrazoloacridine		NCI
C10776	SY	G-CSF/PZA		NCI
C10776	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10776	RO	chemotherapy regimen has component Filgrastim	NCI
C10776	RO	chemotherapy regimen has component Pyrazoloacridine	NCI
C11402	STY	Therapeutic or Preventive Procedure		NCI
C11402	PT	Carboplatin/Thalidomide		NCI
C11402	SY	CBDCA/THAL		NCI
C11402	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11402	RO	chemotherapy regimen has component Thalidomide	NCI
C11402	RO	chemotherapy regimen has component Carboplatin	NCI
C11198	STY	Therapeutic or Preventive Procedure		NCI
C11198	PT	Fluorouracil/Gemcitabine		NCI
C11198	SY	dFdC/5-FU		NCI
C11198	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11198	RO	chemotherapy regimen has component Fluorouracil	NCI
C11198	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11846	STY	Therapeutic or Preventive Procedure		NCI
C11846	PT	Filgrastim/Mycophenolate Mofetil/Tacrolimus		NCI
C11846	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11846	RO	chemotherapy regimen has component Tacrolimus	NCI
C11846	RO	chemotherapy regimen has component Mycophenolate Mofetil	NCI
C11846	RO	chemotherapy regimen has component Filgrastim	NCI
C10685	STY	Therapeutic or Preventive Procedure		NCI
C10685	PT	Cytarabine/Idarubicin/Teniposide		NCI
C10685	SY	ARA-C/IDA/VM-26		NCI
C10685	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10685	RO	chemotherapy regimen has component Cytarabine	NCI
C10685	RO	chemotherapy regimen has component Idarubicin	NCI
C10685	RO	chemotherapy regimen has component Teniposide	NCI
C11055	STY	Therapeutic or Preventive Procedure		NCI
C11055	PT	Filgrastim/Interferon Alfa		NCI
C11055	SY	G-CSF/IFN-A		NCI
C11055	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11055	RO	chemotherapy regimen has component Filgrastim	NCI
C11055	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10688	STY	Therapeutic or Preventive Procedure		NCI
C10688	PT	Ifosfamide/Paclitaxel		NCI
C10688	SY	IFF/TAX		NCI
C10688	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10688	RO	chemotherapy regimen has component Ifosfamide	NCI
C10688	RO	chemotherapy regimen has component Paclitaxel	NCI
C11521	STY	Therapeutic or Preventive Procedure		NCI
C11521	PT	Amifostine/Carmustine/Cyclophosphamide/Cytarabine/Etoposide		NCI
C11521	SY	ARA-C/BCNU/CTX/VP-16/WR-2721		NCI
C11521	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11521	RO	chemotherapy regimen has component Carmustine	NCI
C11521	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11521	RO	chemotherapy regimen has component Cytarabine	NCI
C11521	RO	chemotherapy regimen has component Amifostine	NCI
C11521	RO	chemotherapy regimen has component Etoposide	NCI
C12115	STY	Therapeutic or Preventive Procedure		NCI
C12115	PT	Paclitaxel/R101933		NCI
C12115	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12115	RO	chemotherapy regimen has component Paclitaxel	NCI
C12115	RO	chemotherapy regimen has component Laniquidar	NCI
C10465	STY	Therapeutic or Preventive Procedure		NCI
C10465	PT	Interferon Gamma/Interleukin-2/Tumor Infiltrating Lymphocytes		NCI
C10465	SY	IFN-G/IL-2/TIL		NCI
C10465	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10465	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C10465	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C10465	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37475	STY	Therapeutic or Preventive Procedure		NCI
C37475	PT	Docetaxel/Estramustine/Vitaxin-2/Zoledronate		NCI
C37475	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37475	RO	chemotherapy regimen has component Estramustine	NCI
C37475	RO	chemotherapy regimen has component Docetaxel	NCI
C37475	RO	chemotherapy regimen has component Zoledronic Acid	NCI
C37475	RO	chemotherapy regimen has component Vitaxin-2	NCI
C9872	STY	Therapeutic or Preventive Procedure		NCI
C9872	PT	Asparaginase/Cytarabine/Methotrexate/Prednisone/Thioguanine/Vincristine		NCI
C9872	SY	ARA-C/ASP/MTX/PRED/TG/VCR		NCI
C9872	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9872	RO	chemotherapy regimen has component Asparaginase	NCI
C9872	RO	chemotherapy regimen has component Cytarabine	NCI
C9872	RO	chemotherapy regimen has component Methotrexate	NCI
C9872	RO	chemotherapy regimen has component Prednisone	NCI
C9872	RO	chemotherapy regimen has component Thioguanine	NCI
C9872	RO	chemotherapy regimen has component Vincristine	NCI
C10682	STY	Therapeutic or Preventive Procedure		NCI
C10682	PT	Asparaginase/Daunorubicin/Dexamethasone/Ifosfamide/Mercaptopurine/Methotrexate/Vindesine		NCI
C10682	SY	ASP/DAVA/DM/DNR/IFF/MP/MTX		NCI
C10682	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10682	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10682	RO	chemotherapy regimen has component Asparaginase	NCI
C10682	RO	chemotherapy regimen has component Dexamethasone	NCI
C10682	RO	chemotherapy regimen has component Ifosfamide	NCI
C10682	RO	chemotherapy regimen has component Methotrexate	NCI
C10682	RO	chemotherapy regimen has component Vindesine	NCI
C10682	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C150687	STY	Therapeutic or Preventive Procedure		NCI
C150687	PT	Carboplatin/Cetuximab Regimen		NCI
C150687	SY	Carboplatin-Cetuximab		NCI
C150687	SY	Carboplatin/Cetuximab		NCI
C150687	SY	Carboplatin-Cetuximab Regimen		NCI
C150687	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C150687	RO	chemotherapy regimen has component Carboplatin	NCI
C150687	RO	chemotherapy regimen has component Cetuximab	NCI
C150687	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C37579	STY	Therapeutic or Preventive Procedure		NCI
C37579	PT	Bortezomib/Topotecan		NCI
C37579	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37579	RO	chemotherapy regimen has component Topotecan	NCI
C37579	RO	chemotherapy regimen has component Bortezomib	NCI
C11235	STY	Therapeutic or Preventive Procedure		NCI
C11235	PT	Doxorubicin/Progesterone		NCI
C11235	SY	DOX/progesterone		NCI
C11235	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11235	RO	chemotherapy regimen has component Doxorubicin	NCI
C11235	RO	chemotherapy regimen has component Progesterone	NCI
C10982	STY	Therapeutic or Preventive Procedure		NCI
C10982	PT	Cyclophosphamide/Fluorouracil/Pirarubicin		NCI
C10982	SY	CTX/5-FU/THP-DOX		NCI
C10982	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10982	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10982	RO	chemotherapy regimen has component Fluorouracil	NCI
C10982	RO	chemotherapy regimen has component Pirarubicin	NCI
C37767	STY	Therapeutic or Preventive Procedure		NCI
C37767	PT	Erlotinib/Temozolomide		NCI
C37767	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37767	RO	chemotherapy regimen has component Temozolomide	NCI
C37767	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C37653	STY	Therapeutic or Preventive Procedure		NCI
C37653	PT	Cisplatin/Etoposide/Topotecan		NCI
C37653	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37653	RO	chemotherapy regimen has component Cisplatin	NCI
C37653	RO	chemotherapy regimen has component Etoposide	NCI
C37653	RO	chemotherapy regimen has component Topotecan	NCI
C10738	STY	Therapeutic or Preventive Procedure		NCI
C10738	PT	Asparaginase/Cyclophosphamide/Mercaptopurine/Methotrexate		NCI
C10738	SY	ASP/CTX/MP/MTX		NCI
C10738	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10738	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10738	RO	chemotherapy regimen has component Asparaginase	NCI
C10738	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10738	RO	chemotherapy regimen has component Methotrexate	NCI
C11797	STY	Therapeutic or Preventive Procedure		NCI
C11797	PT	Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide/Thalidomide		NCI
C11797	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11797	RO	chemotherapy regimen has component Cisplatin	NCI
C11797	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11797	RO	chemotherapy regimen has component Dexamethasone	NCI
C11797	RO	chemotherapy regimen has component Etoposide	NCI
C11797	RO	chemotherapy regimen has component Thalidomide	NCI
C140180	STY	Therapeutic or Preventive Procedure		NCI
C140180	PT	Chemotherapy Regimen Used to Treat Central Nervous System Neoplasm		NCI
C140180	SY	Chemotherapy Regimen Used to Treat CNS Neoplasm		NCI
C140180	CHD	Chemotherapy Regimen	NCI
C140180	PAR	Chemotherapy Regimen Used to Treat Malignant Brain Neoplasm	NCI
C140180	PAR	MRT Regimen	NCI
C140180	PAR	MATRix Regimen	NCI
C140180	PAR	MPV Regimen	NCI
C140180	PAR	R-MPV Regimen	NCI
C140180	PAR	High-dose Methotrexate/Leucovorin Regimen	NCI
C10032	STY	Therapeutic or Preventive Procedure		NCI
C10032	PT	Cyclophosphamide/Prednisolone/Teniposide		NCI
C10032	SY	CTX/PRDL/VM-26		NCI
C10032	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10032	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10032	RO	chemotherapy regimen has component Prednisolone	NCI
C10032	RO	chemotherapy regimen has component Teniposide	NCI
C37728	STY	Therapeutic or Preventive Procedure		NCI
C37728	PT	Decitabine/Valproic Acid		NCI
C37728	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37728	RO	chemotherapy regimen has component Valproic Acid	NCI
C37728	RO	chemotherapy regimen has component Decitabine	NCI
C10793	STY	Therapeutic or Preventive Procedure		NCI
C10793	PT	Carboxypeptidase-G2/Leucovorin Calcium/Methotrexate		NCI
C10793	SY	CF/CPG2/MTX		NCI
C10793	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10793	RO	chemotherapy regimen has component Glucarpidase	NCI
C10793	RO	chemotherapy regimen has component Methotrexate	NCI
C10793	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11689	STY	Therapeutic or Preventive Procedure		NCI
C11689	PT	Mutant p53 peptide pulsed dendritic cell vaccine/Sargramostim		NCI
C11689	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11689	RO	chemotherapy regimen has component Sargramostim	NCI
C11689	RO	chemotherapy regimen has component Mutant p53 Peptide Pulsed Dendritic Cell Vaccine	NCI
C9534	STY	Therapeutic or Preventive Procedure		NCI
C9534	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Prednisone/Vincristine		NCI
C9534	SY	CAFVP		NCI
C9534	SY	CTX/DOX/5-FU/PRED/VCR		NCI
C9534	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9534	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9534	RO	chemotherapy regimen has component Doxorubicin	NCI
C9534	RO	chemotherapy regimen has component Fluorouracil	NCI
C9534	RO	chemotherapy regimen has component Prednisone	NCI
C9534	RO	chemotherapy regimen has component Vincristine	NCI
C9846	STY	Therapeutic or Preventive Procedure		NCI
C9846	PT	Etoposide/Ifosfamide/Vincristine		NCI
C9846	SY	IFF/VCR/VP-16		NCI
C9846	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9846	RO	chemotherapy regimen has component Etoposide	NCI
C9846	RO	chemotherapy regimen has component Ifosfamide	NCI
C9846	RO	chemotherapy regimen has component Vincristine	NCI
C9842	STY	Therapeutic or Preventive Procedure		NCI
C9842	PT	Etoposide/Trimetrexate Glucuronate		NCI
C9842	SY	TMTX/VP-16		NCI
C9842	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9842	RO	chemotherapy regimen has component Etoposide	NCI
C9842	RO	chemotherapy regimen has component Trimetrexate Glucuronate	NCI
C9544	STY	Therapeutic or Preventive Procedure		NCI
C9544	PT	Cyclophosphamide/Doxorubicin/Lomustine/Vincristine		NCI
C9544	SY	CCNU/CTX/DOX/VCR		NCI
C9544	SY	CVAC		NCI
C9544	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9544	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9544	RO	chemotherapy regimen has component Doxorubicin	NCI
C9544	RO	chemotherapy regimen has component Lomustine	NCI
C9544	RO	chemotherapy regimen has component Vincristine	NCI
C12034	STY	Therapeutic or Preventive Procedure		NCI
C12034	PT	Calcium Gluconate/Cholecalciferol		NCI
C12034	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12034	RO	chemotherapy regimen has component Calcium Gluconate	NCI
C12034	RO	chemotherapy regimen has component D Vitamin	NCI
C11640	STY	Therapeutic or Preventive Procedure		NCI
C11640	PT	Cisplatin/Fluorouracil/Gemcitabine		NCI
C11640	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11640	RO	chemotherapy regimen has component Cisplatin	NCI
C11640	RO	chemotherapy regimen has component Fluorouracil	NCI
C11640	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C9608	STY	Therapeutic or Preventive Procedure		NCI
C9608	PT	Cisplatin/Doxorubicin/Mitomycin		NCI
C9608	SY	CDDP/DOX/MITO		NCI
C9608	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9608	RO	chemotherapy regimen has component Mitomycin	NCI
C9608	RO	chemotherapy regimen has component Cisplatin	NCI
C9608	RO	chemotherapy regimen has component Doxorubicin	NCI
C10475	STY	Therapeutic or Preventive Procedure		NCI
C10475	PT	Filgrastim/Piroxantrone		NCI
C10475	SY	G-CSF/PXT		NCI
C10475	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10475	RO	chemotherapy regimen has component Piroxantrone	NCI
C10475	RO	chemotherapy regimen has component Filgrastim	NCI
C63600	STY	Therapeutic or Preventive Procedure		NCI
C63600	PT	AIDA Regimen		NCI
C63600	SY	ATRA-Idarubicin Regimen		NCI
C63600	SY	Tretinoin-Idarubicin Regimen		NCI
C63600	CHD	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C63600	RO	chemotherapy regimen has component Idarubicin	NCI
C63600	RO	chemotherapy regimen has component Tretinoin	NCI
C63600	RO	regimen has accepted use for disease Adult Acute Promyelocytic Leukemia with PML-RARA	NCI
C11030	STY	Therapeutic or Preventive Procedure		NCI
C11030	PT	Fluorouracil/Interferon Alfa/Leucovorin Calcium/Methotrexate		NCI
C11030	SY	CF/5-FU/IFN-A/MTX		NCI
C11030	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11030	RO	chemotherapy regimen has component Fluorouracil	NCI
C11030	RO	chemotherapy regimen has component Methotrexate	NCI
C11030	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11030	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11990	STY	Therapeutic or Preventive Procedure		NCI
C11990	PT	Asparaginase/cytarabine/daunorubicin/methotrexate/prednisolone/vincristine		NCI
C11990	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11990	RO	chemotherapy regimen has component Asparaginase	NCI
C11990	RO	chemotherapy regimen has component Cytarabine	NCI
C11990	RO	chemotherapy regimen has component Methotrexate	NCI
C11990	RO	chemotherapy regimen has component Prednisolone	NCI
C11990	RO	chemotherapy regimen has component Vincristine	NCI
C11990	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11143	STY	Therapeutic or Preventive Procedure		NCI
C11143	PT	Asparaginase/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C11143	SY	ASP/DOX/MP/MTX/PRED/VCR		NCI
C11143	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11143	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11143	RO	chemotherapy regimen has component Asparaginase	NCI
C11143	RO	chemotherapy regimen has component Doxorubicin	NCI
C11143	RO	chemotherapy regimen has component Methotrexate	NCI
C11143	RO	chemotherapy regimen has component Prednisone	NCI
C11143	RO	chemotherapy regimen has component Vincristine	NCI
C11883	STY	Therapeutic or Preventive Procedure		NCI
C11883	PT	Oxaliplatin/Topotecan		NCI
C11883	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11883	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11883	RO	chemotherapy regimen has component Topotecan	NCI
C10912	STY	Therapeutic or Preventive Procedure		NCI
C10912	PT	Antineoplaston A10/Antineoplaston AS2-1		NCI
C10912	SY	A10/AS2-1		NCI
C10912	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10912	RO	chemotherapy regimen has component Antineoplaston A10	NCI
C10912	RO	chemotherapy regimen has component Antineoplaston AS2-1	NCI
C11598	STY	Therapeutic or Preventive Procedure		NCI
C11598	PT	Gemcitabine/Monoclonal Antibody HER2		NCI
C11598	SY	dFdC/MOAB HER2		NCI
C11598	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11598	RO	chemotherapy regimen has component Trastuzumab	NCI
C11598	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10730	STY	Therapeutic or Preventive Procedure		NCI
C10730	PT	Dexamethasone/Floxuridine/Mitomycin		NCI
C10730	SY	DM/FUDR/MITO		NCI
C10730	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10730	RO	chemotherapy regimen has component Mitomycin	NCI
C10730	RO	chemotherapy regimen has component Dexamethasone	NCI
C10730	RO	chemotherapy regimen has component Floxuridine	NCI
C10625	STY	Therapeutic or Preventive Procedure		NCI
C10625	PT	Busulfan/Cyclophosphamide/Cytarabine		NCI
C10625	SY	ARA-C/BU/CTX		NCI
C10625	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10625	RO	chemotherapy regimen has component Busulfan	NCI
C10625	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10625	RO	chemotherapy regimen has component Cytarabine	NCI
C63441	STY	Therapeutic or Preventive Procedure		NCI
C63441	PT	DHAP Regimen		NCI
C63441	SY	Dexamethasone-High Dose AraC-Platinol Regimen		NCI
C63441	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63441	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63441	RO	chemotherapy regimen has component Cisplatin	NCI
C63441	RO	chemotherapy regimen has component Cytarabine	NCI
C63441	RO	chemotherapy regimen has component Dexamethasone	NCI
C63441	RO	regimen has accepted use for disease Recurrent Adult Hodgkin Lymphoma	NCI
C63441	RO	regimen has accepted use for disease Recurrent Adult Non-Hodgkin Lymphoma	NCI
C63441	RO	regimen has accepted use for disease Refractory Non-Hodgkin Lymphoma	NCI
C63441	RO	regimen has accepted use for disease Refractory Hodgkin Lymphoma	NCI
C10505	STY	Therapeutic or Preventive Procedure		NCI
C10505	PT	Carboplatin/Cytarabine/Dexamethasone		NCI
C10505	SY	ARA-C/CBDCA/DM		NCI
C10505	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10505	RO	chemotherapy regimen has component Cytarabine	NCI
C10505	RO	chemotherapy regimen has component Dexamethasone	NCI
C10505	RO	chemotherapy regimen has component Carboplatin	NCI
C11313	STY	Therapeutic or Preventive Procedure		NCI
C11313	PT	Fluorouracil/Gemcitabine/Leucovorin Calcium		NCI
C11313	SY	5FU/Leucovorin/Gemcitabine		NCI
C11313	SY	CF/dFdC/5-FU		NCI
C11313	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11313	RO	chemotherapy regimen has component Fluorouracil	NCI
C11313	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11313	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37705	STY	Therapeutic or Preventive Procedure		NCI
C37705	PT	Cytarabine/EL625/Idarubicin		NCI
C37705	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37705	RO	chemotherapy regimen has component Cytarabine	NCI
C37705	RO	chemotherapy regimen has component Idarubicin	NCI
C37705	RO	chemotherapy regimen has component Cenersen	NCI
C9961	STY	Therapeutic or Preventive Procedure		NCI
C9961	PT	Bleomycin/Cyclophosphamide/Lomustine/Prednisone/Procarbazine/Vincristine		NCI
C9961	SY	BLEO/CCNU/CTX/PCB/PRED/VCR		NCI
C9961	SY	BLEO-CCVPP		NCI
C9961	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9961	RO	chemotherapy regimen has component Bleomycin	NCI
C9961	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9961	RO	chemotherapy regimen has component Lomustine	NCI
C9961	RO	chemotherapy regimen has component Prednisone	NCI
C9961	RO	chemotherapy regimen has component Vincristine	NCI
C9961	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11246	STY	Therapeutic or Preventive Procedure		NCI
C11246	PT	Cyclophosphamide/Epirubicin/Filgrastim/Fluorouracil		NCI
C11246	SY	CTX/EPI/5-FU/G-CSF		NCI
C11246	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11246	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11246	RO	chemotherapy regimen has component Fluorouracil	NCI
C11246	RO	chemotherapy regimen has component Filgrastim	NCI
C11246	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11223	STY	Therapeutic or Preventive Procedure		NCI
C11223	PT	Dexamethasone/Doxorubicin/PSC 833/Vincristine		NCI
C11223	SY	DM/DOX/PSC 833/VCR		NCI
C11223	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11223	RO	chemotherapy regimen has component Dexamethasone	NCI
C11223	RO	chemotherapy regimen has component Doxorubicin	NCI
C11223	RO	chemotherapy regimen has component Vincristine	NCI
C11223	RO	chemotherapy regimen has component Valspodar	NCI
C136244	STY	Therapeutic or Preventive Procedure		NCI
C136244	PT	Capecitabine/Cetuximab Regimen		NCI
C136244	SY	Capecitabine-Cetuximab		NCI
C136244	SY	Xeloda/Erbitux Regimen		NCI
C136244	SY	Capecitabine-Cetuximab Regimen		NCI
C136244	SY	Capecitabine/Cetuximab		NCI
C136244	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136244	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136244	RO	chemotherapy regimen has component Capecitabine	NCI
C136244	RO	chemotherapy regimen has component Cetuximab	NCI
C9711	STY	Therapeutic or Preventive Procedure		NCI
C9711	PT	Cyclophosphamide/Etoposide/Lomustine/Vincristine		NCI
C9711	SY	CCNU/CTX/VCR/VP-16		NCI
C9711	SY	CCVV		NCI
C9711	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9711	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9711	RO	chemotherapy regimen has component Etoposide	NCI
C9711	RO	chemotherapy regimen has component Lomustine	NCI
C9711	RO	chemotherapy regimen has component Vincristine	NCI
C11731	STY	Therapeutic or Preventive Procedure		NCI
C11731	PT	Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Prednisone		NCI
C11731	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11731	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11731	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11731	RO	chemotherapy regimen has component Cytarabine	NCI
C11731	RO	chemotherapy regimen has component Methotrexate	NCI
C11731	RO	chemotherapy regimen has component Prednisone	NCI
C11942	STY	Therapeutic or Preventive Procedure		NCI
C11942	PT	Bevacizumab/Fluorouracil/Leucovorin Calcium		NCI
C11942	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11942	RO	chemotherapy regimen has component Fluorouracil	NCI
C11942	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11942	RO	chemotherapy regimen has component Bevacizumab	NCI
C11006	STY	Therapeutic or Preventive Procedure		NCI
C11006	PT	Interferon Alfa/Interferon Gamma		NCI
C11006	SY	IFN-A/IFN-G		NCI
C11006	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11006	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C11006	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C63404	STY	Therapeutic or Preventive Procedure		NCI
C63404	PT	Cisplatin-Taxol Regimen		NCI
C63404	SY	Cisplatin-Paclitaxel Regimen		NCI
C63404	CHD	Chemotherapy Regimen Used to Treat Cervical Carcinoma	NCI
C63404	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C63404	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63404	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C63404	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63404	RO	chemotherapy regimen has component Cisplatin	NCI
C63404	RO	chemotherapy regimen has component Paclitaxel	NCI
C63404	RO	regimen has accepted use for disease Cervical Carcinoma	NCI
C63404	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C63404	RO	regimen has accepted use for disease Ovarian Carcinoma	NCI
C11138	STY	Therapeutic or Preventive Procedure		NCI
C11138	PT	Interferon Gamma/Monoclonal Antibody CC49		NCI
C11138	SY	IFN-G/MOAB CC49		NCI
C11138	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11138	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C11138	RO	chemotherapy regimen has component Minretumomab	NCI
C11551	STY	Therapeutic or Preventive Procedure		NCI
C11551	PT	gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen		NCI
C11551	SY	gp100/IFA/MART-1		NCI
C11551	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11551	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11551	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11551	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10603	STY	Therapeutic or Preventive Procedure		NCI
C10603	PT	Interleukin-1-Beta/Interleukin-2		NCI
C10603	SY	IL-1B/IL-2		NCI
C10603	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10603	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10603	RO	chemotherapy regimen has component Recombinant Interleukin-1-beta	NCI
C15479	STY	Therapeutic or Preventive Procedure		NCI
C15479	PT	Immune Globulin/Zidovudine		NCI
C15479	SY	immune globulin/ZDV		NCI
C15479	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15479	RO	chemotherapy regimen has component Zidovudine	NCI
C15479	RO	chemotherapy regimen has component Therapeutic Immune Globulin	NCI
C11363	STY	Therapeutic or Preventive Procedure		NCI
C11363	PT	Interferon Alfa/Isotretinoin/Vitamin E		NCI
C11363	SY	13-CRA/IFN-A/VIT-E		NCI
C11363	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11363	RO	chemotherapy regimen has component Isotretinoin	NCI
C11363	RO	chemotherapy regimen has component Vitamin E Compound	NCI
C11363	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C28967	STY	Therapeutic or Preventive Procedure		NCI
C28967	PT	Dacarbazine/Mesna		NCI
C28967	SY	DTIC/Mesna		NCI
C28967	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C28967	RO	chemotherapy regimen has component Mesna	NCI
C28967	RO	chemotherapy regimen has component Dacarbazine	NCI
C12013	STY	Therapeutic or Preventive Procedure		NCI
C12013	PT	Epirubicin/Irinotecan		NCI
C12013	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12013	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C12013	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11121	STY	Therapeutic or Preventive Procedure		NCI
C11121	PT	Cyclophosphamide/Losoxantrone		NCI
C11121	SY	CTX/DuP-941		NCI
C11121	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11121	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11121	RO	chemotherapy regimen has component Losoxantrone	NCI
C63601	STY	Therapeutic or Preventive Procedure		NCI
C63601	PT	Cytarabine-Idarubicin Regimen		NCI
C63601	SY	Ara-C-Idaubicin Regimen		NCI
C63601	SY	Cytarabine/Idarubicin		NCI
C63601	CHD	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C63601	RO	chemotherapy regimen has component Cytarabine	NCI
C63601	RO	chemotherapy regimen has component Idarubicin	NCI
C63601	RO	regimen has accepted use for disease Adult Acute Myeloid Leukemia	NCI
C12003	STY	Therapeutic or Preventive Procedure		NCI
C12003	PT	SU5416/Thalidomide		NCI
C12003	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12003	RO	chemotherapy regimen has component Thalidomide	NCI
C12003	RO	chemotherapy regimen has component Semaxanib	NCI
C9969	STY	Therapeutic or Preventive Procedure		NCI
C9969	PT	Fluorouracil/Methotrexate/Prednisone/Thiotepa/Vinblastine		NCI
C9969	SY	5-FU/MTX/PRED/TSPA/VBL		NCI
C9969	SY	VTMFP		NCI
C9969	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9969	RO	chemotherapy regimen has component Fluorouracil	NCI
C9969	RO	chemotherapy regimen has component Methotrexate	NCI
C9969	RO	chemotherapy regimen has component Prednisone	NCI
C9969	RO	chemotherapy regimen has component Thiotepa	NCI
C9969	RO	chemotherapy regimen has component Vinblastine	NCI
C10527	STY	Therapeutic or Preventive Procedure		NCI
C10527	PT	Pentoxifylline/Suramin/Thiotepa		NCI
C10527	SY	PTX/SUR/TSPA		NCI
C10527	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10527	RO	chemotherapy regimen has component Pentoxifylline	NCI
C10527	RO	chemotherapy regimen has component Suramin	NCI
C10527	RO	chemotherapy regimen has component Thiotepa	NCI
C10155	STY	Therapeutic or Preventive Procedure		NCI
C10155	PT	Cyclophosphamide/Dactinomycin/Doxorubicin/Hydroxyurea/Methotrexate/Vincristine		NCI
C10155	SY	CTX/DACT/DOX/HU/MTX/VCR		NCI
C10155	SY	CHAMOCA		NCI
C10155	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10155	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10155	RO	chemotherapy regimen has component Dactinomycin	NCI
C10155	RO	chemotherapy regimen has component Doxorubicin	NCI
C10155	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10155	RO	chemotherapy regimen has component Methotrexate	NCI
C10155	RO	chemotherapy regimen has component Vincristine	NCI
C9827	STY	Therapeutic or Preventive Procedure		NCI
C9827	PT	Asparaginase/Methotrexate/Prednisone/Vincristine		NCI
C9827	SY	ASP/MTX/PRED/VCR		NCI
C9827	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9827	RO	chemotherapy regimen has component Asparaginase	NCI
C9827	RO	chemotherapy regimen has component Methotrexate	NCI
C9827	RO	chemotherapy regimen has component Prednisone	NCI
C9827	RO	chemotherapy regimen has component Vincristine	NCI
C9768	STY	Therapeutic or Preventive Procedure		NCI
C9768	PT	Cisplatin/Mitomycin		NCI
C9768	SY	CDDP/MITO		NCI
C9768	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9768	RO	chemotherapy regimen has component Mitomycin	NCI
C9768	RO	chemotherapy regimen has component Cisplatin	NCI
C11857	STY	Therapeutic or Preventive Procedure		NCI
C11857	PT	rV-B7.1 Vaccine/Vaccinia-Prostate-Specific-Antigen Vaccine		NCI
C11857	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11857	RO	chemotherapy regimen has component Recombinant Vaccinia PSA Vaccine	NCI
C11857	RO	chemotherapy regimen has component Recombinant Vaccinia-B7.1 Vaccine	NCI
C11770	STY	Therapeutic or Preventive Procedure		NCI
C11770	PT	Carboplatin/Etoposide/Ifosfamide/Rituximab		NCI
C11770	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11770	RO	chemotherapy regimen has component Etoposide	NCI
C11770	RO	chemotherapy regimen has component Ifosfamide	NCI
C11770	RO	chemotherapy regimen has component Carboplatin	NCI
C11770	RO	chemotherapy regimen has component Rituximab	NCI
C11499	STY	Therapeutic or Preventive Procedure		NCI
C11499	PT	Carboplatin/Melphalan		NCI
C11499	SY	CBDCA/L-PAM		NCI
C11499	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11499	RO	chemotherapy regimen has component Melphalan	NCI
C11499	RO	chemotherapy regimen has component Carboplatin	NCI
C11146	STY	Therapeutic or Preventive Procedure		NCI
C11146	PT	Methotrexate/Pegaspargase/Vincristine		NCI
C11146	SY	capi33i I		NCI
C11146	SY	MTX/PEG-ASP/VCR		NCI
C11146	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11146	RO	chemotherapy regimen has component Methotrexate	NCI
C11146	RO	chemotherapy regimen has component Vincristine	NCI
C11146	RO	chemotherapy regimen has component Pegaspargase	NCI
C10197	STY	Therapeutic or Preventive Procedure		NCI
C10197	PT	Floxuridine/Fluorouracil/Leucovorin Calcium		NCI
C10197	SY	CF/5-FU/FUDR		NCI
C10197	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10197	RO	chemotherapy regimen has component Floxuridine	NCI
C10197	RO	chemotherapy regimen has component Fluorouracil	NCI
C10197	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9779	STY	Therapeutic or Preventive Procedure		NCI
C9779	PT	Interferon Gamma/Interleukin-2		NCI
C9779	SY	IFN-G/IL-2		NCI
C9779	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9779	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C9779	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11443	STY	Therapeutic or Preventive Procedure		NCI
C11443	PT	Cisplatin/Floxuridine/Paclitaxel		NCI
C11443	SY	CDDP/FUDR/TAX		NCI
C11443	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11443	RO	chemotherapy regimen has component Cisplatin	NCI
C11443	RO	chemotherapy regimen has component Floxuridine	NCI
C11443	RO	chemotherapy regimen has component Paclitaxel	NCI
C10426	STY	Therapeutic or Preventive Procedure		NCI
C10426	PT	Cisplatin/Doxorubicin/Etoposide/Sargramostim		NCI
C10426	SY	CDDP/DOX/GM-CSF/VP-16		NCI
C10426	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10426	RO	chemotherapy regimen has component Cisplatin	NCI
C10426	RO	chemotherapy regimen has component Doxorubicin	NCI
C10426	RO	chemotherapy regimen has component Etoposide	NCI
C10426	RO	chemotherapy regimen has component Sargramostim	NCI
C37491	STY	Therapeutic or Preventive Procedure		NCI
C37491	PT	Interleukin-2/p53 Peptide Vaccine		NCI
C37491	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37491	RO	chemotherapy regimen has component p53 Peptide Vaccine	NCI
C37491	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9906	STY	Therapeutic or Preventive Procedure		NCI
C9906	PT	Etoposide/Melphalan		NCI
C9906	SY	L-PAM/VP-16		NCI
C9906	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9906	RO	chemotherapy regimen has component Etoposide	NCI
C9906	RO	chemotherapy regimen has component Melphalan	NCI
C11630	STY	Therapeutic or Preventive Procedure		NCI
C11630	PT	Irinotecan/Vincristine		NCI
C11630	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11630	RO	chemotherapy regimen has component Vincristine	NCI
C11630	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C9800	STY	Therapeutic or Preventive Procedure		NCI
C9800	PT	Cyclophosphamide/Cytarabine/Doxorubicin/Hydroxyurea/Lomustine/Methotrexate/Thioguanine/Vincristine		NCI
C9800	SY	ARA-C/CCNU/CTX/DOX/HU/MTX/TG/VCR		NCI
C9800	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9800	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9800	RO	chemotherapy regimen has component Cytarabine	NCI
C9800	RO	chemotherapy regimen has component Doxorubicin	NCI
C9800	RO	chemotherapy regimen has component Hydroxyurea	NCI
C9800	RO	chemotherapy regimen has component Lomustine	NCI
C9800	RO	chemotherapy regimen has component Methotrexate	NCI
C9800	RO	chemotherapy regimen has component Thioguanine	NCI
C9800	RO	chemotherapy regimen has component Vincristine	NCI
C9745	STY	Therapeutic or Preventive Procedure		NCI
C9745	PT	Carboplatin/Etoposide/Cyclophosphamide/Thiotepa		NCI
C9745	SY	CECaT		NCI
C9745	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9745	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9745	RO	chemotherapy regimen has component Etoposide	NCI
C9745	RO	chemotherapy regimen has component Thiotepa	NCI
C9745	RO	chemotherapy regimen has component Carboplatin	NCI
C10653	STY	Therapeutic or Preventive Procedure		NCI
C10653	PT	Cisplatin/Topotecan		NCI
C10653	SY	CDDP/TOPO		NCI
C10653	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10653	RO	chemotherapy regimen has component Cisplatin	NCI
C10653	RO	chemotherapy regimen has component Topotecan	NCI
C63434	STY	Therapeutic or Preventive Procedure		NCI
C63434	PT	Vinorelbine-Epirubicin Regimen		NCI
C63434	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63434	RO	chemotherapy regimen has component Vinorelbine	NCI
C63434	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C63434	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C10288	STY	Therapeutic or Preventive Procedure		NCI
C10288	PT	Altretamine/Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Methotrexate/Prednisone/Tamoxifen/Vinblastine		NCI
C10288	SY	CTX/DOX/5-FU/FXM/HMM/MTX/PRED/TMX/VBL		NCI
C10288	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10288	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10288	RO	chemotherapy regimen has component Doxorubicin	NCI
C10288	RO	chemotherapy regimen has component Fluorouracil	NCI
C10288	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C10288	RO	chemotherapy regimen has component Altretamine	NCI
C10288	RO	chemotherapy regimen has component Methotrexate	NCI
C10288	RO	chemotherapy regimen has component Prednisone	NCI
C10288	RO	chemotherapy regimen has component Vinblastine	NCI
C10288	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C37550	STY	Therapeutic or Preventive Procedure		NCI
C37550	PT	Beclomethasone/Prednisone		NCI
C37550	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37550	RO	chemotherapy regimen has component Beclomethasone Dipropionate	NCI
C37550	RO	chemotherapy regimen has component Prednisone	NCI
C10657	STY	Therapeutic or Preventive Procedure		NCI
C10657	PT	Cytarabine/Dexamethasone/Etoposide/Ifosfamide/Methotrexate/Vincristine		NCI
C10657	SY	ARA-C/DM/IFF/MTX/VCR/VP-16		NCI
C10657	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10657	RO	chemotherapy regimen has component Cytarabine	NCI
C10657	RO	chemotherapy regimen has component Dexamethasone	NCI
C10657	RO	chemotherapy regimen has component Etoposide	NCI
C10657	RO	chemotherapy regimen has component Ifosfamide	NCI
C10657	RO	chemotherapy regimen has component Methotrexate	NCI
C10657	RO	chemotherapy regimen has component Vincristine	NCI
C12102	STY	Therapeutic or Preventive Procedure		NCI
C12102	PT	Anti-thymocyte globulin/Cyclophosphamide/Cytarabine		NCI
C12102	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12102	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C12102	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12102	RO	chemotherapy regimen has component Cytarabine	NCI
C63603	STY	Therapeutic or Preventive Procedure		NCI
C63603	PT	Cytarabine-Mitoxantrone Regimen		NCI
C63603	SY	COG 2951 Regimen		NCI
C63603	SY	AraC-Mitoxantrone Regimen		NCI
C63603	CHD	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C63603	RO	chemotherapy regimen has component Cytarabine	NCI
C63603	RO	regimen has accepted use for disease Adult Acute Myeloid Leukemia	NCI
C63603	RO	regimen has accepted use for disease Recurrent Childhood Acute Myeloid Leukemia	NCI
C63603	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9892	STY	Therapeutic or Preventive Procedure		NCI
C9892	PT	Etoposide/Ifosfamide/Interleukin-3		NCI
C9892	SY	IFF/IL-3/VP-16		NCI
C9892	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9892	RO	chemotherapy regimen has component Etoposide	NCI
C9892	RO	chemotherapy regimen has component Ifosfamide	NCI
C9892	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C11360	STY	Therapeutic or Preventive Procedure		NCI
C11360	PT	Dexamethasone/Metoclopramide		NCI
C11360	SY	DM/MCP		NCI
C11360	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11360	RO	chemotherapy regimen has component Dexamethasone	NCI
C11360	RO	chemotherapy regimen has component Metoclopramide Hydrochloride	NCI
C10268	STY	Therapeutic or Preventive Procedure		NCI
C10268	PT	Cisplatin/Cyclophosphamide/Etoposide		NCI
C10268	SY	PCE		NCI
C10268	SY	VCP-1		NCI
C10268	SY	PVC		NCI
C10268	SY	CVP		NCI
C10268	SY	CDDP/CTX/VP-16		NCI
C10268	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10268	RO	chemotherapy regimen has component Cisplatin	NCI
C10268	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10268	RO	chemotherapy regimen has component Etoposide	NCI
C10474	STY	Therapeutic or Preventive Procedure		NCI
C10474	PT	Fluorouracil/Leucovorin Calcium/Zidovudine		NCI
C10474	SY	CF/5-FU/ZDV		NCI
C10474	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10474	RO	chemotherapy regimen has component Fluorouracil	NCI
C10474	RO	chemotherapy regimen has component Zidovudine	NCI
C10474	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11819	STY	Therapeutic or Preventive Procedure		NCI
C11819	PT	Cyclophosphamide/Cytarabine/Dexamethasone/Mitoxantrone		NCI
C11819	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11819	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11819	RO	chemotherapy regimen has component Cytarabine	NCI
C11819	RO	chemotherapy regimen has component Dexamethasone	NCI
C11819	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C156374	STY	Therapeutic or Preventive Procedure		NCI
C156374	PT	Tamoxifen/Trastuzumab Regimen		NCI
C156374	SY	Tamoxifen/Trastuzumab		NCI
C156374	SY	Tamoxifen-Trastuzumab		NCI
C156374	SY	Trastuzumab-Tamoxifen		NCI
C156374	SY	Trastuzumab/Tamoxifen Regimen		NCI
C156374	SY	Trastuzumab/Tamoxifen		NCI
C156374	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156374	RO	chemotherapy regimen has component Tamoxifen	NCI
C156374	RO	chemotherapy regimen has component Trastuzumab	NCI
C10988	STY	Therapeutic or Preventive Procedure		NCI
C10988	PT	Interferon Alfa/Sargramostim/Zidovudine		NCI
C10988	SY	GM-CSF/IFN-A/ZDV		NCI
C10988	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10988	RO	chemotherapy regimen has component Zidovudine	NCI
C10988	RO	chemotherapy regimen has component Sargramostim	NCI
C10988	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C12073	STY	Therapeutic or Preventive Procedure		NCI
C12073	PT	Alum Adjuvant/Monoclonal Antibody 105AD7 Anti-Idiotype Vaccine		NCI
C12073	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12073	RO	chemotherapy regimen has component Monoclonal Antibody 105AD7 Anti-idiotype Vaccine	NCI
C12073	RO	chemotherapy regimen has component Aluminum Sulfate Anhydrous	NCI
C11467	STY	Therapeutic or Preventive Procedure		NCI
C11467	PT	Melphalan/Prednisolone		NCI
C11467	SY	L-PAM/PRDL		NCI
C11467	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11467	RO	chemotherapy regimen has component Melphalan	NCI
C11467	RO	chemotherapy regimen has component Prednisolone	NCI
C37838	STY	Therapeutic or Preventive Procedure		NCI
C37838	PT	Multivitamins/Soy Protein Isolate		NCI
C37838	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37838	RO	chemotherapy regimen has component Multivitamin	NCI
C37838	RO	chemotherapy regimen has component Soy Protein Isolate	NCI
C11038	STY	Therapeutic or Preventive Procedure		NCI
C11038	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Interferon Alfa		NCI
C11038	SY	CTX/DOX/5-FU/IFN-A		NCI
C11038	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11038	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11038	RO	chemotherapy regimen has component Doxorubicin	NCI
C11038	RO	chemotherapy regimen has component Fluorouracil	NCI
C11038	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C138032	STY	Therapeutic or Preventive Procedure		NCI
C138032	PT	AC Followed by Pertuzumab/Trastuzumab/Paclitaxel Regimen		NCI
C138032	SY	Doxorubicin/Cyclophosphamide Followed by Pertuzumab + Trastuzumab + Paclitaxel		NCI
C138032	SY	AC Followed by Paclitaxel + Trastuzumab + Pertuzumab		NCI
C138032	SY	AC Followed by Pertuzumab + Trastuzumab + Paclitaxel		NCI
C138032	SY	AC Followed by Paclitaxel + Pertuzumab + Trastuzumab		NCI
C138032	SY	Doxorubicin/Cyclophosphamide Followed by Pertuzumab/Trastuzumab/Paclitaxel		NCI
C138032	SY	AC-Pertuzumab + Trastuzumab + Paclitaxel		NCI
C138032	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138032	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138032	RO	chemotherapy regimen has component Doxorubicin	NCI
C138032	RO	chemotherapy regimen has component Paclitaxel	NCI
C138032	RO	chemotherapy regimen has component Trastuzumab	NCI
C138032	RO	chemotherapy regimen has component Pertuzumab	NCI
C64732	STY	Therapeutic or Preventive Procedure		NCI
C64732	PT	Lenalidomide-Dexamethasone Regimen		NCI
C64732	SY	Revlimid-Dexamethasone Regimen		NCI
C64732	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C64732	RO	chemotherapy regimen has component Dexamethasone	NCI
C64732	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C64732	RO	chemotherapy regimen has component Lenalidomide	NCI
C15441	STY	Therapeutic or Preventive Procedure		NCI
C15441	PT	Interleukin-2/Poly ICLC		NCI
C15441	SY	IL-2/Poly ICLC		NCI
C15441	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15441	RO	chemotherapy regimen has component Poly ICLC	NCI
C15441	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12140	STY	Therapeutic or Preventive Procedure		NCI
C12140	PT	Cyclosporine/Hydroxychloroquine/Prednisone		NCI
C12140	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12140	RO	chemotherapy regimen has component Cyclosporine	NCI
C12140	RO	chemotherapy regimen has component Hydroxychloroquine	NCI
C12140	RO	chemotherapy regimen has component Prednisone	NCI
C11187	STY	Therapeutic or Preventive Procedure		NCI
C11187	PT	Prednisone/Tacrolimus		NCI
C11187	SY	FK506/PRED		NCI
C11187	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11187	RO	chemotherapy regimen has component Prednisone	NCI
C11187	RO	chemotherapy regimen has component Tacrolimus	NCI
C9615	STY	Therapeutic or Preventive Procedure		NCI
C9615	PT	Etoposide/Ifosfamide/Methotrexate/Mitoguazone		NCI
C9615	SY	MIME		NCI
C9615	SY	IFF/MGBG/MTX/VP-16		NCI
C9615	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9615	RO	chemotherapy regimen has component Etoposide	NCI
C9615	RO	chemotherapy regimen has component Ifosfamide	NCI
C9615	RO	chemotherapy regimen has component Methotrexate	NCI
C9615	RO	chemotherapy regimen has component Mitoguazone	NCI
C11863	STY	Therapeutic or Preventive Procedure		NCI
C11863	PT	DX-8951f/Gemcitabine		NCI
C11863	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11863	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11863	RO	chemotherapy regimen has component Exatecan Mesylate	NCI
C11670	STY	Therapeutic or Preventive Procedure		NCI
C11670	PT	Interleukin-2/Montanide ISA-51/Tyrosinase Peptide		NCI
C11670	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11670	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11670	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11670	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10448	STY	Therapeutic or Preventive Procedure		NCI
C10448	PT	Cytarabine/Interleukin-3		NCI
C10448	SY	ARA-C/IL-3		NCI
C10448	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10448	RO	chemotherapy regimen has component Cytarabine	NCI
C10448	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C11873	STY	Therapeutic or Preventive Procedure		NCI
C11873	PT	Arsenic trioxide/Tretinoin		NCI
C11873	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11873	RO	chemotherapy regimen has component Tretinoin	NCI
C11873	RO	chemotherapy regimen has component Arsenic Trioxide	NCI
C11483	STY	Therapeutic or Preventive Procedure		NCI
C11483	PT	Fluorouracil/Gemcitabine/Interferon Alfa/Interleukin-2		NCI
C11483	SY	DFdC/5-FU/IFN-A/IL-2		NCI
C11483	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11483	RO	chemotherapy regimen has component Fluorouracil	NCI
C11483	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11483	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11483	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12016	STY	Therapeutic or Preventive Procedure		NCI
C12016	PT	Cisplatin/Fluorouracil/G17DT		NCI
C12016	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12016	RO	chemotherapy regimen has component Cisplatin	NCI
C12016	RO	chemotherapy regimen has component Fluorouracil	NCI
C12016	RO	chemotherapy regimen has component Gastrin Immunotoxin	NCI
C12021	STY	Therapeutic or Preventive Procedure		NCI
C12021	PT	Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Prednisone/Rituximab/Vincristine		NCI
C12021	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12021	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12021	RO	chemotherapy regimen has component Doxorubicin	NCI
C12021	RO	chemotherapy regimen has component Methotrexate	NCI
C12021	RO	chemotherapy regimen has component Prednisone	NCI
C12021	RO	chemotherapy regimen has component Vincristine	NCI
C12021	RO	chemotherapy regimen has component Rituximab	NCI
C12021	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63372	STY	Therapeutic or Preventive Procedure		NCI
C63372	PT	Mini-BEAM Regimen		NCI
C63372	SY	BCNU-Etoposide-Ara-C-Melphalan Regimen		NCI
C63372	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63372	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63372	RO	chemotherapy regimen has component Carmustine	NCI
C63372	RO	chemotherapy regimen has component Cytarabine	NCI
C63372	RO	chemotherapy regimen has component Etoposide	NCI
C63372	RO	chemotherapy regimen has component Melphalan	NCI
C63372	RO	regimen has accepted use for disease Recurrent Adult Hodgkin Lymphoma	NCI
C63372	RO	regimen has accepted use for disease Refractory Hodgkin Lymphoma	NCI
C11253	STY	Therapeutic or Preventive Procedure		NCI
C11253	PT	Ethynyluracil/Fluorouracil/Leucovorin Calcium		NCI
C11253	SY	776C85/CF/5-FU		NCI
C11253	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11253	RO	chemotherapy regimen has component Fluorouracil	NCI
C11253	RO	chemotherapy regimen has component Eniluracil	NCI
C11253	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11561	STY	Therapeutic or Preventive Procedure		NCI
C11561	PT	Fluorouracil/Interferon Alfa/Leucovorin Calcium/Mitoxantrone/Vinblastine		NCI
C11561	SY	CF/DHAD/5-FU/IFN-A/VBL		NCI
C11561	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11561	RO	chemotherapy regimen has component Fluorouracil	NCI
C11561	RO	chemotherapy regimen has component Vinblastine	NCI
C11561	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11561	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11561	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C138042	STY	Therapeutic or Preventive Procedure		NCI
C138042	PT	Pertuzumab/Trastuzumab Regimen		NCI
C138042	SY	Pertuzumab + Trastuzumab		NCI
C138042	SY	Pertuzumab/Trastuzumab		NCI
C138042	SY	Pertuzumab Plus Trastuzumab		NCI
C138042	SY	Pertuzumab-Trastuzumab Regimen		NCI
C138042	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138042	RO	chemotherapy regimen has component Trastuzumab	NCI
C138042	RO	chemotherapy regimen has component Pertuzumab	NCI
C140733	STY	Therapeutic or Preventive Procedure		NCI
C140733	PT	R-GVD Regimen		NCI
C140733	SY	R-GVD		NCI
C140733	SY	Gemcitabine-Vinorelbine-Pegylated Liposomal Doxorubicin-Rituximab		NCI
C140733	SY	Gemcitabine/Vinorelbine/Pegylated Liposomal Doxorubicin/Rituximab		NCI
C140733	SY	Rituximab/Gemcitabine/Vinorelbine/Pegylated Liposomal Doxorubicin		NCI
C140733	SY	Gemcitabine/Vinorelbine/Doxil/Rituximab		NCI
C140733	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C140733	RO	chemotherapy regimen has component Gemcitabine	NCI
C140733	RO	chemotherapy regimen has component Vinorelbine	NCI
C140733	RO	chemotherapy regimen has component Rituximab	NCI
C140733	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C9788	STY	Therapeutic or Preventive Procedure		NCI
C9788	PT	Mechlorethamine/Prednisone/Procarbazine/Vinblastine		NCI
C9788	SY	MVPP		NCI
C9788	SY	NM/PCB/PRED/VBL		NCI
C9788	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9788	RO	chemotherapy regimen has component Prednisone	NCI
C9788	RO	chemotherapy regimen has component Vinblastine	NCI
C9788	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9788	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C11905	STY	Therapeutic or Preventive Procedure		NCI
C11905	PT	Indium In 111 Monoclonal Antibody Bre-3/Yttrium Y 90 Monoclonal Antibody Bre-3		NCI
C11905	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11905	RO	chemotherapy regimen has component Yttrium Y 90 Monoclonal Antibody BrE-3	NCI
C11905	RO	chemotherapy regimen has component Indium In 111 Monoclonal Antibody BrE-3	NCI
C10903	STY	Therapeutic or Preventive Procedure		NCI
C10903	PT	Altretamine/Etoposide		NCI
C10903	SY	HMM/VP-16		NCI
C10903	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10903	RO	chemotherapy regimen has component Etoposide	NCI
C10903	RO	chemotherapy regimen has component Altretamine	NCI
C9877	STY	Therapeutic or Preventive Procedure		NCI
C9877	PT	Indomethacin/Interleukin-1-Alpha		NCI
C9877	SY	IL-1A/indomethacin		NCI
C9877	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9877	RO	chemotherapy regimen has component Indomethacin	NCI
C9877	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C12097	STY	Therapeutic or Preventive Procedure		NCI
C12097	PT	Temozolomide/ZD 1839		NCI
C12097	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12097	RO	chemotherapy regimen has component Temozolomide	NCI
C12097	RO	chemotherapy regimen has component Gefitinib	NCI
C67298	STY	Therapeutic or Preventive Procedure		NCI
C67298	PT	Vincristine-Dactinomycin Rhabdomyosarcoma Regimen		NCI
C67298	SY	Vincristine-Dactinomycin Regimen		NCI
C67298	CHD	Chemotherapy Regimen Used to Treat Childhood Rhabdomyosarcoma	NCI
C67298	RO	chemotherapy regimen has component Dactinomycin	NCI
C67298	RO	chemotherapy regimen has component Vincristine	NCI
C67298	RO	regimen has accepted use for disease Childhood Rhabdomyosarcoma	NCI
C10878	STY	Therapeutic or Preventive Procedure		NCI
C10878	PT	Cisplatin/Tumor Necrosis Factor		NCI
C10878	SY	CDDP/TNF		NCI
C10878	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10878	RO	chemotherapy regimen has component Cisplatin	NCI
C10878	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C11536	STY	Therapeutic or Preventive Procedure		NCI
C11536	PT	Asparaginase/Cyclophosphamide/Daunorubicin/Dexamethasone/Leucovorin Calcium/Methotrexate/Thioguanine/Vindesine		NCI
C11536	SY	ASP/CF/CTX/DAVA/DM/DNR/MTX/TG		NCI
C11536	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11536	RO	chemotherapy regimen has component Asparaginase	NCI
C11536	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11536	RO	chemotherapy regimen has component Dexamethasone	NCI
C11536	RO	chemotherapy regimen has component Methotrexate	NCI
C11536	RO	chemotherapy regimen has component Thioguanine	NCI
C11536	RO	chemotherapy regimen has component Vindesine	NCI
C11536	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11536	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10597	STY	Therapeutic or Preventive Procedure		NCI
C10597	PT	Trifluoperazine/Verapamil/Vinblastine		NCI
C10597	SY	TFPZ/VBL/VPAM		NCI
C10597	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10597	RO	chemotherapy regimen has component Verapamil	NCI
C10597	RO	chemotherapy regimen has component Vinblastine	NCI
C10597	RO	chemotherapy regimen has component Trifluoperazine Hydrochloride	NCI
C10767	STY	Therapeutic or Preventive Procedure		NCI
C10767	PT	Fluorouracil/Leucovorin Calcium/Paclitaxel		NCI
C10767	SY	CF/5-FU/TAX		NCI
C10767	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10767	RO	chemotherapy regimen has component Fluorouracil	NCI
C10767	RO	chemotherapy regimen has component Paclitaxel	NCI
C10767	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9659	STY	Therapeutic or Preventive Procedure		NCI
C9659	PT	Cisplatin/Etoposide/Ifosfamide		NCI
C9659	SY	CDDP/IFF/VP-16		NCI
C9659	SY	VIP		NCI
C9659	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9659	RO	chemotherapy regimen has component Cisplatin	NCI
C9659	RO	chemotherapy regimen has component Etoposide	NCI
C9659	RO	chemotherapy regimen has component Ifosfamide	NCI
C11281	STY	Therapeutic or Preventive Procedure		NCI
C11281	PT	Fluorouracil/Hydroxyurea/Paclitaxel		NCI
C11281	SY	5-FU/HU/TAX		NCI
C11281	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11281	RO	chemotherapy regimen has component Fluorouracil	NCI
C11281	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11281	RO	chemotherapy regimen has component Paclitaxel	NCI
C11680	STY	Therapeutic or Preventive Procedure		NCI
C11680	PT	gp100 Antigen/Interleukin-2/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide		NCI
C11680	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11680	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11680	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11680	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11680	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11680	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10515	STY	Therapeutic or Preventive Procedure		NCI
C10515	PT	Brequinar/Fluorouracil		NCI
C10515	SY	BREQ/5-FU		NCI
C10515	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10515	RO	chemotherapy regimen has component Fluorouracil	NCI
C10515	RO	chemotherapy regimen has component Brequinar	NCI
C10844	STY	Therapeutic or Preventive Procedure		NCI
C10844	PT	Cyclophosphamide/Filgrastim/Topotecan		NCI
C10844	SY	CTX/G-CSF/TOPO		NCI
C10844	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10844	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10844	RO	chemotherapy regimen has component Topotecan	NCI
C10844	RO	chemotherapy regimen has component Filgrastim	NCI
C11613	STY	Therapeutic or Preventive Procedure		NCI
C11613	PT	Docetaxel/GEM 231		NCI
C11613	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11613	RO	chemotherapy regimen has component Docetaxel	NCI
C11613	RO	chemotherapy regimen has component GEM 231	NCI
C63440	STY	Therapeutic or Preventive Procedure		NCI
C63440	PT	MINE Regimen		NCI
C63440	SY	Mesna-Ifosfamide-Novantrone-Etoposide Regimen		NCI
C63440	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63440	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63440	RO	chemotherapy regimen has component Mesna	NCI
C63440	RO	chemotherapy regimen has component Etoposide	NCI
C63440	RO	chemotherapy regimen has component Ifosfamide	NCI
C63440	RO	regimen has accepted use for disease Recurrent Adult Hodgkin Lymphoma	NCI
C63440	RO	regimen has accepted use for disease Recurrent Adult Non-Hodgkin Lymphoma	NCI
C63440	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C63440	RO	regimen has accepted use for disease Refractory Non-Hodgkin Lymphoma	NCI
C63440	RO	regimen has accepted use for disease Refractory Hodgkin Lymphoma	NCI
C9620	STY	Therapeutic or Preventive Procedure		NCI
C9620	PT	Bleomycin/Doxorubicin/Mechlorethamine/Prednisone/Procarbazine/Vinblastine/Vincristine		NCI
C9620	SY	MOPP/ABV		NCI
C9620	SY	BLEO/DOX/NM/PCB/PRED/VBL/VCR		NCI
C9620	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9620	RO	chemotherapy regimen has component Bleomycin	NCI
C9620	RO	chemotherapy regimen has component Doxorubicin	NCI
C9620	RO	chemotherapy regimen has component Prednisone	NCI
C9620	RO	chemotherapy regimen has component Vinblastine	NCI
C9620	RO	chemotherapy regimen has component Vincristine	NCI
C9620	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9620	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C37660	STY	Therapeutic or Preventive Procedure		NCI
C37660	PT	Cisplatin/Gefitinib/Gemcitabine		NCI
C37660	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37660	RO	chemotherapy regimen has component Cisplatin	NCI
C37660	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37660	RO	chemotherapy regimen has component Gefitinib	NCI
C11796	STY	Therapeutic or Preventive Procedure		NCI
C11796	PT	Cisplatin/Fenretinide/Paclitaxel		NCI
C11796	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11796	RO	chemotherapy regimen has component Cisplatin	NCI
C11796	RO	chemotherapy regimen has component Fenretinide	NCI
C11796	RO	chemotherapy regimen has component Paclitaxel	NCI
C11165	STY	Therapeutic or Preventive Procedure		NCI
C11165	PT	Mercaptopurine/Prednisolone/Vincristine		NCI
C11165	SY	MP/PRDL/VCR		NCI
C11165	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11165	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11165	RO	chemotherapy regimen has component Prednisolone	NCI
C11165	RO	chemotherapy regimen has component Vincristine	NCI
C9592	STY	Therapeutic or Preventive Procedure		NCI
C9592	PT	Doxorubicin/Fluorouracil/Mitomycin		NCI
C9592	SY	MIFA		NCI
C9592	SY	DMF		NCI
C9592	SY	DOX/5-FU/MITO		NCI
C9592	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9592	RO	chemotherapy regimen has component Mitomycin	NCI
C9592	RO	chemotherapy regimen has component Doxorubicin	NCI
C9592	RO	chemotherapy regimen has component Fluorouracil	NCI
C9841	STY	Therapeutic or Preventive Procedure		NCI
C9841	PT	Cisplatin/Trimetrexate Glucuronate		NCI
C9841	SY	CDDP/TMTX		NCI
C9841	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9841	RO	chemotherapy regimen has component Cisplatin	NCI
C9841	RO	chemotherapy regimen has component Trimetrexate Glucuronate	NCI
C141508	STY	Therapeutic or Preventive Procedure		NCI
C141508	PT	EOX Regimen		NCI
C141508	SY	Capecitabine/Epirubicin/Oxaliplatin Regimen		NCI
C141508	SY	Capecitabine/Epirubicin/Oxaliplatin		NCI
C141508	SY	Epirubicin/Oxaliplatin/Xeloda		NCI
C141508	SY	Capecitabine-Epirubicin-Oxaliplatin		NCI
C141508	SY	Capecitabine-Epirubicin-Oxaliplatin Regimen		NCI
C141508	SY	Epirubicin-Oxaliplatin-Xeloda		NCI
C141508	SY	EOX		NCI
C141508	CHD	Chemotherapy Regimen Used to Treat Esophageal Carcinoma	NCI
C141508	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C141508	RO	chemotherapy regimen has component Oxaliplatin	NCI
C141508	RO	chemotherapy regimen has component Capecitabine	NCI
C141508	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11224	STY	Therapeutic or Preventive Procedure		NCI
C11224	PT	Cyclosporine/Methotrexate/Sirolimus		NCI
C11224	SY	CYSP/MTX/sirolimus		NCI
C11224	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11224	RO	chemotherapy regimen has component Cyclosporine	NCI
C11224	RO	chemotherapy regimen has component Methotrexate	NCI
C11224	RO	chemotherapy regimen has component Sirolimus	NCI
C9990	STY	Therapeutic or Preventive Procedure		NCI
C9990	PT	Cisplatin/Cyclophosphamide/Etoposide/Interleukin-2		NCI
C9990	SY	CDDP/CTX/IL-2/VP-16		NCI
C9990	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9990	RO	chemotherapy regimen has component Cisplatin	NCI
C9990	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9990	RO	chemotherapy regimen has component Etoposide	NCI
C9990	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9829	STY	Therapeutic or Preventive Procedure		NCI
C9829	PT	Asparaginase/Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Thioguanine/Vincristine		NCI
C9829	SY	ARA-C/ASP/CTX/DOX/MTX/TG/VCR		NCI
C9829	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9829	RO	chemotherapy regimen has component Asparaginase	NCI
C9829	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9829	RO	chemotherapy regimen has component Cytarabine	NCI
C9829	RO	chemotherapy regimen has component Doxorubicin	NCI
C9829	RO	chemotherapy regimen has component Methotrexate	NCI
C9829	RO	chemotherapy regimen has component Thioguanine	NCI
C9829	RO	chemotherapy regimen has component Vincristine	NCI
C136248	STY	Therapeutic or Preventive Procedure		NCI
C136248	PT	FOLFOX/Bevacizumab Regimen		NCI
C136248	SY	FOLFOX Plus Avastin		NCI
C136248	SY	Folfox + Bevacizumab		NCI
C136248	SY	Folinic Acid/Fluorouracil/Oxaliplatin/Bevacizumab Regimen		NCI
C136248	SY	FOLFOX Plus Bevacizumab		NCI
C136248	SY	FOLFOX-Bevacizumab Regimen		NCI
C136248	SY	FOLFOX-Avastin Regimen		NCI
C136248	SY	Folfox + Bevacizumab Regimen		NCI
C136248	SY	Leucovorin/Fluorouracil/Oxaliplatin/Bevacizumab		NCI
C136248	SY	FOLFOX/Avastin Regimen		NCI
C136248	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136248	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136248	RO	chemotherapy regimen has component Fluorouracil	NCI
C136248	RO	chemotherapy regimen has component Oxaliplatin	NCI
C136248	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C136248	RO	chemotherapy regimen has component Bevacizumab	NCI
C140101	STY	Therapeutic or Preventive Procedure		NCI
C140101	PT	R-GDP Regimen		NCI
C140101	SY	Rituximab/Gemcitabine/Dexamethasone/Cisplatin		NCI
C140101	SY	Gemcitabine-Dexamethasone-Platinol-Rituximab		NCI
C140101	SY	R-GDP		NCI
C140101	SY	GDP-R Regimen		NCI
C140101	SY	GDP Plus RITU Regimen		NCI
C140101	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C140101	RO	chemotherapy regimen has component Cisplatin	NCI
C140101	RO	chemotherapy regimen has component Dexamethasone	NCI
C140101	RO	chemotherapy regimen has component Gemcitabine	NCI
C140101	RO	chemotherapy regimen has component Rituximab	NCI
C10502	STY	Therapeutic or Preventive Procedure		NCI
C10502	PT	Cyclophosphamide/Etoposide/Sargramostim		NCI
C10502	SY	CTX/GM-CSF/VP-16		NCI
C10502	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10502	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10502	RO	chemotherapy regimen has component Etoposide	NCI
C10502	RO	chemotherapy regimen has component Sargramostim	NCI
C10179	STY	Therapeutic or Preventive Procedure		NCI
C10179	PT	Cyclophosphamide/Dactinomycin/Vinblastine		NCI
C10179	SY	CTX/DACT/VBL		NCI
C10179	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10179	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10179	RO	chemotherapy regimen has component Dactinomycin	NCI
C10179	RO	chemotherapy regimen has component Vinblastine	NCI
C9918	STY	Therapeutic or Preventive Procedure		NCI
C9918	PT	Doxorubicin/Methotrexate/Prednisone/Vincristine		NCI
C9918	SY	M-HOP		NCI
C9918	SY	DOX/MTX/PRED/VCR		NCI
C9918	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9918	RO	chemotherapy regimen has component Doxorubicin	NCI
C9918	RO	chemotherapy regimen has component Methotrexate	NCI
C9918	RO	chemotherapy regimen has component Prednisone	NCI
C9918	RO	chemotherapy regimen has component Vincristine	NCI
C63609	STY	Therapeutic or Preventive Procedure		NCI
C63609	PT	CAPOX-Bevacizumab Regimen		NCI
C63609	SY	CAPOX-Avastin Regimen		NCI
C63609	SY	Capecitabine-Oxaliplatin-Bevacizumab Regimen		NCI
C63609	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63609	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63609	RO	chemotherapy regimen has component Oxaliplatin	NCI
C63609	RO	chemotherapy regimen has component Capecitabine	NCI
C63609	RO	chemotherapy regimen has component Bevacizumab	NCI
C37862	STY	Therapeutic or Preventive Procedure		NCI
C37862	PT	Vaccinia-MUC-1 Vaccine/Vaccinia-TRICOM Vaccine		NCI
C37862	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37862	RO	chemotherapy regimen has component Recombinant Vaccinia-TRICOM Vaccine	NCI
C37862	RO	chemotherapy regimen has component Recombinant Vaccinia-MUC-1 Vaccine	NCI
C11935	STY	Therapeutic or Preventive Procedure		NCI
C11935	PT	Calcitriol/Paclitaxel		NCI
C11935	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11935	RO	chemotherapy regimen has component Calcitriol	NCI
C11935	RO	chemotherapy regimen has component Paclitaxel	NCI
C12106	STY	Therapeutic or Preventive Procedure		NCI
C12106	PT	Interleukin-12/Paclitaxel/Trastuzumab		NCI
C12106	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12106	RO	chemotherapy regimen has component Paclitaxel	NCI
C12106	RO	chemotherapy regimen has component Trastuzumab	NCI
C12106	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C134623	STY	Therapeutic or Preventive Procedure		NCI
C134623	PT	GNP Regimen		NCI
C134623	SY	Abraxane/Gemcitabine Regimen		NCI
C134623	SY	GEMCNPAC Regimen		NCI
C134623	SY	Gemcitabine-Nab-paclitaxel Regimen		NCI
C134623	SY	GNP		NCI
C134623	SY	Gemcitabine/Nab-paclitaxel		NCI
C134623	SY	Gemcitabine-Albumin-bound Paclitaxel Regimen		NCI
C134623	SY	Abraxane-Gemictabine Regimen		NCI
C134623	CHD	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C134623	RO	chemotherapy regimen has component Gemcitabine	NCI
C134623	RO	chemotherapy regimen has component Nab-paclitaxel	NCI
C134623	RO	concept in subset CTRP Terminology	NCI
C134623	RO	concept in subset CTRP Intervention Terminology	NCI
C37647	STY	Therapeutic or Preventive Procedure		NCI
C37647	PT	Cisplatin/Dimesna/Docetaxel		NCI
C37647	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37647	RO	chemotherapy regimen has component Cisplatin	NCI
C37647	RO	chemotherapy regimen has component Dimesna	NCI
C37647	RO	chemotherapy regimen has component Docetaxel	NCI
C63496	STY	Therapeutic or Preventive Procedure		NCI
C63496	PT	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma		NCI
C63496	CHD	Chemotherapy Regimen	NCI
C63496	PAR	VBMCP Regimen	NCI
C63496	PAR	Bortezomib-Dexamethasone Regimen	NCI
C63496	PAR	Cyclophosphamide-VAD Regimen	NCI
C63496	PAR	DT-PACE Regimen	NCI
C63496	PAR	DVD Regimen	NCI
C63496	PAR	Lenalidomide-Dexamethasone Regimen	NCI
C63496	PAR	MP-Myeloma Regimen	NCI
C63496	PAR	MPB Regimen	NCI
C63496	PAR	MPT Regimen	NCI
C63496	PAR	Thalidomide-Dexamethasone Regimen	NCI
C63496	PAR	VMCP-VBAP Regimen	NCI
C63496	PAR	VAD Regimen	NCI
C63496	PAR	Bortezomib/Dexamethasone/Pegylated Liposomal Doxorubicin Regimen	NCI
C63496	PAR	Bortezomib/Dexamethasone/Lenalidomide Regimen	NCI
C63496	PAR	PAD Regimen	NCI
C63496	PAR	Bortezomib/Cyclophosphamide/Dexamethasone Regimen	NCI
C63496	PAR	Pomalidomide/Bortezomib/Dexamethasone Regimen	NCI
C63496	PAR	Daratumumab/Bortezomib/Dexamethasone Regimen	NCI
C63496	PAR	Pomalidomide/Cyclophosphamide/Dexamethasone Regimen	NCI
C63496	PAR	Pomalidomide/Carfilzomib/Dexamethasone Regimen	NCI
C63496	PAR	Bendamustine/Bortezomib/Dexamethasone Regimen	NCI
C63496	PAR	Bendamustine/Lenalidomide/Dexamethasone Regimen	NCI
C63496	PAR	Bortezomib/Liposomal Doxorubicin Regimen	NCI
C63496	PAR	Carfilzomib/Dexamethasone Regimen	NCI
C63496	PAR	Cyclophosphamide/Lenalidomide/Dexamethasone Regimen	NCI
C63496	PAR	Daratumumab/Lenalidomide/Dexamethasone Regimen	NCI
C63496	PAR	VTD-PACE Regimen	NCI
C63496	PAR	Elotuzumab/Lenalidomide/Dexamethasone Regimen	NCI
C63496	PAR	Elotuzumab/Bortezomib/Dexamethasone Regimen	NCI
C63496	PAR	Ixazomib/Lenalidomide/Dexamethasone Regimen	NCI
C63496	PAR	Ixazomib/Dexamethasone Regimen	NCI
C63496	PAR	Lenalidomide/Low-dose Dexamethasone Regimen	NCI
C63496	PAR	Panobinostat/Bortezomib/Dexamethasone Regimen	NCI
C63496	PAR	Panobinostat/Carfilzomib Regimen	NCI
C63496	PAR	Pomalidomide/Dexamethasone Regimen	NCI
C63496	PAR	DPACE Regimen	NCI
C63496	PAR	DCEP Regimen	NCI
C63496	PAR	Carfilzomib/Lenalidomide/Dexamethasone Regimen	NCI
C15612	STY	Therapeutic or Preventive Procedure		NCI
C15612	PT	interleukin-2/Monoclonal Antibody OKT3		NCI
C15612	SY	IL-2/MOAB OKT3		NCI
C15612	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C15612	RO	chemotherapy regimen has component Muromonab-CD3	NCI
C15612	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37851	STY	Therapeutic or Preventive Procedure		NCI
C37851	PT	Rifampin/Tetracycline		NCI
C37851	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37851	RO	chemotherapy regimen has component Rifampin	NCI
C37851	RO	chemotherapy regimen has component Tetracycline	NCI
C10319	STY	Therapeutic or Preventive Procedure		NCI
C10319	PT	Cisplatin/Cyclophosphamide/10-EdAM		NCI
C10319	SY	CDDP/CTX/EDAM		NCI
C10319	SY	Cisplatin/Cyclophosphamide/Edatrexate		NCI
C10319	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10319	RO	chemotherapy regimen has component Cisplatin	NCI
C10319	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10319	RO	chemotherapy regimen has component Edatrexate	NCI
C141507	STY	Therapeutic or Preventive Procedure		NCI
C141507	PT	ECX Regimen		NCI
C141507	SY	Capecitabine-Cisplatin-Epirubicin		NCI
C141507	SY	Cisplatin-Epirubicin-Xeloda		NCI
C141507	SY	Cisplatin/Epirubicin/Xeloda		NCI
C141507	SY	Capecitabine/Cisplatin/Epirubicin		NCI
C141507	SY	Capecitabine-Cisplatin-Epirubicin Regimen		NCI
C141507	SY	Capecitabine/Cisplatin/Epirubicin Regimen		NCI
C141507	SY	ECX		NCI
C141507	CHD	Chemotherapy Regimen Used to Treat Esophageal Carcinoma	NCI
C141507	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C141507	RO	chemotherapy regimen has component Cisplatin	NCI
C141507	RO	chemotherapy regimen has component Capecitabine	NCI
C141507	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11523	STY	Therapeutic or Preventive Procedure		NCI
C11523	PT	Fluorouracil/Oxaliplatin		NCI
C11523	SY	5-FU/L-OHP		NCI
C11523	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11523	RO	chemotherapy regimen has component Fluorouracil	NCI
C11523	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11185	STY	Therapeutic or Preventive Procedure		NCI
C11185	PT	P-30 Protein/Tamoxifen		NCI
C11185	SY	Onconase/Tamoxifen		NCI
C11185	SY	Ranpirnase/Tamoxifen		NCI
C11185	SY	Onconase/TMX		NCI
C11185	SY	Onconase/TAM		NCI
C11185	SY	P-30 Protein/TAM		NCI
C11185	SY	P-30 Protein/TMX		NCI
C11185	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11185	RO	chemotherapy regimen has component Ranpirnase	NCI
C11185	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C37760	STY	Therapeutic or Preventive Procedure		NCI
C37760	PT	Epirubicin/Rituximab		NCI
C37760	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37760	RO	chemotherapy regimen has component Rituximab	NCI
C37760	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C37552	STY	Therapeutic or Preventive Procedure		NCI
C37552	PT	Bevacizumab/Capecitabine/Oxaliplatin		NCI
C37552	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37552	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37552	RO	chemotherapy regimen has component Capecitabine	NCI
C37552	RO	chemotherapy regimen has component Bevacizumab	NCI
C11779	STY	Therapeutic or Preventive Procedure		NCI
C11779	PT	Carboplatin/Fludarabine		NCI
C11779	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11779	RO	chemotherapy regimen has component Fludarabine	NCI
C11779	RO	chemotherapy regimen has component Carboplatin	NCI
C136283	STY	Therapeutic or Preventive Procedure		NCI
C136283	PT	Carboplatin/Nab-paclitaxel Regimen		NCI
C136283	SY	Carboplatin-Albumin-bound Paclitaxel Regimen		NCI
C136283	SY	Carboplatin/Abraxane Regimen		NCI
C136283	SY	Carboplatin-Albumin-bound Paclitaxel		NCI
C136283	SY	Nab-PC Regimen		NCI
C136283	SY	Nab-P/C Regimen		NCI
C136283	SY	Carboplatin/Albumin-bound Paclitaxel		NCI
C136283	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C136283	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C136283	RO	chemotherapy regimen has component Carboplatin	NCI
C136283	RO	chemotherapy regimen has component Nab-paclitaxel	NCI
C11917	STY	Therapeutic or Preventive Procedure		NCI
C11917	PT	Cyclosporine/Paclitaxel/Yttrium Y 90 Monoclonal Antibody M170		NCI
C11917	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11917	RO	chemotherapy regimen has component Cyclosporine	NCI
C11917	RO	chemotherapy regimen has component Paclitaxel	NCI
C11917	RO	chemotherapy regimen has component Y 90 Monoclonal Antibody m170	NCI
C9867	STY	Therapeutic or Preventive Procedure		NCI
C9867	PT	Cyclophosphamide/Cytarabine/Teniposide		NCI
C9867	SY	ARA-C/CTX/VM-26		NCI
C9867	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9867	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9867	RO	chemotherapy regimen has component Cytarabine	NCI
C9867	RO	chemotherapy regimen has component Teniposide	NCI
C12098	STY	Therapeutic or Preventive Procedure		NCI
C12098	PT	Carboplatin/Cetuximab/Gemcitabine		NCI
C12098	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12098	RO	chemotherapy regimen has component Carboplatin	NCI
C12098	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12098	RO	chemotherapy regimen has component Cetuximab	NCI
C11120	STY	Therapeutic or Preventive Procedure		NCI
C11120	PT	Allovectin-7/Interleukin-2		NCI
C11120	SY	allovectin-7/IL-2		NCI
C11120	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11120	RO	chemotherapy regimen has component Allovectin-7	NCI
C11120	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37749	STY	Therapeutic or Preventive Procedure		NCI
C37749	PT	Doxorubicin/Etoposide/Mitotane/Tariquidar/Vincristine		NCI
C37749	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37749	RO	chemotherapy regimen has component Doxorubicin	NCI
C37749	RO	chemotherapy regimen has component Etoposide	NCI
C37749	RO	chemotherapy regimen has component Mitotane	NCI
C37749	RO	chemotherapy regimen has component Vincristine	NCI
C37749	RO	chemotherapy regimen has component Tariquidar	NCI
C12179	STY	Therapeutic or Preventive Procedure		NCI
C12179	PT	gp100 Antigen/Melan-A/Na17.A2 Antigen/Tyrosinase Peptide		NCI
C12179	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12179	RO	chemotherapy regimen has component gp100 Antigen	NCI
C12179	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C12179	RO	chemotherapy regimen has component NA17.A2 Peptide Vaccine	NCI
C12179	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C12192	STY	Therapeutic or Preventive Procedure		NCI
C12192	PT	Cyclophosphamide/Dexrazoxane/Doxorubicin/Oblimersen		NCI
C12192	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12192	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12192	RO	chemotherapy regimen has component Doxorubicin	NCI
C12192	RO	chemotherapy regimen has component Dexrazoxane	NCI
C12192	RO	chemotherapy regimen has component Oblimersen	NCI
C11825	STY	Therapeutic or Preventive Procedure		NCI
C11825	PT	Interleukin-2/Stem Cell Factor		NCI
C11825	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11825	RO	chemotherapy regimen has component Recombinant Granulocyte Colony-Stimulating Factor	NCI
C11825	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11485	STY	Therapeutic or Preventive Procedure		NCI
C11485	PT	Doxorubicin/Methylprednisolone		NCI
C11485	SY	DOX/MePRDL		NCI
C11485	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11485	RO	chemotherapy regimen has component Doxorubicin	NCI
C11485	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11614	STY	Therapeutic or Preventive Procedure		NCI
C11614	PT	GEM 231/Paclitaxel		NCI
C11614	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11614	RO	chemotherapy regimen has component Paclitaxel	NCI
C11614	RO	chemotherapy regimen has component GEM 231	NCI
C141433	STY	Therapeutic or Preventive Procedure		NCI
C141433	PT	Dose-dense AC Followed by Dose-Dense Paclitaxel Regimen		NCI
C141433	SY	Dose-dense Adriamycin/Cytoxan Followed by Dose-dense Taxol		NCI
C141433	SY	ACT Dose Dense		NCI
C141433	SY	DD ACT Regimen		NCI
C141433	SY	Dose-dense AC Followed by Dose-dense Paclitaxel		NCI
C141433	SY	Dose-dense ACT Regimen		NCI
C141433	SY	Dose-dense Doxorubicin/Cyclophosphamide Followed by Dose-dense Paclitaxel		NCI
C141433	SY	ACT Dose-dense		NCI
C141433	SY	Dose-dense AC Regimen Followed by Dose-dense Paclitaxel		NCI
C141433	SY	DD AC Followed by DD Paclitaxel Regimen		NCI
C141433	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C12095	STY	Therapeutic or Preventive Procedure		NCI
C12095	PT	Anti-CD3 x Anti-HER-2-Neu Bispecific Monoclonal Antibody/Autologous Lymphocytes/Interleukin-2/Sargramostim		NCI
C12095	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12095	RO	chemotherapy regimen has component Sargramostim	NCI
C12095	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12095	RO	chemotherapy regimen has component Therapeutic Autologous Lymphocytes	NCI
C12095	RO	chemotherapy regimen has component Ertumaxomab	NCI
C9569	STY	Therapeutic or Preventive Procedure		NCI
C9569	PT	Cisplatin/Cyclophosphamide		NCI
C9569	SY	CD		NCI
C9569	SY	PC		NCI
C9569	SY	CDDP/CTX		NCI
C9569	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9569	RO	chemotherapy regimen has component Cisplatin	NCI
C9569	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C65071	STY	Therapeutic or Preventive Procedure		NCI
C65071	PT	Cisplatin-Topotecan Regimen		NCI
C65071	CHD	Chemotherapy Regimen Used to Treat Cervical Carcinoma	NCI
C65071	RO	chemotherapy regimen has component Cisplatin	NCI
C65071	RO	chemotherapy regimen has component Topotecan	NCI
C65071	RO	regimen has accepted use for disease Cervical Carcinoma	NCI
C140097	STY	Therapeutic or Preventive Procedure		NCI
C140097	PT	R-DA-EPOCH Regimen		NCI
C140097	SY	Etoposide/Prednisone/Vincristine/Cyclophosphamide/Doxorubicin/Rituximab		NCI
C140097	SY	Rituximab-Etoposide-Prednisone-Oncovin-Cyclophosphamide-Hydroxydaunorubicin Regimen		NCI
C140097	SY	R-DA-EPOCH		NCI
C140097	SY	Dose-adjusted EPOCH-R		NCI
C140097	SY	DA-R-EPOCH		NCI
C140097	SY	DA-EPOCH-R		NCI
C140097	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140097	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C140097	RO	chemotherapy regimen has component Doxorubicin	NCI
C140097	RO	chemotherapy regimen has component Etoposide	NCI
C140097	RO	chemotherapy regimen has component Prednisone	NCI
C140097	RO	chemotherapy regimen has component Vincristine	NCI
C140097	RO	chemotherapy regimen has component Rituximab	NCI
C11104	STY	Therapeutic or Preventive Procedure		NCI
C11104	PT	Idarubicin/Tretinoin Liposome		NCI
C11104	SY	IDA/L-ATRA		NCI
C11104	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11104	RO	chemotherapy regimen has component Idarubicin	NCI
C11104	RO	chemotherapy regimen has component Tretinoin Liposome	NCI
C9861	STY	Therapeutic or Preventive Procedure		NCI
C9861	PT	Pegaspargase/Prednisone/Vincristine		NCI
C9861	SY	PEG-ASP/PRED/VCR		NCI
C9861	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9861	RO	chemotherapy regimen has component Prednisone	NCI
C9861	RO	chemotherapy regimen has component Vincristine	NCI
C9861	RO	chemotherapy regimen has component Pegaspargase	NCI
C11273	STY	Therapeutic or Preventive Procedure		NCI
C11273	PT	Carmustine/Topotecan		NCI
C11273	SY	BCNU/TOPO		NCI
C11273	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11273	RO	chemotherapy regimen has component Carmustine	NCI
C11273	RO	chemotherapy regimen has component Topotecan	NCI
C11232	STY	Therapeutic or Preventive Procedure		NCI
C11232	PT	Carboplatin/Epirubicin/Vincristine		NCI
C11232	SY	CBDCA/EPI/VCR		NCI
C11232	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11232	RO	chemotherapy regimen has component Vincristine	NCI
C11232	RO	chemotherapy regimen has component Carboplatin	NCI
C11232	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C10679	STY	Therapeutic or Preventive Procedure		NCI
C10679	PT	Tamoxifen/Vinblastine		NCI
C10679	SY	TMX/VBL		NCI
C10679	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10679	RO	chemotherapy regimen has component Vinblastine	NCI
C10679	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10729	STY	Therapeutic or Preventive Procedure		NCI
C10729	PT	Cyclophosphamide/Cytarabine/Daunorubicin/Thioguanine		NCI
C10729	SY	ARA-C/CTX/DNR/TG		NCI
C10729	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10729	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10729	RO	chemotherapy regimen has component Cytarabine	NCI
C10729	RO	chemotherapy regimen has component Thioguanine	NCI
C10729	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37663	STY	Therapeutic or Preventive Procedure		NCI
C37663	PT	Cisplatin/Gemcitabine/Tipifarnib		NCI
C37663	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37663	RO	chemotherapy regimen has component Cisplatin	NCI
C37663	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37663	RO	chemotherapy regimen has component Tipifarnib	NCI
C10674	STY	Therapeutic or Preventive Procedure		NCI
C10674	PT	Cytarabine/Dexverapamil/Etoposide/Idarubicin		NCI
C10674	SY	ARA-C/IDA/R-VPAM/VP-16		NCI
C10674	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10674	RO	chemotherapy regimen has component Cytarabine	NCI
C10674	RO	chemotherapy regimen has component Etoposide	NCI
C10674	RO	chemotherapy regimen has component Idarubicin	NCI
C10674	RO	chemotherapy regimen has component Dexverapamil	NCI
C9537	STY	Therapeutic or Preventive Procedure		NCI
C9537	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate		NCI
C9537	SY	FAC-M		NCI
C9537	SY	CTX/DOX/5-FU/MTX		NCI
C9537	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9537	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9537	RO	chemotherapy regimen has component Doxorubicin	NCI
C9537	RO	chemotherapy regimen has component Fluorouracil	NCI
C9537	RO	chemotherapy regimen has component Methotrexate	NCI
C37592	STY	Therapeutic or Preventive Procedure		NCI
C37592	PT	Capecitabine/Tipifarnib		NCI
C37592	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37592	RO	chemotherapy regimen has component Capecitabine	NCI
C37592	RO	chemotherapy regimen has component Tipifarnib	NCI
C11008	STY	Therapeutic or Preventive Procedure		NCI
C11008	PT	Interferon Alfa/Interleukin-2		NCI
C11008	SY	IFN-A/IL-2		NCI
C11008	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11008	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11008	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9798	STY	Therapeutic or Preventive Procedure		NCI
C9798	PT	Cyclophosphamide/Etoposide/Methotrexate		NCI
C9798	SY	CMV		NCI
C9798	SY	CTX/MTX/VP-16		NCI
C9798	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9798	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9798	RO	chemotherapy regimen has component Etoposide	NCI
C9798	RO	chemotherapy regimen has component Methotrexate	NCI
C37619	STY	Therapeutic or Preventive Procedure		NCI
C37619	PT	Carboplatin/Paclitaxel/Prinomastat		NCI
C37619	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37619	RO	chemotherapy regimen has component Carboplatin	NCI
C37619	RO	chemotherapy regimen has component Paclitaxel	NCI
C37619	RO	chemotherapy regimen has component Prinomastat	NCI
C63586	STY	Therapeutic or Preventive Procedure		NCI
C63586	PT	Chemotherapy Regimen Used to Treat Colorectal Carcinoma		NCI
C63586	CHD	Chemotherapy Regimen	NCI
C63586	PAR	FOLFOX Regimen	NCI
C63586	PAR	Bevacizumab/Irinotecan/Oxaliplatin	NCI
C63586	PAR	CAPOX-Bevacizumab Regimen	NCI
C63586	PAR	CAPOX Regimen	NCI
C63586	PAR	FOLFIRI-Bevacizumab Regimen	NCI
C63586	PAR	FOLFIRI Regimen	NCI
C63586	PAR	FU-LV-Bevacizumab Regimen	NCI
C63586	PAR	FU-LV Regimen	NCI
C63586	PAR	IFL-Bevacizumab Regimen	NCI
C63586	PAR	IFL-Douillard Regimen	NCI
C63586	PAR	IFL-FOLFIRI Regimen	NCI
C63586	PAR	IFL Regimen	NCI
C63586	PAR	Irinotecan-Cetuximab Regimen	NCI
C63586	PAR	XELOX Regimen	NCI
C63586	PAR	FOLFIRI-Cetuximab Regimen	NCI
C63586	PAR	XELIRI Regimen	NCI
C63586	PAR	Capecitabine/Bevacizumab Regimen	NCI
C63586	PAR	Capecitabine/Cetuximab Regimen	NCI
C63586	PAR	FOLFOX/Cetuximab Regimen	NCI
C63586	PAR	FOLFOX/Panitumumab Regimen	NCI
C63586	PAR	FOLFOX/Bevacizumab Regimen	NCI
C63586	PAR	FOLFIRI/Panitumumab Regimen	NCI
C63586	PAR	FOLFIRI/Ziv-aflibercept Regimen	NCI
C63586	PAR	FOLFIRI/Ramucirumab Regimen	NCI
C63586	PAR	FOLFOXIRI	NCI
C63586	PAR	FOLFOXIRI/Bevacizumab Regimen	NCI
C63586	PAR	Bolus Fluorouracil/Leucovorin Regimen	NCI
C63586	PAR	Bolus Fluorouracil/Leucovorin/Bevacizumab Regimen	NCI
C63586	PAR	Infusional Fluorouracil/Leucovorin Regimen	NCI
C63586	PAR	Infusional Fluorouracil/Leucovorin/Bevacizumab Regimen	NCI
C63586	PAR	Irinotecan/Bevacizumab Regimen	NCI
C63586	PAR	Irinotecan/Ziv-aflibercept Regimen	NCI
C63586	PAR	Irinotecan/Ramucirumab Regimen	NCI
C63586	PAR	Capecitabine/Panitumumab Regimen	NCI
C63586	PAR	Irinotecan/Panitumumab/Vemurafenib Regimen	NCI
C63586	PAR	Irinotecan/Panitumumab Regimen	NCI
C63586	PAR	Cetuximab/Irinotecan/Vemurafenib Regimen	NCI
C63586	PAR	Fluorouracil/Oxaliplatin Regimen	NCI
C37574	STY	Therapeutic or Preventive Procedure		NCI
C37574	PT	Bortezomib/Gemcitabine		NCI
C37574	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37574	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37574	RO	chemotherapy regimen has component Bortezomib	NCI
C37501	STY	Therapeutic or Preventive Procedure		NCI
C37501	PT	CpG 7909/Dacarbazine		NCI
C37501	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37501	RO	chemotherapy regimen has component Dacarbazine	NCI
C37501	RO	chemotherapy regimen has component Agatolimod Sodium	NCI
C11871	STY	Therapeutic or Preventive Procedure		NCI
C11871	PT	Interferon Alfa/Paclitaxel/Yttrium Y 90 Monoclonal Antibody CC49		NCI
C11871	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11871	RO	chemotherapy regimen has component Paclitaxel	NCI
C11871	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11871	RO	chemotherapy regimen has component Y 90 Monoclonal Antibody CC49	NCI
C150690	STY	Therapeutic or Preventive Procedure		NCI
C150690	PT	Carboplatin/Docetaxel/Cetuximab Regimen		NCI
C150690	SY	Carboplatin/Docetaxel/Cetuximab		NCI
C150690	SY	Carboplatin-Docetaxel-Cetuximab		NCI
C150690	SY	Carboplatin-Docetaxel-Cetuximab Regimen		NCI
C150690	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C150690	RO	chemotherapy regimen has component Carboplatin	NCI
C150690	RO	chemotherapy regimen has component Docetaxel	NCI
C150690	RO	chemotherapy regimen has component Cetuximab	NCI
C150690	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C10075	STY	Therapeutic or Preventive Procedure		NCI
C10075	PT	Etoposide/Methotrexate		NCI
C10075	SY	MTX/VP-16		NCI
C10075	SY	VMC		NCI
C10075	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10075	RO	chemotherapy regimen has component Etoposide	NCI
C10075	RO	chemotherapy regimen has component Methotrexate	NCI
C138037	STY	Therapeutic or Preventive Procedure		NCI
C138037	PT	Dose-dense AC Followed by Paclitaxel Regimen		NCI
C138037	SY	Dose-dense AC Regimen Followed by Paclitaxel		NCI
C138037	SY	Dose-dense AC Followed by Paclitaxel		NCI
C138037	SY	Dose-dense AC-T		NCI
C138037	SY	Dose-dense Doxorubicin/Cyclophosphamide Followed by Paclitaxel		NCI
C138037	SY	Dose-dense AC-Taxol		NCI
C138037	SY	Dose-dense Adriamycin/Cytoxan Followed by Paclitaxel		NCI
C138037	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138037	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138037	RO	chemotherapy regimen has component Doxorubicin	NCI
C138037	RO	chemotherapy regimen has component Paclitaxel	NCI
C11864	STY	Therapeutic or Preventive Procedure		NCI
C11864	PT	Docetaxel/Cyclophosphamide		NCI
C11864	SY	Cyclophosphamide/Docetaxel		NCI
C11864	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11864	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11864	RO	chemotherapy regimen has component Docetaxel	NCI
C11973	STY	Therapeutic or Preventive Procedure		NCI
C11973	PT	Methotrexate/Prednisolone/Prednisone		NCI
C11973	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11973	RO	chemotherapy regimen has component Methotrexate	NCI
C11973	RO	chemotherapy regimen has component Prednisolone	NCI
C11973	RO	chemotherapy regimen has component Prednisone	NCI
C11211	STY	Therapeutic or Preventive Procedure		NCI
C11211	PT	Docetaxel/Epirubicin/Filgrastim		NCI
C11211	SY	EPI/G-CSF/TXT		NCI
C11211	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11211	RO	chemotherapy regimen has component Filgrastim	NCI
C11211	RO	chemotherapy regimen has component Docetaxel	NCI
C11211	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11117	STY	Therapeutic or Preventive Procedure		NCI
C11117	PT	Cisplatin/Gemcitabine		NCI
C11117	SY	CDDP/dFdC		NCI
C11117	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11117	RO	chemotherapy regimen has component Cisplatin	NCI
C11117	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12158	STY	Therapeutic or Preventive Procedure		NCI
C12158	PT	Celecoxib/Eflornithine		NCI
C12158	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12158	RO	chemotherapy regimen has component Eflornithine	NCI
C12158	RO	chemotherapy regimen has component Celecoxib	NCI
C10989	STY	Therapeutic or Preventive Procedure		NCI
C10989	PT	Doxorubicin/eflornithine/Interferon Alfa		NCI
C10989	SY	DFMO/DOX/IFN-A		NCI
C10989	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10989	RO	chemotherapy regimen has component Eflornithine	NCI
C10989	RO	chemotherapy regimen has component Doxorubicin	NCI
C10989	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10589	STY	Therapeutic or Preventive Procedure		NCI
C10589	PT	Carboplatin/Edatrexate		NCI
C10589	SY	CBDCA/EDAM		NCI
C10589	SY	Carboplatin/10-EdAM		NCI
C10589	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10589	RO	chemotherapy regimen has component Edatrexate	NCI
C10589	RO	chemotherapy regimen has component Carboplatin	NCI
C10779	STY	Therapeutic or Preventive Procedure		NCI
C10779	PT	Cisplatin/Pentoxifylline		NCI
C10779	SY	CDDP/PTX		NCI
C10779	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10779	RO	chemotherapy regimen has component Cisplatin	NCI
C10779	RO	chemotherapy regimen has component Pentoxifylline	NCI
C12150	STY	Therapeutic or Preventive Procedure		NCI
C12150	PT	Fowlpox Virus Vaccine/gp100 Antigen/Interleukin-2		NCI
C12150	SY	fowlpox virus vaccine vector/gp100 antigen/interleukin-2		NCI
C12150	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12150	RO	chemotherapy regimen has component gp100 Antigen	NCI
C12150	RO	chemotherapy regimen has component Fowlpox Virus Vaccine	NCI
C12150	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11268	STY	Therapeutic or Preventive Procedure		NCI
C11268	PT	Cyclophosphamide/Doxorubicin/Octreotide Pamoate/Tamoxifen		NCI
C11268	SY	CTX/DOX/SMS 201-995 pa/TMX		NCI
C11268	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11268	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11268	RO	chemotherapy regimen has component Doxorubicin	NCI
C11268	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11268	RO	chemotherapy regimen has component Octreotide Pamoate	NCI
C9793	STY	Therapeutic or Preventive Procedure		NCI
C9793	PT	Carmustine/Cisplatin/Etoposide		NCI
C9793	SY	BCNU/CDDP/VP-16		NCI
C9793	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9793	RO	chemotherapy regimen has component Carmustine	NCI
C9793	RO	chemotherapy regimen has component Cisplatin	NCI
C9793	RO	chemotherapy regimen has component Etoposide	NCI
C11501	STY	Therapeutic or Preventive Procedure		NCI
C11501	PT	Amifostine/Etoposide		NCI
C11501	SY	VP-16/WR-2721		NCI
C11501	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11501	RO	chemotherapy regimen has component Amifostine	NCI
C11501	RO	chemotherapy regimen has component Etoposide	NCI
C11816	STY	Therapeutic or Preventive Procedure		NCI
C11816	PT	Cisplatin/Lurtotecan Liposome		NCI
C11816	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11816	RO	chemotherapy regimen has component Cisplatin	NCI
C11816	RO	chemotherapy regimen has component Lurtotecan Liposome	NCI
C10602	STY	Therapeutic or Preventive Procedure		NCI
C10602	PT	Carboplatin/Etoposide/Interleukin-3		NCI
C10602	SY	CBDCA/IL-3/VP-16		NCI
C10602	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10602	RO	chemotherapy regimen has component Etoposide	NCI
C10602	RO	chemotherapy regimen has component Carboplatin	NCI
C10602	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C37555	STY	Therapeutic or Preventive Procedure		NCI
C37555	PT	Bevacizumab/Cyclophosphamide		NCI
C37555	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37555	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37555	RO	chemotherapy regimen has component Bevacizumab	NCI
C67165	STY	Therapeutic or Preventive Procedure		NCI
C67165	PT	OEPA Regimen		NCI
C67165	SY	OEPA		NCI
C67165	SY	Oncovin-Etoposide-Prednisone-Adriamycin Regimen		NCI
C67165	SY	GPOH-HD 95 Regimen		NCI
C67165	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67165	RO	chemotherapy regimen has component Doxorubicin	NCI
C67165	RO	chemotherapy regimen has component Etoposide	NCI
C67165	RO	chemotherapy regimen has component Prednisone	NCI
C67165	RO	chemotherapy regimen has component Vincristine	NCI
C67165	RO	regimen has accepted use for disease Childhood Hodgkin Lymphoma	NCI
C11303	STY	Therapeutic or Preventive Procedure		NCI
C11303	PT	Docetaxel/Estramustine		NCI
C11303	SY	EM/TXT		NCI
C11303	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11303	RO	chemotherapy regimen has component Estramustine	NCI
C11303	RO	chemotherapy regimen has component Docetaxel	NCI
C10335	STY	Therapeutic or Preventive Procedure		NCI
C10335	PT	Cyclophosphamide/Daunorubicin/Methotrexate/Prednisone/Vincristine		NCI
C10335	SY	CTX/DNR/MTX/PRED/VCR		NCI
C10335	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10335	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10335	RO	chemotherapy regimen has component Methotrexate	NCI
C10335	RO	chemotherapy regimen has component Prednisone	NCI
C10335	RO	chemotherapy regimen has component Vincristine	NCI
C10335	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C63780	STY	Therapeutic or Preventive Procedure		NCI
C63780	PT	Magrath Regimen		NCI
C63780	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63780	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63780	RO	chemotherapy regimen has component Cytarabine	NCI
C63780	RO	chemotherapy regimen has component Doxorubicin	NCI
C63780	RO	chemotherapy regimen has component Methotrexate	NCI
C63780	RO	chemotherapy regimen has component Prednisone	NCI
C63780	RO	chemotherapy regimen has component Vincristine	NCI
C63780	RO	regimen has accepted use for disease Adult Burkitt Lymphoma	NCI
C63780	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63780	RO	regimen has accepted use for disease AIDS-Related Non-Hodgkin Lymphoma	NCI
C15528	STY	Therapeutic or Preventive Procedure		NCI
C15528	PT	Interleukin-2/Monoclonal Antibody Lym-1		NCI
C15528	SY	IL-2/MOAB Lym-1		NCI
C15528	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C15528	RO	chemotherapy regimen has component Monoclonal Antibody Lym-1	NCI
C15528	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12132	STY	Therapeutic or Preventive Procedure		NCI
C12132	PT	Irinotecan/UCN-01		NCI
C12132	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12132	RO	chemotherapy regimen has component 7-Hydroxystaurosporine	NCI
C12132	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C9699	STY	Therapeutic or Preventive Procedure		NCI
C9699	PT	Doxorubicin/Fluorouracil/Mitomycin/Streptozocin		NCI
C9699	SY	FAM-S		NCI
C9699	SY	DOX/5-FU/MITO/SZC		NCI
C9699	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9699	RO	chemotherapy regimen has component Mitomycin	NCI
C9699	RO	chemotherapy regimen has component Doxorubicin	NCI
C9699	RO	chemotherapy regimen has component Fluorouracil	NCI
C9699	RO	chemotherapy regimen has component Streptozocin	NCI
C10764	STY	Therapeutic or Preventive Procedure		NCI
C10764	PT	Edatrexate/Filgrastim/Paclitaxel		NCI
C10764	SY	EDAM/G-CSF/TAX		NCI
C10764	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10764	RO	chemotherapy regimen has component Edatrexate	NCI
C10764	RO	chemotherapy regimen has component Paclitaxel	NCI
C10764	RO	chemotherapy regimen has component Filgrastim	NCI
C11711	STY	Therapeutic or Preventive Procedure		NCI
C11711	PT	Bryostatin 1/Gemcitabine		NCI
C11711	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11711	RO	chemotherapy regimen has component Bryostatin 1	NCI
C11711	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C9818	STY	Therapeutic or Preventive Procedure		NCI
C9818	PT	Doxorubicin/Ifosfamide		NCI
C9818	SY	DOX/IFF		NCI
C9818	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9818	RO	chemotherapy regimen has component Doxorubicin	NCI
C9818	RO	chemotherapy regimen has component Ifosfamide	NCI
C10955	STY	Therapeutic or Preventive Procedure		NCI
C10955	PT	Doxorubicin/Ketoconazole		NCI
C10955	SY	DOX/KCZ		NCI
C10955	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10955	RO	chemotherapy regimen has component Doxorubicin	NCI
C10955	RO	chemotherapy regimen has component Ketoconazole	NCI
C10154	STY	Therapeutic or Preventive Procedure		NCI
C10154	PT	Hydrocortisone/Suramin		NCI
C10154	SY	Suramin/HC		NCI
C10154	SY	HC/SUR		NCI
C10154	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10154	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C10154	RO	chemotherapy regimen has component Suramin	NCI
C10931	STY	Therapeutic or Preventive Procedure		NCI
C10931	PT	Cisplatin/Doxorubicin/Paclitaxel		NCI
C10931	SY	CDDP/DOX/TAX		NCI
C10931	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10931	RO	chemotherapy regimen has component Cisplatin	NCI
C10931	RO	chemotherapy regimen has component Doxorubicin	NCI
C10931	RO	chemotherapy regimen has component Paclitaxel	NCI
C9973	STY	Therapeutic or Preventive Procedure		NCI
C9973	PT	Amiodarone/Doxorubicin/Etoposide		NCI
C9973	SY	amiodarone/DOX/VP-16		NCI
C9973	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9973	RO	chemotherapy regimen has component Doxorubicin	NCI
C9973	RO	chemotherapy regimen has component Etoposide	NCI
C9973	RO	chemotherapy regimen has component Amiodarone Hydrochloride	NCI
C11684	STY	Therapeutic or Preventive Procedure		NCI
C11684	PT	gp100 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide		NCI
C11684	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11684	RO	chemotherapy regimen has component Sargramostim	NCI
C11684	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11684	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11684	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C10773	STY	Therapeutic or Preventive Procedure		NCI
C10773	PT	BCG/Bropirimine		NCI
C10773	SY	ABPP/BCG		NCI
C10773	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10773	RO	chemotherapy regimen has component BCG Vaccine	NCI
C10773	RO	chemotherapy regimen has component Bropirimine	NCI
C15563	STY	Therapeutic or Preventive Procedure		NCI
C15563	PT	Interleukin-3/Zidovudine		NCI
C15563	SY	IL-3/ZDV		NCI
C15563	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15563	RO	chemotherapy regimen has component Zidovudine	NCI
C15563	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C11594	STY	Therapeutic or Preventive Procedure		NCI
C11594	PT	Interleukin-2/Monoclonal Antibody Anti-Tac		NCI
C11594	SY	IL-2/MOAB anti-Tac		NCI
C11594	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11594	RO	chemotherapy regimen has component Daclizumab	NCI
C11594	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12104	STY	Therapeutic or Preventive Procedure		NCI
C12104	PT	BMS-247550/Carboplatin		NCI
C12104	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12104	RO	chemotherapy regimen has component Carboplatin	NCI
C12104	RO	chemotherapy regimen has component Ixabepilone	NCI
C11983	STY	Therapeutic or Preventive Procedure		NCI
C11983	PT	Docetaxel/Flavopiridol		NCI
C11983	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11983	RO	chemotherapy regimen has component Docetaxel	NCI
C11983	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C138099	STY	Therapeutic or Preventive Procedure		NCI
C138099	PT	FAC Regimen		NCI
C138099	SY	Fluorouracil/Doxorubicin/IV Cyclophosphamide		NCI
C138099	SY	5-Fluorouracil/Adriamycin/IV Cyclophosphamide		NCI
C138099	SY	Fluorouracil/Doxorubicin/Intravenous Cyclophosphamide		NCI
C138099	SY	FAC		NCI
C138099	SY	Fluorouracil-Doxorubicin-IV Cyclophosphamide		NCI
C138099	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138099	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138099	RO	chemotherapy regimen has component Doxorubicin	NCI
C138099	RO	chemotherapy regimen has component Fluorouracil	NCI
C138099	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C11002	STY	Therapeutic or Preventive Procedure		NCI
C11002	PT	Cyclophosphamide/Interferon Alfa/interleukin-2/Tumor Infiltrating Lymphocytes		NCI
C11002	SY	CTX/IFN-A/IL-2/TIL		NCI
C11002	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11002	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11002	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11002	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C11002	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9525	STY	Therapeutic or Preventive Procedure		NCI
C9525	PT	Carmustine/Cyclophosphamide/Prednisone/Vincristine		NCI
C9525	SY	BCVP		NCI
C9525	SY	BCNU/CTX/PRED/VCR		NCI
C9525	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9525	RO	chemotherapy regimen has component Carmustine	NCI
C9525	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9525	RO	chemotherapy regimen has component Prednisone	NCI
C9525	RO	chemotherapy regimen has component Vincristine	NCI
C11795	STY	Therapeutic or Preventive Procedure		NCI
C11795	PT	Cisplatin/Tretinoin/Vinorelbine		NCI
C11795	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11795	RO	chemotherapy regimen has component Cisplatin	NCI
C11795	RO	chemotherapy regimen has component Tretinoin	NCI
C11795	RO	chemotherapy regimen has component Vinorelbine	NCI
C9697	STY	Therapeutic or Preventive Procedure		NCI
C9697	PT	Cyclophosphamide/Dacarbazine/Doxorubicin		NCI
C9697	SY	CTX/DOX/DTIC		NCI
C9697	SY	CAD		NCI
C9697	SY	CIA		NCI
C9697	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9697	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9697	RO	chemotherapy regimen has component Dacarbazine	NCI
C9697	RO	chemotherapy regimen has component Doxorubicin	NCI
C12015	STY	Therapeutic or Preventive Procedure		NCI
C12015	PT	Flutamide/Toremifene		NCI
C12015	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12015	RO	chemotherapy regimen has component Flutamide	NCI
C12015	RO	chemotherapy regimen has component Toremifene	NCI
C37756	STY	Therapeutic or Preventive Procedure		NCI
C37756	PT	Edrecolomab/Fluorouracil/Levamisole		NCI
C37756	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37756	RO	chemotherapy regimen has component Fluorouracil	NCI
C37756	RO	chemotherapy regimen has component Edrecolomab	NCI
C37756	RO	chemotherapy regimen has component Levamisole Hydrochloride	NCI
C11662	STY	Therapeutic or Preventive Procedure		NCI
C11662	PT	gp100 Antigen/Montanide ISA-51/Sargramostim/Tetanus Peptide Melanoma Vaccine/Tyrosinase Peptide		NCI
C11662	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11662	RO	chemotherapy regimen has component Sargramostim	NCI
C11662	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11662	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11662	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11662	RO	chemotherapy regimen has component Tetanus Peptide Melanoma Vaccine	NCI
C10203	STY	Therapeutic or Preventive Procedure		NCI
C10203	PT	Doxorubicin/Fluorouracil/Leucovorin Calcium/Mitomycin		NCI
C10203	SY	FAM-CF		NCI
C10203	SY	CF/DOX/5-FU/MITO		NCI
C10203	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10203	RO	chemotherapy regimen has component Mitomycin	NCI
C10203	RO	chemotherapy regimen has component Doxorubicin	NCI
C10203	RO	chemotherapy regimen has component Fluorouracil	NCI
C10203	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11895	STY	Therapeutic or Preventive Procedure		NCI
C11895	PT	Doxorubicin/Hydrocortisone/Methotrexate		NCI
C11895	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11895	RO	chemotherapy regimen has component Doxorubicin	NCI
C11895	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C11895	RO	chemotherapy regimen has component Methotrexate	NCI
C11815	STY	Therapeutic or Preventive Procedure		NCI
C11815	PT	Interleukin-2/Staphylococcal Enterotoxin B		NCI
C11815	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11815	RO	chemotherapy regimen has component Staphylococcal Enterotoxin B	NCI
C11815	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11980	STY	Therapeutic or Preventive Procedure		NCI
C11980	PT	CD40-Ligand/flt3 Ligand		NCI
C11980	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11980	RO	chemotherapy regimen has component Recombinant Flt3 Ligand	NCI
C11980	RO	chemotherapy regimen has component Recombinant CD40-Ligand	NCI
C67212	STY	Therapeutic or Preventive Procedure		NCI
C67212	PT	HM89 Regimen		NCI
C67212	SY	HM89		NCI
C67212	SY	COP-COPADM-VEM-VAD Regimen		NCI
C67212	SY	SFOP-HM89 Regimen		NCI
C67212	CHD	Chemotherapy Regimen Used to Treat Childhood Non-Hodgkin's Lymphoma	NCI
C67212	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67212	RO	chemotherapy regimen has component Doxorubicin	NCI
C67212	RO	chemotherapy regimen has component Etoposide	NCI
C67212	RO	chemotherapy regimen has component Methotrexate	NCI
C67212	RO	chemotherapy regimen has component Prednisone	NCI
C67212	RO	chemotherapy regimen has component Vincristine	NCI
C67212	RO	regimen has accepted use for disease Childhood Anaplastic Large Cell Lymphoma	NCI
C11741	STY	Therapeutic or Preventive Procedure		NCI
C11741	PT	Dactinomycin/Melphalan		NCI
C11741	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11741	RO	chemotherapy regimen has component Dactinomycin	NCI
C11741	RO	chemotherapy regimen has component Melphalan	NCI
C37644	STY	Therapeutic or Preventive Procedure		NCI
C37644	PT	Cisplatin/S-1		NCI
C37644	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37644	RO	chemotherapy regimen has component Cisplatin	NCI
C37644	RO	chemotherapy regimen has component Tegafur-gimeracil-oteracil Potassium	NCI
C10632	STY	Therapeutic or Preventive Procedure		NCI
C10632	PT	Cytarabine/Filgrastim/Tretinoin		NCI
C10632	SY	ARA-C/ATRA/G-CSF		NCI
C10632	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10632	RO	chemotherapy regimen has component Cytarabine	NCI
C10632	RO	chemotherapy regimen has component Tretinoin	NCI
C10632	RO	chemotherapy regimen has component Filgrastim	NCI
C63368	STY	Therapeutic or Preventive Procedure		NCI
C63368	PT	MOPP/ABVD Alternating Regimen		NCI
C63368	SY	Mustargen-Oncovin-Procarbazine-Prednisone plus Adriamycin-Bleomycin-Vinblastine-Dacarbazine Alternating Regimen		NCI
C63368	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63368	RO	chemotherapy regimen has component Bleomycin	NCI
C63368	RO	chemotherapy regimen has component Doxorubicin	NCI
C63368	RO	chemotherapy regimen has component Prednisone	NCI
C63368	RO	chemotherapy regimen has component Vinblastine	NCI
C63368	RO	chemotherapy regimen has component Vincristine	NCI
C63368	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C63368	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C63368	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C10361	STY	Therapeutic or Preventive Procedure		NCI
C10361	PT	Carboplatin/Cisplatin/Etoposide		NCI
C10361	SY	CBDCA/CDDP/VP-16		NCI
C10361	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10361	RO	chemotherapy regimen has component Cisplatin	NCI
C10361	RO	chemotherapy regimen has component Etoposide	NCI
C10361	RO	chemotherapy regimen has component Carboplatin	NCI
C37719	STY	Therapeutic or Preventive Procedure		NCI
C37719	PT	Cytarabine/Oblimersen		NCI
C37719	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37719	RO	chemotherapy regimen has component Cytarabine	NCI
C37719	RO	chemotherapy regimen has component Oblimersen	NCI
C37697	STY	Therapeutic or Preventive Procedure		NCI
C37697	PT	Cyclophosphamide/Methylprednisolone/Rasburicase/Vincristine		NCI
C37697	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37697	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37697	RO	chemotherapy regimen has component Methylprednisolone	NCI
C37697	RO	chemotherapy regimen has component Vincristine	NCI
C37697	RO	chemotherapy regimen has component Rasburicase	NCI
C11766	STY	Therapeutic or Preventive Procedure		NCI
C11766	PT	Docetaxel/Methotrexate		NCI
C11766	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11766	RO	chemotherapy regimen has component Methotrexate	NCI
C11766	RO	chemotherapy regimen has component Docetaxel	NCI
C63491	STY	Therapeutic or Preventive Procedure		NCI
C63491	PT	PCV Regimen		NCI
C63491	SY	PCV		NCI
C63491	SY	Procarbazine-Lomustine-Vincristine Regimen		NCI
C63491	SY	Matulane-CCNU-Oncovin Regimen		NCI
C63491	CHD	Chemotherapy Regimen Used to Treat Malignant Brain Neoplasm	NCI
C63491	RO	chemotherapy regimen has component Lomustine	NCI
C63491	RO	chemotherapy regimen has component Vincristine	NCI
C63491	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C63491	RO	regimen has accepted use for disease Adult Brain Oligodendroglioma	NCI
C67216	STY	Therapeutic or Preventive Procedure		NCI
C67216	PT	NHL-BFM-95 Regimen		NCI
C67216	SY	BFM 95 Regimen		NCI
C67216	CHD	Chemotherapy Regimen Used to Treat Childhood Non-Hodgkin's Lymphoma	NCI
C67216	RO	chemotherapy regimen has component Mercaptopurine	NCI
C67216	RO	chemotherapy regimen has component Asparaginase	NCI
C67216	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67216	RO	chemotherapy regimen has component Cytarabine	NCI
C67216	RO	chemotherapy regimen has component Daunorubicin	NCI
C67216	RO	chemotherapy regimen has component Dexamethasone	NCI
C67216	RO	chemotherapy regimen has component Doxorubicin	NCI
C67216	RO	chemotherapy regimen has component Methotrexate	NCI
C67216	RO	chemotherapy regimen has component Prednisone	NCI
C67216	RO	chemotherapy regimen has component Thioguanine	NCI
C67216	RO	chemotherapy regimen has component Vincristine	NCI
C67216	RO	regimen has accepted use for disease Childhood Lymphoblastic Lymphoma	NCI
C9811	STY	Therapeutic or Preventive Procedure		NCI
C9811	PT	Cisplatin/Thiotepa		NCI
C9811	SY	CDDP/TSPA		NCI
C9811	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9811	RO	chemotherapy regimen has component Cisplatin	NCI
C9811	RO	chemotherapy regimen has component Thiotepa	NCI
C10276	STY	Therapeutic or Preventive Procedure		NCI
C10276	PT	Cytarabine/Methotrexate		NCI
C10276	SY	CCM		NCI
C10276	SY	ARA-C/MTX		NCI
C10276	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10276	RO	chemotherapy regimen has component Cytarabine	NCI
C10276	RO	chemotherapy regimen has component Methotrexate	NCI
C37652	STY	Therapeutic or Preventive Procedure		NCI
C37652	PT	Cisplatin/Etoposide/Monoclonal Antibody 11D10 Anti-Idiotype Vaccine/Monoclonal Antibody GD2 Anti-Idiotype Vaccine		NCI
C37652	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37652	RO	chemotherapy regimen has component Cisplatin	NCI
C37652	RO	chemotherapy regimen has component Etoposide	NCI
C37652	RO	chemotherapy regimen has component Monoclonal Antibody 11D10 Anti-Idiotype Vaccine	NCI
C37652	RO	chemotherapy regimen has component Monoclonal Antibody GD2 Anti-Idiotype Vaccine	NCI
C11638	STY	Therapeutic or Preventive Procedure		NCI
C11638	PT	BEACOPP Regimen		NCI
C11638	SY	Bleomycin-Etoposide-Adriamycin-Cyclophosphamide-Oncovin-Procarbazine-Prednisone Regimen		NCI
C11638	SY	Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Procarbazine/Vincristine		NCI
C11638	SY	BEACOPP		NCI
C11638	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C11638	RO	chemotherapy regimen has component Bleomycin	NCI
C11638	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11638	RO	chemotherapy regimen has component Doxorubicin	NCI
C11638	RO	chemotherapy regimen has component Etoposide	NCI
C11638	RO	chemotherapy regimen has component Prednisone	NCI
C11638	RO	chemotherapy regimen has component Vincristine	NCI
C11638	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11638	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C11638	RO	regimen has accepted use for disease Childhood Hodgkin Lymphoma	NCI
C11638	RO	concept in subset CTRP Terminology	NCI
C11638	RO	concept in subset CTRP Agent Terminology	NCI
C9958	STY	Therapeutic or Preventive Procedure		NCI
C9958	PT	Bleomycin/Methotrexate/Vinblastine		NCI
C9958	SY	BVM		NCI
C9958	SY	BLEO/MTX/VBL		NCI
C9958	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9958	RO	chemotherapy regimen has component Bleomycin	NCI
C9958	RO	chemotherapy regimen has component Methotrexate	NCI
C9958	RO	chemotherapy regimen has component Vinblastine	NCI
C11681	STY	Therapeutic or Preventive Procedure		NCI
C11681	PT	gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide		NCI
C11681	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11681	RO	chemotherapy regimen has component Sargramostim	NCI
C11681	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11681	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11681	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11681	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11813	STY	Therapeutic or Preventive Procedure		NCI
C11813	PT	Floxuridine/Leucovorin Calcium/Oxaliplatin		NCI
C11813	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11813	RO	chemotherapy regimen has component Floxuridine	NCI
C11813	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11813	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11295	STY	Therapeutic or Preventive Procedure		NCI
C11295	PT	Etoposide Phosphate/Topotecan		NCI
C11295	SY	ETOP/TOPO		NCI
C11295	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11295	RO	chemotherapy regimen has component Etoposide Phosphate	NCI
C11295	RO	chemotherapy regimen has component Topotecan	NCI
C63483	STY	Therapeutic or Preventive Procedure		NCI
C63483	PT	MP Regimen		NCI
C63483	SY	Mitoxantrone-Prednisone Regimen		NCI
C63483	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C63483	RO	chemotherapy regimen has component Prednisone	NCI
C63483	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C63483	RO	regimen has accepted use for disease Metastatic Prostate Carcinoma	NCI
C37611	STY	Therapeutic or Preventive Procedure		NCI
C37611	PT	Carboplatin/Gefitinib/Paclitaxel		NCI
C37611	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37611	RO	chemotherapy regimen has component Carboplatin	NCI
C37611	RO	chemotherapy regimen has component Paclitaxel	NCI
C37611	RO	chemotherapy regimen has component Gefitinib	NCI
C10849	STY	Therapeutic or Preventive Procedure		NCI
C10849	PT	Cisplatin/Etoposide/Filgrastim		NCI
C10849	SY	CDDP/G-CSF/VP-16		NCI
C10849	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10849	RO	chemotherapy regimen has component Cisplatin	NCI
C10849	RO	chemotherapy regimen has component Etoposide	NCI
C10849	RO	chemotherapy regimen has component Filgrastim	NCI
C11610	STY	Therapeutic or Preventive Procedure		NCI
C11610	PT	Fowlpox Virus Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine		NCI
C11610	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11610	RO	chemotherapy regimen has component Fowlpox Virus Vaccine	NCI
C11610	RO	chemotherapy regimen has component Vaccinia-Tyrosinase Vaccine	NCI
C11610	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10458	STY	Therapeutic or Preventive Procedure		NCI
C10458	PT	Flutamide/Leuprolide/Suramin		NCI
C10458	SY	FLUT/LEUP/SUR		NCI
C10458	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10458	RO	chemotherapy regimen has component Flutamide	NCI
C10458	RO	chemotherapy regimen has component Suramin	NCI
C10458	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C10350	STY	Therapeutic or Preventive Procedure		NCI
C10350	PT	Cisplatin/Doxorubicin/Etoposide/Ifosfamide		NCI
C10350	SY	CDDP/DOX/IFF/VP-16		NCI
C10350	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10350	RO	chemotherapy regimen has component Cisplatin	NCI
C10350	RO	chemotherapy regimen has component Doxorubicin	NCI
C10350	RO	chemotherapy regimen has component Etoposide	NCI
C10350	RO	chemotherapy regimen has component Ifosfamide	NCI
C11894	STY	Therapeutic or Preventive Procedure		NCI
C11894	PT	Gemcitabine/ISIS 2503		NCI
C11894	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11894	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11894	RO	chemotherapy regimen has component ISIS 2503	NCI
C10396	STY	Therapeutic or Preventive Procedure		NCI
C10396	PT	Cisplatin/Lomustine/Vincristine		NCI
C10396	SY	CCNU/CDDP/VCR		NCI
C10396	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10396	RO	chemotherapy regimen has component Cisplatin	NCI
C10396	RO	chemotherapy regimen has component Lomustine	NCI
C10396	RO	chemotherapy regimen has component Vincristine	NCI
C10449	STY	Therapeutic or Preventive Procedure		NCI
C10449	PT	Carboplatin/Cisplatin/Etoposide/Sargramostim		NCI
C10449	SY	CBDCA/CDDP/GM-CSF/VP-16		NCI
C10449	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10449	RO	chemotherapy regimen has component Cisplatin	NCI
C10449	RO	chemotherapy regimen has component Etoposide	NCI
C10449	RO	chemotherapy regimen has component Carboplatin	NCI
C10449	RO	chemotherapy regimen has component Sargramostim	NCI
C10414	STY	Therapeutic or Preventive Procedure		NCI
C10414	PT	Dactinomycin/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C10414	SY	DACT/DOX/MP/MTX/PRED/VCR		NCI
C10414	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10414	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10414	RO	chemotherapy regimen has component Dactinomycin	NCI
C10414	RO	chemotherapy regimen has component Doxorubicin	NCI
C10414	RO	chemotherapy regimen has component Methotrexate	NCI
C10414	RO	chemotherapy regimen has component Prednisone	NCI
C10414	RO	chemotherapy regimen has component Vincristine	NCI
C11312	STY	Therapeutic or Preventive Procedure		NCI
C11312	PT	Doxorubicin/Gemcitabine		NCI
C11312	SY	dFdC/DOX		NCI
C11312	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11312	RO	chemotherapy regimen has component Doxorubicin	NCI
C11312	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12185	STY	Therapeutic or Preventive Procedure		NCI
C12185	PT	BMS-275291/Zoledronate		NCI
C12185	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12185	RO	chemotherapy regimen has component Zoledronic Acid	NCI
C12185	RO	chemotherapy regimen has component Rebimastat	NCI
C15625	STY	Therapeutic or Preventive Procedure		NCI
C15625	PT	QS21/Tyrosinase Peptide		NCI
C15625	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C15625	RO	chemotherapy regimen has component QS21	NCI
C15625	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C10529	STY	Therapeutic or Preventive Procedure		NCI
C10529	PT	Doxorubicin/Filgrastim/Thiotepa		NCI
C10529	SY	DOX/G-CSF/TSPA		NCI
C10529	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10529	RO	chemotherapy regimen has component Doxorubicin	NCI
C10529	RO	chemotherapy regimen has component Thiotepa	NCI
C10529	RO	chemotherapy regimen has component Filgrastim	NCI
C11424	STY	Therapeutic or Preventive Procedure		NCI
C11424	PT	Gemcitabine/Topotecan		NCI
C11424	SY	dFdC/TOPO		NCI
C11424	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11424	RO	chemotherapy regimen has component Topotecan	NCI
C11424	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11423	STY	Therapeutic or Preventive Procedure		NCI
C11423	PT	Amifostine/Cytarabine/Mitoxantrone		NCI
C11423	SY	ARA-C/DHAD/WR-2721		NCI
C11423	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11423	RO	chemotherapy regimen has component Cytarabine	NCI
C11423	RO	chemotherapy regimen has component Amifostine	NCI
C11423	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11428	STY	Therapeutic or Preventive Procedure		NCI
C11428	PT	Incomplete Freund's Adjuvant/Peptide 946 Melanoma Vaccine		NCI
C11428	SY	IFA/p946		NCI
C11428	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11428	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11428	RO	chemotherapy regimen has component Peptide 946 Melanoma Vaccine	NCI
C10584	STY	Therapeutic or Preventive Procedure		NCI
C10584	PT	Bleomycin/Doxorubicin/Etoposide/Mechlorethamine/Vinblastine/Vincristine		NCI
C10584	SY	BLEO/DOX/NM/VBL/VCR/VP-16		NCI
C10584	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10584	RO	chemotherapy regimen has component Bleomycin	NCI
C10584	RO	chemotherapy regimen has component Doxorubicin	NCI
C10584	RO	chemotherapy regimen has component Etoposide	NCI
C10584	RO	chemotherapy regimen has component Vinblastine	NCI
C10584	RO	chemotherapy regimen has component Vincristine	NCI
C10584	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C10621	STY	Therapeutic or Preventive Procedure		NCI
C10621	PT	Carboplatin/Cyclophosphamide/Etoposide/Vincristine		NCI
C10621	SY	CBDCA/CTX/VCR/VP-16		NCI
C10621	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10621	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10621	RO	chemotherapy regimen has component Etoposide	NCI
C10621	RO	chemotherapy regimen has component Vincristine	NCI
C10621	RO	chemotherapy regimen has component Carboplatin	NCI
C37800	STY	Therapeutic or Preventive Procedure		NCI
C37800	PT	Gemcitabine/Virulizin		NCI
C37800	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37800	RO	chemotherapy regimen has component Virulizin	NCI
C37800	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C136284	STY	Therapeutic or Preventive Procedure		NCI
C136284	PT	Carboplatin/Pemetrexed Regimen		NCI
C136284	SY	Carboplatin-Pemetrexed		NCI
C136284	SY	Carboplatin-Pemetrexed Regimen		NCI
C136284	SY	Carboplatin-Alimta Regimen		NCI
C136284	SY	Carboplatin/Pemetrexed		NCI
C136284	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C136284	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C136284	RO	chemotherapy regimen has component Carboplatin	NCI
C136284	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C9988	STY	Therapeutic or Preventive Procedure		NCI
C9988	PT	Dacarbazine/Doxorubicin/Ifosfamide/Sargramostim		NCI
C9988	SY	DOX/DTIC/GM-CSF/IFF		NCI
C9988	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9988	RO	chemotherapy regimen has component Dacarbazine	NCI
C9988	RO	chemotherapy regimen has component Doxorubicin	NCI
C9988	RO	chemotherapy regimen has component Ifosfamide	NCI
C9988	RO	chemotherapy regimen has component Sargramostim	NCI
C11719	STY	Therapeutic or Preventive Procedure		NCI
C11719	PT	Cisplatin/Gemcitabine/Prinomastat		NCI
C11719	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11719	RO	chemotherapy regimen has component Cisplatin	NCI
C11719	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11719	RO	chemotherapy regimen has component Prinomastat	NCI
C10704	STY	Therapeutic or Preventive Procedure		NCI
C10704	PT	Cisplatin/Floxuridine/Leucovorin Calcium		NCI
C10704	SY	CDDP/CF/FUDR		NCI
C10704	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10704	RO	chemotherapy regimen has component Cisplatin	NCI
C10704	RO	chemotherapy regimen has component Floxuridine	NCI
C10704	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C156264	STY	Therapeutic or Preventive Procedure		NCI
C156264	PT	High-dose Methotrexate/Leucovorin Regimen		NCI
C156264	SY	HD Methotrexate-Leucovorin		NCI
C156264	SY	High-Dose Methotrexate/Leucovorin		NCI
C156264	SY	HD-MTX-LCV		NCI
C156264	SY	HD Methotrexate/Leucovorin		NCI
C156264	CHD	Chemotherapy Regimen Used to Treat Central Nervous System Neoplasm	NCI
C156264	RO	chemotherapy regimen has component Methotrexate	NCI
C156264	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10517	STY	Therapeutic or Preventive Procedure		NCI
C10517	PT	Cyclophosphamide/Detox/Interleukin-2		NCI
C10517	SY	CTX/DETOX/IL-2		NCI
C10517	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10517	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10517	RO	chemotherapy regimen has component Detox	NCI
C10517	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11927	STY	Therapeutic or Preventive Procedure		NCI
C11927	PT	Anti-thymocyte globulin/fludarabine/melphalan		NCI
C11927	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11927	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11927	RO	chemotherapy regimen has component Melphalan	NCI
C11927	RO	chemotherapy regimen has component Fludarabine	NCI
C11580	STY	Therapeutic or Preventive Procedure		NCI
C11580	PT	gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide		NCI
C11580	SY	gp100/IFA/IL-12/MART-1/TYRP		NCI
C11580	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11580	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11580	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11580	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11580	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C11580	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C9748	STY	Therapeutic or Preventive Procedure		NCI
C9748	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Tegafur/Tamoxifen		NCI
C9748	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9748	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9748	RO	chemotherapy regimen has component Doxorubicin	NCI
C9748	RO	chemotherapy regimen has component Fluorouracil	NCI
C9748	RO	chemotherapy regimen has component Tegafur	NCI
C9748	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10149	STY	Therapeutic or Preventive Procedure		NCI
C10149	PT	Bleomycin/Cisplatin/Mitomycin/Vindesine		NCI
C10149	SY	BLEO/CDDP/DAVA/MITO		NCI
C10149	SY	BEMP		NCI
C10149	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10149	RO	chemotherapy regimen has component Mitomycin	NCI
C10149	RO	chemotherapy regimen has component Bleomycin	NCI
C10149	RO	chemotherapy regimen has component Cisplatin	NCI
C10149	RO	chemotherapy regimen has component Vindesine	NCI
C9681	STY	Therapeutic or Preventive Procedure		NCI
C9681	PT	Asparaginase/Doxorubicin/Prednisone/Vincristine		NCI
C9681	SY	VAAP		NCI
C9681	SY	ASP/DOX/PRED/VCR		NCI
C9681	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9681	RO	chemotherapy regimen has component Asparaginase	NCI
C9681	RO	chemotherapy regimen has component Doxorubicin	NCI
C9681	RO	chemotherapy regimen has component Prednisone	NCI
C9681	RO	chemotherapy regimen has component Vincristine	NCI
C136272	STY	Therapeutic or Preventive Procedure		NCI
C136272	PT	Ixazomib/Lenalidomide/Dexamethasone Regimen		NCI
C136272	SY	Ixazomib-Lenalidomide-Dexamethasone Regimen		NCI
C136272	SY	Ixazomib/Lenalidomide/Dexamethasone		NCI
C136272	SY	Ixazomib-Lenalidomide-Dexamethasone		NCI
C136272	SY	Ninlaro/Revlimid/Dexamethasone		NCI
C136272	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136272	RO	chemotherapy regimen has component Dexamethasone	NCI
C136272	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136272	RO	chemotherapy regimen has component Lenalidomide	NCI
C136272	RO	chemotherapy regimen has component Ixazomib Citrate	NCI
C37671	STY	Therapeutic or Preventive Procedure		NCI
C37671	PT	Clofarabine/Idarubicin		NCI
C37671	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37671	RO	chemotherapy regimen has component Idarubicin	NCI
C37671	RO	chemotherapy regimen has component Clofarabine	NCI
C63360	STY	Therapeutic or Preventive Procedure		NCI
C63360	PT	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma		NCI
C63360	SY	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Cancer		NCI
C63360	CHD	Chemotherapy Regimen	NCI
C63360	PAR	Cisplatin-Taxol Regimen	NCI
C63360	PAR	Carboplatin-Taxol-Bevacizumab Regimen	NCI
C63360	PAR	Carboplatin-Taxol Regimen	NCI
C63360	PAR	Cisplatin-Mitomycin-Vinblastine Regimen	NCI
C63360	PAR	Cisplatin-Irinotecan Regimen	NCI
C63360	PAR	Docetaxel-Carboplatin Regimen	NCI
C63360	PAR	Docetaxel-Cisplatin Regimen	NCI
C63360	PAR	Docetaxel-Gemcitabine Regimen	NCI
C63360	PAR	EP Regimen	NCI
C63360	PAR	Gemcitabine-Carboplatin Regimen	NCI
C63360	PAR	Gemcitabine-Cisplatin Regimen	NCI
C63360	PAR	Gemcitabine-Vinorelbine Regimen	NCI
C63360	PAR	Cisplatin-Vinorelbine Regimen	NCI
C63360	PAR	Cisplatin-Vinblastine Regimen	NCI
C63360	PAR	Vinorelbine-Carboplatin Regimen	NCI
C63360	PAR	Bevacizumab/Carboplatin/Pemetrexed Regimen	NCI
C63360	PAR	Carboplatin/Nab-paclitaxel Regimen	NCI
C63360	PAR	Carboplatin/Pemetrexed Regimen	NCI
C63360	PAR	Ramucirumab/Docetaxel Regimen	NCI
C63360	PAR	Bevacizumab/Cisplatin/Pemetrexed Regimen	NCI
C63360	PAR	Carboplatin-Pembrolizumab-Pemetrexed Regimen	NCI
C63360	PAR	Bevacizumab-Pemetrexed Regimen	NCI
C63360	PAR	Dabrafenib/Trametinib Regimen	NCI
C63360	PAR	Temozolomide/Veliparib Regimen	NCI
C63360	PAR	Docetaxel/Vandetanib Regimen	NCI
C11919	STY	Therapeutic or Preventive Procedure		NCI
C11919	PT	Cyclosporine/Yttrium Y 90 Monoclonal Antibody Lym-1		NCI
C11919	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11919	RO	chemotherapy regimen has component Cyclosporine	NCI
C11919	RO	chemotherapy regimen has component Y 90 Monoclonal Antibody Lym-1	NCI
C37591	STY	Therapeutic or Preventive Procedure		NCI
C37591	PT	Capecitabine/Ixabepilone		NCI
C37591	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37591	RO	chemotherapy regimen has component Capecitabine	NCI
C37591	RO	chemotherapy regimen has component Ixabepilone	NCI
C12077	STY	Therapeutic or Preventive Procedure		NCI
C12077	PT	Oxaliplatin/ZD 1839		NCI
C12077	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12077	RO	chemotherapy regimen has component Oxaliplatin	NCI
C12077	RO	chemotherapy regimen has component Gefitinib	NCI
C9570	STY	Therapeutic or Preventive Procedure		NCI
C9570	PT	Altretamine/Cisplatin/Cyclophosphamide/Doxorubicin		NCI
C9570	SY	CHAP-5		NCI
C9570	SY	CDDP/CTX/DOX/HMM		NCI
C9570	SY	HCAP		NCI
C9570	SY	HEXA-CAP		NCI
C9570	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9570	RO	chemotherapy regimen has component Cisplatin	NCI
C9570	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9570	RO	chemotherapy regimen has component Doxorubicin	NCI
C9570	RO	chemotherapy regimen has component Altretamine	NCI
C10219	STY	Therapeutic or Preventive Procedure		NCI
C10219	PT	Bleomycin/Vincristine		NCI
C10219	SY	BO		NCI
C10219	SY	BLEO/VCR		NCI
C10219	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10219	RO	chemotherapy regimen has component Bleomycin	NCI
C10219	RO	chemotherapy regimen has component Vincristine	NCI
C10486	STY	Therapeutic or Preventive Procedure		NCI
C10486	PT	Carmustine/Cisplatin/Cyclophosphamide/Filgrastim		NCI
C10486	SY	BCNU/CDDP/CTX/G-CSF		NCI
C10486	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10486	RO	chemotherapy regimen has component Carmustine	NCI
C10486	RO	chemotherapy regimen has component Cisplatin	NCI
C10486	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10486	RO	chemotherapy regimen has component Filgrastim	NCI
C9646	STY	Therapeutic or Preventive Procedure		NCI
C9646	PT	Doxorubicin/Procarbazine/Vincristine		NCI
C9646	SY	DOX/PCB/VCR		NCI
C9646	SY	AVP		NCI
C9646	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9646	RO	chemotherapy regimen has component Doxorubicin	NCI
C9646	RO	chemotherapy regimen has component Vincristine	NCI
C9646	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10803	STY	Therapeutic or Preventive Procedure		NCI
C10803	PT	Cytarabine/Ifosfamide		NCI
C10803	SY	ARA-C/IFF		NCI
C10803	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10803	RO	chemotherapy regimen has component Cytarabine	NCI
C10803	RO	chemotherapy regimen has component Ifosfamide	NCI
C9957	STY	Therapeutic or Preventive Procedure		NCI
C9957	PT	Cisplatin/Etoposide/Melphalan		NCI
C9957	SY	CDDP/L-PAM/VP-16		NCI
C9957	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9957	RO	chemotherapy regimen has component Cisplatin	NCI
C9957	RO	chemotherapy regimen has component Etoposide	NCI
C9957	RO	chemotherapy regimen has component Melphalan	NCI
C9634	STY	Therapeutic or Preventive Procedure		NCI
C9634	PT	Asparaginase/Daunorubicin/Prednisone/Vincristine		NCI
C9634	SY	ASP/DNR/PRED/VCR		NCI
C9634	SY	DVLP		NCI
C9634	SY	VPLD		NCI
C9634	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9634	RO	chemotherapy regimen has component Asparaginase	NCI
C9634	RO	chemotherapy regimen has component Prednisone	NCI
C9634	RO	chemotherapy regimen has component Vincristine	NCI
C9634	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11110	STY	Therapeutic or Preventive Procedure		NCI
C11110	PT	Cytarabine/Idarubicin/Thioguanine		NCI
C11110	SY	ARA-C/IDA/TG		NCI
C11110	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11110	RO	chemotherapy regimen has component Cytarabine	NCI
C11110	RO	chemotherapy regimen has component Idarubicin	NCI
C11110	RO	chemotherapy regimen has component Thioguanine	NCI
C10412	STY	Therapeutic or Preventive Procedure		NCI
C10412	PT	Cisplatin/Cytarabine/Fluorouracil/Sargramostim		NCI
C10412	SY	ARA-C/CDDP/5-FU/GM-CSF		NCI
C10412	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10412	RO	chemotherapy regimen has component Cisplatin	NCI
C10412	RO	chemotherapy regimen has component Cytarabine	NCI
C10412	RO	chemotherapy regimen has component Fluorouracil	NCI
C10412	RO	chemotherapy regimen has component Sargramostim	NCI
C37670	STY	Therapeutic or Preventive Procedure		NCI
C37670	PT	Clofarabine/Cytarabine/Idarubicin		NCI
C37670	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37670	RO	chemotherapy regimen has component Cytarabine	NCI
C37670	RO	chemotherapy regimen has component Idarubicin	NCI
C37670	RO	chemotherapy regimen has component Clofarabine	NCI
C37571	STY	Therapeutic or Preventive Procedure		NCI
C37571	PT	Bortezomib/Doxorubicin		NCI
C37571	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37571	RO	chemotherapy regimen has component Doxorubicin	NCI
C37571	RO	chemotherapy regimen has component Bortezomib	NCI
C11078	STY	Therapeutic or Preventive Procedure		NCI
C11078	PT	Fluorouracil/Interferon Alfa/Interleukin-2/Isotretinoin		NCI
C11078	SY	13-CRA/5-FU/IFN-A/IL-2		NCI
C11078	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11078	RO	chemotherapy regimen has component Fluorouracil	NCI
C11078	RO	chemotherapy regimen has component Isotretinoin	NCI
C11078	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11078	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11712	STY	Therapeutic or Preventive Procedure		NCI
C11712	PT	Carboplatin/Ifosfamide/Thiotepa		NCI
C11712	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11712	RO	chemotherapy regimen has component Ifosfamide	NCI
C11712	RO	chemotherapy regimen has component Thiotepa	NCI
C11712	RO	chemotherapy regimen has component Carboplatin	NCI
C63463	STY	Therapeutic or Preventive Procedure		NCI
C63463	PT	R-FCM Regimen		NCI
C63463	SY	FCMR Regimen		NCI
C63463	SY	Rituximab-Fludarabine-Cyclophosphamide-Mitoxantrone Regimen		NCI
C63463	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63463	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63463	RO	chemotherapy regimen has component Fludarabine	NCI
C63463	RO	chemotherapy regimen has component Rituximab	NCI
C63463	RO	regimen has accepted use for disease Recurrent Mantle Cell Lymphoma	NCI
C63463	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C63463	RO	regimen has accepted use for disease Refractory Mantle Cell Lymphoma	NCI
C63463	RO	regimen has accepted use for disease Indolent Non-Hodgkin Lymphoma	NCI
C37725	STY	Therapeutic or Preventive Procedure		NCI
C37725	PT	Daclizumab/Methylprednisolone		NCI
C37725	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37725	RO	chemotherapy regimen has component Methylprednisolone	NCI
C37725	RO	chemotherapy regimen has component Daclizumab	NCI
C9773	STY	Therapeutic or Preventive Procedure		NCI
C9773	PT	Bleomycin/Lomustine/Methotrexate/Vinblastine		NCI
C9773	SY	BLEO/CCNU/MTX/VBL		NCI
C9773	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9773	RO	chemotherapy regimen has component Bleomycin	NCI
C9773	RO	chemotherapy regimen has component Lomustine	NCI
C9773	RO	chemotherapy regimen has component Methotrexate	NCI
C9773	RO	chemotherapy regimen has component Vinblastine	NCI
C37860	STY	Therapeutic or Preventive Procedure		NCI
C37860	PT	Tipifarnib/Trastuzumab		NCI
C37860	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37860	RO	chemotherapy regimen has component Trastuzumab	NCI
C37860	RO	chemotherapy regimen has component Tipifarnib	NCI
C67195	STY	Therapeutic or Preventive Procedure		NCI
C67195	PT	LMB-89 Regimen		NCI
C67195	SY	LMB-89		NCI
C67195	SY	French LMB-89 Regimen		NCI
C67195	CHD	Chemotherapy Regimen Used to Treat Childhood Non-Hodgkin's Lymphoma	NCI
C67195	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67195	RO	chemotherapy regimen has component Doxorubicin	NCI
C67195	RO	chemotherapy regimen has component Prednisone	NCI
C67195	RO	chemotherapy regimen has component Vincristine	NCI
C67195	RO	regimen has accepted use for disease Childhood Burkitt Lymphoma	NCI
C67195	RO	regimen has accepted use for disease Childhood Diffuse Large B-Cell Lymphoma	NCI
C37645	STY	Therapeutic or Preventive Procedure		NCI
C37645	PT	Cisplatin/Cytarabine/Methylprednisolone/Pixantrone		NCI
C37645	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37645	RO	chemotherapy regimen has component Cisplatin	NCI
C37645	RO	chemotherapy regimen has component Cytarabine	NCI
C37645	RO	chemotherapy regimen has component Methylprednisolone	NCI
C37645	RO	chemotherapy regimen has component Pixantrone	NCI
C37812	STY	Therapeutic or Preventive Procedure		NCI
C37812	PT	Incomplete Freund's Adjuvant/MART-1 Antigen		NCI
C37812	SY	Incomplete Freund's Adjuvant/MART-1		NCI
C37812	SY	IFA/MART-1		NCI
C37812	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37812	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C37812	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C12161	STY	Therapeutic or Preventive Procedure		NCI
C12161	PT	Etoposide/Filgrastim/Paclitaxel/Topotecan		NCI
C12161	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12161	RO	chemotherapy regimen has component Etoposide	NCI
C12161	RO	chemotherapy regimen has component Paclitaxel	NCI
C12161	RO	chemotherapy regimen has component Topotecan	NCI
C12161	RO	chemotherapy regimen has component Filgrastim	NCI
C37498	STY	Therapeutic or Preventive Procedure		NCI
C37498	PT	CC-5013/Dexamethasone		NCI
C37498	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37498	RO	chemotherapy regimen has component Dexamethasone	NCI
C37498	RO	chemotherapy regimen has component Lenalidomide	NCI
C10480	STY	Therapeutic or Preventive Procedure		NCI
C10480	PT	Asparaginase/Cytarabine/Etoposide		NCI
C10480	SY	ARA-C/ASP/VP-16		NCI
C10480	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10480	RO	chemotherapy regimen has component Asparaginase	NCI
C10480	RO	chemotherapy regimen has component Cytarabine	NCI
C10480	RO	chemotherapy regimen has component Etoposide	NCI
C37568	STY	Therapeutic or Preventive Procedure		NCI
C37568	PT	Bortezomib/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine		NCI
C37568	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37568	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37568	RO	chemotherapy regimen has component Doxorubicin	NCI
C37568	RO	chemotherapy regimen has component Etoposide	NCI
C37568	RO	chemotherapy regimen has component Prednisone	NCI
C37568	RO	chemotherapy regimen has component Vincristine	NCI
C37568	RO	chemotherapy regimen has component Bortezomib	NCI
C11046	STY	Therapeutic or Preventive Procedure		NCI
C11046	PT	Floxuridine/Interferon Alfa		NCI
C11046	SY	FUDR/IFN-A		NCI
C11046	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11046	RO	chemotherapy regimen has component Floxuridine	NCI
C11046	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9825	STY	Therapeutic or Preventive Procedure		NCI
C9825	PT	Asparaginase/Daunorubicin/Methotrexate/Prednisone/Vincristine		NCI
C9825	SY	ASP/DNR/MTX/PRED/VCR		NCI
C9825	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9825	RO	chemotherapy regimen has component Asparaginase	NCI
C9825	RO	chemotherapy regimen has component Methotrexate	NCI
C9825	RO	chemotherapy regimen has component Prednisone	NCI
C9825	RO	chemotherapy regimen has component Vincristine	NCI
C9825	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9607	STY	Therapeutic or Preventive Procedure		NCI
C9607	PT	Cyclophosphamide/Doxorubicin/Lomustine/Methotrexate		NCI
C9607	SY	MACC		NCI
C9607	SY	CCNU/CTX/DOX/MTX		NCI
C9607	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9607	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9607	RO	chemotherapy regimen has component Doxorubicin	NCI
C9607	RO	chemotherapy regimen has component Lomustine	NCI
C9607	RO	chemotherapy regimen has component Methotrexate	NCI
C11545	STY	Therapeutic or Preventive Procedure		NCI
C11545	PT	Isotretinoin/Temozolomide		NCI
C11545	SY	13-CRA/TMZ		NCI
C11545	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11545	RO	chemotherapy regimen has component Isotretinoin	NCI
C11545	RO	chemotherapy regimen has component Temozolomide	NCI
C9675	STY	Therapeutic or Preventive Procedure		NCI
C9675	PT	Amsacrine/Azacitidine/Etoposide		NCI
C9675	SY	Amsacrine/Azacytidine/Etoposide		NCI
C9675	SY	AVA		NCI
C9675	SY	MAZE		NCI
C9675	SY	AMSA/AZA/VP-16		NCI
C9675	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9675	RO	chemotherapy regimen has component Amsacrine	NCI
C9675	RO	chemotherapy regimen has component Azacitidine	NCI
C9675	RO	chemotherapy regimen has component Etoposide	NCI
C11184	STY	Therapeutic or Preventive Procedure		NCI
C11184	PT	Carboplatin/filgrastim/Paclitaxel/Topotecan		NCI
C11184	SY	CBDCA/G-CSF/TAX/TOPO		NCI
C11184	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11184	RO	chemotherapy regimen has component Carboplatin	NCI
C11184	RO	chemotherapy regimen has component Paclitaxel	NCI
C11184	RO	chemotherapy regimen has component Topotecan	NCI
C11184	RO	chemotherapy regimen has component Filgrastim	NCI
C9891	STY	Therapeutic or Preventive Procedure		NCI
C9891	PT	Etoposide/Filgrastim/Ifosfamide		NCI
C9891	SY	G-CSF/IFF/VP-16		NCI
C9891	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9891	RO	chemotherapy regimen has component Etoposide	NCI
C9891	RO	chemotherapy regimen has component Ifosfamide	NCI
C9891	RO	chemotherapy regimen has component Filgrastim	NCI
C12046	STY	Therapeutic or Preventive Procedure		NCI
C12046	PT	Interleukin-2/Montanide ISA-51/Tyrosinase-Related Protein-2		NCI
C12046	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12046	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C12046	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12046	RO	chemotherapy regimen has component Recombinant Tyrosinase-Related Protein-2	NCI
C11035	STY	Therapeutic or Preventive Procedure		NCI
C11035	PT	Carboplatin/Cisplatin/Interferon Alfa/Tamoxifen		NCI
C11035	SY	CBDCA/CDDP/IFN-A/TMX		NCI
C11035	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11035	RO	chemotherapy regimen has component Cisplatin	NCI
C11035	RO	chemotherapy regimen has component Carboplatin	NCI
C11035	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11035	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C12067	STY	Therapeutic or Preventive Procedure		NCI
C12067	PT	Docetaxel/Ifosfamide		NCI
C12067	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12067	RO	chemotherapy regimen has component Ifosfamide	NCI
C12067	RO	chemotherapy regimen has component Docetaxel	NCI
C11254	STY	Therapeutic or Preventive Procedure		NCI
C11254	PT	Epirubicin/Paclitaxel		NCI
C11254	SY	EPI/TAX		NCI
C11254	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11254	RO	chemotherapy regimen has component Paclitaxel	NCI
C11254	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C10954	STY	Therapeutic or Preventive Procedure		NCI
C10954	PT	Cisplatin/Safingol		NCI
C10954	SY	CDDP/safingol		NCI
C10954	SY	Cisplatin/Dihydrosphingosine		NCI
C10954	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10954	RO	chemotherapy regimen has component Cisplatin	NCI
C10954	RO	chemotherapy regimen has component Safingol	NCI
C9806	STY	Therapeutic or Preventive Procedure		NCI
C9806	PT	Dacarbazine/Etoposide/Hydroxyurea		NCI
C9806	SY	HED		NCI
C9806	SY	DTIC/HU/VP-16		NCI
C9806	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9806	RO	chemotherapy regimen has component Dacarbazine	NCI
C9806	RO	chemotherapy regimen has component Etoposide	NCI
C9806	RO	chemotherapy regimen has component Hydroxyurea	NCI
C138035	STY	Therapeutic or Preventive Procedure		NCI
C138035	PT	Dose-dense AC Regimen		NCI
C138035	SY	Dose-dense Doxorubicin/Cyclophosphamide		NCI
C138035	SY	Dose-dense AC		NCI
C138035	SY	Dose-dense Doxorubicin-Cyclophosphamide Regimen		NCI
C138035	SY	Dose-dense Adriamycin/Cytoxan		NCI
C138035	SY	DD AC		NCI
C138035	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138035	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138035	RO	chemotherapy regimen has component Doxorubicin	NCI
C10977	STY	Therapeutic or Preventive Procedure		NCI
C10977	PT	Dexverapamil/Doxorubicin		NCI
C10977	SY	DOX/R-VPAM		NCI
C10977	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10977	RO	chemotherapy regimen has component Doxorubicin	NCI
C10977	RO	chemotherapy regimen has component Dexverapamil	NCI
C9529	STY	Therapeutic or Preventive Procedure		NCI
C9529	PT	Bleomycin/Cisplatin/Mitomycin/Vincristine		NCI
C9529	SY	POMB		NCI
C9529	SY	BLEO/CDDP/MITO/VCR		NCI
C9529	SY	BOMP		NCI
C9529	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9529	RO	chemotherapy regimen has component Mitomycin	NCI
C9529	RO	chemotherapy regimen has component Bleomycin	NCI
C9529	RO	chemotherapy regimen has component Cisplatin	NCI
C9529	RO	chemotherapy regimen has component Vincristine	NCI
C63682	STY	Therapeutic or Preventive Procedure		NCI
C63682	PT	PF Regimen		NCI
C63682	SY	Platinol-Fluorouracil Regimen		NCI
C63682	SY	CF Regimen		NCI
C63682	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C63682	RO	chemotherapy regimen has component Cisplatin	NCI
C63682	RO	chemotherapy regimen has component Fluorouracil	NCI
C63682	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C9623	STY	Therapeutic or Preventive Procedure		NCI
C9623	PT	Cytarabine/Mitoxantrone		NCI
C9623	SY	ARA-C/DHAD		NCI
C9623	SY	S-HAM		NCI
C9623	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9623	RO	chemotherapy regimen has component Cytarabine	NCI
C9623	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10447	STY	Therapeutic or Preventive Procedure		NCI
C10447	PT	Amifostine/Mitomycin		NCI
C10447	SY	MITO/WR-2721		NCI
C10447	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10447	RO	chemotherapy regimen has component Mitomycin	NCI
C10447	RO	chemotherapy regimen has component Amifostine	NCI
C63447	STY	Therapeutic or Preventive Procedure		NCI
C63447	PT	CODOX-M Regimen		NCI
C63447	SY	Cyclophosphamide-Oncovin-Doxorubicin-Methotrexate Regimen		NCI
C63447	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63447	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63447	RO	chemotherapy regimen has component Doxorubicin	NCI
C63447	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C63447	RO	chemotherapy regimen has component Methotrexate	NCI
C63447	RO	chemotherapy regimen has component Vincristine	NCI
C63447	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63447	RO	regimen has accepted use for disease AIDS-Related Non-Hodgkin Lymphoma	NCI
C9530	STY	Therapeutic or Preventive Procedure		NCI
C9530	PT	Carmustine/Cyclophosphamide/Prednisone/Procarbazine/Vinblastine		NCI
C9530	SY	BCVPP		NCI
C9530	SY	BCNU/CTX/PCB/PRED/VBL		NCI
C9530	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9530	RO	chemotherapy regimen has component Carmustine	NCI
C9530	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9530	RO	chemotherapy regimen has component Prednisone	NCI
C9530	RO	chemotherapy regimen has component Vinblastine	NCI
C9530	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C12058	STY	Therapeutic or Preventive Procedure		NCI
C12058	PT	Doxorubicin/Strontium Chloride Sr 89		NCI
C12058	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12058	RO	chemotherapy regimen has component Doxorubicin	NCI
C12058	RO	chemotherapy regimen has component Strontium Chloride Sr-89	NCI
C9845	STY	Therapeutic or Preventive Procedure		NCI
C9845	PT	Asparaginase/Cytarabine/Daunorubicin/Methotrexate/Prednisone/Teniposide/Vincristine		NCI
C9845	SY	ARA-C/ASP/DNR/MTX/PRED/VCR/VM-26		NCI
C9845	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9845	RO	chemotherapy regimen has component Asparaginase	NCI
C9845	RO	chemotherapy regimen has component Cytarabine	NCI
C9845	RO	chemotherapy regimen has component Methotrexate	NCI
C9845	RO	chemotherapy regimen has component Prednisone	NCI
C9845	RO	chemotherapy regimen has component Teniposide	NCI
C9845	RO	chemotherapy regimen has component Vincristine	NCI
C9845	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9644	STY	Therapeutic or Preventive Procedure		NCI
C9644	PT	Doxorubicin/Etoposide		NCI
C9644	SY	DOX/VP-16		NCI
C9644	SY	AVP-16		NCI
C9644	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9644	RO	chemotherapy regimen has component Doxorubicin	NCI
C9644	RO	chemotherapy regimen has component Etoposide	NCI
C37608	STY	Therapeutic or Preventive Procedure		NCI
C37608	PT	Carboplatin/Etoposide/Thalidomide		NCI
C37608	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37608	RO	chemotherapy regimen has component Etoposide	NCI
C37608	RO	chemotherapy regimen has component Thalidomide	NCI
C37608	RO	chemotherapy regimen has component Carboplatin	NCI
C9924	STY	Therapeutic or Preventive Procedure		NCI
C9924	PT	Carboplatin/Sargramostim		NCI
C9924	SY	CBDCA/GM-CSF		NCI
C9924	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9924	RO	chemotherapy regimen has component Carboplatin	NCI
C9924	RO	chemotherapy regimen has component Sargramostim	NCI
C37792	STY	Therapeutic or Preventive Procedure		NCI
C37792	PT	Fowlpox-PSA-TRICOM Vaccine/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine		NCI
C37792	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37792	RO	chemotherapy regimen has component Fowlpox-PSA-TRICOM Vaccine	NCI
C37792	RO	chemotherapy regimen has component Rilimogene Galvacirepvec	NCI
C10951	STY	Therapeutic or Preventive Procedure		NCI
C10951	PT	Detox/Keyhole Limpet Hemocyanin/Sialyl Tn Antigen		NCI
C10951	SY	DETOX/KLH/STn antigen		NCI
C10951	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10951	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C10951	RO	chemotherapy regimen has component Sialyl Tn Antigen	NCI
C10951	RO	chemotherapy regimen has component Detox	NCI
C67293	STY	Therapeutic or Preventive Procedure		NCI
C67293	PT	EE-4A Regimen		NCI
C67293	SY	Vincristine-Dactinomycin Wilm's Tumor Regimen		NCI
C67293	SY	NWTS EE-4A Regimen		NCI
C67293	SY	Vincristine-Pulse Intense Dactinomycin Regimen		NCI
C67293	SY	NWTS-EE4A		NCI
C67293	CHD	Chemotherapy Regimen Used to Treat Childhood Malignant Renal Neoplasm	NCI
C67293	RO	chemotherapy regimen has component Dactinomycin	NCI
C67293	RO	chemotherapy regimen has component Vincristine	NCI
C67293	RO	regimen has accepted use for disease Childhood Kidney Wilms Tumor	NCI
C37473	STY	Therapeutic or Preventive Procedure		NCI
C37473	PT	Cytarabine/Triapine		NCI
C37473	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37473	RO	chemotherapy regimen has component Cytarabine	NCI
C37473	RO	chemotherapy regimen has component Triapine	NCI
C9757	STY	Therapeutic or Preventive Procedure		NCI
C9757	PT	Thymalfasin/Dacarbazine		NCI
C9757	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9757	RO	chemotherapy regimen has component Dacarbazine	NCI
C9757	RO	chemotherapy regimen has component Thymalfasin	NCI
C11954	STY	Therapeutic or Preventive Procedure		NCI
C11954	PT	Sulindac/Thalidomide		NCI
C11954	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11954	RO	chemotherapy regimen has component Sulindac	NCI
C11954	RO	chemotherapy regimen has component Thalidomide	NCI
C63790	STY	Therapeutic or Preventive Procedure		NCI
C63790	PT	Flutamide-Leuprolide Regimen		NCI
C63790	SY	Flutamide-Lupron Regimen		NCI
C63790	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C63790	RO	chemotherapy regimen has component Flutamide	NCI
C63790	RO	regimen has accepted use for disease Prostate Carcinoma	NCI
C63790	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C153482	STY	Therapeutic or Preventive Procedure		NCI
C153482	PT	Irinotecan/Panitumumab/Vemurafenib Regimen		NCI
C153482	SY	Irinotecan/Panitumumab/Vemurafenib		NCI
C153482	SY	Irinotecan + Panitumumab Regimen		NCI
C153482	SY	Irinotecan + Panitumumab + Vemurafenib		NCI
C153482	SY	Irinotecan + Panitumumab + Vemurafenib Regimen		NCI
C153482	SY	Irinotecan-Panitumumab-Vemurafenib Regimen		NCI
C153482	SY	Irinotecan-Panitumumab-Vemurafenib		NCI
C153482	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C153482	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C153482	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C153482	RO	chemotherapy regimen has component Panitumumab	NCI
C153482	RO	chemotherapy regimen has component Vemurafenib	NCI
C10672	STY	Therapeutic or Preventive Procedure		NCI
C10672	PT	Hydrocortisone/Mitoxantrone		NCI
C10672	SY	DHAD/HC		NCI
C10672	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10672	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C10672	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10681	STY	Therapeutic or Preventive Procedure		NCI
C10681	PT	Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Mercaptopurine/Methotrexate/Vincristine		NCI
C10681	SY	ARA-C/ASP/CTX/DNR/MP/MTX/VCR		NCI
C10681	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10681	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10681	RO	chemotherapy regimen has component Asparaginase	NCI
C10681	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10681	RO	chemotherapy regimen has component Cytarabine	NCI
C10681	RO	chemotherapy regimen has component Methotrexate	NCI
C10681	RO	chemotherapy regimen has component Vincristine	NCI
C10681	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11506	STY	Therapeutic or Preventive Procedure		NCI
C11506	PT	Cytarabine/Hydrocortisone/Leucovorin Calcium/Methotrexate		NCI
C11506	SY	ARA-C/CF/HC/MTX		NCI
C11506	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11506	RO	chemotherapy regimen has component Cytarabine	NCI
C11506	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C11506	RO	chemotherapy regimen has component Methotrexate	NCI
C11506	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10947	STY	Amino Acid, Peptide, or Protein		NCI
C10947	STY	Immunologic Factor		NCI
C10947	PT	Interleukin-2/Monoclonal Antibody Ch14.18/Monoclonal Antibody R24		NCI
C10947	SY	IL-2/MOAB Ch14.18/MOAB R24		NCI
C10947	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10947	RO	chemotherapy regimen has component Monoclonal Antibody R24	NCI
C10947	RO	chemotherapy regimen has component Dinutuximab	NCI
C10947	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10919	STY	Therapeutic or Preventive Procedure		NCI
C10919	PT	Cytarabine/Etoposide/Filgrastim/Mitoxantrone		NCI
C10919	SY	ARA-C/DHAD/G-CSF/VP-16		NCI
C10919	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10919	RO	chemotherapy regimen has component Cytarabine	NCI
C10919	RO	chemotherapy regimen has component Etoposide	NCI
C10919	RO	chemotherapy regimen has component Filgrastim	NCI
C10919	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9721	STY	Therapeutic or Preventive Procedure		NCI
C9721	PT	Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisolone/Vincristine		NCI
C9721	SY	CTX/DOX/MTX/PRDL/VCR/VP-16		NCI
C9721	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9721	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9721	RO	chemotherapy regimen has component Doxorubicin	NCI
C9721	RO	chemotherapy regimen has component Etoposide	NCI
C9721	RO	chemotherapy regimen has component Methotrexate	NCI
C9721	RO	chemotherapy regimen has component Prednisolone	NCI
C9721	RO	chemotherapy regimen has component Vincristine	NCI
C9823	STY	Therapeutic or Preventive Procedure		NCI
C9823	PT	Bleomycin/Lomustine		NCI
C9823	SY	BLEO/CCNU		NCI
C9823	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9823	RO	chemotherapy regimen has component Bleomycin	NCI
C9823	RO	chemotherapy regimen has component Lomustine	NCI
C9684	STY	Therapeutic or Preventive Procedure		NCI
C9684	PT	Cyclophosphamide/Doxorubicin/Etoposide		NCI
C9684	SY	AVE		NCI
C9684	SY	ACE-II		NCI
C9684	SY	CED		NCI
C9684	SY	CDE		NCI
C9684	SY	CAE		NCI
C9684	SY	CAVP-16		NCI
C9684	SY	CAVP		NCI
C9684	SY	CTX/DOX/VP-16		NCI
C9684	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9684	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9684	RO	chemotherapy regimen has component Doxorubicin	NCI
C9684	RO	chemotherapy regimen has component Etoposide	NCI
C37564	STY	Therapeutic or Preventive Procedure		NCI
C37564	PT	Bortezomib/Carboplatin		NCI
C37564	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37564	RO	chemotherapy regimen has component Carboplatin	NCI
C37564	RO	chemotherapy regimen has component Bortezomib	NCI
C138043	STY	Therapeutic or Preventive Procedure		NCI
C138043	PT	Pertuzumab/Trastuzumab/Docetaxel Regimen		NCI
C138043	SY	Pertuzumab-Trastuzumab-Docetaxel		NCI
C138043	SY	Pertuzumab + Trastuzumab + Docetaxel		NCI
C138043	SY	Pertuzumab/Trastuzumab/Docetaxel		NCI
C138043	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138043	RO	chemotherapy regimen has component Docetaxel	NCI
C138043	RO	chemotherapy regimen has component Trastuzumab	NCI
C138043	RO	chemotherapy regimen has component Pertuzumab	NCI
C9976	STY	Therapeutic or Preventive Procedure		NCI
C9976	PT	Mitomycin/Vinblastine		NCI
C9976	SY	MITO/VBL		NCI
C9976	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9976	RO	chemotherapy regimen has component Mitomycin	NCI
C9976	RO	chemotherapy regimen has component Vinblastine	NCI
C11658	STY	Therapeutic or Preventive Procedure		NCI
C11658	PT	Montanide ISA-51/Peptide 946 melanoma vaccine/Tetanus peptide melanoma vaccine		NCI
C11658	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11658	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11658	RO	chemotherapy regimen has component Peptide 946 Melanoma Vaccine	NCI
C11658	RO	chemotherapy regimen has component Tetanus Peptide Melanoma Vaccine	NCI
C37531	STY	Therapeutic or Preventive Procedure		NCI
C37531	PT	Anti-Thymocyte Globulin/Busulfan/Melphalan/Methylprednisolone		NCI
C37531	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37531	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C37531	RO	chemotherapy regimen has component Busulfan	NCI
C37531	RO	chemotherapy regimen has component Melphalan	NCI
C37531	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11004	STY	Therapeutic or Preventive Procedure		NCI
C11004	PT	Cyclophosphamide/Interferon Alfa/Prednisone		NCI
C11004	SY	CTX/IFN-A/PRED		NCI
C11004	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11004	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11004	RO	chemotherapy regimen has component Prednisone	NCI
C11004	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9571	STY	Therapeutic or Preventive Procedure		NCI
C9571	PT	Bleomycin/Cisplatin/Vindesine		NCI
C9571	SY	BLEO/CDDP/DAVA		NCI
C9571	SY	DVB		NCI
C9571	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9571	RO	chemotherapy regimen has component Bleomycin	NCI
C9571	RO	chemotherapy regimen has component Cisplatin	NCI
C9571	RO	chemotherapy regimen has component Vindesine	NCI
C37630	STY	Therapeutic or Preventive Procedure		NCI
C37630	PT	Celecoxib/Erlotinib		NCI
C37630	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37630	RO	chemotherapy regimen has component Celecoxib	NCI
C37630	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C156290	STY	Therapeutic or Preventive Procedure		NCI
C156290	PT	Chemotherapy Regimen Used to Treat Malignant Neuroendocrine and Adrenal Neoplasm		NCI
C156290	SY	Chemotherapy Regimen Used to Treat Malignant Neuroendocrine and Adrenal Carcinoma		NCI
C156290	CHD	Chemotherapy Regimen	NCI
C156290	PAR	Cyclophosphamide/Vincristine/Dacarbazine Regimen	NCI
C11394	STY	Therapeutic or Preventive Procedure		NCI
C11394	PT	Busulfan/Cyclophosphamide/Anti-Thymocyte Globulin		NCI
C11394	SY	ATG/BU/CTX		NCI
C11394	SY	Anti-Thymocyte Globulin/Busulfan/Cyclophosphamide		NCI
C11394	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11394	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11394	RO	chemotherapy regimen has component Busulfan	NCI
C11394	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10373	STY	Therapeutic or Preventive Procedure		NCI
C10373	PT	Chlorambucil/Etoposide/Prednisone/Vincristine		NCI
C10373	SY	CLB/PRED/VCR/VP-16		NCI
C10373	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10373	RO	chemotherapy regimen has component Chlorambucil	NCI
C10373	RO	chemotherapy regimen has component Etoposide	NCI
C10373	RO	chemotherapy regimen has component Prednisone	NCI
C10373	RO	chemotherapy regimen has component Vincristine	NCI
C11368	STY	Therapeutic or Preventive Procedure		NCI
C11368	PT	Cladribine/Cyclophosphamide/Prednisone		NCI
C11368	SY	2-CdA/CTX/PRED		NCI
C11368	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11368	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11368	RO	chemotherapy regimen has component Prednisone	NCI
C11368	RO	chemotherapy regimen has component Cladribine	NCI
C37570	STY	Therapeutic or Preventive Procedure		NCI
C37570	PT	Bortezomib/Docetaxel		NCI
C37570	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37570	RO	chemotherapy regimen has component Docetaxel	NCI
C37570	RO	chemotherapy regimen has component Bortezomib	NCI
C11255	STY	Therapeutic or Preventive Procedure		NCI
C11255	PT	Dexamethasone/Fludarabine/Mitoxantrone		NCI
C11255	SY	DHAD/DM/FAMP		NCI
C11255	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11255	RO	chemotherapy regimen has component Dexamethasone	NCI
C11255	RO	chemotherapy regimen has component Fludarabine	NCI
C11255	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37762	STY	Therapeutic or Preventive Procedure		NCI
C37762	PT	Epoetin Alfa/Thalidomide		NCI
C37762	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37762	RO	chemotherapy regimen has component Thalidomide	NCI
C37762	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C37505	STY	Therapeutic or Preventive Procedure		NCI
C37505	PT	Lapatinib/Letrozole		NCI
C37505	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37505	RO	chemotherapy regimen has component Letrozole	NCI
C37505	RO	chemotherapy regimen has component Lapatinib	NCI
C11318	STY	Therapeutic or Preventive Procedure		NCI
C11318	PT	Amifostine/Carboplatin/Cyclophosphamide		NCI
C11318	SY	CBDCA/CTX/WR-2721		NCI
C11318	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11318	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11318	RO	chemotherapy regimen has component Amifostine	NCI
C11318	RO	chemotherapy regimen has component Carboplatin	NCI
C136254	STY	Therapeutic or Preventive Procedure		NCI
C136254	PT	Bolus Fluorouracil/Leucovorin Regimen		NCI
C136254	SY	Bolus 5-Fluorouracil-Leucovorin		NCI
C136254	SY	Bolus Fluorouracil-Leucovorin Regimen		NCI
C136254	SY	Bolus 5-FU/LV		NCI
C136254	SY	Bolus Fluorouracil/Folinic Acid		NCI
C136254	SY	Bolus 5-FU/LV Regimen		NCI
C136254	SY	Bolus 5-FU/Leucovorin		NCI
C136254	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136254	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136254	RO	chemotherapy regimen has component Fluorouracil	NCI
C136254	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10298	STY	Therapeutic or Preventive Procedure		NCI
C10298	PT	Asparaginase/Daunorubicin/Prednisolone/Vincristine		NCI
C10298	SY	ASP/DNR/PRDL/VCR		NCI
C10298	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10298	RO	chemotherapy regimen has component Asparaginase	NCI
C10298	RO	chemotherapy regimen has component Prednisolone	NCI
C10298	RO	chemotherapy regimen has component Vincristine	NCI
C10298	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9619	STY	Therapeutic or Preventive Procedure		NCI
C9619	PT	MOPP Regimen		NCI
C9619	SY	MOPP		NCI
C9619	SY	Mechlorethamine/Prednisone/Procarbazine/Vincristine Regimen		NCI
C9619	SY	NM/PCB/PRED/VCR		NCI
C9619	SY	Mustargen-Oncovin-Procarbazine-Prednisone Regimen		NCI
C9619	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C9619	RO	chemotherapy regimen has component Prednisone	NCI
C9619	RO	chemotherapy regimen has component Vincristine	NCI
C9619	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9619	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C9619	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C10648	STY	Therapeutic or Preventive Procedure		NCI
C10648	PT	Amifostine/Cyclophosphamide		NCI
C10648	SY	CTX/WR-2721		NCI
C10648	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10648	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10648	RO	chemotherapy regimen has component Amifostine	NCI
C11659	STY	Therapeutic or Preventive Procedure		NCI
C11659	PT	gp100 Antigen/HPV-16 E7(12-20) Peptide Vaccine/Montanide ISA-51		NCI
C11659	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11659	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11659	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11659	RO	chemotherapy regimen has component HPV 16 E7:12-20 Peptide Vaccine	NCI
C37650	STY	Therapeutic or Preventive Procedure		NCI
C37650	PT	Cisplatin/Erlotinib/Etoposide		NCI
C37650	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37650	RO	chemotherapy regimen has component Cisplatin	NCI
C37650	RO	chemotherapy regimen has component Etoposide	NCI
C37650	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C12084	STY	Therapeutic or Preventive Procedure		NCI
C12084	PT	cBR96-Doxorubicin Immunoconjugate/Docetaxel		NCI
C12084	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12084	RO	chemotherapy regimen has component Docetaxel	NCI
C12084	RO	chemotherapy regimen has component BR96-Doxorubicin Immunoconjugate	NCI
C37642	STY	Therapeutic or Preventive Procedure		NCI
C37642	PT	Cetuximab/Fluorouracil/Leucovorin Calcium/Oxaliplatin		NCI
C37642	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37642	RO	chemotherapy regimen has component Fluorouracil	NCI
C37642	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37642	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37642	RO	chemotherapy regimen has component Cetuximab	NCI
C9903	STY	Therapeutic or Preventive Procedure		NCI
C9903	PT	Floxuridine/Streptozocin		NCI
C9903	SY	FUDR/SZC		NCI
C9903	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9903	RO	chemotherapy regimen has component Floxuridine	NCI
C9903	RO	chemotherapy regimen has component Streptozocin	NCI
C37659	STY	Therapeutic or Preventive Procedure		NCI
C37659	PT	Cisplatin/Gefitinib		NCI
C37659	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37659	RO	chemotherapy regimen has component Cisplatin	NCI
C37659	RO	chemotherapy regimen has component Gefitinib	NCI
C9579	STY	Therapeutic or Preventive Procedure		NCI
C9579	PT	ADE Regimen		NCI
C9579	SY	ADE		NCI
C9579	SY	Cytarabine/Daunorubicin/Etoposide		NCI
C9579	SY	MRC AML10 Study-ADE Regimen		NCI
C9579	SY	ARA-C/DNR/VP-16		NCI
C9579	SY	Cytarabine-Daunorubicin-Etoposide Regimen		NCI
C9579	SY	AraC-Daunorubicin-Etoposide Regimen		NCI
C9579	CHD	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia	NCI
C9579	RO	chemotherapy regimen has component Cytarabine	NCI
C9579	RO	chemotherapy regimen has component Daunorubicin	NCI
C9579	RO	chemotherapy regimen has component Etoposide	NCI
C9579	RO	regimen has accepted use for disease Childhood Acute Myeloid Leukemia	NCI
C9579	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10360	STY	Therapeutic or Preventive Procedure		NCI
C10360	PT	Cyclophosphamide/Doxorubicin/Etoposide/Filgrastim/Prednisone/Vincristine		NCI
C10360	SY	CTX/DOX/G-CSF/PRED/VCR/VP-16		NCI
C10360	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10360	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10360	RO	chemotherapy regimen has component Doxorubicin	NCI
C10360	RO	chemotherapy regimen has component Etoposide	NCI
C10360	RO	chemotherapy regimen has component Prednisone	NCI
C10360	RO	chemotherapy regimen has component Vincristine	NCI
C10360	RO	chemotherapy regimen has component Filgrastim	NCI
C10164	STY	Therapeutic or Preventive Procedure		NCI
C10164	PT	Bleomycin/Cisplatin/Doxorubicin/Etoposide		NCI
C10164	SY	EBAP		NCI
C10164	SY	BLEO/CDDP/DOX/VP-16		NCI
C10164	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10164	RO	chemotherapy regimen has component Bleomycin	NCI
C10164	RO	chemotherapy regimen has component Cisplatin	NCI
C10164	RO	chemotherapy regimen has component Doxorubicin	NCI
C10164	RO	chemotherapy regimen has component Etoposide	NCI
C10159	STY	Therapeutic or Preventive Procedure		NCI
C10159	PT	Cyclophosphamide/Dacarbazine/Dactinomycin/Doxorubicin/Vincristine		NCI
C10159	SY	VACAD		NCI
C10159	SY	CTX/DACT/DOX/DTIC/VCR		NCI
C10159	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10159	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10159	RO	chemotherapy regimen has component Dacarbazine	NCI
C10159	RO	chemotherapy regimen has component Dactinomycin	NCI
C10159	RO	chemotherapy regimen has component Doxorubicin	NCI
C10159	RO	chemotherapy regimen has component Vincristine	NCI
C11433	STY	Therapeutic or Preventive Procedure		NCI
C11433	PT	Cytarabine/Daunorubicin/Etoposide/Methotrexate/Prednisolone/Thioguanine/Vincristine		NCI
C11433	SY	ARA-C/DNR/MTX/PRDL/TG/VCR/VP-16		NCI
C11433	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11433	RO	chemotherapy regimen has component Cytarabine	NCI
C11433	RO	chemotherapy regimen has component Etoposide	NCI
C11433	RO	chemotherapy regimen has component Methotrexate	NCI
C11433	RO	chemotherapy regimen has component Prednisolone	NCI
C11433	RO	chemotherapy regimen has component Thioguanine	NCI
C11433	RO	chemotherapy regimen has component Vincristine	NCI
C11433	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10851	STY	Therapeutic or Preventive Procedure		NCI
C10851	PT	Ciprofloxacin/Cisplatin/Etoposide/Filgrastim		NCI
C10851	SY	CDDP/CPFX/G-CSF/VP-16		NCI
C10851	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10851	RO	chemotherapy regimen has component Ciprofloxacin	NCI
C10851	RO	chemotherapy regimen has component Cisplatin	NCI
C10851	RO	chemotherapy regimen has component Etoposide	NCI
C10851	RO	chemotherapy regimen has component Filgrastim	NCI
C154214	STY	Therapeutic or Preventive Procedure		NCI
C154214	PT	R-CEPP Regimen		NCI
C154214	SY	CEPP + Rituximab Regimen		NCI
C154214	SY	Cyclophosphamide/Etoposide/Prednisone/Procarbazine + Rituximab		NCI
C154214	SY	Rituximab/Cyclophosphamide/Etoposide/Prednisone/Procarbazine		NCI
C154214	SY	Rituximab-Cyclophosphamide-Etoposide-Prednisone-Procarbazine		NCI
C154214	SY	CEPP-Rituximab Regimen		NCI
C154214	SY	Rituximab/Cyclophosphamide/Etoposide/Prednisone/Procarbazine Regimen		NCI
C154214	SY	Cyclophosphamide/Etoposide/Prednisone/Procarbazine Plus Rituximab		NCI
C154214	SY	RCEPP		NCI
C154214	SY	Cyclophosphamide/Etoposide/Prednisone/Procarbazine Plus Rituximab Regimen		NCI
C154214	SY	Rituximab-Cyclophosphamide-Etoposide-Prednisone-Procarbazine Regimen		NCI
C154214	SY	R-CEPP		NCI
C154214	SY	CEPP Plus Rituximab Regimen		NCI
C154214	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C154214	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C154214	RO	chemotherapy regimen has component Etoposide	NCI
C154214	RO	chemotherapy regimen has component Prednisone	NCI
C154214	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C154214	RO	chemotherapy regimen has component Rituximab	NCI
C11822	STY	Therapeutic or Preventive Procedure		NCI
C11822	PT	Carboplatin/Pyrazoloacridine		NCI
C11822	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11822	RO	chemotherapy regimen has component Carboplatin	NCI
C11822	RO	chemotherapy regimen has component Pyrazoloacridine	NCI
C37614	STY	Therapeutic or Preventive Procedure		NCI
C37614	PT	Carboplatin/Ixabepilone		NCI
C37614	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37614	RO	chemotherapy regimen has component Carboplatin	NCI
C37614	RO	chemotherapy regimen has component Ixabepilone	NCI
C11672	STY	Therapeutic or Preventive Procedure		NCI
C11672	PT	Montanide ISA-51/Sargramostim/Tyrosinase peptide		NCI
C11672	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11672	RO	chemotherapy regimen has component Sargramostim	NCI
C11672	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11672	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C12087	STY	Therapeutic or Preventive Procedure		NCI
C12087	PT	Bevacizumab/Cisplatin/Gemcitabine		NCI
C12087	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12087	RO	chemotherapy regimen has component Cisplatin	NCI
C12087	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12087	RO	chemotherapy regimen has component Bevacizumab	NCI
C63464	STY	Therapeutic or Preventive Procedure		NCI
C63464	PT	R-FM Regimen		NCI
C63464	SY	Rituximab-Fludarabine-Mitoxantrone Regimen		NCI
C63464	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63464	RO	chemotherapy regimen has component Fludarabine	NCI
C63464	RO	chemotherapy regimen has component Rituximab	NCI
C63464	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C63464	RO	regimen has accepted use for disease Indolent Non-Hodgkin Lymphoma	NCI
C10683	STY	Therapeutic or Preventive Procedure		NCI
C10683	PT	Asparaginase/Cytarabine/Dexamethasone/Etoposide		NCI
C10683	SY	ARA-C/ASP/DM/VP-16		NCI
C10683	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10683	RO	chemotherapy regimen has component Asparaginase	NCI
C10683	RO	chemotherapy regimen has component Cytarabine	NCI
C10683	RO	chemotherapy regimen has component Dexamethasone	NCI
C10683	RO	chemotherapy regimen has component Etoposide	NCI
C10117	STY	Therapeutic or Preventive Procedure		NCI
C10117	PT	Mitolactol/Mitoxantrone/Vincristine		NCI
C10117	SY	DBD/DHAD/VCR		NCI
C10117	SY	D(DHAD)V		NCI
C10117	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10117	RO	chemotherapy regimen has component Mitolactol	NCI
C10117	RO	chemotherapy regimen has component Vincristine	NCI
C10117	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C12075	STY	Therapeutic or Preventive Procedure		NCI
C12075	PT	Bevacizumab/Interferon Alfa		NCI
C12075	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12075	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C12075	RO	chemotherapy regimen has component Bevacizumab	NCI
C10607	STY	Therapeutic or Preventive Procedure		NCI
C10607	PT	Cytarabine/Idarubicin/Interleukin-3		NCI
C10607	SY	ARA-C/IDA/IL-3		NCI
C10607	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10607	RO	chemotherapy regimen has component Cytarabine	NCI
C10607	RO	chemotherapy regimen has component Idarubicin	NCI
C10607	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C37537	STY	Therapeutic or Preventive Procedure		NCI
C37537	PT	Autologous Dendritic Cells/Carcinoembryonic Antigen Peptide 1-6D/CMV Pp65 Peptide		NCI
C37537	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37537	RO	chemotherapy regimen has component Therapeutic Autologous Dendritic Cells	NCI
C37537	RO	chemotherapy regimen has component Carcinoembryonic Antigen Peptide 1-6D	NCI
C37537	RO	chemotherapy regimen has component CMV N495 Peptide	NCI
C10003	STY	Therapeutic or Preventive Procedure		NCI
C10003	PT	Methotrexate/Teniposide		NCI
C10003	SY	MTX/VM-26		NCI
C10003	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10003	RO	chemotherapy regimen has component Methotrexate	NCI
C10003	RO	chemotherapy regimen has component Teniposide	NCI
C12103	STY	Therapeutic or Preventive Procedure		NCI
C12103	PT	Carboplatin/Erlotinib/Paclitaxel		NCI
C12103	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12103	RO	chemotherapy regimen has component Carboplatin	NCI
C12103	RO	chemotherapy regimen has component Paclitaxel	NCI
C12103	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C11943	STY	Therapeutic or Preventive Procedure		NCI
C11943	PT	Bevacizumab/Irinotecan		NCI
C11943	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11943	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11943	RO	chemotherapy regimen has component Bevacizumab	NCI
C11761	STY	Therapeutic or Preventive Procedure		NCI
C11761	PT	Cisplatin/Tirapazamine/Vinorelbine		NCI
C11761	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11761	RO	chemotherapy regimen has component Cisplatin	NCI
C11761	RO	chemotherapy regimen has component Vinorelbine	NCI
C11761	RO	chemotherapy regimen has component Tirapazamine	NCI
C37465	STY	Therapeutic or Preventive Procedure		NCI
C37465	PT	Carboplatin/Neovastat/Paclitaxel		NCI
C37465	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37465	RO	chemotherapy regimen has component Carboplatin	NCI
C37465	RO	chemotherapy regimen has component Paclitaxel	NCI
C37465	RO	chemotherapy regimen has component Shark Cartilage Extract AE-941	NCI
C10834	STY	Therapeutic or Preventive Procedure		NCI
C10834	PT	Cyclosporine/Dexamethasone/Vinblastine		NCI
C10834	SY	CYSP/DM/VBL		NCI
C10834	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10834	RO	chemotherapy regimen has component Cyclosporine	NCI
C10834	RO	chemotherapy regimen has component Dexamethasone	NCI
C10834	RO	chemotherapy regimen has component Vinblastine	NCI
C37703	STY	Therapeutic or Preventive Procedure		NCI
C37703	PT	Cyproterone/Leuprolide		NCI
C37703	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37703	RO	chemotherapy regimen has component Cyproterone	NCI
C37703	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C11108	STY	Therapeutic or Preventive Procedure		NCI
C11108	PT	Filgrastim/Losoxantrone/Paclitaxel		NCI
C11108	SY	DuP-941/G-CSF/TAX		NCI
C11108	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11108	RO	chemotherapy regimen has component Paclitaxel	NCI
C11108	RO	chemotherapy regimen has component Filgrastim	NCI
C11108	RO	chemotherapy regimen has component Losoxantrone	NCI
C10970	STY	Therapeutic or Preventive Procedure		NCI
C10970	PT	Carbogen/Niacinamide		NCI
C10970	SY	NICOGEN/UN1014		NCI
C10970	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10970	RO	chemotherapy regimen has component Niacinamide	NCI
C10970	RO	chemotherapy regimen has component Carbogen	NCI
C10984	STY	Therapeutic or Preventive Procedure		NCI
C10984	PT	Zalcitabine/Zidovudine		NCI
C10984	SY	ddC/ZDV		NCI
C10984	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10984	RO	chemotherapy regimen has component Zalcitabine	NCI
C10984	RO	chemotherapy regimen has component Zidovudine	NCI
C63462	STY	Therapeutic or Preventive Procedure		NCI
C63462	PT	RF Regimen		NCI
C63462	SY	Rituximab-Fludarabine Regimen		NCI
C63462	SY	FR Regimen		NCI
C63462	CHD	Chemotherapy Regimen Used to Treat Chronic Lymphocytic Leukemia	NCI
C63462	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63462	RO	regimen has accepted use for disease Chronic Lymphocytic Leukemia	NCI
C63462	RO	chemotherapy regimen has component Fludarabine	NCI
C63462	RO	chemotherapy regimen has component Rituximab	NCI
C63462	RO	regimen has accepted use for disease Indolent Adult Non-Hodgkin Lymphoma	NCI
C11464	STY	Therapeutic or Preventive Procedure		NCI
C11464	PT	Cytarabine/Idarubicin/Recombinant Human Thrombopoietin		NCI
C11464	SY	ARA-C/IDA/rhTPO		NCI
C11464	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11464	RO	chemotherapy regimen has component Cytarabine	NCI
C11464	RO	chemotherapy regimen has component Idarubicin	NCI
C11464	RO	chemotherapy regimen has component Recombinant Human Thrombopoietin	NCI
C11798	STY	Therapeutic or Preventive Procedure		NCI
C11798	PT	Carboplatin/Paclitaxel/Shark Cartilage		NCI
C11798	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11798	RO	chemotherapy regimen has component Carboplatin	NCI
C11798	RO	chemotherapy regimen has component Paclitaxel	NCI
C11798	RO	chemotherapy regimen has component Shark Cartilage	NCI
C37585	STY	Therapeutic or Preventive Procedure		NCI
C37585	PT	Capecitabine/GTI-2040		NCI
C37585	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37585	RO	chemotherapy regimen has component Capecitabine	NCI
C37585	RO	chemotherapy regimen has component GTI-2040	NCI
C9690	STY	Therapeutic or Preventive Procedure		NCI
C9690	PT	Cyclophosphamide/Fluorouracil/Mitoxantrone		NCI
C9690	SY	CTX/DHAD/5-FU		NCI
C9690	SY	CNF		NCI
C9690	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9690	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9690	RO	chemotherapy regimen has component Fluorouracil	NCI
C9690	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11627	STY	Therapeutic or Preventive Procedure		NCI
C11627	PT	Anti-thymocyte globulin/Methylprednisolone		NCI
C11627	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11627	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11627	RO	chemotherapy regimen has component Methylprednisolone	NCI
C138030	STY	Therapeutic or Preventive Procedure		NCI
C138030	PT	AC Followed by Docetaxel Regimen		NCI
C138030	SY	AC Followed by Docetaxel		NCI
C138030	SY	AC-T		NCI
C138030	SY	AC-D		NCI
C138030	SY	AC-Docetaxel		NCI
C138030	SY	AC-Taxotere		NCI
C138030	SY	Doxorubicin/Cyclophosphamide Followed by Docetaxel		NCI
C138030	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138030	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138030	RO	chemotherapy regimen has component Doxorubicin	NCI
C138030	RO	chemotherapy regimen has component Docetaxel	NCI
C136241	STY	Therapeutic or Preventive Procedure		NCI
C136241	PT	Cisplatin/Paclitaxel/Bevacizumab Regimen		NCI
C136241	SY	Platinol/Taxol/Avastin Regimen		NCI
C136241	SY	Cisplatin-Paclitaxel-Bevacizumab		NCI
C136241	SY	Cisplatin-Paclitaxel-Bevacizumab Regimen		NCI
C136241	SY	Platinol-Taxol-Avastin Regimen		NCI
C136241	SY	Cisplatin/Paclitaxel/Bevacizumab		NCI
C136241	CHD	Chemotherapy Regimen Used to Treat Cervical Carcinoma	NCI
C136241	RO	chemotherapy regimen has component Cisplatin	NCI
C136241	RO	chemotherapy regimen has component Paclitaxel	NCI
C136241	RO	regimen has accepted use for disease Cervical Carcinoma	NCI
C136241	RO	chemotherapy regimen has component Bevacizumab	NCI
C9560	STY	Therapeutic or Preventive Procedure		NCI
C9560	PT	Cyclophosphamide/Fluorouracil/Vincristine		NCI
C9560	SY	CTX/5-FU/VCR		NCI
C9560	SY	VCF		NCI
C9560	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9560	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9560	RO	chemotherapy regimen has component Fluorouracil	NCI
C9560	RO	chemotherapy regimen has component Vincristine	NCI
C10958	STY	Therapeutic or Preventive Procedure		NCI
C10958	PT	Hydroxyurea/Pentoxifylline		NCI
C10958	SY	HU/PTX		NCI
C10958	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10958	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10958	RO	chemotherapy regimen has component Pentoxifylline	NCI
C11974	STY	Therapeutic or Preventive Procedure		NCI
C11974	PT	Asparaginase/cytarabine/daunorubicin/dexamethasone/methotrexate/prednisolone/vincristine		NCI
C11974	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11974	RO	chemotherapy regimen has component Asparaginase	NCI
C11974	RO	chemotherapy regimen has component Cytarabine	NCI
C11974	RO	chemotherapy regimen has component Dexamethasone	NCI
C11974	RO	chemotherapy regimen has component Methotrexate	NCI
C11974	RO	chemotherapy regimen has component Prednisolone	NCI
C11974	RO	chemotherapy regimen has component Vincristine	NCI
C11974	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C63410	STY	Therapeutic or Preventive Procedure		NCI
C63410	PT	Gemcitabine-Carboplatin Regimen		NCI
C63410	CHD	Chemotherapy Regimen Used to Treat Malignant Mesothelioma	NCI
C63410	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63410	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C63410	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63410	RO	chemotherapy regimen has component Carboplatin	NCI
C63410	RO	regimen has accepted use for disease Malignant Mesothelioma	NCI
C63410	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63410	RO	regimen has accepted use for disease Ovarian Carcinoma	NCI
C11510	STY	Therapeutic or Preventive Procedure		NCI
C11510	PT	Cyclophosphamide/Thalidomide		NCI
C11510	SY	CTX/THAL		NCI
C11510	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11510	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11510	RO	chemotherapy regimen has component Thalidomide	NCI
C63501	STY	Therapeutic or Preventive Procedure		NCI
C63501	PT	DT-PACE Regimen		NCI
C63501	SY	Dexamethasone-Thalidomide-Platinol-Adriamycin-Cytoxan-Etoposide Regimen		NCI
C63501	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C63501	RO	chemotherapy regimen has component Cisplatin	NCI
C63501	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63501	RO	chemotherapy regimen has component Dexamethasone	NCI
C63501	RO	chemotherapy regimen has component Doxorubicin	NCI
C63501	RO	chemotherapy regimen has component Etoposide	NCI
C63501	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C63501	RO	chemotherapy regimen has component Thalidomide	NCI
C9694	STY	Therapeutic or Preventive Procedure		NCI
C9694	PT	Bleomycin/Cisplatin/Methotrexate/Vinblastine		NCI
C9694	SY	BLEO/CDDP/MTX/VBL		NCI
C9694	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9694	RO	chemotherapy regimen has component Bleomycin	NCI
C9694	RO	chemotherapy regimen has component Cisplatin	NCI
C9694	RO	chemotherapy regimen has component Methotrexate	NCI
C9694	RO	chemotherapy regimen has component Vinblastine	NCI
C10820	STY	Therapeutic or Preventive Procedure		NCI
C10820	PT	Carboplatin/Topotecan		NCI
C10820	SY	CBDCA/TOPO		NCI
C10820	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10820	RO	chemotherapy regimen has component Carboplatin	NCI
C10820	RO	chemotherapy regimen has component Topotecan	NCI
C10810	STY	Therapeutic or Preventive Procedure		NCI
C10810	PT	Cyclophosphamide/Epirubicin/Tamoxifen		NCI
C10810	SY	CTX/EPI/TMX		NCI
C10810	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10810	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10810	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10810	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C10645	STY	Therapeutic or Preventive Procedure		NCI
C10645	PT	Carboplatin/Thymidine		NCI
C10645	SY	CBDCA/TDR		NCI
C10645	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10645	RO	chemotherapy regimen has component Thymidine	NCI
C10645	RO	chemotherapy regimen has component Carboplatin	NCI
C10008	STY	Therapeutic or Preventive Procedure		NCI
C10008	PT	Asparaginase/Methotrexate/Vincristine		NCI
C10008	SY	ASP/MTX/VCR		NCI
C10008	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10008	RO	chemotherapy regimen has component Asparaginase	NCI
C10008	RO	chemotherapy regimen has component Methotrexate	NCI
C10008	RO	chemotherapy regimen has component Vincristine	NCI
C9601	STY	Therapeutic or Preventive Procedure		NCI
C9601	PT	Etoposide/Ifosfamide/Methotrexate		NCI
C9601	SY	IFF/MTX/VP-16		NCI
C9601	SY	IMVP-16		NCI
C9601	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9601	RO	chemotherapy regimen has component Etoposide	NCI
C9601	RO	chemotherapy regimen has component Ifosfamide	NCI
C9601	RO	chemotherapy regimen has component Methotrexate	NCI
C11646	STY	Therapeutic or Preventive Procedure		NCI
C11646	PT	Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Vincristine		NCI
C11646	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11646	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11646	RO	chemotherapy regimen has component Doxorubicin	NCI
C11646	RO	chemotherapy regimen has component Etoposide	NCI
C11646	RO	chemotherapy regimen has component Prednisone	NCI
C11646	RO	chemotherapy regimen has component Vincristine	NCI
C11646	RO	chemotherapy regimen has component Fludarabine	NCI
C10129	STY	Therapeutic or Preventive Procedure		NCI
C10129	PT	Fluorouracil/Methotrexate/Vinblastine		NCI
C10129	SY	MFV		NCI
C10129	SY	5-FU/MTX/VBL		NCI
C10129	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10129	RO	chemotherapy regimen has component Fluorouracil	NCI
C10129	RO	chemotherapy regimen has component Methotrexate	NCI
C10129	RO	chemotherapy regimen has component Vinblastine	NCI
C11156	STY	Therapeutic or Preventive Procedure		NCI
C11156	PT	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Epirubicin/Etoposide/Thioguanine/Vincristine		NCI
C11156	SY	ARA-C/ASP/CTX/DM/EPI/TG/VCR/VP-16		NCI
C11156	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11156	RO	chemotherapy regimen has component Asparaginase	NCI
C11156	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11156	RO	chemotherapy regimen has component Cytarabine	NCI
C11156	RO	chemotherapy regimen has component Dexamethasone	NCI
C11156	RO	chemotherapy regimen has component Etoposide	NCI
C11156	RO	chemotherapy regimen has component Thioguanine	NCI
C11156	RO	chemotherapy regimen has component Vincristine	NCI
C11156	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11757	STY	Therapeutic or Preventive Procedure		NCI
C11757	PT	Biomed 101/Interleukin-2		NCI
C11757	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11757	RO	chemotherapy regimen has component Biomed 101	NCI
C11757	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9564	STY	Therapeutic or Preventive Procedure		NCI
C9564	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Procarbazine/Vincristine		NCI
C9564	SY	CAP-BOP		NCI
C9564	SY	COP-BLAM III		NCI
C9564	SY	BLEO/CTX/DOX/PCB/PRED/VCR		NCI
C9564	SY	CAOPP		NCI
C9564	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9564	RO	chemotherapy regimen has component Bleomycin	NCI
C9564	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9564	RO	chemotherapy regimen has component Doxorubicin	NCI
C9564	RO	chemotherapy regimen has component Prednisone	NCI
C9564	RO	chemotherapy regimen has component Vincristine	NCI
C9564	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C156265	STY	Therapeutic or Preventive Procedure		NCI
C156265	PT	Fluorouracil/Mitomycin Regimen		NCI
C156265	SY	Mitomycin/5-FU		NCI
C156265	SY	Mitomycin-Fluorouracil		NCI
C156265	SY	Mitomycin-5-FU		NCI
C156265	SY	Fluorouracil-Adriamycin-Mitomycin Regimen		NCI
C156265	SY	Fluorouracil-Mitomycin		NCI
C156265	CHD	Chemotherapy Regimen Used to Treat Bladder Carcinoma	NCI
C156265	RO	chemotherapy regimen has component Mitomycin	NCI
C156265	RO	chemotherapy regimen has component Fluorouracil	NCI
C15619	STY	Therapeutic or Preventive Procedure		NCI
C15619	PT	Edetate Calcium Disodium/Interferon Alfa/Monoclonal Antibody CC49		NCI
C15619	SY	EDTA/IFN-A/MOAB CC49		NCI
C15619	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15619	RO	chemotherapy regimen has component Edetate Calcium Disodium	NCI
C15619	RO	chemotherapy regimen has component Minretumomab	NCI
C15619	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11481	STY	Therapeutic or Preventive Procedure		NCI
C11481	PT	Antineoplaston A10/Methotrexate		NCI
C11481	SY	A10/MTX		NCI
C11481	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11481	RO	chemotherapy regimen has component Methotrexate	NCI
C11481	RO	chemotherapy regimen has component Antineoplaston A10	NCI
C9581	STY	Therapeutic or Preventive Procedure		NCI
C9581	PT	Cytarabine/Daunorubicin/Mercaptopurine/Prednisolone		NCI
C9581	SY	ARA-C/DNR/MP/PRDL		NCI
C9581	SY	DCMP		NCI
C9581	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9581	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9581	RO	chemotherapy regimen has component Cytarabine	NCI
C9581	RO	chemotherapy regimen has component Prednisolone	NCI
C9581	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C15610	STY	Therapeutic or Preventive Procedure		NCI
C15610	PT	Aspirin/Interferon Alfa		NCI
C15610	SY	ASA/IFN-A		NCI
C15610	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15610	RO	chemotherapy regimen has component Aspirin	NCI
C15610	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9790	STY	Therapeutic or Preventive Procedure		NCI
C9790	PT	Busulfan/Cyclophosphamide/Etoposide		NCI
C9790	SY	BU/CTX/VP-16		NCI
C9790	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9790	RO	chemotherapy regimen has component Busulfan	NCI
C9790	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9790	RO	chemotherapy regimen has component Etoposide	NCI
C9605	STY	Therapeutic or Preventive Procedure		NCI
C9605	PT	Cisplatin/Epirubicin/Methotrexate/Vinblastine		NCI
C9605	SY	CDDP/EPI/MTX/VBL		NCI
C9605	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9605	RO	chemotherapy regimen has component Cisplatin	NCI
C9605	RO	chemotherapy regimen has component Methotrexate	NCI
C9605	RO	chemotherapy regimen has component Vinblastine	NCI
C9605	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C140108	STY	Therapeutic or Preventive Procedure		NCI
C140108	PT	MPV Regimen		NCI
C140108	SY	MPV		NCI
C140108	SY	Methotrexate-Procarbazine-Vincristine		NCI
C140108	SY	Methotrexate/Procarbazine/Vincristine		NCI
C140108	CHD	Chemotherapy Regimen Used to Treat Central Nervous System Neoplasm	NCI
C140108	RO	chemotherapy regimen has component Methotrexate	NCI
C140108	RO	chemotherapy regimen has component Procarbazine	NCI
C140108	RO	chemotherapy regimen has component Vincristine	NCI
C11381	STY	Therapeutic or Preventive Procedure		NCI
C11381	PT	BCG/Monoclonal Antibody BEC2		NCI
C11381	SY	BCG/MOAB BEC2		NCI
C11381	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11381	RO	chemotherapy regimen has component BCG Vaccine	NCI
C11381	RO	chemotherapy regimen has component Anti-idiotypic Monoclonal Antibody BEC2	NCI
C11890	STY	Therapeutic or Preventive Procedure		NCI
C11890	PT	Docetaxel/Oblimersen		NCI
C11890	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11890	RO	chemotherapy regimen has component Docetaxel	NCI
C11890	RO	chemotherapy regimen has component Oblimersen	NCI
C9865	STY	Therapeutic or Preventive Procedure		NCI
C9865	PT	Cyclophosphamide/Doxorubicin/Methylprednisolone/Prednisone/Vincristine		NCI
C9865	SY	CTX/DOX/MePRDL/PRED/VCR		NCI
C9865	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9865	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9865	RO	chemotherapy regimen has component Doxorubicin	NCI
C9865	RO	chemotherapy regimen has component Methylprednisolone	NCI
C9865	RO	chemotherapy regimen has component Prednisone	NCI
C9865	RO	chemotherapy regimen has component Vincristine	NCI
C10542	STY	Therapeutic or Preventive Procedure		NCI
C10542	PT	Etoposide/Metronidazole		NCI
C10542	SY	METRO/VP-16		NCI
C10542	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10542	RO	chemotherapy regimen has component Etoposide	NCI
C10542	RO	chemotherapy regimen has component Metronidazole	NCI
C10327	STY	Therapeutic or Preventive Procedure		NCI
C10327	PT	Carmustine/Cyclophosphamide/Melphalan/Misonidazole/Prednisone		NCI
C10327	SY	BCNU/CTX/L-PAM/MNI/PRED		NCI
C10327	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10327	RO	chemotherapy regimen has component Carmustine	NCI
C10327	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10327	RO	chemotherapy regimen has component Melphalan	NCI
C10327	RO	chemotherapy regimen has component Misonidazole	NCI
C10327	RO	chemotherapy regimen has component Prednisone	NCI
C10444	STY	Therapeutic or Preventive Procedure		NCI
C10444	PT	Cyclophosphamide/Dexverapamil/Doxorubicin/Etoposide/Prednisolone/Vincristine		NCI
C10444	SY	CTX/DOX/PRDL/R-VPAM/VCR/VP-16		NCI
C10444	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10444	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10444	RO	chemotherapy regimen has component Doxorubicin	NCI
C10444	RO	chemotherapy regimen has component Etoposide	NCI
C10444	RO	chemotherapy regimen has component Prednisolone	NCI
C10444	RO	chemotherapy regimen has component Vincristine	NCI
C10444	RO	chemotherapy regimen has component Dexverapamil	NCI
C9801	STY	Therapeutic or Preventive Procedure		NCI
C9801	PT	Cisplatin/Dacarbazine		NCI
C9801	SY	CDDP/DTIC		NCI
C9801	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9801	RO	chemotherapy regimen has component Cisplatin	NCI
C9801	RO	chemotherapy regimen has component Dacarbazine	NCI
C11032	STY	Therapeutic or Preventive Procedure		NCI
C11032	PT	Cisplatin/Fluorouracil/Interferon Alfa		NCI
C11032	SY	CDDP/5-FU/IFN-A		NCI
C11032	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11032	RO	chemotherapy regimen has component Cisplatin	NCI
C11032	RO	chemotherapy regimen has component Fluorouracil	NCI
C11032	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11831	STY	Therapeutic or Preventive Procedure		NCI
C11831	PT	Cyclophosphamide/Methotrexate/Pegaspargase/Vincristine		NCI
C11831	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11831	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11831	RO	chemotherapy regimen has component Methotrexate	NCI
C11831	RO	chemotherapy regimen has component Vincristine	NCI
C11831	RO	chemotherapy regimen has component Pegaspargase	NCI
C12096	STY	Therapeutic or Preventive Procedure		NCI
C12096	PT	Busulfan/Fludarabine		NCI
C12096	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12096	RO	chemotherapy regimen has component Busulfan	NCI
C12096	RO	chemotherapy regimen has component Fludarabine	NCI
C67206	STY	Therapeutic or Preventive Procedure		NCI
C67206	PT	DAT Regimen		NCI
C67206	SY	Daunorubicin-AraC-Thioguanine Regimen		NCI
C67206	SY	Daunorubicin-Cytarabine-Thioguanine Regimen		NCI
C67206	SY	MRC AML10 Study-DAT Regimen		NCI
C67206	CHD	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia	NCI
C67206	RO	chemotherapy regimen has component Cytarabine	NCI
C67206	RO	chemotherapy regimen has component Daunorubicin	NCI
C67206	RO	chemotherapy regimen has component Thioguanine	NCI
C67206	RO	regimen has accepted use for disease Childhood Acute Myeloid Leukemia	NCI
C37621	STY	Therapeutic or Preventive Procedure		NCI
C37621	PT	Carboplatin/Pemetrexed Disodium		NCI
C37621	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37621	RO	chemotherapy regimen has component Carboplatin	NCI
C37621	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C37575	STY	Therapeutic or Preventive Procedure		NCI
C37575	PT	Bortezomib/Irinotecan		NCI
C37575	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37575	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37575	RO	chemotherapy regimen has component Bortezomib	NCI
C10102	STY	Therapeutic or Preventive Procedure		NCI
C10102	PT	Asparaginase/Cyclophosphamide/Daunorubicin/Methotrexate/Prednisone/Vincristine		NCI
C10102	SY	ASP/CTX/DNR/MTX/PRED/VCR		NCI
C10102	SY	ADCOMP		NCI
C10102	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10102	RO	chemotherapy regimen has component Asparaginase	NCI
C10102	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10102	RO	chemotherapy regimen has component Methotrexate	NCI
C10102	RO	chemotherapy regimen has component Prednisone	NCI
C10102	RO	chemotherapy regimen has component Vincristine	NCI
C10102	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9810	STY	Therapeutic or Preventive Procedure		NCI
C9810	PT	Carmustine/Cyclophosphamide/Dactinomycin/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C9810	SY	BCNU/CTX/DACT/DOX/MP/MTX/PRED/VCR		NCI
C9810	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9810	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9810	RO	chemotherapy regimen has component Carmustine	NCI
C9810	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9810	RO	chemotherapy regimen has component Dactinomycin	NCI
C9810	RO	chemotherapy regimen has component Doxorubicin	NCI
C9810	RO	chemotherapy regimen has component Methotrexate	NCI
C9810	RO	chemotherapy regimen has component Prednisone	NCI
C9810	RO	chemotherapy regimen has component Vincristine	NCI
C10978	STY	Therapeutic or Preventive Procedure		NCI
C10978	PT	Daunorubicin/Pegaspargase/Prednisone/Vincristine		NCI
C10978	SY	DNR/PEG-ASP/PRED/VCR		NCI
C10978	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10978	RO	chemotherapy regimen has component Prednisone	NCI
C10978	RO	chemotherapy regimen has component Vincristine	NCI
C10978	RO	chemotherapy regimen has component Pegaspargase	NCI
C10978	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10511	STY	Therapeutic or Preventive Procedure		NCI
C10511	PT	Filgrastim/Interleukin-1-Beta		NCI
C10511	SY	G-CSF/IL-1B		NCI
C10511	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10511	RO	chemotherapy regimen has component Filgrastim	NCI
C10511	RO	chemotherapy regimen has component Recombinant Interleukin-1-beta	NCI
C11191	STY	Therapeutic or Preventive Procedure		NCI
C11191	PT	Carboplatin/Etoposide/Paclitaxel		NCI
C11191	SY	CBDCA/TAX/VP-16		NCI
C11191	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11191	RO	chemotherapy regimen has component Etoposide	NCI
C11191	RO	chemotherapy regimen has component Carboplatin	NCI
C11191	RO	chemotherapy regimen has component Paclitaxel	NCI
C10907	STY	Therapeutic or Preventive Procedure		NCI
C10907	PT	Gallium Nitrate/Paclitaxel		NCI
C10907	SY	GAN/TAX		NCI
C10907	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10907	RO	chemotherapy regimen has component Gallium Nitrate	NCI
C10907	RO	chemotherapy regimen has component Paclitaxel	NCI
C11907	STY	Therapeutic or Preventive Procedure		NCI
C11907	PT	Prednisone/Thalidomide		NCI
C11907	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11907	RO	chemotherapy regimen has component Prednisone	NCI
C11907	RO	chemotherapy regimen has component Thalidomide	NCI
C11033	STY	Therapeutic or Preventive Procedure		NCI
C11033	PT	Dacarbazine/Interferon Alfa		NCI
C11033	SY	DTIC/IFN-A		NCI
C11033	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11033	RO	chemotherapy regimen has component Dacarbazine	NCI
C11033	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10473	STY	Therapeutic or Preventive Procedure		NCI
C10473	PT	Carboplatin/Fluorouracil/Procarbazine		NCI
C10473	SY	CBDCA/5-FU/PCB		NCI
C10473	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10473	RO	chemotherapy regimen has component Fluorouracil	NCI
C10473	RO	chemotherapy regimen has component Carboplatin	NCI
C10473	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11500	STY	Therapeutic or Preventive Procedure		NCI
C11500	PT	Cisplatin/Flavopiridol		NCI
C11500	SY	CDDP/FLAVO		NCI
C11500	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11500	RO	chemotherapy regimen has component Cisplatin	NCI
C11500	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C11783	STY	Therapeutic or Preventive Procedure		NCI
C11783	PT	gp209-2M Antigen/Heat Shock Protein 70/OVA Bip Peptide/Tyrosinase Peptide		NCI
C11783	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11783	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11783	RO	chemotherapy regimen has component gp209-2M Antigen	NCI
C11783	RO	chemotherapy regimen has component OVA BiP Peptide	NCI
C11783	RO	chemotherapy regimen has component Recombinant 70-kD Heat-Shock Protein	NCI
C37623	STY	Therapeutic or Preventive Procedure		NCI
C37623	PT	Carcinoembryonic Antigen Peptide 1-6D/Montanide ISA-51		NCI
C37623	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37623	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C37623	RO	chemotherapy regimen has component Carcinoembryonic Antigen Peptide 1-6D	NCI
C11459	STY	Therapeutic or Preventive Procedure		NCI
C11459	PT	Cisplatin/Dexamethasone/Paclitaxel		NCI
C11459	SY	CDDP/DM/TAX		NCI
C11459	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11459	RO	chemotherapy regimen has component Cisplatin	NCI
C11459	RO	chemotherapy regimen has component Dexamethasone	NCI
C11459	RO	chemotherapy regimen has component Paclitaxel	NCI
C10808	STY	Therapeutic or Preventive Procedure		NCI
C10808	PT	Asparaginase/Vincristine		NCI
C10808	SY	ASP/VCR		NCI
C10808	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10808	RO	chemotherapy regimen has component Asparaginase	NCI
C10808	RO	chemotherapy regimen has component Vincristine	NCI
C15523	STY	Therapeutic or Preventive Procedure		NCI
C15523	PT	Interleukin-2/Tumor Infiltrating Lymphocytes		NCI
C15523	SY	IL-2/TIL		NCI
C15523	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C15523	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C15523	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11061	STY	Therapeutic or Preventive Procedure		NCI
C11061	PT	Doxorubicin/Interferon Alfa/Tretinoin		NCI
C11061	SY	ATRA/DOX/IFN-A		NCI
C11061	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11061	RO	chemotherapy regimen has component Doxorubicin	NCI
C11061	RO	chemotherapy regimen has component Tretinoin	NCI
C11061	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11102	STY	Therapeutic or Preventive Procedure		NCI
C11102	PT	Dexamethasone/Pegaspargase/Vincristine		NCI
C11102	SY	DM/PEG-ASP/VCR		NCI
C11102	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11102	RO	chemotherapy regimen has component Dexamethasone	NCI
C11102	RO	chemotherapy regimen has component Vincristine	NCI
C11102	RO	chemotherapy regimen has component Pegaspargase	NCI
C9928	STY	Therapeutic or Preventive Procedure		NCI
C9928	PT	Dexamethasone/Methotrexate/Procarbazine/Teniposide		NCI
C9928	SY	MVPD-26		NCI
C9928	SY	DM/MTX/PCB/VM-26		NCI
C9928	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9928	RO	chemotherapy regimen has component Dexamethasone	NCI
C9928	RO	chemotherapy regimen has component Methotrexate	NCI
C9928	RO	chemotherapy regimen has component Teniposide	NCI
C9928	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C12135	STY	Therapeutic or Preventive Procedure		NCI
C12135	PT	gp100 Antigen/Interleukin-12/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide		NCI
C12135	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12135	RO	chemotherapy regimen has component Sargramostim	NCI
C12135	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C12135	RO	chemotherapy regimen has component gp100 Antigen	NCI
C12135	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C12135	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C12135	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C113828	STY	Therapeutic or Preventive Procedure		NCI
C113828	PT	Bortezomib/Dexamethasone/Pegylated Liposomal Doxorubicin Regimen		NCI
C113828	SY	DVD		NCI
C113828	SY	Velcade/Doxil/Dexamethasone		NCI
C113828	SY	VDD		NCI
C113828	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C113828	RO	chemotherapy regimen has component Dexamethasone	NCI
C113828	RO	chemotherapy regimen has component Bortezomib	NCI
C113828	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C63587	STY	Therapeutic or Preventive Procedure		NCI
C63587	PT	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm		NCI
C63587	CHD	Chemotherapy Regimen	NCI
C63587	PAR	PF Regimen	NCI
C63587	PAR	TIP Regimen	NCI
C63587	PAR	TIC Regimen	NCI
C63587	PAR	Carboplatin/Cetuximab Regimen	NCI
C63587	PAR	Carboplatin/Fluorouracil/Cetuximab Regimen	NCI
C63587	PAR	Cisplatin/Fluorouracil/Cetuximab Regimen	NCI
C63587	PAR	CABO Regimen	NCI
C63587	PAR	Cisplatin-Taxol Regimen	NCI
C63587	PAR	Carboplatin-Taxol Regimen	NCI
C63587	PAR	Cisplatin-Cetuximab Regimen	NCI
C63587	PAR	Docetaxel-Cisplatin Regimen	NCI
C63587	PAR	PFL Regimen	NCI
C63587	PAR	TPF Regimen	NCI
C63587	PAR	Cisplatin/Fluorouracil Regimen	NCI
C63587	PAR	Cisplatin/Docetaxel/Cetuximab Regimen	NCI
C63587	PAR	Carboplatin/Docetaxel/Cetuximab Regimen	NCI
C63587	PAR	Cisplatin/Paclitaxel/Cetuximab Regimen	NCI
C63587	PAR	Carboplatin/Paclitaxel/Nivolumab Regimen	NCI
C9642	STY	Therapeutic or Preventive Procedure		NCI
C9642	PT	Cyclophosphamide/Dactinomycin/Vincristine		NCI
C9642	SY	CTX/DACT/VCR		NCI
C9642	SY	VAC		NCI
C9642	SY	VAC (CTX/DACT/VCR)		NCI
C9642	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9642	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9642	RO	chemotherapy regimen has component Dactinomycin	NCI
C9642	RO	chemotherapy regimen has component Vincristine	NCI
C10018	STY	Therapeutic or Preventive Procedure		NCI
C10018	PT	Dianhydrogalactitol/Etoposide		NCI
C10018	SY	DV		NCI
C10018	SY	DAG/VP-16		NCI
C10018	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10018	RO	chemotherapy regimen has component Dianhydrogalactitol	NCI
C10018	RO	chemotherapy regimen has component Etoposide	NCI
C9950	STY	Therapeutic or Preventive Procedure		NCI
C9950	PT	Dapsone/Trimetrexate Glucuronate		NCI
C9950	SY	dapsone/TMTX		NCI
C9950	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9950	RO	chemotherapy regimen has component Dapsone	NCI
C9950	RO	chemotherapy regimen has component Trimetrexate Glucuronate	NCI
C37830	STY	Therapeutic or Preventive Procedure		NCI
C37830	PT	Methotrexate/Mycophenolate Mofetil/Tacrolimus		NCI
C37830	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37830	RO	chemotherapy regimen has component Methotrexate	NCI
C37830	RO	chemotherapy regimen has component Tacrolimus	NCI
C37830	RO	chemotherapy regimen has component Mycophenolate Mofetil	NCI
C12025	STY	Therapeutic or Preventive Procedure		NCI
C12025	PT	Bevacizumab/Docetaxel/Doxorubicin		NCI
C12025	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12025	RO	chemotherapy regimen has component Doxorubicin	NCI
C12025	RO	chemotherapy regimen has component Docetaxel	NCI
C12025	RO	chemotherapy regimen has component Bevacizumab	NCI
C10352	STY	Therapeutic or Preventive Procedure		NCI
C10352	PT	Edatrexate/Mitomycin/Vinblastine		NCI
C10352	SY	EDAM/MITO/VBL		NCI
C10352	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10352	RO	chemotherapy regimen has component Mitomycin	NCI
C10352	RO	chemotherapy regimen has component Vinblastine	NCI
C10352	RO	chemotherapy regimen has component Edatrexate	NCI
C63755	STY	Therapeutic or Preventive Procedure		NCI
C63755	PT	FCR Regimen		NCI
C63755	CHD	Chemotherapy Regimen Used to Treat Chronic Lymphocytic Leukemia	NCI
C63755	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63755	RO	regimen has accepted use for disease Chronic Lymphocytic Leukemia	NCI
C63755	RO	chemotherapy regimen has component Fludarabine	NCI
C63755	RO	chemotherapy regimen has component Rituximab	NCI
C11084	STY	Therapeutic or Preventive Procedure		NCI
C11084	PT	Cisplatin/Dacarbazine/Interferon Alfa/interleukin-2		NCI
C11084	SY	CDDP/DTIC/IFN-A/IL-2		NCI
C11084	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11084	RO	chemotherapy regimen has component Cisplatin	NCI
C11084	RO	chemotherapy regimen has component Dacarbazine	NCI
C11084	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11084	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10338	STY	Therapeutic or Preventive Procedure		NCI
C10338	PT	Carmustine/Methotrexate		NCI
C10338	SY	BCNU/MTX		NCI
C10338	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10338	RO	chemotherapy regimen has component Carmustine	NCI
C10338	RO	chemotherapy regimen has component Methotrexate	NCI
C10212	STY	Therapeutic or Preventive Procedure		NCI
C10212	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Thiotepa/Vinblastine		NCI
C10212	SY	CTX/DOX/5-FU/FXM/TSPA/VBL		NCI
C10212	SY	CAF/TsAVbH		NCI
C10212	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10212	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10212	RO	chemotherapy regimen has component Doxorubicin	NCI
C10212	RO	chemotherapy regimen has component Fluorouracil	NCI
C10212	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C10212	RO	chemotherapy regimen has component Thiotepa	NCI
C10212	RO	chemotherapy regimen has component Vinblastine	NCI
C10459	STY	Therapeutic or Preventive Procedure		NCI
C10459	PT	Fluorouracil/Leucovorin Calcium/Mitoxantrone/Vincristine		NCI
C10459	SY	CF/DHAD/5-FU/VCR		NCI
C10459	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10459	RO	chemotherapy regimen has component Fluorouracil	NCI
C10459	RO	chemotherapy regimen has component Vincristine	NCI
C10459	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10459	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37856	STY	Therapeutic or Preventive Procedure		NCI
C37856	PT	Sulindac/Tamoxifen		NCI
C37856	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37856	RO	chemotherapy regimen has component Sulindac	NCI
C37856	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10735	STY	Therapeutic or Preventive Procedure		NCI
C10735	PT	Methotrexate/Zidovudine		NCI
C10735	SY	MTX/ZDV		NCI
C10735	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10735	RO	chemotherapy regimen has component Methotrexate	NCI
C10735	RO	chemotherapy regimen has component Zidovudine	NCI
C63438	STY	Therapeutic or Preventive Procedure		NCI
C63438	PT	EVA-ChlVPP Regimen		NCI
C63438	SY	Etoposide-Vincristine-Adriamycin-Chlorambucil-Vinblastine-Procarbazine-Prednisone Regimen		NCI
C63438	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63438	RO	chemotherapy regimen has component Chlorambucil	NCI
C63438	RO	chemotherapy regimen has component Doxorubicin	NCI
C63438	RO	chemotherapy regimen has component Etoposide	NCI
C63438	RO	chemotherapy regimen has component Prednisone	NCI
C63438	RO	chemotherapy regimen has component Vinblastine	NCI
C63438	RO	chemotherapy regimen has component Vincristine	NCI
C63438	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C63438	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C11074	STY	Therapeutic or Preventive Procedure		NCI
C11074	PT	Fluorouracil/Interferon Alfa/Leucovorin Calcium/Raltitrexed		NCI
C11074	SY	CF/5-FU/ICI D1694/IFN-A		NCI
C11074	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11074	RO	chemotherapy regimen has component Fluorouracil	NCI
C11074	RO	chemotherapy regimen has component Raltitrexed	NCI
C11074	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11074	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9985	STY	Therapeutic or Preventive Procedure		NCI
C9985	PT	Carboplatin/Etoposide/Sargramostim		NCI
C9985	SY	CBDCA/GM-CSF/VP-16		NCI
C9985	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9985	RO	chemotherapy regimen has component Etoposide	NCI
C9985	RO	chemotherapy regimen has component Carboplatin	NCI
C9985	RO	chemotherapy regimen has component Sargramostim	NCI
C9639	STY	Therapeutic or Preventive Procedure		NCI
C9639	PT	Bleomycin/Cisplatin/Dactinomycin/Vinblastine		NCI
C9639	SY	BLEO/CDDP/DACT/VBL		NCI
C9639	SY	VAB-II		NCI
C9639	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9639	RO	chemotherapy regimen has component Bleomycin	NCI
C9639	RO	chemotherapy regimen has component Cisplatin	NCI
C9639	RO	chemotherapy regimen has component Dactinomycin	NCI
C9639	RO	chemotherapy regimen has component Vinblastine	NCI
C9994	STY	Therapeutic or Preventive Procedure		NCI
C9994	PT	Azacitidine/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine		NCI
C9994	SY	Azacytidine/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine		NCI
C9994	SY	ARA-C/AZA/CTX/TG/VCR		NCI
C9994	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9994	RO	chemotherapy regimen has component Azacitidine	NCI
C9994	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9994	RO	chemotherapy regimen has component Cytarabine	NCI
C9994	RO	chemotherapy regimen has component Thioguanine	NCI
C9994	RO	chemotherapy regimen has component Vincristine	NCI
C11271	STY	Therapeutic or Preventive Procedure		NCI
C11271	PT	Carboplatin/filgrastim/Ifosfamide/Mesna		NCI
C11271	SY	carboplatin/filgrastim/ifosfamide/mercaptoethane sulfonate		NCI
C11271	SY	CBDCA/G-CSF/IFF/mesna		NCI
C11271	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11271	RO	chemotherapy regimen has component Mesna	NCI
C11271	RO	chemotherapy regimen has component Ifosfamide	NCI
C11271	RO	chemotherapy regimen has component Carboplatin	NCI
C11271	RO	chemotherapy regimen has component Filgrastim	NCI
C9942	STY	Therapeutic or Preventive Procedure		NCI
C9942	PT	Bleomycin/Doxorubicin/Prednisone		NCI
C9942	SY	BAP		NCI
C9942	SY	BLEO/DOX/PRED		NCI
C9942	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9942	RO	chemotherapy regimen has component Bleomycin	NCI
C9942	RO	chemotherapy regimen has component Doxorubicin	NCI
C9942	RO	chemotherapy regimen has component Prednisone	NCI
C10182	STY	Therapeutic or Preventive Procedure		NCI
C10182	PT	Etoposide/Ifosfamide		NCI
C10182	SY	EIM		NCI
C10182	SY	IFF/VP-16		NCI
C10182	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10182	RO	chemotherapy regimen has component Etoposide	NCI
C10182	RO	chemotherapy regimen has component Ifosfamide	NCI
C136246	STY	Therapeutic or Preventive Procedure		NCI
C136246	PT	FOLFOX/Cetuximab Regimen		NCI
C136246	SY	FOLFOX Plus Erbitux		NCI
C136246	SY	FOLFOX/Cetuximab		NCI
C136246	SY	FOLFOX/Erbitux Regimen		NCI
C136246	SY	Leucovorin/Fluorouracil/Oxaliplatin/Cetuximab		NCI
C136246	SY	FOLFOX-Cetuximab Regimen		NCI
C136246	SY	FOLFOX Plus Cetuximab		NCI
C136246	SY	FOLFOX-Cetuximab		NCI
C136246	SY	Folinic Acid/Fluorouracil/Oxaliplatin/Cetuximab Regimen		NCI
C136246	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136246	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136246	RO	chemotherapy regimen has component Fluorouracil	NCI
C136246	RO	chemotherapy regimen has component Oxaliplatin	NCI
C136246	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C136246	RO	chemotherapy regimen has component Cetuximab	NCI
C9972	STY	Therapeutic or Preventive Procedure		NCI
C9972	PT	Doxorubicin/Fluorouracil/Methotrexate/Prednisone/Thiotepa/Vinblastine		NCI
C9972	SY	VTMAFP		NCI
C9972	SY	DOX/5-FU/MTX/PRED/TSPA/VBL		NCI
C9972	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9972	RO	chemotherapy regimen has component Doxorubicin	NCI
C9972	RO	chemotherapy regimen has component Fluorouracil	NCI
C9972	RO	chemotherapy regimen has component Methotrexate	NCI
C9972	RO	chemotherapy regimen has component Prednisone	NCI
C9972	RO	chemotherapy regimen has component Thiotepa	NCI
C9972	RO	chemotherapy regimen has component Vinblastine	NCI
C11554	STY	Therapeutic or Preventive Procedure		NCI
C11554	PT	Asparaginase/Prednisone/Vincristine		NCI
C11554	SY	VPL		NCI
C11554	SY	PVA		NCI
C11554	SY	VLP		NCI
C11554	SY	ASP/PRED/VCR		NCI
C11554	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11554	RO	chemotherapy regimen has component Asparaginase	NCI
C11554	RO	chemotherapy regimen has component Prednisone	NCI
C11554	RO	chemotherapy regimen has component Vincristine	NCI
C9679	STY	Therapeutic or Preventive Procedure		NCI
C9679	PT	Cyclophosphamide/Doxorubicin/Etoposide/Mechlorethamine/Methotrexate/Prednisone/Procarbazine/Vincristine		NCI
C9679	SY	CTX/DOX/MTX/NM/PCB/PRED/VCR/VP-16		NCI
C9679	SY	ProMACE/MOPP		NCI
C9679	SY	ProMACE-MOPP		NCI
C9679	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9679	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9679	RO	chemotherapy regimen has component Doxorubicin	NCI
C9679	RO	chemotherapy regimen has component Etoposide	NCI
C9679	RO	chemotherapy regimen has component Methotrexate	NCI
C9679	RO	chemotherapy regimen has component Prednisone	NCI
C9679	RO	chemotherapy regimen has component Vincristine	NCI
C9679	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9679	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C11302	STY	Therapeutic or Preventive Procedure		NCI
C11302	PT	Amifostine/Ciprofloxacin/Dexamethasone/Pentoxifylline		NCI
C11302	SY	CPFX/DM/PTX/WR-2721		NCI
C11302	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11302	RO	chemotherapy regimen has component Ciprofloxacin	NCI
C11302	RO	chemotherapy regimen has component Dexamethasone	NCI
C11302	RO	chemotherapy regimen has component Amifostine	NCI
C11302	RO	chemotherapy regimen has component Pentoxifylline	NCI
C67159	STY	Therapeutic or Preventive Procedure		NCI
C67159	PT	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma		NCI
C67159	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C67159	PAR	OPPA Regimen	NCI
C67159	PAR	VAMP Regimen	NCI
C67159	PAR	Vinorelbine-Gemcitabine Regimen	NCI
C67159	PAR	ABVE Regimen	NCI
C67159	PAR	APE Regimen	NCI
C67159	PAR	COPP-ABV Regimen	NCI
C67159	PAR	DBVE-PC Regimen	NCI
C67159	PAR	DECA Regimen	NCI
C67159	PAR	IEP-ABVD-COPP Regimen	NCI
C67159	PAR	OEPA-COPP Regimen	NCI
C67159	PAR	OEPA Regimen	NCI
C67159	PAR	OPPA-COPP Regimen	NCI
C67159	PAR	ST-HD-86 Regimen	NCI
C67159	PAR	COPDAC Regimen	NCI
C11557	STY	Therapeutic or Preventive Procedure		NCI
C11557	PT	Amikacin/Ceftriaxone		NCI
C11557	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11557	RO	chemotherapy regimen has component Amikacin Sulfate	NCI
C11557	RO	chemotherapy regimen has component Ceftriaxone Sodium	NCI
C37701	STY	Therapeutic or Preventive Procedure		NCI
C37701	PT	Cyclophosphamide/Prednisone/Rituximab		NCI
C37701	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37701	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37701	RO	chemotherapy regimen has component Prednisone	NCI
C37701	RO	chemotherapy regimen has component Rituximab	NCI
C37661	STY	Therapeutic or Preventive Procedure		NCI
C37661	PT	Cisplatin/Gemcitabine/ISIS 3521		NCI
C37661	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37661	RO	chemotherapy regimen has component Cisplatin	NCI
C37661	RO	chemotherapy regimen has component ISIS 3521	NCI
C37661	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C141506	STY	Therapeutic or Preventive Procedure		NCI
C141506	PT	Capecitabine/Cisplatin Regimen		NCI
C141506	SY	Capecitabine-Cisplatin		NCI
C141506	SY	Xeloda-Platinol		NCI
C141506	SY	XP		NCI
C141506	SY	Capecitabine-Cisplatin Regimen		NCI
C141506	SY	Capecitabine/Cisplatin		NCI
C141506	SY	Xeloda/Platinol		NCI
C141506	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C141506	RO	chemotherapy regimen has component Cisplatin	NCI
C141506	RO	chemotherapy regimen has component Capecitabine	NCI
C10318	STY	Therapeutic or Preventive Procedure		NCI
C10318	PT	Dexamethasone/Metoclopramide/Midazolam		NCI
C10318	SY	DM/MCP/Midazolam		NCI
C10318	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10318	RO	chemotherapy regimen has component Dexamethasone	NCI
C10318	RO	chemotherapy regimen has component Midazolam Hydrochloride	NCI
C10318	RO	chemotherapy regimen has component Metoclopramide Hydrochloride	NCI
C11558	STY	Therapeutic or Preventive Procedure		NCI
C11558	PT	Azacitidine/Carboplatin		NCI
C11558	SY	Azacytidine/Carboplatin		NCI
C11558	SY	AZA/CBDCA		NCI
C11558	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11558	RO	chemotherapy regimen has component Azacitidine	NCI
C11558	RO	chemotherapy regimen has component Carboplatin	NCI
C11166	STY	Therapeutic or Preventive Procedure		NCI
C11166	PT	Fludarabine/Octreotide		NCI
C11166	SY	FAMP/SSTN		NCI
C11166	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11166	RO	chemotherapy regimen has component Octreotide	NCI
C11166	RO	chemotherapy regimen has component Fludarabine	NCI
C11674	STY	Therapeutic or Preventive Procedure		NCI
C11674	PT	gp100 Antigen/Montanide ISA-51/Sargramostim		NCI
C11674	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11674	RO	chemotherapy regimen has component Sargramostim	NCI
C11674	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11674	RO	chemotherapy regimen has component gp100 Antigen	NCI
C37542	STY	Therapeutic or Preventive Procedure		NCI
C37542	PT	Autologous Lymphocytes/Fludarabine		NCI
C37542	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37542	RO	chemotherapy regimen has component Fludarabine	NCI
C37542	RO	chemotherapy regimen has component Therapeutic Autologous Lymphocytes	NCI
C10717	STY	Therapeutic or Preventive Procedure		NCI
C10717	PT	Cisplatin/Cytarabine/Etoposide/Prednisone		NCI
C10717	SY	ARA-C/CDDP/PRED/VP-16		NCI
C10717	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10717	RO	chemotherapy regimen has component Cisplatin	NCI
C10717	RO	chemotherapy regimen has component Cytarabine	NCI
C10717	RO	chemotherapy regimen has component Etoposide	NCI
C10717	RO	chemotherapy regimen has component Prednisone	NCI
C10643	STY	Therapeutic or Preventive Procedure		NCI
C10643	PT	Asparaginase/Mercaptopurine/Methotrexate		NCI
C10643	SY	ASP/MP/MTX		NCI
C10643	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10643	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10643	RO	chemotherapy regimen has component Asparaginase	NCI
C10643	RO	chemotherapy regimen has component Methotrexate	NCI
C37569	STY	Therapeutic or Preventive Procedure		NCI
C37569	PT	Bortezomib/Dexamethasone		NCI
C37569	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37569	RO	chemotherapy regimen has component Dexamethasone	NCI
C37569	RO	chemotherapy regimen has component Bortezomib	NCI
C11793	STY	Therapeutic or Preventive Procedure		NCI
C11793	PT	Cytarabine/Daunorubicin/Etoposide/Topotecan		NCI
C11793	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11793	RO	chemotherapy regimen has component Cytarabine	NCI
C11793	RO	chemotherapy regimen has component Etoposide	NCI
C11793	RO	chemotherapy regimen has component Topotecan	NCI
C11793	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11209	STY	Therapeutic or Preventive Procedure		NCI
C11209	PT	Cisplatin/Cyclophosphamide/Cyclosporine/Paclitaxel		NCI
C11209	SY	CDDP/CTX/CYSP/TAX		NCI
C11209	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11209	RO	chemotherapy regimen has component Cisplatin	NCI
C11209	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11209	RO	chemotherapy regimen has component Cyclosporine	NCI
C11209	RO	chemotherapy regimen has component Paclitaxel	NCI
C11044	STY	Therapeutic or Preventive Procedure		NCI
C11044	PT	Interferon Alfa/Megestrol/Tamoxifen		NCI
C11044	SY	IFN-A/MEG/TMX		NCI
C11044	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11044	RO	chemotherapy regimen has component Megestrol	NCI
C11044	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11044	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9863	STY	Therapeutic or Preventive Procedure		NCI
C9863	PT	Etoposide/Mitoxantrone		NCI
C9863	SY	DHAD/VP-16		NCI
C9863	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9863	RO	chemotherapy regimen has component Etoposide	NCI
C9863	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9834	STY	Therapeutic or Preventive Procedure		NCI
C9834	PT	Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C9834	SY	DOX/MP/MTX/PRED/VCR		NCI
C9834	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9834	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9834	RO	chemotherapy regimen has component Doxorubicin	NCI
C9834	RO	chemotherapy regimen has component Methotrexate	NCI
C9834	RO	chemotherapy regimen has component Prednisone	NCI
C9834	RO	chemotherapy regimen has component Vincristine	NCI
C63419	STY	Therapeutic or Preventive Procedure		NCI
C63419	PT	Capecitabine/Docetaxel Regimen		NCI
C63419	SY	Capecitabine-Docetaxel		NCI
C63419	SY	Xeloda/Taxotere		NCI
C63419	SY	XT Regimen		NCI
C63419	SY	Capecitabine/Docetaxel		NCI
C63419	SY	Capecitabine-Docetaxel Regimen		NCI
C63419	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63419	RO	chemotherapy regimen has component Docetaxel	NCI
C63419	RO	chemotherapy regimen has component Capecitabine	NCI
C63419	RO	regimen has accepted use for disease Breast Carcinoma	NCI
C11916	STY	Therapeutic or Preventive Procedure		NCI
C11916	PT	Cyclosporine/Yttrium Y 90 Monoclonal Antibody M170		NCI
C11916	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11916	RO	chemotherapy regimen has component Cyclosporine	NCI
C11916	RO	chemotherapy regimen has component Y 90 Monoclonal Antibody m170	NCI
C12081	STY	Therapeutic or Preventive Procedure		NCI
C12081	PT	Isotretinoin/Monoclonal antibody Ch14.18/Sargramostim		NCI
C12081	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12081	RO	chemotherapy regimen has component Isotretinoin	NCI
C12081	RO	chemotherapy regimen has component Sargramostim	NCI
C12081	RO	chemotherapy regimen has component Dinutuximab	NCI
C10942	STY	Therapeutic or Preventive Procedure		NCI
C10942	PT	Cytarabine/Dexamethasone/Etoposide/Idarubicin/Ifosfamide/Methotrexate/Pegaspargase/Thioguanine/Vincristine		NCI
C10942	SY	ARA-C/DM/IDA/IFF/MTX/PEG-ASP/TG/VCR/VP-16		NCI
C10942	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10942	RO	chemotherapy regimen has component Cytarabine	NCI
C10942	RO	chemotherapy regimen has component Dexamethasone	NCI
C10942	RO	chemotherapy regimen has component Etoposide	NCI
C10942	RO	chemotherapy regimen has component Idarubicin	NCI
C10942	RO	chemotherapy regimen has component Ifosfamide	NCI
C10942	RO	chemotherapy regimen has component Methotrexate	NCI
C10942	RO	chemotherapy regimen has component Thioguanine	NCI
C10942	RO	chemotherapy regimen has component Vincristine	NCI
C10942	RO	chemotherapy regimen has component Pegaspargase	NCI
C11469	STY	Therapeutic or Preventive Procedure		NCI
C11469	PT	Carboplatin/Gemcitabine		NCI
C11469	SY	CBDCA/dFdC		NCI
C11469	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11469	RO	chemotherapy regimen has component Carboplatin	NCI
C11469	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11107	STY	Therapeutic or Preventive Procedure		NCI
C11107	PT	Floxuridine/Gemcitabine/Leucovorin Calcium		NCI
C11107	SY	CF/dFdC/FUDR		NCI
C11107	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11107	RO	chemotherapy regimen has component Floxuridine	NCI
C11107	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11107	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37562	STY	Therapeutic or Preventive Procedure		NCI
C37562	PT	Bleomycin/Cyclophosphamide/Etoposide/Mitoxantrone/Prednisolone/Rituximab/Vincristine		NCI
C37562	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37562	RO	chemotherapy regimen has component Bleomycin	NCI
C37562	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37562	RO	chemotherapy regimen has component Etoposide	NCI
C37562	RO	chemotherapy regimen has component Prednisolone	NCI
C37562	RO	chemotherapy regimen has component Vincristine	NCI
C37562	RO	chemotherapy regimen has component Rituximab	NCI
C37562	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37549	STY	Therapeutic or Preventive Procedure		NCI
C37549	PT	Beclomethasone/Methylprednisolone		NCI
C37549	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37549	RO	chemotherapy regimen has component Beclomethasone Dipropionate	NCI
C37549	RO	chemotherapy regimen has component Methylprednisolone	NCI
C63503	STY	Therapeutic or Preventive Procedure		NCI
C63503	PT	Gemcitabine-Erlotinib Regimen		NCI
C63503	SY	Gemcitabine-Tarceva Regimen		NCI
C63503	CHD	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C63503	RO	regimen has accepted use for disease Pancreatic Carcinoma	NCI
C63503	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63503	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C11327	STY	Therapeutic or Preventive Procedure		NCI
C11327	PT	Incomplete Freund's Adjuvant/Interleukin-2/Tyrosinase Related Protein-1		NCI
C11327	SY	IFA/IL-2/TRP-1		NCI
C11327	SY	Incomplete Freund's Adjuvant/Interleukin-2/Tyrosinase-Related Protein-1		NCI
C11327	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11327	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11327	RO	chemotherapy regimen has component Recombinant Tyrosinase-Related Protein-1	NCI
C11327	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11720	STY	Therapeutic or Preventive Procedure		NCI
C11720	PT	Gemcitabine/Oxaliplatin		NCI
C11720	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11720	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11720	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C9932	STY	Therapeutic or Preventive Procedure		NCI
C9932	PT	Bleomycin/Cytarabine/Prednisone/Vincristine		NCI
C9932	SY	ARA-C/BLEO/PRED/VCR		NCI
C9932	SY	OAP-BLEO		NCI
C9932	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9932	RO	chemotherapy regimen has component Bleomycin	NCI
C9932	RO	chemotherapy regimen has component Cytarabine	NCI
C9932	RO	chemotherapy regimen has component Prednisone	NCI
C9932	RO	chemotherapy regimen has component Vincristine	NCI
C67292	STY	Therapeutic or Preventive Procedure		NCI
C67292	PT	Chemotherapy Regimen Used to Treat Primary Malignant Neoplasm of Liver		NCI
C67292	SY	Chemotherapy Regimen Used to Treat Liver Cancer		NCI
C67292	CHD	Chemotherapy Regimen	NCI
C67292	PAR	Chemotherapy Regimen Used to Treat Childhood Liver Cancer	NCI
C37777	STY	Therapeutic or Preventive Procedure		NCI
C37777	PT	Flavopiridol/Fluorouracil/Leucovorin Calcium		NCI
C37777	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37777	RO	chemotherapy regimen has component Fluorouracil	NCI
C37777	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37777	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C10243	STY	Therapeutic or Preventive Procedure		NCI
C10243	PT	Fluorouracil/PALA		NCI
C10243	SY	5-FU/PALA		NCI
C10243	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10243	RO	chemotherapy regimen has component Fluorouracil	NCI
C10243	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C9916	STY	Therapeutic or Preventive Procedure		NCI
C9916	PT	Cisplatin/Novobiocin		NCI
C9916	SY	CDDP/NBC		NCI
C9916	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9916	RO	chemotherapy regimen has component Cisplatin	NCI
C9916	RO	chemotherapy regimen has component Novobiocin	NCI
C12190	STY	Therapeutic or Preventive Procedure		NCI
C12190	PT	Cytarabine/Dexamethasone/Etoposide/Filgrastim/Ifosfamide/Leucovorin Calcium/Methotrexate/Rituximab/Vincristine		NCI
C12190	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12190	RO	chemotherapy regimen has component Cytarabine	NCI
C12190	RO	chemotherapy regimen has component Dexamethasone	NCI
C12190	RO	chemotherapy regimen has component Etoposide	NCI
C12190	RO	chemotherapy regimen has component Ifosfamide	NCI
C12190	RO	chemotherapy regimen has component Methotrexate	NCI
C12190	RO	chemotherapy regimen has component Vincristine	NCI
C12190	RO	chemotherapy regimen has component Filgrastim	NCI
C12190	RO	chemotherapy regimen has component Rituximab	NCI
C12190	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11333	STY	Therapeutic or Preventive Procedure		NCI
C11333	PT	Bryostatin 1/Cladribine		NCI
C11333	SY	BRYO/2-CdA		NCI
C11333	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11333	RO	chemotherapy regimen has component Bryostatin 1	NCI
C11333	RO	chemotherapy regimen has component Cladribine	NCI
C140098	STY	Therapeutic or Preventive Procedure		NCI
C140098	PT	DeVIC Regimen		NCI
C140098	SY	DeVIC		NCI
C140098	SY	Dexamethasone/Etoposide/Ifosfamide/Carboplatin		NCI
C140098	SY	Dexamethasone-Etoposide-Ifosfamide-Carboplatin		NCI
C140098	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140098	RO	chemotherapy regimen has component Dexamethasone	NCI
C140098	RO	chemotherapy regimen has component Etoposide	NCI
C140098	RO	chemotherapy regimen has component Ifosfamide	NCI
C140098	RO	chemotherapy regimen has component Carboplatin	NCI
C37688	STY	Therapeutic or Preventive Procedure		NCI
C37688	PT	Cyclophosphamide/Epirubicin/Trastuzumab		NCI
C37688	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37688	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37688	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C37688	RO	chemotherapy regimen has component Trastuzumab	NCI
C37610	STY	Therapeutic or Preventive Procedure		NCI
C37610	PT	Carboplatin/Fluorouracil/Leucovorin Calcium		NCI
C37610	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37610	RO	chemotherapy regimen has component Fluorouracil	NCI
C37610	RO	chemotherapy regimen has component Carboplatin	NCI
C37610	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C140105	STY	Therapeutic or Preventive Procedure		NCI
C140105	PT	IVE Regimen		NCI
C140105	SY	Ifosfamide/Epirubicin/Etoposide		NCI
C140105	SY	IVE		NCI
C140105	SY	Ifosfamide-Epirubicin-Etoposide		NCI
C140105	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C140105	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140105	RO	chemotherapy regimen has component Etoposide	NCI
C140105	RO	chemotherapy regimen has component Ifosfamide	NCI
C140105	RO	chemotherapy regimen has component Vincristine	NCI
C11555	STY	Therapeutic or Preventive Procedure		NCI
C11555	PT	Cisplatin/Epirubicin		NCI
C11555	SY	CDDP/EPI		NCI
C11555	SY	Cisplatin-e therapeutic implant		NCI
C11555	SY	CDDP-e TI		NCI
C11555	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11555	RO	chemotherapy regimen has component Cisplatin	NCI
C11555	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C37782	STY	Therapeutic or Preventive Procedure		NCI
C37782	PT	Fluorouracil/Gefitinib/Leucovorin Calcium/Oxaliplatin		NCI
C37782	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37782	RO	chemotherapy regimen has component Fluorouracil	NCI
C37782	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37782	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37782	RO	chemotherapy regimen has component Gefitinib	NCI
C15614	STY	Therapeutic or Preventive Procedure		NCI
C15614	PT	interleukin-2/Monoclonal Antibody OKT3/pentoxifylline		NCI
C15614	SY	IL-2/MOAB OKT3/PTX		NCI
C15614	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15614	RO	chemotherapy regimen has component Pentoxifylline	NCI
C15614	RO	chemotherapy regimen has component Muromonab-CD3	NCI
C15614	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10136	STY	Therapeutic or Preventive Procedure		NCI
C10136	PT	Cisplatin/Etoposide/Mitoxantrone/Tamoxifen		NCI
C10136	SY	TEMP		NCI
C10136	SY	CDDP/DHAD/TMX/VP-16		NCI
C10136	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10136	RO	chemotherapy regimen has component Cisplatin	NCI
C10136	RO	chemotherapy regimen has component Etoposide	NCI
C10136	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10136	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10703	STY	Therapeutic or Preventive Procedure		NCI
C10703	PT	Fluorouracil/Triacetyluridine		NCI
C10703	SY	5-FU/TAU		NCI
C10703	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10703	RO	chemotherapy regimen has component Fluorouracil	NCI
C10703	RO	chemotherapy regimen has component Uridine Triacetate	NCI
C11599	STY	Therapeutic or Preventive Procedure		NCI
C11599	PT	KSA Glycoprotein/QS21		NCI
C11599	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11599	RO	chemotherapy regimen has component QS21	NCI
C11599	RO	chemotherapy regimen has component Recombinant KSA Glycoprotein	NCI
C63412	STY	Therapeutic or Preventive Procedure		NCI
C63412	PT	Gemcitabine-Vinorelbine Regimen		NCI
C63412	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63412	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63412	RO	chemotherapy regimen has component Vinorelbine	NCI
C63412	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10462	STY	Therapeutic or Preventive Procedure		NCI
C10462	PT	Carboplatin/Interleukin-1-Alpha		NCI
C10462	SY	CBDCA/IL-1A		NCI
C10462	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10462	RO	chemotherapy regimen has component Carboplatin	NCI
C10462	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C63524	STY	Therapeutic or Preventive Procedure		NCI
C63524	PT	Chemotherapy Regimen Used to Treat Melanoma		NCI
C63524	CHD	Chemotherapy Regimen	NCI
C63524	PAR	Dartmouth Regimen	NCI
C63524	PAR	CVD Regimen	NCI
C63524	PAR	DTIC-BCNU-Cisplatin Regimen	NCI
C63524	PAR	IFN-DTIC Regimen	NCI
C63524	PAR	Encorafenib/Binimetinib Regimen	NCI
C63524	PAR	Ipilimumab/Nivolumab Regimen	NCI
C63524	PAR	Dabrafenib/Trametinib Regimen	NCI
C63524	PAR	Vemurafenib/Cobimetinib Regimen	NCI
C63524	PAR	CVD IL-2/IFNa2b Regimen	NCI
C63524	PAR	Ipilimumab/Talimogene Laherparepvec Regimen	NCI
C37754	STY	Therapeutic or Preventive Procedure		NCI
C37754	PT	Doxorubicin/Ranpirnase		NCI
C37754	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37754	RO	chemotherapy regimen has component Doxorubicin	NCI
C37754	RO	chemotherapy regimen has component Ranpirnase	NCI
C11844	STY	Therapeutic or Preventive Procedure		NCI
C11844	PT	Cytarabine/Etoposide/Mitoxantrone/Monoclonal Antibody Hug1-M195		NCI
C11844	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11844	RO	chemotherapy regimen has component Cytarabine	NCI
C11844	RO	chemotherapy regimen has component Etoposide	NCI
C11844	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11844	RO	chemotherapy regimen has component Lintuzumab	NCI
C63765	STY	Therapeutic or Preventive Procedure		NCI
C63765	PT	EVAP Regimen		NCI
C63765	SY	Etoposide/Vinblastine/Cytarabine/Cisplatin Regimen		NCI
C63765	SY	Etoposide-Vinblastine-Ara-C-Platinol Regimen		NCI
C63765	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63765	RO	chemotherapy regimen has component Cisplatin	NCI
C63765	RO	chemotherapy regimen has component Cytarabine	NCI
C63765	RO	chemotherapy regimen has component Etoposide	NCI
C63765	RO	chemotherapy regimen has component Vinblastine	NCI
C63765	RO	regimen has accepted use for disease Refractory Hodgkin Lymphoma	NCI
C10344	STY	Therapeutic or Preventive Procedure		NCI
C10344	PT	Lomustine/Mitolactol/Procarbazine/Thioguanine		NCI
C10344	SY	CCNU/DBD/PCB/TG		NCI
C10344	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10344	RO	chemotherapy regimen has component Lomustine	NCI
C10344	RO	chemotherapy regimen has component Mitolactol	NCI
C10344	RO	chemotherapy regimen has component Thioguanine	NCI
C10344	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C136242	STY	Therapeutic or Preventive Procedure		NCI
C136242	PT	Topotecan/Paclitaxel/Bevacizumab Regimen		NCI
C136242	SY	Topotecan/Paclitaxel/Bevacizumab		NCI
C136242	SY	PACLTOPO+BEVA Regimen		NCI
C136242	SY	Topotecan-Paclitaxel-Bevacizumab Regimen		NCI
C136242	SY	Hycamtin-Taxol-Avastin Regimen		NCI
C136242	SY	TPB Regimen		NCI
C136242	SY	Topotecan-Paclitaxel-Bevacizumab		NCI
C136242	SY	Hycamtin/Taxol/Avastin Regimen		NCI
C136242	CHD	Chemotherapy Regimen Used to Treat Cervical Carcinoma	NCI
C136242	RO	chemotherapy regimen has component Paclitaxel	NCI
C136242	RO	regimen has accepted use for disease Cervical Carcinoma	NCI
C136242	RO	chemotherapy regimen has component Bevacizumab	NCI
C136242	RO	chemotherapy regimen has component Topotecan Hydrochloride	NCI
C11060	STY	Therapeutic or Preventive Procedure		NCI
C11060	PT	Fluorouracil/Hydroxyurea/Interferon Alfa		NCI
C11060	SY	5-FU/HU/IFN-A		NCI
C11060	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11060	RO	chemotherapy regimen has component Fluorouracil	NCI
C11060	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11060	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11347	STY	Therapeutic or Preventive Procedure		NCI
C11347	PT	Ifosfamide/Topotecan		NCI
C11347	SY	IFF/TOPO		NCI
C11347	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11347	RO	chemotherapy regimen has component Ifosfamide	NCI
C11347	RO	chemotherapy regimen has component Topotecan	NCI
C63445	STY	Therapeutic or Preventive Procedure		NCI
C63445	PT	PC Regimen		NCI
C63445	SY	Pentostatin-Cyclophosphamide Regimen		NCI
C63445	CHD	Chemotherapy Regimen Used to Treat Chronic Lymphocytic Leukemia	NCI
C63445	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63445	RO	chemotherapy regimen has component Pentostatin	NCI
C63445	RO	regimen has accepted use for disease Refractory Chronic Lymphocytic Leukemia	NCI
C63445	RO	regimen has accepted use for disease Recurrent Chronic Lymphocytic Leukemia	NCI
C10871	STY	Therapeutic or Preventive Procedure		NCI
C10871	PT	Filgrastim/Interleukin-6		NCI
C10871	SY	G-CSF/IL-6		NCI
C10871	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10871	RO	chemotherapy regimen has component Filgrastim	NCI
C10871	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C10228	STY	Therapeutic or Preventive Procedure		NCI
C10228	PT	Cisplatin/Paclitaxel		NCI
C10228	SY	CDDP/TAX		NCI
C10228	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10228	RO	chemotherapy regimen has component Cisplatin	NCI
C10228	RO	chemotherapy regimen has component Paclitaxel	NCI
C11531	STY	Therapeutic or Preventive Procedure		NCI
C11531	PT	Asparaginase/Cyclophosphamide/Daunorubicin/Methotrexate/Prednisolone/Vincristine		NCI
C11531	SY	ASP/CTX/DNR/MTX/PRDL/VCR		NCI
C11531	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11531	RO	chemotherapy regimen has component Asparaginase	NCI
C11531	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11531	RO	chemotherapy regimen has component Methotrexate	NCI
C11531	RO	chemotherapy regimen has component Prednisolone	NCI
C11531	RO	chemotherapy regimen has component Vincristine	NCI
C11531	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11593	STY	Therapeutic or Preventive Procedure		NCI
C11593	PT	Irinotecan/LY231514		NCI
C11593	SY	CPT-11/LY231514		NCI
C11593	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11593	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11593	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C37461	STY	Therapeutic or Preventive Procedure		NCI
C37461	PT	Autologous Dendritic Cells/MAGE-3/Melan-A/Survivin Antigen		NCI
C37461	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37461	RO	chemotherapy regimen has component Survivin Antigen	NCI
C37461	RO	chemotherapy regimen has component Therapeutic Autologous Dendritic Cells	NCI
C37461	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C37461	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C63446	STY	Therapeutic or Preventive Procedure		NCI
C63446	PT	ACVBP Regimen		NCI
C63446	SY	Adriamycin-Cytoxan-Vindesine-Bleomycin-Prednisone Regimen		NCI
C63446	SY	LNH-87		NCI
C63446	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63446	RO	chemotherapy regimen has component Bleomycin	NCI
C63446	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63446	RO	chemotherapy regimen has component Doxorubicin	NCI
C63446	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C63446	RO	chemotherapy regimen has component Prednisone	NCI
C63446	RO	chemotherapy regimen has component Vindesine	NCI
C12083	STY	Therapeutic or Preventive Procedure		NCI
C12083	PT	Fluorouracil/Irinotecan/Leucovorin Calcium/ZD 1839		NCI
C12083	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12083	RO	chemotherapy regimen has component Fluorouracil	NCI
C12083	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C12083	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12083	RO	chemotherapy regimen has component Gefitinib	NCI
C11323	STY	Therapeutic or Preventive Procedure		NCI
C11323	PT	Incomplete Freund's Adjuvant/Interleukin-2/Tyrosinase Peptide		NCI
C11323	SY	IFA/IL-2/TYRP		NCI
C11323	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11323	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11323	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11323	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12094	STY	Therapeutic or Preventive Procedure		NCI
C12094	PT	NY-ESO-1 peptide vaccine/Sargramostim		NCI
C12094	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12094	RO	chemotherapy regimen has component Sargramostim	NCI
C12094	RO	chemotherapy regimen has component NY-ESO-1 Peptide Vaccine	NCI
C11168	STY	Therapeutic or Preventive Procedure		NCI
C11168	PT	BCG/Dacarbazine		NCI
C11168	SY	BCG/DTIC		NCI
C11168	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11168	RO	chemotherapy regimen has component BCG Vaccine	NCI
C11168	RO	chemotherapy regimen has component Dacarbazine	NCI
C113827	STY	Therapeutic or Preventive Procedure		NCI
C113827	PT	Bortezomib/Dexamethasone/Lenalidomide Regimen		NCI
C113827	SY	RVD		NCI
C113827	SY	Velcade/Revlimid/Dexamethasone		NCI
C113827	SY	VRD		NCI
C113827	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C113827	RO	chemotherapy regimen has component Dexamethasone	NCI
C113827	RO	chemotherapy regimen has component Lenalidomide	NCI
C113827	RO	chemotherapy regimen has component Bortezomib	NCI
C10171	STY	Therapeutic or Preventive Procedure		NCI
C10171	PT	Bleomycin/Cyclophosphamide/Methotrexate/Vincristine		NCI
C10171	SY	BLEO/CTX/MTX/VCR		NCI
C10171	SY	COMB		NCI
C10171	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10171	RO	chemotherapy regimen has component Bleomycin	NCI
C10171	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10171	RO	chemotherapy regimen has component Methotrexate	NCI
C10171	RO	chemotherapy regimen has component Vincristine	NCI
C15442	STY	Therapeutic or Preventive Procedure		NCI
C15442	PT	Interleukin-2/Zidovudine		NCI
C15442	SY	IL-2/ZDV		NCI
C15442	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15442	RO	chemotherapy regimen has component Zidovudine	NCI
C15442	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10101	STY	Therapeutic or Preventive Procedure		NCI
C10101	PT	Lomustine/Methotrexate/Vincristine		NCI
C10101	SY	CCNU/MTX/VCR		NCI
C10101	SY	CcOM		NCI
C10101	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10101	RO	chemotherapy regimen has component Lomustine	NCI
C10101	RO	chemotherapy regimen has component Methotrexate	NCI
C10101	RO	chemotherapy regimen has component Vincristine	NCI
C12059	STY	Therapeutic or Preventive Procedure		NCI
C12059	PT	Dacarbazine/Doxorubicin/Ifosfamide/SU5416		NCI
C12059	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12059	RO	chemotherapy regimen has component Dacarbazine	NCI
C12059	RO	chemotherapy regimen has component Doxorubicin	NCI
C12059	RO	chemotherapy regimen has component Ifosfamide	NCI
C12059	RO	chemotherapy regimen has component Semaxanib	NCI
C9883	STY	Therapeutic or Preventive Procedure		NCI
C9883	PT	Cytarabine/Daunorubicin/Etoposide/Sargramostim		NCI
C9883	SY	ARA-C/DNR/GM-CSF/VP-16		NCI
C9883	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9883	RO	chemotherapy regimen has component Cytarabine	NCI
C9883	RO	chemotherapy regimen has component Etoposide	NCI
C9883	RO	chemotherapy regimen has component Sargramostim	NCI
C9883	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C156263	STY	Therapeutic or Preventive Procedure		NCI
C156263	PT	Doxorubicin/Cyclophosphamide/Tamoxifen Regimen		NCI
C156263	SY	Adriamycin/Cyclophosphamide/Tamoxifen		NCI
C156263	SY	Doxorubicin-Cyclophosphamide-Tamoxifen		NCI
C156263	SY	Doxorubicin/Cyclophosphamide/Tamoxifen		NCI
C156263	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156263	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C156263	RO	chemotherapy regimen has component Doxorubicin	NCI
C156263	RO	chemotherapy regimen has component Tamoxifen	NCI
C67175	STY	Therapeutic or Preventive Procedure		NCI
C67175	PT	DBVE-PC Regimen		NCI
C67175	SY	DBVE-PC		NCI
C67175	SY	ABVE-PC Regimen		NCI
C67175	SY	POG 9245 Regimen		NCI
C67175	SY	Adriamycin-Bleomycin-Vincristine-Etoposide/Prednisone-Cyclophosphamide Regimen		NCI
C67175	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67175	RO	chemotherapy regimen has component Bleomycin	NCI
C67175	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67175	RO	chemotherapy regimen has component Doxorubicin	NCI
C67175	RO	chemotherapy regimen has component Etoposide	NCI
C67175	RO	chemotherapy regimen has component Prednisone	NCI
C67175	RO	chemotherapy regimen has component Vincristine	NCI
C67175	RO	regimen has accepted use for disease Childhood Hodgkin Lymphoma	NCI
C10063	STY	Therapeutic or Preventive Procedure		NCI
C10063	PT	Cyclophosphamide/Doxorubicin/Ethinyl Estradiol/Fluorouracil/Leucovorin Calcium		NCI
C10063	SY	CF/CTX/DOX/ethinyl estradiol/5-FU		NCI
C10063	SY	CALF-E		NCI
C10063	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10063	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10063	RO	chemotherapy regimen has component Doxorubicin	NCI
C10063	RO	chemotherapy regimen has component Ethinyl Estradiol	NCI
C10063	RO	chemotherapy regimen has component Fluorouracil	NCI
C10063	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12205	STY	Therapeutic or Preventive Procedure		NCI
C12205	PT	Carboplatin/Exisulind/Gemcitabine		NCI
C12205	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12205	RO	chemotherapy regimen has component Exisulind	NCI
C12205	RO	chemotherapy regimen has component Carboplatin	NCI
C12205	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11278	STY	Therapeutic or Preventive Procedure		NCI
C11278	PT	Flavopiridol/Paclitaxel		NCI
C11278	SY	FLAVO/TAX		NCI
C11278	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11278	RO	chemotherapy regimen has component Paclitaxel	NCI
C11278	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C37821	STY	Therapeutic or Preventive Procedure		NCI
C37821	PT	Irinotecan/Pemetrexed Disodium		NCI
C37821	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37821	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37821	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C10618	STY	Therapeutic or Preventive Procedure		NCI
C10618	PT	Cyclophosphamide/Cytarabine/Pegaspargase		NCI
C10618	SY	ARA-C/CTX/PEG-ASP		NCI
C10618	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10618	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10618	RO	chemotherapy regimen has component Cytarabine	NCI
C10618	RO	chemotherapy regimen has component Pegaspargase	NCI
C11651	STY	Therapeutic or Preventive Procedure		NCI
C11651	PT	gp100 Antigen/Montanide ISA-51/Tyrosinase Peptide		NCI
C11651	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11651	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11651	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11651	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11040	STY	Therapeutic or Preventive Procedure		NCI
C11040	PT	Chlorambucil/Interferon Alfa		NCI
C11040	SY	CLB/IFN-A		NCI
C11040	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11040	RO	chemotherapy regimen has component Chlorambucil	NCI
C11040	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C12127	STY	Therapeutic or Preventive Procedure		NCI
C12127	PT	Carboplatin/Erlotinib		NCI
C12127	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12127	RO	chemotherapy regimen has component Carboplatin	NCI
C12127	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C9939	STY	Therapeutic or Preventive Procedure		NCI
C9939	PT	Fluorouracil/Interleukin-2/Leucovorin Calcium		NCI
C9939	SY	CF/5-FU/IL-2		NCI
C9939	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9939	RO	chemotherapy regimen has component Fluorouracil	NCI
C9939	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9939	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10700	STY	Therapeutic or Preventive Procedure		NCI
C10700	PT	Interleukin-2/Macrophage Colony-Stimulating Factor		NCI
C10700	SY	IL-2/M-CSF		NCI
C10700	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10700	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10700	RO	chemotherapy regimen has component Recombinant Macrophage Colony-Stimulating Factor	NCI
C9580	STY	Therapeutic or Preventive Procedure		NCI
C9580	PT	Doxorubicin/Fluoxymesterone/Mitolactol/Vincristine		NCI
C9580	SY	DAVCH		NCI
C9580	SY	DBD/DOX/FXM/VCR		NCI
C9580	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9580	RO	chemotherapy regimen has component Doxorubicin	NCI
C9580	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C9580	RO	chemotherapy regimen has component Mitolactol	NCI
C9580	RO	chemotherapy regimen has component Vincristine	NCI
C11755	STY	Therapeutic or Preventive Procedure		NCI
C11755	PT	Tariquidar/Vinorelbine		NCI
C11755	SY	Vinorelbine/XR9576		NCI
C11755	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11755	RO	chemotherapy regimen has component Vinorelbine	NCI
C11755	RO	chemotherapy regimen has component Tariquidar	NCI
C9856	STY	Therapeutic or Preventive Procedure		NCI
C9856	PT	Fluorouracil/Methotrexate/Tamoxifen		NCI
C9856	SY	5-FU/MTX/TMX		NCI
C9856	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9856	RO	chemotherapy regimen has component Fluorouracil	NCI
C9856	RO	chemotherapy regimen has component Methotrexate	NCI
C9856	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10640	STY	Therapeutic or Preventive Procedure		NCI
C10640	PT	Etoposide/Procarbazine/Vincristine		NCI
C10640	SY	PCB/VCR/VP-16		NCI
C10640	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10640	RO	chemotherapy regimen has component Etoposide	NCI
C10640	RO	chemotherapy regimen has component Vincristine	NCI
C10640	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C63358	STY	Therapeutic or Preventive Procedure		NCI
C63358	PT	Chemotherapy Regimen Used to Treat Breast Carcinoma		NCI
C63358	CHD	Chemotherapy Regimen	NCI
C63358	PAR	CAF Regimen	NCI
C63358	PAR	FEC Regimen	NCI
C63358	PAR	CEF Regimen	NCI
C63358	PAR	CMF Regimen	NCI
C63358	PAR	Lapatinib/Trastuzumab Regimen	NCI
C63358	PAR	Capecitabine/Trastuzumab Regimen	NCI
C63358	PAR	A-CMF Regimen	NCI
C63358	PAR	A-T-C Regimen	NCI
C63358	PAR	AC-T-T Regimen	NCI
C63358	PAR	AC-T Regimen	NCI
C63358	PAR	AC Regimen	NCI
C63358	PAR	AT Regimen	NCI
C63358	PAR	Capecitabine/Docetaxel Regimen	NCI
C63358	PAR	Doxorubicin-Docetaxel Regimen	NCI
C63358	PAR	E-CMF Regimen	NCI
C63358	PAR	EC Breast Regimen	NCI
C63358	PAR	GT Regimen	NCI
C63358	PAR	PCH Regimen	NCI
C63358	PAR	TAC Regimen	NCI
C63358	PAR	TCH Regimen	NCI
C63358	PAR	Vinorelbine-Epirubicin Regimen	NCI
C63358	PAR	FAC Regimen	NCI
C63358	PAR	Trastuzumab/Vinorelbine Regimen	NCI
C63358	PAR	Docetaxel/Trastuzumab Regimen	NCI
C63358	PAR	TC Regimen	NCI
C63358	PAR	Paclitaxel/Trastuzumab Regimen	NCI
C63358	PAR	Carboplatin/Gemcitabine Regimen	NCI
C63358	PAR	Bevacizumab/Paclitaxel Regimen	NCI
C63358	PAR	Carboplatin/Paclitaxel/Trastuzumab Regimen	NCI
C63358	PAR	AC Followed by Docetaxel Regimen	NCI
C63358	PAR	Capecitabine/Methotrexate/Vinorelbine Regimen	NCI
C63358	PAR	AC Followed by Docetaxel/Trastuzumab Regimen	NCI
C63358	PAR	AC Followed by Pertuzumab/Trastuzumab/Docetaxel Regimen	NCI
C63358	PAR	AC Followed by Pertuzumab/Trastuzumab/Paclitaxel Regimen	NCI
C63358	PAR	Docetaxel/Cyclophosphamide/Trastuzumab Regimen	NCI
C63358	PAR	Dose-dense AC Regimen	NCI
C63358	PAR	Dose-dense AC Followed by Paclitaxel/Trastuzumab Regimen	NCI
C63358	PAR	Dose-dense AC Followed by Paclitaxel Regimen	NCI
C63358	PAR	FEC Followed by Pertuzumab/Trastuzumab/Docetaxel Regimen	NCI
C63358	PAR	FEC Followed by Pertuzumab/Trastuzumab/Paclitaxel Regimen	NCI
C63358	PAR	Lapatinib/Capecitabine Regimen	NCI
C63358	PAR	Pertuzumab/Trastuzumab Regimen	NCI
C63358	PAR	Pertuzumab/Trastuzumab/Docetaxel Regimen	NCI
C63358	PAR	Pertuzumab/Trastuzumab/Docetaxel Followed by FEC Regimen	NCI
C63358	PAR	Pertuzumab/Trastuzumab/Paclitaxel Regimen	NCI
C63358	PAR	Pertuzumab/Trastuzumab/Paclitaxel Followed by FEC Regimen	NCI
C63358	PAR	Docetaxel/Carboplatin/Trastuzumab/Pertuzumab Regimen	NCI
C63358	PAR	Dose-dense AC Followed by Dose-Dense Paclitaxel Regimen	NCI
C63358	PAR	Lapatinib/Letrozole Regimen	NCI
C63358	PAR	Everolimus/Exemestane Regimen	NCI
C63358	PAR	Letrozole/Palbociclib Regimen	NCI
C63358	PAR	Fulvestrant/Trastuzumab Regimen	NCI
C63358	PAR	Tamoxifen/Trastuzumab Regimen	NCI
C63358	PAR	Ixabepilone/Trastuzumab Regimen	NCI
C63358	PAR	Gemcitabine/Cisplatin/Everolimus Regimen	NCI
C63358	PAR	Tamoxifen/Anastrozole Regimen	NCI
C63358	PAR	Anastrozole/Lapatinib Regimen	NCI
C63358	PAR	Anastrozole/Lapatinib/Trastuzumab Regimen	NCI
C63358	PAR	Doxorubicin/Cyclophosphamide/Tamoxifen Regimen	NCI
C63358	PAR	Everolimus/Fulvestrant Regimen	NCI
C63358	PAR	Exemestane/Lapatinib/Trastuzumab Regimen	NCI
C63358	PAR	Exemestane/Lapatinib Regimen	NCI
C63358	PAR	Lapatinib/Letrozole/Trastuzumab Regimen	NCI
C63358	PAR	Letrozole/Trastuzumab Regimen	NCI
C63358	PAR	Docetaxel/Vandetanib Regimen	NCI
C63358	PAR	Eribulin/Trastuzumab Regimen	NCI
C63358	PAR	Cyclophosphamide/Trastuzumab Regimen	NCI
C63358	PAR	Cisplatin/Trastuzumab Regimen	NCI
C63358	PAR	Exemestane/Palbociclib Regimen	NCI
C63358	PAR	Fulvestrant/Palbociclib Regimen	NCI
C63358	PAR	Anastrozole/Ribociclib Regimen	NCI
C63358	PAR	Exemestane/Ribociclib Regimen	NCI
C63358	PAR	Trastuzumab/Nab-paclitaxel Regimen	NCI
C63358	PAR	Carboplatin/Trastuzumab Regimen	NCI
C63358	PAR	Tamoxifen/Ribociclib Regimen	NCI
C63358	PAR	Fulvestrant/Ribociclib Regimen	NCI
C63358	PAR	Abemaciclib/Letrozole Regimen	NCI
C63358	PAR	Abemaciclib/Exemestane Regimen	NCI
C63358	PAR	Abemaciclib/Anastrozole Regimen	NCI
C63358	PAR	Trastuzumab/Pertuzumab/Vinorelbine Regimen	NCI
C63358	PAR	Abemaciclib/Fulvestrant Regimen	NCI
C63358	PAR	Everolimus/Tamoxifen Regimen	NCI
C63358	PAR	Anastrozole/Palbociclib Regimen	NCI
C37502	STY	Therapeutic or Preventive Procedure		NCI
C37502	PT	DHA-Paclitaxel/Gemcitabine		NCI
C37502	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37502	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37502	RO	chemotherapy regimen has component DHA-Paclitaxel	NCI
C15562	STY	Therapeutic or Preventive Procedure		NCI
C15562	PT	Interleukin-3/Melphalan		NCI
C15562	SY	IL-3/L-PAM		NCI
C15562	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C15562	RO	chemotherapy regimen has component Melphalan	NCI
C15562	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C67213	STY	Therapeutic or Preventive Procedure		NCI
C67213	PT	HM91 Regimen		NCI
C67213	SY	SFOP-HM91 Regimen		NCI
C67213	SY	HM91		NCI
C67213	SY	COP-COPADM-VEBBP-Sequence I Regimen		NCI
C67213	CHD	Chemotherapy Regimen Used to Treat Childhood Non-Hodgkin's Lymphoma	NCI
C67213	RO	chemotherapy regimen has component Bleomycin	NCI
C67213	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67213	RO	chemotherapy regimen has component Doxorubicin	NCI
C67213	RO	chemotherapy regimen has component Etoposide	NCI
C67213	RO	chemotherapy regimen has component Methotrexate	NCI
C67213	RO	chemotherapy regimen has component Prednisone	NCI
C67213	RO	chemotherapy regimen has component Vinblastine	NCI
C67213	RO	chemotherapy regimen has component Vincristine	NCI
C67213	RO	regimen has accepted use for disease Childhood Anaplastic Large Cell Lymphoma	NCI
C10313	STY	Therapeutic or Preventive Procedure		NCI
C10313	PT	Cyclophosphamide/Vincristine		NCI
C10313	SY	CTX/VCR		NCI
C10313	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10313	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10313	RO	chemotherapy regimen has component Vincristine	NCI
C37731	STY	Therapeutic or Preventive Procedure		NCI
C37731	PT	Dexamethasone/Fludarabine/Pixantrone/Rituximab		NCI
C37731	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37731	RO	chemotherapy regimen has component Dexamethasone	NCI
C37731	RO	chemotherapy regimen has component Fludarabine	NCI
C37731	RO	chemotherapy regimen has component Pixantrone	NCI
C37731	RO	chemotherapy regimen has component Rituximab	NCI
C11900	STY	Therapeutic or Preventive Procedure		NCI
C11900	PT	Monoclonal antibody 11D10 anti-idiotype vaccine/Monoclonal antibody 3H1 anti-idiotype vaccine		NCI
C11900	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11900	RO	chemotherapy regimen has component Monoclonal Antibody 3H1 Anti-Idiotype Vaccine	NCI
C11900	RO	chemotherapy regimen has component Monoclonal Antibody 11D10 Anti-Idiotype Vaccine	NCI
C9948	STY	Therapeutic or Preventive Procedure		NCI
C9948	PT	Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Vincristine		NCI
C9948	SY	ARA-C/ASP/CTX/MP/VCR		NCI
C9948	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9948	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9948	RO	chemotherapy regimen has component Asparaginase	NCI
C9948	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9948	RO	chemotherapy regimen has component Cytarabine	NCI
C9948	RO	chemotherapy regimen has component Vincristine	NCI
C10784	STY	Therapeutic or Preventive Procedure		NCI
C10784	PT	Fazarabine/Filgrastim		NCI
C10784	SY	ARA-AC/G-CSF		NCI
C10784	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10784	RO	chemotherapy regimen has component Fazarabine	NCI
C10784	RO	chemotherapy regimen has component Filgrastim	NCI
C10831	STY	Therapeutic or Preventive Procedure		NCI
C10831	PT	Bleomycin/Cisplatin/Etoposide/Ifosfamide/Vinblastine		NCI
C10831	SY	BLEO/CDDP/IFF/VBL/VP-16		NCI
C10831	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10831	RO	chemotherapy regimen has component Bleomycin	NCI
C10831	RO	chemotherapy regimen has component Cisplatin	NCI
C10831	RO	chemotherapy regimen has component Etoposide	NCI
C10831	RO	chemotherapy regimen has component Ifosfamide	NCI
C10831	RO	chemotherapy regimen has component Vinblastine	NCI
C11285	STY	Therapeutic or Preventive Procedure		NCI
C11285	PT	Carboplatin/Estramustine/Paclitaxel		NCI
C11285	SY	CBDCA/EM/TAX		NCI
C11285	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11285	RO	chemotherapy regimen has component Estramustine	NCI
C11285	RO	chemotherapy regimen has component Carboplatin	NCI
C11285	RO	chemotherapy regimen has component Paclitaxel	NCI
C11203	STY	Therapeutic or Preventive Procedure		NCI
C11203	PT	Dexamethasone/Methotrexate/Pegaspargase/Vincristine		NCI
C11203	SY	DM/MTX/PEG-ASP/VCR		NCI
C11203	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11203	RO	chemotherapy regimen has component Dexamethasone	NCI
C11203	RO	chemotherapy regimen has component Methotrexate	NCI
C11203	RO	chemotherapy regimen has component Vincristine	NCI
C11203	RO	chemotherapy regimen has component Pegaspargase	NCI
C10816	STY	Therapeutic or Preventive Procedure		NCI
C10816	PT	Bryostatin 1/Tretinoin		NCI
C10816	SY	ATRA/BRYO		NCI
C10816	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10816	RO	chemotherapy regimen has component Tretinoin	NCI
C10816	RO	chemotherapy regimen has component Bryostatin 1	NCI
C10238	STY	Therapeutic or Preventive Procedure		NCI
C10238	PT	Cytarabine/Daunorubicin/Dexamethasone/Etoposide/Thioguanine		NCI
C10238	SY	ARA-C/DM/DNR/TG/VP-16		NCI
C10238	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10238	RO	chemotherapy regimen has component Cytarabine	NCI
C10238	RO	chemotherapy regimen has component Dexamethasone	NCI
C10238	RO	chemotherapy regimen has component Etoposide	NCI
C10238	RO	chemotherapy regimen has component Thioguanine	NCI
C10238	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11517	STY	Therapeutic or Preventive Procedure		NCI
C11517	PT	Penicillamine/Pyridoxine		NCI
C11517	SY	penicillamine/VIT-B6		NCI
C11517	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11517	RO	chemotherapy regimen has component Penicillamine	NCI
C11517	RO	chemotherapy regimen has component Vitamin B6	NCI
C37839	STY	Therapeutic or Preventive Procedure		NCI
C37839	PT	Nilutamide/Triptorelin		NCI
C37839	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37839	RO	chemotherapy regimen has component Nilutamide	NCI
C37839	RO	chemotherapy regimen has component Triptorelin	NCI
C37747	STY	Therapeutic or Preventive Procedure		NCI
C37747	PT	Docetaxel/Suramin		NCI
C37747	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37747	RO	chemotherapy regimen has component Suramin	NCI
C37747	RO	chemotherapy regimen has component Docetaxel	NCI
C64842	STY	Therapeutic or Preventive Procedure		NCI
C64842	PT	Estramustine-Vinblastine Regimen		NCI
C64842	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C64842	RO	chemotherapy regimen has component Estramustine	NCI
C64842	RO	chemotherapy regimen has component Vinblastine	NCI
C64842	RO	regimen has accepted use for disease Metastatic Prostate Carcinoma	NCI
C10691	STY	Therapeutic or Preventive Procedure		NCI
C10691	PT	PSC 833/Vinblastine		NCI
C10691	SY	PSC/Vinblastine		NCI
C10691	SY	PSC 833/VBL		NCI
C10691	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10691	RO	chemotherapy regimen has component Vinblastine	NCI
C10691	RO	chemotherapy regimen has component Valspodar	NCI
C37831	STY	Therapeutic or Preventive Procedure		NCI
C37831	PT	Methotrexate/Procarbazine/Rituximab/Vincristine		NCI
C37831	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37831	RO	chemotherapy regimen has component Methotrexate	NCI
C37831	RO	chemotherapy regimen has component Vincristine	NCI
C37831	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C37831	RO	chemotherapy regimen has component Rituximab	NCI
C67210	STY	Therapeutic or Preventive Procedure		NCI
C67210	PT	APO Regimen		NCI
C67210	SY	APO		NCI
C67210	SY	Adriamycin-Prednisone-Oncovin Regimen		NCI
C67210	CHD	Chemotherapy Regimen Used to Treat Childhood Non-Hodgkin's Lymphoma	NCI
C67210	RO	chemotherapy regimen has component Doxorubicin	NCI
C67210	RO	chemotherapy regimen has component Prednisone	NCI
C67210	RO	chemotherapy regimen has component Vincristine	NCI
C67210	RO	regimen has accepted use for disease Childhood Anaplastic Large Cell Lymphoma	NCI
C67161	STY	Therapeutic or Preventive Procedure		NCI
C67161	PT	VAMP Regimen		NCI
C67161	SY	VAMP		NCI
C67161	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67161	RO	chemotherapy regimen has component Doxorubicin	NCI
C67161	RO	chemotherapy regimen has component Methotrexate	NCI
C67161	RO	chemotherapy regimen has component Prednisone	NCI
C67161	RO	chemotherapy regimen has component Vincristine	NCI
C67161	RO	regimen has accepted use for disease Childhood Hodgkin Lymphoma	NCI
C63606	STY	Therapeutic or Preventive Procedure		NCI
C63606	PT	Irinotecan-Cetuximab Regimen		NCI
C63606	SY	Cetuximab-Irinotecan Regimen		NCI
C63606	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63606	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63606	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C63606	RO	chemotherapy regimen has component Cetuximab	NCI
C11829	STY	Therapeutic or Preventive Procedure		NCI
C11829	PT	Arsenic trioxide/Ascorbic acid		NCI
C11829	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11829	RO	chemotherapy regimen has component Ascorbic Acid	NCI
C11829	RO	chemotherapy regimen has component Arsenic Trioxide	NCI
C9826	STY	Therapeutic or Preventive Procedure		NCI
C9826	PT	Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate		NCI
C9826	SY	ARA-C/CTX/MP/MTX		NCI
C9826	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9826	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9826	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9826	RO	chemotherapy regimen has component Cytarabine	NCI
C9826	RO	chemotherapy regimen has component Methotrexate	NCI
C11322	STY	Pharmacologic Substance		NCI
C11322	PT	Amoxicillin/Clarithromycin/Omeprazole		NCI
C11322	SY	AMOX/CLARITH/OMEP		NCI
C11322	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11322	RO	chemotherapy regimen has component Amoxicillin	NCI
C11322	RO	chemotherapy regimen has component Omeprazole	NCI
C11322	RO	chemotherapy regimen has component Clarithromycin	NCI
C11462	STY	Therapeutic or Preventive Procedure		NCI
C11462	PT	Cisplatin/Dimesna/Paclitaxel		NCI
C11462	SY	CDDP/DIM/TAX		NCI
C11462	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11462	RO	chemotherapy regimen has component Cisplatin	NCI
C11462	RO	chemotherapy regimen has component Dimesna	NCI
C11462	RO	chemotherapy regimen has component Paclitaxel	NCI
C10091	STY	Therapeutic or Preventive Procedure		NCI
C10091	PT	Altretamine/Doxorubicin/Melphalan		NCI
C10091	SY	HAM		NCI
C10091	SY	DOX/HMM/L-PAM		NCI
C10091	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10091	RO	chemotherapy regimen has component Doxorubicin	NCI
C10091	RO	chemotherapy regimen has component Altretamine	NCI
C10091	RO	chemotherapy regimen has component Melphalan	NCI
C10930	STY	Therapeutic or Preventive Procedure		NCI
C10930	PT	Cisplatin/Docetaxel/Fluorouracil/Leucovorin Calcium		NCI
C10930	SY	CDDP/CF/5-FU/TXT		NCI
C10930	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10930	RO	chemotherapy regimen has component Cisplatin	NCI
C10930	RO	chemotherapy regimen has component Fluorouracil	NCI
C10930	RO	chemotherapy regimen has component Docetaxel	NCI
C10930	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10731	STY	Therapeutic or Preventive Procedure		NCI
C10731	PT	Cisplatin/Edatrexate/Ifosfamide		NCI
C10731	SY	CDDP/EDAM/IFF		NCI
C10731	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10731	RO	chemotherapy regimen has component Cisplatin	NCI
C10731	RO	chemotherapy regimen has component Ifosfamide	NCI
C10731	RO	chemotherapy regimen has component Edatrexate	NCI
C11149	STY	Therapeutic or Preventive Procedure		NCI
C11149	PT	AG337/Cisplatin		NCI
C11149	SY	AG337/CDDP		NCI
C11149	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11149	RO	chemotherapy regimen has component Cisplatin	NCI
C11149	RO	chemotherapy regimen has component Nolatrexed Dihydrochloride	NCI
C11565	STY	Therapeutic or Preventive Procedure		NCI
C11565	PT	Keyhole Limpet Hemocyanin/QS21/Sialyl Tn Antigen		NCI
C11565	SY	KLH/QS21/STn Antigen		NCI
C11565	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11565	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C11565	RO	chemotherapy regimen has component Sialyl Tn Antigen	NCI
C11565	RO	chemotherapy regimen has component QS21	NCI
C11788	STY	Therapeutic or Preventive Procedure		NCI
C11788	PT	Carmustine/RSR13		NCI
C11788	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11788	RO	chemotherapy regimen has component Carmustine	NCI
C11788	RO	chemotherapy regimen has component Efaproxiral	NCI
C10772	STY	Therapeutic or Preventive Procedure		NCI
C10772	PT	Cisplatin/Etoposide/Tamoxifen		NCI
C10772	SY	CDDP/TMX/VP-16		NCI
C10772	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10772	RO	chemotherapy regimen has component Cisplatin	NCI
C10772	RO	chemotherapy regimen has component Etoposide	NCI
C10772	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11239	STY	Therapeutic or Preventive Procedure		NCI
C11239	PT	Cisplatin/Paclitaxel/Topotecan		NCI
C11239	SY	CDDP/TAX/TOPO		NCI
C11239	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11239	RO	chemotherapy regimen has component Cisplatin	NCI
C11239	RO	chemotherapy regimen has component Paclitaxel	NCI
C11239	RO	chemotherapy regimen has component Topotecan	NCI
C11016	STY	Therapeutic or Preventive Procedure		NCI
C11016	PT	Cisplatin/Interferon Alfa/Tamoxifen		NCI
C11016	SY	CDDP/IFN-A/TMX		NCI
C11016	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11016	RO	chemotherapy regimen has component Cisplatin	NCI
C11016	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11016	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C138044	STY	Therapeutic or Preventive Procedure		NCI
C138044	PT	Pertuzumab/Trastuzumab/Docetaxel Followed by FEC Regimen		NCI
C138044	SY	Pertuzumab + Trastuzumab + Docetaxel Followed by FEC		NCI
C138044	SY	Pertuzumab + Trastuzumab + Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide		NCI
C138044	SY	Pertuzumab/Trastuzumab/Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide		NCI
C138044	SY	Pertuzumab-Trastuzumab-Docetaxel Followed by Fluorouracil-Epirubicin-Cyclophosphamide		NCI
C138044	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138044	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138044	RO	chemotherapy regimen has component Fluorouracil	NCI
C138044	RO	chemotherapy regimen has component Docetaxel	NCI
C138044	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C138044	RO	chemotherapy regimen has component Trastuzumab	NCI
C138044	RO	chemotherapy regimen has component Pertuzumab	NCI
C37707	STY	Therapeutic or Preventive Procedure		NCI
C37707	PT	Cytarabine/VNP40101M		NCI
C37707	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37707	RO	chemotherapy regimen has component Cytarabine	NCI
C37707	RO	chemotherapy regimen has component Laromustine	NCI
C10641	STY	Therapeutic or Preventive Procedure		NCI
C10641	PT	Doxorubicin/Streptozocin		NCI
C10641	SY	DOX/SZC		NCI
C10641	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10641	RO	chemotherapy regimen has component Doxorubicin	NCI
C10641	RO	chemotherapy regimen has component Streptozocin	NCI
C140093	STY	Therapeutic or Preventive Procedure		NCI
C140093	PT	AVD Regimen		NCI
C140093	SY	Doxorubicin/Vinblastine/Dacarbazine		NCI
C140093	SY	Adriamycin-Vinblastine-Dacarbazine		NCI
C140093	SY	AVD		NCI
C140093	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C140093	RO	chemotherapy regimen has component Dacarbazine	NCI
C140093	RO	chemotherapy regimen has component Vinblastine	NCI
C140093	RO	chemotherapy regimen has component Doxorubicin Hydrochloride	NCI
C9616	STY	Therapeutic or Preventive Procedure		NCI
C9616	PT	Fluorouracil/Semustine/Vincristine		NCI
C9616	SY	MOF		NCI
C9616	SY	5-FU/MeCCNU/VCR		NCI
C9616	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9616	RO	chemotherapy regimen has component Fluorouracil	NCI
C9616	RO	chemotherapy regimen has component Semustine	NCI
C9616	RO	chemotherapy regimen has component Vincristine	NCI
C11683	STY	Therapeutic or Preventive Procedure		NCI
C11683	PT	CRL 1005/gp100 Antigen/Montanide ISA-51/Tyrosinase Peptide		NCI
C11683	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11683	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11683	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11683	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11683	RO	chemotherapy regimen has component CRL 1005	NCI
C10425	STY	Therapeutic or Preventive Procedure		NCI
C10425	PT	Cisplatin/Etoposide/Thiotepa		NCI
C10425	SY	CDDP/TSPA/VP-16		NCI
C10425	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10425	RO	chemotherapy regimen has component Cisplatin	NCI
C10425	RO	chemotherapy regimen has component Etoposide	NCI
C10425	RO	chemotherapy regimen has component Thiotepa	NCI
C11077	STY	Therapeutic or Preventive Procedure		NCI
C11077	PT	Interferon Alfa/Interleukin-2/Isotretinoin		NCI
C11077	SY	13-CRA/IFN-A/IL-2		NCI
C11077	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11077	RO	chemotherapy regimen has component Isotretinoin	NCI
C11077	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11077	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11065	STY	Therapeutic or Preventive Procedure		NCI
C11065	PT	Carmustine/Cyclophosphamide/Etoposide/Interferon Alfa		NCI
C11065	SY	BCNU/CTX/IFN-A/VP-16		NCI
C11065	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11065	RO	chemotherapy regimen has component Carmustine	NCI
C11065	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11065	RO	chemotherapy regimen has component Etoposide	NCI
C11065	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10174	STY	Therapeutic or Preventive Procedure		NCI
C10174	PT	Amsacrine/Cyclophosphamide/Hydroxyurea		NCI
C10174	SY	AMSA/CTX/HU		NCI
C10174	SY	CMH		NCI
C10174	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10174	RO	chemotherapy regimen has component Amsacrine	NCI
C10174	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10174	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11768	STY	Therapeutic or Preventive Procedure		NCI
C11768	PT	Cetuximab/Gemcitabine		NCI
C11768	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11768	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11768	RO	chemotherapy regimen has component Cetuximab	NCI
C9546	STY	Therapeutic or Preventive Procedure		NCI
C9546	PT	Cyclophosphamide/Epirubicin/Vincristine		NCI
C9546	SY	CTX/EPI/VCR		NCI
C9546	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9546	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9546	RO	chemotherapy regimen has component Vincristine	NCI
C9546	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11415	STY	Therapeutic or Preventive Procedure		NCI
C11415	PT	gp100 Antigen/Sargramostim/Tyrosinase Peptide		NCI
C11415	SY	gp100/GM-CSF/TYRP		NCI
C11415	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11415	RO	chemotherapy regimen has component Sargramostim	NCI
C11415	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11415	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C37683	STY	Therapeutic or Preventive Procedure		NCI
C37683	PT	Cyclophosphamide/Doxorubicin/Oblimersen/Prednisone/Rituximab/Vincristine		NCI
C37683	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37683	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37683	RO	chemotherapy regimen has component Doxorubicin	NCI
C37683	RO	chemotherapy regimen has component Prednisone	NCI
C37683	RO	chemotherapy regimen has component Vincristine	NCI
C37683	RO	chemotherapy regimen has component Rituximab	NCI
C37683	RO	chemotherapy regimen has component Oblimersen	NCI
C11628	STY	Therapeutic or Preventive Procedure		NCI
C11628	PT	Anti-thymocyte globulin/Cyclophosphamide/Methylprednisolone		NCI
C11628	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11628	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11628	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11628	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11706	STY	Therapeutic or Preventive Procedure		NCI
C11706	PT	BCG/Polyvalent Melanoma Vaccine		NCI
C11706	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11706	RO	chemotherapy regimen has component BCG Vaccine	NCI
C11706	RO	chemotherapy regimen has component Polyvalent Melanoma Vaccine	NCI
C10928	STY	Therapeutic or Preventive Procedure		NCI
C10928	PT	Isotretinoin/Vitamin E		NCI
C10928	SY	13-CRA/VIT-E		NCI
C10928	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10928	RO	chemotherapy regimen has component Isotretinoin	NCI
C10928	RO	chemotherapy regimen has component Vitamin E Compound	NCI
C10043	STY	Therapeutic or Preventive Procedure		NCI
C10043	PT	Cisplatin/Cyclophosphamide/Fluorouracil/Vincristine		NCI
C10043	SY	CDDP/CTX/5-FU/VCR		NCI
C10043	SY	CO-5P		NCI
C10043	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10043	RO	chemotherapy regimen has component Cisplatin	NCI
C10043	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10043	RO	chemotherapy regimen has component Fluorouracil	NCI
C10043	RO	chemotherapy regimen has component Vincristine	NCI
C11742	STY	Therapeutic or Preventive Procedure		NCI
C11742	PT	Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Rituximab/Vincristine		NCI
C11742	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11742	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11742	RO	chemotherapy regimen has component Doxorubicin	NCI
C11742	RO	chemotherapy regimen has component Etoposide	NCI
C11742	RO	chemotherapy regimen has component Prednisone	NCI
C11742	RO	chemotherapy regimen has component Vincristine	NCI
C11742	RO	chemotherapy regimen has component Rituximab	NCI
C10512	STY	Therapeutic or Preventive Procedure		NCI
C10512	PT	Cisplatin/Fluorouracil/Hydroxyurea		NCI
C10512	SY	CDDP/5-FU/HU		NCI
C10512	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10512	RO	chemotherapy regimen has component Cisplatin	NCI
C10512	RO	chemotherapy regimen has component Fluorouracil	NCI
C10512	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10724	STY	Therapeutic or Preventive Procedure		NCI
C10724	PT	Edatrexate/Paclitaxel		NCI
C10724	SY	EDAM/TAX		NCI
C10724	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10724	RO	chemotherapy regimen has component Edatrexate	NCI
C10724	RO	chemotherapy regimen has component Paclitaxel	NCI
C63591	STY	Therapeutic or Preventive Procedure		NCI
C63591	PT	FOLFOX-6 Regimen		NCI
C63591	SY	Folinic Acid-Fluorouracil-Oxaliplatin-6 Regimen		NCI
C63591	CHD	FOLFOX Regimen	NCI
C63591	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63591	RO	chemotherapy regimen has component Fluorouracil	NCI
C63591	RO	chemotherapy regimen has component Oxaliplatin	NCI
C63591	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63591	RO	concept in subset CTRP Terminology	NCI
C63591	RO	concept in subset CTRP Intervention Terminology	NCI
C10398	STY	Therapeutic or Preventive Procedure		NCI
C10398	PT	Cyclophosphamide/Etoposide/Mercaptopurine/Methotrexate		NCI
C10398	SY	CTX/MP/MTX/VP-16		NCI
C10398	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10398	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10398	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10398	RO	chemotherapy regimen has component Etoposide	NCI
C10398	RO	chemotherapy regimen has component Methotrexate	NCI
C9759	STY	Therapeutic or Preventive Procedure		NCI
C9759	PT	Herceptin/Paclitaxel		NCI
C9759	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9759	RO	chemotherapy regimen has component Paclitaxel	NCI
C9759	RO	chemotherapy regimen has component Trastuzumab	NCI
C10610	STY	Therapeutic or Preventive Procedure		NCI
C10610	PT	Cisplatin/Muramyl Tripeptide Phosphatidylethanolamine Liposome		NCI
C10610	SY	CDDP/MTP-PE Liposome		NCI
C10610	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10610	RO	chemotherapy regimen has component Cisplatin	NCI
C10610	RO	chemotherapy regimen has component Mifamurtide	NCI
C140102	STY	Therapeutic or Preventive Procedure		NCI
C140102	PT	HD-MTX/ARA-C Regimen		NCI
C140102	SY	HD MTX Plus HD AraC		NCI
C140102	SY	HD-Methotrexate/Cytarabine		NCI
C140102	SY	High-dose Methotrexate Plus High-dose Cytarabine		NCI
C140102	SY	HD-MTX/ARA-C		NCI
C140102	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140102	RO	chemotherapy regimen has component Cytarabine	NCI
C140102	RO	chemotherapy regimen has component Methotrexate	NCI
C11550	STY	Therapeutic or Preventive Procedure		NCI
C11550	PT	Carboplatin/Thiotepa/Vincristine		NCI
C11550	SY	CBDCA/TSPA/VCR		NCI
C11550	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11550	RO	chemotherapy regimen has component Thiotepa	NCI
C11550	RO	chemotherapy regimen has component Vincristine	NCI
C11550	RO	chemotherapy regimen has component Carboplatin	NCI
C9704	STY	Therapeutic or Preventive Procedure		NCI
C9704	PT	Cisplatin/Cyclophosphamide/Vindesine		NCI
C9704	SY	PCE		NCI
C9704	SY	CDDP/CTX/DAVA		NCI
C9704	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9704	RO	chemotherapy regimen has component Cisplatin	NCI
C9704	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9704	RO	chemotherapy regimen has component Vindesine	NCI
C11730	STY	Therapeutic or Preventive Procedure		NCI
C11730	PT	Asparaginase/cyclophosphamide/cytarabine/daunorubicin/methotrexate/prednisone/vincristine		NCI
C11730	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11730	RO	chemotherapy regimen has component Asparaginase	NCI
C11730	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11730	RO	chemotherapy regimen has component Cytarabine	NCI
C11730	RO	chemotherapy regimen has component Methotrexate	NCI
C11730	RO	chemotherapy regimen has component Prednisone	NCI
C11730	RO	chemotherapy regimen has component Vincristine	NCI
C11730	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10535	STY	Therapeutic or Preventive Procedure		NCI
C10535	PT	Filgrastim/Topotecan		NCI
C10535	SY	G-CSF/TOPO		NCI
C10535	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10535	RO	chemotherapy regimen has component Topotecan	NCI
C10535	RO	chemotherapy regimen has component Filgrastim	NCI
C10595	STY	Therapeutic or Preventive Procedure		NCI
C10595	PT	Flutamide/Ketoconazole/Leuprolide		NCI
C10595	SY	FLUT/KCZ/LEUP		NCI
C10595	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10595	RO	chemotherapy regimen has component Flutamide	NCI
C10595	RO	chemotherapy regimen has component Ketoconazole	NCI
C10595	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C37474	STY	Therapeutic or Preventive Procedure		NCI
C37474	PT	D1/3-MAGE-3 Fusion Protein/SB-AS02B Adjuvant		NCI
C37474	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37474	RO	chemotherapy regimen has component D1/3-Mage-3-His Fusion Protein	NCI
C37474	RO	chemotherapy regimen has component SB-AS02B Adjuvant	NCI
C10980	STY	Therapeutic or Preventive Procedure		NCI
C10980	PT	Interleukin-2/NG-Monomethyl-L-Arginine		NCI
C10980	SY	IL-2/NMA		NCI
C10980	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10980	RO	chemotherapy regimen has component Tilarginine	NCI
C10980	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11898	STY	Therapeutic or Preventive Procedure		NCI
C11898	PT	Autologous Lymphocytes/Interleukin-2		NCI
C11898	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11898	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11898	RO	chemotherapy regimen has component Therapeutic Autologous Lymphocytes	NCI
C28504	STY	Therapeutic or Preventive Procedure		NCI
C28504	PT	Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine/QS21		NCI
C28504	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C28504	RO	chemotherapy regimen has component QS21	NCI
C28504	RO	chemotherapy regimen has component Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine	NCI
C37514	STY	Therapeutic or Preventive Procedure		NCI
C37514	PT	Adenovirus-L523S Vaccine/L523S DNA Vaccine		NCI
C37514	SY	L523S Vaccine		NCI
C37514	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37514	RO	chemotherapy regimen has component Recombinant Adenovirus-L523S Vaccine	NCI
C37514	RO	chemotherapy regimen has component Recombinant DNA-L523S Vaccine	NCI
C10678	STY	Therapeutic or Preventive Procedure		NCI
C10678	PT	Cyclosporine/Vinblastine		NCI
C10678	SY	CYSP/VBL		NCI
C10678	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10678	RO	chemotherapy regimen has component Cyclosporine	NCI
C10678	RO	chemotherapy regimen has component Vinblastine	NCI
C63383	STY	Therapeutic or Preventive Procedure		NCI
C63383	PT	Irinotecan-Cisplatin Regimen		NCI
C63383	CHD	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C63383	RO	chemotherapy regimen has component Cisplatin	NCI
C63383	RO	regimen has accepted use for disease Lung Small Cell Carcinoma	NCI
C63383	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C10935	STY	Therapeutic or Preventive Procedure		NCI
C10935	PT	Cisplatin/Tirapazamine		NCI
C10935	SY	CDDP/SR-4233		NCI
C10935	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10935	RO	chemotherapy regimen has component Cisplatin	NCI
C10935	RO	chemotherapy regimen has component Tirapazamine	NCI
C63422	STY	Therapeutic or Preventive Procedure		NCI
C63422	PT	GT Regimen		NCI
C63422	SY	Gemcitabine-Taxol Regimen		NCI
C63422	SY	Paclitaxel/Gemcitabine		NCI
C63422	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63422	RO	chemotherapy regimen has component Paclitaxel	NCI
C63422	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63422	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C10635	STY	Therapeutic or Preventive Procedure		NCI
C10635	PT	Dexrazoxane/Doxorubicin		NCI
C10635	SY	ADR-529/DOX		NCI
C10635	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10635	RO	chemotherapy regimen has component Doxorubicin	NCI
C10635	RO	chemotherapy regimen has component Dexrazoxane	NCI
C11325	STY	Therapeutic or Preventive Procedure		NCI
C11325	PT	Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase Peptide		NCI
C11325	SY	GM-CSF/IFA/TYRP		NCI
C11325	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11325	RO	chemotherapy regimen has component Sargramostim	NCI
C11325	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11325	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C10390	STY	Therapeutic or Preventive Procedure		NCI
C10390	PT	Dipyridamole/Fluorouracil/Leucovorin Calcium/Zidovudine		NCI
C10390	SY	CF/DP/5-FU/ZDV		NCI
C10390	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10390	RO	chemotherapy regimen has component Dipyridamole	NCI
C10390	RO	chemotherapy regimen has component Fluorouracil	NCI
C10390	RO	chemotherapy regimen has component Zidovudine	NCI
C10390	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37635	STY	Therapeutic or Preventive Procedure		NCI
C37635	PT	Celecoxib/Gefitinib		NCI
C37635	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37635	RO	chemotherapy regimen has component Celecoxib	NCI
C37635	RO	chemotherapy regimen has component Gefitinib	NCI
C11196	STY	Therapeutic or Preventive Procedure		NCI
C11196	PT	Bleomycin/Dexrazoxane/Doxorubicin/Etoposide/Vincristine		NCI
C11196	SY	ADR-529/BLEO/DOX/VCR/VP-16		NCI
C11196	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11196	RO	chemotherapy regimen has component Bleomycin	NCI
C11196	RO	chemotherapy regimen has component Doxorubicin	NCI
C11196	RO	chemotherapy regimen has component Etoposide	NCI
C11196	RO	chemotherapy regimen has component Vincristine	NCI
C11196	RO	chemotherapy regimen has component Dexrazoxane	NCI
C12144	STY	Therapeutic or Preventive Procedure		NCI
C12144	PT	Detoxpc/Interleukin-2/RAS Peptide Cancer Vaccine/Sargramostim		NCI
C12144	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12144	RO	chemotherapy regimen has component Sargramostim	NCI
C12144	RO	chemotherapy regimen has component DetoxPC	NCI
C12144	RO	chemotherapy regimen has component RAS Peptide Cancer Vaccine	NCI
C12144	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10797	STY	Therapeutic or Preventive Procedure		NCI
C10797	PT	Cyclophosphamide/Prednisolone		NCI
C10797	SY	CTX/PRDL		NCI
C10797	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10797	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10797	RO	chemotherapy regimen has component Prednisolone	NCI
C11186	STY	Therapeutic or Preventive Procedure		NCI
C11186	PT	Cladribine/Etoposide		NCI
C11186	SY	2-CdA/VP-16		NCI
C11186	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11186	RO	chemotherapy regimen has component Etoposide	NCI
C11186	RO	chemotherapy regimen has component Cladribine	NCI
C11644	STY	Therapeutic or Preventive Procedure		NCI
C11644	PT	MAGE-3/SB AS-2		NCI
C11644	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11644	RO	chemotherapy regimen has component SB AS-2	NCI
C11644	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C10911	STY	Therapeutic or Preventive Procedure		NCI
C10911	PT	Cyclophosphamide/Didanosine/Doxorubicin/Etoposide		NCI
C10911	SY	CTX/ddI/DOX/VP-16		NCI
C10911	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10911	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10911	RO	chemotherapy regimen has component Didanosine	NCI
C10911	RO	chemotherapy regimen has component Doxorubicin	NCI
C10911	RO	chemotherapy regimen has component Etoposide	NCI
C10590	STY	Therapeutic or Preventive Procedure		NCI
C10590	PT	BCG/Isoniazid		NCI
C10590	SY	BCG/INH		NCI
C10590	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10590	RO	chemotherapy regimen has component BCG Vaccine	NCI
C10590	RO	chemotherapy regimen has component Isoniazid	NCI
C10953	STY	Therapeutic or Preventive Procedure		NCI
C10953	PT	ImmTher/Indomethacin		NCI
C10953	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10953	RO	chemotherapy regimen has component Indomethacin	NCI
C10953	RO	chemotherapy regimen has component Disaccharide Tripeptide Glycerol Dipalmitoyl	NCI
C9662	STY	Therapeutic or Preventive Procedure		NCI
C9662	PT	Fluorouracil/Methotrexate/Vincristine		NCI
C9662	SY	5-FU/MTX/VCR		NCI
C9662	SY	VMF		NCI
C9662	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9662	RO	chemotherapy regimen has component Fluorouracil	NCI
C9662	RO	chemotherapy regimen has component Methotrexate	NCI
C9662	RO	chemotherapy regimen has component Vincristine	NCI
C11715	STY	Therapeutic or Preventive Procedure		NCI
C11715	PT	Asparaginase/Dexamethasone		NCI
C11715	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11715	RO	chemotherapy regimen has component Asparaginase	NCI
C11715	RO	chemotherapy regimen has component Dexamethasone	NCI
C11909	STY	Therapeutic or Preventive Procedure		NCI
C11909	PT	Bevacizumab/Fluorouracil/Irinotecan/Leucovorin Calcium		NCI
C11909	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11909	RO	chemotherapy regimen has component Fluorouracil	NCI
C11909	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11909	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11909	RO	chemotherapy regimen has component Bevacizumab	NCI
C11876	STY	Therapeutic or Preventive Procedure		NCI
C11876	PT	Ganciclovir/Interleukin-2/Zidovudine		NCI
C11876	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11876	RO	chemotherapy regimen has component Ganciclovir	NCI
C11876	RO	chemotherapy regimen has component Zidovudine	NCI
C11876	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10771	STY	Therapeutic or Preventive Procedure		NCI
C10771	PT	Cyclophosphamide/Doxorubicin/Methotrexate/Methylprednisolone/Prednisone/Vincristine		NCI
C10771	SY	CTX/DOX/MePRDL/MTX/PRED/VCR		NCI
C10771	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10771	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10771	RO	chemotherapy regimen has component Doxorubicin	NCI
C10771	RO	chemotherapy regimen has component Methotrexate	NCI
C10771	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10771	RO	chemotherapy regimen has component Prednisone	NCI
C10771	RO	chemotherapy regimen has component Vincristine	NCI
C11150	STY	Therapeutic or Preventive Procedure		NCI
C11150	PT	Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Vincristine		NCI
C11150	SY	ARA-C/CTX/DM/DNR/VCR		NCI
C11150	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11150	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11150	RO	chemotherapy regimen has component Cytarabine	NCI
C11150	RO	chemotherapy regimen has component Dexamethasone	NCI
C11150	RO	chemotherapy regimen has component Vincristine	NCI
C11150	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37589	STY	Therapeutic or Preventive Procedure		NCI
C37589	PT	Capecitabine/Docetaxel/Tipifarnib		NCI
C37589	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37589	RO	chemotherapy regimen has component Docetaxel	NCI
C37589	RO	chemotherapy regimen has component Capecitabine	NCI
C37589	RO	chemotherapy regimen has component Tipifarnib	NCI
C37820	STY	Therapeutic or Preventive Procedure		NCI
C37820	PT	Interleukin-12/Paclitaxel		NCI
C37820	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37820	RO	chemotherapy regimen has component Paclitaxel	NCI
C37820	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C37535	STY	Therapeutic or Preventive Procedure		NCI
C37535	PT	Asparaginase/Daunorubicin/Methotrexate/Nelarabine/Prednisone/Vincristine		NCI
C37535	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37535	RO	chemotherapy regimen has component Asparaginase	NCI
C37535	RO	chemotherapy regimen has component Methotrexate	NCI
C37535	RO	chemotherapy regimen has component Prednisone	NCI
C37535	RO	chemotherapy regimen has component Vincristine	NCI
C37535	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37535	RO	chemotherapy regimen has component Nelarabine	NCI
C140730	STY	Therapeutic or Preventive Procedure		NCI
C140730	PT	FCM Regimen		NCI
C140730	SY	FCM		NCI
C140730	SY	Fludarabine/Cyclophosphamide/Mitoxantrone		NCI
C140730	SY	Fludarabine-Cyclophosphamide-Mitoxantrone		NCI
C140730	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140730	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C140730	RO	chemotherapy regimen has component Mitoxantrone	NCI
C140730	RO	chemotherapy regimen has component Fludarabine	NCI
C10493	STY	Therapeutic or Preventive Procedure		NCI
C10493	PT	Methotrexate/Thioguanine		NCI
C10493	SY	MTX/TG		NCI
C10493	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10493	RO	chemotherapy regimen has component Methotrexate	NCI
C10493	RO	chemotherapy regimen has component Thioguanine	NCI
C63405	STY	Therapeutic or Preventive Procedure		NCI
C63405	PT	Docetaxel-Cisplatin Regimen		NCI
C63405	SY	Cisplatin/Docetaxel		NCI
C63405	SY	Docetaxel-Cisplatin		NCI
C63405	SY	Cisplatin-Docetaxel Regimen		NCI
C63405	SY	Cisplatin/Docetaxel Regimen		NCI
C63405	SY	Docetaxel/Cisplatin		NCI
C63405	SY	Cisplatin-Docetaxel		NCI
C63405	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C63405	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63405	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63405	RO	chemotherapy regimen has component Cisplatin	NCI
C63405	RO	chemotherapy regimen has component Docetaxel	NCI
C63405	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C37850	STY	Therapeutic or Preventive Procedure		NCI
C37850	PT	Ranpirnase/Tamoxifen		NCI
C37850	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37850	RO	chemotherapy regimen has component Ranpirnase	NCI
C37850	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C9875	STY	Therapeutic or Preventive Procedure		NCI
C9875	PT	Cisplatin/Cytarabine/Etoposide		NCI
C9875	SY	ACE		NCI
C9875	SY	APE		NCI
C9875	SY	ARA-C/CDDP/VP-16		NCI
C9875	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9875	RO	chemotherapy regimen has component Cisplatin	NCI
C9875	RO	chemotherapy regimen has component Cytarabine	NCI
C9875	RO	chemotherapy regimen has component Etoposide	NCI
C10267	STY	Therapeutic or Preventive Procedure		NCI
C10267	PT	Bleomycin/Dacarbazine/Doxorubicin/Mechlorethamine/Prednisone/Procarbazine/Vinblastine/Vincristine		NCI
C10267	SY	MOPP/ABVD		NCI
C10267	SY	MA/MA		NCI
C10267	SY	MOPP alternating with ABVD		NCI
C10267	SY	ABVD/MOPP		NCI
C10267	SY	BLEO/DOX/DTIC/NM/PCB/PRED/VBL/VCR		NCI
C10267	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10267	RO	chemotherapy regimen has component Bleomycin	NCI
C10267	RO	chemotherapy regimen has component Dacarbazine	NCI
C10267	RO	chemotherapy regimen has component Doxorubicin	NCI
C10267	RO	chemotherapy regimen has component Prednisone	NCI
C10267	RO	chemotherapy regimen has component Vinblastine	NCI
C10267	RO	chemotherapy regimen has component Vincristine	NCI
C10267	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10267	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C9631	STY	Therapeutic or Preventive Procedure		NCI
C9631	PT	Ifosfamide/Methotrexate/Procarbazine		NCI
C9631	SY	PRIME		NCI
C9631	SY	IFF/MTX/PCB		NCI
C9631	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9631	RO	chemotherapy regimen has component Ifosfamide	NCI
C9631	RO	chemotherapy regimen has component Methotrexate	NCI
C9631	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11970	STY	Therapeutic or Preventive Procedure		NCI
C11970	PT	Interleukin-12/PSA Prostate Cancer Vaccine		NCI
C11970	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11970	RO	chemotherapy regimen has component PSA Prostate Cancer Vaccine	NCI
C11970	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C134702	STY	Therapeutic or Preventive Procedure		NCI
C134702	PT	Capecitabine/Methotrexate/Vinorelbine Regimen		NCI
C134702	SY	Capecitabine-Methotrexate-Vinorelbine Regimen		NCI
C134702	SY	Xeloda-Methotrexate-Navelbine Regimen		NCI
C134702	SY	Xeloda/Methotrexate/Navelbine Regimen		NCI
C134702	SY	Capecitabine/Methotrexate/Vinorelbine Tartrate Regimen		NCI
C134702	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C134702	RO	chemotherapy regimen has component Methotrexate	NCI
C134702	RO	chemotherapy regimen has component Vinorelbine Tartrate	NCI
C134702	RO	chemotherapy regimen has component Capecitabine	NCI
C12195	STY	Therapeutic or Preventive Procedure		NCI
C12195	PT	Cyclophosphamide/Epirubicin/Gemcitabine/Paclitaxel		NCI
C12195	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12195	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12195	RO	chemotherapy regimen has component Paclitaxel	NCI
C12195	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C12195	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63377	STY	Therapeutic or Preventive Procedure		NCI
C63377	PT	ESHAP Regimen		NCI
C63377	SY	Etoposide-Solumedrol-High Dose Ara-C, Platinol Regimen		NCI
C63377	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63377	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63377	RO	chemotherapy regimen has component Cisplatin	NCI
C63377	RO	chemotherapy regimen has component Cytarabine	NCI
C63377	RO	chemotherapy regimen has component Etoposide	NCI
C63377	RO	chemotherapy regimen has component Methylprednisolone	NCI
C63377	RO	regimen has accepted use for disease Recurrent Adult Hodgkin Lymphoma	NCI
C63377	RO	regimen has accepted use for disease Recurrent Adult Non-Hodgkin Lymphoma	NCI
C63377	RO	regimen has accepted use for disease Refractory Non-Hodgkin Lymphoma	NCI
C63377	RO	regimen has accepted use for disease Refractory Hodgkin Lymphoma	NCI
C11346	STY	Therapeutic or Preventive Procedure		NCI
C11346	PT	Amifostine/Busulfan/Melphalan/Thiotepa		NCI
C11346	SY	BU/L-PAM/TSPA/WR-2721		NCI
C11346	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11346	RO	chemotherapy regimen has component Busulfan	NCI
C11346	RO	chemotherapy regimen has component Amifostine	NCI
C11346	RO	chemotherapy regimen has component Melphalan	NCI
C11346	RO	chemotherapy regimen has component Thiotepa	NCI
C156381	STY	Therapeutic or Preventive Procedure		NCI
C156381	PT	Ixabepilone/Trastuzumab Regimen		NCI
C156381	SY	Ixabepilone/Trastuzumab		NCI
C156381	SY	Trastuzumab/Ixabepilone		NCI
C156381	SY	Tamoxifen-Trastuzumab		NCI
C156381	SY	Ixempra/Herceptin		NCI
C156381	SY	Trastuzumab-Ixabepilone		NCI
C156381	SY	Trastuzumab/Ixabepilone Regimen		NCI
C156381	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156381	RO	chemotherapy regimen has component Trastuzumab	NCI
C156381	RO	chemotherapy regimen has component Ixabepilone	NCI
C10216	STY	Therapeutic or Preventive Procedure		NCI
C10216	PT	Doxorubicin/Etoposide/Prednisone/Vincristine		NCI
C10216	SY	DOX/PRED/VCR/VP-16		NCI
C10216	SY	AOPE		NCI
C10216	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10216	RO	chemotherapy regimen has component Doxorubicin	NCI
C10216	RO	chemotherapy regimen has component Etoposide	NCI
C10216	RO	chemotherapy regimen has component Prednisone	NCI
C10216	RO	chemotherapy regimen has component Vincristine	NCI
C37499	STY	Therapeutic or Preventive Procedure		NCI
C37499	PT	CCI-779/Interferon Alfa		NCI
C37499	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37499	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37499	RO	chemotherapy regimen has component Temsirolimus	NCI
C9660	STY	Therapeutic or Preventive Procedure		NCI
C9660	PT	Bleomycin/Cisplatin/Methotrexate/Vincristine		NCI
C9660	SY	CABO		NCI
C9660	SY	BLEO/CDDP/MTX/VCR		NCI
C9660	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9660	RO	chemotherapy regimen has component Bleomycin	NCI
C9660	RO	chemotherapy regimen has component Cisplatin	NCI
C9660	RO	chemotherapy regimen has component Methotrexate	NCI
C9660	RO	chemotherapy regimen has component Vincristine	NCI
C10139	STY	Therapeutic or Preventive Procedure		NCI
C10139	PT	Cisplatin/Doxorubicin/Melphalan/Teniposide		NCI
C10139	SY	CDDP/DOX/L-PAM/VM-26		NCI
C10139	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10139	RO	chemotherapy regimen has component Cisplatin	NCI
C10139	RO	chemotherapy regimen has component Doxorubicin	NCI
C10139	RO	chemotherapy regimen has component Melphalan	NCI
C10139	RO	chemotherapy regimen has component Teniposide	NCI
C37711	STY	Therapeutic or Preventive Procedure		NCI
C37711	PT	Cytarabine/Daunorubicin/Zosuquidar Trihydrochloride		NCI
C37711	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37711	RO	chemotherapy regimen has component Cytarabine	NCI
C37711	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37711	RO	chemotherapy regimen has component Zosuquidar Trihydrochloride	NCI
C10142	STY	Therapeutic or Preventive Procedure		NCI
C10142	PT	Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Vincristine		NCI
C10142	SY	ARA-C/ASP/CTX/MP/MTX/VCR		NCI
C10142	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10142	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10142	RO	chemotherapy regimen has component Asparaginase	NCI
C10142	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10142	RO	chemotherapy regimen has component Cytarabine	NCI
C10142	RO	chemotherapy regimen has component Methotrexate	NCI
C10142	RO	chemotherapy regimen has component Vincristine	NCI
C10723	STY	Therapeutic or Preventive Procedure		NCI
C10723	PT	Filgrastim/Merbarone		NCI
C10723	SY	G-CSF/MERB		NCI
C10723	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10723	RO	chemotherapy regimen has component Merbarone	NCI
C10723	RO	chemotherapy regimen has component Filgrastim	NCI
C153483	STY	Therapeutic or Preventive Procedure		NCI
C153483	PT	Bevacizumab/Irinotecan/Oxaliplatin		NCI
C153483	SY	IROX + Bevacizumab Regimen		NCI
C153483	SY	IROX/Bev		NCI
C153483	SY	Oxaliplatin/Irinotecan + Bevacizumab		NCI
C153483	SY	IROX Plus Bevacizumab		NCI
C153483	SY	IROX (Irinotecan/Oxaliplatin) + Bevacizumab		NCI
C153483	SY	Bevacizumab-Irinotecan-Oxaliplatin Regimen		NCI
C153483	SY	IROX + Bevacizumab		NCI
C153483	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C153483	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C153483	RO	chemotherapy regimen has component Oxaliplatin	NCI
C153483	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C153483	RO	chemotherapy regimen has component Bevacizumab	NCI
C10642	STY	Therapeutic or Preventive Procedure		NCI
C10642	PT	Leucovorin Calcium/Mercaptopurine/Methotrexate		NCI
C10642	SY	CF/MP/MTX		NCI
C10642	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10642	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10642	RO	chemotherapy regimen has component Methotrexate	NCI
C10642	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11311	STY	Therapeutic or Preventive Procedure		NCI
C11311	PT	Carboplatin/Cyclophosphamide/Doxorubicin		NCI
C11311	SY	CBDCA/CTX/DOX		NCI
C11311	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11311	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11311	RO	chemotherapy regimen has component Doxorubicin	NCI
C11311	RO	chemotherapy regimen has component Carboplatin	NCI
C10711	STY	Therapeutic or Preventive Procedure		NCI
C10711	PT	Asparaginase/Cytarabine/Dexamethasone/Doxorubicin/Mercaptopurine/Vincristine		NCI
C10711	SY	ARA-C/ASP/DM/DOX/MP/VCR		NCI
C10711	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10711	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10711	RO	chemotherapy regimen has component Asparaginase	NCI
C10711	RO	chemotherapy regimen has component Cytarabine	NCI
C10711	RO	chemotherapy regimen has component Dexamethasone	NCI
C10711	RO	chemotherapy regimen has component Doxorubicin	NCI
C10711	RO	chemotherapy regimen has component Vincristine	NCI
C156366	STY	Therapeutic or Preventive Procedure		NCI
C156366	PT	Cisplatin/Trastuzumab Regimen		NCI
C156366	SY	Cisplatin/Herceptin		NCI
C156366	SY	Cisplatin/Trastuzumab		NCI
C156366	SY	Trastuzumab/Cisplatin Regimen		NCI
C156366	SY	Cisplatin-Trastuzumab		NCI
C156366	SY	Trastuzumab-Cisplatin		NCI
C156366	SY	Trastuzumab/Cisplatin		NCI
C156366	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156366	RO	chemotherapy regimen has component Cisplatin	NCI
C156366	RO	chemotherapy regimen has component Trastuzumab	NCI
C12050	STY	Therapeutic or Preventive Procedure		NCI
C12050	PT	Celecoxib/Cisplatin/Fluorouracil		NCI
C12050	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12050	RO	chemotherapy regimen has component Cisplatin	NCI
C12050	RO	chemotherapy regimen has component Fluorouracil	NCI
C12050	RO	chemotherapy regimen has component Celecoxib	NCI
C11382	STY	Therapeutic or Preventive Procedure		NCI
C11382	PT	Cyclophosphamide/Tirapazamine		NCI
C11382	SY	CTX/SR-4233		NCI
C11382	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11382	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11382	RO	chemotherapy regimen has component Tirapazamine	NCI
C9692	STY	Therapeutic or Preventive Procedure		NCI
C9692	PT	Cisplatin/Cyclophosphamide/Dacarbazine/Doxorubicin/Mechlorethamine/Vincristine		NCI
C9692	SY	CDDP/CTX/DOX/DTIC/NM/VCR		NCI
C9692	SY	MADDOC		NCI
C9692	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9692	RO	chemotherapy regimen has component Cisplatin	NCI
C9692	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9692	RO	chemotherapy regimen has component Dacarbazine	NCI
C9692	RO	chemotherapy regimen has component Doxorubicin	NCI
C9692	RO	chemotherapy regimen has component Vincristine	NCI
C9692	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C10211	STY	Therapeutic or Preventive Procedure		NCI
C10211	PT	Cyclophosphamide/Mitoxantrone/Prednisone/Vincristine		NCI
C10211	SY	CNOP		NCI
C10211	SY	CTX/DHAD/PRED/VCR		NCI
C10211	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10211	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10211	RO	chemotherapy regimen has component Prednisone	NCI
C10211	RO	chemotherapy regimen has component Vincristine	NCI
C10211	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C67303	STY	Therapeutic or Preventive Procedure		NCI
C67303	PT	DD-4A Regimen		NCI
C67303	SY	NWTS-DD4A		NCI
C67303	SY	Vincristine-Dactinomycin-Doxorubicin Wilm's Tumor Regimen		NCI
C67303	SY	NWTS DD-4A Regimen		NCI
C67303	CHD	Chemotherapy Regimen Used to Treat Childhood Malignant Renal Neoplasm	NCI
C67303	RO	chemotherapy regimen has component Dactinomycin	NCI
C67303	RO	chemotherapy regimen has component Doxorubicin	NCI
C67303	RO	chemotherapy regimen has component Vincristine	NCI
C67303	RO	regimen has accepted use for disease Childhood Kidney Wilms Tumor	NCI
C37478	STY	Therapeutic or Preventive Procedure		NCI
C37478	PT	Flt3 Ligand/gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Tyrosinase		NCI
C37478	SY	Flt3L/gp100/IFA/MART-1/TYR		NCI
C37478	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37478	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C37478	RO	chemotherapy regimen has component gp100 Antigen	NCI
C37478	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C37478	RO	chemotherapy regimen has component Recombinant Flt3 Ligand	NCI
C37478	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C136269	STY	Therapeutic or Preventive Procedure		NCI
C136269	PT	VTD-PACE Regimen		NCI
C136269	SY	Bortezomib-Thalidomide-Dexamethasone-Cisplatin-Doxorubicin-Cyclophosphamide-Etoposide Regimen		NCI
C136269	SY	VTD-PACE		NCI
C136269	SY	DT-PACE Plus Velcade		NCI
C136269	SY	Velcade/Thalomid/Decadron/Platinol/Adriamycin/Cytoxan/Vepesid Regimen		NCI
C136269	SY	DT-PACE-Bortezomib Regimen		NCI
C136269	SY	VDT-PACE Regimen		NCI
C136269	SY	DT-PACE Plus Bortezomib		NCI
C136269	SY	DT-PACE/Bortezomib Regimen		NCI
C136269	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136269	RO	chemotherapy regimen has component Cisplatin	NCI
C136269	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C136269	RO	chemotherapy regimen has component Dexamethasone	NCI
C136269	RO	chemotherapy regimen has component Etoposide	NCI
C136269	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136269	RO	chemotherapy regimen has component Thalidomide	NCI
C136269	RO	chemotherapy regimen has component Doxorubicin Hydrochloride	NCI
C136269	RO	chemotherapy regimen has component Bortezomib	NCI
C11858	STY	Therapeutic or Preventive Procedure		NCI
C11858	PT	Dexamethasone/Idarubicin		NCI
C11858	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11858	RO	chemotherapy regimen has component Dexamethasone	NCI
C11858	RO	chemotherapy regimen has component Idarubicin	NCI
C11976	STY	Therapeutic or Preventive Procedure		NCI
C11976	PT	Asparaginase/cytarabine/daunorubicin/dexamethasone/methotrexate/prednisolone/vindesine		NCI
C11976	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11976	RO	chemotherapy regimen has component Asparaginase	NCI
C11976	RO	chemotherapy regimen has component Cytarabine	NCI
C11976	RO	chemotherapy regimen has component Dexamethasone	NCI
C11976	RO	chemotherapy regimen has component Methotrexate	NCI
C11976	RO	chemotherapy regimen has component Prednisolone	NCI
C11976	RO	chemotherapy regimen has component Vindesine	NCI
C11976	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C12030	STY	Therapeutic or Preventive Procedure		NCI
C12030	PT	Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Methotrexate/Pegaspargase/Thioguanine/Vincristine		NCI
C12030	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12030	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12030	RO	chemotherapy regimen has component Cytarabine	NCI
C12030	RO	chemotherapy regimen has component Dexamethasone	NCI
C12030	RO	chemotherapy regimen has component Doxorubicin	NCI
C12030	RO	chemotherapy regimen has component Methotrexate	NCI
C12030	RO	chemotherapy regimen has component Thioguanine	NCI
C12030	RO	chemotherapy regimen has component Vincristine	NCI
C12030	RO	chemotherapy regimen has component Pegaspargase	NCI
C37804	STY	Therapeutic or Preventive Procedure		NCI
C37804	PT	Gemcitabine/Oblimersen		NCI
C37804	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37804	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37804	RO	chemotherapy regimen has component Oblimersen	NCI
C11261	STY	Therapeutic or Preventive Procedure		NCI
C11261	PT	Anti-thymocyte Globulin/Melphalan		NCI
C11261	SY	ATG/L-PAM		NCI
C11261	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11261	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11261	RO	chemotherapy regimen has component Melphalan	NCI
C9938	STY	Therapeutic or Preventive Procedure		NCI
C9938	PT	Bleomycin/Doxorubicin/Lomustine/Vincristine		NCI
C9938	SY	BACO		NCI
C9938	SY	BLEO/CCNU/DOX/VCR		NCI
C9938	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9938	RO	chemotherapy regimen has component Bleomycin	NCI
C9938	RO	chemotherapy regimen has component Doxorubicin	NCI
C9938	RO	chemotherapy regimen has component Lomustine	NCI
C9938	RO	chemotherapy regimen has component Vincristine	NCI
C10411	STY	Therapeutic or Preventive Procedure		NCI
C10411	PT	Cisplatin/Cytarabine/Fluorouracil		NCI
C10411	SY	ARA-C/CDDP/5-FU		NCI
C10411	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10411	RO	chemotherapy regimen has component Cisplatin	NCI
C10411	RO	chemotherapy regimen has component Cytarabine	NCI
C10411	RO	chemotherapy regimen has component Fluorouracil	NCI
C10514	STY	Therapeutic or Preventive Procedure		NCI
C10514	PT	Etoposide/Fluorouracil/Leucovorin Calcium		NCI
C10514	SY	CF/5-FU/VP-16		NCI
C10514	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10514	RO	chemotherapy regimen has component Etoposide	NCI
C10514	RO	chemotherapy regimen has component Fluorouracil	NCI
C10514	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12022	STY	Therapeutic or Preventive Procedure		NCI
C12022	PT	Interleukin-2/Montanide ISA-51/Telomerase: 540-548 Peptide Vaccine		NCI
C12022	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12022	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C12022	RO	chemotherapy regimen has component Telomerase: 540-548 Peptide Vaccine	NCI
C12022	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11645	STY	Therapeutic or Preventive Procedure		NCI
C11645	PT	Bryostatin 1/Interleukin-2		NCI
C11645	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11645	RO	chemotherapy regimen has component Bryostatin 1	NCI
C11645	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C150693	STY	Therapeutic or Preventive Procedure		NCI
C150693	PT	Cisplatin/Paclitaxel/Cetuximab Regimen		NCI
C150693	SY	Cisplatin-Paclitaxel-Cetuximab Regimen		NCI
C150693	SY	Cisplatin/Paclitaxel/Cetuximab		NCI
C150693	SY	Cisplatin-Paclitaxel-Cetuximab		NCI
C150693	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C150693	RO	chemotherapy regimen has component Cisplatin	NCI
C150693	RO	chemotherapy regimen has component Paclitaxel	NCI
C150693	RO	chemotherapy regimen has component Cetuximab	NCI
C150693	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C9689	STY	Therapeutic or Preventive Procedure		NCI
C9689	PT	Cisplatin/Etoposide/Vindesine		NCI
C9689	SY	VEP		NCI
C9689	SY	PEV		NCI
C9689	SY	CDDP/DAVA/VP-16		NCI
C9689	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9689	RO	chemotherapy regimen has component Cisplatin	NCI
C9689	RO	chemotherapy regimen has component Etoposide	NCI
C9689	RO	chemotherapy regimen has component Vindesine	NCI
C11130	STY	Therapeutic or Preventive Procedure		NCI
C11130	PT	Amsacrine/Carmustine/Cytarabine/Etoposide		NCI
C11130	SY	AMSA/ARA-C/BCNU/VP-16		NCI
C11130	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11130	RO	chemotherapy regimen has component Amsacrine	NCI
C11130	RO	chemotherapy regimen has component Carmustine	NCI
C11130	RO	chemotherapy regimen has component Cytarabine	NCI
C11130	RO	chemotherapy regimen has component Etoposide	NCI
C10485	STY	Therapeutic or Preventive Procedure		NCI
C10485	PT	Cyclophosphamide/Dexamethasone/Filgrastim/Vincristine		NCI
C10485	SY	CTX/DM/G-CSF/VCR		NCI
C10485	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10485	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10485	RO	chemotherapy regimen has component Dexamethasone	NCI
C10485	RO	chemotherapy regimen has component Vincristine	NCI
C10485	RO	chemotherapy regimen has component Filgrastim	NCI
C10073	STY	Therapeutic or Preventive Procedure		NCI
C10073	PT	Doxorubicin/Fluorouracil/Mitomycin/Triazinate		NCI
C10073	SY	FAM-T		NCI
C10073	SY	DOX/5-FU/MITO/TZT		NCI
C10073	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10073	RO	chemotherapy regimen has component Mitomycin	NCI
C10073	RO	chemotherapy regimen has component Doxorubicin	NCI
C10073	RO	chemotherapy regimen has component Fluorouracil	NCI
C10073	RO	chemotherapy regimen has component Triazinate	NCI
C11473	STY	Therapeutic or Preventive Procedure		NCI
C11473	PT	Docetaxel/Estramustine/Mitoxantrone/Prednisone		NCI
C11473	SY	EM/DHAD/PRED/TXT		NCI
C11473	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11473	RO	chemotherapy regimen has component Estramustine	NCI
C11473	RO	chemotherapy regimen has component Prednisone	NCI
C11473	RO	chemotherapy regimen has component Docetaxel	NCI
C11473	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C63460	STY	Therapeutic or Preventive Procedure		NCI
C63460	PT	ProMACE-CytaBOM Regimen		NCI
C63460	SY	Prednisone-Methotrexate-Adriamycin-Cytoxan-Etoposide-Cytarabine-Bleomycin-Oncovin-Methotrexate Regimen		NCI
C63460	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63460	RO	chemotherapy regimen has component Bleomycin	NCI
C63460	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63460	RO	chemotherapy regimen has component Cytarabine	NCI
C63460	RO	chemotherapy regimen has component Doxorubicin	NCI
C63460	RO	chemotherapy regimen has component Etoposide	NCI
C63460	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C63460	RO	chemotherapy regimen has component Methotrexate	NCI
C63460	RO	chemotherapy regimen has component Prednisone	NCI
C63460	RO	chemotherapy regimen has component Trimethoprim-Sulfamethoxazole	NCI
C63460	RO	chemotherapy regimen has component Vincristine	NCI
C63460	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11136	STY	Therapeutic or Preventive Procedure		NCI
C11136	PT	Doxorubicin/Estramustine		NCI
C11136	SY	DOX/EM		NCI
C11136	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11136	RO	chemotherapy regimen has component Doxorubicin	NCI
C11136	RO	chemotherapy regimen has component Estramustine	NCI
C12173	STY	Therapeutic or Preventive Procedure		NCI
C12173	PT	Carboplatin/UCN-01		NCI
C12173	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12173	RO	chemotherapy regimen has component 7-Hydroxystaurosporine	NCI
C12173	RO	chemotherapy regimen has component Carboplatin	NCI
C153480	STY	Therapeutic or Preventive Procedure		NCI
C153480	PT	Cetuximab/Irinotecan/Vemurafenib Regimen		NCI
C153480	SY	Cetuximab-Irinotecan-Vemurafenib		NCI
C153480	SY	Cetuximab-Irinotecan-Vemurafenib Regimen		NCI
C153480	SY	Irinotecan/Cetuximab/Vemurafenib Regimen		NCI
C153480	SY	Irinotecan + Cetuximab + Vemurafenib Regimen		NCI
C153480	SY	Irinotecan + Cetuximab + Vemurafenib		NCI
C153480	SY	Irinotecan/Cetuximab/Vemurafenib		NCI
C153480	SY	Cetuximab/Irinotecan/Vemurafenib		NCI
C153480	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C153480	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C153480	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C153480	RO	chemotherapy regimen has component Cetuximab	NCI
C153480	RO	chemotherapy regimen has component Vemurafenib	NCI
C37521	STY	Therapeutic or Preventive Procedure		NCI
C37521	PT	Allogeneic Lymphocytes/Interleukin-2/MOv-Gamma Chimeric Receptor Gene		NCI
C37521	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37521	RO	chemotherapy regimen has component Therapeutic Allogeneic Lymphocytes	NCI
C37521	RO	chemotherapy regimen has component MOv-gamma Chimeric Receptor Gene	NCI
C37521	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11835	STY	Therapeutic or Preventive Procedure		NCI
C11835	PT	Dexamethasone/Etoposide/Ifosfamide		NCI
C11835	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11835	RO	chemotherapy regimen has component Dexamethasone	NCI
C11835	RO	chemotherapy regimen has component Etoposide	NCI
C11835	RO	chemotherapy regimen has component Ifosfamide	NCI
C11374	STY	Therapeutic or Preventive Procedure		NCI
C11374	PT	Mycophenolate Mofetil/Tacrolimus		NCI
C11374	SY	FK506/MMF		NCI
C11374	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11374	RO	chemotherapy regimen has component Tacrolimus	NCI
C11374	RO	chemotherapy regimen has component Mycophenolate Mofetil	NCI
C11070	STY	Therapeutic or Preventive Procedure		NCI
C11070	PT	Filgrastim/Fluorouracil/Hydroxyurea/Interferon Alfa		NCI
C11070	SY	5-FU/G-CSF/HU/IFN-A		NCI
C11070	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11070	RO	chemotherapy regimen has component Fluorouracil	NCI
C11070	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11070	RO	chemotherapy regimen has component Filgrastim	NCI
C11070	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C140107	STY	Therapeutic or Preventive Procedure		NCI
C140107	PT	MRT Regimen		NCI
C140107	SY	Methotrexate-Rituximab-Temozolomide		NCI
C140107	SY	MRT		NCI
C140107	SY	Methotrexate/Rituximab/Temozolomide		NCI
C140107	CHD	Chemotherapy Regimen Used to Treat Central Nervous System Neoplasm	NCI
C140107	RO	chemotherapy regimen has component Methotrexate	NCI
C140107	RO	chemotherapy regimen has component Temozolomide	NCI
C140107	RO	chemotherapy regimen has component Rituximab	NCI
C136268	STY	Therapeutic or Preventive Procedure		NCI
C136268	PT	Daratumumab/Lenalidomide/Dexamethasone Regimen		NCI
C136268	SY	Daratumumab-Lenalidomide-Dexamethasone		NCI
C136268	SY	Daratumumab-Lenalidomide-Dexamethasone Regimen		NCI
C136268	SY	Daratumumab/Lenalidomide/Dexamethasone		NCI
C136268	SY	Darzalex/Revlimid/Dexamethasone		NCI
C136268	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136268	RO	chemotherapy regimen has component Dexamethasone	NCI
C136268	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136268	RO	chemotherapy regimen has component Lenalidomide	NCI
C136268	RO	chemotherapy regimen has component Daratumumab	NCI
C9962	STY	Therapeutic or Preventive Procedure		NCI
C9962	PT	Lomustine/Prednisolone/Vincristine		NCI
C9962	SY	CCNU/PRDL/VCR		NCI
C9962	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9962	RO	chemotherapy regimen has component Lomustine	NCI
C9962	RO	chemotherapy regimen has component Prednisolone	NCI
C9962	RO	chemotherapy regimen has component Vincristine	NCI
C63398	STY	Therapeutic or Preventive Procedure		NCI
C63398	PT	FAP Regimen		NCI
C63398	SY	Fluorouracil-Adriamycin-Platinol Regimen		NCI
C63398	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C63398	RO	chemotherapy regimen has component Cisplatin	NCI
C63398	RO	chemotherapy regimen has component Doxorubicin	NCI
C63398	RO	chemotherapy regimen has component Fluorouracil	NCI
C63398	RO	regimen has accepted use for disease Gastric Carcinoma	NCI
C9734	STY	Pharmacologic Substance		NCI
C9734	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide		NCI
C9734	SY	PACE		NCI
C9734	SY	CDDP/CTX/DOX/VP-16		NCI
C9734	SY	CECA		NCI
C9734	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9734	RO	chemotherapy regimen has component Cisplatin	NCI
C9734	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9734	RO	chemotherapy regimen has component Doxorubicin	NCI
C9734	RO	chemotherapy regimen has component Etoposide	NCI
C10897	STY	Therapeutic or Preventive Procedure		NCI
C10897	PT	Leuprolide/Tamoxifen		NCI
C10897	SY	LEUP/TMX		NCI
C10897	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10897	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10897	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C10245	STY	Therapeutic or Preventive Procedure		NCI
C10245	PT	Interferon Gamma/Tumor Necrosis Factor		NCI
C10245	SY	IFN-G/TNF		NCI
C10245	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10245	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C10245	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C11676	STY	Therapeutic or Preventive Procedure		NCI
C11676	PT	Interleukin-2/Montanide ISA-51/Tyrosinase-Related Protein-1		NCI
C11676	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11676	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11676	RO	chemotherapy regimen has component Recombinant Tyrosinase-Related Protein-1	NCI
C11676	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10005	STY	Therapeutic or Preventive Procedure		NCI
C10005	PT	Altretamine/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine		NCI
C10005	SY	CHHOP		NCI
C10005	SY	CTX/DOX/HMM/PRED/VCR		NCI
C10005	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10005	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10005	RO	chemotherapy regimen has component Doxorubicin	NCI
C10005	RO	chemotherapy regimen has component Altretamine	NCI
C10005	RO	chemotherapy regimen has component Prednisone	NCI
C10005	RO	chemotherapy regimen has component Vincristine	NCI
C10045	STY	Therapeutic or Preventive Procedure		NCI
C10045	PT	Cisplatin/Mitoguazone/Vinblastine		NCI
C10045	SY	CDDP/MGBG/VBL		NCI
C10045	SY	CVeM		NCI
C10045	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10045	RO	chemotherapy regimen has component Cisplatin	NCI
C10045	RO	chemotherapy regimen has component Mitoguazone	NCI
C10045	RO	chemotherapy regimen has component Vinblastine	NCI
C10060	STY	Therapeutic or Preventive Procedure		NCI
C10060	PT	Cisplatin/Doxorubicin/Fluorouracil/Leucovorin Calcium		NCI
C10060	SY	CDDP/CF/DOX/5-FU		NCI
C10060	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10060	RO	chemotherapy regimen has component Cisplatin	NCI
C10060	RO	chemotherapy regimen has component Doxorubicin	NCI
C10060	RO	chemotherapy regimen has component Fluorouracil	NCI
C10060	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C123278	STY	Therapeutic or Preventive Procedure		NCI
C123278	PT	COPDAC Regimen		NCI
C123278	SY	COPDAC		NCI
C123278	SY	Cyclophosphamide/Vincristine/Prednisone/Dacarbazine Regimen		NCI
C123278	SY	Cyclophosphamide/Oncovin/Prednisone/Dacarbazine Regimen		NCI
C123278	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C123278	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C123278	RO	chemotherapy regimen has component Dacarbazine	NCI
C123278	RO	chemotherapy regimen has component Prednisone	NCI
C123278	RO	chemotherapy regimen has component Vincristine	NCI
C11397	STY	Therapeutic or Preventive Procedure		NCI
C11397	PT	AG3340/Carboplatin/Paclitaxel		NCI
C11397	SY	AG3340/CBDCA/TAX		NCI
C11397	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11397	RO	chemotherapy regimen has component Carboplatin	NCI
C11397	RO	chemotherapy regimen has component Paclitaxel	NCI
C11397	RO	chemotherapy regimen has component Prinomastat	NCI
C136243	STY	Therapeutic or Preventive Procedure		NCI
C136243	PT	Capecitabine/Bevacizumab Regimen		NCI
C136243	SY	Capecitabine-Bevacizumab Regimen		NCI
C136243	SY	Xeloda-Avastin Regimen		NCI
C136243	SY	Capecitabine-Bevacizumab		NCI
C136243	SY	Capecitabine/Bevacizumab		NCI
C136243	SY	Xeloda/Avastin Regimen		NCI
C136243	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136243	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136243	RO	chemotherapy regimen has component Capecitabine	NCI
C136243	RO	chemotherapy regimen has component Bevacizumab	NCI
C10286	STY	Therapeutic or Preventive Procedure		NCI
C10286	PT	Cisplatin/Ifosfamide		NCI
C10286	SY	CDDP/IFF		NCI
C10286	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10286	RO	chemotherapy regimen has component Cisplatin	NCI
C10286	RO	chemotherapy regimen has component Ifosfamide	NCI
C11673	STY	Therapeutic or Preventive Procedure		NCI
C11673	PT	gp100 Antigen/Interleukin-12/Montanide ISA-51		NCI
C11673	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11673	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11673	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11673	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C37722	STY	Therapeutic or Preventive Procedure		NCI
C37722	PT	Dacarbazine/Monoclonal Antibody Anti-Avb3 Integrin		NCI
C37722	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37722	RO	chemotherapy regimen has component Dacarbazine	NCI
C37722	RO	chemotherapy regimen has component Vitaxin-2	NCI
C37693	STY	Therapeutic or Preventive Procedure		NCI
C37693	PT	Cyclophosphamide/Etoposide/Prednisone		NCI
C37693	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37693	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37693	RO	chemotherapy regimen has component Etoposide	NCI
C37693	RO	chemotherapy regimen has component Prednisone	NCI
C10760	STY	Therapeutic or Preventive Procedure		NCI
C10760	PT	Carmustine/Cyclophosphamide/Etoposide/Melphalan		NCI
C10760	SY	BCNU/CTX/L-PAM/VP-16		NCI
C10760	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10760	RO	chemotherapy regimen has component Carmustine	NCI
C10760	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10760	RO	chemotherapy regimen has component Etoposide	NCI
C10760	RO	chemotherapy regimen has component Melphalan	NCI
C10570	STY	Therapeutic or Preventive Procedure		NCI
C10570	PT	Asparaginase/Dexamethasone/Doxorubicin/Mercaptopurine/Methotrexate/Vincristine		NCI
C10570	SY	ASP/DM/DOX/MP/MTX/VCR		NCI
C10570	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10570	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10570	RO	chemotherapy regimen has component Asparaginase	NCI
C10570	RO	chemotherapy regimen has component Dexamethasone	NCI
C10570	RO	chemotherapy regimen has component Doxorubicin	NCI
C10570	RO	chemotherapy regimen has component Methotrexate	NCI
C10570	RO	chemotherapy regimen has component Vincristine	NCI
C11721	STY	Therapeutic or Preventive Procedure		NCI
C11721	PT	Cisplatin/Rebeccamycin Analogue		NCI
C11721	SY	Cisplatin/Rebeccamycin Analog		NCI
C11721	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11721	RO	chemotherapy regimen has component Cisplatin	NCI
C11721	RO	chemotherapy regimen has component Becatecarin	NCI
C37573	STY	Therapeutic or Preventive Procedure		NCI
C37573	PT	Bortezomib/Fluorouracil/Leucovorin Calcium		NCI
C37573	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37573	RO	chemotherapy regimen has component Fluorouracil	NCI
C37573	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37573	RO	chemotherapy regimen has component Bortezomib	NCI
C11466	STY	Therapeutic or Preventive Procedure		NCI
C11466	PT	Fenretinide/Tretinoin		NCI
C11466	SY	ATRA/HPR		NCI
C11466	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11466	RO	chemotherapy regimen has component Tretinoin	NCI
C11466	RO	chemotherapy regimen has component Fenretinide	NCI
C12000	STY	Therapeutic or Preventive Procedure		NCI
C12000	PT	Carboplatin/Etoposide/Oblimersen		NCI
C12000	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12000	RO	chemotherapy regimen has component Etoposide	NCI
C12000	RO	chemotherapy regimen has component Carboplatin	NCI
C12000	RO	chemotherapy regimen has component Oblimersen	NCI
C37558	STY	Therapeutic or Preventive Procedure		NCI
C37558	PT	Bevacizumab/Fluorouracil		NCI
C37558	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37558	RO	chemotherapy regimen has component Fluorouracil	NCI
C37558	RO	chemotherapy regimen has component Bevacizumab	NCI
C11234	STY	Therapeutic or Preventive Procedure		NCI
C11234	PT	Bryostatin 1/Vincristine		NCI
C11234	SY	BRYO/VCR		NCI
C11234	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11234	RO	chemotherapy regimen has component Vincristine	NCI
C11234	RO	chemotherapy regimen has component Bryostatin 1	NCI
C12047	STY	Therapeutic or Preventive Procedure		NCI
C12047	PT	Carboplatin/Flavopiridol		NCI
C12047	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12047	RO	chemotherapy regimen has component Carboplatin	NCI
C12047	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C10291	STY	Therapeutic or Preventive Procedure		NCI
C10291	PT	Asparaginase/Cytarabine/Daunorubicin/Prednisone/Teniposide/Vincristine		NCI
C10291	SY	ARA-C/ASP/DNR/PRED/VCR/VM-26		NCI
C10291	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10291	RO	chemotherapy regimen has component Asparaginase	NCI
C10291	RO	chemotherapy regimen has component Cytarabine	NCI
C10291	RO	chemotherapy regimen has component Prednisone	NCI
C10291	RO	chemotherapy regimen has component Teniposide	NCI
C10291	RO	chemotherapy regimen has component Vincristine	NCI
C10291	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9885	STY	Therapeutic or Preventive Procedure		NCI
C9885	PT	Cisplatin/Mitotane		NCI
C9885	SY	CDDP/DDD		NCI
C9885	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9885	RO	chemotherapy regimen has component Cisplatin	NCI
C9885	RO	chemotherapy regimen has component Mitotane	NCI
C11390	STY	Therapeutic or Preventive Procedure		NCI
C11390	PT	gp100 Antigen/Tyrosinase Peptide		NCI
C11390	SY	gp100/TYRP		NCI
C11390	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11390	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11390	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C10739	STY	Therapeutic or Preventive Procedure		NCI
C10739	PT	Cytarabine/Mercaptopurine/Methotrexate/Teniposide/Thioguanine		NCI
C10739	SY	ARA-C/MP/MTX/TG/VM-26		NCI
C10739	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10739	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10739	RO	chemotherapy regimen has component Cytarabine	NCI
C10739	RO	chemotherapy regimen has component Methotrexate	NCI
C10739	RO	chemotherapy regimen has component Teniposide	NCI
C10739	RO	chemotherapy regimen has component Thioguanine	NCI
C10533	STY	Therapeutic or Preventive Procedure		NCI
C10533	PT	Melphalan/Vincristine		NCI
C10533	SY	L-PAM/VCR		NCI
C10533	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10533	RO	chemotherapy regimen has component Melphalan	NCI
C10533	RO	chemotherapy regimen has component Vincristine	NCI
C10864	STY	Therapeutic or Preventive Procedure		NCI
C10864	PT	Cytarabine/Idarubicin/Sargramostim		NCI
C10864	SY	ARA-C/GM-CSF/IDA		NCI
C10864	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10864	RO	chemotherapy regimen has component Cytarabine	NCI
C10864	RO	chemotherapy regimen has component Idarubicin	NCI
C10864	RO	chemotherapy regimen has component Sargramostim	NCI
C11123	STY	Therapeutic or Preventive Procedure		NCI
C11123	PT	Cyclophosphamide/Daunorubicin		NCI
C11123	SY	Cyclophosphamide/Daunomycin		NCI
C11123	SY	CTX/DNR		NCI
C11123	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11123	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11123	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C12123	STY	Therapeutic or Preventive Procedure		NCI
C12123	PT	Capecitabine/Gemcitabine		NCI
C12123	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12123	RO	chemotherapy regimen has component Capecitabine	NCI
C12123	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10891	STY	Therapeutic or Preventive Procedure		NCI
C10891	PT	Carboplatin/Filgrastim/Interleukin-6/Paclitaxel		NCI
C10891	SY	CBDCA/G-CSF/IL-6/TAX		NCI
C10891	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10891	RO	chemotherapy regimen has component Carboplatin	NCI
C10891	RO	chemotherapy regimen has component Paclitaxel	NCI
C10891	RO	chemotherapy regimen has component Filgrastim	NCI
C10891	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C10692	STY	Therapeutic or Preventive Procedure		NCI
C10692	PT	Cytarabine/Fludarabine/Idarubicin		NCI
C10692	SY	ARA-C/FAMP/IDA		NCI
C10692	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10692	RO	chemotherapy regimen has component Cytarabine	NCI
C10692	RO	chemotherapy regimen has component Idarubicin	NCI
C10692	RO	chemotherapy regimen has component Fludarabine	NCI
C9797	STY	Therapeutic or Preventive Procedure		NCI
C9797	PT	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Methotrexate/Thioguanine/Vincristine		NCI
C9797	SY	ARA-C/ASP/CTX/DM/DOX/MTX/TG/VCR		NCI
C9797	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9797	RO	chemotherapy regimen has component Asparaginase	NCI
C9797	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9797	RO	chemotherapy regimen has component Cytarabine	NCI
C9797	RO	chemotherapy regimen has component Dexamethasone	NCI
C9797	RO	chemotherapy regimen has component Doxorubicin	NCI
C9797	RO	chemotherapy regimen has component Methotrexate	NCI
C9797	RO	chemotherapy regimen has component Thioguanine	NCI
C9797	RO	chemotherapy regimen has component Vincristine	NCI
C11834	STY	Therapeutic or Preventive Procedure		NCI
C11834	PT	Cytarabine/Dexamethasone/Leucovorin Calcium/Methotrexate		NCI
C11834	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11834	RO	chemotherapy regimen has component Cytarabine	NCI
C11834	RO	chemotherapy regimen has component Dexamethasone	NCI
C11834	RO	chemotherapy regimen has component Methotrexate	NCI
C11834	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11893	STY	Therapeutic or Preventive Procedure		NCI
C11893	PT	Carboplatin/Fluorouracil/Paclitaxel		NCI
C11893	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11893	RO	chemotherapy regimen has component Fluorouracil	NCI
C11893	RO	chemotherapy regimen has component Carboplatin	NCI
C11893	RO	chemotherapy regimen has component Paclitaxel	NCI
C37490	STY	Therapeutic or Preventive Procedure		NCI
C37490	PT	gp100 Antigen/Melan-A/NA17-A Antigen/Tyrosinase Peptide		NCI
C37490	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37490	RO	chemotherapy regimen has component gp100 Antigen	NCI
C37490	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C37490	RO	chemotherapy regimen has component NA17-A Antigen	NCI
C37490	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11328	STY	Therapeutic or Preventive Procedure		NCI
C11328	PT	Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase Related Protein-1		NCI
C11328	SY	GM-CSF/IFA/TRP-1		NCI
C11328	SY	Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase-Related Protein-1		NCI
C11328	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11328	RO	chemotherapy regimen has component Sargramostim	NCI
C11328	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11328	RO	chemotherapy regimen has component Recombinant Tyrosinase-Related Protein-1	NCI
C11751	STY	Therapeutic or Preventive Procedure		NCI
C11751	PT	MUC-2-KLH Vaccine/QS21		NCI
C11751	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11751	RO	chemotherapy regimen has component QS21	NCI
C11751	RO	chemotherapy regimen has component MUC-2-KLH Vaccine	NCI
C10069	STY	Therapeutic or Preventive Procedure		NCI
C10069	PT	Melphalan/Methylprednisolone/Vincristine		NCI
C10069	SY	L-PAM/MePRDL/VCR		NCI
C10069	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10069	RO	chemotherapy regimen has component Melphalan	NCI
C10069	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10069	RO	chemotherapy regimen has component Vincristine	NCI
C63361	STY	Therapeutic or Preventive Procedure		NCI
C63361	PT	Chemotherapy Regimen Used to Treat Gastric Carcinoma		NCI
C63361	CHD	Chemotherapy Regimen	NCI
C63361	PAR	ECF Regimen	NCI
C63361	PAR	PELF Regimen	NCI
C63361	PAR	FLAP Regimen	NCI
C63361	PAR	FAMTX Regimen	NCI
C63361	PAR	FAP Regimen	NCI
C63361	PAR	ELF Regimen	NCI
C63361	PAR	FAM Regimen	NCI
C63361	PAR	FUP Regimen	NCI
C63361	PAR	FU-LV Regimen	NCI
C63361	PAR	TPF Regimen	NCI
C63361	PAR	Cisplatin/Fluorouracil/Trastuzumab Regimen	NCI
C63361	PAR	Capecitabine/Cisplatin Regimen	NCI
C63361	PAR	ECX Regimen	NCI
C63361	PAR	EOX Regimen	NCI
C9586	STY	Therapeutic or Preventive Procedure		NCI
C9586	PT	Carmustine/Doxorubicin/Prednisone/Vindesine		NCI
C9586	SY	BCNU/DAVA/DOX/PRED		NCI
C9586	SY	EBAP		NCI
C9586	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9586	RO	chemotherapy regimen has component Carmustine	NCI
C9586	RO	chemotherapy regimen has component Doxorubicin	NCI
C9586	RO	chemotherapy regimen has component Prednisone	NCI
C9586	RO	chemotherapy regimen has component Vindesine	NCI
C9698	STY	Therapeutic or Preventive Procedure		NCI
C9698	PT	Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine		NCI
C9698	SY	BACOD		NCI
C9698	SY	BLEO/CTX/DM/DOX/VCR		NCI
C9698	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9698	RO	chemotherapy regimen has component Bleomycin	NCI
C9698	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9698	RO	chemotherapy regimen has component Dexamethasone	NCI
C9698	RO	chemotherapy regimen has component Doxorubicin	NCI
C9698	RO	chemotherapy regimen has component Vincristine	NCI
C10795	STY	Therapeutic or Preventive Procedure		NCI
C10795	PT	Cytarabine/Etoposide/Ifosfamide/Methotrexate/Prednisolone		NCI
C10795	SY	ARA-C/IFF/MTX/PRDL/VP-16		NCI
C10795	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10795	RO	chemotherapy regimen has component Cytarabine	NCI
C10795	RO	chemotherapy regimen has component Etoposide	NCI
C10795	RO	chemotherapy regimen has component Ifosfamide	NCI
C10795	RO	chemotherapy regimen has component Methotrexate	NCI
C10795	RO	chemotherapy regimen has component Prednisolone	NCI
C67299	STY	Therapeutic or Preventive Procedure		NCI
C67299	PT	VAC Regimen		NCI
C67299	SY	Vincristine/Dactinomycin/Cyclophosphamide		NCI
C67299	SY	VAC		NCI
C67299	SY	Vincristine/Actinomycin-D/Cyclophosphamide		NCI
C67299	CHD	Chemotherapy Regimen Used to Treat Childhood Rhabdomyosarcoma	NCI
C67299	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67299	RO	chemotherapy regimen has component Dactinomycin	NCI
C67299	RO	chemotherapy regimen has component Vincristine	NCI
C67299	RO	regimen has accepted use for disease Childhood Rhabdomyosarcoma	NCI
C37607	STY	Therapeutic or Preventive Procedure		NCI
C37607	PT	Carboplatin/Etoposide/Filgrastim		NCI
C37607	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37607	RO	chemotherapy regimen has component Etoposide	NCI
C37607	RO	chemotherapy regimen has component Carboplatin	NCI
C37607	RO	chemotherapy regimen has component Filgrastim	NCI
C10270	STY	Therapeutic or Preventive Procedure		NCI
C10270	PT	Cyclophosphamide/Cytarabine/Prednisone/Thioguanine/Vincristine		NCI
C10270	SY	ARA-C/CTX/PRED/TG/VCR		NCI
C10270	SY	T-COAP		NCI
C10270	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10270	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10270	RO	chemotherapy regimen has component Cytarabine	NCI
C10270	RO	chemotherapy regimen has component Prednisone	NCI
C10270	RO	chemotherapy regimen has component Thioguanine	NCI
C10270	RO	chemotherapy regimen has component Vincristine	NCI
C9956	STY	Therapeutic or Preventive Procedure		NCI
C9956	PT	Carmustine/Procarbazine/Vincristine		NCI
C9956	SY	BCNU/PCB/VCR		NCI
C9956	SY	BVP		NCI
C9956	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9956	RO	chemotherapy regimen has component Carmustine	NCI
C9956	RO	chemotherapy regimen has component Vincristine	NCI
C9956	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9946	STY	Therapeutic or Preventive Procedure		NCI
C9946	PT	Bleomycin/Doxorubicin/Streptozocin/Vincristine		NCI
C9946	SY	BAVS		NCI
C9946	SY	BLEO/DOX/SZC/VCR		NCI
C9946	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9946	RO	chemotherapy regimen has component Bleomycin	NCI
C9946	RO	chemotherapy regimen has component Doxorubicin	NCI
C9946	RO	chemotherapy regimen has component Streptozocin	NCI
C9946	RO	chemotherapy regimen has component Vincristine	NCI
C37779	STY	Therapeutic or Preventive Procedure		NCI
C37779	PT	Floxuridine/Irinotecan		NCI
C37779	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37779	RO	chemotherapy regimen has component Floxuridine	NCI
C37779	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11319	STY	Therapeutic or Preventive Procedure		NCI
C11319	PT	Cyclosporine/Mycophenolate Mofetil		NCI
C11319	SY	CYSP/MMF		NCI
C11319	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11319	RO	chemotherapy regimen has component Cyclosporine	NCI
C11319	RO	chemotherapy regimen has component Mycophenolate Mofetil	NCI
C10531	STY	Therapeutic or Preventive Procedure		NCI
C10531	PT	Cisplatin/Fluorouracil/Mitomycin/Vindesine		NCI
C10531	SY	CDDP/DAVA/5-FU/MITO		NCI
C10531	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10531	RO	chemotherapy regimen has component Mitomycin	NCI
C10531	RO	chemotherapy regimen has component Cisplatin	NCI
C10531	RO	chemotherapy regimen has component Fluorouracil	NCI
C10531	RO	chemotherapy regimen has component Vindesine	NCI
C37694	STY	Therapeutic or Preventive Procedure		NCI
C37694	PT	Cyclophosphamide/Filgrastim/Rituximab		NCI
C37694	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37694	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37694	RO	chemotherapy regimen has component Filgrastim	NCI
C37694	RO	chemotherapy regimen has component Rituximab	NCI
C11479	STY	Therapeutic or Preventive Procedure		NCI
C11479	PT	Cytarabine/Etoposide/Melphalan		NCI
C11479	SY	ARA-C/L-PAM/VP-16		NCI
C11479	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11479	RO	chemotherapy regimen has component Cytarabine	NCI
C11479	RO	chemotherapy regimen has component Etoposide	NCI
C11479	RO	chemotherapy regimen has component Melphalan	NCI
C10122	STY	Therapeutic or Preventive Procedure		NCI
C10122	PT	Lomustine/Mitolactol/Procarbazine/Thioguanine/Vincristine		NCI
C10122	SY	CCNU/DBD/PCB/TG/VCR		NCI
C10122	SY	TPDCV		NCI
C10122	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10122	RO	chemotherapy regimen has component Lomustine	NCI
C10122	RO	chemotherapy regimen has component Mitolactol	NCI
C10122	RO	chemotherapy regimen has component Thioguanine	NCI
C10122	RO	chemotherapy regimen has component Vincristine	NCI
C10122	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11622	STY	Therapeutic or Preventive Procedure		NCI
C11622	PT	Lomustine/Procarbazine		NCI
C11622	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11622	RO	chemotherapy regimen has component Lomustine	NCI
C11622	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10394	STY	Therapeutic or Preventive Procedure		NCI
C10394	PT	Carboplatin/Doxorubicin		NCI
C10394	SY	CBDCA/DOX		NCI
C10394	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10394	RO	chemotherapy regimen has component Doxorubicin	NCI
C10394	RO	chemotherapy regimen has component Carboplatin	NCI
C37605	STY	Therapeutic or Preventive Procedure		NCI
C37605	PT	Carboplatin/Dexamethasone/Gemcitabine		NCI
C37605	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37605	RO	chemotherapy regimen has component Dexamethasone	NCI
C37605	RO	chemotherapy regimen has component Carboplatin	NCI
C37605	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37787	STY	Therapeutic or Preventive Procedure		NCI
C37787	PT	Fluorouracil/Leucovorin Calcium/Oxaliplatin/ZD6126		NCI
C37787	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37787	RO	chemotherapy regimen has component Fluorouracil	NCI
C37787	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37787	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37787	RO	chemotherapy regimen has component Vascular Disrupting Agent ZD6126	NCI
C11371	STY	Therapeutic or Preventive Procedure		NCI
C11371	PT	Fludarabine/Rituximab		NCI
C11371	SY	rituximab/fludarabine		NCI
C11371	SY	FAMP/MOAB IDEC-C2B8		NCI
C11371	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11371	RO	chemotherapy regimen has component Fludarabine	NCI
C11371	RO	chemotherapy regimen has component Rituximab	NCI
C9815	STY	Therapeutic or Preventive Procedure		NCI
C9815	PT	Asparaginase/Doxorubicin/Mercaptopurine/Prednisone/Vincristine		NCI
C9815	SY	ASP/DOX/MP/PRED/VCR		NCI
C9815	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9815	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9815	RO	chemotherapy regimen has component Asparaginase	NCI
C9815	RO	chemotherapy regimen has component Doxorubicin	NCI
C9815	RO	chemotherapy regimen has component Prednisone	NCI
C9815	RO	chemotherapy regimen has component Vincristine	NCI
C156367	STY	Therapeutic or Preventive Procedure		NCI
C156367	PT	Anastrozole/Palbociclib Regimen		NCI
C156367	SY	Anastrozole-Palbociclib		NCI
C156367	SY	Arimidex/Ibrance		NCI
C156367	SY	Palbociclib-Anastrozole		NCI
C156367	SY	Anastrozole/Palbociclib		NCI
C156367	SY	Palbociclib/Anastrozole		NCI
C156367	SY	Palbociclib/Anastrozole Regimen		NCI
C156367	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156367	RO	chemotherapy regimen has component Anastrozole	NCI
C156367	RO	chemotherapy regimen has component Palbociclib	NCI
C11245	STY	Therapeutic or Preventive Procedure		NCI
C11245	PT	Carboplatin/Cyclophosphamide/Etoposide/Filgrastim/Paclitaxel		NCI
C11245	SY	CBDCA/CTX/G-CSF/TAX/VP-16		NCI
C11245	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11245	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11245	RO	chemotherapy regimen has component Etoposide	NCI
C11245	RO	chemotherapy regimen has component Carboplatin	NCI
C11245	RO	chemotherapy regimen has component Paclitaxel	NCI
C11245	RO	chemotherapy regimen has component Filgrastim	NCI
C11039	STY	Therapeutic or Preventive Procedure		NCI
C11039	PT	Interferon Alfa/Interleukin-2/Tumor Necrosis Factor		NCI
C11039	SY	IFN-A/IL-2/TNF		NCI
C11039	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11039	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11039	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11039	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C11514	STY	Therapeutic or Preventive Procedure		NCI
C11514	PT	Cisplatin/OXi-104		NCI
C11514	SY	CDDP/OXi-104		NCI
C11514	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11514	RO	chemotherapy regimen has component Cisplatin	NCI
C11514	RO	chemotherapy regimen has component Declopramide	NCI
C11351	STY	Therapeutic or Preventive Procedure		NCI
C11351	PT	Carboplatin/Thiotepa/Topotecan		NCI
C11351	SY	CBDCA/TOPO/TSPA		NCI
C11351	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11351	RO	chemotherapy regimen has component Thiotepa	NCI
C11351	RO	chemotherapy regimen has component Carboplatin	NCI
C11351	RO	chemotherapy regimen has component Topotecan	NCI
C37739	STY	Therapeutic or Preventive Procedure		NCI
C37739	PT	Docetaxel/Doxorubicin/Oblimersen		NCI
C37739	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37739	RO	chemotherapy regimen has component Doxorubicin	NCI
C37739	RO	chemotherapy regimen has component Docetaxel	NCI
C37739	RO	chemotherapy regimen has component Oblimersen	NCI
C11493	STY	Therapeutic or Preventive Procedure		NCI
C11493	PT	Dexamethasone/Rituximab		NCI
C11493	SY	DM/MOAB IDEC-C2B8		NCI
C11493	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11493	RO	chemotherapy regimen has component Dexamethasone	NCI
C11493	RO	chemotherapy regimen has component Rituximab	NCI
C11480	STY	Therapeutic or Preventive Procedure		NCI
C11480	PT	Cytarabine/Daunorubicin/Filgrastim		NCI
C11480	SY	ARA-C/DNR/G-CSF		NCI
C11480	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11480	RO	chemotherapy regimen has component Cytarabine	NCI
C11480	RO	chemotherapy regimen has component Filgrastim	NCI
C11480	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11774	STY	Therapeutic or Preventive Procedure		NCI
C11774	PT	Carboplatin/Docetaxel/Estramustine		NCI
C11774	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11774	RO	chemotherapy regimen has component Estramustine	NCI
C11774	RO	chemotherapy regimen has component Carboplatin	NCI
C11774	RO	chemotherapy regimen has component Docetaxel	NCI
C9751	STY	Therapeutic or Preventive Procedure		NCI
C9751	PT	Maxamine/Interleukin-2		NCI
C9751	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9751	RO	chemotherapy regimen has component Histamine Dihydrochloride	NCI
C9751	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10647	STY	Therapeutic or Preventive Procedure		NCI
C10647	PT	Dexamethasone/Floxuridine/Leucovorin Calcium		NCI
C10647	SY	CF/DM/FUDR		NCI
C10647	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10647	RO	chemotherapy regimen has component Dexamethasone	NCI
C10647	RO	chemotherapy regimen has component Floxuridine	NCI
C10647	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10541	STY	Therapeutic or Preventive Procedure		NCI
C10541	PT	Cisplatin/Cyclophosphamide/Etoposide/Interleukin-2/Sargramostim		NCI
C10541	SY	CDDP/CTX/GM-CSF/IL-2/VP-16		NCI
C10541	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10541	RO	chemotherapy regimen has component Cisplatin	NCI
C10541	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10541	RO	chemotherapy regimen has component Etoposide	NCI
C10541	RO	chemotherapy regimen has component Sargramostim	NCI
C10541	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10588	STY	Therapeutic or Preventive Procedure		NCI
C10588	PT	Doxorubicin/Trifluoperazine/Vinblastine/Verapamil		NCI
C10588	SY	DOX/Trifluoperazine/VBL/VPAM		NCI
C10588	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10588	RO	chemotherapy regimen has component Doxorubicin	NCI
C10588	RO	chemotherapy regimen has component Verapamil	NCI
C10588	RO	chemotherapy regimen has component Vinblastine	NCI
C10588	RO	chemotherapy regimen has component Trifluoperazine Hydrochloride	NCI
C61063	STY	Therapeutic or Preventive Procedure		NCI
C61063	PT	Agent Combination Not Indexed in Open Clinical Trials		NCI
C61063	CHD	Agent Combination	NCI
C61063	PAR	Cytarabine/Doxorubicin	NCI
C61063	PAR	Cyclophosphamide/Dactinomycin/Fluorouracil	NCI
C61063	PAR	Melphalan/Thiotepa	NCI
C61063	PAR	Dacarbazine/Doxorubicin	NCI
C61063	PAR	Cytarabine/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Methotrexate	NCI
C61063	PAR	Amsacrine/Cytarabine/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Doxorubicin/Vindesine	NCI
C61063	PAR	Amsacrine/Cytarabine/Thioguanine	NCI
C61063	PAR	Doxorubicin/Mitomycin/Vinblastine	NCI
C61063	PAR	Bleomycin/Dacarbazine/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Doxorubicin/Lomustine/Mechlorethamine/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Dactinomycin	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Prednisone	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Bleomycin/Cisplatin/Ifosfamide	NCI
C61063	PAR	Bleomycin/Cisplatin/Mitomycin/Vincristine	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Prednisone/Procarbazine/Vinblastine	NCI
C61063	PAR	Lomustine/Methotrexate/Procarbazine	NCI
C61063	PAR	Carboplatin/Cyclophosphamide	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Methotrexate	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Methotrexate/Procarbazine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Fluorouracil	NCI
C61063	PAR	Cyclophosphamide/Lomustine/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Lomustine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Lomustine/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Epirubicin	NCI
C61063	PAR	Cyclophosphamide/Epirubicin/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Prednisone	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Prednisone/Teniposide	NCI
C61063	PAR	Cisplatin/Fluorouracil/Methotrexate	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Fluorouracil/Methotrexate	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Cisplatin/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Procarbazine/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Lomustine/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide	NCI
C61063	PAR	Altretamine/Cisplatin/Cyclophosphamide/Doxorubicin	NCI
C61063	PAR	Bleomycin/Cisplatin/Vindesine	NCI
C61063	PAR	Cyclophosphamide/Dacarbazine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Prednisone/Procarbazine/Vinblastine	NCI
C61063	PAR	Lomustine/Prednisone/Procarbazine/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Dacarbazine/Doxorubicin/Vincristine	NCI
C61063	PAR	Doxorubicin/Fluoxymesterone/Mitolactol/Vincristine	NCI
C61063	PAR	Cytarabine/Daunorubicin/Mercaptopurine/Prednisolone	NCI
C61063	PAR	Bleomycin/Cisplatin	NCI
C61063	PAR	Doxorubicin/Procarbazine/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Doxorubicin/Etoposide	NCI
C61063	PAR	Carmustine/Doxorubicin/Prednisone/Vindesine	NCI
C61063	PAR	Epirubicin/Bleomycin/Vinblastine/Prednisone	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Vincristine	NCI
C61063	PAR	Carmustine/Doxorubicin/Fluorouracil	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Tegafur	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Mitomycin	NCI
C61063	PAR	Cisplatin/Doxorubicin/Fluorouracil/Mitomycin	NCI
C61063	PAR	Cisplatin/Doxorubicin/Fluorouracil	NCI
C61063	PAR	Fluorouracil/Mitomycin/Vincristine	NCI
C61063	PAR	Altretamine/Cisplatin/Doxorubicin	NCI
C61063	PAR	Altretamine/Cyclophosphamide/Fluorouracil/Methotrexate	NCI
C61063	PAR	Bleomycin/Cytarabine/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Doxorubicin/Ifosfamide	NCI
C61063	PAR	Chlorambucil/Fluorouracil/Methotrexate	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Melphalan/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Epirubicin/Methotrexate/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Dactinomycin/Methotrexate	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Lomustine/Methotrexate	NCI
C61063	PAR	Bleomycin/Cisplatin/Methotrexate	NCI
C61063	PAR	Cyclophosphamide/Lomustine/Methotrexate	NCI
C61063	PAR	Altretamine/Cisplatin/Etoposide/Mitomycin	NCI
C61063	PAR	Cyclophosphamide/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Methotrexate	NCI
C61063	PAR	Etoposide/Ifosfamide/Methotrexate/Mitoguazone	NCI
C61063	PAR	Fluorouracil/Semustine/Vincristine	NCI
C61063	PAR	Fluorouracil/Semustine/Streptozocin/Vincristine	NCI
C61063	PAR	Mechlorethamine/Procarbazine/Vincristine	NCI
C61063	PAR	Bleomycin/Doxorubicin/Mechlorethamine/Prednisone/Procarbazine/Vinblastine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Vincristine	NCI
C61063	PAR	Mechlorethamine/Prednisone/Procarbazine/Vinblastine	NCI
C61063	PAR	Mechlorethamine/Prednisone/Procarbazine/Vinblastine/Vincristine	NCI
C61063	PAR	Cytarabine/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Cyclophosphamide/Lomustine/Procarbazine/Vincristine	NCI
C61063	PAR	Ifosfamide/Methotrexate/Procarbazine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Cisplatin/Vinblastine	NCI
C61063	PAR	Bleomycin/Cisplatin/Etoposide/Vinblastine	NCI
C61063	PAR	Cytarabine/Daunorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Doxorubicin/Lomustine/Streptozocin	NCI
C61063	PAR	Doxorubicin/Fluoxymesterone/Thiotepa/Vinblastine	NCI
C61063	PAR	Bleomycin/Cisplatin/Dactinomycin/Vinblastine	NCI
C61063	PAR	Bleomycin/Dactinomycin/Vinblastine	NCI
C61063	PAR	Bleomycin/Chlorambucil/Cisplatin/Cyclophosphamide/Dactinomycin/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Dactinomycin/Doxorubicin/Vincristine	NCI
C61063	PAR	Doxorubicin/Etoposide	NCI
C61063	PAR	Doxorubicin/Procarbazine/Vincristine	NCI
C61063	PAR	Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Prednisolone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Doxorubicin/Etoposide/Vincristine	NCI
C61063	PAR	Bleomycin/Doxorubicin/Vinblastine	NCI
C61063	PAR	Carmustine/Dexamethasone/Doxorubicin/Melphalan/Vincristine	NCI
C61063	PAR	Carmustine/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Prednisolone/Vincristine	NCI
C61063	PAR	Daunorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Interleukin-2	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Methotrexate/Prednisolone/Vincristine	NCI
C61063	PAR	Bleomycin/Cisplatin/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Melphalan/Prednisone/Vincristine	NCI
C61063	PAR	Fluorouracil/Methotrexate/Vincristine	NCI
C61063	PAR	Etoposide/Methotrexate/Vincristine	NCI
C61063	PAR	Prednisolone/Vincristine	NCI
C61063	PAR	Bleomycin/Dacarbazine/Doxorubicin/Lomustine/Prednisone	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine	NCI
C61063	PAR	Fluorouracil/Mitomycin/Streptozocin	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Methotrexate/Vincristine	NCI
C61063	PAR	Bleomycin/Carboplatin/Etoposide	NCI
C61063	PAR	Epirubicin/Fluorouracil/Mitomycin	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Dexamethasone/Methotrexate/Mitoxantrone/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vincristine	NCI
C61063	PAR	Amsacrine/Azacitidine/Etoposide	NCI
C61063	PAR	Chlorambucil/Dactinomycin/Methotrexate	NCI
C61063	PAR	Fluorouracil/Methotrexate/Mitoxantrone	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Mechlorethamine/Methotrexate/Prednisone/Procarbazine/Vincristine	NCI
C61063	PAR	Cisplatin/Etoposide/Methotrexate	NCI
C61063	PAR	Asparaginase/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Vincristine	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Cytarabine/Etoposide	NCI
C61063	PAR	Cyclophosphamide/Mechlorethamine/Prednisone/Procarbazine/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Vincristine	NCI
C61063	PAR	Cisplatin/Etoposide/Fluorouracil	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Mitoxantrone	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Dacarbazine/Doxorubicin/Mechlorethamine/Vincristine	NCI
C61063	PAR	Cisplatin/Etoposide/Vinblastine	NCI
C61063	PAR	Bleomycin/Cisplatin/Methotrexate/Vinblastine	NCI
C61063	PAR	Doxorubicin/Fluoxymesterone/Mitolactol/Tamoxifen/Vincristine	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Doxorubicin/Melphalan	NCI
C61063	PAR	Cyclophosphamide/Dacarbazine/Doxorubicin	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Mitomycin/Streptozocin	NCI
C61063	PAR	Melphalan/Procarbazine/Vinblastine	NCI
C61063	PAR	Fluorouracil/Methotrexate/Thiotepa	NCI
C61063	PAR	Cisplatin/Doxorubicin/Ifosfamide/Methotrexate	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Mitoxantrone	NCI
C61063	PAR	Mitoxantrone/Prednisone/Procarbazine/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Teniposide/Vincristine	NCI
C61063	PAR	Doxorubicin/Etoposide/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Lomustine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Interferon Alfa/Tamoxifen	NCI
C61063	PAR	Amsacrine/Cytarabine	NCI
C61063	PAR	Azacitidine/Etoposide	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisone	NCI
C61063	PAR	Bleomycin/Lomustine/Methotrexate	NCI
C61063	PAR	Bleomycin/Lomustine/Methotrexate/Vinblastine	NCI
C61063	PAR	Amsacrine/Cyclophosphamide/Etoposide	NCI
C61063	PAR	Cisplatin/Cytarabine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Prednisone	NCI
C61063	PAR	Etoposide/Vincristine	NCI
C61063	PAR	Interleukin-2/Poly ICLC	NCI
C61063	PAR	Interferon Gamma/Interleukin-2	NCI
C61063	PAR	Asparaginase/Mercaptopurine/Prednisone/Vincristine	NCI
C61063	PAR	Cytarabine/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Carmustine/Cisplatin/Cyclophosphamide	NCI
C61063	PAR	Fluorouracil/Idoxuridine	NCI
C61063	PAR	Interleukin-2/Zidovudine	NCI
C61063	PAR	Asparaginase/Etoposide/Prednisone/Vincristine	NCI
C61063	PAR	Fluorouracil/Methylmercaptopurine Riboside/PALA	NCI
C61063	PAR	Doxorubicin/Interleukin-2	NCI
C61063	PAR	Cyclophosphamide/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Busulfan/Cyclophosphamide/Etoposide	NCI
C61063	PAR	Carmustine/Cisplatin/Etoposide	NCI
C61063	PAR	Cisplatin/Mitolactol	NCI
C61063	PAR	Cytarabine/Methotrexate/Methylprednisolone	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Doxorubicin/Hydroxyurea/Lomustine/Methotrexate/Thioguanine/Vincristine	NCI
C61063	PAR	Cisplatin/Dacarbazine	NCI
C61063	PAR	Interferon Beta/Interleukin-2	NCI
C61063	PAR	Interferon Beta/Interferon Gamma	NCI
C61063	PAR	Dacarbazine/Etoposide/Hydroxyurea	NCI
C61063	PAR	Carboplatin/Fluorouracil	NCI
C61063	PAR	Carboplatin/Etoposide/Thiotepa	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate/Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Dactinomycin/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Thiotepa	NCI
C61063	PAR	Carboplatin/Cisplatin/Cyclophosphamide	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Levamisole	NCI
C61063	PAR	Asparaginase/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Asparaginase/Doxorubicin/Mercaptopurine/Prednisone/Vincristine	NCI
C61063	PAR	Fluorouracil/Methotrexate/Mitomycin	NCI
C61063	PAR	Mercaptopurine/Methotrexate/Prednisone/Vindesine	NCI
C61063	PAR	Doxorubicin/Ifosfamide	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Interferon alfa/Interleukin-2/Lymphokine-Activated Killer Cells	NCI
C61063	PAR	Cisplatin/Teniposide	NCI
C61063	PAR	Cisplatin/Cytarabine/Etoposide/Vinblastine	NCI
C61063	PAR	Ifosfamide/Lomustine/Vinblastine	NCI
C61063	PAR	Bleomycin/Lomustine	NCI
C61063	PAR	Doxorubicin/Floxuridine	NCI
C61063	PAR	Asparaginase/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Dexamethasone/Methotrexate/Thioguanine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Thioguanine/Vincristine	NCI
C61063	PAR	Fluorouracil/Streptozocin	NCI
C61063	PAR	Doxorubicin/Mitolactol	NCI
C61063	PAR	Amsacrine/Etoposide	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Buserelin/Tamoxifen	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Mercaptopurine/Methotrexate/Pentostatin	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Menogaril	NCI
C61063	PAR	Aminoglutethimide/Megestrol	NCI
C61063	PAR	Cisplatin/Trimetrexate Glucuronate	NCI
C61063	PAR	Etoposide/Trimetrexate Glucuronate	NCI
C61063	PAR	Carmustine/Cisplatin	NCI
C61063	PAR	Asparaginase/Cytarabine/Daunorubicin/Methotrexate/Prednisone/Teniposide/Vincristine	NCI
C61063	PAR	Cytarabine/Sargramostim	NCI
C61063	PAR	Amsacrine/Cytarabine/Daunorubicin	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Vincristine	NCI
C61063	PAR	Dexamethasone/Methotrexate/Zidovudine	NCI
C61063	PAR	Doxorubicin/Ifosfamide/Sargramostim	NCI
C61063	PAR	Cisplatin/Etoposide/Interleukin-2/Lymphokine-Activated Killer Cells	NCI
C61063	PAR	Doxorubicin/Prednisone	NCI
C61063	PAR	Doxorubicin/Etoposide/Quinidine	NCI
C61063	PAR	Fluorouracil/Methotrexate/Tamoxifen	NCI
C61063	PAR	Etoposide/Methotrexate/Mitomycin	NCI
C61063	PAR	Cyclophosphamide/Etanidazole	NCI
C61063	PAR	Fludarabine/Pentostatin	NCI
C61063	PAR	Diaziquone/Mitoxantrone	NCI
C61063	PAR	Pegaspargase/Prednisone/Vincristine	NCI
C61063	PAR	Diaziquone/Etoposide	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Melphalan	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Methylprednisolone/Prednisone/Vincristine	NCI
C61063	PAR	Asparaginase/Cytarabine/Doxorubicin/Teniposide	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Teniposide	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Daunorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Asparaginase/Cytarabine/Carmustine/Thioguanine	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Cytarabine/Daunorubicin/Hydroxyurea/Methotrexate/Thioguanine/Vincristine	NCI
C61063	PAR	Asparaginase/Cytarabine/Methotrexate/Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Cisplatin/Cytarabine/Etoposide	NCI
C61063	PAR	Indomethacin/Interleukin-1-Alpha	NCI
C61063	PAR	Mitoxantrone/Sargramostim	NCI
C61063	PAR	Dexrazoxane/Doxorubicin/Sargramostim	NCI
C61063	PAR	Cyclophosphamide/Diaziquone	NCI
C61063	PAR	Cytarabine/Daunorubicin/Etoposide/Sargramostim	NCI
C61063	PAR	Chlorambucil/Pentostatin/Prednisone	NCI
C61063	PAR	Cisplatin/Mitotane	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Methotrexate/Methylprednisolone/Vincristine	NCI
C61063	PAR	Etoposide/Mitoxantrone/Prednimustine	NCI
C61063	PAR	Cisplatin/Melphalan	NCI
C61063	PAR	Cytarabine/Doxorubicin/Thioguanine	NCI
C61063	PAR	Etoposide/Ifosfamide/Sargramostim	NCI
C61063	PAR	Etoposide/Filgrastim/Ifosfamide	NCI
C61063	PAR	Etoposide/Ifosfamide/Interleukin-3	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Methotrexate/Sargramostim/Vincristine	NCI
C61063	PAR	Cytarabine/Etoposide/Ifosfamide/Sargramostim	NCI
C61063	PAR	Bleomycin/Doxorubicin/Vincristine/Zidovudine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Diethyldithiocarbamate	NCI
C61063	PAR	Carmustine/Cisplatin/Dacarbazine/Interleukin-2/Tamoxifen	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Dacarbazine/Doxorubicin/Etoposide/Vincristine	NCI
C61063	PAR	Medroxyprogesterone/Tamoxifen	NCI
C61063	PAR	Cisplatin/Doxorubicin/Octreotide	NCI
C61063	PAR	Floxuridine/Streptozocin	NCI
C61063	PAR	Floxuridine/Octreotide/Streptozocin	NCI
C61063	PAR	Asparaginase/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Mitomycin	NCI
C61063	PAR	Altretamine/Cyclophosphamide/Doxorubicin/Vincristine	NCI
C61063	PAR	Altretamine/Fluorouracil/Mitomycin	NCI
C61063	PAR	Doxorubicin/Ifosfamide/Prednisone/Vincristine	NCI
C61063	PAR	Etoposide/Lomustine/Methotrexate/Prednisone	NCI
C61063	PAR	Doxorubicin/Mitomycin	NCI
C61063	PAR	Altretamine/Carmustine/Mitomycin	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Mitomycin	NCI
C61063	PAR	Asparaginase/Dexamethasone/Methotrexate/Vincristine	NCI
C61063	PAR	Cisplatin/Novobiocin	NCI
C61063	PAR	Cisplatin/Cytarabine/Dexamethasone/Doxorubicin	NCI
C61063	PAR	Doxorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Fluorouracil/Hydroxyurea/Leucovorin Calcium	NCI
C61063	PAR	Interleukin-2/Interleukin-4	NCI
C61063	PAR	Carmustine/Thymidine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Prednisone/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Prednisone/Vincristine	NCI
C61063	PAR	Carboplatin/Sargramostim	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Tamoxifen	NCI
C61063	PAR	Doxorubicin/Ifosfamide/Methotrexate	NCI
C61063	PAR	Doxorubicin/Ifosfamide/Vincristine	NCI
C61063	PAR	Dexamethasone/Methotrexate/Procarbazine/Teniposide	NCI
C61063	PAR	Methotrexate/Piritrexim	NCI
C61063	PAR	Asparaginase/Ifosfamide/Methotrexate	NCI
C61063	PAR	Bleomycin/Cytarabine/Prednisone/Vincristine	NCI
C61063	PAR	Chlorambucil/Dacarbazine/Dactinomycin/Doxorubicin/Methotrexate/Vincristine	NCI
C61063	PAR	Cytarabine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Dianhydrogalactitol/Doxorubicin/Vincristine	NCI
C61063	PAR	Prednisone/Procarbazine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Prednisone/Tamoxifen	NCI
C61063	PAR	Bleomycin/Doxorubicin/Lomustine/Vincristine	NCI
C61063	PAR	Fluorouracil/Interleukin-2/Leucovorin Calcium	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Etoposide/Sargramostim	NCI
C61063	PAR	Carboplatin/Ifosfamide/Vincristine	NCI
C61063	PAR	Bleomycin/Doxorubicin/Prednisone	NCI
C61063	PAR	Fluorouracil/Melphalan/Tamoxifen	NCI
C61063	PAR	Bleomycin/Doxorubicin/Mechlorethamine/Methotrexate/Vincristine	NCI
C61063	PAR	Dipyridamole/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Bleomycin/Doxorubicin/Streptozocin/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Thioguanine/Vincristine	NCI
C61063	PAR	Dapsone/Trimetrexate Glucuronate	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Tamoxifen	NCI
C61063	PAR	Pentamidine/Trimetrexate Glucuronate	NCI
C61063	PAR	Interferon Beta/Zidovudine	NCI
C61063	PAR	Carmustine/Procarbazine/Vincristine	NCI
C61063	PAR	Cisplatin/Etoposide/Melphalan	NCI
C61063	PAR	Bleomycin/Methotrexate/Vinblastine	NCI
C61063	PAR	Immune Globulin/Zidovudine	NCI
C61063	PAR	Bleomycin/Mechlorethamine/Prednisone/Procarbazine/Vincristine	NCI
C61063	PAR	Cisplatin/Cytarabine/Dacarbazine/Hydroxyurea/Lomustine/Methylprednisolone/Procarbazine/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Lomustine/Prednisone/Procarbazine/Vincristine	NCI
C61063	PAR	Lomustine/Prednisolone/Vincristine	NCI
C61063	PAR	Carmustine/Methotrexate/Procarbazine	NCI
C61063	PAR	Doxorubicin/Semustine/Streptozocin	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Triazinate	NCI
C61063	PAR	Doxorubicin/Fluoxymesterone/Tamoxifen/Thiotepa/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Sargramostim	NCI
C61063	PAR	Interleukin-2/Thiotepa	NCI
C61063	PAR	Fluorouracil/Methotrexate/Prednisone/Thiotepa/Vinblastine	NCI
C61063	PAR	Doxorubicin/Mercaptopurine/Prednisone/Vincristine	NCI
C61063	PAR	Dacarbazine/Piritrexim	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Methotrexate/Prednisone/Thiotepa/Vinblastine	NCI
C61063	PAR	Amiodarone/Doxorubicin/Etoposide	NCI
C61063	PAR	Amiodarone/Doxorubicin	NCI
C61063	PAR	Cytarabine/Methotrexate/Vincristine	NCI
C61063	PAR	Mitomycin/Vinblastine	NCI
C61063	PAR	Chlorambucil/Fludarabine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Lomustine	NCI
C61063	PAR	Cisplatin/Dacarbazine/Interleukin-2	NCI
C61063	PAR	Sargramostim/Zidovudine	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Semustine	NCI
C61063	PAR	Fluorouracil/Levamisole	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Sargramostim/Vincristine	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Sargramostim	NCI
C61063	PAR	Lomustine/Prednisone/Vincristine	NCI
C61063	PAR	Carboplatin/Etoposide/Sargramostim	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Sargramostim	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Sargramostim	NCI
C61063	PAR	Dacarbazine/Doxorubicin/Ifosfamide/Sargramostim	NCI
C61063	PAR	Prednisone/Sargramostim/Vincristine	NCI
C61063	PAR	Melphalan/Sargramostim	NCI
C61063	PAR	Doxorubicin/Ifosfamide/Lomustine	NCI
C61063	PAR	Fludarabine/Hydroxyurea	NCI
C61063	PAR	Azacitidine/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Teniposide	NCI
C61063	PAR	Daunorubicin/Etoposide/Prednisone/Teniposide/Thioguanine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Daunorubicin/Etoposide/Prednisone/Teniposide/Thioguanine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Semustine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Fluoxymesterone/Methotrexate/Prednisone/Tamoxifen	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Semustine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Melphalan/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Methotrexate/Teniposide	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Tamoxifen/Vincristine	NCI
C61063	PAR	Altretamine/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Altretamine/Cisplatin/Cyclophosphamide/Misonidazole	NCI
C61063	PAR	Bleomycin/Cytarabine/Methotrexate/Vincristine	NCI
C61063	PAR	Asparaginase/Methotrexate/Vincristine	NCI
C61063	PAR	Prednisolone/Tamoxifen	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Methotrexate/Prednisone/Vincristine/Zorubicin	NCI
C61063	PAR	Cyclophosphamide/Melphalan/Methylprednisolone	NCI
C61063	PAR	Cyclophosphamide/Prednisone/Vincristine/Zorubicin	NCI
C61063	PAR	Doxorubicin/Fluoxymesterone/Mitolactol/Tamoxifen	NCI
C61063	PAR	Fluoxymesterone/Mitolactol/Mitoxantrone/Tamoxifen	NCI
C61063	PAR	Cisplatin/Dianhydrogalactitol/Doxorubicin	NCI
C61063	PAR	Ancitabine Hydrochloride/Daunorubicin/Mercaptopurine/Prednisolone	NCI
C61063	PAR	Doxorubicin/Fluoxymesterone/Methotrexate/Mitolactol/Tamoxifen/Vincristine	NCI
C61063	PAR	Dianhydrogalactitol/Etoposide	NCI
C61063	PAR	Azacitidine/Cytarabine/Daunorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Fluorouracil/Methotrexate/Mitolactol/Prednisone	NCI
C61063	PAR	Fluorouracil/Razoxane/Semustine	NCI
C61063	PAR	Doxorubicin/Mitomycin/Tegafur	NCI
C61063	PAR	Asparaginase/Methotrexate	NCI
C61063	PAR	Asparaginase/Cytarabine/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Chlorambucil/Prednisone/Vinblastine/Vincristine	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Melphalan/Prednisone	NCI
C61063	PAR	Doxorubicin/Lomustine/Mechlorethamine	NCI
C61063	PAR	Doxorubicin/Semustine	NCI
C61063	PAR	Dactinomycin/Doxorubicin/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Prednisolone/Teniposide	NCI
C61063	PAR	Fluorouracil/Melphalan	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Melphalan	NCI
C61063	PAR	Cytarabine/Prednisone/Vincristine/Zorubicin	NCI
C61063	PAR	Dacarbazine/Zorubicin	NCI
C61063	PAR	Methotrexate/Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Amifostine/Cisplatin/Monoclonal Antibody R24	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Sargramostim	NCI
C61063	PAR	Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin/Fluorouracil/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Methotrexate/Prednisone/Sargramostim/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Fluorouracil/Vincristine	NCI
C61063	PAR	Altretamine/Cyclophosphamide/Methotrexate	NCI
C61063	PAR	Cisplatin/Mitoguazone/Vinblastine	NCI
C61063	PAR	Ampligen/Interleukin-2	NCI
C61063	PAR	Cisplatin/Cytarabine/Etoposide/Sargramostim	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Thiotepa/Vincristine	NCI
C61063	PAR	Asparaginase/Idarubicin/Prednisone/Vincristine	NCI
C61063	PAR	Carmustine/Triazinate	NCI
C61063	PAR	Asparaginase/Cytarabine/Idarubicin	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Prednisone	NCI
C61063	PAR	Asparaginase/Cytarabine/Daunorubicin	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Folic Acid/Methotrexate	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Thioguanine/Vincristine	NCI
C61063	PAR	Fenretinide/Tamoxifen	NCI
C61063	PAR	Altretamine/Cisplatin/Cyclophosphamide/Fluorouracil	NCI
C61063	PAR	Dactinomycin/Tumor Necrosis Factor	NCI
C61063	PAR	Cisplatin/Doxorubicin/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Altretamine/Lomustine/Methotrexate	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Melphalan/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Ethinyl Estradiol/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Leucovorin Calcium/Mitoxantrone	NCI
C61063	PAR	Fluorouracil/Interferon Beta	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Streptozocin	NCI
C61063	PAR	Octreotide/Tamoxifen	NCI
C61063	PAR	Melphalan/Methylprednisolone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Fluorouracil	NCI
C61063	PAR	Cyclophosphamide/Mercaptopurine/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Dexrazoxane/Doxorubicin/Fluorouracil	NCI
C61063	PAR	Etoposide/Methotrexate	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Triazinate	NCI
C61063	PAR	Interferon Gamma/Levamisole	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Sargramostim	NCI
C61063	PAR	Bleomycin/Procarbazine/Vinblastine	NCI
C61063	PAR	Cytarabine/Doxorubicin/Mercaptopurine/Prednisone/Vincristine	NCI
C61063	PAR	Altretamine/Etoposide/Procarbazine	NCI
C61063	PAR	Bleomycin/Cisplatin/Doxorubicin	NCI
C61063	PAR	Cisplatin/Doxorubicin/Fluorouracil/Vinblastine	NCI
C61063	PAR	Cytarabine/Doxorubicin/Mercaptopurine	NCI
C61063	PAR	Altretamine/Cyclophosphamide/Doxorubicin	NCI
C61063	PAR	Cytarabine/Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Dacarbazine/Dactinomycin/Vincristine	NCI
C61063	PAR	Cytarabine/Zorubicin	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Cytarabine/Hydroxyurea/Lomustine/Methylprednisolone/Procarbazine/Vincristine	NCI
C61063	PAR	Doxorubicin/Methotrexate/Vinblastine	NCI
C61063	PAR	Altretamine/Doxorubicin/Melphalan	NCI
C61063	PAR	Altretamine/Doxorubicin/Methotrexate	NCI
C61063	PAR	Bleomycin/Cisplatin/Dacarbazine/Vinblastine	NCI
C61063	PAR	Bleomycin/Prednisone/Vincristine	NCI
C61063	PAR	Altretamine/Cisplatin	NCI
C61063	PAR	Altretamine/Doxorubicin/Fluorouracil/Mitomycin	NCI
C61063	PAR	Carmustine/Cisplatin/Cyclophosphamide/Cytarabine/Hydroxyurea/Methylprednisolone/Procarbazine/Vincristine	NCI
C61063	PAR	Amsacrine/Decitabine	NCI
C61063	PAR	Decitabine/Idarubicin	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Methotrexate/Tamoxifen	NCI
C61063	PAR	Lomustine/Methotrexate/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Daunorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Cisplatin/Mitoguazone/Vindesine	NCI
C61063	PAR	Cisplatin/Dacarbazine/Etoposide	NCI
C61063	PAR	Cytarabine/Etoposide/Prednisone/Teniposide	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Methotrexate/Prednisone/Procarbazine/Vincristine	NCI
C61063	PAR	Doxorubicin/Prednisone/Teniposide	NCI
C61063	PAR	Cytarabine/Daunorubicin/Prednisone/Thioguanine	NCI
C61063	PAR	Melphalan/Prednisone/Vincristine	NCI
C61063	PAR	Biostim/Melphalan/Prednisone/Vincristine	NCI
C61063	PAR	Conjugated Estrogens/Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Tamoxifen	NCI
C61063	PAR	Biostim/Doxorubicin/Etoposide/Prednisone	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Methotrexate/Mitomycin	NCI
C61063	PAR	Daunorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Mitolactol/Mitoxantrone/Vincristine	NCI
C61063	PAR	Doxorubicin/Thiotepa/Vinblastine	NCI
C61063	PAR	Cytarabine/Melphalan	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Etoposide/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Lomustine/Mitolactol/Procarbazine/Thioguanine/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Misonidazole	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Cytarabine/Dexamethasone/Methotrexate	NCI
C61063	PAR	Fluorouracil/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Fluorouracil/Mitomycin/Vincristine	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Melphalan/Tamoxifen	NCI
C61063	PAR	Fluorouracil/Methotrexate/Vinblastine	NCI
C61063	PAR	Cisplatin/Hydrazine Sulfate/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Doxorubicin/Verapamil/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Fluorouracil/Methotrexate/Vincristine	NCI
C61063	PAR	Mechlorethamine/Methotrexate/Prednisone/Procarbazine/Vincristine	NCI
C61063	PAR	Cytarabine/Filgrastim	NCI
C61063	PAR	Cisplatin/Etoposide/Mitoxantrone/Tamoxifen	NCI
C61063	PAR	Etanidazole/Melphalan/Prednisone	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Doxorubicin/Melphalan/Teniposide	NCI
C61063	PAR	Cytarabine/Daunorubicin/Etoposide/Thioguanine	NCI
C61063	PAR	Cisplatin/Etoposide/Interleukin-2	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Vincristine	NCI
C61063	PAR	Doxorubicin/Etoposide/Prednisone	NCI
C61063	PAR	Trifluoperazine/Vinblastine	NCI
C61063	PAR	BCG/Cyclophosphamide/Interleukin-2	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine/Vindesine	NCI
C61063	PAR	Dipyridamole/Vinblastine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Procarbazine/Vincristine	NCI
C61063	PAR	Bleomycin/Cisplatin/Mitomycin/Vindesine	NCI
C61063	PAR	Chlorambucil/Etoposide/Lomustine	NCI
C61063	PAR	Doxorubicin/Melphalan/Teniposide	NCI
C61063	PAR	Etoposide/Ifosfamide/Vindesine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Methotrexate/Vinblastine	NCI
C61063	PAR	Hydrocortisone/Suramin	NCI
C61063	PAR	Cyclophosphamide/Dactinomycin/Doxorubicin/Hydroxyurea/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Altretamine/Carboplatin/Cyclophosphamide/Doxorubicin	NCI
C61063	PAR	Cisplatin/Fluorouracil/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Dacarbazine/Dactinomycin/Doxorubicin/Vincristine	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Prednisolone/Vincristine	NCI
C61063	PAR	Cisplatin/Dexamethasone/Etoposide	NCI
C61063	PAR	Bleomycin/Cisplatin/Doxorubicin/Etoposide	NCI
C61063	PAR	Doxorubicin/Floxuridine/Mitomycin	NCI
C61063	PAR	Medroxyprogesterone/Mitomycin/Vinblastine	NCI
C61063	PAR	Procarbazine/Semustine/Vincristine	NCI
C61063	PAR	Doxorubicin/Mitomycin/Vindesine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Vindesine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Methotrexate/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Cytarabine/Prednisone/Vincristine	NCI
C61063	PAR	Amsacrine/Cyclophosphamide/Hydroxyurea	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Dexamethasone	NCI
C61063	PAR	Doxorubicin/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Dactinomycin/Vinblastine	NCI
C61063	PAR	Carmustine/Mercaptopurine	NCI
C61063	PAR	Doxorubicin/Etoposide/Mitomycin	NCI
C61063	PAR	Chlorambucil/Prednisone/Procarbazine/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Lomustine/Prednisone/Procarbazine/Vincristine	NCI
C61063	PAR	Mercaptopurine/Methotrexate/Methylprednisolone/Vincristine	NCI
C61063	PAR	Aminoglutethimide/Danazol/Hydrocortisone/Tamoxifen	NCI
C61063	PAR	Aminoglutethimide/Danazol/Medroxyprogesterone/Tamoxifen	NCI
C61063	PAR	Bleomycin/Doxorubicin/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Lomustine/Melphalan/Prednisolone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Mitomycin/Vindesine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Interleukin-2	NCI
C61063	PAR	Floxuridine/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Epirubicin/Prednisone/Vincristine	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Doxorubicin/Melphalan/Prednisone/Vincristine	NCI
C61063	PAR	Etoposide/Tumor Necrosis Factor	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Leucovorin Calcium/Mitomycin	NCI
C61063	PAR	Asparaginase/Doxorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Methotrexate/Sargramostim	NCI
C61063	PAR	Asparaginase/Cytarabine/Methotrexate/Vincristine	NCI
C61063	PAR	Thiotepa/Vinblastine	NCI
C61063	PAR	Amifostine/Cisplatin/Interleukin-2	NCI
C61063	PAR	Amifostine/Thiotepa	NCI
C61063	PAR	Cyclophosphamide/Mitoxantrone/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Thiotepa/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Fluoxymesterone/Methotrexate	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Prednisone/Teniposide/Vincristine	NCI
C61063	PAR	Doxorubicin/Etoposide/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Carmustine/Etoposide/Methotrexate/Prednisone	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Thiotepa	NCI
C61063	PAR	Gentamicin/Piperacillin/Vancomycin	NCI
C61063	PAR	Pefloxacin/Penicillin V	NCI
C61063	PAR	Bleomycin/Vincristine	NCI
C61063	PAR	Bleomycin/Vinblastine	NCI
C61063	PAR	Dactinomycin/Etoposide/Ifosfamide/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Fluoxymesterone/Methotrexate/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Cisplatin/Melphalan/Teniposide	NCI
C61063	PAR	Asparaginase/Doxorubicin/Vincristine	NCI
C61063	PAR	Caffeine/Cisplatin/Cytarabine	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Tamoxifen	NCI
C61063	PAR	Cytarabine/Etoposide/Methylprednisolone	NCI
C61063	PAR	Etoposide/Mitoguazone/Mitoxantrone/Vinblastine	NCI
C61063	PAR	Fluorouracil/Interleukin-1-Beta	NCI
C61063	PAR	Amifostine/Carboplatin	NCI
C61063	PAR	Bleomycin/Cisplatin/Cyclophosphamide/Dactinomycin/Vinblastine	NCI
C61063	PAR	Cisplatin/Fluorouracil/Interleukin-2	NCI
C61063	PAR	Cisplatin/Mitoxantrone	NCI
C61063	PAR	Cyclophosphamide/Interleukin-2	NCI
C61063	PAR	Cytarabine/Daunorubicin/Dexamethasone/Etoposide/Thioguanine	NCI
C61063	PAR	Cytarabine/Mitoxantrone/Thioguanine	NCI
C61063	PAR	Cytarabine/Mitoxantrone/Thioguanine/Vincristine	NCI
C61063	PAR	Etoposide/Mitomycin	NCI
C61063	PAR	Flavone Acetic Acid/Interleukin-2	NCI
C61063	PAR	Fluorouracil/PALA	NCI
C61063	PAR	Ifosfamide/Mitoxantrone	NCI
C61063	PAR	Interferon Gamma/Tumor Necrosis Factor	NCI
C61063	PAR	Asparaginase/Cytarabine/Prednisone/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine	NCI
C61063	PAR	Fluorouracil/Methotrexate/PALA	NCI
C61063	PAR	Carboplatin/Vinblastine	NCI
C61063	PAR	Cisplatin/Mitomycin/Triazinate	NCI
C61063	PAR	Cytarabine/Teniposide	NCI
C61063	PAR	Etoposide/Mitoxantrone/Thiotepa	NCI
C61063	PAR	Fluorouracil/Semustine	NCI
C61063	PAR	Asparaginase/Prednisone/Vincristine	NCI
C61063	PAR	Mercaptopurine/Prednisone/Vincristine	NCI
C61063	PAR	Fludarabine/Prednisone	NCI
C61063	PAR	Cyclophosphamide/Diethylstilbestrol/Fluorouracil/Methotrexate	NCI
C61063	PAR	Cisplatin/Etoposide/Mitoguazone	NCI
C61063	PAR	Cisplatin/Mitomycin/Vinblastine	NCI
C61063	PAR	Cisplatin/Mitomycin/Vindesine	NCI
C61063	PAR	Cisplatin/Vinblastine	NCI
C61063	PAR	Cisplatin/Vindesine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Lomustine/Prednisone/Vincristine	NCI
C61063	PAR	Bleomycin/Dacarbazine/Doxorubicin/Mechlorethamine/Prednisone/Procarbazine/Vinblastine/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Teniposide	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Cytarabine/Doxorubicin/Etoposide/Thioguanine	NCI
C61063	PAR	Cytarabine/Etoposide/Methotrexate	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Lomustine/Vincristine	NCI
C61063	PAR	Cytarabine/Thioguanine	NCI
C61063	PAR	Doxorubicin/Etoposide/Methotrexate	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Mitomycin/Vincristine	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Semustine	NCI
C61063	PAR	Doxorubicin/Vincristine	NCI
C61063	PAR	Altretamine/Etoposide/Methotrexate	NCI
C61063	PAR	Fluorouracil/Methotrexate	NCI
C61063	PAR	Altretamine/Cisplatin/Cyclophosphamide	NCI
C61063	PAR	Cisplatin/Methotrexate	NCI
C61063	PAR	Cisplatin/Ifosfamide	NCI
C61063	PAR	Interleukin-2/Tumor Necrosis Factor	NCI
C61063	PAR	Altretamine/Doxorubicin/Fluoxymesterone/Methotrexate/Mitolactol/Prednisone/Tamoxifen/Vincristine	NCI
C61063	PAR	Altretamine/Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Methotrexate/Prednisone/Tamoxifen/Vinblastine	NCI
C61063	PAR	Carboplatin/Fluorouracil/Methotrexate	NCI
C61063	PAR	Asparaginase/Cytarabine/Daunorubicin/Prednisone/Teniposide/Vincristine	NCI
C61063	PAR	Cisplatin/Ifosfamide/Vinblastine	NCI
C61063	PAR	Amphotericin B/Flucytosine	NCI
C61063	PAR	Doxorubicin/Ethiodized Oil	NCI
C61063	PAR	Mechlorethamine/Prednisone/Procarbazine/Sargramostim/Vincristine	NCI
C61063	PAR	Asparaginase/Daunorubicin/Prednisolone/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate	NCI
C61063	PAR	Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Prednisolone/Teniposide/Vincristine	NCI
C61063	PAR	Daunorubicin/Dexamethasone/Ifosfamide/Methotrexate/Thioguanine/Vindesine	NCI
C61063	PAR	Carmustine/Cisplatin/Dacarbazine	NCI
C61063	PAR	Cisplatin/Tamoxifen	NCI
C61063	PAR	Eflornithine/Mitoguazone	NCI
C61063	PAR	Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Prednisone/Teniposide	NCI
C61063	PAR	Amiodarone/Vinblastine	NCI
C61063	PAR	Doxorubicin/Quinidine	NCI
C61063	PAR	Quinidine/Vinblastine	NCI
C61063	PAR	BCG/Fluorouracil	NCI
C61063	PAR	Bropirimine/Tamoxifen	NCI
C61063	PAR	Acyclovir/Zidovudine	NCI
C61063	PAR	Lomustine/Mitoxantrone/Vinblastine	NCI
C61063	PAR	Dexamethasone/Metoclopramide/Midazolam	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/10-EdAM	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Sargramostim/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Sargramostim	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Etoposide/Filgrastim	NCI
C61063	PAR	Methotrexate/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Melphalan/Misonidazole/Prednisone	NCI
C61063	PAR	Cytarabine/Hydroxyurea	NCI
C61063	PAR	Fluorouracil/Hydroxyurea	NCI
C61063	PAR	Melphalan/Misonidazole	NCI
C61063	PAR	Cyclophosphamide/Interleukin-2/Tumor Infiltrating Lymphocytes	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Thiotepa	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Tamoxifen	NCI
C61063	PAR	Mitoxantrone/Thiotepa	NCI
C61063	PAR	Daunorubicin/Hydroxyurea	NCI
C61063	PAR	Carmustine/Methotrexate	NCI
C61063	PAR	Cytarabine/Vincristine	NCI
C61063	PAR	Etoposide/Ifosfamide/Mitoxantrone	NCI
C61063	PAR	Thiotepa/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Etoposide/Thiotepa/Vincristine	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/PALA	NCI
C61063	PAR	Amikacin/Ceftazidime	NCI
C61063	PAR	Amikacin/Ceftriaxone	NCI
C61063	PAR	Lomustine/Mitolactol/Procarbazine/Thioguanine	NCI
C61063	PAR	Dexamethasone/Doxorubicin/Verapamil/Vincristine	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Tamoxifen/Thiotepa	NCI
C61063	PAR	Fluorouracil/Methotrexate/Tamoxifen/Thiotepa	NCI
C61063	PAR	Cisplatin/Etoposide/Sargramostim	NCI
C61063	PAR	Cisplatin/Doxorubicin/Etoposide/Ifosfamide	NCI
C61063	PAR	Cyclophosphamide/Interleukin-2/Lymphokine-Activated Killer Cells	NCI
C61063	PAR	Edatrexate/Mitomycin/Vinblastine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Goserelin/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Goserelin	NCI
C61063	PAR	Carmustine/Tiazofurin	NCI
C61063	PAR	Cisplatin/Fluorouracil/Leucovorin Calcium/Mitomycin	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine	NCI
C61063	PAR	Interferon Gamma/Sargramostim	NCI
C61063	PAR	Interleukin-2/Sargramostim	NCI
C61063	PAR	Cytarabine/Daunorubicin/Etoposide/Prednisolone/Thioguanine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Filgrastim/Prednisone/Vincristine	NCI
C61063	PAR	Carboplatin/Cisplatin/Etoposide	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Idarubicin/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Dactinomycin/Idarubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Dactinomycin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Mitoxantrone	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Thiotepa	NCI
C61063	PAR	Interleukin-2/Lymphokine-Activated Killer Cells/Monoclonal Antibody R24	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Thiotepa	NCI
C61063	PAR	Dacarbazine/Interleukin-2	NCI
C61063	PAR	Cisplatin/Dacarbazine/Tamoxifen	NCI
C61063	PAR	Busulfan/Mitoxantrone	NCI
C61063	PAR	Cyclophosphamide/Interleukin-2/Monoclonal Antibody R24	NCI
C61063	PAR	Chlorambucil/Etoposide/Prednisone/Vincristine	NCI
C61063	PAR	Cytarabine/Etoposide/Prednisone	NCI
C61063	PAR	Busulfan/Cytarabine/Etoposide	NCI
C61063	PAR	Doxorubicin/Prochlorperazine	NCI
C61063	PAR	Doxorubicin/Sargramostim	NCI
C61063	PAR	Carboplatin/Cisplatin/Ifosfamide	NCI
C61063	PAR	Carboplatin/Doxorubicin/Etoposide/Vincristine	NCI
C61063	PAR	Mechlorethamine/Vincristine	NCI
C61063	PAR	Carboplatin/Etoposide/Mechlorethamine/Vincristine	NCI
C61063	PAR	Cisplatin/Ifosfamide/Sargramostim/Vinblastine	NCI
C61063	PAR	Cisplatin/Etoposide/Ifosfamide/Sargramostim	NCI
C61063	PAR	Cytarabine/Daunorubicin/Sargramostim	NCI
C61063	PAR	Ethacrynic Acid/Melphalan	NCI
C61063	PAR	BCG/Mitomycin	NCI
C61063	PAR	Carboplatin/Etoposide/Interleukin-1-Beta	NCI
C61063	PAR	Dipyridamole/Fluorouracil/Leucovorin Calcium/Zidovudine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Sargramostim/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Pentamidine/Sargramostim/Vincristine/Zidovudine	NCI
C61063	PAR	Eflornithine/Lomustine/Procarbazine/Vincristine	NCI
C61063	PAR	Carboplatin/Doxorubicin/Sargramostim	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Mercaptopurine/Methotrexate	NCI
C61063	PAR	Asparaginase/Dexamethasone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Mercaptopurine/Methotrexate/Vincristine	NCI
C61063	PAR	Cisplatin/Etoposide/Hydrazine Sulfate	NCI
C61063	PAR	Carboplatin/Cytarabine/Etoposide/Methylprednisolone	NCI
C61063	PAR	Carboplatin/Mitoxantrone	NCI
C61063	PAR	Carmustine/Vincristine	NCI
C61063	PAR	Carmustine/Nimodipine/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Interleukin-2	NCI
C61063	PAR	Cisplatin/Cytarabine/Fluorouracil	NCI
C61063	PAR	Cisplatin/Cytarabine/Fluorouracil/Sargramostim	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate	NCI
C61063	PAR	Dactinomycin/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Nimodipine/Vincristine	NCI
C61063	PAR	Cytarabine/Methylprednisolone/Mitoxantrone/Vincristine	NCI
C61063	PAR	Carboplatin/Cytarabine/Etoposide	NCI
C61063	PAR	Fluorouracil/Hydroxyurea/Idoxuridine	NCI
C61063	PAR	Carboplatin/Cisplatin/Doxorubicin/Methotrexate/Vinblastine	NCI
C61063	PAR	Cisplatin/Cyclosporine	NCI
C61063	PAR	Acivicin/Aminosyn	NCI
C61063	PAR	Carboplatin/Doxorubicin/Methotrexate/Vinblastine	NCI
C61063	PAR	Cisplatin/Etoposide/Thiotepa	NCI
C61063	PAR	Cisplatin/Doxorubicin/Etoposide/Sargramostim	NCI
C61063	PAR	Cisplatin/Etoposide/Megestrol	NCI
C61063	PAR	BCG/Interleukin-2	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Prednisone	NCI
C61063	PAR	Cisplatin/Dihydro-5-Azacytidine	NCI
C61063	PAR	Interleukin-2/Monoclonal Antibody 14G2A	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Etanidazole	NCI
C61063	PAR	Cyclosporine/Interferon Gamma	NCI
C61063	PAR	Floxuridine/Fluorouracil/Leucovorin Calcium/Levamisole	NCI
C61063	PAR	Cimetidine/Cyclophosphamide/Indomethacin/Interleukin-2	NCI
C61063	PAR	Amifostine/Carboplatin/Cisplatin	NCI
C61063	PAR	Daunorubicin/Tamoxifen	NCI
C61063	PAR	Cisplatin/Cytarabine/Dexamethasone/Etoposide/Sargramostim	NCI
C61063	PAR	Carboplatin/Etoposide/Monoclonal Antibody 3F8	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Prednisolone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Dexverapamil/Doxorubicin/Etoposide/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Dexverapamil/Doxorubicin/Etoposide/Prednisolone/Vincristine	NCI
C61063	PAR	Fluorouracil/Idoxuridine/Leucovorin Calcium	NCI
C61063	PAR	Filgrastim/Paclitaxel	NCI
C61063	PAR	Amifostine/Mitomycin	NCI
C61063	PAR	Cytarabine/Interleukin-3	NCI
C61063	PAR	Carboplatin/Cisplatin/Etoposide/Sargramostim	NCI
C61063	PAR	Chlorambucil/Epirubicin	NCI
C61063	PAR	Altretamine/Carboplatin/Cyclophosphamide	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Prednisone	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone	NCI
C61063	PAR	Cyclophosphamide/Melphalan	NCI
C61063	PAR	Bleomycin/Cisplatin/Etoposide/Ifosfamide	NCI
C61063	PAR	Cisplatin/Doxorubicin/Filgrastim/Methotrexate/Vinblastine	NCI
C61063	PAR	Cisplatin/Filgrastim/Paclitaxel	NCI
C61063	PAR	Flutamide/Leuprolide/Suramin	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Mitoxantrone/Vincristine	NCI
C61063	PAR	Cytarabine/Daunorubicin/Pegaspargase/Prednisone/Vincristine	NCI
C61063	PAR	Fluorouracil/Interleukin-2/Leucovorin Calcium/Lymphokine-Activated Killer Cells	NCI
C61063	PAR	Carboplatin/Interleukin-1-Alpha	NCI
C61063	PAR	Carboplatin/Etoposide/Ifosfamide/Sargramostim	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Leuprolide	NCI
C61063	PAR	Interferon Gamma/Interleukin-2/Tumor Infiltrating Lymphocytes	NCI
C61063	PAR	Interleukin-2/Monoclonal Antibody R24	NCI
C61063	PAR	Asparaginase/Cytarabine/Methotrexate/Prednisone/Thioguanine	NCI
C61063	PAR	Asparaginase/Cytarabine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Asparaginase/Prednisone	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Daunorubicin/Methotrexate/Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Methotrexate/Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Doxorubicin/Estradiol/Goserelin/Thiotepa/Vinblastine	NCI
C61063	PAR	Fluoxymesterone/Tamoxifen	NCI
C61063	PAR	Carboplatin/Fluorouracil/Procarbazine	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Zidovudine	NCI
C61063	PAR	Monoclonal Antibody R24/Sargramostim	NCI
C61063	PAR	Filgrastim/Piroxantrone	NCI
C61063	PAR	Doxorubicin/Paclitaxel	NCI
C61063	PAR	Doxorubicin/Filgrastim/Paclitaxel	NCI
C61063	PAR	Cyclophosphamide/Daunorubicin/Dexamethasone/Etoposide/Methotrexate/Thiotepa/Vincristine	NCI
C61063	PAR	Asparaginase/Cytarabine/Etoposide/Methotrexate/Methylprednisolone/Vincristine	NCI
C61063	PAR	Asparaginase/Cytarabine/Etoposide	NCI
C61063	PAR	Interleukin-2/PEG-Interleukin-2	NCI
C61063	PAR	Cisplatin/Dacarbazine/Interleukin-2/Tamoxifen	NCI
C61063	PAR	Idoxuridine/Leucovorin Calcium	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Filgrastim/Vincristine	NCI
C61063	PAR	Carmustine/Cisplatin/Cyclophosphamide/Filgrastim	NCI
C61063	PAR	Diaziquone/Sargramostim	NCI
C61063	PAR	Filgrastim/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Carboplatin/Interleukin-3	NCI
C61063	PAR	Methotrexate/Thioguanine	NCI
C61063	PAR	Carboplatin/Fluorouracil/Hydroxyurea/Leucovorin Calcium	NCI
C61063	PAR	Cisplatin/Fluorouracil/Hydroxyurea/Leucovorin Calcium	NCI
C61063	PAR	Carboplatin/Doxorubicin/Ifosfamide	NCI
C61063	PAR	Doxorubicin/Vinblastine	NCI
C61063	PAR	Dimethylbusulfan/Etoposide	NCI
C61063	PAR	Dacarbazine/Tamoxifen	NCI
C61063	PAR	Amifostine/Cisplatin/Etoposide	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Sargramostim	NCI
C61063	PAR	Piroxantrone/Sargramostim	NCI
C61063	PAR	Carboplatin/Epoetin Alfa/Etoposide	NCI
C61063	PAR	Carboplatin/Cytarabine/Dexamethasone/Sargramostim	NCI
C61063	PAR	Carboplatin/Dacarbazine	NCI
C61063	PAR	Carboplatin/Dacarbazine/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vincristine	NCI
C61063	PAR	Filgrastim/Interleukin-1-Beta	NCI
C61063	PAR	Cisplatin/Fluorouracil/Hydroxyurea	NCI
C61063	PAR	Cisplatin/Filgrastim/Fluorouracil/Hydroxyurea	NCI
C61063	PAR	Etoposide/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Brequinar/Fluorouracil	NCI
C61063	PAR	Cyclophosphamide/Interleukin-3/Sargramostim	NCI
C61063	PAR	Azacitidine/Carboplatin	NCI
C61063	PAR	Bleomycin/Cisplatin/Etoposide/Filgrastim	NCI
C61063	PAR	Bleomycin/Cisplatin/Filgrastim/Vincristine	NCI
C61063	PAR	Bleomycin/Cisplatin/Etoposide/Filgrastim/Ifosfamide	NCI
C61063	PAR	Chlorambucil/Ethacrynic Acid	NCI
C61063	PAR	Cyclosporine/Dexamethasone/Doxorubicin/Vincristine	NCI
C61063	PAR	Interferon Gamma/Macrophage Colony-Stimulating Factor	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Interleukin-3/Leucovorin Calcium	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Interleukin-3/Leucovorin Calcium/Sargramostim	NCI
C61063	PAR	Doxorubicin/Suramin	NCI
C61063	PAR	Pentoxifylline/Suramin/Thiotepa	NCI
C61063	PAR	Cisplatin/Filgrastim/Methotrexate/Vinblastine	NCI
C61063	PAR	Doxorubicin/Filgrastim/Thiotepa	NCI
C61063	PAR	Doxorubicin/Thiotepa	NCI
C61063	PAR	Cisplatin/Fluorouracil/Mitomycin/Vindesine	NCI
C61063	PAR	Cisplatin/Doxorubicin/Methotrexate/Sargramostim/Vinblastine	NCI
C61063	PAR	Melphalan/Vincristine	NCI
C61063	PAR	Carboplatin/Cisplatin/Cyclophosphamide/Filgrastim	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Doxorubicin/Quinine/Verapamil/Vincristine	NCI
C61063	PAR	Carboplatin/Ifosfamide/Sargramostim	NCI
C61063	PAR	Epoetin Alfa/Filgrastim	NCI
C61063	PAR	Interleukin-2/Levamisole	NCI
C61063	PAR	Carboplatin/Etoposide/Ifosfamide/Interleukin-1-Alpha	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Etoposide/Interleukin-2/Sargramostim	NCI
C61063	PAR	Etoposide/Metronidazole	NCI
C61063	PAR	Etoposide/Ketoconazole/Metronidazole	NCI
C61063	PAR	Dipyridamole/Etoposide/Ketoconazole/Metronidazole	NCI
C61063	PAR	Dipyridamole/Etoposide/Ketoconazole/Metronidazole/Tamoxifen	NCI
C61063	PAR	Dipyridamole/Etoposide/Ketoconazole/Metronidazole/Quinidine/Tamoxifen	NCI
C61063	PAR	Cyclosporine/Dipyridamole/Etoposide/Ketoconazole/Metronidazole/Quinidine/Tamoxifen	NCI
C61063	PAR	Doxorubicin/Verapamil	NCI
C61063	PAR	Cisplatin/Etoposide/Filgrastim/Melphalan	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Daunorubicin/Filgrastim/Prednisone/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Filgrastim/Mercaptopurine/Vincristine	NCI
C61063	PAR	Altretamine/Cisplatin/Etoposide	NCI
C61063	PAR	Amifostine/Melphalan	NCI
C61063	PAR	Idarubicin/Tretinoin	NCI
C61063	PAR	Idarubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Medroxyprogesterone/Quinine	NCI
C61063	PAR	Pentostatin/Sargramostim	NCI
C61063	PAR	Carboplatin/Diethyldithiocarbamate	NCI
C61063	PAR	Levamisole/Tamoxifen	NCI
C61063	PAR	Fluorouracil/Idoxuridine/Leucovorin Calcium/PALA	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/PALA/Zidovudine	NCI
C61063	PAR	Gusperimus/Monoclonal Antibody L6	NCI
C61063	PAR	Somatuline/Suramin	NCI
C61063	PAR	Flutamide/Leuprolide/Somatuline/Suramin	NCI
C61063	PAR	Interleukin-2/Interleukin-6	NCI
C61063	PAR	Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Vincristine	NCI
C61063	PAR	Asparaginase/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine	NCI
C61063	PAR	Dexamethasone/Doxorubicin/Methotrexate/Pegaspargase/Vincristine	NCI
C61063	PAR	Asparaginase/Dexamethasone/Doxorubicin/Mercaptopurine/Methotrexate/Vincristine	NCI
C61063	PAR	Asparaginase/Dexamethasone/Doxorubicin/Methotrexate/Vincristine	NCI
C61063	PAR	Asparaginase/Dexamethasone/Mercaptopurine/Methotrexate/Vincristine	NCI
C61063	PAR	Dexamethasone/Doxorubicin/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Filgrastim	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Filgrastim	NCI
C61063	PAR	Asparaginase/Filgrastim/Teniposide	NCI
C61063	PAR	Doxorubicin/Filgrastim/Mercaptopurine/Prednisone/Vincristine	NCI
C61063	PAR	Doxorubicin/Filgrastim/Prednisone/Vincristine	NCI
C61063	PAR	Etoposide/Filgrastim/Melphalan	NCI
C61063	PAR	Cisplatin/Doxorubicin/Etoposide/Filgrastim/Ifosfamide	NCI
C61063	PAR	Bleomycin/Doxorubicin/Etoposide/Mechlorethamine/Vinblastine/Vincristine	NCI
C61063	PAR	Interleukin-1-Alpha/Interleukin-2	NCI
C61063	PAR	Trifluoperazine/Verapamil	NCI
C61063	PAR	Doxorubicin/Trifluoperazine/Vinblastine/Verapamil	NCI
C61063	PAR	Carboplatin/Edatrexate	NCI
C61063	PAR	BCG/Isoniazid	NCI
C61063	PAR	Cisplatin/Edatrexate	NCI
C61063	PAR	Hexamethylene Bisacetamide/Tretinoin	NCI
C61063	PAR	Bromocriptine/Flutamide/Leuprolide	NCI
C61063	PAR	Flutamide/Ketoconazole/Leuprolide	NCI
C61063	PAR	Flutamide/Ketoconazole	NCI
C61063	PAR	Trifluoperazine/Verapamil/Vinblastine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Fluorouracil/Vincristine	NCI
C61063	PAR	Cytarabine/Etoposide/Methotrexate/Prednisone	NCI
C61063	PAR	Cisplatin/Ifosfamide/Mitomycin	NCI
C61063	PAR	Carboplatin/Etoposide/Interleukin-3	NCI
C61063	PAR	Interleukin-1-Beta/Interleukin-2	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Paclitaxel	NCI
C61063	PAR	Indomethacin/Interleukin-1-Alpha/Etoposide	NCI
C61063	PAR	Amphotericin B/Colistin Sulfate/Tobramycin	NCI
C61063	PAR	Interleukin-3/Thiotepa	NCI
C61063	PAR	Cytarabine/Idarubicin/Interleukin-3	NCI
C61063	PAR	Carboplatin/Cytarabine/Idarubicin	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Methylmercaptopurine Riboside/PALA	NCI
C61063	PAR	Cisplatin/Muramyl Tripeptide Phosphatidylethanolamine Liposome	NCI
C61063	PAR	Ifosfamide/Muramyl Tripeptide Phosphatidylethanolamine Liposome	NCI
C61063	PAR	Asparaginase/Daunorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Mercaptopurine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Doxorubicin/Vincristine	NCI
C61063	PAR	Etoposide/Ifosfamide/Methotrexate/Vincristine	NCI
C61063	PAR	Dexamethasone/Mercaptopurine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Pegaspargase	NCI
C61063	PAR	Doxorubicin/Pegaspargase/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Doxorubicin/Edatrexate/Vinblastine	NCI
C61063	PAR	Cytarabine/Etoposide/Ifosfamide/Mercaptopurine/Methotrexate	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Etoposide/Vincristine	NCI
C61063	PAR	Carboplatin/Carmustine/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Interleukin-1-Alpha	NCI
C61063	PAR	Carboplatin/Milodistim	NCI
C61063	PAR	Busulfan/Cyclophosphamide/Cytarabine	NCI
C61063	PAR	Cyclosporine/Tamoxifen/Vinblastine	NCI
C61063	PAR	Interleukin-2/Interleukin-4/Tumor Infiltrating Lymphocytes	NCI
C61063	PAR	Edatrexate/Ifosfamide	NCI
C61063	PAR	Cisplatin/Etoposide/Tretinoin	NCI
C61063	PAR	Asparaginase/Cisplatin/Cytarabine/Dexamethasone/Etoposide	NCI
C61063	PAR	Cytarabine/Filgrastim/Tretinoin	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Etoposide/Melphalan	NCI
C61063	PAR	Interleukin-3/Zidovudine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Interleukin-3/Prednisone/Vincristine/Zidovudine	NCI
C61063	PAR	Doxorubicin/Vinorelbine	NCI
C61063	PAR	Fluorouracil/Vinorelbine	NCI
C61063	PAR	Carboplatin/Etoposide/Ifosfamide/Etanidazole	NCI
C61063	PAR	Bleomycin/Doxorubicin/Etoposide/Vincristine	NCI
C61063	PAR	Etoposide/Procarbazine/Vincristine	NCI
C61063	PAR	Doxorubicin/Streptozocin	NCI
C61063	PAR	Asparaginase/Mercaptopurine/Methotrexate	NCI
C61063	PAR	Carboplatin/Thymidine	NCI
C61063	PAR	Etoposide/Topotecan	NCI
C61063	PAR	Amifostine/Cyclophosphamide	NCI
C61063	PAR	Cyclosporine/Etoposide/Mitoxantrone	NCI
C61063	PAR	Cyclophosphamide/Didanosine/Doxorubicin/Etoposide/Vincristine	NCI
C61063	PAR	Cisplatin/Cytarabine/Hydroxyurea	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Vincristine/Zidovudine	NCI
C61063	PAR	Estramustine/Vinblastine	NCI
C61063	PAR	Cytarabine/Dexamethasone/Etoposide/Ifosfamide/Methotrexate/Vincristine	NCI
C61063	PAR	Bleomycin/Didanosine/Doxorubicin/Vincristine	NCI
C61063	PAR	Cyclosporine/Dactinomycin/Vincristine	NCI
C61063	PAR	Busulfan/Cyclophosphamide/Diaziquone	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Interleukin-1-Beta	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Vinorelbine	NCI
C61063	PAR	Etoposide/Paclitaxel	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Leucovorin Calcium/Vinorelbine	NCI
C61063	PAR	Interferon Gamma/Melphalan/Tumor Necrosis Factor	NCI
C61063	PAR	Altretamine/Paclitaxel	NCI
C61063	PAR	Carboplatin/Cisplatin/Paclitaxel	NCI
C61063	PAR	Paclitaxel/Topotecan	NCI
C61063	PAR	Eflornithine/Piroxicam	NCI
C61063	PAR	Chlorambucil/Cladribine	NCI
C61063	PAR	Hydrocortisone/Mitoxantrone	NCI
C61063	PAR	Cytarabine/Daunorubicin/Etoposide/Interleukin-3	NCI
C61063	PAR	Cytarabine/Dexverapamil/Etoposide/Idarubicin	NCI
C61063	PAR	Doxorubicin/Melphalan/Methylprednisolone	NCI
C61063	PAR	Cyclosporine/Vinblastine	NCI
C61063	PAR	Tamoxifen/Vinblastine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Doxorubicin/Mercaptopurine/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Mercaptopurine/Methotrexate/Vincristine	NCI
C61063	PAR	Asparaginase/Daunorubicin/Dexamethasone/Ifosfamide/Mercaptopurine/Methotrexate/Vindesine	NCI
C61063	PAR	Dactinomycin/Doxorubicin/Etoposide/Ifosfamide/Vincristine	NCI
C61063	PAR	Cytarabine/Idarubicin/Teniposide	NCI
C61063	PAR	Cyclosporine/Paclitaxel	NCI
C61063	PAR	Dexverapamil/Paclitaxel	NCI
C61063	PAR	Etoposide/Tretinoin	NCI
C61063	PAR	Aminoglutethimide/Suramin	NCI
C61063	PAR	PSC 833/Vinblastine	NCI
C61063	PAR	Cytarabine/Fludarabine/Idarubicin	NCI
C61063	PAR	Cisplatin/Fluorouracil/Paclitaxel	NCI
C61063	PAR	Cisplatin/Estramustine/Etoposide	NCI
C61063	PAR	Cisplatin/Decitabine	NCI
C61063	PAR	Cisplatin/Doxorubicin/Etoposide/Vincristine	NCI
C61063	PAR	Carboplatin/Estramustine/Etoposide	NCI
C61063	PAR	Epoetin Alfa/Interleukin-3	NCI
C61063	PAR	Interleukin-2/Macrophage Colony-Stimulating Factor	NCI
C61063	PAR	Fluorouracil/Triacetyluridine	NCI
C61063	PAR	Cisplatin/Floxuridine/Leucovorin Calcium	NCI
C61063	PAR	Carmustine/Cisplatin/Thiotepa	NCI
C61063	PAR	Carboplatin/Cisplatin/Cyclophosphamide/Etoposide	NCI
C61063	PAR	Leuprolide/Suramin	NCI
C61063	PAR	Aminoglutethimide/Leuprolide	NCI
C61063	PAR	Ketoconazole/Paclitaxel	NCI
C61063	PAR	Carboplatin/Interleukin-1-Alpha/Methylene Blue	NCI
C61063	PAR	Asparaginase/Cytarabine/Dexamethasone/Doxorubicin/Mercaptopurine/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Mercaptopurine/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Mercaptopurine/Methotrexate/Vincristine	NCI
C61063	PAR	Cyclosporine/Interleukin-2/Methylprednisolone	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/Zidovudine	NCI
C61063	PAR	Interleukin-2/Monoclonal Antibody 14G2A/Sargramostim	NCI
C61063	PAR	Cisplatin/Cytarabine/Etoposide/Prednisone	NCI
C61063	PAR	Dexamethasone/Methotrexate/Thiotepa/Vincristine	NCI
C61063	PAR	Carboplatin/Etoposide/Ifosfamide/Vincristine	NCI
C61063	PAR	Busulfan/Cyclophosphamide/Cytarabine/Sargramostim	NCI
C61063	PAR	Filgrastim/Fludarabine	NCI
C61063	PAR	Thioguanine/Tiazofurin	NCI
C61063	PAR	Filgrastim/Merbarone	NCI
C61063	PAR	Edatrexate/Paclitaxel	NCI
C61063	PAR	Fluorouracil/Gallium Nitrate	NCI
C61063	PAR	Paclitaxel/Quinine	NCI
C61063	PAR	Floxuridine/Leucovorin Calcium/PALA	NCI
C61063	PAR	Dexamethasone/Floxuridine/Mitomycin	NCI
C61063	PAR	Cisplatin/Edatrexate/Ifosfamide	NCI
C61063	PAR	Busulfan/Cyclophosphamide/Mitoxantrone	NCI
C61063	PAR	Floxuridine/Mitomycin	NCI
C61063	PAR	Doxorubicin/Topotecan	NCI
C61063	PAR	Daunorubicin/Methylprednisolone/Vincristine	NCI
C61063	PAR	Cytarabine/Methotrexate/Teniposide/Thioguanine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Mercaptopurine/Methotrexate	NCI
C61063	PAR	Etoposide/Mitoxantrone/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Etoposide/Vincristine	NCI
C61063	PAR	Doxorubicin/Edatrexate	NCI
C61063	PAR	Filgrastim/Tretinoin	NCI
C61063	PAR	Cyclophosphamide/Procarbazine/Vincristine	NCI
C61063	PAR	Dexamethasone/Doxorubicin/Prednisone/Quinine/Vincristine	NCI
C61063	PAR	Dexamethasone/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Estramustine/Etoposide	NCI
C61063	PAR	Interferon Beta/Isotretinoin	NCI
C61063	PAR	Beta Carotene/Vitamin A	NCI
C61063	PAR	Dipyridamole/Fluorouracil/Leucovorin Calcium/Mitomycin	NCI
C61063	PAR	Methotrexate/Paclitaxel	NCI
C61063	PAR	Filgrastim/Methotrexate/Paclitaxel	NCI
C61063	PAR	Cisplatin/Etoposide/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Etoposide/Ifosfamide/Melphalan	NCI
C61063	PAR	Cisplatin/Interleukin-1-Alpha	NCI
C61063	PAR	Carboplatin/Etoposide/Interleukin-6/Sargramostim	NCI
C61063	PAR	Ciprofloxacin/Cisplatin/Cyclophosphamide/Etoposide/Pentoxifylline	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Etoposide/Melphalan	NCI
C61063	PAR	Doxorubicin/Hydroxyurea	NCI
C61063	PAR	Lomustine/Methotrexate	NCI
C61063	PAR	Estramustine/Paclitaxel	NCI
C61063	PAR	Edatrexate/Filgrastim/Paclitaxel	NCI
C61063	PAR	interleukin-3/interleukin-6	NCI
C61063	PAR	Carboplatin/Etoposide/Ifosfamide/Milodistim	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Methotrexate/PALA/Triacetyluridine	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Paclitaxel	NCI
C61063	PAR	Filgrastim/Fluorouracil/Leucovorin Calcium/Paclitaxel	NCI
C61063	PAR	Edatrexate/Leucovorin Calcium	NCI
C61063	PAR	Cyclosporine/Cytarabine/Etoposide/Mitoxantrone	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Methotrexate/Methylprednisolone/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Etoposide/Tamoxifen	NCI
C61063	PAR	BCG/Bropirimine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Leucovorin Calcium/Milodistim	NCI
C61063	PAR	Carboplatin/Fluorouracil/Vincristine	NCI
C61063	PAR	Filgrastim/Pyrazoloacridine	NCI
C61063	PAR	Filgrastim/Paclitaxel/Topotecan	NCI
C61063	PAR	Cisplatin/Cyclosporine/Doxorubicin	NCI
C61063	PAR	Cisplatin/Pentoxifylline	NCI
C61063	PAR	Methotrexate/Pegaspargase	NCI
C61063	PAR	Cisplatin/Etoposide/Filgrastim/Ifosfamide/Interleukin-3	NCI
C61063	PAR	Cisplatin/Filgrastim/Ifosfamide/Interleukin-3/Vinblastine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Prednisolone/Vindesine	NCI
C61063	PAR	Fazarabine/Filgrastim	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Thiotepa	NCI
C61063	PAR	Gallium Nitrate/Ifosfamide/Vinblastine	NCI
C61063	PAR	Busulfan/Thiotepa	NCI
C61063	PAR	Mitoxantrone/Paclitaxel/Thiotepa	NCI
C61063	PAR	Busulfan/Ciprofloxacin/Cyclophosphamide/Pentoxifylline	NCI
C61063	PAR	Busulfan/Melphalan/Thiotepa	NCI
C61063	PAR	Busulfan/Ciprofloxacin/Melphalan/Pentoxifylline/Thiotepa	NCI
C61063	PAR	Carboxypeptidase-G2/Leucovorin Calcium/Methotrexate	NCI
C61063	PAR	Asparaginase/Daunorubicin/Prednisolone/Vindesine	NCI
C61063	PAR	Cytarabine/Etoposide/Ifosfamide/Methotrexate/Prednisolone	NCI
C61063	PAR	Doxorubicin/Prednisolone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Prednisolone	NCI
C61063	PAR	Cytarabine/Dexamethasone/Ifosfamide/Methotrexate/Teniposide/Vincristine	NCI
C61063	PAR	Cytarabine/Dexamethasone/Etoposide/Vindesine	NCI
C61063	PAR	Doxorubicin/Etoposide/Mitotane/Vincristine	NCI
C61063	PAR	Carmustine/Dacarbazine/Thymidine	NCI
C61063	PAR	Cytarabine/Ifosfamide	NCI
C61063	PAR	Cyclophosphamide/Indomethacin/Interleukin-2/Tumor Infiltrating Lymphocytes	NCI
C61063	PAR	Indomethacin/Interleukin-2/Lymphokine-Activated Killer Cells	NCI
C61063	PAR	Dipyridamole/Methotrexate	NCI
C61063	PAR	Interleukin-2/Tumor Necrosis Factor Receptor IgG Chimera	NCI
C61063	PAR	Cyclophosphamide/Epirubicin/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Epirubicin/Toremifene	NCI
C61063	PAR	Bryostatin 1/Tretinoin	NCI
C61063	PAR	Floxuridine/Hydroxyurea/Leucovorin Calcium	NCI
C61063	PAR	Carboplatin/Cytarabine/Hydroxyurea	NCI
C61063	PAR	Cyclophosphamide/Perflubron	NCI
C61063	PAR	Carboplatin/Topotecan	NCI
C61063	PAR	Cytarabine/Topotecan	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Filgrastim/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Cisplatin/Etoposide/Paclitaxel	NCI
C61063	PAR	Cisplatin/Etoposide/Filgrastim/Paclitaxel	NCI
C61063	PAR	Filgrastim/Penclomedine	NCI
C61063	PAR	Doxorubicin/Methotrexate	NCI
C61063	PAR	Cisplatin/Ifosfamide/Muramyl Tripeptide Phosphatidylethanolamine Liposome	NCI
C61063	PAR	Doxorubicin/Ifosfamide/Methotrexate/Muramyl Tripeptide Phosphatidylethanolamine Liposome	NCI
C61063	PAR	Carboplatin/Interleukin-6/Sargramostim	NCI
C61063	PAR	Bleomycin/Cisplatin/Etoposide/Ifosfamide/Vinblastine	NCI
C61063	PAR	Cisplatin/Doxorubicin/Floxuridine/Leucovorin Calcium	NCI
C61063	PAR	Cisplatin/Dexamethasone/Doxorubicin/Floxuridine/Leucovorin Calcium	NCI
C61063	PAR	Cyclosporine/Dexamethasone/Vinblastine	NCI
C61063	PAR	Carboplatin/Cisplatin/Cyclophosphamide/Etoposide/Paclitaxel	NCI
C61063	PAR	Gallium Nitrate/Hydroxyurea	NCI
C61063	PAR	Cyclophosphamide/Milodistim	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Milodistim/Thiotepa	NCI
C61063	PAR	Interleukin-1-Alpha/Methotrexate	NCI
C61063	PAR	Lomustine/Vincristine	NCI
C61063	PAR	Interferon Gamma/Interleukin-2/Melphalan/Tumor Necrosis Factor	NCI
C61063	PAR	Cyclophosphamide/Filgrastim/Topotecan	NCI
C61063	PAR	Methotrexate/Procarbazine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Idarubicin/Prednisone/Vincristine	NCI
C61063	PAR	Carboplatin/Filgrastim/Paclitaxel	NCI
C61063	PAR	Asparaginase/Cytarabine/Filgrastim	NCI
C61063	PAR	Cisplatin/Etoposide/Filgrastim	NCI
C61063	PAR	Ciprofloxacin/Cisplatin/Etoposide/Filgrastim	NCI
C61063	PAR	Dacarbazine/Interleukin-1-Alpha	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Filgrastim	NCI
C61063	PAR	Paclitaxel/PSC 833	NCI
C61063	PAR	Dexamethasone/Vincristine	NCI
C61063	PAR	Etoposide/Interleukin-1-Alpha	NCI
C61063	PAR	Carboplatin/Etoposide/Tamoxifen	NCI
C61063	PAR	Cisplatin/Ifosfamide/Paclitaxel	NCI
C61063	PAR	Cytarabine/Homoharringtonine	NCI
C61063	PAR	Sargramostim/Tumor Necrosis Factor	NCI
C61063	PAR	Cytarabine/Mitoxantrone/Sargramostim	NCI
C61063	PAR	Cytarabine/Idarubicin/Sargramostim	NCI
C61063	PAR	Aminocamptothecin/Filgrastim	NCI
C61063	PAR	Bleomycin/Doxorubicin/Etoposide/Prednisolone/Vincristine	NCI
C61063	PAR	Cisplatin/Cytarabine/Idarubicin/Methylprednisolone	NCI
C61063	PAR	Bleomycin/Idarubicin/Methylprednisolone/Vincristine	NCI
C61063	PAR	Filgrastim/Interleukin-6	NCI
C61063	PAR	Carboplatin/Etoposide/Filgrastim/Ifosfamide/Interleukin-6	NCI
C61063	PAR	Cyclophosphamide/Topotecan/Vincristine	NCI
C61063	PAR	Dacarbazine/Doxorubicin/Filgrastim/Ifosfamide	NCI
C61063	PAR	Carboplatin/Pentoxifylline	NCI
C61063	PAR	Bleomycin/Cisplatin/Etoposide/Mitomycin	NCI
C61063	PAR	Mitoxantrone/Paclitaxel	NCI
C61063	PAR	Bispecific Antibody 520C9XH22/Interferon Gamma	NCI
C61063	PAR	Cisplatin/Tumor Necrosis Factor	NCI
C61063	PAR	Busulfan/Cyclophosphamide/Thiotepa	NCI
C61063	PAR	Cytarabine/Etoposide/Filgrastim/Interleukin-6/Mitoxantrone	NCI
C61063	PAR	Cyclophosphamide/Filgrastim/Interleukin-6	NCI
C61063	PAR	Carboplatin/Etoposide/Ifosfamide/Paclitaxel	NCI
C61063	PAR	Melphalan/Paclitaxel	NCI
C61063	PAR	Cyclophosphamide/Mitoxantrone/Prednisolone/Vincristine	NCI
C61063	PAR	Carboplatin/Cyclosporine/Paclitaxel	NCI
C61063	PAR	Cisplatin/Filgrastim/Topotecan	NCI
C61063	PAR	Bleomycin/Cisplatin/Epoetin Alfa/Etoposide/Filgrastim/Ifosfamide/Vinblastine	NCI
C61063	PAR	Cisplatin/Epoetin Alfa/Etoposide/Filgrastim/Ifosfamide	NCI
C61063	PAR	Carboplatin/Filgrastim/Interleukin-6/Paclitaxel	NCI
C61063	PAR	Benznidazole/Lomustine	NCI
C61063	PAR	Flutamide/Goserelin/Suramin	NCI
C61063	PAR	Doxorubicin/Filgrastim/Ifosfamide	NCI
C61063	PAR	Leuprolide/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Leuprolide/Methotrexate/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Goserelin/Methotrexate/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Leuprolide/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Goserelin/Tamoxifen	NCI
C61063	PAR	interleukin-6/sargramostim	NCI
C61063	PAR	Asparaginase/Cytarabine/Etoposide/Methotrexate/Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Melphalan/Tumor Necrosis Factor	NCI
C61063	PAR	Altretamine/Etoposide	NCI
C61063	PAR	Dexamethasone/Dexniguldipine/Doxorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Dexamethasone/Dexniguldipine/Doxorubicin/Vincristine	NCI
C61063	PAR	Gallium Nitrate/Paclitaxel	NCI
C61063	PAR	Filgrastim/Gallium Nitrate/Paclitaxel	NCI
C61063	PAR	Paclitaxel/Thiotepa	NCI
C61063	PAR	Cisplatin/Cytarabine/Dexamethasone/Idarubicin	NCI
C61063	PAR	Cisplatin/Cytarabine/Dexamethasone/Idarubicin/Methotrexate	NCI
C61063	PAR	Etoposide/Fluorouracil	NCI
C61063	PAR	Carboplatin/Milodistim/Paclitaxel	NCI
C61063	PAR	Cisplatin/Dacarbazine/Interleukin-2/Vinblastine	NCI
C61063	PAR	Cytarabine/Filgrastim/Idarubicin	NCI
C61063	PAR	Cytarabine/Etoposide/Filgrastim/Mitoxantrone	NCI
C61063	PAR	Dexamethasone/Methotrexate/Procarbazine/Vincristine	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Filgrastim	NCI
C61063	PAR	Cisplatin/Pyrazoloacridine	NCI
C61063	PAR	Cisplatin/Filgrastim/Pyrazoloacridine	NCI
C61063	PAR	Carboxyamidotriazole/Paclitaxel	NCI
C61063	PAR	BMS-182751/Etoposide	NCI
C61063	PAR	Etoposide/Satraplatin	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Doxorubicin/Etoposide	NCI
C61063	PAR	Isotretinoin/Vitamin E	NCI
C61063	PAR	Dexverapamil/Vinblastine	NCI
C61063	PAR	Cisplatin/Docetaxel/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Etoposide/Mitoxantrone/Sargramostim	NCI
C61063	PAR	Etoposide/Novobiocin	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Procarbazine/Vinblastine/Vincristine	NCI
C61063	PAR	Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Carboplatin/Etoposide/Mitoxantrone/Thiotepa	NCI
C61063	PAR	CI-980/Filgrastim	NCI
C61063	PAR	Dexamethasone/Etoposide/Ifosfamide/Methotrexate/Pegaspargase/Vincristine	NCI
C61063	PAR	Cytarabine/Dexamethasone/Etoposide/Idarubicin/Ifosfamide/Methotrexate/Pegaspargase/Thioguanine/Vincristine	NCI
C61063	PAR	Cytarabine/Dexamethasone/Etoposide/Methotrexate/Pegaspargase/Thioguanine/Vincristine	NCI
C61063	PAR	Dexamethasone/Idarubicin/Ifosfamide/Methotrexate/Thioguanine/Vincristine	NCI
C61063	PAR	Methotrexate/Thioguanine/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Mitoxantrone	NCI
C61063	PAR	Interleukin-2/Monoclonal Antibody Ch14.18/Monoclonal Antibody R24	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Paclitaxel	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Filgrastim/Paclitaxel	NCI
C61063	PAR	Cisplatin/Epoetin Alfa/Iron	NCI
C61063	PAR	CT-1501R/Interleukin-2	NCI
C61063	PAR	ImmTher/Indomethacin	NCI
C61063	PAR	Doxorubicin/Ketoconazole	NCI
C61063	PAR	Cytarabine/Dexamethasone/Etoposide/Idarubicin/Thioguanine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Filgrastim/Paclitaxel	NCI
C61063	PAR	Hydroxyurea/Pentoxifylline	NCI
C61063	PAR	Flutamide/Isotretinoin/Leuprolide	NCI
C61063	PAR	Incomplete Freund's Adjuvant/MART-1 Antigen	NCI
C61063	PAR	Interleukin-2/MART-1 Antigen	NCI
C61063	PAR	gp100 Antigen/Interleukin-2	NCI
C61063	PAR	Cisplatin/Doxorubicin/Tamoxifen	NCI
C61063	PAR	Etoposide/Mitoxantrone/PSC 833	NCI
C61063	PAR	Interleukin-2/Monoclonal Antibody HuG1-M195	NCI
C61063	PAR	Estramustine/Vinorelbine	NCI
C61063	PAR	Folic Acid/Lometrexol	NCI
C61063	PAR	Interleukin-2/Vinblastine	NCI
C61063	PAR	Fluorouracil/Levamisole/L-Leucovorin	NCI
C61063	PAR	Keyhole Limpet Hemocyanin/QS21/Sialyl Tn Antigen	NCI
C61063	PAR	Leucovorin Calcium/Tegafur/Uracil	NCI
C61063	PAR	Fludarabine/Mitoxantrone	NCI
C61063	PAR	Ifosfamide/Vinorelbine	NCI
C61063	PAR	Fluorouracil/L-Leucovorin/Methotrexate	NCI
C61063	PAR	Cytarabine/Daunorubicin/Etoposide/Filgrastim	NCI
C61063	PAR	Busulfan/Cytarabine/Melphalan	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen	NCI
C61063	PAR	Dexverapamil/Doxorubicin	NCI
C61063	PAR	Daunorubicin/Milodistim/Pegaspargase/Prednisone/Vincristine	NCI
C61063	PAR	Interleukin-2/NG-Monomethyl-L-Arginine	NCI
C61063	PAR	Leucovorin Calcium/Trimetrexate Glucuronate	NCI
C61063	PAR	Bispecific Antibody 520C9XH22/Filgrastim	NCI
C61063	PAR	Cisplatin/Methotrexate/Vinblastine	NCI
C61063	PAR	Cisplatin/Dacarbazine/Vinblastine	NCI
C61063	PAR	Cisplatin/Doxorubicin/Vincristine	NCI
C61063	PAR	Cisplatin/Cytarabine/Etoposide/Methylprednisolone	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisolone/Vincristine	NCI
C61063	PAR	Amsacrine/Cytarabine/Etoposide	NCI
C61063	PAR	Doxorubicin/Etoposide/Procarbazine/Vincristine	NCI
C61063	PAR	Altretamine/Mitomycin/Vinblastine	NCI
C61063	PAR	Doxorubicin/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Cisplatin/Ifosfamide/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Bleomycin/Epirubicin/Prednisone/Vincristine	NCI
C61063	PAR	Cisplatin/Cytarabine/Doxorubicin/Methylprednisolone	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Etoposide/Hydroxyurea	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Pirarubicin	NCI
C61063	PAR	Dacarbazine/Pirarubicin	NCI
C61063	PAR	Zalcitabine/Zidovudine	NCI
C61063	PAR	Cyclophosphamide/Interferon Alfa/Interleukin-2	NCI
C61063	PAR	Interferon Alfa/Vinblastine	NCI
C61063	PAR	Interferon Alfa/Sargramostim/Zidovudine	NCI
C61063	PAR	Doxorubicin/eflornithine/Interferon Alfa	NCI
C61063	PAR	Interferon Alfa/Prednisone	NCI
C61063	PAR	Aspirin/Interferon Alfa	NCI
C61063	PAR	Fluorouracil/Interferon Alfa/Mitomycin	NCI
C61063	PAR	Eflornithine/Interferon Alfa	NCI
C61063	PAR	Interferon Alfa/interleukin-2/Tumor Infiltrating Lymphocytes	NCI
C61063	PAR	Dexamethasone/Doxorubicin/Interferon Alfa/Vincristine	NCI
C61063	PAR	Cisplatin/Interferon Alfa/interleukin-2	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Interferon Alfa/Prednisone/Vincristine	NCI
C61063	PAR	Fluorouracil/Interferon Alfa/PALA	NCI
C61063	PAR	Mitoxantrone/Interferon Alfa	NCI
C61063	PAR	Interferon Alfa/Zidovudine	NCI
C61063	PAR	Lomustine/Interferon Alfa	NCI
C61063	PAR	Cyclophosphamide/Interferon Alfa/interleukin-2/Tumor Infiltrating Lymphocytes	NCI
C61063	PAR	Cyclophosphamide/Interferon Alfa/Prednisone	NCI
C61063	PAR	Cisplatin/Interferon Alfa	NCI
C61063	PAR	Interferon Alfa/Interferon Gamma	NCI
C61063	PAR	Doxorubicin/Interferon Alfa	NCI
C61063	PAR	Interferon Alfa/Interleukin-2	NCI
C61063	PAR	Interferon Alfa/Isotretinoin	NCI
C61063	PAR	Carmustine/Interferon Alfa	NCI
C61063	PAR	Cyclophosphamide/Interferon Alfa	NCI
C61063	PAR	Interferon Alfa/Mercaptopurine/Methotrexate	NCI
C61063	PAR	Interferon Alfa/Interleukin-2/Lymphokine-Activated Killer Cells	NCI
C61063	PAR	Fluorouracil/Interferon Alfa/Leucovorin Calcium	NCI
C61063	PAR	Cisplatin/Interferon Alfa/Tamoxifen	NCI
C61063	PAR	Interferon Alfa/Melphalan/Prednisone	NCI
C61063	PAR	Interferon Alfa/Poly ICLC	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Interferon Alfa	NCI
C61063	PAR	Cisplatin/Etoposide/Interferon Alfa	NCI
C61063	PAR	Carboplatin/Interferon Alfa	NCI
C61063	PAR	Cyclophosphamide/Interferon Alfa/Melphalan/Prednisone/Vincristine	NCI
C61063	PAR	Carmustine/Cisplatin/Dacarbazine/Interferon Alfa/Tamoxifen	NCI
C61063	PAR	Floxuridine/Fluorouracil/Interferon Alfa/Leucovorin Calcium	NCI
C61063	PAR	Floxuridine/Interferon Alfa/Mitomycin	NCI
C61063	PAR	Cisplatin/Fluorouracil/Interferon Alfa/Leucovorin Calcium	NCI
C61063	PAR	Fludarabine/Interferon Alfa	NCI
C61063	PAR	Fluorouracil/Interferon Alfa/Leucovorin Calcium/Methotrexate	NCI
C61063	PAR	Cisplatin/Interferon Alfa/interleukin-2/Vinblastine	NCI
C61063	PAR	Dacarbazine/Interferon Alfa	NCI
C61063	PAR	Dacarbazine/Interferon Alfa/Tamoxifen	NCI
C61063	PAR	Carboplatin/Cisplatin/Interferon Alfa/Tamoxifen	NCI
C61063	PAR	Interferon Alfa/Interleukin-2/Monoclonal Antibody R24	NCI
C61063	PAR	Filgrastim/Fluorouracil/Interferon Alfa	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Interferon Alfa	NCI
C61063	PAR	Interferon Alfa/Interleukin-2/Tumor Necrosis Factor	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Filgrastim	NCI
C61063	PAR	Hydroxyurea/Interferon Alfa	NCI
C61063	PAR	Fluorouracil/Interferon Alfa/Leucovorin Calcium/Mitoxantrone/Vinblastine	NCI
C61063	PAR	Carboplatin/Etoposide/Interferon Alfa/Mitoxantrone	NCI
C61063	PAR	Interferon Alfa/Megestrol/Tamoxifen	NCI
C61063	PAR	Fluorouracil/Interferon Alfa/Leucovorin Calcium/Mitomycin	NCI
C61063	PAR	Floxuridine/Interferon Alfa	NCI
C61063	PAR	Cisplatin/Etoposide/Fluorouracil/Interferon Alfa	NCI
C61063	PAR	Allopurinol/Fluorouracil/Interferon Alfa	NCI
C61063	PAR	Fluorouracil/Interferon Alfa/Interferon Gamma/Leucovorin Calcium	NCI
C61063	PAR	Bleomycin/Doxorubicin/Vincristine/zalcitabine	NCI
C61063	PAR	Bleomycin/Cisplatin/Ifosfamide/Interferon Alfa	NCI
C61063	PAR	Interferon Alfa/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Busulfan/Interferon Alfa	NCI
C61063	PAR	Filgrastim/Interferon Alfa	NCI
C61063	PAR	Hydralazine/Interferon Alfa	NCI
C61063	PAR	Carmustine/Fluorouracil/Interferon Alfa	NCI
C61063	PAR	Carmustine/Doxorubicin/Interferon Alfa/Prednisone/Vincristine	NCI
C61063	PAR	Busulfan/Cyclophosphamide/Interferon Alfa/Zidovudine	NCI
C61063	PAR	Fluorouracil/Hydroxyurea/Interferon Alfa	NCI
C61063	PAR	Doxorubicin/Interferon Alfa/Tretinoin	NCI
C61063	PAR	Cisplatin/Dacarbazine/Interferon Alfa/Tamoxifen	NCI
C61063	PAR	Ifosfamide/Interferon Alfa/Pentostatin	NCI
C61063	PAR	Interferon Alfa/Monoclonal Antibody CC49	NCI
C61063	PAR	Fluorouracil/Interferon Alfa/Leucovorin Calcium/Sargramostim	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Etoposide/Interferon Alfa	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Filgrastim/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Dexamethasone/Interferon Alfa	NCI
C61063	PAR	Homoharringtonine/Interferon Alfa	NCI
C61063	PAR	Cisplatin/Dacarbazine/Interferon Alfa/Interleukin-2/Tamoxifen/Tumor Infiltrating Lymphocytes	NCI
C61063	PAR	Epoetin Alfa/Interleukin-6/Sargramostim	NCI
C61063	PAR	Interferon Alfa/Interleukin-2/Tamoxifen	NCI
C61063	PAR	Fluorouracil/Interferon Alfa/Leucovorin Calcium/Raltitrexed	NCI
C61063	PAR	Carmustine/Cisplatin/Dacarbazine/Interferon Alfa/interleukin-2/Tamoxifen	NCI
C61063	PAR	Etoposide/Fluorouracil/Interferon Alfa/Leucovorin Calcium	NCI
C61063	PAR	Interferon Alfa/Interleukin-2/Isotretinoin	NCI
C61063	PAR	Fluorouracil/Interferon Alfa/Interleukin-2/Isotretinoin	NCI
C61063	PAR	interleukin-2/Monoclonal Antibody OKT3/Tumor Necrosis Factor	NCI
C61063	PAR	Cyclophosphamide/Interleukin-2/Monoclonal Antibody OKT3/Tumor Necrosis Factor	NCI
C61063	PAR	interleukin-2/Monoclonal Antibody OKT3/pentoxifylline	NCI
C61063	PAR	Cyclophosphamide/Interleukin-2/Monoclonal Antibody OKT3	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Monoclonal Antibody HER2	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Trastuzumab	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant	NCI
C61063	PAR	Bleomycin/Dacarbazine/Lomustine/Vincristine	NCI
C61063	PAR	Bleomycin/Dacarbazine/Interferon Alfa/Lomustine/Vincristine	NCI
C61063	PAR	Interleukin-2/Zinc Oxide	NCI
C61063	PAR	Cisplatin/Dacarbazine/Interferon Alfa/interleukin-2	NCI
C61063	PAR	Cisplatin/Dacarbazine/Interferon Alfa	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Thioguanine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Daunorubicin/Pegaspargase/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Mercaptopurine/Pegaspargase/Vincristine	NCI
C61063	PAR	Edrecolomab/Sargramostim	NCI
C61063	PAR	Monoclonal Antibody 17-1A/sargramostim	NCI
C61063	PAR	Etoposide/Mitoxantrone/Tretinoin Liposome	NCI
C61063	PAR	Cytarabine/Tretinoin Liposome	NCI
C61063	PAR	Ketoconazole/Tretinoin	NCI
C61063	PAR	Disulfiram/Tretinoin	NCI
C61063	PAR	Carmustine/Cytarabine/Methotrexate/Vincristine	NCI
C61063	PAR	Edetate Calcium Disodium/Interferon Alfa/Monoclonal Antibody CC49	NCI
C61063	PAR	Human Chorionic Gonadotropin/Staphage Lysate	NCI
C61063	PAR	Cisplatin/Fluorouracil/L-Leucovorin	NCI
C61063	PAR	Dexamethasone/Melphalan	NCI
C61063	PAR	Busulfan/Dexamethasone/Thiotepa	NCI
C61063	PAR	Dexamethasone/Doxorubicin/Pegaspargase/Vincristine	NCI
C61063	PAR	9-cis-Retinoic Acid/Interferon Alfa	NCI
C61063	PAR	Idarubicin/Tretinoin Liposome	NCI
C61063	PAR	Docetaxel/Vinorelbine	NCI
C61063	PAR	Floxuridine/Gemcitabine/Leucovorin Calcium	NCI
C61063	PAR	Filgrastim/Losoxantrone/Paclitaxel	NCI
C61063	PAR	Cyclophosphamide/Daunorubicin/Dexamethasone/Vincristine	NCI
C61063	PAR	Cytarabine/Idarubicin/Thioguanine	NCI
C61063	PAR	Interferon Alfa/Interleukin-2/Paclitaxel	NCI
C61063	PAR	Mercaptopurine/Methotrexate/Tretinoin	NCI
C61063	PAR	Carboplatin/Cisplatin/Interferon Alfa/interleukin-2/Paclitaxel	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Etoposide/Mercaptopurine/Methotrexate	NCI
C61063	PAR	Carboplatin/RMP-7	NCI
C61063	PAR	Epirubicin/Vinorelbine	NCI
C61063	PAR	Allovectin-7/Interleukin-2	NCI
C61063	PAR	Cyclophosphamide/Losoxantrone	NCI
C61063	PAR	Cyclophosphamide/Daunorubicin	NCI
C61063	PAR	Asparaginase/Cytarabine/Methotrexate	NCI
C61063	PAR	Daunorubicin/Dexamethasone	NCI
C61063	PAR	Fluorouracil/Octreotide Pamoate	NCI
C61063	PAR	9-cis-Retinoic Acid/Tamoxifen	NCI
C61063	PAR	Dexrazoxane/Doxorubicin/Paclitaxel	NCI
C61063	PAR	Dexrazoxane/Doxorubicin/Filgrastim/Paclitaxel	NCI
C61063	PAR	Amsacrine/Carmustine/Cytarabine/Etoposide	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Mitoxantrone	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Topotecan	NCI
C61063	PAR	Carmustine/Etoposide	NCI
C61063	PAR	Interferon Alfa/Monoclonal Antibody CC49/Paclitaxel	NCI
C61063	PAR	Letrozole/Tamoxifen	NCI
C61063	PAR	Edrecolomab/Fluorouracil/Levamisole	NCI
C61063	PAR	Fluorouracil/Levamisole/Monoclonal Antibody 17-1A	NCI
C61063	PAR	Cetuximab/Paclitaxel	NCI
C61063	PAR	Monoclonal Antibody C225/Paclitaxel	NCI
C61063	PAR	Doxorubicin/Estramustine	NCI
C61063	PAR	Cetuximab/Doxorubicin	NCI
C61063	PAR	Etoposide/Ifosfamide/Mesna/Mitoxantrone	NCI
C61063	PAR	Interferon Gamma/Monoclonal Antibody CC49	NCI
C61063	PAR	Cyclosporine/Cytarabine/Daunorubicin/Etoposide	NCI
C61063	PAR	Cyclosporine/Cytarabine/Etoposide/Idarubicin	NCI
C61063	PAR	Asparaginase/Dexrazoxane/Doxorubicin/Mercaptopurine/Prednisone/Vincristine	NCI
C61063	PAR	Asparaginase/dexrazoxane/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Asparaginase/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Dexrazoxane/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Pegaspargase/Thioguanine/Vincristine	NCI
C61063	PAR	Mercaptopurine/Vincristine	NCI
C61063	PAR	Nolatrexed Dihydrochloride/Cisplatin	NCI
C61063	PAR	AG337/Cisplatin	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Methylprednisolone	NCI
C61063	PAR	Hydrocortisone/Methotrexate	NCI
C61063	PAR	Asparaginase/Dexamethasone/Epirubicin/Vincristine	NCI
C61063	PAR	Cytarabine/Etoposide/Vincristine	NCI
C61063	PAR	Cytarabine/Etoposide/Thioguanine/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Epirubicin/Etoposide/Thioguanine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Etoposide/Mercaptopurine/Methotrexate/Prednisolone/Thioguanine/Vincristine	NCI
C61063	PAR	Carboplatin/Filgrastim	NCI
C61063	PAR	Cimetidine/Tumor Infiltrating Lymphocytes	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Daunorubicin/Dexamethasone/Vincristine	NCI
C61063	PAR	GM2-KLH Vaccine/Interferon Alfa	NCI
C61063	PAR	Cisplatin/Fluorouracil/Tirapazamine	NCI
C61063	PAR	Cytarabine/Etoposide/Methotrexate/Pegaspargase/Prednisone/Thioguanine/Vincristine	NCI
C61063	PAR	Asparaginase/Prednisolone/Vincristine	NCI
C61063	PAR	Mercaptopurine/Prednisolone/Vincristine	NCI
C61063	PAR	Fludarabine/Octreotide	NCI
C61063	PAR	Cytarabine/Hydroxyurea/Interferon Alfa	NCI
C61063	PAR	Interferon Alfa/Bexarotene	NCI
C61063	PAR	BCG/Dacarbazine	NCI
C61063	PAR	Amifostine/Paclitaxel	NCI
C61063	PAR	Cisplatin/Isotretinoin	NCI
C61063	PAR	Cyclophosphamide/Cyclosporine/Cytarabine/Daunorubicin	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Mitoxantrone/Pegaspargase/Prednisone/Vincristine	NCI
C61063	PAR	Suramin/Topotecan	NCI
C61063	PAR	Interferon Alfa/Monoclonal Antibody CC49/Pentetic Acid	NCI
C61063	PAR	Doxorubicin/VX-710	NCI
C61063	PAR	Keyhole Limpet Hemocyanin/MUC-1 Antigen	NCI
C61063	PAR	Carmustine/Interferon Alfa/Tamoxifen	NCI
C61063	PAR	Bleomycin/Carboplatin/Cisplatin/Vincristine	NCI
C61063	PAR	Dacarbazine/Doxorubicin/Ifosfamide/Mesna	NCI
C61063	PAR	Cyclosporine/Methylprednisolone/Prednisone	NCI
C61063	PAR	Cyclophosphamide/Epirubicin/Monoclonal Antibody HER2	NCI
C61063	PAR	Cyclophosphamide/Epirubicin/Trastuzumab	NCI
C61063	PAR	Monoclonal Antibody HER2/Paclitaxel	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Daunorubicin	NCI
C61063	PAR	Cisplatin/interleukin-2/Paclitaxel/Tumor Infiltrating Lymphocytes	NCI
C61063	PAR	Carboplatin/filgrastim/Paclitaxel/Topotecan	NCI
C61063	PAR	P-30 Protein/Tamoxifen	NCI
C61063	PAR	Ranpirnase/Tamoxifen	NCI
C61063	PAR	Cladribine/Etoposide	NCI
C61063	PAR	70-kD Heat-Shock Protein/MUC-1 Antigen	NCI
C61063	PAR	Fluorouracil/Phenylbutyrate	NCI
C61063	PAR	Etoposide/Methylprednisolone	NCI
C61063	PAR	Melphalan/Mitoxantrone	NCI
C61063	PAR	Carboplatin/Etoposide/Paclitaxel	NCI
C61063	PAR	Carboplatin/Cyclosporine/Doxorubicin	NCI
C61063	PAR	Cytarabine/Deoxycytidine	NCI
C61063	PAR	Carboplatin/9-cis-Retinoic Acid	NCI
C61063	PAR	Bleomycin/Dexrazoxane/Doxorubicin/Etoposide/Vincristine	NCI
C61063	PAR	Fluorouracil/Gemcitabine	NCI
C61063	PAR	Carboplatin/Cyclosporine/Dipyridamole/Etoposide/Prochlorperazine	NCI
C61063	PAR	Carboplatin/Cyclosporine/Interferon Alfa	NCI
C61063	PAR	Cisplatin/Toremifene	NCI
C61063	PAR	Dexamethasone/Etoposide/Ifosfamide/Pegaspargase/Vincristine	NCI
C61063	PAR	Dexamethasone/Methotrexate/Pegaspargase/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Idarubicin/Pegaspargase/Vincristine	NCI
C61063	PAR	Cytarabine/Pegaspargase/Thioguanine/Vincristine	NCI
C61063	PAR	Pegaspargase/Vincristine	NCI
C61063	PAR	Carboplatin/Ifosfamide/Paclitaxel	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Cyclosporine/Paclitaxel	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Cyclosporine/Paclitaxel	NCI
C61063	PAR	Docetaxel/Epirubicin/Filgrastim	NCI
C61063	PAR	Dronabinol/Megestrol	NCI
C61063	PAR	Cisplatin/Doxorubicin/Edatrexate/Filgrastim/Vinblastine	NCI
C61063	PAR	Doxorubicin/PSC 833	NCI
C61063	PAR	Cyclophosphamide/Melphalan/Mitoxantrone	NCI
C61063	PAR	Aminoglutethimide/Bicalutamide/Hydrocortisone	NCI
C61063	PAR	Aminoglutethimide/Hydrocortisone	NCI
C61063	PAR	Docetaxel/Doxorubicin	NCI
C61063	PAR	Cisplatin/Doxorubicin/Ifosfamide/Mitomycin	NCI
C61063	PAR	Cisplatin/Doxorubicin/Ifosfamide/Mitomycin/Sargramostim	NCI
C61063	PAR	Edrecolomab/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Monoclonal Antibody 17-1A	NCI
C61063	PAR	Doxorubicin/DPPE	NCI
C61063	PAR	Dacarbazine/Doxorubicin/Ifosfamide/Vincristine	NCI
C61063	PAR	Dexamethasone/Doxorubicin/PSC 833/Vincristine	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/interleukin-2	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12	NCI
C61063	PAR	gp100 Antigen/interleukin-2/MART-1 Antigen	NCI
C61063	PAR	Cisplatin/Hydroxyurea/Vinblastine	NCI
C61063	PAR	Cisplatin/Etoposide/Hydroxyurea	NCI
C61063	PAR	Cisplatin/Hydroxyurea/Vinorelbine	NCI
C61063	PAR	Cisplatin/Hydroxyurea/Vindesine	NCI
C61063	PAR	Cisplatin/Hydroxyurea	NCI
C61063	PAR	Carboplatin/Epirubicin/Vincristine	NCI
C61063	PAR	gp100 Antigen/MART-1 Antigen	NCI
C61063	PAR	Doxorubicin/Progesterone	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Filgrastim/Paclitaxel	NCI
C61063	PAR	Irinotecan/Raltitrexed	NCI
C61063	PAR	Cisplatin/Filgrastim/Paclitaxel/Topotecan	NCI
C61063	PAR	Cisplatin/Paclitaxel/Topotecan	NCI
C61063	PAR	Chlorodihydroxypyridine/Potassium Oxonate/Tegafur	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Idarubicin/Methylprednisolone/Methotrexate/Vincristine	NCI
C61063	PAR	Indinavir/Lamivudine/Stavudine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Prednisone/Sargramostim/Vincristine	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Etoposide/Filgrastim/Paclitaxel	NCI
C61063	PAR	Cyclophosphamide/Epirubicin/Filgrastim/Fluorouracil	NCI
C61063	PAR	Irinotecan/Paclitaxel	NCI
C61063	PAR	Lomustine/Procarbazine/Thioguanine/Vincristine	NCI
C61063	PAR	Carmustine/Cyclophosphamide/Etoposide/Mesna	NCI
C61063	PAR	Eniluracil/Fluorouracil	NCI
C61063	PAR	Ethynyluracil/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Eniluracil/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Epirubicin/Paclitaxel	NCI
C61063	PAR	Paclitaxel/VX-710	NCI
C61063	PAR	Docetaxel/Estramustine/Hydrocortisone	NCI
C61063	PAR	Busulfan/Cyclophosphamide/Decitabine	NCI
C61063	PAR	Cladribine/Cytarabine	NCI
C61063	PAR	Cisplatin/Ifosfamide/Mesna/Mitomycin	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Etoposide	NCI
C61063	PAR	Fluorouracil/Marimastat	NCI
C61063	PAR	Cytarabine/Lomustine/Methotrexate/Methylprednisolone/Procarbazine	NCI
C61063	PAR	Etoposide/Ifosfamide/Mesna	NCI
C61063	PAR	Ifosfamide/Mesna/Mitoxantrone	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Octreotide Pamoate/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Filgrastim/Vincristine	NCI
C61063	PAR	Carboplatin/Ifosfamide/Mesna	NCI
C61063	PAR	Carboplatin/filgrastim/Ifosfamide/Mesna	NCI
C61063	PAR	Cisplatin/Paclitaxel/Tirapazamine	NCI
C61063	PAR	Carmustine/Topotecan	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisolone/Vincristine	NCI
C61063	PAR	Interferon Alfa/Ritonavir/Stavudine	NCI
C61063	PAR	Cordycepin/Pentostatin	NCI
C61063	PAR	Bleomycin/Doxorubicin/Vindesine	NCI
C61063	PAR	UFT/Leucovorin	NCI
C61063	PAR	Fluorouracil/Hydroxyurea/Paclitaxel	NCI
C61063	PAR	Epoetin Alfa/Fluorouracil/Hydroxyurea/Paclitaxel	NCI
C61063	PAR	Cisplatin/Docetaxel/Gemcitabine	NCI
C61063	PAR	Cytarabine/Etoposide/Mitoxantrone/PSC 833	NCI
C61063	PAR	Amifostine/Topotecan	NCI
C61063	PAR	Marimastat/Tamoxifen	NCI
C61063	PAR	Amifostine/Cisplatin/Fluorouracil	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Marimastat	NCI
C61063	PAR	Floxuridine/Leucovorin Calcium/Melphalan	NCI
C61063	PAR	Etoposide/Ifosfamide/Mesna/Topotecan	NCI
C61063	PAR	Etoposide Phosphate/Topotecan	NCI
C61063	PAR	Doxorubicin/Raltitrexed	NCI
C61063	PAR	Estramustine/Etoposide/Paclitaxel	NCI
C61063	PAR	Amifostine/Ciprofloxacin/Pentoxifylline	NCI
C61063	PAR	Amifostine/Ciprofloxacin/Dexamethasone/Pentoxifylline	NCI
C61063	PAR	Oltipraz/Vitamin A	NCI
C61063	PAR	Fenretinide/Vitamin A	NCI
C61063	PAR	Calcium Carbonate/Cholecalciferol	NCI
C61063	PAR	Bryostatin 1/Cytarabine	NCI
C61063	PAR	Amifostine/Cyclophosphamide/Mitoxantrone/Thiotepa	NCI
C61063	PAR	Fluorouracil/Raltitrexed	NCI
C61063	PAR	Bryostatin 1/Cisplatin	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Doxorubicin	NCI
C61063	PAR	Fluorouracil/Gemcitabine/Leucovorin Calcium	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Lomustine/Procarbazine	NCI
C61063	PAR	Bacitracin/Clotrimazole/Gentamicin	NCI
C61063	PAR	AUT-OV-ALVAC-hB7.1/Interferon Gamma	NCI
C61063	PAR	Amifostine/Carboplatin/Cyclophosphamide	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Tyrosinase Peptide	NCI
C61063	PAR	Bismuth Subcitrate/Metronidazole/Omeprazole/Tetracycline	NCI
C61063	PAR	Amoxicillin/Clarithromycin/Omeprazole	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Interleukin-2/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/Sargramostim	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase Peptide	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Peptide	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Interleukin-2/Tyrosinase Related Protein-1	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase Related Protein-1	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Related Protein-1	NCI
C61063	PAR	Carboplatin/Cisplatin/Floxuridine	NCI
C61063	PAR	Carboplatin/Floxuridine	NCI
C61063	PAR	Cisplatin/Floxuridine	NCI
C61063	PAR	Amifostine/Cisplatin/Gemcitabine	NCI
C61063	PAR	Bryostatin 1/Cladribine	NCI
C61063	PAR	Cladribine/Idarubicin	NCI
C61063	PAR	Histamine Dihydrochloride/Interleukin-2	NCI
C61063	PAR	Cisplatin/Monoclonal Antibody C225	NCI
C61063	PAR	Carboplatin/Etoposide/Fluorouracil	NCI
C61063	PAR	Amifostine/Fludarabine	NCI
C61063	PAR	Flt3 Ligand/gp100 Antigen	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Dexrazoxane/Doxorubicin/Etoposide/Prednisone/Vincristine	NCI
C61063	PAR	Doxorubicin HCl Liposome/PSC 833	NCI
C61063	PAR	Amifostine/Busulfan/Melphalan/Thiotepa	NCI
C61063	PAR	Ifosfamide/Topotecan	NCI
C61063	PAR	Cytarabine/Daunorubicin/Etoposide/PSC 833	NCI
C61063	PAR	Mitoxantrone/Vinorelbine	NCI
C61063	PAR	Carboplatin/Thiotepa/Topotecan	NCI
C61063	PAR	Amifostine/Cisplatin/Cytarabine/Dexamethasone	NCI
C61063	PAR	Interleukin-2/Sargramostim/Vinblastine	NCI
C61063	PAR	Peptide 946 Melanoma Vaccine/QS21	NCI
C61063	PAR	Peptide 946 Melanoma Vaccine/QS21/Tetanus Peptide Melanoma Vaccine	NCI
C61063	PAR	Interleukin-2/Monoclonal Antibody 3622W94/Sargramostim	NCI
C61063	PAR	Interleukin-2/Monoclonal Antibody 3622W94	NCI
C61063	PAR	ALVAC-CEA Vaccine/Sargramostim	NCI
C61063	PAR	Amifostine/Irinotecan	NCI
C61063	PAR	Dexamethasone/Metoclopramide	NCI
C61063	PAR	Bryostatin 1/Paclitaxel	NCI
C61063	PAR	Interferon Alfa/Isotretinoin/Vitamin E	NCI
C61063	PAR	Cytarabine/Homoharringtonine/Interferon Alfa	NCI
C61063	PAR	Clodronate/Mitoxantrone/Prednisone	NCI
C61063	PAR	Cladribine/Cyclophosphamide/Prednisone	NCI
C61063	PAR	Interferon Alfa/Ritonavir	NCI
C61063	PAR	Cyclophosphamide/Mercaptopurine/Methotrexate	NCI
C61063	PAR	Carboxyamidotriazole/Ketoconazole	NCI
C61063	PAR	Omeprazole/Porfimer Sodium	NCI
C61063	PAR	Amifostine/Cisplatin/Cyclophosphamide/Etoposide	NCI
C61063	PAR	Octreotide/Prednisone	NCI
C61063	PAR	Carboplatin/Estramustine/Filgrastim/Paclitaxel	NCI
C61063	PAR	BCG/Monoclonal Antibody BEC2	NCI
C61063	PAR	Amifostine/Cytarabine/Idarubicin	NCI
C61063	PAR	Fluorouracil/Trimetrexate Glucuronate	NCI
C61063	PAR	Cisplatin/Fluorouracil/ONYX-015	NCI
C61063	PAR	Mitoxantrone/Thiotepa/Topotecan	NCI
C61063	PAR	Cytarabine/Daunorubicin/Interleukin-11/Sargramostim	NCI
C61063	PAR	Interleukin-11/Sargramostim	NCI
C61063	PAR	gp100 Antigen/Tyrosinase Peptide	NCI
C61063	PAR	Bryostatin 1/Interleukin-2/Ionomycin	NCI
C61063	PAR	Finasteride/Flutamide	NCI
C61063	PAR	Cyclophosphamide/DPPE	NCI
C61063	PAR	Busulfan/Cyclophosphamide/Methylprednisolone	NCI
C61063	PAR	Carboplatin/Paclitaxel/Prinomastat	NCI
C61063	PAR	AG3340/Carboplatin/Paclitaxel	NCI
C61063	PAR	AG3340/Mitoxantrone/Prednisone	NCI
C61063	PAR	Mitoxantrone/Prednisone/Prinomastat	NCI
C61063	PAR	Docetaxel/Doxorubicin HCl Liposome	NCI
C61063	PAR	Carboplatin/Lomustine/Procarbazine/Vincristine	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Etoposide/Leucovorin calcium/Methotrexate/Vincristine	NCI
C61063	PAR	Doxorubicin HCl Liposome/Paclitaxel	NCI
C61063	PAR	Filgrastim/Pegylated Recombinant Human Megakaryocyte Growth and Development Factor	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/Tyrosinase Peptide	NCI
C61063	PAR	QS21/Tn(c)-KLH Conjugate Vaccine	NCI
C61063	PAR	Acetaminophen/Acetylcysteine/Carmustine	NCI
C61063	PAR	Acetaminophen/Acetylcysteine	NCI
C61063	PAR	Filgrastim/Promegapoietin	NCI
C61063	PAR	Doxorubicin HCl Liposome/Topotecan	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Iodine I 131 Tositumomab	NCI
C61063	PAR	Cyclophosphamide/Etoposide/iodine I 131 Monoclonal Antibody Anti-B1	NCI
C61063	PAR	Ciprofloxacin/Dexamethasone/Pentoxifylline	NCI
C61063	PAR	Cisplatin/LY231514	NCI
C61063	PAR	Etoposide/Gemcitabine	NCI
C61063	PAR	Carboplatin/Doxorubicin HCl Liposome/Paclitaxel	NCI
C61063	PAR	gp100 Antigen/QS21/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/Sargramostim/Tyrosinase Peptide	NCI
C61063	PAR	Bryostatin 1/Fludarabine	NCI
C61063	PAR	BMS-182751/Prednisone	NCI
C61063	PAR	Prednisone/Satraplatin	NCI
C61063	PAR	Doxorubicin HCl Liposome/Etoposide	NCI
C61063	PAR	Interleukin-2/Rituximab	NCI
C61063	PAR	Amifostine/Cytarabine/Mitoxantrone	NCI
C61063	PAR	Gemcitabine/Topotecan	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin HCl Liposome/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Daunorubicin/Prednisone/Vincristine	NCI
C61063	PAR	Lamivudine/Zidovudine	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Peptide 946 Melanoma Vaccine	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine	NCI
C61063	PAR	Chlorambucil/Doxorubicin/Etoposide/Prednisolone/Procarbazine/Vinblastine/Vincristine	NCI
C61063	PAR	Cytarabine/Daunorubicin/Etoposide/Methotrexate/Prednisolone/Thioguanine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Methotrexate/Thioguanine	NCI
C61063	PAR	BAY 12-9566/Doxorubicin	NCI
C61063	PAR	Asparaginase/Methotrexate/Prednisolone/Vincristine	NCI
C61063	PAR	Interferon Alfa/Interleukin-12	NCI
C61063	PAR	Carcinoembryonic Antigen Peptide 1/Hepatitis B Antigen Peptide	NCI
C61063	PAR	Carmustine/Gemcitabine/Melphalan	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide/Gemcitabine	NCI
C61063	PAR	Cisplatin/Floxuridine/Paclitaxel	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide	NCI
C61063	PAR	Carboplatin/Docetaxel/Ifosfamide	NCI
C61063	PAR	Interferon Alfa/Interleukin-2/Sargramostim	NCI
C61063	PAR	Amifostine/Epoetin Alfa	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Von Hippel-Lindau Peptide Vaccine	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Interleukin-2/Von Hippel-Lindau Peptide Vaccine	NCI
C61063	PAR	Incomplete Freund's Adjuvant/Sargramostim/Von Hippel-Lindau Peptide Vaccine	NCI
C61063	PAR	Carmustine/Fluorouracil/Streptozocin/Vincristine	NCI
C61063	PAR	ALVAC-hB7.1/Canarypox-hIL-12 Melanoma Vaccine	NCI
C61063	PAR	Adenovirus 5-CD40-L Vector/Interleukin-2	NCI
C61063	PAR	Cyclophosphamide/Prednisone/Sargramostim/Vincristine	NCI
C61063	PAR	Isotretinoin/Procarbazine	NCI
C61063	PAR	Dexamethasone/Methotrexate/Thioguanine/Vincristine	NCI
C61063	PAR	Methotrexate/Prednisolone/Thioguanine/Vincristine	NCI
C61063	PAR	Flt3 Ligand/gp100 Antigen/MART-1 Antigen/Tyrosinase	NCI
C61063	PAR	Flt3 Ligand/gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Tyrosinase	NCI
C61063	PAR	Cisplatin/Dexamethasone/Paclitaxel	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Epirubicin/Etoposide	NCI
C61063	PAR	Interferon Alfa/Sargramostim	NCI
C61063	PAR	Cisplatin/Dimesna/Paclitaxel	NCI
C61063	PAR	Etoposide/Idarubicin	NCI
C61063	PAR	Cytarabine/Idarubicin/Recombinant Human Thrombopoietin	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Hydrocortisone/Leucovorin Calcium	NCI
C61063	PAR	Fenretinide/Tretinoin	NCI
C61063	PAR	Melphalan/Prednisolone	NCI
C61063	PAR	Dexamethasone/Idarubicin/Lomustine	NCI
C61063	PAR	gp209-2M Antigen/Incomplete Freund's Adjuvant/Interleukin-2	NCI
C61063	PAR	Allovectin-7/Dacarbazine	NCI
C61063	PAR	Carboplatin/Monoclonal Antibody HER2/Paclitaxel	NCI
C61063	PAR	Carboplatin/Paclitaxel/Trastuzumab	NCI
C61063	PAR	Docetaxel/Estramustine/Mitoxantrone/Prednisone	NCI
C61063	PAR	Cyclosporine/Etoposide/Vincristine	NCI
C61063	PAR	Cytarabine/Fludarabine/Topotecan	NCI
C61063	PAR	Chlorambucil/Dexamethasone/Idarubicin	NCI
C61063	PAR	Chlorambucil/Dexamethasone	NCI
C61063	PAR	Cytarabine/Etoposide/Melphalan	NCI
C61063	PAR	Cytarabine/Daunorubicin/Filgrastim	NCI
C61063	PAR	Cyclophosphamide/Theratope STn-KLH Vaccine	NCI
C61063	PAR	Fluorouracil/Gemcitabine/Interferon Alfa/Interleukin-2	NCI
C61063	PAR	Doxorubicin/Methylprednisolone	NCI
C61063	PAR	Clarithromycin/Omeprazole/Tinidazole	NCI
C61063	PAR	Cyclophosphamide/Pentostatin	NCI
C61063	PAR	Phenylbutyrate/Tretinoin	NCI
C61063	PAR	Asparaginase/Dexamethasone/Mercaptopurine/Vincristine	NCI
C61063	PAR	Asparaginase/Daunorubicin/Dexamethasone/Vincristine	NCI
C61063	PAR	Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Mercaptopurine/Methotrexate/Thioguanine/Vincristine	NCI
C61063	PAR	Asparaginase/Dexamethasone/Etoposide/Mitoxantrone	NCI
C61063	PAR	Asparaginase/Mercaptopurine/Methotrexate/Vincristine	NCI
C61063	PAR	Cytarabine/Mercaptopurine/Methotrexate/Prednisone	NCI
C61063	PAR	Carboplatin/Melphalan	NCI
C61063	PAR	Irinotecan/LY231514	NCI
C61063	PAR	Irinotecan/Pemetrexed Disodium	NCI
C61063	PAR	Amifostine/Etoposide	NCI
C61063	PAR	Gemcitabine/R115777	NCI
C61063	PAR	Amifostine/Carboplatin/Etoposide/Ifosfamide	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Methotrexate	NCI
C61063	PAR	Dextromethorphan/Morphine	NCI
C61063	PAR	Irinotecan/Mitomycin	NCI
C61063	PAR	Cisplatin/Irinotecan/Paclitaxel	NCI
C61063	PAR	Cyclophosphamide/Thalidomide	NCI
C61063	PAR	Dexamethasone/Floxuridine/Irinotecan	NCI
C61063	PAR	Carboplatin/Temozolomide	NCI
C61063	PAR	Cisplatin/OXi-104	NCI
C61063	PAR	Interleukin-2/Ras Peptide Cancer Vaccine	NCI
C61063	PAR	Penicillamine/Pyridoxine	NCI
C61063	PAR	Daclizumab/Interleukin-2	NCI
C61063	PAR	Interleukin-2/Monoclonal Antibody Anti-Tac	NCI
C61063	PAR	Interferon Alfa/Toremifene	NCI
C61063	PAR	Asparaginase/Dexamethasone/Prednisone/Vincristine	NCI
C61063	PAR	Amifostine/Carmustine/Cyclophosphamide/Cytarabine/Etoposide	NCI
C61063	PAR	Amifostine/Carboplatin/Cyclophosphamide/Thiotepa	NCI
C61063	PAR	IDEC-In2B8/Rituximab	NCI
C61063	PAR	gp100 Antigen/MAGE-3/MART-1 Antigen/Tyrosinase Peptide	NCI
C61063	PAR	Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Tyrosinase Peptide	NCI
C61063	PAR	Docetaxel/Doxorubicin/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Docetaxel/Doxorubicin/Tamoxifen	NCI
C61063	PAR	Gemcitabine/Monoclonal Antibody HER2	NCI
C61063	PAR	Gemcitabine/Trastuzumab	NCI
C61063	PAR	Cytarabine/Methotrexate/Thioguanine	NCI
C61063	PAR	Asparaginase/Daunorubicin/Methotrexate/Prednisolone/Vincristine	NCI
C61063	PAR	Alendronate Sodium/Ketoconazole	NCI
C61063	PAR	Amifostine/Bleomycin/Cisplatin/Etoposide	NCI
C61063	PAR	Piperacillin/Tazobactam/Vancomycin	NCI
C61063	PAR	KSA Glycoprotein/QS21	NCI
C61063	PAR	KSA-KLH Conjugate Vaccine/QS21	NCI
C61063	PAR	Fowlpox Virus Vaccine/Interleukin-2	NCI
C61063	PAR	Doxorubicin/Vincristine/VX-710	NCI
C61063	PAR	Cyclosporine/Interferon Alfa/Sargramostim	NCI
C61063	PAR	Carboplatin/Paclitaxel/SCH-58500	NCI
C61063	PAR	Amifostine/Cytarabine/Topotecan	NCI
C61063	PAR	Aminopterin/Leucovorin Calcium	NCI
C61063	PAR	Carboplatin/Thiotepa/Vincristine	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-2/MART-1 Antigen	NCI
C61063	PAR	Iodine I 125/Polifeprosan 20 With Carmustine Implant	NCI
C61063	PAR	Amifostine/Cisplatin/Fluorouracil/Paclitaxel	NCI
C61063	PAR	Cisplatin/Flavopiridol/Paclitaxel	NCI
C61063	PAR	Cyclophosphamide/Epirubicin/Fluorouracil/Methotrexate	NCI
C61063	PAR	Fowlpox Virus Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine	NCI
C61063	PAR	Interleukin-2/Vaccinia-Tyrosinase Vaccine	NCI
C61063	PAR	Amifostine/Cyclophosphamide/Doxorubicin/Paclitaxel	NCI
C61063	PAR	Docetaxel/GEM 231	NCI
C61063	PAR	GEM 231/Paclitaxel	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Lonafarnib	NCI
C61063	PAR	Cytarabine/Daunorubicin/Tretinoin	NCI
C61063	PAR	Daunorubicin/Tretinoin	NCI
C61063	PAR	Fluorouracil-Uracil/Gemcitabine/Leucovorin Calcium	NCI
C61063	PAR	CRL 1005/gp100 Antigen/Incomplete Freund's Adjuvant/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase Peptide	NCI
C61063	PAR	Lomustine/Procarbazine	NCI
C61063	PAR	Leflunomide/Mitoxantrone	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/SU5416	NCI
C61063	PAR	Cyclosporine/Irinotecan	NCI
C61063	PAR	Detoxpc/Lung Tumor Associated Antigen	NCI
C61063	PAR	Anti-thymocyte globulin/Methylprednisolone	NCI
C61063	PAR	Anti-thymocyte globulin/melphalan/methylprednisolone	NCI
C61063	PAR	Rituximab/Vinorelbine	NCI
C61063	PAR	Dexrazoxane/Doxorubicin/Ifosfamide	NCI
C61063	PAR	MAGE-3/PADRE 965.10	NCI
C61063	PAR	Fluorouracil/Vincristine	NCI
C61063	PAR	Cisplatin/Fluorouracil/Gemcitabine	NCI
C61063	PAR	Tamoxifen/Trastuzumab	NCI
C61063	PAR	Fludarabine/UCN-01	NCI
C61063	PAR	Irinotecan/Trastuzumab	NCI
C61063	PAR	RAS Peptide Cancer Vaccine/Sargramostim	NCI
C61063	PAR	MAGE-3/SB AS-2	NCI
C61063	PAR	Anti-thymocyte globulin/thiotepa	NCI
C61063	PAR	Leflunomide/Mitoxantrone/Prednisone	NCI
C61063	PAR	L-778,123/Paclitaxel	NCI
C61063	PAR	Fluorouracil/UCN-01	NCI
C61063	PAR	gp100 Antigen/Montanide ISA-51/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/MART-1 Antigen/Montanide ISA-51	NCI
C61063	PAR	gp100 Antigen/Interleukin-2/MART-1 Antigen/Montanide ISA-51	NCI
C61063	PAR	Montanide ISA-51/Peptide 946 melanoma vaccine	NCI
C61063	PAR	Montanide ISA-51/Peptide 946 melanoma vaccine/Tetanus peptide melanoma vaccine	NCI
C61063	PAR	Montanide ISA-51/Peptide 946-tetanus peptide conjugate melanoma vaccine	NCI
C61063	PAR	Docetaxel/Mitoxantrone	NCI
C61063	PAR	gp100 Antigen/HPV-16 E7(12-20) Peptide Vaccine/Montanide ISA-51	NCI
C61063	PAR	gp100 Antigen/Interleukin-12/Montanide ISA-51/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/Montanide ISA-51/Sargramostim/Tetanus Peptide Melanoma Vaccine/Tyrosinase Peptide	NCI
C61063	PAR	Montanide ISA-51/von Hippel-Lindau peptide vaccine	NCI
C61063	PAR	Interleukin-2/Montanide ISA-51/Von Hippel-Lindau Peptide Vaccine	NCI
C61063	PAR	Montanide ISA-51/Sargramostim/von Hippel-Lindau peptide vaccine	NCI
C61063	PAR	Cyclosporine/Irinotecan/Phenobarbital	NCI
C61063	PAR	gp100 Antigen/Montanide ISA-51	NCI
C61063	PAR	Montanide ISA-51/Tyrosinase peptide	NCI
C61063	PAR	Interleukin-2/Montanide ISA-51/Tyrosinase Peptide	NCI
C61063	PAR	Interleukin-12/Montanide ISA-51/Tyrosinase Peptide	NCI
C61063	PAR	Montanide ISA-51/Sargramostim/Tyrosinase peptide	NCI
C61063	PAR	gp100 Antigen/Interleukin-12/Montanide ISA-51	NCI
C61063	PAR	gp100 Antigen/Montanide ISA-51/Sargramostim	NCI
C61063	PAR	Montanide ISA-51/Tyrosinase-Related Protein-1	NCI
C61063	PAR	Interleukin-2/Montanide ISA-51/Tyrosinase-Related Protein-1	NCI
C61063	PAR	Interleukin-12/Montanide ISA-51/Tyrosinase Related Protein-1	NCI
C61063	PAR	Montanide ISA-51/Sargramostim/Tyrosinase-Related Protein-1	NCI
C61063	PAR	gp100 Antigen/Interleukin-2/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide	NCI
C61063	PAR	Flt3 Ligand/gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide	NCI
C61063	PAR	CRL 1005/gp100 Antigen/Montanide ISA-51/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide	NCI
C61063	PAR	Interleukin-12/MART-1 Antigen/Montanide ISA-51	NCI
C61063	PAR	HER-2-neu peptide vaccine/Montanide ISA-51	NCI
C61063	PAR	Bcr-Abl Peptide Vaccine/QS21	NCI
C61063	PAR	E7(86-93) Lipopeptide/HPV-16 E7(12-20) Peptide Vaccine/Montanide ISA-51	NCI
C61063	PAR	Mutant p53 peptide pulsed dendritic cell vaccine/Sargramostim	NCI
C61063	PAR	Montanide ISA-51/p53 peptide vaccine/Sargramostim	NCI
C61063	PAR	gp100 Antigen/MART-1 Antigen/Tyrosinase Peptide	NCI
C61063	PAR	Carboplatin/Vinorelbine	NCI
C61063	PAR	Fluorouracil/Gemcitabine/Paclitaxel	NCI
C61063	PAR	gp100 Antigen/Tetanus Peptide Melanoma Vaccine/Tyrosinase Peptide	NCI
C61063	PAR	Carboplatin/Docetaxel/Gemcitabine	NCI
C61063	PAR	Estramustine/Paclitaxel/Vinorelbine	NCI
C61063	PAR	Interleukin-2/Vaccine-Sensitized Draining Lymph Node Cells	NCI
C61063	PAR	HER-2-Neu Peptide Vaccine/Sargramostim	NCI
C61063	PAR	Vinorelbine/Zosuquidar Trihydrochloride	NCI
C61063	PAR	BCG/Polyvalent Melanoma Vaccine	NCI
C61063	PAR	Cisplatin/Cytarabine/Etoposide/Ifosfamide/Yttrium Y 90 Humanized Epratuzumab	NCI
C61063	PAR	Filgrastim/Interleukin-11	NCI
C61063	PAR	Keyhole Limpet Hemocyanin/MUC-1 Antigen/QS21	NCI
C61063	PAR	BCG/Interferon alfa	NCI
C61063	PAR	Bryostatin 1/Gemcitabine	NCI
C61063	PAR	Carboplatin/Ifosfamide/Thiotepa	NCI
C61063	PAR	Doxorubicin Hcl Liposome/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Fludarabine	NCI
C61063	PAR	Asparaginase/Dexamethasone	NCI
C61063	PAR	Dexamethasone/Methotrexate/Vincristine	NCI
C61063	PAR	Daunorubicin/Vincristine	NCI
C61063	PAR	Prinomastat/Temozolomide	NCI
C61063	PAR	Cisplatin/Gemcitabine/Prinomastat	NCI
C61063	PAR	Gemcitabine/Oxaliplatin	NCI
C61063	PAR	Cisplatin/Rebeccamycin Analogue	NCI
C61063	PAR	Alum adjuvant/Monoclonal antibody 4B5 anti-idiotype vaccine	NCI
C61063	PAR	Monoclonal antibody 4B5 anti-idiotype vaccine/Sargramostim	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Triacetyluridine	NCI
C61063	PAR	Cytarabine/Leucovorin Calcium	NCI
C61063	PAR	Cytarabine/Daunorubicin/PSC 833	NCI
C61063	PAR	Tamoxifen/Tretinoin	NCI
C61063	PAR	Docetaxel/Oxaliplatin	NCI
C61063	PAR	Amifostine/Cisplatin/Docetaxel	NCI
C61063	PAR	Keyhole Limpet Hemocyanin/Polysialic Acid	NCI
C61063	PAR	Keyhole Limpet Hemocyanin/Polysialic Acid/QS21	NCI
C61063	PAR	Exemestane/Raloxifene	NCI
C61063	PAR	Cytarabine/UCN-01	NCI
C61063	PAR	Interleukin-12/Rituximab	NCI
C61063	PAR	Fluorouracil/Gemcitabine/Oxaliplatin	NCI
C61063	PAR	Irinotecan/Oblimersen	NCI
C61063	PAR	Doxorubicin HCl Liposome/Trastuzumab	NCI
C61063	PAR	Amifostine/Cisplatin/Irinotecan	NCI
C61063	PAR	Cisplatin/Raltitrexed	NCI
C61063	PAR	Carboplatin/Epirubicin/Paclitaxel	NCI
C61063	PAR	Cytarabine/Fludarabine/Oblimersen	NCI
C61063	PAR	Docetaxel/MS-209	NCI
C61063	PAR	MUC-2-KLH Vaccine/QS21	NCI
C61063	PAR	O6-Benzylguanine/Polifeprosan 20 With Carmustine Implant	NCI
C61063	PAR	Ifosfamide/Paclitaxel/Teniposide	NCI
C61063	PAR	Docetaxel/Doxorubicin Hcl Liposome/Trastuzumab	NCI
C61063	PAR	Biomed 101/Interleukin-2	NCI
C61063	PAR	Anti-thymocyte globulin/methylprednisolone/tacrolimus	NCI
C61063	PAR	CI-994/Gemcitabine	NCI
C61063	PAR	Eniluracil/Fluorouracil/Oxaliplatin	NCI
C61063	PAR	Cisplatin/Tirapazamine/Vinorelbine	NCI
C61063	PAR	Cetuximab/Irinotecan	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Etoposide/Mafosfamide/Vincristine	NCI
C61063	PAR	Docetaxel/Methotrexate	NCI
C61063	PAR	Oblimersen/Paclitaxel	NCI
C61063	PAR	Cetuximab/Gemcitabine	NCI
C61063	PAR	Carboplatin/Etoposide/Topotecan	NCI
C61063	PAR	Asparaginase/cyclophosphamide/cytarabine/daunorubicin/thioguanine	NCI
C61063	PAR	Asparaginase/cyclophosphamide/cytarabine/daunorubicin/dexamethasone/leucovorin calcium/mercaptopurine/methotrexate/thioguanine/vincristine	NCI
C61063	PAR	Interleukin-2/interleukin-12	NCI
C61063	PAR	Carboplatin/Docetaxel/Estramustine	NCI
C61063	PAR	Capecitabine/Paclitaxel	NCI
C61063	PAR	Amifostine/Azacitidine	NCI
C61063	PAR	Paclitaxel/SU5416	NCI
C61063	PAR	Carboplatin/Fludarabine	NCI
C61063	PAR	AFP Gene Hepatocellular Carcinoma Vaccine/Montanide ISA-51	NCI
C61063	PAR	Azacitidine/Phenylbutyrate	NCI
C61063	PAR	gp209-2M Antigen/Heat Shock Protein 70/OVA Bip Peptide/Tyrosinase Peptide	NCI
C61063	PAR	Carboplatin/Gefitinib/Paclitaxel	NCI
C61063	PAR	Filgrastim/Flt3 Ligand/Milodistim/Sargramostim	NCI
C61063	PAR	Bispecific Antibody MDX447/Lymphokine-Activated Killer Cells	NCI
C61063	PAR	Doxorubicin/SU5416	NCI
C61063	PAR	Estramustine/Mitoxantrone/Vinorelbine	NCI
C61063	PAR	Cisplatin/Fluorouracil/Irinotecan	NCI
C61063	PAR	Etoposide Phosphate/Melphalan/Topotecan	NCI
C61063	PAR	Cytarabine/Daunorubicin/Etoposide/Topotecan	NCI
C61063	PAR	Cisplatin/Mitomycin/Tretinoin/Vinorelbine	NCI
C61063	PAR	Cisplatin/Tretinoin/Vinorelbine	NCI
C61063	PAR	Cisplatin/Fenretinide/Paclitaxel	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide/Thalidomide	NCI
C61063	PAR	Docetaxel/Trastuzumab	NCI
C61063	PAR	Cytarabine/Daunorubicin/Etoposide/Tretinoin	NCI
C61063	PAR	Cytarabine/Filgrastim/Fludarabine	NCI
C61063	PAR	Cytarabine/Fludarabine/Tretinoin	NCI
C61063	PAR	Carboplatin/Gemcitabine/Paclitaxel/Trastuzumab	NCI
C61063	PAR	Filgrastim-Fetal Liver Tyrosine Kinase-3 Fusion Protein/gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide	NCI
C61063	PAR	Eflornithine/Sulindac	NCI
C61063	PAR	Celecoxib/Selenium	NCI
C61063	PAR	Irinotecan/SU5416	NCI
C61063	PAR	Cyclosporine/Filgrastim/Methylprednisolone/Monoclonal Antibody Okt3	NCI
C61063	PAR	Floxuridine/Leucovorin Calcium/Oxaliplatin	NCI
C61063	PAR	Tipifarnib/Trastuzumab	NCI
C61063	PAR	Interleukin-2/Staphylococcal Enterotoxin B	NCI
C61063	PAR	Cisplatin/Lurtotecan Liposome	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Mitoxantrone	NCI
C61063	PAR	Cisplatin/Gefitinib/Gemcitabine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Dexamethasone/Mitoxantrone	NCI
C61063	PAR	Irinotecan/Temozolomide	NCI
C61063	PAR	Anti-human chorionic gonadotropin vaccine/Gemcitabine	NCI
C61063	PAR	Carboplatin/Pyrazoloacridine	NCI
C61063	PAR	Cisplatin/Irinotecan/SU5416	NCI
C61063	PAR	Interleukin-2/Stem Cell Factor	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Oxaliplatin/Trastuzumab	NCI
C61063	PAR	Doxorubicin/Methotrexate/Pegaspargase/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Methotrexate/Pegaspargase/Vincristine	NCI
C61063	PAR	Daunorubicin/dexamethasone/methotrexate/vincristine	NCI
C61063	PAR	Gemcitabine/SU5416	NCI
C61063	PAR	Cytarabine/Dexamethasone/Leucovorin Calcium/Methotrexate	NCI
C61063	PAR	Dexamethasone/Etoposide/Ifosfamide	NCI
C61063	PAR	Daunorubicin Liposomal/SU5416	NCI
C61063	PAR	Tipifarnib/Topotecan	NCI
C61063	PAR	Doxorubicin Hcl Liposome/Gemcitabine/Vinorelbine	NCI
C61063	PAR	Fluorouracil/IM-862	NCI
C61063	PAR	IM-862/Irinotecan	NCI
C61063	PAR	Etoposide/Nitrocamptothecin	NCI
C61063	PAR	Cytarabine/Etoposide/Mitoxantrone/Monoclonal Antibody Hug1-M195	NCI
C61063	PAR	Filgrastim/Mycophenolate Mofetil/Tacrolimus	NCI
C61063	PAR	BMS-214662/Paclitaxel	NCI
C61063	PAR	Cytarabine/Gemtuzumab Ozogamicin	NCI
C61063	PAR	Cytarabine/Daunorubicin Liposomal	NCI
C61063	PAR	Doxorubicin Hcl Liposome/Gemcitabine	NCI
C61063	PAR	gp209-2M Antigen/Interleukin-2/Montanide ISA-51	NCI
C61063	PAR	BMS-188797/Carboplatin	NCI
C61063	PAR	Autologous Dendritic Cells/Candida Albicans Skin Test Reagent/CD40-Ligand/gp100 Antigen/Interferon Gamma/Interleukin-4/MART-1 Antigen/Sargramostim/Tyrosinase Peptide	NCI
C61063	PAR	Capecitabine/Paclitaxel/Trastuzumab	NCI
C61063	PAR	rV-B7.1 Vaccine/Vaccinia-Prostate-Specific-Antigen Vaccine	NCI
C61063	PAR	Dexamethasone/SU5416	NCI
C61063	PAR	Cyclophosphamide/Detox-B Adjuvant/Interleukin-2	NCI
C61063	PAR	Detox-B Adjuvant/Keyhole Limpet Hemocyanin/Sialyl Tn Antigen	NCI
C61063	PAR	Epirubicin/Fluorouracil	NCI
C61063	PAR	Arginine butyrate/Ganciclovir	NCI
C61063	PAR	Irinotecan/Octreotide	NCI
C61063	PAR	DX-8951f/Gemcitabine	NCI
C61063	PAR	Docetaxel/Cyclophosphamide	NCI
C61063	PAR	Interleukin-2/Trastuzumab	NCI
C61063	PAR	MAGE-12 peptide vaccine/Montanide ISA-51	NCI
C61063	PAR	Interleukin-2/MAGE-12 Peptide Vaccine/Montanide ISA-51	NCI
C61063	PAR	Dexamethasone/Phenylbutyrate/Sargramostim	NCI
C61063	PAR	Interferon Alfa/Lutetium Lu 177 Monoclonal Antibody CC49/Paclitaxel	NCI
C61063	PAR	Interferon Alfa/Lutetium Lu 177 Monoclonal Antibody CC49/Topotecan	NCI
C61063	PAR	Interferon Alfa/Paclitaxel/Yttrium Y 90 Monoclonal Antibody CC49	NCI
C61063	PAR	BMS-275291/Carboplatin/Paclitaxel	NCI
C61063	PAR	Arsenic trioxide/Tretinoin	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Etoposide/Methotrexate/Vincristine	NCI
C61063	PAR	Carboplatin/Doxorubicin HCl Liposome	NCI
C61063	PAR	Carboplatin/Doxorubicin Hydrochloride Liposome	NCI
C61063	PAR	Ganciclovir/Interleukin-2/Zidovudine	NCI
C61063	PAR	Denileukin Diftitox/Dexamethasone	NCI
C61063	PAR	QS21/RAS peptide cancer vaccine	NCI
C61063	PAR	Interferon Alfa/SU5416	NCI
C61063	PAR	Celecoxib/Trastuzumab	NCI
C61063	PAR	Carboplatin/SU5416	NCI
C61063	PAR	Donepezil/Vitamin E	NCI
C61063	PAR	Oxaliplatin/Topotecan	NCI
C61063	PAR	Gemcitabine/Lonafarnib	NCI
C61063	PAR	gp100 Antigen/Interferon Alfa/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/Interferon Alfa/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide	NCI
C61063	PAR	Etoposide/Ifosfamide/Topotecan	NCI
C61063	PAR	Docetaxel/Oblimersen	NCI
C61063	PAR	Cisplatin/Etoposide/Tirapazamine	NCI
C61063	PAR	Paclitaxel/Prinomastat	NCI
C61063	PAR	Carboplatin/Fluorouracil/Paclitaxel	NCI
C61063	PAR	Gemcitabine/ISIS 2503	NCI
C61063	PAR	Monoclonal antibody 11D10 anti-idiotype vaccine/Monoclonal antibody 3H1 anti-idiotype vaccine	NCI
C61063	PAR	Bevacizumab/Thalidomide	NCI
C61063	PAR	Ascorbic acid/Selenium	NCI
C61063	PAR	Ascorbic acid/Selenium/Vitamin E	NCI
C61063	PAR	Flavopiridol/irinotecan	NCI
C61063	PAR	Indium In 111 Monoclonal Antibody Bre-3/Yttrium Y 90 Monoclonal Antibody Bre-3	NCI
C61063	PAR	Amifostine/Carboplatin/Epirubicin/Paclitaxel	NCI
C61063	PAR	Bevacizumab/Fluorouracil/Irinotecan/Leucovorin Calcium	NCI
C61063	PAR	Carboplatin/Paclitaxel/Suramin	NCI
C61063	PAR	Capecitabine/Cyclophosphamide/Epirubicin	NCI
C61063	PAR	Doxorubicin/Octreotide	NCI
C61063	PAR	Detox-B Adjuvant/Verteporfin	NCI
C61063	PAR	Cyclosporine/Yttrium Y 90 Monoclonal Antibody M170	NCI
C61063	PAR	Cyclosporine/Paclitaxel/Yttrium Y 90 Monoclonal Antibody M170	NCI
C61063	PAR	Cyclosporine/Paclitaxel/Yttrium Y 90 Monoclonal Antibody Lym-1	NCI
C61063	PAR	Cyclosporine/Yttrium Y 90 Monoclonal Antibody Lym-1	NCI
C61063	PAR	Dexamethasone/Doxorubicin/Thalidomide	NCI
C61063	PAR	Filgrastim/Melphalan	NCI
C61063	PAR	Calcitriol/Carboplatin	NCI
C61063	PAR	Cyclosporine/Methylprednisolone/Mycophenolate Mofetil	NCI
C61063	PAR	Selenium/vitamin E	NCI
C61063	PAR	Atamestane/Toremifene	NCI
C61063	PAR	Exemestane/Goserelin	NCI
C61063	PAR	Daunorubicin/Imatinib Mesylate/Prednisone/Vincristine	NCI
C61063	PAR	DC-Chol Liposomes/EGFR Antisense DNA	NCI
C61063	PAR	Calcitriol/Paclitaxel	NCI
C61063	PAR	Etoposide/Fluorouracil-Uracil/Leucovorin Calcium	NCI
C61063	PAR	Epirubicin/Tamoxifen	NCI
C61063	PAR	Docetaxel/Tamoxifen	NCI
C61063	PAR	Bevacizumab/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Bevacizumab/Irinotecan	NCI
C61063	PAR	Doxorubicin Hcl Liposome/Interleukin-12	NCI
C61063	PAR	Autologous Tumor Cell Vaccine/Interleukin-2	NCI
C61063	PAR	Bryostatin 1/Sargramostim	NCI
C61063	PAR	IDEC-In2B8/Rituximab/Yttrium Y 90 Ibritumomab Tiuxetan	NCI
C61063	PAR	Melphalan/Prednisone/Wobe-Mugos E	NCI
C61063	PAR	Thalidomide/Topotecan	NCI
C61063	PAR	Docetaxel/Filgrastim/XR9576	NCI
C61063	PAR	Doxorubicin/Filgrastim/XR9576	NCI
C61063	PAR	Trastuzumab/Vinorelbine	NCI
C61063	PAR	Topotecan/ZD9331	NCI
C61063	PAR	Docetaxel/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Detox-B Adjuvant/RAS Peptide Cancer Vaccine	NCI
C61063	PAR	Autologous Tumor Cell Vaccine/BCG	NCI
C61063	PAR	Dacarbazine/Oblimersen	NCI
C61063	PAR	3-AP/Cisplatin/Paclitaxel	NCI
C61063	PAR	GPI-0100/MUC-2-Globo H-KLH Conjugate Vaccine	NCI
C61063	PAR	Globo H-GM2-Lewis-y-MUC1-32-mer-TF(c)-Tn(c)-KLH Conjugate Vaccine/QS21	NCI
C61063	PAR	Interleukin-12/PSA Prostate Cancer Vaccine	NCI
C61063	PAR	Asparaginase/cytarabine/daunorubicin/dexamethasone/methotrexate/prednisolone/vindesine	NCI
C61063	PAR	Cytarabine/Etoposide/Ifosfamide/Leucovorin Calcium/Methotrexate/Prednisolone	NCI
C61063	PAR	Cyclophosphamide/Dexrazoxane/Doxorubicin	NCI
C61063	PAR	Mercaptopurine/Methotrexate/Nelarabine	NCI
C61063	PAR	CD40-Ligand/flt3 Ligand	NCI
C61063	PAR	Interferon Alfa/Lymphokine-Activated Killer Cells	NCI
C61063	PAR	Doxorubicin Hcl Liposome/ZD0473	NCI
C61063	PAR	Docetaxel/Flavopiridol	NCI
C61063	PAR	Bevacizumab/Docetaxel/Estramustine	NCI
C61063	PAR	Cisplatin/Gemcitabine/Trastuzumab	NCI
C61063	PAR	Dexamethasone/Ondansetron	NCI
C61063	PAR	Asparaginase/cytarabine/dexamethasone/vincristine	NCI
C61063	PAR	Asparaginase/cytarabine/prednisolone/vincristine	NCI
C61063	PAR	Asparaginase/Doxorubicin/Methotrexate/Prednisolone/Vincristine	NCI
C61063	PAR	Asparaginase/cytarabine/daunorubicin/methotrexate/prednisolone/vincristine	NCI
C61063	PAR	Cyclophosphamide/cytarabine/mercaptopurine/methotrexate/prednisolone	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Dexamethasone/Mercaptopurine/Methotrexate	NCI
C61063	PAR	Dexamethasone/Pegaspargase	NCI
C61063	PAR	Carboplatin/ISIS 3521/Paclitaxel	NCI
C61063	PAR	Arsenic trioxide/Dexamethasone	NCI
C61063	PAR	Epirubicin/Gemcitabine	NCI
C61063	PAR	Bevacizumab/Vinorelbine	NCI
C61063	PAR	Carboplatin/Etoposide/Oblimersen	NCI
C61063	PAR	Carmustine/Cytarabine/Dexamethasone/Etoposide/Melphalan	NCI
C61063	PAR	Carboplatin/Etoposide Phosphate/Melphalan	NCI
C61063	PAR	SU5416/Thalidomide	NCI
C61063	PAR	Cisplatin/Epoetin Alfa	NCI
C61063	PAR	Monoclonal antibody Ch14.18/Sargramostim	NCI
C61063	PAR	Carboplatin/Epirubicin	NCI
C61063	PAR	Bevacizumab/Carboplatin/Paclitaxel	NCI
C61063	PAR	Dexamethasone/Isotretinoin	NCI
C61063	PAR	Docetaxel/Exisulind	NCI
C61063	PAR	Epirubicin/Irinotecan	NCI
C61063	PAR	Flutamide/Toremifene	NCI
C61063	PAR	Cisplatin/Fluorouracil/G17DT	NCI
C61063	PAR	Eflornithine/Triamcinolone	NCI
C61063	PAR	Interleukin-2/Montanide ISA-51/Telomerase: 540-548 Peptide Vaccine	NCI
C61063	PAR	Cisplatin/Docetaxel/Trastuzumab	NCI
C61063	PAR	Bevacizumab/Docetaxel/Doxorubicin	NCI
C61063	PAR	Palivizumab/Ribavirin	NCI
C61063	PAR	Carboplatin/Squalamine Lactate	NCI
C61063	PAR	Carboplatin/Cisplatin-epinephrine/Paclitaxel	NCI
C61063	PAR	Anastrozole/Trastuzumab	NCI
C61063	PAR	Calcium Citrate/Cholecalciferol	NCI
C61063	PAR	Calcium Gluconate/Cholecalciferol	NCI
C61063	PAR	Calcium Citrate/Cholecalciferol/Zoledronate	NCI
C61063	PAR	Calcium Carbonate/Cholecalciferol/Zoledronate	NCI
C61063	PAR	BMS-214662/Trastuzumab	NCI
C61063	PAR	Amifostine/Carboplatin/Fluorouracil/Paclitaxel	NCI
C61063	PAR	Montanide ISA-51/Tyrosinase-related protein-2	NCI
C61063	PAR	Interleukin-2/Montanide ISA-51/Tyrosinase-Related Protein-2	NCI
C61063	PAR	Carboplatin/Flavopiridol	NCI
C61063	PAR	Cyclophosphamide/Fludarabine/Oblimersen	NCI
C61063	PAR	Celecoxib/Cisplatin/Fluorouracil	NCI
C61063	PAR	Bevacizumab/Fluorouracil/Hydroxyurea	NCI
C61063	PAR	Doxorubicin/PS-341	NCI
C61063	PAR	Folic Acid/Lometrexol/Paclitaxel	NCI
C61063	PAR	Gefitinib/Trastuzumab	NCI
C61063	PAR	Dacarbazine/Doxorubicin/Ifosfamide/SU5416	NCI
C61063	PAR	Cisplatin/Doxorubicin/Methotrexate/Trastuzumab	NCI
C61063	PAR	Cisplatin/Doxorubicin/Etoposide/Ifosfamide/Methotrexate/Trastuzumab	NCI
C61063	PAR	Carboplatin/Irinotecan/Thalidomide	NCI
C61063	PAR	Fluorouracil/Gefitinib/Leucovorin Calcium/Oxaliplatin	NCI
C61063	PAR	Estramustine/Ixabepilone	NCI
C61063	PAR	Carboplatin/Temozolomide/Thiotepa	NCI
C61063	PAR	Apolizumab/Rituximab	NCI
C61063	PAR	BCG/Monoclonal Antibody 105AD7 Anti-idiotype Vaccine	NCI
C61063	PAR	Alum Adjuvant/Monoclonal Antibody 105AD7 Anti-Idiotype Vaccine	NCI
C61063	PAR	Pentostatin/Rituximab	NCI
C61063	PAR	Gefitinib/Oxaliplatin	NCI
C61063	PAR	Fluorouracil/Gefitinib/Irinotecan/Leucovorin Calcium	NCI
C61063	PAR	cBR96-Doxorubicin Immunoconjugate/Docetaxel	NCI
C61063	PAR	Cytarabine/Etoposide/Ifosfamide/Methotrexate/Vincristine	NCI
C61063	PAR	Bortezomib/Carboplatin/Etoposide	NCI
C61063	PAR	Pegylated Interferon Alfa/Temozolomide	NCI
C61063	PAR	NY-ESO-1 peptide vaccine/Sargramostim	NCI
C61063	PAR	Gefitinib/Temozolomide	NCI
C61063	PAR	APC8015/Bevacizumab	NCI
C61063	PAR	ALVAC-CEA-B7.1 vaccine/Fluorouracil/Irinotecan/Leucovorin calcium	NCI
C61063	PAR	ALVAC-CEA-B7.1 vaccine/Fluorouracil/Irinotecan/Leucovorin calcium/Tetanus toxoid	NCI
C61063	PAR	Anti-thymocyte globulin/Cyclophosphamide/Cytarabine	NCI
C61063	PAR	Carboplatin/Ixabepilone	NCI
C61063	PAR	Bevacizumab/Gemcitabine	NCI
C61063	PAR	Cytarabine/Gemtuzumab Ozogamicin/Mitoxantrone	NCI
C61063	PAR	Asparaginase/Cytarabine/Gemtuzumab ozogamicin	NCI
C61063	PAR	Carboplatin/Epoetin alfa/Paclitaxel	NCI
C61063	PAR	Bortezomib/Carboplatin	NCI
C61063	PAR	Paclitaxel/R101933	NCI
C61063	PAR	Chinese Herbs/Cyclophosphamide/Doxorubicin	NCI
C61063	PAR	Bexarotene/Cisplatin/Vinorelbine	NCI
C61063	PAR	Doxorubicin Hcl Liposome/Ifosfamide	NCI
C61063	PAR	Autologous Lymphocytes/Fluorouracil/Pegylated Interferon Alfa/Sargramostim	NCI
C61063	PAR	Carboplatin/Erlotinib	NCI
C61063	PAR	Montanide ISA-51/PSA prostate cancer vaccine	NCI
C61063	PAR	Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine/QS21	NCI
C61063	PAR	Asparaginase/Daunorubicin/Methotrexate/Nelarabine/Prednisone/Vincristine	NCI
C61063	PAR	Alum adjuvant/gp100 antigen/Interleukin-12/MART-1 antigen/Montanide ISA-51/tyrosinase peptide	NCI
C61063	PAR	gp100 Antigen/Interleukin-12/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide	NCI
C61063	PAR	Bicalutamide/Exemestane	NCI
C61063	PAR	Megestrol/Omega-3 Fatty acids	NCI
C61063	PAR	Cyclosporine/Hydroxychloroquine/Prednisone	NCI
C61063	PAR	Hydroxychloroquine/Prednisone/Tacrolimus	NCI
C61063	PAR	Bleomycin/Prednisolone/Rituximab/Vincristine	NCI
C61063	PAR	Detoxpc/Interleukin-2/RAS Peptide Cancer Vaccine/Sargramostim	NCI
C61063	PAR	Cytarabine/Etoposide/Rituximab	NCI
C61063	PAR	Epoetin Alfa/Filgrastim/Flt3 Ligand/Interleukin-3/Sargramostim	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Idarubicin/Leucovorin calcium/methotrexate/methylprednisolone/vincristine	NCI
C61063	PAR	Capecitabine/Carboplatin/Epirubicin	NCI
C61063	PAR	Gemtuzumab Ozogamicin/Oblimersen	NCI
C61063	PAR	Dexamethasone/Oblimersen	NCI
C61063	PAR	Aspirin/Folic acid	NCI
C61063	PAR	Bupropion/Nicotine	NCI
C61063	PAR	Etoposide/Filgrastim/Paclitaxel/Topotecan	NCI
C61063	PAR	Cytarabine/Filgrastim/Mitoxantrone	NCI
C61063	PAR	Corticotropin/Cyclophosphamide	NCI
C61063	PAR	Cisplatin/Dacarbazine/Doxorubicin/Mitomycin/Sargramostim	NCI
C61063	PAR	Interferon Alfa/Temozolomide	NCI
C61063	PAR	Aspirin/Clopidogrel Bisulfate	NCI
C61063	PAR	Cytarabine/Dexamethasone/Ifosfamide/Leucovorin Calcium/Methotrexate/Teniposide/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Dexamethasone/Doxorubicin/Leucovorin Calcium/Methotrexate/Vincristine	NCI
C61063	PAR	Bexarotene/Carboplatin/Paclitaxel	NCI
C61063	PAR	Doxorubicin/Motexafin Gadolinium	NCI
C61063	PAR	Carboplatin/UCN-01	NCI
C61063	PAR	Isotretinoin/Sargramostim	NCI
C61063	PAR	Cyclophosphamide/Fluorouracil/Methotrexate/Trastuzumab	NCI
C61063	PAR	Cisplatin/Fluoxetine/Gemcitabine	NCI
C61063	PAR	Beta-Glucan/Monoclonal Antibody 3F8	NCI
C61063	PAR	MUC-2-Globo H-KLH Conjugate Vaccine/QS21	NCI
C61063	PAR	MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Tyrosinase peptide	NCI
C61063	PAR	MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Sargramostim/tyrosinase peptide	NCI
C61063	PAR	CpG 7909/Trastuzumab	NCI
C61063	PAR	BMS-275291/Zoledronate	NCI
C61063	PAR	Irinotecan/Thalidomide	NCI
C61063	PAR	Capecitabine/Celecoxib/Gefitinib	NCI
C61063	PAR	Docetaxel/Sulindac	NCI
C61063	PAR	Cyclophosphamide/Dexrazoxane/Doxorubicin/Oblimersen	NCI
C61063	PAR	Flavopiridol/Trastuzumab	NCI
C61063	PAR	Gemcitabine/UCN-01	NCI
C61063	PAR	Cyclophosphamide/Epirubicin/Gemcitabine/Paclitaxel	NCI
C61063	PAR	Fowlpox-CEA-TRICOM Vaccine/Vaccinia-CEA-TRICOM Vaccine	NCI
C61063	PAR	Carboplatin/Exisulind/Gemcitabine	NCI
C61063	PAR	Carboplatin/Etoposide/Exisulind	NCI
C61063	PAR	Docetaxel/Infliximab	NCI
C61063	PAR	CpG 7909/Rituximab	NCI
C61063	PAR	Interferon Alfa/Lamivudine/Zidovudine	NCI
C61063	PAR	Docetaxel/Hypericum perforatum	NCI
C61063	PAR	Pentoxifylline/vitamin E	NCI
C61063	PAR	Interleukin-12/Paclitaxel/Trastuzumab	NCI
C61063	PAR	Cisplatin/Etoposide/Vindesine	NCI
C61063	PAR	Calcitriol/Zoledronate	NCI
C61063	PAR	Flavopiridol/Fluorouracil/Irinotecan/Leucovorin Calcium	NCI
C61063	PAR	Gemcitabine/Ixabepilone	NCI
C61063	PAR	Cisplatin/Erlotinib/Etoposide	NCI
C61063	PAR	Docetaxel/Erlotinib	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/UCN-01	NCI
C61063	PAR	Capecitabine/Fluorouracil/Leucovorin Calcium/Oxaliplatin	NCI
C61063	PAR	Erlotinib/Paclitaxel/Trastuzumab	NCI
C61063	PAR	Calcium Carbonate/Cholecalciferol/Risedronate	NCI
C61063	PAR	Calcium Carbonate/Cholecalciferol/Conjugated Estrogens	NCI
C61063	PAR	Calcium Carbonate/Cholecalciferol/Conjugated Estrogens/Risedronate	NCI
C61063	PAR	Cetuximab/Docetaxel/Irinotecan	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Prednisone	NCI
C61063	PAR	Ad5CMV-p53 Gene/Docetaxel/Doxorubicin	NCI
C61063	PAR	Gemcitabine/Virulizin	NCI
C61063	PAR	Fluorouracil/Virulizin	NCI
C61063	PAR	Cisplatin/Imatinib Mesylate/Irinotecan	NCI
C61063	PAR	Cisplatin/Etoposide/Monoclonal Antibody 11D10 Anti-Idiotype Vaccine/Monoclonal Antibody GD2 Anti-Idiotype Vaccine	NCI
C61063	PAR	Topotecan/UCN-01	NCI
C61063	PAR	Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3 /MART-1 Antigen/NY-ESO-B/QS21/Tyrosinase Peptide	NCI
C61063	PAR	Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3/MART-1 Antigen/NY-ESO-B/Tyrosinase Peptide	NCI
C61063	PAR	Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/NY-ESO-B/Tyrosinase Peptide	NCI
C61063	PAR	Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/NY-ESO-B/QS21/Tyrosinase Peptide	NCI
C61063	PAR	Monoclonal Antibody 11D10 Anti-Idiotype Vaccine/Monoclonal Antibody GD2 Anti-Idiotype Vaccine	NCI
C61063	PAR	Methotrexate/Thiotepa	NCI
C61063	PAR	CCI-779/Interferon Alfa	NCI
C61063	PAR	Prednisone/UCN-01	NCI
C61063	PAR	Fowlpox-PSA Vaccine/Sargramostim	NCI
C61063	PAR	Rv-B7.1 Vaccine/Sargramostim/Vaccinia-Prostate-Specific Antigen Vaccine	NCI
C61063	PAR	Docetaxel/Fowlpox-PSA Vaccine	NCI
C61063	PAR	Erlotinib/Irinotecan	NCI
C61063	PAR	Carboplatin/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Cisplatin/Flavopiridol/Irinotecan	NCI
C61063	PAR	Doxorubicin/Oblimersen	NCI
C61063	PAR	Celecoxib/Cyclophosphamide/Etoposide/Thalidomide	NCI
C61063	PAR	Carboplatin/Etoposide/Filgrastim	NCI
C61063	PAR	Fluorouracil/Irinotecan/Leucovorin Calcium/Monoclonal Antibody ABX-EGF	NCI
C61063	PAR	Cytarabine/Daunorubicin/Zosuquidar Trihydrochloride	NCI
C61063	PAR	Alemtuzumab/Fludarabine	NCI
C61063	PAR	Celecoxib/Temozolomide/Thalidomide	NCI
C61063	PAR	Dacarbazine/Temozolomide	NCI
C61063	PAR	Dacarbazine/Interleukin-2/Temozolomide	NCI
C61063	PAR	Cyclophosphamide/Fludarabine/Melphalan	NCI
C61063	PAR	Gemcitabine/Mistletoe	NCI
C61063	PAR	Imatinib Mesylate/Oblimersen	NCI
C61063	PAR	Anastrozole/Gefitinib	NCI
C61063	PAR	Erlotinib/Fluorouracil/Leucovorin Calcium/Oxaliplatin	NCI
C61063	PAR	Flavopiridol/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Capecitabine/Ixabepilone	NCI
C61063	PAR	Bortezomib/Docetaxel	NCI
C61063	PAR	Dexamethasone/Oblimersen/Thalidomide	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Tipifarnib	NCI
C61063	PAR	Estradiol/Zoledronate	NCI
C61063	PAR	Dexamethasone/Idarubicin/Imatinib Mesylate/Pegaspargase/Vincristine	NCI
C61063	PAR	Bortezomib/Dexamethasone	NCI
C61063	PAR	Dexamethasone/Idarubicin/Pegaspargase/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Imatinib Mesylate	NCI
C61063	PAR	Cisplatin/Doxorubicin Hydrochloride Liposome/Mitomycin	NCI
C61063	PAR	Cytarabine/Leucovorin Calcium/Methotrexate	NCI
C61063	PAR	Interleukin-2/p53 Peptide Vaccine	NCI
C61063	PAR	Epoetin Alfa/Thalidomide	NCI
C61063	PAR	Bevacizumab/Doxorubicin	NCI
C61063	PAR	Sargramostim/Vaccinia-CEA-TRICOM Vaccine	NCI
C61063	PAR	Cytarabine/Etoposide/Gemtuzumab Ozogamicin/Idarubicin	NCI
C61063	PAR	Capecitabine/LY317615	NCI
C61063	PAR	Cyproterone/Leuprolide	NCI
C61063	PAR	Tamoxifen/Tipifarnib	NCI
C61063	PAR	Autologous Dendritic Cells/CD40-Ligand	NCI
C61063	PAR	PEG-Interferon Alfa-2b/Thalidomide	NCI
C61063	PAR	Patent Blue V Dye/Technetium Tc 99m Sulfur Colloid	NCI
C61063	PAR	Bevacizumab/Fluorouracil	NCI
C61063	PAR	Filgrastim/Monoclonal Antibody Hu1D10	NCI
C61063	PAR	Bortezomib/Carboplatin/Gemcitabine	NCI
C61063	PAR	Bortezomib/Gemcitabine	NCI
C61063	PAR	Marijuana/Morphine	NCI
C61063	PAR	Docetaxel/Estramustine/Exisulind	NCI
C61063	PAR	Autologous Lymphocytes/Fluorouracil/Interferon Alfa/Sargramostim	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Doxorubicin/Etoposide	NCI
C61063	PAR	Cisplatin/Doxorubicin Hydrochloride Liposome/Paclitaxel	NCI
C61063	PAR	Docetaxel/Fowlpox-PSA Vaccine/Sargramostim	NCI
C61063	PAR	Carcinoembryonic Antigen Peptide 1-6D/Montanide ISA-51	NCI
C61063	PAR	Carcinoembryonic Antigen Peptide 1-6D/Sargramostim	NCI
C61063	PAR	Cladribine/Rituximab	NCI
C61063	PAR	Cisplatin/Cytarabine/Methylprednisolone/Pixantrone	NCI
C61063	PAR	Dexamethasone/Fludarabine/Pixantrone/Rituximab	NCI
C61063	PAR	Etoposide/Monoclonal Antibody 3F8	NCI
C61063	PAR	Cytarabine/Irinotecan	NCI
C61063	PAR	Carboplatin/Fludarabine/Thalidomide/Topotecan	NCI
C61063	PAR	Arsenic Trioxide/Imatinib Mesylate	NCI
C61063	PAR	Interleukin-12/Paclitaxel	NCI
C61063	PAR	Cytarabine/Flavopiridol/Mitoxantrone	NCI
C61063	PAR	Anti-Thymocyte Globulin/Methotrexate/Mycophenolate Mofetil/Tacrolimus	NCI
C61063	PAR	Cyclophosphamide/Fludarabine/Rituximab	NCI
C61063	PAR	Anti-Thymocyte Globulin/Busulfan/Cyclophosphamide/Methylprednisolone	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Leucovorin Calcium/Methotrexate	NCI
C61063	PAR	Cyclophosphamide/Etoposide/Imatinib Mesylate/Leucovorin Calcium/Methotrexate	NCI
C61063	PAR	Mitoxantrone/Prednisone/YM598	NCI
C61063	PAR	Carboplatin/Polyglutamate Paclitaxel	NCI
C61063	PAR	DHA-Paclitaxel/Gemcitabine	NCI
C61063	PAR	Paclitaxel/Suramin	NCI
C61063	PAR	Daclizumab/Methylprednisolone	NCI
C61063	PAR	Carboplatin/Oblimersen/Paclitaxel	NCI
C61063	PAR	Dexamethasone/Doxorubicin/Thalidomide/Vincristine	NCI
C61063	PAR	Epratuzumab/Rituximab	NCI
C61063	PAR	Decitabine/Imatinib Mesylate	NCI
C61063	PAR	Docetaxel/ZD6474	NCI
C61063	PAR	Bevacizumab/Erlotinib	NCI
C61063	PAR	Oblimersen/Rituximab	NCI
C61063	PAR	Fowlpox-Tyrosinase Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine	NCI
C61063	PAR	Methylprednisolone/Mycophenolate Mofetil/Tacrolimus	NCI
C61063	PAR	Methotrexate/Mycophenolate Mofetil/Tacrolimus	NCI
C61063	PAR	Autologous Dendritic Cells/Indinavir	NCI
C61063	PAR	Beclomethasone/Prednisone	NCI
C61063	PAR	Beclomethasone/Methylprednisolone	NCI
C61063	PAR	Allogeneic Lymphocytes/MOv-Gamma Chimeric Receptor Gene	NCI
C61063	PAR	Allogeneic Lymphocytes/Interleukin-2/MOv-Gamma Chimeric Receptor Gene	NCI
C61063	PAR	Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate/Thioguanine/Vincristine	NCI
C61063	PAR	Autologous Dendritic Cells/Tetanus Toxoid	NCI
C61063	PAR	Autologous Dendritic Cells/CMV pp65 Peptide	NCI
C61063	PAR	Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine/Sargramostim	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Rituximab/Vincristine	NCI
C61063	PAR	Cisplatin/Gemcitabine/Tipifarnib	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Oblimersen/Oxaliplatin	NCI
C61063	PAR	Bicalutamide/Triptorelin	NCI
C61063	PAR	Cyproterone/Triptorelin	NCI
C61063	PAR	Nilutamide/Triptorelin	NCI
C61063	PAR	Cisplatin/Gemcitabine/ISIS 3521	NCI
C61063	PAR	cBR96-Doxorubicin Immunoconjugate/Gemcitabine	NCI
C61063	PAR	Bevacizumab/PEG-Interferon Alfa-2b	NCI
C61063	PAR	Cetuximab/Fluorouracil/Leucovorin Calcium/Oxaliplatin	NCI
C61063	PAR	IDEC-114 Monoclonal Antibody/Rituximab	NCI
C61063	PAR	Anti-Thymocyte Globulin/Busulfan/Melphalan/Methylprednisolone	NCI
C61063	PAR	Bortezomib/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine	NCI
C61063	PAR	Autologous Dendritic Cells/Carcinoembryonic Antigen Peptide 1-6D/CMV Pp65 Peptide	NCI
C61063	PAR	Cisplatin/Ixabepilone	NCI
C61063	PAR	Celecoxib/Epirubicin	NCI
C61063	PAR	Celecoxib/Docetaxel/Irinotecan	NCI
C61063	PAR	Exemestane/Trastuzumab	NCI
C61063	PAR	Fulvestrant/Gefitinib	NCI
C61063	PAR	ALVAC-CEA-B7.1 Vaccine/Tetanus Toxoid	NCI
C61063	PAR	Cytarabine/Etoposide/Methotrexate/Rituximab	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Rituximab/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Prednisone/Rasburicase/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Methylprednisolone/Rasburicase/Vincristine	NCI
C61063	PAR	Cisplatin/Etoposide/Topotecan	NCI
C61063	PAR	Cisplatin/Etoposide/Irinotecan	NCI
C61063	PAR	Epirubicin/Thalidomide	NCI
C61063	PAR	Flavopiridol/Fludarabine/Rituximab	NCI
C61063	PAR	Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody/Interleukin-2	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Epratuzumab/Prednisone/Rituximab/Vincristine	NCI
C61063	PAR	Carboplatin/Cytarabine/Etoposide/Ifosfamide/Methotrexate/Rituximab	NCI
C61063	PAR	Interferon Alfa/Oblimersen	NCI
C61063	PAR	Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vinblastine	NCI
C61063	PAR	Capecitabine/GTI-2040	NCI
C61063	PAR	Gemcitabine/Oblimersen	NCI
C61063	PAR	Letrozole/Tipifarnib	NCI
C61063	PAR	Methotrexate/Rituximab/Temozolomide	NCI
C61063	PAR	Cyclophosphamide/Oblimersen	NCI
C61063	PAR	EP-2101/Montanide ISA-51	NCI
C61063	PAR	Methotrexate/Procarbazine/Rituximab/Vincristine	NCI
C61063	PAR	Interferon Gamma/Voriconazole	NCI
C61063	PAR	Sargramostim/Telomerase: 540-548 Peptide Vaccine	NCI
C61063	PAR	Dexamethasone/Epoetin Alfa	NCI
C61063	PAR	Carboplatin/Pemetrexed Disodium	NCI
C61063	PAR	Carboplatin/Etoposide/Thalidomide	NCI
C61063	PAR	Bortezomib/Irinotecan	NCI
C61063	PAR	CCI-779/Letrozole	NCI
C61063	PAR	Celecoxib/Erlotinib	NCI
C61063	PAR	Fowlpox-PSA-TRICOM Vaccine/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine	NCI
C61063	PAR	Fowlpox-PSA-TRICOM Vaccine/Sargramostim/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine	NCI
C61063	PAR	Fowlpox-PSA-TRICOM Vaccine/Fowlpox-Sargramostim Vaccine/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine	NCI
C61063	PAR	Epirubicin/Rituximab	NCI
C61063	PAR	Carboplatin/Celecoxib/Paclitaxel	NCI
C61063	PAR	Docetaxel/Gefitinib	NCI
C61063	PAR	Boronophenylalanine-Fructose Complex/Sodium Borocaptate	NCI
C61063	PAR	Amoxicillin-Clavulanate Potassium/Ciprofloxacin	NCI
C61063	PAR	Pixantrone/Rituximab	NCI
C61063	PAR	Celecoxib/Cyclophosphamide/Doxorubicin/Etoposide/Ifosfamide/Vinblastine/Vincristine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Pegaspargase/Thioguanine/Vincristine	NCI
C61063	PAR	Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine	NCI
C61063	PAR	Cisplatin/Fluorouracil/Oblimersen	NCI
C61063	PAR	Capecitabine/Celecoxib/Irinotecan	NCI
C61063	PAR	Celecoxib/Fluorouracil/Irinotecan/Leucovorin Calcium	NCI
C61063	PAR	Flavopiridol/Imatinib Mesylate	NCI
C61063	PAR	Selenium/Soy Protein Isolate/Vitamin E	NCI
C61063	PAR	CC-5013/Dexamethasone	NCI
C61063	PAR	Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody/Sargramostim	NCI
C61063	PAR	Docetaxel/Doxorubicin/Oblimersen	NCI
C61063	PAR	Floxuridine/Irinotecan	NCI
C61063	PAR	Cisplatin/Filgrastim/Fluorouracil/Paclitaxel	NCI
C61063	PAR	Cisplatin/Fluorouracil/Paclitaxel/Pegfilgrastim	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Prednisolone/Rituximab/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Rituximab/Vincristine	NCI
C61063	PAR	Bleomycin/Cyclophosphamide/Etoposide/Mitoxantrone/Prednisolone/Rituximab/Vincristine	NCI
C61063	PAR	Bortezomib/Oxaliplatin	NCI
C61063	PAR	Celecoxib/Exemestane	NCI
C61063	PAR	Anastrozole/Celecoxib	NCI
C61063	PAR	Cyclophosphamide/Methylprednisolone/Rituximab	NCI
C61063	PAR	Cyclophosphamide/Prednisone/Rituximab	NCI
C61063	PAR	Cyclophosphamide/Cyclosporine/Fludarabine/Methylprednisolone/Thiotepa	NCI
C61063	PAR	Docetaxel/Epirubicin/Pegfilgrastim	NCI
C61063	PAR	Exemestane/Triptorelin	NCI
C61063	PAR	Tamoxifen/Triptorelin	NCI
C61063	PAR	Cisplatin/Cytarabine/Methylprednisolone/Pixantrone/Rituximab	NCI
C61063	PAR	Docetaxel/Suramin	NCI
C61063	PAR	Gemcitabine/Suramin	NCI
C61063	PAR	Rifampin/Tetracycline	NCI
C61063	PAR	Sulindac/Tamoxifen	NCI
C61063	PAR	Celecoxib/Gemcitabine	NCI
C61063	PAR	Bortezomib/Fludarabine	NCI
C61063	PAR	Bortezomib/Topotecan	NCI
C61063	PAR	Carboplatin/Monoclonal Antibody ABX-EGF/Paclitaxel	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Oxaliplatin/PTK787	NCI
C61063	PAR	Lonafarnib/Paclitaxel/Trastuzumab	NCI
C61063	PAR	Celecoxib/Gefitinib	NCI
C61063	PAR	Docetaxel/TLK286	NCI
C61063	PAR	Bevacizumab/Capecitabine/Oxaliplatin	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Oblimersen/Prednisone/Rituximab/Vincristine	NCI
C61063	PAR	Carboplatin/Cetuximab/Paclitaxel	NCI
C61063	PAR	BCG/NY-ESO-1 Peptide Vaccine	NCI
C61063	PAR	Cytarabine/Daunorubicin/Etoposide/Gemtuzumab Ozogamicin	NCI
C61063	PAR	Coenzyme Q10/Vitamin E	NCI
C61063	PAR	Capecitabine/Docetaxel/Tipifarnib	NCI
C61063	PAR	Cyclophosphamide/Dactinomycin/Irinotecan/Vincristine	NCI
C61063	PAR	Cytarabine/VNP40101M	NCI
C61063	PAR	Doxorubicin/Imatinib Mesylate/Pegaspargase/Prednisone/Vincristine	NCI
C61063	PAR	Docetaxel/Leuprolide/Testosterone	NCI
C61063	PAR	AG-858/Imatinib Mesylate	NCI
C61063	PAR	Cytarabine/GTI-2040	NCI
C61063	PAR	Imatinib Mesylate/PEG-Interferon Alfa-2a	NCI
C61063	PAR	Carboplatin/Celecoxib/Gemcitabine	NCI
C61063	PAR	Carboplatin/Gemcitabine/Zileuton	NCI
C61063	PAR	Carboplatin/Celecoxib/Gemcitabine/Zileuton	NCI
C61063	PAR	Paclitaxel/Pegfilgrastim	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Pegfilgrastim	NCI
C61063	PAR	Cyclophosphamide/Filgrastim/Rituximab	NCI
C61063	PAR	Vaccinia-MUC-1 Vaccine/Vaccinia-TRICOM Vaccine	NCI
C61063	PAR	Sargramostim/Vaccinia-MUC-1 Vaccine/Vaccinia-TRICOM Vaccine	NCI
C61063	PAR	Gemcitabine/Soblidotin	NCI
C61063	PAR	Adenovirus 5-Tumor Necrosis Factor Alpha/Capecitabine	NCI
C61063	PAR	Docetaxel/Tariquidar	NCI
C61063	PAR	Fowlpox-Sargramostim Vaccine/Fowlpox-TRICOM Vaccine	NCI
C61063	PAR	Cisplatin/Edotecarin	NCI
C61063	PAR	Lomustine/Temozolomide/Thalidomide	NCI
C61063	PAR	Alemtuzumab/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine	NCI
C61063	PAR	Autologous Lymphocytes/Fludarabine	NCI
C61063	PAR	Carboplatin/Dexamethasone/Gemcitabine	NCI
C61063	PAR	Carboplatin/Dexamethasone/Gemcitabine/Rituximab	NCI
C61063	PAR	Celecoxib/Fluorouracil/Leucovorin Calcium/Oxaliplatin	NCI
C61063	PAR	Celecoxib/Fluorouracil/Leucovorin Calcium	NCI
C61063	PAR	Bevacizumab/Cyclophosphamide	NCI
C61063	PAR	Montanide ISA-51/Multi-Epitope Melanoma Peptide Vaccine/Sargramostim	NCI
C61063	PAR	Montanide ISA-51/Multi-Epitope Melanoma Peptide Vaccine/Sargramostim/Tetanus Peptide Melanoma Vaccine	NCI
C61063	PAR	Melanoma Helper Peptide Vaccine/Montanide ISA-51/Multi-Epitope Melanoma Peptide Vaccine/Sargramostim	NCI
C61063	PAR	Melanoma Helper Peptide Vaccine/Montanide ISA-51/Sargramostim	NCI
C61063	PAR	Doxorubicin/Etoposide/Mitotane/Tariquidar/Vincristine	NCI
C61063	PAR	Docetaxel/GTI-2040	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Cytarabine/Etoposide/Rituximab/Sodium Thiosulfate	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Cytarabine/Etoposide Phosphate/Rituximab/Sodium Thiosulfate	NCI
C61063	PAR	Cytarabine/Dexamethasone/Lomustine/Methotrexate/Procarbazine	NCI
C61063	PAR	Cyclophosphamide/Cytarabine/Dexamethasone/Etoposide Phosphate/Methotrexate	NCI
C61063	PAR	Bevacizumab/Imatinib Mesylate	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Etoposide/Sodium Thiosulfate	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Etoposide Phosphate/Sodium Thiosulfate	NCI
C61063	PAR	Carboplatin/Cyclophosphamide/Etoposide Phosphate	NCI
C61063	PAR	Capecitabine/DJ-927	NCI
C61063	PAR	Cytarabine/Oblimersen	NCI
C61063	PAR	Captopril/Tissue Plasminogen Activator	NCI
C61063	PAR	Cisplatin/Fluorouracil/Irinotecan/Leucovorin Calcium	NCI
C61063	PAR	Cyclophosphamide/Decitabine/Doxorubicin	NCI
C61063	PAR	Celecoxib/Vinorelbine	NCI
C61063	PAR	Anastrozole/Fulvestrant	NCI
C61063	PAR	Cytarabine/Daunorubicin/Dexamethasone/Methotrexate/Pegaspargase/Vincristine	NCI
C61063	PAR	Cytarabine/Daunorubicin/Methotrexate/Pegaspargase/Prednisone/Vincristine	NCI
C61063	PAR	Daunorubicin/Dexamethasone/Pegaspargase/Vincristine	NCI
C61063	PAR	Cisplatin/S-1	NCI
C61063	PAR	Cisplatin/Gemcitabine/LY293111	NCI
C61063	PAR	Gefitinib/Tamoxifen	NCI
C61063	PAR	Cytarabine/Gemtuzumab Ozogamicin/Idarubicin	NCI
C61063	PAR	Bevacizumab/Cetuximab	NCI
C61063	PAR	Bevacizumab/Cetuximab/Irinotecan	NCI
C61063	PAR	CpG 7909/Dacarbazine	NCI
C61063	PAR	Cisplatin/Dimesna/Docetaxel	NCI
C61063	PAR	Carboplatin/Irinotecan/Vincristine	NCI
C61063	PAR	AN-9/Docetaxel	NCI
C61063	PAR	Capecitabine/Tipifarnib	NCI
C61063	PAR	Erlotinib/Temozolomide	NCI
C61063	PAR	Carboplatin/Ixabepilone/Trastuzumab	NCI
C61063	PAR	Clofarabine/Cytarabine	NCI
C61063	PAR	Clofarabine/Idarubicin	NCI
C61063	PAR	Clofarabine/Cytarabine/Idarubicin	NCI
C61063	PAR	Cyclosporine/Sirolimus	NCI
C61063	PAR	Allogeneic Lymphocytes/Cyclosporine	NCI
C61063	PAR	Allogeneic Lymphocytes/Cyclosporine/Sirolimus	NCI
C61063	PAR	Adenovirus-L523S Vaccine/L523S DNA Vaccine	NCI
C61063	PAR	3-AP/Fludarabine	NCI
C61063	PAR	Decitabine/Valproic Acid	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Oxaliplatin/ZD6126	NCI
C61063	PAR	Bortezomib/Mitoxantrone	NCI
C61063	PAR	Autologous Tumor Cell Vaccine/CD40-Ligand/Interleukin-2 Gene	NCI
C61063	PAR	Docetaxel/DN-101	NCI
C61063	PAR	Cytochlor/Tetrahydrouridine	NCI
C61063	PAR	ABT-510/Carboplatin/Paclitaxel	NCI
C61063	PAR	E7070/Irinotecan	NCI
C61063	PAR	Cytarabine/EL625/Idarubicin	NCI
C61063	PAR	Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin	NCI
C61063	PAR	Aminoglutethimide/Hydrocortisone/Suramin	NCI
C61063	PAR	Autologous Dendritic Cells/Keyhole Limpet Hemocyanin/MAGE-3/Melan-A/Survivin Antigen	NCI
C61063	PAR	Autologous Dendritic Cells/MAGE-3/Melan-A/Survivin Antigen	NCI
C61063	PAR	Autologous Lymphocytes/gp100 Antigen/Interleukin-12/MAGE-3/Melan-A/NA17-A Antigen	NCI
C61063	PAR	Autologous Lymphocytes/gp100 Antigen/Interleukin-2/Interleukin-12/MAGE-3/Melan-A/NA17-A Antigen	NCI
C61063	PAR	BMS-247550/Carboplatin	NCI
C61063	PAR	BMS-247550/Estramustine	NCI
C61063	PAR	Cyclophosphamide/Detox/Interleukin-2	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/R-Verapamil	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Fluorouracil/Tegafur/Tamoxifen	NCI
C61063	PAR	Cyclophosphamide/Doxorubicin/Uracil/Tegafur/Tamoxifen	NCI
C61063	PAR	Cytarabine/Triapine	NCI
C61063	PAR	D1/3-MAGE-3 Fusion Protein/SB-AS02B Adjuvant	NCI
C61063	PAR	Dacarbazine/Mesna	NCI
C61063	PAR	Dacarbazine/Monoclonal Antibody Anti-Avb3 Integrin	NCI
C61063	PAR	Detox/Keyhole Limpet Hemocyanin/Sialyl Tn Antigen	NCI
C61063	PAR	Devil's Foot/Jambul	NCI
C61063	PAR	Docetaxel/Estramustine/Vitaxin-2/Zoledronate	NCI
C61063	PAR	Docetaxel/Geldanamycin Analogue	NCI
C61063	PAR	Docetaxel/Vinblastine	NCI
C61063	PAR	Docetaxel/Vincristine	NCI
C61063	PAR	Docetaxel/Vitaxin-2	NCI
C61063	PAR	Docetaxol/Etoposide	NCI
C61063	PAR	Docetaxol/Vinblastine	NCI
C61063	PAR	Doxifluridine/L-Leucovorin	NCI
C61063	PAR	Doxorubicin/P-30 Protein	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Dexamethasone/Doxorubicin/Etoposide/Thalidomide	NCI
C61063	PAR	Herceptin/Paclitaxel	NCI
C61063	PAR	IDEC-Y2B8 Monoclonal Antibody/Rituximab	NCI
C61063	PAR	Maxamine/Interferon Alpha	NCI
C61063	PAR	Maxamine/Interleukin-2	NCI
C61063	PAR	Probenecid/10-Propargyl-10-Deazaaminopterin	NCI
C61063	PAR	R115777/Topotecan	NCI
C61063	PAR	R115777/Trastuzumab	NCI
C61063	PAR	Temozolomide/ZD 1839	NCI
C61063	PAR	Thymalfasin/Dacarbazine	NCI
C61063	PAR	gp100 Antigen/MAGE-3.1/MART-1 Antigen/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/Melan-A/NA17-A Antigen/Tyrosinase Peptide	NCI
C61063	PAR	gp100 Antigen/Melan-A/Na17.A2 Antigen/Tyrosinase Peptide	NCI
C61063	PAR	p53 Adenovirus/SCH 66336	NCI
C61063	PAR	Capecitabine/Celecoxib/ZD 1839	NCI
C61063	PAR	Carboplatin/Etoposide/Cyclophosphamide/Thiotepa	NCI
C61063	PAR	Carboplatin/Etoposide/PS-341	NCI
C61063	PAR	Carboplatin/Neovastat/Paclitaxel	NCI
C61063	PAR	Carboplatin/PS-341	NCI
C61063	PAR	Carboplatin/Paclitaxel/PS-341	NCI
C61063	PAR	Carboplatin/Paclitaxel/Shark Cartilage	NCI
C61063	PAR	Carboplatin/Paclitaxel/ZD 1839	NCI
C61063	PAR	Carboplatin/Paclitaxel/ZD-6474	NCI
C61063	PAR	Carmustine/RSR13	NCI
C61063	PAR	Cisplatin/Dacarbazine/Interferon-alpha/Tamoxifen/Tumor Infiltrating Lymphocytes	NCI
C61063	PAR	Cisplatin/Doxorubicin/Methotrexate/Pamidronate Disodium	NCI
C61063	PAR	Cisplatin/Geldanamycin Analogue/Gemcitabine	NCI
C61063	PAR	Cisplatin/Gemcitabine/ZD 1839	NCI
C61063	PAR	Cisplatin/Neovastat/Vinorelbine	NCI
C61063	PAR	Cisplatin/Shark Cartilage/Vinorelbine	NCI
C61063	PAR	Cisplatin/ZD 1839	NCI
C61063	PAR	Epirubicin/Folinic Acid/Fluorouracil/Etoposide	NCI
C61063	PAR	Etoposide/Fluorouracil/Folinic Acid	NCI
C61063	PAR	Etoposide/Prednisone	NCI
C61063	PAR	Etoposide/Prednisone/Vinblastine	NCI
C61063	PAR	Flu Matrix/gp100 Antigen/MAGE-3.1/MART-1 Antigen/Tyrosinase Peptide	NCI
C61063	PAR	Fludarabine/Triapine	NCI
C61063	PAR	Fluorouracil/Interferon alpha/Interleukin-2/Leucovorin Calcium	NCI
C61063	PAR	Fluorouracil/Irinotecan/Leucovorin Calcium/ZD 1839	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/Oxaliplatin/ZD 1839	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/PS-341	NCI
C61063	PAR	Fluorouracil/Leucovorin Calcium/SCH 66336	NCI
C61063	PAR	Fluorouracil/Leucovorin/Rhumab-Vegf	NCI
C61063	PAR	Fluorouracil/Mitomycin C/Cisplatin	NCI
C61063	PAR	Flutamide/Hydrocortisone/Suramin	NCI
C61063	PAR	Geldanamycin Analogue (AAG)/Imatinib Mesylate	NCI
C61063	PAR	Gemcitabine/SCH 66336	NCI
C61063	PAR	Gemcitabine/Triapine	NCI
C61063	PAR	L-744,832/Paclitaxel	NCI
C61063	PAR	LY335979/Vinorelbine	NCI
C61063	PAR	Lovastatin/Sulindac	NCI
C61063	PAR	Oxaliplatin/ZD 1839	NCI
C61063	PAR	Paclitaxel/Beta-Lapachone	NCI
C61063	PAR	Paclitaxel/Cisplatin/Topotecan/G-CSF	NCI
C61063	PAR	Paclitaxel/PS-341	NCI
C61063	PAR	Trastuzumab/ZD 1839	NCI
C61063	PAR	Vitamin E/Fluorouracil	NCI
C61063	PAR	16.88/88BV59	NCI
C61063	PAR	506U78/Asparaginase/Daunorubicin/Methotrexate/Prednisone/Vincristine	NCI
C61063	PAR	506U78/Mercaptopurine/Methotrexate	NCI
C61063	PAR	Ifosfamide/Cyclophosphamide/Etoposide	NCI
C61063	PAR	PEG-Interferon Alfa-2b/Temozolomide	NCI
C61063	PAR	Triapine/Cisplatin	NCI
C61063	PAR	Conjugated Estrogens/Medroxyprogesterone	NCI
C61063	PAR	Cytarabine/Hydrocortisone	NCI
C61063	PAR	Estradiol/Norethindrone	NCI
C61063	PAR	Everolimus/Gefitinib	NCI
C61063	PAR	HER-2-neu, CEA Peptides, GM-CSF, Montanide ISA-51 Vaccine	NCI
C61063	PAR	Hydrocortisone/Ketoconazole	NCI
C61063	PAR	Deoxyspergualin/Monoclonal Antibody L6	NCI
C61063	PAR	Cisplatin/Doxorubicin/Methotrexate/Muramyl Tripeptide Phosphatidylethanolamine Liposome	NCI
C61063	PAR	NY-ESO-1 Protein Vaccine Plus Montanide ISA-51 VG	NCI
C61063	PAR	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide	NCI
C61063	PAR	Docetaxel/Laniquidar	NCI
C61063	PAR	Lapatinib/Letrozole	NCI
C11867	STY	Therapeutic or Preventive Procedure		NCI
C11867	PT	Interleukin-2/MAGE-12 Peptide Vaccine/Montanide ISA-51		NCI
C11867	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11867	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11867	RO	chemotherapy regimen has component MAGE-12 Peptide Vaccine	NCI
C11867	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11756	STY	Therapeutic or Preventive Procedure		NCI
C11756	PT	Montanide ISA-51/PR1 leukemia peptide vaccine/Sargramostim		NCI
C11756	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11756	RO	chemotherapy regimen has component Sargramostim	NCI
C11756	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11756	RO	chemotherapy regimen has component PR1 Leukemia Peptide Vaccine	NCI
C10368	STY	Therapeutic or Preventive Procedure		NCI
C10368	PT	Cyclophosphamide/Etoposide/Thiotepa		NCI
C10368	SY	CTX/TSPA/VP-16		NCI
C10368	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10368	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10368	RO	chemotherapy regimen has component Etoposide	NCI
C10368	RO	chemotherapy regimen has component Thiotepa	NCI
C37691	STY	Therapeutic or Preventive Procedure		NCI
C37691	PT	Cyclophosphamide/Etoposide/Iodine I 131 Tositumomab		NCI
C37691	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37691	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37691	RO	chemotherapy regimen has component Etoposide	NCI
C37691	RO	chemotherapy regimen has component Iodine I 131 Tositumomab	NCI
C11532	STY	Therapeutic or Preventive Procedure		NCI
C11532	PT	Asparaginase/Cytarabine/Mercaptopurine/Methotrexate		NCI
C11532	SY	ARA-C/ASP/MP/MTX		NCI
C11532	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11532	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11532	RO	chemotherapy regimen has component Asparaginase	NCI
C11532	RO	chemotherapy regimen has component Cytarabine	NCI
C11532	RO	chemotherapy regimen has component Methotrexate	NCI
C11152	STY	Therapeutic or Preventive Procedure		NCI
C11152	PT	Hydrocortisone/Methotrexate		NCI
C11152	SY	HC/MTX		NCI
C11152	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11152	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C11152	RO	chemotherapy regimen has component Methotrexate	NCI
C9807	STY	Therapeutic or Preventive Procedure		NCI
C9807	PT	Carboplatin/Fluorouracil		NCI
C9807	SY	CBDCA/5-FU		NCI
C9807	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9807	RO	chemotherapy regimen has component Fluorouracil	NCI
C9807	RO	chemotherapy regimen has component Carboplatin	NCI
C37771	STY	Therapeutic or Preventive Procedure		NCI
C37771	PT	Etoposide/Satraplatin		NCI
C37771	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37771	RO	chemotherapy regimen has component Etoposide	NCI
C37771	RO	chemotherapy regimen has component Satraplatin	NCI
C10858	STY	Therapeutic or Preventive Procedure		NCI
C10858	PT	Etoposide/Interleukin-1-Alpha		NCI
C10858	SY	IL-1A/VP-16		NCI
C10858	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10858	RO	chemotherapy regimen has component Etoposide	NCI
C10858	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C9533	STY	Therapeutic or Preventive Procedure		NCI
C9533	PT	CAF Regimen		NCI
C9533	SY	Oral CTX/DOX/5-FU		NCI
C9533	SY	Oral Cyclophosphamide-Adriamycin-Fluorouracil Regimen		NCI
C9533	SY	CDF		NCI
C9533	SY	CAFFI		NCI
C9533	SY	CAF		NCI
C9533	SY	Oral Cyclophosphamide/Doxorubicin/Fluorouracil		NCI
C9533	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C9533	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9533	RO	chemotherapy regimen has component Doxorubicin	NCI
C9533	RO	chemotherapy regimen has component Fluorouracil	NCI
C9533	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C10680	STY	Therapeutic or Preventive Procedure		NCI
C10680	PT	Asparaginase/Cyclophosphamide/Cytarabine/Daunorubicin/Doxorubicin/Mercaptopurine/Vincristine		NCI
C10680	SY	ARA-C/ASP/CTX/DNR/DOX/MP/VCR		NCI
C10680	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10680	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10680	RO	chemotherapy regimen has component Asparaginase	NCI
C10680	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10680	RO	chemotherapy regimen has component Cytarabine	NCI
C10680	RO	chemotherapy regimen has component Doxorubicin	NCI
C10680	RO	chemotherapy regimen has component Vincristine	NCI
C10680	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9657	STY	Therapeutic or Preventive Procedure		NCI
C9657	PT	Cisplatin/Interleukin-2		NCI
C9657	SY	CDDP/IL-2		NCI
C9657	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9657	RO	chemotherapy regimen has component Cisplatin	NCI
C9657	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10332	STY	Therapeutic or Preventive Procedure		NCI
C10332	PT	Doxorubicin/Fluorouracil/Thiotepa		NCI
C10332	SY	DOX/5-FU/TSPA		NCI
C10332	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10332	RO	chemotherapy regimen has component Doxorubicin	NCI
C10332	RO	chemotherapy regimen has component Fluorouracil	NCI
C10332	RO	chemotherapy regimen has component Thiotepa	NCI
C140658	STY	Therapeutic or Preventive Procedure		NCI
C140658	PT	R-ACVBP Regimen		NCI
C140658	SY	Rituximab/Doxorubicin/Cyclophosphamide/Vindesine/Bleomycin/Prednisone		NCI
C140658	SY	ACVBP-R		NCI
C140658	SY	Doxorubicin/Cyclophosphamide/Vindesine/Bleomycin/Prednisone/Rituximab		NCI
C140658	SY	R-ACVBP		NCI
C140658	SY	Rituximab-Doxorubicin-Cyclophosphamide-Vindesine-Bleomycin-Prednisone		NCI
C140658	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140658	RO	chemotherapy regimen has component Bleomycin	NCI
C140658	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C140658	RO	chemotherapy regimen has component Doxorubicin	NCI
C140658	RO	chemotherapy regimen has component Prednisone	NCI
C140658	RO	chemotherapy regimen has component Vindesine	NCI
C140658	RO	chemotherapy regimen has component Rituximab	NCI
C10205	STY	Therapeutic or Preventive Procedure		NCI
C10205	PT	Doxorubicin/Fluorouracil/Methotrexate/Sargramostim		NCI
C10205	SY	DOX/5-FU/GM-CSF/MTX		NCI
C10205	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10205	RO	chemotherapy regimen has component Doxorubicin	NCI
C10205	RO	chemotherapy regimen has component Fluorouracil	NCI
C10205	RO	chemotherapy regimen has component Methotrexate	NCI
C10205	RO	chemotherapy regimen has component Sargramostim	NCI
C10162	STY	Therapeutic or Preventive Procedure		NCI
C10162	PT	Cisplatin/Dexamethasone/Etoposide		NCI
C10162	SY	CED		NCI
C10162	SY	CDDP/DM/VP-16		NCI
C10162	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10162	RO	chemotherapy regimen has component Cisplatin	NCI
C10162	RO	chemotherapy regimen has component Dexamethasone	NCI
C10162	RO	chemotherapy regimen has component Etoposide	NCI
C37525	STY	Therapeutic or Preventive Procedure		NCI
C37525	PT	Anastrozole/Fulvestrant		NCI
C37525	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37525	RO	chemotherapy regimen has component Anastrozole	NCI
C37525	RO	chemotherapy regimen has component Fulvestrant	NCI
C9915	STY	Therapeutic or Preventive Procedure		NCI
C9915	PT	Asparaginase/Dexamethasone/Methotrexate/Vincristine		NCI
C9915	SY	MOAD		NCI
C9915	SY	ASP/DM/MTX/VCR		NCI
C9915	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9915	RO	chemotherapy regimen has component Asparaginase	NCI
C9915	RO	chemotherapy regimen has component Dexamethasone	NCI
C9915	RO	chemotherapy regimen has component Methotrexate	NCI
C9915	RO	chemotherapy regimen has component Vincristine	NCI
C10626	STY	Therapeutic or Preventive Procedure		NCI
C10626	PT	Cyclosporine/Tamoxifen/Vinblastine		NCI
C10626	SY	CYSP/TMX/VBL		NCI
C10626	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10626	RO	chemotherapy regimen has component Cyclosporine	NCI
C10626	RO	chemotherapy regimen has component Vinblastine	NCI
C10626	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11028	STY	Therapeutic or Preventive Procedure		NCI
C11028	PT	Cytarabine/Interferon Alfa		NCI
C11028	SY	ARA-C/IFN-A		NCI
C11028	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11028	RO	chemotherapy regimen has component Cytarabine	NCI
C11028	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37741	STY	Therapeutic or Preventive Procedure		NCI
C37741	PT	Docetaxel/Erlotinib		NCI
C37741	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37741	RO	chemotherapy regimen has component Docetaxel	NCI
C37741	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C10316	STY	Therapeutic or Preventive Procedure		NCI
C10316	PT	Amifostine/Cisplatin		NCI
C10316	SY	CDDP/WR-2721		NCI
C10316	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10316	RO	chemotherapy regimen has component Cisplatin	NCI
C10316	RO	chemotherapy regimen has component Amifostine	NCI
C11775	STY	Therapeutic or Preventive Procedure		NCI
C11775	PT	Capecitabine/Paclitaxel		NCI
C11775	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11775	RO	chemotherapy regimen has component Paclitaxel	NCI
C11775	RO	chemotherapy regimen has component Capecitabine	NCI
C10842	STY	Therapeutic or Preventive Procedure		NCI
C10842	PT	Lomustine/Vincristine		NCI
C10842	SY	CCNU/VCR		NCI
C10842	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10842	RO	chemotherapy regimen has component Lomustine	NCI
C10842	RO	chemotherapy regimen has component Vincristine	NCI
C11468	STY	Therapeutic or Preventive Procedure		NCI
C11468	PT	Dexamethasone/Idarubicin/Lomustine		NCI
C11468	SY	CCNU/DM/IDA		NCI
C11468	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11468	RO	chemotherapy regimen has component Dexamethasone	NCI
C11468	RO	chemotherapy regimen has component Idarubicin	NCI
C11468	RO	chemotherapy regimen has component Lomustine	NCI
C11215	STY	Therapeutic or Preventive Procedure		NCI
C11215	PT	Cyclophosphamide/Melphalan/Mitoxantrone		NCI
C11215	SY	CTX/DHAD/L-PAM		NCI
C11215	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11215	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11215	RO	chemotherapy regimen has component Melphalan	NCI
C11215	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9775	STY	Therapeutic or Preventive Procedure		NCI
C9775	PT	Amsacrine/Cyclophosphamide/Etoposide		NCI
C9775	SY	AMSA/CTX/VP-16		NCI
C9775	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9775	RO	chemotherapy regimen has component Amsacrine	NCI
C9775	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9775	RO	chemotherapy regimen has component Etoposide	NCI
C37797	STY	Therapeutic or Preventive Procedure		NCI
C37797	PT	Gefitinib/Tamoxifen		NCI
C37797	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37797	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C37797	RO	chemotherapy regimen has component Gefitinib	NCI
C10165	STY	Therapeutic or Preventive Procedure		NCI
C10165	PT	Doxorubicin/Floxuridine/Mitomycin		NCI
C10165	SY	FAM		NCI
C10165	SY	DOX/FUDR/MITO		NCI
C10165	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10165	RO	chemotherapy regimen has component Mitomycin	NCI
C10165	RO	chemotherapy regimen has component Doxorubicin	NCI
C10165	RO	chemotherapy regimen has component Floxuridine	NCI
C37459	STY	Therapeutic or Preventive Procedure		NCI
C37459	PT	Autologous Dendritic Cells/CMV pp65 Peptide		NCI
C37459	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37459	RO	chemotherapy regimen has component Therapeutic Autologous Dendritic Cells	NCI
C37459	RO	chemotherapy regimen has component CMV N495 Peptide	NCI
C11330	STY	Therapeutic or Preventive Procedure		NCI
C11330	PT	Carboplatin/Floxuridine		NCI
C11330	SY	CBDCA/FUDR		NCI
C11330	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11330	RO	chemotherapy regimen has component Floxuridine	NCI
C11330	RO	chemotherapy regimen has component Carboplatin	NCI
C11076	STY	Therapeutic or Preventive Procedure		NCI
C11076	PT	Etoposide/Fluorouracil/Interferon Alfa/Leucovorin Calcium		NCI
C11076	SY	CF/5-FU/IFN-A/VP-16		NCI
C11076	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11076	RO	chemotherapy regimen has component Etoposide	NCI
C11076	RO	chemotherapy regimen has component Fluorouracil	NCI
C11076	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11076	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C156364	STY	Therapeutic or Preventive Procedure		NCI
C156364	PT	Eribulin/Trastuzumab Regimen		NCI
C156364	SY	Eribulin/Trastuzumab		NCI
C156364	SY	Trastuzumab/Eribulin Regimen		NCI
C156364	SY	Trastuzumab/Eribulin		NCI
C156364	SY	Halaven/Herceptin		NCI
C156364	SY	Eribulin-Trastuzumab		NCI
C156364	SY	Trastuzumab-Eribulin		NCI
C156364	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156364	RO	chemotherapy regimen has component Trastuzumab	NCI
C156364	RO	chemotherapy regimen has component Eribulin Mesylate	NCI
C10591	STY	Therapeutic or Preventive Procedure		NCI
C10591	PT	Cisplatin/Edatrexate		NCI
C10591	SY	CDDP/EDAM		NCI
C10591	SY	Cisplatin/10-EdAM		NCI
C10591	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10591	RO	chemotherapy regimen has component Cisplatin	NCI
C10591	RO	chemotherapy regimen has component Edatrexate	NCI
C11701	STY	Therapeutic or Preventive Procedure		NCI
C11701	PT	Interleukin-2/Vaccine-Sensitized Draining Lymph Node Cells		NCI
C11701	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11701	RO	chemotherapy regimen has component Vaccine-Sensitized Draining Lymph Node Cells	NCI
C11701	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10874	STY	Therapeutic or Preventive Procedure		NCI
C10874	PT	Dacarbazine/Doxorubicin/Filgrastim/Ifosfamide		NCI
C10874	SY	DOX/DTIC/G-CSF/IFF		NCI
C10874	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10874	RO	chemotherapy regimen has component Dacarbazine	NCI
C10874	RO	chemotherapy regimen has component Doxorubicin	NCI
C10874	RO	chemotherapy regimen has component Ifosfamide	NCI
C10874	RO	chemotherapy regimen has component Filgrastim	NCI
C10285	STY	Therapeutic or Preventive Procedure		NCI
C10285	PT	Cisplatin/Methotrexate		NCI
C10285	SY	CDDP/MTX		NCI
C10285	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10285	RO	chemotherapy regimen has component Cisplatin	NCI
C10285	RO	chemotherapy regimen has component Methotrexate	NCI
C10805	STY	Therapeutic or Preventive Procedure		NCI
C10805	PT	Indomethacin/Interleukin-2/Lymphokine-Activated Killer Cells		NCI
C10805	SY	IL-2/Indomethacin/LAK		NCI
C10805	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10805	RO	chemotherapy regimen has component Indomethacin	NCI
C10805	RO	chemotherapy regimen has component Lymphokine-Activated Killer Cells	NCI
C10805	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11631	STY	Therapeutic or Preventive Procedure		NCI
C11631	PT	Rituximab/Vinorelbine		NCI
C11631	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11631	RO	chemotherapy regimen has component Vinorelbine	NCI
C11631	RO	chemotherapy regimen has component Rituximab	NCI
C10766	STY	Therapeutic or Preventive Procedure		NCI
C10766	PT	Fluorouracil/Leucovorin Calcium/Methotrexate/PALA/Triacetyluridine		NCI
C10766	SY	CF/5-FU/MTX/PALA/TAU		NCI
C10766	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10766	RO	chemotherapy regimen has component Fluorouracil	NCI
C10766	RO	chemotherapy regimen has component Methotrexate	NCI
C10766	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C10766	RO	chemotherapy regimen has component Uridine Triacetate	NCI
C10766	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10148	STY	Therapeutic or Preventive Procedure		NCI
C10148	PT	Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Procarbazine/Vincristine		NCI
C10148	SY	COD-BLAM IV		NCI
C10148	SY	BLEO/CTX/DM/DOX/PCB/VCR		NCI
C10148	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10148	RO	chemotherapy regimen has component Bleomycin	NCI
C10148	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10148	RO	chemotherapy regimen has component Dexamethasone	NCI
C10148	RO	chemotherapy regimen has component Doxorubicin	NCI
C10148	RO	chemotherapy regimen has component Vincristine	NCI
C10148	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11792	STY	Therapeutic or Preventive Procedure		NCI
C11792	PT	Etoposide Phosphate/Melphalan/Topotecan		NCI
C11792	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11792	RO	chemotherapy regimen has component Melphalan	NCI
C11792	RO	chemotherapy regimen has component Etoposide Phosphate	NCI
C11792	RO	chemotherapy regimen has component Topotecan	NCI
C10321	STY	Therapeutic or Preventive Procedure		NCI
C10321	PT	Cyclophosphamide/Doxorubicin/Sargramostim		NCI
C10321	SY	CTX/DOX/GM-CSF		NCI
C10321	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10321	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10321	RO	chemotherapy regimen has component Doxorubicin	NCI
C10321	RO	chemotherapy regimen has component Sargramostim	NCI
C9572	STY	Therapeutic or Preventive Procedure		NCI
C9572	PT	Cyclophosphamide/Dacarbazine/Vincristine		NCI
C9572	SY	CDV		NCI
C9572	SY	CTX/DTIC/VCR		NCI
C9572	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9572	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9572	RO	chemotherapy regimen has component Dacarbazine	NCI
C9572	RO	chemotherapy regimen has component Vincristine	NCI
C154212	STY	Therapeutic or Preventive Procedure		NCI
C154212	PT	Bendamustine/Obinutuzumab Regimen		NCI
C154212	SY	Bendamustine-Obinutuzumab Regimen		NCI
C154212	SY	Obinutuzumab Plus Bendamustine		NCI
C154212	SY	Bendamustine-Obinutuzumab		NCI
C154212	SY	Bendamustine/Obinutuzumab		NCI
C154212	SY	Bendamustine + Obinutuzumab		NCI
C154212	SY	Obinutuzumab-Bendamustine		NCI
C154212	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C154212	RO	chemotherapy regimen has component Bendamustine	NCI
C154212	RO	chemotherapy regimen has component Obinutuzumab	NCI
C10992	STY	Therapeutic or Preventive Procedure		NCI
C10992	PT	Fluorouracil/Interferon Alfa/Mitomycin		NCI
C10992	SY	5-FU/IFN-A/MITO		NCI
C10992	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10992	RO	chemotherapy regimen has component Mitomycin	NCI
C10992	RO	chemotherapy regimen has component Fluorouracil	NCI
C10992	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10132	STY	Therapeutic or Preventive Procedure		NCI
C10132	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Fluorouracil/Methotrexate/Vincristine		NCI
C10132	SY	CDDP/CTX/DOX/5-FU/MTX/VCR/VP-16		NCI
C10132	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10132	RO	chemotherapy regimen has component Cisplatin	NCI
C10132	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10132	RO	chemotherapy regimen has component Doxorubicin	NCI
C10132	RO	chemotherapy regimen has component Etoposide	NCI
C10132	RO	chemotherapy regimen has component Fluorouracil	NCI
C10132	RO	chemotherapy regimen has component Methotrexate	NCI
C10132	RO	chemotherapy regimen has component Vincristine	NCI
C37518	STY	Therapeutic or Preventive Procedure		NCI
C37518	PT	Allogeneic Lymphocytes/MOv-Gamma Chimeric Receptor Gene		NCI
C37518	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37518	RO	chemotherapy regimen has component Therapeutic Allogeneic Lymphocytes	NCI
C37518	RO	chemotherapy regimen has component MOv-gamma Chimeric Receptor Gene	NCI
C37643	STY	Therapeutic or Preventive Procedure		NCI
C37643	PT	Cetuximab/Paclitaxel		NCI
C37643	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37643	RO	chemotherapy regimen has component Paclitaxel	NCI
C37643	RO	chemotherapy regimen has component Cetuximab	NCI
C9887	STY	Therapeutic or Preventive Procedure		NCI
C9887	PT	Etoposide/Mitoxantrone/Prednimustine		NCI
C9887	SY	DHAD/PM/VP-16		NCI
C9887	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9887	RO	chemotherapy regimen has component Etoposide	NCI
C9887	RO	chemotherapy regimen has component Prednimustine	NCI
C9887	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10789	STY	Therapeutic or Preventive Procedure		NCI
C10789	PT	Mitoxantrone/Paclitaxel/Thiotepa		NCI
C10789	SY	DHAD/TAX/TSPA		NCI
C10789	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10789	RO	chemotherapy regimen has component Thiotepa	NCI
C10789	RO	chemotherapy regimen has component Paclitaxel	NCI
C10789	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37598	STY	Therapeutic or Preventive Procedure		NCI
C37598	PT	Carboplatin/Cyclophosphamide/Cytarabine/Etoposide Phosphate/Rituximab/Sodium Thiosulfate		NCI
C37598	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37598	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37598	RO	chemotherapy regimen has component Cytarabine	NCI
C37598	RO	chemotherapy regimen has component Etoposide Phosphate	NCI
C37598	RO	chemotherapy regimen has component Sodium Thiosulfate	NCI
C37598	RO	chemotherapy regimen has component Carboplatin	NCI
C37598	RO	chemotherapy regimen has component Rituximab	NCI
C29376	STY	Therapeutic or Preventive Procedure		NCI
C29376	PT	Etoposide/Prednisone		NCI
C29376	SY	Prednisone/Etoposide		NCI
C29376	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C29376	RO	chemotherapy regimen has component Etoposide	NCI
C29376	RO	chemotherapy regimen has component Prednisone	NCI
C10528	STY	Therapeutic or Preventive Procedure		NCI
C10528	PT	Cisplatin/Filgrastim/Methotrexate/Vinblastine		NCI
C10528	SY	CDDP/G-CSF/MTX/VBL		NCI
C10528	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10528	RO	chemotherapy regimen has component Cisplatin	NCI
C10528	RO	chemotherapy regimen has component Methotrexate	NCI
C10528	RO	chemotherapy regimen has component Vinblastine	NCI
C10528	RO	chemotherapy regimen has component Filgrastim	NCI
C37534	STY	Therapeutic or Preventive Procedure		NCI
C37534	PT	Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate/Thioguanine/Vincristine		NCI
C37534	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37534	RO	chemotherapy regimen has component Asparaginase	NCI
C37534	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37534	RO	chemotherapy regimen has component Cytarabine	NCI
C37534	RO	chemotherapy regimen has component Methotrexate	NCI
C37534	RO	chemotherapy regimen has component Thioguanine	NCI
C37534	RO	chemotherapy regimen has component Vincristine	NCI
C37832	STY	Therapeutic or Preventive Procedure		NCI
C37832	PT	Methotrexate/Rituximab/Temozolomide		NCI
C37832	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37832	RO	chemotherapy regimen has component Methotrexate	NCI
C37832	RO	chemotherapy regimen has component Temozolomide	NCI
C37832	RO	chemotherapy regimen has component Rituximab	NCI
C10551	STY	Therapeutic or Preventive Procedure		NCI
C10551	PT	Asparaginase/Cyclophosphamide/Cytarabine/Filgrastim/Mercaptopurine/Vincristine		NCI
C10551	SY	ARA-C/ASP/CTX/G-CSF/MP/VCR		NCI
C10551	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10551	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10551	RO	chemotherapy regimen has component Asparaginase	NCI
C10551	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10551	RO	chemotherapy regimen has component Cytarabine	NCI
C10551	RO	chemotherapy regimen has component Vincristine	NCI
C10551	RO	chemotherapy regimen has component Filgrastim	NCI
C9621	STY	Therapeutic or Preventive Procedure		NCI
C9621	PT	Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Vincristine		NCI
C9621	SY	COMA-A		NCI
C9621	SY	ARA-C/CTX/DOX/MTX/VCR		NCI
C9621	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9621	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9621	RO	chemotherapy regimen has component Cytarabine	NCI
C9621	RO	chemotherapy regimen has component Doxorubicin	NCI
C9621	RO	chemotherapy regimen has component Methotrexate	NCI
C9621	RO	chemotherapy regimen has component Vincristine	NCI
C10633	STY	Therapeutic or Preventive Procedure		NCI
C10633	PT	Carboplatin/Cyclophosphamide/Etoposide/Melphalan		NCI
C10633	SY	CBDCA/CTX/L-PAM/VP-16		NCI
C10633	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10633	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10633	RO	chemotherapy regimen has component Etoposide	NCI
C10633	RO	chemotherapy regimen has component Melphalan	NCI
C10633	RO	chemotherapy regimen has component Carboplatin	NCI
C140109	STY	Therapeutic or Preventive Procedure		NCI
C140109	PT	R-MPV Regimen		NCI
C140109	SY	R-MPV		NCI
C140109	SY	Rituximab/Methotrexate/Procarbazine/Vincristine		NCI
C140109	SY	Rituximab-Methotrexate-Procarbazine-Vincristine		NCI
C140109	CHD	Chemotherapy Regimen Used to Treat Central Nervous System Neoplasm	NCI
C140109	RO	chemotherapy regimen has component Methotrexate	NCI
C140109	RO	chemotherapy regimen has component Procarbazine	NCI
C140109	RO	chemotherapy regimen has component Vincristine	NCI
C140109	RO	chemotherapy regimen has component Rituximab	NCI
C37677	STY	Therapeutic or Preventive Procedure		NCI
C37677	PT	Cyclophosphamide/Decitabine/Doxorubicin		NCI
C37677	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37677	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37677	RO	chemotherapy regimen has component Doxorubicin	NCI
C37677	RO	chemotherapy regimen has component Decitabine	NCI
C10825	STY	Therapeutic or Preventive Procedure		NCI
C10825	PT	Filgrastim/Penclomedine		NCI
C10825	SY	G-CSF/PEN		NCI
C10825	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10825	RO	chemotherapy regimen has component Penclomedine	NCI
C10825	RO	chemotherapy regimen has component Filgrastim	NCI
C37633	STY	Therapeutic or Preventive Procedure		NCI
C37633	PT	Celecoxib/Fluorouracil/Leucovorin Calcium		NCI
C37633	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37633	RO	chemotherapy regimen has component Fluorouracil	NCI
C37633	RO	chemotherapy regimen has component Celecoxib	NCI
C37633	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9968	STY	Therapeutic or Preventive Procedure		NCI
C9968	PT	Interleukin-2/Thiotepa		NCI
C9968	SY	IL-2/TSPA		NCI
C9968	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9968	RO	chemotherapy regimen has component Thiotepa	NCI
C9968	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C141505	STY	Therapeutic or Preventive Procedure		NCI
C141505	PT	Cisplatin/Fluorouracil/Trastuzumab Regimen		NCI
C141505	SY	CFT		NCI
C141505	SY	Cisplatin-Fluorouracil-Trastuzumab		NCI
C141505	SY	Cisplatin/5-FU/Trastuzumab		NCI
C141505	SY	Cisplatin-Fluorouracil-Trastuzumab Regimen		NCI
C141505	SY	Cisplatin/Fluorouracil/Trastuzumab		NCI
C141505	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C141505	RO	chemotherapy regimen has component Cisplatin	NCI
C141505	RO	chemotherapy regimen has component Fluorouracil	NCI
C141505	RO	chemotherapy regimen has component Trastuzumab	NCI
C10184	STY	Therapeutic or Preventive Procedure		NCI
C10184	PT	Cyclophosphamide/Lomustine/Prednisone/Procarbazine/Vincristine		NCI
C10184	SY	CCNU/CTX/PCB/PRED/VCR		NCI
C10184	SY	COPP-CCNU		NCI
C10184	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10184	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10184	RO	chemotherapy regimen has component Lomustine	NCI
C10184	RO	chemotherapy regimen has component Prednisone	NCI
C10184	RO	chemotherapy regimen has component Vincristine	NCI
C10184	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9952	STY	Therapeutic or Preventive Procedure		NCI
C9952	PT	Carmustine/Dacarbazine/Hydroxyurea/Vincristine		NCI
C9952	SY	BHD-V		NCI
C9952	SY	BCNU/DTIC/HU/VCR		NCI
C9952	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9952	RO	chemotherapy regimen has component Carmustine	NCI
C9952	RO	chemotherapy regimen has component Dacarbazine	NCI
C9952	RO	chemotherapy regimen has component Hydroxyurea	NCI
C9952	RO	chemotherapy regimen has component Vincristine	NCI
C11548	STY	Therapeutic or Preventive Procedure		NCI
C11548	PT	Amifostine/Cytarabine/Topotecan		NCI
C11548	SY	ARA-C/TOPO/WR-2721		NCI
C11548	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11548	RO	chemotherapy regimen has component Cytarabine	NCI
C11548	RO	chemotherapy regimen has component Amifostine	NCI
C11548	RO	chemotherapy regimen has component Topotecan	NCI
C10293	STY	Therapeutic or Preventive Procedure		NCI
C10293	PT	Etoposide/Thiotepa		NCI
C10293	SY	TSPA/VP-16		NCI
C10293	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10293	RO	chemotherapy regimen has component Etoposide	NCI
C10293	RO	chemotherapy regimen has component Thiotepa	NCI
C11338	STY	Therapeutic or Preventive Procedure		NCI
C11338	PT	Leuprolide/Nilutamide		NCI
C11338	SY	ANAN/LEUP		NCI
C11338	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11338	RO	chemotherapy regimen has component Nilutamide	NCI
C11338	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C15583	STY	Therapeutic or Preventive Procedure		NCI
C15583	PT	Sargramostim/Tumor Necrosis Factor		NCI
C15583	SY	GM-CSF/TNF		NCI
C15583	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15583	RO	chemotherapy regimen has component Sargramostim	NCI
C15583	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C10229	STY	Therapeutic or Preventive Procedure		NCI
C10229	PT	Cyclophosphamide/Fluorouracil/Tamoxifen		NCI
C10229	SY	CTX/5-FU/TMX		NCI
C10229	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10229	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10229	RO	chemotherapy regimen has component Fluorouracil	NCI
C10229	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10757	STY	Therapeutic or Preventive Procedure		NCI
C10757	PT	Cisplatin/Interleukin-1-Alpha		NCI
C10757	SY	CDDP/IL-1A		NCI
C10757	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10757	RO	chemotherapy regimen has component Cisplatin	NCI
C10757	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C10791	STY	Therapeutic or Preventive Procedure		NCI
C10791	PT	Busulfan/Melphalan/Thiotepa		NCI
C10791	SY	BuMelT		NCI
C10791	SY	BU/L-PAM/TSPA		NCI
C10791	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10791	RO	chemotherapy regimen has component Busulfan	NCI
C10791	RO	chemotherapy regimen has component Melphalan	NCI
C10791	RO	chemotherapy regimen has component Thiotepa	NCI
C63424	STY	Therapeutic or Preventive Procedure		NCI
C63424	PT	TCH Regimen		NCI
C63424	SY	Taxotere-Carboplatin-Herceptin Regimen		NCI
C63424	SY	Docetaxel-Carboplatin-Trastuzumab Regimen		NCI
C63424	SY	TCH		NCI
C63424	SY	Docetaxel/Doxorubicin/Cyclophosphamide		NCI
C63424	SY	Docetaxel/Carboplatin Plus Trastuzumab		NCI
C63424	SY	Docetaxel/Carboplatin + Trastuzumab		NCI
C63424	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63424	RO	chemotherapy regimen has component Carboplatin	NCI
C63424	RO	chemotherapy regimen has component Docetaxel	NCI
C63424	RO	chemotherapy regimen has component Trastuzumab	NCI
C63424	RO	regimen has accepted use for disease HER2 Positive Breast Carcinoma	NCI
C9551	STY	Therapeutic or Preventive Procedure		NCI
C9551	PT	Cyclophosphamide/Doxorubicin/Prednisone/Teniposide		NCI
C9551	SY	CHVP		NCI
C9551	SY	CTX/DOX/PRED/VM-26		NCI
C9551	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9551	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9551	RO	chemotherapy regimen has component Doxorubicin	NCI
C9551	RO	chemotherapy regimen has component Prednisone	NCI
C9551	RO	chemotherapy regimen has component Teniposide	NCI
C11042	STY	Therapeutic or Preventive Procedure		NCI
C11042	PT	Hydroxyurea/Interferon Alfa		NCI
C11042	SY	HU/IFN-A		NCI
C11042	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11042	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11042	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10759	STY	Therapeutic or Preventive Procedure		NCI
C10759	PT	Ciprofloxacin/Cisplatin/Cyclophosphamide/Etoposide/Pentoxifylline		NCI
C10759	SY	CDDP/CPFX/CTX/PTX/VP-16		NCI
C10759	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10759	RO	chemotherapy regimen has component Ciprofloxacin	NCI
C10759	RO	chemotherapy regimen has component Cisplatin	NCI
C10759	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10759	RO	chemotherapy regimen has component Etoposide	NCI
C10759	RO	chemotherapy regimen has component Pentoxifylline	NCI
C10558	STY	Therapeutic or Preventive Procedure		NCI
C10558	PT	Pentostatin/Sargramostim		NCI
C10558	SY	DCF/GM-CSF		NCI
C10558	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10558	RO	chemotherapy regimen has component Pentostatin	NCI
C10558	RO	chemotherapy regimen has component Sargramostim	NCI
C9756	STY	Therapeutic or Preventive Procedure		NCI
C9756	PT	Paclitaxel/Beta-Lapachone		NCI
C9756	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9756	RO	chemotherapy regimen has component Lapachone	NCI
C9756	RO	chemotherapy regimen has component Paclitaxel	NCI
C11818	STY	Therapeutic or Preventive Procedure		NCI
C11818	PT	Cisplatin/Gemcitabine/ZD 1839		NCI
C11818	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11818	RO	chemotherapy regimen has component Cisplatin	NCI
C11818	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11818	RO	chemotherapy regimen has component Gefitinib	NCI
C15598	STY	Therapeutic or Preventive Procedure		NCI
C15598	PT	Bispecific Antibody 520C9XH22/Filgrastim		NCI
C15598	SY	BsAb 520C9xH22/G-CSF		NCI
C15598	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15598	RO	chemotherapy regimen has component Filgrastim	NCI
C15598	RO	chemotherapy regimen has component Bispecific Antibody MDX-H210	NCI
C11690	STY	Therapeutic or Preventive Procedure		NCI
C11690	PT	Montanide ISA-51/p53 peptide vaccine/Sargramostim		NCI
C11690	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11690	RO	chemotherapy regimen has component Sargramostim	NCI
C11690	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11690	RO	chemotherapy regimen has component p53 Peptide Vaccine	NCI
C63596	STY	Therapeutic or Preventive Procedure		NCI
C63596	PT	CAPOX Regimen		NCI
C63596	SY	Capecitabine-Oxaliplatin Regimen		NCI
C63596	SY	Capecitabine-Oxaliplatin		NCI
C63596	SY	Capecitabine/Oxaliplatin		NCI
C63596	SY	Capecitabine/Oxaliplatin Regimen		NCI
C63596	SY	CAPEOX Regimen		NCI
C63596	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63596	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63596	RO	chemotherapy regimen has component Oxaliplatin	NCI
C63596	RO	chemotherapy regimen has component Capecitabine	NCI
C11636	STY	Therapeutic or Preventive Procedure		NCI
C11636	PT	Fluorouracil/Vincristine		NCI
C11636	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11636	RO	chemotherapy regimen has component Fluorouracil	NCI
C11636	RO	chemotherapy regimen has component Vincristine	NCI
C10167	STY	Therapeutic or Preventive Procedure		NCI
C10167	PT	Procarbazine/Semustine/Vincristine		NCI
C10167	SY	MeCCNU/PCB/VCR		NCI
C10167	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10167	RO	chemotherapy regimen has component Semustine	NCI
C10167	RO	chemotherapy regimen has component Vincristine	NCI
C10167	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11299	STY	Therapeutic or Preventive Procedure		NCI
C11299	PT	Estramustine/Etoposide/Paclitaxel		NCI
C11299	SY	EM/TAX/VP-16		NCI
C11299	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11299	RO	chemotherapy regimen has component Estramustine	NCI
C11299	RO	chemotherapy regimen has component Etoposide	NCI
C11299	RO	chemotherapy regimen has component Paclitaxel	NCI
C10665	STY	Therapeutic or Preventive Procedure		NCI
C10665	PT	Doxorubicin/Fluorouracil/Leucovorin Calcium/Vinorelbine		NCI
C10665	SY	CF/DOX/5-FU/VNB		NCI
C10665	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10665	RO	chemotherapy regimen has component Doxorubicin	NCI
C10665	RO	chemotherapy regimen has component Fluorouracil	NCI
C10665	RO	chemotherapy regimen has component Vinorelbine	NCI
C10665	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11021	STY	Therapeutic or Preventive Procedure		NCI
C11021	PT	Carboplatin/Interferon Alfa		NCI
C11021	SY	CBDCA/IFN-A		NCI
C11021	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11021	RO	chemotherapy regimen has component Carboplatin	NCI
C11021	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9712	STY	Therapeutic or Preventive Procedure		NCI
C9712	PT	Bleomycin/Cyclophosphamide/Semustine/Vincristine		NCI
C9712	SY	BLEO/CTX/MeCCNU/VCR		NCI
C9712	SY	COMB		NCI
C9712	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9712	RO	chemotherapy regimen has component Bleomycin	NCI
C9712	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9712	RO	chemotherapy regimen has component Semustine	NCI
C9712	RO	chemotherapy regimen has component Vincristine	NCI
C11576	STY	Therapeutic or Preventive Procedure		NCI
C11576	PT	UFT/Leucovorin		NCI
C11576	SY	Orzel		NCI
C11576	SY	tegafur/uracil/leucovorin		NCI
C11576	SY	UFT/LV		NCI
C11576	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11576	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11576	RO	chemotherapy regimen has component Tegafur-Uracil	NCI
C37780	STY	Therapeutic or Preventive Procedure		NCI
C37780	PT	Fluorouracil/Virulizin		NCI
C37780	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37780	RO	chemotherapy regimen has component Fluorouracil	NCI
C37780	RO	chemotherapy regimen has component Virulizin	NCI
C10002	STY	Therapeutic or Preventive Procedure		NCI
C10002	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Prednisone/Vincristine		NCI
C10002	SY	CMFP-VA		NCI
C10002	SY	CTX/DOX/5-FU/MTX/PRED/VCR		NCI
C10002	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10002	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10002	RO	chemotherapy regimen has component Doxorubicin	NCI
C10002	RO	chemotherapy regimen has component Fluorouracil	NCI
C10002	RO	chemotherapy regimen has component Methotrexate	NCI
C10002	RO	chemotherapy regimen has component Prednisone	NCI
C10002	RO	chemotherapy regimen has component Vincristine	NCI
C9583	STY	Therapeutic or Preventive Procedure		NCI
C9583	PT	Cisplatin/Cytarabine/Dexamethasone		NCI
C9583	SY	ARA-C/CDDP/DM		NCI
C9583	SY	DHAP		NCI
C9583	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9583	RO	chemotherapy regimen has component Cisplatin	NCI
C9583	RO	chemotherapy regimen has component Cytarabine	NCI
C9583	RO	chemotherapy regimen has component Dexamethasone	NCI
C63366	STY	Therapeutic or Preventive Procedure		NCI
C63366	PT	MOPP/ABV Hybrid Regimen		NCI
C63366	SY	Mustargen-Oncovin-Procarbazine-Prednisone plus Adriamycin-Bleomycin-Vinblastine Hybrid Regimen		NCI
C63366	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63366	RO	chemotherapy regimen has component Bleomycin	NCI
C63366	RO	chemotherapy regimen has component Doxorubicin	NCI
C63366	RO	chemotherapy regimen has component Prednisone	NCI
C63366	RO	chemotherapy regimen has component Vinblastine	NCI
C63366	RO	chemotherapy regimen has component Vincristine	NCI
C63366	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C63366	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C63366	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C11782	STY	Therapeutic or Preventive Procedure		NCI
C11782	PT	Azacitidine/Phenylbutyrate		NCI
C11782	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11782	RO	chemotherapy regimen has component Azacitidine	NCI
C11782	RO	chemotherapy regimen has component Sodium Phenylbutyrate	NCI
C37513	STY	Therapeutic or Preventive Procedure		NCI
C37513	PT	Adenovirus 5-Tumor Necrosis Factor Alpha/Capecitabine		NCI
C37513	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37513	RO	chemotherapy regimen has component Capecitabine	NCI
C37513	RO	chemotherapy regimen has component Golnerminogene Pradenovec	NCI
C63689	STY	Therapeutic or Preventive Procedure		NCI
C63689	PT	CABO Regimen		NCI
C63689	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C63689	RO	chemotherapy regimen has component Bleomycin	NCI
C63689	RO	chemotherapy regimen has component Cisplatin	NCI
C63689	RO	chemotherapy regimen has component Methotrexate	NCI
C63689	RO	chemotherapy regimen has component Vincristine	NCI
C63689	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C12049	STY	Therapeutic or Preventive Procedure		NCI
C12049	PT	Triapine/Cisplatin		NCI
C12049	SY	3AP/CDDP		NCI
C12049	SY	3-AP/cisplatin		NCI
C12049	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12049	RO	chemotherapy regimen has component Cisplatin	NCI
C12049	RO	chemotherapy regimen has component Triapine	NCI
C140112	STY	Therapeutic or Preventive Procedure		NCI
C140112	PT	R-Squared Regimen		NCI
C140112	SY	R-squared		NCI
C140112	SY	Lenalidomide-Rituximab		NCI
C140112	SY	Lenalidomide/Rituximab		NCI
C140112	SY	R2 Regimen		NCI
C140112	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140112	RO	chemotherapy regimen has component Rituximab	NCI
C140112	RO	chemotherapy regimen has component Lenalidomide	NCI
C12085	STY	Therapeutic or Preventive Procedure		NCI
C12085	PT	Cytarabine/dexamethasone/methotrexate/pegaspargase/vincristine		NCI
C12085	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12085	RO	chemotherapy regimen has component Cytarabine	NCI
C12085	RO	chemotherapy regimen has component Dexamethasone	NCI
C12085	RO	chemotherapy regimen has component Methotrexate	NCI
C12085	RO	chemotherapy regimen has component Vincristine	NCI
C12085	RO	chemotherapy regimen has component Pegaspargase	NCI
C10469	STY	Therapeutic or Preventive Procedure		NCI
C10469	PT	Cyclophosphamide/Cytarabine/Daunorubicin/Methotrexate/Prednisone/Thioguanine/Vincristine		NCI
C10469	SY	ARA-C/CTX/DNR/MTX/PRED/TG/VCR		NCI
C10469	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10469	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10469	RO	chemotherapy regimen has component Cytarabine	NCI
C10469	RO	chemotherapy regimen has component Methotrexate	NCI
C10469	RO	chemotherapy regimen has component Prednisone	NCI
C10469	RO	chemotherapy regimen has component Thioguanine	NCI
C10469	RO	chemotherapy regimen has component Vincristine	NCI
C10469	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C12167	STY	Therapeutic or Preventive Procedure		NCI
C12167	PT	IDEC-Y2B8 Monoclonal Antibody/Rituximab		NCI
C12167	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12167	RO	chemotherapy regimen has component Rituximab	NCI
C12167	RO	chemotherapy regimen has component Yttrium Y-90 Ibritumomab Tiuxetan	NCI
C11663	STY	Therapeutic or Preventive Procedure		NCI
C11663	PT	Montanide ISA-51/von Hippel-Lindau peptide vaccine		NCI
C11663	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11663	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11663	RO	chemotherapy regimen has component Von Hippel-Lindau Peptide Vaccine	NCI
C11671	STY	Therapeutic or Preventive Procedure		NCI
C11671	PT	Interleukin-12/Montanide ISA-51/Tyrosinase Peptide		NCI
C11671	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11671	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11671	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11671	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C11729	STY	Therapeutic or Preventive Procedure		NCI
C11729	PT	Asparaginase/cyclophosphamide/cytarabine/daunorubicin/dexamethasone/methotrexate/thioguanine/vincristine		NCI
C11729	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11729	RO	chemotherapy regimen has component Asparaginase	NCI
C11729	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11729	RO	chemotherapy regimen has component Cytarabine	NCI
C11729	RO	chemotherapy regimen has component Dexamethasone	NCI
C11729	RO	chemotherapy regimen has component Methotrexate	NCI
C11729	RO	chemotherapy regimen has component Thioguanine	NCI
C11729	RO	chemotherapy regimen has component Vincristine	NCI
C11729	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C156376	STY	Therapeutic or Preventive Procedure		NCI
C156376	PT	Fulvestrant/Ribociclib Regimen		NCI
C156376	SY	Fulvestrant/Ribociclib		NCI
C156376	SY	Faslodex/Kisqali		NCI
C156376	SY	Fulvestrant-Ribociclib		NCI
C156376	SY	Ribociclib/Fulvestrant Regimen		NCI
C156376	SY	Ribociclib/Fulvestrant		NCI
C156376	SY	Ribociclib-Fulvestrant		NCI
C156376	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156376	RO	chemotherapy regimen has component Fulvestrant	NCI
C156376	RO	chemotherapy regimen has component Ribociclib	NCI
C11098	STY	Therapeutic or Preventive Procedure		NCI
C11098	PT	Cyclophosphamide/Paclitaxel/Sargramostim		NCI
C11098	SY	CTX/GM-CSF/TAX		NCI
C11098	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11098	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11098	RO	chemotherapy regimen has component Paclitaxel	NCI
C11098	RO	chemotherapy regimen has component Sargramostim	NCI
C10933	STY	Therapeutic or Preventive Procedure		NCI
C10933	PT	Etoposide/Mitoxantrone/Sargramostim		NCI
C10933	SY	DHAD/GM-CSF/VP-16		NCI
C10933	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10933	RO	chemotherapy regimen has component Etoposide	NCI
C10933	RO	chemotherapy regimen has component Sargramostim	NCI
C10933	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37504	STY	Therapeutic or Preventive Procedure		NCI
C37504	PT	EP-2101/Montanide ISA-51		NCI
C37504	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37504	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C37504	RO	chemotherapy regimen has component OSE 2101	NCI
C11308	STY	Therapeutic or Preventive Procedure		NCI
C11308	PT	Amifostine/Cyclophosphamide/Mitoxantrone/Thiotepa		NCI
C11308	SY	CTX/DHAD/TSPA/WR-2721		NCI
C11308	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11308	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11308	RO	chemotherapy regimen has component Amifostine	NCI
C11308	RO	chemotherapy regimen has component Thiotepa	NCI
C11308	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11329	STY	Therapeutic or Preventive Procedure		NCI
C11329	PT	Carboplatin/Cisplatin/Floxuridine		NCI
C11329	SY	CBDCA/CDDP/FUDR		NCI
C11329	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11329	RO	chemotherapy regimen has component Cisplatin	NCI
C11329	RO	chemotherapy regimen has component Floxuridine	NCI
C11329	RO	chemotherapy regimen has component Carboplatin	NCI
C11438	STY	Therapeutic or Preventive Procedure		NCI
C11438	PT	Interferon Alfa/Interleukin-12		NCI
C11438	SY	IFN-A/IL-12		NCI
C11438	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11438	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11438	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C10074	STY	Therapeutic or Preventive Procedure		NCI
C10074	PT	Asparaginase/Cytarabine/Sargramostim		NCI
C10074	SY	ARA-C/ASP/GM-CSF		NCI
C10074	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10074	RO	chemotherapy regimen has component Asparaginase	NCI
C10074	RO	chemotherapy regimen has component Cytarabine	NCI
C10074	RO	chemotherapy regimen has component Sargramostim	NCI
C12142	STY	Therapeutic or Preventive Procedure		NCI
C12142	PT	Bleomycin/Prednisolone/Rituximab/Vincristine		NCI
C12142	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12142	RO	chemotherapy regimen has component Bleomycin	NCI
C12142	RO	chemotherapy regimen has component Prednisolone	NCI
C12142	RO	chemotherapy regimen has component Vincristine	NCI
C12142	RO	chemotherapy regimen has component Rituximab	NCI
C37551	STY	Therapeutic or Preventive Procedure		NCI
C37551	PT	Bevacizumab/PEG-Interferon Alfa-2b		NCI
C37551	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37551	RO	chemotherapy regimen has component Bevacizumab	NCI
C37551	RO	chemotherapy regimen has component Peginterferon Alfa-2b	NCI
C37796	STY	Therapeutic or Preventive Procedure		NCI
C37796	PT	Gefitinib/Oxaliplatin		NCI
C37796	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37796	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37796	RO	chemotherapy regimen has component Gefitinib	NCI
C11989	STY	Therapeutic or Preventive Procedure		NCI
C11989	PT	Asparaginase/Doxorubicin/Methotrexate/Prednisolone/Vincristine		NCI
C11989	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11989	RO	chemotherapy regimen has component Asparaginase	NCI
C11989	RO	chemotherapy regimen has component Doxorubicin	NCI
C11989	RO	chemotherapy regimen has component Methotrexate	NCI
C11989	RO	chemotherapy regimen has component Prednisolone	NCI
C11989	RO	chemotherapy regimen has component Vincristine	NCI
C11620	STY	Therapeutic or Preventive Procedure		NCI
C11620	PT	gp100 Antigen/Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase Peptide		NCI
C11620	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11620	RO	chemotherapy regimen has component Sargramostim	NCI
C11620	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11620	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11620	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C10401	STY	Therapeutic or Preventive Procedure		NCI
C10401	PT	Flutamide/Leuprolide		NCI
C10401	SY	FLUT/LEUP		NCI
C10401	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10401	RO	chemotherapy regimen has component Flutamide	NCI
C10401	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C37727	STY	Therapeutic or Preventive Procedure		NCI
C37727	PT	Decitabine/Imatinib Mesylate		NCI
C37727	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37727	RO	chemotherapy regimen has component Decitabine	NCI
C37727	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C11263	STY	Therapeutic or Preventive Procedure		NCI
C11263	PT	Cyclophosphamide/Dexamethasone/Etoposide		NCI
C11263	SY	CTX/DM/VP-16		NCI
C11263	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11263	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11263	RO	chemotherapy regimen has component Dexamethasone	NCI
C11263	RO	chemotherapy regimen has component Etoposide	NCI
C63415	STY	Therapeutic or Preventive Procedure		NCI
C63415	PT	AC Regimen		NCI
C63415	SY	Adriamycin-Cytoxan Regimen		NCI
C63415	SY	AC		NCI
C63415	SY	Doxorubicin/Cyclophosphamide		NCI
C63415	SY	CA Regimen		NCI
C63415	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63415	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63415	RO	chemotherapy regimen has component Doxorubicin	NCI
C63415	RO	regimen has accepted use for disease Breast Carcinoma	NCI
C63415	RO	concept in subset CTRP Terminology	NCI
C63415	RO	concept in subset CTRP Agent Terminology	NCI
C11937	STY	Therapeutic or Preventive Procedure		NCI
C11937	PT	Epirubicin/Tamoxifen		NCI
C11937	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11937	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11937	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C156303	STY	Therapeutic or Preventive Procedure		NCI
C156303	PT	Exemestane/Lapatinib/Trastuzumab Regimen		NCI
C156303	SY	Exemestane-Lapatinib-Trastuzumab		NCI
C156303	SY	Exemestane/Trastuzumab/Lapatinib		NCI
C156303	SY	Exemestane/Trastuzumab/Lapatinib Regimen		NCI
C156303	SY	Exemestane-Trastuzumab-Lapatinib		NCI
C156303	SY	Exemestane/Lapatinib/Herceptin		NCI
C156303	SY	Exemestane/Lapatinib/Trastuzumab		NCI
C156303	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156303	RO	chemotherapy regimen has component Trastuzumab	NCI
C156303	RO	chemotherapy regimen has component Exemestane	NCI
C156303	RO	chemotherapy regimen has component Lapatinib	NCI
C9604	STY	Therapeutic or Preventive Procedure		NCI
C9604	PT	Cisplatin/Doxorubicin/Methotrexate/Vinblastine		NCI
C9604	SY	CDDP/DOX/MTX/VBL		NCI
C9604	SY	MVAC		NCI
C9604	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9604	RO	chemotherapy regimen has component Cisplatin	NCI
C9604	RO	chemotherapy regimen has component Doxorubicin	NCI
C9604	RO	chemotherapy regimen has component Methotrexate	NCI
C9604	RO	chemotherapy regimen has component Vinblastine	NCI
C10107	STY	Therapeutic or Preventive Procedure		NCI
C10107	PT	Asparaginase/Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Vincristine		NCI
C10107	SY	ASP/CTX/DOX/MTX/PRED/VCR		NCI
C10107	SY	MACHO		NCI
C10107	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10107	RO	chemotherapy regimen has component Asparaginase	NCI
C10107	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10107	RO	chemotherapy regimen has component Doxorubicin	NCI
C10107	RO	chemotherapy regimen has component Methotrexate	NCI
C10107	RO	chemotherapy regimen has component Prednisone	NCI
C10107	RO	chemotherapy regimen has component Vincristine	NCI
C11201	STY	Therapeutic or Preventive Procedure		NCI
C11201	PT	Cisplatin/Toremifene		NCI
C11201	SY	CDDP/TOR		NCI
C11201	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11201	RO	chemotherapy regimen has component Cisplatin	NCI
C11201	RO	chemotherapy regimen has component Toremifene	NCI
C10421	STY	Therapeutic or Preventive Procedure		NCI
C10421	PT	Acivicin/Aminosyn		NCI
C10421	SY	Aminosyn/AT-125		NCI
C10421	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10421	RO	chemotherapy regimen has component Acivicin	NCI
C10421	RO	chemotherapy regimen has component Aminosyn	NCI
C64725	STY	Therapeutic or Preventive Procedure		NCI
C64725	PT	Cyclophosphamide-VAD Regimen		NCI
C64725	SY	Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone Regimen		NCI
C64725	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C64725	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C64725	RO	chemotherapy regimen has component Dexamethasone	NCI
C64725	RO	chemotherapy regimen has component Doxorubicin	NCI
C64725	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C64725	RO	chemotherapy regimen has component Vincristine	NCI
C67512	STY	Therapeutic or Preventive Procedure		NCI
C67512	PT	EMA-CE Regimen		NCI
C67512	SY	EMA/CE Regimen		NCI
C67512	SY	Etoposide-Methotrexate-Actinomycin/Cisplatin-Etoposide Regimen		NCI
C67512	SY	EMA-CE		NCI
C67512	CHD	Chemotherapy Regimen Used to Treat Gestational Trophoblastic Tumor	NCI
C67512	RO	chemotherapy regimen has component Cisplatin	NCI
C67512	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67512	RO	chemotherapy regimen has component Dactinomycin	NCI
C67512	RO	chemotherapy regimen has component Etoposide	NCI
C67512	RO	chemotherapy regimen has component Methotrexate	NCI
C67512	RO	regimen has accepted use for disease Gestational Trophoblastic Tumor	NCI
C10119	STY	Therapeutic or Preventive Procedure		NCI
C10119	PT	Cytarabine/Melphalan		NCI
C10119	SY	ARA-C/L-PAM		NCI
C10119	SY	AMA		NCI
C10119	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10119	RO	chemotherapy regimen has component Cytarabine	NCI
C10119	RO	chemotherapy regimen has component Melphalan	NCI
C37466	STY	Therapeutic or Preventive Procedure		NCI
C37466	PT	Carboplatin/Paclitaxel/ZD-6474		NCI
C37466	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37466	RO	chemotherapy regimen has component Carboplatin	NCI
C37466	RO	chemotherapy regimen has component Paclitaxel	NCI
C37466	RO	chemotherapy regimen has component Vandetanib	NCI
C10848	STY	Therapeutic or Preventive Procedure		NCI
C10848	PT	Asparaginase/Cytarabine/Filgrastim		NCI
C10848	SY	ARA-C/ASP/G-CSF		NCI
C10848	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10848	RO	chemotherapy regimen has component Asparaginase	NCI
C10848	RO	chemotherapy regimen has component Cytarabine	NCI
C10848	RO	chemotherapy regimen has component Filgrastim	NCI
C9508	STY	Therapeutic or Preventive Procedure		NCI
C9508	PT	Bleomycin/Dacarbazine/Doxorubicin/Vincristine		NCI
C9508	SY	BLEO/DOX/DTIC/VCR		NCI
C9508	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9508	RO	chemotherapy regimen has component Bleomycin	NCI
C9508	RO	chemotherapy regimen has component Dacarbazine	NCI
C9508	RO	chemotherapy regimen has component Doxorubicin	NCI
C9508	RO	chemotherapy regimen has component Vincristine	NCI
C11633	STY	Therapeutic or Preventive Procedure		NCI
C11633	PT	Dexrazoxane/Doxorubicin/Ifosfamide		NCI
C11633	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11633	RO	chemotherapy regimen has component Doxorubicin	NCI
C11633	RO	chemotherapy regimen has component Ifosfamide	NCI
C11633	RO	chemotherapy regimen has component Dexrazoxane	NCI
C11685	STY	Therapeutic or Preventive Procedure		NCI
C11685	PT	Interleukin-12/MART-1 Antigen/Montanide ISA-51		NCI
C11685	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11685	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11685	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C11685	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C156375	STY	Therapeutic or Preventive Procedure		NCI
C156375	PT	Tamoxifen/Ribociclib Regimen		NCI
C156375	SY	Tamoxifen/Kisqali		NCI
C156375	SY	Tamoxifen-Ribociclib		NCI
C156375	SY	Ribociclib/Tamoxifen		NCI
C156375	SY	Ribociclib/Tamoxifen Regimen		NCI
C156375	SY	Tamoxifen/Ribociclib		NCI
C156375	SY	Ribociclib-Tamoxifen		NCI
C156375	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156375	RO	chemotherapy regimen has component Tamoxifen	NCI
C156375	RO	chemotherapy regimen has component Ribociclib	NCI
C67289	STY	Therapeutic or Preventive Procedure		NCI
C67289	PT	JEB Regimen		NCI
C67289	SY	JM8-Etoposide-Bleomycin Regimen		NCI
C67289	SY	Bleomycin-Etoposide-Carboplatin Regimen		NCI
C67289	SY	Carboplatin-Etoposide-Bleomycin Regimen		NCI
C67289	SY	JM-8-Etoposide-Bleomycin regimen		NCI
C67289	CHD	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm	NCI
C67289	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C67289	RO	chemotherapy regimen has component Bleomycin	NCI
C67289	RO	chemotherapy regimen has component Etoposide	NCI
C67289	RO	chemotherapy regimen has component Carboplatin	NCI
C67289	RO	regimen has accepted use for disease Childhood Testicular Germ Cell Tumor	NCI
C67289	RO	regimen has accepted use for disease Childhood Ovarian Germ Cell Tumor	NCI
C63413	STY	Therapeutic or Preventive Procedure		NCI
C63413	PT	Carboplatin-Taxol-Bevacizumab Regimen		NCI
C63413	SY	Carboplatin-Taxol-Bevacizumab		NCI
C63413	SY	Carboplatin/Paclitaxel/Bevacizumab		NCI
C63413	SY	Carbo-Taxol-Avastin Regimen		NCI
C63413	SY	Carboplatin-Paclitaxel-Bevacizumab		NCI
C63413	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63413	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63413	RO	chemotherapy regimen has component Carboplatin	NCI
C63413	RO	chemotherapy regimen has component Paclitaxel	NCI
C63413	RO	chemotherapy regimen has component Bevacizumab	NCI
C10125	STY	Therapeutic or Preventive Procedure		NCI
C10125	PT	Cytarabine/Dexamethasone/Methotrexate		NCI
C10125	SY	ARA-C/DM/MTX		NCI
C10125	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10125	RO	chemotherapy regimen has component Cytarabine	NCI
C10125	RO	chemotherapy regimen has component Dexamethasone	NCI
C10125	RO	chemotherapy regimen has component Methotrexate	NCI
C10181	STY	Therapeutic or Preventive Procedure		NCI
C10181	PT	Doxorubicin/Etoposide/Mitomycin		NCI
C10181	SY	VAM		NCI
C10181	SY	DOX/MITO/VP-16		NCI
C10181	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10181	RO	chemotherapy regimen has component Mitomycin	NCI
C10181	RO	chemotherapy regimen has component Doxorubicin	NCI
C10181	RO	chemotherapy regimen has component Etoposide	NCI
C12116	STY	Therapeutic or Preventive Procedure		NCI
C12116	PT	Chinese Herbs/Cyclophosphamide/Doxorubicin		NCI
C12116	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12116	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12116	RO	chemotherapy regimen has component Doxorubicin	NCI
C12116	RO	chemotherapy regimen has component Chinese Herbs	NCI
C10749	STY	Therapeutic or Preventive Procedure		NCI
C10749	PT	Interferon Beta/Isotretinoin		NCI
C10749	SY	13-CRA/IFN-B		NCI
C10749	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10749	RO	chemotherapy regimen has component Isotretinoin	NCI
C10749	RO	chemotherapy regimen has component Recombinant Interferon Beta	NCI
C11106	STY	Therapeutic or Preventive Procedure		NCI
C11106	PT	Docetaxel/Filgrastim/Vinorelbine		NCI
C11106	SY	G-CSF/TXT/VNB		NCI
C11106	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11106	RO	chemotherapy regimen has component Vinorelbine	NCI
C11106	RO	chemotherapy regimen has component Filgrastim	NCI
C11106	RO	chemotherapy regimen has component Docetaxel	NCI
C16204	STY	Therapeutic or Preventive Procedure		NCI
C16204	PT	MAGE-3/PADRE 965.10		NCI
C16204	SY	MAGE-3.1/PADRE 965.10		NCI
C16204	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C16204	RO	chemotherapy regimen has component PADRE 965.10	NCI
C16204	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C9789	STY	Therapeutic or Preventive Procedure		NCI
C9789	PT	Cyclophosphamide/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C9789	SY	COMMP		NCI
C9789	SY	CTX/MP/MTX/PRED/VCR		NCI
C9789	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9789	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9789	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9789	RO	chemotherapy regimen has component Methotrexate	NCI
C9789	RO	chemotherapy regimen has component Prednisone	NCI
C9789	RO	chemotherapy regimen has component Vincristine	NCI
C10979	STY	Therapeutic or Preventive Procedure		NCI
C10979	PT	Daunorubicin/Milodistim/Pegaspargase/Prednisone/Vincristine		NCI
C10979	SY	DNR/PEG-ASP/PIXY321/PRED/VCR		NCI
C10979	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10979	RO	chemotherapy regimen has component Prednisone	NCI
C10979	RO	chemotherapy regimen has component Vincristine	NCI
C10979	RO	chemotherapy regimen has component Pegaspargase	NCI
C10979	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10979	RO	chemotherapy regimen has component Milodistim	NCI
C9597	STY	Therapeutic or Preventive Procedure		NCI
C9597	PT	Altretamine/Cisplatin/Doxorubicin		NCI
C9597	SY	HAD		NCI
C9597	SY	CDDP/DOX/HMM		NCI
C9597	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9597	RO	chemotherapy regimen has component Cisplatin	NCI
C9597	RO	chemotherapy regimen has component Doxorubicin	NCI
C9597	RO	chemotherapy regimen has component Altretamine	NCI
C11227	STY	Therapeutic or Preventive Procedure		NCI
C11227	PT	Cisplatin/Hydroxyurea/Vinblastine		NCI
C11227	SY	CDDP/HU/VBL		NCI
C11227	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11227	RO	chemotherapy regimen has component Cisplatin	NCI
C11227	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11227	RO	chemotherapy regimen has component Vinblastine	NCI
C12043	STY	Therapeutic or Preventive Procedure		NCI
C12043	PT	BMS-214662/Trastuzumab		NCI
C12043	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12043	RO	chemotherapy regimen has component Trastuzumab	NCI
C12043	RO	chemotherapy regimen has component BMS-214662	NCI
C10223	STY	Therapeutic or Preventive Procedure		NCI
C10223	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Leucovorin Calcium		NCI
C10223	SY	CF/CTX/DOX/5-FU		NCI
C10223	SY	FLAC		NCI
C10223	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10223	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10223	RO	chemotherapy regimen has component Doxorubicin	NCI
C10223	RO	chemotherapy regimen has component Fluorouracil	NCI
C10223	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11625	STY	Therapeutic or Preventive Procedure		NCI
C11625	PT	Cyclosporine/Irinotecan		NCI
C11625	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11625	RO	chemotherapy regimen has component Cyclosporine	NCI
C11625	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C10081	STY	Therapeutic or Preventive Procedure		NCI
C10081	PT	Altretamine/Etoposide/Procarbazine		NCI
C10081	SY	HMM/PCB/VP-16		NCI
C10081	SY	VPH		NCI
C10081	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10081	RO	chemotherapy regimen has component Etoposide	NCI
C10081	RO	chemotherapy regimen has component Altretamine	NCI
C10081	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C12048	STY	Therapeutic or Preventive Procedure		NCI
C12048	PT	Cyclophosphamide/Fludarabine/Oblimersen		NCI
C12048	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12048	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12048	RO	chemotherapy regimen has component Fludarabine	NCI
C12048	RO	chemotherapy regimen has component Oblimersen	NCI
C10496	STY	Therapeutic or Preventive Procedure		NCI
C10496	PT	Carboplatin/Doxorubicin/Ifosfamide		NCI
C10496	SY	CBDCA/DOX/IFF		NCI
C10496	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10496	RO	chemotherapy regimen has component Doxorubicin	NCI
C10496	RO	chemotherapy regimen has component Ifosfamide	NCI
C10496	RO	chemotherapy regimen has component Carboplatin	NCI
C10221	STY	Therapeutic or Preventive Procedure		NCI
C10221	PT	Dactinomycin/Etoposide/Ifosfamide/Vincristine		NCI
C10221	SY	DACT/IFF/VCR/VP-16		NCI
C10221	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10221	RO	chemotherapy regimen has component Dactinomycin	NCI
C10221	RO	chemotherapy regimen has component Etoposide	NCI
C10221	RO	chemotherapy regimen has component Ifosfamide	NCI
C10221	RO	chemotherapy regimen has component Vincristine	NCI
C10867	STY	Therapeutic or Preventive Procedure		NCI
C10867	PT	Chlorambucil/Prednisolone/Procarbazine/Vinblastine		NCI
C10867	SY	CLB/PCB/PRDL/VBL		NCI
C10867	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10867	RO	chemotherapy regimen has component Chlorambucil	NCI
C10867	RO	chemotherapy regimen has component Prednisolone	NCI
C10867	RO	chemotherapy regimen has component Vinblastine	NCI
C10867	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11887	STY	Pharmacologic Substance		NCI
C11887	PT	Hydrocortisone/Ketoconazole		NCI
C11887	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11887	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C11887	RO	chemotherapy regimen has component Ketoconazole	NCI
C9636	STY	Therapeutic or Preventive Procedure		NCI
C9636	PT	Cytarabine/Daunorubicin/Prednisone/Vincristine		NCI
C9636	SY	ARA-C/DNR/PRED/VCR		NCI
C9636	SY	DOAP		NCI
C9636	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9636	RO	chemotherapy regimen has component Cytarabine	NCI
C9636	RO	chemotherapy regimen has component Prednisone	NCI
C9636	RO	chemotherapy regimen has component Vincristine	NCI
C9636	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11386	STY	Therapeutic or Preventive Procedure		NCI
C11386	PT	Mitoxantrone/Thiotepa/Topotecan		NCI
C11386	SY	DHAD/TOPO/TSPA		NCI
C11386	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11386	RO	chemotherapy regimen has component Thiotepa	NCI
C11386	RO	chemotherapy regimen has component Topotecan	NCI
C11386	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10901	STY	Therapeutic or Preventive Procedure		NCI
C10901	PT	Cyclophosphamide/Doxorubicin/Goserelin/Tamoxifen		NCI
C10901	SY	CTX/DOX/TMX/ZDX		NCI
C10901	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10901	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10901	RO	chemotherapy regimen has component Doxorubicin	NCI
C10901	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10901	RO	chemotherapy regimen has component Goserelin	NCI
C37613	STY	Therapeutic or Preventive Procedure		NCI
C37613	PT	Carboplatin/Irinotecan/Vincristine		NCI
C37613	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37613	RO	chemotherapy regimen has component Vincristine	NCI
C37613	RO	chemotherapy regimen has component Carboplatin	NCI
C37613	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C63380	STY	Therapeutic or Preventive Procedure		NCI
C63380	PT	CAV Regimen		NCI
C63380	SY	Cyclophosphamide-Adriamycin-Vincristine Regimen		NCI
C63380	SY	CAV		NCI
C63380	SY	Cytoxan-Adriamycin-Vincristine Regimen		NCI
C63380	CHD	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C63380	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63380	RO	chemotherapy regimen has component Doxorubicin	NCI
C63380	RO	chemotherapy regimen has component Vincristine	NCI
C63380	RO	regimen has accepted use for disease Lung Small Cell Carcinoma	NCI
C63726	STY	Therapeutic or Preventive Procedure		NCI
C63726	PT	TIC Regimen		NCI
C63726	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C63726	RO	chemotherapy regimen has component Ifosfamide	NCI
C63726	RO	chemotherapy regimen has component Carboplatin	NCI
C63726	RO	chemotherapy regimen has component Paclitaxel	NCI
C63726	RO	regimen has accepted use for disease Malignant Testicular Germ Cell Tumor	NCI
C63726	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C11553	STY	Therapeutic or Preventive Procedure		NCI
C11553	PT	Gentamicin/Piperacillin/Vancomycin		NCI
C11553	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11553	RO	chemotherapy regimen has component Vancomycin	NCI
C11553	RO	chemotherapy regimen has component Piperacillin Sodium	NCI
C11553	RO	chemotherapy regimen has component Gentamicin	NCI
C11210	STY	Therapeutic or Preventive Procedure		NCI
C11210	PT	Docetaxel/Epirubicin		NCI
C11210	SY	EPI/TXT		NCI
C11210	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11210	RO	chemotherapy regimen has component Docetaxel	NCI
C11210	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C63489	STY	Therapeutic or Preventive Procedure		NCI
C63489	PT	VeIP Regimen		NCI
C63489	SY	Velban-Ifosfamide-Platinol Regimen		NCI
C63489	CHD	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm	NCI
C63489	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C63489	RO	chemotherapy regimen has component Mesna	NCI
C63489	RO	chemotherapy regimen has component Cisplatin	NCI
C63489	RO	chemotherapy regimen has component Ifosfamide	NCI
C63489	RO	chemotherapy regimen has component Vinblastine Sulfate	NCI
C63489	RO	regimen has accepted use for disease Malignant Testicular Germ Cell Tumor	NCI
C48392	STY	Pharmacologic Substance		NCI
C48392	STY	Immunologic Factor		NCI
C48392	PT	HER-2-neu, CEA Peptides, GM-CSF, Montanide ISA-51 Vaccine		NCI
C48392	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C48392	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C48392	RO	chemotherapy regimen has component Recombinant Granulocyte-Macrophage Colony-Stimulating Factor	NCI
C48392	RO	chemotherapy regimen has component HER-2/neu Peptide Vaccine	NCI
C48392	RO	chemotherapy regimen has component Carcinoembryonic Antigen Peptide	NCI
C11103	STY	Therapeutic or Preventive Procedure		NCI
C11103	PT	Carmustine/Cytarabine/Etoposide/Melphalan		NCI
C11103	SY	BEAM		NCI
C11103	SY	ARA-C/BCNU/L-PAM/VP-16		NCI
C11103	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11103	RO	chemotherapy regimen has component Carmustine	NCI
C11103	RO	chemotherapy regimen has component Cytarabine	NCI
C11103	RO	chemotherapy regimen has component Etoposide	NCI
C11103	RO	chemotherapy regimen has component Melphalan	NCI
C10066	STY	Therapeutic or Preventive Procedure		NCI
C10066	PT	Fluorouracil/Interferon Beta		NCI
C10066	SY	5-FU/IFN-B		NCI
C10066	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10066	RO	chemotherapy regimen has component Fluorouracil	NCI
C10066	RO	chemotherapy regimen has component Recombinant Interferon Beta	NCI
C37597	STY	Therapeutic or Preventive Procedure		NCI
C37597	PT	Carboplatin/Cetuximab/Paclitaxel		NCI
C37597	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37597	RO	chemotherapy regimen has component Carboplatin	NCI
C37597	RO	chemotherapy regimen has component Paclitaxel	NCI
C37597	RO	chemotherapy regimen has component Cetuximab	NCI
C10516	STY	Therapeutic or Preventive Procedure		NCI
C10516	PT	Cyclophosphamide/Interleukin-3/Sargramostim		NCI
C10516	SY	CTX/GM-CSF/IL-3		NCI
C10516	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10516	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10516	RO	chemotherapy regimen has component Sargramostim	NCI
C10516	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C12008	STY	Therapeutic or Preventive Procedure		NCI
C12008	PT	Interleukin-2/Monoclonal Antibody Ch14.18		NCI
C12008	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12008	RO	chemotherapy regimen has component Dinutuximab	NCI
C12008	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C136273	STY	Therapeutic or Preventive Procedure		NCI
C136273	PT	Ixazomib/Dexamethasone Regimen		NCI
C136273	SY	Ninlaro/Dexamethasone		NCI
C136273	SY	Ixazomib/Dexamethasone		NCI
C136273	SY	Ixazomib-Dexamethasone		NCI
C136273	SY	Ixazomib-Dexamethasone Regimen		NCI
C136273	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136273	RO	chemotherapy regimen has component Dexamethasone	NCI
C136273	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136273	RO	chemotherapy regimen has component Ixazomib Citrate	NCI
C12172	STY	Therapeutic or Preventive Procedure		NCI
C12172	PT	Doxorubicin/Motexafin Gadolinium		NCI
C12172	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12172	RO	chemotherapy regimen has component Doxorubicin	NCI
C12172	RO	chemotherapy regimen has component Motexafin Gadolinium	NCI
C11395	STY	Therapeutic or Preventive Procedure		NCI
C11395	PT	Cyclophosphamide/Methylprednisolone		NCI
C11395	SY	CTX/MePRDL		NCI
C11395	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11395	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11395	RO	chemotherapy regimen has component Methylprednisolone	NCI
C12136	STY	Therapeutic or Preventive Procedure		NCI
C12136	PT	Bicalutamide/Exemestane		NCI
C12136	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12136	RO	chemotherapy regimen has component Bicalutamide	NCI
C12136	RO	chemotherapy regimen has component Exemestane	NCI
C63486	STY	Therapeutic or Preventive Procedure		NCI
C63486	PT	MVAC Regimen		NCI
C63486	SY	Methotrexate-Vinblastine-Adriamycin-Cisplatin Regimen		NCI
C63486	SY	M-VAC		NCI
C63486	SY	Methotrexate/Vinblastine/Adriamycin/Cisplatin		NCI
C63486	SY	MVAC		NCI
C63486	CHD	Chemotherapy Regimen Used to Treat Bladder Carcinoma	NCI
C63486	RO	chemotherapy regimen has component Cisplatin	NCI
C63486	RO	chemotherapy regimen has component Doxorubicin	NCI
C63486	RO	chemotherapy regimen has component Methotrexate	NCI
C63486	RO	chemotherapy regimen has component Vinblastine	NCI
C63486	RO	regimen has accepted use for disease Bladder Carcinoma	NCI
C11205	STY	Therapeutic or Preventive Procedure		NCI
C11205	PT	Cytarabine/Pegaspargase/Thioguanine/Vincristine		NCI
C11205	SY	ARA-C/PEG-ASP/TG/VCR		NCI
C11205	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11205	RO	chemotherapy regimen has component Cytarabine	NCI
C11205	RO	chemotherapy regimen has component Thioguanine	NCI
C11205	RO	chemotherapy regimen has component Vincristine	NCI
C11205	RO	chemotherapy regimen has component Pegaspargase	NCI
C37698	STY	Therapeutic or Preventive Procedure		NCI
C37698	PT	Cyclophosphamide/Methylprednisolone/Rituximab		NCI
C37698	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37698	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37698	RO	chemotherapy regimen has component Methylprednisolone	NCI
C37698	RO	chemotherapy regimen has component Rituximab	NCI
C11855	STY	Therapeutic or Preventive Procedure		NCI
C11855	PT	Autologous Dendritic Cells/Candida Albicans Skin Test Reagent/CD40-Ligand/gp100 Antigen/Interferon Gamma/Interleukin-4/MART-1 Antigen/Sargramostim/Tyrosinase Peptide		NCI
C11855	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11855	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C11855	RO	chemotherapy regimen has component Sargramostim	NCI
C11855	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11855	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11855	RO	chemotherapy regimen has component Therapeutic Autologous Dendritic Cells	NCI
C11855	RO	chemotherapy regimen has component Candida Albicans Skin Test Reagent	NCI
C11855	RO	chemotherapy regimen has component Recombinant CD40-Ligand	NCI
C11855	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11855	RO	chemotherapy regimen has component Binetrakin	NCI
C37842	STY	Therapeutic or Preventive Procedure		NCI
C37842	PT	Paclitaxel/Pegfilgrastim		NCI
C37842	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37842	RO	chemotherapy regimen has component Paclitaxel	NCI
C37842	RO	chemotherapy regimen has component Pegfilgrastim	NCI
C11242	STY	Therapeutic or Preventive Procedure		NCI
C11242	PT	Methotrexate/Tacrolimus		NCI
C11242	SY	FK506/MTX		NCI
C11242	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11242	RO	chemotherapy regimen has component Methotrexate	NCI
C11242	RO	chemotherapy regimen has component Tacrolimus	NCI
C11410	STY	Therapeutic or Preventive Procedure		NCI
C11410	PT	Ciprofloxacin/Dexamethasone/Pentoxifylline		NCI
C11410	SY	CPFX/DM/PTX		NCI
C11410	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11410	RO	chemotherapy regimen has component Ciprofloxacin	NCI
C11410	RO	chemotherapy regimen has component Dexamethasone	NCI
C11410	RO	chemotherapy regimen has component Pentoxifylline	NCI
C37674	STY	Therapeutic or Preventive Procedure		NCI
C37674	PT	Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Pegaspargase/Thioguanine/Vincristine		NCI
C37674	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37674	RO	chemotherapy regimen has component Mercaptopurine	NCI
C37674	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37674	RO	chemotherapy regimen has component Cytarabine	NCI
C37674	RO	chemotherapy regimen has component Dexamethasone	NCI
C37674	RO	chemotherapy regimen has component Methotrexate	NCI
C37674	RO	chemotherapy regimen has component Thioguanine	NCI
C37674	RO	chemotherapy regimen has component Vincristine	NCI
C37674	RO	chemotherapy regimen has component Pegaspargase	NCI
C37674	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37674	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C136250	STY	Therapeutic or Preventive Procedure		NCI
C136250	PT	FOLFIRI/Ziv-aflibercept Regimen		NCI
C136250	SY	FOLFIRI/Zaltrap		NCI
C136250	SY	FOLFIRI Plus Zaltrap		NCI
C136250	SY	FOLFIRI-Zaltrap Regimen		NCI
C136250	SY	FOLFIRI-Ziv-aflibercept Regimen		NCI
C136250	SY	Folinic Acid/Fluorouracil/Irinotecan/Ziv-aflibercept		NCI
C136250	SY	FOLFIRI Plus Ziv-aflibercept		NCI
C136250	SY	FOLFIRI/Ziv-aflibercept		NCI
C136250	SY	FOLFIRI/Zaltrap Regimen		NCI
C136250	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136250	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136250	RO	chemotherapy regimen has component Fluorouracil	NCI
C136250	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C136250	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C136250	RO	chemotherapy regimen has component Ziv-Aflibercept	NCI
C10763	STY	Therapeutic or Preventive Procedure		NCI
C10763	PT	Estramustine/Paclitaxel		NCI
C10763	SY	EM/TAX		NCI
C10763	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10763	RO	chemotherapy regimen has component Estramustine	NCI
C10763	RO	chemotherapy regimen has component Paclitaxel	NCI
C11359	STY	Therapeutic or Preventive Procedure		NCI
C11359	PT	Amifostine/Irinotecan		NCI
C11359	SY	CPT-11/WR-2721		NCI
C11359	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11359	RO	chemotherapy regimen has component Amifostine	NCI
C11359	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37845	STY	Therapeutic or Preventive Procedure		NCI
C37845	PT	Patent Blue V Dye/Technetium Tc 99m Sulfur Colloid		NCI
C37845	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37845	RO	chemotherapy regimen has component Technetium Tc-99m Sulfur Colloid	NCI
C37845	RO	chemotherapy regimen has component Patent Blue V Dye	NCI
C10969	STY	Therapeutic or Preventive Procedure		NCI
C10969	PT	Fluorouracil/Levamisole/L-Leucovorin		NCI
C10969	SY	5-FU/L-CF/LEV		NCI
C10969	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10969	RO	chemotherapy regimen has component Fluorouracil	NCI
C10969	RO	chemotherapy regimen has component Levamisole Hydrochloride	NCI
C10969	RO	chemotherapy regimen has component Levoleucovorin	NCI
C11090	STY	Therapeutic or Preventive Procedure		NCI
C11090	PT	Cytarabine/Tretinoin Liposome		NCI
C11090	SY	ARA-C/L-ATRA		NCI
C11090	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11090	RO	chemotherapy regimen has component Cytarabine	NCI
C11090	RO	chemotherapy regimen has component Tretinoin Liposome	NCI
C10364	STY	Therapeutic or Preventive Procedure		NCI
C10364	PT	Carmustine/Cyclophosphamide/Dactinomycin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C10364	SY	BCNU/CTX/DACT/MP/MTX/PRED/VCR		NCI
C10364	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10364	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10364	RO	chemotherapy regimen has component Carmustine	NCI
C10364	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10364	RO	chemotherapy regimen has component Dactinomycin	NCI
C10364	RO	chemotherapy regimen has component Methotrexate	NCI
C10364	RO	chemotherapy regimen has component Prednisone	NCI
C10364	RO	chemotherapy regimen has component Vincristine	NCI
C10047	STY	Therapeutic or Preventive Procedure		NCI
C10047	PT	Cisplatin/Cytarabine/Etoposide/Sargramostim		NCI
C10047	SY	ARA-C/CDDP/GM-CSF/VP-16		NCI
C10047	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10047	RO	chemotherapy regimen has component Cisplatin	NCI
C10047	RO	chemotherapy regimen has component Cytarabine	NCI
C10047	RO	chemotherapy regimen has component Etoposide	NCI
C10047	RO	chemotherapy regimen has component Sargramostim	NCI
C9702	STY	Therapeutic or Preventive Procedure		NCI
C9702	PT	CHOPE Regimen		NCI
C9702	SY	Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone-Etoposide Regimen		NCI
C9702	SY	VAC0P		NCI
C9702	SY	CHOEP		NCI
C9702	SY	Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine		NCI
C9702	SY	CHOEP Regimen		NCI
C9702	SY	CHOPE		NCI
C9702	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C9702	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9702	RO	chemotherapy regimen has component Doxorubicin	NCI
C9702	RO	chemotherapy regimen has component Etoposide	NCI
C9702	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C9702	RO	chemotherapy regimen has component Prednisone	NCI
C9702	RO	chemotherapy regimen has component Vincristine	NCI
C11148	STY	Therapeutic or Preventive Procedure		NCI
C11148	PT	Estramustine/Strontium Chloride Sr 89/Vinblastine		NCI
C11148	SY	EM/Strontium Chloride Sr 89/VBL		NCI
C11148	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11148	RO	chemotherapy regimen has component Estramustine	NCI
C11148	RO	chemotherapy regimen has component Vinblastine	NCI
C11148	RO	chemotherapy regimen has component Strontium Chloride Sr-89	NCI
C11045	STY	Therapeutic or Preventive Procedure		NCI
C11045	PT	Fluorouracil/Interferon Alfa/Leucovorin Calcium/Mitomycin		NCI
C11045	SY	CF/5-FU/IFN-A/MITO		NCI
C11045	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11045	RO	chemotherapy regimen has component Mitomycin	NCI
C11045	RO	chemotherapy regimen has component Fluorouracil	NCI
C11045	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11045	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C150686	STY	Therapeutic or Preventive Procedure		NCI
C150686	PT	Carboplatin/Fluorouracil/Cetuximab Regimen		NCI
C150686	SY	Carboplatin/5-FU/Cetuximab		NCI
C150686	SY	Carboplatin-Fluorouracil-Cetuximab		NCI
C150686	SY	Cetuximab-Carboplatin-5-Fluorouracil		NCI
C150686	SY	Carboplatin-Fluorouracil-Cetuximab Regimen		NCI
C150686	SY	Carboplatin/Fluorouracil/Cetuximab		NCI
C150686	SY	Carboplatin/5-Fluorouracil/Cetuximab		NCI
C150686	SY	Carboplatin/5-FU/Cetuximab Regimen		NCI
C150686	SY	Carboplatin/Fluorouracil Plus Cetuximab		NCI
C150686	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C150686	RO	chemotherapy regimen has component Fluorouracil	NCI
C150686	RO	chemotherapy regimen has component Carboplatin	NCI
C150686	RO	chemotherapy regimen has component Cetuximab	NCI
C150686	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C10596	STY	Therapeutic or Preventive Procedure		NCI
C10596	PT	Flutamide/Ketoconazole		NCI
C10596	SY	FLUT/KCZ		NCI
C10596	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10596	RO	chemotherapy regimen has component Flutamide	NCI
C10596	RO	chemotherapy regimen has component Ketoconazole	NCI
C11773	STY	Therapeutic or Preventive Procedure		NCI
C11773	PT	Interleukin-2/interleukin-12		NCI
C11773	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11773	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11773	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C153481	STY	Therapeutic or Preventive Procedure		NCI
C153481	PT	Irinotecan/Panitumumab Regimen		NCI
C153481	SY	Irinotecan/Panitumumab		NCI
C153481	SY	Irinotecan + Panitumumab Regimen		NCI
C153481	SY	Irinotecan-Panitumumab Regimen		NCI
C153481	SY	Irinotecan-Panitumumab		NCI
C153481	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C153481	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C153481	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C153481	RO	chemotherapy regimen has component Panitumumab	NCI
C11229	STY	Therapeutic or Preventive Procedure		NCI
C11229	PT	Cisplatin/Hydroxyurea/Vinorelbine		NCI
C11229	SY	CDDP/HU/VNB		NCI
C11229	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11229	RO	chemotherapy regimen has component Cisplatin	NCI
C11229	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11229	RO	chemotherapy regimen has component Vinorelbine	NCI
C11865	STY	Therapeutic or Preventive Procedure		NCI
C11865	PT	Interleukin-2/Trastuzumab		NCI
C11865	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11865	RO	chemotherapy regimen has component Trastuzumab	NCI
C11865	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11132	STY	Therapeutic or Preventive Procedure		NCI
C11132	PT	Fluorouracil/Leucovorin Calcium/Topotecan		NCI
C11132	SY	CF/5-FU/TOPO		NCI
C11132	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11132	RO	chemotherapy regimen has component Fluorouracil	NCI
C11132	RO	chemotherapy regimen has component Topotecan	NCI
C11132	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63787	STY	Therapeutic or Preventive Procedure		NCI
C63787	PT	Chemotherapy Regimen Used to Treat Malignant Mesothelioma		NCI
C63787	CHD	Chemotherapy Regimen	NCI
C63787	PAR	CAP Regimen	NCI
C63787	PAR	Doxorubicin-Cisplatin Regimen	NCI
C63787	PAR	Gemcitabine-Carboplatin Regimen	NCI
C63787	PAR	Gemcitabine-Cisplatin Regimen	NCI
C63787	PAR	Pemetrexed-Cisplatin Regimen	NCI
C63469	STY	Therapeutic or Preventive Procedure		NCI
C63469	PT	CDE Regimen		NCI
C63469	SY	Cyclophosphamide-Doxorubicin-Etoposide Regimen		NCI
C63469	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63469	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63469	RO	chemotherapy regimen has component Doxorubicin	NCI
C63469	RO	chemotherapy regimen has component Etoposide	NCI
C63469	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C63469	RO	regimen has accepted use for disease AIDS-Related Non-Hodgkin Lymphoma	NCI
C37624	STY	Therapeutic or Preventive Procedure		NCI
C37624	PT	Carcinoembryonic Antigen Peptide 1-6D/Sargramostim		NCI
C37624	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37624	RO	chemotherapy regimen has component Sargramostim	NCI
C37624	RO	chemotherapy regimen has component Carcinoembryonic Antigen Peptide 1-6D	NCI
C11059	STY	Therapeutic or Preventive Procedure		NCI
C11059	PT	Busulfan/Cyclophosphamide/Interferon Alfa/Zidovudine		NCI
C11059	SY	BU/CTX/IFN-A/ZDV		NCI
C11059	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11059	RO	chemotherapy regimen has component Busulfan	NCI
C11059	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11059	RO	chemotherapy regimen has component Zidovudine	NCI
C11059	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9941	STY	Therapeutic or Preventive Procedure		NCI
C9941	PT	Carboplatin/Ifosfamide/Vincristine		NCI
C9941	SY	CBDCA/IFF/VCR		NCI
C9941	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9941	RO	chemotherapy regimen has component Ifosfamide	NCI
C9941	RO	chemotherapy regimen has component Vincristine	NCI
C9941	RO	chemotherapy regimen has component Carboplatin	NCI
C63470	STY	Therapeutic or Preventive Procedure		NCI
C63470	PT	Chemotherapy Regimen Used to Treat Malignant Brain Neoplasm		NCI
C63470	CHD	Chemotherapy Regimen Used to Treat Central Nervous System Neoplasm	NCI
C63470	PAR	PCV Regimen	NCI
C11092	STY	Therapeutic or Preventive Procedure		NCI
C11092	PT	Disulfiram/Tretinoin		NCI
C11092	SY	ATRA/DS		NCI
C11092	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11092	RO	chemotherapy regimen has component Disulfiram	NCI
C11092	RO	chemotherapy regimen has component Tretinoin	NCI
C9784	STY	Therapeutic or Preventive Procedure		NCI
C9784	PT	Fluorouracil/Idoxuridine		NCI
C9784	SY	5-FU/IUDR		NCI
C9784	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9784	RO	chemotherapy regimen has component Fluorouracil	NCI
C9784	RO	chemotherapy regimen has component Idoxuridine	NCI
C9792	STY	Therapeutic or Preventive Procedure		NCI
C9792	PT	Carboplatin/Cisplatin		NCI
C9792	SY	CBDCA/CDDP		NCI
C9792	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9792	RO	chemotherapy regimen has component Cisplatin	NCI
C9792	RO	chemotherapy regimen has component Carboplatin	NCI
C9869	STY	Therapeutic or Preventive Procedure		NCI
C9869	PT	Asparaginase/Cyclophosphamide/Daunorubicin/Prednisone/Vincristine		NCI
C9869	SY	ASP/CTX/DNR/PRED/VCR		NCI
C9869	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9869	RO	chemotherapy regimen has component Asparaginase	NCI
C9869	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9869	RO	chemotherapy regimen has component Prednisone	NCI
C9869	RO	chemotherapy regimen has component Vincristine	NCI
C9869	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37626	STY	Therapeutic or Preventive Procedure		NCI
C37626	PT	Celecoxib/Cyclophosphamide/Doxorubicin/Etoposide/Ifosfamide/Vinblastine/Vincristine		NCI
C37626	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37626	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37626	RO	chemotherapy regimen has component Doxorubicin	NCI
C37626	RO	chemotherapy regimen has component Etoposide	NCI
C37626	RO	chemotherapy regimen has component Ifosfamide	NCI
C37626	RO	chemotherapy regimen has component Vinblastine	NCI
C37626	RO	chemotherapy regimen has component Vincristine	NCI
C37626	RO	chemotherapy regimen has component Celecoxib	NCI
C10787	STY	Therapeutic or Preventive Procedure		NCI
C10787	PT	Gallium Nitrate/Ifosfamide/Vinblastine		NCI
C10787	SY	GAN/IFF/VBL		NCI
C10787	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10787	RO	chemotherapy regimen has component Ifosfamide	NCI
C10787	RO	chemotherapy regimen has component Vinblastine	NCI
C10787	RO	chemotherapy regimen has component Gallium Nitrate	NCI
C9895	STY	Therapeutic or Preventive Procedure		NCI
C9895	PT	Cytarabine/Etoposide/Ifosfamide/Sargramostim		NCI
C9895	SY	ARA-C/GM-CSF/IFF/VP-16		NCI
C9895	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9895	RO	chemotherapy regimen has component Cytarabine	NCI
C9895	RO	chemotherapy regimen has component Etoposide	NCI
C9895	RO	chemotherapy regimen has component Ifosfamide	NCI
C9895	RO	chemotherapy regimen has component Sargramostim	NCI
C10824	STY	Therapeutic or Preventive Procedure		NCI
C10824	PT	Cisplatin/Etoposide/Filgrastim/Paclitaxel		NCI
C10824	SY	CDDP/G-CSF/TAX/VP-16		NCI
C10824	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10824	RO	chemotherapy regimen has component Cisplatin	NCI
C10824	RO	chemotherapy regimen has component Etoposide	NCI
C10824	RO	chemotherapy regimen has component Paclitaxel	NCI
C10824	RO	chemotherapy regimen has component Filgrastim	NCI
C10755	STY	Therapeutic or Preventive Procedure		NCI
C10755	PT	Cisplatin/Etoposide/Fluorouracil/Leucovorin Calcium		NCI
C10755	SY	CDDP/CF/5-FU/VP-16		NCI
C10755	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10755	RO	chemotherapy regimen has component Cisplatin	NCI
C10755	RO	chemotherapy regimen has component Etoposide	NCI
C10755	RO	chemotherapy regimen has component Fluorouracil	NCI
C10755	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10488	STY	Therapeutic or Preventive Procedure		NCI
C10488	PT	Diaziquone/Sargramostim		NCI
C10488	SY	AZQ/GM-CSF		NCI
C10488	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10488	RO	chemotherapy regimen has component Diaziquone	NCI
C10488	RO	chemotherapy regimen has component Sargramostim	NCI
C63388	STY	Therapeutic or Preventive Procedure		NCI
C63388	PT	FU-LV Regimen		NCI
C63388	SY	5FU/LV		NCI
C63388	SY	de Gramont Regimen		NCI
C63388	SY	Fluorouracil-Leucovorin Regimen		NCI
C63388	SY	Roswell Park Regimen		NCI
C63388	SY	Mayo Clinic Regimen		NCI
C63388	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63388	CHD	Chemotherapy Regimen Used to Treat Esophageal Carcinoma	NCI
C63388	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C63388	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63388	RO	chemotherapy regimen has component Fluorouracil	NCI
C63388	RO	regimen has accepted use for disease Esophageal Carcinoma	NCI
C63388	RO	regimen has accepted use for disease Gastric Carcinoma	NCI
C63388	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10743	STY	Therapeutic or Preventive Procedure		NCI
C10743	PT	Doxorubicin/Edatrexate		NCI
C10743	SY	DOX/EDAM		NCI
C10743	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10743	RO	chemotherapy regimen has component Doxorubicin	NCI
C10743	RO	chemotherapy regimen has component Edatrexate	NCI
C11922	STY	Therapeutic or Preventive Procedure		NCI
C11922	PT	Dexamethasone/Doxorubicin/Thalidomide		NCI
C11922	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11922	RO	chemotherapy regimen has component Dexamethasone	NCI
C11922	RO	chemotherapy regimen has component Doxorubicin	NCI
C11922	RO	chemotherapy regimen has component Thalidomide	NCI
C12072	STY	Therapeutic or Preventive Procedure		NCI
C12072	PT	BCG/Monoclonal Antibody 105AD7 Anti-idiotype Vaccine		NCI
C12072	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12072	RO	chemotherapy regimen has component BCG Vaccine	NCI
C12072	RO	chemotherapy regimen has component Monoclonal Antibody 105AD7 Anti-idiotype Vaccine	NCI
C10585	STY	Therapeutic or Preventive Procedure		NCI
C10585	PT	Interleukin-1-Alpha/Interleukin-2		NCI
C10585	SY	IL-1A/IL-2		NCI
C10585	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10585	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10585	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C37786	STY	Therapeutic or Preventive Procedure		NCI
C37786	PT	Fluorouracil/Leucovorin Calcium/Oblimersen/Oxaliplatin		NCI
C37786	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37786	RO	chemotherapy regimen has component Fluorouracil	NCI
C37786	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37786	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37786	RO	chemotherapy regimen has component Oblimersen	NCI
C37848	STY	Therapeutic or Preventive Procedure		NCI
C37848	PT	Prednisone/Satraplatin		NCI
C37848	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37848	RO	chemotherapy regimen has component Prednisone	NCI
C37848	RO	chemotherapy regimen has component Satraplatin	NCI
C63472	STY	Therapeutic or Preventive Procedure		NCI
C63472	PT	HyperCVAD/HD MTX AraC Regimen		NCI
C63472	SY	HyperCVAD Alternating with High Dose Methotrexate and Cytarabine		NCI
C63472	SY	Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone Alternating with Cytarabine/Methotrexate Regimen		NCI
C63472	SY	HyperCVAD/MTX-Ara-C		NCI
C63472	SY	HyperCVAD/MTX/AraC		NCI
C63472	SY	Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone/High-dose Methotrexate-Cytarabine Regimen		NCI
C63472	SY	Cyclophosphamide/Vincristine/Doxorubicin/Dexamethasone Alternating with High-Dose Methotrexate/Cytarabine		NCI
C63472	SY	HyperCVAD Alternating with Methotrexate/Cytarabine		NCI
C63472	CHD	Chemotherapy Regimen Used to Treat Acute Lymphoblastic Leukemia	NCI
C63472	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63472	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63472	RO	chemotherapy regimen has component Cytarabine	NCI
C63472	RO	chemotherapy regimen has component Dexamethasone	NCI
C63472	RO	chemotherapy regimen has component Doxorubicin	NCI
C63472	RO	chemotherapy regimen has component Methotrexate	NCI
C63472	RO	chemotherapy regimen has component Vincristine	NCI
C63472	RO	regimen has accepted use for disease Adult Burkitt Lymphoma	NCI
C63472	RO	regimen has accepted use for disease Adult Burkitt Leukemia	NCI
C63472	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37854	STY	Therapeutic or Preventive Procedure		NCI
C37854	PT	Sargramostim/Vaccinia-MUC-1 Vaccine/Vaccinia-TRICOM Vaccine		NCI
C37854	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37854	RO	chemotherapy regimen has component Sargramostim	NCI
C37854	RO	chemotherapy regimen has component Recombinant Vaccinia-TRICOM Vaccine	NCI
C37854	RO	chemotherapy regimen has component Recombinant Vaccinia-MUC-1 Vaccine	NCI
C10233	STY	Therapeutic or Preventive Procedure		NCI
C10233	PT	Amifostine/Carboplatin		NCI
C10233	SY	CBDCA/WR-2721		NCI
C10233	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10233	RO	chemotherapy regimen has component Amifostine	NCI
C10233	RO	chemotherapy regimen has component Carboplatin	NCI
C10226	STY	Therapeutic or Preventive Procedure		NCI
C10226	PT	Caffeine/Cisplatin/Cytarabine		NCI
C10226	SY	ARA-C/CAF/CDDP		NCI
C10226	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10226	RO	chemotherapy regimen has component Caffeine	NCI
C10226	RO	chemotherapy regimen has component Cisplatin	NCI
C10226	RO	chemotherapy regimen has component Cytarabine	NCI
C11434	STY	Therapeutic or Preventive Procedure		NCI
C11434	PT	Cyclophosphamide/Cytarabine/Methotrexate/Thioguanine		NCI
C11434	SY	ARA-C/CTX/MTX/TG		NCI
C11434	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11434	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11434	RO	chemotherapy regimen has component Cytarabine	NCI
C11434	RO	chemotherapy regimen has component Methotrexate	NCI
C11434	RO	chemotherapy regimen has component Thioguanine	NCI
C37679	STY	Therapeutic or Preventive Procedure		NCI
C37679	PT	Cyclophosphamide/Doxorubicin/Epratuzumab/Prednisone/Rituximab/Vincristine		NCI
C37679	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37679	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37679	RO	chemotherapy regimen has component Doxorubicin	NCI
C37679	RO	chemotherapy regimen has component Prednisone	NCI
C37679	RO	chemotherapy regimen has component Vincristine	NCI
C37679	RO	chemotherapy regimen has component Rituximab	NCI
C37679	RO	chemotherapy regimen has component Epratuzumab	NCI
C10104	STY	Therapeutic or Preventive Procedure		NCI
C10104	PT	Cisplatin/Cyclophosphamide/Vincristine		NCI
C10104	SY	CDDP/CTX/VCR		NCI
C10104	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10104	RO	chemotherapy regimen has component Cisplatin	NCI
C10104	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10104	RO	chemotherapy regimen has component Vincristine	NCI
C10639	STY	Therapeutic or Preventive Procedure		NCI
C10639	PT	Bleomycin/Doxorubicin/Etoposide/Vincristine		NCI
C10639	SY	BLEO/DOX/VCR/VP-16		NCI
C10639	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10639	RO	chemotherapy regimen has component Bleomycin	NCI
C10639	RO	chemotherapy regimen has component Doxorubicin	NCI
C10639	RO	chemotherapy regimen has component Etoposide	NCI
C10639	RO	chemotherapy regimen has component Vincristine	NCI
C11170	STY	Therapeutic or Preventive Procedure		NCI
C11170	PT	Cisplatin/Isotretinoin		NCI
C11170	SY	CDDP/13-CRA		NCI
C11170	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11170	RO	chemotherapy regimen has component Cisplatin	NCI
C11170	RO	chemotherapy regimen has component Isotretinoin	NCI
C11956	STY	Therapeutic or Preventive Procedure		NCI
C11956	PT	Carboplatin/Methotrexate/Vinblastine		NCI
C11956	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11956	RO	chemotherapy regimen has component Methotrexate	NCI
C11956	RO	chemotherapy regimen has component Vinblastine	NCI
C11956	RO	chemotherapy regimen has component Carboplatin	NCI
C38719	STY	Therapeutic or Preventive Procedure		NCI
C38719	PT	3-AP/Fludarabine		NCI
C38719	SY	3AP/FAMP		NCI
C38719	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C38719	RO	chemotherapy regimen has component Fludarabine	NCI
C38719	RO	chemotherapy regimen has component Triapine	NCI
C10894	STY	Therapeutic or Preventive Procedure		NCI
C10894	PT	Carboplatin/Etoposide/Vincristine		NCI
C10894	SY	CBDCA/VCR/VP-16		NCI
C10894	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10894	RO	chemotherapy regimen has component Etoposide	NCI
C10894	RO	chemotherapy regimen has component Vincristine	NCI
C10894	RO	chemotherapy regimen has component Carboplatin	NCI
C11236	STY	Therapeutic or Preventive Procedure		NCI
C11236	PT	Cyclophosphamide/Doxorubicin/Filgrastim/Paclitaxel		NCI
C11236	SY	CTX/DOX/G-CSF/TAX		NCI
C11236	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11236	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11236	RO	chemotherapy regimen has component Doxorubicin	NCI
C11236	RO	chemotherapy regimen has component Paclitaxel	NCI
C11236	RO	chemotherapy regimen has component Filgrastim	NCI
C11609	STY	Therapeutic or Preventive Procedure		NCI
C11609	PT	Docetaxel/Irinotecan		NCI
C11609	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11609	RO	chemotherapy regimen has component Docetaxel	NCI
C11609	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11924	STY	Therapeutic or Preventive Procedure		NCI
C11924	PT	Calcitriol/Carboplatin		NCI
C11924	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11924	RO	chemotherapy regimen has component Calcitriol	NCI
C11924	RO	chemotherapy regimen has component Carboplatin	NCI
C11031	STY	Therapeutic or Preventive Procedure		NCI
C11031	PT	Cisplatin/Interferon Alfa/interleukin-2/Vinblastine		NCI
C11031	SY	CDDP/IFN-A/IL-2/VBL		NCI
C11031	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11031	RO	chemotherapy regimen has component Cisplatin	NCI
C11031	RO	chemotherapy regimen has component Vinblastine	NCI
C11031	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11031	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37823	STY	Therapeutic or Preventive Procedure		NCI
C37823	PT	Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine		NCI
C37823	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37823	RO	chemotherapy regimen has component Mercaptopurine	NCI
C37823	RO	chemotherapy regimen has component Methotrexate	NCI
C37823	RO	chemotherapy regimen has component Vincristine	NCI
C37823	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11811	STY	Therapeutic or Preventive Procedure		NCI
C11811	PT	Irinotecan/SU5416		NCI
C11811	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11811	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11811	RO	chemotherapy regimen has component Semaxanib	NCI
C37849	STY	Therapeutic or Preventive Procedure		NCI
C37849	PT	Rv-B7.1 Vaccine/Sargramostim/Vaccinia-Prostate-Specific Antigen Vaccine		NCI
C37849	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37849	RO	chemotherapy regimen has component Sargramostim	NCI
C37849	RO	chemotherapy regimen has component Recombinant Vaccinia PSA Vaccine	NCI
C37849	RO	chemotherapy regimen has component Recombinant Vaccinia-B7.1 Vaccine	NCI
C10799	STY	Therapeutic or Preventive Procedure		NCI
C10799	PT	Cytarabine/Dexamethasone/Etoposide/Vindesine		NCI
C10799	SY	ARA-C/DAVA/DM/VP-16		NCI
C10799	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10799	RO	chemotherapy regimen has component Cytarabine	NCI
C10799	RO	chemotherapy regimen has component Dexamethasone	NCI
C10799	RO	chemotherapy regimen has component Etoposide	NCI
C10799	RO	chemotherapy regimen has component Vindesine	NCI
C11665	STY	Therapeutic or Preventive Procedure		NCI
C11665	PT	Montanide ISA-51/Sargramostim/von Hippel-Lindau peptide vaccine		NCI
C11665	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11665	RO	chemotherapy regimen has component Sargramostim	NCI
C11665	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11665	RO	chemotherapy regimen has component Von Hippel-Lindau Peptide Vaccine	NCI
C37829	STY	Therapeutic or Preventive Procedure		NCI
C37829	PT	Mercaptopurine/Methotrexate/Nelarabine		NCI
C37829	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37829	RO	chemotherapy regimen has component Mercaptopurine	NCI
C37829	RO	chemotherapy regimen has component Methotrexate	NCI
C37829	RO	chemotherapy regimen has component Nelarabine	NCI
C67163	STY	Therapeutic or Preventive Procedure		NCI
C67163	PT	OPPA Regimen		NCI
C67163	SY	Oncovin-Prednisone-Procarbazine-Adriamycin Regimen		NCI
C67163	SY	OPPA		NCI
C67163	SY	GPOH-HD 95 Regimen		NCI
C67163	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67163	RO	chemotherapy regimen has component Doxorubicin	NCI
C67163	RO	chemotherapy regimen has component Prednisone	NCI
C67163	RO	chemotherapy regimen has component Vincristine	NCI
C67163	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C67163	RO	regimen has accepted use for disease Childhood Hodgkin Lymphoma	NCI
C12131	STY	Therapeutic or Preventive Procedure		NCI
C12131	PT	506U78/Asparaginase/Daunorubicin/Methotrexate/Prednisone/Vincristine		NCI
C12131	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12131	RO	chemotherapy regimen has component Asparaginase	NCI
C12131	RO	chemotherapy regimen has component Methotrexate	NCI
C12131	RO	chemotherapy regimen has component Prednisone	NCI
C12131	RO	chemotherapy regimen has component Vincristine	NCI
C12131	RO	chemotherapy regimen has component Duborimycin	NCI
C12131	RO	chemotherapy regimen has component Nelarabine	NCI
C10840	STY	Therapeutic or Preventive Procedure		NCI
C10840	PT	Cytarabine/Doxorubicin/Prednisone/Thioguanine/Vincristine		NCI
C10840	SY	ARA-C/DOX/PRED/TG/VCR		NCI
C10840	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10840	RO	chemotherapy regimen has component Cytarabine	NCI
C10840	RO	chemotherapy regimen has component Doxorubicin	NCI
C10840	RO	chemotherapy regimen has component Prednisone	NCI
C10840	RO	chemotherapy regimen has component Thioguanine	NCI
C10840	RO	chemotherapy regimen has component Vincristine	NCI
C11882	STY	Therapeutic or Preventive Procedure		NCI
C11882	PT	Donepezil/Vitamin E		NCI
C11882	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11882	RO	chemotherapy regimen has component Vitamin E Compound	NCI
C11882	RO	chemotherapy regimen has component Donepezil Hydrochloride	NCI
C37486	STY	Therapeutic or Preventive Procedure		NCI
C37486	PT	Gemcitabine/Triapine		NCI
C37486	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37486	RO	chemotherapy regimen has component Triapine	NCI
C37486	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10334	STY	Therapeutic or Preventive Procedure		NCI
C10334	PT	Mitoxantrone/Thiotepa		NCI
C10334	SY	DHAD/TSPA		NCI
C10334	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10334	RO	chemotherapy regimen has component Thiotepa	NCI
C10334	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9931	STY	Therapeutic or Preventive Procedure		NCI
C9931	PT	Asparaginase/Ifosfamide/Methotrexate		NCI
C9931	SY	AIM		NCI
C9931	SY	ASP/IFF/MTX		NCI
C9931	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9931	RO	chemotherapy regimen has component Asparaginase	NCI
C9931	RO	chemotherapy regimen has component Ifosfamide	NCI
C9931	RO	chemotherapy regimen has component Methotrexate	NCI
C9770	STY	Therapeutic or Preventive Procedure		NCI
C9770	PT	Azacitidine/Etoposide		NCI
C9770	SY	AZA/VP-16		NCI
C9770	SY	Azacytidine/Etoposide		NCI
C9770	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9770	RO	chemotherapy regimen has component Azacitidine	NCI
C9770	RO	chemotherapy regimen has component Etoposide	NCI
C9975	STY	Therapeutic or Preventive Procedure		NCI
C9975	PT	Cytarabine/Methotrexate/Vincristine		NCI
C9975	SY	ARA-C/MTX/VCR		NCI
C9975	SY	CAMELEON		NCI
C9975	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9975	RO	chemotherapy regimen has component Cytarabine	NCI
C9975	RO	chemotherapy regimen has component Methotrexate	NCI
C9975	RO	chemotherapy regimen has component Vincristine	NCI
C67204	STY	Therapeutic or Preventive Procedure		NCI
C67204	PT	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia		NCI
C67204	CHD	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C67204	PAR	ADE Regimen	NCI
C67204	PAR	MAE Regimen	NCI
C67204	PAR	IDA-FLAG Regimen	NCI
C67204	PAR	DAT Regimen	NCI
C67204	PAR	AIE Regimen	NCI
C67204	PAR	CCG-0922 APL Regimen	NCI
C67204	PAR	COG-C9710 APL Regimen	NCI
C67204	PAR	DCTER Regimen	NCI
C67204	PAR	IDA-DCTER Regimen	NCI
C15596	STY	Therapeutic or Preventive Procedure		NCI
C15596	PT	Interleukin-2/Vinblastine		NCI
C15596	SY	IL-2/VBL		NCI
C15596	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15596	RO	chemotherapy regimen has component Vinblastine	NCI
C15596	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10134	STY	Therapeutic or Preventive Procedure		NCI
C10134	PT	Mechlorethamine/Methotrexate/Prednisone/Procarbazine/Vincristine		NCI
C10134	SY	echlorethamine/methotrexate/prednisone/procarbazine/vincristine		NCI
C10134	SY	MTX/NM/PCB/PRED/VCR		NCI
C10134	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10134	RO	chemotherapy regimen has component Methotrexate	NCI
C10134	RO	chemotherapy regimen has component Prednisone	NCI
C10134	RO	chemotherapy regimen has component Vincristine	NCI
C10134	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10134	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C11810	STY	Therapeutic or Preventive Procedure		NCI
C11810	PT	O6-benzylguanine/Temozolomide		NCI
C11810	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11810	RO	chemotherapy regimen has component Temozolomide	NCI
C11810	RO	chemotherapy regimen has component O6-Benzylguanine	NCI
C11885	STY	Therapeutic or Preventive Procedure		NCI
C11885	PT	gp100 Antigen/Interferon Alfa/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide		NCI
C11885	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11885	RO	chemotherapy regimen has component Sargramostim	NCI
C11885	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11885	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11885	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11885	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11885	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10705	STY	Therapeutic or Preventive Procedure		NCI
C10705	PT	Carmustine/Cisplatin/Thiotepa		NCI
C10705	SY	BCNU/CDDP/TSPA		NCI
C10705	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10705	RO	chemotherapy regimen has component Carmustine	NCI
C10705	RO	chemotherapy regimen has component Cisplatin	NCI
C10705	RO	chemotherapy regimen has component Thiotepa	NCI
C136277	STY	Therapeutic or Preventive Procedure		NCI
C136277	PT	Pomalidomide/Dexamethasone Regimen		NCI
C136277	SY	Pomalidomide-Dexamethasone		NCI
C136277	SY	Pomalidomide-Dexamethasone Regimen		NCI
C136277	SY	Pomalidomide/Dexamethasone		NCI
C136277	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136277	RO	chemotherapy regimen has component Dexamethasone	NCI
C136277	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136277	RO	chemotherapy regimen has component Pomalidomide	NCI
C15635	STY	Therapeutic or Preventive Procedure		NCI
C15635	PT	gp100 Antigen/Incomplete Freund's Adjuvant/interleukin-2		NCI
C15635	SY	gp100/IFA/IL-2		NCI
C15635	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15635	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C15635	RO	chemotherapy regimen has component gp100 Antigen	NCI
C15635	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37595	STY	Therapeutic or Preventive Procedure		NCI
C37595	PT	Carboplatin/Celecoxib/Gemcitabine/Zileuton		NCI
C37595	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37595	RO	chemotherapy regimen has component Carboplatin	NCI
C37595	RO	chemotherapy regimen has component Zileuton	NCI
C37595	RO	chemotherapy regimen has component Celecoxib	NCI
C37595	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10030	STY	Therapeutic or Preventive Procedure		NCI
C10030	PT	Doxorubicin/Semustine		NCI
C10030	SY	MAD		NCI
C10030	SY	DOX/MeCCNU		NCI
C10030	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10030	RO	chemotherapy regimen has component Doxorubicin	NCI
C10030	RO	chemotherapy regimen has component Semustine	NCI
C11337	STY	Therapeutic or Preventive Procedure		NCI
C11337	PT	Bicalutamide/Buserelin		NCI
C11337	SY	BSRL/CDX		NCI
C11337	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11337	RO	chemotherapy regimen has component Buserelin	NCI
C11337	RO	chemotherapy regimen has component Bicalutamide	NCI
C37682	STY	Therapeutic or Preventive Procedure		NCI
C37682	PT	Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Vincristine		NCI
C37682	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37682	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37682	RO	chemotherapy regimen has component Doxorubicin	NCI
C37682	RO	chemotherapy regimen has component Methotrexate	NCI
C37682	RO	chemotherapy regimen has component Methylprednisolone	NCI
C37682	RO	chemotherapy regimen has component Vincristine	NCI
C37682	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C99696	STY	Therapeutic or Preventive Procedure		NCI
C99696	PT	M-BACOP Regimen		NCI
C99696	SY	Methotrexate-Leucovorin-Doxorubicin-Cyclophosphamide-Vincristine-Prednisolone-Bleomycin Regimen		NCI
C99696	SY	ACOMP-B (D) Regimen		NCI
C99696	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C99696	RO	chemotherapy regimen has component Bleomycin	NCI
C99696	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C99696	RO	chemotherapy regimen has component Doxorubicin	NCI
C99696	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C99696	RO	chemotherapy regimen has component Methotrexate	NCI
C99696	RO	chemotherapy regimen has component Prednisolone	NCI
C99696	RO	chemotherapy regimen has component Vincristine	NCI
C99696	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37834	STY	Therapeutic or Preventive Procedure		NCI
C37834	PT	Methylprednisolone/Mycophenolate Mofetil/Tacrolimus		NCI
C37834	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37834	RO	chemotherapy regimen has component Methylprednisolone	NCI
C37834	RO	chemotherapy regimen has component Tacrolimus	NCI
C37834	RO	chemotherapy regimen has component Mycophenolate Mofetil	NCI
C9781	STY	Therapeutic or Preventive Procedure		NCI
C9781	PT	Cytarabine/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C9781	SY	ARA-C/MP/MTX/PRED/VCR		NCI
C9781	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9781	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9781	RO	chemotherapy regimen has component Cytarabine	NCI
C9781	RO	chemotherapy regimen has component Methotrexate	NCI
C9781	RO	chemotherapy regimen has component Prednisone	NCI
C9781	RO	chemotherapy regimen has component Vincristine	NCI
C9844	STY	Therapeutic or Preventive Procedure		NCI
C9844	PT	Prednisone/Vincristine		NCI
C9844	SY	PRED/VCR		NCI
C9844	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9844	RO	chemotherapy regimen has component Prednisone	NCI
C9844	RO	chemotherapy regimen has component Vincristine	NCI
C9812	STY	Therapeutic or Preventive Procedure		NCI
C9812	PT	Carboplatin/Cisplatin/Cyclophosphamide		NCI
C9812	SY	CBDCA/CDDP/CTX		NCI
C9812	SY	CPC		NCI
C9812	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9812	RO	chemotherapy regimen has component Cisplatin	NCI
C9812	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9812	RO	chemotherapy regimen has component Carboplatin	NCI
C11277	STY	Therapeutic or Preventive Procedure		NCI
C11277	PT	Cordycepin/Pentostatin		NCI
C11277	SY	COR/DCF		NCI
C11277	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11277	RO	chemotherapy regimen has component Pentostatin	NCI
C11277	RO	chemotherapy regimen has component Cordycepin	NCI
C12035	STY	Therapeutic or Preventive Procedure		NCI
C12035	PT	Calcium Gluconate/Cholecalciferol/Zoledronate		NCI
C12035	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12035	RO	chemotherapy regimen has component Calcium Gluconate	NCI
C12035	RO	chemotherapy regimen has component Zoledronic Acid	NCI
C12035	RO	chemotherapy regimen has component D Vitamin	NCI
C11275	STY	Therapeutic or Preventive Procedure		NCI
C11275	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisolone/Vincristine		NCI
C11275	SY	BLEO/CTX/DOX/PRDL/VCR/VP-16		NCI
C11275	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11275	RO	chemotherapy regimen has component Bleomycin	NCI
C11275	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11275	RO	chemotherapy regimen has component Doxorubicin	NCI
C11275	RO	chemotherapy regimen has component Etoposide	NCI
C11275	RO	chemotherapy regimen has component Prednisolone	NCI
C11275	RO	chemotherapy regimen has component Vincristine	NCI
C9874	STY	Therapeutic or Preventive Procedure		NCI
C9874	PT	CMF Regimen		NCI
C9874	SY	Oral Cyclophosphamide/Methotrexate/Fluorouracil		NCI
C9874	SY	Cytoxan-Methotrexate-Fluorouracil Regimen		NCI
C9874	SY	CTX/5-FU/MTX		NCI
C9874	SY	CMF		NCI
C9874	SY	Cyclophosphamide/Fluorouracil/Methotrexate		NCI
C9874	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C9874	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9874	RO	chemotherapy regimen has component Fluorouracil	NCI
C9874	RO	chemotherapy regimen has component Methotrexate	NCI
C9874	RO	regimen has accepted use for disease Breast Carcinoma	NCI
C10582	STY	Therapeutic or Preventive Procedure		NCI
C10582	PT	Etoposide/Filgrastim/Melphalan		NCI
C10582	SY	G-CSF/L-PAM/VP-16		NCI
C10582	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10582	RO	chemotherapy regimen has component Etoposide	NCI
C10582	RO	chemotherapy regimen has component Melphalan	NCI
C10582	RO	chemotherapy regimen has component Filgrastim	NCI
C140732	STY	Therapeutic or Preventive Procedure		NCI
C140732	PT	GVD Regimen		NCI
C140732	SY	Gemcitabine/Vinorelbine/Doxil		NCI
C140732	SY	GVD		NCI
C140732	SY	Gemcitabine/Vinorelbine/Pegylated Liposomal Doxorubicin		NCI
C140732	SY	Gemcitabine-Vinorelbine-Pegylated Liposomal Doxorubicin		NCI
C140732	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C140732	RO	chemotherapy regimen has component Gemcitabine	NCI
C140732	RO	chemotherapy regimen has component Vinorelbine	NCI
C140732	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C10346	STY	Therapeutic or Preventive Procedure		NCI
C10346	PT	Dexamethasone/Doxorubicin/Verapamil/Vincristine		NCI
C10346	SY	DM/DOX/VCR/VPAM		NCI
C10346	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10346	RO	chemotherapy regimen has component Dexamethasone	NCI
C10346	RO	chemotherapy regimen has component Doxorubicin	NCI
C10346	RO	chemotherapy regimen has component Verapamil	NCI
C10346	RO	chemotherapy regimen has component Vincristine	NCI
C37509	STY	Therapeutic or Preventive Procedure		NCI
C37509	PT	Montanide ISA-51/Multi-Epitope Melanoma Peptide Vaccine/Sargramostim/Tetanus Peptide Melanoma Vaccine		NCI
C37509	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37509	RO	chemotherapy regimen has component Sargramostim	NCI
C37509	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C37509	RO	chemotherapy regimen has component Tetanus Peptide Melanoma Vaccine	NCI
C37509	RO	chemotherapy regimen has component Multi-epitope Melanoma Peptide Vaccine	NCI
C10105	STY	Therapeutic or Preventive Procedure		NCI
C10105	PT	Cisplatin/Dacarbazine/Etoposide		NCI
C10105	SY	CDDP/DTIC/VP-16		NCI
C10105	SY	DVD		NCI
C10105	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10105	RO	chemotherapy regimen has component Cisplatin	NCI
C10105	RO	chemotherapy regimen has component Dacarbazine	NCI
C10105	RO	chemotherapy regimen has component Etoposide	NCI
C10218	STY	Therapeutic or Preventive Procedure		NCI
C10218	PT	Carmustine/Cyclophosphamide/Thiotepa		NCI
C10218	SY	BCNU/CTX/TSPA		NCI
C10218	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10218	RO	chemotherapy regimen has component Carmustine	NCI
C10218	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10218	RO	chemotherapy regimen has component Thiotepa	NCI
C11804	STY	Therapeutic or Preventive Procedure		NCI
C11804	PT	Carboplatin/Gemcitabine/Paclitaxel/Trastuzumab		NCI
C11804	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11804	RO	chemotherapy regimen has component Carboplatin	NCI
C11804	RO	chemotherapy regimen has component Paclitaxel	NCI
C11804	RO	chemotherapy regimen has component Trastuzumab	NCI
C11804	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11632	STY	Therapeutic or Preventive Procedure		NCI
C11632	PT	Cisplatin/Dexrazoxane/Doxorubicin		NCI
C11632	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11632	RO	chemotherapy regimen has component Cisplatin	NCI
C11632	RO	chemotherapy regimen has component Doxorubicin	NCI
C11632	RO	chemotherapy regimen has component Dexrazoxane	NCI
C37807	STY	Therapeutic or Preventive Procedure		NCI
C37807	PT	Gemcitabine/Tipifarnib		NCI
C37807	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37807	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37807	RO	chemotherapy regimen has component Tipifarnib	NCI
C37638	STY	Therapeutic or Preventive Procedure		NCI
C37638	PT	Celecoxib/Vinorelbine		NCI
C37638	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37638	RO	chemotherapy regimen has component Vinorelbine	NCI
C37638	RO	chemotherapy regimen has component Celecoxib	NCI
C10031	STY	Therapeutic or Preventive Procedure		NCI
C10031	PT	Dactinomycin/Doxorubicin/Methotrexate/Vincristine		NCI
C10031	SY	OMAD		NCI
C10031	SY	DACT/DOX/MTX/VCR		NCI
C10031	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10031	RO	chemotherapy regimen has component Dactinomycin	NCI
C10031	RO	chemotherapy regimen has component Doxorubicin	NCI
C10031	RO	chemotherapy regimen has component Methotrexate	NCI
C10031	RO	chemotherapy regimen has component Vincristine	NCI
C11559	STY	Therapeutic or Preventive Procedure		NCI
C11559	PT	Cyclophosphamide/Detox-B Adjuvant/Interleukin-2		NCI
C11559	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11559	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11559	RO	chemotherapy regimen has component Detox-B Adjuvant	NCI
C11559	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11832	STY	Therapeutic or Preventive Procedure		NCI
C11832	PT	Daunorubicin/dexamethasone/methotrexate/vincristine		NCI
C11832	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11832	RO	chemotherapy regimen has component Dexamethasone	NCI
C11832	RO	chemotherapy regimen has component Methotrexate	NCI
C11832	RO	chemotherapy regimen has component Vincristine	NCI
C11832	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11361	STY	Therapeutic or Preventive Procedure		NCI
C11361	PT	Dexamethasone/Granisetron		NCI
C11361	SY	DM/GRAN		NCI
C11361	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11361	RO	chemotherapy regimen has component Dexamethasone	NCI
C11361	RO	chemotherapy regimen has component Granisetron Hydrochloride	NCI
C9997	STY	Therapeutic or Preventive Procedure		NCI
C9997	PT	Cyclophosphamide/Daunorubicin/Etoposide/Prednisone/Teniposide/Thioguanine/Vincristine		NCI
C9997	SY	CTX/DNR/PRED/TG/VCR/VM-26/VP-16		NCI
C9997	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9997	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9997	RO	chemotherapy regimen has component Etoposide	NCI
C9997	RO	chemotherapy regimen has component Prednisone	NCI
C9997	RO	chemotherapy regimen has component Teniposide	NCI
C9997	RO	chemotherapy regimen has component Thioguanine	NCI
C9997	RO	chemotherapy regimen has component Vincristine	NCI
C9997	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37795	STY	Therapeutic or Preventive Procedure		NCI
C37795	PT	Fulvestrant/Gefitinib		NCI
C37795	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37795	RO	chemotherapy regimen has component Fulvestrant	NCI
C37795	RO	chemotherapy regimen has component Gefitinib	NCI
C10044	STY	Therapeutic or Preventive Procedure		NCI
C10044	PT	Altretamine/Cyclophosphamide/Methotrexate		NCI
C10044	SY	CTX/HMM/MTX		NCI
C10044	SY	CMH		NCI
C10044	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10044	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10044	RO	chemotherapy regimen has component Altretamine	NCI
C10044	RO	chemotherapy regimen has component Methotrexate	NCI
C67509	STY	Therapeutic or Preventive Procedure		NCI
C67509	PT	Chemotherapy Regimen Used to Treat Gestational Trophoblastic Tumor		NCI
C67509	CHD	Chemotherapy Regimen	NCI
C67509	PAR	MAC Regimen	NCI
C67509	PAR	PVB Regimen	NCI
C67509	PAR	PEBA Regimen	NCI
C67509	PAR	EMA-CE Regimen	NCI
C67509	PAR	EMA-CO Regimen	NCI
C67509	PAR	APE/Gestational Trophoblastic Tumor Regimen	NCI
C138038	STY	Therapeutic or Preventive Procedure		NCI
C138038	PT	FEC Followed by Pertuzumab/Trastuzumab/Docetaxel Regimen		NCI
C138038	SY	FEC Followed by Docetaxel/Trastuzumab/Pertuzumab		NCI
C138038	SY	FEC Followed by Pertuzumab + Trastuzumab + Docetaxel		NCI
C138038	SY	Fluorouracil/Epirubicin/Cyclophosphamide Followed by Pertuzumab/Trastuzumab/Docetaxel		NCI
C138038	SY	Fluorouracil/Epirubicin/Cyclophosphamide Followed by Pertuzumab + Trastuzumab + Docetaxel		NCI
C138038	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138038	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138038	RO	chemotherapy regimen has component Doxorubicin	NCI
C138038	RO	chemotherapy regimen has component Fluorouracil	NCI
C138038	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C138038	RO	chemotherapy regimen has component Pertuzumab	NCI
C11417	STY	Therapeutic or Preventive Procedure		NCI
C11417	PT	Bryostatin 1/Fludarabine		NCI
C11417	SY	BRYO/FAMP		NCI
C11417	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11417	RO	chemotherapy regimen has component Bryostatin 1	NCI
C11417	RO	chemotherapy regimen has component Fludarabine	NCI
C11342	STY	Therapeutic or Preventive Procedure		NCI
C11342	PT	Flt3 Ligand/gp100 Antigen		NCI
C11342	SY	Flt3L/gp100		NCI
C11342	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11342	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11342	RO	chemotherapy regimen has component Recombinant Flt3 Ligand	NCI
C11519	STY	Therapeutic or Preventive Procedure		NCI
C11519	PT	Asparaginase/Dexamethasone/Prednisone/Vincristine		NCI
C11519	SY	ASP/DM/PRED/VCR		NCI
C11519	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11519	RO	chemotherapy regimen has component Asparaginase	NCI
C11519	RO	chemotherapy regimen has component Dexamethasone	NCI
C11519	RO	chemotherapy regimen has component Prednisone	NCI
C11519	RO	chemotherapy regimen has component Vincristine	NCI
C10035	STY	Therapeutic or Preventive Procedure		NCI
C10035	PT	Mercaptopurine/Methotrexate/Vincristine		NCI
C10035	SY	PIP		NCI
C10035	SY	MP/MTX/VCR		NCI
C10035	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10035	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10035	RO	chemotherapy regimen has component Methotrexate	NCI
C10035	RO	chemotherapy regimen has component Vincristine	NCI
C11785	STY	Therapeutic or Preventive Procedure		NCI
C11785	PT	Filgrastim/Flt3 Ligand/Milodistim/Sargramostim		NCI
C11785	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11785	RO	chemotherapy regimen has component Filgrastim	NCI
C11785	RO	chemotherapy regimen has component Sargramostim	NCI
C11785	RO	chemotherapy regimen has component Recombinant Flt3 Ligand	NCI
C11785	RO	chemotherapy regimen has component Milodistim	NCI
C11145	STY	Therapeutic or Preventive Procedure		NCI
C11145	PT	Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Pegaspargase/Thioguanine/Vincristine		NCI
C11145	SY	ARA-C/CTX/DM/DOX/PEG-ASP/TG/VCR		NCI
C11145	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11145	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11145	RO	chemotherapy regimen has component Cytarabine	NCI
C11145	RO	chemotherapy regimen has component Dexamethasone	NCI
C11145	RO	chemotherapy regimen has component Doxorubicin	NCI
C11145	RO	chemotherapy regimen has component Thioguanine	NCI
C11145	RO	chemotherapy regimen has component Vincristine	NCI
C11145	RO	chemotherapy regimen has component Pegaspargase	NCI
C12153	STY	Therapeutic or Preventive Procedure		NCI
C12153	PT	Gemtuzumab Ozogamicin/Oblimersen		NCI
C12153	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12153	RO	chemotherapy regimen has component Oblimersen	NCI
C12153	RO	chemotherapy regimen has component Gemtuzumab Ozogamicin	NCI
C11789	STY	Therapeutic or Preventive Procedure		NCI
C11789	PT	Estramustine/Mitoxantrone/Vinorelbine		NCI
C11789	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11789	RO	chemotherapy regimen has component Estramustine	NCI
C11789	RO	chemotherapy regimen has component Vinorelbine	NCI
C11789	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37751	STY	Therapeutic or Preventive Procedure		NCI
C37751	PT	Doxorubicin/Imatinib Mesylate/Pegaspargase/Prednisone/Vincristine		NCI
C37751	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37751	RO	chemotherapy regimen has component Doxorubicin	NCI
C37751	RO	chemotherapy regimen has component Prednisone	NCI
C37751	RO	chemotherapy regimen has component Vincristine	NCI
C37751	RO	chemotherapy regimen has component Pegaspargase	NCI
C37751	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C10328	STY	Therapeutic or Preventive Procedure		NCI
C10328	PT	Cytarabine/Hydroxyurea		NCI
C10328	SY	ARA-C/HU		NCI
C10328	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10328	RO	chemotherapy regimen has component Cytarabine	NCI
C10328	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10667	STY	Therapeutic or Preventive Procedure		NCI
C10667	PT	Altretamine/Paclitaxel		NCI
C10667	SY	HMM/TAX		NCI
C10667	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10667	RO	chemotherapy regimen has component Altretamine	NCI
C10667	RO	chemotherapy regimen has component Paclitaxel	NCI
C11292	STY	Therapeutic or Preventive Procedure		NCI
C11292	PT	Cyclophosphamide/Doxorubicin/Marimastat		NCI
C11292	SY	BB-2516/CTX/DOX		NCI
C11292	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11292	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11292	RO	chemotherapy regimen has component Doxorubicin	NCI
C11292	RO	chemotherapy regimen has component Marimastat	NCI
C11508	STY	Therapeutic or Preventive Procedure		NCI
C11508	PT	Capecitabine/Docetaxel		NCI
C11508	SY	CAPE/TXT		NCI
C11508	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11508	RO	chemotherapy regimen has component Docetaxel	NCI
C11508	RO	chemotherapy regimen has component Capecitabine	NCI
C37463	STY	Therapeutic or Preventive Procedure		NCI
C37463	PT	Autologous Lymphocytes/gp100 Antigen/Interleukin-2/Interleukin-12/MAGE-3/Melan-A/NA17-A Antigen		NCI
C37463	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37463	RO	chemotherapy regimen has component gp100 Antigen	NCI
C37463	RO	chemotherapy regimen has component NA17-A Antigen	NCI
C37463	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C37463	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37463	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C37463	RO	chemotherapy regimen has component Therapeutic Autologous Lymphocytes	NCI
C37463	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11573	STY	Therapeutic or Preventive Procedure		NCI
C11573	PT	Cyclophosphamide/Epirubicin/Monoclonal Antibody HER2		NCI
C11573	SY	CTX/EPI/MOAB HER2		NCI
C11573	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11573	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11573	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11573	RO	chemotherapy regimen has component Trastuzumab	NCI
C9937	STY	Therapeutic or Preventive Procedure		NCI
C9937	PT	Cyclophosphamide/Doxorubicin/Prednisone/Tamoxifen		NCI
C9937	SY	CTX/DOX/PRED/TMX		NCI
C9937	SY	PACT		NCI
C9937	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9937	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9937	RO	chemotherapy regimen has component Doxorubicin	NCI
C9937	RO	chemotherapy regimen has component Prednisone	NCI
C9937	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11724	STY	Therapeutic or Preventive Procedure		NCI
C11724	PT	Anti-thymocyte globulin/Cyclosporine		NCI
C11724	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11724	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11724	RO	chemotherapy regimen has component Cyclosporine	NCI
C37606	STY	Therapeutic or Preventive Procedure		NCI
C37606	PT	Carboplatin/Dexamethasone/Gemcitabine/Rituximab		NCI
C37606	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37606	RO	chemotherapy regimen has component Dexamethasone	NCI
C37606	RO	chemotherapy regimen has component Carboplatin	NCI
C37606	RO	chemotherapy regimen has component Rituximab	NCI
C37606	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11367	STY	Therapeutic or Preventive Procedure		NCI
C11367	PT	Mitoxantrone/Prednisone		NCI
C11367	SY	DHAD/PRED		NCI
C11367	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11367	RO	chemotherapy regimen has component Prednisone	NCI
C11367	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11230	STY	Therapeutic or Preventive Procedure		NCI
C11230	PT	Cisplatin/Hydroxyurea/Vindesine		NCI
C11230	SY	CDDP/DAVA/HU		NCI
C11230	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11230	RO	chemotherapy regimen has component Cisplatin	NCI
C11230	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11230	RO	chemotherapy regimen has component Vindesine	NCI
C10460	STY	Therapeutic or Preventive Procedure		NCI
C10460	PT	Cytarabine/Daunorubicin/Pegaspargase/Prednisone/Vincristine		NCI
C10460	SY	ARA-C/DNR/PEG-ASP/PRED/VCR		NCI
C10460	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10460	RO	chemotherapy regimen has component Cytarabine	NCI
C10460	RO	chemotherapy regimen has component Prednisone	NCI
C10460	RO	chemotherapy regimen has component Vincristine	NCI
C10460	RO	chemotherapy regimen has component Pegaspargase	NCI
C10460	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C67162	STY	Therapeutic or Preventive Procedure		NCI
C67162	PT	ABVE Regimen		NCI
C67162	SY	DBVE Regimen		NCI
C67162	SY	DBVE		NCI
C67162	SY	Adriamycin-Bleomycin Sulfate-Vincristine Sulfate-Etoposide Regimen		NCI
C67162	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67162	RO	chemotherapy regimen has component Bleomycin Sulfate	NCI
C67162	RO	chemotherapy regimen has component Etoposide	NCI
C67162	RO	chemotherapy regimen has component Vincristine Sulfate	NCI
C67162	RO	regimen has accepted use for disease Childhood Hodgkin Lymphoma	NCI
C67162	RO	chemotherapy regimen has component Doxorubicin Hydrochloride	NCI
C10273	STY	Therapeutic or Preventive Procedure		NCI
C10273	PT	Cytarabine/Etoposide/Methotrexate		NCI
C10273	SY	MACE		NCI
C10273	SY	ARA-C/MTX/VP-16		NCI
C10273	SY	EMCC (EMC2)		NCI
C10273	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10273	RO	chemotherapy regimen has component Cytarabine	NCI
C10273	RO	chemotherapy regimen has component Etoposide	NCI
C10273	RO	chemotherapy regimen has component Methotrexate	NCI
C37808	STY	Therapeutic or Preventive Procedure		NCI
C37808	PT	Gemcitabine/Trastuzumab		NCI
C37808	SY	Trastuzumab/Gemcitabine		NCI
C37808	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37808	RO	chemotherapy regimen has component Trastuzumab	NCI
C37808	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10868	STY	Therapeutic or Preventive Procedure		NCI
C10868	PT	Cisplatin/Cyclophosphamide/Etoposide/Filgrastim		NCI
C10868	SY	CDDP/CTX/G-CSF/VP-16		NCI
C10868	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10868	RO	chemotherapy regimen has component Cisplatin	NCI
C10868	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10868	RO	chemotherapy regimen has component Etoposide	NCI
C10868	RO	chemotherapy regimen has component Filgrastim	NCI
C37706	STY	Therapeutic or Preventive Procedure		NCI
C37706	PT	Cytarabine/GTI-2040		NCI
C37706	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37706	RO	chemotherapy regimen has component Cytarabine	NCI
C37706	RO	chemotherapy regimen has component GTI-2040	NCI
C9593	STY	Therapeutic or Preventive Procedure		NCI
C9593	PT	Cisplatin/Doxorubicin/Fluorouracil/Mitomycin		NCI
C9593	SY	CDDP/DOX/5-FU/MITO		NCI
C9593	SY	FAMP		NCI
C9593	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9593	RO	chemotherapy regimen has component Mitomycin	NCI
C9593	RO	chemotherapy regimen has component Cisplatin	NCI
C9593	RO	chemotherapy regimen has component Doxorubicin	NCI
C9593	RO	chemotherapy regimen has component Fluorouracil	NCI
C10343	STY	Therapeutic or Preventive Procedure		NCI
C10343	PT	Fluorouracil/Leucovorin Calcium/PALA		NCI
C10343	SY	CF/5-FU/PALA		NCI
C10343	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10343	RO	chemotherapy regimen has component Fluorouracil	NCI
C10343	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C10343	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12054	STY	Therapeutic or Preventive Procedure		NCI
C12054	PT	Bevacizumab/Cytarabine/Idarubicin		NCI
C12054	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12054	RO	chemotherapy regimen has component Cytarabine	NCI
C12054	RO	chemotherapy regimen has component Idarubicin	NCI
C12054	RO	chemotherapy regimen has component Bevacizumab	NCI
C10510	STY	Therapeutic or Preventive Procedure		NCI
C10510	PT	Cyclophosphamide/Filgrastim		NCI
C10510	SY	CTX/G-CSF		NCI
C10510	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10510	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10510	RO	chemotherapy regimen has component Filgrastim	NCI
C10836	STY	Therapeutic or Preventive Procedure		NCI
C10836	PT	Fluorouracil/Irinotecan/Leucovorin Calcium		NCI
C10836	SY	Saltz Regimen		NCI
C10836	SY	CF/CPT-11/5-FU		NCI
C10836	SY	5FU/Leucovorin/Irinotecan		NCI
C10836	SY	IFL		NCI
C10836	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10836	RO	chemotherapy regimen has component Fluorouracil	NCI
C10836	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C10836	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C64368	STY	Therapeutic or Preventive Procedure		NCI
C64368	PT	A-T-C Regimen		NCI
C64368	SY	Adriamycin-Taxol-Cytoxan Regimen		NCI
C64368	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C64368	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C64368	RO	chemotherapy regimen has component Doxorubicin	NCI
C64368	RO	chemotherapy regimen has component Paclitaxel	NCI
C64368	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C11699	STY	Therapeutic or Preventive Procedure		NCI
C11699	PT	Bicalutamide/Goserelin/Mitoxantrone/Prednisone		NCI
C11699	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11699	RO	chemotherapy regimen has component Prednisone	NCI
C11699	RO	chemotherapy regimen has component Goserelin	NCI
C11699	RO	chemotherapy regimen has component Bicalutamide	NCI
C11699	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11568	STY	Therapeutic or Preventive Procedure		NCI
C11568	PT	Fluorouracil/Levamisole/Monoclonal Antibody 17-1A		NCI
C11568	SY	5-FU/LEV/MOAB 17-1A		NCI
C11568	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11568	RO	chemotherapy regimen has component Fluorouracil	NCI
C11568	RO	chemotherapy regimen has component Edrecolomab	NCI
C11568	RO	chemotherapy regimen has component Levamisole Hydrochloride	NCI
C9814	STY	Therapeutic or Preventive Procedure		NCI
C9814	PT	Asparaginase/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C9814	SY	ASP/MP/MTX/PRED/VCR		NCI
C9814	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9814	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9814	RO	chemotherapy regimen has component Asparaginase	NCI
C9814	RO	chemotherapy regimen has component Methotrexate	NCI
C9814	RO	chemotherapy regimen has component Prednisone	NCI
C9814	RO	chemotherapy regimen has component Vincristine	NCI
C37761	STY	Therapeutic or Preventive Procedure		NCI
C37761	PT	Epirubicin/Thalidomide		NCI
C37761	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37761	RO	chemotherapy regimen has component Thalidomide	NCI
C37761	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C67482	STY	Therapeutic or Preventive Procedure		NCI
C67482	PT	CCG-0922 APL Regimen		NCI
C67482	CHD	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia	NCI
C67482	RO	chemotherapy regimen has component Cytarabine	NCI
C67482	RO	chemotherapy regimen has component Idarubicin	NCI
C67482	RO	chemotherapy regimen has component Fludarabine	NCI
C67482	RO	regimen has accepted use for disease Childhood Acute Promyelocytic Leukemia with PML-RARA	NCI
C11279	STY	Therapeutic or Preventive Procedure		NCI
C11279	PT	Bleomycin/Doxorubicin/Vindesine		NCI
C11279	SY	BLEO/DAVA/DOX		NCI
C11279	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11279	RO	chemotherapy regimen has component Bleomycin	NCI
C11279	RO	chemotherapy regimen has component Doxorubicin	NCI
C11279	RO	chemotherapy regimen has component Vindesine	NCI
C63519	STY	Therapeutic or Preventive Procedure		NCI
C63519	PT	Chemotherapy Regimen Used to Treat Endometrial Carcinoma		NCI
C63519	CHD	Chemotherapy Regimen	NCI
C63519	PAR	CAP Regimen	NCI
C63519	PAR	Carboplatin-Taxol Regimen	NCI
C63519	PAR	Cisplatin-Doxorubicin-Paclitaxel Regimen	NCI
C63519	PAR	Megestrol/Tamoxifen Regimen	NCI
C12111	STY	Therapeutic or Preventive Procedure		NCI
C12111	PT	Asparaginase/Cytarabine/Gemtuzumab ozogamicin		NCI
C12111	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12111	RO	chemotherapy regimen has component Asparaginase	NCI
C12111	RO	chemotherapy regimen has component Cytarabine	NCI
C12111	RO	chemotherapy regimen has component Gemtuzumab Ozogamicin	NCI
C10264	STY	Therapeutic or Preventive Procedure		NCI
C10264	PT	Cisplatin/Vindesine		NCI
C10264	SY	CDDP/DAVA		NCI
C10264	SY	Vind-Plat		NCI
C10264	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10264	RO	chemotherapy regimen has component Cisplatin	NCI
C10264	RO	chemotherapy regimen has component Vindesine	NCI
C10744	STY	Therapeutic or Preventive Procedure		NCI
C10744	PT	Filgrastim/Tretinoin		NCI
C10744	SY	ATRA/G-CSF		NCI
C10744	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10744	RO	chemotherapy regimen has component Tretinoin	NCI
C10744	RO	chemotherapy regimen has component Filgrastim	NCI
C11889	STY	Therapeutic or Preventive Procedure		NCI
C11889	PT	Fluorouracil/Irinotecan		NCI
C11889	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11889	RO	chemotherapy regimen has component Fluorouracil	NCI
C11889	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11455	STY	Therapeutic or Preventive Procedure		NCI
C11455	PT	Methotrexate/Prednisolone/Thioguanine/Vincristine		NCI
C11455	SY	MTX/PRDL/TG/VCR		NCI
C11455	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11455	RO	chemotherapy regimen has component Methotrexate	NCI
C11455	RO	chemotherapy regimen has component Prednisolone	NCI
C11455	RO	chemotherapy regimen has component Thioguanine	NCI
C11455	RO	chemotherapy regimen has component Vincristine	NCI
C11169	STY	Therapeutic or Preventive Procedure		NCI
C11169	PT	Amifostine/Paclitaxel		NCI
C11169	SY	TAX/WR-2721		NCI
C11169	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11169	RO	chemotherapy regimen has component Amifostine	NCI
C11169	RO	chemotherapy regimen has component Paclitaxel	NCI
C11964	STY	Therapeutic or Preventive Procedure		NCI
C11964	PT	Docetaxel/Filgrastim/Gemcitabine		NCI
C11964	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11964	RO	chemotherapy regimen has component Filgrastim	NCI
C11964	RO	chemotherapy regimen has component Docetaxel	NCI
C11964	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11162	STY	Therapeutic or Preventive Procedure		NCI
C11162	PT	Cisplatin/Fluorouracil/Tirapazamine		NCI
C11162	SY	CDDP/5-FU/SR-4233		NCI
C11162	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11162	RO	chemotherapy regimen has component Cisplatin	NCI
C11162	RO	chemotherapy regimen has component Fluorouracil	NCI
C11162	RO	chemotherapy regimen has component Tirapazamine	NCI
C11515	STY	Therapeutic or Preventive Procedure		NCI
C11515	PT	Docetaxel/Gemcitabine		NCI
C11515	SY	TXT/dFdC		NCI
C11515	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11515	RO	chemotherapy regimen has component Docetaxel	NCI
C11515	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11385	STY	Therapeutic or Preventive Procedure		NCI
C11385	PT	Cisplatin/Fluorouracil/ONYX-015		NCI
C11385	SY	CDDP/5-FU/ONYX-015		NCI
C11385	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11385	RO	chemotherapy regimen has component Cisplatin	NCI
C11385	RO	chemotherapy regimen has component Fluorouracil	NCI
C11385	RO	chemotherapy regimen has component ONYX-015	NCI
C9548	STY	Therapeutic or Preventive Procedure		NCI
C9548	PT	Cyclophosphamide/Fluorouracil/Prednisone		NCI
C9548	SY	CTX/5-FU/PRED		NCI
C9548	SY	CFP		NCI
C9548	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9548	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9548	RO	chemotherapy regimen has component Fluorouracil	NCI
C9548	RO	chemotherapy regimen has component Prednisone	NCI
C156240	STY	Therapeutic or Preventive Procedure		NCI
C156240	PT	Fluorouracil/Oxaliplatin Regimen		NCI
C156240	SY	Fluorouracil-Oxaliplatin Regimen		NCI
C156240	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C156240	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C156240	RO	chemotherapy regimen has component Fluorouracil	NCI
C156240	RO	chemotherapy regimen has component Oxaliplatin	NCI
C63416	STY	Therapeutic or Preventive Procedure		NCI
C63416	PT	AT Regimen		NCI
C63416	SY	Adriamycin-Taxol Regimen		NCI
C63416	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63416	RO	chemotherapy regimen has component Doxorubicin	NCI
C63416	RO	chemotherapy regimen has component Paclitaxel	NCI
C63416	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C37540	STY	Therapeutic or Preventive Procedure		NCI
C37540	PT	Autologous Dendritic Cells/Tetanus Toxoid		NCI
C37540	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37540	RO	chemotherapy regimen has component Tetanus Toxoid Vaccine	NCI
C37540	RO	chemotherapy regimen has component Therapeutic Autologous Dendritic Cells	NCI
C9964	STY	Therapeutic or Preventive Procedure		NCI
C9964	PT	Doxorubicin/Semustine/Streptozocin		NCI
C9964	SY	DOX/MeCCNU/SZC		NCI
C9964	SY	SAM		NCI
C9964	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9964	RO	chemotherapy regimen has component Doxorubicin	NCI
C9964	RO	chemotherapy regimen has component Semustine	NCI
C9964	RO	chemotherapy regimen has component Streptozocin	NCI
C12207	STY	Therapeutic or Preventive Procedure		NCI
C12207	PT	Carboplatin/Etoposide/Exisulind		NCI
C12207	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12207	RO	chemotherapy regimen has component Etoposide	NCI
C12207	RO	chemotherapy regimen has component Exisulind	NCI
C12207	RO	chemotherapy regimen has component Carboplatin	NCI
C12091	STY	Therapeutic or Preventive Procedure		NCI
C12091	PT	Carboplatin/Etoposide/PS-341		NCI
C12091	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12091	RO	chemotherapy regimen has component Etoposide	NCI
C12091	RO	chemotherapy regimen has component Carboplatin	NCI
C12091	RO	chemotherapy regimen has component Bortezomib	NCI
C10751	STY	Therapeutic or Preventive Procedure		NCI
C10751	PT	Dipyridamole/Fluorouracil/Leucovorin Calcium/Mitomycin		NCI
C10751	SY	CF/DP/5-FU/MITO		NCI
C10751	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10751	RO	chemotherapy regimen has component Mitomycin	NCI
C10751	RO	chemotherapy regimen has component Dipyridamole	NCI
C10751	RO	chemotherapy regimen has component Fluorouracil	NCI
C10751	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10445	STY	Therapeutic or Preventive Procedure		NCI
C10445	PT	Fluorouracil/Idoxuridine/Leucovorin Calcium		NCI
C10445	SY	CF/5-FU/IUDR		NCI
C10445	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10445	RO	chemotherapy regimen has component Fluorouracil	NCI
C10445	RO	chemotherapy regimen has component Idoxuridine	NCI
C10445	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10169	STY	Therapeutic or Preventive Procedure		NCI
C10169	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Vindesine		NCI
C10169	SY	CDDP/CTX/DAVA/DOX		NCI
C10169	SY	PACE		NCI
C10169	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10169	RO	chemotherapy regimen has component Cisplatin	NCI
C10169	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10169	RO	chemotherapy regimen has component Doxorubicin	NCI
C10169	RO	chemotherapy regimen has component Vindesine	NCI
C11527	STY	Therapeutic or Preventive Procedure		NCI
C11527	PT	Cyclophosphamide/Docetaxel/Doxorubicin/Tamoxifen		NCI
C11527	SY	CTX/DOX/TMX/TXT		NCI
C11527	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11527	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11527	RO	chemotherapy regimen has component Doxorubicin	NCI
C11527	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11527	RO	chemotherapy regimen has component Docetaxel	NCI
C10943	STY	Therapeutic or Preventive Procedure		NCI
C10943	PT	Cytarabine/Dexamethasone/Etoposide/Methotrexate/Pegaspargase/Thioguanine/Vincristine		NCI
C10943	SY	ARA-C/DM/MTX/PEG-ASP/TG/VCR/VP-16		NCI
C10943	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10943	RO	chemotherapy regimen has component Cytarabine	NCI
C10943	RO	chemotherapy regimen has component Dexamethasone	NCI
C10943	RO	chemotherapy regimen has component Etoposide	NCI
C10943	RO	chemotherapy regimen has component Methotrexate	NCI
C10943	RO	chemotherapy regimen has component Thioguanine	NCI
C10943	RO	chemotherapy regimen has component Vincristine	NCI
C10943	RO	chemotherapy regimen has component Pegaspargase	NCI
C11516	STY	Therapeutic or Preventive Procedure		NCI
C11516	PT	Interleukin-2/Ras Peptide Cancer Vaccine		NCI
C11516	SY	IL-2/ras pep vac		NCI
C11516	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11516	RO	chemotherapy regimen has component RAS Peptide Cancer Vaccine	NCI
C11516	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9685	STY	Therapeutic or Preventive Procedure		NCI
C9685	PT	Carboplatin/Cyclophosphamide/Thiotepa		NCI
C9685	SY	CBDCA/CTX/TSPA		NCI
C9685	SY	STAMP V		NCI
C9685	SY	CTCb		NCI
C9685	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9685	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9685	RO	chemotherapy regimen has component Thiotepa	NCI
C9685	RO	chemotherapy regimen has component Carboplatin	NCI
C9612	STY	Therapeutic or Preventive Procedure		NCI
C9612	PT	Cyclophosphamide/Methotrexate/Vincristine		NCI
C9612	SY	COM		NCI
C9612	SY	CTX/MTX/VCR		NCI
C9612	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9612	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9612	RO	chemotherapy regimen has component Methotrexate	NCI
C9612	RO	chemotherapy regimen has component Vincristine	NCI
C10116	STY	Therapeutic or Preventive Procedure		NCI
C10116	PT	Daunorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C10116	SY	MTX-DOMP		NCI
C10116	SY	DNR/MP/MTX/PRED/VCR		NCI
C10116	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10116	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10116	RO	chemotherapy regimen has component Methotrexate	NCI
C10116	RO	chemotherapy regimen has component Prednisone	NCI
C10116	RO	chemotherapy regimen has component Vincristine	NCI
C10116	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C63719	STY	Therapeutic or Preventive Procedure		NCI
C63719	PT	Chemotherapy Regimen Used to Treat Esophageal Carcinoma		NCI
C63719	CHD	Chemotherapy Regimen	NCI
C63719	PAR	FU-LV Regimen	NCI
C63719	PAR	ECX Regimen	NCI
C63719	PAR	EOX Regimen	NCI
C11437	STY	Therapeutic or Preventive Procedure		NCI
C11437	PT	Asparaginase/Methotrexate/Prednisolone/Vincristine		NCI
C11437	SY	ASP/MTX/PRDL/VCR		NCI
C11437	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11437	RO	chemotherapy regimen has component Asparaginase	NCI
C11437	RO	chemotherapy regimen has component Methotrexate	NCI
C11437	RO	chemotherapy regimen has component Prednisolone	NCI
C11437	RO	chemotherapy regimen has component Vincristine	NCI
C10240	STY	Therapeutic or Preventive Procedure		NCI
C10240	PT	Cytarabine/Mitoxantrone/Thioguanine		NCI
C10240	SY	ARA-C/DHAD/TG		NCI
C10240	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10240	RO	chemotherapy regimen has component Cytarabine	NCI
C10240	RO	chemotherapy regimen has component Thioguanine	NCI
C10240	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10990	STY	Therapeutic or Preventive Procedure		NCI
C10990	PT	Interferon Alfa/Prednisone		NCI
C10990	SY	IFN-A/PRED		NCI
C10990	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10990	RO	chemotherapy regimen has component Prednisone	NCI
C10990	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11903	STY	Therapeutic or Preventive Procedure		NCI
C11903	PT	Ascorbic acid/Selenium/Vitamin E		NCI
C11903	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11903	RO	chemotherapy regimen has component Ascorbic Acid	NCI
C11903	RO	chemotherapy regimen has component Selenium	NCI
C11903	RO	chemotherapy regimen has component Vitamin E Compound	NCI
C11809	STY	Therapeutic or Preventive Procedure		NCI
C11809	PT	Celecoxib/Selenium		NCI
C11809	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11809	RO	chemotherapy regimen has component Selenium	NCI
C11809	RO	chemotherapy regimen has component Celecoxib	NCI
C9513	STY	Therapeutic or Preventive Procedure		NCI
C9513	PT	Dacarbazine/Doxorubicin		NCI
C9513	SY	Doxorubicin/Dacarbazine		NCI
C9513	SY	DOX/DTIC		NCI
C9513	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9513	RO	chemotherapy regimen has component Dacarbazine	NCI
C9513	RO	chemotherapy regimen has component Doxorubicin	NCI
C37759	STY	Therapeutic or Preventive Procedure		NCI
C37759	PT	Eniluracil/Fluorouracil/Leucovorin Calcium		NCI
C37759	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37759	RO	chemotherapy regimen has component Fluorouracil	NCI
C37759	RO	chemotherapy regimen has component Eniluracil	NCI
C37759	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10651	STY	Therapeutic or Preventive Procedure		NCI
C10651	PT	Cyclosporine/Cytarabine/Daunorubicin		NCI
C10651	SY	ARA-C/CYSP/DNR		NCI
C10651	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10651	RO	chemotherapy regimen has component Cyclosporine	NCI
C10651	RO	chemotherapy regimen has component Cytarabine	NCI
C10651	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11228	STY	Therapeutic or Preventive Procedure		NCI
C11228	PT	Cisplatin/Etoposide/Hydroxyurea		NCI
C11228	SY	CDDP/HU/VP-16		NCI
C11228	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11228	RO	chemotherapy regimen has component Cisplatin	NCI
C11228	RO	chemotherapy regimen has component Etoposide	NCI
C11228	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10613	STY	Therapeutic or Preventive Procedure		NCI
C10613	PT	Cyclophosphamide/Cytarabine/Mercaptopurine/Vincristine		NCI
C10613	SY	ARA-C/CTX/MP/VCR		NCI
C10613	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10613	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10613	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10613	RO	chemotherapy regimen has component Cytarabine	NCI
C10613	RO	chemotherapy regimen has component Vincristine	NCI
C11180	STY	Therapeutic or Preventive Procedure		NCI
C11180	PT	Cyclosporine/Methylprednisolone/Prednisone		NCI
C11180	SY	CYSP/MePRDL/PRED		NCI
C11180	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11180	RO	chemotherapy regimen has component Cyclosporine	NCI
C11180	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11180	RO	chemotherapy regimen has component Prednisone	NCI
C10236	STY	Therapeutic or Preventive Procedure		NCI
C10236	PT	Cisplatin/Mitoxantrone		NCI
C10236	SY	CDDP/DHAD		NCI
C10236	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10236	RO	chemotherapy regimen has component Cisplatin	NCI
C10236	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10454	STY	Therapeutic or Preventive Procedure		NCI
C10454	PT	Cyclophosphamide/Melphalan		NCI
C10454	SY	CTX/L-PAM		NCI
C10454	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10454	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10454	RO	chemotherapy regimen has component Melphalan	NCI
C37583	STY	Therapeutic or Preventive Procedure		NCI
C37583	PT	Calcium Carbonate/Cholecalciferol/Risedronate		NCI
C37583	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37583	RO	chemotherapy regimen has component Calcium Carbonate	NCI
C37583	RO	chemotherapy regimen has component Risedronate Sodium	NCI
C37583	RO	chemotherapy regimen has component D Vitamin	NCI
C11027	STY	Therapeutic or Preventive Procedure		NCI
C11027	PT	Fluorouracil/Interferon Alfa/Interleukin-2		NCI
C11027	SY	IFN/5FU/IL2		NCI
C11027	SY	5-FU/IFN-A/IL-2		NCI
C11027	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11027	RO	chemotherapy regimen has component Fluorouracil	NCI
C11027	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11027	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11091	STY	Therapeutic or Preventive Procedure		NCI
C11091	PT	Ketoconazole/Tretinoin		NCI
C11091	SY	ATRA/KCZ		NCI
C11091	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11091	RO	chemotherapy regimen has component Ketoconazole	NCI
C11091	RO	chemotherapy regimen has component Tretinoin	NCI
C63751	STY	Therapeutic or Preventive Procedure		NCI
C63751	PT	FP Regimen		NCI
C63751	SY	Fludarabine-Prednisone Regimen		NCI
C63751	CHD	Chemotherapy Regimen Used to Treat Chronic Lymphocytic Leukemia	NCI
C63751	RO	regimen has accepted use for disease Chronic Lymphocytic Leukemia	NCI
C63751	RO	chemotherapy regimen has component Prednisone	NCI
C63751	RO	chemotherapy regimen has component Fludarabine	NCI
C11387	STY	Therapeutic or Preventive Procedure		NCI
C11387	PT	Amifostine/Carboplatin/Filgrastim/Paclitaxel		NCI
C11387	SY	CBDCA/G-CSF/TAX/WR-2721		NCI
C11387	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11387	RO	chemotherapy regimen has component Amifostine	NCI
C11387	RO	chemotherapy regimen has component Carboplatin	NCI
C11387	RO	chemotherapy regimen has component Paclitaxel	NCI
C11387	RO	chemotherapy regimen has component Filgrastim	NCI
C11265	STY	Therapeutic or Preventive Procedure		NCI
C11265	PT	Cytarabine/Lomustine/Methotrexate/Methylprednisolone/Procarbazine		NCI
C11265	SY	ARA-C/CCNU/MePRDL/MTX/PCB		NCI
C11265	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11265	RO	chemotherapy regimen has component Cytarabine	NCI
C11265	RO	chemotherapy regimen has component Lomustine	NCI
C11265	RO	chemotherapy regimen has component Methotrexate	NCI
C11265	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11265	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11461	STY	Therapeutic or Preventive Procedure		NCI
C11461	PT	Interferon Alfa/Sargramostim		NCI
C11461	SY	GM-CSF/IFN-A		NCI
C11461	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11461	RO	chemotherapy regimen has component Sargramostim	NCI
C11461	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C64731	STY	Therapeutic or Preventive Procedure		NCI
C64731	PT	Bortezomib-Dexamethasone Regimen		NCI
C64731	SY	Velcade-Dexamethasone Regimen		NCI
C64731	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C64731	RO	chemotherapy regimen has component Dexamethasone	NCI
C64731	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C64731	RO	chemotherapy regimen has component Bortezomib	NCI
C11790	STY	Therapeutic or Preventive Procedure		NCI
C11790	PT	Interferon Alfa/Isotretinoin/Paclitaxel		NCI
C11790	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11790	RO	chemotherapy regimen has component Isotretinoin	NCI
C11790	RO	chemotherapy regimen has component Paclitaxel	NCI
C11790	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C12181	STY	Therapeutic or Preventive Procedure		NCI
C12181	PT	MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Sargramostim/tyrosinase peptide		NCI
C12181	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12181	RO	chemotherapy regimen has component Sargramostim	NCI
C12181	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C12181	RO	chemotherapy regimen has component NY-ESO-1 Peptide Vaccine	NCI
C12181	RO	chemotherapy regimen has component MAGE-10.A2	NCI
C12181	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11769	STY	Therapeutic or Preventive Procedure		NCI
C11769	PT	Carboplatin/Etoposide/Topotecan		NCI
C11769	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11769	RO	chemotherapy regimen has component Etoposide	NCI
C11769	RO	chemotherapy regimen has component Carboplatin	NCI
C11769	RO	chemotherapy regimen has component Topotecan	NCI
C11639	STY	Therapeutic or Preventive Procedure		NCI
C11639	PT	Autologous Tumor Cell Vaccine/Sargramostim		NCI
C11639	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11639	RO	chemotherapy regimen has component Sargramostim	NCI
C11639	RO	chemotherapy regimen has component Autologous Tumor Cell Vaccine	NCI
C9998	STY	Therapeutic or Preventive Procedure		NCI
C9998	PT	Cyclophosphamide/Semustine/Vincristine		NCI
C9998	SY	CTX/MeCCNU/VCR		NCI
C9998	SY	COM		NCI
C9998	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9998	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9998	RO	chemotherapy regimen has component Semustine	NCI
C9998	RO	chemotherapy regimen has component Vincristine	NCI
C9511	STY	Therapeutic or Preventive Procedure		NCI
C9511	PT	Cyclophosphamide/Dactinomycin/Fluorouracil		NCI
C9511	SY	ACFUCY		NCI
C9511	SY	CTX/DACT/5-FU		NCI
C9511	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9511	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9511	RO	chemotherapy regimen has component Dactinomycin	NCI
C9511	RO	chemotherapy regimen has component Fluorouracil	NCI
C11884	STY	Therapeutic or Preventive Procedure		NCI
C11884	PT	Gemcitabine/SCH 66336		NCI
C11884	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11884	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11884	RO	chemotherapy regimen has component Lonafarnib	NCI
C9995	STY	Therapeutic or Preventive Procedure		NCI
C9995	PT	Cyclophosphamide/Etoposide/Teniposide		NCI
C9995	SY	CTX/VM-26/VP-16		NCI
C9995	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9995	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9995	RO	chemotherapy regimen has component Etoposide	NCI
C9995	RO	chemotherapy regimen has component Teniposide	NCI
C63468	STY	Therapeutic or Preventive Procedure		NCI
C63468	PT	Chemotherapy Regimen Used to Treat Prostate Carcinoma		NCI
C63468	CHD	Chemotherapy Regimen	NCI
C63468	PAR	Docetaxel-Carboplatin Regimen	NCI
C63468	PAR	Docetaxel-Estramustine Regimen	NCI
C63468	PAR	Docetaxel-Prednisone Regimen	NCI
C63468	PAR	EP Regimen	NCI
C63468	PAR	Estramustine-Etoposide Regimen	NCI
C63468	PAR	Estramustine-Vinblastine Regimen	NCI
C63468	PAR	Flutamide-Goserelin Regimen	NCI
C63468	PAR	Flutamide-Leuprolide Regimen	NCI
C63468	PAR	Estramustine-Paclitaxel Regimen	NCI
C63468	PAR	MP Regimen	NCI
C63468	PAR	EC Regimen	NCI
C63468	PAR	Cabazitaxel-Prednisone Regimen	NCI
C37485	STY	Therapeutic or Preventive Procedure		NCI
C37485	PT	Geldanamycin Analogue (AAG)/Imatinib Mesylate		NCI
C37485	SY	17-AAG/Imatinib Mesylate		NCI
C37485	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37485	RO	chemotherapy regimen has component Tanespimycin	NCI
C37485	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C10624	STY	Therapeutic or Preventive Procedure		NCI
C10624	PT	Carboplatin/Milodistim		NCI
C10624	SY	CBDCA/PIXY321		NCI
C10624	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10624	RO	chemotherapy regimen has component Carboplatin	NCI
C10624	RO	chemotherapy regimen has component Milodistim	NCI
C11378	STY	Therapeutic or Preventive Procedure		NCI
C11378	PT	Cyproterone/Luteinizing Hormone-Releasing Factor		NCI
C11378	SY	CPTR/LHRH		NCI
C11378	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11378	RO	chemotherapy regimen has component Cyproterone	NCI
C11378	RO	chemotherapy regimen has component Recombinant Gonadorelin	NCI
C37582	STY	Therapeutic or Preventive Procedure		NCI
C37582	PT	Calcium Carbonate/Cholecalciferol/Conjugated Estrogens/Risedronate		NCI
C37582	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37582	RO	chemotherapy regimen has component Calcium Carbonate	NCI
C37582	RO	chemotherapy regimen has component Estrogens, Conjugated	NCI
C37582	RO	chemotherapy regimen has component Risedronate Sodium	NCI
C37582	RO	chemotherapy regimen has component D Vitamin	NCI
C10564	STY	Therapeutic or Preventive Procedure		NCI
C10564	PT	Flutamide/Leuprolide/Somatuline/Suramin		NCI
C10564	SY	FLUT/LEUP/somatuline/SUR		NCI
C10564	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10564	RO	chemotherapy regimen has component Flutamide	NCI
C10564	RO	chemotherapy regimen has component Suramin	NCI
C10564	RO	chemotherapy regimen has component Lanreotide	NCI
C10564	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C67340	STY	Therapeutic or Preventive Procedure		NCI
C67340	PT	OS-86 Regimen		NCI
C67340	SY	Ifosfamide-Cisplatin-Doxorubicin-Methotrexate Osteosarcoma Regimen		NCI
C67340	SY	Ifosfamide-Cisplatin-Doxorubicin-Methotrexate Regimen		NCI
C67340	CHD	Chemotherapy Regimen Used to Treat Childhood Osteosarcoma	NCI
C67340	RO	chemotherapy regimen has component Cisplatin	NCI
C67340	RO	chemotherapy regimen has component Doxorubicin	NCI
C67340	RO	chemotherapy regimen has component Ifosfamide	NCI
C67340	RO	chemotherapy regimen has component Methotrexate	NCI
C67340	RO	regimen has accepted use for disease Childhood Osteosarcoma	NCI
C64787	STY	Therapeutic or Preventive Procedure		NCI
C64787	PT	PELF Regimen		NCI
C64787	SY	Platinol-Epirubicin-Leucovorin-Fluorouracil Regimen		NCI
C64787	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C64787	RO	chemotherapy regimen has component Cisplatin	NCI
C64787	RO	chemotherapy regimen has component Fluorouracil	NCI
C64787	RO	regimen has accepted use for disease Gastric Carcinoma	NCI
C64787	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C64787	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10457	STY	Therapeutic or Preventive Procedure		NCI
C10457	PT	Cisplatin/Filgrastim/Paclitaxel		NCI
C10457	SY	CDDP/G-CSF/TAX		NCI
C10457	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10457	RO	chemotherapy regimen has component Cisplatin	NCI
C10457	RO	chemotherapy regimen has component Paclitaxel	NCI
C10457	RO	chemotherapy regimen has component Filgrastim	NCI
C10914	STY	Therapeutic or Preventive Procedure		NCI
C10914	PT	Cisplatin/Cytarabine/Dexamethasone/Idarubicin/Methotrexate		NCI
C10914	SY	ARA-C/CDDP/DM/IDA/MTX		NCI
C10914	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10914	RO	chemotherapy regimen has component Cisplatin	NCI
C10914	RO	chemotherapy regimen has component Cytarabine	NCI
C10914	RO	chemotherapy regimen has component Dexamethasone	NCI
C10914	RO	chemotherapy regimen has component Idarubicin	NCI
C10914	RO	chemotherapy regimen has component Methotrexate	NCI
C10716	STY	Therapeutic or Preventive Procedure		NCI
C10716	PT	Interleukin-2/Monoclonal Antibody 14G2A/Sargramostim		NCI
C10716	SY	GM-CSF/IL-2/MOAB 14G2A		NCI
C10716	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10716	RO	chemotherapy regimen has component Sargramostim	NCI
C10716	RO	chemotherapy regimen has component Monoclonal Antibody 14G2A	NCI
C10716	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11617	STY	Therapeutic or Preventive Procedure		NCI
C11617	PT	Daunorubicin/Tretinoin		NCI
C11617	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11617	RO	chemotherapy regimen has component Tretinoin	NCI
C11617	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C12020	STY	Therapeutic or Preventive Procedure		NCI
C12020	PT	Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Prednisone/Vincristine		NCI
C12020	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12020	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12020	RO	chemotherapy regimen has component Doxorubicin	NCI
C12020	RO	chemotherapy regimen has component Methotrexate	NCI
C12020	RO	chemotherapy regimen has component Prednisone	NCI
C12020	RO	chemotherapy regimen has component Vincristine	NCI
C12020	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10798	STY	Therapeutic or Preventive Procedure		NCI
C10798	PT	Cytarabine/Dexamethasone/Ifosfamide/Methotrexate/Teniposide/Vincristine		NCI
C10798	SY	ARA-C/DM/IFF/MTX/VCR/VM-26		NCI
C10798	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10798	RO	chemotherapy regimen has component Cytarabine	NCI
C10798	RO	chemotherapy regimen has component Dexamethasone	NCI
C10798	RO	chemotherapy regimen has component Ifosfamide	NCI
C10798	RO	chemotherapy regimen has component Methotrexate	NCI
C10798	RO	chemotherapy regimen has component Teniposide	NCI
C10798	RO	chemotherapy regimen has component Vincristine	NCI
C10986	STY	Therapeutic or Preventive Procedure		NCI
C10986	PT	Interferon Alfa/Vinblastine		NCI
C10986	SY	IFN-A/VBL		NCI
C10986	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10986	RO	chemotherapy regimen has component Vinblastine	NCI
C10986	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11955	STY	Therapeutic or Preventive Procedure		NCI
C11955	PT	Cisplatin/Dexamethasone/Gemcitabine		NCI
C11955	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11955	RO	chemotherapy regimen has component Cisplatin	NCI
C11955	RO	chemotherapy regimen has component Dexamethasone	NCI
C11955	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12057	STY	Therapeutic or Preventive Procedure		NCI
C12057	PT	Trastuzumab/ZD 1839		NCI
C12057	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12057	RO	chemotherapy regimen has component Trastuzumab	NCI
C12057	RO	chemotherapy regimen has component Gefitinib	NCI
C37560	STY	Therapeutic or Preventive Procedure		NCI
C37560	PT	Bicalutamide/Triptorelin		NCI
C37560	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37560	RO	chemotherapy regimen has component Triptorelin	NCI
C37560	RO	chemotherapy regimen has component Bicalutamide	NCI
C9643	STY	Therapeutic or Preventive Procedure		NCI
C9643	PT	Cyclophosphamide/Dactinomycin/Doxorubicin/Vincristine		NCI
C9643	SY	VACA		NCI
C9643	SY	CTX/DACT/DOX/VCR		NCI
C9643	SY	CY-VA-DACT		NCI
C9643	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9643	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9643	RO	chemotherapy regimen has component Dactinomycin	NCI
C9643	RO	chemotherapy regimen has component Doxorubicin	NCI
C9643	RO	chemotherapy regimen has component Vincristine	NCI
C64834	STY	Therapeutic or Preventive Procedure		NCI
C64834	PT	GTX Regimen		NCI
C64834	SY	Gemcitabine-Taxotere-Xeloda Regimen		NCI
C64834	CHD	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C64834	RO	regimen has accepted use for disease Pancreatic Carcinoma	NCI
C64834	RO	chemotherapy regimen has component Docetaxel	NCI
C64834	RO	chemotherapy regimen has component Capecitabine	NCI
C64834	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C9585	STY	Therapeutic or Preventive Procedure		NCI
C9585	PT	Cisplatin/Doxorubicin/Etoposide		NCI
C9585	SY	CDDP/DOX/VP-16		NCI
C9585	SY	PAV		NCI
C9585	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9585	RO	chemotherapy regimen has component Cisplatin	NCI
C9585	RO	chemotherapy regimen has component Doxorubicin	NCI
C9585	RO	chemotherapy regimen has component Etoposide	NCI
C37587	STY	Therapeutic or Preventive Procedure		NCI
C37587	PT	Capecitabine/Celecoxib/Gefitinib		NCI
C37587	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37587	RO	chemotherapy regimen has component Celecoxib	NCI
C37587	RO	chemotherapy regimen has component Capecitabine	NCI
C37587	RO	chemotherapy regimen has component Gefitinib	NCI
C138050	STY	Therapeutic or Preventive Procedure		NCI
C138050	PT	Bevacizumab/Paclitaxel Regimen		NCI
C138050	SY	Bevacizumab/Paclitaxel		NCI
C138050	SY	Bevacizumab-Paclitaxel		NCI
C138050	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138050	RO	chemotherapy regimen has component Paclitaxel	NCI
C138050	RO	chemotherapy regimen has component Bevacizumab	NCI
C9629	STY	Therapeutic or Preventive Procedure		NCI
C9629	PT	Cyclophosphamide/Lomustine/Procarbazine/Vincristine		NCI
C9629	SY	CCNU/CTX/PCB/VCR		NCI
C9629	SY	POCC		NCI
C9629	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9629	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9629	RO	chemotherapy regimen has component Lomustine	NCI
C9629	RO	chemotherapy regimen has component Vincristine	NCI
C9629	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11452	STY	Therapeutic or Preventive Procedure		NCI
C11452	PT	Isotretinoin/Procarbazine		NCI
C11452	SY	13-CRA/PCB		NCI
C11452	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11452	RO	chemotherapy regimen has component Isotretinoin	NCI
C11452	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C12154	STY	Therapeutic or Preventive Procedure		NCI
C12154	PT	Dexamethasone/Oblimersen		NCI
C12154	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12154	RO	chemotherapy regimen has component Dexamethasone	NCI
C12154	RO	chemotherapy regimen has component Oblimersen	NCI
C9765	STY	Therapeutic or Preventive Procedure		NCI
C9765	PT	Cytarabine/Etoposide/Idarubicin		NCI
C9765	SY	ARA-C/IDA/VP-16		NCI
C9765	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9765	RO	chemotherapy regimen has component Cytarabine	NCI
C9765	RO	chemotherapy regimen has component Etoposide	NCI
C9765	RO	chemotherapy regimen has component Idarubicin	NCI
C11258	STY	Therapeutic or Preventive Procedure		NCI
C11258	PT	Busulfan/Cyclophosphamide/Decitabine		NCI
C11258	SY	BU/CTX/DAC		NCI
C11258	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11258	RO	chemotherapy regimen has component Busulfan	NCI
C11258	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11258	RO	chemotherapy regimen has component Decitabine	NCI
C11926	STY	Therapeutic or Preventive Procedure		NCI
C11926	PT	Cyclosporine/Methylprednisolone/Mycophenolate Mofetil		NCI
C11926	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11926	RO	chemotherapy regimen has component Cyclosporine	NCI
C11926	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11926	RO	chemotherapy regimen has component Mycophenolate Mofetil	NCI
C10538	STY	Therapeutic or Preventive Procedure		NCI
C10538	PT	Epoetin Alfa/Filgrastim		NCI
C10538	SY	EPO/G-CSF		NCI
C10538	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10538	RO	chemotherapy regimen has component Filgrastim	NCI
C10538	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C37735	STY	Therapeutic or Preventive Procedure		NCI
C37735	PT	Docetaxel/DN-101		NCI
C37735	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37735	RO	chemotherapy regimen has component Docetaxel	NCI
C37735	RO	chemotherapy regimen has component DN-101	NCI
C11289	STY	Therapeutic or Preventive Procedure		NCI
C11289	PT	Marimastat/Tamoxifen		NCI
C11289	SY	BB-2516/TMX		NCI
C11289	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11289	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11289	RO	chemotherapy regimen has component Marimastat	NCI
C10477	STY	Therapeutic or Preventive Procedure		NCI
C10477	PT	Doxorubicin/Filgrastim/Paclitaxel		NCI
C10477	SY	DOX/G-CSF/TAX		NCI
C10477	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10477	RO	chemotherapy regimen has component Doxorubicin	NCI
C10477	RO	chemotherapy regimen has component Paclitaxel	NCI
C10477	RO	chemotherapy regimen has component Filgrastim	NCI
C12147	STY	Therapeutic or Preventive Procedure		NCI
C12147	PT	Epoetin Alfa/Filgrastim/Flt3 Ligand/Interleukin-3/Sargramostim		NCI
C12147	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12147	RO	chemotherapy regimen has component Filgrastim	NCI
C12147	RO	chemotherapy regimen has component Sargramostim	NCI
C12147	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C12147	RO	chemotherapy regimen has component Recombinant Flt3 Ligand	NCI
C12147	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C156307	STY	Therapeutic or Preventive Procedure		NCI
C156307	PT	Lapatinib/Letrozole/Trastuzumab Regimen		NCI
C156307	SY	Lapatinib/Letrozole/Trastuzumab		NCI
C156307	SY	Letrozole/Lapatinib/Trastuzumab Regimen		NCI
C156307	SY	Letrozole/Lapatinib/Trastuzumab		NCI
C156307	SY	Lapatinib/Letrozole/Herceptin		NCI
C156307	SY	Lapatinib-Letrozole-Trastuzumab		NCI
C156307	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156307	RO	chemotherapy regimen has component Letrozole	NCI
C156307	RO	chemotherapy regimen has component Trastuzumab	NCI
C156307	RO	chemotherapy regimen has component Lapatinib	NCI
C10581	STY	Therapeutic or Preventive Procedure		NCI
C10581	PT	Cyclophosphamide/Dactinomycin/Doxorubicin/Filgrastim/Vincristine		NCI
C10581	SY	CTX/DACT/DOX/G-CSF/VCR		NCI
C10581	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10581	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10581	RO	chemotherapy regimen has component Dactinomycin	NCI
C10581	RO	chemotherapy regimen has component Doxorubicin	NCI
C10581	RO	chemotherapy regimen has component Vincristine	NCI
C10581	RO	chemotherapy regimen has component Filgrastim	NCI
C11847	STY	Therapeutic or Preventive Procedure		NCI
C11847	PT	BMS-214662/Paclitaxel		NCI
C11847	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11847	RO	chemotherapy regimen has component Paclitaxel	NCI
C11847	RO	chemotherapy regimen has component BMS-214662	NCI
C11377	STY	Therapeutic or Preventive Procedure		NCI
C11377	PT	Amifostine/Cisplatin/Cyclophosphamide/Etoposide		NCI
C11377	SY	CDDP/CTX/VP-16/WR-2721		NCI
C11377	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11377	RO	chemotherapy regimen has component Cisplatin	NCI
C11377	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11377	RO	chemotherapy regimen has component Amifostine	NCI
C11377	RO	chemotherapy regimen has component Etoposide	NCI
C10200	STY	Therapeutic or Preventive Procedure		NCI
C10200	PT	Bleomycin/Idoxuridine		NCI
C10200	SY	BLEO/IUDR		NCI
C10200	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10200	RO	chemotherapy regimen has component Bleomycin	NCI
C10200	RO	chemotherapy regimen has component Idoxuridine	NCI
C10193	STY	Therapeutic or Preventive Procedure		NCI
C10193	PT	Cyclophosphamide/Etoposide/Methotrexate/Prednisone/Vincristine		NCI
C10193	SY	CTX/MTX/PRED/VCR/VP-16		NCI
C10193	SY	MOPLEC		NCI
C10193	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10193	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10193	RO	chemotherapy regimen has component Etoposide	NCI
C10193	RO	chemotherapy regimen has component Methotrexate	NCI
C10193	RO	chemotherapy regimen has component Prednisone	NCI
C10193	RO	chemotherapy regimen has component Vincristine	NCI
C37714	STY	Therapeutic or Preventive Procedure		NCI
C37714	PT	Cytarabine/Etoposide/Methotrexate/Rituximab		NCI
C37714	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37714	RO	chemotherapy regimen has component Cytarabine	NCI
C37714	RO	chemotherapy regimen has component Etoposide	NCI
C37714	RO	chemotherapy regimen has component Methotrexate	NCI
C37714	RO	chemotherapy regimen has component Rituximab	NCI
C10827	STY	Therapeutic or Preventive Procedure		NCI
C10827	PT	Cisplatin/Doxorubicin/Methotrexate/Muramyl Tripeptide Phosphatidylethanolamine Liposome		NCI
C10827	SY	Cisplatin/Doxorubicin/Methotrexate/Muramyl Tripeptide Phosphatidylethanolamine		NCI
C10827	SY	CDDP/DOX/MTP-PE Liposome/MTX		NCI
C10827	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10827	RO	chemotherapy regimen has component Cisplatin	NCI
C10827	RO	chemotherapy regimen has component Doxorubicin	NCI
C10827	RO	chemotherapy regimen has component Methotrexate	NCI
C10827	RO	chemotherapy regimen has component Mifamurtide	NCI
C10379	STY	Therapeutic or Preventive Procedure		NCI
C10379	PT	Carboplatin/Cisplatin/Ifosfamide		NCI
C10379	SY	CBDCA/CDDP/IFF		NCI
C10379	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10379	RO	chemotherapy regimen has component Cisplatin	NCI
C10379	RO	chemotherapy regimen has component Ifosfamide	NCI
C10379	RO	chemotherapy regimen has component Carboplatin	NCI
C9523	STY	Therapeutic or Preventive Procedure		NCI
C9523	PT	Bleomycin/Cyclophosphamide/Dactinomycin		NCI
C9523	SY	BCD		NCI
C9523	SY	BLEO/CTX/DACT		NCI
C9523	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9523	RO	chemotherapy regimen has component Bleomycin	NCI
C9523	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9523	RO	chemotherapy regimen has component Dactinomycin	NCI
C9817	STY	Therapeutic or Preventive Procedure		NCI
C9817	PT	Mercaptopurine/Methotrexate/Prednisone/Vindesine		NCI
C9817	SY	DAVA/MP/MTX/PRED		NCI
C9817	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9817	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9817	RO	chemotherapy regimen has component Methotrexate	NCI
C9817	RO	chemotherapy regimen has component Prednisone	NCI
C9817	RO	chemotherapy regimen has component Vindesine	NCI
C10038	STY	Therapeutic or Preventive Procedure		NCI
C10038	PT	Methotrexate/Prednisone/Thioguanine/Vincristine		NCI
C10038	SY	T-MOP		NCI
C10038	SY	MTX/PRED/TG/VCR		NCI
C10038	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10038	RO	chemotherapy regimen has component Methotrexate	NCI
C10038	RO	chemotherapy regimen has component Prednisone	NCI
C10038	RO	chemotherapy regimen has component Thioguanine	NCI
C10038	RO	chemotherapy regimen has component Vincristine	NCI
C11010	STY	Therapeutic or Preventive Procedure		NCI
C11010	PT	Carmustine/Interferon Alfa		NCI
C11010	SY	BCNU/IFN-A		NCI
C11010	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11010	RO	chemotherapy regimen has component Carmustine	NCI
C11010	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11862	STY	Therapeutic or Preventive Procedure		NCI
C11862	PT	Irinotecan/Octreotide		NCI
C11862	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11862	RO	chemotherapy regimen has component Octreotide	NCI
C11862	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C10109	STY	Therapeutic or Preventive Procedure		NCI
C10109	PT	Doxorubicin/Prednisone/Teniposide		NCI
C10109	SY	PATen		NCI
C10109	SY	DOX/PRED/VM-26		NCI
C10109	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10109	RO	chemotherapy regimen has component Doxorubicin	NCI
C10109	RO	chemotherapy regimen has component Prednisone	NCI
C10109	RO	chemotherapy regimen has component Teniposide	NCI
C9729	STY	Therapeutic or Preventive Procedure		NCI
C9729	PT	Cyclophosphamide/Bleomycin/Epirubicin/Prednisone/Vincristine		NCI
C9729	SY	BLEO/CTX/EPI/PRED/VCR		NCI
C9729	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9729	RO	chemotherapy regimen has component Bleomycin	NCI
C9729	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9729	RO	chemotherapy regimen has component Prednisone	NCI
C9729	RO	chemotherapy regimen has component Vincristine	NCI
C9729	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C9730	STY	Therapeutic or Preventive Procedure		NCI
C9730	PT	Cisplatin/Cytarabine/Doxorubicin/Methylprednisolone		NCI
C9730	SY	ARA-C/CDDP/DOX/MePRDL		NCI
C9730	SY	A-SHAP		NCI
C9730	SY	ASHAP		NCI
C9730	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9730	RO	chemotherapy regimen has component Cisplatin	NCI
C9730	RO	chemotherapy regimen has component Cytarabine	NCI
C9730	RO	chemotherapy regimen has component Doxorubicin	NCI
C9730	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10128	STY	Therapeutic or Preventive Procedure		NCI
C10128	PT	Doxorubicin/Fluorouracil/Melphalan/Tamoxifen		NCI
C10128	SY	DOX/5-FU/L-PAM/TMX		NCI
C10128	SY	PAFT		NCI
C10128	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10128	RO	chemotherapy regimen has component Doxorubicin	NCI
C10128	RO	chemotherapy regimen has component Fluorouracil	NCI
C10128	RO	chemotherapy regimen has component Melphalan	NCI
C10128	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10885	STY	Therapeutic or Preventive Procedure		NCI
C10885	PT	Melphalan/Paclitaxel		NCI
C10885	SY	L-PAM/TAX		NCI
C10885	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10885	RO	chemotherapy regimen has component Melphalan	NCI
C10885	RO	chemotherapy regimen has component Paclitaxel	NCI
C10742	STY	Therapeutic or Preventive Procedure		NCI
C10742	PT	Cisplatin/Etoposide/Vincristine		NCI
C10742	SY	CDDP/VCR/VP-16		NCI
C10742	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10742	RO	chemotherapy regimen has component Cisplatin	NCI
C10742	RO	chemotherapy regimen has component Etoposide	NCI
C10742	RO	chemotherapy regimen has component Vincristine	NCI
C9701	STY	Therapeutic or Preventive Procedure		NCI
C9701	PT	Melphalan/Procarbazine/Vinblastine		NCI
C9701	SY	PAVe		NCI
C9701	SY	L-PAM/PCB/VBL		NCI
C9701	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9701	RO	chemotherapy regimen has component Melphalan	NCI
C9701	RO	chemotherapy regimen has component Vinblastine	NCI
C9701	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C63382	STY	Therapeutic or Preventive Procedure		NCI
C63382	PT	EP Regimen		NCI
C63382	SY	Etoposide/Cisplatin		NCI
C63382	SY	Etoposide-Cisplatin		NCI
C63382	SY	PE		NCI
C63382	SY	PE Regimen		NCI
C63382	SY	Etoposide-Platinol Regimen		NCI
C63382	SY	Cisplatin/Etoposide		NCI
C63382	SY	EP		NCI
C63382	SY	Etoposide-Cisplatin Regimen		NCI
C63382	CHD	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm	NCI
C63382	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63382	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C63382	CHD	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C63382	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63382	RO	chemotherapy regimen has component Cisplatin	NCI
C63382	RO	chemotherapy regimen has component Etoposide	NCI
C63382	RO	regimen has accepted use for disease Lung Small Cell Carcinoma	NCI
C63382	RO	regimen has accepted use for disease Malignant Testicular Germ Cell Tumor	NCI
C10892	STY	Therapeutic or Preventive Procedure		NCI
C10892	PT	Benznidazole/Lomustine		NCI
C10892	SY	benznidazole/CCNU		NCI
C10892	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10892	RO	chemotherapy regimen has component Lomustine	NCI
C10892	RO	chemotherapy regimen has component Benznidazole	NCI
C140110	STY	Therapeutic or Preventive Procedure		NCI
C140110	PT	Nordic Regimen		NCI
C140110	SY	Rituximab Plus Maxi-CHOP Alternating with Rituximab Plus High-Dose Cytarabine		NCI
C140110	SY	Rituximab Plus Cyclophosphamide/Vincristine/Doxorubicin/Prednisone Alternating with Rituximab Plus High-Dose Cytarabine		NCI
C140110	SY	Rituximab/Maxi-CHOP Alternating with Rituximab/High-Dose Cytarabine		NCI
C140110	SY	Rituximab Plus Maxi-CHOP Alternating with Rituximab Plus HD Ara-C		NCI
C140110	SY	Rituximab with Alternating Cycles of Maxi-CHOP and High-dose Cytarabine		NCI
C140110	SY	Maxi-R-CHOP/R-HiDAC		NCI
C140110	SY	Rituximab Plus Cyclophosphamide/Hydroxydaunorubicin/Oncovin/Prednisone and R-HD-Ara-C		NCI
C140110	SY	R-MaxiCHOP Plus R-HDAraC		NCI
C140110	SY	Noridc		NCI
C140110	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140110	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C140110	RO	chemotherapy regimen has component Cytarabine	NCI
C140110	RO	chemotherapy regimen has component Doxorubicin	NCI
C140110	RO	chemotherapy regimen has component Prednisone	NCI
C140110	RO	chemotherapy regimen has component Vincristine	NCI
C140110	RO	chemotherapy regimen has component Rituximab	NCI
C10838	STY	Therapeutic or Preventive Procedure		NCI
C10838	PT	Cyclophosphamide/Milodistim		NCI
C10838	SY	CTX/PIXY321		NCI
C10838	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10838	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10838	RO	chemotherapy regimen has component Milodistim	NCI
C10841	STY	Therapeutic or Preventive Procedure		NCI
C10841	PT	Interleukin-1-Alpha/Methotrexate		NCI
C10841	SY	IL-1A/MTX		NCI
C10841	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10841	RO	chemotherapy regimen has component Methotrexate	NCI
C10841	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C63515	STY	Therapeutic or Preventive Procedure		NCI
C63515	PT	AIM Regimen		NCI
C63515	SY	Adriamycin-Ifosfamide-Mesna Regimen		NCI
C63515	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C63515	RO	chemotherapy regimen has component Mesna	NCI
C63515	RO	chemotherapy regimen has component Doxorubicin	NCI
C63515	RO	chemotherapy regimen has component Ifosfamide	NCI
C63515	RO	regimen has accepted use for disease Soft Tissue Sarcoma	NCI
C10721	STY	Therapeutic or Preventive Procedure		NCI
C10721	PT	Filgrastim/Fludarabine		NCI
C10721	SY	FAMP/G-CSF		NCI
C10721	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10721	RO	chemotherapy regimen has component Fludarabine	NCI
C10721	RO	chemotherapy regimen has component Filgrastim	NCI
C63402	STY	Therapeutic or Preventive Procedure		NCI
C63402	PT	Carboplatin-Taxol Regimen		NCI
C63402	SY	PC Regimen		NCI
C63402	SY	Carboplatin/Paclitaxel Regimen		NCI
C63402	SY	CaT Regimen		NCI
C63402	SY	Carboplatin/Paclitaxel		NCI
C63402	SY	Carboplatin-Paclitaxel Regimen		NCI
C63402	SY	Carbo-Tax Regimen		NCI
C63402	CHD	Chemotherapy Regimen Used to Treat Endometrial Carcinoma	NCI
C63402	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C63402	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63402	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C63402	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63402	RO	chemotherapy regimen has component Carboplatin	NCI
C63402	RO	chemotherapy regimen has component Paclitaxel	NCI
C63402	RO	regimen has accepted use for disease Endometrial Carcinoma	NCI
C63402	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C63402	RO	concept in subset CTRP Terminology	NCI
C63402	RO	concept in subset CTRP Agent Terminology	NCI
C63402	RO	regimen has accepted use for disease Ovarian Carcinoma	NCI
C10187	STY	Therapeutic or Preventive Procedure		NCI
C10187	PT	Aminoglutethimide/Danazol/Medroxyprogesterone/Tamoxifen		NCI
C10187	SY	POND		NCI
C10187	SY	AGT/DAN/MPA/TMX		NCI
C10187	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10187	RO	chemotherapy regimen has component Aminoglutethimide	NCI
C10187	RO	chemotherapy regimen has component Danazol	NCI
C10187	RO	chemotherapy regimen has component Medroxyprogesterone	NCI
C10187	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10994	STY	Therapeutic or Preventive Procedure		NCI
C10994	PT	Interferon Alfa/interleukin-2/Tumor Infiltrating Lymphocytes		NCI
C10994	SY	IFN-A/IL-2/TIL		NCI
C10994	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10994	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10994	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C10994	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37702	STY	Therapeutic or Preventive Procedure		NCI
C37702	PT	Cyclosporine/Sirolimus		NCI
C37702	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37702	RO	chemotherapy regimen has component Cyclosporine	NCI
C37702	RO	chemotherapy regimen has component Sirolimus	NCI
C11332	STY	Therapeutic or Preventive Procedure		NCI
C11332	PT	Amifostine/Cisplatin/Gemcitabine		NCI
C11332	SY	CDDP/dFdC/WR-2721		NCI
C11332	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11332	RO	chemotherapy regimen has component Cisplatin	NCI
C11332	RO	chemotherapy regimen has component Amifostine	NCI
C11332	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11073	STY	Therapeutic or Preventive Procedure		NCI
C11073	PT	Interferon Alfa/Interleukin-2/Tamoxifen		NCI
C11073	SY	IFN-A/IL-2/TMX		NCI
C11073	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11073	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11073	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11073	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10161	STY	Therapeutic or Preventive Procedure		NCI
C10161	PT	Cyclophosphamide/Cytarabine/Prednisolone/Vincristine		NCI
C10161	SY	COAP		NCI
C10161	SY	ARA-C/CTX/PRDL/VCR		NCI
C10161	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10161	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10161	RO	chemotherapy regimen has component Cytarabine	NCI
C10161	RO	chemotherapy regimen has component Prednisolone	NCI
C10161	RO	chemotherapy regimen has component Vincristine	NCI
C10290	STY	Therapeutic or Preventive Procedure		NCI
C10290	PT	Carboplatin/Fluorouracil/Methotrexate		NCI
C10290	SY	CBDCA/5-FU/MTX		NCI
C10290	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10290	RO	chemotherapy regimen has component Fluorouracil	NCI
C10290	RO	chemotherapy regimen has component Methotrexate	NCI
C10290	RO	chemotherapy regimen has component Carboplatin	NCI
C11778	STY	Therapeutic or Preventive Procedure		NCI
C11778	PT	Paclitaxel/SU5416		NCI
C11778	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11778	RO	chemotherapy regimen has component Paclitaxel	NCI
C11778	RO	chemotherapy regimen has component Semaxanib	NCI
C9633	STY	Therapeutic or Preventive Procedure		NCI
C9633	PT	Bleomycin/Cisplatin/Vinblastine		NCI
C9633	SY	VBP		NCI
C9633	SY	BLEO/CDDP/VBL		NCI
C9633	SY	VBD		NCI
C9633	SY	CVB		NCI
C9633	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9633	RO	chemotherapy regimen has component Bleomycin	NCI
C9633	RO	chemotherapy regimen has component Cisplatin	NCI
C9633	RO	chemotherapy regimen has component Vinblastine	NCI
C11088	STY	Therapeutic or Preventive Procedure		NCI
C11088	PT	Cyclophosphamide/Cytarabine/Mercaptopurine/Pegaspargase/Vincristine		NCI
C11088	SY	ARA-C/CTX/MP/PEG-ASP/VCR		NCI
C11088	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11088	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11088	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11088	RO	chemotherapy regimen has component Cytarabine	NCI
C11088	RO	chemotherapy regimen has component Vincristine	NCI
C11088	RO	chemotherapy regimen has component Pegaspargase	NCI
C10696	STY	Therapeutic or Preventive Procedure		NCI
C10696	PT	Cisplatin/Doxorubicin/Etoposide/Vincristine		NCI
C10696	SY	CDDP/DOX/VCR/VP-16		NCI
C10696	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10696	RO	chemotherapy regimen has component Cisplatin	NCI
C10696	RO	chemotherapy regimen has component Doxorubicin	NCI
C10696	RO	chemotherapy regimen has component Etoposide	NCI
C10696	RO	chemotherapy regimen has component Vincristine	NCI
C11533	STY	Therapeutic or Preventive Procedure		NCI
C11533	PT	Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine		NCI
C11533	SY	ARA-C/ASP/CTX/MP		NCI
C11533	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11533	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11533	RO	chemotherapy regimen has component Asparaginase	NCI
C11533	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11533	RO	chemotherapy regimen has component Cytarabine	NCI
C9983	STY	Therapeutic or Preventive Procedure		NCI
C9983	PT	Carboplatin/Cyclophosphamide/Sargramostim		NCI
C9983	SY	CBDCA/CTX/GM-CSF		NCI
C9983	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9983	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9983	RO	chemotherapy regimen has component Carboplatin	NCI
C9983	RO	chemotherapy regimen has component Sargramostim	NCI
C10587	STY	Therapeutic or Preventive Procedure		NCI
C10587	PT	Doxorubicin/Filgrastim		NCI
C10587	SY	DOX/G-CSF		NCI
C10587	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10587	RO	chemotherapy regimen has component Doxorubicin	NCI
C10587	RO	chemotherapy regimen has component Filgrastim	NCI
C15613	STY	Therapeutic or Preventive Procedure		NCI
C15613	PT	interleukin-2/Monoclonal Antibody OKT3/Tumor Necrosis Factor		NCI
C15613	SY	IL-2/MOAB OKT3/TNF		NCI
C15613	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15613	RO	chemotherapy regimen has component Muromonab-CD3	NCI
C15613	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C15613	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C11826	STY	Therapeutic or Preventive Procedure		NCI
C11826	PT	Fluorouracil/Leucovorin Calcium/Oxaliplatin/Trastuzumab		NCI
C11826	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11826	RO	chemotherapy regimen has component Fluorouracil	NCI
C11826	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11826	RO	chemotherapy regimen has component Trastuzumab	NCI
C11826	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12009	STY	Therapeutic or Preventive Procedure		NCI
C12009	PT	Carboplatin/Epirubicin		NCI
C12009	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12009	RO	chemotherapy regimen has component Carboplatin	NCI
C12009	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C9749	STY	Therapeutic or Preventive Procedure		NCI
C9749	PT	Paclitaxel/Cisplatin/Topotecan/G-CSF		NCI
C9749	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9749	RO	chemotherapy regimen has component Cisplatin	NCI
C9749	RO	chemotherapy regimen has component Paclitaxel	NCI
C9749	RO	chemotherapy regimen has component Topotecan	NCI
C9749	RO	chemotherapy regimen has component Recombinant Granulocyte Colony-Stimulating Factor	NCI
C37745	STY	Therapeutic or Preventive Procedure		NCI
C37745	PT	Docetaxel/Gefitinib		NCI
C37745	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37745	RO	chemotherapy regimen has component Docetaxel	NCI
C37745	RO	chemotherapy regimen has component Gefitinib	NCI
C10072	STY	Therapeutic or Preventive Procedure		NCI
C10072	PT	Cyclophosphamide/Dexrazoxane/Doxorubicin/Fluorouracil		NCI
C10072	SY	ADR-529/CTX/DOX/5-FU		NCI
C10072	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10072	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10072	RO	chemotherapy regimen has component Doxorubicin	NCI
C10072	RO	chemotherapy regimen has component Fluorouracil	NCI
C10072	RO	chemotherapy regimen has component Dexrazoxane	NCI
C11978	STY	Therapeutic or Preventive Procedure		NCI
C11978	PT	Cyclophosphamide/Dexrazoxane/Doxorubicin		NCI
C11978	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11978	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11978	RO	chemotherapy regimen has component Doxorubicin	NCI
C11978	RO	chemotherapy regimen has component Dexrazoxane	NCI
C10422	STY	Therapeutic or Preventive Procedure		NCI
C10422	PT	Carboplatin/Doxorubicin/Methotrexate/Vinblastine		NCI
C10422	SY	CBDCA/DOX/MTX/VBL		NCI
C10422	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10422	RO	chemotherapy regimen has component Doxorubicin	NCI
C10422	RO	chemotherapy regimen has component Methotrexate	NCI
C10422	RO	chemotherapy regimen has component Vinblastine	NCI
C10422	RO	chemotherapy regimen has component Carboplatin	NCI
C11352	STY	Therapeutic or Preventive Procedure		NCI
C11352	PT	Amifostine/Cisplatin/Cytarabine/Dexamethasone		NCI
C11352	SY	ARA-C/CDDP/DM/WR-2721		NCI
C11352	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11352	RO	chemotherapy regimen has component Cisplatin	NCI
C11352	RO	chemotherapy regimen has component Cytarabine	NCI
C11352	RO	chemotherapy regimen has component Dexamethasone	NCI
C11352	RO	chemotherapy regimen has component Amifostine	NCI
C11653	STY	Therapeutic or Preventive Procedure		NCI
C11653	PT	gp100 Antigen/Interleukin-2/MART-1 Antigen/Montanide ISA-51		NCI
C11653	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11653	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11653	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11653	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11653	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C136251	STY	Therapeutic or Preventive Procedure		NCI
C136251	PT	FOLFIRI/Ramucirumab Regimen		NCI
C136251	SY	FOLFIRI-Cyramza		NCI
C136251	SY	FOLFIRI-Ramucirumab Regimen		NCI
C136251	SY	FOLFIRI Plus Ramucirumab		NCI
C136251	SY	Folinic Acid/Fluorouracil/Irinotecan/Ramucirumab		NCI
C136251	SY	FOLFIRI-Cyramza Regimen		NCI
C136251	SY	FOLFIRI Plus Cyramza		NCI
C136251	SY	FOLFIRI/Cyramza Regimen		NCI
C136251	SY	FOLFIRI/Ramucirumab		NCI
C136251	SY	FOLFIRI/Cyramza		NCI
C136251	SY	FOLFIRI-Ramucirumab		NCI
C136251	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136251	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136251	RO	chemotherapy regimen has component Fluorouracil	NCI
C136251	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C136251	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C136251	RO	chemotherapy regimen has component Ramucirumab	NCI
C12126	STY	Therapeutic or Preventive Procedure		NCI
C12126	PT	Isotretinoin/Monoclonal antibody Ch14.18		NCI
C12126	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12126	RO	chemotherapy regimen has component Isotretinoin	NCI
C12126	RO	chemotherapy regimen has component Dinutuximab	NCI
C11908	STY	Therapeutic or Preventive Procedure		NCI
C11908	PT	Cyclophosphamide/Doxorubicin/Iodine I 131 Tositumomab/Prednisone/Vincristine		NCI
C11908	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11908	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11908	RO	chemotherapy regimen has component Doxorubicin	NCI
C11908	RO	chemotherapy regimen has component Prednisone	NCI
C11908	RO	chemotherapy regimen has component Vincristine	NCI
C11908	RO	chemotherapy regimen has component Iodine I 131 Tositumomab	NCI
C10495	STY	Therapeutic or Preventive Procedure		NCI
C10495	PT	Cisplatin/Fluorouracil/Hydroxyurea/Leucovorin Calcium		NCI
C10495	SY	CDDP/CF/5-FU/HU		NCI
C10495	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10495	RO	chemotherapy regimen has component Cisplatin	NCI
C10495	RO	chemotherapy regimen has component Fluorouracil	NCI
C10495	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10495	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11013	STY	Therapeutic or Preventive Procedure		NCI
C11013	PT	Interferon Alfa/Interleukin-2/Lymphokine-Activated Killer Cells		NCI
C11013	SY	IFN-A/IL-2/LAK		NCI
C11013	SY	IL2/LAK/IFN		NCI
C11013	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11013	RO	chemotherapy regimen has component Lymphokine-Activated Killer Cells	NCI
C11013	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11013	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C15531	STY	Therapeutic or Preventive Procedure		NCI
C15531	PT	Monoclonal Antibody R24/Sargramostim		NCI
C15531	SY	GM-CSF/MOAB R24		NCI
C15531	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15531	RO	chemotherapy regimen has component Sargramostim	NCI
C15531	RO	chemotherapy regimen has component Monoclonal Antibody R24	NCI
C10341	STY	Therapeutic or Preventive Procedure		NCI
C10341	PT	Thiotepa/Vincristine		NCI
C10341	SY	TSPA/VCR		NCI
C10341	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10341	RO	chemotherapy regimen has component Thiotepa	NCI
C10341	RO	chemotherapy regimen has component Vincristine	NCI
C10577	STY	Therapeutic or Preventive Procedure		NCI
C10577	PT	Asparaginase/Cyclophosphamide/Filgrastim		NCI
C10577	SY	ARA-C/CTX/G-CSF		NCI
C10577	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10577	RO	chemotherapy regimen has component Asparaginase	NCI
C10577	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10577	RO	chemotherapy regimen has component Filgrastim	NCI
C11083	STY	Therapeutic or Preventive Procedure		NCI
C11083	PT	Interleukin-2/Zinc Oxide		NCI
C11083	SY	IL-2/ZnO		NCI
C11083	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11083	RO	chemotherapy regimen has component Zinc Oxide	NCI
C11083	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10210	STY	Therapeutic or Preventive Procedure		NCI
C10210	PT	Amifostine/Thiotepa		NCI
C10210	SY	TSPA/WR-2721		NCI
C10210	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10210	RO	chemotherapy regimen has component Amifostine	NCI
C10210	RO	chemotherapy regimen has component Thiotepa	NCI
C11562	STY	Therapeutic or Preventive Procedure		NCI
C11562	PT	Doxorubicin/Pegaspargase/Prednisone/Vincristine		NCI
C11562	SY	DOX/PEG-ASP/PRED/VCR		NCI
C11562	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11562	RO	chemotherapy regimen has component Doxorubicin	NCI
C11562	RO	chemotherapy regimen has component Prednisone	NCI
C11562	RO	chemotherapy regimen has component Vincristine	NCI
C11562	RO	chemotherapy regimen has component Pegaspargase	NCI
C11981	STY	Therapeutic or Preventive Procedure		NCI
C11981	PT	Interferon Alfa/Lymphokine-Activated Killer Cells		NCI
C11981	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11981	RO	chemotherapy regimen has component Lymphokine-Activated Killer Cells	NCI
C11981	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11093	STY	Therapeutic or Preventive Procedure		NCI
C11093	PT	Carmustine/Cytarabine/Methotrexate/Vincristine		NCI
C11093	SY	ARA-C/BCNU/MTX/VCR		NCI
C11093	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11093	RO	chemotherapy regimen has component Carmustine	NCI
C11093	RO	chemotherapy regimen has component Cytarabine	NCI
C11093	RO	chemotherapy regimen has component Methotrexate	NCI
C11093	RO	chemotherapy regimen has component Vincristine	NCI
C37852	STY	Therapeutic or Preventive Procedure		NCI
C37852	PT	Sargramostim/Telomerase: 540-548 Peptide Vaccine		NCI
C37852	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37852	RO	chemotherapy regimen has component Sargramostim	NCI
C37852	RO	chemotherapy regimen has component Telomerase: 540-548 Peptide Vaccine	NCI
C11637	STY	Therapeutic or Preventive Procedure		NCI
C11637	PT	Carboplatin/Paclitaxel/Thalidomide		NCI
C11637	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11637	RO	chemotherapy regimen has component Thalidomide	NCI
C11637	RO	chemotherapy regimen has component Carboplatin	NCI
C11637	RO	chemotherapy regimen has component Paclitaxel	NCI
C10147	STY	Therapeutic or Preventive Procedure		NCI
C10147	PT	Dipyridamole/Vinblastine		NCI
C10147	SY	DP/VBL		NCI
C10147	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10147	RO	chemotherapy regimen has component Dipyridamole	NCI
C10147	RO	chemotherapy regimen has component Vinblastine	NCI
C11081	STY	Therapeutic or Preventive Procedure		NCI
C11081	PT	Bleomycin/Dacarbazine/Lomustine/Vincristine		NCI
C11081	SY	BLEO/CCNU/DTIC/VCR		NCI
C11081	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11081	RO	chemotherapy regimen has component Bleomycin	NCI
C11081	RO	chemotherapy regimen has component Dacarbazine	NCI
C11081	RO	chemotherapy regimen has component Lomustine	NCI
C11081	RO	chemotherapy regimen has component Vincristine	NCI
C11753	STY	Therapeutic or Preventive Procedure		NCI
C11753	PT	Ifosfamide/Paclitaxel/Teniposide		NCI
C11753	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11753	RO	chemotherapy regimen has component Ifosfamide	NCI
C11753	RO	chemotherapy regimen has component Teniposide	NCI
C11753	RO	chemotherapy regimen has component Paclitaxel	NCI
C9767	STY	Therapeutic or Preventive Procedure		NCI
C9767	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Interferon Alfa/Tamoxifen		NCI
C9767	SY	CTX/DOX/5-FU/FXM/IFN-A/TMX		NCI
C9767	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9767	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9767	RO	chemotherapy regimen has component Doxorubicin	NCI
C9767	RO	chemotherapy regimen has component Fluorouracil	NCI
C9767	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C9767	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C84861	STY	Pharmacologic Substance		NCI
C84861	PT	dHER2 Vaccine+AS15 Adjuvant		NCI
C84861	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C84861	RO	concept in subset CTRP Terminology	NCI
C84861	RO	concept in subset CTRP Agent Terminology	NCI
C10754	STY	Therapeutic or Preventive Procedure		NCI
C10754	PT	Cyclophosphamide/Doxorubicin/Paclitaxel		NCI
C10754	SY	CTX/DOX/TAX		NCI
C10754	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10754	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10754	RO	chemotherapy regimen has component Doxorubicin	NCI
C10754	RO	chemotherapy regimen has component Paclitaxel	NCI
C67485	STY	Therapeutic or Preventive Procedure		NCI
C67485	PT	MAE Regimen		NCI
C67485	SY	Mitoxantrone-Cytarabine-Etoposide Regimen		NCI
C67485	SY	Mitoxantrone-AraC-Etoposide Regimen		NCI
C67485	SY	MRC AML10 Study-MAE Regimen		NCI
C67485	CHD	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia	NCI
C67485	RO	chemotherapy regimen has component Cytarabine	NCI
C67485	RO	chemotherapy regimen has component Etoposide	NCI
C67485	RO	regimen has accepted use for disease Childhood Acute Myeloid Leukemia	NCI
C67485	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37836	STY	Therapeutic or Preventive Procedure		NCI
C37836	PT	Mitoxantrone/Prednisone/Prinomastat		NCI
C37836	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37836	RO	chemotherapy regimen has component Prednisone	NCI
C37836	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37836	RO	chemotherapy regimen has component Prinomastat	NCI
C37833	STY	Therapeutic or Preventive Procedure		NCI
C37833	PT	Methotrexate/Thiotepa		NCI
C37833	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37833	RO	chemotherapy regimen has component Methotrexate	NCI
C37833	RO	chemotherapy regimen has component Thiotepa	NCI
C12074	STY	Therapeutic or Preventive Procedure		NCI
C12074	PT	Pentostatin/Rituximab		NCI
C12074	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12074	RO	chemotherapy regimen has component Pentostatin	NCI
C12074	RO	chemotherapy regimen has component Rituximab	NCI
C63444	STY	Therapeutic or Preventive Procedure		NCI
C63444	PT	FC Regimen		NCI
C63444	SY	Fludarabine-Cyclophosphamide Regimen		NCI
C63444	SY	CF Regimen		NCI
C63444	SY	Flu-Cy Regimen		NCI
C63444	CHD	Chemotherapy Regimen Used to Treat Chronic Lymphocytic Leukemia	NCI
C63444	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63444	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63444	RO	regimen has accepted use for disease Chronic Lymphocytic Leukemia	NCI
C63444	RO	chemotherapy regimen has component Fludarabine	NCI
C63444	RO	regimen has accepted use for disease Recurrent Mantle Cell Lymphoma	NCI
C63444	RO	regimen has accepted use for disease Refractory Mantle Cell Lymphoma	NCI
C11968	STY	Therapeutic or Preventive Procedure		NCI
C11968	PT	3-AP/Cisplatin/Paclitaxel		NCI
C11968	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11968	RO	chemotherapy regimen has component Cisplatin	NCI
C11968	RO	chemotherapy regimen has component Paclitaxel	NCI
C11968	RO	chemotherapy regimen has component Triapine	NCI
C9926	STY	Therapeutic or Preventive Procedure		NCI
C9926	PT	Doxorubicin/Ifosfamide/Methotrexate		NCI
C9926	SY	DOX/IFF/MTX		NCI
C9926	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9926	RO	chemotherapy regimen has component Doxorubicin	NCI
C9926	RO	chemotherapy regimen has component Ifosfamide	NCI
C9926	RO	chemotherapy regimen has component Methotrexate	NCI
C10552	STY	Therapeutic or Preventive Procedure		NCI
C10552	PT	Altretamine/Cisplatin/Etoposide		NCI
C10552	SY	CDDP/HMM/VP-16		NCI
C10552	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10552	RO	chemotherapy regimen has component Cisplatin	NCI
C10552	RO	chemotherapy regimen has component Etoposide	NCI
C10552	RO	chemotherapy regimen has component Altretamine	NCI
C11966	STY	Therapeutic or Preventive Procedure		NCI
C11966	PT	Autologous Tumor Cell Vaccine/BCG		NCI
C11966	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11966	RO	chemotherapy regimen has component BCG Vaccine	NCI
C11966	RO	chemotherapy regimen has component Autologous Tumor Cell Vaccine	NCI
C37629	STY	Therapeutic or Preventive Procedure		NCI
C37629	PT	Celecoxib/Epirubicin		NCI
C37629	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37629	RO	chemotherapy regimen has component Celecoxib	NCI
C37629	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11037	STY	Therapeutic or Preventive Procedure		NCI
C11037	PT	Filgrastim/Fluorouracil/Interferon Alfa		NCI
C11037	SY	5-FU/G-CSF/IFN-A		NCI
C11037	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11037	RO	chemotherapy regimen has component Fluorouracil	NCI
C11037	RO	chemotherapy regimen has component Filgrastim	NCI
C11037	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37841	STY	Therapeutic or Preventive Procedure		NCI
C37841	PT	Oblimersen/Rituximab		NCI
C37841	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37841	RO	chemotherapy regimen has component Rituximab	NCI
C37841	RO	chemotherapy regimen has component Oblimersen	NCI
C64833	STY	Pharmacologic Substance		NCI
C64833	STY	Nucleic Acid, Nucleoside, or Nucleotide		NCI
C64833	PT	Gemcitabine-Oxaliplatin Regimen		NCI
C64833	SY	GEMOX Regimen		NCI
C64833	SY	GEM-OX Regimen		NCI
C64833	CHD	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C64833	RO	chemotherapy regimen has component Oxaliplatin	NCI
C64833	RO	regimen has accepted use for disease Pancreatic Carcinoma	NCI
C64833	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10843	STY	Therapeutic or Preventive Procedure		NCI
C10843	PT	Interferon Gamma/Interleukin-2/Melphalan/Tumor Necrosis Factor		NCI
C10843	SY	IFN-G/IL-2/L-PAM/TNF		NCI
C10843	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10843	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C10843	RO	chemotherapy regimen has component Melphalan	NCI
C10843	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10843	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C11218	STY	Therapeutic or Preventive Procedure		NCI
C11218	PT	Docetaxel/Doxorubicin		NCI
C11218	SY	DOX/TXT		NCI
C11218	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11218	RO	chemotherapy regimen has component Doxorubicin	NCI
C11218	RO	chemotherapy regimen has component Docetaxel	NCI
C10050	STY	Therapeutic or Preventive Procedure		NCI
C10050	PT	Asparaginase/Idarubicin/Prednisone/Vincristine		NCI
C10050	SY	ASP/IDA/PRED/VCR		NCI
C10050	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10050	RO	chemotherapy regimen has component Asparaginase	NCI
C10050	RO	chemotherapy regimen has component Idarubicin	NCI
C10050	RO	chemotherapy regimen has component Prednisone	NCI
C10050	RO	chemotherapy regimen has component Vincristine	NCI
C12146	STY	Therapeutic or Preventive Procedure		NCI
C12146	PT	Cytarabine/Etoposide/Rituximab		NCI
C12146	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12146	RO	chemotherapy regimen has component Cytarabine	NCI
C12146	RO	chemotherapy regimen has component Etoposide	NCI
C12146	RO	chemotherapy regimen has component Rituximab	NCI
C10253	STY	Therapeutic or Preventive Procedure		NCI
C10253	PT	Cytarabine/Teniposide		NCI
C10253	SY	ARA-C/VM-26		NCI
C10253	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10253	RO	chemotherapy regimen has component Cytarabine	NCI
C10253	RO	chemotherapy regimen has component Teniposide	NCI
C10158	STY	Therapeutic or Preventive Procedure		NCI
C10158	PT	Cisplatin/Fluorouracil/Vinblastine		NCI
C10158	SY	FVP		NCI
C10158	SY	CDDP/5-FU/VBL		NCI
C10158	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10158	RO	chemotherapy regimen has component Cisplatin	NCI
C10158	RO	chemotherapy regimen has component Fluorouracil	NCI
C10158	RO	chemotherapy regimen has component Vinblastine	NCI
C11947	STY	Therapeutic or Preventive Procedure		NCI
C11947	PT	Cisplatin/UCN-01		NCI
C11947	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11947	RO	chemotherapy regimen has component Cisplatin	NCI
C11947	RO	chemotherapy regimen has component 7-Hydroxystaurosporine	NCI
C10067	STY	Therapeutic or Preventive Procedure		NCI
C10067	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Streptozocin		NCI
C10067	SY	FAC-S		NCI
C10067	SY	CTX/DOX/5-FU/SZC		NCI
C10067	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10067	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10067	RO	chemotherapy regimen has component Doxorubicin	NCI
C10067	RO	chemotherapy regimen has component Fluorouracil	NCI
C10067	RO	chemotherapy regimen has component Streptozocin	NCI
C11765	STY	Therapeutic or Preventive Procedure		NCI
C11765	PT	Carboplatin/Paclitaxel/Tirapazamine		NCI
C11765	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11765	RO	chemotherapy regimen has component Carboplatin	NCI
C11765	RO	chemotherapy regimen has component Paclitaxel	NCI
C11765	RO	chemotherapy regimen has component Tirapazamine	NCI
C11019	STY	Therapeutic or Preventive Procedure		NCI
C11019	PT	Cisplatin/Cyclophosphamide/Interferon Alfa		NCI
C11019	SY	CDDP/CTX/IFN-A		NCI
C11019	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11019	RO	chemotherapy regimen has component Cisplatin	NCI
C11019	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11019	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11537	STY	Therapeutic or Preventive Procedure		NCI
C11537	PT	Asparaginase/Cytarabine/Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine		NCI
C11537	SY	ARA-C/ASP/CF/DM/MP/MTX/VCR		NCI
C11537	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11537	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11537	RO	chemotherapy regimen has component Asparaginase	NCI
C11537	RO	chemotherapy regimen has component Cytarabine	NCI
C11537	RO	chemotherapy regimen has component Dexamethasone	NCI
C11537	RO	chemotherapy regimen has component Methotrexate	NCI
C11537	RO	chemotherapy regimen has component Vincristine	NCI
C11537	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10952	STY	Therapeutic or Preventive Procedure		NCI
C10952	PT	CT-1501R/Interleukin-2		NCI
C10952	SY	CT-1501R/IL-2		NCI
C10952	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10952	RO	chemotherapy regimen has component Lisofylline	NCI
C10952	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10482	STY	Therapeutic or Preventive Procedure		NCI
C10482	PT	Cisplatin/Dacarbazine/Interleukin-2/Tamoxifen		NCI
C10482	SY	CDDP/DTIC/IL-2/TMX		NCI
C10482	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10482	RO	chemotherapy regimen has component Cisplatin	NCI
C10482	RO	chemotherapy regimen has component Dacarbazine	NCI
C10482	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10482	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10991	STY	Therapeutic or Preventive Procedure		NCI
C10991	PT	Interferon Alfa/Tamoxifen		NCI
C10991	SY	IFN-A/TMX		NCI
C10991	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10991	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10991	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9864	STY	Therapeutic or Preventive Procedure		NCI
C9864	PT	Cisplatin/Cyclophosphamide/Melphalan		NCI
C9864	SY	CDDP/CTX/L-PAM		NCI
C9864	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9864	RO	chemotherapy regimen has component Cisplatin	NCI
C9864	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9864	RO	chemotherapy regimen has component Melphalan	NCI
C10413	STY	Therapeutic or Preventive Procedure		NCI
C10413	PT	Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate		NCI
C10413	SY	ARA-C/ASP/CTX/MTX		NCI
C10413	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10413	RO	chemotherapy regimen has component Asparaginase	NCI
C10413	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10413	RO	chemotherapy regimen has component Cytarabine	NCI
C10413	RO	chemotherapy regimen has component Methotrexate	NCI
C10170	STY	Therapeutic or Preventive Procedure		NCI
C10170	PT	Mercaptopurine/Methotrexate/Prednisolone/Vincristine		NCI
C10170	SY	POMP		NCI
C10170	SY	MP/MTX/PRDL/VCR		NCI
C10170	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10170	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10170	RO	chemotherapy regimen has component Methotrexate	NCI
C10170	RO	chemotherapy regimen has component Prednisolone	NCI
C10170	RO	chemotherapy regimen has component Vincristine	NCI
C10052	STY	Therapeutic or Preventive Procedure		NCI
C10052	PT	Asparaginase/Cytarabine/Idarubicin		NCI
C10052	SY	ARA-C/ASP/IDA		NCI
C10052	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10052	RO	chemotherapy regimen has component Asparaginase	NCI
C10052	RO	chemotherapy regimen has component Cytarabine	NCI
C10052	RO	chemotherapy regimen has component Idarubicin	NCI
C10339	STY	Therapeutic or Preventive Procedure		NCI
C10339	PT	Cytarabine/Vincristine		NCI
C10339	SY	ARA-C/VCR		NCI
C10339	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10339	RO	chemotherapy regimen has component Cytarabine	NCI
C10339	RO	chemotherapy regimen has component Vincristine	NCI
C10262	STY	Therapeutic or Preventive Procedure		NCI
C10262	PT	Cisplatin/Mitomycin/Vindesine		NCI
C10262	SY	MiPE		NCI
C10262	SY	MVP		NCI
C10262	SY	CDDP/DAVA/MITO		NCI
C10262	SY	MiViP		NCI
C10262	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10262	RO	chemotherapy regimen has component Mitomycin	NCI
C10262	RO	chemotherapy regimen has component Cisplatin	NCI
C10262	RO	chemotherapy regimen has component Vindesine	NCI
C10847	STY	Therapeutic or Preventive Procedure		NCI
C10847	PT	Carboplatin/Filgrastim/Paclitaxel		NCI
C10847	SY	CBDCA/G-CSF/TAX		NCI
C10847	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10847	RO	chemotherapy regimen has component Carboplatin	NCI
C10847	RO	chemotherapy regimen has component Paclitaxel	NCI
C10847	RO	chemotherapy regimen has component Filgrastim	NCI
C10251	STY	Therapeutic or Preventive Procedure		NCI
C10251	PT	Cisplatin/Mitomycin/Triazinate		NCI
C10251	SY	CDDP/MITO/TZT		NCI
C10251	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10251	RO	chemotherapy regimen has component Mitomycin	NCI
C10251	RO	chemotherapy regimen has component Cisplatin	NCI
C10251	RO	chemotherapy regimen has component Triazinate	NCI
C12051	STY	Therapeutic or Preventive Procedure		NCI
C12051	PT	Bevacizumab/Fluorouracil/Hydroxyurea		NCI
C12051	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12051	RO	chemotherapy regimen has component Fluorouracil	NCI
C12051	RO	chemotherapy regimen has component Hydroxyurea	NCI
C12051	RO	chemotherapy regimen has component Bevacizumab	NCI
C11147	STY	Therapeutic or Preventive Procedure		NCI
C11147	PT	Mercaptopurine/Vincristine		NCI
C11147	SY	MP/VCR		NCI
C11147	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11147	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11147	RO	chemotherapy regimen has component Vincristine	NCI
C63359	STY	Therapeutic or Preventive Procedure		NCI
C63359	PT	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma		NCI
C63359	CHD	Chemotherapy Regimen	NCI
C63359	PAR	EVAC Regimen	NCI
C63359	PAR	Cyclophosphamide-Etoposide-Vincristine Regimen	NCI
C63359	PAR	CAV Regimen	NCI
C63359	PAR	CAE Regimen	NCI
C63359	PAR	Carboplatin-Paclitaxel-Etoposide Regimen	NCI
C63359	PAR	EP Regimen	NCI
C63359	PAR	Irinotecan-Cisplatin Regimen	NCI
C63359	PAR	PET Regimen	NCI
C63359	PAR	EC Regimen	NCI
C63359	PAR	Carboplatin/Topotecan Regimen	NCI
C9747	STY	Therapeutic or Preventive Procedure		NCI
C9747	PT	Docetaxel/Vinblastine		NCI
C9747	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9747	RO	chemotherapy regimen has component Vinblastine	NCI
C9747	RO	chemotherapy regimen has component Docetaxel	NCI
C11284	STY	Therapeutic or Preventive Procedure		NCI
C11284	PT	Cytarabine/Etoposide/Mitoxantrone/PSC 833		NCI
C11284	SY	ARA-C/DHAD/PSC 833/VP-16		NCI
C11284	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11284	RO	chemotherapy regimen has component Cytarabine	NCI
C11284	RO	chemotherapy regimen has component Etoposide	NCI
C11284	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11284	RO	chemotherapy regimen has component Valspodar	NCI
C37715	STY	Therapeutic or Preventive Procedure		NCI
C37715	PT	Cytarabine/Flavopiridol/Mitoxantrone		NCI
C37715	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37715	RO	chemotherapy regimen has component Cytarabine	NCI
C37715	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37715	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C10553	STY	Therapeutic or Preventive Procedure		NCI
C10553	PT	Amifostine/Melphalan		NCI
C10553	SY	L-PAM/WR-2721		NCI
C10553	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10553	RO	chemotherapy regimen has component Amifostine	NCI
C10553	RO	chemotherapy regimen has component Melphalan	NCI
C10859	STY	Therapeutic or Preventive Procedure		NCI
C10859	PT	Carboplatin/Etoposide/Tamoxifen		NCI
C10859	SY	CBDCA/TMX/VP-16		NCI
C10859	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10859	RO	chemotherapy regimen has component Etoposide	NCI
C10859	RO	chemotherapy regimen has component Carboplatin	NCI
C10859	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11881	STY	Therapeutic or Preventive Procedure		NCI
C11881	PT	Carboplatin/SU5416		NCI
C11881	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11881	RO	chemotherapy regimen has component Carboplatin	NCI
C11881	RO	chemotherapy regimen has component Semaxanib	NCI
C10195	STY	Therapeutic or Preventive Procedure		NCI
C10195	PT	Dacarbazine/Doxorubicin/Ifosfamide		NCI
C10195	SY	DOX/DTIC/IFF		NCI
C10195	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10195	RO	chemotherapy regimen has component Dacarbazine	NCI
C10195	RO	chemotherapy regimen has component Doxorubicin	NCI
C10195	RO	chemotherapy regimen has component Ifosfamide	NCI
C12119	STY	Therapeutic or Preventive Procedure		NCI
C12119	PT	Cyclophosphamide/Dexamethasone/Doxorubicin		NCI
C12119	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12119	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12119	RO	chemotherapy regimen has component Dexamethasone	NCI
C12119	RO	chemotherapy regimen has component Doxorubicin	NCI
C140657	STY	Therapeutic or Preventive Procedure		NCI
C140657	PT	BAC Regimen		NCI
C140657	SY	BAC		NCI
C140657	SY	Bendamustine/Ara-C		NCI
C140657	SY	Bendamustine/Cytarabine		NCI
C140657	SY	Bendamustine-Cytarabine		NCI
C140657	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140657	RO	chemotherapy regimen has component Cytarabine	NCI
C140657	RO	chemotherapy regimen has component Bendamustine	NCI
C10215	STY	Therapeutic or Preventive Procedure		NCI
C10215	PT	Cyclophosphamide/Doxorubicin/Prednisone/Teniposide/Vincristine		NCI
C10215	SY	CAVPE		NCI
C10215	SY	CTX/DOX/PRED/VCR/VM-26		NCI
C10215	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10215	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10215	RO	chemotherapy regimen has component Doxorubicin	NCI
C10215	RO	chemotherapy regimen has component Prednisone	NCI
C10215	RO	chemotherapy regimen has component Teniposide	NCI
C10215	RO	chemotherapy regimen has component Vincristine	NCI
C10747	STY	Therapeutic or Preventive Procedure		NCI
C10747	PT	Dexamethasone/Doxorubicin/Prednisone/Vincristine		NCI
C10747	SY	DM/DOX/PRED/VCR		NCI
C10747	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10747	RO	chemotherapy regimen has component Dexamethasone	NCI
C10747	RO	chemotherapy regimen has component Doxorubicin	NCI
C10747	RO	chemotherapy regimen has component Prednisone	NCI
C10747	RO	chemotherapy regimen has component Vincristine	NCI
C10224	STY	Therapeutic or Preventive Procedure		NCI
C10224	PT	Cisplatin/Melphalan/Teniposide		NCI
C10224	SY	CDDP/L-PAM/VM-26		NCI
C10224	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10224	RO	chemotherapy regimen has component Cisplatin	NCI
C10224	RO	chemotherapy regimen has component Melphalan	NCI
C10224	RO	chemotherapy regimen has component Teniposide	NCI
C10061	STY	Therapeutic or Preventive Procedure		NCI
C10061	PT	Altretamine/Lomustine/Methotrexate		NCI
C10061	SY	CCNU/HMM/MTX		NCI
C10061	SY	CHEXM		NCI
C10061	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10061	RO	chemotherapy regimen has component Altretamine	NCI
C10061	RO	chemotherapy regimen has component Lomustine	NCI
C10061	RO	chemotherapy regimen has component Methotrexate	NCI
C37541	STY	Therapeutic or Preventive Procedure		NCI
C37541	PT	Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine/Sargramostim		NCI
C37541	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37541	RO	chemotherapy regimen has component Sargramostim	NCI
C37541	RO	chemotherapy regimen has component Autologous Immunoglobulin Idiotype-KLH Conjugate Vaccine	NCI
C12214	STY	Therapeutic or Preventive Procedure		NCI
C12214	PT	Docetaxel/Hypericum perforatum		NCI
C12214	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12214	RO	chemotherapy regimen has component Docetaxel	NCI
C12214	RO	chemotherapy regimen has component St. John's Wort	NCI
C9667	STY	Therapeutic or Preventive Procedure		NCI
C9667	PT	Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine		NCI
C9667	SY	CHOD		NCI
C9667	SY	CVAD		NCI
C9667	SY	CTX/DM/DOX/VCR		NCI
C9667	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9667	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9667	RO	chemotherapy regimen has component Dexamethasone	NCI
C9667	RO	chemotherapy regimen has component Doxorubicin	NCI
C9667	RO	chemotherapy regimen has component Vincristine	NCI
C63497	STY	Therapeutic or Preventive Procedure		NCI
C63497	PT	MP-Myeloma Regimen		NCI
C63497	SY	Melphalan-Prednisone Regimen		NCI
C63497	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C63497	RO	chemotherapy regimen has component Melphalan	NCI
C63497	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C63497	RO	chemotherapy regimen has component Prednisone	NCI
C10296	STY	Therapeutic or Preventive Procedure		NCI
C10296	PT	Cisplatin/Doxorubicin/Etoposide/Fluorouracil/Mitomycin		NCI
C10296	SY	CDDP/DOX/5-FU/MITO/VP-16		NCI
C10296	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10296	RO	chemotherapy regimen has component Mitomycin	NCI
C10296	RO	chemotherapy regimen has component Cisplatin	NCI
C10296	RO	chemotherapy regimen has component Doxorubicin	NCI
C10296	RO	chemotherapy regimen has component Etoposide	NCI
C10296	RO	chemotherapy regimen has component Fluorouracil	NCI
C9552	STY	Therapeutic or Preventive Procedure		NCI
C9552	PT	Cisplatin/Fluorouracil/Methotrexate		NCI
C9552	SY	CDDP/5-FU/MTX		NCI
C9552	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9552	RO	chemotherapy regimen has component Cisplatin	NCI
C9552	RO	chemotherapy regimen has component Fluorouracil	NCI
C9552	RO	chemotherapy regimen has component Methotrexate	NCI
C10317	STY	Therapeutic or Preventive Procedure		NCI
C10317	PT	Lomustine/Mitoxantrone/Vinblastine		NCI
C10317	SY	CCNU/DHAD/VBL		NCI
C10317	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10317	RO	chemotherapy regimen has component Lomustine	NCI
C10317	RO	chemotherapy regimen has component Vinblastine	NCI
C10317	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10053	STY	Therapeutic or Preventive Procedure		NCI
C10053	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Prednisone		NCI
C10053	SY	CTX/DOX/5-FU/PRED		NCI
C10053	SY	CAFP		NCI
C10053	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10053	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10053	RO	chemotherapy regimen has component Doxorubicin	NCI
C10053	RO	chemotherapy regimen has component Fluorouracil	NCI
C10053	RO	chemotherapy regimen has component Prednisone	NCI
C11589	STY	Therapeutic or Preventive Procedure		NCI
C11589	PT	Incomplete Freund's Adjuvant/Interleukin-2/Von Hippel-Lindau Peptide Vaccine		NCI
C11589	SY	Incomplete Freund's IFA/IL-2/VHL peptide		NCI
C11589	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11589	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11589	RO	chemotherapy regimen has component Von Hippel-Lindau Peptide Vaccine	NCI
C11589	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11409	STY	Therapeutic or Preventive Procedure		NCI
C11409	PT	Doxorubicin HCl Liposome/Topotecan		NCI
C11409	SY	LipoDox/TOPO		NCI
C11409	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11409	RO	chemotherapy regimen has component Topotecan	NCI
C11409	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C9902	STY	Therapeutic or Preventive Procedure		NCI
C9902	PT	Cisplatin/Doxorubicin/Octreotide		NCI
C9902	SY	CDDP/DOX/SSTN		NCI
C9902	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9902	RO	chemotherapy regimen has component Cisplatin	NCI
C9902	RO	chemotherapy regimen has component Doxorubicin	NCI
C9902	RO	chemotherapy regimen has component Octreotide	NCI
C37859	STY	Therapeutic or Preventive Procedure		NCI
C37859	PT	Tipifarnib/Topotecan		NCI
C37859	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37859	RO	chemotherapy regimen has component Topotecan	NCI
C37859	RO	chemotherapy regimen has component Tipifarnib	NCI
C11800	STY	Therapeutic or Preventive Procedure		NCI
C11800	PT	Docetaxel/Trastuzumab		NCI
C11800	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11800	RO	chemotherapy regimen has component Docetaxel	NCI
C11800	RO	chemotherapy regimen has component Trastuzumab	NCI
C37628	STY	Therapeutic or Preventive Procedure		NCI
C37628	PT	Celecoxib/Docetaxel/Irinotecan		NCI
C37628	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37628	RO	chemotherapy regimen has component Docetaxel	NCI
C37628	RO	chemotherapy regimen has component Celecoxib	NCI
C37628	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C28890	STY	Therapeutic or Preventive Procedure		NCI
C28890	PT	Cyclophosphamide/Mechlorethamine/Prednisone/Procarbazine/Vincristine		NCI
C28890	SY	CMOPP		NCI
C28890	SY	C-MOPP		NCI
C28890	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C28890	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C28890	RO	chemotherapy regimen has component Prednisone	NCI
C28890	RO	chemotherapy regimen has component Vincristine	NCI
C28890	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C28890	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C11897	STY	Therapeutic or Preventive Procedure		NCI
C11897	PT	Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vinblastine		NCI
C11897	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11897	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11897	RO	chemotherapy regimen has component Dexamethasone	NCI
C11897	RO	chemotherapy regimen has component Doxorubicin	NCI
C11897	RO	chemotherapy regimen has component Methotrexate	NCI
C11897	RO	chemotherapy regimen has component Vinblastine	NCI
C64835	STY	Therapeutic or Preventive Procedure		NCI
C64835	PT	Gemcitabine-Irinotecan Regimen		NCI
C64835	CHD	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C64835	RO	regimen has accepted use for disease Pancreatic Carcinoma	NCI
C64835	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C64835	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10925	STY	Therapeutic or Preventive Procedure		NCI
C10925	PT	Cyclophosphamide/Doxorubicin/Methylprednisolone/Vincristine		NCI
C10925	SY	CTX/DOX/MePRDL/VCR		NCI
C10925	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10925	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10925	RO	chemotherapy regimen has component Doxorubicin	NCI
C10925	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10925	RO	chemotherapy regimen has component Vincristine	NCI
C9849	STY	Therapeutic or Preventive Procedure		NCI
C9849	PT	Cyclophosphamide/Cytarabine/Vincristine		NCI
C9849	SY	cytarabine/cyclophosphamide/vincristine		NCI
C9849	SY	ARA-C/CTX/VCR		NCI
C9849	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9849	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9849	RO	chemotherapy regimen has component Cytarabine	NCI
C9849	RO	chemotherapy regimen has component Vincristine	NCI
C37662	STY	Therapeutic or Preventive Procedure		NCI
C37662	PT	Cisplatin/Gemcitabine/LY293111		NCI
C37662	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37662	RO	chemotherapy regimen has component Cisplatin	NCI
C37662	RO	chemotherapy regimen has component Etalocib	NCI
C37662	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10424	STY	Therapeutic or Preventive Procedure		NCI
C10424	PT	Etoposide/Idarubicin/Methotrexate		NCI
C10424	SY	IDA/MTX/VP-16		NCI
C10424	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10424	RO	chemotherapy regimen has component Etoposide	NCI
C10424	RO	chemotherapy regimen has component Idarubicin	NCI
C10424	RO	chemotherapy regimen has component Methotrexate	NCI
C10898	STY	Therapeutic or Preventive Procedure		NCI
C10898	PT	Cyclophosphamide/Fluorouracil/Leuprolide/Methotrexate/Tamoxifen		NCI
C10898	SY	CTX/5-FU/LEUP/MTX/TMX		NCI
C10898	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10898	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10898	RO	chemotherapy regimen has component Fluorouracil	NCI
C10898	RO	chemotherapy regimen has component Methotrexate	NCI
C10898	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10898	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C10222	STY	Therapeutic or Preventive Procedure		NCI
C10222	PT	Cyclophosphamide/Fluorouracil/Fluoxymesterone/Methotrexate/Tamoxifen		NCI
C10222	SY	CTX/5-FU/FXM/MTX/TMX		NCI
C10222	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10222	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10222	RO	chemotherapy regimen has component Fluorouracil	NCI
C10222	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C10222	RO	chemotherapy regimen has component Methotrexate	NCI
C10222	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C63588	STY	Therapeutic or Preventive Procedure		NCI
C63588	PT	Chemotherapy Regimen Used to Treat Acute Lymphoblastic Leukemia		NCI
C63588	CHD	Chemotherapy Regimen	NCI
C63588	PAR	CALGB 9251 Regimen	NCI
C63588	PAR	HyperCVAD/HD MTX AraC Regimen	NCI
C63588	PAR	HyperCVAD Regimen	NCI
C63588	PAR	LMB-84 Regimen	NCI
C63588	PAR	LMB-86 Regimen	NCI
C63588	PAR	Larson Regimen	NCI
C63588	PAR	Linker Regimen	NCI
C63588	PAR	R-HyperCVAD/HD MTX AraC Regimen	NCI
C138033	STY	Therapeutic or Preventive Procedure		NCI
C138033	PT	Capecitabine/Trastuzumab Regimen		NCI
C138033	SY	Capecitabine + Trastuzumab		NCI
C138033	SY	Capecitabine/Trastuzumab		NCI
C138033	SY	Capecitabine-Trastuzumab		NCI
C138033	SY	Capecitabine Plus Trastuzumab		NCI
C138033	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138033	RO	chemotherapy regimen has component Capecitabine	NCI
C138033	RO	chemotherapy regimen has component Trastuzumab	NCI
C9718	STY	Therapeutic or Preventive Procedure		NCI
C9718	PT	Cisplatin/Dacarbazine/Vinblastine		NCI
C9718	SY	VDP		NCI
C9718	SY	CDDP/DTIC/VBL		NCI
C9718	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9718	RO	chemotherapy regimen has component Cisplatin	NCI
C9718	RO	chemotherapy regimen has component Dacarbazine	NCI
C9718	RO	chemotherapy regimen has component Vinblastine	NCI
C10770	STY	Therapeutic or Preventive Procedure		NCI
C10770	PT	Cyclosporine/Cytarabine/Etoposide/Mitoxantrone		NCI
C10770	SY	ARA-C/CYSP/DHAD/VP-16		NCI
C10770	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10770	RO	chemotherapy regimen has component Cyclosporine	NCI
C10770	RO	chemotherapy regimen has component Cytarabine	NCI
C10770	RO	chemotherapy regimen has component Etoposide	NCI
C10770	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37484	STY	Therapeutic or Preventive Procedure		NCI
C37484	PT	Fluorouracil/Leucovorin Calcium/Oxaliplatin/PTK787		NCI
C37484	SY	Fluorouracil/Leucovorin Calcium/Oxaliplatin/PTK787(ZK 222584)		NCI
C37484	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37484	RO	chemotherapy regimen has component Fluorouracil	NCI
C37484	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37484	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37484	RO	chemotherapy regimen has component Vatalanib	NCI
C11225	STY	Therapeutic or Preventive Procedure		NCI
C11225	PT	Interferon Gamma/Interleukin-1-Beta/Interleukin-2/Sargramostim/Tumor Necrosis Factor		NCI
C11225	SY	GM-CSF/IFN-G/IL-1B/IL-2/TNF		NCI
C11225	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11225	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C11225	RO	chemotherapy regimen has component Sargramostim	NCI
C11225	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11225	RO	chemotherapy regimen has component Recombinant Interleukin-1-beta	NCI
C11225	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C9897	STY	Therapeutic or Preventive Procedure		NCI
C9897	PT	Cisplatin/Cyclophosphamide/Diethyldithiocarbamate		NCI
C9897	SY	CDDP/CTX/DTC		NCI
C9897	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9897	RO	chemotherapy regimen has component Cisplatin	NCI
C9897	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9897	RO	chemotherapy regimen has component Ditiocarb	NCI
C63781	STY	Therapeutic or Preventive Procedure		NCI
C63781	PT	Dartmouth Regimen		NCI
C63781	SY	Dacarbazine-Cisplatin-Carmustine-Tamoxifen Regimen		NCI
C63781	SY	DTIC-Cisplatin-BCNU-Tamoxifen Regimen		NCI
C63781	CHD	Chemotherapy Regimen Used to Treat Melanoma	NCI
C63781	RO	chemotherapy regimen has component Carmustine	NCI
C63781	RO	chemotherapy regimen has component Cisplatin	NCI
C63781	RO	chemotherapy regimen has component Dacarbazine	NCI
C63781	RO	regimen has accepted use for disease Melanoma	NCI
C63781	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C63467	STY	Therapeutic or Preventive Procedure		NCI
C63467	PT	Chemotherapy Regimen Used to Treat Bladder Carcinoma		NCI
C63467	CHD	Chemotherapy Regimen	NCI
C63467	PAR	CISCA Regimen	NCI
C63467	PAR	Gemcitabine-Cisplatin Regimen	NCI
C63467	PAR	MVAC Regimen	NCI
C63467	PAR	Cisplatin-Methotrexate Regimen	NCI
C63467	PAR	Fluorouracil/Mitomycin Regimen	NCI
C63467	PAR	Gemcitabine/Cisplatin/Everolimus Regimen	NCI
C11067	STY	Therapeutic or Preventive Procedure		NCI
C11067	PT	Dexamethasone/Interferon Alfa		NCI
C11067	SY	DM/IFN-A		NCI
C11067	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11067	RO	chemotherapy regimen has component Dexamethasone	NCI
C11067	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37609	STY	Therapeutic or Preventive Procedure		NCI
C37609	PT	Carboplatin/Fludarabine/Thalidomide/Topotecan		NCI
C37609	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37609	RO	chemotherapy regimen has component Thalidomide	NCI
C37609	RO	chemotherapy regimen has component Fludarabine	NCI
C37609	RO	chemotherapy regimen has component Carboplatin	NCI
C37609	RO	chemotherapy regimen has component Topotecan	NCI
C12193	STY	Therapeutic or Preventive Procedure		NCI
C12193	PT	Flavopiridol/Trastuzumab		NCI
C12193	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12193	RO	chemotherapy regimen has component Trastuzumab	NCI
C12193	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C9732	STY	Therapeutic or Preventive Procedure		NCI
C9732	PT	Carmustine/Cyclophosphamide/Etoposide/Hydroxyurea		NCI
C9732	SY	BCNU/CTX/HU/VP-16		NCI
C9732	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9732	RO	chemotherapy regimen has component Carmustine	NCI
C9732	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9732	RO	chemotherapy regimen has component Etoposide	NCI
C9732	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10987	STY	Therapeutic or Preventive Procedure		NCI
C10987	PT	Fluorouracil/Interferon Alfa		NCI
C10987	SY	5FU/Interferon		NCI
C10987	SY	5-FU/IFN-A		NCI
C10987	SY	IFN/5FU		NCI
C10987	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10987	RO	chemotherapy regimen has component Fluorouracil	NCI
C10987	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10899	STY	Therapeutic or Preventive Procedure		NCI
C10899	PT	Cyclophosphamide/Fluorouracil/Goserelin/Methotrexate/Tamoxifen		NCI
C10899	SY	CTX/5-FU/MTX/TMX/ZDX		NCI
C10899	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10899	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10899	RO	chemotherapy regimen has component Fluorouracil	NCI
C10899	RO	chemotherapy regimen has component Methotrexate	NCI
C10899	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10899	RO	chemotherapy regimen has component Goserelin	NCI
C11541	STY	Therapeutic or Preventive Procedure		NCI
C11541	PT	Alendronate Sodium/Ketoconazole		NCI
C11541	SY	KCZ/MK-217		NCI
C11541	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11541	RO	chemotherapy regimen has component Ketoconazole	NCI
C11541	RO	chemotherapy regimen has component Alendronate Sodium	NCI
C9785	STY	Therapeutic or Preventive Procedure		NCI
C9785	PT	Asparaginase/Etoposide/Prednisone/Vincristine		NCI
C9785	SY	ASP/PRED/VCR/VP-16		NCI
C9785	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9785	RO	chemotherapy regimen has component Asparaginase	NCI
C9785	RO	chemotherapy regimen has component Etoposide	NCI
C9785	RO	chemotherapy regimen has component Prednisone	NCI
C9785	RO	chemotherapy regimen has component Vincristine	NCI
C12169	STY	Therapeutic or Preventive Procedure		NCI
C12169	PT	Cytarabine/Dexamethasone/Ifosfamide/Leucovorin Calcium/Methotrexate/Teniposide/Vincristine		NCI
C12169	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12169	RO	chemotherapy regimen has component Cytarabine	NCI
C12169	RO	chemotherapy regimen has component Dexamethasone	NCI
C12169	RO	chemotherapy regimen has component Ifosfamide	NCI
C12169	RO	chemotherapy regimen has component Methotrexate	NCI
C12169	RO	chemotherapy regimen has component Teniposide	NCI
C12169	RO	chemotherapy regimen has component Vincristine	NCI
C12169	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37524	STY	Therapeutic or Preventive Procedure		NCI
C37524	PT	Anastrozole/Celecoxib		NCI
C37524	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37524	RO	chemotherapy regimen has component Anastrozole	NCI
C37524	RO	chemotherapy regimen has component Celecoxib	NCI
C11298	STY	Therapeutic or Preventive Procedure		NCI
C11298	PT	Anti-thymocyte Globulin/Cyclophosphamide		NCI
C11298	SY	ATG/CTX		NCI
C11298	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11298	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11298	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12139	STY	Therapeutic or Preventive Procedure		NCI
C12139	PT	Megestrol/Omega-3 Fatty acids		NCI
C12139	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12139	RO	chemotherapy regimen has component Omega-3 Fatty Acid	NCI
C12139	RO	chemotherapy regimen has component Megestrol	NCI
C156053	STY	Therapeutic or Preventive Procedure		NCI
C156053	PT	Cabazitaxel-Prednisone Regimen		NCI
C156053	SY	Cabazitaxel/Prednisone		NCI
C156053	SY	Cabazitaxel/Prednisone Regimen		NCI
C156053	SY	Cabazitaxel-Prednisone		NCI
C156053	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C156053	RO	chemotherapy regimen has component Prednisone	NCI
C156053	RO	regimen has accepted use for disease Metastatic Prostate Carcinoma	NCI
C156053	RO	chemotherapy regimen has component Cabazitaxel	NCI
C37508	STY	Therapeutic or Preventive Procedure		NCI
C37508	PT	Montanide ISA-51/Multi-Epitope Melanoma Peptide Vaccine/Sargramostim		NCI
C37508	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37508	RO	chemotherapy regimen has component Sargramostim	NCI
C37508	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C37508	RO	chemotherapy regimen has component Multi-epitope Melanoma Peptide Vaccine	NCI
C136261	STY	Therapeutic or Preventive Procedure		NCI
C136261	PT	Bendamustine/Bortezomib/Dexamethasone Regimen		NCI
C136261	SY	BVD		NCI
C136261	SY	BBD		NCI
C136261	SY	Treanda/Velcade/Dexamethasone		NCI
C136261	SY	Bendamustine/Bortezomib/Dexamethasone		NCI
C136261	SY	Bendamustine-Bortezomib-Dexamethasone		NCI
C136261	SY	Bendamustine-Bortezomib-Dexamethasone Regimen		NCI
C136261	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136261	RO	chemotherapy regimen has component Dexamethasone	NCI
C136261	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136261	RO	chemotherapy regimen has component Bendamustine Hydrochloride	NCI
C136261	RO	chemotherapy regimen has component Bortezomib	NCI
C10968	STY	Therapeutic or Preventive Procedure		NCI
C10968	PT	Carmustine/Temozolomide		NCI
C10968	SY	BCNU/TMZ		NCI
C10968	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10968	RO	chemotherapy regimen has component Carmustine	NCI
C10968	RO	chemotherapy regimen has component Temozolomide	NCI
C150691	STY	Therapeutic or Preventive Procedure		NCI
C150691	PT	Cisplatin/Fluorouracil/Cetuximab Regimen		NCI
C150691	SY	Cisplatin/Fluorouracil Plus Cetuximab		NCI
C150691	SY	Cisplatin-Fluorouracil-Cetuximab		NCI
C150691	SY	Cisplatin/5-FU/Cetuximab		NCI
C150691	SY	Cisplatin/5-FU/Cetuximab Regimen		NCI
C150691	SY	Cisplatin/Fluorouracil/Cetuximab		NCI
C150691	SY	Platinol/Fluorouracil/Erbitux		NCI
C150691	SY	Cisplatin-Fluorouracil-Cetuximab Regimen		NCI
C150691	SY	Cisplatin/5-Fluorouracil/Cetuximab		NCI
C150691	SY	PFE		NCI
C150691	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C150691	RO	chemotherapy regimen has component Cisplatin	NCI
C150691	RO	chemotherapy regimen has component Fluorouracil	NCI
C150691	RO	chemotherapy regimen has component Cetuximab	NCI
C150691	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C11772	STY	Therapeutic or Preventive Procedure		NCI
C11772	PT	Asparaginase/cyclophosphamide/cytarabine/daunorubicin/dexamethasone/leucovorin calcium/mercaptopurine/methotrexate/thioguanine/vincristine		NCI
C11772	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11772	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11772	RO	chemotherapy regimen has component Asparaginase	NCI
C11772	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11772	RO	chemotherapy regimen has component Cytarabine	NCI
C11772	RO	chemotherapy regimen has component Dexamethasone	NCI
C11772	RO	chemotherapy regimen has component Methotrexate	NCI
C11772	RO	chemotherapy regimen has component Thioguanine	NCI
C11772	RO	chemotherapy regimen has component Vincristine	NCI
C11772	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11772	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10961	STY	Therapeutic or Preventive Procedure		NCI
C10961	PT	Cisplatin/Irinotecan		NCI
C10961	SY	CDDP/CPT-11		NCI
C10961	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10961	RO	chemotherapy regimen has component Cisplatin	NCI
C10961	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37464	STY	Therapeutic or Preventive Procedure		NCI
C37464	PT	Carboplatin/Doxorubicin Hydrochloride Liposome		NCI
C37464	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37464	RO	chemotherapy regimen has component Carboplatin	NCI
C37464	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C10093	STY	Therapeutic or Preventive Procedure		NCI
C10093	PT	Bleomycin/Cisplatin/Dacarbazine/Vinblastine		NCI
C10093	SY	BLEO/CDDP/DTIC/VBL		NCI
C10093	SY	BVDD		NCI
C10093	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10093	RO	chemotherapy regimen has component Bleomycin	NCI
C10093	RO	chemotherapy regimen has component Cisplatin	NCI
C10093	RO	chemotherapy regimen has component Dacarbazine	NCI
C10093	RO	chemotherapy regimen has component Vinblastine	NCI
C10563	STY	Therapeutic or Preventive Procedure		NCI
C10563	PT	Somatuline/Suramin		NCI
C10563	SY	Suramin/Somatuline		NCI
C10563	SY	Somatuline/SUR		NCI
C10563	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10563	RO	chemotherapy regimen has component Suramin	NCI
C10563	RO	chemotherapy regimen has component Lanreotide	NCI
C37495	STY	Therapeutic or Preventive Procedure		NCI
C37495	PT	ALVAC-CEA-B7.1 Vaccine/Tetanus Toxoid		NCI
C37495	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37495	RO	chemotherapy regimen has component Tetanus Toxoid Vaccine	NCI
C37495	RO	chemotherapy regimen has component ALVAC-CEA B7.1 Vaccine	NCI
C12033	STY	Therapeutic or Preventive Procedure		NCI
C12033	PT	Calcium Citrate/Cholecalciferol		NCI
C12033	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12033	RO	chemotherapy regimen has component Calcium Citrate	NCI
C12033	RO	chemotherapy regimen has component D Vitamin	NCI
C67209	STY	Pharmacologic Substance		NCI
C67209	PT	DECAL Regimen		NCI
C67209	SY	Dexamethasone-Etoposide-Cisplatin-Cytarabine-L-asparaginase Regimen		NCI
C67209	SY	DECAL		NCI
C67209	CHD	Chemotherapy Regimen Used to Treat Childhood Non-Hodgkin's Lymphoma	NCI
C67209	RO	chemotherapy regimen has component Asparaginase	NCI
C67209	RO	chemotherapy regimen has component Cisplatin	NCI
C67209	RO	chemotherapy regimen has component Cytarabine	NCI
C67209	RO	chemotherapy regimen has component Dexamethasone	NCI
C67209	RO	chemotherapy regimen has component Etoposide	NCI
C67209	RO	regimen has accepted use for disease Recurrent Childhood Hodgkin Lymphoma	NCI
C10862	STY	Therapeutic or Preventive Procedure		NCI
C10862	PT	Cytarabine/Homoharringtonine		NCI
C10862	SY	ARA-C/HH		NCI
C10862	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10862	RO	chemotherapy regimen has component Cytarabine	NCI
C10862	RO	chemotherapy regimen has component Omacetaxine Mepesuccinate	NCI
C9705	STY	Therapeutic or Preventive Procedure		NCI
C9705	PT	Cisplatin/Doxorubicin/Ifosfamide/Methotrexate		NCI
C9705	SY	CDDP/DOX/IFF/MTX		NCI
C9705	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9705	RO	chemotherapy regimen has component Cisplatin	NCI
C9705	RO	chemotherapy regimen has component Doxorubicin	NCI
C9705	RO	chemotherapy regimen has component Ifosfamide	NCI
C9705	RO	chemotherapy regimen has component Methotrexate	NCI
C37666	STY	Therapeutic or Preventive Procedure		NCI
C37666	PT	Cisplatin/Ixabepilone		NCI
C37666	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37666	RO	chemotherapy regimen has component Cisplatin	NCI
C37666	RO	chemotherapy regimen has component Ixabepilone	NCI
C11760	STY	Therapeutic or Preventive Procedure		NCI
C11760	PT	Eniluracil/Fluorouracil/Oxaliplatin		NCI
C11760	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11760	RO	chemotherapy regimen has component Fluorouracil	NCI
C11760	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11760	RO	chemotherapy regimen has component Eniluracil	NCI
C10230	STY	Therapeutic or Preventive Procedure		NCI
C10230	PT	Cytarabine/Etoposide/Methylprednisolone		NCI
C10230	SY	ARA-C/MePRDL/VP-16		NCI
C10230	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10230	RO	chemotherapy regimen has component Cytarabine	NCI
C10230	RO	chemotherapy regimen has component Etoposide	NCI
C10230	RO	chemotherapy regimen has component Methylprednisolone	NCI
C140731	STY	Therapeutic or Preventive Procedure		NCI
C140731	PT	R-GemOx Regimen		NCI
C140731	SY	Rituximab-Gemcitabine-Oxaliplatin		NCI
C140731	SY	GEMOX-R		NCI
C140731	SY	Rituximab/Gemcitabine/Oxaliplatin		NCI
C140731	SY	R-GemOx		NCI
C140731	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140731	RO	chemotherapy regimen has component Gemcitabine	NCI
C140731	RO	chemotherapy regimen has component Oxaliplatin	NCI
C140731	RO	chemotherapy regimen has component Rituximab	NCI
C11560	STY	Therapeutic or Preventive Procedure		NCI
C11560	PT	Deoxyspergualin/Monoclonal Antibody L6		NCI
C11560	SY	DSG/MOAB L6		NCI
C11560	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11560	RO	chemotherapy regimen has component Monoclonal Antibody L6	NCI
C11560	RO	chemotherapy regimen has component Gusperimus Trihydrochloride	NCI
C9878	STY	Therapeutic or Preventive Procedure		NCI
C9878	PT	Carboplatin/Cyclophosphamide/Etoposide		NCI
C9878	SY	CBDCA/CTX/VP-16		NCI
C9878	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9878	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9878	RO	chemotherapy regimen has component Etoposide	NCI
C9878	RO	chemotherapy regimen has component Carboplatin	NCI
C37718	STY	Therapeutic or Preventive Procedure		NCI
C37718	PT	Cytarabine/Leucovorin Calcium/Methotrexate		NCI
C37718	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37718	RO	chemotherapy regimen has component Cytarabine	NCI
C37718	RO	chemotherapy regimen has component Methotrexate	NCI
C37718	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10567	STY	Therapeutic or Preventive Procedure		NCI
C10567	PT	Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Vincristine		NCI
C10567	SY	ARA-C/ASP/MP/MTX/VCR		NCI
C10567	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10567	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10567	RO	chemotherapy regimen has component Asparaginase	NCI
C10567	RO	chemotherapy regimen has component Cytarabine	NCI
C10567	RO	chemotherapy regimen has component Methotrexate	NCI
C10567	RO	chemotherapy regimen has component Vincristine	NCI
C37496	STY	Therapeutic or Preventive Procedure		NCI
C37496	PT	AN-9/Docetaxel		NCI
C37496	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37496	RO	chemotherapy regimen has component Pivaloyloxymethylbutyrate	NCI
C37496	RO	chemotherapy regimen has component Docetaxel	NCI
C11629	STY	Therapeutic or Preventive Procedure		NCI
C11629	PT	Anti-thymocyte globulin/melphalan/methylprednisolone		NCI
C11629	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11629	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11629	RO	chemotherapy regimen has component Melphalan	NCI
C11629	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10277	STY	Therapeutic or Preventive Procedure		NCI
C10277	PT	Cytarabine/Thioguanine		NCI
C10277	SY	ARA-C/TG		NCI
C10277	SY	TA		NCI
C10277	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10277	RO	chemotherapy regimen has component Cytarabine	NCI
C10277	RO	chemotherapy regimen has component Thioguanine	NCI
C37784	STY	Therapeutic or Preventive Procedure		NCI
C37784	PT	Fluorouracil/Leucovorin Calcium/UCN-01		NCI
C37784	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37784	RO	chemotherapy regimen has component Fluorouracil	NCI
C37784	RO	chemotherapy regimen has component 7-Hydroxystaurosporine	NCI
C37784	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10434	STY	Therapeutic or Preventive Procedure		NCI
C10434	PT	Floxuridine/Fluorouracil/Leucovorin Calcium/Levamisole		NCI
C10434	SY	CF/5-FU/FUDR/LEV		NCI
C10434	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10434	RO	chemotherapy regimen has component Floxuridine	NCI
C10434	RO	chemotherapy regimen has component Fluorouracil	NCI
C10434	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10434	RO	chemotherapy regimen has component Levamisole Hydrochloride	NCI
C10945	STY	Therapeutic or Preventive Procedure		NCI
C10945	PT	Methotrexate/Thioguanine/Vincristine		NCI
C10945	SY	MTX/TG/VCR		NCI
C10945	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10945	RO	chemotherapy regimen has component Methotrexate	NCI
C10945	RO	chemotherapy regimen has component Thioguanine	NCI
C10945	RO	chemotherapy regimen has component Vincristine	NCI
C11951	STY	Therapeutic or Preventive Procedure		NCI
C11951	PT	Melphalan/Prednisone/Wobe-Mugos E		NCI
C11951	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11951	RO	chemotherapy regimen has component Melphalan	NCI
C11951	RO	chemotherapy regimen has component Prednisone	NCI
C11951	RO	chemotherapy regimen has component Wobe-Mugos E	NCI
C10042	STY	Therapeutic or Preventive Procedure		NCI
C10042	PT	Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Methotrexate/Prednisone/Sargramostim/Vincristine		NCI
C10042	SY	ARA-C/BLEO/CTX/DOX/GM-CSF/MTX/PRED/VCR/VP-16		NCI
C10042	SY	ProMACE/CytaBOM/GM-CSF		NCI
C10042	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10042	RO	chemotherapy regimen has component Bleomycin	NCI
C10042	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10042	RO	chemotherapy regimen has component Cytarabine	NCI
C10042	RO	chemotherapy regimen has component Doxorubicin	NCI
C10042	RO	chemotherapy regimen has component Etoposide	NCI
C10042	RO	chemotherapy regimen has component Methotrexate	NCI
C10042	RO	chemotherapy regimen has component Prednisone	NCI
C10042	RO	chemotherapy regimen has component Vincristine	NCI
C10042	RO	chemotherapy regimen has component Sargramostim	NCI
C15589	STY	Therapeutic or Preventive Procedure		NCI
C15589	PT	Melphalan/Tumor Necrosis Factor		NCI
C15589	SY	L-PAM/TNF		NCI
C15589	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15589	RO	chemotherapy regimen has component Melphalan	NCI
C15589	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C37781	STY	Therapeutic or Preventive Procedure		NCI
C37781	PT	Fluorouracil/Gefitinib/Irinotecan/Leucovorin Calcium		NCI
C37781	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37781	RO	chemotherapy regimen has component Fluorouracil	NCI
C37781	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37781	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37781	RO	chemotherapy regimen has component Gefitinib	NCI
C10489	STY	Therapeutic or Preventive Procedure		NCI
C10489	PT	Cyclophosphamide/Fludarabine		NCI
C10489	SY	CTX/FAMP		NCI
C10489	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10489	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10489	RO	chemotherapy regimen has component Fludarabine	NCI
C11677	STY	Therapeutic or Preventive Procedure		NCI
C11677	PT	Interleukin-12/Montanide ISA-51/Tyrosinase Related Protein-1		NCI
C11677	SY	Interleukin-12/Montanide ISA-51/Tyrosinase-Related Protein-1		NCI
C11677	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11677	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11677	RO	chemotherapy regimen has component Recombinant Tyrosinase-Related Protein-1	NCI
C11677	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C37620	STY	Therapeutic or Preventive Procedure		NCI
C37620	PT	Carboplatin/Paclitaxel/Trastuzumab		NCI
C37620	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37620	RO	chemotherapy regimen has component Carboplatin	NCI
C37620	RO	chemotherapy regimen has component Paclitaxel	NCI
C37620	RO	chemotherapy regimen has component Trastuzumab	NCI
C10071	STY	Therapeutic or Preventive Procedure		NCI
C10071	PT	Cyclophosphamide/Mercaptopurine/Prednisone/Vincristine		NCI
C10071	SY	CTX/MP/PRED/VCR		NCI
C10071	SY	VEMP		NCI
C10071	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10071	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10071	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10071	RO	chemotherapy regimen has component Prednisone	NCI
C10071	RO	chemotherapy regimen has component Vincristine	NCI
C141479	STY	Therapeutic or Preventive Procedure		NCI
C141479	PT	Bevacizumab-Pemetrexed Regimen		NCI
C141479	SY	Bevacizumab/Pemetrexed Regimen		NCI
C141479	SY	Bevacizumab-Pemetrexed		NCI
C141479	SY	Bevacizumab/Pemetrexed		NCI
C141479	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C141479	RO	chemotherapy regimen has component Bevacizumab	NCI
C141479	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C11294	STY	Therapeutic or Preventive Procedure		NCI
C11294	PT	Etoposide/Ifosfamide/Mesna/Topotecan		NCI
C11294	SY	VP-16/IFF/Mesna/TOPO		NCI
C11294	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11294	RO	chemotherapy regimen has component Mesna	NCI
C11294	RO	chemotherapy regimen has component Etoposide	NCI
C11294	RO	chemotherapy regimen has component Ifosfamide	NCI
C11294	RO	chemotherapy regimen has component Topotecan	NCI
C37604	STY	Therapeutic or Preventive Procedure		NCI
C37604	PT	Carboplatin/Cytarabine/Etoposide/Ifosfamide/Methotrexate/Rituximab		NCI
C37604	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37604	RO	chemotherapy regimen has component Cytarabine	NCI
C37604	RO	chemotherapy regimen has component Etoposide	NCI
C37604	RO	chemotherapy regimen has component Ifosfamide	NCI
C37604	RO	chemotherapy regimen has component Methotrexate	NCI
C37604	RO	chemotherapy regimen has component Carboplatin	NCI
C37604	RO	chemotherapy regimen has component Rituximab	NCI
C11475	STY	Therapeutic or Preventive Procedure		NCI
C11475	PT	Bleomycin/Cisplatin/Etoposide/Paclitaxel		NCI
C11475	SY	BLEO/CDDP/TAX/VP-16		NCI
C11475	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11475	RO	chemotherapy regimen has component Bleomycin	NCI
C11475	RO	chemotherapy regimen has component Cisplatin	NCI
C11475	RO	chemotherapy regimen has component Etoposide	NCI
C11475	RO	chemotherapy regimen has component Paclitaxel	NCI
C10086	STY	Therapeutic or Preventive Procedure		NCI
C10086	PT	Cytarabine/Prednisone/Thioguanine/Vincristine		NCI
C10086	SY	ARA-C/PRED/TG/VCR		NCI
C10086	SY	ATOP		NCI
C10086	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10086	RO	chemotherapy regimen has component Cytarabine	NCI
C10086	RO	chemotherapy regimen has component Prednisone	NCI
C10086	RO	chemotherapy regimen has component Thioguanine	NCI
C10086	RO	chemotherapy regimen has component Vincristine	NCI
C67510	STY	Therapeutic or Preventive Procedure		NCI
C67510	PT	MAC Regimen		NCI
C67510	SY	Methotrexate-Actinomycin-D-Chlorambucil Regimen		NCI
C67510	SY	Methotrexate/Dactinomycin/Cyclophosphamide Regimen		NCI
C67510	SY	MAC		NCI
C67510	CHD	Chemotherapy Regimen Used to Treat Gestational Trophoblastic Tumor	NCI
C67510	RO	chemotherapy regimen has component Chlorambucil	NCI
C67510	RO	chemotherapy regimen has component Dactinomycin	NCI
C67510	RO	chemotherapy regimen has component Methotrexate	NCI
C67510	RO	regimen has accepted use for disease Gestational Trophoblastic Tumor	NCI
C10983	STY	Therapeutic or Preventive Procedure		NCI
C10983	PT	Dacarbazine/Pirarubicin		NCI
C10983	SY	DTIC/THP-DOX		NCI
C10983	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10983	RO	chemotherapy regimen has component Dacarbazine	NCI
C10983	RO	chemotherapy regimen has component Pirarubicin	NCI
C37709	STY	Therapeutic or Preventive Procedure		NCI
C37709	PT	Cytarabine/Daunorubicin/Etoposide/Gemtuzumab Ozogamicin		NCI
C37709	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37709	RO	chemotherapy regimen has component Cytarabine	NCI
C37709	RO	chemotherapy regimen has component Etoposide	NCI
C37709	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37709	RO	chemotherapy regimen has component Gemtuzumab Ozogamicin	NCI
C10837	STY	Therapeutic or Preventive Procedure		NCI
C10837	PT	Gallium Nitrate/Hydroxyurea		NCI
C10837	SY	GAN/HU		NCI
C10837	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10837	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10837	RO	chemotherapy regimen has component Gallium Nitrate	NCI
C9993	STY	Therapeutic or Preventive Procedure		NCI
C9993	PT	Fludarabine/Hydroxyurea		NCI
C9993	SY	FAMP/HU		NCI
C9993	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9993	RO	chemotherapy regimen has component Hydroxyurea	NCI
C9993	RO	chemotherapy regimen has component Fludarabine	NCI
C136266	STY	Therapeutic or Preventive Procedure		NCI
C136266	PT	Cyclophosphamide/Lenalidomide/Dexamethasone Regimen		NCI
C136266	SY	Cyclophosphamide-Lenalidomide-Dexamethasone		NCI
C136266	SY	Cyclophosphamide-Lenalidomide-Dexamethasone Regimen		NCI
C136266	SY	Cyclophosphamide/Lenalidomide/Dexamethasone		NCI
C136266	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136266	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C136266	RO	chemotherapy regimen has component Dexamethasone	NCI
C136266	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136266	RO	chemotherapy regimen has component Lenalidomide	NCI
C10875	STY	Therapeutic or Preventive Procedure		NCI
C10875	PT	Carboplatin/Pentoxifylline		NCI
C10875	SY	CBDCA/PTX		NCI
C10875	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10875	RO	chemotherapy regimen has component Pentoxifylline	NCI
C10875	RO	chemotherapy regimen has component Carboplatin	NCI
C11807	STY	Therapeutic or Preventive Procedure		NCI
C11807	PT	Bleomycin/Cyclophosphamide/Etoposide/Mitoxantrone/Prednisolone/Vincristine		NCI
C11807	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11807	RO	chemotherapy regimen has component Bleomycin	NCI
C11807	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11807	RO	chemotherapy regimen has component Etoposide	NCI
C11807	RO	chemotherapy regimen has component Prednisolone	NCI
C11807	RO	chemotherapy regimen has component Vincristine	NCI
C11807	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11436	STY	Therapeutic or Preventive Procedure		NCI
C11436	PT	BAY 12-9566/Fluorouracil/Leucovorin Calcium		NCI
C11436	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11436	RO	chemotherapy regimen has component Fluorouracil	NCI
C11436	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11436	RO	chemotherapy regimen has component Tanomastat	NCI
C63660	STY	Therapeutic or Preventive Procedure		NCI
C63660	PT	Cytarabine-Thioguanine Regimen		NCI
C63660	CHD	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C63660	RO	chemotherapy regimen has component Cytarabine	NCI
C63660	RO	chemotherapy regimen has component Thioguanine	NCI
C63660	RO	regimen has accepted use for disease Adult Acute Myeloid Leukemia	NCI
C10879	STY	Therapeutic or Preventive Procedure		NCI
C10879	PT	Busulfan/Cyclophosphamide/Thiotepa		NCI
C10879	SY	BU/CTX/TSPA		NCI
C10879	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10879	RO	chemotherapy regimen has component Busulfan	NCI
C10879	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10879	RO	chemotherapy regimen has component Thiotepa	NCI
C10476	STY	Therapeutic or Preventive Procedure		NCI
C10476	PT	Doxorubicin/Paclitaxel		NCI
C10476	SY	Paclitaxel/Doxorubicin		NCI
C10476	SY	DOX/TAX		NCI
C10476	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10476	RO	chemotherapy regimen has component Doxorubicin	NCI
C10476	RO	chemotherapy regimen has component Paclitaxel	NCI
C9919	STY	Therapeutic or Preventive Procedure		NCI
C9919	PT	Fluorouracil/Hydroxyurea/Leucovorin Calcium		NCI
C9919	SY	CF/5-FU/HU		NCI
C9919	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9919	RO	chemotherapy regimen has component Fluorouracil	NCI
C9919	RO	chemotherapy regimen has component Hydroxyurea	NCI
C9919	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63752	STY	Therapeutic or Preventive Procedure		NCI
C63752	PT	Chlorambucil-Prednisone Regimen		NCI
C63752	SY	CP Regimen		NCI
C63752	CHD	Chemotherapy Regimen Used to Treat Chronic Lymphocytic Leukemia	NCI
C63752	RO	chemotherapy regimen has component Chlorambucil	NCI
C63752	RO	regimen has accepted use for disease Chronic Lymphocytic Leukemia	NCI
C63752	RO	chemotherapy regimen has component Prednisone	NCI
C12040	STY	Therapeutic or Preventive Procedure		NCI
C12040	PT	Asparaginase/Cytarabine/Imatinib mesylate		NCI
C12040	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12040	RO	chemotherapy regimen has component Asparaginase	NCI
C12040	RO	chemotherapy regimen has component Cytarabine	NCI
C12040	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C10088	STY	Therapeutic or Preventive Procedure		NCI
C10088	PT	Cytarabine/Zorubicin		NCI
C10088	SY	ARA-C/RBZ		NCI
C10088	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10088	RO	chemotherapy regimen has component Cytarabine	NCI
C10088	RO	chemotherapy regimen has component Zorubicin Hydrochloride	NCI
C11611	STY	Therapeutic or Preventive Procedure		NCI
C11611	PT	Interleukin-2/Vaccinia-Tyrosinase Vaccine		NCI
C11611	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11611	RO	chemotherapy regimen has component Vaccinia-Tyrosinase Vaccine	NCI
C11611	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10160	STY	Therapeutic or Preventive Procedure		NCI
C10160	PT	Doxorubicin/Fluorouracil/Vinblastine		NCI
C10160	SY	DOX/5-FU/VBL		NCI
C10160	SY	FUVA		NCI
C10160	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10160	RO	chemotherapy regimen has component Doxorubicin	NCI
C10160	RO	chemotherapy regimen has component Fluorouracil	NCI
C10160	RO	chemotherapy regimen has component Vinblastine	NCI
C37769	STY	Therapeutic or Preventive Procedure		NCI
C37769	PT	Estramustine/Ixabepilone		NCI
C37769	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37769	RO	chemotherapy regimen has component Estramustine	NCI
C37769	RO	chemotherapy regimen has component Ixabepilone	NCI
C11535	STY	Therapeutic or Preventive Procedure		NCI
C11535	PT	Asparaginase/Leucovorin Calcium/Mercaptopurine/Methotrexate		NCI
C11535	SY	ASP/CF/MP/MTX		NCI
C11535	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11535	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11535	RO	chemotherapy regimen has component Asparaginase	NCI
C11535	RO	chemotherapy regimen has component Methotrexate	NCI
C11535	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63499	STY	Therapeutic or Preventive Procedure		NCI
C63499	PT	Thalidomide-Dexamethasone Regimen		NCI
C63499	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C63499	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C63499	RO	chemotherapy regimen has component Prednisone	NCI
C63499	RO	chemotherapy regimen has component Thalidomide	NCI
C10660	STY	Therapeutic or Preventive Procedure		NCI
C10660	PT	Busulfan/Cyclophosphamide/Diaziquone		NCI
C10660	SY	AZQ/BU/CTX		NCI
C10660	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10660	RO	chemotherapy regimen has component Busulfan	NCI
C10660	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10660	RO	chemotherapy regimen has component Diaziquone	NCI
C9671	STY	Therapeutic or Preventive Procedure		NCI
C9671	PT	Bleomycin/Carboplatin/Etoposide		NCI
C9671	SY	BLEO/CBDCA/VP-16		NCI
C9671	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9671	RO	chemotherapy regimen has component Bleomycin	NCI
C9671	RO	chemotherapy regimen has component Etoposide	NCI
C9671	RO	chemotherapy regimen has component Carboplatin	NCI
C11079	STY	Therapeutic or Preventive Procedure		NCI
C11079	PT	Cyclophosphamide/Interleukin-2/Monoclonal Antibody OKT3/Tumor Necrosis Factor		NCI
C11079	SY	CTX/IL-2/MOAB OKT3/TNF		NCI
C11079	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11079	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11079	RO	chemotherapy regimen has component Muromonab-CD3	NCI
C11079	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11079	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C10111	STY	Therapeutic or Preventive Procedure		NCI
C10111	PT	Melphalan/Prednisone/Vincristine		NCI
C10111	SY	L-PAM/PRED/VCR		NCI
C10111	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10111	RO	chemotherapy regimen has component Melphalan	NCI
C10111	RO	chemotherapy regimen has component Prednisone	NCI
C10111	RO	chemotherapy regimen has component Vincristine	NCI
C10714	STY	Therapeutic or Preventive Procedure		NCI
C10714	PT	Cyclosporine/Interleukin-2/Methylprednisolone		NCI
C10714	SY	CYSP/IL-2/MePRDL		NCI
C10714	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10714	RO	chemotherapy regimen has component Cyclosporine	NCI
C10714	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10714	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10433	STY	Therapeutic or Preventive Procedure		NCI
C10433	PT	Cyclosporine/Interferon Gamma		NCI
C10433	SY	CYSP/IFN-G		NCI
C10433	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10433	RO	chemotherapy regimen has component Cyclosporine	NCI
C10433	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C12010	STY	Therapeutic or Preventive Procedure		NCI
C12010	PT	Bevacizumab/Carboplatin/Paclitaxel		NCI
C12010	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12010	RO	chemotherapy regimen has component Carboplatin	NCI
C12010	RO	chemotherapy regimen has component Paclitaxel	NCI
C12010	RO	chemotherapy regimen has component Bevacizumab	NCI
C9724	STY	Therapeutic or Preventive Procedure		NCI
C9724	PT	Doxorubicin/Etoposide/Procarbazine/Vincristine		NCI
C9724	SY	APVV		NCI
C9724	SY	DOX/PCB/VCR/VP-16		NCI
C9724	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9724	RO	chemotherapy regimen has component Doxorubicin	NCI
C9724	RO	chemotherapy regimen has component Etoposide	NCI
C9724	RO	chemotherapy regimen has component Vincristine	NCI
C9724	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C37809	STY	Therapeutic or Preventive Procedure		NCI
C37809	PT	Gusperimus/Monoclonal Antibody L6		NCI
C37809	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37809	RO	chemotherapy regimen has component Monoclonal Antibody L6	NCI
C37809	RO	chemotherapy regimen has component Gusperimus Trihydrochloride	NCI
C37773	STY	Therapeutic or Preventive Procedure		NCI
C37773	PT	Exemestane/Triptorelin		NCI
C37773	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37773	RO	chemotherapy regimen has component Triptorelin	NCI
C37773	RO	chemotherapy regimen has component Exemestane	NCI
C11936	STY	Therapeutic or Preventive Procedure		NCI
C11936	PT	Etoposide/Fluorouracil-Uracil/Leucovorin Calcium		NCI
C11936	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11936	RO	chemotherapy regimen has component Etoposide	NCI
C11936	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11936	RO	chemotherapy regimen has component Tegafur-Uracil	NCI
C10720	STY	Therapeutic or Preventive Procedure		NCI
C10720	PT	Busulfan/Cyclophosphamide/Cytarabine/Sargramostim		NCI
C10720	SY	ARA-C/BU/CTX/GM-CSF		NCI
C10720	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10720	RO	chemotherapy regimen has component Busulfan	NCI
C10720	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10720	RO	chemotherapy regimen has component Cytarabine	NCI
C10720	RO	chemotherapy regimen has component Sargramostim	NCI
C11331	STY	Therapeutic or Preventive Procedure		NCI
C11331	PT	Cisplatin/Floxuridine		NCI
C11331	SY	CDDP/FUDR		NCI
C11331	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11331	RO	chemotherapy regimen has component Cisplatin	NCI
C11331	RO	chemotherapy regimen has component Floxuridine	NCI
C63397	STY	Therapeutic or Preventive Procedure		NCI
C63397	PT	FUP Regimen		NCI
C63397	SY	Fluorouracil-Platinol Regimen		NCI
C63397	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C63397	RO	chemotherapy regimen has component Cisplatin	NCI
C63397	RO	chemotherapy regimen has component Fluorouracil	NCI
C63397	RO	regimen has accepted use for disease Gastric Carcinoma	NCI
C12143	STY	Therapeutic or Preventive Procedure		NCI
C12143	PT	Autologous Lymphocytes/gp100 Antigen/Interleukin-2/Montanide ISA-51		NCI
C12143	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12143	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C12143	RO	chemotherapy regimen has component gp100 Antigen	NCI
C12143	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12143	RO	chemotherapy regimen has component Therapeutic Autologous Lymphocytes	NCI
C10016	STY	Therapeutic or Preventive Procedure		NCI
C10016	PT	Ancitabine Hydrochloride/Daunorubicin/Mercaptopurine/Prednisolone		NCI
C10016	SY	DCCMP		NCI
C10016	SY	CYC/DNR/MP/PRDL		NCI
C10016	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10016	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10016	RO	chemotherapy regimen has component Prednisolone	NCI
C10016	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10016	RO	chemotherapy regimen has component Ancitabine Hydrochloride	NCI
C10007	STY	Therapeutic or Preventive Procedure		NCI
C10007	PT	Bleomycin/Cytarabine/Methotrexate/Vincristine		NCI
C10007	SY	ARA-C/BLEO/MTX/VCR		NCI
C10007	SY	CytaBOM		NCI
C10007	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10007	RO	chemotherapy regimen has component Bleomycin	NCI
C10007	RO	chemotherapy regimen has component Cytarabine	NCI
C10007	RO	chemotherapy regimen has component Methotrexate	NCI
C10007	RO	chemotherapy regimen has component Vincristine	NCI
C67191	STY	Therapeutic or Preventive Procedure		NCI
C67191	PT	IEP-ABVD-COPP Regimen		NCI
C67191	SY	IEP-ABVD-COPP		NCI
C67191	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67191	RO	chemotherapy regimen has component Bleomycin	NCI
C67191	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67191	RO	chemotherapy regimen has component Dacarbazine	NCI
C67191	RO	chemotherapy regimen has component Doxorubicin	NCI
C67191	RO	chemotherapy regimen has component Etoposide	NCI
C67191	RO	chemotherapy regimen has component Ifosfamide	NCI
C67191	RO	chemotherapy regimen has component Prednisone	NCI
C67191	RO	chemotherapy regimen has component Vinblastine	NCI
C67191	RO	chemotherapy regimen has component Vincristine	NCI
C67191	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C63510	STY	Therapeutic or Preventive Procedure		NCI
C63510	PT	Chemotherapy Regimen Used to Treat Sarcoma		NCI
C63510	CHD	Chemotherapy Regimen	NCI
C63510	PAR	MAID Regimen	NCI
C63510	PAR	ABV Regimen	NCI
C63510	PAR	AD Regimen	NCI
C63510	PAR	AIM Regimen	NCI
C63510	PAR	AI Regimen	NCI
C63510	PAR	BV Regimen	NCI
C63510	PAR	Chemotherapy Regimen Used to Treat Ewing's Family of Tumors	NCI
C63510	PAR	Chemotherapy Regimen Used to Treat Childhood Osteosarcoma	NCI
C63510	PAR	Chemotherapy Regimen Used to Treat Childhood Rhabdomyosarcoma	NCI
C63510	PAR	CyVADIC Regimen	NCI
C63510	PAR	Gemcitabine-Docetaxel Regimen	NCI
C11975	STY	Therapeutic or Preventive Procedure		NCI
C11975	PT	Leucovorin Calcium/Mercaptopurine/Methotrexate/Prednisolone		NCI
C11975	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11975	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11975	RO	chemotherapy regimen has component Methotrexate	NCI
C11975	RO	chemotherapy regimen has component Prednisolone	NCI
C11975	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63484	STY	Therapeutic or Preventive Procedure		NCI
C63484	PT	Docetaxel-Prednisone Regimen		NCI
C63484	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C63484	RO	chemotherapy regimen has component Prednisone	NCI
C63484	RO	chemotherapy regimen has component Docetaxel	NCI
C63484	RO	regimen has accepted use for disease Metastatic Prostate Carcinoma	NCI
C11840	STY	Therapeutic or Preventive Procedure		NCI
C11840	PT	Lomustine/Temozolomide		NCI
C11840	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11840	RO	chemotherapy regimen has component Lomustine	NCI
C11840	RO	chemotherapy regimen has component Temozolomide	NCI
C11870	STY	Therapeutic or Preventive Procedure		NCI
C11870	PT	Interferon Alfa/Lutetium Lu 177 Monoclonal Antibody CC49/Topotecan		NCI
C11870	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11870	RO	chemotherapy regimen has component Topotecan	NCI
C11870	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11870	RO	chemotherapy regimen has component Lutetium Lu 177 Monoclonal Antibody CC49	NCI
C10966	STY	Therapeutic or Preventive Procedure		NCI
C10966	PT	Cisplatin/Docetaxel		NCI
C10966	SY	CDDP/TXT		NCI
C10966	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10966	RO	chemotherapy regimen has component Cisplatin	NCI
C10966	RO	chemotherapy regimen has component Docetaxel	NCI
C11869	STY	Therapeutic or Preventive Procedure		NCI
C11869	PT	Interferon Alfa/Lutetium Lu 177 Monoclonal Antibody CC49/Paclitaxel		NCI
C11869	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11869	RO	chemotherapy regimen has component Paclitaxel	NCI
C11869	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11869	RO	chemotherapy regimen has component Lutetium Lu 177 Monoclonal Antibody CC49	NCI
C11474	STY	Therapeutic or Preventive Procedure		NCI
C11474	PT	Cyclosporine/Etoposide/Vincristine		NCI
C11474	SY	CYSP/VCR/VP-16		NCI
C11474	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11474	RO	chemotherapy regimen has component Cyclosporine	NCI
C11474	RO	chemotherapy regimen has component Etoposide	NCI
C11474	RO	chemotherapy regimen has component Vincristine	NCI
C67288	STY	Therapeutic or Preventive Procedure		NCI
C67288	PT	Chemotherapy Regimen Used to Treat Childhood Liver Cancer		NCI
C67288	SY	Chemotherapy Regimen Used to Treat Childhood Hepatocellular Carcinoma		NCI
C67288	CHD	Chemotherapy Regimen Used to Treat Primary Malignant Neoplasm of Liver	NCI
C67288	PAR	Doxorubicin-Cisplatin Regimen	NCI
C67288	PAR	IPA Liver Cancer Regimen	NCI
C67288	PAR	POG-8697 Liver Cancer Regimen	NCI
C10011	STY	Therapeutic or Preventive Procedure		NCI
C10011	PT	Cyclophosphamide/Melphalan/Methylprednisolone		NCI
C10011	SY	CTX/L-PAM/MePRDL		NCI
C10011	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10011	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10011	RO	chemotherapy regimen has component Melphalan	NCI
C10011	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11357	STY	Therapeutic or Preventive Procedure		NCI
C11357	PT	Interleukin-2/Monoclonal Antibody 3622W94		NCI
C11357	SY	IL-2/MOAB 3622W94		NCI
C11357	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11357	RO	chemotherapy regimen has component Monoclonal Antibody 3622W94	NCI
C11357	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37527	STY	Therapeutic or Preventive Procedure		NCI
C37527	PT	Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody/Interleukin-2		NCI
C37527	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37527	RO	chemotherapy regimen has component Ipilimumab	NCI
C37527	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11938	STY	Therapeutic or Preventive Procedure		NCI
C11938	PT	Docetaxel/Tamoxifen		NCI
C11938	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11938	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11938	RO	chemotherapy regimen has component Docetaxel	NCI
C10661	STY	Therapeutic or Preventive Procedure		NCI
C10661	PT	Carboplatin/Cyclophosphamide/Interleukin-1-Beta		NCI
C10661	SY	CBDCA/CTX/IL-1B		NCI
C10661	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10661	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10661	RO	chemotherapy regimen has component Carboplatin	NCI
C10661	RO	chemotherapy regimen has component Recombinant Interleukin-1-beta	NCI
C9777	STY	Therapeutic or Preventive Procedure		NCI
C9777	PT	Cyclophosphamide/Doxorubicin/Prednisone		NCI
C9777	SY	CTX/DOX/PRED		NCI
C9777	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9777	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9777	RO	chemotherapy regimen has component Doxorubicin	NCI
C9777	RO	chemotherapy regimen has component Prednisone	NCI
C37637	STY	Therapeutic or Preventive Procedure		NCI
C37637	PT	Celecoxib/Temozolomide/Thalidomide		NCI
C37637	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37637	RO	chemotherapy regimen has component Thalidomide	NCI
C37637	RO	chemotherapy regimen has component Temozolomide	NCI
C37637	RO	chemotherapy regimen has component Celecoxib	NCI
C140104	STY	Therapeutic or Preventive Procedure		NCI
C140104	PT	R-Hyper-CVAD Regimen		NCI
C140104	SY	R-Hyper-CVAD		NCI
C140104	SY	Hyper-CVAD Plus Rituximab		NCI
C140104	SY	Rituximab-HyperCVAD		NCI
C140104	SY	Rituximab Plus HyperCVAD		NCI
C140104	SY	R-HCVAD		NCI
C140104	SY	Rituximab and Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone Regimen		NCI
C140104	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140104	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C140104	RO	chemotherapy regimen has component Dexamethasone	NCI
C140104	RO	chemotherapy regimen has component Doxorubicin	NCI
C140104	RO	chemotherapy regimen has component Vincristine	NCI
C140104	RO	chemotherapy regimen has component Rituximab	NCI
C37778	STY	Therapeutic or Preventive Procedure		NCI
C37778	PT	Flavopiridol/Imatinib Mesylate		NCI
C37778	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37778	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C37778	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C11615	STY	Therapeutic or Preventive Procedure		NCI
C11615	PT	Fluorouracil/Leucovorin Calcium/SCH 66336		NCI
C11615	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11615	RO	chemotherapy regimen has component Fluorouracil	NCI
C11615	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11615	RO	chemotherapy regimen has component Lonafarnib	NCI
C37858	STY	Therapeutic or Preventive Procedure		NCI
C37858	PT	Tamoxifen/Triptorelin		NCI
C37858	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37858	RO	chemotherapy regimen has component Triptorelin	NCI
C37858	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C9687	STY	Therapeutic or Preventive Procedure		NCI
C9687	PT	Carmustine/Cisplatin/Dacarbazine/Tamoxifen		NCI
C9687	SY	BCNU/CDDP/DTIC/TMX		NCI
C9687	SY	Dartmouth Regimen		NCI
C9687	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9687	RO	chemotherapy regimen has component Carmustine	NCI
C9687	RO	chemotherapy regimen has component Cisplatin	NCI
C9687	RO	chemotherapy regimen has component Dacarbazine	NCI
C9687	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C9904	STY	Therapeutic or Preventive Procedure		NCI
C9904	PT	Floxuridine/Octreotide/Streptozocin		NCI
C9904	SY	FUDR/SSTN/SZC		NCI
C9904	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9904	RO	chemotherapy regimen has component Floxuridine	NCI
C9904	RO	chemotherapy regimen has component Octreotide	NCI
C9904	RO	chemotherapy regimen has component Streptozocin	NCI
C12029	STY	Therapeutic or Preventive Procedure		NCI
C12029	PT	Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine		NCI
C12029	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12029	RO	chemotherapy regimen has component Mercaptopurine	NCI
C12029	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12029	RO	chemotherapy regimen has component Cytarabine	NCI
C12029	RO	chemotherapy regimen has component Methotrexate	NCI
C12029	RO	chemotherapy regimen has component Vincristine	NCI
C12029	RO	chemotherapy regimen has component Pegaspargase	NCI
C10732	STY	Therapeutic or Preventive Procedure		NCI
C10732	PT	Busulfan/Cyclophosphamide/Mitoxantrone		NCI
C10732	SY	BU/CTX/DHAD		NCI
C10732	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10732	RO	chemotherapy regimen has component Busulfan	NCI
C10732	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10732	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11931	STY	Therapeutic or Preventive Procedure		NCI
C11931	PT	Exemestane/Goserelin		NCI
C11931	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11931	RO	chemotherapy regimen has component Goserelin	NCI
C11931	RO	chemotherapy regimen has component Exemestane	NCI
C12122	STY	Therapeutic or Preventive Procedure		NCI
C12122	PT	Anti-thymocyte globulin/Cyclophosphamide/Fludarabine/methylprednisolone		NCI
C12122	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12122	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C12122	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12122	RO	chemotherapy regimen has component Methylprednisolone	NCI
C12122	RO	chemotherapy regimen has component Fludarabine	NCI
C11708	STY	Therapeutic or Preventive Procedure		NCI
C11708	PT	Filgrastim/Interleukin-11		NCI
C11708	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11708	RO	chemotherapy regimen has component Filgrastim	NCI
C11708	RO	chemotherapy regimen has component Oprelvekin	NCI
C37600	STY	Therapeutic or Preventive Procedure		NCI
C37600	PT	Carboplatin/Cyclophosphamide/Doxorubicin/Etoposide		NCI
C37600	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37600	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37600	RO	chemotherapy regimen has component Doxorubicin	NCI
C37600	RO	chemotherapy regimen has component Etoposide	NCI
C37600	RO	chemotherapy regimen has component Carboplatin	NCI
C11886	STY	Therapeutic or Preventive Procedure		NCI
C11886	PT	gp100 Antigen/Interferon Alfa/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide		NCI
C11886	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11886	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11886	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11886	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11886	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11886	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10248	STY	Therapeutic or Preventive Procedure		NCI
C10248	PT	Asparaginase/Cyclophosphamide/Cytarabine		NCI
C10248	SY	ARA-C/ASP/CTX		NCI
C10248	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10248	RO	chemotherapy regimen has component Asparaginase	NCI
C10248	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10248	RO	chemotherapy regimen has component Cytarabine	NCI
C9764	STY	Therapeutic or Preventive Procedure		NCI
C9764	PT	16.88/88BV59		NCI
C9764	SY	HumaRAD		NCI
C9764	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9764	RO	chemotherapy regimen has component Monoclonal Antibody 16.88	NCI
C9764	RO	chemotherapy regimen has component Votumumab	NCI
C9953	STY	Therapeutic or Preventive Procedure		NCI
C9953	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Fluoxymesterone/Tamoxifen		NCI
C9953	SY	CAFTH		NCI
C9953	SY	CTX/DOX/5-FU/FXM/TMX		NCI
C9953	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9953	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9953	RO	chemotherapy regimen has component Doxorubicin	NCI
C9953	RO	chemotherapy regimen has component Fluorouracil	NCI
C9953	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C9953	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11216	STY	Therapeutic or Preventive Procedure		NCI
C11216	PT	Aminoglutethimide/Bicalutamide/Hydrocortisone		NCI
C11216	SY	AGT/CDX/HC		NCI
C11216	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11216	RO	chemotherapy regimen has component Aminoglutethimide	NCI
C11216	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C11216	RO	chemotherapy regimen has component Bicalutamide	NCI
C37584	STY	Therapeutic or Preventive Procedure		NCI
C37584	PT	Capecitabine/DJ-927		NCI
C37584	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37584	RO	chemotherapy regimen has component Capecitabine	NCI
C37584	RO	chemotherapy regimen has component Tesetaxel	NCI
C10622	STY	Therapeutic or Preventive Procedure		NCI
C10622	PT	Carboplatin/Carmustine/Tamoxifen		NCI
C10622	SY	BCNU/CBDCA/TMX		NCI
C10622	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10622	RO	chemotherapy regimen has component Carmustine	NCI
C10622	RO	chemotherapy regimen has component Carboplatin	NCI
C10622	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10441	STY	Therapeutic or Preventive Procedure		NCI
C10441	PT	Carboplatin/Etoposide/Monoclonal Antibody 3F8		NCI
C10441	SY	CBDCA/MOAB 3F8/VP-16		NCI
C10441	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10441	RO	chemotherapy regimen has component Etoposide	NCI
C10441	RO	chemotherapy regimen has component Carboplatin	NCI
C10441	RO	chemotherapy regimen has component Monoclonal Antibody 3F8	NCI
C10130	STY	Therapeutic or Preventive Procedure		NCI
C10130	PT	Cisplatin/Hydrazine Sulfate/Vinblastine		NCI
C10130	SY	CDDP/HDZ/VBL		NCI
C10130	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10130	RO	chemotherapy regimen has component Cisplatin	NCI
C10130	RO	chemotherapy regimen has component Vinblastine	NCI
C10130	RO	chemotherapy regimen has component Hydrazine Sulfate	NCI
C10504	STY	Therapeutic or Preventive Procedure		NCI
C10504	PT	Carboplatin/Epoetin Alfa/Etoposide		NCI
C10504	SY	CBDCA/EPO/VP-16		NCI
C10504	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10504	RO	chemotherapy regimen has component Etoposide	NCI
C10504	RO	chemotherapy regimen has component Carboplatin	NCI
C10504	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C63522	STY	Therapeutic or Preventive Procedure		NCI
C63522	PT	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm		NCI
C63522	CHD	Chemotherapy Regimen	NCI
C63522	PAR	JEB Regimen	NCI
C63522	PAR	BEP Regimen	NCI
C63522	PAR	Cisplatin-Taxol Regimen	NCI
C63522	PAR	Carboplatin-Taxol Regimen	NCI
C63522	PAR	Docetaxel-Carboplatin Regimen	NCI
C63522	PAR	Gemcitabine-Carboplatin Regimen	NCI
C63522	PAR	Gemcitabine-Cisplatin Regimen	NCI
C63522	PAR	Gemcitabine-Liposomal Doxorubicin Regimen	NCI
C63522	PAR	VeIP Regimen	NCI
C63522	PAR	PEB Regimen	NCI
C63522	PAR	Carboplatin/Paclitaxel/Nivolumab Regimen	NCI
C63522	PAR	Liposomal Doxorubicin HCl/Carboplatin Regimen	NCI
C29480	STY	Therapeutic or Preventive Procedure		NCI
C29480	PT	Cisplatin/Dacarbazine/Interferon-alpha/Tamoxifen/Tumor Infiltrating Lymphocytes		NCI
C29480	SY	TIL/DTIC/Cisplat/Tam/IFN		NCI
C29480	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C29480	RO	chemotherapy regimen has component Cisplatin	NCI
C29480	RO	chemotherapy regimen has component Dacarbazine	NCI
C29480	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C29480	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C29480	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C11603	STY	Therapeutic or Preventive Procedure		NCI
C11603	PT	Iodine I 125/Polifeprosan 20 With Carmustine Implant		NCI
C11603	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11603	RO	chemotherapy regimen has component Carmustine Implant	NCI
C11603	RO	chemotherapy regimen has component Iodine I-125	NCI
C37576	STY	Therapeutic or Preventive Procedure		NCI
C37576	PT	Bortezomib/Mitoxantrone		NCI
C37576	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37576	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37576	RO	chemotherapy regimen has component Bortezomib	NCI
C11089	STY	Therapeutic or Preventive Procedure		NCI
C11089	PT	Etoposide/Mitoxantrone/Tretinoin Liposome		NCI
C11089	SY	DHAD/L-ATRA/VP-16		NCI
C11089	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11089	RO	chemotherapy regimen has component Etoposide	NCI
C11089	RO	chemotherapy regimen has component Tretinoin Liposome	NCI
C11089	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10191	STY	Therapeutic or Preventive Procedure		NCI
C10191	PT	Carboplatin/Vincristine		NCI
C10191	SY	CBDCA/VCR		NCI
C10191	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10191	RO	chemotherapy regimen has component Vincristine	NCI
C10191	RO	chemotherapy regimen has component Carboplatin	NCI
C9731	STY	Therapeutic or Preventive Procedure		NCI
C9731	PT	Bleomycin/Doxorubicin/Etoposide/Mechlorethamine/Prednisone/Vinblastine/Vincristine		NCI
C9731	SY	BLEO/DOX/NM/PRED/VBL/VCR/VP-16		NCI
C9731	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9731	RO	chemotherapy regimen has component Bleomycin	NCI
C9731	RO	chemotherapy regimen has component Doxorubicin	NCI
C9731	RO	chemotherapy regimen has component Etoposide	NCI
C9731	RO	chemotherapy regimen has component Prednisone	NCI
C9731	RO	chemotherapy regimen has component Vinblastine	NCI
C9731	RO	chemotherapy regimen has component Vincristine	NCI
C9731	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C9693	STY	Therapeutic or Preventive Procedure		NCI
C9693	PT	Cisplatin/Etoposide/Vinblastine		NCI
C9693	SY	CDDP/VBL/VP-16		NCI
C9693	SY	VPV		NCI
C9693	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9693	RO	chemotherapy regimen has component Cisplatin	NCI
C9693	RO	chemotherapy regimen has component Etoposide	NCI
C9693	RO	chemotherapy regimen has component Vinblastine	NCI
C10606	STY	Therapeutic or Preventive Procedure		NCI
C10606	PT	Amphotericin B/Colistin Sulfate/Tobramycin		NCI
C10606	SY	amphotericin B/colistin sulfate/TBM		NCI
C10606	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10606	RO	chemotherapy regimen has component Amphotericin B	NCI
C10606	RO	chemotherapy regimen has component Colistin Sulfate	NCI
C10606	RO	chemotherapy regimen has component Tobramycin Sulfate	NCI
C11930	STY	Therapeutic or Preventive Procedure		NCI
C11930	PT	Atamestane/Toremifene		NCI
C11930	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11930	RO	chemotherapy regimen has component Atamestane	NCI
C11930	RO	chemotherapy regimen has component Toremifene	NCI
C12156	STY	Therapeutic or Preventive Procedure		NCI
C12156	PT	Aspirin/Folic acid		NCI
C12156	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12156	RO	chemotherapy regimen has component Aspirin	NCI
C12156	RO	chemotherapy regimen has component Folic Acid	NCI
C9900	STY	Therapeutic or Preventive Procedure		NCI
C9900	PT	Cisplatin/Cyclophosphamide/Dacarbazine/Doxorubicin/Etoposide/Vincristine		NCI
C9900	SY	CDDP/CTX/DOX/DTIC/VCR/VP-16		NCI
C9900	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9900	RO	chemotherapy regimen has component Cisplatin	NCI
C9900	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9900	RO	chemotherapy regimen has component Dacarbazine	NCI
C9900	RO	chemotherapy regimen has component Doxorubicin	NCI
C9900	RO	chemotherapy regimen has component Etoposide	NCI
C9900	RO	chemotherapy regimen has component Vincristine	NCI
C10537	STY	Therapeutic or Preventive Procedure		NCI
C10537	PT	Carboplatin/Ifosfamide/Sargramostim		NCI
C10537	SY	CBDCA/GM-CSF/IFF		NCI
C10537	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10537	RO	chemotherapy regimen has component Ifosfamide	NCI
C10537	RO	chemotherapy regimen has component Carboplatin	NCI
C10537	RO	chemotherapy regimen has component Sargramostim	NCI
C64844	STY	Therapeutic or Preventive Procedure		NCI
C64844	PT	EVAC Regimen		NCI
C64844	CHD	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C64844	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C64844	RO	chemotherapy regimen has component Doxorubicin	NCI
C64844	RO	chemotherapy regimen has component Etoposide	NCI
C64844	RO	chemotherapy regimen has component Vincristine	NCI
C64844	RO	regimen has accepted use for disease Lung Small Cell Carcinoma	NCI
C37712	STY	Therapeutic or Preventive Procedure		NCI
C37712	PT	Cytarabine/Dexamethasone/Lomustine/Methotrexate/Procarbazine		NCI
C37712	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37712	RO	chemotherapy regimen has component Cytarabine	NCI
C37712	RO	chemotherapy regimen has component Dexamethasone	NCI
C37712	RO	chemotherapy regimen has component Lomustine	NCI
C37712	RO	chemotherapy regimen has component Methotrexate	NCI
C37712	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11511	STY	Therapeutic or Preventive Procedure		NCI
C11511	PT	Dexamethasone/Floxuridine/Irinotecan		NCI
C11511	SY	CPT-11/DM/FUDR		NCI
C11511	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11511	RO	chemotherapy regimen has component Dexamethasone	NCI
C11511	RO	chemotherapy regimen has component Floxuridine	NCI
C11511	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C9709	STY	Therapeutic or Preventive Procedure		NCI
C9709	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Teniposide/Vincristine		NCI
C9709	SY	CHVMP/VCR-BLEO		NCI
C9709	SY	BLEO/CTX/DOX/PRED/VCR/VM-26		NCI
C9709	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9709	RO	chemotherapy regimen has component Bleomycin	NCI
C9709	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9709	RO	chemotherapy regimen has component Doxorubicin	NCI
C9709	RO	chemotherapy regimen has component Prednisone	NCI
C9709	RO	chemotherapy regimen has component Teniposide	NCI
C9709	RO	chemotherapy regimen has component Vincristine	NCI
C63610	STY	Therapeutic or Preventive Procedure		NCI
C63610	PT	FU-LV-Bevacizumab Regimen		NCI
C63610	SY	FU-LV-Avastin Regimen		NCI
C63610	SY	5FU/LV-Bevacizumab Regimen		NCI
C63610	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63610	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63610	RO	chemotherapy regimen has component Fluorouracil	NCI
C63610	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11817	STY	Therapeutic or Preventive Procedure		NCI
C11817	PT	Cyclophosphamide/Dexamethasone/Mitoxantrone		NCI
C11817	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11817	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11817	RO	chemotherapy regimen has component Dexamethasone	NCI
C11817	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10869	STY	Therapeutic or Preventive Procedure		NCI
C10869	PT	Cisplatin/Cytarabine/Idarubicin/Methylprednisolone		NCI
C10869	SY	ARA-C/CDDP/IDA/MePRDL		NCI
C10869	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10869	RO	chemotherapy regimen has component Cisplatin	NCI
C10869	RO	chemotherapy regimen has component Cytarabine	NCI
C10869	RO	chemotherapy regimen has component Idarubicin	NCI
C10869	RO	chemotherapy regimen has component Methylprednisolone	NCI
C9855	STY	Therapeutic or Preventive Procedure		NCI
C9855	PT	Doxorubicin/Etoposide/Quinidine		NCI
C9855	SY	DOX/QND/VP-16		NCI
C9855	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9855	RO	chemotherapy regimen has component Doxorubicin	NCI
C9855	RO	chemotherapy regimen has component Etoposide	NCI
C9855	RO	chemotherapy regimen has component Quinidine	NCI
C10565	STY	Therapeutic or Preventive Procedure		NCI
C10565	PT	Interleukin-2/Interleukin-6		NCI
C10565	SY	IL-2/IL-6		NCI
C10565	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10565	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10565	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C12032	STY	Therapeutic or Preventive Procedure		NCI
C12032	PT	EGFR Antisense DNA/Keyhole Limpet Hemocyanin		NCI
C12032	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12032	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C12032	RO	chemotherapy regimen has component EGFR Antisense DNA	NCI
C11682	STY	Therapeutic or Preventive Procedure		NCI
C11682	PT	Flt3 Ligand/gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide		NCI
C11682	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11682	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11682	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11682	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11682	RO	chemotherapy regimen has component Recombinant Flt3 Ligand	NCI
C11682	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11317	STY	Therapeutic or Preventive Procedure		NCI
C11317	PT	Gemcitabine/Irinotecan		NCI
C11317	SY	CPT-11/dFdC		NCI
C11317	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11317	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11317	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10689	STY	Therapeutic or Preventive Procedure		NCI
C10689	PT	Etoposide/Tretinoin		NCI
C10689	SY	ATRA/VP-16		NCI
C10689	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10689	RO	chemotherapy regimen has component Etoposide	NCI
C10689	RO	chemotherapy regimen has component Tretinoin	NCI
C11799	STY	Therapeutic or Preventive Procedure		NCI
C11799	PT	Cisplatin/Shark Cartilage/Vinorelbine		NCI
C11799	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11799	RO	chemotherapy regimen has component Cisplatin	NCI
C11799	RO	chemotherapy regimen has component Vinorelbine	NCI
C11799	RO	chemotherapy regimen has component Shark Cartilage	NCI
C12065	STY	Therapeutic or Preventive Procedure		NCI
C12065	PT	BMS-247550/Estramustine		NCI
C12065	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12065	RO	chemotherapy regimen has component Estramustine	NCI
C12065	RO	chemotherapy regimen has component Ixabepilone	NCI
C10096	STY	Therapeutic or Preventive Procedure		NCI
C10096	PT	Altretamine/Doxorubicin/Fluorouracil/Mitomycin		NCI
C10096	SY	DOX/5-FU/HMM/MITO		NCI
C10096	SY	HEXA-FAM		NCI
C10096	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10096	RO	chemotherapy regimen has component Mitomycin	NCI
C10096	RO	chemotherapy regimen has component Doxorubicin	NCI
C10096	RO	chemotherapy regimen has component Fluorouracil	NCI
C10096	RO	chemotherapy regimen has component Altretamine	NCI
C10650	STY	Therapeutic or Preventive Procedure		NCI
C10650	PT	Cyclophosphamide/Didanosine/Doxorubicin/Etoposide/Vincristine		NCI
C10650	SY	CTX/ddI/DOX/VCR/VP-16		NCI
C10650	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10650	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10650	RO	chemotherapy regimen has component Didanosine	NCI
C10650	RO	chemotherapy regimen has component Doxorubicin	NCI
C10650	RO	chemotherapy regimen has component Etoposide	NCI
C10650	RO	chemotherapy regimen has component Vincristine	NCI
C67479	STY	Therapeutic or Preventive Procedure		NCI
C67479	PT	IDA-DCTER Regimen		NCI
C67479	CHD	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia	NCI
C67479	RO	chemotherapy regimen has component Cytarabine	NCI
C67479	RO	chemotherapy regimen has component Dexamethasone	NCI
C67479	RO	chemotherapy regimen has component Etoposide	NCI
C67479	RO	chemotherapy regimen has component Idarubicin	NCI
C67479	RO	chemotherapy regimen has component Thioguanine	NCI
C67479	RO	regimen has accepted use for disease Childhood Acute Myeloid Leukemia	NCI
C11343	STY	Therapeutic or Preventive Procedure		NCI
C11343	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine		NCI
C11343	SY	VACOP-B		NCI
C11343	SY	BLEO/CTX/DOX/PRED/VCR/VP-16		NCI
C11343	SY	P-VABEC		NCI
C11343	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11343	RO	chemotherapy regimen has component Bleomycin	NCI
C11343	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11343	RO	chemotherapy regimen has component Doxorubicin	NCI
C11343	RO	chemotherapy regimen has component Etoposide	NCI
C11343	RO	chemotherapy regimen has component Prednisone	NCI
C11343	RO	chemotherapy regimen has component Vincristine	NCI
C11999	STY	Therapeutic or Preventive Procedure		NCI
C11999	PT	Bevacizumab/Vinorelbine		NCI
C11999	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11999	RO	chemotherapy regimen has component Vinorelbine	NCI
C11999	RO	chemotherapy regimen has component Bevacizumab	NCI
C37805	STY	Therapeutic or Preventive Procedure		NCI
C37805	PT	Gemcitabine/Soblidotin		NCI
C37805	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37805	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37805	RO	chemotherapy regimen has component Soblidotin	NCI
C11345	STY	Therapeutic or Preventive Procedure		NCI
C11345	PT	Doxorubicin HCl Liposome/PSC 833		NCI
C11345	SY	Lipodox/PSC 833		NCI
C11345	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11345	RO	chemotherapy regimen has component Valspodar	NCI
C11345	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C11814	STY	Therapeutic or Preventive Procedure		NCI
C11814	PT	R115777/Trastuzumab		NCI
C11814	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11814	RO	chemotherapy regimen has component Trastuzumab	NCI
C11814	RO	chemotherapy regimen has component Tipifarnib	NCI
C10000	STY	Therapeutic or Preventive Procedure		NCI
C10000	PT	Cyclophosphamide/Fluoxymesterone/Mitolactol/Prednisone/Tamoxifen		NCI
C10000	SY	CD(P)TH		NCI
C10000	SY	CTX/DBD/FXM/PRED/TMX		NCI
C10000	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10000	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10000	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C10000	RO	chemotherapy regimen has component Mitolactol	NCI
C10000	RO	chemotherapy regimen has component Prednisone	NCI
C10000	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C37801	STY	Therapeutic or Preventive Procedure		NCI
C37801	PT	Gemcitabine/Ixabepilone		NCI
C37801	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37801	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37801	RO	chemotherapy regimen has component Ixabepilone	NCI
C10143	STY	Therapeutic or Preventive Procedure		NCI
C10143	PT	Doxorubicin/Etoposide/Prednisone		NCI
C10143	SY	DOX/PRED/VP-16		NCI
C10143	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10143	RO	chemotherapy regimen has component Doxorubicin	NCI
C10143	RO	chemotherapy regimen has component Etoposide	NCI
C10143	RO	chemotherapy regimen has component Prednisone	NCI
C10522	STY	Therapeutic or Preventive Procedure		NCI
C10522	PT	Cyclosporine/Dexamethasone/Doxorubicin/Vincristine		NCI
C10522	SY	CYSP/DM/DOX/VCR		NCI
C10522	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10522	RO	chemotherapy regimen has component Cyclosporine	NCI
C10522	RO	chemotherapy regimen has component Dexamethasone	NCI
C10522	RO	chemotherapy regimen has component Doxorubicin	NCI
C10522	RO	chemotherapy regimen has component Vincristine	NCI
C11445	STY	Therapeutic or Preventive Procedure		NCI
C11445	PT	Interferon Alfa/Interleukin-2/Sargramostim		NCI
C11445	SY	GM-CSF/IFN-A/IL-2		NCI
C11445	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11445	RO	chemotherapy regimen has component Sargramostim	NCI
C11445	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11445	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37699	STY	Therapeutic or Preventive Procedure		NCI
C37699	PT	Cyclophosphamide/Oblimersen		NCI
C37699	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37699	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37699	RO	chemotherapy regimen has component Oblimersen	NCI
C10278	STY	Therapeutic or Preventive Procedure		NCI
C10278	PT	Doxorubicin/Etoposide/Methotrexate		NCI
C10278	SY	DOX/MTX/VP-16		NCI
C10278	SY	AMV		NCI
C10278	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10278	RO	chemotherapy regimen has component Doxorubicin	NCI
C10278	RO	chemotherapy regimen has component Etoposide	NCI
C10278	RO	chemotherapy regimen has component Methotrexate	NCI
C12189	STY	Therapeutic or Preventive Procedure		NCI
C12189	PT	Docetaxel/Ketoconazole		NCI
C12189	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12189	RO	chemotherapy regimen has component Ketoconazole	NCI
C12189	RO	chemotherapy regimen has component Docetaxel	NCI
C37730	STY	Therapeutic or Preventive Procedure		NCI
C37730	PT	Dexamethasone/Epoetin Alfa		NCI
C37730	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37730	RO	chemotherapy regimen has component Dexamethasone	NCI
C37730	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C156266	STY	Therapeutic or Preventive Procedure		NCI
C156266	PT	Gemcitabine/Cisplatin/Everolimus Regimen		NCI
C156266	SY	Gemcitabine-Cisplatin-Everolimus		NCI
C156266	SY	Gemcitabine/Cisplatin/Everolimus		NCI
C156266	SY	Everolimus/Gemcitabine/Cisplatin		NCI
C156266	SY	Gemcitabine/Platinol/Everolimus		NCI
C156266	SY	GPE		NCI
C156266	SY	Gemcitabine and Cisplatin with Everolimus		NCI
C156266	CHD	Chemotherapy Regimen Used to Treat Bladder Carcinoma	NCI
C156266	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156266	RO	chemotherapy regimen has component Cisplatin	NCI
C156266	RO	chemotherapy regimen has component Everolimus	NCI
C156266	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10752	STY	Therapeutic or Preventive Procedure		NCI
C10752	PT	Methotrexate/Paclitaxel		NCI
C10752	SY	MTX/TAX		NCI
C10752	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10752	RO	chemotherapy regimen has component Methotrexate	NCI
C10752	RO	chemotherapy regimen has component Paclitaxel	NCI
C67290	STY	Therapeutic or Preventive Procedure		NCI
C67290	PT	Chemotherapy Regimen Used to Treat Malignant Renal Neoplasm		NCI
C67290	SY	Chemotherapy Regimen Used to Treat Kidney Cancer		NCI
C67290	CHD	Chemotherapy Regimen	NCI
C67290	PAR	Chemotherapy Regimen Used to Treat Childhood Malignant Renal Neoplasm	NCI
C67290	PAR	Bevacizumab/Everolimus Regimen	NCI
C67290	PAR	Lenvatinib/Everolimus Regimen	NCI
C67290	PAR	Ipilimumab/Nivolumab Regimen	NCI
C37668	STY	Therapeutic or Preventive Procedure		NCI
C37668	PT	Cladribine/Rituximab		NCI
C37668	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37668	RO	chemotherapy regimen has component Cladribine	NCI
C37668	RO	chemotherapy regimen has component Rituximab	NCI
C10403	STY	Therapeutic or Preventive Procedure		NCI
C10403	PT	Fluorouracil/L-Leucovorin		NCI
C10403	SY	5-FU/L-CF		NCI
C10403	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10403	RO	chemotherapy regimen has component Fluorouracil	NCI
C10403	RO	chemotherapy regimen has component Levoleucovorin	NCI
C9713	STY	Therapeutic or Preventive Procedure		NCI
C9713	PT	Cyclophosphamide/Etoposide		NCI
C9713	SY	CV		NCI
C9713	SY	CTX/VP-16		NCI
C9713	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9713	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9713	RO	chemotherapy regimen has component Etoposide	NCI
C12164	STY	Therapeutic or Preventive Procedure		NCI
C12164	PT	Corticotropin/Cyclophosphamide		NCI
C12164	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12164	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12164	RO	chemotherapy regimen has component Recombinant Corticotropin	NCI
C9824	STY	Therapeutic or Preventive Procedure		NCI
C9824	PT	Doxorubicin/Floxuridine		NCI
C9824	SY	DOX/FUDR		NCI
C9824	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9824	RO	chemotherapy regimen has component Doxorubicin	NCI
C9824	RO	chemotherapy regimen has component Floxuridine	NCI
C11291	STY	Therapeutic or Preventive Procedure		NCI
C11291	PT	Doxorubicin HCl Liposome/VX-853		NCI
C11291	SY	LipoDox/VX-853		NCI
C11291	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11291	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C11291	RO	chemotherapy regimen has component Timcodar Dimesylate	NCI
C11190	STY	Therapeutic or Preventive Procedure		NCI
C11190	PT	Melphalan/Mitoxantrone		NCI
C11190	SY	DHAD/L-PAM		NCI
C11190	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11190	RO	chemotherapy regimen has component Melphalan	NCI
C11190	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11249	STY	Therapeutic or Preventive Procedure		NCI
C11249	PT	Lomustine/Procarbazine/Thioguanine/Vincristine		NCI
C11249	SY	CCNU/PCB/TG/VCR		NCI
C11249	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11249	RO	chemotherapy regimen has component Lomustine	NCI
C11249	RO	chemotherapy regimen has component Thioguanine	NCI
C11249	RO	chemotherapy regimen has component Vincristine	NCI
C11249	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C12171	STY	Therapeutic or Preventive Procedure		NCI
C12171	PT	Bexarotene/Carboplatin/Paclitaxel		NCI
C12171	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12171	RO	chemotherapy regimen has component Carboplatin	NCI
C12171	RO	chemotherapy regimen has component Paclitaxel	NCI
C12171	RO	chemotherapy regimen has component Bexarotene	NCI
C10630	STY	Therapeutic or Preventive Procedure		NCI
C10630	PT	Cisplatin/Etoposide/Tretinoin		NCI
C10630	SY	ATRA/CDDP/VP-16		NCI
C10630	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10630	RO	chemotherapy regimen has component Cisplatin	NCI
C10630	RO	chemotherapy regimen has component Etoposide	NCI
C10630	RO	chemotherapy regimen has component Tretinoin	NCI
C11439	STY	Therapeutic or Preventive Procedure		NCI
C11439	PT	Carcinoembryonic Antigen Peptide 1/Hepatitis B Antigen Peptide		NCI
C11439	SY	CAP-1/HBsAg		NCI
C11439	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11439	RO	chemotherapy regimen has component Hepatitis B Vaccine	NCI
C11439	RO	chemotherapy regimen has component Carcinoembryonic Antigen Peptide 1	NCI
C9624	STY	Therapeutic or Preventive Procedure		NCI
C9624	PT	Cytarabine/Prednisone/Vincristine		NCI
C9624	SY	OAP		NCI
C9624	SY	ARA-C/PRED/VCR		NCI
C9624	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9624	RO	chemotherapy regimen has component Cytarabine	NCI
C9624	RO	chemotherapy regimen has component Prednisone	NCI
C9624	RO	chemotherapy regimen has component Vincristine	NCI
C11852	STY	Therapeutic or Preventive Procedure		NCI
C11852	PT	gp209-2M Antigen/Interleukin-2/Montanide ISA-51		NCI
C11852	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11852	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11852	RO	chemotherapy regimen has component gp209-2M Antigen	NCI
C11852	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C29472	STY	Therapeutic or Preventive Procedure		NCI
C29472	PT	Flutamide/Hydrocortisone/Suramin		NCI
C29472	SY	Suramin/HC/Flut		NCI
C29472	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C29472	RO	chemotherapy regimen has component Flutamide	NCI
C29472	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C29472	RO	chemotherapy regimen has component Suramin	NCI
C37828	STY	Therapeutic or Preventive Procedure		NCI
C37828	PT	Melanoma Helper Peptide Vaccine/Montanide ISA-51/Sargramostim		NCI
C37828	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37828	RO	chemotherapy regimen has component Sargramostim	NCI
C37828	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C37828	RO	chemotherapy regimen has component Melanoma Helper Peptide Vaccine	NCI
C136267	STY	Therapeutic or Preventive Procedure		NCI
C136267	PT	Daratumumab/Bortezomib/Dexamethasone Regimen		NCI
C136267	SY	Daratumumab-Bortezomib-Dexamethasone		NCI
C136267	SY	DVD		NCI
C136267	SY	Daratumumab-Bortezomib-Dexamethasone Regimen		NCI
C136267	SY	Daratumumab/Bortezomib/Dexamethasone		NCI
C136267	SY	Darzalex/Velcade/Dexamethasone		NCI
C136267	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136267	RO	chemotherapy regimen has component Dexamethasone	NCI
C136267	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136267	RO	chemotherapy regimen has component Bortezomib	NCI
C136267	RO	chemotherapy regimen has component Daratumumab	NCI
C10850	STY	Therapeutic or Preventive Procedure		NCI
C10850	PT	Ciprofloxacin/Cisplatin/Etoposide		NCI
C10850	SY	CDDP/CPFX/VP-16		NCI
C10850	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10850	RO	chemotherapy regimen has component Ciprofloxacin	NCI
C10850	RO	chemotherapy regimen has component Cisplatin	NCI
C10850	RO	chemotherapy regimen has component Etoposide	NCI
C10059	STY	Therapeutic or Preventive Procedure		NCI
C10059	PT	Dactinomycin/Tumor Necrosis Factor		NCI
C10059	SY	DACT/TNF		NCI
C10059	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10059	RO	chemotherapy regimen has component Dactinomycin	NCI
C10059	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C136258	STY	Therapeutic or Preventive Procedure		NCI
C136258	PT	Irinotecan/Bevacizumab Regimen		NCI
C136258	SY	Irinotecan-Avastin Regimen		NCI
C136258	SY	Irinotecan/Bevacizumab		NCI
C136258	SY	Irinotecan-Bevacizumab Regimen		NCI
C136258	SY	Irinotecan-Bevacizumab		NCI
C136258	SY	Irinotecan/Avastin Regimen		NCI
C136258	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136258	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136258	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C136258	RO	chemotherapy regimen has component Bevacizumab	NCI
C11525	STY	Therapeutic or Preventive Procedure		NCI
C11525	PT	Flu Matrix/gp100 Antigen/MAGE-3.1/MART-1 Antigen/Tyrosinase Peptide		NCI
C11525	SY	Flu/Gp100/MAGE-3.1/MART-1/TYRP		NCI
C11525	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11525	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11525	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11525	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C11525	RO	chemotherapy regimen has component Flu Matrix Peptide p58-66	NCI
C11525	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C28552	STY	Therapeutic or Preventive Procedure		NCI
C28552	PT	Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine/QS21		NCI
C28552	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C28552	RO	chemotherapy regimen has component QS21	NCI
C28552	RO	chemotherapy regimen has component Globo-H-GM2-Lewis-y-MUC1-32(aa)-sTn(c)-TF(c)-Tn(c)-KLH Conjugate Vaccine	NCI
C10959	STY	Therapeutic or Preventive Procedure		NCI
C10959	PT	Flutamide/Isotretinoin/Leuprolide		NCI
C10959	SY	13-CRA/FLUT/LEUP		NCI
C10959	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10959	RO	chemotherapy regimen has component Flutamide	NCI
C10959	RO	chemotherapy regimen has component Isotretinoin	NCI
C10959	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C11921	STY	Therapeutic or Preventive Procedure		NCI
C11921	PT	Dexamethasone/Floxuridine		NCI
C11921	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11921	RO	chemotherapy regimen has component Dexamethasone	NCI
C11921	RO	chemotherapy regimen has component Floxuridine	NCI
C37696	STY	Therapeutic or Preventive Procedure		NCI
C37696	PT	Cyclophosphamide/Fludarabine/Rituximab		NCI
C37696	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37696	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37696	RO	chemotherapy regimen has component Fludarabine	NCI
C37696	RO	chemotherapy regimen has component Rituximab	NCI
C10259	STY	Therapeutic or Preventive Procedure		NCI
C10259	PT	Cyclophosphamide/Diethylstilbestrol/Fluorouracil/Methotrexate		NCI
C10259	SY	CTX/DES/5-FU/MTX		NCI
C10259	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10259	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10259	RO	chemotherapy regimen has component Diethylstilbestrol	NCI
C10259	RO	chemotherapy regimen has component Fluorouracil	NCI
C10259	RO	chemotherapy regimen has component Methotrexate	NCI
C10846	STY	Therapeutic or Preventive Procedure		NCI
C10846	PT	Cyclophosphamide/Idarubicin/Prednisone/Vincristine		NCI
C10846	SY	CTX/IDA/PRED/VCR		NCI
C10846	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10846	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10846	RO	chemotherapy regimen has component Idarubicin	NCI
C10846	RO	chemotherapy regimen has component Prednisone	NCI
C10846	RO	chemotherapy regimen has component Vincristine	NCI
C63791	STY	Therapeutic or Preventive Procedure		NCI
C63791	PT	Flutamide-Goserelin Regimen		NCI
C63791	SY	Flutamide-Zoladex Regimen		NCI
C63791	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C63791	RO	chemotherapy regimen has component Flutamide	NCI
C63791	RO	chemotherapy regimen has component Goserelin	NCI
C63791	RO	regimen has accepted use for disease Prostate Carcinoma	NCI
C12160	STY	Therapeutic or Preventive Procedure		NCI
C12160	PT	Bupropion/Nicotine		NCI
C12160	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12160	RO	chemotherapy regimen has component Nicotine	NCI
C12160	RO	chemotherapy regimen has component Bupropion Hydrochloride	NCI
C9550	STY	Therapeutic or Preventive Procedure		NCI
C9550	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine		NCI
C9550	SY	CAVPB		NCI
C9550	SY	BACOP		NCI
C9550	SY	BLEO/CTX/DOX/PRED/VCR		NCI
C9550	SY	CA-BOP		NCI
C9550	SY	CHOP-B		NCI
C9550	SY	CHOP-Bleo		NCI
C9550	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9550	RO	chemotherapy regimen has component Bleomycin	NCI
C9550	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9550	RO	chemotherapy regimen has component Doxorubicin	NCI
C9550	RO	chemotherapy regimen has component Prednisone	NCI
C9550	RO	chemotherapy regimen has component Vincristine	NCI
C10437	STY	Therapeutic or Preventive Procedure		NCI
C10437	PT	Dipyridamole/Fluorouracil/PALA		NCI
C10437	SY	DP/5-FU/PALA		NCI
C10437	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10437	RO	chemotherapy regimen has component Dipyridamole	NCI
C10437	RO	chemotherapy regimen has component Fluorouracil	NCI
C10437	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C11896	STY	Therapeutic or Preventive Procedure		NCI
C11896	PT	Cytarabine/Dexamethasone/Etoposide/Ifosfamide/Methotrexate/Vinblastine		NCI
C11896	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11896	RO	chemotherapy regimen has component Cytarabine	NCI
C11896	RO	chemotherapy regimen has component Dexamethasone	NCI
C11896	RO	chemotherapy regimen has component Doxorubicin	NCI
C11896	RO	chemotherapy regimen has component Ifosfamide	NCI
C11896	RO	chemotherapy regimen has component Methotrexate	NCI
C11896	RO	chemotherapy regimen has component Vinblastine	NCI
C11085	STY	Therapeutic or Preventive Procedure		NCI
C11085	PT	Cisplatin/Dacarbazine/Interferon Alfa		NCI
C11085	SY	CDDP/DTIC/IFN-A		NCI
C11085	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11085	RO	chemotherapy regimen has component Cisplatin	NCI
C11085	RO	chemotherapy regimen has component Dacarbazine	NCI
C11085	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10156	STY	Therapeutic or Preventive Procedure		NCI
C10156	PT	Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Methotrexate/Prednisone/Vincristine		NCI
C10156	SY	AMOPLACE		NCI
C10156	SY	ARA-C/CTX/DOX/MTX/PRED/VCR/VP-16		NCI
C10156	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10156	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10156	RO	chemotherapy regimen has component Cytarabine	NCI
C10156	RO	chemotherapy regimen has component Doxorubicin	NCI
C10156	RO	chemotherapy regimen has component Etoposide	NCI
C10156	RO	chemotherapy regimen has component Methotrexate	NCI
C10156	RO	chemotherapy regimen has component Prednisone	NCI
C10156	RO	chemotherapy regimen has component Vincristine	NCI
C12200	STY	Therapeutic or Preventive Procedure		NCI
C12200	PT	Ad5CMV-p53 gene/Docetaxel		NCI
C12200	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12200	RO	chemotherapy regimen has component Docetaxel	NCI
C12200	RO	chemotherapy regimen has component Ad5CMV-p53 Gene	NCI
C10479	STY	Therapeutic or Preventive Procedure		NCI
C10479	PT	Asparaginase/Cytarabine/Etoposide/Methotrexate/Methylprednisolone/Vincristine		NCI
C10479	SY	ARA-C/ASP/MePRDL/MTX/VCR/VP-16		NCI
C10479	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10479	RO	chemotherapy regimen has component Asparaginase	NCI
C10479	RO	chemotherapy regimen has component Cytarabine	NCI
C10479	RO	chemotherapy regimen has component Etoposide	NCI
C10479	RO	chemotherapy regimen has component Methotrexate	NCI
C10479	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10479	RO	chemotherapy regimen has component Vincristine	NCI
C140674	STY	Therapeutic or Preventive Procedure		NCI
C140674	PT	Carboplatin-Pembrolizumab-Pemetrexed Regimen		NCI
C140674	SY	Carboplatin/Pembrolizumab/Pemetrexed		NCI
C140674	SY	Carboplatin-Keytruda-Alimta		NCI
C140674	SY	Carboplatin-Pembrolizumab-Pemetrexed		NCI
C140674	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C140674	RO	chemotherapy regimen has component Carboplatin	NCI
C140674	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C140674	RO	chemotherapy regimen has component Pembrolizumab	NCI
C10775	STY	Therapeutic or Preventive Procedure		NCI
C10775	PT	Carboplatin/Fluorouracil/Vincristine		NCI
C10775	SY	CBDCA/5-FU/VCR		NCI
C10775	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10775	RO	chemotherapy regimen has component Fluorouracil	NCI
C10775	RO	chemotherapy regimen has component Vincristine	NCI
C10775	RO	chemotherapy regimen has component Carboplatin	NCI
C9977	STY	Therapeutic or Preventive Procedure		NCI
C9977	PT	Chlorambucil/Fludarabine		NCI
C9977	SY	CLB/FAMP		NCI
C9977	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9977	RO	chemotherapy regimen has component Chlorambucil	NCI
C9977	RO	chemotherapy regimen has component Fludarabine	NCI
C11460	STY	Therapeutic or Preventive Procedure		NCI
C11460	PT	Cisplatin/Cyclophosphamide/Epirubicin/Etoposide		NCI
C11460	SY	CDDP/CTX/EPI/VP-16		NCI
C11460	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11460	RO	chemotherapy regimen has component Cisplatin	NCI
C11460	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11460	RO	chemotherapy regimen has component Etoposide	NCI
C11460	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C9710	STY	Therapeutic or Preventive Procedure		NCI
C9710	PT	Doxorubicin/Etoposide/Vinblastine		NCI
C9710	SY	EVA		NCI
C9710	SY	DOX/VBL/VP-16		NCI
C9710	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9710	RO	chemotherapy regimen has component Doxorubicin	NCI
C9710	RO	chemotherapy regimen has component Etoposide	NCI
C9710	RO	chemotherapy regimen has component Vinblastine	NCI
C11430	STY	Therapeutic or Preventive Procedure		NCI
C11430	PT	Gemcitabine/Paclitaxel		NCI
C11430	SY	dFdC/TAX		NCI
C11430	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11430	RO	chemotherapy regimen has component Paclitaxel	NCI
C11430	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C156257	STY	Therapeutic or Preventive Procedure		NCI
C156257	PT	Anastrozole/Lapatinib Regimen		NCI
C156257	SY	Anastrozole-Lapatinib Regimen		NCI
C156257	SY	Lapatinib/Anastrozole Regimen		NCI
C156257	SY	Anastrozole/Lapatinib		NCI
C156257	SY	Anastrozole-Lapatinib		NCI
C156257	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156257	RO	chemotherapy regimen has component Anastrozole	NCI
C156257	RO	chemotherapy regimen has component Lapatinib	NCI
C10404	STY	Therapeutic or Preventive Procedure		NCI
C10404	PT	Carboplatin/Cytarabine/Etoposide/Methylprednisolone		NCI
C10404	SY	ARA-C/CBDCA/MePRDL/VP-16		NCI
C10404	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10404	RO	chemotherapy regimen has component Cytarabine	NCI
C10404	RO	chemotherapy regimen has component Etoposide	NCI
C10404	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10404	RO	chemotherapy regimen has component Carboplatin	NCI
C11267	STY	Therapeutic or Preventive Procedure		NCI
C11267	PT	Ifosfamide/Mesna/Mitoxantrone		NCI
C11267	SY	DHAD/IFF/mesna		NCI
C11267	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11267	RO	chemotherapy regimen has component Mesna	NCI
C11267	RO	chemotherapy regimen has component Ifosfamide	NCI
C11267	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C138040	STY	Therapeutic or Preventive Procedure		NCI
C138040	PT	Lapatinib/Trastuzumab Regimen		NCI
C138040	SY	Lapatinib + Trastuzumab		NCI
C138040	SY	Lapatinib Plus Trastuzumab		NCI
C138040	SY	Lapatinib/Trastuzumab		NCI
C138040	SY	Lapatinib + Trastuzumab Regimen		NCI
C138040	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138040	RO	chemotherapy regimen has component Trastuzumab	NCI
C138040	RO	chemotherapy regimen has component Lapatinib	NCI
C10828	STY	Therapeutic or Preventive Procedure		NCI
C10828	PT	Cisplatin/Ifosfamide/Muramyl Tripeptide Phosphatidylethanolamine Liposome		NCI
C10828	SY	CDDP/IFF/MTP-PE Liposome		NCI
C10828	SY	Cisplatin/Ifosfamide/Muramyl Tripeptide Phosphatidylethanolamine		NCI
C10828	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10828	RO	chemotherapy regimen has component Cisplatin	NCI
C10828	RO	chemotherapy regimen has component Ifosfamide	NCI
C10828	RO	chemotherapy regimen has component Mifamurtide	NCI
C10272	STY	Therapeutic or Preventive Procedure		NCI
C10272	PT	Cytarabine/Doxorubicin/Etoposide/Thioguanine		NCI
C10272	SY	VATA-II		NCI
C10272	SY	ARA-C/DOX/TG/VP-16		NCI
C10272	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10272	RO	chemotherapy regimen has component Cytarabine	NCI
C10272	RO	chemotherapy regimen has component Doxorubicin	NCI
C10272	RO	chemotherapy regimen has component Etoposide	NCI
C10272	RO	chemotherapy regimen has component Thioguanine	NCI
C10359	STY	Therapeutic or Preventive Procedure		NCI
C10359	PT	Cytarabine/Daunorubicin/Etoposide/Prednisolone/Thioguanine/Vincristine		NCI
C10359	SY	ARA-C/DNR/PRDL/TG/VCR/VP-16		NCI
C10359	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10359	RO	chemotherapy regimen has component Cytarabine	NCI
C10359	RO	chemotherapy regimen has component Etoposide	NCI
C10359	RO	chemotherapy regimen has component Prednisolone	NCI
C10359	RO	chemotherapy regimen has component Thioguanine	NCI
C10359	RO	chemotherapy regimen has component Vincristine	NCI
C10359	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C12134	STY	Therapeutic or Preventive Procedure		NCI
C12134	PT	Alum adjuvant/gp100 antigen/Interleukin-12/MART-1 antigen/Montanide ISA-51/tyrosinase peptide		NCI
C12134	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12134	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C12134	RO	chemotherapy regimen has component gp100 Antigen	NCI
C12134	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C12134	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C12134	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C12134	RO	chemotherapy regimen has component Aluminum Sulfate Anhydrous	NCI
C12148	STY	Therapeutic or Preventive Procedure		NCI
C12148	PT	Bleomycin/Cyclophosphamide/Idarubicin/Leucovorin calcium/methotrexate/methylprednisolone/vincristine		NCI
C12148	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12148	RO	chemotherapy regimen has component Bleomycin	NCI
C12148	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12148	RO	chemotherapy regimen has component Idarubicin	NCI
C12148	RO	chemotherapy regimen has component Methotrexate	NCI
C12148	RO	chemotherapy regimen has component Methylprednisolone	NCI
C12148	RO	chemotherapy regimen has component Vincristine	NCI
C12148	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11509	STY	Therapeutic or Preventive Procedure		NCI
C11509	PT	Cisplatin/Irinotecan/Paclitaxel		NCI
C11509	SY	CDDP/CPT-11/TAX		NCI
C11509	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11509	RO	chemotherapy regimen has component Cisplatin	NCI
C11509	RO	chemotherapy regimen has component Paclitaxel	NCI
C11509	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C10497	STY	Therapeutic or Preventive Procedure		NCI
C10497	PT	Cyclophosphamide/Doxorubicin/Filgrastim		NCI
C10497	SY	CTX/DOX/G-CSF		NCI
C10497	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10497	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10497	RO	chemotherapy regimen has component Doxorubicin	NCI
C10497	RO	chemotherapy regimen has component Filgrastim	NCI
C12044	STY	Therapeutic or Preventive Procedure		NCI
C12044	PT	Amifostine/Carboplatin/Fluorouracil/Paclitaxel		NCI
C12044	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12044	RO	chemotherapy regimen has component Amifostine	NCI
C12044	RO	chemotherapy regimen has component Fluorouracil	NCI
C12044	RO	chemotherapy regimen has component Carboplatin	NCI
C12044	RO	chemotherapy regimen has component Paclitaxel	NCI
C136255	STY	Therapeutic or Preventive Procedure		NCI
C136255	PT	Bolus Fluorouracil/Leucovorin/Bevacizumab Regimen		NCI
C136255	SY	Bolus Fluorouracil/Leucovorin Plus Avastin Regimen		NCI
C136255	SY	Bolus Fluorouracil/Leucovorin/Avastin Regimen		NCI
C136255	SY	Bolus 5-FU/LV Plus Bevacizumab		NCI
C136255	SY	Bolus Fluorouracil/Leucovorin Plus Bevacizumab		NCI
C136255	SY	Bolus 5-FU/LV Plus Bevacizumab Regimen		NCI
C136255	SY	Bolus Fluorouracil/Leucovorin/Bevacizumab		NCI
C136255	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136255	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136255	RO	chemotherapy regimen has component Fluorouracil	NCI
C136255	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C136255	RO	chemotherapy regimen has component Bevacizumab	NCI
C11066	STY	Therapeutic or Preventive Procedure		NCI
C11066	PT	Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Etoposide/Filgrastim/Methotrexate/Prednisone/Vincristine		NCI
C11066	SY	ARA-C/BLEO/CTX/DOX/G-CSF/MTX/PRED/VCR/VP-16		NCI
C11066	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11066	RO	chemotherapy regimen has component Bleomycin	NCI
C11066	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11066	RO	chemotherapy regimen has component Cytarabine	NCI
C11066	RO	chemotherapy regimen has component Doxorubicin	NCI
C11066	RO	chemotherapy regimen has component Etoposide	NCI
C11066	RO	chemotherapy regimen has component Methotrexate	NCI
C11066	RO	chemotherapy regimen has component Prednisone	NCI
C11066	RO	chemotherapy regimen has component Vincristine	NCI
C11066	RO	chemotherapy regimen has component Filgrastim	NCI
C63488	STY	Therapeutic or Preventive Procedure		NCI
C63488	PT	BEP Regimen		NCI
C63488	SY	Bleomycin-Etoposide-Cisplatin Regimen		NCI
C63488	SY	Bleomycin/Etoposide/Platinum		NCI
C63488	SY	Adult BEP		NCI
C63488	SY	Bleomycin-Etoposide-Platinol Regimen		NCI
C63488	SY	Adult BEP Regimen		NCI
C63488	CHD	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm	NCI
C63488	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C63488	RO	chemotherapy regimen has component Bleomycin	NCI
C63488	RO	chemotherapy regimen has component Cisplatin	NCI
C63488	RO	chemotherapy regimen has component Etoposide	NCI
C63488	RO	regimen has accepted use for disease Childhood Testicular Germ Cell Tumor	NCI
C63488	RO	regimen has accepted use for disease Childhood Ovarian Germ Cell Tumor	NCI
C63488	RO	regimen has accepted use for disease Malignant Testicular Germ Cell Tumor	NCI
C63488	RO	regimen has accepted use for disease Ovarian Carcinoma	NCI
C9737	STY	Therapeutic or Preventive Procedure		NCI
C9737	PT	Asparaginase/Cyclophosphamide/Daunorubicin/Dexamethasone/Methotrexate/Vincristine		NCI
C9737	SY	ASP/CTX/DM/DNR/MTX/VCR		NCI
C9737	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9737	RO	chemotherapy regimen has component Asparaginase	NCI
C9737	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9737	RO	chemotherapy regimen has component Dexamethasone	NCI
C9737	RO	chemotherapy regimen has component Methotrexate	NCI
C9737	RO	chemotherapy regimen has component Vincristine	NCI
C9737	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10287	STY	Therapeutic or Preventive Procedure		NCI
C10287	PT	Altretamine/Doxorubicin/Fluoxymesterone/Methotrexate/Mitolactol/Prednisone/Tamoxifen/Vincristine		NCI
C10287	SY	DBD/DOX/FXM/HMM/MTX/PRED/TMX/VCR		NCI
C10287	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10287	RO	chemotherapy regimen has component Doxorubicin	NCI
C10287	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C10287	RO	chemotherapy regimen has component Altretamine	NCI
C10287	RO	chemotherapy regimen has component Methotrexate	NCI
C10287	RO	chemotherapy regimen has component Mitolactol	NCI
C10287	RO	chemotherapy regimen has component Prednisone	NCI
C10287	RO	chemotherapy regimen has component Vincristine	NCI
C10287	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11431	STY	Therapeutic or Preventive Procedure		NCI
C11431	PT	Chlorambucil/Doxorubicin/Etoposide/Prednisolone/Procarbazine/Vinblastine/Vincristine		NCI
C11431	SY	CLB/DOX/PCB/PRDL/VBL/VCR/VP-16		NCI
C11431	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11431	RO	chemotherapy regimen has component Chlorambucil	NCI
C11431	RO	chemotherapy regimen has component Doxorubicin	NCI
C11431	RO	chemotherapy regimen has component Etoposide	NCI
C11431	RO	chemotherapy regimen has component Prednisolone	NCI
C11431	RO	chemotherapy regimen has component Vinblastine	NCI
C11431	RO	chemotherapy regimen has component Vincristine	NCI
C11431	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10260	STY	Therapeutic or Preventive Procedure		NCI
C10260	PT	Cisplatin/Etoposide/Mitoguazone		NCI
C10260	SY	CDDP/MGBG/VP-16		NCI
C10260	SY	CVM		NCI
C10260	SY	CVpMG		NCI
C10260	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10260	RO	chemotherapy regimen has component Cisplatin	NCI
C10260	RO	chemotherapy regimen has component Etoposide	NCI
C10260	RO	chemotherapy regimen has component Mitoguazone	NCI
C9809	STY	Therapeutic or Preventive Procedure		NCI
C9809	PT	Asparaginase/Cyclophosphamide/Cytarabine/Methotrexate/Prednisone/Thioguanine/Vincristine		NCI
C9809	SY	ARA-C/ASP/CTX/MTX/PRED/TG/VCR		NCI
C9809	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9809	RO	chemotherapy regimen has component Asparaginase	NCI
C9809	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9809	RO	chemotherapy regimen has component Cytarabine	NCI
C9809	RO	chemotherapy regimen has component Methotrexate	NCI
C9809	RO	chemotherapy regimen has component Prednisone	NCI
C9809	RO	chemotherapy regimen has component Thioguanine	NCI
C9809	RO	chemotherapy regimen has component Vincristine	NCI
C9760	STY	Therapeutic or Preventive Procedure		NCI
C9760	PT	R-CHOP Regimen		NCI
C9760	SY	Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone Regimen		NCI
C9760	SY	CTX/DOX/MOAB IDEC-C2B8/PRED/VCR		NCI
C9760	SY	Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine		NCI
C9760	SY	Rituximab/Cyclophosphamide/Doxorubicin/Prednisone/Vincristine		NCI
C9760	SY	Rituxan/CHOP		NCI
C9760	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C9760	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9760	RO	chemotherapy regimen has component Doxorubicin	NCI
C9760	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C9760	RO	chemotherapy regimen has component Prednisone	NCI
C9760	RO	chemotherapy regimen has component Vincristine	NCI
C9760	RO	chemotherapy regimen has component Rituximab	NCI
C9760	RO	concept in subset CTRP Terminology	NCI
C9760	RO	concept in subset CTRP Agent Terminology	NCI
C9760	RO	regimen has accepted use for disease Mantle Cell Lymphoma	NCI
C12133	STY	Therapeutic or Preventive Procedure		NCI
C12133	PT	Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/Montanide ISA-51		NCI
C12133	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12133	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C12133	RO	chemotherapy regimen has component gp100 Antigen	NCI
C12133	RO	chemotherapy regimen has component Ipilimumab	NCI
C10244	STY	Therapeutic or Preventive Procedure		NCI
C10244	PT	Ifosfamide/Mitoxantrone		NCI
C10244	SY	DHAD/IFF		NCI
C10244	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10244	RO	chemotherapy regimen has component Ifosfamide	NCI
C10244	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9922	STY	Therapeutic or Preventive Procedure		NCI
C9922	PT	Asparaginase/Cyclophosphamide/Cytarabine/Prednisone/Vincristine		NCI
C9922	SY	ARA-C/ASP/CTX/PRED/VCR		NCI
C9922	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9922	RO	chemotherapy regimen has component Asparaginase	NCI
C9922	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9922	RO	chemotherapy regimen has component Cytarabine	NCI
C9922	RO	chemotherapy regimen has component Prednisone	NCI
C9922	RO	chemotherapy regimen has component Vincristine	NCI
C37846	STY	Therapeutic or Preventive Procedure		NCI
C37846	PT	Pixantrone/Rituximab		NCI
C37846	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37846	RO	chemotherapy regimen has component Pixantrone	NCI
C37846	RO	chemotherapy regimen has component Rituximab	NCI
C37467	STY	Therapeutic or Preventive Procedure		NCI
C37467	PT	cBR96-Doxorubicin Immunoconjugate/Gemcitabine		NCI
C37467	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37467	RO	chemotherapy regimen has component BR96-Doxorubicin Immunoconjugate	NCI
C37467	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10012	STY	Therapeutic or Preventive Procedure		NCI
C10012	PT	Cyclophosphamide/Prednisone/Vincristine/Zorubicin		NCI
C10012	SY	CTX/PRED/VCR/RBZ		NCI
C10012	SY	CROP		NCI
C10012	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10012	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10012	RO	chemotherapy regimen has component Prednisone	NCI
C10012	RO	chemotherapy regimen has component Vincristine	NCI
C10012	RO	chemotherapy regimen has component Zorubicin Hydrochloride	NCI
C10483	STY	Therapeutic or Preventive Procedure		NCI
C10483	PT	Idoxuridine/Leucovorin Calcium		NCI
C10483	SY	CF/IUDR		NCI
C10483	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10483	RO	chemotherapy regimen has component Idoxuridine	NCI
C10483	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9853	STY	Therapeutic or Preventive Procedure		NCI
C9853	PT	Cisplatin/Etoposide/Interleukin-2/Lymphokine-Activated Killer Cells		NCI
C9853	SY	CDDP/IL-2/LAK/VP-16		NCI
C9853	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9853	RO	chemotherapy regimen has component Cisplatin	NCI
C9853	RO	chemotherapy regimen has component Etoposide	NCI
C9853	RO	chemotherapy regimen has component Lymphokine-Activated Killer Cells	NCI
C9853	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9524	STY	Therapeutic or Preventive Procedure		NCI
C9524	PT	Carmustine/Cyclophosphamide/Prednisone		NCI
C9524	SY	BCNU/CTX/PRED		NCI
C9524	SY	BCP		NCI
C9524	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9524	RO	chemotherapy regimen has component Carmustine	NCI
C9524	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9524	RO	chemotherapy regimen has component Prednisone	NCI
C37837	STY	Therapeutic or Preventive Procedure		NCI
C37837	PT	Monoclonal Antibody 11D10 Anti-Idiotype Vaccine/Monoclonal Antibody GD2 Anti-Idiotype Vaccine		NCI
C37837	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37837	RO	chemotherapy regimen has component Monoclonal Antibody 11D10 Anti-Idiotype Vaccine	NCI
C37837	RO	chemotherapy regimen has component Monoclonal Antibody GD2 Anti-Idiotype Vaccine	NCI
C64771	STY	Therapeutic or Preventive Procedure		NCI
C64771	PT	Mitoxantrone-Etoposide Regimen		NCI
C64771	CHD	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C64771	RO	chemotherapy regimen has component Etoposide	NCI
C64771	RO	regimen has accepted use for disease Adult Acute Myeloid Leukemia	NCI
C64771	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9647	STY	Therapeutic or Preventive Procedure		NCI
C9647	PT	Doxorubicin/Prednisone/Vincristine		NCI
C9647	SY	APO		NCI
C9647	SY	VAP		NCI
C9647	SY	DOX/PRED/VCR		NCI
C9647	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9647	RO	chemotherapy regimen has component Doxorubicin	NCI
C9647	RO	chemotherapy regimen has component Prednisone	NCI
C9647	RO	chemotherapy regimen has component Vincristine	NCI
C11370	STY	Therapeutic or Preventive Procedure		NCI
C11370	PT	Interferon Alfa/Ritonavir		NCI
C11370	SY	IFN-A/RIT		NCI
C11370	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11370	RO	chemotherapy regimen has component Ritonavir	NCI
C11370	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11859	STY	Therapeutic or Preventive Procedure		NCI
C11859	PT	Carboplatin/Temozolomide/Vincristine		NCI
C11859	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11859	RO	chemotherapy regimen has component Vincristine	NCI
C11859	RO	chemotherapy regimen has component Temozolomide	NCI
C11859	RO	chemotherapy regimen has component Carboplatin	NCI
C10099	STY	Therapeutic or Preventive Procedure		NCI
C10099	PT	Decitabine/Idarubicin		NCI
C10099	SY	DAC/IDA		NCI
C10099	SY	5-AZA-dCyd/IDA		NCI
C10099	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10099	RO	chemotherapy regimen has component Idarubicin	NCI
C10099	RO	chemotherapy regimen has component Decitabine	NCI
C11181	STY	Therapeutic or Preventive Procedure		NCI
C11181	PT	Cyclophosphamide/Cytarabine/Daunorubicin		NCI
C11181	SY	ARA-C/CTX/DNR		NCI
C11181	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11181	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11181	RO	chemotherapy regimen has component Cytarabine	NCI
C11181	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10028	STY	Therapeutic or Preventive Procedure		NCI
C10028	PT	Carmustine/Cyclophosphamide/Melphalan/Prednisone		NCI
C10028	SY	MCBP		NCI
C10028	SY	BCNU/CTX/L-PAM/PRED		NCI
C10028	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10028	RO	chemotherapy regimen has component Carmustine	NCI
C10028	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10028	RO	chemotherapy regimen has component Melphalan	NCI
C10028	RO	chemotherapy regimen has component Prednisone	NCI
C10701	STY	Therapeutic or Preventive Procedure		NCI
C10701	PT	Bicalutamide/Leuprolide		NCI
C10701	SY	CDX/LEUP		NCI
C10701	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10701	RO	chemotherapy regimen has component Bicalutamide	NCI
C10701	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C10574	STY	Therapeutic or Preventive Procedure		NCI
C10574	PT	Dexamethasone/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine		NCI
C10574	SY	DM/MP/MTX/PEG-ASP/VCR		NCI
C10574	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10574	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10574	RO	chemotherapy regimen has component Dexamethasone	NCI
C10574	RO	chemotherapy regimen has component Methotrexate	NCI
C10574	RO	chemotherapy regimen has component Vincristine	NCI
C10574	RO	chemotherapy regimen has component Pegaspargase	NCI
C10967	STY	Therapeutic or Preventive Procedure		NCI
C10967	PT	Bleomycin/Cisplatin/Cyclophosphamide/Etoposide		NCI
C10967	SY	BLEO/CDDP/CTX/VP-16		NCI
C10967	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10967	RO	chemotherapy regimen has component Bleomycin	NCI
C10967	RO	chemotherapy regimen has component Cisplatin	NCI
C10967	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10967	RO	chemotherapy regimen has component Etoposide	NCI
C9535	STY	Therapeutic or Preventive Procedure		NCI
C9535	PT	Cyclophosphamide/Doxorubicin/Methotrexate		NCI
C9535	SY	CTX/DOX/MTX		NCI
C9535	SY	CAM		NCI
C9535	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9535	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9535	RO	chemotherapy regimen has component Doxorubicin	NCI
C9535	RO	chemotherapy regimen has component Methotrexate	NCI
C12038	STY	Therapeutic or Preventive Procedure		NCI
C12038	PT	Etoposide/Ifosfamide/Imatinib Mesylate/Methotrexate		NCI
C12038	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12038	RO	chemotherapy regimen has component Etoposide	NCI
C12038	RO	chemotherapy regimen has component Ifosfamide	NCI
C12038	RO	chemotherapy regimen has component Methotrexate	NCI
C12038	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C67233	STY	Therapeutic or Preventive Procedure		NCI
C67233	PT	Cyclophosphamide-Topotecan Regimen		NCI
C67233	SY	Cytoxan-Hycamtin Regimen		NCI
C67233	CHD	Chemotherapy Regimen Used to Treat Ewing's Family of Tumors	NCI
C67233	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67233	RO	chemotherapy regimen has component Topotecan	NCI
C67233	RO	regimen has accepted use for disease Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	NCI
C9518	STY	Therapeutic or Preventive Procedure		NCI
C9518	PT	Cisplatin/Doxorubicin/Vindesine		NCI
C9518	SY	VAP		NCI
C9518	SY	CDDP/DAVA/DOX		NCI
C9518	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9518	RO	chemotherapy regimen has component Cisplatin	NCI
C9518	RO	chemotherapy regimen has component Doxorubicin	NCI
C9518	RO	chemotherapy regimen has component Vindesine	NCI
C10762	STY	Therapeutic or Preventive Procedure		NCI
C10762	PT	Lomustine/Methotrexate		NCI
C10762	SY	CCNU/MTX		NCI
C10762	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10762	RO	chemotherapy regimen has component Lomustine	NCI
C10762	RO	chemotherapy regimen has component Methotrexate	NCI
C9563	STY	Therapeutic or Preventive Procedure		NCI
C9563	PT	Bleomycin/Cyclophosphamide/Prednisone/Vincristine		NCI
C9563	SY	COPB		NCI
C9563	SY	COP-BLEO		NCI
C9563	SY	BLEO/CTX/PRED/VCR		NCI
C9563	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9563	RO	chemotherapy regimen has component Bleomycin	NCI
C9563	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9563	RO	chemotherapy regimen has component Prednisone	NCI
C9563	RO	chemotherapy regimen has component Vincristine	NCI
C11379	STY	Therapeutic or Preventive Procedure		NCI
C11379	PT	Octreotide/Prednisone		NCI
C11379	SY	PRED/SSTN		NCI
C11379	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11379	RO	chemotherapy regimen has component Octreotide	NCI
C11379	RO	chemotherapy regimen has component Prednisone	NCI
C10540	STY	Therapeutic or Preventive Procedure		NCI
C10540	PT	Carboplatin/Etoposide/Ifosfamide/Interleukin-1-Alpha		NCI
C10540	SY	CBDCA/IFF/IL-1A/VP-16		NCI
C10540	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10540	RO	chemotherapy regimen has component Etoposide	NCI
C10540	RO	chemotherapy regimen has component Ifosfamide	NCI
C10540	RO	chemotherapy regimen has component Carboplatin	NCI
C10540	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C11349	STY	Therapeutic or Preventive Procedure		NCI
C11349	PT	Mitoxantrone/Vinorelbine		NCI
C11349	SY	DHAD/VNB		NCI
C11349	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11349	RO	chemotherapy regimen has component Vinorelbine	NCI
C11349	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11072	STY	Therapeutic or Preventive Procedure		NCI
C11072	PT	Epoetin Alfa/Interleukin-6/Sargramostim		NCI
C11072	SY	EPO/GM-CSF/IL-6		NCI
C11072	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11072	RO	chemotherapy regimen has component Sargramostim	NCI
C11072	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C11072	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C140096	STY	Therapeutic or Preventive Procedure		NCI
C140096	PT	IVAC Regimen		NCI
C140096	SY	Ifosfamide/VP-16/ARA-C		NCI
C140096	SY	Ifosfamide/Etoposide/High Dose Cytarabine		NCI
C140096	SY	IVAC		NCI
C140096	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140096	RO	chemotherapy regimen has component Cytarabine	NCI
C140096	RO	chemotherapy regimen has component Etoposide	NCI
C140096	RO	chemotherapy regimen has component Ifosfamide	NCI
C10034	STY	Therapeutic or Preventive Procedure		NCI
C10034	PT	Doxorubicin/Fluorouracil/Melphalan		NCI
C10034	SY	PAF		NCI
C10034	SY	DOX/5-FU/L-PAM		NCI
C10034	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10034	RO	chemotherapy regimen has component Doxorubicin	NCI
C10034	RO	chemotherapy regimen has component Fluorouracil	NCI
C10034	RO	chemotherapy regimen has component Melphalan	NCI
C37539	STY	Therapeutic or Preventive Procedure		NCI
C37539	PT	Autologous Dendritic Cells/Indinavir		NCI
C37539	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37539	RO	chemotherapy regimen has component Indinavir Sulfate	NCI
C37539	RO	chemotherapy regimen has component Therapeutic Autologous Dendritic Cells	NCI
C10409	STY	Therapeutic or Preventive Procedure		NCI
C10409	PT	Floxuridine/Fluorouracil		NCI
C10409	SY	5-FU/FUDR		NCI
C10409	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10409	RO	chemotherapy regimen has component Floxuridine	NCI
C10409	RO	chemotherapy regimen has component Fluorouracil	NCI
C37785	STY	Therapeutic or Preventive Procedure		NCI
C37785	PT	Fluorouracil/Leucovorin Calcium/Lonafarnib		NCI
C37785	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37785	RO	chemotherapy regimen has component Fluorouracil	NCI
C37785	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37785	RO	chemotherapy regimen has component Lonafarnib	NCI
C12210	STY	Therapeutic or Preventive Procedure		NCI
C12210	PT	Asparaginase/Cytarabine/Dexamethasone/Doxorubicin/methotrexate/thioguanine/vincristine		NCI
C12210	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12210	RO	chemotherapy regimen has component Asparaginase	NCI
C12210	RO	chemotherapy regimen has component Cytarabine	NCI
C12210	RO	chemotherapy regimen has component Dexamethasone	NCI
C12210	RO	chemotherapy regimen has component Doxorubicin	NCI
C12210	RO	chemotherapy regimen has component Methotrexate	NCI
C12210	RO	chemotherapy regimen has component Thioguanine	NCI
C12210	RO	chemotherapy regimen has component Vincristine	NCI
C10056	STY	Therapeutic or Preventive Procedure		NCI
C10056	PT	Cyclophosphamide/Cytarabine/Daunorubicin/Dexamethasone/Thioguanine/Vincristine		NCI
C10056	SY	ARA-C/CTX/DM/DNR/TG/VCR		NCI
C10056	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10056	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10056	RO	chemotherapy regimen has component Cytarabine	NCI
C10056	RO	chemotherapy regimen has component Dexamethasone	NCI
C10056	RO	chemotherapy regimen has component Thioguanine	NCI
C10056	RO	chemotherapy regimen has component Vincristine	NCI
C10056	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37578	STY	Therapeutic or Preventive Procedure		NCI
C37578	PT	Bortezomib/Paclitaxel		NCI
C37578	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37578	RO	chemotherapy regimen has component Paclitaxel	NCI
C37578	RO	chemotherapy regimen has component Bortezomib	NCI
C11806	STY	Therapeutic or Preventive Procedure		NCI
C11806	PT	Filgrastim-Fetal Liver Tyrosine Kinase-3 Fusion Protein/gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide		NCI
C11806	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11806	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11806	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11806	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11806	RO	chemotherapy regimen has component Progenipoietin	NCI
C11806	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11734	STY	Therapeutic or Preventive Procedure		NCI
C11734	PT	Amifostine/Cisplatin/Docetaxel		NCI
C11734	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11734	RO	chemotherapy regimen has component Cisplatin	NCI
C11734	RO	chemotherapy regimen has component Amifostine	NCI
C11734	RO	chemotherapy regimen has component Docetaxel	NCI
C37493	STY	Therapeutic or Preventive Procedure		NCI
C37493	PT	ABT-510/Carboplatin/Paclitaxel		NCI
C37493	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37493	RO	chemotherapy regimen has component Carboplatin	NCI
C37493	RO	chemotherapy regimen has component Paclitaxel	NCI
C37493	RO	chemotherapy regimen has component ABT-510	NCI
C9627	STY	Therapeutic or Preventive Procedure		NCI
C9627	PT	Lomustine/Procarbazine/Vincristine		NCI
C9627	SY	PCV		NCI
C9627	SY	CCNU/PCB/VCR		NCI
C9627	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9627	RO	chemotherapy regimen has component Lomustine	NCI
C9627	RO	chemotherapy regimen has component Vincristine	NCI
C9627	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10562	STY	Therapeutic or Preventive Procedure		NCI
C10562	PT	Fluorouracil/Leucovorin Calcium/PALA/Zidovudine		NCI
C10562	SY	CF/5-FU/PALA/ZDV		NCI
C10562	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10562	RO	chemotherapy regimen has component Fluorouracil	NCI
C10562	RO	chemotherapy regimen has component Zidovudine	NCI
C10562	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C10562	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10923	STY	Therapeutic or Preventive Procedure		NCI
C10923	PT	Cisplatin/Filgrastim/Pyrazoloacridine		NCI
C10923	SY	CDDP/G-CSF/PZA		NCI
C10923	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10923	RO	chemotherapy regimen has component Cisplatin	NCI
C10923	RO	chemotherapy regimen has component Filgrastim	NCI
C10923	RO	chemotherapy regimen has component Pyrazoloacridine	NCI
C10127	STY	Therapeutic or Preventive Procedure		NCI
C10127	PT	Cisplatin/Fluorouracil/Mitomycin/Vincristine		NCI
C10127	SY	CDDP/5-FU/MITO/VCR		NCI
C10127	SY	MVPF		NCI
C10127	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10127	RO	chemotherapy regimen has component Mitomycin	NCI
C10127	RO	chemotherapy regimen has component Cisplatin	NCI
C10127	RO	chemotherapy regimen has component Fluorouracil	NCI
C10127	RO	chemotherapy regimen has component Vincristine	NCI
C11406	STY	Therapeutic or Preventive Procedure		NCI
C11406	PT	Acetaminophen/Acetylcysteine/Carmustine		NCI
C11406	SY	ACMP/BCNU/NAC		NCI
C11406	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11406	RO	chemotherapy regimen has component Acetaminophen	NCI
C11406	RO	chemotherapy regimen has component Acetylcysteine	NCI
C11406	RO	chemotherapy regimen has component Carmustine	NCI
C37618	STY	Therapeutic or Preventive Procedure		NCI
C37618	PT	Carboplatin/Oblimersen/Paclitaxel		NCI
C37618	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37618	RO	chemotherapy regimen has component Carboplatin	NCI
C37618	RO	chemotherapy regimen has component Paclitaxel	NCI
C37618	RO	chemotherapy regimen has component Oblimersen	NCI
C10266	STY	Therapeutic or Preventive Procedure		NCI
C10266	PT	Cyclophosphamide/Doxorubicin/Lomustine/Prednisone/Vincristine		NCI
C10266	SY	COPAC		NCI
C10266	SY	CCNU/CTX/DOX/PRED/VCR		NCI
C10266	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10266	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10266	RO	chemotherapy regimen has component Doxorubicin	NCI
C10266	RO	chemotherapy regimen has component Lomustine	NCI
C10266	RO	chemotherapy regimen has component Prednisone	NCI
C10266	RO	chemotherapy regimen has component Vincristine	NCI
C37758	STY	Therapeutic or Preventive Procedure		NCI
C37758	PT	Eniluracil/Fluorouracil		NCI
C37758	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37758	RO	chemotherapy regimen has component Fluorouracil	NCI
C37758	RO	chemotherapy regimen has component Eniluracil	NCI
C10573	STY	Therapeutic or Preventive Procedure		NCI
C10573	PT	Dexamethasone/Doxorubicin/Mercaptopurine/Methotrexate/Pegaspargase/Vincristine		NCI
C10573	SY	DM/DOX/MP/MTX/PEG-ASP/VCR		NCI
C10573	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10573	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10573	RO	chemotherapy regimen has component Dexamethasone	NCI
C10573	RO	chemotherapy regimen has component Doxorubicin	NCI
C10573	RO	chemotherapy regimen has component Methotrexate	NCI
C10573	RO	chemotherapy regimen has component Vincristine	NCI
C10573	RO	chemotherapy regimen has component Pegaspargase	NCI
C37538	STY	Therapeutic or Preventive Procedure		NCI
C37538	PT	Autologous Dendritic Cells/Fowlpox-CEA-TRICOM Vaccine		NCI
C37538	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37538	RO	chemotherapy regimen has component Therapeutic Autologous Dendritic Cells	NCI
C37538	RO	chemotherapy regimen has component Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine	NCI
C10971	STY	Therapeutic or Preventive Procedure		NCI
C10971	PT	Leucovorin Calcium/Tegafur/Uracil		NCI
C10971	SY	CF/UFT		NCI
C10971	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10971	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10971	RO	chemotherapy regimen has component Tegafur-Uracil	NCI
C63613	STY	Therapeutic or Preventive Procedure		NCI
C63613	PT	Cytarabine-Daunorubicin-Etoposide Regimen		NCI
C63613	SY	Ara-C-Daunorubicin-Etoposide Regimen		NCI
C63613	CHD	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C63613	RO	chemotherapy regimen has component Cytarabine	NCI
C63613	RO	chemotherapy regimen has component Etoposide	NCI
C63613	RO	regimen has accepted use for disease Adult Acute Myeloid Leukemia	NCI
C63613	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10201	STY	Therapeutic or Preventive Procedure		NCI
C10201	PT	Cytarabine/Hydrocortisone/Methotrexate		NCI
C10201	SY	ARA-C/HC/MTX		NCI
C10201	SY	MHA		NCI
C10201	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10201	RO	chemotherapy regimen has component Cytarabine	NCI
C10201	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C10201	RO	chemotherapy regimen has component Methotrexate	NCI
C12202	STY	Therapeutic or Preventive Procedure		NCI
C12202	PT	Fowlpox-CEA-TRICOM Vaccine/Sargramostim/Vaccinia-CEA-TRICOM Vaccine		NCI
C12202	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12202	RO	chemotherapy regimen has component Sargramostim	NCI
C12202	RO	chemotherapy regimen has component Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine	NCI
C12202	RO	chemotherapy regimen has component Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine	NCI
C11820	STY	Therapeutic or Preventive Procedure		NCI
C11820	PT	Irinotecan/Temozolomide		NCI
C11820	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11820	RO	chemotherapy regimen has component Temozolomide	NCI
C11820	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C10378	STY	Therapeutic or Preventive Procedure		NCI
C10378	PT	Doxorubicin/Sargramostim		NCI
C10378	SY	DOX/GM-CSF		NCI
C10378	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10378	RO	chemotherapy regimen has component Doxorubicin	NCI
C10378	RO	chemotherapy regimen has component Sargramostim	NCI
C10399	STY	Therapeutic or Preventive Procedure		NCI
C10399	PT	Asparaginase/Dexamethasone/Vincristine		NCI
C10399	SY	ASP/DM/VCR		NCI
C10399	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10399	RO	chemotherapy regimen has component Asparaginase	NCI
C10399	RO	chemotherapy regimen has component Dexamethasone	NCI
C10399	RO	chemotherapy regimen has component Vincristine	NCI
C9871	STY	Therapeutic or Preventive Procedure		NCI
C9871	PT	Carmustine/Cyclophosphamide/Cytarabine/Daunorubicin/Hydroxyurea/Methotrexate/Thioguanine/Vincristine		NCI
C9871	SY	ARA-C/BCNU/CTX/DNR/HU/MTX/TG/VCR		NCI
C9871	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9871	RO	chemotherapy regimen has component Carmustine	NCI
C9871	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9871	RO	chemotherapy regimen has component Cytarabine	NCI
C9871	RO	chemotherapy regimen has component Hydroxyurea	NCI
C9871	RO	chemotherapy regimen has component Methotrexate	NCI
C9871	RO	chemotherapy regimen has component Thioguanine	NCI
C9871	RO	chemotherapy regimen has component Vincristine	NCI
C9871	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C67339	STY	Therapeutic or Preventive Procedure		NCI
C67339	PT	MAP Regimen		NCI
C67339	SY	Cisplatin-Doxorubicin-High Dose Methotrexate Regimen		NCI
C67339	SY	High-dose Methotrexate/Doxorubicin/Cisplatin		NCI
C67339	SY	Cisplatin-Doxorubicin-Methotrexate Osteosarcoma Regimen		NCI
C67339	SY	Methotrexate/Doxorubicin/Cisplatin		NCI
C67339	SY	HD Methotrexate/Doxorubicin/Cisplatin		NCI
C67339	SY	MAP		NCI
C67339	SY	Cisplatin-Doxorubicin-Methotrexate Regimen		NCI
C67339	CHD	Chemotherapy Regimen Used to Treat Childhood Osteosarcoma	NCI
C67339	RO	chemotherapy regimen has component Cisplatin	NCI
C67339	RO	chemotherapy regimen has component Doxorubicin	NCI
C67339	RO	chemotherapy regimen has component Methotrexate	NCI
C67339	RO	regimen has accepted use for disease Childhood Osteosarcoma	NCI
C11986	STY	Therapeutic or Preventive Procedure		NCI
C11986	PT	Dexamethasone/Ondansetron		NCI
C11986	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11986	RO	chemotherapy regimen has component Dexamethasone	NCI
C11986	RO	chemotherapy regimen has component Ondansetron	NCI
C10981	STY	Therapeutic or Preventive Procedure		NCI
C10981	PT	Leucovorin Calcium/Trimetrexate Glucuronate		NCI
C10981	SY	CF/TMTX		NCI
C10981	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10981	RO	chemotherapy regimen has component Trimetrexate Glucuronate	NCI
C10981	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11524	STY	Therapeutic or Preventive Procedure		NCI
C11524	PT	gp100 Antigen/MAGE-3.1/MART-1 Antigen/Tyrosinase Peptide		NCI
C11524	SY	gp100/MAGE-3.1/MART-1/TYRP		NCI
C11524	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11524	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11524	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11524	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C11524	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C15522	STY	Therapeutic or Preventive Procedure		NCI
C15522	PT	Interleukin-2/Tumor Necrosis Factor		NCI
C15522	SY	IL-2/TNF		NCI
C15522	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15522	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C15522	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C10870	STY	Therapeutic or Preventive Procedure		NCI
C10870	PT	Bleomycin/Idarubicin/Methylprednisolone/Vincristine		NCI
C10870	SY	BLEO/CTX/IDA/MePRDL/VCR		NCI
C10870	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10870	RO	chemotherapy regimen has component Bleomycin	NCI
C10870	RO	chemotherapy regimen has component Idarubicin	NCI
C10870	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10870	RO	chemotherapy regimen has component Vincristine	NCI
C140095	STY	Therapeutic or Preventive Procedure		NCI
C140095	PT	R-DHAP Regimen		NCI
C140095	SY	Rituximab/Dexamethasone/High-dose Ara-C/Platinol		NCI
C140095	SY	Rituximab-Dexamethasone-High Dose Cytarabine-Cisplatin		NCI
C140095	SY	RDHAP		NCI
C140095	SY	Rituximab-DHAP		NCI
C140095	SY	R-DHAP		NCI
C140095	SY	Rituximab Plus Cisplatin/Cytarabine/Dexamethasone		NCI
C140095	SY	Rituximab-Dexamethasone-High Dose ARA-C-Platinol		NCI
C140095	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140095	RO	chemotherapy regimen has component Cisplatin	NCI
C140095	RO	chemotherapy regimen has component Cytarabine	NCI
C140095	RO	chemotherapy regimen has component Dexamethasone	NCI
C140095	RO	chemotherapy regimen has component Rituximab	NCI
C10292	STY	Therapeutic or Preventive Procedure		NCI
C10292	PT	Cisplatin/Ifosfamide/Vinblastine		NCI
C10292	SY	CDDP/IFF/VBL		NCI
C10292	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10292	RO	chemotherapy regimen has component Cisplatin	NCI
C10292	RO	chemotherapy regimen has component Ifosfamide	NCI
C10292	RO	chemotherapy regimen has component Vinblastine	NCI
C10427	STY	Therapeutic or Preventive Procedure		NCI
C10427	PT	Cisplatin/Etoposide/Megestrol		NCI
C10427	SY	CDDP/MEG/VP-16		NCI
C10427	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10427	RO	chemotherapy regimen has component Cisplatin	NCI
C10427	RO	chemotherapy regimen has component Etoposide	NCI
C10427	RO	chemotherapy regimen has component Megestrol	NCI
C11087	STY	Therapeutic or Preventive Procedure		NCI
C11087	PT	Cyclophosphamide/Daunorubicin/Pegaspargase/Prednisone/Vincristine		NCI
C11087	SY	CTX/DNR/PEG-ASP/PRED/VCR		NCI
C11087	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11087	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11087	RO	chemotherapy regimen has component Prednisone	NCI
C11087	RO	chemotherapy regimen has component Vincristine	NCI
C11087	RO	chemotherapy regimen has component Pegaspargase	NCI
C11087	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C12204	STY	Therapeutic or Preventive Procedure		NCI
C12204	PT	Cytarabine/Leucovorin Calcium/Methotrexate/Rituximab		NCI
C12204	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12204	RO	chemotherapy regimen has component Cytarabine	NCI
C12204	RO	chemotherapy regimen has component Methotrexate	NCI
C12204	RO	chemotherapy regimen has component Rituximab	NCI
C12204	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37561	STY	Therapeutic or Preventive Procedure		NCI
C37561	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Rituximab/Vincristine		NCI
C37561	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37561	RO	chemotherapy regimen has component Bleomycin	NCI
C37561	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37561	RO	chemotherapy regimen has component Doxorubicin	NCI
C37561	RO	chemotherapy regimen has component Methotrexate	NCI
C37561	RO	chemotherapy regimen has component Prednisone	NCI
C37561	RO	chemotherapy regimen has component Vincristine	NCI
C37561	RO	chemotherapy regimen has component Rituximab	NCI
C10395	STY	Therapeutic or Preventive Procedure		NCI
C10395	PT	Carboplatin/Doxorubicin/Sargramostim		NCI
C10395	SY	CBDCA/DOX/GM-CSF		NCI
C10395	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10395	RO	chemotherapy regimen has component Doxorubicin	NCI
C10395	RO	chemotherapy regimen has component Carboplatin	NCI
C10395	RO	chemotherapy regimen has component Sargramostim	NCI
C140673	STY	Therapeutic or Preventive Procedure		NCI
C140673	PT	R-CHOPE Regimen		NCI
C140673	SY	Rituximab-Cyclophosphamide-Doxorubicin-Etoposide-Prednisone-Vincristine		NCI
C140673	SY	R-CHOEP		NCI
C140673	SY	R-CHOEP Regimen		NCI
C140673	SY	Rituximab/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine		NCI
C140673	SY	R-CHOPE		NCI
C140673	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140673	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C140673	RO	chemotherapy regimen has component Doxorubicin	NCI
C140673	RO	chemotherapy regimen has component Etoposide	NCI
C140673	RO	chemotherapy regimen has component Prednisone	NCI
C140673	RO	chemotherapy regimen has component Vincristine	NCI
C140673	RO	chemotherapy regimen has component Rituximab	NCI
C138045	STY	Therapeutic or Preventive Procedure		NCI
C138045	PT	Pertuzumab/Trastuzumab/Paclitaxel Regimen		NCI
C138045	SY	Pertuzumab + Trastuzumab + Paclitaxel		NCI
C138045	SY	Pertuzumab-Trastuzumab-Paclitaxel		NCI
C138045	SY	Pertuzumab-Trastuzumab-Paclitaxel Regimen		NCI
C138045	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138045	RO	chemotherapy regimen has component Paclitaxel	NCI
C138045	RO	chemotherapy regimen has component Trastuzumab	NCI
C138045	RO	chemotherapy regimen has component Pertuzumab	NCI
C11929	STY	Therapeutic or Preventive Procedure		NCI
C11929	PT	Imatinib Mesylate/Interferon Alfa		NCI
C11929	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11929	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11929	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C10301	STY	Therapeutic or Preventive Procedure		NCI
C10301	PT	Asparaginase/Cytarabine/Mercaptopurine/Methotrexate/Prednisolone/Teniposide/Vincristine		NCI
C10301	SY	ARA-C/ASP/MP/MTX/PRDL/VCR/VM-26		NCI
C10301	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10301	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10301	RO	chemotherapy regimen has component Asparaginase	NCI
C10301	RO	chemotherapy regimen has component Cytarabine	NCI
C10301	RO	chemotherapy regimen has component Methotrexate	NCI
C10301	RO	chemotherapy regimen has component Prednisolone	NCI
C10301	RO	chemotherapy regimen has component Teniposide	NCI
C10301	RO	chemotherapy regimen has component Vincristine	NCI
C11458	STY	Therapeutic or Preventive Procedure		NCI
C11458	PT	Carboplatin/Docetaxel		NCI
C11458	SY	CBDCA/TXT		NCI
C11458	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11458	RO	chemotherapy regimen has component Carboplatin	NCI
C11458	RO	chemotherapy regimen has component Docetaxel	NCI
C12124	STY	Therapeutic or Preventive Procedure		NCI
C12124	PT	Autologous Lymphocytes/Fluorouracil/Pegylated Interferon Alfa/Sargramostim		NCI
C12124	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12124	RO	chemotherapy regimen has component Fluorouracil	NCI
C12124	RO	chemotherapy regimen has component Sargramostim	NCI
C12124	RO	chemotherapy regimen has component Pegylated Interferon Alfa	NCI
C12124	RO	chemotherapy regimen has component Therapeutic Autologous Lymphocytes	NCI
C11262	STY	Therapeutic or Preventive Procedure		NCI
C11262	PT	Carmustine/Cisplatin/Filgrastim/Thiotepa		NCI
C11262	SY	BCNU/CTX/G-CSF/TSPA		NCI
C11262	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11262	RO	chemotherapy regimen has component Carmustine	NCI
C11262	RO	chemotherapy regimen has component Cisplatin	NCI
C11262	RO	chemotherapy regimen has component Thiotepa	NCI
C11262	RO	chemotherapy regimen has component Filgrastim	NCI
C11419	STY	Therapeutic or Preventive Procedure		NCI
C11419	PT	Doxorubicin HCl Liposome/Etoposide		NCI
C11419	SY	LipoDox/VP-16		NCI
C11419	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11419	RO	chemotherapy regimen has component Etoposide	NCI
C11419	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C11998	STY	Therapeutic or Preventive Procedure		NCI
C11998	PT	Epirubicin/Gemcitabine		NCI
C11998	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11998	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11998	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12108	STY	Therapeutic or Preventive Procedure		NCI
C12108	PT	Cyclophosphamide/Doxorubicin/Filgrastim/Prednisone/Rituximab/Vincristine		NCI
C12108	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12108	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12108	RO	chemotherapy regimen has component Doxorubicin	NCI
C12108	RO	chemotherapy regimen has component Prednisone	NCI
C12108	RO	chemotherapy regimen has component Vincristine	NCI
C12108	RO	chemotherapy regimen has component Filgrastim	NCI
C12108	RO	chemotherapy regimen has component Rituximab	NCI
C10644	STY	Therapeutic or Preventive Procedure		NCI
C10644	PT	Fluorouracil/Leucovorin Calcium/Mitomycin		NCI
C10644	SY	CF/5-FU/MITO		NCI
C10644	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10644	RO	chemotherapy regimen has component Mitomycin	NCI
C10644	RO	chemotherapy regimen has component Fluorouracil	NCI
C10644	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37577	STY	Therapeutic or Preventive Procedure		NCI
C37577	PT	Bortezomib/Oxaliplatin		NCI
C37577	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37577	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37577	RO	chemotherapy regimen has component Bortezomib	NCI
C63457	STY	Therapeutic or Preventive Procedure		NCI
C63457	PT	MACOP-B Regimen		NCI
C63457	SY	Methotrexate-Adriamycin-Cytoxan-Oncovin-Prednisone-Bleomycin Regimen		NCI
C63457	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63457	RO	chemotherapy regimen has component Bleomycin	NCI
C63457	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63457	RO	chemotherapy regimen has component Doxorubicin	NCI
C63457	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C63457	RO	chemotherapy regimen has component Methotrexate	NCI
C63457	RO	chemotherapy regimen has component Prednisone	NCI
C63457	RO	chemotherapy regimen has component Vincristine	NCI
C63457	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11693	STY	Therapeutic or Preventive Procedure		NCI
C11693	PT	Fluorouracil/Gemcitabine/Paclitaxel		NCI
C11693	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11693	RO	chemotherapy regimen has component Fluorouracil	NCI
C11693	RO	chemotherapy regimen has component Paclitaxel	NCI
C11693	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C9613	STY	Therapeutic or Preventive Procedure		NCI
C9613	PT	Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Vincristine		NCI
C9613	SY	CTX/DOX/MTX/PRED/VCR		NCI
C9613	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9613	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9613	RO	chemotherapy regimen has component Doxorubicin	NCI
C9613	RO	chemotherapy regimen has component Methotrexate	NCI
C9613	RO	chemotherapy regimen has component Prednisone	NCI
C9613	RO	chemotherapy regimen has component Vincristine	NCI
C11716	STY	Therapeutic or Preventive Procedure		NCI
C11716	PT	Dexamethasone/Methotrexate/Vincristine		NCI
C11716	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11716	RO	chemotherapy regimen has component Dexamethasone	NCI
C11716	RO	chemotherapy regimen has component Methotrexate	NCI
C11716	RO	chemotherapy regimen has component Vincristine	NCI
C11941	STY	Therapeutic or Preventive Procedure		NCI
C11941	PT	Carboplatin/Etoposide Phosphate/Ifosfamide		NCI
C11941	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11941	RO	chemotherapy regimen has component Ifosfamide	NCI
C11941	RO	chemotherapy regimen has component Etoposide Phosphate	NCI
C11941	RO	chemotherapy regimen has component Carboplatin	NCI
C10466	STY	Therapeutic or Preventive Procedure		NCI
C10466	PT	Asparaginase/Cytarabine/Methotrexate/Prednisone/Thioguanine		NCI
C10466	SY	ARA-C/ASP/MTX/PRED/TG		NCI
C10466	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10466	RO	chemotherapy regimen has component Asparaginase	NCI
C10466	RO	chemotherapy regimen has component Cytarabine	NCI
C10466	RO	chemotherapy regimen has component Methotrexate	NCI
C10466	RO	chemotherapy regimen has component Prednisone	NCI
C10466	RO	chemotherapy regimen has component Thioguanine	NCI
C67480	STY	Therapeutic or Preventive Procedure		NCI
C67480	PT	COG-C9710 APL Regimen		NCI
C67480	SY	CALGB-C9710 Regimen		NCI
C67480	CHD	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia	NCI
C67480	RO	chemotherapy regimen has component Cytarabine	NCI
C67480	RO	chemotherapy regimen has component Idarubicin	NCI
C67480	RO	chemotherapy regimen has component Methotrexate	NCI
C67480	RO	chemotherapy regimen has component Thioguanine	NCI
C67480	RO	chemotherapy regimen has component Tretinoin	NCI
C67480	RO	regimen has accepted use for disease Childhood Acute Promyelocytic Leukemia with PML-RARA	NCI
C9556	STY	Therapeutic or Preventive Procedure		NCI
C9556	PT	Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Tamoxifen		NCI
C9556	SY	CMFPT		NCI
C9556	SY	CTX/5-FU/MTX/PRED/TMX		NCI
C9556	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9556	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9556	RO	chemotherapy regimen has component Fluorouracil	NCI
C9556	RO	chemotherapy regimen has component Methotrexate	NCI
C9556	RO	chemotherapy regimen has component Prednisone	NCI
C9556	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11071	STY	Therapeutic or Preventive Procedure		NCI
C11071	PT	Cisplatin/Dacarbazine/Interferon Alfa/Interleukin-2/Tamoxifen/Tumor Infiltrating Lymphocytes		NCI
C11071	SY	CDDP/DTIC/IFN-A/IL-2/TIL/TMX		NCI
C11071	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11071	RO	chemotherapy regimen has component Cisplatin	NCI
C11071	RO	chemotherapy regimen has component Dacarbazine	NCI
C11071	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11071	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11071	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C11071	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9991	STY	Therapeutic or Preventive Procedure		NCI
C9991	PT	Melphalan/Sargramostim		NCI
C9991	SY	GM-CSF/L-PAM		NCI
C9991	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9991	RO	chemotherapy regimen has component Melphalan	NCI
C9991	RO	chemotherapy regimen has component Sargramostim	NCI
C10305	STY	Therapeutic or Preventive Procedure		NCI
C10305	PT	Eflornithine/Mitoguazone		NCI
C10305	SY	DFMO/MGBG		NCI
C10305	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10305	RO	chemotherapy regimen has component Eflornithine	NCI
C10305	RO	chemotherapy regimen has component Mitoguazone	NCI
C11606	STY	Therapeutic or Preventive Procedure		NCI
C11606	PT	Capecitabine/Vinorelbine		NCI
C11606	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11606	RO	chemotherapy regimen has component Vinorelbine	NCI
C11606	RO	chemotherapy regimen has component Capecitabine	NCI
C9776	STY	Therapeutic or Preventive Procedure		NCI
C9776	PT	Cisplatin/Cytarabine		NCI
C9776	SY	ARA-C/CDDP		NCI
C9776	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9776	RO	chemotherapy regimen has component Cisplatin	NCI
C9776	RO	chemotherapy regimen has component Cytarabine	NCI
C11014	STY	Therapeutic or Preventive Procedure		NCI
C11014	PT	Fluorouracil/Interferon Alfa/Leucovorin Calcium		NCI
C11014	SY	IFN/5FU/Leucovorin		NCI
C11014	SY	CF/5-FU/IFN-A		NCI
C11014	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11014	RO	chemotherapy regimen has component Fluorouracil	NCI
C11014	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11014	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11194	STY	Therapeutic or Preventive Procedure		NCI
C11194	PT	Octreotide Pamoate/Tamoxifen		NCI
C11194	SY	SMS 201-995 pa/TMX		NCI
C11194	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11194	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11194	RO	chemotherapy regimen has component Octreotide Pamoate	NCI
C11762	STY	Therapeutic or Preventive Procedure		NCI
C11762	PT	Cetuximab/Irinotecan		NCI
C11762	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11762	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11762	RO	chemotherapy regimen has component Cetuximab	NCI
C37733	STY	Therapeutic or Preventive Procedure		NCI
C37733	PT	Dexamethasone/Idarubicin/Pegaspargase/Vincristine		NCI
C37733	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37733	RO	chemotherapy regimen has component Dexamethasone	NCI
C37733	RO	chemotherapy regimen has component Idarubicin	NCI
C37733	RO	chemotherapy regimen has component Vincristine	NCI
C37733	RO	chemotherapy regimen has component Pegaspargase	NCI
C156305	STY	Therapeutic or Preventive Procedure		NCI
C156305	PT	Exemestane/Lapatinib Regimen		NCI
C156305	SY	Exemestane-Lapatinib		NCI
C156305	SY	Lapatinib/Exemestane Regimen		NCI
C156305	SY	Exemestane/Lapatinib		NCI
C156305	SY	Lapatinib/Exemestane		NCI
C156305	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156305	RO	chemotherapy regimen has component Exemestane	NCI
C156305	RO	chemotherapy regimen has component Lapatinib	NCI
C12079	STY	Therapeutic or Preventive Procedure		NCI
C12079	PT	Erlotinib/Gemcitabine		NCI
C12079	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12079	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12079	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C10377	STY	Therapeutic or Preventive Procedure		NCI
C10377	PT	Cytarabine/Fludarabine		NCI
C10377	SY	ARA-C/FAMP		NCI
C10377	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10377	RO	chemotherapy regimen has component Cytarabine	NCI
C10377	RO	chemotherapy regimen has component Fludarabine	NCI
C10220	STY	Therapeutic or Preventive Procedure		NCI
C10220	PT	Bleomycin/Vinblastine		NCI
C10220	SY	BLEO/VBL		NCI
C10220	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10220	RO	chemotherapy regimen has component Bleomycin	NCI
C10220	RO	chemotherapy regimen has component Vinblastine	NCI
C10699	STY	Therapeutic or Preventive Procedure		NCI
C10699	PT	Epoetin Alfa/Interleukin-3		NCI
C10699	SY	EPO/IL-3		NCI
C10699	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10699	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C10699	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C12152	STY	Therapeutic or Preventive Procedure		NCI
C12152	PT	Capecitabine/Carboplatin/Epirubicin		NCI
C12152	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12152	RO	chemotherapy regimen has component Carboplatin	NCI
C12152	RO	chemotherapy regimen has component Capecitabine	NCI
C12152	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11588	STY	Therapeutic or Preventive Procedure		NCI
C11588	PT	Carboplatin/Docetaxel/Ifosfamide		NCI
C11588	SY	CBDCA/DTIC/IFF		NCI
C11588	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11588	RO	chemotherapy regimen has component Ifosfamide	NCI
C11588	RO	chemotherapy regimen has component Carboplatin	NCI
C11588	RO	chemotherapy regimen has component Docetaxel	NCI
C11214	STY	Therapeutic or Preventive Procedure		NCI
C11214	PT	Doxorubicin/PSC 833		NCI
C11214	SY	DOX/PSC 833		NCI
C11214	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11214	RO	chemotherapy regimen has component Doxorubicin	NCI
C11214	RO	chemotherapy regimen has component Valspodar	NCI
C11086	STY	Therapeutic or Preventive Procedure		NCI
C11086	PT	Cyclophosphamide/Cytarabine/Thioguanine/Vincristine		NCI
C11086	SY	ARA-C/CTX/TG/VCR		NCI
C11086	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11086	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11086	RO	chemotherapy regimen has component Cytarabine	NCI
C11086	RO	chemotherapy regimen has component Thioguanine	NCI
C11086	RO	chemotherapy regimen has component Vincristine	NCI
C63602	STY	Therapeutic or Preventive Procedure		NCI
C63602	PT	Cytarabine-Daunorubicin Regimen		NCI
C63602	SY	7-3 Induction Regimen		NCI
C63602	SY	AraC-Daunorubicin Regimen		NCI
C63602	SY	5 and 2 Consolidation Regimen		NCI
C63602	SY	5-2 Consolidation Regimen		NCI
C63602	SY	7 and 3 Induction Regimen		NCI
C63602	SY	Cytarabine-Daunomycin Regimen		NCI
C63602	CHD	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C63602	RO	chemotherapy regimen has component Cytarabine	NCI
C63602	RO	regimen has accepted use for disease Adult Acute Myeloid Leukemia	NCI
C63602	RO	regimen has accepted use for disease Childhood Acute Myeloid Leukemia	NCI
C63602	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10183	STY	Therapeutic or Preventive Procedure		NCI
C10183	PT	Chlorambucil/Prednisone/Procarbazine/Vinblastine		NCI
C10183	SY	CLB/PCB/PRED/VBL		NCI
C10183	SY	ChlVPP		NCI
C10183	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10183	RO	chemotherapy regimen has component Chlorambucil	NCI
C10183	RO	chemotherapy regimen has component Prednisone	NCI
C10183	RO	chemotherapy regimen has component Vinblastine	NCI
C10183	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C12026	STY	Therapeutic or Preventive Procedure		NCI
C12026	PT	Carboplatin/Cisplatin-epinephrine/Paclitaxel		NCI
C12026	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12026	RO	chemotherapy regimen has component Carboplatin	NCI
C12026	RO	chemotherapy regimen has component Paclitaxel	NCI
C12026	RO	chemotherapy regimen has component Cisplatin-E Therapeutic Implant	NCI
C9668	STY	Therapeutic or Preventive Procedure		NCI
C9668	PT	Fluorouracil/Mitomycin/Streptozocin		NCI
C9668	SY	5-FU/MITO/SZC		NCI
C9668	SY	SMF		NCI
C9668	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9668	RO	chemotherapy regimen has component Mitomycin	NCI
C9668	RO	chemotherapy regimen has component Fluorouracil	NCI
C9668	RO	chemotherapy regimen has component Streptozocin	NCI
C11549	STY	Therapeutic or Preventive Procedure		NCI
C11549	PT	Aminopterin/Leucovorin Calcium		NCI
C11549	SY	APGA/CF		NCI
C11549	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11549	RO	chemotherapy regimen has component Aminopterin	NCI
C11549	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11174	STY	Therapeutic or Preventive Procedure		NCI
C11174	PT	Doxorubicin/VX-710		NCI
C11174	SY	DOX/VX-710		NCI
C11174	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11174	RO	chemotherapy regimen has component Doxorubicin	NCI
C11174	RO	chemotherapy regimen has component Biricodar Dicitrate	NCI
C11384	STY	Therapeutic or Preventive Procedure		NCI
C11384	PT	Fluorouracil/Trimetrexate Glucuronate		NCI
C11384	SY	5-FU/TMTX		NCI
C11384	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11384	RO	chemotherapy regimen has component Fluorouracil	NCI
C11384	RO	chemotherapy regimen has component Trimetrexate Glucuronate	NCI
C11465	STY	Therapeutic or Preventive Procedure		NCI
C11465	PT	Cyclophosphamide/Cytarabine/Hydrocortisone/Leucovorin Calcium		NCI
C11465	SY	ARA-C/CF/CTX/HC		NCI
C11465	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11465	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11465	RO	chemotherapy regimen has component Cytarabine	NCI
C11465	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C11465	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63590	STY	Therapeutic or Preventive Procedure		NCI
C63590	PT	FOLFOX-4 Regimen		NCI
C63590	SY	Folinic Acid-Fluororuracil-Oxaliplatin-4 Regimen		NCI
C63590	CHD	FOLFOX Regimen	NCI
C63590	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63590	RO	chemotherapy regimen has component Fluorouracil	NCI
C63590	RO	chemotherapy regimen has component Oxaliplatin	NCI
C63590	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11097	STY	Therapeutic or Preventive Procedure		NCI
C11097	PT	Cyclophosphamide/Filgrastim/Paclitaxel		NCI
C11097	SY	CTX/G-CSF/TAX		NCI
C11097	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11097	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11097	RO	chemotherapy regimen has component Paclitaxel	NCI
C11097	RO	chemotherapy regimen has component Filgrastim	NCI
C11204	STY	Therapeutic or Preventive Procedure		NCI
C11204	PT	Cyclophosphamide/Dexamethasone/Idarubicin/Pegaspargase/Vincristine		NCI
C11204	SY	CTX/DM/IDA/PEG-ASP/VCR		NCI
C11204	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11204	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11204	RO	chemotherapy regimen has component Dexamethasone	NCI
C11204	RO	chemotherapy regimen has component Idarubicin	NCI
C11204	RO	chemotherapy regimen has component Vincristine	NCI
C11204	RO	chemotherapy regimen has component Pegaspargase	NCI
C10329	STY	Therapeutic or Preventive Procedure		NCI
C10329	PT	Fluorouracil/Hydroxyurea		NCI
C10329	SY	5-FU/HU		NCI
C10329	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10329	RO	chemotherapy regimen has component Fluorouracil	NCI
C10329	RO	chemotherapy regimen has component Hydroxyurea	NCI
C11100	STY	Therapeutic or Preventive Procedure		NCI
C11100	PT	Cyclosporine/Methylprednisolone		NCI
C11100	SY	CYSP/MePRDL		NCI
C11100	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11100	RO	chemotherapy regimen has component Cyclosporine	NCI
C11100	RO	chemotherapy regimen has component Methylprednisolone	NCI
C63599	STY	Therapeutic or Preventive Procedure		NCI
C63599	PT	ATRA-Daunorubicin Regimen		NCI
C63599	SY	Tretinoin-Daunorubicin Regimen		NCI
C63599	CHD	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C63599	RO	chemotherapy regimen has component Daunorubicin	NCI
C63599	RO	chemotherapy regimen has component Tretinoin	NCI
C63599	RO	regimen has accepted use for disease Adult Acute Promyelocytic Leukemia with PML-RARA	NCI
C11582	STY	Therapeutic or Preventive Procedure		NCI
C11582	PT	Cisplatin/Monoclonal Antibody C225		NCI
C11582	SY	CDDP/MOAB C225		NCI
C11582	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11582	RO	chemotherapy regimen has component Cisplatin	NCI
C11582	RO	chemotherapy regimen has component Cetuximab	NCI
C37667	STY	Therapeutic or Preventive Procedure		NCI
C37667	PT	Cisplatin/Pemetrexed Disodium		NCI
C37667	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37667	RO	chemotherapy regimen has component Cisplatin	NCI
C37667	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C11600	STY	Therapeutic or Preventive Procedure		NCI
C11600	PT	KSA-KLH Conjugate Vaccine/QS21		NCI
C11600	SY	KSA-KLH/QS21		NCI
C11600	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11600	RO	chemotherapy regimen has component QS21	NCI
C11600	RO	chemotherapy regimen has component KSA-KLH Conjugate Vaccine	NCI
C10710	STY	Therapeutic or Preventive Procedure		NCI
C10710	PT	Carboplatin/Interleukin-1-Alpha/Methylene Blue		NCI
C10710	SY	CBDCA/IL-1A/MB		NCI
C10710	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10710	RO	chemotherapy regimen has component Methylene Blue	NCI
C10710	RO	chemotherapy regimen has component Carboplatin	NCI
C10710	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C10112	STY	Therapeutic or Preventive Procedure		NCI
C10112	PT	Biostim/Melphalan/Prednisone/Vincristine		NCI
C10112	SY	biostim/L-PAM/PRED/VCR		NCI
C10112	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10112	RO	chemotherapy regimen has component Melphalan	NCI
C10112	RO	chemotherapy regimen has component Prednisone	NCI
C10112	RO	chemotherapy regimen has component Vincristine	NCI
C10112	RO	chemotherapy regimen has component Klebsiella pneumoniae Glycoprotein	NCI
C37566	STY	Therapeutic or Preventive Procedure		NCI
C37566	PT	Bortezomib/Carboplatin/Gemcitabine		NCI
C37566	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37566	RO	chemotherapy regimen has component Carboplatin	NCI
C37566	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37566	RO	chemotherapy regimen has component Bortezomib	NCI
C64724	STY	Therapeutic or Preventive Procedure		NCI
C64724	PT	MPT Regimen		NCI
C64724	SY	Melphalan-Prednisone-Thalidomide Regimen		NCI
C64724	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C64724	RO	chemotherapy regimen has component Melphalan	NCI
C64724	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C64724	RO	chemotherapy regimen has component Prednisone	NCI
C64724	RO	chemotherapy regimen has component Thalidomide	NCI
C140106	STY	Therapeutic or Preventive Procedure		NCI
C140106	PT	MATRix Regimen		NCI
C140106	SY	MATRix		NCI
C140106	SY	HD-MTX/HD-ARAC/Thiotepa/Rituximab		NCI
C140106	SY	Methotrexate-Cytarabine-Thiotepa-Rituximab		NCI
C140106	SY	Methotrexate/Cytarabine/Thiotepa/Rituximab		NCI
C140106	CHD	Chemotherapy Regimen Used to Treat Central Nervous System Neoplasm	NCI
C140106	RO	chemotherapy regimen has component Cytarabine	NCI
C140106	RO	chemotherapy regimen has component Methotrexate	NCI
C140106	RO	chemotherapy regimen has component Thiotepa	NCI
C140106	RO	chemotherapy regimen has component Rituximab	NCI
C11270	STY	Therapeutic or Preventive Procedure		NCI
C11270	PT	Carboplatin/Ifosfamide/Mesna		NCI
C11270	SY	carboplatin/ifosfamide/mercaptoethane sulfonate		NCI
C11270	SY	CBDCA/IFF/mesna		NCI
C11270	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11270	RO	chemotherapy regimen has component Mesna	NCI
C11270	RO	chemotherapy regimen has component Ifosfamide	NCI
C11270	RO	chemotherapy regimen has component Carboplatin	NCI
C37586	STY	Therapeutic or Preventive Procedure		NCI
C37586	PT	Capecitabine/LY317615		NCI
C37586	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37586	RO	chemotherapy regimen has component Capecitabine	NCI
C37586	RO	chemotherapy regimen has component Enzastaurin Hydrochloride	NCI
C10663	STY	Therapeutic or Preventive Procedure		NCI
C10663	PT	Doxorubicin/Fluorouracil/Vinorelbine		NCI
C10663	SY	DOX/5-FU/VNB		NCI
C10663	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10663	RO	chemotherapy regimen has component Doxorubicin	NCI
C10663	RO	chemotherapy regimen has component Fluorouracil	NCI
C10663	RO	chemotherapy regimen has component Vinorelbine	NCI
C12031	STY	Therapeutic or Preventive Procedure		NCI
C12031	PT	EGFR Antisense DNA/Sargramostim		NCI
C12031	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12031	RO	chemotherapy regimen has component Sargramostim	NCI
C12031	RO	chemotherapy regimen has component EGFR Antisense DNA	NCI
C10442	STY	Therapeutic or Preventive Procedure		NCI
C10442	PT	Cyclophosphamide/Doxorubicin/Etoposide/Prednisolone/Vincristine		NCI
C10442	SY	CTX/DOX/PRDL/VCR/VP-16		NCI
C10442	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10442	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10442	RO	chemotherapy regimen has component Doxorubicin	NCI
C10442	RO	chemotherapy regimen has component Etoposide	NCI
C10442	RO	chemotherapy regimen has component Prednisolone	NCI
C10442	RO	chemotherapy regimen has component Vincristine	NCI
C37482	STY	Therapeutic or Preventive Procedure		NCI
C37482	PT	Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/NY-ESO-B/Tyrosinase Peptide		NCI
C37482	SY	Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Melan-A/NY-ESO-B/Tyrosinase Peptide		NCI
C37482	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37482	RO	chemotherapy regimen has component gp100 Antigen	NCI
C37482	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C37482	RO	chemotherapy regimen has component NY-ESO-B	NCI
C37482	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C37482	RO	chemotherapy regimen has component Flu Matrix Peptide p58-66	NCI
C37482	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11750	STY	Therapeutic or Preventive Procedure		NCI
C11750	PT	Docetaxel/MS-209		NCI
C11750	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11750	RO	chemotherapy regimen has component Docetaxel	NCI
C11750	RO	chemotherapy regimen has component Dofequidar Fumarate	NCI
C9536	STY	Therapeutic or Preventive Procedure		NCI
C9536	PT	Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine		NCI
C9536	SY	VMV-VAC		NCI
C9536	SY	CTX/DOX/MTX/VCR/VP-16		NCI
C9536	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9536	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9536	RO	chemotherapy regimen has component Doxorubicin	NCI
C9536	RO	chemotherapy regimen has component Etoposide	NCI
C9536	RO	chemotherapy regimen has component Methotrexate	NCI
C9536	RO	chemotherapy regimen has component Vincristine	NCI
C9743	STY	Therapeutic or Preventive Procedure		NCI
C9743	PT	Cyclophosphamide/Doxorubicin/Uracil/Tegafur/Tamoxifen		NCI
C9743	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9743	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9743	RO	chemotherapy regimen has component Doxorubicin	NCI
C9743	RO	chemotherapy regimen has component Tegafur	NCI
C9743	RO	chemotherapy regimen has component Uracil	NCI
C9743	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C136270	STY	Therapeutic or Preventive Procedure		NCI
C136270	PT	Elotuzumab/Lenalidomide/Dexamethasone Regimen		NCI
C136270	SY	Elotuzumab/Lenalidomide/Dexamethasone		NCI
C136270	SY	Elotuzumab-Lenalidomide-Dexamethasone Regimen		NCI
C136270	SY	Elotuzumab-Lenalidomide-Dexamethasone		NCI
C136270	SY	Empliciti/Revlimid/Dexamethasone		NCI
C136270	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136270	RO	chemotherapy regimen has component Dexamethasone	NCI
C136270	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136270	RO	chemotherapy regimen has component Lenalidomide	NCI
C136270	RO	chemotherapy regimen has component Elotuzumab	NCI
C9912	STY	Therapeutic or Preventive Procedure		NCI
C9912	PT	Doxorubicin/Mitomycin		NCI
C9912	SY	MA		NCI
C9912	SY	DOX/MITO		NCI
C9912	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9912	RO	chemotherapy regimen has component Mitomycin	NCI
C9912	RO	chemotherapy regimen has component Doxorubicin	NCI
C10263	STY	Therapeutic or Preventive Procedure		NCI
C10263	PT	Cisplatin/Vinblastine		NCI
C10263	SY	CDDP/VBL		NCI
C10263	SY	V-DDP		NCI
C10263	SY	VP		NCI
C10263	SY	PVe		NCI
C10263	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10263	RO	chemotherapy regimen has component Cisplatin	NCI
C10263	RO	chemotherapy regimen has component Vinblastine	NCI
C10168	STY	Therapeutic or Preventive Procedure		NCI
C10168	PT	Doxorubicin/Mitomycin/Vindesine		NCI
C10168	SY	VAM		NCI
C10168	SY	DAVA/DOX/MITO		NCI
C10168	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10168	RO	chemotherapy regimen has component Mitomycin	NCI
C10168	RO	chemotherapy regimen has component Doxorubicin	NCI
C10168	RO	chemotherapy regimen has component Vindesine	NCI
C10440	STY	Therapeutic or Preventive Procedure		NCI
C10440	PT	Dexamethasone/Doxorubicin/Quinine/Verapamil/Vincristine		NCI
C10440	SY	DM/DOX/QUIN/VCR/VPAM		NCI
C10440	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10440	RO	chemotherapy regimen has component Dexamethasone	NCI
C10440	RO	chemotherapy regimen has component Doxorubicin	NCI
C10440	RO	chemotherapy regimen has component Quinine	NCI
C10440	RO	chemotherapy regimen has component Verapamil	NCI
C10440	RO	chemotherapy regimen has component Vincristine	NCI
C63465	STY	Therapeutic or Preventive Procedure		NCI
C63465	PT	R-ICE Regimen		NCI
C63465	SY	RICE Regimen		NCI
C63465	SY	Rituximab-Ifosfamide-Carboplatin-Etoposide Regimen		NCI
C63465	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63465	RO	chemotherapy regimen has component Mesna	NCI
C63465	RO	chemotherapy regimen has component Etoposide	NCI
C63465	RO	chemotherapy regimen has component Ifosfamide	NCI
C63465	RO	chemotherapy regimen has component Carboplatin	NCI
C63465	RO	regimen has accepted use for disease Recurrent Adult Hodgkin Lymphoma	NCI
C63465	RO	chemotherapy regimen has component Rituximab	NCI
C63465	RO	regimen has accepted use for disease Indolent Adult Non-Hodgkin Lymphoma	NCI
C63465	RO	regimen has accepted use for disease Refractory Non-Hodgkin Lymphoma	NCI
C11540	STY	Therapeutic or Preventive Procedure		NCI
C11540	PT	Asparaginase/Daunorubicin/Methotrexate/Prednisolone/Vincristine		NCI
C11540	SY	ASP/DNR/MTX/PRDL/VCR		NCI
C11540	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11540	RO	chemotherapy regimen has component Asparaginase	NCI
C11540	RO	chemotherapy regimen has component Methotrexate	NCI
C11540	RO	chemotherapy regimen has component Prednisolone	NCI
C11540	RO	chemotherapy regimen has component Vincristine	NCI
C11540	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11113	STY	Therapeutic or Preventive Procedure		NCI
C11113	PT	Carboplatin/Cisplatin/Interferon Alfa/interleukin-2/Paclitaxel		NCI
C11113	SY	CBDCA/CDDP/IFN-A/IL-2/TAX		NCI
C11113	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11113	RO	chemotherapy regimen has component Cisplatin	NCI
C11113	RO	chemotherapy regimen has component Carboplatin	NCI
C11113	RO	chemotherapy regimen has component Paclitaxel	NCI
C11113	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11113	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9596	STY	Therapeutic or Preventive Procedure		NCI
C9596	PT	Fluorouracil/Mitomycin/Vincristine		NCI
C9596	SY	FOM		NCI
C9596	SY	5-FU/MITO/VCR		NCI
C9596	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9596	RO	chemotherapy regimen has component Mitomycin	NCI
C9596	RO	chemotherapy regimen has component Fluorouracil	NCI
C9596	RO	chemotherapy regimen has component Vincristine	NCI
C136247	STY	Therapeutic or Preventive Procedure		NCI
C136247	PT	FOLFOX/Panitumumab Regimen		NCI
C136247	SY	FOLFOX Plus Panitumumab		NCI
C136247	SY	Leucovorin/Fluorouracil/Oxaliplatin/Panitumumab		NCI
C136247	SY	FOLFOX/Panitumumab		NCI
C136247	SY	FOLFOX/Vectibix		NCI
C136247	SY	FOLFOX/Vectibix Regimen		NCI
C136247	SY	FOLFOX-Panitumumab		NCI
C136247	SY	FOLFOX Plus Vectibix		NCI
C136247	SY	FOLFOX-Panitumumab Regimen		NCI
C136247	SY	Folinic Acid/Fluorouracil/Oxaliplatin/Panitumumab Regimen		NCI
C136247	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136247	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136247	RO	chemotherapy regimen has component Fluorouracil	NCI
C136247	RO	chemotherapy regimen has component Oxaliplatin	NCI
C136247	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C136247	RO	chemotherapy regimen has component Panitumumab	NCI
C11309	STY	Therapeutic or Preventive Procedure		NCI
C11309	PT	Fluorouracil/Raltitrexed		NCI
C11309	SY	5-FU/ICI D1694		NCI
C11309	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11309	RO	chemotherapy regimen has component Fluorouracil	NCI
C11309	RO	chemotherapy regimen has component Raltitrexed	NCI
C11172	STY	Therapeutic or Preventive Procedure		NCI
C11172	PT	Cyclophosphamide/Etoposide/Mitoxantrone/Pegaspargase/Prednisone/Vincristine		NCI
C11172	SY	CTX/DHAD/PEG-ASP/PRED/VCR/VP-16		NCI
C11172	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11172	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11172	RO	chemotherapy regimen has component Etoposide	NCI
C11172	RO	chemotherapy regimen has component Prednisone	NCI
C11172	RO	chemotherapy regimen has component Vincristine	NCI
C11172	RO	chemotherapy regimen has component Pegaspargase	NCI
C11172	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37543	STY	Therapeutic or Preventive Procedure		NCI
C37543	PT	Autologous Lymphocytes/Fluorouracil/Interferon Alfa/Sargramostim		NCI
C37543	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37543	RO	chemotherapy regimen has component Fluorouracil	NCI
C37543	RO	chemotherapy regimen has component Sargramostim	NCI
C37543	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37543	RO	chemotherapy regimen has component Therapeutic Autologous Lymphocytes	NCI
C11906	STY	Therapeutic or Preventive Procedure		NCI
C11906	PT	Amifostine/Carboplatin/Epirubicin/Paclitaxel		NCI
C11906	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11906	RO	chemotherapy regimen has component Amifostine	NCI
C11906	RO	chemotherapy regimen has component Carboplatin	NCI
C11906	RO	chemotherapy regimen has component Paclitaxel	NCI
C11906	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C156371	STY	Therapeutic or Preventive Procedure		NCI
C156371	PT	Exemestane/Ribociclib Regimen		NCI
C156371	SY	Ribociclib-Exemestane		NCI
C156371	SY	Ribociclib/Exemestane Regimen		NCI
C156371	SY	Exemestane-Ribociclib		NCI
C156371	SY	Ribociclib/Exemestane		NCI
C156371	SY	Exemestane/Ribociclib		NCI
C156371	SY	Aromasin/Kisqali		NCI
C156371	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156371	RO	chemotherapy regimen has component Exemestane	NCI
C156371	RO	chemotherapy regimen has component Ribociclib	NCI
C12180	STY	Therapeutic or Preventive Procedure		NCI
C12180	PT	MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Tyrosinase peptide		NCI
C12180	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12180	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C12180	RO	chemotherapy regimen has component NY-ESO-1 Peptide Vaccine	NCI
C12180	RO	chemotherapy regimen has component MAGE-10.A2	NCI
C12180	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C63369	STY	Therapeutic or Preventive Procedure		NCI
C63369	PT	Stanford V Regimen		NCI
C63369	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63369	RO	chemotherapy regimen has component Bleomycin	NCI
C63369	RO	chemotherapy regimen has component Doxorubicin	NCI
C63369	RO	chemotherapy regimen has component Etoposide	NCI
C63369	RO	chemotherapy regimen has component Prednisone	NCI
C63369	RO	chemotherapy regimen has component Vinblastine	NCI
C63369	RO	chemotherapy regimen has component Vincristine	NCI
C63369	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C63369	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C10809	STY	Therapeutic or Preventive Procedure		NCI
C10809	PT	Dipyridamole/Methotrexate		NCI
C10809	SY	DP/MTX		NCI
C10809	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10809	RO	chemotherapy regimen has component Dipyridamole	NCI
C10809	RO	chemotherapy regimen has component Methotrexate	NCI
C11569	STY	Therapeutic or Preventive Procedure		NCI
C11569	PT	Monoclonal Antibody C225/Paclitaxel		NCI
C11569	SY	MOAB C225/TAX		NCI
C11569	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11569	RO	chemotherapy regimen has component Paclitaxel	NCI
C11569	RO	chemotherapy regimen has component Cetuximab	NCI
C12014	STY	Therapeutic or Preventive Procedure		NCI
C12014	PT	Carboplatin/Squalamine Lactate		NCI
C12014	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12014	RO	chemotherapy regimen has component Carboplatin	NCI
C12014	RO	chemotherapy regimen has component Squalamine Lactate	NCI
C10068	STY	Therapeutic or Preventive Procedure		NCI
C10068	PT	Octreotide/Tamoxifen		NCI
C10068	SY	SSTN/TMX		NCI
C10068	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10068	RO	chemotherapy regimen has component Octreotide	NCI
C10068	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C37775	STY	Therapeutic or Preventive Procedure		NCI
C37775	PT	Flavopiridol/Fludarabine/Rituximab		NCI
C37775	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37775	RO	chemotherapy regimen has component Fludarabine	NCI
C37775	RO	chemotherapy regimen has component Rituximab	NCI
C37775	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C9674	STY	Therapeutic or Preventive Procedure		NCI
C9674	PT	Bleomycin/Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vincristine		NCI
C9674	SY	M-BACOD		NCI
C9674	SY	BLEO/CTX/DM/DOX/MTX/VCR		NCI
C9674	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9674	RO	chemotherapy regimen has component Bleomycin	NCI
C9674	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9674	RO	chemotherapy regimen has component Dexamethasone	NCI
C9674	RO	chemotherapy regimen has component Doxorubicin	NCI
C9674	RO	chemotherapy regimen has component Methotrexate	NCI
C9674	RO	chemotherapy regimen has component Vincristine	NCI
C37680	STY	Therapeutic or Preventive Procedure		NCI
C37680	PT	Cyclophosphamide/Doxorubicin/Etoposide/Fludarabine/Prednisone/Rituximab/Vincristine		NCI
C37680	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37680	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37680	RO	chemotherapy regimen has component Doxorubicin	NCI
C37680	RO	chemotherapy regimen has component Etoposide	NCI
C37680	RO	chemotherapy regimen has component Prednisone	NCI
C37680	RO	chemotherapy regimen has component Vincristine	NCI
C37680	RO	chemotherapy regimen has component Fludarabine	NCI
C37680	RO	chemotherapy regimen has component Rituximab	NCI
C11001	STY	Therapeutic or Preventive Procedure		NCI
C11001	PT	Lomustine/Interferon Alfa		NCI
C11001	SY	CCNU/IFN-A		NCI
C11001	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11001	RO	chemotherapy regimen has component Lomustine	NCI
C11001	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37790	STY	Therapeutic or Preventive Procedure		NCI
C37790	PT	Fowlpox-PSA-TRICOM Vaccine/Fowlpox-Sargramostim Vaccine/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine		NCI
C37790	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37790	RO	chemotherapy regimen has component Recombinant Fowlpox GM-CSF Vaccine Adjuvant	NCI
C37790	RO	chemotherapy regimen has component Fowlpox-PSA-TRICOM Vaccine	NCI
C37790	RO	chemotherapy regimen has component Rilimogene Galvacirepvec	NCI
C10586	STY	Therapeutic or Preventive Procedure		NCI
C10586	PT	Trifluoperazine/Verapamil		NCI
C10586	SY	TFPZ/VPAM		NCI
C10586	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10586	RO	chemotherapy regimen has component Verapamil	NCI
C10586	RO	chemotherapy regimen has component Trifluoperazine Hydrochloride	NCI
C9521	STY	Therapeutic or Preventive Procedure		NCI
C9521	PT	Bleomycin/Dacarbazine/Doxorubicin/Prednisone/Vincristine		NCI
C9521	SY	BLEO/DOX/DTIC/PRED/VCR		NCI
C9521	SY	BAVIP		NCI
C9521	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9521	RO	chemotherapy regimen has component Bleomycin	NCI
C9521	RO	chemotherapy regimen has component Dacarbazine	NCI
C9521	RO	chemotherapy regimen has component Doxorubicin	NCI
C9521	RO	chemotherapy regimen has component Prednisone	NCI
C9521	RO	chemotherapy regimen has component Vincristine	NCI
C11726	STY	Therapeutic or Preventive Procedure		NCI
C11726	PT	Cytarabine/Leucovorin Calcium		NCI
C11726	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11726	RO	chemotherapy regimen has component Cytarabine	NCI
C11726	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C114387	STY	Therapeutic or Preventive Procedure		NCI
C114387	PT	PAD Regimen		NCI
C114387	SY	PAD		NCI
C114387	SY	PS-341/Adriamycin/Dexamethasone Regimen		NCI
C114387	SY	Velcade/Adriamycin/Dexamethasone Regimen		NCI
C114387	SY	Bortezomib/Doxorubicin/Dexamethasone Regimen		NCI
C114387	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C114387	RO	chemotherapy regimen has component Dexamethasone	NCI
C114387	RO	chemotherapy regimen has component Doxorubicin	NCI
C114387	RO	chemotherapy regimen has component Bortezomib	NCI
C10017	STY	Therapeutic or Preventive Procedure		NCI
C10017	PT	Doxorubicin/Fluoxymesterone/Methotrexate/Mitolactol/Tamoxifen/Vincristine		NCI
C10017	SY	DAVTHML		NCI
C10017	SY	DBD/DOX/FXM/MTX/TMX/VCR		NCI
C10017	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10017	RO	chemotherapy regimen has component Doxorubicin	NCI
C10017	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C10017	RO	chemotherapy regimen has component Methotrexate	NCI
C10017	RO	chemotherapy regimen has component Mitolactol	NCI
C10017	RO	chemotherapy regimen has component Vincristine	NCI
C10017	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11526	STY	Therapeutic or Preventive Procedure		NCI
C11526	PT	Docetaxel/Doxorubicin/Tamoxifen		NCI
C11526	SY	DOX/TMX/TXT		NCI
C11526	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11526	RO	chemotherapy regimen has component Doxorubicin	NCI
C11526	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11526	RO	chemotherapy regimen has component Docetaxel	NCI
C10909	STY	Therapeutic or Preventive Procedure		NCI
C10909	PT	Paclitaxel/Thiotepa		NCI
C10909	SY	TAX/TSPA		NCI
C10909	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10909	RO	chemotherapy regimen has component Thiotepa	NCI
C10909	RO	chemotherapy regimen has component Paclitaxel	NCI
C12092	STY	Therapeutic or Preventive Procedure		NCI
C12092	PT	Pegylated Interferon Alfa/Temozolomide		NCI
C12092	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12092	RO	chemotherapy regimen has component Temozolomide	NCI
C12092	RO	chemotherapy regimen has component Pegylated Interferon Alfa	NCI
C138041	STY	Therapeutic or Preventive Procedure		NCI
C138041	PT	Lapatinib/Capecitabine Regimen		NCI
C138041	SY	Lapatinib + Capecitabine Regimen		NCI
C138041	SY	Lapatinib Plus Capecitabine Regimen		NCI
C138041	SY	Lapatinib/Capecitabine		NCI
C138041	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138041	RO	chemotherapy regimen has component Capecitabine	NCI
C138041	RO	chemotherapy regimen has component Lapatinib	NCI
C11383	STY	Therapeutic or Preventive Procedure		NCI
C11383	PT	Amifostine/Cytarabine/Idarubicin		NCI
C11383	SY	ARA-C/IDA/WR-2721		NCI
C11383	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11383	RO	chemotherapy regimen has component Cytarabine	NCI
C11383	RO	chemotherapy regimen has component Amifostine	NCI
C11383	RO	chemotherapy regimen has component Idarubicin	NCI
C156248	STY	Therapeutic or Preventive Procedure		NCI
C156248	PT	Tamoxifen/Anastrozole Regimen		NCI
C156248	SY	Tamoxifen-Anastrozole Regimen		NCI
C156248	SY	Arimidex-Tamoxifen Regimen		NCI
C156248	SY	Tamoxifen/Arimidex Regimen		NCI
C156248	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156248	RO	chemotherapy regimen has component Tamoxifen	NCI
C156248	RO	chemotherapy regimen has component Anastrozole	NCI
C11192	STY	Therapeutic or Preventive Procedure		NCI
C11192	PT	Carboplatin/Cyclosporine/Doxorubicin		NCI
C11192	SY	CBDCA/CYSP/DOX		NCI
C11192	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11192	RO	chemotherapy regimen has component Cyclosporine	NCI
C11192	RO	chemotherapy regimen has component Doxorubicin	NCI
C11192	RO	chemotherapy regimen has component Carboplatin	NCI
C10857	STY	Therapeutic or Preventive Procedure		NCI
C10857	PT	Dexamethasone/Vincristine		NCI
C10857	SY	DM/VCR		NCI
C10857	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10857	RO	chemotherapy regimen has component Dexamethasone	NCI
C10857	RO	chemotherapy regimen has component Vincristine	NCI
C11257	STY	Therapeutic or Preventive Procedure		NCI
C11257	PT	Docetaxel/Estramustine/Hydrocortisone		NCI
C11257	SY	EM/HC/TXT		NCI
C11257	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11257	RO	chemotherapy regimen has component Estramustine	NCI
C11257	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C11257	RO	chemotherapy regimen has component Docetaxel	NCI
C10265	STY	Therapeutic or Preventive Procedure		NCI
C10265	PT	Cisplatin/Cyclophosphamide/Doxorubicin		NCI
C10265	SY	CAP-I		NCI
C10265	SY	PAC		NCI
C10265	SY	CDDP/CTX/DOX		NCI
C10265	SY	CISCA-II		NCI
C10265	SY	CAP-II		NCI
C10265	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10265	RO	chemotherapy regimen has component Cisplatin	NCI
C10265	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10265	RO	chemotherapy regimen has component Doxorubicin	NCI
C9960	STY	Therapeutic or Preventive Procedure		NCI
C9960	PT	Cisplatin/Cytarabine/Dacarbazine/Hydroxyurea/Lomustine/Methylprednisolone/Procarbazine/Vincristine		NCI
C9960	SY	ARA-C/CCNU/CDDP/DTIC/HU/MePRDL/PCB/VCR		NCI
C9960	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9960	RO	chemotherapy regimen has component Cisplatin	NCI
C9960	RO	chemotherapy regimen has component Cytarabine	NCI
C9960	RO	chemotherapy regimen has component Dacarbazine	NCI
C9960	RO	chemotherapy regimen has component Hydroxyurea	NCI
C9960	RO	chemotherapy regimen has component Lomustine	NCI
C9960	RO	chemotherapy regimen has component Methylprednisolone	NCI
C9960	RO	chemotherapy regimen has component Vincristine	NCI
C9960	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11920	STY	Therapeutic or Preventive Procedure		NCI
C11920	PT	Flavopiridol/Gemcitabine		NCI
C11920	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11920	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11920	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C140100	STY	Therapeutic or Preventive Procedure		NCI
C140100	PT	GDP Regimen		NCI
C140100	SY	GDP		NCI
C140100	SY	Gemcitabine-Dexamethasone-Platinol		NCI
C140100	SY	Gemcitabine/Dexamethasone/Cisplatin		NCI
C140100	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C140100	RO	chemotherapy regimen has component Cisplatin	NCI
C140100	RO	chemotherapy regimen has component Dexamethasone	NCI
C140100	RO	chemotherapy regimen has component Gemcitabine	NCI
C10131	STY	Therapeutic or Preventive Procedure		NCI
C10131	PT	Cyclophosphamide/Dexamethasone/Doxorubicin/Verapamil/Vincristine		NCI
C10131	SY	CTX/DM/DOX/VCR/VPAM		NCI
C10131	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10131	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10131	RO	chemotherapy regimen has component Dexamethasone	NCI
C10131	RO	chemotherapy regimen has component Doxorubicin	NCI
C10131	RO	chemotherapy regimen has component Verapamil	NCI
C10131	RO	chemotherapy regimen has component Vincristine	NCI
C12089	STY	Therapeutic or Preventive Procedure		NCI
C12089	PT	Alemtuzumab/Fludarabine/Melphalan		NCI
C12089	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12089	RO	chemotherapy regimen has component Melphalan	NCI
C12089	RO	chemotherapy regimen has component Fludarabine	NCI
C12089	RO	chemotherapy regimen has component Alemtuzumab	NCI
C10388	STY	Therapeutic or Preventive Procedure		NCI
C10388	PT	BCG/Mitomycin		NCI
C10388	SY	BCG/MITO		NCI
C10388	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10388	RO	chemotherapy regimen has component Mitomycin	NCI
C10388	RO	chemotherapy regimen has component BCG Vaccine	NCI
C11022	STY	Therapeutic or Preventive Procedure		NCI
C11022	PT	Cyclophosphamide/Interferon Alfa/Melphalan/Prednisone/Vincristine		NCI
C11022	SY	CTX/IFN-A/L-PAM/PRED/VCR		NCI
C11022	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11022	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11022	RO	chemotherapy regimen has component Melphalan	NCI
C11022	RO	chemotherapy regimen has component Prednisone	NCI
C11022	RO	chemotherapy regimen has component Vincristine	NCI
C11022	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10137	STY	Therapeutic or Preventive Procedure		NCI
C10137	PT	Etanidazole/Melphalan/Prednisone		NCI
C10137	SY	L-PAM/PRED/SR-2508		NCI
C10137	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10137	RO	chemotherapy regimen has component Melphalan	NCI
C10137	RO	chemotherapy regimen has component Prednisone	NCI
C10137	RO	chemotherapy regimen has component Etanidazole	NCI
C37656	STY	Therapeutic or Preventive Procedure		NCI
C37656	PT	Cisplatin/Fluorouracil/Irinotecan/Leucovorin Calcium		NCI
C37656	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37656	RO	chemotherapy regimen has component Cisplatin	NCI
C37656	RO	chemotherapy regimen has component Fluorouracil	NCI
C37656	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37656	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9835	STY	Therapeutic or Preventive Procedure		NCI
C9835	PT	Buserelin/Tamoxifen		NCI
C9835	SY	BSRL/TMX		NCI
C9835	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9835	RO	chemotherapy regimen has component Buserelin	NCI
C9835	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C37684	STY	Therapeutic or Preventive Procedure		NCI
C37684	PT	Cyclophosphamide/Doxorubicin/Pegfilgrastim		NCI
C37684	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37684	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37684	RO	chemotherapy regimen has component Doxorubicin	NCI
C37684	RO	chemotherapy regimen has component Pegfilgrastim	NCI
C9598	STY	Therapeutic or Preventive Procedure		NCI
C9598	PT	Altretamine/Cyclophosphamide/Fluorouracil/Methotrexate		NCI
C9598	SY	HEXA-CAF		NCI
C9598	SY	CTX/5-FU/HMM/MTX		NCI
C9598	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9598	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9598	RO	chemotherapy regimen has component Fluorouracil	NCI
C9598	RO	chemotherapy regimen has component Altretamine	NCI
C9598	RO	chemotherapy regimen has component Methotrexate	NCI
C10796	STY	Therapeutic or Preventive Procedure		NCI
C10796	PT	Doxorubicin/Prednisolone/Vincristine		NCI
C10796	SY	DOX/PRDL/VCR		NCI
C10796	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10796	RO	chemotherapy regimen has component Doxorubicin	NCI
C10796	RO	chemotherapy regimen has component Prednisolone	NCI
C10796	RO	chemotherapy regimen has component Vincristine	NCI
C11791	STY	Therapeutic or Preventive Procedure		NCI
C11791	PT	Cisplatin/Fluorouracil/Irinotecan		NCI
C11791	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11791	RO	chemotherapy regimen has component Cisplatin	NCI
C11791	RO	chemotherapy regimen has component Fluorouracil	NCI
C11791	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11244	STY	Therapeutic or Preventive Procedure		NCI
C11244	PT	Cyclophosphamide/Doxorubicin/Prednisone/Sargramostim/Vincristine		NCI
C11244	SY	CTX/DOX/GM-CSF/PRED/VCR		NCI
C11244	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11244	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11244	RO	chemotherapy regimen has component Doxorubicin	NCI
C11244	RO	chemotherapy regimen has component Prednisone	NCI
C11244	RO	chemotherapy regimen has component Vincristine	NCI
C11244	RO	chemotherapy regimen has component Sargramostim	NCI
C10905	STY	Therapeutic or Preventive Procedure		NCI
C10905	PT	Dexamethasone/Dexniguldipine/Doxorubicin/Vincristine		NCI
C10905	SY	DM/DNIG/DOX/VCR		NCI
C10905	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10905	RO	chemotherapy regimen has component Dexamethasone	NCI
C10905	RO	chemotherapy regimen has component Doxorubicin	NCI
C10905	RO	chemotherapy regimen has component Vincristine	NCI
C10905	RO	chemotherapy regimen has component Dexniguldipine	NCI
C11495	STY	Therapeutic or Preventive Procedure		NCI
C11495	PT	Asparaginase/Dexamethasone/Etoposide/Mitoxantrone		NCI
C11495	SY	ASP/DHAD/DM/VP-16		NCI
C11495	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11495	RO	chemotherapy regimen has component Asparaginase	NCI
C11495	RO	chemotherapy regimen has component Dexamethasone	NCI
C11495	RO	chemotherapy regimen has component Etoposide	NCI
C11495	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11054	STY	Therapeutic or Preventive Procedure		NCI
C11054	PT	Busulfan/Interferon Alfa		NCI
C11054	SY	BU/IFN-A		NCI
C11054	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11054	RO	chemotherapy regimen has component Busulfan	NCI
C11054	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10600	STY	Therapeutic or Preventive Procedure		NCI
C10600	PT	Cytarabine/Etoposide/Methotrexate/Prednisone		NCI
C10600	SY	ARA-C/MTX/PRED/VP-16		NCI
C10600	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10600	RO	chemotherapy regimen has component Cytarabine	NCI
C10600	RO	chemotherapy regimen has component Etoposide	NCI
C10600	RO	chemotherapy regimen has component Methotrexate	NCI
C10600	RO	chemotherapy regimen has component Prednisone	NCI
C10845	STY	Therapeutic or Preventive Procedure		NCI
C10845	PT	Methotrexate/Procarbazine/Vincristine		NCI
C10845	SY	MTX/PCB/VCR		NCI
C10845	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10845	RO	chemotherapy regimen has component Methotrexate	NCI
C10845	RO	chemotherapy regimen has component Vincristine	NCI
C10845	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10300	STY	Therapeutic or Preventive Procedure		NCI
C10300	PT	Asparaginase/Cyclophosphamide/Cytarabine/Mercaptopurine/Methotrexate		NCI
C10300	SY	ARA-C/ASP/CTX/MP/MTX		NCI
C10300	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10300	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10300	RO	chemotherapy regimen has component Asparaginase	NCI
C10300	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10300	RO	chemotherapy regimen has component Cytarabine	NCI
C10300	RO	chemotherapy regimen has component Methotrexate	NCI
C9611	STY	Therapeutic or Preventive Procedure		NCI
C9611	PT	Altretamine/Cisplatin/Etoposide/Mitomycin		NCI
C9611	SY	CDDP/HMM/MITO/VP-16		NCI
C9611	SY	MEPH		NCI
C9611	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9611	RO	chemotherapy regimen has component Mitomycin	NCI
C9611	RO	chemotherapy regimen has component Cisplatin	NCI
C9611	RO	chemotherapy regimen has component Etoposide	NCI
C9611	RO	chemotherapy regimen has component Altretamine	NCI
C37689	STY	Therapeutic or Preventive Procedure		NCI
C37689	PT	Cyclophosphamide/Etoposide/Imatinib Mesylate		NCI
C37689	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37689	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37689	RO	chemotherapy regimen has component Etoposide	NCI
C37689	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C11412	STY	Therapeutic or Preventive Procedure		NCI
C11412	PT	Etoposide/Gemcitabine		NCI
C11412	SY	dFdC/VP-16		NCI
C11412	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11412	RO	chemotherapy regimen has component Etoposide	NCI
C11412	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C10719	STY	Therapeutic or Preventive Procedure		NCI
C10719	PT	Carboplatin/Etoposide/Ifosfamide/Vincristine		NCI
C10719	SY	CBDCA/IFF/VCR/VP-16		NCI
C10719	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10719	RO	chemotherapy regimen has component Etoposide	NCI
C10719	RO	chemotherapy regimen has component Ifosfamide	NCI
C10719	RO	chemotherapy regimen has component Vincristine	NCI
C10719	RO	chemotherapy regimen has component Carboplatin	NCI
C10638	STY	Therapeutic or Preventive Procedure		NCI
C10638	PT	Carboplatin/Etoposide/Ifosfamide/Etanidazole		NCI
C10638	SY	CBDCA/IFF/SR-2508/VP-16		NCI
C10638	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10638	RO	chemotherapy regimen has component Etoposide	NCI
C10638	RO	chemotherapy regimen has component Ifosfamide	NCI
C10638	RO	chemotherapy regimen has component Etanidazole	NCI
C10638	RO	chemotherapy regimen has component Carboplatin	NCI
C64843	STY	Therapeutic or Preventive Procedure		NCI
C64843	PT	Estramustine-Paclitaxel Regimen		NCI
C64843	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C64843	RO	chemotherapy regimen has component Estramustine	NCI
C64843	RO	chemotherapy regimen has component Paclitaxel	NCI
C64843	RO	regimen has accepted use for disease Metastatic Prostate Carcinoma	NCI
C65070	STY	Therapeutic or Preventive Procedure		NCI
C65070	PT	Chemotherapy Regimen Used to Treat Cervical Carcinoma		NCI
C65070	CHD	Chemotherapy Regimen	NCI
C65070	PAR	Cisplatin-Taxol Regimen	NCI
C65070	PAR	Cisplatin-Topotecan Regimen	NCI
C65070	PAR	Gemcitabine-Cisplatin Regimen	NCI
C65070	PAR	Cisplatin/Paclitaxel/Bevacizumab Regimen	NCI
C65070	PAR	Topotecan/Paclitaxel/Bevacizumab Regimen	NCI
C63779	STY	Therapeutic or Preventive Procedure		NCI
C63779	PT	EPOCH Regimen		NCI
C63779	SY	Dose-adjusted Etoposide/Vincristine/Doxorubicin/Cyclophosphamide/Prednisone Regimen		NCI
C63779	SY	Etoposide-Prednisone-Oncovin-Cyclophosphamide-Hydroxydaunorubicin Regimen		NCI
C63779	SY	DA-EPOCH		NCI
C63779	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63779	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63779	RO	chemotherapy regimen has component Doxorubicin	NCI
C63779	RO	chemotherapy regimen has component Etoposide	NCI
C63779	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C63779	RO	chemotherapy regimen has component Prednisone	NCI
C63779	RO	chemotherapy regimen has component Vincristine	NCI
C63779	RO	concept in subset CTRP Terminology	NCI
C63779	RO	concept in subset CTRP Agent Terminology	NCI
C63779	RO	regimen has accepted use for disease Mantle Cell Lymphoma	NCI
C11490	STY	Therapeutic or Preventive Procedure		NCI
C11490	PT	Asparaginase/Daunorubicin/Dexamethasone/Vincristine		NCI
C11490	SY	ASP/DM/DNR/VCR		NCI
C11490	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11490	RO	chemotherapy regimen has component Asparaginase	NCI
C11490	RO	chemotherapy regimen has component Dexamethasone	NCI
C11490	RO	chemotherapy regimen has component Vincristine	NCI
C11490	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C37520	STY	Therapeutic or Preventive Procedure		NCI
C37520	PT	Allogeneic Lymphocytes/Cyclosporine/Sirolimus		NCI
C37520	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37520	RO	chemotherapy regimen has component Cyclosporine	NCI
C37520	RO	chemotherapy regimen has component Sirolimus	NCI
C37520	RO	chemotherapy regimen has component Therapeutic Allogeneic Lymphocytes	NCI
C37723	STY	Therapeutic or Preventive Procedure		NCI
C37723	PT	Dacarbazine/Temozolomide		NCI
C37723	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37723	RO	chemotherapy regimen has component Dacarbazine	NCI
C37723	RO	chemotherapy regimen has component Temozolomide	NCI
C11411	STY	Therapeutic or Preventive Procedure		NCI
C11411	PT	Cisplatin/LY231514		NCI
C11411	SY	CDDP/LY231514		NCI
C11411	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11411	RO	chemotherapy regimen has component Cisplatin	NCI
C11411	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C11453	STY	Therapeutic or Preventive Procedure		NCI
C11453	PT	Anti-Thymocyte Globulin/Cyclophosphamide/Fludarabine		NCI
C11453	SY	ATG/CTX/FAMP		NCI
C11453	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11453	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11453	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11453	RO	chemotherapy regimen has component Fludarabine	NCI
C11484	STY	Therapeutic or Preventive Procedure		NCI
C11484	PT	Interferon Alfa/Tretinoin Liposome		NCI
C11484	SY	IFN-A/L-ATRA		NCI
C11484	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11484	RO	chemotherapy regimen has component Tretinoin Liposome	NCI
C11484	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C15530	STY	Therapeutic or Preventive Procedure		NCI
C15530	PT	Interleukin-2/Monoclonal Antibody R24		NCI
C15530	SY	IL-2/MOAB R24		NCI
C15530	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15530	RO	chemotherapy regimen has component Monoclonal Antibody R24	NCI
C15530	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11366	STY	Therapeutic or Preventive Procedure		NCI
C11366	PT	Clodronate/Mitoxantrone/Prednisone		NCI
C11366	SY	CLOD/DHAD/PRED		NCI
C11366	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11366	RO	chemotherapy regimen has component Clodronate Disodium	NCI
C11366	RO	chemotherapy regimen has component Prednisone	NCI
C11366	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11700	STY	Therapeutic or Preventive Procedure		NCI
C11700	PT	Autologous Tumor Cell Vaccine/Keyhole Limpet Hemocyanin/Sargramostim		NCI
C11700	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11700	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C11700	RO	chemotherapy regimen has component Sargramostim	NCI
C11700	RO	chemotherapy regimen has component Autologous Tumor Cell Vaccine	NCI
C37669	STY	Therapeutic or Preventive Procedure		NCI
C37669	PT	Clofarabine/Cytarabine		NCI
C37669	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37669	RO	chemotherapy regimen has component Cytarabine	NCI
C37669	RO	chemotherapy regimen has component Clofarabine	NCI
C9566	STY	Therapeutic or Preventive Procedure		NCI
C9566	PT	Asparaginase/Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Prednisone/Vincristine		NCI
C9566	SY	ARA-C/ASP/CTX/DOX/MTX/PRED/VCR		NCI
C9566	SY	CHOP-AMA		NCI
C9566	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9566	RO	chemotherapy regimen has component Asparaginase	NCI
C9566	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9566	RO	chemotherapy regimen has component Cytarabine	NCI
C9566	RO	chemotherapy regimen has component Doxorubicin	NCI
C9566	RO	chemotherapy regimen has component Methotrexate	NCI
C9566	RO	chemotherapy regimen has component Prednisone	NCI
C9566	RO	chemotherapy regimen has component Vincristine	NCI
C10962	STY	Therapeutic or Preventive Procedure		NCI
C10962	PT	Cisplatin/Doxorubicin/Tamoxifen		NCI
C10962	SY	CDDP/DOX/TMX		NCI
C10962	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10962	RO	chemotherapy regimen has component Cisplatin	NCI
C10962	RO	chemotherapy regimen has component Doxorubicin	NCI
C10962	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C67300	STY	Therapeutic or Preventive Procedure		NCI
C67300	PT	IE Rhabdomyosarcoma Regimen		NCI
C67300	SY	IE Regimen		NCI
C67300	SY	IRS-IV IE Regimen		NCI
C67300	SY	Ifosfamide-Etoposide Rhabdomyosarcoma Regimen		NCI
C67300	CHD	Chemotherapy Regimen Used to Treat Childhood Rhabdomyosarcoma	NCI
C67300	RO	chemotherapy regimen has component Etoposide	NCI
C67300	RO	chemotherapy regimen has component Ifosfamide	NCI
C67300	RO	regimen has accepted use for disease Childhood Rhabdomyosarcoma	NCI
C11713	STY	Therapeutic or Preventive Procedure		NCI
C11713	PT	Doxorubicin Hcl Liposome/Methotrexate/Prednisone/Vincristine		NCI
C11713	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11713	RO	chemotherapy regimen has component Methotrexate	NCI
C11713	RO	chemotherapy regimen has component Prednisone	NCI
C11713	RO	chemotherapy regimen has component Vincristine	NCI
C11713	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C10153	STY	Therapeutic or Preventive Procedure		NCI
C10153	PT	Cyclophosphamide/Doxorubicin/Methotrexate/Vinblastine		NCI
C10153	SY	M-CAVE		NCI
C10153	SY	CTX/DOX/MTX/VBL		NCI
C10153	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10153	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10153	RO	chemotherapy regimen has component Doxorubicin	NCI
C10153	RO	chemotherapy regimen has component Methotrexate	NCI
C10153	RO	chemotherapy regimen has component Vinblastine	NCI
C10741	STY	Therapeutic or Preventive Procedure		NCI
C10741	PT	Carboplatin/Thiotepa		NCI
C10741	SY	CBDCA/TSPA		NCI
C10741	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10741	RO	chemotherapy regimen has component Thiotepa	NCI
C10741	RO	chemotherapy regimen has component Carboplatin	NCI
C10575	STY	Therapeutic or Preventive Procedure		NCI
C10575	PT	Dexamethasone/Mercaptopurine/Methotrexate/Vincristine		NCI
C10575	SY	DM/MP/MTX/VCR		NCI
C10575	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10575	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10575	RO	chemotherapy regimen has component Dexamethasone	NCI
C10575	RO	chemotherapy regimen has component Methotrexate	NCI
C10575	RO	chemotherapy regimen has component Vincristine	NCI
C37468	STY	Therapeutic or Preventive Procedure		NCI
C37468	PT	Cisplatin/Doxorubicin Hydrochloride Liposome/Mitomycin		NCI
C37468	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37468	RO	chemotherapy regimen has component Mitomycin	NCI
C37468	RO	chemotherapy regimen has component Cisplatin	NCI
C37468	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C37553	STY	Therapeutic or Preventive Procedure		NCI
C37553	PT	Bevacizumab/Cetuximab		NCI
C37553	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37553	RO	chemotherapy regimen has component Bevacizumab	NCI
C37553	RO	chemotherapy regimen has component Cetuximab	NCI
C11157	STY	Therapeutic or Preventive Procedure		NCI
C11157	PT	Cyclophosphamide/Cytarabine/Etoposide/Mercaptopurine/Methotrexate/Prednisolone/Thioguanine/Vincristine		NCI
C11157	SY	ARA-C/CTX/MP/MTX/PRDL/TG/VCR/VP-16		NCI
C11157	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11157	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11157	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11157	RO	chemotherapy regimen has component Cytarabine	NCI
C11157	RO	chemotherapy regimen has component Etoposide	NCI
C11157	RO	chemotherapy regimen has component Methotrexate	NCI
C11157	RO	chemotherapy regimen has component Prednisolone	NCI
C11157	RO	chemotherapy regimen has component Thioguanine	NCI
C11157	RO	chemotherapy regimen has component Vincristine	NCI
C11240	STY	Therapeutic or Preventive Procedure		NCI
C11240	PT	Chlorodihydroxypyridine/Potassium Oxonate/Tegafur		NCI
C11240	SY	CDHP/FT/Oxo		NCI
C11240	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11240	RO	chemotherapy regimen has component Tegafur	NCI
C11240	RO	chemotherapy regimen has component Oteracil Potassium	NCI
C11240	RO	chemotherapy regimen has component Gimeracil	NCI
C37738	STY	Therapeutic or Preventive Procedure		NCI
C37738	PT	Docetaxel/ZD6474		NCI
C37738	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37738	RO	chemotherapy regimen has component Docetaxel	NCI
C37738	RO	chemotherapy regimen has component Vandetanib	NCI
C63597	STY	Therapeutic or Preventive Procedure		NCI
C63597	PT	XELOX Regimen		NCI
C63597	SY	Xeloda-Oxaliplatin Regimen		NCI
C63597	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63597	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63597	RO	chemotherapy regimen has component Oxaliplatin	NCI
C63597	RO	chemotherapy regimen has component Capecitabine	NCI
C63597	RO	concept in subset CTRP Terminology	NCI
C63597	RO	concept in subset CTRP Agent Terminology	NCI
C10029	STY	Therapeutic or Preventive Procedure		NCI
C10029	PT	Doxorubicin/Lomustine/Mechlorethamine		NCI
C10029	SY	CCNU/DOX/NM		NCI
C10029	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10029	RO	chemotherapy regimen has component Doxorubicin	NCI
C10029	RO	chemotherapy regimen has component Lomustine	NCI
C10029	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C11000	STY	Therapeutic or Preventive Procedure		NCI
C11000	PT	Interferon Alfa/Zidovudine		NCI
C11000	SY	IFN-A/ZDV		NCI
C11000	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11000	RO	chemotherapy regimen has component Zidovudine	NCI
C11000	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C12159	STY	Therapeutic or Preventive Procedure		NCI
C12159	PT	Dexamethasone/Thalidomide		NCI
C12159	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12159	RO	chemotherapy regimen has component Dexamethasone	NCI
C12159	RO	chemotherapy regimen has component Thalidomide	NCI
C37627	STY	Therapeutic or Preventive Procedure		NCI
C37627	PT	Celecoxib/Cyclophosphamide/Etoposide/Thalidomide		NCI
C37627	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37627	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37627	RO	chemotherapy regimen has component Etoposide	NCI
C37627	RO	chemotherapy regimen has component Thalidomide	NCI
C37627	RO	chemotherapy regimen has component Celecoxib	NCI
C37764	STY	Therapeutic or Preventive Procedure		NCI
C37764	PT	Erlotinib/Fluorouracil/Leucovorin Calcium/Oxaliplatin		NCI
C37764	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37764	RO	chemotherapy regimen has component Fluorouracil	NCI
C37764	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37764	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37764	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C10281	STY	Therapeutic or Preventive Procedure		NCI
C10281	PT	Doxorubicin/Vincristine		NCI
C10281	SY	DOX/VCR		NCI
C10281	SY	AO		NCI
C10281	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10281	RO	chemotherapy regimen has component Doxorubicin	NCI
C10281	RO	chemotherapy regimen has component Vincristine	NCI
C63414	STY	Therapeutic or Preventive Procedure		NCI
C63414	PT	Cisplatin-Irinotecan Regimen		NCI
C63414	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63414	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63414	RO	chemotherapy regimen has component Cisplatin	NCI
C63414	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C10337	STY	Therapeutic or Preventive Procedure		NCI
C10337	PT	Daunorubicin/Hydroxyurea		NCI
C10337	SY	DNR/HU		NCI
C10337	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10337	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10337	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9653	STY	Therapeutic or Preventive Procedure		NCI
C9653	PT	Carmustine/Doxorubicin/Prednisone/Vincristine		NCI
C9653	SY	BCNU/DOX/PRED/VCR		NCI
C9653	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9653	RO	chemotherapy regimen has component Carmustine	NCI
C9653	RO	chemotherapy regimen has component Doxorubicin	NCI
C9653	RO	chemotherapy regimen has component Prednisone	NCI
C9653	RO	chemotherapy regimen has component Vincristine	NCI
C67190	STY	Therapeutic or Preventive Procedure		NCI
C67190	PT	DECA Regimen		NCI
C67190	SY	DECA		NCI
C67190	SY	CCG-5912 Regimen		NCI
C67190	SY	Dexamethasone-Etoposide-Cisplatin-Adriamycin Regimen		NCI
C67190	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67190	RO	chemotherapy regimen has component Cisplatin	NCI
C67190	RO	chemotherapy regimen has component Cytarabine	NCI
C67190	RO	chemotherapy regimen has component Dexamethasone	NCI
C67190	RO	chemotherapy regimen has component Etoposide	NCI
C67190	RO	regimen has accepted use for disease Recurrent Childhood Hodgkin Lymphoma	NCI
C11710	STY	Therapeutic or Preventive Procedure		NCI
C11710	PT	BCG/Interferon alfa		NCI
C11710	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11710	RO	chemotherapy regimen has component BCG Vaccine	NCI
C11710	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37686	STY	Therapeutic or Preventive Procedure		NCI
C37686	PT	Cyclophosphamide/Doxorubicin/Tipifarnib		NCI
C37686	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37686	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37686	RO	chemotherapy regimen has component Doxorubicin	NCI
C37686	RO	chemotherapy regimen has component Tipifarnib	NCI
C37772	STY	Therapeutic or Preventive Procedure		NCI
C37772	PT	Exemestane/Trastuzumab		NCI
C37772	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37772	RO	chemotherapy regimen has component Trastuzumab	NCI
C37772	RO	chemotherapy regimen has component Exemestane	NCI
C11444	STY	Therapeutic or Preventive Procedure		NCI
C11444	PT	Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide		NCI
C11444	SY	CDDP/CTX/DM/VP-16		NCI
C11444	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11444	RO	chemotherapy regimen has component Cisplatin	NCI
C11444	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11444	RO	chemotherapy regimen has component Dexamethasone	NCI
C11444	RO	chemotherapy regimen has component Etoposide	NCI
C10915	STY	Therapeutic or Preventive Procedure		NCI
C10915	PT	Etoposide/Fluorouracil		NCI
C10915	SY	5-FU/VP-16		NCI
C10915	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10915	RO	chemotherapy regimen has component Etoposide	NCI
C10915	RO	chemotherapy regimen has component Fluorouracil	NCI
C10889	STY	Therapeutic or Preventive Procedure		NCI
C10889	PT	Bleomycin/Cisplatin/Epoetin Alfa/Etoposide/Filgrastim/Ifosfamide/Vinblastine		NCI
C10889	SY	BLEO/CDDP/EPO/G-CSF/IFF/VBL/VP-16		NCI
C10889	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10889	RO	chemotherapy regimen has component Bleomycin	NCI
C10889	RO	chemotherapy regimen has component Cisplatin	NCI
C10889	RO	chemotherapy regimen has component Etoposide	NCI
C10889	RO	chemotherapy regimen has component Ifosfamide	NCI
C10889	RO	chemotherapy regimen has component Vinblastine	NCI
C10889	RO	chemotherapy regimen has component Filgrastim	NCI
C10889	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C11115	STY	Therapeutic or Preventive Procedure		NCI
C11115	PT	Paclitaxel/Vinorelbine		NCI
C11115	SY	TAX/VNB		NCI
C11115	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11115	RO	chemotherapy regimen has component Vinorelbine	NCI
C11115	RO	chemotherapy regimen has component Paclitaxel	NCI
C10054	STY	Therapeutic or Preventive Procedure		NCI
C10054	PT	Asparaginase/Cytarabine/Daunorubicin		NCI
C10054	SY	ARA-C/ASP/DNR		NCI
C10054	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10054	RO	chemotherapy regimen has component Asparaginase	NCI
C10054	RO	chemotherapy regimen has component Cytarabine	NCI
C10054	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10311	STY	Therapeutic or Preventive Procedure		NCI
C10311	PT	Bropirimine/Tamoxifen		NCI
C10311	SY	ABPP/TAX		NCI
C10311	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10311	RO	chemotherapy regimen has component Bropirimine	NCI
C10311	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11425	STY	Therapeutic or Preventive Procedure		NCI
C11425	PT	Cyclophosphamide/Docetaxel/Doxorubicin		NCI
C11425	SY	CTX/DOX/TXT		NCI
C11425	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11425	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11425	RO	chemotherapy regimen has component Doxorubicin	NCI
C11425	RO	chemotherapy regimen has component Docetaxel	NCI
C11552	STY	Therapeutic or Preventive Procedure		NCI
C11552	PT	gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-2/MART-1 Antigen		NCI
C11552	SY	gp100/IFA/IL-2/MART-1		NCI
C11552	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11552	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11552	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11552	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11552	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11231	STY	Therapeutic or Preventive Procedure		NCI
C11231	PT	Cisplatin/Hydroxyurea		NCI
C11231	SY	CDDP/HU		NCI
C11231	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11231	RO	chemotherapy regimen has component Cisplatin	NCI
C11231	RO	chemotherapy regimen has component Hydroxyurea	NCI
C9545	STY	Therapeutic or Preventive Procedure		NCI
C9545	PT	Cisplatin/Cyclophosphamide/Epirubicin		NCI
C9545	SY	CDDP/CTX/EPI		NCI
C9545	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9545	RO	chemotherapy regimen has component Cisplatin	NCI
C9545	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9545	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C154327	STY	Therapeutic or Preventive Procedure		NCI
C154327	PT	Vemurafenib/Cobimetinib Regimen		NCI
C154327	SY	Vemurafenib-Cobimetinib		NCI
C154327	SY	Vemurafenib Plus Cobimetinib		NCI
C154327	SY	Cobimetinib/Vemurafenib Regimen		NCI
C154327	SY	Vemurafenib + Cobimetinib		NCI
C154327	SY	Cobimetinib/Vemurafenib		NCI
C154327	CHD	Chemotherapy Regimen Used to Treat Melanoma	NCI
C154327	RO	chemotherapy regimen has component Vemurafenib	NCI
C154327	RO	chemotherapy regimen has component Cobimetinib	NCI
C9638	STY	Therapeutic or Preventive Procedure		NCI
C9638	PT	Doxorubicin/Fluoxymesterone/Thiotepa/Vinblastine		NCI
C9638	SY	TsAVbH		NCI
C9638	SY	VATH		NCI
C9638	SY	DOX/FXM/TSPA/VBL		NCI
C9638	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9638	RO	chemotherapy regimen has component Doxorubicin	NCI
C9638	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C9638	RO	chemotherapy regimen has component Thiotepa	NCI
C9638	RO	chemotherapy regimen has component Vinblastine	NCI
C10673	STY	Therapeutic or Preventive Procedure		NCI
C10673	PT	Cytarabine/Daunorubicin/Etoposide/Interleukin-3		NCI
C10673	SY	ARA-C/DNR/IL-3/VP-16		NCI
C10673	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10673	RO	chemotherapy regimen has component Cytarabine	NCI
C10673	RO	chemotherapy regimen has component Etoposide	NCI
C10673	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10673	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C136285	STY	Therapeutic or Preventive Procedure		NCI
C136285	PT	Ramucirumab/Docetaxel Regimen		NCI
C136285	SY	Ramucirumab/Docetaxel		NCI
C136285	SY	Ramucirumab-Docetaxel Regimen		NCI
C136285	SY	Ramucirumab-Docetaxel		NCI
C136285	SY	Cyramza/Docetaxel Regimen		NCI
C136285	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C136285	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C136285	RO	chemotherapy regimen has component Docetaxel	NCI
C136285	RO	chemotherapy regimen has component Ramucirumab	NCI
C10684	STY	Therapeutic or Preventive Procedure		NCI
C10684	PT	Dactinomycin/Doxorubicin/Etoposide/Ifosfamide/Vincristine		NCI
C10684	SY	DACT/DOX/IFF/VCR/VP-16		NCI
C10684	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10684	RO	chemotherapy regimen has component Dactinomycin	NCI
C10684	RO	chemotherapy regimen has component Doxorubicin	NCI
C10684	RO	chemotherapy regimen has component Etoposide	NCI
C10684	RO	chemotherapy regimen has component Ifosfamide	NCI
C10684	RO	chemotherapy regimen has component Vincristine	NCI
C11692	STY	Therapeutic or Preventive Procedure		NCI
C11692	PT	Carboplatin/Vinorelbine		NCI
C11692	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11692	RO	chemotherapy regimen has component Vinorelbine	NCI
C11692	RO	chemotherapy regimen has component Carboplatin	NCI
C10040	STY	Therapeutic or Preventive Procedure		NCI
C10040	PT	Fluorouracil/Leucovorin Calcium/Sargramostim		NCI
C10040	SY	CF/5-FU/GM-CSF		NCI
C10040	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10040	RO	chemotherapy regimen has component Fluorouracil	NCI
C10040	RO	chemotherapy regimen has component Sargramostim	NCI
C10040	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11375	STY	Therapeutic or Preventive Procedure		NCI
C11375	PT	Omeprazole/Porfimer Sodium		NCI
C11375	SY	DHE/OMEP		NCI
C11375	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11375	RO	chemotherapy regimen has component Omeprazole	NCI
C11375	RO	chemotherapy regimen has component Porfimer Sodium	NCI
C10274	STY	Therapeutic or Preventive Procedure		NCI
C10274	PT	Doxorubicin/Fluorouracil		NCI
C10274	SY	AFA		NCI
C10274	SY	DOX/5-FU		NCI
C10274	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10274	RO	chemotherapy regimen has component Doxorubicin	NCI
C10274	RO	chemotherapy regimen has component Fluorouracil	NCI
C10758	STY	Therapeutic or Preventive Procedure		NCI
C10758	PT	Carboplatin/Etoposide/Interleukin-6/Sargramostim		NCI
C10758	SY	CBDCA/GM-CSF/IL-6/VP-16		NCI
C10758	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10758	RO	chemotherapy regimen has component Etoposide	NCI
C10758	RO	chemotherapy regimen has component Carboplatin	NCI
C10758	RO	chemotherapy regimen has component Sargramostim	NCI
C10758	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C12187	STY	Therapeutic or Preventive Procedure		NCI
C12187	PT	Capecitabine/Celecoxib/ZD 1839		NCI
C12187	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12187	RO	chemotherapy regimen has component Celecoxib	NCI
C12187	RO	chemotherapy regimen has component Capecitabine	NCI
C12187	RO	chemotherapy regimen has component Gefitinib	NCI
C37744	STY	Therapeutic or Preventive Procedure		NCI
C37744	PT	Docetaxel/Fowlpox-PSA Vaccine/Sargramostim		NCI
C37744	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37744	RO	chemotherapy regimen has component Sargramostim	NCI
C37744	RO	chemotherapy regimen has component Docetaxel	NCI
C37744	RO	chemotherapy regimen has component Recombinant Fowlpox-Prostate Specific Antigen Vaccine	NCI
C10120	STY	Therapeutic or Preventive Procedure		NCI
C10120	PT	Buthionine Sulfoximine/Melphalan		NCI
C10120	SY	BSO/L-PAM		NCI
C10120	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10120	RO	chemotherapy regimen has component Melphalan	NCI
C10120	RO	chemotherapy regimen has component Buthionine Sulfoximine	NCI
C11686	STY	Therapeutic or Preventive Procedure		NCI
C11686	PT	HER-2-neu peptide vaccine/Montanide ISA-51		NCI
C11686	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11686	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11686	RO	chemotherapy regimen has component HER-2/neu Peptide Vaccine	NCI
C10615	STY	Therapeutic or Preventive Procedure		NCI
C10615	PT	Etoposide/Ifosfamide/Methotrexate/Vincristine		NCI
C10615	SY	IFF/MTX/VCR/VP-16		NCI
C10615	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10615	RO	chemotherapy regimen has component Etoposide	NCI
C10615	RO	chemotherapy regimen has component Ifosfamide	NCI
C10615	RO	chemotherapy regimen has component Methotrexate	NCI
C10615	RO	chemotherapy regimen has component Vincristine	NCI
C10544	STY	Therapeutic or Preventive Procedure		NCI
C10544	PT	Dipyridamole/Etoposide/Ketoconazole/Metronidazole		NCI
C10544	SY	DP/KCZ/METRO/VP-16		NCI
C10544	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10544	RO	chemotherapy regimen has component Dipyridamole	NCI
C10544	RO	chemotherapy regimen has component Etoposide	NCI
C10544	RO	chemotherapy regimen has component Ketoconazole	NCI
C10544	RO	chemotherapy regimen has component Metronidazole	NCI
C11648	STY	Therapeutic or Preventive Procedure		NCI
C11648	PT	Leflunomide/Mitoxantrone/Prednisone		NCI
C11648	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11648	RO	chemotherapy regimen has component Prednisone	NCI
C11648	RO	chemotherapy regimen has component Leflunomide	NCI
C11648	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C67174	STY	Therapeutic or Preventive Procedure		NCI
C67174	PT	COPP-ABV Regimen		NCI
C67174	SY	Cytoxan-Oncovin-Procarbazine-Prednisone/Adriamycin-Bleomycin-Vinblastine Regimen		NCI
C67174	SY	COPP-ABV		NCI
C67174	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67174	RO	chemotherapy regimen has component Bleomycin	NCI
C67174	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67174	RO	chemotherapy regimen has component Doxorubicin	NCI
C67174	RO	chemotherapy regimen has component Prednisone	NCI
C67174	RO	chemotherapy regimen has component Vinblastine	NCI
C67174	RO	chemotherapy regimen has component Vincristine	NCI
C67174	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C67174	RO	regimen has accepted use for disease Childhood Hodgkin Lymphoma	NCI
C11985	STY	Therapeutic or Preventive Procedure		NCI
C11985	PT	Cisplatin/Gemcitabine/Trastuzumab		NCI
C11985	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11985	RO	chemotherapy regimen has component Cisplatin	NCI
C11985	RO	chemotherapy regimen has component Trastuzumab	NCI
C11985	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11634	STY	Therapeutic or Preventive Procedure		NCI
C11634	PT	Doxorubicin/P-30 Protein		NCI
C11634	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11634	RO	chemotherapy regimen has component Doxorubicin	NCI
C11634	RO	chemotherapy regimen has component Ranpirnase	NCI
C12170	STY	Therapeutic or Preventive Procedure		NCI
C12170	PT	Cyclophosphamide/Dexamethasone/Doxorubicin/Leucovorin Calcium/Methotrexate/Vincristine		NCI
C12170	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12170	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12170	RO	chemotherapy regimen has component Dexamethasone	NCI
C12170	RO	chemotherapy regimen has component Doxorubicin	NCI
C12170	RO	chemotherapy regimen has component Methotrexate	NCI
C12170	RO	chemotherapy regimen has component Vincristine	NCI
C12170	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63621	STY	Therapeutic or Preventive Procedure		NCI
C63621	PT	CALGB 9251 Regimen		NCI
C63621	CHD	Chemotherapy Regimen Used to Treat Acute Lymphoblastic Leukemia	NCI
C63621	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63621	RO	chemotherapy regimen has component Mesna	NCI
C63621	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63621	RO	chemotherapy regimen has component Cytarabine	NCI
C63621	RO	chemotherapy regimen has component Dexamethasone	NCI
C63621	RO	chemotherapy regimen has component Doxorubicin	NCI
C63621	RO	chemotherapy regimen has component Etoposide	NCI
C63621	RO	chemotherapy regimen has component Ifosfamide	NCI
C63621	RO	chemotherapy regimen has component Methotrexate	NCI
C63621	RO	chemotherapy regimen has component Prednisone	NCI
C63621	RO	chemotherapy regimen has component Vincristine	NCI
C63621	RO	regimen has accepted use for disease Adult Burkitt Lymphoma	NCI
C63621	RO	regimen has accepted use for disease Adult Burkitt Leukemia	NCI
C10145	STY	Therapeutic or Preventive Procedure		NCI
C10145	PT	BCG/Cyclophosphamide/Interleukin-2		NCI
C10145	SY	BCG/CTX/IL-2		NCI
C10145	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10145	RO	chemotherapy regimen has component BCG Vaccine	NCI
C10145	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10145	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11155	STY	Therapeutic or Preventive Procedure		NCI
C11155	PT	Cytarabine/Etoposide/Thioguanine/Vincristine		NCI
C11155	SY	ARA-C/CTX/TG/VP-16		NCI
C11155	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11155	RO	chemotherapy regimen has component Cytarabine	NCI
C11155	RO	chemotherapy regimen has component Etoposide	NCI
C11155	RO	chemotherapy regimen has component Thioguanine	NCI
C11155	RO	chemotherapy regimen has component Vincristine	NCI
C9839	STY	Therapeutic or Preventive Procedure		NCI
C9839	PT	Cyclophosphamide/Fluorouracil/Menogaril		NCI
C9839	SY	CTX/5-FU/MEN		NCI
C9839	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9839	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9839	RO	chemotherapy regimen has component Fluorouracil	NCI
C9839	RO	chemotherapy regimen has component Menogaril	NCI
C10740	STY	Therapeutic or Preventive Procedure		NCI
C10740	PT	Etoposide/Mitoxantrone/Prednisone/Vincristine		NCI
C10740	SY	DHAD/PRED/VCR/VP-16		NCI
C10740	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10740	RO	chemotherapy regimen has component Etoposide	NCI
C10740	RO	chemotherapy regimen has component Prednisone	NCI
C10740	RO	chemotherapy regimen has component Vincristine	NCI
C10740	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11451	STY	Therapeutic or Preventive Procedure		NCI
C11451	PT	Cyclophosphamide/Prednisone/Sargramostim/Vincristine		NCI
C11451	SY	CTX/GM-CSF/PRED/VCR		NCI
C11451	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11451	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11451	RO	chemotherapy regimen has component Prednisone	NCI
C11451	RO	chemotherapy regimen has component Vincristine	NCI
C11451	RO	chemotherapy regimen has component Sargramostim	NCI
C63724	STY	Therapeutic or Preventive Procedure		NCI
C63724	PT	CAP Regimen		NCI
C63724	SY	Cytoxan-Adriamycin-Platinol Regimen		NCI
C63724	CHD	Chemotherapy Regimen Used to Treat Endometrial Carcinoma	NCI
C63724	CHD	Chemotherapy Regimen Used to Treat Malignant Mesothelioma	NCI
C63724	RO	chemotherapy regimen has component Cisplatin	NCI
C63724	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63724	RO	chemotherapy regimen has component Doxorubicin	NCI
C63724	RO	regimen has accepted use for disease Endometrial Carcinoma	NCI
C10876	STY	Therapeutic or Preventive Procedure		NCI
C10876	PT	Bleomycin/Cisplatin/Etoposide/Mitomycin		NCI
C10876	SY	BLEO/CDDP/MITO/VP-16		NCI
C10876	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10876	RO	chemotherapy regimen has component Mitomycin	NCI
C10876	RO	chemotherapy regimen has component Bleomycin	NCI
C10876	RO	chemotherapy regimen has component Cisplatin	NCI
C10876	RO	chemotherapy regimen has component Etoposide	NCI
C10939	STY	Therapeutic or Preventive Procedure		NCI
C10939	PT	Carboplatin/Etoposide/Mitoxantrone/Thiotepa		NCI
C10939	SY	CBDCA/DHAD/TSPA/VP-16		NCI
C10939	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10939	RO	chemotherapy regimen has component Etoposide	NCI
C10939	RO	chemotherapy regimen has component Thiotepa	NCI
C10939	RO	chemotherapy regimen has component Carboplatin	NCI
C10939	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10534	STY	Therapeutic or Preventive Procedure		NCI
C10534	PT	Carboplatin/Cisplatin/Cyclophosphamide/Filgrastim		NCI
C10534	SY	CBDCA/CDDP/CTX/G-CSF		NCI
C10534	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10534	RO	chemotherapy regimen has component Cisplatin	NCI
C10534	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10534	RO	chemotherapy regimen has component Carboplatin	NCI
C10534	RO	chemotherapy regimen has component Filgrastim	NCI
C9669	STY	Therapeutic or Preventive Procedure		NCI
C9669	PT	Cyclophosphamide/Cytarabine/Methotrexate/Vincristine		NCI
C9669	SY	COMLA		NCI
C9669	SY	ARA-C/CTX/MTX/VCR		NCI
C9669	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9669	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9669	RO	chemotherapy regimen has component Cytarabine	NCI
C9669	RO	chemotherapy regimen has component Methotrexate	NCI
C9669	RO	chemotherapy regimen has component Vincristine	NCI
C10087	STY	Therapeutic or Preventive Procedure		NCI
C10087	PT	Dacarbazine/Dactinomycin/Vincristine		NCI
C10087	SY	DACT/DTIC/VCR		NCI
C10087	SY	AVD		NCI
C10087	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10087	RO	chemotherapy regimen has component Dacarbazine	NCI
C10087	RO	chemotherapy regimen has component Dactinomycin	NCI
C10087	RO	chemotherapy regimen has component Vincristine	NCI
C9796	STY	Therapeutic or Preventive Procedure		NCI
C9796	PT	Cytarabine/Methotrexate/Methylprednisolone		NCI
C9796	SY	ARA-C/MePRDL/MTX		NCI
C9796	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9796	RO	chemotherapy regimen has component Cytarabine	NCI
C9796	RO	chemotherapy regimen has component Methotrexate	NCI
C9796	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11740	STY	Therapeutic or Preventive Procedure		NCI
C11740	PT	Fluorouracil/Gemcitabine/Oxaliplatin		NCI
C11740	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11740	RO	chemotherapy regimen has component Fluorouracil	NCI
C11740	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11740	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63423	STY	Therapeutic or Preventive Procedure		NCI
C63423	PT	Doxorubicin-Docetaxel Regimen		NCI
C63423	SY	Adriamycin-Taxotere Regimen		NCI
C63423	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63423	RO	chemotherapy regimen has component Doxorubicin	NCI
C63423	RO	chemotherapy regimen has component Docetaxel	NCI
C63423	RO	regimen has accepted use for disease Breast Carcinoma	NCI
C9908	STY	Therapeutic or Preventive Procedure		NCI
C9908	PT	Altretamine/Cyclophosphamide/Doxorubicin/Vincristine		NCI
C9908	SY	HEXA-VAC		NCI
C9908	SY	CTX/DOX/HMM/VCR		NCI
C9908	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9908	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9908	RO	chemotherapy regimen has component Doxorubicin	NCI
C9908	RO	chemotherapy regimen has component Altretamine	NCI
C9908	RO	chemotherapy regimen has component Vincristine	NCI
C12129	STY	Therapeutic or Preventive Procedure		NCI
C12129	PT	Paclitaxel/PS-341		NCI
C12129	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12129	RO	chemotherapy regimen has component Paclitaxel	NCI
C12129	RO	chemotherapy regimen has component Bortezomib	NCI
C10938	STY	Therapeutic or Preventive Procedure		NCI
C10938	PT	Prednisone/Thioguanine/Vincristine		NCI
C10938	SY	PRED/TG/VCR		NCI
C10938	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10938	RO	chemotherapy regimen has component Prednisone	NCI
C10938	RO	chemotherapy regimen has component Thioguanine	NCI
C10938	RO	chemotherapy regimen has component Vincristine	NCI
C67302	STY	Therapeutic or Preventive Procedure		NCI
C67302	PT	ID Rhabdomyosarcoma Regimen		NCI
C67302	SY	Ifosfamide-Doxorubicin Rhabdomyosarcoma Regimen		NCI
C67302	SY	ID Regimen		NCI
C67302	SY	IRS-IV ID Regimen		NCI
C67302	CHD	Chemotherapy Regimen Used to Treat Childhood Rhabdomyosarcoma	NCI
C67302	RO	chemotherapy regimen has component Doxorubicin	NCI
C67302	RO	chemotherapy regimen has component Ifosfamide	NCI
C67302	RO	regimen has accepted use for disease Childhood Rhabdomyosarcoma	NCI
C10718	STY	Therapeutic or Preventive Procedure		NCI
C10718	PT	Dexamethasone/Methotrexate/Thiotepa/Vincristine		NCI
C10718	SY	DM/MTX/TSPA/VCR		NCI
C10718	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10718	RO	chemotherapy regimen has component Dexamethasone	NCI
C10718	RO	chemotherapy regimen has component Methotrexate	NCI
C10718	RO	chemotherapy regimen has component Thiotepa	NCI
C10718	RO	chemotherapy regimen has component Vincristine	NCI
C9549	STY	Therapeutic or Preventive Procedure		NCI
C9549	PT	CHOP Regimen		NCI
C9549	SY	VACP		NCI
C9549	SY	COPA		NCI
C9549	SY	Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone Regimen		NCI
C9549	SY	VCAP		NCI
C9549	SY	Cyclophosphamide/Doxorubicin/Prednisone/Vincristine		NCI
C9549	SY	CAVP		NCI
C9549	SY	CHOP		NCI
C9549	SY	CTX/DOX/PRED/VCR		NCI
C9549	SY	ACOP		NCI
C9549	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C9549	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9549	RO	chemotherapy regimen has component Doxorubicin	NCI
C9549	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C9549	RO	chemotherapy regimen has component Prednisone	NCI
C9549	RO	chemotherapy regimen has component Vincristine	NCI
C9549	RO	concept in subset CTRP Terminology	NCI
C9549	RO	concept in subset CTRP Agent Terminology	NCI
C11416	STY	Therapeutic or Preventive Procedure		NCI
C11416	PT	Fluorouracil/Paclitaxel		NCI
C11416	SY	5-FU/TAX		NCI
C11416	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11416	RO	chemotherapy regimen has component Fluorouracil	NCI
C11416	RO	chemotherapy regimen has component Paclitaxel	NCI
C11808	STY	Therapeutic or Preventive Procedure		NCI
C11808	PT	Eflornithine/Sulindac		NCI
C11808	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11808	RO	chemotherapy regimen has component Eflornithine	NCI
C11808	RO	chemotherapy regimen has component Sulindac	NCI
C10637	STY	Therapeutic or Preventive Procedure		NCI
C10637	PT	Fluorouracil/Vinorelbine		NCI
C10637	SY	5-FU/VNB		NCI
C10637	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10637	RO	chemotherapy regimen has component Fluorouracil	NCI
C10637	RO	chemotherapy regimen has component Vinorelbine	NCI
C9590	STY	Therapeutic or Preventive Procedure		NCI
C9590	PT	Carmustine/Doxorubicin/Fluorouracil		NCI
C9590	SY	FAB		NCI
C9590	SY	BCNU/DOX/5-FU		NCI
C9590	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9590	RO	chemotherapy regimen has component Carmustine	NCI
C9590	RO	chemotherapy regimen has component Doxorubicin	NCI
C9590	RO	chemotherapy regimen has component Fluorouracil	NCI
C136276	STY	Therapeutic or Preventive Procedure		NCI
C136276	PT	Panobinostat/Carfilzomib Regimen		NCI
C136276	SY	Farydak/Kyprolis		NCI
C136276	SY	Panobinostat/Carfilzomib		NCI
C136276	SY	Panobinostat-Carfilzomib		NCI
C136276	SY	Panobinostat-Carfilzomib Regimen		NCI
C136276	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136276	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136276	RO	chemotherapy regimen has component Panobinostat	NCI
C136276	RO	chemotherapy regimen has component Carfilzomib	NCI
C37556	STY	Therapeutic or Preventive Procedure		NCI
C37556	PT	Bevacizumab/Doxorubicin		NCI
C37556	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37556	RO	chemotherapy regimen has component Doxorubicin	NCI
C37556	RO	chemotherapy regimen has component Bevacizumab	NCI
C10860	STY	Therapeutic or Preventive Procedure		NCI
C10860	PT	Cisplatin/Ifosfamide/Paclitaxel		NCI
C10860	SY	CDDP/IFF/TAX		NCI
C10860	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10860	RO	chemotherapy regimen has component Cisplatin	NCI
C10860	RO	chemotherapy regimen has component Ifosfamide	NCI
C10860	RO	chemotherapy regimen has component Paclitaxel	NCI
C10432	STY	Therapeutic or Preventive Procedure		NCI
C10432	PT	Carboplatin/Cyclophosphamide/Etanidazole		NCI
C10432	SY	CBDCA/CTX/SR-2508		NCI
C10432	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10432	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10432	RO	chemotherapy regimen has component Etanidazole	NCI
C10432	RO	chemotherapy regimen has component Carboplatin	NCI
C11248	STY	Therapeutic or Preventive Procedure		NCI
C11248	PT	Cisplatin/Mitomycin/Vincristine		NCI
C11248	SY	CDDP/MITO/VCR		NCI
C11248	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11248	RO	chemotherapy regimen has component Mitomycin	NCI
C11248	RO	chemotherapy regimen has component Cisplatin	NCI
C11248	RO	chemotherapy regimen has component Vincristine	NCI
C11748	STY	Therapeutic or Preventive Procedure		NCI
C11748	PT	Carboplatin/Epirubicin/Paclitaxel		NCI
C11748	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11748	RO	chemotherapy regimen has component Carboplatin	NCI
C11748	RO	chemotherapy regimen has component Paclitaxel	NCI
C11748	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C9707	STY	Therapeutic or Preventive Procedure		NCI
C9707	PT	Cyclophosphamide/Etoposide/Vincristine		NCI
C9707	SY	CTX/VCR/VP-16		NCI
C9707	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9707	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9707	RO	chemotherapy regimen has component Etoposide	NCI
C9707	RO	chemotherapy regimen has component Vincristine	NCI
C11577	STY	Therapeutic or Preventive Procedure		NCI
C11577	PT	Epirubicin/Fluorouracil		NCI
C11577	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11577	RO	chemotherapy regimen has component Fluorouracil	NCI
C11577	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C10420	STY	Therapeutic or Preventive Procedure		NCI
C10420	PT	Cisplatin/Cyclosporine		NCI
C10420	SY	CDDP/CYSP		NCI
C10420	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10420	RO	chemotherapy regimen has component Cisplatin	NCI
C10420	RO	chemotherapy regimen has component Cyclosporine	NCI
C9879	STY	Therapeutic or Preventive Procedure		NCI
C9879	PT	Cyclophosphamide/Interleukin-2/Tumor Necrosis Factor		NCI
C9879	SY	CTX/IL-2/TNF		NCI
C9879	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9879	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9879	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9879	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C11736	STY	Therapeutic or Preventive Procedure		NCI
C11736	PT	Keyhole Limpet Hemocyanin/Polysialic Acid/QS21		NCI
C11736	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11736	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C11736	RO	chemotherapy regimen has component Polysialic Acid	NCI
C11736	RO	chemotherapy regimen has component QS21	NCI
C10917	STY	Therapeutic or Preventive Procedure		NCI
C10917	PT	Cisplatin/Dacarbazine/Interleukin-2/Vinblastine		NCI
C10917	SY	CDDP/DTIC/IL-2/VBL		NCI
C10917	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10917	RO	chemotherapy regimen has component Cisplatin	NCI
C10917	RO	chemotherapy regimen has component Dacarbazine	NCI
C10917	RO	chemotherapy regimen has component Vinblastine	NCI
C10917	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10083	STY	Therapeutic or Preventive Procedure		NCI
C10083	PT	Cisplatin/Doxorubicin/Fluorouracil/Vinblastine		NCI
C10083	SY	CDDP/DOX/5-FU/VBL		NCI
C10083	SY	FUVAC		NCI
C10083	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10083	RO	chemotherapy regimen has component Cisplatin	NCI
C10083	RO	chemotherapy regimen has component Doxorubicin	NCI
C10083	RO	chemotherapy regimen has component Fluorouracil	NCI
C10083	RO	chemotherapy regimen has component Vinblastine	NCI
C10509	STY	Therapeutic or Preventive Procedure		NCI
C10509	PT	Cyclophosphamide/Dexamethasone/Doxorubicin/Methotrexate/Vincristine		NCI
C10509	SY	CTX/DM/DOX/MTX/VCR		NCI
C10509	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10509	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10509	RO	chemotherapy regimen has component Dexamethasone	NCI
C10509	RO	chemotherapy regimen has component Doxorubicin	NCI
C10509	RO	chemotherapy regimen has component Methotrexate	NCI
C10509	RO	chemotherapy regimen has component Vincristine	NCI
C9992	STY	Therapeutic or Preventive Procedure		NCI
C9992	PT	Doxorubicin/Ifosfamide/Lomustine		NCI
C9992	SY	CCNU/DOX/IFF		NCI
C9992	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9992	RO	chemotherapy regimen has component Doxorubicin	NCI
C9992	RO	chemotherapy regimen has component Ifosfamide	NCI
C9992	RO	chemotherapy regimen has component Lomustine	NCI
C12211	STY	Therapeutic or Preventive Procedure		NCI
C12211	PT	CpG 7909/Rituximab		NCI
C12211	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12211	RO	chemotherapy regimen has component Rituximab	NCI
C12211	RO	chemotherapy regimen has component Agatolimod Sodium	NCI
C9786	STY	Therapeutic or Preventive Procedure		NCI
C9786	PT	Fluorouracil/Methylmercaptopurine Riboside/PALA		NCI
C9786	SY	5-FU/MMPR/PALA		NCI
C9786	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9786	RO	chemotherapy regimen has component Fluorouracil	NCI
C9786	RO	chemotherapy regimen has component Methylmercaptopurine Riboside	NCI
C9786	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C155746	STY	Therapeutic or Preventive Procedure		NCI
C155746	PT	Modified FOLFOX6 Regimen		NCI
C155746	SY	Modified FOLFOX-6		NCI
C155746	SY	mFOLFOX-6		NCI
C155746	SY	Modified FOLFOX6		NCI
C155746	SY	Modified Folinic Acid-Fluorouracil-Oxaliplatin-6 Regimen		NCI
C155746	SY	mFOLFOX-6 Regimen		NCI
C155746	SY	mFOLFOX6		NCI
C155746	CHD	FOLFOX Regimen	NCI
C155746	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C155746	RO	chemotherapy regimen has component Fluorouracil	NCI
C155746	RO	chemotherapy regimen has component Oxaliplatin	NCI
C155746	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C155746	RO	concept in subset CTRP Terminology	NCI
C155746	RO	concept in subset CTRP Intervention Terminology	NCI
C10309	STY	Therapeutic or Preventive Procedure		NCI
C10309	PT	Quinidine/Vinblastine		NCI
C10309	SY	QND/VBL		NCI
C10309	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10309	RO	chemotherapy regimen has component Quinidine	NCI
C10309	RO	chemotherapy regimen has component Vinblastine	NCI
C12023	STY	Therapeutic or Preventive Procedure		NCI
C12023	PT	Carboplatin/Docetaxel/Trastuzumab		NCI
C12023	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12023	RO	chemotherapy regimen has component Carboplatin	NCI
C12023	RO	chemotherapy regimen has component Docetaxel	NCI
C12023	RO	chemotherapy regimen has component Trastuzumab	NCI
C104152	STY	Therapeutic or Preventive Procedure		NCI
C104152	PT	FOLFIRI-Cetuximab Regimen		NCI
C104152	SY	FOLFIRI-Erbitux Regimen		NCI
C104152	SY	Leucovorin-Fluorouracil-Irinotecan-Cetuximab Regimen		NCI
C104152	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C104152	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C104152	RO	chemotherapy regimen has component Fluorouracil	NCI
C104152	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C104152	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C104152	RO	chemotherapy regimen has component Cetuximab	NCI
C9830	STY	Therapeutic or Preventive Procedure		NCI
C9830	PT	Fluorouracil/Streptozocin		NCI
C9830	SY	5-FU/SZC		NCI
C9830	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9830	RO	chemotherapy regimen has component Fluorouracil	NCI
C9830	RO	chemotherapy regimen has component Streptozocin	NCI
C10697	STY	Therapeutic or Preventive Procedure		NCI
C10697	PT	Carboplatin/Estramustine/Etoposide		NCI
C10697	SY	CBDCA/EM/VP-16		NCI
C10697	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10697	RO	chemotherapy regimen has component Estramustine	NCI
C10697	RO	chemotherapy regimen has component Etoposide	NCI
C10697	RO	chemotherapy regimen has component Carboplatin	NCI
C12113	STY	Therapeutic or Preventive Procedure		NCI
C12113	PT	Carboplatin/PS-341		NCI
C12113	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12113	RO	chemotherapy regimen has component Carboplatin	NCI
C12113	RO	chemotherapy regimen has component Bortezomib	NCI
C10609	STY	Therapeutic or Preventive Procedure		NCI
C10609	PT	Fluorouracil/Leucovorin Calcium/Methylmercaptopurine Riboside/PALA		NCI
C10609	SY	CF/5-FU/MMPR/PALA		NCI
C10609	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10609	RO	chemotherapy regimen has component Fluorouracil	NCI
C10609	RO	chemotherapy regimen has component Methylmercaptopurine Riboside	NCI
C10609	RO	chemotherapy regimen has component Sparfosic Acid	NCI
C10609	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10503	STY	Therapeutic or Preventive Procedure		NCI
C10503	PT	Piroxantrone/Sargramostim		NCI
C10503	SY	GM-CSF/PXT		NCI
C10503	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10503	RO	chemotherapy regimen has component Piroxantrone	NCI
C10503	RO	chemotherapy regimen has component Sargramostim	NCI
C37774	STY	Therapeutic or Preventive Procedure		NCI
C37774	PT	Filgrastim/Monoclonal Antibody Hu1D10		NCI
C37774	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37774	RO	chemotherapy regimen has component Filgrastim	NCI
C37774	RO	chemotherapy regimen has component Apolizumab	NCI
C11875	STY	Therapeutic or Preventive Procedure		NCI
C11875	PT	Carboplatin/Doxorubicin HCl Liposome		NCI
C11875	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11875	RO	chemotherapy regimen has component Carboplatin	NCI
C11875	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C64365	STY	Therapeutic or Preventive Procedure		NCI
C64365	PT	A-CMF Regimen		NCI
C64365	SY	Adriamycin-Cytoxan-Methotrexate-Fluorouracil Regimen		NCI
C64365	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C64365	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C64365	RO	chemotherapy regimen has component Doxorubicin	NCI
C64365	RO	chemotherapy regimen has component Fluorouracil	NCI
C64365	RO	chemotherapy regimen has component Methotrexate	NCI
C64365	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C11836	STY	Therapeutic or Preventive Procedure		NCI
C11836	PT	Daunorubicin Liposomal/SU5416		NCI
C11836	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11836	RO	chemotherapy regimen has component Liposomal Daunorubicin Citrate	NCI
C11836	RO	chemotherapy regimen has component Semaxanib	NCI
C9758	STY	Therapeutic or Preventive Procedure		NCI
C9758	PT	Vitamin E/Fluorouracil		NCI
C9758	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9758	RO	chemotherapy regimen has component Fluorouracil	NCI
C9758	RO	chemotherapy regimen has component Vitamin E Compound	NCI
C10566	STY	Therapeutic or Preventive Procedure		NCI
C10566	PT	Fluorouracil/Leucovorin Calcium/Trimetrexate Glucuronate		NCI
C10566	SY	CF/5-FU/TMTX		NCI
C10566	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10566	RO	chemotherapy regimen has component Fluorouracil	NCI
C10566	RO	chemotherapy regimen has component Trimetrexate Glucuronate	NCI
C10566	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9553	STY	Therapeutic or Preventive Procedure		NCI
C9553	PT	Bleomycin/Cyclophosphamide/Fluorouracil/Methotrexate		NCI
C9553	SY	BLEO/CTX/5-FU/MTX		NCI
C9553	SY	CMF-BLEO		NCI
C9553	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9553	RO	chemotherapy regimen has component Bleomycin	NCI
C9553	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9553	RO	chemotherapy regimen has component Fluorouracil	NCI
C9553	RO	chemotherapy regimen has component Methotrexate	NCI
C138100	STY	Therapeutic or Preventive Procedure		NCI
C138100	PT	CEF Regimen		NCI
C138100	SY	Oral CTX/EPI/5-FU		NCI
C138100	SY	Fluorouracil/Epirubicin/Oral Cyclophosphamide		NCI
C138100	SY	Oral Cyclophosphamide/Epirubicin/Fluorouracil		NCI
C138100	SY	CEF		NCI
C138100	SY	Fluorouracil-Epirubicin- Oral Cytoxan Regimen		NCI
C138100	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138100	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138100	RO	chemotherapy regimen has component Fluorouracil	NCI
C138100	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C138100	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C10172	STY	Therapeutic or Preventive Procedure		NCI
C10172	PT	Cisplatin/Fluorouracil		NCI
C10172	SY	P-FU		NCI
C10172	SY	CDDP/5-FU		NCI
C10172	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10172	RO	chemotherapy regimen has component Cisplatin	NCI
C10172	RO	chemotherapy regimen has component Fluorouracil	NCI
C11293	STY	Therapeutic or Preventive Procedure		NCI
C11293	PT	Floxuridine/Leucovorin Calcium/Melphalan		NCI
C11293	SY	CF/FUDR/L-PAM		NCI
C11293	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11293	RO	chemotherapy regimen has component Floxuridine	NCI
C11293	RO	chemotherapy regimen has component Melphalan	NCI
C11293	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10231	STY	Therapeutic or Preventive Procedure		NCI
C10231	PT	Etoposide/Mitoguazone/Mitoxantrone/Vinblastine		NCI
C10231	SY	DHAD/MGBG/VBL/VP-16		NCI
C10231	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10231	RO	chemotherapy regimen has component Etoposide	NCI
C10231	RO	chemotherapy regimen has component Mitoguazone	NCI
C10231	RO	chemotherapy regimen has component Vinblastine	NCI
C10231	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11403	STY	Therapeutic or Preventive Procedure		NCI
C11403	PT	Filgrastim/Pegylated Recombinant Human Megakaryocyte Growth and Development Factor		NCI
C11403	SY	G-CSF/PEG-MGDF		NCI
C11403	SY	Filgrastim/Pegylated Recombinant Human Megakaryocyte Growth and developmentfactor		NCI
C11403	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11403	RO	chemotherapy regimen has component Filgrastim	NCI
C11403	RO	chemotherapy regimen has component PEG Recombinant Human Megakaryocyte Growth and Development Factor	NCI
C10297	STY	Therapeutic or Preventive Procedure		NCI
C10297	PT	Mechlorethamine/Prednisone/Procarbazine/Sargramostim/Vincristine		NCI
C10297	SY	GM-CSF/NM/PCB/PRED/VCR		NCI
C10297	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10297	RO	chemotherapy regimen has component Prednisone	NCI
C10297	RO	chemotherapy regimen has component Vincristine	NCI
C10297	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10297	RO	chemotherapy regimen has component Sargramostim	NCI
C10297	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C10675	STY	Therapeutic or Preventive Procedure		NCI
C10675	PT	Doxorubicin/Melphalan/Methylprednisolone		NCI
C10675	SY	DOX/L-PAM/MePRDL		NCI
C10675	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10675	RO	chemotherapy regimen has component Doxorubicin	NCI
C10675	RO	chemotherapy regimen has component Melphalan	NCI
C10675	RO	chemotherapy regimen has component Methylprednisolone	NCI
C9851	STY	Therapeutic or Preventive Procedure		NCI
C9851	PT	Dexamethasone/Methotrexate/Zidovudine		NCI
C9851	SY	DM/MTX/ZDV		NCI
C9851	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9851	RO	chemotherapy regimen has component Dexamethasone	NCI
C9851	RO	chemotherapy regimen has component Methotrexate	NCI
C9851	RO	chemotherapy regimen has component Zidovudine	NCI
C11823	STY	Therapeutic or Preventive Procedure		NCI
C11823	PT	Leucovorin Calcium/Methotrexate		NCI
C11823	SY	Methotrexate w/Leucovorin		NCI
C11823	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11823	RO	chemotherapy regimen has component Methotrexate	NCI
C11823	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63760	STY	Therapeutic or Preventive Procedure		NCI
C63760	PT	Docetaxel-Gemcitabine Regimen		NCI
C63760	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63760	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63760	RO	chemotherapy regimen has component Docetaxel	NCI
C63760	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C142863	STY	Therapeutic or Preventive Procedure		NCI
C142863	PT	Everolimus/Exemestane Regimen		NCI
C142863	SY	Everolimus-Exemestane		NCI
C142863	SY	Everolimus + Exemestane		NCI
C142863	SY	Afinitor/Aromasin		NCI
C142863	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C142863	RO	chemotherapy regimen has component Everolimus	NCI
C142863	RO	chemotherapy regimen has component Exemestane	NCI
C142863	RO	concept in subset CTRP Terminology	NCI
C142863	RO	concept in subset CTRP Agent Terminology	NCI
C10468	STY	Therapeutic or Preventive Procedure		NCI
C10468	PT	Asparaginase/Prednisone		NCI
C10468	SY	ASP/PRED		NCI
C10468	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10468	RO	chemotherapy regimen has component Asparaginase	NCI
C10468	RO	chemotherapy regimen has component Prednisone	NCI
C63487	STY	Therapeutic or Preventive Procedure		NCI
C63487	PT	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm		NCI
C63487	SY	Chemotherapy Regimen Used to Treat Testicular Cancer		NCI
C63487	CHD	Chemotherapy Regimen	NCI
C63487	PAR	JEB Regimen	NCI
C63487	PAR	POMB/ACE Regimen	NCI
C63487	PAR	TIP Regimen	NCI
C63487	PAR	BEP Regimen	NCI
C63487	PAR	EP Regimen	NCI
C63487	PAR	PVB Regimen	NCI
C63487	PAR	VIP Regimen	NCI
C63487	PAR	VeIP Regimen	NCI
C63487	PAR	PEB Regimen	NCI
C156368	STY	Therapeutic or Preventive Procedure		NCI
C156368	PT	Exemestane/Palbociclib Regimen		NCI
C156368	SY	Palbociclib/Exemestane		NCI
C156368	SY	Exemestane/Palbociclib		NCI
C156368	SY	Palbociclib/Exemestane Regimen		NCI
C156368	SY	Aromasin/Ibrance		NCI
C156368	SY	Exemestane-Palbociclib		NCI
C156368	SY	Palbociclib-Exemestane		NCI
C156368	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156368	RO	chemotherapy regimen has component Exemestane	NCI
C156368	RO	chemotherapy regimen has component Palbociclib	NCI
C11668	STY	Therapeutic or Preventive Procedure		NCI
C11668	PT	gp100 Antigen/Montanide ISA-51		NCI
C11668	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11668	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11668	RO	chemotherapy regimen has component gp100 Antigen	NCI
C37559	STY	Therapeutic or Preventive Procedure		NCI
C37559	PT	Bevacizumab/Imatinib Mesylate		NCI
C37559	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37559	RO	chemotherapy regimen has component Bevacizumab	NCI
C37559	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C11801	STY	Therapeutic or Preventive Procedure		NCI
C11801	PT	Cytarabine/Daunorubicin/Etoposide/Tretinoin		NCI
C11801	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11801	RO	chemotherapy regimen has component Cytarabine	NCI
C11801	RO	chemotherapy regimen has component Etoposide	NCI
C11801	RO	chemotherapy regimen has component Tretinoin	NCI
C11801	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10453	STY	Therapeutic or Preventive Procedure		NCI
C10453	PT	Cisplatin/Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone		NCI
C10453	SY	CDDP/CTX/5-FU/MTX/PRED		NCI
C10453	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10453	RO	chemotherapy regimen has component Cisplatin	NCI
C10453	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10453	RO	chemotherapy regimen has component Fluorouracil	NCI
C10453	RO	chemotherapy regimen has component Methotrexate	NCI
C10453	RO	chemotherapy regimen has component Prednisone	NCI
C12041	STY	Therapeutic or Preventive Procedure		NCI
C12041	PT	Cyclophosphamide/Dexamethasone/Etoposide/Imatinib Mesylate/Mercaptopurine/Methotrexate/Vincristine		NCI
C12041	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12041	RO	chemotherapy regimen has component Mercaptopurine	NCI
C12041	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12041	RO	chemotherapy regimen has component Dexamethasone	NCI
C12041	RO	chemotherapy regimen has component Etoposide	NCI
C12041	RO	chemotherapy regimen has component Methotrexate	NCI
C12041	RO	chemotherapy regimen has component Vincristine	NCI
C12041	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C11127	STY	Therapeutic or Preventive Procedure		NCI
C11127	PT	9-cis-Retinoic Acid/Tamoxifen		NCI
C11127	SY	9-CRA/TMX		NCI
C11127	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11127	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11127	RO	chemotherapy regimen has component Alitretinoin	NCI
C15637	STY	Therapeutic or Preventive Procedure		NCI
C15637	PT	gp100 Antigen/interleukin-2/MART-1 Antigen		NCI
C15637	SY	gp100/IL-2/MART-1		NCI
C15637	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15637	RO	chemotherapy regimen has component gp100 Antigen	NCI
C15637	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C15637	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11520	STY	Therapeutic or Preventive Procedure		NCI
C11520	PT	Carboplatin/Paclitaxel/PSC 833		NCI
C11520	SY	CBDCA/PSC 833/TAX		NCI
C11520	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11520	RO	chemotherapy regimen has component Carboplatin	NCI
C11520	RO	chemotherapy regimen has component Paclitaxel	NCI
C11520	RO	chemotherapy regimen has component Valspodar	NCI
C9739	STY	Therapeutic or Preventive Procedure		NCI
C9739	PT	Carboplatin/Cyclophosphamide/Vincristine		NCI
C9739	SY	CBDCA/CTX/VCR		NCI
C9739	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9739	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9739	RO	chemotherapy regimen has component Vincristine	NCI
C9739	RO	chemotherapy regimen has component Carboplatin	NCI
C11420	STY	Therapeutic or Preventive Procedure		NCI
C11420	PT	Anti-Thymocyte Globulin/Busulfan/Melphalan		NCI
C11420	SY	ATG/BU/L-PAM		NCI
C11420	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11420	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11420	RO	chemotherapy regimen has component Busulfan	NCI
C11420	RO	chemotherapy regimen has component Melphalan	NCI
C10084	STY	Therapeutic or Preventive Procedure		NCI
C10084	PT	Cytarabine/Doxorubicin/Mercaptopurine		NCI
C10084	SY	ARA-C/DOX/MP		NCI
C10084	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10084	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10084	RO	chemotherapy regimen has component Cytarabine	NCI
C10084	RO	chemotherapy regimen has component Doxorubicin	NCI
C11306	STY	Therapeutic or Preventive Procedure		NCI
C11306	PT	Calcium Carbonate/Cholecalciferol		NCI
C11306	SY	CACO3/VIT-D		NCI
C11306	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11306	RO	chemotherapy regimen has component Calcium Carbonate	NCI
C11306	RO	chemotherapy regimen has component D Vitamin	NCI
C9755	STY	Therapeutic or Preventive Procedure		NCI
C9755	PT	Epirubicin/Folinic Acid/Fluorouracil/Etoposide		NCI
C9755	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9755	RO	chemotherapy regimen has component Etoposide	NCI
C9755	RO	chemotherapy regimen has component Fluorouracil	NCI
C9755	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C9755	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9655	STY	Therapeutic or Preventive Procedure		NCI
C9655	PT	Cyclophosphamide/Prednisolone/Vincristine		NCI
C9655	SY	PentaCOP		NCI
C9655	SY	CTX/PRDL/VCR		NCI
C9655	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9655	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9655	RO	chemotherapy regimen has component Prednisolone	NCI
C9655	RO	chemotherapy regimen has component Vincristine	NCI
C63516	STY	Therapeutic or Preventive Procedure		NCI
C63516	PT	AD Regimen		NCI
C63516	SY	Adriamycin-DTIC Regimen		NCI
C63516	SY	Adriamycin-Dacarbazine Regimen		NCI
C63516	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C63516	RO	chemotherapy regimen has component Dacarbazine	NCI
C63516	RO	chemotherapy regimen has component Doxorubicin	NCI
C63516	RO	regimen has accepted use for disease Soft Tissue Sarcoma	NCI
C10887	STY	Therapeutic or Preventive Procedure		NCI
C10887	PT	Carboplatin/Cyclosporine/Paclitaxel		NCI
C10887	SY	CBDCA/CYSP/TAX		NCI
C10887	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10887	RO	chemotherapy regimen has component Cyclosporine	NCI
C10887	RO	chemotherapy regimen has component Carboplatin	NCI
C10887	RO	chemotherapy regimen has component Paclitaxel	NCI
C63500	STY	Therapeutic or Preventive Procedure		NCI
C63500	PT	DVD Regimen		NCI
C63500	SY	Doxil-Vincristine-Dexamethasone Regimen		NCI
C63500	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C63500	RO	chemotherapy regimen has component Dexamethasone	NCI
C63500	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C63500	RO	chemotherapy regimen has component Vincristine	NCI
C63500	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C37847	STY	Therapeutic or Preventive Procedure		NCI
C37847	PT	Prednisone/UCN-01		NCI
C37847	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37847	RO	chemotherapy regimen has component Prednisone	NCI
C37847	RO	chemotherapy regimen has component 7-Hydroxystaurosporine	NCI
C10209	STY	Therapeutic or Preventive Procedure		NCI
C10209	PT	Amifostine/Cisplatin/Interleukin-2		NCI
C10209	SY	CDDP/IL-2/WR-2721		NCI
C10209	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10209	RO	chemotherapy regimen has component Cisplatin	NCI
C10209	RO	chemotherapy regimen has component Amifostine	NCI
C10209	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C136278	STY	Therapeutic or Preventive Procedure		NCI
C136278	PT	Pomalidomide/Bortezomib/Dexamethasone Regimen		NCI
C136278	SY	Pomalidomide-Bortezomib-Dexamethasone		NCI
C136278	SY	Pomalidomide/Velcade/Dexamethasone Regimen		NCI
C136278	SY	Pomalidomide/Bortezomib/Dexamethasone		NCI
C136278	SY	Pomalidomide-Bortezomib-Dexamethasone Regimen		NCI
C136278	SY	PVD		NCI
C136278	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136278	RO	chemotherapy regimen has component Dexamethasone	NCI
C136278	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136278	RO	chemotherapy regimen has component Bortezomib	NCI
C136278	RO	chemotherapy regimen has component Pomalidomide	NCI
C63421	STY	Therapeutic or Preventive Procedure		NCI
C63421	PT	EC Breast Regimen		NCI
C63421	SY	Epirubicin-Cytoxan Regimen		NCI
C63421	SY	EC Regimen		NCI
C63421	SY	Epirubicin/Cyclophosphamide		NCI
C63421	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63421	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63421	RO	regimen has accepted use for disease Breast Carcinoma	NCI
C63421	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C10788	STY	Therapeutic or Preventive Procedure		NCI
C10788	PT	Busulfan/Thiotepa		NCI
C10788	SY	BU/TSPA		NCI
C10788	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10788	RO	chemotherapy regimen has component Busulfan	NCI
C10788	RO	chemotherapy regimen has component Thiotepa	NCI
C11728	STY	Therapeutic or Preventive Procedure		NCI
C11728	PT	Tamoxifen/Tretinoin		NCI
C11728	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11728	RO	chemotherapy regimen has component Tretinoin	NCI
C11728	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C12024	STY	Therapeutic or Preventive Procedure		NCI
C12024	PT	Cisplatin/Docetaxel/Trastuzumab		NCI
C12024	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12024	RO	chemotherapy regimen has component Cisplatin	NCI
C12024	RO	chemotherapy regimen has component Docetaxel	NCI
C12024	RO	chemotherapy regimen has component Trastuzumab	NCI
C12183	STY	Therapeutic or Preventive Procedure		NCI
C12183	PT	CpG 7909/Trastuzumab		NCI
C12183	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12183	RO	chemotherapy regimen has component Trastuzumab	NCI
C12183	RO	chemotherapy regimen has component Agatolimod Sodium	NCI
C11350	STY	Therapeutic or Preventive Procedure		NCI
C11350	PT	Docetaxel/Fluorouracil		NCI
C11350	SY	5-FU/TXT		NCI
C11350	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11350	RO	chemotherapy regimen has component Fluorouracil	NCI
C11350	RO	chemotherapy regimen has component Docetaxel	NCI
C11463	STY	Therapeutic or Preventive Procedure		NCI
C11463	PT	Etoposide/Idarubicin		NCI
C11463	SY	IDA/VP-16		NCI
C11463	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11463	RO	chemotherapy regimen has component Etoposide	NCI
C11463	RO	chemotherapy regimen has component Idarubicin	NCI
C9733	STY	Therapeutic or Preventive Procedure		NCI
C9733	PT	Cisplatin/Doxorubicin/Methotrexate		NCI
C9733	SY	CDDP/DOX/MTX		NCI
C9733	SY	AMDDP		NCI
C9733	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9733	RO	chemotherapy regimen has component Cisplatin	NCI
C9733	RO	chemotherapy regimen has component Doxorubicin	NCI
C9733	RO	chemotherapy regimen has component Methotrexate	NCI
C9832	STY	Therapeutic or Preventive Procedure		NCI
C9832	PT	Amsacrine/Etoposide		NCI
C9832	SY	AMSA/VP-16		NCI
C9832	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9832	RO	chemotherapy regimen has component Amsacrine	NCI
C9832	RO	chemotherapy regimen has component Etoposide	NCI
C37532	STY	Therapeutic or Preventive Procedure		NCI
C37532	PT	Anti-Thymocyte Globulin/Methotrexate/Mycophenolate Mofetil/Tacrolimus		NCI
C37532	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37532	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C37532	RO	chemotherapy regimen has component Methotrexate	NCI
C37532	RO	chemotherapy regimen has component Tacrolimus	NCI
C37532	RO	chemotherapy regimen has component Mycophenolate Mofetil	NCI
C9723	STY	Therapeutic or Preventive Procedure		NCI
C9723	PT	Cytarabine/Etoposide/Mitoxantrone		NCI
C9723	SY	ARA-C/DHAD/VP-16		NCI
C9723	SY	MCE		NCI
C9723	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9723	RO	chemotherapy regimen has component Cytarabine	NCI
C9723	RO	chemotherapy regimen has component Etoposide	NCI
C9723	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C138031	STY	Therapeutic or Preventive Procedure		NCI
C138031	PT	AC Followed by Pertuzumab/Trastuzumab/Docetaxel Regimen		NCI
C138031	SY	AC Followed by Docetaxel + Pertuzumab + Trastuzumab		NCI
C138031	SY	AC Followed by Pertuzumab + Trastuzumab + Docetaxel (SY); AC-Pertuzumab + Trastuzumab + Docetaxel		NCI
C138031	SY	AC Followed by Docetaxel + Trastuzumab + Pertuzumab		NCI
C138031	SY	Doxorubicin/Cyclophosphamide Followed by Pertuzumab/Trastuzumab/Docetaxel		NCI
C138031	SY	Doxorubicin/Cyclophosphamide Followed by Pertuzumab + Trastuzumab + Docetaxel		NCI
C138031	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138031	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138031	RO	chemotherapy regimen has component Doxorubicin	NCI
C138031	RO	chemotherapy regimen has component Docetaxel	NCI
C138031	RO	chemotherapy regimen has component Trastuzumab	NCI
C138031	RO	chemotherapy regimen has component Pertuzumab	NCI
C10015	STY	Therapeutic or Preventive Procedure		NCI
C10015	PT	Cisplatin/Dianhydrogalactitol/Doxorubicin		NCI
C10015	SY	DAP-II		NCI
C10015	SY	CDDP/DAG/DOX		NCI
C10015	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10015	RO	chemotherapy regimen has component Cisplatin	NCI
C10015	RO	chemotherapy regimen has component Dianhydrogalactitol	NCI
C10015	RO	chemotherapy regimen has component Doxorubicin	NCI
C10026	STY	Therapeutic or Preventive Procedure		NCI
C10026	PT	Chlorambucil/Prednisone/Vinblastine/Vincristine		NCI
C10026	SY	CLB/PRED/VBL/VCR		NCI
C10026	SY	LVVP		NCI
C10026	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10026	RO	chemotherapy regimen has component Chlorambucil	NCI
C10026	RO	chemotherapy regimen has component Prednisone	NCI
C10026	RO	chemotherapy regimen has component Vinblastine	NCI
C10026	RO	chemotherapy regimen has component Vincristine	NCI
C9971	STY	Therapeutic or Preventive Procedure		NCI
C9971	PT	Dacarbazine/Piritrexim		NCI
C9971	SY	DTIC/piritrexim		NCI
C9971	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9971	RO	chemotherapy regimen has component Dacarbazine	NCI
C9971	RO	chemotherapy regimen has component Piritrexim	NCI
C12005	STY	Therapeutic or Preventive Procedure		NCI
C12005	PT	Doxorubicin/Etoposide/Ifosfamide/Vincristine		NCI
C12005	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12005	RO	chemotherapy regimen has component Doxorubicin	NCI
C12005	RO	chemotherapy regimen has component Etoposide	NCI
C12005	RO	chemotherapy regimen has component Ifosfamide	NCI
C12005	RO	chemotherapy regimen has component Vincristine	NCI
C10166	STY	Therapeutic or Preventive Procedure		NCI
C10166	PT	Medroxyprogesterone/Mitomycin/Vinblastine		NCI
C10166	SY	MITO/MPA/VBL		NCI
C10166	SY	MVP		NCI
C10166	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10166	RO	chemotherapy regimen has component Mitomycin	NCI
C10166	RO	chemotherapy regimen has component Medroxyprogesterone	NCI
C10166	RO	chemotherapy regimen has component Vinblastine	NCI
C9648	STY	Therapeutic or Preventive Procedure		NCI
C9648	PT	Cyclophosphamide/Doxorubicin/Prednisolone/Vincristine		NCI
C9648	SY	CTX/DOX/PRDL/VCR		NCI
C9648	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9648	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9648	RO	chemotherapy regimen has component Doxorubicin	NCI
C9648	RO	chemotherapy regimen has component Prednisolone	NCI
C9648	RO	chemotherapy regimen has component Vincristine	NCI
C37641	STY	Therapeutic or Preventive Procedure		NCI
C37641	PT	Cetuximab/Doxorubicin		NCI
C37641	SY	Doxorubicin/Monoclonal Antibody C225		NCI
C37641	SY	DOX/MOAB C225		NCI
C37641	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37641	RO	chemotherapy regimen has component Doxorubicin	NCI
C37641	RO	chemotherapy regimen has component Cetuximab	NCI
C154272	STY	Therapeutic or Preventive Procedure		NCI
C154272	PT	Ipilimumab/Nivolumab Regimen		NCI
C154272	SY	Ipilimumab Plus Nivolumab		NCI
C154272	SY	Ipilimumab + Nivolumab		NCI
C154272	SY	Ipilimumab-Nivolumab		NCI
C154272	SY	Nivolumab/Ipilimumab		NCI
C154272	SY	Ipilimumab/Nivolumab		NCI
C154272	CHD	Chemotherapy Regimen Used to Treat Malignant Renal Neoplasm	NCI
C154272	CHD	Chemotherapy Regimen Used to Treat Melanoma	NCI
C154272	RO	chemotherapy regimen has component Ipilimumab	NCI
C154272	RO	chemotherapy regimen has component Nivolumab	NCI
C10500	STY	Therapeutic or Preventive Procedure		NCI
C10500	PT	Dacarbazine/Tamoxifen		NCI
C10500	SY	DTIC/TMX		NCI
C10500	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10500	RO	chemotherapy regimen has component Dacarbazine	NCI
C10500	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10861	STY	Pharmacologic Substance		NCI
C10861	PT	Cyclophosphamide/Doxorubicin/Etoposide/Prednisone		NCI
C10861	SY	PACE		NCI
C10861	SY	CTX/DOX/PRED/VP-16		NCI
C10861	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10861	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10861	RO	chemotherapy regimen has component Doxorubicin	NCI
C10861	RO	chemotherapy regimen has component Etoposide	NCI
C10861	RO	chemotherapy regimen has component Prednisone	NCI
C11472	STY	Therapeutic or Preventive Procedure		NCI
C11472	PT	Cyclophosphamide/Rituximab		NCI
C11472	SY	CTX/MOAB IDEC-C2B8		NCI
C11472	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11472	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11472	RO	chemotherapy regimen has component Rituximab	NCI
C10114	STY	Therapeutic or Preventive Procedure		NCI
C10114	PT	Biostim/Doxorubicin/Etoposide/Prednisone		NCI
C10114	SY	biostim/DOX/PRED/VP-16		NCI
C10114	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10114	RO	chemotherapy regimen has component Doxorubicin	NCI
C10114	RO	chemotherapy regimen has component Etoposide	NCI
C10114	RO	chemotherapy regimen has component Prednisone	NCI
C10114	RO	chemotherapy regimen has component Klebsiella pneumoniae Glycoprotein	NCI
C11256	STY	Therapeutic or Preventive Procedure		NCI
C11256	PT	Paclitaxel/VX-710		NCI
C11256	SY	TAX/VX-710		NCI
C11256	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11256	RO	chemotherapy regimen has component Paclitaxel	NCI
C11256	RO	chemotherapy regimen has component Biricodar Dicitrate	NCI
C10501	STY	Therapeutic or Preventive Procedure		NCI
C10501	PT	Amifostine/Cisplatin/Etoposide		NCI
C10501	SY	CDDP/VP-16/WR-2721		NCI
C10501	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10501	RO	chemotherapy regimen has component Cisplatin	NCI
C10501	RO	chemotherapy regimen has component Amifostine	NCI
C10501	RO	chemotherapy regimen has component Etoposide	NCI
C156372	STY	Therapeutic or Preventive Procedure		NCI
C156372	PT	Trastuzumab/Nab-paclitaxel Regimen		NCI
C156372	SY	Nab-paclitaxel/Trastuzumab		NCI
C156372	SY	Trastuzumab/Albumin-bound Paclitaxel Regimen		NCI
C156372	SY	Albumin-bound Paclitaxel/Trastuzumab		NCI
C156372	SY	Trastuzumab/Albumin-bound Paclitaxel		NCI
C156372	SY	Trastuzumab-Albumin-bound Paclitaxel		NCI
C156372	SY	Trastuzumab/Nab-paclitaxel		NCI
C156372	SY	Nab-paclitaxel-Trastuzumab		NCI
C156372	SY	Trastuzumab-Nab-paclitaxel		NCI
C156372	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156372	RO	chemotherapy regimen has component Trastuzumab	NCI
C156372	RO	chemotherapy regimen has component Nab-paclitaxel	NCI
C10094	STY	Therapeutic or Preventive Procedure		NCI
C10094	PT	Bleomycin/Prednisone/Vincristine		NCI
C10094	SY	BLEO/PRED/VCR		NCI
C10094	SY	BOP		NCI
C10094	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10094	RO	chemotherapy regimen has component Bleomycin	NCI
C10094	RO	chemotherapy regimen has component Prednisone	NCI
C10094	RO	chemotherapy regimen has component Vincristine	NCI
C9741	STY	Therapeutic or Preventive Procedure		NCI
C9741	PT	Docetaxol/Etoposide		NCI
C9741	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9741	RO	chemotherapy regimen has component Etoposide	NCI
C9741	RO	chemotherapy regimen has component Docetaxel	NCI
C67304	STY	Therapeutic or Preventive Procedure		NCI
C67304	PT	CE-PE Childhood Kidney Cancer Regimen		NCI
C67304	SY	Cyclophosphamide-Etoposide/Carboplatin-Etoposide Regimen		NCI
C67304	SY	POG 9445 Regimen		NCI
C67304	SY	CCG 4921 Regimen		NCI
C67304	SY	CE-PE Pediatric Kidney Cancer Regimen		NCI
C67304	CHD	Chemotherapy Regimen Used to Treat Childhood Malignant Renal Neoplasm	NCI
C67304	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67304	RO	chemotherapy regimen has component Etoposide	NCI
C67304	RO	chemotherapy regimen has component Carboplatin	NCI
C67304	RO	regimen has accepted use for disease Recurrent Kidney Wilms Tumor	NCI
C10829	STY	Therapeutic or Preventive Procedure		NCI
C10829	PT	Carboplatin/Interleukin-6/Sargramostim		NCI
C10829	SY	CBDCA/GM-CSF/IL-6		NCI
C10829	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10829	RO	chemotherapy regimen has component Carboplatin	NCI
C10829	RO	chemotherapy regimen has component Sargramostim	NCI
C10829	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C10896	STY	Therapeutic or Preventive Procedure		NCI
C10896	PT	Goserelin/Tamoxifen		NCI
C10896	SY	TMX/ZDX		NCI
C10896	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10896	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10896	RO	chemotherapy regimen has component Goserelin	NCI
C9816	STY	Therapeutic or Preventive Procedure		NCI
C9816	PT	Fluorouracil/Methotrexate/Mitomycin		NCI
C9816	SY	5-FU/MITO/MTX		NCI
C9816	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9816	RO	chemotherapy regimen has component Mitomycin	NCI
C9816	RO	chemotherapy regimen has component Fluorouracil	NCI
C9816	RO	chemotherapy regimen has component Methotrexate	NCI
C11269	STY	Therapeutic or Preventive Procedure		NCI
C11269	PT	Cyclophosphamide/Filgrastim/Vincristine		NCI
C11269	SY	CTX/G-CSF/VCR		NCI
C11269	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11269	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11269	RO	chemotherapy regimen has component Vincristine	NCI
C11269	RO	chemotherapy regimen has component Filgrastim	NCI
C11925	STY	Therapeutic or Preventive Procedure		NCI
C11925	PT	Cyclophosphamide/Doxorubicin/Etoposide/Rituximab/Vincristine		NCI
C11925	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11925	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11925	RO	chemotherapy regimen has component Doxorubicin	NCI
C11925	RO	chemotherapy regimen has component Etoposide	NCI
C11925	RO	chemotherapy regimen has component Vincristine	NCI
C11925	RO	chemotherapy regimen has component Rituximab	NCI
C9686	STY	Therapeutic or Preventive Procedure		NCI
C9686	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Vincristine		NCI
C9686	SY	CDDP/CTX/DOX/VCR/VP-16		NCI
C9686	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9686	RO	chemotherapy regimen has component Cisplatin	NCI
C9686	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9686	RO	chemotherapy regimen has component Doxorubicin	NCI
C9686	RO	chemotherapy regimen has component Etoposide	NCI
C9686	RO	chemotherapy regimen has component Vincristine	NCI
C15586	STY	Therapeutic or Preventive Procedure		NCI
C15586	PT	Bispecific Antibody 520C9XH22/Interferon Gamma		NCI
C15586	SY	BsAb 520C9xH22/IFN-G		NCI
C15586	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15586	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C15586	RO	chemotherapy regimen has component Bispecific Antibody MDX-H210	NCI
C12071	STY	Therapeutic or Preventive Procedure		NCI
C12071	PT	Cyclophosphamide/Doxorubicin/Tirapazamine		NCI
C12071	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12071	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12071	RO	chemotherapy regimen has component Doxorubicin	NCI
C12071	RO	chemotherapy regimen has component Tirapazamine	NCI
C10064	STY	Therapeutic or Preventive Procedure		NCI
C10064	PT	Cyclophosphamide/Fluorouracil/Leucovorin Calcium/Mitoxantrone		NCI
C10064	SY	CF/CTX/DHAD/5-FU		NCI
C10064	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10064	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10064	RO	chemotherapy regimen has component Fluorouracil	NCI
C10064	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10064	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63490	STY	Therapeutic or Preventive Procedure		NCI
C63490	PT	TIP Regimen		NCI
C63490	SY	Taxol-Ifosfamide-Platinol Regimen		NCI
C63490	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C63490	CHD	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm	NCI
C63490	RO	chemotherapy regimen has component Mesna	NCI
C63490	RO	chemotherapy regimen has component Cisplatin	NCI
C63490	RO	chemotherapy regimen has component Ifosfamide	NCI
C63490	RO	chemotherapy regimen has component Paclitaxel	NCI
C63490	RO	regimen has accepted use for disease Malignant Testicular Germ Cell Tumor	NCI
C63490	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C11733	STY	Therapeutic or Preventive Procedure		NCI
C11733	PT	Docetaxel/Oxaliplatin		NCI
C11733	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11733	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11733	RO	chemotherapy regimen has component Docetaxel	NCI
C11604	STY	Therapeutic or Preventive Procedure		NCI
C11604	PT	Amifostine/Cisplatin/Fluorouracil/Paclitaxel		NCI
C11604	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11604	RO	chemotherapy regimen has component Cisplatin	NCI
C11604	RO	chemotherapy regimen has component Amifostine	NCI
C11604	RO	chemotherapy regimen has component Fluorouracil	NCI
C11604	RO	chemotherapy regimen has component Paclitaxel	NCI
C11053	STY	Therapeutic or Preventive Procedure		NCI
C11053	PT	Interferon Alfa/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C11053	SY	IFN-A/MP/MTX/PRED/VCR		NCI
C11053	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11053	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11053	RO	chemotherapy regimen has component Methotrexate	NCI
C11053	RO	chemotherapy regimen has component Prednisone	NCI
C11053	RO	chemotherapy regimen has component Vincristine	NCI
C11053	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10078	STY	Therapeutic or Preventive Procedure		NCI
C10078	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Sargramostim		NCI
C10078	SY	CTX/DOX/5-FU/GM-CSF		NCI
C10078	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10078	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10078	RO	chemotherapy regimen has component Doxorubicin	NCI
C10078	RO	chemotherapy regimen has component Fluorouracil	NCI
C10078	RO	chemotherapy regimen has component Sargramostim	NCI
C12011	STY	Therapeutic or Preventive Procedure		NCI
C12011	PT	Dexamethasone/Isotretinoin		NCI
C12011	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12011	RO	chemotherapy regimen has component Dexamethasone	NCI
C12011	RO	chemotherapy regimen has component Isotretinoin	NCI
C37757	STY	Therapeutic or Preventive Procedure		NCI
C37757	PT	Edrecolomab/Sargramostim		NCI
C37757	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37757	RO	chemotherapy regimen has component Sargramostim	NCI
C37757	RO	chemotherapy regimen has component Edrecolomab	NCI
C11160	STY	Therapeutic or Preventive Procedure		NCI
C11160	PT	Asparaginase/Cyclophosphamide/Daunorubicin/Dexamethasone/Vincristine		NCI
C11160	SY	ASP/CTX/DM/DNR/VCR		NCI
C11160	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11160	RO	chemotherapy regimen has component Asparaginase	NCI
C11160	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11160	RO	chemotherapy regimen has component Dexamethasone	NCI
C11160	RO	chemotherapy regimen has component Vincristine	NCI
C11160	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10294	STY	Therapeutic or Preventive Procedure		NCI
C10294	PT	Amphotericin B/Flucytosine		NCI
C10294	SY	Amphotericin B/5-FC		NCI
C10294	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10294	RO	chemotherapy regimen has component Amphotericin B	NCI
C10294	RO	chemotherapy regimen has component Flucytosine	NCI
C63619	STY	Therapeutic or Preventive Procedure		NCI
C63619	PT	LMB-84 Regimen		NCI
C63619	SY	LMB-89 Group B		NCI
C63619	SY	LMB-81		NCI
C63619	CHD	Chemotherapy Regimen Used to Treat Acute Lymphoblastic Leukemia	NCI
C63619	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63619	RO	chemotherapy regimen has component Cytarabine	NCI
C63619	RO	chemotherapy regimen has component Doxorubicin	NCI
C63619	RO	chemotherapy regimen has component Methotrexate	NCI
C63619	RO	chemotherapy regimen has component Prednisone	NCI
C63619	RO	chemotherapy regimen has component Vincristine	NCI
C63619	RO	regimen has accepted use for disease Adult Burkitt Lymphoma	NCI
C63619	RO	regimen has accepted use for disease Adult Burkitt Leukemia	NCI
C37743	STY	Therapeutic or Preventive Procedure		NCI
C37743	PT	Docetaxel/Fowlpox-PSA Vaccine		NCI
C37743	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37743	RO	chemotherapy regimen has component Docetaxel	NCI
C37743	RO	chemotherapy regimen has component Recombinant Fowlpox-Prostate Specific Antigen Vaccine	NCI
C11283	STY	Therapeutic or Preventive Procedure		NCI
C11283	PT	Cisplatin/Docetaxel/Gemcitabine		NCI
C11283	SY	CDDP/dFdC/TXT		NCI
C11283	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11283	RO	chemotherapy regimen has component Cisplatin	NCI
C11283	RO	chemotherapy regimen has component Docetaxel	NCI
C11283	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63593	STY	Therapeutic or Preventive Procedure		NCI
C63593	PT	FOLFIRI Regimen		NCI
C63593	SY	Folinic Acid-Fluorouracil-Irinotecan Regimen		NCI
C63593	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63593	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63593	RO	chemotherapy regimen has component Fluorouracil	NCI
C63593	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C63593	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63593	RO	concept in subset CTRP Terminology	NCI
C63593	RO	concept in subset CTRP Agent Terminology	NCI
C10452	STY	Therapeutic or Preventive Procedure		NCI
C10452	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Prednisone		NCI
C10452	SY	CTX/DOX/5-FU/MTX/PRED		NCI
C10452	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10452	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10452	RO	chemotherapy regimen has component Doxorubicin	NCI
C10452	RO	chemotherapy regimen has component Fluorouracil	NCI
C10452	RO	chemotherapy regimen has component Methotrexate	NCI
C10452	RO	chemotherapy regimen has component Prednisone	NCI
C12177	STY	Therapeutic or Preventive Procedure		NCI
C12177	PT	Beta-Glucan/Monoclonal Antibody 3F8		NCI
C12177	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12177	RO	chemotherapy regimen has component Monoclonal Antibody 3F8	NCI
C12177	RO	chemotherapy regimen has component Beta-Glucan	NCI
C154269	STY	Therapeutic or Preventive Procedure		NCI
C154269	PT	Bevacizumab/Everolimus Regimen		NCI
C154269	SY	Bevacizumab Plus Everolimus		NCI
C154269	SY	Bevacizumab + Everolimus		NCI
C154269	SY	Everolimus/Bevacizumab		NCI
C154269	SY	Bevacizumab/Everolimus		NCI
C154269	SY	Bevacizumab-Everolimus		NCI
C154269	CHD	Chemotherapy Regimen Used to Treat Malignant Renal Neoplasm	NCI
C154269	RO	chemotherapy regimen has component Everolimus	NCI
C154269	RO	chemotherapy regimen has component Bevacizumab	NCI
C11952	STY	Therapeutic or Preventive Procedure		NCI
C11952	PT	Thalidomide/Topotecan		NCI
C11952	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11952	RO	chemotherapy regimen has component Thalidomide	NCI
C11952	RO	chemotherapy regimen has component Topotecan	NCI
C62634	STY	Therapeutic or Preventive Procedure		NCI
C62634	PT	Chemotherapy Regimen		NCI
C62634	CHD	Chemotherapy Regimen or Agent Combination	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Acute Lymphoblastic Leukemia	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Bladder Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Cervical Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Chronic Lymphocytic Leukemia	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Endometrial Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Esophageal Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Malignant Mesothelioma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Malignant Renal Neoplasm	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Melanoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Primary Malignant Neoplasm of Liver	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Gestational Trophoblastic Tumor	NCI
C62634	PAR	Busulfan/Melphalan Regimen	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Retinoblastoma	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Central Nervous System Neoplasm	NCI
C62634	PAR	Chemotherapy Regimen Used to Treat Malignant Neuroendocrine and Adrenal Neoplasm	NCI
C10312	STY	Therapeutic or Preventive Procedure		NCI
C10312	PT	Acyclovir/Zidovudine		NCI
C10312	SY	ACV/ZDV		NCI
C10312	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10312	RO	chemotherapy regimen has component Acyclovir	NCI
C10312	RO	chemotherapy regimen has component Zidovudine	NCI
C10163	STY	Therapeutic or Preventive Procedure		NCI
C10163	PT	Cyclophosphamide/Prednisone		NCI
C10163	SY	CTX/PRED		NCI
C10163	SY	CP		NCI
C10163	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10163	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10163	RO	chemotherapy regimen has component Prednisone	NCI
C11878	STY	Therapeutic or Preventive Procedure		NCI
C11878	PT	QS21/RAS peptide cancer vaccine		NCI
C11878	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11878	RO	chemotherapy regimen has component QS21	NCI
C11878	RO	chemotherapy regimen has component RAS Peptide Cancer Vaccine	NCI
C11803	STY	Therapeutic or Preventive Procedure		NCI
C11803	PT	Cytarabine/Fludarabine/Tretinoin		NCI
C11803	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11803	RO	chemotherapy regimen has component Cytarabine	NCI
C11803	RO	chemotherapy regimen has component Tretinoin	NCI
C11803	RO	chemotherapy regimen has component Fludarabine	NCI
C12056	STY	Therapeutic or Preventive Procedure		NCI
C12056	PT	Folic Acid/Lometrexol/Paclitaxel		NCI
C12056	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12056	RO	chemotherapy regimen has component Folic Acid	NCI
C12056	RO	chemotherapy regimen has component Lometrexol	NCI
C12056	RO	chemotherapy regimen has component Paclitaxel	NCI
C37713	STY	Therapeutic or Preventive Procedure		NCI
C37713	PT	Cytarabine/Etoposide/Gemtuzumab Ozogamicin/Idarubicin		NCI
C37713	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37713	RO	chemotherapy regimen has component Cytarabine	NCI
C37713	RO	chemotherapy regimen has component Etoposide	NCI
C37713	RO	chemotherapy regimen has component Idarubicin	NCI
C37713	RO	chemotherapy regimen has component Gemtuzumab Ozogamicin	NCI
C37716	STY	Therapeutic or Preventive Procedure		NCI
C37716	PT	Cytarabine/Gemtuzumab Ozogamicin/Idarubicin		NCI
C37716	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37716	RO	chemotherapy regimen has component Cytarabine	NCI
C37716	RO	chemotherapy regimen has component Idarubicin	NCI
C37716	RO	chemotherapy regimen has component Gemtuzumab Ozogamicin	NCI
C11144	STY	Therapeutic or Preventive Procedure		NCI
C11144	PT	Dexrazoxane/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C11144	SY	ADR-529/DOX/MP/MTX/PRED/VCR		NCI
C11144	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11144	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11144	RO	chemotherapy regimen has component Doxorubicin	NCI
C11144	RO	chemotherapy regimen has component Methotrexate	NCI
C11144	RO	chemotherapy regimen has component Prednisone	NCI
C11144	RO	chemotherapy regimen has component Vincristine	NCI
C11144	RO	chemotherapy regimen has component Dexrazoxane	NCI
C9532	STY	Therapeutic or Preventive Procedure		NCI
C9532	PT	Carboplatin/Cyclophosphamide		NCI
C9532	SY	CBDCA/Cyclophosphamide		NCI
C9532	SY	CBDCA/CTX		NCI
C9532	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9532	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9532	RO	chemotherapy regimen has component Carboplatin	NCI
C63379	STY	Therapeutic or Preventive Procedure		NCI
C63379	PT	CAE Regimen		NCI
C63379	SY	ACE Regimen		NCI
C63379	SY	Cytoxan-Adriamycin-Etoposide Regimen		NCI
C63379	CHD	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C63379	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63379	RO	chemotherapy regimen has component Doxorubicin	NCI
C63379	RO	chemotherapy regimen has component Etoposide	NCI
C63379	RO	regimen has accepted use for disease Lung Small Cell Carcinoma	NCI
C9554	STY	Therapeutic or Preventive Procedure		NCI
C9554	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Methotrexate/Vincristine		NCI
C9554	SY	CTX/DOX/5-FU/MTX/VCR		NCI
C9554	SY	VAFMC		NCI
C9554	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9554	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9554	RO	chemotherapy regimen has component Doxorubicin	NCI
C9554	RO	chemotherapy regimen has component Fluorouracil	NCI
C9554	RO	chemotherapy regimen has component Methotrexate	NCI
C9554	RO	chemotherapy regimen has component Vincristine	NCI
C9574	STY	Therapeutic or Preventive Procedure		NCI
C9574	PT	Cyclophosphamide/Prednisone/Procarbazine/Vinblastine		NCI
C9574	SY	CVPP		NCI
C9574	SY	CTX/PCB/PRED/VBL		NCI
C9574	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9574	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9574	RO	chemotherapy regimen has component Prednisone	NCI
C9574	RO	chemotherapy regimen has component Vinblastine	NCI
C9574	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11050	STY	Therapeutic or Preventive Procedure		NCI
C11050	PT	Fluorouracil/Interferon Alfa/Interferon Gamma/Leucovorin Calcium		NCI
C11050	SY	CF/5-FU/IFN-A/IFN-G		NCI
C11050	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11050	RO	chemotherapy regimen has component Fluorouracil	NCI
C11050	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C11050	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11050	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10964	STY	Therapeutic or Preventive Procedure		NCI
C10964	PT	Estramustine/Vinorelbine		NCI
C10964	SY	EM/VNB		NCI
C10964	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10964	RO	chemotherapy regimen has component Estramustine	NCI
C10964	RO	chemotherapy regimen has component Vinorelbine	NCI
C11687	STY	Therapeutic or Preventive Procedure		NCI
C11687	PT	Bcr-Abl Peptide Vaccine/QS21		NCI
C11687	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11687	RO	chemotherapy regimen has component QS21	NCI
C11687	RO	chemotherapy regimen has component BCR-ABL Peptide Vaccine	NCI
C11450	STY	Therapeutic or Preventive Procedure		NCI
C11450	PT	Adenovirus 5-CD40-L Vector/Interleukin-2		NCI
C11450	SY	AD-CD40-L/IL-2		NCI
C11450	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11450	RO	chemotherapy regimen has component Adenovirus 5-CD40 Ligand	NCI
C11450	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C15574	STY	Therapeutic or Preventive Procedure		NCI
C15574	PT	interleukin-3/interleukin-6		NCI
C15574	SY	IL-3/IL-6		NCI
C15574	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15574	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C15574	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C63485	STY	Therapeutic or Preventive Procedure		NCI
C63485	PT	Docetaxel-Estramustine Regimen		NCI
C63485	SY	Docetaxel/Estramustine Regimen		NCI
C63485	SY	Docetaxel-Estramustine		NCI
C63485	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C63485	RO	chemotherapy regimen has component Estramustine	NCI
C63485	RO	chemotherapy regimen has component Docetaxel	NCI
C63485	RO	regimen has accepted use for disease Metastatic Prostate Carcinoma	NCI
C12037	STY	Therapeutic or Preventive Procedure		NCI
C12037	PT	Calcium Carbonate/Cholecalciferol/Zoledronate		NCI
C12037	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12037	RO	chemotherapy regimen has component Calcium Carbonate	NCI
C12037	RO	chemotherapy regimen has component Zoledronic Acid	NCI
C12037	RO	chemotherapy regimen has component D Vitamin	NCI
C10866	STY	Therapeutic or Preventive Procedure		NCI
C10866	PT	Bleomycin/Doxorubicin/Etoposide/Prednisolone/Vincristine		NCI
C10866	SY	BLEO/DOX/PRDL/VCR/VP-16		NCI
C10866	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10866	RO	chemotherapy regimen has component Bleomycin	NCI
C10866	RO	chemotherapy regimen has component Doxorubicin	NCI
C10866	RO	chemotherapy regimen has component Etoposide	NCI
C10866	RO	chemotherapy regimen has component Prednisolone	NCI
C10866	RO	chemotherapy regimen has component Vincristine	NCI
C11171	STY	Therapeutic or Preventive Procedure		NCI
C11171	PT	Cyclophosphamide/Cyclosporine/Cytarabine/Daunorubicin		NCI
C11171	SY	ARA-C/CTX/CYSP/DNR		NCI
C11171	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11171	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11171	RO	chemotherapy regimen has component Cyclosporine	NCI
C11171	RO	chemotherapy regimen has component Cytarabine	NCI
C11171	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C156262	STY	Therapeutic or Preventive Procedure		NCI
C156262	PT	Liposomal Doxorubicin HCl/Carboplatin Regimen		NCI
C156262	SY	Doxil/Carboplatin Regimen		NCI
C156262	SY	Carboplatin-Doxil Regimen		NCI
C156262	SY	Doxil-Carboplatin		NCI
C156262	SY	Doxil/Carboplatin		NCI
C156262	SY	Liposomal Doxorubicin/Carboplatin Regimen		NCI
C156262	SY	Carboplatin-Doxil		NCI
C156262	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C156262	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C156262	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C156262	RO	regimen has accepted use for disease Ovarian Carcinoma	NCI
C10416	STY	Therapeutic or Preventive Procedure		NCI
C10416	PT	Cytarabine/Methylprednisolone/Mitoxantrone/Vincristine		NCI
C10416	SY	ARA-C/DHAD/MePRDL/VCR		NCI
C10416	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10416	RO	chemotherapy regimen has component Cytarabine	NCI
C10416	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10416	RO	chemotherapy regimen has component Vincristine	NCI
C10416	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37783	STY	Therapeutic or Preventive Procedure		NCI
C37783	PT	Fluorouracil/Irinotecan/Leucovorin Calcium/Monoclonal Antibody ABX-EGF		NCI
C37783	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37783	RO	chemotherapy regimen has component Fluorouracil	NCI
C37783	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37783	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37783	RO	chemotherapy regimen has component Panitumumab	NCI
C10547	STY	Therapeutic or Preventive Procedure		NCI
C10547	PT	Cyclosporine/Dipyridamole/Etoposide/Ketoconazole/Metronidazole/Quinidine/Tamoxifen		NCI
C10547	SY	CYSP/DP/KCZ/METRO/QND/TMX/VP-16		NCI
C10547	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10547	RO	chemotherapy regimen has component Cyclosporine	NCI
C10547	RO	chemotherapy regimen has component Dipyridamole	NCI
C10547	RO	chemotherapy regimen has component Etoposide	NCI
C10547	RO	chemotherapy regimen has component Ketoconazole	NCI
C10547	RO	chemotherapy regimen has component Metronidazole	NCI
C10547	RO	chemotherapy regimen has component Quinidine	NCI
C10547	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10048	STY	Therapeutic or Preventive Procedure		NCI
C10048	PT	Cyclophosphamide/Dexrazoxane/Doxorubicin/Vincristine		NCI
C10048	SY	ADR-529/CTX/DOX/VCR		NCI
C10048	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10048	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10048	RO	chemotherapy regimen has component Doxorubicin	NCI
C10048	RO	chemotherapy regimen has component Vincristine	NCI
C10048	RO	chemotherapy regimen has component Dexrazoxane	NCI
C11944	STY	Therapeutic or Preventive Procedure		NCI
C11944	PT	Autologous Dendritic Cells/Autologous Tumor Cell Vaccine/Sargramostim		NCI
C11944	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11944	RO	chemotherapy regimen has component Sargramostim	NCI
C11944	RO	chemotherapy regimen has component Autologous Tumor Cell Vaccine	NCI
C11944	RO	chemotherapy regimen has component Therapeutic Autologous Dendritic Cells	NCI
C10884	STY	Therapeutic or Preventive Procedure		NCI
C10884	PT	Carboplatin/Etoposide/Ifosfamide/Paclitaxel		NCI
C10884	SY	CBDCA/IFF/TAX/VP-16		NCI
C10884	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10884	RO	chemotherapy regimen has component Etoposide	NCI
C10884	RO	chemotherapy regimen has component Ifosfamide	NCI
C10884	RO	chemotherapy regimen has component Carboplatin	NCI
C10884	RO	chemotherapy regimen has component Paclitaxel	NCI
C15597	STY	Therapeutic or Preventive Procedure		NCI
C15597	PT	Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen		NCI
C15597	SY	IFA/IL-12/MART-1		NCI
C15597	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15597	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C15597	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C15597	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11595	STY	Therapeutic or Preventive Procedure		NCI
C11595	PT	IDEC-In2B8/Rituximab		NCI
C11595	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11595	RO	chemotherapy regimen has component Rituximab	NCI
C11595	RO	chemotherapy regimen has component Indium In-111 Ibritumomab Tiuxetan	NCI
C11940	STY	Therapeutic or Preventive Procedure		NCI
C11940	PT	Fludarabine/Thalidomide		NCI
C11940	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11940	RO	chemotherapy regimen has component Thalidomide	NCI
C11940	RO	chemotherapy regimen has component Fludarabine	NCI
C11747	STY	Therapeutic or Preventive Procedure		NCI
C11747	PT	Cisplatin/Raltitrexed		NCI
C11747	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11747	RO	chemotherapy regimen has component Cisplatin	NCI
C11747	RO	chemotherapy regimen has component Raltitrexed	NCI
C9706	STY	Therapeutic or Preventive Procedure		NCI
C9706	PT	Fluorouracil/Leucovorin Calcium/Mitoxantrone		NCI
C9706	SY	CF/DHAD/5-FU		NCI
C9706	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9706	RO	chemotherapy regimen has component Fluorouracil	NCI
C9706	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9706	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10239	STY	Therapeutic or Preventive Procedure		NCI
C10239	PT	Cytarabine/Etoposide		NCI
C10239	SY	ARA-C/VP-16		NCI
C10239	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10239	RO	chemotherapy regimen has component Cytarabine	NCI
C10239	RO	chemotherapy regimen has component Etoposide	NCI
C11572	STY	Therapeutic or Preventive Procedure		NCI
C11572	PT	Interferon Alfa/Bexarotene		NCI
C11572	SY	IFN-A/LGD 1069		NCI
C11572	SY	Bexarotene/Interferon Alfa		NCI
C11572	SY	interferon alfa/LGD 1069		NCI
C11572	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11572	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11572	RO	chemotherapy regimen has component Bexarotene	NCI
C9609	STY	Therapeutic or Preventive Procedure		NCI
C9609	PT	Bleomycin/Cisplatin/Methotrexate		NCI
C9609	SY	PBM		NCI
C9609	SY	BLEO/CDDP/MTX		NCI
C9609	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9609	RO	chemotherapy regimen has component Bleomycin	NCI
C9609	RO	chemotherapy regimen has component Cisplatin	NCI
C9609	RO	chemotherapy regimen has component Methotrexate	NCI
C10384	STY	Therapeutic or Preventive Procedure		NCI
C10384	PT	Cisplatin/Etoposide/Ifosfamide/Sargramostim		NCI
C10384	SY	CDDP/GM-CSF/IFF/VP-16		NCI
C10384	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10384	RO	chemotherapy regimen has component Cisplatin	NCI
C10384	RO	chemotherapy regimen has component Etoposide	NCI
C10384	RO	chemotherapy regimen has component Ifosfamide	NCI
C10384	RO	chemotherapy regimen has component Sargramostim	NCI
C37826	STY	Therapeutic or Preventive Procedure		NCI
C37826	PT	Marijuana/Morphine		NCI
C37826	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37826	RO	chemotherapy regimen has component Marijuana	NCI
C37826	RO	chemotherapy regimen has component Morphine Sulfate	NCI
C37690	STY	Therapeutic or Preventive Procedure		NCI
C37690	PT	Cyclophosphamide/Etoposide/Imatinib Mesylate/Leucovorin Calcium/Methotrexate		NCI
C37690	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37690	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37690	RO	chemotherapy regimen has component Etoposide	NCI
C37690	RO	chemotherapy regimen has component Methotrexate	NCI
C37690	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37690	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C37462	STY	Therapeutic or Preventive Procedure		NCI
C37462	PT	Autologous Lymphocytes/gp100 Antigen/Interleukin-12/MAGE-3/Melan-A/NA17-A Antigen		NCI
C37462	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37462	RO	chemotherapy regimen has component gp100 Antigen	NCI
C37462	RO	chemotherapy regimen has component NA17-A Antigen	NCI
C37462	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C37462	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C37462	RO	chemotherapy regimen has component Therapeutic Autologous Lymphocytes	NCI
C37462	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10880	STY	Therapeutic or Preventive Procedure		NCI
C10880	PT	Cytarabine/Filgrastim/Idarubicin/Interleukin-6		NCI
C10880	SY	ARA-C/G-CSF/IDA/IL-6		NCI
C10880	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10880	RO	chemotherapy regimen has component Cytarabine	NCI
C10880	RO	chemotherapy regimen has component Idarubicin	NCI
C10880	RO	chemotherapy regimen has component Filgrastim	NCI
C10880	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C37522	STY	Therapeutic or Preventive Procedure		NCI
C37522	PT	Amoxicillin-Clavulanate Potassium/Ciprofloxacin		NCI
C37522	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37522	RO	chemotherapy regimen has component Ciprofloxacin	NCI
C37522	RO	chemotherapy regimen has component Amoxicillin-Clavulanate Potassium	NCI
C9819	STY	Therapeutic or Preventive Procedure		NCI
C9819	PT	Cyclophosphamide/Doxorubicin/Interferon alfa/Interleukin-2/Lymphokine-Activated Killer Cells		NCI
C9819	SY	CTX/DOX/IFN-A/IL-2/LAK		NCI
C9819	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9819	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9819	RO	chemotherapy regimen has component Doxorubicin	NCI
C9819	RO	chemotherapy regimen has component Lymphokine-Activated Killer Cells	NCI
C9819	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9728	STY	Therapeutic or Preventive Procedure		NCI
C9728	PT	Carboplatin/Doxorubicin/Etoposide		NCI
C9728	SY	CBDCA/DOX/VP-16		NCI
C9728	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9728	RO	chemotherapy regimen has component Doxorubicin	NCI
C9728	RO	chemotherapy regimen has component Etoposide	NCI
C9728	RO	chemotherapy regimen has component Carboplatin	NCI
C67486	STY	Therapeutic or Preventive Procedure		NCI
C67486	PT	ST-HD-86 Regimen		NCI
C67486	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67486	RO	chemotherapy regimen has component Bleomycin	NCI
C67486	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67486	RO	chemotherapy regimen has component Dacarbazine	NCI
C67486	RO	chemotherapy regimen has component Doxorubicin	NCI
C67486	RO	chemotherapy regimen has component Etoposide	NCI
C67486	RO	chemotherapy regimen has component Ifosfamide	NCI
C67486	RO	chemotherapy regimen has component Prednisone	NCI
C67486	RO	chemotherapy regimen has component Vinblastine	NCI
C67486	RO	chemotherapy regimen has component Vincristine	NCI
C67486	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10406	STY	Therapeutic or Preventive Procedure		NCI
C10406	PT	Carboplatin/Etoposide/Melphalan		NCI
C10406	SY	CBDCA/L-PAM/VP-16		NCI
C10406	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10406	RO	chemotherapy regimen has component Etoposide	NCI
C10406	RO	chemotherapy regimen has component Melphalan	NCI
C10406	RO	chemotherapy regimen has component Carboplatin	NCI
C10085	STY	Therapeutic or Preventive Procedure		NCI
C10085	PT	Altretamine/Cyclophosphamide/Doxorubicin		NCI
C10085	SY	CTX/DOX/HMM		NCI
C10085	SY	HAC		NCI
C10085	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10085	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10085	RO	chemotherapy regimen has component Doxorubicin	NCI
C10085	RO	chemotherapy regimen has component Altretamine	NCI
C10546	STY	Therapeutic or Preventive Procedure		NCI
C10546	PT	Dipyridamole/Etoposide/Ketoconazole/Metronidazole/Quinidine/Tamoxifen		NCI
C10546	SY	DP/KCZ/METRO/QND/TMX/VP-16		NCI
C10546	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10546	RO	chemotherapy regimen has component Dipyridamole	NCI
C10546	RO	chemotherapy regimen has component Etoposide	NCI
C10546	RO	chemotherapy regimen has component Ketoconazole	NCI
C10546	RO	chemotherapy regimen has component Metronidazole	NCI
C10546	RO	chemotherapy regimen has component Quinidine	NCI
C10546	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11421	STY	Therapeutic or Preventive Procedure		NCI
C11421	PT	Busulfan/Melphalan/Methylprednisolone		NCI
C11421	SY	BU/L-PAM/MePRDL		NCI
C11421	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11421	RO	chemotherapy regimen has component Busulfan	NCI
C11421	RO	chemotherapy regimen has component Melphalan	NCI
C11421	RO	chemotherapy regimen has component Methylprednisolone	NCI
C63371	STY	Therapeutic or Preventive Procedure		NCI
C63371	PT	EVA Regimen		NCI
C63371	SY	Etoposide-Vincristine-Adriamycin Regimen		NCI
C63371	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C63371	RO	chemotherapy regimen has component Doxorubicin	NCI
C63371	RO	chemotherapy regimen has component Etoposide	NCI
C63371	RO	chemotherapy regimen has component Vinblastine	NCI
C63371	RO	regimen has accepted use for disease Recurrent Adult Hodgkin Lymphoma	NCI
C63371	RO	regimen has accepted use for disease Refractory Hodgkin Lymphoma	NCI
C11854	STY	Therapeutic or Preventive Procedure		NCI
C11854	PT	BMS-188797/Carboplatin		NCI
C11854	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11854	RO	chemotherapy regimen has component Carboplatin	NCI
C11854	RO	chemotherapy regimen has component BMS-188797	NCI
C10371	STY	Therapeutic or Preventive Procedure		NCI
C10371	PT	Busulfan/Mitoxantrone		NCI
C10371	SY	BU/DHAD		NCI
C10371	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10371	RO	chemotherapy regimen has component Busulfan	NCI
C10371	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11850	STY	Therapeutic or Preventive Procedure		NCI
C11850	PT	Cyclophosphamide/Cytarabine/Topotecan		NCI
C11850	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11850	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11850	RO	chemotherapy regimen has component Cytarabine	NCI
C11850	RO	chemotherapy regimen has component Topotecan	NCI
C12151	STY	Therapeutic or Preventive Procedure		NCI
C12151	PT	Alemtuzumab/Cyclophosphamide/Fludarabine		NCI
C12151	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12151	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12151	RO	chemotherapy regimen has component Fludarabine	NCI
C12151	RO	chemotherapy regimen has component Alemtuzumab	NCI
C11348	STY	Therapeutic or Preventive Procedure		NCI
C11348	PT	Cytarabine/Daunorubicin/Etoposide/PSC 833		NCI
C11348	SY	ARA-C/DNR/PSC 833/VP-16		NCI
C11348	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11348	RO	chemotherapy regimen has component Cytarabine	NCI
C11348	RO	chemotherapy regimen has component Etoposide	NCI
C11348	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11348	RO	chemotherapy regimen has component Valspodar	NCI
C67205	STY	Therapeutic or Preventive Procedure		NCI
C67205	PT	DCTER Regimen		NCI
C67205	SY	COG 2891 Study Regimen		NCI
C67205	CHD	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia	NCI
C67205	RO	chemotherapy regimen has component Cytarabine	NCI
C67205	RO	chemotherapy regimen has component Daunorubicin	NCI
C67205	RO	chemotherapy regimen has component Dexamethasone	NCI
C67205	RO	chemotherapy regimen has component Etoposide	NCI
C67205	RO	chemotherapy regimen has component Thioguanine	NCI
C67205	RO	regimen has accepted use for disease Childhood Acute Myeloid Leukemia	NCI
C10769	STY	Therapeutic or Preventive Procedure		NCI
C10769	PT	Edatrexate/Leucovorin Calcium		NCI
C10769	SY	CF/EDAM		NCI
C10769	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10769	RO	chemotherapy regimen has component Edatrexate	NCI
C10769	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C15617	STY	Therapeutic or Preventive Procedure		NCI
C15617	PT	Monoclonal Antibody 17-1A/sargramostim		NCI
C15617	SY	GM-CSF/MOAB 17-1A		NCI
C15617	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15617	RO	chemotherapy regimen has component Sargramostim	NCI
C15617	RO	chemotherapy regimen has component Edrecolomab	NCI
C11780	STY	Therapeutic or Preventive Procedure		NCI
C11780	PT	AFP Gene Hepatocellular Carcinoma Vaccine/Montanide ISA-51		NCI
C11780	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11780	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11780	RO	chemotherapy regimen has component AFP Gene Hepatocellular Carcinoma Vaccine	NCI
C12001	STY	Therapeutic or Preventive Procedure		NCI
C12001	PT	Carmustine/Cytarabine/Dexamethasone/Etoposide/Melphalan		NCI
C12001	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12001	RO	chemotherapy regimen has component Carmustine	NCI
C12001	RO	chemotherapy regimen has component Cytarabine	NCI
C12001	RO	chemotherapy regimen has component Dexamethasone	NCI
C12001	RO	chemotherapy regimen has component Etoposide	NCI
C12001	RO	chemotherapy regimen has component Melphalan	NCI
C11408	STY	Therapeutic or Preventive Procedure		NCI
C11408	PT	Filgrastim/Promegapoietin		NCI
C11408	SY	G-CSF/PMP		NCI
C11408	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11408	RO	chemotherapy regimen has component Filgrastim	NCI
C11408	RO	chemotherapy regimen has component Promegapoietin	NCI
C10918	STY	Therapeutic or Preventive Procedure		NCI
C10918	PT	Cytarabine/Filgrastim/Idarubicin		NCI
C10918	SY	ARA-C/G-CSF/IDA		NCI
C10918	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10918	RO	chemotherapy regimen has component Cytarabine	NCI
C10918	RO	chemotherapy regimen has component Idarubicin	NCI
C10918	RO	chemotherapy regimen has component Filgrastim	NCI
C10254	STY	Therapeutic or Preventive Procedure		NCI
C10254	PT	Etoposide/Mitoxantrone/Thiotepa		NCI
C10254	SY	DHAD/TSPA/VP-16		NCI
C10254	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10254	RO	chemotherapy regimen has component Etoposide	NCI
C10254	RO	chemotherapy regimen has component Thiotepa	NCI
C10254	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9890	STY	Therapeutic or Preventive Procedure		NCI
C9890	PT	Etoposide/Ifosfamide/Sargramostim		NCI
C9890	SY	GM-CSF/IFF/VP-16		NCI
C9890	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9890	RO	chemotherapy regimen has component Etoposide	NCI
C9890	RO	chemotherapy regimen has component Ifosfamide	NCI
C9890	RO	chemotherapy regimen has component Sargramostim	NCI
C9750	STY	Therapeutic or Preventive Procedure		NCI
C9750	PT	Lovastatin/Sulindac		NCI
C9750	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9750	RO	chemotherapy regimen has component Lovastatin	NCI
C9750	RO	chemotherapy regimen has component Sulindac	NCI
C11217	STY	Therapeutic or Preventive Procedure		NCI
C11217	PT	Aminoglutethimide/Hydrocortisone		NCI
C11217	SY	AGT/HC		NCI
C11217	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11217	RO	chemotherapy regimen has component Aminoglutethimide	NCI
C11217	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C10194	STY	Therapeutic or Preventive Procedure		NCI
C10194	PT	Bleomycin/Mitomycin/Vindesine		NCI
C10194	SY	BLEO/DAVA/MITO		NCI
C10194	SY	BEM		NCI
C10194	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10194	RO	chemotherapy regimen has component Mitomycin	NCI
C10194	RO	chemotherapy regimen has component Bleomycin	NCI
C10194	RO	chemotherapy regimen has component Vindesine	NCI
C37494	STY	Therapeutic or Preventive Procedure		NCI
C37494	PT	AG-858/Imatinib Mesylate		NCI
C37494	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37494	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C37494	RO	chemotherapy regimen has component Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858	NCI
C11949	STY	Therapeutic or Preventive Procedure		NCI
C11949	PT	Bryostatin 1/Sargramostim		NCI
C11949	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11949	RO	chemotherapy regimen has component Bryostatin 1	NCI
C11949	RO	chemotherapy regimen has component Sargramostim	NCI
C11272	STY	Therapeutic or Preventive Procedure		NCI
C11272	PT	Cisplatin/Paclitaxel/Tirapazamine		NCI
C11272	SY	CDDP/SR-4233/TAX		NCI
C11272	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11272	RO	chemotherapy regimen has component Cisplatin	NCI
C11272	RO	chemotherapy regimen has component Paclitaxel	NCI
C11272	RO	chemotherapy regimen has component Tirapazamine	NCI
C11391	STY	Therapeutic or Preventive Procedure		NCI
C11391	PT	Bryostatin 1/Interleukin-2/Ionomycin		NCI
C11391	SY	BRYO/IL-2/IONO		NCI
C11391	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11391	RO	chemotherapy regimen has component Ionomycin	NCI
C11391	RO	chemotherapy regimen has component Bryostatin 1	NCI
C11391	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10407	STY	Therapeutic or Preventive Procedure		NCI
C10407	PT	Carmustine/Vincristine		NCI
C10407	SY	BCNU/VCR		NCI
C10407	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10407	RO	chemotherapy regimen has component Carmustine	NCI
C10407	RO	chemotherapy regimen has component Vincristine	NCI
C11538	STY	Therapeutic or Preventive Procedure		NCI
C11538	PT	Asparaginase/Cytarabine/Dexamethasone/Etoposide/Mitoxantrone		NCI
C11538	SY	ARA-C/ASP/DHAD/DM/VP-16		NCI
C11538	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11538	RO	chemotherapy regimen has component Asparaginase	NCI
C11538	RO	chemotherapy regimen has component Cytarabine	NCI
C11538	RO	chemotherapy regimen has component Dexamethasone	NCI
C11538	RO	chemotherapy regimen has component Etoposide	NCI
C11538	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10199	STY	Therapeutic or Preventive Procedure		NCI
C10199	PT	Carmustine/Cyclophosphamide/Doxorubicin/Melphalan/Prednisone/Vincristine		NCI
C10199	SY	BCNU/CTX/DOX/L-PAM/PRED/VCR		NCI
C10199	SY	VMCPP alternating with VBAPP		NCI
C10199	SY	VMCPP/VBAPP		NCI
C10199	SY	VBAPP/VMCPP		NCI
C10199	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10199	RO	chemotherapy regimen has component Carmustine	NCI
C10199	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10199	RO	chemotherapy regimen has component Doxorubicin	NCI
C10199	RO	chemotherapy regimen has component Melphalan	NCI
C10199	RO	chemotherapy regimen has component Prednisone	NCI
C10199	RO	chemotherapy regimen has component Vincristine	NCI
C12121	STY	Therapeutic or Preventive Procedure		NCI
C12121	PT	Doxorubicin Hcl Liposome/Ifosfamide		NCI
C12121	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12121	RO	chemotherapy regimen has component Ifosfamide	NCI
C12121	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C9543	STY	Therapeutic or Preventive Procedure		NCI
C9543	PT	Cyclophosphamide/Lomustine/Vincristine		NCI
C9543	SY	CCNU/CTX/VCR		NCI
C9543	SY	CCV		NCI
C9543	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9543	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9543	RO	chemotherapy regimen has component Lomustine	NCI
C9543	RO	chemotherapy regimen has component Vincristine	NCI
C12039	STY	Therapeutic or Preventive Procedure		NCI
C12039	PT	Cyclophosphamide/Daunorubicin/Dexamethasone/Imatinib Mesylate/Methotrexate/Pegaspargase/Vincristine		NCI
C12039	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12039	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12039	RO	chemotherapy regimen has component Dexamethasone	NCI
C12039	RO	chemotherapy regimen has component Methotrexate	NCI
C12039	RO	chemotherapy regimen has component Vincristine	NCI
C12039	RO	chemotherapy regimen has component Pegaspargase	NCI
C12039	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C12039	RO	chemotherapy regimen has component Imatinib Mesylate	NCI
C11933	STY	Therapeutic or Preventive Procedure		NCI
C11933	PT	DC-Chol Liposomes/EGFR Antisense DNA		NCI
C11933	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11933	RO	chemotherapy regimen has component EGFR Antisense DNA	NCI
C11933	RO	chemotherapy regimen has component DC-Cholesterol Liposome	NCI
C12064	STY	Therapeutic or Preventive Procedure		NCI
C12064	PT	Fluorouracil/Leucovorin Calcium/Oxaliplatin/ZD 1839		NCI
C12064	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12064	RO	chemotherapy regimen has component Fluorouracil	NCI
C12064	RO	chemotherapy regimen has component Oxaliplatin	NCI
C12064	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12064	RO	chemotherapy regimen has component Gefitinib	NCI
C9678	STY	Therapeutic or Preventive Procedure		NCI
C9678	PT	Fluorouracil/Methotrexate/Mitoxantrone		NCI
C9678	SY	NMF		NCI
C9678	SY	MMF		NCI
C9678	SY	DHAD/5-FU/MTX		NCI
C9678	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9678	RO	chemotherapy regimen has component Fluorouracil	NCI
C9678	RO	chemotherapy regimen has component Methotrexate	NCI
C9678	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10702	STY	Therapeutic or Preventive Procedure		NCI
C10702	PT	Bicalutamide/Goserelin		NCI
C10702	SY	CDX/ZDX		NCI
C10702	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10702	RO	chemotherapy regimen has component Goserelin	NCI
C10702	RO	chemotherapy regimen has component Bicalutamide	NCI
C156211	STY	Therapeutic or Preventive Procedure		NCI
C156211	PT	Carboplatin/Paclitaxel/Nivolumab Regimen		NCI
C156211	SY	Carboplatin/Paclitaxel/Opdivo		NCI
C156211	SY	Carboplatin/Paclitaxel/Nivolumab		NCI
C156211	SY	Carboplatin-Paclitaxel-Nivolumab		NCI
C156211	SY	Carboplatin/Paclitaxel Plus Nivolumab		NCI
C156211	SY	Carboplatin-Paclitaxel-Nivolumab Regimen		NCI
C156211	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C156211	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C156211	RO	chemotherapy regimen has component Carboplatin	NCI
C156211	RO	chemotherapy regimen has component Paclitaxel	NCI
C156211	RO	chemotherapy regimen has component Nivolumab	NCI
C10150	STY	Therapeutic or Preventive Procedure		NCI
C10150	PT	Chlorambucil/Etoposide/Lomustine		NCI
C10150	SY	CEC		NCI
C10150	SY	CCNU/CLB/VP-16		NCI
C10150	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10150	RO	chemotherapy regimen has component Chlorambucil	NCI
C10150	RO	chemotherapy regimen has component Etoposide	NCI
C10150	RO	chemotherapy regimen has component Lomustine	NCI
C11767	STY	Therapeutic or Preventive Procedure		NCI
C11767	PT	Oblimersen/Paclitaxel		NCI
C11767	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11767	RO	chemotherapy regimen has component Paclitaxel	NCI
C11767	RO	chemotherapy regimen has component Oblimersen	NCI
C11208	STY	Therapeutic or Preventive Procedure		NCI
C11208	PT	Carboplatin/Cyclophosphamide/Cyclosporine/Paclitaxel		NCI
C11208	SY	CBDCA/CTX/CYSP/TAX		NCI
C11208	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11208	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11208	RO	chemotherapy regimen has component Cyclosporine	NCI
C11208	RO	chemotherapy regimen has component Carboplatin	NCI
C11208	RO	chemotherapy regimen has component Paclitaxel	NCI
C10180	STY	Therapeutic or Preventive Procedure		NCI
C10180	PT	Carmustine/Mercaptopurine		NCI
C10180	SY	BCNU/MP		NCI
C10180	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10180	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10180	RO	chemotherapy regimen has component Carmustine	NCI
C63396	STY	Therapeutic or Preventive Procedure		NCI
C63396	PT	FAMTX Regimen		NCI
C63396	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C63396	RO	chemotherapy regimen has component Doxorubicin	NCI
C63396	RO	chemotherapy regimen has component Fluorouracil	NCI
C63396	RO	chemotherapy regimen has component Methotrexate	NCI
C63396	RO	regimen has accepted use for disease Gastric Carcinoma	NCI
C9594	STY	Therapeutic or Preventive Procedure		NCI
C9594	PT	Cisplatin/Doxorubicin/Fluorouracil		NCI
C9594	SY	FAP		NCI
C9594	SY	CDDP/DOX/5-FU		NCI
C9594	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9594	RO	chemotherapy regimen has component Cisplatin	NCI
C9594	RO	chemotherapy regimen has component Doxorubicin	NCI
C9594	RO	chemotherapy regimen has component Fluorouracil	NCI
C11259	STY	Therapeutic or Preventive Procedure		NCI
C11259	PT	Cladribine/Cytarabine		NCI
C11259	SY	ARA-C/2-CdA		NCI
C11259	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11259	RO	chemotherapy regimen has component Cytarabine	NCI
C11259	RO	chemotherapy regimen has component Cladribine	NCI
C12082	STY	Therapeutic or Preventive Procedure		NCI
C12082	PT	Interleukin-2/Isotretinoin/Monoclonal Antibody Ch14.18		NCI
C12082	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12082	RO	chemotherapy regimen has component Isotretinoin	NCI
C12082	RO	chemotherapy regimen has component Dinutuximab	NCI
C12082	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C63406	STY	Therapeutic or Preventive Procedure		NCI
C63406	PT	Gemcitabine-Cisplatin Regimen		NCI
C63406	SY	Gemcitabine/Cisplatin		NCI
C63406	SY	Gemcitabine-Cisplatin		NCI
C63406	SY	GemCis		NCI
C63406	CHD	Chemotherapy Regimen Used to Treat Bladder Carcinoma	NCI
C63406	CHD	Chemotherapy Regimen Used to Treat Cervical Carcinoma	NCI
C63406	CHD	Chemotherapy Regimen Used to Treat Malignant Mesothelioma	NCI
C63406	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63406	CHD	Chemotherapy Regimen Used to Treat Malignant Ovarian Neoplasm	NCI
C63406	CHD	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C63406	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63406	RO	chemotherapy regimen has component Cisplatin	NCI
C63406	RO	regimen has accepted use for disease Pancreatic Carcinoma	NCI
C63406	RO	regimen has accepted use for disease Cervical Adenocarcinoma	NCI
C63406	RO	regimen has accepted use for disease Bladder Carcinoma	NCI
C63406	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63406	RO	regimen has accepted use for disease Ovarian Carcinoma	NCI
C11902	STY	Therapeutic or Preventive Procedure		NCI
C11902	PT	Ascorbic acid/Selenium		NCI
C11902	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11902	RO	chemotherapy regimen has component Ascorbic Acid	NCI
C11902	RO	chemotherapy regimen has component Selenium	NCI
C9859	STY	Therapeutic or Preventive Procedure		NCI
C9859	PT	Fludarabine/Pentostatin		NCI
C9859	SY	DCF/FAMP		NCI
C9859	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9859	RO	chemotherapy regimen has component Pentostatin	NCI
C9859	RO	chemotherapy regimen has component Fludarabine	NCI
C9540	STY	Therapeutic or Preventive Procedure		NCI
C9540	PT	Cyclophosphamide/Doxorubicin/Vincristine		NCI
C9540	SY	VADRC		NCI
C9540	SY	CDV		NCI
C9540	SY	VA-C		NCI
C9540	SY	VAC		NCI
C9540	SY	CHO		NCI
C9540	SY	OCA		NCI
C9540	SY	CTX/DOX/VCR		NCI
C9540	SY	ACO		NCI
C9540	SY	CVA		NCI
C9540	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9540	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9540	RO	chemotherapy regimen has component Doxorubicin	NCI
C9540	RO	chemotherapy regimen has component Vincristine	NCI
C10995	STY	Therapeutic or Preventive Procedure		NCI
C10995	PT	Dexamethasone/Doxorubicin/Interferon Alfa/Vincristine		NCI
C10995	SY	DM/DOX/IFN-A/VCR		NCI
C10995	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10995	RO	chemotherapy regimen has component Dexamethasone	NCI
C10995	RO	chemotherapy regimen has component Doxorubicin	NCI
C10995	RO	chemotherapy regimen has component Vincristine	NCI
C10995	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C136249	STY	Therapeutic or Preventive Procedure		NCI
C136249	PT	FOLFIRI/Panitumumab Regimen		NCI
C136249	SY	Folinic Acid/Fluorouracil/Irinotecan/Panitumumab Regimen		NCI
C136249	SY	FOLFIRI-Vectibix Regimen		NCI
C136249	SY	FOLFIRI Plus Panitumumab		NCI
C136249	SY	FOLFIRI/Vectibix Regimen		NCI
C136249	SY	FOLFIRI Plus Vectibix		NCI
C136249	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136249	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136249	RO	chemotherapy regimen has component Fluorouracil	NCI
C136249	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C136249	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C136249	RO	chemotherapy regimen has component Panitumumab	NCI
C11744	STY	Therapeutic or Preventive Procedure		NCI
C11744	PT	Doxorubicin HCl Liposome/Trastuzumab		NCI
C11744	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11744	RO	chemotherapy regimen has component Trastuzumab	NCI
C11744	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C12060	STY	Therapeutic or Preventive Procedure		NCI
C12060	PT	Cisplatin/Doxorubicin/Methotrexate/Trastuzumab		NCI
C12060	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12060	RO	chemotherapy regimen has component Cisplatin	NCI
C12060	RO	chemotherapy regimen has component Doxorubicin	NCI
C12060	RO	chemotherapy regimen has component Methotrexate	NCI
C12060	RO	chemotherapy regimen has component Trastuzumab	NCI
C37822	STY	Therapeutic or Preventive Procedure		NCI
C37822	PT	Letrozole/Tipifarnib		NCI
C37822	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37822	RO	chemotherapy regimen has component Letrozole	NCI
C37822	RO	chemotherapy regimen has component Tipifarnib	NCI
C9837	STY	Therapeutic or Preventive Procedure		NCI
C9837	PT	Cytarabine/Idarubicin		NCI
C9837	SY	ARA-C/IDA		NCI
C9837	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9837	RO	chemotherapy regimen has component Cytarabine	NCI
C9837	RO	chemotherapy regimen has component Idarubicin	NCI
C156380	STY	Therapeutic or Preventive Procedure		NCI
C156380	PT	Trastuzumab/Pertuzumab/Vinorelbine Regimen		NCI
C156380	SY	Pertuzumab/Trastuzumab/Vinorelbine		NCI
C156380	SY	Trastuzumab-Pertuzumab-Vinorelbine		NCI
C156380	SY	Trastuzumab/Pertuzumab/Vinorelbine		NCI
C156380	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156380	RO	chemotherapy regimen has component Vinorelbine	NCI
C156380	RO	chemotherapy regimen has component Trastuzumab	NCI
C156380	RO	chemotherapy regimen has component Pertuzumab	NCI
C67232	STY	Therapeutic or Preventive Procedure		NCI
C67232	PT	VAdriaC-IE Regimen		NCI
C67232	SY	VAC/IE		NCI
C67232	SY	VAC-IE		NCI
C67232	SY	Vincristine/Doxorubicin/Cyclophosphamide Alternating with Ifosfamide/Etoposide Regimen		NCI
C67232	SY	Vincristine/Doxorubicin/Cyclophosphamide-Ifosfamide/Etoposide Regimen		NCI
C67232	SY	Vincristine/Adriamycin/Cyclophosphamide-Ifosfamide/Etoposide Regimen		NCI
C67232	SY	VAdriaC Alternating with IE		NCI
C67232	SY	VDC/IE		NCI
C67232	SY	VAdriaC-IE		NCI
C67232	SY	VDC/IE Regimen		NCI
C67232	CHD	Chemotherapy Regimen Used to Treat Ewing's Family of Tumors	NCI
C67232	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67232	RO	chemotherapy regimen has component Doxorubicin	NCI
C67232	RO	chemotherapy regimen has component Etoposide	NCI
C67232	RO	chemotherapy regimen has component Ifosfamide	NCI
C67232	RO	chemotherapy regimen has component Vincristine	NCI
C67232	RO	regimen has accepted use for disease Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	NCI
C137681	STY	Therapeutic or Preventive Procedure		NCI
C137681	PT	DCEP Regimen		NCI
C137681	SY	Dexamethasone/Cyclophosphamide/Etoposide/Cisplatin		NCI
C137681	SY	DCEP		NCI
C137681	SY	Dexamethasone-Cyclophosphamide-Etoposide-Cisplatin		NCI
C137681	SY	Dexamethasone/Cyclophosphamide/Etoposide/Cisplatin Regimen		NCI
C137681	SY	Dexamethasone-Cytoxan-Vepesid-Platinol		NCI
C137681	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C137681	RO	chemotherapy regimen has component Cisplatin	NCI
C137681	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C137681	RO	chemotherapy regimen has component Dexamethasone	NCI
C137681	RO	chemotherapy regimen has component Etoposide	NCI
C137681	RO	concept in subset CTRP Terminology	NCI
C137681	RO	concept in subset CTRP Agent Terminology	NCI
C9522	STY	Therapeutic or Preventive Procedure		NCI
C9522	PT	Bleomycin/Doxorubicin/Lomustine/Mechlorethamine/Vincristine		NCI
C9522	SY	BACON		NCI
C9522	SY	BLEO/CCNU/DOX/NM/VCR		NCI
C9522	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9522	RO	chemotherapy regimen has component Bleomycin	NCI
C9522	RO	chemotherapy regimen has component Doxorubicin	NCI
C9522	RO	chemotherapy regimen has component Lomustine	NCI
C9522	RO	chemotherapy regimen has component Vincristine	NCI
C9522	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C11177	STY	Therapeutic or Preventive Procedure		NCI
C11177	PT	Bleomycin/Carboplatin/Cisplatin/Vincristine		NCI
C11177	SY	BLEO/CBDCA/CDDP/VCR		NCI
C11177	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11177	RO	chemotherapy regimen has component Bleomycin	NCI
C11177	RO	chemotherapy regimen has component Cisplatin	NCI
C11177	RO	chemotherapy regimen has component Vincristine	NCI
C11177	RO	chemotherapy regimen has component Carboplatin	NCI
C11879	STY	Therapeutic or Preventive Procedure		NCI
C11879	PT	Interferon Alfa/SU5416		NCI
C11879	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11879	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11879	RO	chemotherapy regimen has component Semaxanib	NCI
C10021	STY	Therapeutic or Preventive Procedure		NCI
C10021	PT	BCG/Cyclophosphamide/Doxorubicin/Tegafur		NCI
C10021	SY	FAC-BCG		NCI
C10021	SY	BCG/CTX/DOX/FT		NCI
C10021	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10021	RO	chemotherapy regimen has component BCG Vaccine	NCI
C10021	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10021	RO	chemotherapy regimen has component Doxorubicin	NCI
C10021	RO	chemotherapy regimen has component Tegafur	NCI
C37765	STY	Therapeutic or Preventive Procedure		NCI
C37765	PT	Erlotinib/Irinotecan		NCI
C37765	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37765	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37765	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C10662	STY	Therapeutic or Preventive Procedure		NCI
C10662	PT	Carboplatin/Paclitaxel		NCI
C10662	SY	CBDCA/Paclitaxel		NCI
C10662	SY	CBDCA/TAX		NCI
C10662	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10662	RO	chemotherapy regimen has component Carboplatin	NCI
C10662	RO	chemotherapy regimen has component Paclitaxel	NCI
C10176	STY	Therapeutic or Preventive Procedure		NCI
C10176	PT	Bleomycin/Fluorouracil/Methotrexate/Vincristine		NCI
C10176	SY	BLEO/5-FU/MTX/VCR		NCI
C10176	SY	VBMF		NCI
C10176	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10176	RO	chemotherapy regimen has component Bleomycin	NCI
C10176	RO	chemotherapy regimen has component Fluorouracil	NCI
C10176	RO	chemotherapy regimen has component Methotrexate	NCI
C10176	RO	chemotherapy regimen has component Vincristine	NCI
C11365	STY	Therapeutic or Preventive Procedure		NCI
C11365	PT	Leucovorin Calcium/Methotrexate/Vincristine		NCI
C11365	SY	CF/MTX/VCR		NCI
C11365	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11365	RO	chemotherapy regimen has component Methotrexate	NCI
C11365	RO	chemotherapy regimen has component Vincristine	NCI
C11365	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12184	STY	Therapeutic or Preventive Procedure		NCI
C12184	PT	Cytarabine/Daunorubicin/Oblimersen		NCI
C12184	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12184	RO	chemotherapy regimen has component Cytarabine	NCI
C12184	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C12184	RO	chemotherapy regimen has component Oblimersen	NCI
C15418	STY	Therapeutic or Preventive Procedure		NCI
C15418	PT	Sargramostim/Thiotepa		NCI
C15418	SY	GM-CSF/TSPA		NCI
C15418	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C15418	RO	chemotherapy regimen has component Thiotepa	NCI
C15418	RO	chemotherapy regimen has component Sargramostim	NCI
C12099	STY	Therapeutic or Preventive Procedure		NCI
C12099	PT	APC8015/Bevacizumab		NCI
C12099	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12099	RO	chemotherapy regimen has component Bevacizumab	NCI
C12099	RO	chemotherapy regimen has component Sipuleucel-T	NCI
C9880	STY	Therapeutic or Preventive Procedure		NCI
C9880	PT	Mitoxantrone/Sargramostim		NCI
C9880	SY	DHAD/GM-CSF		NCI
C9880	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9880	RO	chemotherapy regimen has component Sargramostim	NCI
C9880	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10548	STY	Therapeutic or Preventive Procedure		NCI
C10548	PT	Doxorubicin/Verapamil		NCI
C10548	SY	DOX/VPAM		NCI
C10548	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10548	RO	chemotherapy regimen has component Doxorubicin	NCI
C10548	RO	chemotherapy regimen has component Verapamil	NCI
C10336	STY	Therapeutic or Preventive Procedure		NCI
C10336	PT	Cyclophosphamide/Thioguanine		NCI
C10336	SY	CTX/TG		NCI
C10336	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10336	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10336	RO	chemotherapy regimen has component Thioguanine	NCI
C9656	STY	Therapeutic or Preventive Procedure		NCI
C9656	PT	Daunorubicin/Prednisone/Vincristine		NCI
C9656	SY	DNR/PRED/VCR		NCI
C9656	SY	DVP		NCI
C9656	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9656	RO	chemotherapy regimen has component Prednisone	NCI
C9656	RO	chemotherapy regimen has component Vincristine	NCI
C9656	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11843	STY	Therapeutic or Preventive Procedure		NCI
C11843	PT	Etoposide/Nitrocamptothecin		NCI
C11843	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11843	RO	chemotherapy regimen has component Etoposide	NCI
C11843	RO	chemotherapy regimen has component Rubitecan	NCI
C11068	STY	Therapeutic or Preventive Procedure		NCI
C11068	PT	Cisplatin/Dacarbazine/Interferon Alfa/interleukin-2/Vinblastine		NCI
C11068	SY	CDDP/DTIC/IFN-A/IL-2/VBL		NCI
C11068	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11068	RO	chemotherapy regimen has component Cisplatin	NCI
C11068	RO	chemotherapy regimen has component Dacarbazine	NCI
C11068	RO	chemotherapy regimen has component Vinblastine	NCI
C11068	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11068	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11470	STY	Therapeutic or Preventive Procedure		NCI
C11470	PT	Filgrastim/Sargramostim		NCI
C11470	SY	G-CSF/GM-CSF		NCI
C11470	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11470	RO	chemotherapy regimen has component Filgrastim	NCI
C11470	RO	chemotherapy regimen has component Sargramostim	NCI
C12149	STY	Therapeutic or Preventive Procedure		NCI
C12149	PT	Allogeneic lymphocytes/Interleukin-2		NCI
C12149	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12149	RO	chemotherapy regimen has component Therapeutic Allogeneic Lymphocytes	NCI
C12149	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12215	STY	Therapeutic or Preventive Procedure		NCI
C12215	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Teniposide		NCI
C12215	SY	VACP		NCI
C12215	SY	CDDP/CTX/DOX/VM-26		NCI
C12215	SY	AVEC		NCI
C12215	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12215	RO	chemotherapy regimen has component Cisplatin	NCI
C12215	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12215	RO	chemotherapy regimen has component Doxorubicin	NCI
C12215	RO	chemotherapy regimen has component Teniposide	NCI
C12137	STY	Therapeutic or Preventive Procedure		NCI
C12137	PT	Goserelin/Raloxifene		NCI
C12137	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12137	RO	chemotherapy regimen has component Goserelin	NCI
C12137	RO	chemotherapy regimen has component Raloxifene	NCI
C9746	STY	Therapeutic or Preventive Procedure		NCI
C9746	PT	Docetaxel/Vincristine		NCI
C9746	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9746	RO	chemotherapy regimen has component Vincristine	NCI
C9746	RO	chemotherapy regimen has component Docetaxel	NCI
C11315	STY	Therapeutic or Preventive Procedure		NCI
C11315	PT	Bacitracin/Clotrimazole/Gentamicin		NCI
C11315	SY	BAC/CLOT/GM		NCI
C11315	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11315	RO	chemotherapy regimen has component Bacitracin	NCI
C11315	RO	chemotherapy regimen has component Clotrimazole	NCI
C11315	RO	chemotherapy regimen has component Gentamicin	NCI
C136271	STY	Therapeutic or Preventive Procedure		NCI
C136271	PT	Elotuzumab/Bortezomib/Dexamethasone Regimen		NCI
C136271	SY	Elotuzumab/Bortezomib/Dexamethasone		NCI
C136271	SY	Elotuzumab-Bortezomib-Dexamethasone Regimen		NCI
C136271	SY	Elotuzumab-Bortezomib-Dexamethasone		NCI
C136271	SY	Empliciti/Velcade/Dexamethasone		NCI
C136271	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136271	RO	chemotherapy regimen has component Dexamethasone	NCI
C136271	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136271	RO	chemotherapy regimen has component Bortezomib	NCI
C136271	RO	chemotherapy regimen has component Elotuzumab	NCI
C11866	STY	Therapeutic or Preventive Procedure		NCI
C11866	PT	MAGE-12 peptide vaccine/Montanide ISA-51		NCI
C11866	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11866	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11866	RO	chemotherapy regimen has component MAGE-12 Peptide Vaccine	NCI
C63784	STY	Therapeutic or Preventive Procedure		NCI
C63784	PT	DTIC-BCNU-Cisplatin Regimen		NCI
C63784	SY	Dacarbazine-Carmustine-Cisplatin Regimen		NCI
C63784	SY	CDB Regimen		NCI
C63784	CHD	Chemotherapy Regimen Used to Treat Melanoma	NCI
C63784	RO	chemotherapy regimen has component Carmustine	NCI
C63784	RO	chemotherapy regimen has component Cisplatin	NCI
C63784	RO	chemotherapy regimen has component Dacarbazine	NCI
C63784	RO	regimen has accepted use for disease Melanoma	NCI
C11605	STY	Therapeutic or Preventive Procedure		NCI
C11605	PT	Cisplatin/Flavopiridol/Paclitaxel		NCI
C11605	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11605	RO	chemotherapy regimen has component Cisplatin	NCI
C11605	RO	chemotherapy regimen has component Paclitaxel	NCI
C11605	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C9763	STY	Therapeutic or Preventive Procedure		NCI
C9763	PT	p53 Adenovirus/SCH 66336		NCI
C9763	SY	p53 Adenovirus/Lonafarnib		NCI
C9763	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9763	RO	chemotherapy regimen has component Ad5CMV-p53 Gene	NCI
C9763	RO	chemotherapy regimen has component Lonafarnib	NCI
C10006	STY	Therapeutic or Preventive Procedure		NCI
C10006	PT	Altretamine/Cisplatin/Cyclophosphamide/Misonidazole		NCI
C10006	SY	CHIPS		NCI
C10006	SY	CDDP/CTX/HMM/MNI		NCI
C10006	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10006	RO	chemotherapy regimen has component Cisplatin	NCI
C10006	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10006	RO	chemotherapy regimen has component Altretamine	NCI
C10006	RO	chemotherapy regimen has component Misonidazole	NCI
C10571	STY	Therapeutic or Preventive Procedure		NCI
C10571	PT	Asparaginase/Dexamethasone/Doxorubicin/Methotrexate/Vincristine		NCI
C10571	SY	ASP/DM/DOX/MTX/VCR		NCI
C10571	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10571	RO	chemotherapy regimen has component Asparaginase	NCI
C10571	RO	chemotherapy regimen has component Dexamethasone	NCI
C10571	RO	chemotherapy regimen has component Doxorubicin	NCI
C10571	RO	chemotherapy regimen has component Methotrexate	NCI
C10571	RO	chemotherapy regimen has component Vincristine	NCI
C10780	STY	Therapeutic or Preventive Procedure		NCI
C10780	PT	Methotrexate/Pegaspargase		NCI
C10780	SY	MTX/PEG-ASP		NCI
C10780	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10780	RO	chemotherapy regimen has component Methotrexate	NCI
C10780	RO	chemotherapy regimen has component Pegaspargase	NCI
C11287	STY	Therapeutic or Preventive Procedure		NCI
C11287	PT	Amifostine/Carboplatin/Paclitaxel		NCI
C11287	SY	CBDCA/TAX/WR-2721		NCI
C11287	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11287	RO	chemotherapy regimen has component Amifostine	NCI
C11287	RO	chemotherapy regimen has component Carboplatin	NCI
C11287	RO	chemotherapy regimen has component Paclitaxel	NCI
C11154	STY	Therapeutic or Preventive Procedure		NCI
C11154	PT	Cytarabine/Etoposide/Vincristine		NCI
C11154	SY	ARA-C/VCR/VP-16		NCI
C11154	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11154	RO	chemotherapy regimen has component Cytarabine	NCI
C11154	RO	chemotherapy regimen has component Etoposide	NCI
C11154	RO	chemotherapy regimen has component Vincristine	NCI
C140115	STY	Therapeutic or Preventive Procedure		NCI
C140115	PT	R-HyperCVAD/HD MTX AraC Regimen		NCI
C140115	SY	Rituximab Plus HyperCVAD Alternating with Rituximab Plus High-dose Cytarabine and Methotrexate		NCI
C140115	SY	Rituximab Plus HyperCVAD Alternating with Rituximab-Methotrexate/Cytarabine		NCI
C140115	SY	Rituximab-Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone Alternating with Rituximab/Cytarabine/Methotrexate		NCI
C140115	SY	R-HyperCVAD/MTX/AraC		NCI
C140115	SY	R-hyperCVAD Alternating with R-Methotrexate-Cytarabine		NCI
C140115	SY	Rituximab Plus HyperCVAD Alternating with R-Methotrexate/Cytarabine		NCI
C140115	SY	Rituximab Plus Hyper-CVAD Alternating with R-Methotrexate/Cytarabine		NCI
C140115	SY	R-HCVAD Plus Methotrexate/Cytarabine		NCI
C140115	CHD	Chemotherapy Regimen Used to Treat Acute Lymphoblastic Leukemia	NCI
C140115	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140115	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C140115	RO	chemotherapy regimen has component Cytarabine	NCI
C140115	RO	chemotherapy regimen has component Dexamethasone	NCI
C140115	RO	chemotherapy regimen has component Doxorubicin	NCI
C140115	RO	chemotherapy regimen has component Methotrexate	NCI
C140115	RO	chemotherapy regimen has component Vincristine	NCI
C140115	RO	chemotherapy regimen has component Rituximab	NCI
C137680	STY	Therapeutic or Preventive Procedure		NCI
C137680	PT	DPACE Regimen		NCI
C137680	SY	DPACE		NCI
C137680	SY	Dexamethasone/Cisplatin/Doxorubicin/Cyclophosphamide/Etoposide		NCI
C137680	SY	Dexamethasone-Cisplatin-Doxorubicin-Cyclophosphamide-Etoposide Regimen		NCI
C137680	SY	Decadron/Platinol/Adriamycin/Cytoxan/Etoposide Regimen		NCI
C137680	SY	Dexamethasone/Cisplatin/Doxorubicin/Cyclophosphamide/Etoposide Regimen		NCI
C137680	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C137680	RO	chemotherapy regimen has component Cisplatin	NCI
C137680	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C137680	RO	chemotherapy regimen has component Dexamethasone	NCI
C137680	RO	chemotherapy regimen has component Doxorubicin	NCI
C137680	RO	chemotherapy regimen has component Etoposide	NCI
C137680	RO	concept in subset CTRP Terminology	NCI
C137680	RO	concept in subset CTRP Agent Terminology	NCI
C10323	STY	Therapeutic or Preventive Procedure		NCI
C10323	PT	Cyclophosphamide/Doxorubicin/Etoposide/Filgrastim		NCI
C10323	SY	CTX/DOX/G-CSF/VP-16		NCI
C10323	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10323	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10323	RO	chemotherapy regimen has component Doxorubicin	NCI
C10323	RO	chemotherapy regimen has component Etoposide	NCI
C10323	RO	chemotherapy regimen has component Filgrastim	NCI
C63408	STY	Therapeutic or Preventive Procedure		NCI
C63408	PT	Cisplatin-Mitomycin-Vinblastine Regimen		NCI
C63408	SY	MVP Regimen		NCI
C63408	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63408	RO	chemotherapy regimen has component Mitomycin	NCI
C63408	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63408	RO	chemotherapy regimen has component Cisplatin	NCI
C63408	RO	chemotherapy regimen has component Vinblastine	NCI
C12076	STY	Therapeutic or Preventive Procedure		NCI
C12076	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vinblastine/Vincristine		NCI
C12076	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12076	RO	chemotherapy regimen has component Bleomycin	NCI
C12076	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12076	RO	chemotherapy regimen has component Doxorubicin	NCI
C12076	RO	chemotherapy regimen has component Etoposide	NCI
C12076	RO	chemotherapy regimen has component Prednisone	NCI
C12076	RO	chemotherapy regimen has component Vinblastine	NCI
C12076	RO	chemotherapy regimen has component Vincristine	NCI
C15629	STY	Therapeutic or Preventive Procedure		NCI
C15629	PT	Keyhole Limpet Hemocyanin/MUC-1 Antigen		NCI
C15629	SY	KLH/MUC-1 Antigen		NCI
C15629	SY	Keyhole Limpet Hemocyanin/Mucin Peptide		NCI
C15629	SY	KLH/MUC-1		NCI
C15629	SY	KLH/Mucin Peptide		NCI
C15629	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15629	RO	chemotherapy regimen has component MUC-1 Antigen	NCI
C15629	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C10397	STY	Therapeutic or Preventive Procedure		NCI
C10397	PT	Daunorubicin/Dexamethasone/Vincristine		NCI
C10397	SY	DM/DNR/VCR		NCI
C10397	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10397	RO	chemotherapy regimen has component Dexamethasone	NCI
C10397	RO	chemotherapy regimen has component Vincristine	NCI
C10397	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10478	STY	Therapeutic or Preventive Procedure		NCI
C10478	PT	Cyclophosphamide/Daunorubicin/Dexamethasone/Etoposide/Methotrexate/Thiotepa/Vincristine		NCI
C10478	SY	CTX/DM/DNR/MTX/TSPA/VCR/VP-16		NCI
C10478	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10478	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10478	RO	chemotherapy regimen has component Dexamethasone	NCI
C10478	RO	chemotherapy regimen has component Etoposide	NCI
C10478	RO	chemotherapy regimen has component Methotrexate	NCI
C10478	RO	chemotherapy regimen has component Thiotepa	NCI
C10478	RO	chemotherapy regimen has component Vincristine	NCI
C10478	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9539	STY	Therapeutic or Preventive Procedure		NCI
C9539	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Fluorouracil		NCI
C9539	SY	CDDP/CTX/DOX/5-FU		NCI
C9539	SY	FACP		NCI
C9539	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9539	RO	chemotherapy regimen has component Cisplatin	NCI
C9539	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9539	RO	chemotherapy regimen has component Doxorubicin	NCI
C9539	RO	chemotherapy regimen has component Fluorouracil	NCI
C11839	STY	Therapeutic or Preventive Procedure		NCI
C11839	PT	Doxorubicin Hcl Liposome/Gemcitabine/Vinorelbine		NCI
C11839	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11839	RO	chemotherapy regimen has component Vinorelbine	NCI
C11839	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11839	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C10832	STY	Therapeutic or Preventive Procedure		NCI
C10832	PT	Cisplatin/Doxorubicin/Floxuridine/Leucovorin Calcium		NCI
C10832	SY	CDDP/CF/DOX/FUDR		NCI
C10832	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10832	RO	chemotherapy regimen has component Cisplatin	NCI
C10832	RO	chemotherapy regimen has component Doxorubicin	NCI
C10832	RO	chemotherapy regimen has component Floxuridine	NCI
C10832	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11011	STY	Therapeutic or Preventive Procedure		NCI
C11011	PT	Cyclophosphamide/Interferon Alfa		NCI
C11011	SY	CTX/IFN-A		NCI
C11011	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11011	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11011	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37802	STY	Therapeutic or Preventive Procedure		NCI
C37802	PT	Gemcitabine/Lonafarnib		NCI
C37802	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37802	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37802	RO	chemotherapy regimen has component Lonafarnib	NCI
C67291	STY	Therapeutic or Preventive Procedure		NCI
C67291	PT	Chemotherapy Regimen Used to Treat Childhood Malignant Renal Neoplasm		NCI
C67291	SY	Chemotherapy Regimen Used to Treat Pediatric Kidney Cancer		NCI
C67291	SY	Chemotherapy Regimen Used to Treat Childhood Kidney Cancer		NCI
C67291	CHD	Chemotherapy Regimen Used to Treat Malignant Renal Neoplasm	NCI
C67291	PAR	CE-PE Childhood Kidney Cancer Regimen	NCI
C67291	PAR	EE-4A Regimen	NCI
C67291	PAR	NWTS Regimen 1	NCI
C67291	PAR	DD-4A Regimen	NCI
C10438	STY	Therapeutic or Preventive Procedure		NCI
C10438	PT	Daunorubicin/Tamoxifen		NCI
C10438	SY	DNR/TMX		NCI
C10438	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10438	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10438	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10133	STY	Therapeutic or Preventive Procedure		NCI
C10133	PT	Busulfan/Melphalan		NCI
C10133	SY	BU/L-PAM		NCI
C10133	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10133	RO	chemotherapy regimen has component Busulfan	NCI
C10133	RO	chemotherapy regimen has component Melphalan	NCI
C37835	STY	Therapeutic or Preventive Procedure		NCI
C37835	PT	Mitoxantrone/Prednisone/YM598		NCI
C37835	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37835	RO	chemotherapy regimen has component Prednisone	NCI
C37835	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C37835	RO	chemotherapy regimen has component YM598	NCI
C9528	STY	Therapeutic or Preventive Procedure		NCI
C9528	PT	Bleomycin/Cisplatin/Ifosfamide		NCI
C9528	SY	BLEO/CDDP/IFF		NCI
C9528	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9528	RO	chemotherapy regimen has component Bleomycin	NCI
C9528	RO	chemotherapy regimen has component Cisplatin	NCI
C9528	RO	chemotherapy regimen has component Ifosfamide	NCI
C138052	STY	Therapeutic or Preventive Procedure		NCI
C138052	PT	Carboplatin/Paclitaxel/Trastuzumab Regimen		NCI
C138052	SY	Carboplatin/Paclitaxel/Trastuzumab		NCI
C138052	SY	Carboplatin-Paclitaxel-Trastuzumab		NCI
C138052	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138052	RO	chemotherapy regimen has component Trastuzumab	NCI
C10778	STY	Therapeutic or Preventive Procedure		NCI
C10778	PT	Cisplatin/Cyclosporine/Doxorubicin		NCI
C10778	SY	CDDP/CYSP/DOX		NCI
C10778	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10778	RO	chemotherapy regimen has component Cisplatin	NCI
C10778	RO	chemotherapy regimen has component Cyclosporine	NCI
C10778	RO	chemotherapy regimen has component Doxorubicin	NCI
C10027	STY	Therapeutic or Preventive Procedure		NCI
C10027	PT	Fluorouracil/Mitomycin		NCI
C10027	SY	5-FU/MITO		NCI
C10027	SY	MF		NCI
C10027	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10027	RO	chemotherapy regimen has component Mitomycin	NCI
C10027	RO	chemotherapy regimen has component Fluorouracil	NCI
C10598	STY	Therapeutic or Preventive Procedure		NCI
C10598	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Fluorouracil/Vincristine		NCI
C10598	SY	CDDP/CTX/DOX/5-FU/VCR/VP-16		NCI
C10598	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10598	RO	chemotherapy regimen has component Cisplatin	NCI
C10598	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10598	RO	chemotherapy regimen has component Doxorubicin	NCI
C10598	RO	chemotherapy regimen has component Etoposide	NCI
C10598	RO	chemotherapy regimen has component Fluorouracil	NCI
C10598	RO	chemotherapy regimen has component Vincristine	NCI
C9766	STY	Therapeutic or Preventive Procedure		NCI
C9766	PT	Cyclophosphamide/Thiotepa		NCI
C9766	SY	CTX/TSPA		NCI
C9766	SY	CHUT		NCI
C9766	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9766	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9766	RO	chemotherapy regimen has component Thiotepa	NCI
C9761	STY	Therapeutic or Preventive Procedure		NCI
C9761	PT	Fluorouracil/Leucovorin/Rhumab-Vegf		NCI
C9761	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9761	RO	chemotherapy regimen has component Fluorouracil	NCI
C9761	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9761	RO	chemotherapy regimen has component Bevacizumab	NCI
C10815	STY	Therapeutic or Preventive Procedure		NCI
C10815	PT	Cyclophosphamide/Dexamethasone		NCI
C10815	SY	CTX/DM		NCI
C10815	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10815	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10815	RO	chemotherapy regimen has component Dexamethasone	NCI
C9517	STY	Therapeutic or Preventive Procedure		NCI
C9517	PT	Cyclophosphamide/Doxorubicin/Methotrexate/Vincristine		NCI
C9517	SY	CODOX-M		NCI
C9517	SY	MACO		NCI
C9517	SY	AMCO		NCI
C9517	SY	CTX/DOX/MTX/VCR		NCI
C9517	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9517	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9517	RO	chemotherapy regimen has component Doxorubicin	NCI
C9517	RO	chemotherapy regimen has component Methotrexate	NCI
C9517	RO	chemotherapy regimen has component Vincristine	NCI
C10507	STY	Therapeutic or Preventive Procedure		NCI
C10507	PT	Carboplatin/Dacarbazine		NCI
C10507	SY	CBDCA/DTIC		NCI
C10507	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10507	RO	chemotherapy regimen has component Dacarbazine	NCI
C10507	RO	chemotherapy regimen has component Carboplatin	NCI
C10801	STY	Therapeutic or Preventive Procedure		NCI
C10801	PT	Cyclophosphamide/Methotrexate		NCI
C10801	SY	CTX/MTX		NCI
C10801	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10801	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10801	RO	chemotherapy regimen has component Methotrexate	NCI
C37843	STY	Therapeutic or Preventive Procedure		NCI
C37843	PT	Paclitaxel/Suramin		NCI
C37843	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37843	RO	chemotherapy regimen has component Suramin	NCI
C37843	RO	chemotherapy regimen has component Paclitaxel	NCI
C11401	STY	Therapeutic or Preventive Procedure		NCI
C11401	PT	Doxorubicin HCl Liposome/Paclitaxel		NCI
C11401	SY	LipoDox/TAX		NCI
C11401	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11401	RO	chemotherapy regimen has component Paclitaxel	NCI
C11401	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C11996	STY	Therapeutic or Preventive Procedure		NCI
C11996	PT	Carboplatin/IM-862/Paclitaxel		NCI
C11996	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11996	RO	chemotherapy regimen has component Carboplatin	NCI
C11996	RO	chemotherapy regimen has component Paclitaxel	NCI
C11996	RO	chemotherapy regimen has component Oglufanide Disodium	NCI
C10670	STY	Therapeutic or Preventive Procedure		NCI
C10670	PT	Eflornithine/Piroxicam		NCI
C10670	SY	DFMO/PXM		NCI
C10670	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10670	RO	chemotherapy regimen has component Eflornithine	NCI
C10670	RO	chemotherapy regimen has component Piroxicam	NCI
C11056	STY	Therapeutic or Preventive Procedure		NCI
C11056	PT	Hydralazine/Interferon Alfa		NCI
C11056	SY	hydralazine/IFN-A		NCI
C11056	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11056	RO	chemotherapy regimen has component Hydralazine Hydrochloride	NCI
C11056	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9873	STY	Therapeutic or Preventive Procedure		NCI
C9873	PT	Cyclophosphamide/Cytarabine/Mercaptopurine		NCI
C9873	SY	ARA-C/CTX/MP		NCI
C9873	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9873	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9873	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9873	RO	chemotherapy regimen has component Cytarabine	NCI
C11530	STY	Therapeutic or Preventive Procedure		NCI
C11530	PT	Asparaginase/Daunorubicin/Dexamethasone/Methotrexate/Vincristine		NCI
C11530	SY	ASP/DM/DNR/MTX/VCR		NCI
C11530	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11530	RO	chemotherapy regimen has component Asparaginase	NCI
C11530	RO	chemotherapy regimen has component Dexamethasone	NCI
C11530	RO	chemotherapy regimen has component Methotrexate	NCI
C11530	RO	chemotherapy regimen has component Vincristine	NCI
C11530	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11837	STY	Therapeutic or Preventive Procedure		NCI
C11837	PT	Interferon Alfa/Thalidomide		NCI
C11837	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11837	RO	chemotherapy regimen has component Thalidomide	NCI
C11837	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10355	STY	Therapeutic or Preventive Procedure		NCI
C10355	PT	Carmustine/Tiazofurin		NCI
C10355	SY	BCNU/TCAR		NCI
C10355	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10355	RO	chemotherapy regimen has component Carmustine	NCI
C10355	RO	chemotherapy regimen has component Tiazofurin	NCI
C10175	STY	Therapeutic or Preventive Procedure		NCI
C10175	PT	Carmustine/Cyclophosphamide/Dexamethasone		NCI
C10175	SY	CCD		NCI
C10175	SY	BCNU/CTX/DM		NCI
C10175	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10175	RO	chemotherapy regimen has component Carmustine	NCI
C10175	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10175	RO	chemotherapy regimen has component Dexamethasone	NCI
C37625	STY	Therapeutic or Preventive Procedure		NCI
C37625	PT	Carmustine/Efaproxiral		NCI
C37625	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C37625	RO	chemotherapy regimen has component Carmustine	NCI
C37625	RO	chemotherapy regimen has component Efaproxiral	NCI
C11872	STY	Therapeutic or Preventive Procedure		NCI
C11872	PT	BMS-275291/Carboplatin/Paclitaxel		NCI
C11872	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11872	RO	chemotherapy regimen has component Carboplatin	NCI
C11872	RO	chemotherapy regimen has component Paclitaxel	NCI
C11872	RO	chemotherapy regimen has component Rebimastat	NCI
C10051	STY	Therapeutic or Preventive Procedure		NCI
C10051	PT	Carmustine/Triazinate		NCI
C10051	SY	BT		NCI
C10051	SY	BCNU/TZT		NCI
C10051	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10051	RO	chemotherapy regimen has component Carmustine	NCI
C10051	RO	chemotherapy regimen has component Triazinate	NCI
C11528	STY	Therapeutic or Preventive Procedure		NCI
C11528	PT	Methotrexate/Prednisolone		NCI
C11528	SY	MTX/PRDL		NCI
C11528	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11528	RO	chemotherapy regimen has component Methotrexate	NCI
C11528	RO	chemotherapy regimen has component Prednisolone	NCI
C10975	STY	Therapeutic or Preventive Procedure		NCI
C10975	PT	Cytarabine/Daunorubicin/Etoposide/Filgrastim		NCI
C10975	SY	ARA-C/DNR/G-CSF/VP-16		NCI
C10975	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10975	RO	chemotherapy regimen has component Cytarabine	NCI
C10975	RO	chemotherapy regimen has component Etoposide	NCI
C10975	RO	chemotherapy regimen has component Filgrastim	NCI
C10975	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11116	STY	Therapeutic or Preventive Procedure		NCI
C11116	PT	Asparaginase/Cyclophosphamide/Cytarabine/Etoposide/Mercaptopurine/Methotrexate		NCI
C11116	SY	ARA-C/ASP/CTX/MP/MTX/VP-16		NCI
C11116	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11116	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11116	RO	chemotherapy regimen has component Asparaginase	NCI
C11116	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11116	RO	chemotherapy regimen has component Cytarabine	NCI
C11116	RO	chemotherapy regimen has component Etoposide	NCI
C11116	RO	chemotherapy regimen has component Methotrexate	NCI
C11961	STY	Therapeutic or Preventive Procedure		NCI
C11961	PT	Palivizumab/Ribavirin		NCI
C11961	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11961	RO	chemotherapy regimen has component Ribavirin	NCI
C11961	RO	chemotherapy regimen has component Palivizumab	NCI
C11892	STY	Therapeutic or Preventive Procedure		NCI
C11892	PT	Paclitaxel/Prinomastat		NCI
C11892	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11892	RO	chemotherapy regimen has component Paclitaxel	NCI
C11892	RO	chemotherapy regimen has component Prinomastat	NCI
C10347	STY	Therapeutic or Preventive Procedure		NCI
C10347	PT	Doxorubicin/Fluorouracil/Tamoxifen/Thiotepa		NCI
C10347	SY	DOX/5-FU/TMX/TSPA		NCI
C10347	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10347	RO	chemotherapy regimen has component Doxorubicin	NCI
C10347	RO	chemotherapy regimen has component Fluorouracil	NCI
C10347	RO	chemotherapy regimen has component Thiotepa	NCI
C10347	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C67296	STY	Therapeutic or Preventive Procedure		NCI
C67296	PT	IPA Liver Cancer Regimen		NCI
C67296	SY	Ifosfamide-Platinol-Adriamycin Liver Cancer Regimen		NCI
C67296	SY	HB-89 Regimen		NCI
C67296	SY	IPA		NCI
C67296	SY	IPA Regimen		NCI
C67296	CHD	Chemotherapy Regimen Used to Treat Childhood Liver Cancer	NCI
C67296	RO	chemotherapy regimen has component Cisplatin	NCI
C67296	RO	chemotherapy regimen has component Doxorubicin	NCI
C67296	RO	chemotherapy regimen has component Ifosfamide	NCI
C67296	RO	regimen has accepted use for disease Hepatoblastoma	NCI
C138046	STY	Therapeutic or Preventive Procedure		NCI
C138046	PT	Pertuzumab/Trastuzumab/Paclitaxel Followed by FEC Regimen		NCI
C138046	SY	Pertuzumab/Trastuzumab/Paclitaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide		NCI
C138046	SY	Pertuzumab-Trastuzumab-Paclitaxel Followed by Fluorouracil-Epirubicin-Cyclophosphamide		NCI
C138046	SY	Pertuzumab + Trastuzumab + Paclitaxel Followed by FEC		NCI
C138046	SY	Pertuzumab + Trastuzumab + Paclitaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide		NCI
C138046	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138046	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138046	RO	chemotherapy regimen has component Fluorouracil	NCI
C138046	RO	chemotherapy regimen has component Paclitaxel	NCI
C138046	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C138046	RO	chemotherapy regimen has component Trastuzumab	NCI
C138046	RO	chemotherapy regimen has component Pertuzumab	NCI
C10324	STY	Therapeutic or Preventive Procedure		NCI
C10324	PT	Methotrexate/Vincristine		NCI
C10324	SY	MTX/VCR		NCI
C10324	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10324	RO	chemotherapy regimen has component Methotrexate	NCI
C10324	RO	chemotherapy regimen has component Vincristine	NCI
C10554	STY	Therapeutic or Preventive Procedure		NCI
C10554	PT	Cytarabine/Pegaspargase		NCI
C10554	SY	ARA-C/PEG-ASP		NCI
C10554	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10554	RO	chemotherapy regimen has component Cytarabine	NCI
C10554	RO	chemotherapy regimen has component Pegaspargase	NCI
C11997	STY	Therapeutic or Preventive Procedure		NCI
C11997	PT	Arsenic trioxide/Dexamethasone		NCI
C11997	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11997	RO	chemotherapy regimen has component Dexamethasone	NCI
C11997	RO	chemotherapy regimen has component Arsenic Trioxide	NCI
C11784	STY	Therapeutic or Preventive Procedure		NCI
C11784	PT	Carboplatin/Paclitaxel/ZD 1839		NCI
C11784	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11784	RO	chemotherapy regimen has component Carboplatin	NCI
C11784	RO	chemotherapy regimen has component Paclitaxel	NCI
C11784	RO	chemotherapy regimen has component Gefitinib	NCI
C9914	STY	Therapeutic or Preventive Procedure		NCI
C9914	PT	Cyclophosphamide/Doxorubicin/Mitomycin		NCI
C9914	SY	CTX/DOX/MITO		NCI
C9914	SY	MAC		NCI
C9914	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9914	RO	chemotherapy regimen has component Mitomycin	NCI
C9914	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9914	RO	chemotherapy regimen has component Doxorubicin	NCI
C10934	STY	Therapeutic or Preventive Procedure		NCI
C10934	PT	Etoposide/Novobiocin		NCI
C10934	SY	NBC/VP-16		NCI
C10934	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10934	RO	chemotherapy regimen has component Etoposide	NCI
C10934	RO	chemotherapy regimen has component Novobiocin	NCI
C11173	STY	Therapeutic or Preventive Procedure		NCI
C11173	PT	Suramin/Topotecan		NCI
C11173	SY	SUR/TOPO		NCI
C11173	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11173	RO	chemotherapy regimen has component Suramin	NCI
C11173	RO	chemotherapy regimen has component Topotecan	NCI
C11657	STY	Therapeutic or Preventive Procedure		NCI
C11657	PT	Docetaxel/Mitoxantrone		NCI
C11657	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11657	RO	chemotherapy regimen has component Docetaxel	NCI
C11657	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C63473	STY	Therapeutic or Preventive Procedure		NCI
C63473	PT	R-CVP Regimen		NCI
C63473	SY	Rituximab-Cyclophosphamide-Vincristine-Prednisone Regimen		NCI
C63473	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63473	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63473	RO	chemotherapy regimen has component Prednisone	NCI
C63473	RO	chemotherapy regimen has component Vincristine	NCI
C63473	RO	chemotherapy regimen has component Rituximab	NCI
C63473	RO	regimen has accepted use for disease Indolent Non-Hodgkin Lymphoma	NCI
C63473	RO	concept in subset CTRP Terminology	NCI
C63473	RO	concept in subset CTRP Agent Terminology	NCI
C10830	STY	Therapeutic or Preventive Procedure		NCI
C10830	PT	Carboplatin/Filgrastim/Topotecan		NCI
C10830	SY	CBDCA/G-CSF/TOPO		NCI
C10830	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10830	RO	chemotherapy regimen has component Carboplatin	NCI
C10830	RO	chemotherapy regimen has component Topotecan	NCI
C10830	RO	chemotherapy regimen has component Filgrastim	NCI
C11134	STY	Therapeutic or Preventive Procedure		NCI
C11134	PT	Letrozole/Tamoxifen		NCI
C11134	SY	letrozole/TMX		NCI
C11134	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11134	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11134	RO	chemotherapy regimen has component Letrozole	NCI
C11133	STY	Therapeutic or Preventive Procedure		NCI
C11133	PT	Carmustine/Etoposide		NCI
C11133	SY	BCNU/VP-16		NCI
C11133	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11133	RO	chemotherapy regimen has component Carmustine	NCI
C11133	RO	chemotherapy regimen has component Etoposide	NCI
C11274	STY	Therapeutic or Preventive Procedure		NCI
C11274	PT	Carmustine/Irinotecan		NCI
C11274	SY	BCNU/CPT-11		NCI
C11274	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11274	RO	chemotherapy regimen has component Carmustine	NCI
C11274	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C9803	STY	Therapeutic or Preventive Procedure		NCI
C9803	PT	Interferon Beta/Interferon Gamma		NCI
C9803	SY	IFN-B/IFN-G		NCI
C9803	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9803	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C9803	RO	chemotherapy regimen has component Recombinant Interferon Beta	NCI
C37590	STY	Therapeutic or Preventive Procedure		NCI
C37590	PT	Capecitabine/Fluorouracil/Leucovorin Calcium/Oxaliplatin		NCI
C37590	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37590	RO	chemotherapy regimen has component Fluorouracil	NCI
C37590	RO	chemotherapy regimen has component Oxaliplatin	NCI
C37590	RO	chemotherapy regimen has component Capecitabine	NCI
C37590	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10146	STY	Therapeutic or Preventive Procedure		NCI
C10146	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine/Vindesine		NCI
C10146	SY	CDDP/CTX/DAVA/DOX/MTX/VCR/VP-16		NCI
C10146	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10146	RO	chemotherapy regimen has component Cisplatin	NCI
C10146	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10146	RO	chemotherapy regimen has component Doxorubicin	NCI
C10146	RO	chemotherapy regimen has component Etoposide	NCI
C10146	RO	chemotherapy regimen has component Methotrexate	NCI
C10146	RO	chemotherapy regimen has component Vincristine	NCI
C10146	RO	chemotherapy regimen has component Vindesine	NCI
C12112	STY	Therapeutic or Preventive Procedure		NCI
C12112	PT	Carboplatin/Epoetin alfa/Paclitaxel		NCI
C12112	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12112	RO	chemotherapy regimen has component Carboplatin	NCI
C12112	RO	chemotherapy regimen has component Paclitaxel	NCI
C12112	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C37734	STY	Therapeutic or Preventive Procedure		NCI
C37734	PT	Dexamethasone/Oblimersen/Thalidomide		NCI
C37734	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37734	RO	chemotherapy regimen has component Dexamethasone	NCI
C37734	RO	chemotherapy regimen has component Thalidomide	NCI
C37734	RO	chemotherapy regimen has component Oblimersen	NCI
C37483	STY	Therapeutic or Preventive Procedure		NCI
C37483	PT	Fludarabine/Triapine		NCI
C37483	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37483	RO	chemotherapy regimen has component Fludarabine	NCI
C37483	RO	chemotherapy regimen has component Triapine	NCI
C9509	STY	Therapeutic or Preventive Procedure		NCI
C9509	PT	ABVD Regimen		NCI
C9509	SY	ABVD		NCI
C9509	SY	Adriamycin-Bleomycin-Vinblastine-Dacarbazine Regimen		NCI
C9509	SY	Bleomycin/Dacarbazine/Doxorubicin/Vinblastine		NCI
C9509	SY	BLEO/DOX/DTIC/VBL		NCI
C9509	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C9509	RO	chemotherapy regimen has component Bleomycin	NCI
C9509	RO	chemotherapy regimen has component Dacarbazine	NCI
C9509	RO	chemotherapy regimen has component Doxorubicin	NCI
C9509	RO	chemotherapy regimen has component Vinblastine	NCI
C9509	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C9509	RO	concept in subset CTRP Terminology	NCI
C9509	RO	concept in subset CTRP Agent Terminology	NCI
C37817	STY	Therapeutic or Preventive Procedure		NCI
C37817	PT	Interferon Alfa/Oblimersen		NCI
C37817	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37817	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37817	RO	chemotherapy regimen has component Oblimersen	NCI
C10999	STY	Therapeutic or Preventive Procedure		NCI
C10999	PT	Mitoxantrone/Interferon Alfa		NCI
C10999	SY	DHAD/IFN-A		NCI
C10999	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10999	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10999	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11063	STY	Therapeutic or Preventive Procedure		NCI
C11063	PT	Ifosfamide/Interferon Alfa/Pentostatin		NCI
C11063	SY	DCF/IFF/IFN-A		NCI
C11063	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11063	RO	chemotherapy regimen has component Ifosfamide	NCI
C11063	RO	chemotherapy regimen has component Pentostatin	NCI
C11063	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11026	STY	Therapeutic or Preventive Procedure		NCI
C11026	PT	Cisplatin/Fluorouracil/Interferon Alfa/Leucovorin Calcium		NCI
C11026	SY	CDDP/CF/5-FU/IFN-A		NCI
C11026	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11026	RO	chemotherapy regimen has component Cisplatin	NCI
C11026	RO	chemotherapy regimen has component Fluorouracil	NCI
C11026	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11026	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C12088	STY	Therapeutic or Preventive Procedure		NCI
C12088	PT	Docetaxel/Estramustine/Thalidomide		NCI
C12088	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12088	RO	chemotherapy regimen has component Estramustine	NCI
C12088	RO	chemotherapy regimen has component Thalidomide	NCI
C12088	RO	chemotherapy regimen has component Docetaxel	NCI
C9752	STY	Therapeutic or Preventive Procedure		NCI
C9752	PT	Maxamine/Interferon Alpha		NCI
C9752	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9752	RO	chemotherapy regimen has component Histamine Dihydrochloride	NCI
C9752	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C136263	STY	Therapeutic or Preventive Procedure		NCI
C136263	PT	Bortezomib/Liposomal Doxorubicin Regimen		NCI
C136263	SY	Bortezomib/Liposomal Doxorubicin		NCI
C136263	SY	Bortezomib-Liposomal Doxorubicin Regimen		NCI
C136263	SY	Bortezomib-Liposomal Doxorubicin		NCI
C136263	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136263	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136263	RO	chemotherapy regimen has component Bortezomib	NCI
C136263	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C63389	STY	Therapeutic or Preventive Procedure		NCI
C63389	PT	ECF Regimen		NCI
C63389	SY	Epirubicin-Cisplatin-Fluorouracil Regimen		NCI
C63389	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C63389	RO	chemotherapy regimen has component Cisplatin	NCI
C63389	RO	chemotherapy regimen has component Fluorouracil	NCI
C63389	RO	regimen has accepted use for disease Gastric Carcinoma	NCI
C63389	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C10283	STY	Therapeutic or Preventive Procedure		NCI
C10283	PT	Fluorouracil/Methotrexate		NCI
C10283	SY	5-FU/MTX		NCI
C10283	SY	MF		NCI
C10283	SY	MeF		NCI
C10283	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10283	RO	chemotherapy regimen has component Fluorouracil	NCI
C10283	RO	chemotherapy regimen has component Methotrexate	NCI
C10405	STY	Therapeutic or Preventive Procedure		NCI
C10405	PT	Carboplatin/Mitoxantrone		NCI
C10405	SY	CBDCA/DHAD		NCI
C10405	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10405	RO	chemotherapy regimen has component Carboplatin	NCI
C10405	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9665	STY	Therapeutic or Preventive Procedure		NCI
C9665	PT	Cisplatin/Etoposide		NCI
C9665	SY	PE		NCI
C9665	SY	VPP		NCI
C9665	SY	VP-Plat		NCI
C9665	SY	CDDP/VP-16		NCI
C9665	SY	PVp		NCI
C9665	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9665	RO	chemotherapy regimen has component Cisplatin	NCI
C9665	RO	chemotherapy regimen has component Etoposide	NCI
C10494	STY	Therapeutic or Preventive Procedure		NCI
C10494	PT	Carboplatin/Fluorouracil/Hydroxyurea/Leucovorin Calcium		NCI
C10494	SY	CBDCA/CF/5-FU/HU		NCI
C10494	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10494	RO	chemotherapy regimen has component Fluorouracil	NCI
C10494	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10494	RO	chemotherapy regimen has component Carboplatin	NCI
C10494	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10631	STY	Therapeutic or Preventive Procedure		NCI
C10631	PT	Asparaginase/Cisplatin/Cytarabine/Dexamethasone/Etoposide		NCI
C10631	SY	ARA-C/ASP/CDDP/DM/VP-16		NCI
C10631	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10631	RO	chemotherapy regimen has component Asparaginase	NCI
C10631	RO	chemotherapy regimen has component Cisplatin	NCI
C10631	RO	chemotherapy regimen has component Cytarabine	NCI
C10631	RO	chemotherapy regimen has component Dexamethasone	NCI
C10631	RO	chemotherapy regimen has component Etoposide	NCI
C10389	STY	Therapeutic or Preventive Procedure		NCI
C10389	PT	Carboplatin/Etoposide/Interleukin-1-Beta		NCI
C10389	SY	CBDCA/IL-1B/VP-16		NCI
C10389	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10389	RO	chemotherapy regimen has component Etoposide	NCI
C10389	RO	chemotherapy regimen has component Carboplatin	NCI
C10389	RO	chemotherapy regimen has component Recombinant Interleukin-1-beta	NCI
C10498	STY	Therapeutic or Preventive Procedure		NCI
C10498	PT	Doxorubicin/Vinblastine		NCI
C10498	SY	DOX/VBL		NCI
C10498	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10498	RO	chemotherapy regimen has component Doxorubicin	NCI
C10498	RO	chemotherapy regimen has component Vinblastine	NCI
C11993	STY	Therapeutic or Preventive Procedure		NCI
C11993	PT	Dexamethasone/Pegaspargase		NCI
C11993	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11993	RO	chemotherapy regimen has component Dexamethasone	NCI
C11993	RO	chemotherapy regimen has component Pegaspargase	NCI
C10103	STY	Therapeutic or Preventive Procedure		NCI
C10103	PT	Bleomycin/Cisplatin/Mitoguazone/Vindesine		NCI
C10103	SY	DVMB		NCI
C10103	SY	BLEO/CDDP/DAVA/MGBG		NCI
C10103	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10103	RO	chemotherapy regimen has component Bleomycin	NCI
C10103	RO	chemotherapy regimen has component Cisplatin	NCI
C10103	RO	chemotherapy regimen has component Mitoguazone	NCI
C10103	RO	chemotherapy regimen has component Vindesine	NCI
C10786	STY	Therapeutic or Preventive Procedure		NCI
C10786	PT	Cisplatin/Cyclophosphamide/Thiotepa		NCI
C10786	SY	CDDP/CTX/TSPA		NCI
C10786	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10786	RO	chemotherapy regimen has component Cisplatin	NCI
C10786	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10786	RO	chemotherapy regimen has component Thiotepa	NCI
C11727	STY	Therapeutic or Preventive Procedure		NCI
C11727	PT	Cytarabine/Daunorubicin/PSC 833		NCI
C11727	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11727	RO	chemotherapy regimen has component Cytarabine	NCI
C11727	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11727	RO	chemotherapy regimen has component Valspodar	NCI
C10382	STY	Therapeutic or Preventive Procedure		NCI
C10382	PT	Carboplatin/Etoposide/Mechlorethamine/Vincristine		NCI
C10382	SY	CBDCA/NM/VCR/VP-16		NCI
C10382	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10382	RO	chemotherapy regimen has component Etoposide	NCI
C10382	RO	chemotherapy regimen has component Vincristine	NCI
C10382	RO	chemotherapy regimen has component Carboplatin	NCI
C10382	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C10765	STY	Therapeutic or Preventive Procedure		NCI
C10765	PT	Carboplatin/Etoposide/Ifosfamide/Milodistim		NCI
C10765	SY	CBDCA/IFF/PIXY321/VP-16		NCI
C10765	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10765	RO	chemotherapy regimen has component Etoposide	NCI
C10765	RO	chemotherapy regimen has component Ifosfamide	NCI
C10765	RO	chemotherapy regimen has component Carboplatin	NCI
C10765	RO	chemotherapy regimen has component Milodistim	NCI
C11326	STY	Therapeutic or Preventive Procedure		NCI
C11326	PT	Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Peptide		NCI
C11326	SY	IFA/IL-12/TYRP		NCI
C11326	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11326	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11326	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11326	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C138048	STY	Therapeutic or Preventive Procedure		NCI
C138048	PT	Docetaxel/Trastuzumab Regimen		NCI
C138048	SY	Taxotere/Herceptin		NCI
C138048	SY	Docetaxel/Trastuzumab		NCI
C138048	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138048	RO	chemotherapy regimen has component Docetaxel	NCI
C138048	RO	chemotherapy regimen has component Trastuzumab	NCI
C10950	STY	Therapeutic or Preventive Procedure		NCI
C10950	PT	Cisplatin/Epoetin Alfa/Iron		NCI
C10950	SY	CDDP/EPO/iron		NCI
C10950	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10950	RO	chemotherapy regimen has component Cisplatin	NCI
C10950	RO	chemotherapy regimen has component Iron	NCI
C10950	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C11448	STY	Therapeutic or Preventive Procedure		NCI
C11448	PT	Incomplete Freund's Adjuvant/Sargramostim/Von Hippel-Lindau Peptide Vaccine		NCI
C11448	SY	GM-CSF/IFA/VHL peptide		NCI
C11448	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11448	RO	chemotherapy regimen has component Sargramostim	NCI
C11448	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11448	RO	chemotherapy regimen has component Von Hippel-Lindau Peptide Vaccine	NCI
C37512	STY	Therapeutic or Preventive Procedure		NCI
C37512	PT	PEG-Interferon Alfa-2b/Thalidomide		NCI
C37512	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37512	RO	chemotherapy regimen has component Thalidomide	NCI
C37512	RO	chemotherapy regimen has component Peginterferon Alfa-2b	NCI
C11477	STY	Therapeutic or Preventive Procedure		NCI
C11477	PT	Chlorambucil/Dexamethasone/Idarubicin		NCI
C11477	SY	CLB/DM/IDA		NCI
C11477	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11477	RO	chemotherapy regimen has component Chlorambucil	NCI
C11477	RO	chemotherapy regimen has component Dexamethasone	NCI
C11477	RO	chemotherapy regimen has component Idarubicin	NCI
C10882	STY	Therapeutic or Preventive Procedure		NCI
C10882	PT	Cyclophosphamide/Filgrastim/Interleukin-6		NCI
C10882	SY	CTX/G-CSF/IL-6		NCI
C10882	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10882	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10882	RO	chemotherapy regimen has component Filgrastim	NCI
C10882	RO	chemotherapy regimen has component Recombinant Interleukin-6	NCI
C10583	STY	Therapeutic or Preventive Procedure		NCI
C10583	PT	Cisplatin/Doxorubicin/Etoposide/Filgrastim/Ifosfamide		NCI
C10583	SY	CDDP/DOX/G-CSF/IFF/VP-16		NCI
C10583	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10583	RO	chemotherapy regimen has component Cisplatin	NCI
C10583	RO	chemotherapy regimen has component Doxorubicin	NCI
C10583	RO	chemotherapy regimen has component Etoposide	NCI
C10583	RO	chemotherapy regimen has component Ifosfamide	NCI
C10583	RO	chemotherapy regimen has component Filgrastim	NCI
C64190	STY	Therapeutic or Preventive Procedure		NCI
C64190	PT	CISCA Regimen		NCI
C64190	SY	Cisplatin-Cytoxan-Adriamycin Regimen		NCI
C64190	CHD	Chemotherapy Regimen Used to Treat Bladder Carcinoma	NCI
C64190	RO	chemotherapy regimen has component Cisplatin	NCI
C64190	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C64190	RO	chemotherapy regimen has component Doxorubicin	NCI
C64190	RO	regimen has accepted use for disease Bladder Carcinoma	NCI
C11848	STY	Therapeutic or Preventive Procedure		NCI
C11848	PT	Cytarabine/Gemtuzumab Ozogamicin		NCI
C11848	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11848	RO	chemotherapy regimen has component Cytarabine	NCI
C11848	RO	chemotherapy regimen has component Gemtuzumab Ozogamicin	NCI
C10521	STY	Therapeutic or Preventive Procedure		NCI
C10521	PT	Chlorambucil/Ethacrynic Acid		NCI
C10521	SY	CLB/EA		NCI
C10521	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10521	RO	chemotherapy regimen has component Chlorambucil	NCI
C10521	RO	chemotherapy regimen has component Ethacrynic Acid	NCI
C140114	STY	Therapeutic or Preventive Procedure		NCI
C140114	PT	VIPD Regimen		NCI
C140114	SY	Etoposide-Ifosfamide-Cisplatin-Dexamethasone		NCI
C140114	SY	Etoposide/Ifosfamide/Cisplatin/Dexamethasone		NCI
C140114	SY	VIPD		NCI
C140114	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140114	RO	chemotherapy regimen has component Cisplatin	NCI
C140114	RO	chemotherapy regimen has component Dexamethasone	NCI
C140114	RO	chemotherapy regimen has component Etoposide	NCI
C140114	RO	chemotherapy regimen has component Ifosfamide	NCI
C10429	STY	Therapeutic or Preventive Procedure		NCI
C10429	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Prednisone		NCI
C10429	SY	CDDP/CTX/DOX/PRED		NCI
C10429	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10429	RO	chemotherapy regimen has component Cisplatin	NCI
C10429	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10429	RO	chemotherapy regimen has component Doxorubicin	NCI
C10429	RO	chemotherapy regimen has component Prednisone	NCI
C11596	STY	Therapeutic or Preventive Procedure		NCI
C11596	PT	gp100 Antigen/MAGE-3/MART-1 Antigen/Tyrosinase Peptide		NCI
C11596	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11596	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11596	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11596	RO	chemotherapy regimen has component Recombinant MAGE-3.1 Antigen	NCI
C11596	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10098	STY	Therapeutic or Preventive Procedure		NCI
C10098	PT	Amsacrine/Decitabine		NCI
C10098	SY	AMSA/5-AZA-dCyd		NCI
C10098	SY	AMSA/DAC		NCI
C10098	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10098	RO	chemotherapy regimen has component Amsacrine	NCI
C10098	RO	chemotherapy regimen has component Decitabine	NCI
C37476	STY	Therapeutic or Preventive Procedure		NCI
C37476	PT	Docetaxel/Geldanamycin Analogue		NCI
C37476	SY	Docetaxel/Geldanamycin Analog		NCI
C37476	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37476	RO	chemotherapy regimen has component Docetaxel	NCI
C37476	RO	chemotherapy regimen has component Geldanamycin Analogue	NCI
C10924	STY	Therapeutic or Preventive Procedure		NCI
C10924	PT	Carboxyamidotriazole/Paclitaxel		NCI
C10924	SY	CAI/TAX		NCI
C10924	SY	CAI/Paclitaxel		NCI
C10924	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10924	RO	chemotherapy regimen has component Carboxyamidotriazole	NCI
C10924	RO	chemotherapy regimen has component Paclitaxel	NCI
C11649	STY	Therapeutic or Preventive Procedure		NCI
C11649	PT	L-778,123/Paclitaxel		NCI
C11649	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11649	RO	chemotherapy regimen has component Paclitaxel	NCI
C11649	RO	chemotherapy regimen has component L-778,123	NCI
C9557	STY	Therapeutic or Preventive Procedure		NCI
C9557	PT	Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Vincristine		NCI
C9557	SY	CTX/5-FU/MTX/PRED/VCR		NCI
C9557	SY	CMFVP		NCI
C9557	SY	VPCMF		NCI
C9557	SY	CFPMV		NCI
C9557	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9557	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9557	RO	chemotherapy regimen has component Fluorouracil	NCI
C9557	RO	chemotherapy regimen has component Methotrexate	NCI
C9557	RO	chemotherapy regimen has component Prednisone	NCI
C9557	RO	chemotherapy regimen has component Vincristine	NCI
C63717	STY	Therapeutic or Preventive Procedure		NCI
C63717	PT	IFL-Douillard Regimen		NCI
C63717	SY	Irinotecan-Fluorouracil-Leucovorin Douillard Regimen		NCI
C63717	SY	Douillard Regimen		NCI
C63717	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C63717	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63717	RO	chemotherapy regimen has component Fluorouracil	NCI
C63717	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C63717	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10036	STY	Therapeutic or Preventive Procedure		NCI
C10036	PT	Cytarabine/Prednisone/Vincristine/Zorubicin		NCI
C10036	SY	ROAP		NCI
C10036	SY	ARA-C/PRED/VCR/RBZ		NCI
C10036	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10036	RO	chemotherapy regimen has component Cytarabine	NCI
C10036	RO	chemotherapy regimen has component Prednisone	NCI
C10036	RO	chemotherapy regimen has component Vincristine	NCI
C10036	RO	chemotherapy regimen has component Zorubicin Hydrochloride	NCI
C37753	STY	Therapeutic or Preventive Procedure		NCI
C37753	PT	Doxorubicin/Oblimersen		NCI
C37753	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37753	RO	chemotherapy regimen has component Doxorubicin	NCI
C37753	RO	chemotherapy regimen has component Oblimersen	NCI
C10393	STY	Therapeutic or Preventive Procedure		NCI
C10393	PT	Eflornithine/Lomustine/Procarbazine/Vincristine		NCI
C10393	SY	CCNU/DFMO/PCB/VCR		NCI
C10393	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10393	RO	chemotherapy regimen has component Eflornithine	NCI
C10393	RO	chemotherapy regimen has component Lomustine	NCI
C10393	RO	chemotherapy regimen has component Vincristine	NCI
C10393	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9820	STY	Therapeutic or Preventive Procedure		NCI
C9820	PT	Cisplatin/Teniposide		NCI
C9820	SY	CDDP/VM-26		NCI
C9820	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9820	RO	chemotherapy regimen has component Cisplatin	NCI
C9820	RO	chemotherapy regimen has component Teniposide	NCI
C10543	STY	Therapeutic or Preventive Procedure		NCI
C10543	PT	Etoposide/Ketoconazole/Metronidazole		NCI
C10543	SY	KCZ/METRO/VP-16		NCI
C10543	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10543	RO	chemotherapy regimen has component Etoposide	NCI
C10543	RO	chemotherapy regimen has component Ketoconazole	NCI
C10543	RO	chemotherapy regimen has component Metronidazole	NCI
C15628	STY	Therapeutic or Preventive Procedure		NCI
C15628	PT	Interferon Alfa/Monoclonal Antibody CC49/Pentetic Acid		NCI
C15628	SY	DTPA/IFN-A/MOAB CC49		NCI
C15628	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15628	RO	chemotherapy regimen has component Pentetic Acid	NCI
C15628	RO	chemotherapy regimen has component Minretumomab	NCI
C15628	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10973	STY	Therapeutic or Preventive Procedure		NCI
C10973	PT	Ifosfamide/Vinorelbine		NCI
C10973	SY	IFF/VNB		NCI
C10973	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10973	RO	chemotherapy regimen has component Ifosfamide	NCI
C10973	RO	chemotherapy regimen has component Vinorelbine	NCI
C63788	STY	Therapeutic or Preventive Procedure		NCI
C63788	PT	Pemetrexed-Cisplatin Regimen		NCI
C63788	SY	Cisplatin/Pemetrexed		NCI
C63788	SY	Cisplatin-Pemetrexed Regimen		NCI
C63788	CHD	Chemotherapy Regimen Used to Treat Malignant Mesothelioma	NCI
C63788	RO	chemotherapy regimen has component Cisplatin	NCI
C63788	RO	regimen has accepted use for disease Malignant Mesothelioma	NCI
C63788	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C9645	STY	Therapeutic or Preventive Procedure		NCI
C9645	PT	Dexamethasone/Doxorubicin/Vincristine		NCI
C9645	SY	VAD		NCI
C9645	SY	DM/DOX/VCR		NCI
C9645	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9645	RO	chemotherapy regimen has component Dexamethasone	NCI
C9645	RO	chemotherapy regimen has component Doxorubicin	NCI
C9645	RO	chemotherapy regimen has component Vincristine	NCI
C156306	STY	Therapeutic or Preventive Procedure		NCI
C156306	PT	Fulvestrant/Trastuzumab Regimen		NCI
C156306	SY	Fulvestrant/Trastuzumab		NCI
C156306	SY	Fulvestrant-Trastuzumab		NCI
C156306	SY	Trastuzumab/Fulvestrant Regimen		NCI
C156306	SY	Trastuzumab/Fulvestrant		NCI
C156306	SY	Fulvestrant/Herceptin		NCI
C156306	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156306	RO	chemotherapy regimen has component Trastuzumab	NCI
C156306	RO	chemotherapy regimen has component Fulvestrant	NCI
C11075	STY	Therapeutic or Preventive Procedure		NCI
C11075	PT	Carmustine/Cisplatin/Dacarbazine/Interferon Alfa/interleukin-2/Tamoxifen		NCI
C11075	SY	BCNU/CDDP/DTIC/IFN-A/IL-2/TMX		NCI
C11075	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11075	RO	chemotherapy regimen has component Carmustine	NCI
C11075	RO	chemotherapy regimen has component Cisplatin	NCI
C11075	RO	chemotherapy regimen has component Dacarbazine	NCI
C11075	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11075	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11075	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C9691	STY	Therapeutic or Preventive Procedure		NCI
C9691	PT	Asparaginase/Cyclophosphamide/Doxorubicin/Prednisolone/Vincristine		NCI
C9691	SY	ASP/CTX/DOX/PRDL/VCR		NCI
C9691	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9691	RO	chemotherapy regimen has component Asparaginase	NCI
C9691	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9691	RO	chemotherapy regimen has component Doxorubicin	NCI
C9691	RO	chemotherapy regimen has component Prednisolone	NCI
C9691	RO	chemotherapy regimen has component Vincristine	NCI
C10070	STY	Therapeutic or Preventive Procedure		NCI
C10070	PT	Cyclophosphamide/Doxorubicin/Etoposide/Fluorouracil		NCI
C10070	SY	CTX/DOX/5-FU/VP-16		NCI
C10070	SY	FACVP		NCI
C10070	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10070	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10070	RO	chemotherapy regimen has component Doxorubicin	NCI
C10070	RO	chemotherapy regimen has component Etoposide	NCI
C10070	RO	chemotherapy regimen has component Fluorouracil	NCI
C11449	STY	Therapeutic or Preventive Procedure		NCI
C11449	PT	Carmustine/Fluorouracil/Streptozocin/Vincristine		NCI
C11449	SY	BCNU/5-FU/SZC/VCR		NCI
C11449	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11449	RO	chemotherapy regimen has component Carmustine	NCI
C11449	RO	chemotherapy regimen has component Fluorouracil	NCI
C11449	RO	chemotherapy regimen has component Streptozocin	NCI
C11449	RO	chemotherapy regimen has component Vincristine	NCI
C136259	STY	Therapeutic or Preventive Procedure		NCI
C136259	PT	Irinotecan/Ziv-aflibercept Regimen		NCI
C136259	SY	Irinotecan-Ziv-aflibercept		NCI
C136259	SY	Irinotecan-Zaltrap Regimen		NCI
C136259	SY	Irinotecan-Ziv-aflibercept Regimen		NCI
C136259	SY	Irinotecan/Zaltrap Regimen		NCI
C136259	SY	Irinotecan/Ziv-aflibercept		NCI
C136259	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136259	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136259	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C136259	RO	chemotherapy regimen has component Ziv-Aflibercept	NCI
C37704	STY	Therapeutic or Preventive Procedure		NCI
C37704	PT	Cyproterone/Triptorelin		NCI
C37704	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37704	RO	chemotherapy regimen has component Cyproterone	NCI
C37704	RO	chemotherapy regimen has component Triptorelin	NCI
C9943	STY	Therapeutic or Preventive Procedure		NCI
C9943	PT	Fluorouracil/Melphalan/Tamoxifen		NCI
C9943	SY	5-FU/L-PAM/TMX		NCI
C9943	SY	PFT		NCI
C9943	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9943	RO	chemotherapy regimen has component Fluorouracil	NCI
C9943	RO	chemotherapy regimen has component Melphalan	NCI
C9943	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C63782	STY	Therapeutic or Preventive Procedure		NCI
C63782	PT	IFN-DTIC Regimen		NCI
C63782	SY	Interferon-Dacarbazine Regimen		NCI
C63782	CHD	Chemotherapy Regimen Used to Treat Melanoma	NCI
C63782	RO	chemotherapy regimen has component Dacarbazine	NCI
C63782	RO	regimen has accepted use for disease Melanoma	NCI
C63782	RO	chemotherapy regimen has component Recombinant Interferon	NCI
C37632	STY	Therapeutic or Preventive Procedure		NCI
C37632	PT	Celecoxib/Fluorouracil/Irinotecan/Leucovorin Calcium		NCI
C37632	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37632	RO	chemotherapy regimen has component Fluorouracil	NCI
C37632	RO	chemotherapy regimen has component Celecoxib	NCI
C37632	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37632	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10715	STY	Therapeutic or Preventive Procedure		NCI
C10715	PT	Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/Zidovudine		NCI
C10715	SY	CTX/DOX/PRED/VCR/VP-16/ZDV		NCI
C10715	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10715	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10715	RO	chemotherapy regimen has component Doxorubicin	NCI
C10715	RO	chemotherapy regimen has component Etoposide	NCI
C10715	RO	chemotherapy regimen has component Prednisone	NCI
C10715	RO	chemotherapy regimen has component Vincristine	NCI
C10715	RO	chemotherapy regimen has component Zidovudine	NCI
C11592	STY	Therapeutic or Preventive Procedure		NCI
C11592	PT	Carboplatin/Monoclonal Antibody HER2/Paclitaxel		NCI
C11592	SY	CBDCA/MOAB HER2/TAX		NCI
C11592	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11592	RO	chemotherapy regimen has component Carboplatin	NCI
C11592	RO	chemotherapy regimen has component Paclitaxel	NCI
C11592	RO	chemotherapy regimen has component Trastuzumab	NCI
C10353	STY	Therapeutic or Preventive Procedure		NCI
C10353	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Goserelin/Tamoxifen		NCI
C10353	SY	CTX/DOX/5-FU/TMX/ZDX		NCI
C10353	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10353	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10353	RO	chemotherapy regimen has component Doxorubicin	NCI
C10353	RO	chemotherapy regimen has component Fluorouracil	NCI
C10353	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10353	RO	chemotherapy regimen has component Goserelin	NCI
C37861	STY	Therapeutic or Preventive Procedure		NCI
C37861	PT	Topotecan/UCN-01		NCI
C37861	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37861	RO	chemotherapy regimen has component 7-Hydroxystaurosporine	NCI
C37861	RO	chemotherapy regimen has component Topotecan	NCI
C63592	STY	Therapeutic or Preventive Procedure		NCI
C63592	PT	FOLFOX-7 Regimen		NCI
C63592	SY	Folinic Acid-Fluorouracil-Oxaliplatin-7 Regimen		NCI
C63592	CHD	FOLFOX Regimen	NCI
C63592	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C63592	RO	chemotherapy regimen has component Fluorouracil	NCI
C63592	RO	chemotherapy regimen has component Oxaliplatin	NCI
C63592	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63454	STY	Therapeutic or Preventive Procedure		NCI
C63454	PT	FND Regimen		NCI
C63454	SY	FMD Regimen		NCI
C63454	SY	Fludarabine-Novantrone-Dexamethasone Regimen		NCI
C63454	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63454	RO	chemotherapy regimen has component Dexamethasone	NCI
C63454	RO	chemotherapy regimen has component Fludarabine	NCI
C63454	RO	regimen has accepted use for disease Indolent Adult Non-Hodgkin Lymphoma	NCI
C63454	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C11581	STY	Therapeutic or Preventive Procedure		NCI
C11581	PT	Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Related Protein-1		NCI
C11581	SY	Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase-Related Protein-1		NCI
C11581	SY	Incomplete Freunds Adjuvant/Interleukin-12/Tyrosinase-Related Protein-1		NCI
C11581	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11581	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11581	RO	chemotherapy regimen has component Recombinant Tyrosinase-Related Protein-1	NCI
C11581	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C10362	STY	Therapeutic or Preventive Procedure		NCI
C10362	PT	Asparaginase/Cyclophosphamide/Cytarabine/Idarubicin/Methotrexate/Prednisone/Vincristine		NCI
C10362	SY	ARA-C/ASP/CTX/IDA/MTX/PRED/VCR		NCI
C10362	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10362	RO	chemotherapy regimen has component Asparaginase	NCI
C10362	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10362	RO	chemotherapy regimen has component Cytarabine	NCI
C10362	RO	chemotherapy regimen has component Idarubicin	NCI
C10362	RO	chemotherapy regimen has component Methotrexate	NCI
C10362	RO	chemotherapy regimen has component Prednisone	NCI
C10362	RO	chemotherapy regimen has component Vincristine	NCI
C138053	STY	Therapeutic or Preventive Procedure		NCI
C138053	PT	Trastuzumab/Vinorelbine Regimen		NCI
C138053	SY	Vinorelbine + Trastuzumab		NCI
C138053	SY	Vinorelbine-Trastuzumab		NCI
C138053	SY	Vinorelbine/Trastuzumab		NCI
C138053	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138053	RO	chemotherapy regimen has component Vinorelbine	NCI
C138053	RO	chemotherapy regimen has component Trastuzumab	NCI
C9791	STY	Therapeutic or Preventive Procedure		NCI
C9791	PT	Fluorouracil/Leucovorin Calcium		NCI
C9791	SY	CF/5-FU		NCI
C9791	SY	5FU/Leucovorin		NCI
C9791	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9791	RO	chemotherapy regimen has component Fluorouracil	NCI
C9791	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12019	STY	Therapeutic or Preventive Procedure		NCI
C12019	PT	Fluorouracil/Irinotecan/Leucovorin Calcium/SU5416		NCI
C12019	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12019	RO	chemotherapy regimen has component Fluorouracil	NCI
C12019	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C12019	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12019	RO	chemotherapy regimen has component Semaxanib	NCI
C10944	STY	Therapeutic or Preventive Procedure		NCI
C10944	PT	Dexamethasone/Idarubicin/Ifosfamide/Methotrexate/Thioguanine/Vincristine		NCI
C10944	SY	DM/IDA/IFF/MTX/TG/VCR		NCI
C10944	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10944	RO	chemotherapy regimen has component Dexamethasone	NCI
C10944	RO	chemotherapy regimen has component Idarubicin	NCI
C10944	RO	chemotherapy regimen has component Ifosfamide	NCI
C10944	RO	chemotherapy regimen has component Methotrexate	NCI
C10944	RO	chemotherapy regimen has component Thioguanine	NCI
C10944	RO	chemotherapy regimen has component Vincristine	NCI
C11972	STY	Therapeutic or Preventive Procedure		NCI
C11972	PT	Cytarabine/Daunorubicin/Dexamethasone/Prednisolone/Thioguanine/Vincristine		NCI
C11972	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11972	RO	chemotherapy regimen has component Cytarabine	NCI
C11972	RO	chemotherapy regimen has component Dexamethasone	NCI
C11972	RO	chemotherapy regimen has component Prednisolone	NCI
C11972	RO	chemotherapy regimen has component Thioguanine	NCI
C11972	RO	chemotherapy regimen has component Vincristine	NCI
C11972	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9934	STY	Therapeutic or Preventive Procedure		NCI
C9934	PT	Cytarabine/Methotrexate/Prednisone/Vincristine		NCI
C9934	SY	AMVP		NCI
C9934	SY	ARA-C/MTX/PRED/VCR		NCI
C9934	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9934	RO	chemotherapy regimen has component Cytarabine	NCI
C9934	RO	chemotherapy regimen has component Methotrexate	NCI
C9934	RO	chemotherapy regimen has component Prednisone	NCI
C9934	RO	chemotherapy regimen has component Vincristine	NCI
C37720	STY	Therapeutic or Preventive Procedure		NCI
C37720	PT	Cytochlor/Tetrahydrouridine		NCI
C37720	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37720	RO	chemotherapy regimen has component Tetrahydrouridine	NCI
C37720	RO	chemotherapy regimen has component Cytochlor	NCI
C9782	STY	Therapeutic or Preventive Procedure		NCI
C9782	PT	Bleomycin/Carboplatin		NCI
C9782	SY	BLEO/CBDCA		NCI
C9782	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9782	RO	chemotherapy regimen has component Bleomycin	NCI
C9782	RO	chemotherapy regimen has component Carboplatin	NCI
C11260	STY	Therapeutic or Preventive Procedure		NCI
C11260	PT	Cisplatin/Ifosfamide/Mesna/Mitomycin		NCI
C11260	SY	CDDP/IFF/mesna/MITO		NCI
C11260	SY	MIMIC		NCI
C11260	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11260	RO	chemotherapy regimen has component Mesna	NCI
C11260	RO	chemotherapy regimen has component Mitomycin	NCI
C11260	RO	chemotherapy regimen has component Cisplatin	NCI
C11260	RO	chemotherapy regimen has component Ifosfamide	NCI
C9610	STY	Therapeutic or Preventive Procedure		NCI
C9610	PT	Cyclophosphamide/Lomustine/Methotrexate		NCI
C9610	SY	CCNU/CTX/MTX		NCI
C9610	SY	CMCC		NCI
C9610	SY	CMC		NCI
C9610	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9610	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9610	RO	chemotherapy regimen has component Lomustine	NCI
C9610	RO	chemotherapy regimen has component Methotrexate	NCI
C64795	STY	Therapeutic or Preventive Procedure		NCI
C64795	PT	COPP-ABVD Regimen		NCI
C64795	SY	Cytoxan-Oncovin-Procarbazine-Prednisone/Adriamycin-Bleomycin-Vinblastine-Dacarbazine Regimen		NCI
C64795	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C64795	RO	chemotherapy regimen has component Bleomycin	NCI
C64795	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C64795	RO	chemotherapy regimen has component Dacarbazine	NCI
C64795	RO	chemotherapy regimen has component Doxorubicin	NCI
C64795	RO	chemotherapy regimen has component Prednisone	NCI
C64795	RO	chemotherapy regimen has component Vinblastine	NCI
C64795	RO	chemotherapy regimen has component Vincristine	NCI
C64795	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C64795	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C9649	STY	Therapeutic or Preventive Procedure		NCI
C9649	PT	Cyclophosphamide/Cytarabine/Doxorubicin/Prednisone/Vincristine		NCI
C9649	SY	POACH		NCI
C9649	SY	ARA-C/CTX/DOX/PRED/VCR		NCI
C9649	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9649	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9649	RO	chemotherapy regimen has component Cytarabine	NCI
C9649	RO	chemotherapy regimen has component Doxorubicin	NCI
C9649	RO	chemotherapy regimen has component Prednisone	NCI
C9649	RO	chemotherapy regimen has component Vincristine	NCI
C37724	STY	Therapeutic or Preventive Procedure		NCI
C37724	PT	Daclizumab/Interleukin-2		NCI
C37724	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37724	RO	chemotherapy regimen has component Daclizumab	NCI
C37724	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10709	STY	Therapeutic or Preventive Procedure		NCI
C10709	PT	Ketoconazole/Paclitaxel		NCI
C10709	SY	KCZ/TAX		NCI
C10709	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10709	RO	chemotherapy regimen has component Ketoconazole	NCI
C10709	RO	chemotherapy regimen has component Paclitaxel	NCI
C10839	STY	Therapeutic or Preventive Procedure		NCI
C10839	PT	Carboplatin/Cyclophosphamide/Milodistim/Thiotepa		NCI
C10839	SY	CBDCA/CTX/PIXY321/TSPA		NCI
C10839	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10839	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10839	RO	chemotherapy regimen has component Thiotepa	NCI
C10839	RO	chemotherapy regimen has component Carboplatin	NCI
C10839	RO	chemotherapy regimen has component Milodistim	NCI
C10124	STY	Therapeutic or Preventive Procedure		NCI
C10124	PT	Bleomycin/Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Prednisone/Vincristine		NCI
C10124	SY	ARA-C/BLEO/CTX/DOX/MTX/PRED/VCR		NCI
C10124	SY	COMLA-Plus		NCI
C10124	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10124	RO	chemotherapy regimen has component Bleomycin	NCI
C10124	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10124	RO	chemotherapy regimen has component Cytarabine	NCI
C10124	RO	chemotherapy regimen has component Doxorubicin	NCI
C10124	RO	chemotherapy regimen has component Methotrexate	NCI
C10124	RO	chemotherapy regimen has component Prednisone	NCI
C10124	RO	chemotherapy regimen has component Vincristine	NCI
C37646	STY	Therapeutic or Preventive Procedure		NCI
C37646	PT	Cisplatin/Cytarabine/Methylprednisolone/Pixantrone/Rituximab		NCI
C37646	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37646	RO	chemotherapy regimen has component Cisplatin	NCI
C37646	RO	chemotherapy regimen has component Cytarabine	NCI
C37646	RO	chemotherapy regimen has component Methylprednisolone	NCI
C37646	RO	chemotherapy regimen has component Pixantrone	NCI
C37646	RO	chemotherapy regimen has component Rituximab	NCI
C29542	STY	Therapeutic or Preventive Procedure		NCI
C29542	PT	Etoposide/Prednisone/Vinblastine		NCI
C29542	SY	Vinblastine/Etoposide/Pred		NCI
C29542	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C29542	RO	chemotherapy regimen has component Etoposide	NCI
C29542	RO	chemotherapy regimen has component Prednisone	NCI
C29542	RO	chemotherapy regimen has component Vinblastine	NCI
C11746	STY	Therapeutic or Preventive Procedure		NCI
C11746	PT	Docetaxel/Thalidomide		NCI
C11746	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11746	RO	chemotherapy regimen has component Thalidomide	NCI
C11746	RO	chemotherapy regimen has component Docetaxel	NCI
C37503	STY	Therapeutic or Preventive Procedure		NCI
C37503	PT	E7070/Irinotecan		NCI
C37503	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37503	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37503	RO	chemotherapy regimen has component Indisulam	NCI
C63458	STY	Therapeutic or Preventive Procedure		NCI
C63458	PT	m-BACOD Regimen		NCI
C63458	SY	Methotrexate-Bleomycin-Adriamycin-Cytoxan-Oncovin-Decadron Regimen		NCI
C63458	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63458	RO	chemotherapy regimen has component Bleomycin	NCI
C63458	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63458	RO	chemotherapy regimen has component Dexamethasone	NCI
C63458	RO	chemotherapy regimen has component Doxorubicin	NCI
C63458	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C63458	RO	chemotherapy regimen has component Methotrexate	NCI
C63458	RO	chemotherapy regimen has component Vincristine	NCI
C63458	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C63687	STY	Therapeutic or Preventive Procedure		NCI
C63687	PT	Gemcitabine-Docetaxel Regimen		NCI
C63687	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C63687	RO	chemotherapy regimen has component Docetaxel	NCI
C63687	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63687	RO	regimen has accepted use for disease Soft Tissue Sarcoma	NCI
C136260	STY	Therapeutic or Preventive Procedure		NCI
C136260	PT	Irinotecan/Ramucirumab Regimen		NCI
C136260	SY	Irinotecan-Cyramza Regimen		NCI
C136260	SY	Irinotecan/Ramucirumab		NCI
C136260	SY	Irinotecan-Ramucirumab		NCI
C136260	SY	Irinotecan-Ramucirumab Regimen		NCI
C136260	SY	Irinotecan/Cyramza Regimen		NCI
C136260	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C136260	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C136260	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C136260	RO	chemotherapy regimen has component Ramucirumab	NCI
C11041	STY	Therapeutic or Preventive Procedure		NCI
C11041	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Filgrastim		NCI
C11041	SY	CDDP/CTX/DOX/G-CSF/VP-16		NCI
C11041	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11041	RO	chemotherapy regimen has component Cisplatin	NCI
C11041	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11041	RO	chemotherapy regimen has component Doxorubicin	NCI
C11041	RO	chemotherapy regimen has component Etoposide	NCI
C11041	RO	chemotherapy regimen has component Filgrastim	NCI
C11095	STY	Therapeutic or Preventive Procedure		NCI
C11095	PT	Cisplatin/Fluorouracil/L-Leucovorin		NCI
C11095	SY	CDDP/5-FU/L-CF		NCI
C11095	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11095	RO	chemotherapy regimen has component Cisplatin	NCI
C11095	RO	chemotherapy regimen has component Fluorouracil	NCI
C11095	RO	chemotherapy regimen has component Levoleucovorin	NCI
C10910	STY	Therapeutic or Preventive Procedure		NCI
C10910	PT	Carmustine/O6-Benzylguanine		NCI
C10910	SY	BCNU/BG		NCI
C10910	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10910	RO	chemotherapy regimen has component Carmustine	NCI
C10910	RO	chemotherapy regimen has component O6-Benzylguanine	NCI
C12118	STY	Therapeutic or Preventive Procedure		NCI
C12118	PT	Dexamethasone/Doxorubicin		NCI
C12118	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12118	RO	chemotherapy regimen has component Dexamethasone	NCI
C12118	RO	chemotherapy regimen has component Doxorubicin	NCI
C10055	STY	Therapeutic or Preventive Procedure		NCI
C10055	PT	Cyclophosphamide/Doxorubicin/Folic Acid/Methotrexate		NCI
C10055	SY	CTX/DOX/FA/MTX		NCI
C10055	SY	CAMF		NCI
C10055	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10055	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10055	RO	chemotherapy regimen has component Doxorubicin	NCI
C10055	RO	chemotherapy regimen has component Folic Acid	NCI
C10055	RO	chemotherapy regimen has component Methotrexate	NCI
C11754	STY	Therapeutic or Preventive Procedure		NCI
C11754	PT	Docetaxel/Doxorubicin Hcl Liposome/Trastuzumab		NCI
C11754	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11754	RO	chemotherapy regimen has component Docetaxel	NCI
C11754	RO	chemotherapy regimen has component Trastuzumab	NCI
C11754	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C12163	STY	Therapeutic or Preventive Procedure		NCI
C12163	PT	Cytarabine/Filgrastim/Mitoxantrone		NCI
C12163	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12163	RO	chemotherapy regimen has component Cytarabine	NCI
C12163	RO	chemotherapy regimen has component Filgrastim	NCI
C12163	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C154218	STY	Therapeutic or Preventive Procedure		NCI
C154218	PT	Chlorambucil/Rituximab Regimen		NCI
C154218	SY	Chlorambucil + Rituximab		NCI
C154218	SY	Chlorambucil/Rituximab		NCI
C154218	SY	Chlorambucil-Rituximab Regimen		NCI
C154218	SY	Rituximab + Chlorambucil		NCI
C154218	SY	Rituximab/Chlorambucil Regimen		NCI
C154218	SY	Chlorambucil-Rituximab		NCI
C154218	SY	Chlorambucil Plus Rituximab		NCI
C154218	CHD	Chemotherapy Regimen Used to Treat Chronic Lymphocytic Leukemia	NCI
C154218	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C154218	RO	chemotherapy regimen has component Chlorambucil	NCI
C154218	RO	chemotherapy regimen has component Rituximab	NCI
C11007	STY	Therapeutic or Preventive Procedure		NCI
C11007	PT	Doxorubicin/Interferon Alfa		NCI
C11007	SY	DOX/IFN-A		NCI
C11007	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11007	RO	chemotherapy regimen has component Doxorubicin	NCI
C11007	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11297	STY	Therapeutic or Preventive Procedure		NCI
C11297	PT	Doxorubicin/Raltitrexed		NCI
C11297	SY	DOX/ICI D1694		NCI
C11297	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11297	RO	chemotherapy regimen has component Doxorubicin	NCI
C11297	RO	chemotherapy regimen has component Raltitrexed	NCI
C63399	STY	Therapeutic or Preventive Procedure		NCI
C63399	PT	FLAP Regimen		NCI
C63399	SY	Fluorouracil-Leucovorin-Adriamycin-Platinol Regimen		NCI
C63399	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C63399	RO	chemotherapy regimen has component Cisplatin	NCI
C63399	RO	chemotherapy regimen has component Doxorubicin	NCI
C63399	RO	chemotherapy regimen has component Fluorouracil	NCI
C63399	RO	regimen has accepted use for disease Gastric Carcinoma	NCI
C63399	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10246	STY	Amino Acid, Peptide, or Protein		NCI
C10246	STY	Immunologic Factor		NCI
C10246	PT	Interleukin-2/Lymphokine-Activated Killer Cells		NCI
C10246	SY	IL2/LAK		NCI
C10246	SY	IL-2/LAK		NCI
C10246	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10246	RO	chemotherapy regimen has component Lymphokine-Activated Killer Cells	NCI
C10246	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11009	STY	Therapeutic or Preventive Procedure		NCI
C11009	PT	Interferon Alfa/Isotretinoin		NCI
C11009	SY	13-CRA/IFN-A		NCI
C11009	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11009	RO	chemotherapy regimen has component Isotretinoin	NCI
C11009	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10004	STY	Therapeutic or Preventive Procedure		NCI
C10004	PT	Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone/Tamoxifen/Vincristine		NCI
C10004	SY	CMFVP(T)		NCI
C10004	SY	CTX/5-FU/MTX/PRED/TMX/VCR		NCI
C10004	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10004	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10004	RO	chemotherapy regimen has component Fluorouracil	NCI
C10004	RO	chemotherapy regimen has component Methotrexate	NCI
C10004	RO	chemotherapy regimen has component Prednisone	NCI
C10004	RO	chemotherapy regimen has component Vincristine	NCI
C10004	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10451	STY	Therapeutic or Preventive Procedure		NCI
C10451	PT	Altretamine/Carboplatin/Cyclophosphamide		NCI
C10451	SY	CBDCA/CTX/HMM		NCI
C10451	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10451	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10451	RO	chemotherapy regimen has component Altretamine	NCI
C10451	RO	chemotherapy regimen has component Carboplatin	NCI
C10956	STY	Therapeutic or Preventive Procedure		NCI
C10956	PT	Cytarabine/Dexamethasone/Etoposide/Idarubicin/Thioguanine		NCI
C10956	SY	IDA DCTER		NCI
C10956	SY	ARA-C/DM/IDA/TG/VP-16		NCI
C10956	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10956	RO	chemotherapy regimen has component Cytarabine	NCI
C10956	RO	chemotherapy regimen has component Dexamethasone	NCI
C10956	RO	chemotherapy regimen has component Etoposide	NCI
C10956	RO	chemotherapy regimen has component Idarubicin	NCI
C10956	RO	chemotherapy regimen has component Thioguanine	NCI
C10926	STY	Therapeutic or Preventive Procedure		NCI
C10926	PT	BMS-182751/Etoposide		NCI
C10926	SY	BMS-182751/VP-16		NCI
C10926	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10926	RO	chemotherapy regimen has component Etoposide	NCI
C10926	RO	chemotherapy regimen has component Satraplatin	NCI
C11735	STY	Therapeutic or Preventive Procedure		NCI
C11735	PT	Keyhole Limpet Hemocyanin/Polysialic Acid		NCI
C11735	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11735	RO	chemotherapy regimen has component Keyhole Limpet Hemocyanin	NCI
C11735	RO	chemotherapy regimen has component Polysialic Acid	NCI
C37824	STY	Therapeutic or Preventive Procedure		NCI
C37824	PT	Lomustine/Temozolomide/Thalidomide		NCI
C37824	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37824	RO	chemotherapy regimen has component Lomustine	NCI
C37824	RO	chemotherapy regimen has component Thalidomide	NCI
C37824	RO	chemotherapy regimen has component Temozolomide	NCI
C11583	STY	Therapeutic or Preventive Procedure		NCI
C11583	PT	Incomplete Freund's Adjuvant/Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine		NCI
C11583	SY	IFA/p946/Tet p		NCI
C11583	SY	Incomplete Freund's Adjuvant/Peptide 946 Melanoma Vaccine/Tetanus Peptide Melanoma Vaccine		NCI
C11583	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11583	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11583	RO	chemotherapy regimen has component Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine	NCI
C9683	STY	Therapeutic or Preventive Procedure		NCI
C9683	PT	Carmustine/Cyclophosphamide/Cytarabine/Etoposide		NCI
C9683	SY	BEAC		NCI
C9683	SY	ARA-C/BCNU/CTX/VP-16		NCI
C9683	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9683	RO	chemotherapy regimen has component Carmustine	NCI
C9683	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9683	RO	chemotherapy regimen has component Cytarabine	NCI
C9683	RO	chemotherapy regimen has component Etoposide	NCI
C9911	STY	Therapeutic or Preventive Procedure		NCI
C9911	PT	Etoposide/Lomustine/Methotrexate/Prednisone		NCI
C9911	SY	CCNU/MTX/PRED/VP-16		NCI
C9911	SY	LEMP		NCI
C9911	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9911	RO	chemotherapy regimen has component Etoposide	NCI
C9911	RO	chemotherapy regimen has component Lomustine	NCI
C9911	RO	chemotherapy regimen has component Methotrexate	NCI
C9911	RO	chemotherapy regimen has component Prednisone	NCI
C10712	STY	Therapeutic or Preventive Procedure		NCI
C10712	PT	Asparaginase/Cyclophosphamide/Cytarabine/Dexamethasone/Doxorubicin/Mercaptopurine/Vincristine		NCI
C10712	SY	ARA-C/ASP/CTX/DM/DOX/MP/VCR		NCI
C10712	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10712	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10712	RO	chemotherapy regimen has component Asparaginase	NCI
C10712	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10712	RO	chemotherapy regimen has component Cytarabine	NCI
C10712	RO	chemotherapy regimen has component Dexamethasone	NCI
C10712	RO	chemotherapy regimen has component Doxorubicin	NCI
C10712	RO	chemotherapy regimen has component Vincristine	NCI
C11912	STY	Therapeutic or Preventive Procedure		NCI
C11912	PT	Capecitabine/Cyclophosphamide/Epirubicin		NCI
C11912	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11912	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11912	RO	chemotherapy regimen has component Capecitabine	NCI
C11912	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C10569	STY	Therapeutic or Preventive Procedure		NCI
C10569	PT	Dexamethasone/Doxorubicin/Methotrexate/Pegaspargase/Vincristine		NCI
C10569	SY	DM/DOX/MTX/PEG-ASP/VCR		NCI
C10569	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10569	RO	chemotherapy regimen has component Dexamethasone	NCI
C10569	RO	chemotherapy regimen has component Doxorubicin	NCI
C10569	RO	chemotherapy regimen has component Methotrexate	NCI
C10569	RO	chemotherapy regimen has component Vincristine	NCI
C10569	RO	chemotherapy regimen has component Pegaspargase	NCI
C12114	STY	Therapeutic or Preventive Procedure		NCI
C12114	PT	Docetaxel/Laniquidar		NCI
C12114	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12114	RO	chemotherapy regimen has component Docetaxel	NCI
C12114	RO	chemotherapy regimen has component Laniquidar	NCI
C11962	STY	Therapeutic or Preventive Procedure		NCI
C11962	PT	Docetaxel/Fluorouracil/Leucovorin Calcium		NCI
C11962	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11962	RO	chemotherapy regimen has component Fluorouracil	NCI
C11962	RO	chemotherapy regimen has component Docetaxel	NCI
C11962	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11356	STY	Therapeutic or Preventive Procedure		NCI
C11356	PT	Interleukin-2/Monoclonal Antibody 3622W94/Sargramostim		NCI
C11356	SY	GM-CSF/IL-2/MOAB 3622W94		NCI
C11356	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11356	RO	chemotherapy regimen has component Sargramostim	NCI
C11356	RO	chemotherapy regimen has component Monoclonal Antibody 3622W94	NCI
C11356	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10594	STY	Therapeutic or Preventive Procedure		NCI
C10594	PT	Bromocriptine/Flutamide/Leuprolide		NCI
C10594	SY	BRCR/FLUT/LEUP		NCI
C10594	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10594	RO	chemotherapy regimen has component Flutamide	NCI
C10594	RO	chemotherapy regimen has component Bromocriptine Mesylate	NCI
C10594	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C10936	STY	Therapeutic or Preventive Procedure		NCI
C10936	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Prednisone/Procarbazine/Vinblastine/Vincristine		NCI
C10936	SY	BLEO/CTX/DOX/PCB/PRED/VBL/VCR		NCI
C10936	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10936	RO	chemotherapy regimen has component Bleomycin	NCI
C10936	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10936	RO	chemotherapy regimen has component Doxorubicin	NCI
C10936	RO	chemotherapy regimen has component Prednisone	NCI
C10936	RO	chemotherapy regimen has component Vinblastine	NCI
C10936	RO	chemotherapy regimen has component Vincristine	NCI
C10936	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C64790	STY	Therapeutic or Preventive Procedure		NCI
C64790	PT	Doxorubicin-Cisplatin Regimen		NCI
C64790	CHD	Chemotherapy Regimen Used to Treat Childhood Liver Cancer	NCI
C64790	CHD	Chemotherapy Regimen Used to Treat Malignant Mesothelioma	NCI
C64790	RO	chemotherapy regimen has component Cisplatin	NCI
C64790	RO	chemotherapy regimen has component Doxorubicin	NCI
C64790	RO	regimen has accepted use for disease Malignant Mesothelioma	NCI
C64790	RO	regimen has accepted use for disease Childhood Malignant Liver Neoplasm	NCI
C63407	STY	Therapeutic or Preventive Procedure		NCI
C63407	PT	Cisplatin-Vinorelbine Regimen		NCI
C63407	SY	PNvb Regimen		NCI
C63407	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63407	RO	chemotherapy regimen has component Cisplatin	NCI
C63407	RO	chemotherapy regimen has component Vinorelbine	NCI
C9565	STY	Therapeutic or Preventive Procedure		NCI
C9565	PT	Cisplatin/Cyclophosphamide/Doxorubicin/Lomustine/Vincristine		NCI
C9565	SY	CCNU/CDDP/CTX/DOX/VCR		NCI
C9565	SY	PACCO		NCI
C9565	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9565	RO	chemotherapy regimen has component Cisplatin	NCI
C9565	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9565	RO	chemotherapy regimen has component Doxorubicin	NCI
C9565	RO	chemotherapy regimen has component Lomustine	NCI
C9565	RO	chemotherapy regimen has component Vincristine	NCI
C11141	STY	Therapeutic or Preventive Procedure		NCI
C11141	PT	Asparaginase/Dexrazoxane/Doxorubicin/Mercaptopurine/Prednisone/Vincristine		NCI
C11141	SY	ADR-529/ASP/DOX/MP/PRED/VCR		NCI
C11141	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11141	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11141	RO	chemotherapy regimen has component Asparaginase	NCI
C11141	RO	chemotherapy regimen has component Doxorubicin	NCI
C11141	RO	chemotherapy regimen has component Prednisone	NCI
C11141	RO	chemotherapy regimen has component Vincristine	NCI
C11141	RO	chemotherapy regimen has component Dexrazoxane	NCI
C12201	STY	Therapeutic or Preventive Procedure		NCI
C12201	PT	Fowlpox-CEA-TRICOM Vaccine/Vaccinia-CEA-TRICOM Vaccine		NCI
C12201	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12201	RO	chemotherapy regimen has component Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine	NCI
C12201	RO	chemotherapy regimen has component Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine	NCI
C63763	STY	Therapeutic or Preventive Procedure		NCI
C63763	PT	Carboplatin-Paclitaxel-Etoposide Regimen		NCI
C63763	CHD	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C63763	RO	chemotherapy regimen has component Etoposide	NCI
C63763	RO	chemotherapy regimen has component Carboplatin	NCI
C63763	RO	chemotherapy regimen has component Paclitaxel	NCI
C63763	RO	regimen has accepted use for disease Lung Small Cell Carcinoma	NCI
C11233	STY	Therapeutic or Preventive Procedure		NCI
C11233	PT	gp100 Antigen/MART-1 Antigen		NCI
C11233	SY	gp100/MART-1		NCI
C11233	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11233	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11233	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C9587	STY	Therapeutic or Preventive Procedure		NCI
C9587	PT	Epirubicin/Bleomycin/Vinblastine/Prednisone		NCI
C9587	SY	Bleomycin/Epirubicin/Prednisone/Vinblastine		NCI
C9587	SY	EBVP		NCI
C9587	SY	BLEO/EPI/PRED/VBL		NCI
C9587	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9587	RO	chemotherapy regimen has component Bleomycin	NCI
C9587	RO	chemotherapy regimen has component Prednisone	NCI
C9587	RO	chemotherapy regimen has component Vinblastine	NCI
C9587	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C9736	STY	Therapeutic or Preventive Procedure		NCI
C9736	PT	Estradiol/Norethindrone		NCI
C9736	SY	ESDL/NORETHIN		NCI
C9736	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9736	RO	chemotherapy regimen has component Estradiol	NCI
C9736	RO	chemotherapy regimen has component Norethindrone Acetate	NCI
C10576	STY	Therapeutic or Preventive Procedure		NCI
C10576	PT	Asparaginase/Cyclophosphamide/Cytarabine/Filgrastim		NCI
C10576	SY	ARA-C/ASP/CTX/G-CSF		NCI
C10576	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10576	RO	chemotherapy regimen has component Asparaginase	NCI
C10576	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10576	RO	chemotherapy regimen has component Cytarabine	NCI
C10576	RO	chemotherapy regimen has component Filgrastim	NCI
C11396	STY	Therapeutic or Preventive Procedure		NCI
C11396	PT	Busulfan/Cyclophosphamide/Methylprednisolone		NCI
C11396	SY	BU/CTX/MePRDL		NCI
C11396	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11396	RO	chemotherapy regimen has component Busulfan	NCI
C11396	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11396	RO	chemotherapy regimen has component Methylprednisolone	NCI
C9519	STY	Therapeutic or Preventive Procedure		NCI
C9519	PT	Amsacrine/Cytarabine/Thioguanine		NCI
C9519	SY	AAT		NCI
C9519	SY	AMSA/ARA-C/TG		NCI
C9519	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9519	RO	chemotherapy regimen has component Amsacrine	NCI
C9519	RO	chemotherapy regimen has component Cytarabine	NCI
C9519	RO	chemotherapy regimen has component Thioguanine	NCI
C9929	STY	Therapeutic or Preventive Procedure		NCI
C9929	PT	Cisplatin/Doxorubicin		NCI
C9929	SY	CDDP/DOX		NCI
C9929	SY	AP		NCI
C9929	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9929	RO	chemotherapy regimen has component Cisplatin	NCI
C9929	RO	chemotherapy regimen has component Doxorubicin	NCI
C156373	STY	Therapeutic or Preventive Procedure		NCI
C156373	PT	Carboplatin/Trastuzumab Regimen		NCI
C156373	SY	Trastuzumab/Carboplatin Regimen		NCI
C156373	SY	Trastuzumab-Carboplatin		NCI
C156373	SY	Carboplatin-Trastuzumab		NCI
C156373	SY	Trastuzumab/Carboplatin		NCI
C156373	SY	Carboplatin/Trastuzumab		NCI
C156373	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156373	RO	chemotherapy regimen has component Carboplatin	NCI
C156373	RO	chemotherapy regimen has component Trastuzumab	NCI
C9884	STY	Therapeutic or Preventive Procedure		NCI
C9884	PT	Chlorambucil/Pentostatin/Prednisone		NCI
C9884	SY	CLB/DCF/PRED		NCI
C9884	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9884	RO	chemotherapy regimen has component Chlorambucil	NCI
C9884	RO	chemotherapy regimen has component Pentostatin	NCI
C9884	RO	chemotherapy regimen has component Prednisone	NCI
C11739	STY	Therapeutic or Preventive Procedure		NCI
C11739	PT	Interleukin-12/Rituximab		NCI
C11739	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11739	RO	chemotherapy regimen has component Rituximab	NCI
C11739	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C10295	STY	Therapeutic or Preventive Procedure		NCI
C10295	PT	Doxorubicin/Ethiodized Oil		NCI
C10295	SY	DOX/Ethiodized Oil		NCI
C10295	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10295	RO	chemotherapy regimen has component Doxorubicin	NCI
C10295	RO	chemotherapy regimen has component Ethiodized Oil	NCI
C12209	STY	Therapeutic or Preventive Procedure		NCI
C12209	PT	Docetaxel/Infliximab		NCI
C12209	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12209	RO	chemotherapy regimen has component Docetaxel	NCI
C12209	RO	chemotherapy regimen has component Infliximab	NCI
C10659	STY	Therapeutic or Preventive Procedure		NCI
C10659	PT	Cyclosporine/Dactinomycin/Vincristine		NCI
C10659	SY	CYSP/DACT/VCR		NCI
C10659	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10659	RO	chemotherapy regimen has component Cyclosporine	NCI
C10659	RO	chemotherapy regimen has component Dactinomycin	NCI
C10659	RO	chemotherapy regimen has component Vincristine	NCI
C11838	STY	Therapeutic or Preventive Procedure		NCI
C11838	PT	R115777/Topotecan		NCI
C11838	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11838	RO	chemotherapy regimen has component Topotecan	NCI
C11838	RO	chemotherapy regimen has component Tipifarnib	NCI
C15611	STY	Therapeutic or Preventive Procedure		NCI
C15611	PT	Interferon Alfa/Monoclonal Antibody CC49		NCI
C15611	SY	IFN-A/MOAB CC49		NCI
C15611	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15611	RO	chemotherapy regimen has component Minretumomab	NCI
C15611	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10895	STY	Therapeutic or Preventive Procedure		NCI
C10895	PT	Doxorubicin/Filgrastim/Ifosfamide		NCI
C10895	SY	DOX/G-CSF/IFF		NCI
C10895	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10895	RO	chemotherapy regimen has component Doxorubicin	NCI
C10895	RO	chemotherapy regimen has component Ifosfamide	NCI
C10895	RO	chemotherapy regimen has component Filgrastim	NCI
C11334	STY	Therapeutic or Preventive Procedure		NCI
C11334	PT	Cladribine/Idarubicin		NCI
C11334	SY	2-CdA/IDA		NCI
C11334	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11334	RO	chemotherapy regimen has component Idarubicin	NCI
C11334	RO	chemotherapy regimen has component Cladribine	NCI
C11213	STY	Therapeutic or Preventive Procedure		NCI
C11213	PT	Cisplatin/Doxorubicin/Edatrexate/Filgrastim/Vinblastine		NCI
C11213	SY	CDDP/DOX/EDAM/G-CSF/VBL		NCI
C11213	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11213	RO	chemotherapy regimen has component Cisplatin	NCI
C11213	RO	chemotherapy regimen has component Doxorubicin	NCI
C11213	RO	chemotherapy regimen has component Vinblastine	NCI
C11213	RO	chemotherapy regimen has component Edatrexate	NCI
C11213	RO	chemotherapy regimen has component Filgrastim	NCI
C10804	STY	Therapeutic or Preventive Procedure		NCI
C10804	PT	Cyclophosphamide/Indomethacin/Interleukin-2/Tumor Infiltrating Lymphocytes		NCI
C10804	SY	CTX/IL-2/Indomethacin/TIL		NCI
C10804	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10804	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10804	RO	chemotherapy regimen has component Indomethacin	NCI
C10804	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C10804	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11512	STY	Therapeutic or Preventive Procedure		NCI
C11512	PT	Flutamide/Triptorelin		NCI
C11512	SY	FLUT/TRIP		NCI
C11512	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11512	RO	chemotherapy regimen has component Flutamide	NCI
C11512	RO	chemotherapy regimen has component Triptorelin	NCI
C11082	STY	Therapeutic or Preventive Procedure		NCI
C11082	PT	Bleomycin/Dacarbazine/Interferon Alfa/Lomustine/Vincristine		NCI
C11082	SY	BLEO/CCNU/DTIC/IFN-A/VCR		NCI
C11082	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11082	RO	chemotherapy regimen has component Bleomycin	NCI
C11082	RO	chemotherapy regimen has component Dacarbazine	NCI
C11082	RO	chemotherapy regimen has component Lomustine	NCI
C11082	RO	chemotherapy regimen has component Vincristine	NCI
C11082	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37770	STY	Therapeutic or Preventive Procedure		NCI
C37770	PT	Etoposide/Monoclonal Antibody 3F8		NCI
C37770	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37770	RO	chemotherapy regimen has component Etoposide	NCI
C37770	RO	chemotherapy regimen has component Monoclonal Antibody 3F8	NCI
C148285	STY	Therapeutic or Preventive Procedure		NCI
C148285	PT	VIT Regimen		NCI
C148285	SY	VIT		NCI
C148285	SY	Vincristine-Irinotecan-Temozolomide		NCI
C148285	SY	Vincristine/Irinotecan/Temozolomide		NCI
C148285	CHD	Chemotherapy Regimen Used to Treat Ewing's Family of Tumors	NCI
C148285	RO	chemotherapy regimen has component Vincristine	NCI
C148285	RO	chemotherapy regimen has component Temozolomide	NCI
C148285	RO	chemotherapy regimen has component Irinotecan	NCI
C12162	STY	Pharmacologic Substance		NCI
C12162	STY	Hormone		NCI
C12162	STY	Organic Chemical		NCI
C12162	PT	Ethinyl Estradiol/Norgestrel		NCI
C12162	SY	Ovral		NCI
C12162	SY	Ogestrel		NCI
C12162	SY	Cryselle		NCI
C12162	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12162	RO	chemotherapy regimen has component Ethinyl Estradiol	NCI
C12162	RO	chemotherapy regimen has component Norgestrel	NCI
C10976	STY	Therapeutic or Preventive Procedure		NCI
C10976	PT	Busulfan/Cytarabine/Melphalan		NCI
C10976	SY	ARA-C/BU/L-PAM		NCI
C10976	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10976	RO	chemotherapy regimen has component Busulfan	NCI
C10976	RO	chemotherapy regimen has component Cytarabine	NCI
C10976	RO	chemotherapy regimen has component Melphalan	NCI
C29400	STY	Therapeutic or Preventive Procedure		NCI
C29400	PT	Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/R-Verapamil		NCI
C29400	SY	R-Verap/EPOCH		NCI
C29400	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C29400	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C29400	RO	chemotherapy regimen has component Doxorubicin	NCI
C29400	RO	chemotherapy regimen has component Etoposide	NCI
C29400	RO	chemotherapy regimen has component Prednisone	NCI
C29400	RO	chemotherapy regimen has component Vincristine	NCI
C29400	RO	chemotherapy regimen has component Dexverapamil	NCI
C11355	STY	Therapeutic or Preventive Procedure		NCI
C11355	PT	Peptide 946 Melanoma Vaccine/QS21/Tetanus Peptide Melanoma Vaccine		NCI
C11355	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11355	RO	chemotherapy regimen has component QS21	NCI
C11355	RO	chemotherapy regimen has component Peptide 946 Melanoma Vaccine	NCI
C11355	RO	chemotherapy regimen has component Tetanus Peptide Melanoma Vaccine	NCI
C12175	STY	Therapeutic or Preventive Procedure		NCI
C12175	PT	Cyclophosphamide/Fluorouracil/Methotrexate/Trastuzumab		NCI
C12175	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12175	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12175	RO	chemotherapy regimen has component Fluorouracil	NCI
C12175	RO	chemotherapy regimen has component Methotrexate	NCI
C12175	RO	chemotherapy regimen has component Trastuzumab	NCI
C136275	STY	Therapeutic or Preventive Procedure		NCI
C136275	PT	Panobinostat/Bortezomib/Dexamethasone Regimen		NCI
C136275	SY	Panobinostat/Bortezomib/Dexamethasone		NCI
C136275	SY	Panobinostat-Bortezomib-Dexamethasone Regimen		NCI
C136275	SY	Panobinostat-Bortezomib-Dexamethasone		NCI
C136275	SY	Farydak/Velcade/Dexamethasone		NCI
C136275	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136275	RO	chemotherapy regimen has component Dexamethasone	NCI
C136275	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136275	RO	chemotherapy regimen has component Bortezomib	NCI
C136275	RO	chemotherapy regimen has component Panobinostat	NCI
C10974	STY	Therapeutic or Preventive Procedure		NCI
C10974	PT	Fluorouracil/L-Leucovorin/Methotrexate		NCI
C10974	SY	5-FU/L-CF/MTX		NCI
C10974	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10974	RO	chemotherapy regimen has component Fluorouracil	NCI
C10974	RO	chemotherapy regimen has component Methotrexate	NCI
C10974	RO	chemotherapy regimen has component Levoleucovorin	NCI
C9907	STY	Therapeutic or Preventive Procedure		NCI
C9907	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Mitomycin		NCI
C9907	SY	ABCM		NCI
C9907	SY	BLEO/CTX/DOX/MITO		NCI
C9907	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9907	RO	chemotherapy regimen has component Mitomycin	NCI
C9907	RO	chemotherapy regimen has component Bleomycin	NCI
C9907	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9907	RO	chemotherapy regimen has component Doxorubicin	NCI
C10235	STY	Therapeutic or Preventive Procedure		NCI
C10235	PT	Cisplatin/Fluorouracil/Interleukin-2		NCI
C10235	SY	CDDP/5-FU/IL-2		NCI
C10235	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10235	RO	chemotherapy regimen has component Cisplatin	NCI
C10235	RO	chemotherapy regimen has component Fluorouracil	NCI
C10235	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12017	STY	Therapeutic or Preventive Procedure		NCI
C12017	PT	Eflornithine/Triamcinolone		NCI
C12017	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12017	RO	chemotherapy regimen has component Eflornithine	NCI
C12017	RO	chemotherapy regimen has component Triamcinolone	NCI
C11064	STY	Therapeutic or Preventive Procedure		NCI
C11064	PT	Fluorouracil/Interferon Alfa/Leucovorin Calcium/Sargramostim		NCI
C11064	SY	CF/5-FU/IFN-A/GM-CSF		NCI
C11064	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11064	RO	chemotherapy regimen has component Fluorouracil	NCI
C11064	RO	chemotherapy regimen has component Sargramostim	NCI
C11064	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11064	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11407	STY	Therapeutic or Preventive Procedure		NCI
C11407	PT	Acetaminophen/Acetylcysteine		NCI
C11407	SY	ACMP/NAC		NCI
C11407	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11407	RO	chemotherapy regimen has component Acetaminophen	NCI
C11407	RO	chemotherapy regimen has component Acetylcysteine	NCI
C10902	STY	Therapeutic or Preventive Procedure		NCI
C10902	PT	Asparaginase/Cytarabine/Etoposide/Methotrexate/Prednisone/Thioguanine/Vincristine		NCI
C10902	SY	ARA-C/ASP/MTX/PRED/TG/VCR/VP-16		NCI
C10902	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10902	RO	chemotherapy regimen has component Asparaginase	NCI
C10902	RO	chemotherapy regimen has component Cytarabine	NCI
C10902	RO	chemotherapy regimen has component Etoposide	NCI
C10902	RO	chemotherapy regimen has component Methotrexate	NCI
C10902	RO	chemotherapy regimen has component Prednisone	NCI
C10902	RO	chemotherapy regimen has component Thioguanine	NCI
C10902	RO	chemotherapy regimen has component Vincristine	NCI
C12213	STY	Therapeutic or Preventive Procedure		NCI
C12213	PT	Interferon Alfa/Lamivudine/Zidovudine		NCI
C12213	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12213	RO	chemotherapy regimen has component Zidovudine	NCI
C12213	RO	chemotherapy regimen has component Lamivudine	NCI
C12213	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9802	STY	Therapeutic or Preventive Procedure		NCI
C9802	PT	Interferon Beta/Interleukin-2		NCI
C9802	SY	IFN-B/IL-2		NCI
C9802	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9802	RO	chemotherapy regimen has component Recombinant Interferon Beta	NCI
C9802	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37676	STY	Therapeutic or Preventive Procedure		NCI
C37676	PT	Cyclophosphamide/Dactinomycin/Irinotecan/Vincristine		NCI
C37676	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37676	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37676	RO	chemotherapy regimen has component Dactinomycin	NCI
C37676	RO	chemotherapy regimen has component Vincristine	NCI
C37676	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11456	STY	Therapeutic or Preventive Procedure		NCI
C11456	PT	Flt3 Ligand/gp100 Antigen/MART-1 Antigen/Tyrosinase		NCI
C11456	SY	Flt3L/gp100/MART-1/TYR		NCI
C11456	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11456	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11456	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11456	RO	chemotherapy regimen has component Recombinant Flt3 Ligand	NCI
C11456	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10383	STY	Therapeutic or Preventive Procedure		NCI
C10383	PT	Cisplatin/Ifosfamide/Sargramostim/Vinblastine		NCI
C10383	SY	CDDP/GM-CSF/IFF/VBL		NCI
C10383	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10383	RO	chemotherapy regimen has component Cisplatin	NCI
C10383	RO	chemotherapy regimen has component Ifosfamide	NCI
C10383	RO	chemotherapy regimen has component Vinblastine	NCI
C10383	RO	chemotherapy regimen has component Sargramostim	NCI
C11264	STY	Therapeutic or Preventive Procedure		NCI
C11264	PT	Fluorouracil/Marimastat		NCI
C11264	SY	BB-2516/5-FU		NCI
C11264	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11264	RO	chemotherapy regimen has component Fluorouracil	NCI
C11264	RO	chemotherapy regimen has component Marimastat	NCI
C37763	STY	Therapeutic or Preventive Procedure		NCI
C37763	PT	Epratuzumab/Rituximab		NCI
C37763	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37763	RO	chemotherapy regimen has component Rituximab	NCI
C37763	RO	chemotherapy regimen has component Epratuzumab	NCI
C28980	STY	Therapeutic or Preventive Procedure		NCI
C28980	PT	Devil's Foot/Jambul		NCI
C28980	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C28980	RO	chemotherapy regimen has component Devils Claw	NCI
C28980	RO	chemotherapy regimen has component Jambul	NCI
C10110	STY	Therapeutic or Preventive Procedure		NCI
C10110	PT	Cytarabine/Daunorubicin/Prednisone/Thioguanine		NCI
C10110	SY	ARA-C/DNR/PRED/TG		NCI
C10110	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10110	RO	chemotherapy regimen has component Cytarabine	NCI
C10110	RO	chemotherapy regimen has component Prednisone	NCI
C10110	RO	chemotherapy regimen has component Thioguanine	NCI
C10110	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9599	STY	Therapeutic or Preventive Procedure		NCI
C9599	PT	Bleomycin/Cytarabine/Doxorubicin/Prednisone/Vincristine		NCI
C9599	SY	HOAP-BLEO		NCI
C9599	SY	ARA-C/BLEO/DOX/PRED/VCR		NCI
C9599	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9599	RO	chemotherapy regimen has component Bleomycin	NCI
C9599	RO	chemotherapy regimen has component Cytarabine	NCI
C9599	RO	chemotherapy regimen has component Doxorubicin	NCI
C9599	RO	chemotherapy regimen has component Prednisone	NCI
C9599	RO	chemotherapy regimen has component Vincristine	NCI
C11441	STY	Therapeutic or Preventive Procedure		NCI
C11441	PT	Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide/Gemcitabine		NCI
C11441	SY	CDDP/CTX/dFdC/DM/VP-16		NCI
C11441	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11441	RO	chemotherapy regimen has component Cisplatin	NCI
C11441	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11441	RO	chemotherapy regimen has component Dexamethasone	NCI
C11441	RO	chemotherapy regimen has component Etoposide	NCI
C11441	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12045	STY	Therapeutic or Preventive Procedure		NCI
C12045	PT	Montanide ISA-51/Tyrosinase-related protein-2		NCI
C12045	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12045	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C12045	RO	chemotherapy regimen has component Recombinant Tyrosinase-Related Protein-2	NCI
C10033	STY	Therapeutic or Preventive Procedure		NCI
C10033	PT	Fluorouracil/Melphalan		NCI
C10033	SY	PF		NCI
C10033	SY	5-FU/L-PAM		NCI
C10033	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10033	RO	chemotherapy regimen has component Fluorouracil	NCI
C10033	RO	chemotherapy regimen has component Melphalan	NCI
C11047	STY	Therapeutic or Preventive Procedure		NCI
C11047	PT	Cisplatin/Etoposide/Fluorouracil/Interferon Alfa		NCI
C11047	SY	CDDP/5-FU/IFN-A/VP-16		NCI
C11047	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11047	RO	chemotherapy regimen has component Cisplatin	NCI
C11047	RO	chemotherapy regimen has component Etoposide	NCI
C11047	RO	chemotherapy regimen has component Fluorouracil	NCI
C11047	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10492	STY	Therapeutic or Preventive Procedure		NCI
C10492	PT	Carboplatin/Interleukin-3		NCI
C10492	SY	CBDCA/IL-3		NCI
C10492	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10492	RO	chemotherapy regimen has component Carboplatin	NCI
C10492	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C10555	STY	Therapeutic or Preventive Procedure		NCI
C10555	PT	Idarubicin/Tretinoin		NCI
C10555	SY	ATRA/IDA		NCI
C10555	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10555	RO	chemotherapy regimen has component Idarubicin	NCI
C10555	RO	chemotherapy regimen has component Tretinoin	NCI
C11621	STY	Therapeutic or Preventive Procedure		NCI
C11621	PT	Methotrexate/Prednisone		NCI
C11621	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11621	RO	chemotherapy regimen has component Methotrexate	NCI
C11621	RO	chemotherapy regimen has component Prednisone	NCI
C12018	STY	Therapeutic or Preventive Procedure		NCI
C12018	PT	Autologous Lymphocytes/Interleukin-2/Sargramostim		NCI
C12018	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12018	RO	chemotherapy regimen has component Sargramostim	NCI
C12018	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C12018	RO	chemotherapy regimen has component Therapeutic Autologous Lymphocytes	NCI
C9700	STY	Therapeutic or Preventive Procedure		NCI
C9700	PT	Cyclophosphamide/Etoposide/Methotrexate/Vincristine		NCI
C9700	SY	ECMV		NCI
C9700	SY	CTX/MTX/VCR/VP-16		NCI
C9700	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9700	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9700	RO	chemotherapy regimen has component Etoposide	NCI
C9700	RO	chemotherapy regimen has component Methotrexate	NCI
C9700	RO	chemotherapy regimen has component Vincristine	NCI
C37737	STY	Therapeutic or Preventive Procedure		NCI
C37737	PT	Docetaxel/TLK286		NCI
C37737	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37737	RO	chemotherapy regimen has component Docetaxel	NCI
C37737	RO	chemotherapy regimen has component Canfosfamide Hydrochloride	NCI
C37681	STY	Therapeutic or Preventive Procedure		NCI
C37681	PT	Cyclophosphamide/Doxorubicin/Leucovorin Calcium/Methotrexate/Methylprednisolone/Rituximab/Vincristine		NCI
C37681	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37681	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37681	RO	chemotherapy regimen has component Doxorubicin	NCI
C37681	RO	chemotherapy regimen has component Methotrexate	NCI
C37681	RO	chemotherapy regimen has component Methylprednisolone	NCI
C37681	RO	chemotherapy regimen has component Vincristine	NCI
C37681	RO	chemotherapy regimen has component Rituximab	NCI
C37681	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9531	STY	Therapeutic or Preventive Procedure		NCI
C9531	PT	Lomustine/Methotrexate/Procarbazine		NCI
C9531	SY	CCNU/MTX/PCB		NCI
C9531	SY	CMP		NCI
C9531	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9531	RO	chemotherapy regimen has component Lomustine	NCI
C9531	RO	chemotherapy regimen has component Methotrexate	NCI
C9531	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C67338	STY	Therapeutic or Preventive Procedure		NCI
C67338	PT	Chemotherapy Regimen Used to Treat Childhood Osteosarcoma		NCI
C67338	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C67338	PAR	MAP Regimen	NCI
C67338	PAR	OS-86 Regimen	NCI
C37472	STY	Therapeutic or Preventive Procedure		NCI
C37472	PT	Cisplatin/Neovastat/Vinorelbine		NCI
C37472	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37472	RO	chemotherapy regimen has component Cisplatin	NCI
C37472	RO	chemotherapy regimen has component Vinorelbine	NCI
C37472	RO	chemotherapy regimen has component Shark Cartilage Extract AE-941	NCI
C10972	STY	Therapeutic or Preventive Procedure		NCI
C10972	PT	Fludarabine/Mitoxantrone		NCI
C10972	SY	DHAD/FAMP		NCI
C10972	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10972	RO	chemotherapy regimen has component Fludarabine	NCI
C10972	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10782	STY	Therapeutic or Preventive Procedure		NCI
C10782	PT	Cisplatin/Filgrastim/Ifosfamide/Interleukin-3/Vinblastine		NCI
C10782	SY	CDDP/G-CSF/IFF/IL-3/VBL		NCI
C10782	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10782	RO	chemotherapy regimen has component Cisplatin	NCI
C10782	RO	chemotherapy regimen has component Ifosfamide	NCI
C10782	RO	chemotherapy regimen has component Vinblastine	NCI
C10782	RO	chemotherapy regimen has component Filgrastim	NCI
C10782	RO	chemotherapy regimen has component Recombinant Interleukin-3	NCI
C11446	STY	Therapeutic or Preventive Procedure		NCI
C11446	PT	Amifostine/Epoetin Alfa		NCI
C11446	SY	EPO/WR-2721		NCI
C11446	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11446	RO	chemotherapy regimen has component Amifostine	NCI
C11446	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C29984	STY	Therapeutic or Preventive Procedure		NCI
C29984	PT	Fluorouracil/Interferon alpha/Interleukin-2/Leucovorin Calcium		NCI
C29984	SY	IFN/5FU/IL2/Leucovorin		NCI
C29984	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C29984	RO	chemotherapy regimen has component Fluorouracil	NCI
C29984	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C29984	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C29984	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C138029	STY	Therapeutic or Preventive Procedure		NCI
C138029	PT	AC Followed by Docetaxel/Trastuzumab Regimen		NCI
C138029	SY	AC-Taxotere/Herceptin		NCI
C138029	SY	AC-Docetaxel + Trastuzumab		NCI
C138029	SY	AC Followed by Docetaxel + Trastuzumab		NCI
C138029	SY	Doxorubicin/Cyclophosphamide Followed by Docetaxel/Trastuzumab		NCI
C138029	SY	Doxorubicin/Cyclophosphamide Followed by Docetaxel + Trastuzumab		NCI
C138029	SY	AC-TH		NCI
C138029	SY	AC-T Plus Trastuzumab		NCI
C138029	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C138029	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C138029	RO	chemotherapy regimen has component Doxorubicin	NCI
C138029	RO	chemotherapy regimen has component Docetaxel	NCI
C138029	RO	chemotherapy regimen has component Trastuzumab	NCI
C10234	STY	Therapeutic or Preventive Procedure		NCI
C10234	PT	Bleomycin/Cisplatin/Cyclophosphamide/Dactinomycin/Vinblastine		NCI
C10234	SY	VAB-V		NCI
C10234	SY	BLEO/CDDP/CTX/DACT/VBL		NCI
C10234	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10234	RO	chemotherapy regimen has component Bleomycin	NCI
C10234	RO	chemotherapy regimen has component Cisplatin	NCI
C10234	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10234	RO	chemotherapy regimen has component Dactinomycin	NCI
C10234	RO	chemotherapy regimen has component Vinblastine	NCI
C9603	STY	Therapeutic or Preventive Procedure		NCI
C9603	PT	Carmustine/Cyclophosphamide/Melphalan/Prednisone/Vincristine		NCI
C9603	SY	VBMCP		NCI
C9603	SY	BCNU/CTX/L-PAM/PRED/VCR		NCI
C9603	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9603	RO	chemotherapy regimen has component Carmustine	NCI
C9603	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9603	RO	chemotherapy regimen has component Melphalan	NCI
C9603	RO	chemotherapy regimen has component Prednisone	NCI
C9603	RO	chemotherapy regimen has component Vincristine	NCI
C10812	STY	Therapeutic or Preventive Procedure		NCI
C10812	PT	Cyclophosphamide/Epirubicin/Toremifene		NCI
C10812	SY	CTX/EPI/TOR		NCI
C10812	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10812	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10812	RO	chemotherapy regimen has component Toremifene	NCI
C10812	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11828	STY	Therapeutic or Preventive Procedure		NCI
C11828	PT	Gemcitabine/Pemetrexed Disodium		NCI
C11828	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11828	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11828	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C11488	STY	Therapeutic or Preventive Procedure		NCI
C11488	PT	Phenylbutyrate/Tretinoin		NCI
C11488	SY	ATRA/PBA		NCI
C11488	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11488	RO	chemotherapy regimen has component Tretinoin	NCI
C11488	RO	chemotherapy regimen has component Sodium Phenylbutyrate	NCI
C11661	STY	Therapeutic or Preventive Procedure		NCI
C11661	PT	gp100 Antigen/Interleukin-12/Montanide ISA-51/Tyrosinase Peptide		NCI
C11661	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11661	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11661	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11661	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11661	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C10204	STY	Therapeutic or Preventive Procedure		NCI
C10204	PT	Asparaginase/Doxorubicin/Methotrexate/Prednisone/Vincristine		NCI
C10204	SY	ASP/DOX/MTX/PRED/VCR		NCI
C10204	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10204	RO	chemotherapy regimen has component Asparaginase	NCI
C10204	RO	chemotherapy regimen has component Doxorubicin	NCI
C10204	RO	chemotherapy regimen has component Methotrexate	NCI
C10204	RO	chemotherapy regimen has component Prednisone	NCI
C10204	RO	chemotherapy regimen has component Vincristine	NCI
C12128	STY	Therapeutic or Preventive Procedure		NCI
C12128	PT	Cisplatin/Erlotinib		NCI
C12128	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12128	RO	chemotherapy regimen has component Cisplatin	NCI
C12128	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C37755	STY	Therapeutic or Preventive Procedure		NCI
C37755	PT	Edrecolomab/Fluorouracil/Leucovorin Calcium		NCI
C37755	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37755	RO	chemotherapy regimen has component Fluorouracil	NCI
C37755	RO	chemotherapy regimen has component Edrecolomab	NCI
C37755	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12208	STY	Therapeutic or Preventive Procedure		NCI
C12208	PT	Decitabine/FR901228		NCI
C12208	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12208	RO	chemotherapy regimen has component Decitabine	NCI
C12208	RO	chemotherapy regimen has component Romidepsin	NCI
C9589	STY	Therapeutic or Preventive Procedure		NCI
C9589	PT	Cisplatin/Cytarabine/Dexamethasone/Etoposide		NCI
C9589	SY	ARA-C/CDDP/DM/VP-16		NCI
C9589	SY	E-DHAP		NCI
C9589	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9589	RO	chemotherapy regimen has component Cisplatin	NCI
C9589	RO	chemotherapy regimen has component Cytarabine	NCI
C9589	RO	chemotherapy regimen has component Dexamethasone	NCI
C9589	RO	chemotherapy regimen has component Etoposide	NCI
C114101	STY	Therapeutic or Preventive Procedure		NCI
C114101	PT	OFF Regimen		NCI
C114101	SY	Oxaliplatin/Folinic Acid/Fluorouracil Regimen		NCI
C114101	SY	Fluorouracil/Leucovorin Calcium/Oxaliplatin Regimen		NCI
C114101	CHD	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C114101	RO	chemotherapy regimen has component Fluorouracil	NCI
C114101	RO	chemotherapy regimen has component Oxaliplatin	NCI
C114101	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11498	STY	Therapeutic or Preventive Procedure		NCI
C11498	PT	Methotrexate/Methylprednisolone		NCI
C11498	SY	MTX/MePRDL		NCI
C11498	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11498	RO	chemotherapy regimen has component Methotrexate	NCI
C11498	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11418	STY	Therapeutic or Preventive Procedure		NCI
C11418	PT	BMS-182751/Prednisone		NCI
C11418	SY	BMS-182751/PRED		NCI
C11418	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11418	RO	chemotherapy regimen has component Prednisone	NCI
C11418	RO	chemotherapy regimen has component Satraplatin	NCI
C9828	STY	Therapeutic or Preventive Procedure		NCI
C9828	PT	Dexamethasone/Methotrexate/Thioguanine		NCI
C9828	SY	DM/MTX/TG		NCI
C9828	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9828	RO	chemotherapy regimen has component Dexamethasone	NCI
C9828	RO	chemotherapy regimen has component Methotrexate	NCI
C9828	RO	chemotherapy regimen has component Thioguanine	NCI
C9771	STY	Therapeutic or Preventive Procedure		NCI
C9771	PT	Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Prednisone		NCI
C9771	SY	CTX/DOX/MTX/PRED/VP-16		NCI
C9771	SY	ProMACE		NCI
C9771	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9771	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9771	RO	chemotherapy regimen has component Doxorubicin	NCI
C9771	RO	chemotherapy regimen has component Etoposide	NCI
C9771	RO	chemotherapy regimen has component Methotrexate	NCI
C9771	RO	chemotherapy regimen has component Prednisone	NCI
C10539	STY	Therapeutic or Preventive Procedure		NCI
C10539	PT	Interleukin-2/Levamisole		NCI
C10539	SY	IL-2/LEV		NCI
C10539	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10539	RO	chemotherapy regimen has component Levamisole Hydrochloride	NCI
C10539	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10092	STY	Therapeutic or Preventive Procedure		NCI
C10092	PT	Altretamine/Doxorubicin/Methotrexate		NCI
C10092	SY	DOX/HMM/MTX		NCI
C10092	SY	HAM-II		NCI
C10092	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10092	RO	chemotherapy regimen has component Doxorubicin	NCI
C10092	RO	chemotherapy regimen has component Altretamine	NCI
C10092	RO	chemotherapy regimen has component Methotrexate	NCI
C11247	STY	Therapeutic or Preventive Procedure		NCI
C11247	PT	Irinotecan/Paclitaxel		NCI
C11247	SY	CPT-11/TAX		NCI
C11247	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11247	RO	chemotherapy regimen has component Paclitaxel	NCI
C11247	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C9625	STY	Therapeutic or Preventive Procedure		NCI
C9625	PT	Cyclophosphamide/Doxorubicin/Prednisone/Procarbazine/Vincristine		NCI
C9625	SY	CTX/DOX/PCB/PRED/VCR		NCI
C9625	SY	ACOPP		NCI
C9625	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9625	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9625	RO	chemotherapy regimen has component Doxorubicin	NCI
C9625	RO	chemotherapy regimen has component Prednisone	NCI
C9625	RO	chemotherapy regimen has component Vincristine	NCI
C9625	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10785	STY	Therapeutic or Preventive Procedure		NCI
C10785	PT	Cyclophosphamide/Topotecan		NCI
C10785	SY	CTX/TOPO		NCI
C10785	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10785	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10785	RO	chemotherapy regimen has component Topotecan	NCI
C9868	STY	Therapeutic or Preventive Procedure		NCI
C9868	PT	Asparaginase/Dexamethasone/Doxorubicin/Vincristine		NCI
C9868	SY	ASP/DM/DOX/VCR		NCI
C9868	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9868	RO	chemotherapy regimen has component Asparaginase	NCI
C9868	RO	chemotherapy regimen has component Dexamethasone	NCI
C9868	RO	chemotherapy regimen has component Doxorubicin	NCI
C9868	RO	chemotherapy regimen has component Vincristine	NCI
C10380	STY	Therapeutic or Preventive Procedure		NCI
C10380	PT	Carboplatin/Doxorubicin/Etoposide/Vincristine		NCI
C10380	SY	CBDCA/DOX/VCR/VP-16		NCI
C10380	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10380	RO	chemotherapy regimen has component Doxorubicin	NCI
C10380	RO	chemotherapy regimen has component Etoposide	NCI
C10380	RO	chemotherapy regimen has component Vincristine	NCI
C10380	RO	chemotherapy regimen has component Carboplatin	NCI
C37603	STY	Therapeutic or Preventive Procedure		NCI
C37603	PT	Carboplatin/Cyclophosphamide/Etoposide/Sodium Thiosulfate		NCI
C37603	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37603	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37603	RO	chemotherapy regimen has component Etoposide	NCI
C37603	RO	chemotherapy regimen has component Sodium Thiosulfate	NCI
C37603	RO	chemotherapy regimen has component Carboplatin	NCI
C12052	STY	Therapeutic or Preventive Procedure		NCI
C12052	PT	Doxorubicin/PS-341		NCI
C12052	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12052	RO	chemotherapy regimen has component Doxorubicin	NCI
C12052	RO	chemotherapy regimen has component Bortezomib	NCI
C9804	STY	Therapeutic or Preventive Procedure		NCI
C9804	PT	Goserelin/Nilutamide		NCI
C9804	SY	ANAN/ZDX		NCI
C9804	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9804	RO	chemotherapy regimen has component Nilutamide	NCI
C9804	RO	chemotherapy regimen has component Goserelin	NCI
C10526	STY	Therapeutic or Preventive Procedure		NCI
C10526	PT	Doxorubicin/Suramin		NCI
C10526	SY	DOX/SUR		NCI
C10526	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10526	RO	chemotherapy regimen has component Doxorubicin	NCI
C10526	RO	chemotherapy regimen has component Suramin	NCI
C9772	STY	Therapeutic or Preventive Procedure		NCI
C9772	PT	Bleomycin/Lomustine/Methotrexate		NCI
C9772	SY	BLEO/CCNU/MTX		NCI
C9772	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9772	RO	chemotherapy regimen has component Bleomycin	NCI
C9772	RO	chemotherapy regimen has component Lomustine	NCI
C9772	RO	chemotherapy regimen has component Methotrexate	NCI
C9909	STY	Therapeutic or Preventive Procedure		NCI
C9909	PT	Altretamine/Fluorouracil/Mitomycin		NCI
C9909	SY	HEXMF		NCI
C9909	SY	5-FU/HMM/MITO		NCI
C9909	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9909	RO	chemotherapy regimen has component Mitomycin	NCI
C9909	RO	chemotherapy regimen has component Fluorouracil	NCI
C9909	RO	chemotherapy regimen has component Altretamine	NCI
C136281	STY	Therapeutic or Preventive Procedure		NCI
C136281	PT	Bevacizumab/Carboplatin/Pemetrexed Regimen		NCI
C136281	SY	Bevacizumab-Carboplatin-Pemetrexed Regimen		NCI
C136281	SY	Avastin/Carboplatin/Alimta		NCI
C136281	SY	Bevacizumab/Carboplatin/Pemetrexed		NCI
C136281	SY	Bevacizumab-Carboplatin-Pemetrexed		NCI
C136281	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C136281	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C136281	RO	chemotherapy regimen has component Carboplatin	NCI
C136281	RO	chemotherapy regimen has component Bevacizumab	NCI
C136281	RO	chemotherapy regimen has component Pemetrexed Disodium	NCI
C10666	STY	Therapeutic or Preventive Procedure		NCI
C10666	PT	Interferon Gamma/Melphalan/Tumor Necrosis Factor		NCI
C10666	SY	IFN-G/L-PAM/TNF		NCI
C10666	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10666	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C10666	RO	chemotherapy regimen has component Melphalan	NCI
C10666	RO	chemotherapy regimen has component Recombinant Tumor Necrosis Factor-Alpha	NCI
C15520	STY	Therapeutic or Preventive Procedure		NCI
C15520	PT	Flavone Acetic Acid/Interleukin-2		NCI
C15520	SY	FAA/IL-2		NCI
C15520	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15520	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C15520	RO	chemotherapy regimen has component Mitoflaxone	NCI
C10423	STY	Therapeutic or Preventive Procedure		NCI
C10423	PT	Carmustine/Etoposide/Thiotepa		NCI
C10423	SY	BCNU/TSPA/VP-16		NCI
C10423	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10423	RO	chemotherapy regimen has component Carmustine	NCI
C10423	RO	chemotherapy regimen has component Etoposide	NCI
C10423	RO	chemotherapy regimen has component Thiotepa	NCI
C12055	STY	Therapeutic or Preventive Procedure		NCI
C12055	PT	Cytarabine/Fludarabine/Isotretinoin		NCI
C12055	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12055	RO	chemotherapy regimen has component Cytarabine	NCI
C12055	RO	chemotherapy regimen has component Isotretinoin	NCI
C12055	RO	chemotherapy regimen has component Fludarabine	NCI
C62633	STY	Therapeutic or Preventive Procedure		NCI
C62633	PT	Agent Combination		NCI
C62633	CHD	Chemotherapy Regimen or Agent Combination	NCI
C62633	PAR	Agent Combination Indexed in Open Clinical Trials	NCI
C62633	PAR	Agent Combination Not Indexed in Open Clinical Trials	NCI
C156260	STY	Therapeutic or Preventive Procedure		NCI
C156260	PT	Temozolomide/Veliparib Regimen		NCI
C156260	SY	Veliparib/Temozolomide		NCI
C156260	SY	Temozolomide-Veliparib		NCI
C156260	SY	Temozolomide/ABT-888		NCI
C156260	SY	Temozolomide Plus Veliparib		NCI
C156260	SY	Veliparib/Temozolomide Regimen		NCI
C156260	SY	Temozolomide/Veliparib		NCI
C156260	SY	ABT-888 and Temozolomide		NCI
C156260	SY	Temozolomide and Veliparib		NCI
C156260	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C156260	RO	chemotherapy regimen has component Temozolomide	NCI
C156260	RO	chemotherapy regimen has component Veliparib	NCI
C10768	STY	Therapeutic or Preventive Procedure		NCI
C10768	PT	Filgrastim/Fluorouracil/Leucovorin Calcium/Paclitaxel		NCI
C10768	SY	CF/5-FU/G-CSF/TAX		NCI
C10768	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10768	RO	chemotherapy regimen has component Fluorouracil	NCI
C10768	RO	chemotherapy regimen has component Paclitaxel	NCI
C10768	RO	chemotherapy regimen has component Filgrastim	NCI
C10768	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10471	STY	Therapeutic or Preventive Procedure		NCI
C10471	PT	Doxorubicin/Estradiol/Goserelin/Thiotepa/Vinblastine		NCI
C10471	SY	DOX/ESDL/TSPA/VBL/ZDX		NCI
C10471	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10471	RO	chemotherapy regimen has component Doxorubicin	NCI
C10471	RO	chemotherapy regimen has component Estradiol	NCI
C10471	RO	chemotherapy regimen has component Thiotepa	NCI
C10471	RO	chemotherapy regimen has component Vinblastine	NCI
C10471	RO	chemotherapy regimen has component Goserelin	NCI
C10345	STY	Therapeutic or Preventive Procedure		NCI
C10345	PT	ICE Regimen		NCI
C10345	SY	CBDCA/IFF/VP-16		NCI
C10345	SY	Ifosfamide-Carboplatin-Etoposide Regimen		NCI
C10345	SY	ICE		NCI
C10345	SY	Carboplatin/Etoposide/Ifosfamide		NCI
C10345	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C10345	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C10345	RO	chemotherapy regimen has component Etoposide	NCI
C10345	RO	chemotherapy regimen has component Ifosfamide	NCI
C10345	RO	chemotherapy regimen has component Carboplatin	NCI
C10345	RO	regimen has accepted use for disease Recurrent Childhood Hodgkin Lymphoma	NCI
C10345	RO	regimen has accepted use for disease Recurrent Non-Hodgkin Lymphoma	NCI
C10345	RO	regimen has accepted use for disease Refractory Non-Hodgkin Lymphoma	NCI
C140113	STY	Therapeutic or Preventive Procedure		NCI
C140113	PT	SMILE Regimen		NCI
C140113	SY	Dexamethasone/Methotrexate/Ifosfamide/L-asparaginase/Etoposide		NCI
C140113	SY	Dexamethasone-Methotrexate-Ifosfamide-L-asparaginase-Etoposide		NCI
C140113	SY	SMILE		NCI
C140113	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140113	RO	chemotherapy regimen has component Asparaginase	NCI
C140113	RO	chemotherapy regimen has component Dexamethasone	NCI
C140113	RO	chemotherapy regimen has component Etoposide	NCI
C140113	RO	chemotherapy regimen has component Ifosfamide	NCI
C140113	RO	chemotherapy regimen has component Methotrexate	NCI
C12155	STY	Therapeutic or Preventive Procedure		NCI
C12155	PT	Cisplatin/ZD 1839		NCI
C12155	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12155	RO	chemotherapy regimen has component Cisplatin	NCI
C12155	RO	chemotherapy regimen has component Gefitinib	NCI
C37789	STY	Therapeutic or Preventive Procedure		NCI
C37789	PT	Fowlpox-PSA Vaccine/Sargramostim		NCI
C37789	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37789	RO	chemotherapy regimen has component Sargramostim	NCI
C37789	RO	chemotherapy regimen has component Recombinant Fowlpox-Prostate Specific Antigen Vaccine	NCI
C10261	STY	Therapeutic or Preventive Procedure		NCI
C10261	PT	Cisplatin/Mitomycin/Vinblastine		NCI
C10261	SY	PVeMi		NCI
C10261	SY	CVeMi		NCI
C10261	SY	MiPV		NCI
C10261	SY	CDDP/MITO/VBL		NCI
C10261	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10261	RO	chemotherapy regimen has component Mitomycin	NCI
C10261	RO	chemotherapy regimen has component Cisplatin	NCI
C10261	RO	chemotherapy regimen has component Vinblastine	NCI
C10304	STY	Therapeutic or Preventive Procedure		NCI
C10304	PT	Cisplatin/Tamoxifen		NCI
C10304	SY	CDDP/TMX		NCI
C10304	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10304	RO	chemotherapy regimen has component Cisplatin	NCI
C10304	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C63617	STY	Therapeutic or Preventive Procedure		NCI
C63617	PT	Larson Regimen		NCI
C63617	CHD	Chemotherapy Regimen Used to Treat Acute Lymphoblastic Leukemia	NCI
C63617	RO	chemotherapy regimen has component Mercaptopurine	NCI
C63617	RO	chemotherapy regimen has component Asparaginase	NCI
C63617	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63617	RO	chemotherapy regimen has component Cytarabine	NCI
C63617	RO	chemotherapy regimen has component Daunorubicin	NCI
C63617	RO	chemotherapy regimen has component Doxorubicin	NCI
C63617	RO	chemotherapy regimen has component Methotrexate	NCI
C63617	RO	chemotherapy regimen has component Prednisone	NCI
C63617	RO	chemotherapy regimen has component Thioguanine	NCI
C63617	RO	chemotherapy regimen has component Vincristine	NCI
C63617	RO	regimen has accepted use for disease Adult Acute Lymphoblastic Leukemia	NCI
C10189	STY	Therapeutic or Preventive Procedure		NCI
C10189	PT	Methotrexate/Vinblastine		NCI
C10189	SY	MTX/VBL		NCI
C10189	SY	MV		NCI
C10189	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10189	RO	chemotherapy regimen has component Methotrexate	NCI
C10189	RO	chemotherapy regimen has component Vinblastine	NCI
C11057	STY	Therapeutic or Preventive Procedure		NCI
C11057	PT	Carmustine/Fluorouracil/Interferon Alfa		NCI
C11057	SY	BCNU/5-FU/IFN-A		NCI
C11057	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11057	RO	chemotherapy regimen has component Carmustine	NCI
C11057	RO	chemotherapy regimen has component Fluorouracil	NCI
C11057	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C10818	STY	Therapeutic or Preventive Procedure		NCI
C10818	PT	Carboplatin/Cytarabine/Hydroxyurea		NCI
C10818	SY	ARA-C/CBDCA/HU		NCI
C10818	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10818	RO	chemotherapy regimen has component Cytarabine	NCI
C10818	RO	chemotherapy regimen has component Hydroxyurea	NCI
C10818	RO	chemotherapy regimen has component Carboplatin	NCI
C11219	STY	Therapeutic or Preventive Procedure		NCI
C11219	PT	Cisplatin/Doxorubicin/Ifosfamide/Mitomycin		NCI
C11219	SY	CDDP/DOX/IFF/MITO		NCI
C11219	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11219	RO	chemotherapy regimen has component Mitomycin	NCI
C11219	RO	chemotherapy regimen has component Cisplatin	NCI
C11219	RO	chemotherapy regimen has component Doxorubicin	NCI
C11219	RO	chemotherapy regimen has component Ifosfamide	NCI
C11737	STY	Therapeutic or Preventive Procedure		NCI
C11737	PT	Exemestane/Raloxifene		NCI
C11737	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11737	RO	chemotherapy regimen has component Raloxifene	NCI
C11737	RO	chemotherapy regimen has component Exemestane	NCI
C9930	STY	Therapeutic or Preventive Procedure		NCI
C9930	PT	Methotrexate/Piritrexim		NCI
C9930	SY	MTX/piritrexim		NCI
C9930	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9930	RO	chemotherapy regimen has component Methotrexate	NCI
C9930	RO	chemotherapy regimen has component Piritrexim	NCI
C11335	STY	Therapeutic or Preventive Procedure		NCI
C11335	PT	Buserelin/Flutamide		NCI
C11335	SY	BSRL/FLUT		NCI
C11335	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11335	RO	chemotherapy regimen has component Buserelin	NCI
C11335	RO	chemotherapy regimen has component Flutamide	NCI
C10227	STY	Therapeutic or Preventive Procedure		NCI
C10227	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Leucovorin Calcium/Sargramostim		NCI
C10227	SY	CF/CTX/DOX/5-FU/GM-CSF		NCI
C10227	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10227	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10227	RO	chemotherapy regimen has component Doxorubicin	NCI
C10227	RO	chemotherapy regimen has component Fluorouracil	NCI
C10227	RO	chemotherapy regimen has component Sargramostim	NCI
C10227	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11504	STY	Therapeutic or Preventive Procedure		NCI
C11504	PT	Cyclophosphamide/Cytarabine/Methotrexate		NCI
C11504	SY	ARA-C/CTX/MTX		NCI
C11504	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11504	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11504	RO	chemotherapy regimen has component Cytarabine	NCI
C11504	RO	chemotherapy regimen has component Methotrexate	NCI
C10185	STY	Therapeutic or Preventive Procedure		NCI
C10185	PT	Mercaptopurine/Methotrexate/Methylprednisolone/Vincristine		NCI
C10185	SY	MePRDL/MP/MTX/VCR		NCI
C10185	SY	POMP		NCI
C10185	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10185	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10185	RO	chemotherapy regimen has component Methotrexate	NCI
C10185	RO	chemotherapy regimen has component Methylprednisolone	NCI
C10185	RO	chemotherapy regimen has component Vincristine	NCI
C10342	STY	Therapeutic or Preventive Procedure		NCI
C10342	PT	Cisplatin/Cyclophosphamide/Etoposide/Thiotepa/Vincristine		NCI
C10342	SY	CDDP/CTX/TSPA/VCR/VP-16		NCI
C10342	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10342	RO	chemotherapy regimen has component Cisplatin	NCI
C10342	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10342	RO	chemotherapy regimen has component Etoposide	NCI
C10342	RO	chemotherapy regimen has component Thiotepa	NCI
C10342	RO	chemotherapy regimen has component Vincristine	NCI
C11718	STY	Therapeutic or Preventive Procedure		NCI
C11718	PT	Prinomastat/Temozolomide		NCI
C11718	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11718	RO	chemotherapy regimen has component Temozolomide	NCI
C11718	RO	chemotherapy regimen has component Prinomastat	NCI
C9520	STY	Therapeutic or Preventive Procedure		NCI
C9520	PT	Doxorubicin/Mitomycin/Vinblastine		NCI
C9520	SY	DOX/MITO/VBL		NCI
C9520	SY	MVA		NCI
C9520	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9520	RO	chemotherapy regimen has component Mitomycin	NCI
C9520	RO	chemotherapy regimen has component Doxorubicin	NCI
C9520	RO	chemotherapy regimen has component Vinblastine	NCI
C11652	STY	Therapeutic or Preventive Procedure		NCI
C11652	PT	gp100 Antigen/MART-1 Antigen/Montanide ISA-51		NCI
C11652	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11652	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11652	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11652	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10400	STY	Therapeutic or Preventive Procedure		NCI
C10400	PT	Cyclophosphamide/Mercaptopurine/Methotrexate/Vincristine		NCI
C10400	SY	CTX/MP/MTX/VCR		NCI
C10400	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10400	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10400	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10400	RO	chemotherapy regimen has component Methotrexate	NCI
C10400	RO	chemotherapy regimen has component Vincristine	NCI
C10118	STY	Therapeutic or Preventive Procedure		NCI
C10118	PT	Doxorubicin/Thiotepa/Vinblastine		NCI
C10118	SY	TAV		NCI
C10118	SY	DOX/TSPA/VBL		NCI
C10118	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10118	RO	chemotherapy regimen has component Doxorubicin	NCI
C10118	RO	chemotherapy regimen has component Thiotepa	NCI
C10118	RO	chemotherapy regimen has component Vinblastine	NCI
C10065	STY	Therapeutic or Preventive Procedure		NCI
C10065	PT	Floxuridine/Leucovorin Calcium		NCI
C10065	SY	CF/FUDR		NCI
C10065	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10065	RO	chemotherapy regimen has component Floxuridine	NCI
C10065	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9651	STY	Therapeutic or Preventive Procedure		NCI
C9651	PT	Bleomycin/Doxorubicin/Vinblastine		NCI
C9651	SY	ABV		NCI
C9651	SY	BLEO/DOX/VBL		NCI
C9651	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9651	RO	chemotherapy regimen has component Bleomycin	NCI
C9651	RO	chemotherapy regimen has component Doxorubicin	NCI
C9651	RO	chemotherapy regimen has component Vinblastine	NCI
C10601	STY	Therapeutic or Preventive Procedure		NCI
C10601	PT	Cisplatin/Ifosfamide/Mitomycin		NCI
C10601	SY	CDDP/IFF/MITO		NCI
C10601	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10601	RO	chemotherapy regimen has component Mitomycin	NCI
C10601	RO	chemotherapy regimen has component Cisplatin	NCI
C10601	RO	chemotherapy regimen has component Ifosfamide	NCI
C9753	STY	Therapeutic or Preventive Procedure		NCI
C9753	PT	Fluorouracil/Mitomycin C/Cisplatin		NCI
C9753	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9753	RO	chemotherapy regimen has component Mitomycin	NCI
C9753	RO	chemotherapy regimen has component Cisplatin	NCI
C9753	RO	chemotherapy regimen has component Fluorouracil	NCI
C10941	STY	Therapeutic or Preventive Procedure		NCI
C10941	PT	Dexamethasone/Etoposide/Ifosfamide/Methotrexate/Pegaspargase/Vincristine		NCI
C10941	SY	DM/IFF/MTX/PEG-ASP/VCR/VP-16		NCI
C10941	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10941	RO	chemotherapy regimen has component Dexamethasone	NCI
C10941	RO	chemotherapy regimen has component Etoposide	NCI
C10941	RO	chemotherapy regimen has component Ifosfamide	NCI
C10941	RO	chemotherapy regimen has component Methotrexate	NCI
C10941	RO	chemotherapy regimen has component Vincristine	NCI
C10941	RO	chemotherapy regimen has component Pegaspargase	NCI
C11015	STY	Therapeutic or Preventive Procedure		NCI
C11015	PT	Carmustine/Cyclophosphamide/Interferon Alfa/Melphalan/Prednisone/Vincristine		NCI
C11015	SY	BCNU/CTX/IFN-A/L-PAM/PRED/VCR		NCI
C11015	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11015	RO	chemotherapy regimen has component Carmustine	NCI
C11015	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11015	RO	chemotherapy regimen has component Melphalan	NCI
C11015	RO	chemotherapy regimen has component Prednisone	NCI
C11015	RO	chemotherapy regimen has component Vincristine	NCI
C11015	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C37655	STY	Therapeutic or Preventive Procedure		NCI
C37655	PT	Cisplatin/Flavopiridol/Irinotecan		NCI
C37655	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37655	RO	chemotherapy regimen has component Cisplatin	NCI
C37655	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C37655	RO	chemotherapy regimen has component Alvocidib Hydrochloride	NCI
C12206	STY	Therapeutic or Preventive Procedure		NCI
C12206	PT	Docetaxel/Filgrastim/Trastuzumab/Vinorelbine		NCI
C12206	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12206	RO	chemotherapy regimen has component Vinorelbine	NCI
C12206	RO	chemotherapy regimen has component Filgrastim	NCI
C12206	RO	chemotherapy regimen has component Docetaxel	NCI
C12206	RO	chemotherapy regimen has component Trastuzumab	NCI
C10450	STY	Therapeutic or Preventive Procedure		NCI
C10450	PT	Chlorambucil/Epirubicin		NCI
C10450	SY	CLB/EPI		NCI
C10450	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10450	RO	chemotherapy regimen has component Chlorambucil	NCI
C10450	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C10658	STY	Therapeutic or Preventive Procedure		NCI
C10658	PT	Bleomycin/Didanosine/Doxorubicin/Vincristine		NCI
C10658	SY	BLEO/ddI/DOX/VCR		NCI
C10658	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10658	RO	chemotherapy regimen has component Bleomycin	NCI
C10658	RO	chemotherapy regimen has component Didanosine	NCI
C10658	RO	chemotherapy regimen has component Doxorubicin	NCI
C10658	RO	chemotherapy regimen has component Vincristine	NCI
C9944	STY	Therapeutic or Preventive Procedure		NCI
C9944	PT	Bleomycin/Doxorubicin/Mechlorethamine/Methotrexate/Vincristine		NCI
C9944	SY	BLEO/DOX/MTX/NM/VCR		NCI
C9944	SY	BAMON		NCI
C9944	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9944	RO	chemotherapy regimen has component Bleomycin	NCI
C9944	RO	chemotherapy regimen has component Doxorubicin	NCI
C9944	RO	chemotherapy regimen has component Methotrexate	NCI
C9944	RO	chemotherapy regimen has component Vincristine	NCI
C9944	RO	chemotherapy regimen has component Mechlorethamine Hydrochloride	NCI
C9602	STY	Therapeutic or Preventive Procedure		NCI
C9602	PT	Chlorambucil/Fluorouracil/Methotrexate		NCI
C9602	SY	LMF		NCI
C9602	SY	CLB/5-FU/MTX		NCI
C9602	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9602	RO	chemotherapy regimen has component Chlorambucil	NCI
C9602	RO	chemotherapy regimen has component Fluorouracil	NCI
C9602	RO	chemotherapy regimen has component Methotrexate	NCI
C9640	STY	Therapeutic or Preventive Procedure		NCI
C9640	PT	Bleomycin/Dactinomycin/Vinblastine		NCI
C9640	SY	VAB		NCI
C9640	SY	BLEO/DACT/VBL		NCI
C9640	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9640	RO	chemotherapy regimen has component Bleomycin	NCI
C9640	RO	chemotherapy regimen has component Dactinomycin	NCI
C9640	RO	chemotherapy regimen has component Vinblastine	NCI
C10852	STY	Therapeutic or Preventive Procedure		NCI
C10852	PT	Dacarbazine/Interleukin-1-Alpha		NCI
C10852	SY	DTIC/IL-1A		NCI
C10852	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10852	RO	chemotherapy regimen has component Dacarbazine	NCI
C10852	RO	chemotherapy regimen has component Recombinant Interleukin-1-alpha	NCI
C63589	STY	Therapeutic or Preventive Procedure		NCI
C63589	PT	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia		NCI
C63589	CHD	Chemotherapy Regimen	NCI
C63589	PAR	Cytarabine-Daunorubicin-Etoposide Regimen	NCI
C63589	PAR	TAD Regimen	NCI
C63589	PAR	AIDA Regimen	NCI
C63589	PAR	ATRA-Daunorubicin Regimen	NCI
C63589	PAR	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia	NCI
C63589	PAR	Cytarabine-Daunorubicin Regimen	NCI
C63589	PAR	Cytarabine-Idarubicin Regimen	NCI
C63589	PAR	Cytarabine-Mitoxantrone Regimen	NCI
C63589	PAR	Cytarabine-Thioguanine Regimen	NCI
C63589	PAR	Mitoxantrone-Etoposide Regimen	NCI
C10408	STY	Therapeutic or Preventive Procedure		NCI
C10408	PT	Carmustine/Nimodipine/Vincristine		NCI
C10408	SY	BCNU/NIMO/VCR		NCI
C10408	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10408	RO	chemotherapy regimen has component Carmustine	NCI
C10408	RO	chemotherapy regimen has component Nimodipine	NCI
C10408	RO	chemotherapy regimen has component Vincristine	NCI
C9808	STY	Therapeutic or Preventive Procedure		NCI
C9808	PT	Carboplatin/Etoposide/Thiotepa		NCI
C9808	SY	CBDCA/TSPA/VP-16		NCI
C9808	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9808	RO	chemotherapy regimen has component Etoposide	NCI
C9808	RO	chemotherapy regimen has component Thiotepa	NCI
C9808	RO	chemotherapy regimen has component Carboplatin	NCI
C37708	STY	Therapeutic or Preventive Procedure		NCI
C37708	PT	Cytarabine/Daunorubicin/Dexamethasone/Methotrexate/Pegaspargase/Vincristine		NCI
C37708	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37708	RO	chemotherapy regimen has component Cytarabine	NCI
C37708	RO	chemotherapy regimen has component Dexamethasone	NCI
C37708	RO	chemotherapy regimen has component Methotrexate	NCI
C37708	RO	chemotherapy regimen has component Vincristine	NCI
C37708	RO	chemotherapy regimen has component Pegaspargase	NCI
C37708	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C9780	STY	Therapeutic or Preventive Procedure		NCI
C9780	PT	Asparaginase/Mercaptopurine/Prednisone/Vincristine		NCI
C9780	SY	ASP/MP/PRED/VCR		NCI
C9780	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9780	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9780	RO	chemotherapy regimen has component Asparaginase	NCI
C9780	RO	chemotherapy regimen has component Prednisone	NCI
C9780	RO	chemotherapy regimen has component Vincristine	NCI
C156369	STY	Therapeutic or Preventive Procedure		NCI
C156369	PT	Fulvestrant/Palbociclib Regimen		NCI
C156369	SY	Palbociclib/Fulvestrant Regimen		NCI
C156369	SY	Palbociclib/Fulvestrant		NCI
C156369	SY	Faslodex/Ibrance		NCI
C156369	SY	Fulvestrant/Palbociclib		NCI
C156369	SY	Fulvestrant-Palbociclib		NCI
C156369	SY	Palbociclib-Fulvestrant		NCI
C156369	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156369	RO	chemotherapy regimen has component Fulvestrant	NCI
C156369	RO	chemotherapy regimen has component Palbociclib	NCI
C37581	STY	Therapeutic or Preventive Procedure		NCI
C37581	PT	Calcium Carbonate/Cholecalciferol/Conjugated Estrogens		NCI
C37581	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37581	RO	chemotherapy regimen has component Calcium Carbonate	NCI
C37581	RO	chemotherapy regimen has component Estrogens, Conjugated	NCI
C37581	RO	chemotherapy regimen has component D Vitamin	NCI
C10126	STY	Therapeutic or Preventive Procedure		NCI
C10126	PT	Fluorouracil/Prednisone/Vincristine		NCI
C10126	SY	5-FU/PRED/VCR		NCI
C10126	SY	VPF		NCI
C10126	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10126	RO	chemotherapy regimen has component Fluorouracil	NCI
C10126	RO	chemotherapy regimen has component Prednisone	NCI
C10126	RO	chemotherapy regimen has component Vincristine	NCI
C10289	STY	Therapeutic or Preventive Procedure		NCI
C10289	PT	Carboplatin/Etoposide		NCI
C10289	SY	CBDCA/VP-16		NCI
C10289	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10289	RO	chemotherapy regimen has component Etoposide	NCI
C10289	RO	chemotherapy regimen has component Carboplatin	NCI
C9617	STY	Therapeutic or Preventive Procedure		NCI
C9617	PT	Fluorouracil/Semustine/Streptozocin/Vincristine		NCI
C9617	SY	MOF-STREP		NCI
C9617	SY	5-FU/MeCCNU/SZC/VCR		NCI
C9617	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9617	RO	chemotherapy regimen has component Fluorouracil	NCI
C9617	RO	chemotherapy regimen has component Semustine	NCI
C9617	RO	chemotherapy regimen has component Streptozocin	NCI
C9617	RO	chemotherapy regimen has component Vincristine	NCI
C10965	STY	Therapeutic or Preventive Procedure		NCI
C10965	PT	Folic Acid/Lometrexol		NCI
C10965	SY	FA/LMTX		NCI
C10965	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10965	RO	chemotherapy regimen has component Folic Acid	NCI
C10965	RO	chemotherapy regimen has component Lometrexol	NCI
C12004	STY	Therapeutic or Preventive Procedure		NCI
C12004	PT	Cisplatin/Epoetin Alfa		NCI
C12004	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12004	RO	chemotherapy regimen has component Cisplatin	NCI
C12004	RO	chemotherapy regimen has component Epoetin Alfa	NCI
C9626	STY	Therapeutic or Preventive Procedure		NCI
C9626	PT	Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin		NCI
C9626	SY	BLEO/CDDP/CTX/DOX		NCI
C9626	SY	BCAP		NCI
C9626	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9626	RO	chemotherapy regimen has component Bleomycin	NCI
C9626	RO	chemotherapy regimen has component Cisplatin	NCI
C9626	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9626	RO	chemotherapy regimen has component Doxorubicin	NCI
C10604	STY	Therapeutic or Preventive Procedure		NCI
C10604	PT	Cisplatin/Cyclophosphamide/Paclitaxel		NCI
C10604	SY	CDDP/CTX/TAX		NCI
C10604	SY	Cisplatin/Paclitaxel/Cyclophosphamide		NCI
C10604	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10604	RO	chemotherapy regimen has component Cisplatin	NCI
C10604	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10604	RO	chemotherapy regimen has component Paclitaxel	NCI
C9940	STY	Therapeutic or Preventive Procedure		NCI
C9940	PT	Cisplatin/Cyclophosphamide/Etoposide/Sargramostim		NCI
C9940	SY	CDDP/CTX/GM-CSF/VP-16		NCI
C9940	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9940	RO	chemotherapy regimen has component Cisplatin	NCI
C9940	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9940	RO	chemotherapy regimen has component Etoposide	NCI
C9940	RO	chemotherapy regimen has component Sargramostim	NCI
C10993	STY	Therapeutic or Preventive Procedure		NCI
C10993	PT	Eflornithine/Interferon Alfa		NCI
C10993	SY	DFMO/IFN-A		NCI
C10993	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10993	RO	chemotherapy regimen has component Eflornithine	NCI
C10993	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9727	STY	Therapeutic or Preventive Procedure		NCI
C9727	PT	Cisplatin/Ifosfamide/Vincristine		NCI
C9727	SY	HOP		NCI
C9727	SY	CDDP/IFF/VCR		NCI
C9727	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9727	RO	chemotherapy regimen has component Cisplatin	NCI
C9727	RO	chemotherapy regimen has component Ifosfamide	NCI
C9727	RO	chemotherapy regimen has component Vincristine	NCI
C10363	STY	Therapeutic or Preventive Procedure		NCI
C10363	PT	Dactinomycin/Idarubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C10363	SY	DACT/IDA/MP/MTX/PRED/VCR		NCI
C10363	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10363	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10363	RO	chemotherapy regimen has component Dactinomycin	NCI
C10363	RO	chemotherapy regimen has component Idarubicin	NCI
C10363	RO	chemotherapy regimen has component Methotrexate	NCI
C10363	RO	chemotherapy regimen has component Prednisone	NCI
C10363	RO	chemotherapy regimen has component Vincristine	NCI
C10188	STY	Therapeutic or Preventive Procedure		NCI
C10188	PT	Bleomycin/Doxorubicin/Vincristine		NCI
C10188	SY	BLEO/DOX/VCR		NCI
C10188	SY	ABV		NCI
C10188	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10188	RO	chemotherapy regimen has component Bleomycin	NCI
C10188	RO	chemotherapy regimen has component Doxorubicin	NCI
C10188	RO	chemotherapy regimen has component Vincristine	NCI
C9696	STY	Therapeutic or Preventive Procedure		NCI
C9696	PT	Carmustine/Cyclophosphamide/Doxorubicin/Melphalan		NCI
C9696	SY	BCNU/CTX/DOX/L-PAM		NCI
C9696	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9696	RO	chemotherapy regimen has component Carmustine	NCI
C9696	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9696	RO	chemotherapy regimen has component Doxorubicin	NCI
C9696	RO	chemotherapy regimen has component Melphalan	NCI
C12165	STY	Therapeutic or Preventive Procedure		NCI
C12165	PT	Cisplatin/Dacarbazine/Doxorubicin/Mitomycin/Sargramostim		NCI
C12165	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12165	RO	chemotherapy regimen has component Mitomycin	NCI
C12165	RO	chemotherapy regimen has component Cisplatin	NCI
C12165	RO	chemotherapy regimen has component Dacarbazine	NCI
C12165	RO	chemotherapy regimen has component Doxorubicin	NCI
C12165	RO	chemotherapy regimen has component Sargramostim	NCI
C156379	STY	Therapeutic or Preventive Procedure		NCI
C156379	PT	Abemaciclib/Anastrozole Regimen		NCI
C156379	SY	Anastrozole/Abemaciclib Regimen		NCI
C156379	SY	Anastrozole/Abemaciclib		NCI
C156379	SY	Arimidex/Verzenio		NCI
C156379	SY	Abemaciclib-Anastrozole		NCI
C156379	SY	Abemaciclib/Anastrozole		NCI
C156379	SY	Anastrozole-Abemaciclib		NCI
C156379	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156379	RO	chemotherapy regimen has component Anastrozole	NCI
C156379	RO	chemotherapy regimen has component Abemaciclib	NCI
C11587	STY	Therapeutic or Preventive Procedure		NCI
C11587	PT	gp100 Antigen/QS21/Tyrosinase Peptide		NCI
C11587	SY	gp100/QS21/TYRP		NCI
C11587	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11587	RO	chemotherapy regimen has component QS21	NCI
C11587	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11587	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C67166	STY	Therapeutic or Preventive Procedure		NCI
C67166	PT	OPPA-COPP Regimen		NCI
C67166	SY	OPPA-COPP		NCI
C67166	SY	GPOH-HD 95 Regimen		NCI
C67166	SY	Oncovin-Prednisone-Procarbazine-Adriamycin/Cyclophosphamide-Oncovin-Prednisone-Procarbazine Regimen		NCI
C67166	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67166	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67166	RO	chemotherapy regimen has component Doxorubicin	NCI
C67166	RO	chemotherapy regimen has component Prednisone	NCI
C67166	RO	chemotherapy regimen has component Vincristine	NCI
C67166	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C67166	RO	regimen has accepted use for disease Childhood Hodgkin Lymphoma	NCI
C64366	STY	Therapeutic or Preventive Procedure		NCI
C64366	PT	E-CMF Regimen		NCI
C64366	SY	Epirubicin-Cytoxan-Methotrexate-Fluorouracil Regimen		NCI
C64366	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C64366	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C64366	RO	chemotherapy regimen has component Fluorouracil	NCI
C64366	RO	chemotherapy regimen has component Methotrexate	NCI
C64366	RO	regimen has accepted use for disease Breast Carcinoma	NCI
C64366	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11696	STY	Therapeutic or Preventive Procedure		NCI
C11696	PT	Carboplatin/Docetaxel/Gemcitabine		NCI
C11696	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11696	RO	chemotherapy regimen has component Carboplatin	NCI
C11696	RO	chemotherapy regimen has component Docetaxel	NCI
C11696	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12178	STY	Therapeutic or Preventive Procedure		NCI
C12178	PT	MUC-2-Globo H-KLH Conjugate Vaccine/QS21		NCI
C12178	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12178	RO	chemotherapy regimen has component QS21	NCI
C12178	RO	chemotherapy regimen has component MUC-2-Globo H-KLH Conjugate Vaccine	NCI
C11616	STY	Therapeutic or Preventive Procedure		NCI
C11616	PT	Cytarabine/Daunorubicin/Tretinoin		NCI
C11616	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11616	RO	chemotherapy regimen has component Cytarabine	NCI
C11616	RO	chemotherapy regimen has component Tretinoin	NCI
C11616	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C64770	STY	Therapeutic or Preventive Procedure		NCI
C64770	PT	TAD Regimen		NCI
C64770	SY	Thioguanine/Cytarabine/Daunorubicin Regimen		NCI
C64770	SY	Thioguanine-Ara-C-Daunorubicin Regimen		NCI
C64770	CHD	Chemotherapy Regimen Used to Treat Acute Myeloid Leukemia	NCI
C64770	RO	chemotherapy regimen has component Cytarabine	NCI
C64770	RO	chemotherapy regimen has component Daunorubicin	NCI
C64770	RO	regimen has accepted use for disease Acute Myeloid Leukemia	NCI
C64770	RO	chemotherapy regimen has component Thioguanine	NCI
C37752	STY	Therapeutic or Preventive Procedure		NCI
C37752	PT	Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vinblastine		NCI
C37752	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37752	RO	chemotherapy regimen has component Mercaptopurine	NCI
C37752	RO	chemotherapy regimen has component Doxorubicin	NCI
C37752	RO	chemotherapy regimen has component Methotrexate	NCI
C37752	RO	chemotherapy regimen has component Prednisone	NCI
C37752	RO	chemotherapy regimen has component Vinblastine	NCI
C10614	STY	Therapeutic or Preventive Procedure		NCI
C10614	PT	Cyclophosphamide/Cytarabine/Doxorubicin/Vincristine		NCI
C10614	SY	ARA-C/CTX/DOX/VCR		NCI
C10614	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10614	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10614	RO	chemotherapy regimen has component Cytarabine	NCI
C10614	RO	chemotherapy regimen has component Doxorubicin	NCI
C10614	RO	chemotherapy regimen has component Vincristine	NCI
C11624	STY	Therapeutic or Preventive Procedure		NCI
C11624	PT	Fluorouracil/Leucovorin Calcium/SU5416		NCI
C11624	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11624	RO	chemotherapy regimen has component Fluorouracil	NCI
C11624	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11624	RO	chemotherapy regimen has component Semaxanib	NCI
C10668	STY	Therapeutic or Preventive Procedure		NCI
C10668	PT	Carboplatin/Cisplatin/Paclitaxel		NCI
C10668	SY	CBDCA/CDDP/TAX		NCI
C10668	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10668	RO	chemotherapy regimen has component Cisplatin	NCI
C10668	RO	chemotherapy regimen has component Carboplatin	NCI
C10668	RO	chemotherapy regimen has component Paclitaxel	NCI
C37612	STY	Therapeutic or Preventive Procedure		NCI
C37612	PT	Carboplatin/Gemcitabine/Zileuton		NCI
C37612	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37612	RO	chemotherapy regimen has component Carboplatin	NCI
C37612	RO	chemotherapy regimen has component Zileuton	NCI
C37612	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C63785	STY	Therapeutic or Preventive Procedure		NCI
C63785	PT	CVD IL-2/IFNa2b Regimen		NCI
C63785	SY	Cisplatin/Vinblastine/Dacarbazine/Aldesleukin/Interferon alfa-2b		NCI
C63785	SY	CVD IL-2-IFNa2b		NCI
C63785	SY	Dacarbazine/Cisplatin/Vinblastine/IL-2/IFNa2b		NCI
C63785	SY	Cisplatin/Vinblastine/Dacarbazine/Interleukin-2/Interferon alfa-2b		NCI
C63785	SY	Cisplatin-Vinblastine-Dacarbazine-Aldesleukin-Interferon alfa-2b		NCI
C63785	SY	Dacarbazine/Cisplatin/Vinblastine/Interleukin-2/Interferon alfa-2b		NCI
C63785	SY	CVD/IL-2/IFNa2b		NCI
C63785	SY	Cisplatin-Vinblastine-Dacarbazine Aldesleukin-Interferon alpha-2b Regimen		NCI
C63785	CHD	Chemotherapy Regimen Used to Treat Melanoma	NCI
C63785	RO	chemotherapy regimen has component Cisplatin	NCI
C63785	RO	chemotherapy regimen has component Dacarbazine	NCI
C63785	RO	chemotherapy regimen has component Recombinant Interferon Alfa-2b	NCI
C63785	RO	regimen has accepted use for disease Melanoma	NCI
C63785	RO	chemotherapy regimen has component Vinblastine	NCI
C63785	RO	chemotherapy regimen has component Aldesleukin	NCI
C63381	STY	Therapeutic or Preventive Procedure		NCI
C63381	PT	EC Regimen		NCI
C63381	SY	Etoposide-Carboplatin Regimen		NCI
C63381	SY	Carboplatin-Etoposide Regimen		NCI
C63381	SY	Etoposide/Carboplatin		NCI
C63381	SY	Carboplatin-Etoposide		NCI
C63381	SY	Carboplatin/Etoposide		NCI
C63381	SY	EC		NCI
C63381	CHD	Chemotherapy Regimen Used to Treat Prostate Carcinoma	NCI
C63381	CHD	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C63381	RO	chemotherapy regimen has component Etoposide	NCI
C63381	RO	chemotherapy regimen has component Carboplatin	NCI
C63381	RO	regimen has accepted use for disease Lung Small Cell Carcinoma	NCI
C10620	STY	Therapeutic or Preventive Procedure		NCI
C10620	PT	Cytarabine/Etoposide/Ifosfamide/Mercaptopurine/Methotrexate		NCI
C10620	SY	ARA-C/IFF/MP/MTX/VP-16		NCI
C10620	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10620	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10620	RO	chemotherapy regimen has component Cytarabine	NCI
C10620	RO	chemotherapy regimen has component Etoposide	NCI
C10620	RO	chemotherapy regimen has component Ifosfamide	NCI
C10620	RO	chemotherapy regimen has component Methotrexate	NCI
C10310	STY	Therapeutic or Preventive Procedure		NCI
C10310	PT	BCG/Fluorouracil		NCI
C10310	SY	BCG/5-FU		NCI
C10310	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10310	RO	chemotherapy regimen has component BCG Vaccine	NCI
C10310	RO	chemotherapy regimen has component Fluorouracil	NCI
C156370	STY	Therapeutic or Preventive Procedure		NCI
C156370	PT	Anastrozole/Ribociclib Regimen		NCI
C156370	SY	Anastrozole-Ribociclib		NCI
C156370	SY	Ribociclib/Anastrozole Regimen		NCI
C156370	SY	Arimidex/Kisqali		NCI
C156370	SY	Ribociclib/Anastrozole		NCI
C156370	SY	Ribociclib-Anastrozole		NCI
C156370	SY	Anastrozole/Ribociclib		NCI
C156370	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156370	RO	chemotherapy regimen has component Anastrozole	NCI
C156370	RO	chemotherapy regimen has component Ribociclib	NCI
C10256	STY	Therapeutic or Preventive Procedure		NCI
C10256	PT	Mercaptopurine/Methotrexate		NCI
C10256	SY	MP/MTX		NCI
C10256	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10256	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10256	RO	chemotherapy regimen has component Methotrexate	NCI
C136274	STY	Therapeutic or Preventive Procedure		NCI
C136274	PT	Lenalidomide/Low-dose Dexamethasone Regimen		NCI
C136274	SY	Revlimid/Low-dose Dexamethasone Regimen		NCI
C136274	SY	Lenalidomide-Low-dose Dexamethasone		NCI
C136274	SY	Lenalidomide Plus Low-dose Dexamethasone Regimen		NCI
C136274	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C136274	RO	chemotherapy regimen has component Dexamethasone	NCI
C136274	RO	regimen has accepted use for disease Plasma Cell Myeloma	NCI
C136274	RO	chemotherapy regimen has component Lenalidomide	NCI
C156296	STY	Therapeutic or Preventive Procedure		NCI
C156296	PT	Everolimus/Fulvestrant Regimen		NCI
C156296	SY	Everolimus-Fulvestrant		NCI
C156296	SY	Everolimus/Fulvestrant		NCI
C156296	SY	Fulvestrant/Everolimus Regimen		NCI
C156296	SY	Fulvestrant/Everolimus		NCI
C156296	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156296	RO	chemotherapy regimen has component Everolimus	NCI
C156296	RO	chemotherapy regimen has component Fulvestrant	NCI
C37602	STY	Therapeutic or Preventive Procedure		NCI
C37602	PT	Carboplatin/Cyclophosphamide/Etoposide Phosphate/Sodium Thiosulfate		NCI
C37602	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37602	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37602	RO	chemotherapy regimen has component Etoposide Phosphate	NCI
C37602	RO	chemotherapy regimen has component Sodium Thiosulfate	NCI
C37602	RO	chemotherapy regimen has component Carboplatin	NCI
C9582	STY	Therapeutic or Preventive Procedure		NCI
C9582	PT	Bleomycin/Cisplatin		NCI
C9582	SY	BLEO/CDDP		NCI
C9582	SY	BP		NCI
C9582	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9582	RO	chemotherapy regimen has component Bleomycin	NCI
C9582	RO	chemotherapy regimen has component Cisplatin	NCI
C10921	STY	Therapeutic or Preventive Procedure		NCI
C10921	PT	Carboplatin/Cyclophosphamide/Filgrastim		NCI
C10921	SY	CBDCA/CTX/G-CSF		NCI
C10921	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10921	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10921	RO	chemotherapy regimen has component Carboplatin	NCI
C10921	RO	chemotherapy regimen has component Filgrastim	NCI
C11977	STY	Therapeutic or Preventive Procedure		NCI
C11977	PT	Cytarabine/Etoposide/Ifosfamide/Leucovorin Calcium/Methotrexate/Prednisolone		NCI
C11977	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11977	RO	chemotherapy regimen has component Cytarabine	NCI
C11977	RO	chemotherapy regimen has component Etoposide	NCI
C11977	RO	chemotherapy regimen has component Ifosfamide	NCI
C11977	RO	chemotherapy regimen has component Methotrexate	NCI
C11977	RO	chemotherapy regimen has component Prednisolone	NCI
C11977	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11607	STY	Therapeutic or Preventive Procedure		NCI
C11607	PT	Fludarabine/Melphalan		NCI
C11607	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11607	RO	chemotherapy regimen has component Melphalan	NCI
C11607	RO	chemotherapy regimen has component Fludarabine	NCI
C37863	STY	Therapeutic or Preventive Procedure		NCI
C37863	PT	Vinorelbine/Zosuquidar Trihydrochloride		NCI
C37863	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37863	RO	chemotherapy regimen has component Vinorelbine	NCI
C37863	RO	chemotherapy regimen has component Zosuquidar Trihydrochloride	NCI
C9774	STY	Therapeutic or Preventive Procedure		NCI
C9774	PT	Busulfan/Cyclophosphamide		NCI
C9774	SY	BU/CTX		NCI
C9774	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9774	RO	chemotherapy regimen has component Busulfan	NCI
C9774	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11743	STY	Therapeutic or Preventive Procedure		NCI
C11743	PT	Irinotecan/Oblimersen		NCI
C11743	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11743	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11743	RO	chemotherapy regimen has component Oblimersen	NCI
C9917	STY	Therapeutic or Preventive Procedure		NCI
C9917	PT	Cisplatin/Cytarabine/Dexamethasone/Doxorubicin		NCI
C9917	SY	ARA-C/CDDP/DM/DOX		NCI
C9917	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9917	RO	chemotherapy regimen has component Cisplatin	NCI
C9917	RO	chemotherapy regimen has component Cytarabine	NCI
C9917	RO	chemotherapy regimen has component Dexamethasone	NCI
C9917	RO	chemotherapy regimen has component Doxorubicin	NCI
C140734	STY	Therapeutic or Preventive Procedure		NCI
C140734	PT	R-CHOP/R-DHAP Regimen		NCI
C140734	SY	R-CHOP/R-DHAP		NCI
C140734	SY	Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine-Rituximab/Cisplatin/Cytarabine/Dexamethasone		NCI
C140734	SY	R-CHOP Alternating with R-DHAP		NCI
C140734	SY	Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine Alternating with Rituximab Plus Cisplatin/Cytarabine/Dexamethasone		NCI
C140734	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C140734	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140734	RO	chemotherapy regimen has component Cisplatin	NCI
C140734	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C140734	RO	chemotherapy regimen has component Cytarabine	NCI
C140734	RO	chemotherapy regimen has component Dexamethasone	NCI
C140734	RO	chemotherapy regimen has component Doxorubicin	NCI
C140734	RO	chemotherapy regimen has component Prednisone	NCI
C140734	RO	chemotherapy regimen has component Vincristine	NCI
C140734	RO	chemotherapy regimen has component Rituximab	NCI
C11556	STY	Therapeutic or Preventive Procedure		NCI
C11556	PT	Amikacin/Ceftazidime		NCI
C11556	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11556	RO	chemotherapy regimen has component Amikacin Sulfate	NCI
C11556	RO	chemotherapy regimen has component Ceftazidime Sodium	NCI
C10041	STY	Therapeutic or Preventive Procedure		NCI
C10041	PT	Bleomycin/Cisplatin/Cyclophosphamide/Doxorubicin/Fluorouracil/Vincristine		NCI
C10041	SY	BLEO/CDDP/CTX/DOX/5-FU/VCR		NCI
C10041	SY	COAd/COB-5P		NCI
C10041	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10041	RO	chemotherapy regimen has component Bleomycin	NCI
C10041	RO	chemotherapy regimen has component Cisplatin	NCI
C10041	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10041	RO	chemotherapy regimen has component Doxorubicin	NCI
C10041	RO	chemotherapy regimen has component Fluorouracil	NCI
C10041	RO	chemotherapy regimen has component Vincristine	NCI
C156258	STY	Therapeutic or Preventive Procedure		NCI
C156258	PT	Abemaciclib/Fulvestrant Regimen		NCI
C156258	SY	Abemaciclib-Fulvestrant Regimen		NCI
C156258	SY	Abemaciclib-Fulvestrant		NCI
C156258	SY	Fulvestrant/Abemaciclib Regimen		NCI
C156258	SY	Abemaciclib/Fulvestrant		NCI
C156258	SY	Verzenio/Faslodex		NCI
C156258	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156258	RO	chemotherapy regimen has component Fulvestrant	NCI
C156258	RO	chemotherapy regimen has component Abemaciclib	NCI
C28969	STY	Therapeutic or Preventive Procedure		NCI
C28969	PT	Cisplatin/Cyclophosphamide/Dexamethasone/Doxorubicin/Etoposide/Thalidomide		NCI
C28969	SY	DTPACE		NCI
C28969	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C28969	RO	chemotherapy regimen has component Cisplatin	NCI
C28969	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C28969	RO	chemotherapy regimen has component Dexamethasone	NCI
C28969	RO	chemotherapy regimen has component Doxorubicin	NCI
C28969	RO	chemotherapy regimen has component Etoposide	NCI
C28969	RO	chemotherapy regimen has component Thalidomide	NCI
C12027	STY	Therapeutic or Preventive Procedure		NCI
C12027	PT	Anastrozole/Trastuzumab		NCI
C12027	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12027	RO	chemotherapy regimen has component Anastrozole	NCI
C12027	RO	chemotherapy regimen has component Trastuzumab	NCI
C11759	STY	Therapeutic or Preventive Procedure		NCI
C11759	PT	CI-994/Gemcitabine		NCI
C11759	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11759	RO	chemotherapy regimen has component Tacedinaline	NCI
C11759	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C9866	STY	Therapeutic or Preventive Procedure		NCI
C9866	PT	Asparaginase/Cytarabine/Doxorubicin/Teniposide		NCI
C9866	SY	ARA-C/ASP/DOX/VM-26		NCI
C9866	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9866	RO	chemotherapy regimen has component Asparaginase	NCI
C9866	RO	chemotherapy regimen has component Cytarabine	NCI
C9866	RO	chemotherapy regimen has component Doxorubicin	NCI
C9866	RO	chemotherapy regimen has component Teniposide	NCI
C11296	STY	Therapeutic or Preventive Procedure		NCI
C11296	PT	Doxorubicin/Etoposide/Ifosfamide		NCI
C11296	SY	DOX/IFF/VP-16		NCI
C11296	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11296	RO	chemotherapy regimen has component Doxorubicin	NCI
C11296	RO	chemotherapy regimen has component Etoposide	NCI
C11296	RO	chemotherapy regimen has component Ifosfamide	NCI
C11849	STY	Therapeutic or Preventive Procedure		NCI
C11849	PT	Cytarabine/Daunorubicin Liposomal		NCI
C11849	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11849	RO	chemotherapy regimen has component Cytarabine	NCI
C11849	RO	chemotherapy regimen has component Liposomal Daunorubicin Citrate	NCI
C10693	STY	Therapeutic or Preventive Procedure		NCI
C10693	PT	Cisplatin/Fluorouracil/Paclitaxel		NCI
C10693	SY	CDDP/5-FU/TAX		NCI
C10693	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10693	RO	chemotherapy regimen has component Cisplatin	NCI
C10693	RO	chemotherapy regimen has component Fluorouracil	NCI
C10693	RO	chemotherapy regimen has component Paclitaxel	NCI
C10856	STY	Therapeutic or Preventive Procedure		NCI
C10856	PT	Cyclosporine/Methotrexate		NCI
C10856	SY	CYSP/MTX		NCI
C10856	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10856	RO	chemotherapy regimen has component Cyclosporine	NCI
C10856	RO	chemotherapy regimen has component Methotrexate	NCI
C10366	STY	Therapeutic or Preventive Procedure		NCI
C10366	PT	Fluorouracil/Leucovorin Calcium/Thiotepa		NCI
C10366	SY	CF/5-FU/TSPA		NCI
C10366	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10366	RO	chemotherapy regimen has component Fluorouracil	NCI
C10366	RO	chemotherapy regimen has component Thiotepa	NCI
C10366	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C37500	STY	Therapeutic or Preventive Procedure		NCI
C37500	PT	CCI-779/Letrozole		NCI
C37500	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37500	RO	chemotherapy regimen has component Letrozole	NCI
C37500	RO	chemotherapy regimen has component Temsirolimus	NCI
C28939	STY	Pharmacologic Substance		NCI
C28939	STY	Nucleic Acid, Nucleoside, or Nucleotide		NCI
C28939	PT	Lamivudine/Zidovudine		NCI
C28939	SY	Combivir		NCI
C28939	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C28939	RO	chemotherapy regimen has component Zidovudine	NCI
C28939	RO	chemotherapy regimen has component Lamivudine	NCI
C37794	STY	Therapeutic or Preventive Procedure		NCI
C37794	PT	Fowlpox-Tyrosinase Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine		NCI
C37794	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37794	RO	chemotherapy regimen has component Vaccinia-Tyrosinase Vaccine	NCI
C37794	RO	chemotherapy regimen has component Recombinant Fowlpox-Tyrosinase Vaccine	NCI
C37794	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11341	STY	Therapeutic or Preventive Procedure		NCI
C11341	PT	Amifostine/Fludarabine		NCI
C11341	SY	FAMP/WR-2721		NCI
C11341	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11341	RO	chemotherapy regimen has component Amifostine	NCI
C11341	RO	chemotherapy regimen has component Fludarabine	NCI
C63683	STY	Therapeutic or Preventive Procedure		NCI
C63683	PT	TPF Regimen		NCI
C63683	SY	DCF Regimen		NCI
C63683	SY	Docetaxel/Cisplatin/Fluorouracil Regimen		NCI
C63683	SY	DCF		NCI
C63683	SY	Taxotere-Platinol-Fluorouracil Regimen		NCI
C63683	SY	TPF		NCI
C63683	SY	Docetaxel-Cisplatin-Fluorouracil Regimen		NCI
C63683	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C63683	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C63683	RO	chemotherapy regimen has component Cisplatin	NCI
C63683	RO	chemotherapy regimen has component Fluorouracil	NCI
C63683	RO	chemotherapy regimen has component Docetaxel	NCI
C63683	RO	regimen has accepted use for disease Gastric Carcinoma	NCI
C63683	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C10748	STY	Therapeutic or Preventive Procedure		NCI
C10748	PT	Estramustine/Etoposide		NCI
C10748	SY	EM/VP-16		NCI
C10748	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10748	RO	chemotherapy regimen has component Estramustine	NCI
C10748	RO	chemotherapy regimen has component Etoposide	NCI
C10734	STY	Therapeutic or Preventive Procedure		NCI
C10734	PT	Doxorubicin/Topotecan		NCI
C10734	SY	DOX/TOPO		NCI
C10734	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10734	RO	chemotherapy regimen has component Doxorubicin	NCI
C10734	RO	chemotherapy regimen has component Topotecan	NCI
C10046	STY	Therapeutic or Preventive Procedure		NCI
C10046	PT	Ampligen/Interleukin-2		NCI
C10046	SY	ampligen/IL-2		NCI
C10046	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10046	RO	chemotherapy regimen has component Rintatolimod	NCI
C10046	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10654	STY	Therapeutic or Preventive Procedure		NCI
C10654	PT	Cyclophosphamide/Doxorubicin/Etoposide/Vincristine/Zidovudine		NCI
C10654	SY	CTX/DOX/VCR/VP-16/ZDV		NCI
C10654	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10654	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10654	RO	chemotherapy regimen has component Doxorubicin	NCI
C10654	RO	chemotherapy regimen has component Etoposide	NCI
C10654	RO	chemotherapy regimen has component Vincristine	NCI
C10654	RO	chemotherapy regimen has component Zidovudine	NCI
C67297	STY	Therapeutic or Preventive Procedure		NCI
C67297	PT	Chemotherapy Regimen Used to Treat Childhood Rhabdomyosarcoma		NCI
C67297	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C67297	PAR	ID Rhabdomyosarcoma Regimen	NCI
C67297	PAR	IE Rhabdomyosarcoma Regimen	NCI
C67297	PAR	VAC Regimen	NCI
C67297	PAR	Vincristine-Dactinomycin Rhabdomyosarcoma Regimen	NCI
C67297	PAR	VAC/VI Regimen	NCI
C12168	STY	Therapeutic or Preventive Procedure		NCI
C12168	PT	Aspirin/Clopidogrel Bisulfate		NCI
C12168	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12168	RO	chemotherapy regimen has component Aspirin	NCI
C12168	RO	chemotherapy regimen has component Clopidogrel Bisulfate	NCI
C11988	STY	Therapeutic or Preventive Procedure		NCI
C11988	PT	Asparaginase/cytarabine/prednisolone/vincristine		NCI
C11988	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11988	RO	chemotherapy regimen has component Asparaginase	NCI
C11988	RO	chemotherapy regimen has component Cytarabine	NCI
C11988	RO	chemotherapy regimen has component Prednisolone	NCI
C11988	RO	chemotherapy regimen has component Vincristine	NCI
C9838	STY	Therapeutic or Preventive Procedure		NCI
C9838	PT	Mercaptopurine/Methotrexate/Pentostatin		NCI
C9838	SY	DCF/MP/MTX		NCI
C9838	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9838	RO	chemotherapy regimen has component Mercaptopurine	NCI
C9838	RO	chemotherapy regimen has component Methotrexate	NCI
C9838	RO	chemotherapy regimen has component Pentostatin	NCI
C37580	STY	Therapeutic or Preventive Procedure		NCI
C37580	PT	Calcitriol/Zoledronate		NCI
C37580	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37580	RO	chemotherapy regimen has component Calcitriol	NCI
C37580	RO	chemotherapy regimen has component Zoledronic Acid	NCI
C37692	STY	Therapeutic or Preventive Procedure		NCI
C37692	PT	Cyclophosphamide/Etoposide/Leucovorin Calcium/Methotrexate		NCI
C37692	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37692	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37692	RO	chemotherapy regimen has component Etoposide	NCI
C37692	RO	chemotherapy regimen has component Methotrexate	NCI
C37692	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C60932	STY	Therapeutic or Preventive Procedure		NCI
C60932	PT	Doxorubicin/Tariquidar		NCI
C60932	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C60932	RO	chemotherapy regimen has component Doxorubicin	NCI
C60932	RO	chemotherapy regimen has component Tariquidar	NCI
C11175	STY	Therapeutic or Preventive Procedure		NCI
C11175	PT	Cyclosporine/Interferon Gamma/Interleukin-2		NCI
C11175	SY	CYSP/IFN-G/IL-2		NCI
C11175	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11175	RO	chemotherapy regimen has component Cyclosporine	NCI
C11175	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C11175	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11404	STY	Therapeutic or Preventive Procedure		NCI
C11404	PT	gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Peptide		NCI
C11404	SY	gp100/IFA/IL-12/TYRP		NCI
C11404	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11404	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11404	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11404	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11404	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C12086	STY	Therapeutic or Preventive Procedure		NCI
C12086	PT	Cytarabine/Etoposide/Ifosfamide/Methotrexate/Vincristine		NCI
C12086	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12086	RO	chemotherapy regimen has component Cytarabine	NCI
C12086	RO	chemotherapy regimen has component Etoposide	NCI
C12086	RO	chemotherapy regimen has component Ifosfamide	NCI
C12086	RO	chemotherapy regimen has component Methotrexate	NCI
C12086	RO	chemotherapy regimen has component Vincristine	NCI
C37657	STY	Therapeutic or Preventive Procedure		NCI
C37657	PT	Cisplatin/Fluorouracil/Oblimersen		NCI
C37657	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37657	RO	chemotherapy regimen has component Cisplatin	NCI
C37657	RO	chemotherapy regimen has component Fluorouracil	NCI
C37657	RO	chemotherapy regimen has component Oblimersen	NCI
C15615	STY	Therapeutic or Preventive Procedure		NCI
C15615	PT	gp100 Antigen/Incomplete Freund's Adjuvant		NCI
C15615	SY	gp100 Antigen with Incomplete Freund's Adjuvant		NCI
C15615	SY	gp100/IFA		NCI
C15615	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15615	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C15615	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11612	STY	Therapeutic or Preventive Procedure		NCI
C11612	PT	Amifostine/Cyclophosphamide/Doxorubicin/Paclitaxel		NCI
C11612	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11612	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11612	RO	chemotherapy regimen has component Doxorubicin	NCI
C11612	RO	chemotherapy regimen has component Amifostine	NCI
C11612	RO	chemotherapy regimen has component Paclitaxel	NCI
C37857	STY	Therapeutic or Preventive Procedure		NCI
C37857	PT	Tamoxifen/Tipifarnib		NCI
C37857	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37857	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C37857	RO	chemotherapy regimen has component Tipifarnib	NCI
C11544	STY	Therapeutic or Preventive Procedure		NCI
C11544	PT	Fowlpox Virus Vaccine/Interleukin-2		NCI
C11544	SY	FOWLVAC/IL-2		NCI
C11544	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11544	RO	chemotherapy regimen has component Fowlpox Virus Vaccine	NCI
C11544	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37799	STY	Therapeutic or Preventive Procedure		NCI
C37799	PT	Gefitinib/Trastuzumab		NCI
C37799	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37799	RO	chemotherapy regimen has component Trastuzumab	NCI
C37799	RO	chemotherapy regimen has component Gefitinib	NCI
C10001	STY	Therapeutic or Preventive Procedure		NCI
C10001	PT	Cyclophosphamide/Doxorubicin/Melphalan/Vincristine		NCI
C10001	SY	CONPADRI-I		NCI
C10001	SY	CTX/DOX/L-PAM/VCR		NCI
C10001	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10001	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10001	RO	chemotherapy regimen has component Doxorubicin	NCI
C10001	RO	chemotherapy regimen has component Melphalan	NCI
C10001	RO	chemotherapy regimen has component Vincristine	NCI
C142860	STY	Therapeutic or Preventive Procedure		NCI
C142860	PT	Lapatinib/Letrozole Regimen		NCI
C142860	SY	Lapatinib Plus Letrozole		NCI
C142860	SY	Lapatinib-Letrozole		NCI
C142860	SY	Lapatinib + Letrozole		NCI
C142860	SY	Tykerb/Femara		NCI
C142860	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C142860	RO	chemotherapy regimen has component Letrozole	NCI
C142860	RO	chemotherapy regimen has component Lapatinib	NCI
C142860	RO	concept in subset CTRP Terminology	NCI
C142860	RO	concept in subset CTRP Agent Terminology	NCI
C37803	STY	Therapeutic or Preventive Procedure		NCI
C37803	PT	Gemcitabine/Mistletoe		NCI
C37803	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37803	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37803	RO	chemotherapy regimen has component Mistletoe Extract	NCI
C9682	STY	Therapeutic or Preventive Procedure		NCI
C9682	PT	Cyclophosphamide/Doxorubicin/Fluorouracil/Vincristine		NCI
C9682	SY	COAd/CO-5		NCI
C9682	SY	FACV		NCI
C9682	SY	CTX/DOX/5-FU/VCR		NCI
C9682	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9682	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9682	RO	chemotherapy regimen has component Doxorubicin	NCI
C9682	RO	chemotherapy regimen has component Fluorouracil	NCI
C9682	RO	chemotherapy regimen has component Vincristine	NCI
C64788	STY	Therapeutic or Preventive Procedure		NCI
C64788	PT	PVB Regimen		NCI
C64788	SY	Platinol-Velban-Bleomycin Regimen		NCI
C64788	CHD	Chemotherapy Regimen Used to Treat Malignant Testicular Neoplasm	NCI
C64788	CHD	Chemotherapy Regimen Used to Treat Gestational Trophoblastic Tumor	NCI
C64788	RO	chemotherapy regimen has component Bleomycin	NCI
C64788	RO	chemotherapy regimen has component Cisplatin	NCI
C64788	RO	chemotherapy regimen has component Vinblastine	NCI
C64788	RO	regimen has accepted use for disease Malignant Testicular Germ Cell Tumor	NCI
C64788	RO	regimen has accepted use for disease Gestational Trophoblastic Tumor	NCI
C113826	STY	Therapeutic or Preventive Procedure		NCI
C113826	PT	Bortezomib/Cyclophosphamide/Dexamethasone Regimen		NCI
C113826	SY	VCD		NCI
C113826	SY	CyBorD		NCI
C113826	SY	Velcade-Cyclophosphamide-Dexamethasone		NCI
C113826	CHD	Chemotherapy Regimen Used to Treat Plasma Cell Myeloma	NCI
C113826	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C113826	RO	chemotherapy regimen has component Dexamethasone	NCI
C113826	RO	chemotherapy regimen has component Bortezomib	NCI
C11853	STY	Therapeutic or Preventive Procedure		NCI
C11853	PT	Cisplatin/Gemcitabine/Paclitaxel		NCI
C11853	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11853	RO	chemotherapy regimen has component Cisplatin	NCI
C11853	RO	chemotherapy regimen has component Paclitaxel	NCI
C11853	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11105	STY	Therapeutic or Preventive Procedure		NCI
C11105	PT	Docetaxel/Vinorelbine		NCI
C11105	SY	TXT/VNB		NCI
C11105	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11105	RO	chemotherapy regimen has component Vinorelbine	NCI
C11105	RO	chemotherapy regimen has component Docetaxel	NCI
C11578	STY	Therapeutic or Preventive Procedure		NCI
C11578	PT	gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Tyrosinase Peptide		NCI
C11578	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11578	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11578	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11578	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11578	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C11197	STY	Therapeutic or Preventive Procedure		NCI
C11197	PT	FOLFOX Regimen		NCI
C11197	SY	Fluorouracil/Leucovorin Calcium/Oxaliplatin		NCI
C11197	SY	CF/5-FU/L-OHP		NCI
C11197	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C11197	PAR	FOLFOX-4 Regimen	NCI
C11197	PAR	FOLFOX-6 Regimen	NCI
C11197	PAR	FOLFOX-7 Regimen	NCI
C11197	PAR	Modified FOLFOX6 Regimen	NCI
C11197	RO	chemotherapy regimen has component Fluorouracil	NCI
C11197	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11197	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11197	RO	concept in subset CTRP Terminology	NCI
C11197	RO	concept in subset CTRP Agent Terminology	NCI
C12028	STY	Therapeutic or Preventive Procedure		NCI
C12028	PT	Pentoxifylline/vitamin E		NCI
C12028	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12028	RO	chemotherapy regimen has component Pentoxifylline	NCI
C12028	RO	chemotherapy regimen has component Vitamin E Compound	NCI
C11314	STY	Therapeutic or Preventive Procedure		NCI
C11314	PT	Cyclophosphamide/Etoposide/Lomustine/Procarbazine		NCI
C11314	SY	CCNU/CTX/PCB/VP-16		NCI
C11314	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11314	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11314	RO	chemotherapy regimen has component Etoposide	NCI
C11314	RO	chemotherapy regimen has component Lomustine	NCI
C11314	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C9787	STY	Therapeutic or Preventive Procedure		NCI
C9787	PT	Doxorubicin/Interleukin-2		NCI
C9787	SY	DOX/IL-2		NCI
C9787	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9787	RO	chemotherapy regimen has component Doxorubicin	NCI
C9787	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37798	STY	Therapeutic or Preventive Procedure		NCI
C37798	PT	Gefitinib/Temozolomide		NCI
C37798	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37798	RO	chemotherapy regimen has component Temozolomide	NCI
C37798	RO	chemotherapy regimen has component Gefitinib	NCI
C63442	STY	Therapeutic or Preventive Procedure		NCI
C63442	PT	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma		NCI
C63442	SY	Chemotherapy Regimen Used to Treat Non-Hodgkin's Lymphoma		NCI
C63442	CHD	Chemotherapy Regimen	NCI
C63442	PAR	CVP Regimen	NCI
C63442	PAR	MACOP-B Regimen	NCI
C63442	PAR	COPP Regimen	NCI
C63442	PAR	CHOP Regimen	NCI
C63442	PAR	CHOPE Regimen	NCI
C63442	PAR	ICE Regimen	NCI
C63442	PAR	CODOX-M Regimen	NCI
C63442	PAR	ESHAP Regimen	NCI
C63442	PAR	ACVBP Regimen	NCI
C63442	PAR	MINE Regimen	NCI
C63442	PAR	R-CHOP Regimen	NCI
C63442	PAR	M-BACOP Regimen	NCI
C63442	PAR	BR Regimen	NCI
C63442	PAR	R-Squared Regimen	NCI
C63442	PAR	R-FCM Regimen	NCI
C63442	PAR	CALGB 9251 Regimen	NCI
C63442	PAR	CDE Regimen	NCI
C63442	PAR	CNOP Regimen	NCI
C63442	PAR	CODOX-M/IVAC Regimen	NCI
C63442	PAR	Chemotherapy Regimen Used to Treat Childhood Non-Hodgkin's Lymphoma	NCI
C63442	PAR	DHAP Regimen	NCI
C63442	PAR	FC Regimen	NCI
C63442	PAR	FND Regimen	NCI
C63442	PAR	HyperCVAD/HD MTX AraC Regimen	NCI
C63442	PAR	HyperCVAD Regimen	NCI
C63442	PAR	Magrath Regimen	NCI
C63442	PAR	PCR Regimen	NCI
C63442	PAR	ProMACE-CytaBOM Regimen	NCI
C63442	PAR	R-CVP Regimen	NCI
C63442	PAR	R-EPOCH Regimen	NCI
C63442	PAR	R-FM Regimen	NCI
C63442	PAR	R-ICE Regimen	NCI
C63442	PAR	RF Regimen	NCI
C63442	PAR	Thalidomide-Rituximab Regimen	NCI
C63442	PAR	m-BACOD Regimen	NCI
C63442	PAR	Mini-BEAM Regimen	NCI
C63442	PAR	F-MACHOP Regimen	NCI
C63442	PAR	EPOCH Regimen	NCI
C63442	PAR	Carboplatin/Etoposide/Melphalan Regimen	NCI
C63442	PAR	EPOCH-O Regimen	NCI
C63442	PAR	R-DA-EPOCH Regimen	NCI
C63442	PAR	BAC Regimen	NCI
C63442	PAR	DeVIC Regimen	NCI
C63442	PAR	SMILE Regimen	NCI
C63442	PAR	FCM Regimen	NCI
C63442	PAR	IVE Regimen	NCI
C63442	PAR	AspaMetDex Regimen	NCI
C63442	PAR	R-DHAP Regimen	NCI
C63442	PAR	IVAC Regimen	NCI
C63442	PAR	R-ESHAP Regimen	NCI
C63442	PAR	HD-MTX/ARA-C Regimen	NCI
C63442	PAR	R-HD-MTX/ARA-C Regimen	NCI
C63442	PAR	R-Hyper-CVAD Regimen	NCI
C63442	PAR	Nordic Regimen	NCI
C63442	PAR	R-BAC Regimen	NCI
C63442	PAR	VIPD Regimen	NCI
C63442	PAR	R-HyperCVAD/HD MTX AraC Regimen	NCI
C63442	PAR	R-ACVBP Regimen	NCI
C63442	PAR	R-CHOPE Regimen	NCI
C63442	PAR	R-GemOx Regimen	NCI
C63442	PAR	R-CHOP/R-DHAP Regimen	NCI
C63442	PAR	RIVAC Regimen	NCI
C63442	PAR	CHOP Plus Obinutuzumab Regimen	NCI
C63442	PAR	R-CEPP Regimen	NCI
C63442	PAR	R-CDOP Regimen	NCI
C63442	PAR	Chlorambucil/Rituximab Regimen	NCI
C63442	PAR	Bendamustine/Obinutuzumab Regimen	NCI
C63442	PAR	R-CHOP Plus Methotrexate Regimen	NCI
C10177	STY	Therapeutic or Preventive Procedure		NCI
C10177	PT	Doxorubicin/Methotrexate/Vincristine		NCI
C10177	SY	VAM		NCI
C10177	SY	DOX/MTX/VCR		NCI
C10177	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10177	RO	chemotherapy regimen has component Doxorubicin	NCI
C10177	RO	chemotherapy regimen has component Methotrexate	NCI
C10177	RO	chemotherapy regimen has component Vincristine	NCI
C9886	STY	Therapeutic or Preventive Procedure		NCI
C9886	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Methotrexate/Methylprednisolone/Vincristine		NCI
C9886	SY	BLEO/CTX/DOX/MePRDL/MTX/VCR		NCI
C9886	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9886	RO	chemotherapy regimen has component Bleomycin	NCI
C9886	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9886	RO	chemotherapy regimen has component Doxorubicin	NCI
C9886	RO	chemotherapy regimen has component Methotrexate	NCI
C9886	RO	chemotherapy regimen has component Methylprednisolone	NCI
C9886	RO	chemotherapy regimen has component Vincristine	NCI
C63356	STY	Therapeutic or Preventive Procedure		NCI
C63356	PT	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma		NCI
C63356	SY	Chemotherapy Regimen Used to Treat Hodgkin's Lymphoma		NCI
C63356	CHD	Chemotherapy Regimen	NCI
C63356	PAR	ABVD Regimen	NCI
C63356	PAR	MOPP Regimen	NCI
C63356	PAR	COPP Regimen	NCI
C63356	PAR	ICE Regimen	NCI
C63356	PAR	Ifosfamide-Vinorelbine Regimen	NCI
C63356	PAR	ESHAP Regimen	NCI
C63356	PAR	MINE Regimen	NCI
C63356	PAR	VIM-D Regimen	NCI
C63356	PAR	EVAP Regimen	NCI
C63356	PAR	BEACOPP Regimen	NCI
C63356	PAR	MOPP/ABV Hybrid Regimen	NCI
C63356	PAR	EVA-ChlVPP Regimen	NCI
C63356	PAR	BR Regimen	NCI
C63356	PAR	ABV Regimen	NCI
C63356	PAR	AV Regimen	NCI
C63356	PAR	COPP-ABVD Regimen	NCI
C63356	PAR	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C63356	PAR	DHAP Regimen	NCI
C63356	PAR	EVA Regimen	NCI
C63356	PAR	MOPP/ABVD Alternating Regimen	NCI
C63356	PAR	Stanford V Regimen	NCI
C63356	PAR	chlVPP Regimen	NCI
C63356	PAR	Mini-BEAM Regimen	NCI
C63356	PAR	AVD Regimen	NCI
C63356	PAR	GDP Regimen	NCI
C63356	PAR	IVE Regimen	NCI
C63356	PAR	R-ESHAP Regimen	NCI
C63356	PAR	R-GDP Regimen	NCI
C63356	PAR	GVD Regimen	NCI
C63356	PAR	R-GVD Regimen	NCI
C63356	PAR	R-CHOP/R-DHAP Regimen	NCI
C11305	STY	Therapeutic or Preventive Procedure		NCI
C11305	PT	Fenretinide/Vitamin A		NCI
C11305	SY	HPR/VIT-A		NCI
C11305	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11305	RO	chemotherapy regimen has component Fenretinide	NCI
C11305	RO	chemotherapy regimen has component Vitamin A Compound	NCI
C11069	STY	Therapeutic or Preventive Procedure		NCI
C11069	PT	Homoharringtonine/Interferon Alfa		NCI
C11069	SY	HH/IFN-A		NCI
C11069	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11069	RO	chemotherapy regimen has component Omacetaxine Mepesuccinate	NCI
C11069	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11251	STY	Therapeutic or Preventive Procedure		NCI
C11251	PT	Carmustine/Cyclophosphamide/Etoposide/Mesna		NCI
C11251	SY	BCNU/CTX/Mesna/VP-16		NCI
C11251	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11251	RO	chemotherapy regimen has component Mesna	NCI
C11251	RO	chemotherapy regimen has component Carmustine	NCI
C11251	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11251	RO	chemotherapy regimen has component Etoposide	NCI
C10225	STY	Therapeutic or Preventive Procedure		NCI
C10225	PT	Asparaginase/Doxorubicin/Vincristine		NCI
C10225	SY	ASP/DOX/VCR		NCI
C10225	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10225	RO	chemotherapy regimen has component Asparaginase	NCI
C10225	RO	chemotherapy regimen has component Doxorubicin	NCI
C10225	RO	chemotherapy regimen has component Vincristine	NCI
C12117	STY	Therapeutic or Preventive Procedure		NCI
C12117	PT	Carboplatin/Paclitaxel/PS-341		NCI
C12117	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12117	RO	chemotherapy regimen has component Carboplatin	NCI
C12117	RO	chemotherapy regimen has component Paclitaxel	NCI
C12117	RO	chemotherapy regimen has component Bortezomib	NCI
C11400	STY	Therapeutic or Preventive Procedure		NCI
C11400	PT	Cisplatin/Cyclophosphamide/Etoposide/Leucovorin calcium/Methotrexate/Vincristine		NCI
C11400	SY	CDDP/CF/CTX/MTX/VCR/VP-16		NCI
C11400	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11400	RO	chemotherapy regimen has component Cisplatin	NCI
C11400	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11400	RO	chemotherapy regimen has component Etoposide	NCI
C11400	RO	chemotherapy regimen has component Methotrexate	NCI
C11400	RO	chemotherapy regimen has component Vincristine	NCI
C11400	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C15634	STY	Therapeutic or Preventive Procedure		NCI
C15634	PT	70-kD Heat-Shock Protein/MUC-1 Antigen		NCI
C15634	SY	HSP70/Mucin/Peptide		NCI
C15634	SY	HSP70/MUC-1		NCI
C15634	SY	HSP70/MUC-1 Antigen		NCI
C15634	SY	70-kD Heat-Shock Protein/Mucin/Peptide		NCI
C15634	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15634	RO	chemotherapy regimen has component MUC-1 Antigen	NCI
C15634	RO	chemotherapy regimen has component Recombinant 70-kD Heat-Shock Protein	NCI
C9670	STY	Therapeutic or Preventive Procedure		NCI
C9670	PT	Dactinomycin/Ifosfamide/Vincristine		NCI
C9670	SY	DACT/IFF/VCR		NCI
C9670	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9670	RO	chemotherapy regimen has component Dactinomycin	NCI
C9670	RO	chemotherapy regimen has component Ifosfamide	NCI
C9670	RO	chemotherapy regimen has component Vincristine	NCI
C9870	STY	Therapeutic or Preventive Procedure		NCI
C9870	PT	Asparaginase/Cytarabine/Carmustine/Thioguanine		NCI
C9870	SY	ARA-C/ASP/BCNU/TG		NCI
C9870	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9870	RO	chemotherapy regimen has component Asparaginase	NCI
C9870	RO	chemotherapy regimen has component Carmustine	NCI
C9870	RO	chemotherapy regimen has component Cytarabine	NCI
C9870	RO	chemotherapy regimen has component Thioguanine	NCI
C10737	STY	Therapeutic or Preventive Procedure		NCI
C10737	PT	Cytarabine/Methotrexate/Teniposide/Thioguanine		NCI
C10737	SY	ARA-C/MTX/TG/VM-26		NCI
C10737	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10737	RO	chemotherapy regimen has component Cytarabine	NCI
C10737	RO	chemotherapy regimen has component Methotrexate	NCI
C10737	RO	chemotherapy regimen has component Teniposide	NCI
C10737	RO	chemotherapy regimen has component Thioguanine	NCI
C11874	STY	Therapeutic or Preventive Procedure		NCI
C11874	PT	Cisplatin/Cyclophosphamide/Etoposide/Methotrexate/Vincristine		NCI
C11874	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11874	RO	chemotherapy regimen has component Cisplatin	NCI
C11874	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11874	RO	chemotherapy regimen has component Etoposide	NCI
C11874	RO	chemotherapy regimen has component Methotrexate	NCI
C11874	RO	chemotherapy regimen has component Vincristine	NCI
C9606	STY	Therapeutic or Preventive Procedure		NCI
C9606	PT	Cyclophosphamide/Dactinomycin/Methotrexate		NCI
C9606	SY	CTX/DACT/MTX		NCI
C9606	SY	MAC		NCI
C9606	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9606	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9606	RO	chemotherapy regimen has component Dactinomycin	NCI
C9606	RO	chemotherapy regimen has component Methotrexate	NCI
C9881	STY	Therapeutic or Preventive Procedure		NCI
C9881	PT	Dexrazoxane/Doxorubicin/Sargramostim		NCI
C9881	SY	ADR-529/DOX/GM-CSF		NCI
C9881	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9881	RO	chemotherapy regimen has component Doxorubicin	NCI
C9881	RO	chemotherapy regimen has component Dexrazoxane	NCI
C9881	RO	chemotherapy regimen has component Sargramostim	NCI
C156250	STY	Therapeutic or Preventive Procedure		NCI
C156250	PT	Carboplatin/Topotecan Regimen		NCI
C156250	CHD	Chemotherapy Regimen Used to Treat Small Cell Lung Carcinoma	NCI
C156250	RO	chemotherapy regimen has component Carboplatin	NCI
C156250	RO	chemotherapy regimen has component Topotecan	NCI
C156250	RO	regimen has accepted use for disease Lung Small Cell Carcinoma	NCI
C12196	STY	Therapeutic or Preventive Procedure		NCI
C12196	PT	Cyclophosphamide/Epirubicin/Paclitaxel		NCI
C12196	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12196	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C12196	RO	chemotherapy regimen has component Paclitaxel	NCI
C12196	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11164	STY	Therapeutic or Preventive Procedure		NCI
C11164	PT	Asparaginase/Prednisolone/Vincristine		NCI
C11164	SY	ASP/PRDL/VCR		NCI
C11164	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11164	RO	chemotherapy regimen has component Asparaginase	NCI
C11164	RO	chemotherapy regimen has component Prednisolone	NCI
C11164	RO	chemotherapy regimen has component Vincristine	NCI
C11738	STY	Therapeutic or Preventive Procedure		NCI
C11738	PT	Cytarabine/UCN-01		NCI
C11738	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11738	RO	chemotherapy regimen has component Cytarabine	NCI
C11738	RO	chemotherapy regimen has component 7-Hydroxystaurosporine	NCI
C37594	STY	Therapeutic or Preventive Procedure		NCI
C37594	PT	Carboplatin/Celecoxib/Gemcitabine		NCI
C37594	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37594	RO	chemotherapy regimen has component Carboplatin	NCI
C37594	RO	chemotherapy regimen has component Celecoxib	NCI
C37594	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C12138	STY	Therapeutic or Preventive Procedure		NCI
C12138	PT	Dalteparin/Gemcitabine		NCI
C12138	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12138	RO	chemotherapy regimen has component Dalteparin	NCI
C12138	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11362	STY	Therapeutic or Preventive Procedure		NCI
C11362	PT	Bryostatin 1/Paclitaxel		NCI
C11362	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11362	RO	chemotherapy regimen has component Bryostatin 1	NCI
C11362	RO	chemotherapy regimen has component Paclitaxel	NCI
C10929	STY	Therapeutic or Preventive Procedure		NCI
C10929	PT	Dexverapamil/Vinblastine		NCI
C10929	SY	R-VPAM/VBL		NCI
C10929	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10929	RO	chemotherapy regimen has component Vinblastine	NCI
C10929	RO	chemotherapy regimen has component Dexverapamil	NCI
C10271	STY	Therapeutic or Preventive Procedure		NCI
C10271	PT	Cytarabine/Daunorubicin		NCI
C10271	SY	CAD		NCI
C10271	SY	ARA-C/DNR		NCI
C10271	SY	DA		NCI
C10271	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10271	RO	chemotherapy regimen has component Cytarabine	NCI
C10271	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11702	STY	Therapeutic or Preventive Procedure		NCI
C11702	PT	HER-2-Neu Peptide Vaccine/Sargramostim		NCI
C11702	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11702	RO	chemotherapy regimen has component Sargramostim	NCI
C11702	RO	chemotherapy regimen has component HER-2/neu Peptide Vaccine	NCI
C10819	STY	Therapeutic or Preventive Procedure		NCI
C10819	PT	Cyclophosphamide/Perflubron		NCI
C10819	SY	CTX/PFOB		NCI
C10819	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10819	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10819	RO	chemotherapy regimen has component Perflubron	NCI
C12036	STY	Therapeutic or Preventive Procedure		NCI
C12036	PT	Calcium Citrate/Cholecalciferol/Zoledronate		NCI
C12036	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12036	RO	chemotherapy regimen has component Calcium Citrate	NCI
C12036	RO	chemotherapy regimen has component Zoledronic Acid	NCI
C12036	RO	chemotherapy regimen has component D Vitamin	NCI
C11963	STY	Therapeutic or Preventive Procedure		NCI
C11963	PT	Detox-B Adjuvant/RAS Peptide Cancer Vaccine		NCI
C11963	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11963	RO	chemotherapy regimen has component RAS Peptide Cancer Vaccine	NCI
C11963	RO	chemotherapy regimen has component Detox-B Adjuvant	NCI
C9799	STY	Therapeutic or Preventive Procedure		NCI
C9799	PT	Cyproterone/Goserelin		NCI
C9799	SY	CPTR/ZDX		NCI
C9799	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9799	RO	chemotherapy regimen has component Cyproterone	NCI
C9799	RO	chemotherapy regimen has component Goserelin	NCI
C11647	STY	Therapeutic or Preventive Procedure		NCI
C11647	PT	Anti-thymocyte globulin/thiotepa		NCI
C11647	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11647	RO	chemotherapy regimen has component Anti-Thymocyte Globulin	NCI
C11647	RO	chemotherapy regimen has component Thiotepa	NCI
C9945	STY	Therapeutic or Preventive Procedure		NCI
C9945	PT	Dipyridamole/Fluorouracil/Leucovorin Calcium		NCI
C9945	SY	CF/DP/5-FU		NCI
C9945	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9945	RO	chemotherapy regimen has component Dipyridamole	NCI
C9945	RO	chemotherapy regimen has component Fluorouracil	NCI
C9945	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C10019	STY	Therapeutic or Preventive Procedure		NCI
C10019	PT	Azacitidine/Cytarabine/Daunorubicin/Prednisone/Vincristine		NCI
C10019	SY	DZAPO		NCI
C10019	SY	ARA-C/AZA/DNR/PRED/VCR		NCI
C10019	SY	Azacytidine/Cytarabine/Daunorubicin/Prednisone/Vincristine		NCI
C10019	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10019	RO	chemotherapy regimen has component Azacitidine	NCI
C10019	RO	chemotherapy regimen has component Cytarabine	NCI
C10019	RO	chemotherapy regimen has component Prednisone	NCI
C10019	RO	chemotherapy regimen has component Vincristine	NCI
C10019	RO	chemotherapy regimen has component Duborimycin	NCI
C9966	STY	Therapeutic or Preventive Procedure		NCI
C9966	PT	Doxorubicin/Fluoxymesterone/Tamoxifen/Thiotepa/Vinblastine		NCI
C9966	SY	TAVTH		NCI
C9966	SY	DOX/FXM/TMX/TSPA/VBL		NCI
C9966	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9966	RO	chemotherapy regimen has component Doxorubicin	NCI
C9966	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C9966	RO	chemotherapy regimen has component Thiotepa	NCI
C9966	RO	chemotherapy regimen has component Vinblastine	NCI
C9966	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C9967	STY	Therapeutic or Preventive Procedure		NCI
C9967	PT	Cyclophosphamide/Sargramostim		NCI
C9967	SY	CTX/GM-CSF		NCI
C9967	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9967	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9967	RO	chemotherapy regimen has component Sargramostim	NCI
C12100	STY	Therapeutic or Preventive Procedure		NCI
C12100	PT	ALVAC-CEA-B7.1 vaccine/Fluorouracil/Irinotecan/Leucovorin calcium		NCI
C12100	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12100	RO	chemotherapy regimen has component Fluorouracil	NCI
C12100	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C12100	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C12100	RO	chemotherapy regimen has component ALVAC-CEA B7.1 Vaccine	NCI
C11017	STY	Therapeutic or Preventive Procedure		NCI
C11017	PT	Interferon Alfa/Melphalan/Prednisone		NCI
C11017	SY	IFN-A/L-PAM/PRED		NCI
C11017	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11017	RO	chemotherapy regimen has component Melphalan	NCI
C11017	RO	chemotherapy regimen has component Prednisone	NCI
C11017	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C9769	STY	Therapeutic or Preventive Procedure		NCI
C9769	PT	Amsacrine/Cytarabine		NCI
C9769	SY	AMSA/ARA-C		NCI
C9769	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9769	RO	chemotherapy regimen has component Amsacrine	NCI
C9769	RO	chemotherapy regimen has component Cytarabine	NCI
C37471	STY	Therapeutic or Preventive Procedure		NCI
C37471	PT	Cisplatin/Geldanamycin Analogue/Gemcitabine		NCI
C37471	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37471	RO	chemotherapy regimen has component Cisplatin	NCI
C37471	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37471	RO	chemotherapy regimen has component Geldanamycin Analogue	NCI
C37673	STY	Therapeutic or Preventive Procedure		NCI
C37673	PT	Cyclophosphamide/Cyclosporine/Fludarabine/Methylprednisolone/Thiotepa		NCI
C37673	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37673	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37673	RO	chemotherapy regimen has component Cyclosporine	NCI
C37673	RO	chemotherapy regimen has component Methylprednisolone	NCI
C37673	RO	chemotherapy regimen has component Thiotepa	NCI
C37673	RO	chemotherapy regimen has component Fludarabine	NCI
C11316	STY	Therapeutic or Preventive Procedure		NCI
C11316	PT	AUT-OV-ALVAC-hB7.1/Interferon Gamma		NCI
C11316	SY	ALVAC-hB7.1/Interferon Gamma		NCI
C11316	SY	ALVAC hB7.1/IFN-G		NCI
C11316	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11316	RO	chemotherapy regimen has component Recombinant Interferon Gamma	NCI
C11316	RO	chemotherapy regimen has component AUT-OV-ALVAC-hB7.1 Vaccine	NCI
C12141	STY	Therapeutic or Preventive Procedure		NCI
C12141	PT	Hydroxychloroquine/Prednisone/Tacrolimus		NCI
C12141	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12141	RO	chemotherapy regimen has component Hydroxychloroquine	NCI
C12141	RO	chemotherapy regimen has component Prednisone	NCI
C12141	RO	chemotherapy regimen has component Tacrolimus	NCI
C9676	STY	Therapeutic or Preventive Procedure		NCI
C9676	PT	Chlorambucil/Dactinomycin/Methotrexate		NCI
C9676	SY	CLB/DACT/MTX		NCI
C9676	SY	MDC		NCI
C9676	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9676	RO	chemotherapy regimen has component Chlorambucil	NCI
C9676	RO	chemotherapy regimen has component Dactinomycin	NCI
C9676	RO	chemotherapy regimen has component Methotrexate	NCI
C12093	STY	Therapeutic or Preventive Procedure		NCI
C12093	PT	Bevacizumab/Docetaxel		NCI
C12093	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12093	RO	chemotherapy regimen has component Docetaxel	NCI
C12093	RO	chemotherapy regimen has component Bevacizumab	NCI
C11958	STY	Therapeutic or Preventive Procedure		NCI
C11958	PT	Doxorubicin/Filgrastim/XR9576		NCI
C11958	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11958	RO	chemotherapy regimen has component Doxorubicin	NCI
C11958	RO	chemotherapy regimen has component Filgrastim	NCI
C11958	RO	chemotherapy regimen has component Tariquidar	NCI
C11786	STY	Therapeutic or Preventive Procedure		NCI
C11786	PT	Bispecific Antibody MDX447/Lymphokine-Activated Killer Cells		NCI
C11786	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11786	RO	chemotherapy regimen has component Lymphokine-Activated Killer Cells	NCI
C11786	RO	chemotherapy regimen has component Bispecific Antibody MDX447	NCI
C11034	STY	Therapeutic or Preventive Procedure		NCI
C11034	PT	Dacarbazine/Interferon Alfa/Tamoxifen		NCI
C11034	SY	DTIC/IFN-A/TMX		NCI
C11034	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11034	RO	chemotherapy regimen has component Dacarbazine	NCI
C11034	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C11034	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11140	STY	Therapeutic or Preventive Procedure		NCI
C11140	PT	Cyclosporine/Cytarabine/Etoposide/Idarubicin		NCI
C11140	SY	ARA-C/CYSP/IDA/VP-16		NCI
C11140	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11140	RO	chemotherapy regimen has component Cyclosporine	NCI
C11140	RO	chemotherapy regimen has component Cytarabine	NCI
C11140	RO	chemotherapy regimen has component Etoposide	NCI
C11140	RO	chemotherapy regimen has component Idarubicin	NCI
C10415	STY	Therapeutic or Preventive Procedure		NCI
C10415	PT	Nimodipine/Vincristine		NCI
C10415	SY	NIMO/VCR		NCI
C10415	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10415	RO	chemotherapy regimen has component Nimodipine	NCI
C10415	RO	chemotherapy regimen has component Vincristine	NCI
C9821	STY	Therapeutic or Preventive Procedure		NCI
C9821	PT	Cisplatin/Cytarabine/Etoposide/Vinblastine		NCI
C9821	SY	EVAP		NCI
C9821	SY	ARA-C/CDDP/VBL/VP-16		NCI
C9821	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9821	RO	chemotherapy regimen has component Cisplatin	NCI
C9821	RO	chemotherapy regimen has component Cytarabine	NCI
C9821	RO	chemotherapy regimen has component Etoposide	NCI
C9821	RO	chemotherapy regimen has component Vinblastine	NCI
C10708	STY	Therapeutic or Preventive Procedure		NCI
C10708	PT	Aminoglutethimide/Leuprolide		NCI
C10708	SY	AGT/LEUP		NCI
C10708	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10708	RO	chemotherapy regimen has component Aminoglutethimide	NCI
C10708	RO	chemotherapy regimen has component Leuprolide Acetate	NCI
C10927	STY	Therapeutic or Preventive Procedure		NCI
C10927	PT	Cyclophosphamide/Dexamethasone/Doxorubicin/Etoposide		NCI
C10927	SY	CTX/DM/DOX/VP-16		NCI
C10927	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10927	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10927	RO	chemotherapy regimen has component Dexamethasone	NCI
C10927	RO	chemotherapy regimen has component Doxorubicin	NCI
C10927	RO	chemotherapy regimen has component Etoposide	NCI
C10756	STY	Therapeutic or Preventive Procedure		NCI
C10756	PT	Etoposide/Ifosfamide/Melphalan		NCI
C10756	SY	IFF/L-PAM/VP-16		NCI
C10756	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10756	RO	chemotherapy regimen has component Etoposide	NCI
C10756	RO	chemotherapy regimen has component Ifosfamide	NCI
C10756	RO	chemotherapy regimen has component Melphalan	NCI
C10948	STY	Therapeutic or Preventive Procedure		NCI
C10948	PT	Carboplatin/Cyclophosphamide/Paclitaxel		NCI
C10948	SY	CBDCA/CTX/TAX		NCI
C10948	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10948	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10948	RO	chemotherapy regimen has component Carboplatin	NCI
C10948	RO	chemotherapy regimen has component Paclitaxel	NCI
C63425	STY	Therapeutic or Preventive Procedure		NCI
C63425	PT	AC-T-T Regimen		NCI
C63425	SY	AC Followed by Paclitaxel + Trastuzumab		NCI
C63425	SY	Doxorubicin/Cyclophosphamide Followed by Paclitaxel + Trastuzumab		NCI
C63425	SY	Sequential AC/Taxol-Trastuzumab Regimen		NCI
C63425	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63425	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63425	RO	chemotherapy regimen has component Doxorubicin	NCI
C63425	RO	chemotherapy regimen has component Paclitaxel	NCI
C63425	RO	chemotherapy regimen has component Trastuzumab	NCI
C63425	RO	regimen has accepted use for disease HER2 Positive Breast Carcinoma	NCI
C10376	STY	Therapeutic or Preventive Procedure		NCI
C10376	PT	Doxorubicin/Prochlorperazine		NCI
C10376	SY	DOX/PCPZ		NCI
C10376	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10376	RO	chemotherapy regimen has component Doxorubicin	NCI
C10376	RO	chemotherapy regimen has component Prochlorperazine	NCI
C11243	STY	Therapeutic or Preventive Procedure		NCI
C11243	PT	Indinavir/Lamivudine/Stavudine		NCI
C11243	SY	3TC/d4T/IDV		NCI
C11243	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11243	RO	chemotherapy regimen has component Stavudine	NCI
C11243	RO	chemotherapy regimen has component Lamivudine	NCI
C11243	RO	chemotherapy regimen has component Indinavir Sulfate	NCI
C15636	STY	Therapeutic or Preventive Procedure		NCI
C15636	PT	gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12		NCI
C15636	SY	gp100/IFA/IL-12		NCI
C15636	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C15636	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C15636	RO	chemotherapy regimen has component gp100 Antigen	NCI
C15636	RO	chemotherapy regimen has component Recombinant Interleukin-12	NCI
C10893	STY	Therapeutic or Preventive Procedure		NCI
C10893	PT	Flutamide/Goserelin/Suramin		NCI
C10893	SY	FLUT/SUR/ZDX		NCI
C10893	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10893	RO	chemotherapy regimen has component Flutamide	NCI
C10893	RO	chemotherapy regimen has component Suramin	NCI
C10893	RO	chemotherapy regimen has component Goserelin	NCI
C9857	STY	Therapeutic or Preventive Procedure		NCI
C9857	PT	Etoposide/Methotrexate/Mitomycin		NCI
C9857	SY	MITO/MTX/VP-16		NCI
C9857	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9857	RO	chemotherapy regimen has component Mitomycin	NCI
C9857	RO	chemotherapy regimen has component Etoposide	NCI
C9857	RO	chemotherapy regimen has component Methotrexate	NCI
C136826	STY	Therapeutic or Preventive Procedure		NCI
C136826	PT	Chemotherapy Regimen Used to Treat Retinoblastoma		NCI
C136826	CHD	Chemotherapy Regimen	NCI
C136826	PAR	Carboplatin-Etoposide-Vincristine Regimen	NCI
C9754	STY	Therapeutic or Preventive Procedure		NCI
C9754	PT	Etoposide/Fluorouracil/Folinic Acid		NCI
C9754	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9754	RO	chemotherapy regimen has component Etoposide	NCI
C9754	RO	chemotherapy regimen has component Fluorouracil	NCI
C9754	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11642	STY	Therapeutic or Preventive Procedure		NCI
C11642	PT	Fludarabine/UCN-01		NCI
C11642	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11642	RO	chemotherapy regimen has component Fludarabine	NCI
C11642	RO	chemotherapy regimen has component 7-Hydroxystaurosporine	NCI
C2365	STY	Therapeutic or Preventive Procedure		NCI
C2365	PT	Pefloxacin/Penicillin V		NCI
C2365	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C2365	RO	chemotherapy regimen has component Pefloxacin	NCI
C2365	RO	chemotherapy regimen has component Penicillin V Potassium	NCI
C67487	STY	Therapeutic or Preventive Procedure		NCI
C67487	PT	APE Regimen		NCI
C67487	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67487	RO	chemotherapy regimen has component Cisplatin	NCI
C67487	RO	chemotherapy regimen has component Cytarabine	NCI
C67487	RO	chemotherapy regimen has component Etoposide	NCI
C11575	STY	Therapeutic or Preventive Procedure		NCI
C11575	PT	Fluorouracil/Leucovorin Calcium/Monoclonal Antibody 17-1A		NCI
C11575	SY	CF/5-FU/MOAB 17-1A		NCI
C11575	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11575	RO	chemotherapy regimen has component Fluorouracil	NCI
C11575	RO	chemotherapy regimen has component Edrecolomab	NCI
C11575	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11128	STY	Therapeutic or Preventive Procedure		NCI
C11128	PT	Dexrazoxane/Doxorubicin/Paclitaxel		NCI
C11128	SY	ADR-529/DOX/TAX		NCI
C11128	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11128	RO	chemotherapy regimen has component Doxorubicin	NCI
C11128	RO	chemotherapy regimen has component Dexrazoxane	NCI
C11128	RO	chemotherapy regimen has component Paclitaxel	NCI
C12063	STY	Therapeutic or Preventive Procedure		NCI
C12063	PT	Carboplatin/Irinotecan/Thalidomide		NCI
C12063	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12063	RO	chemotherapy regimen has component Thalidomide	NCI
C12063	RO	chemotherapy regimen has component Carboplatin	NCI
C12063	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11178	STY	Therapeutic or Preventive Procedure		NCI
C11178	PT	Cyclophosphamide/Dexamethasone/Etoposide/Mercaptopurine/Methotrexate/Vincristine		NCI
C11178	SY	CTX/DM/MP/MTX/VCR/VP-16		NCI
C11178	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11178	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11178	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11178	RO	chemotherapy regimen has component Dexamethasone	NCI
C11178	RO	chemotherapy regimen has component Etoposide	NCI
C11178	RO	chemotherapy regimen has component Methotrexate	NCI
C11178	RO	chemotherapy regimen has component Vincristine	NCI
C11777	STY	Therapeutic or Preventive Procedure		NCI
C11777	PT	Amifostine/Azacitidine		NCI
C11777	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11777	RO	chemotherapy regimen has component Azacitidine	NCI
C11777	RO	chemotherapy regimen has component Amifostine	NCI
C9858	STY	Therapeutic or Preventive Procedure		NCI
C9858	PT	Cyclophosphamide/Etanidazole		NCI
C9858	SY	CTX/SR-2508		NCI
C9858	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9858	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9858	RO	chemotherapy regimen has component Etanidazole	NCI
C64791	STY	Therapeutic or Preventive Procedure		NCI
C64791	PT	Cisplatin-Cetuximab Regimen		NCI
C64791	SY	Cisplatin-C225 Regimen		NCI
C64791	SY	Cisplatin-Erbitux Regimen		NCI
C64791	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C64791	RO	chemotherapy regimen has component Cisplatin	NCI
C64791	RO	chemotherapy regimen has component Cetuximab	NCI
C64791	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C10022	STY	Therapeutic or Preventive Procedure		NCI
C10022	PT	Fluorouracil/Razoxane/Semustine		NCI
C10022	SY	5-FU/ICRF-159/MeCCNU		NCI
C10022	SY	FIME		NCI
C10022	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10022	RO	chemotherapy regimen has component Fluorouracil	NCI
C10022	RO	chemotherapy regimen has component Razoxane	NCI
C10022	RO	chemotherapy regimen has component Semustine	NCI
C10023	STY	Therapeutic or Preventive Procedure		NCI
C10023	PT	Doxorubicin/Mitomycin/Tegafur		NCI
C10023	SY	DOX/FT/MITO		NCI
C10023	SY	FURAM		NCI
C10023	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10023	RO	chemotherapy regimen has component Mitomycin	NCI
C10023	RO	chemotherapy regimen has component Doxorubicin	NCI
C10023	RO	chemotherapy regimen has component Tegafur	NCI
C11372	STY	Therapeutic or Preventive Procedure		NCI
C11372	PT	Cyclophosphamide/Mercaptopurine/Methotrexate		NCI
C11372	SY	CTX/MP/MTX		NCI
C11372	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11372	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11372	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11372	RO	chemotherapy regimen has component Methotrexate	NCI
C63461	STY	Therapeutic or Preventive Procedure		NCI
C63461	PT	R-EPOCH Regimen		NCI
C63461	SY	Rituximab-Etoposide-Prednisone-Oncovin-Cyclophosphamide-Hydroxydaunorubicin Regimen		NCI
C63461	SY	REPOCH Regimen		NCI
C63461	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C63461	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63461	RO	chemotherapy regimen has component Doxorubicin	NCI
C63461	RO	chemotherapy regimen has component Etoposide	NCI
C63461	RO	regimen has accepted use for disease Non-Hodgkin Lymphoma	NCI
C63461	RO	chemotherapy regimen has component Prednisone	NCI
C63461	RO	chemotherapy regimen has component Vincristine	NCI
C63461	RO	chemotherapy regimen has component Rituximab	NCI
C63461	RO	regimen has accepted use for disease Mantle Cell Lymphoma	NCI
C9568	STY	Therapeutic or Preventive Procedure		NCI
C9568	PT	Cytarabine/Hydrocortisone		NCI
C9568	SY	ARA-C/HC		NCI
C9568	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9568	RO	chemotherapy regimen has component Cytarabine	NCI
C9568	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C12176	STY	Therapeutic or Preventive Procedure		NCI
C12176	PT	Cisplatin/Fluoxetine/Gemcitabine		NCI
C12176	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12176	RO	chemotherapy regimen has component Cisplatin	NCI
C12176	RO	chemotherapy regimen has component Fluoxetine	NCI
C12176	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C37516	STY	Therapeutic or Preventive Procedure		NCI
C37516	PT	Alemtuzumab/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine		NCI
C37516	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37516	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37516	RO	chemotherapy regimen has component Doxorubicin	NCI
C37516	RO	chemotherapy regimen has component Etoposide	NCI
C37516	RO	chemotherapy regimen has component Prednisone	NCI
C37516	RO	chemotherapy regimen has component Vincristine	NCI
C37516	RO	chemotherapy regimen has component Alemtuzumab	NCI
C11868	STY	Therapeutic or Preventive Procedure		NCI
C11868	PT	Dexamethasone/Phenylbutyrate/Sargramostim		NCI
C11868	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11868	RO	chemotherapy regimen has component Dexamethasone	NCI
C11868	RO	chemotherapy regimen has component Sargramostim	NCI
C11868	RO	chemotherapy regimen has component Sodium Phenylbutyrate	NCI
C11266	STY	Therapeutic or Preventive Procedure		NCI
C11266	PT	Etoposide/Ifosfamide/Mesna		NCI
C11266	SY	Ifosfa/Mesna/Etop		NCI
C11266	SY	IFF/Mesna/VP-16		NCI
C11266	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11266	RO	chemotherapy regimen has component Mesna	NCI
C11266	RO	chemotherapy regimen has component Etoposide	NCI
C11266	RO	chemotherapy regimen has component Ifosfamide	NCI
C63395	STY	Therapeutic or Preventive Procedure		NCI
C63395	PT	FAM Regimen		NCI
C63395	SY	Fluorouracil-Adriamycin-Mitomycin Regimen		NCI
C63395	CHD	Chemotherapy Regimen Used to Treat Gastric Carcinoma	NCI
C63395	CHD	Chemotherapy Regimen Used to Treat Pancreatic Carcinoma	NCI
C63395	RO	chemotherapy regimen has component Mitomycin	NCI
C63395	RO	chemotherapy regimen has component Doxorubicin	NCI
C63395	RO	chemotherapy regimen has component Fluorouracil	NCI
C63395	RO	regimen has accepted use for disease Pancreatic Carcinoma	NCI
C63395	RO	regimen has accepted use for disease Gastric Carcinoma	NCI
C11142	STY	Therapeutic or Preventive Procedure		NCI
C11142	PT	Asparaginase/dexrazoxane/Doxorubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C11142	SY	ADR-529/ASP/DOX/MP/MTX/PRED/VCR		NCI
C11142	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11142	RO	chemotherapy regimen has component Mercaptopurine	NCI
C11142	RO	chemotherapy regimen has component Asparaginase	NCI
C11142	RO	chemotherapy regimen has component Doxorubicin	NCI
C11142	RO	chemotherapy regimen has component Methotrexate	NCI
C11142	RO	chemotherapy regimen has component Prednisone	NCI
C11142	RO	chemotherapy regimen has component Vincristine	NCI
C11142	RO	chemotherapy regimen has component Dexrazoxane	NCI
C9954	STY	Therapeutic or Preventive Procedure		NCI
C9954	PT	Pentamidine/Trimetrexate Glucuronate		NCI
C9954	SY	PAD/TMTX		NCI
C9954	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9954	RO	chemotherapy regimen has component Pentamidine	NCI
C9954	RO	chemotherapy regimen has component Trimetrexate Glucuronate	NCI
C11824	STY	Therapeutic or Preventive Procedure		NCI
C11824	PT	Cisplatin/Irinotecan/SU5416		NCI
C11824	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11824	RO	chemotherapy regimen has component Cisplatin	NCI
C11824	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11824	RO	chemotherapy regimen has component Semaxanib	NCI
C10783	STY	Therapeutic or Preventive Procedure		NCI
C10783	PT	Bleomycin/Cyclophosphamide/Doxorubicin/Prednisolone/Vindesine		NCI
C10783	SY	CHEP Bleo		NCI
C10783	SY	BLEO/CTX/DAVA/DOX/PRDL		NCI
C10783	SY	LNH-84		NCI
C10783	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10783	RO	chemotherapy regimen has component Bleomycin	NCI
C10783	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10783	RO	chemotherapy regimen has component Doxorubicin	NCI
C10783	RO	chemotherapy regimen has component Prednisolone	NCI
C10783	RO	chemotherapy regimen has component Vindesine	NCI
C9717	STY	Therapeutic or Preventive Procedure		NCI
C9717	PT	Cisplatin/Methotrexate/Vinblastine		NCI
C9717	SY	MEC Protocol 1		NCI
C9717	SY	CMV		NCI
C9717	SY	CDDP/MTX/VBL		NCI
C9717	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9717	RO	chemotherapy regimen has component Cisplatin	NCI
C9717	RO	chemotherapy regimen has component Methotrexate	NCI
C9717	RO	chemotherapy regimen has component Vinblastine	NCI
C10307	STY	Therapeutic or Preventive Procedure		NCI
C10307	PT	Amiodarone/Vinblastine		NCI
C10307	SY	Amiodarone/VBL		NCI
C10307	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10307	RO	chemotherapy regimen has component Vinblastine	NCI
C10307	RO	chemotherapy regimen has component Amiodarone Hydrochloride	NCI
C11476	STY	Therapeutic or Preventive Procedure		NCI
C11476	PT	Cytarabine/Fludarabine/Topotecan		NCI
C11476	SY	ARA-C/FAMP/TOPO		NCI
C11476	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11476	RO	chemotherapy regimen has component Cytarabine	NCI
C11476	RO	chemotherapy regimen has component Fludarabine	NCI
C11476	RO	chemotherapy regimen has component Topotecan	NCI
C37599	STY	Therapeutic or Preventive Procedure		NCI
C37599	PT	Carboplatin/Cyclophosphamide/Cytarabine/Etoposide/Rituximab/Sodium Thiosulfate		NCI
C37599	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37599	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37599	RO	chemotherapy regimen has component Cytarabine	NCI
C37599	RO	chemotherapy regimen has component Etoposide	NCI
C37599	RO	chemotherapy regimen has component Sodium Thiosulfate	NCI
C37599	RO	chemotherapy regimen has component Carboplatin	NCI
C37599	RO	chemotherapy regimen has component Rituximab	NCI
C10792	STY	Therapeutic or Preventive Procedure		NCI
C10792	PT	Busulfan/Ciprofloxacin/Melphalan/Pentoxifylline/Thiotepa		NCI
C10792	SY	BU/CPFX/L-PAM/PTX/TSPA		NCI
C10792	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10792	RO	chemotherapy regimen has component Busulfan	NCI
C10792	RO	chemotherapy regimen has component Ciprofloxacin	NCI
C10792	RO	chemotherapy regimen has component Melphalan	NCI
C10792	RO	chemotherapy regimen has component Pentoxifylline	NCI
C10792	RO	chemotherapy regimen has component Thiotepa	NCI
C10616	STY	Therapeutic or Preventive Procedure		NCI
C10616	PT	Cyclophosphamide/Daunorubicin/Dexamethasone/Methotrexate/Pegaspargase/Vincristine		NCI
C10616	SY	CTX/DM/DNR/MTX/PEG-ASP/VCR		NCI
C10616	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10616	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10616	RO	chemotherapy regimen has component Dexamethasone	NCI
C10616	RO	chemotherapy regimen has component Methotrexate	NCI
C10616	RO	chemotherapy regimen has component Vincristine	NCI
C10616	RO	chemotherapy regimen has component Pegaspargase	NCI
C10616	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C10963	STY	Therapeutic or Preventive Procedure		NCI
C10963	PT	Etoposide/Mitoxantrone/PSC 833		NCI
C10963	SY	DHAD/PSC 833/VP-16		NCI
C10963	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10963	RO	chemotherapy regimen has component Etoposide	NCI
C10963	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10963	RO	chemotherapy regimen has component Valspodar	NCI
C11901	STY	Therapeutic or Preventive Procedure		NCI
C11901	PT	Bevacizumab/Thalidomide		NCI
C11901	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11901	RO	chemotherapy regimen has component Thalidomide	NCI
C11901	RO	chemotherapy regimen has component Bevacizumab	NCI
C11618	STY	Therapeutic or Preventive Procedure		NCI
C11618	PT	Fluorouracil-Uracil/Gemcitabine/Leucovorin Calcium		NCI
C11618	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11618	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C11618	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11618	RO	chemotherapy regimen has component Tegafur-Uracil	NCI
C9831	STY	Therapeutic or Preventive Procedure		NCI
C9831	PT	Doxorubicin/Mitolactol		NCI
C9831	SY	DBD/DOX		NCI
C9831	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9831	RO	chemotherapy regimen has component Doxorubicin	NCI
C9831	RO	chemotherapy regimen has component Mitolactol	NCI
C10269	STY	Therapeutic or Preventive Procedure		NCI
C10269	PT	Cisplatin/Cyclophosphamide/Etoposide/Lomustine/Vincristine		NCI
C10269	SY	CCNU/CDDP/CTX/VCR/VP-16		NCI
C10269	SY	CCVVP		NCI
C10269	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10269	RO	chemotherapy regimen has component Cisplatin	NCI
C10269	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10269	RO	chemotherapy regimen has component Etoposide	NCI
C10269	RO	chemotherapy regimen has component Lomustine	NCI
C10269	RO	chemotherapy regimen has component Vincristine	NCI
C11189	STY	Therapeutic or Preventive Procedure		NCI
C11189	PT	Etoposide/Methylprednisolone		NCI
C11189	SY	MePRDL/VP-16		NCI
C11189	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11189	RO	chemotherapy regimen has component Etoposide	NCI
C11189	RO	chemotherapy regimen has component Methylprednisolone	NCI
C11695	STY	Therapeutic or Preventive Procedure		NCI
C11695	PT	gp100 Antigen/Tetanus Peptide Melanoma Vaccine/Tyrosinase Peptide		NCI
C11695	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11695	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11695	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11695	RO	chemotherapy regimen has component Tetanus Peptide Melanoma Vaccine	NCI
C9888	STY	Therapeutic or Preventive Procedure		NCI
C9888	PT	Cisplatin/Melphalan		NCI
C9888	SY	CDDP/L-PAM		NCI
C9888	SY	Melphalan/Cisplatin		NCI
C9888	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9888	RO	chemotherapy regimen has component Cisplatin	NCI
C9888	RO	chemotherapy regimen has component Melphalan	NCI
C11830	STY	Therapeutic or Preventive Procedure		NCI
C11830	PT	Doxorubicin/Methotrexate/Pegaspargase/Vincristine		NCI
C11830	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11830	RO	chemotherapy regimen has component Doxorubicin	NCI
C11830	RO	chemotherapy regimen has component Methotrexate	NCI
C11830	RO	chemotherapy regimen has component Vincristine	NCI
C11830	RO	chemotherapy regimen has component Pegaspargase	NCI
C10580	STY	Therapeutic or Preventive Procedure		NCI
C10580	PT	Doxorubicin/Filgrastim/Prednisone/Vincristine		NCI
C10580	SY	DOX/G-CSF/PRED/VCR		NCI
C10580	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10580	RO	chemotherapy regimen has component Doxorubicin	NCI
C10580	RO	chemotherapy regimen has component Prednisone	NCI
C10580	RO	chemotherapy regimen has component Vincristine	NCI
C10580	RO	chemotherapy regimen has component Filgrastim	NCI
C67295	STY	Therapeutic or Preventive Procedure		NCI
C67295	PT	POG-8697 Liver Cancer Regimen		NCI
C67295	SY	Cisplatin-Vincristine-Fluorouracil Liver Cancer Regimen		NCI
C67295	CHD	Chemotherapy Regimen Used to Treat Childhood Liver Cancer	NCI
C67295	RO	chemotherapy regimen has component Cisplatin	NCI
C67295	RO	chemotherapy regimen has component Fluorouracil	NCI
C67295	RO	chemotherapy regimen has component Vincristine	NCI
C67295	RO	regimen has accepted use for disease Hepatoblastoma	NCI
C10549	STY	Therapeutic or Preventive Procedure		NCI
C10549	PT	Cisplatin/Etoposide/Filgrastim/Melphalan		NCI
C10549	SY	CDDP/G-CSF/L-PAM/VP-16		NCI
C10549	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10549	RO	chemotherapy regimen has component Cisplatin	NCI
C10549	RO	chemotherapy regimen has component Etoposide	NCI
C10549	RO	chemotherapy regimen has component Melphalan	NCI
C10549	RO	chemotherapy regimen has component Filgrastim	NCI
C11321	STY	Therapeutic or Preventive Procedure		NCI
C11321	PT	Bismuth Subcitrate/Metronidazole/Omeprazole/Tetracycline		NCI
C11321	SY	BISSUBCIT/METRO/OMEP/TETRA		NCI
C11321	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11321	RO	chemotherapy regimen has component Metronidazole	NCI
C11321	RO	chemotherapy regimen has component Omeprazole	NCI
C11321	RO	chemotherapy regimen has component Tetracycline	NCI
C11321	RO	chemotherapy regimen has component Bismuth Subcitrate	NCI
C64191	STY	Therapeutic or Preventive Procedure		NCI
C64191	PT	IFL-FOLFIRI Regimen		NCI
C64191	SY	Irinotecan-Fluorouracil-Leucovorin FOLFIRI Regimen		NCI
C64191	CHD	Chemotherapy Regimen Used to Treat Colorectal Carcinoma	NCI
C64191	RO	regimen has accepted use for disease Colorectal Carcinoma	NCI
C64191	RO	chemotherapy regimen has component Fluorouracil	NCI
C64191	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C64191	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9654	STY	Therapeutic or Preventive Procedure		NCI
C9654	PT	Bleomycin/Methotrexate/Vincristine		NCI
C9654	SY	BLEO/MTX/VCR		NCI
C9654	SY	VBM-L		NCI
C9654	SY	ABO		NCI
C9654	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9654	RO	chemotherapy regimen has component Bleomycin	NCI
C9654	RO	chemotherapy regimen has component Methotrexate	NCI
C9654	RO	chemotherapy regimen has component Vincristine	NCI
C11891	STY	Therapeutic or Preventive Procedure		NCI
C11891	PT	Cisplatin/Etoposide/Tirapazamine		NCI
C11891	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11891	RO	chemotherapy regimen has component Cisplatin	NCI
C11891	RO	chemotherapy regimen has component Etoposide	NCI
C11891	RO	chemotherapy regimen has component Tirapazamine	NCI
C11029	STY	Therapeutic or Preventive Procedure		NCI
C11029	PT	Fludarabine/Interferon Alfa		NCI
C11029	SY	FAMP/IFN-A		NCI
C11029	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11029	RO	chemotherapy regimen has component Fludarabine	NCI
C11029	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11135	STY	Therapeutic or Preventive Procedure		NCI
C11135	PT	Cyclosporine/Prednisone		NCI
C11135	SY	CYSP/PRED		NCI
C11135	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11135	RO	chemotherapy regimen has component Cyclosporine	NCI
C11135	RO	chemotherapy regimen has component Prednisone	NCI
C67294	STY	Therapeutic or Preventive Procedure		NCI
C67294	PT	NWTS Regimen 1		NCI
C67294	SY	Vincristine-Doxorubicin-Etoposide-Cyclophosphamide Wilm's Tumor Regimen		NCI
C67294	CHD	Chemotherapy Regimen Used to Treat Childhood Malignant Renal Neoplasm	NCI
C67294	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C67294	RO	chemotherapy regimen has component Doxorubicin	NCI
C67294	RO	chemotherapy regimen has component Etoposide	NCI
C67294	RO	chemotherapy regimen has component Vincristine	NCI
C67294	RO	regimen has accepted use for disease Clear Cell Sarcoma of the Kidney	NCI
C67294	RO	regimen has accepted use for disease Anaplastic Kidney Wilms Tumor	NCI
C11025	STY	Therapeutic or Preventive Procedure		NCI
C11025	PT	Floxuridine/Interferon Alfa/Mitomycin		NCI
C11025	SY	FUDR/IFN-A/MITO		NCI
C11025	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11025	RO	chemotherapy regimen has component Mitomycin	NCI
C11025	RO	chemotherapy regimen has component Floxuridine	NCI
C11025	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11586	STY	Therapeutic or Preventive Procedure		NCI
C11586	PT	Cyclophosphamide/Etoposide/iodine I 131 Monoclonal Antibody Anti-B1		NCI
C11586	SY	CTX/I131-MOAB-B1/VP-16		NCI
C11586	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11586	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11586	RO	chemotherapy regimen has component Etoposide	NCI
C11586	RO	chemotherapy regimen has component Iodine I 131 Tositumomab	NCI
C11851	STY	Therapeutic or Preventive Procedure		NCI
C11851	PT	Doxorubicin Hcl Liposome/Gemcitabine		NCI
C11851	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11851	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11851	RO	chemotherapy regimen has component Pegylated Liposomal Doxorubicin Hydrochloride	NCI
C37840	STY	Therapeutic or Preventive Procedure		NCI
C37840	PT	Nolatrexed Dihydrochloride/Cisplatin		NCI
C37840	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37840	RO	chemotherapy regimen has component Cisplatin	NCI
C37840	RO	chemotherapy regimen has component Nolatrexed Dihydrochloride	NCI
C9762	STY	Therapeutic or Preventive Procedure		NCI
C9762	PT	L-744,832/Paclitaxel		NCI
C9762	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9762	RO	chemotherapy regimen has component Paclitaxel	NCI
C9762	RO	chemotherapy regimen has component L-744,832	NCI
C9695	STY	Therapeutic or Preventive Procedure		NCI
C9695	PT	Doxorubicin/Fluoxymesterone/Mitolactol/Tamoxifen/Vincristine		NCI
C9695	SY	DAVTH		NCI
C9695	SY	DBD/DOX/FXM/TMX/VCR		NCI
C9695	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9695	RO	chemotherapy regimen has component Doxorubicin	NCI
C9695	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C9695	RO	chemotherapy regimen has component Mitolactol	NCI
C9695	RO	chemotherapy regimen has component Vincristine	NCI
C9695	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C10186	STY	Therapeutic or Preventive Procedure		NCI
C10186	PT	Aminoglutethimide/Danazol/Hydrocortisone/Tamoxifen		NCI
C10186	SY	TAD		NCI
C10186	SY	AGT/DAN/HC/TMX		NCI
C10186	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10186	RO	chemotherapy regimen has component Aminoglutethimide	NCI
C10186	RO	chemotherapy regimen has component Danazol	NCI
C10186	RO	chemotherapy regimen has component Therapeutic Hydrocortisone	NCI
C10186	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C63427	STY	Therapeutic or Preventive Procedure		NCI
C63427	PT	AC-T Regimen		NCI
C63427	SY	Doxorubicin/Cyclophosphamide Followed by Paclitaxel		NCI
C63427	SY	AC-Taxol Regimen		NCI
C63427	SY	AC Followed by Paclitaxel		NCI
C63427	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C63427	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C63427	RO	chemotherapy regimen has component Doxorubicin	NCI
C63427	RO	chemotherapy regimen has component Paclitaxel	NCI
C63427	RO	regimen has accepted use for disease Invasive Breast Carcinoma	NCI
C10141	STY	Therapeutic or Preventive Procedure		NCI
C10141	PT	Cisplatin/Etoposide/Interleukin-2		NCI
C10141	SY	CDDP/IL-2/VP-16		NCI
C10141	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10141	RO	chemotherapy regimen has component Cisplatin	NCI
C10141	RO	chemotherapy regimen has component Etoposide	NCI
C10141	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C37615	STY	Therapeutic or Preventive Procedure		NCI
C37615	PT	Carboplatin/Ixabepilone/Trastuzumab		NCI
C37615	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37615	RO	chemotherapy regimen has component Carboplatin	NCI
C37615	RO	chemotherapy regimen has component Trastuzumab	NCI
C37615	RO	chemotherapy regimen has component Ixabepilone	NCI
C11821	STY	Therapeutic or Preventive Procedure		NCI
C11821	PT	Anti-human chorionic gonadotropin vaccine/Gemcitabine		NCI
C11821	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11821	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C11821	RO	chemotherapy regimen has component CTP-37-DT Vaccine	NCI
C11161	STY	Therapeutic or Preventive Procedure		NCI
C11161	PT	GM2-KLH Vaccine/Interferon Alfa		NCI
C11161	SY	GM2-KLH/IFN-A		NCI
C11161	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11161	RO	chemotherapy regimen has component GM2-KLH Vaccine	NCI
C11161	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C11861	STY	Therapeutic or Preventive Procedure		NCI
C11861	PT	Chlorambucil/Dexamethasone/Mitoxantrone		NCI
C11861	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11861	RO	chemotherapy regimen has component Chlorambucil	NCI
C11861	RO	chemotherapy regimen has component Dexamethasone	NCI
C11861	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9714	STY	Therapeutic or Preventive Procedure		NCI
C9714	PT	Cisplatin/Cyclophosphamide/Etoposide/Vincristine		NCI
C9714	SY	CDDP/CTX/VCR/VP-16		NCI
C9714	SY	COPE		NCI
C9714	SY	EPOC		NCI
C9714	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9714	RO	chemotherapy regimen has component Cisplatin	NCI
C9714	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9714	RO	chemotherapy regimen has component Etoposide	NCI
C9714	RO	chemotherapy regimen has component Vincristine	NCI
C11678	STY	Therapeutic or Preventive Procedure		NCI
C11678	PT	Montanide ISA-51/Sargramostim/Tyrosinase-Related Protein-1		NCI
C11678	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11678	RO	chemotherapy regimen has component Sargramostim	NCI
C11678	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11678	RO	chemotherapy regimen has component Recombinant Tyrosinase-Related Protein-1	NCI
C10690	STY	Therapeutic or Preventive Procedure		NCI
C10690	PT	Aminoglutethimide/Suramin		NCI
C10690	SY	AGT/SUR		NCI
C10690	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10690	RO	chemotherapy regimen has component Aminoglutethimide	NCI
C10690	RO	chemotherapy regimen has component Suramin	NCI
C10726	STY	Therapeutic or Preventive Procedure		NCI
C10726	PT	Paclitaxel/Quinine		NCI
C10726	SY	QUIN/TAX		NCI
C10726	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10726	RO	chemotherapy regimen has component Quinine	NCI
C10726	RO	chemotherapy regimen has component Paclitaxel	NCI
C11608	STY	Therapeutic or Preventive Procedure		NCI
C11608	PT	Cyclophosphamide/Epirubicin/Fluorouracil/Methotrexate		NCI
C11608	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11608	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C11608	RO	chemotherapy regimen has component Fluorouracil	NCI
C11608	RO	chemotherapy regimen has component Methotrexate	NCI
C11608	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C11478	STY	Therapeutic or Preventive Procedure		NCI
C11478	PT	Chlorambucil/Dexamethasone		NCI
C11478	SY	CLB/DM		NCI
C11478	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11478	RO	chemotherapy regimen has component Chlorambucil	NCI
C11478	RO	chemotherapy regimen has component Dexamethasone	NCI
C11717	STY	Therapeutic or Preventive Procedure		NCI
C11717	PT	Daunorubicin/Vincristine		NCI
C11717	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11717	RO	chemotherapy regimen has component Vincristine	NCI
C11717	RO	chemotherapy regimen has component Daunorubicin Hydrochloride	NCI
C11899	STY	Therapeutic or Preventive Procedure		NCI
C11899	PT	Capecitabine/Irinotecan/Oxaliplatin		NCI
C11899	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11899	RO	chemotherapy regimen has component Oxaliplatin	NCI
C11899	RO	chemotherapy regimen has component Irinotecan Hydrochloride	NCI
C11899	RO	chemotherapy regimen has component Capecitabine	NCI
C9822	STY	Therapeutic or Preventive Procedure		NCI
C9822	PT	Ifosfamide/Lomustine/Vinblastine		NCI
C9822	SY	VIC		NCI
C9822	SY	CCNU/IFF/VBL		NCI
C9822	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9822	RO	chemotherapy regimen has component Ifosfamide	NCI
C9822	RO	chemotherapy regimen has component Lomustine	NCI
C9822	RO	chemotherapy regimen has component Vinblastine	NCI
C10932	STY	Therapeutic or Preventive Procedure		NCI
C10932	PT	Cisplatin/Doxorubicin/Filgrastim/Paclitaxel		NCI
C10932	SY	CDDP/DOX/G-CSF/TAX		NCI
C10932	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10932	RO	chemotherapy regimen has component Cisplatin	NCI
C10932	RO	chemotherapy regimen has component Doxorubicin	NCI
C10932	RO	chemotherapy regimen has component Paclitaxel	NCI
C10932	RO	chemotherapy regimen has component Filgrastim	NCI
C10024	STY	Therapeutic or Preventive Procedure		NCI
C10024	PT	Asparaginase/Methotrexate		NCI
C10024	SY	ASP/MTX		NCI
C10024	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10024	RO	chemotherapy regimen has component Asparaginase	NCI
C10024	RO	chemotherapy regimen has component Methotrexate	NCI
C67483	STY	Therapeutic or Preventive Procedure		NCI
C67483	PT	IDA-FLAG Regimen		NCI
C67483	SY	Idarubicin-Fludarabine-AraC/G-CSF Regimen		NCI
C67483	CHD	Chemotherapy Regimen Used to Treat Childhood Acute Myeloid Leukemia	NCI
C67483	RO	chemotherapy regimen has component Cytarabine	NCI
C67483	RO	chemotherapy regimen has component Idarubicin	NCI
C67483	RO	chemotherapy regimen has component Fludarabine	NCI
C67483	RO	chemotherapy regimen has component Filgrastim	NCI
C67483	RO	regimen has accepted use for disease Childhood Acute Promyelocytic Leukemia with PML-RARA	NCI
C10284	STY	Therapeutic or Preventive Procedure		NCI
C10284	PT	Altretamine/Cisplatin/Cyclophosphamide		NCI
C10284	SY	CHD		NCI
C10284	SY	CDDP/CTX/HMM		NCI
C10284	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10284	RO	chemotherapy regimen has component Cisplatin	NCI
C10284	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10284	RO	chemotherapy regimen has component Altretamine	NCI
C156259	STY	Therapeutic or Preventive Procedure		NCI
C156259	PT	Anastrozole/Lapatinib/Trastuzumab Regimen		NCI
C156259	SY	Anastrozole-Lapatinib-Trastuzumab Regimen		NCI
C156259	SY	Anastrozole/Lapatinib/Trastuzumab		NCI
C156259	SY	Anastrozole-Lapatinib-Trastuzumab		NCI
C156259	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156259	RO	chemotherapy regimen has component Anastrozole	NCI
C156259	RO	chemotherapy regimen has component Trastuzumab	NCI
C156259	RO	chemotherapy regimen has component Lapatinib	NCI
C10247	STY	Therapeutic or Preventive Procedure		NCI
C10247	PT	Asparaginase/Cytarabine/Prednisone/Vincristine		NCI
C10247	SY	AOPA		NCI
C10247	SY	ARA-C/ASP/PRED/VCR		NCI
C10247	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10247	RO	chemotherapy regimen has component Asparaginase	NCI
C10247	RO	chemotherapy regimen has component Cytarabine	NCI
C10247	RO	chemotherapy regimen has component Prednisone	NCI
C10247	RO	chemotherapy regimen has component Vincristine	NCI
C11364	STY	Therapeutic or Preventive Procedure		NCI
C11364	PT	Cytarabine/Homoharringtonine/Interferon Alfa		NCI
C11364	SY	ARA-C/HH/IFN-A		NCI
C11364	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11364	RO	chemotherapy regimen has component Cytarabine	NCI
C11364	RO	chemotherapy regimen has component Omacetaxine Mepesuccinate	NCI
C11364	RO	chemotherapy regimen has component Recombinant Interferon Alfa	NCI
C12212	STY	Therapeutic or Preventive Procedure		NCI
C12212	PT	Lycopene/Multivitamins		NCI
C12212	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12212	RO	chemotherapy regimen has component Lycopene	NCI
C12212	RO	chemotherapy regimen has component Multivitamin	NCI
C10499	STY	Therapeutic or Preventive Procedure		NCI
C10499	PT	Dimethylbusulfan/Etoposide		NCI
C10499	SY	DMB/VP-16		NCI
C10499	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10499	RO	chemotherapy regimen has component Etoposide	NCI
C10499	RO	chemotherapy regimen has component Dimethylmyleran	NCI
C9860	STY	Therapeutic or Preventive Procedure		NCI
C9860	PT	Diaziquone/Mitoxantrone		NCI
C9860	SY	AZQ/DHAD		NCI
C9860	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9860	RO	chemotherapy regimen has component Diaziquone	NCI
C9860	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C9527	STY	Therapeutic or Preventive Procedure		NCI
C9527	PT	Cyclophosphamide/Cytarabine/Doxorubicin/Methotrexate/Prednisone/Thioguanine/Vincristine		NCI
C9527	SY	ARA-C/CTX/DOX/MTX/PRED/TG/VCR		NCI
C9527	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9527	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9527	RO	chemotherapy regimen has component Cytarabine	NCI
C9527	RO	chemotherapy regimen has component Doxorubicin	NCI
C9527	RO	chemotherapy regimen has component Methotrexate	NCI
C9527	RO	chemotherapy regimen has component Prednisone	NCI
C9527	RO	chemotherapy regimen has component Thioguanine	NCI
C9527	RO	chemotherapy regimen has component Vincristine	NCI
C11389	STY	Therapeutic or Preventive Procedure		NCI
C11389	PT	Interleukin-11/Sargramostim		NCI
C11389	SY	GM-CSF/IL-11		NCI
C11389	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11389	RO	chemotherapy regimen has component Sargramostim	NCI
C11389	RO	chemotherapy regimen has component Oprelvekin	NCI
C37470	STY	Therapeutic or Preventive Procedure		NCI
C37470	PT	Cisplatin/Doxorubicin/Methotrexate/Pamidronate Disodium		NCI
C37470	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37470	RO	chemotherapy regimen has component Cisplatin	NCI
C37470	RO	chemotherapy regimen has component Doxorubicin	NCI
C37470	RO	chemotherapy regimen has component Methotrexate	NCI
C37470	RO	chemotherapy regimen has component Pamidronate Disodium	NCI
C10178	STY	Therapeutic or Preventive Procedure		NCI
C10178	PT	Cyclophosphamide/Doxorubicin/Vinblastine		NCI
C10178	SY	CTX/DOX/VBL		NCI
C10178	SY	VAC		NCI
C10178	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10178	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10178	RO	chemotherapy regimen has component Doxorubicin	NCI
C10178	RO	chemotherapy regimen has component Vinblastine	NCI
C10835	STY	Therapeutic or Preventive Procedure		NCI
C10835	PT	Carboplatin/Cisplatin/Cyclophosphamide/Etoposide/Paclitaxel		NCI
C10835	SY	CBDCA/CDDP/CTX/TAX/VP-16		NCI
C10835	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10835	RO	chemotherapy regimen has component Cisplatin	NCI
C10835	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10835	RO	chemotherapy regimen has component Etoposide	NCI
C10835	RO	chemotherapy regimen has component Carboplatin	NCI
C10835	RO	chemotherapy regimen has component Paclitaxel	NCI
C12125	STY	Therapeutic or Preventive Procedure		NCI
C12125	PT	Celecoxib/Docetaxel		NCI
C12125	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12125	RO	chemotherapy regimen has component Docetaxel	NCI
C12125	RO	chemotherapy regimen has component Celecoxib	NCI
C10428	STY	Therapeutic or Preventive Procedure		NCI
C10428	PT	BCG/Interleukin-2		NCI
C10428	SY	BCG/IL-2		NCI
C10428	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10428	RO	chemotherapy regimen has component BCG Vaccine	NCI
C10428	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C153313	STY	Therapeutic or Preventive Procedure		NCI
C153313	PT	RIVAC Regimen		NCI
C153313	SY	R-IVAC Regimen		NCI
C153313	SY	Rituximab/Ifosfamide/Cytarabine/Etoposide		NCI
C153313	SY	RIVAC		NCI
C153313	SY	Rituximab + Ifosfamide + Cytarabine + Etoposide		NCI
C153313	SY	Rituximab/Ifosfamide/VP-16/ARA-C		NCI
C153313	SY	Rituximab-Ifosfamide-Cytarabine-Etoposide		NCI
C153313	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C153313	RO	chemotherapy regimen has component Cytarabine	NCI
C153313	RO	chemotherapy regimen has component Etoposide	NCI
C153313	RO	chemotherapy regimen has component Ifosfamide	NCI
C153313	RO	chemotherapy regimen has component Rituximab	NCI
C10687	STY	Therapeutic or Preventive Procedure		NCI
C10687	PT	Dexverapamil/Paclitaxel		NCI
C10687	SY	R-VPAM/TAX		NCI
C10687	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10687	RO	chemotherapy regimen has component Paclitaxel	NCI
C10687	RO	chemotherapy regimen has component Dexverapamil	NCI
C10854	STY	Therapeutic or Preventive Procedure		NCI
C10854	PT	Cytarabine/Milodistim/Mitoxantrone		NCI
C10854	SY	ARA-C/DHAD/PIXY321		NCI
C10854	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10854	RO	chemotherapy regimen has component Cytarabine	NCI
C10854	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C10854	RO	chemotherapy regimen has component Milodistim	NCI
C37695	STY	Therapeutic or Preventive Procedure		NCI
C37695	PT	Cyclophosphamide/Fludarabine/Melphalan		NCI
C37695	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37695	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C37695	RO	chemotherapy regimen has component Melphalan	NCI
C37695	RO	chemotherapy regimen has component Fludarabine	NCI
C156353	STY	Therapeutic or Preventive Procedure		NCI
C156353	PT	Cisplatin/Fluorouracil Regimen		NCI
C156353	SY	Cisplatin-Fluorouracil		NCI
C156353	SY	Fluorouracil/Cisplatin Regimen		NCI
C156353	SY	Fluorouracil/Cisplatin		NCI
C156353	SY	Cisplatin/Fluorouracil		NCI
C156353	CHD	Chemotherapy Regimen Used to Treat Malignant Head and Neck Neoplasm	NCI
C156353	RO	chemotherapy regimen has component Cisplatin	NCI
C156353	RO	chemotherapy regimen has component Fluorouracil	NCI
C156353	RO	regimen has accepted use for disease Malignant Anal Neoplasm	NCI
C156353	RO	regimen has accepted use for disease Malignant Penile Neoplasm	NCI
C156353	RO	regimen has accepted use for disease Malignant Hepatobiliary Neoplasm	NCI
C156353	RO	regimen has accepted use for disease Head and Neck Squamous Cell Carcinoma	NCI
C10556	STY	Therapeutic or Preventive Procedure		NCI
C10556	PT	Idarubicin/Mercaptopurine/Methotrexate/Prednisone/Vincristine		NCI
C10556	SY	IDA/MP/MTX/PRED/VCR		NCI
C10556	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10556	RO	chemotherapy regimen has component Mercaptopurine	NCI
C10556	RO	chemotherapy regimen has component Idarubicin	NCI
C10556	RO	chemotherapy regimen has component Methotrexate	NCI
C10556	RO	chemotherapy regimen has component Prednisone	NCI
C10556	RO	chemotherapy regimen has component Vincristine	NCI
C11153	STY	Therapeutic or Preventive Procedure		NCI
C11153	PT	Asparaginase/Dexamethasone/Epirubicin/Vincristine		NCI
C11153	SY	ASP/DM/EPI/VCR		NCI
C11153	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11153	RO	chemotherapy regimen has component Asparaginase	NCI
C11153	RO	chemotherapy regimen has component Dexamethasone	NCI
C11153	RO	chemotherapy regimen has component Vincristine	NCI
C11153	RO	chemotherapy regimen has component Epirubicin Hydrochloride	NCI
C67203	STY	Therapeutic or Preventive Procedure		NCI
C67203	PT	Vinorelbine-Gemcitabine Regimen		NCI
C67203	SY	Vinorelbine-Gemcitabine		NCI
C67203	CHD	Chemotherapy Regimen Used to Treat Childhood Hodgkins Lymphoma	NCI
C67203	RO	chemotherapy regimen has component Vinorelbine	NCI
C67203	RO	regimen has accepted use for disease Childhood Hodgkin Lymphoma	NCI
C67203	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C9547	STY	Therapeutic or Preventive Procedure		NCI
C9547	PT	Cyclophosphamide/Fluorouracil		NCI
C9547	SY	CTX/5-FU		NCI
C9547	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9547	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9547	RO	chemotherapy regimen has component Fluorouracil	NCI
C12157	STY	Therapeutic or Preventive Procedure		NCI
C12157	PT	Erlotinib/Trastuzumab		NCI
C12157	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C12157	RO	chemotherapy regimen has component Trastuzumab	NCI
C12157	RO	chemotherapy regimen has component Erlotinib Hydrochloride	NCI
C140092	STY	Therapeutic or Preventive Procedure		NCI
C140092	PT	AspaMetDex Regimen		NCI
C140092	SY	Aspa-Met-Dex		NCI
C140092	SY	AspaMetDex		NCI
C140092	SY	L-asparaginase/Methotrexate/Dexamethasone		NCI
C140092	SY	Asparaginase-Methotrexate-Dexamethasone		NCI
C140092	CHD	Chemotherapy Regimen Used to Treat Non-Hodgkin Lymphoma	NCI
C140092	RO	chemotherapy regimen has component Asparaginase	NCI
C140092	RO	chemotherapy regimen has component Dexamethasone	NCI
C140092	RO	chemotherapy regimen has component Methotrexate	NCI
C9847	STY	Therapeutic or Preventive Procedure		NCI
C9847	PT	Cytarabine/Sargramostim		NCI
C9847	SY	ARA-C/GM-CSF		NCI
C9847	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9847	RO	chemotherapy regimen has component Cytarabine	NCI
C9847	RO	chemotherapy regimen has component Sargramostim	NCI
C11579	STY	Therapeutic or Preventive Procedure		NCI
C11579	PT	gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-2/MART-1 Antigen/Tyrosinase Peptide		NCI
C11579	SY	gp100/IFA/IL-2/MART-1/TYRP		NCI
C11579	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11579	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11579	RO	chemotherapy regimen has component gp100 Antigen	NCI
C11579	RO	chemotherapy regimen has component Tyrosinase Peptide	NCI
C11579	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11579	RO	chemotherapy regimen has component MART-1 Antigen	NCI
C10303	STY	Therapeutic or Preventive Procedure		NCI
C10303	PT	Carmustine/Cisplatin/Dacarbazine		NCI
C10303	SY	BCNU/CDDP/DTIC		NCI
C10303	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10303	RO	chemotherapy regimen has component Carmustine	NCI
C10303	RO	chemotherapy regimen has component Cisplatin	NCI
C10303	RO	chemotherapy regimen has component Dacarbazine	NCI
C9979	STY	Therapeutic or Preventive Procedure		NCI
C9979	PT	Cisplatin/Dacarbazine/Interleukin-2		NCI
C9979	SY	CDDP/DTIC/IL-2		NCI
C9979	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9979	RO	chemotherapy regimen has component Cisplatin	NCI
C9979	RO	chemotherapy regimen has component Dacarbazine	NCI
C9979	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10811	STY	Therapeutic or Preventive Procedure		NCI
C10811	PT	Cyclophosphamide/Doxorubicin/Toremifene		NCI
C10811	SY	CTX/DOX/TOR		NCI
C10811	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C10811	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10811	RO	chemotherapy regimen has component Doxorubicin	NCI
C10811	RO	chemotherapy regimen has component Toremifene	NCI
C11660	STY	Therapeutic or Preventive Procedure		NCI
C11660	PT	Dexamethasone/Floxuridine/Leucovorin Calcium/SCH-58500		NCI
C11660	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C11660	RO	chemotherapy regimen has component Dexamethasone	NCI
C11660	RO	chemotherapy regimen has component Floxuridine	NCI
C11660	RO	chemotherapy regimen has component Recombinant Adenovirus-p53 SCH-58500	NCI
C11660	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C156365	STY	Therapeutic or Preventive Procedure		NCI
C156365	PT	Cyclophosphamide/Trastuzumab Regimen		NCI
C156365	SY	Cyclophosphamide/Herceptin		NCI
C156365	SY	Trastuzumab/Cyclophosphamide		NCI
C156365	SY	Cyclophosphamide/Trastuzumab		NCI
C156365	SY	Cyclophosphamide-Trastuzumab		NCI
C156365	SY	Trastuzumab-Cyclophosphamide		NCI
C156365	SY	Trastuzumab/Cyclophosphamide Regimen		NCI
C156365	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156365	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C156365	RO	chemotherapy regimen has component Trastuzumab	NCI
C9813	STY	Therapeutic or Preventive Procedure		NCI
C9813	PT	Fluorouracil/Leucovorin Calcium/Levamisole		NCI
C9813	SY	5FU/Leucovorin/Levamisole		NCI
C9813	SY	CF/5-FU/LEV		NCI
C9813	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9813	RO	chemotherapy regimen has component Fluorouracil	NCI
C9813	RO	chemotherapy regimen has component Leucovorin Calcium	NCI
C9813	RO	chemotherapy regimen has component Levamisole Hydrochloride	NCI
C9854	STY	Therapeutic or Preventive Procedure		NCI
C9854	PT	Doxorubicin/Prednisone		NCI
C9854	SY	DOX/PRED		NCI
C9854	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9854	RO	chemotherapy regimen has component Doxorubicin	NCI
C9854	RO	chemotherapy regimen has component Prednisone	NCI
C63632	STY	Therapeutic or Preventive Procedure		NCI
C63632	PT	Cisplatin-Vinblastine Regimen		NCI
C63632	SY	PVbl Regimen		NCI
C63632	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C63632	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C63632	RO	chemotherapy regimen has component Cisplatin	NCI
C63632	RO	chemotherapy regimen has component Vinblastine	NCI
C64793	STY	Therapeutic or Preventive Procedure		NCI
C64793	PT	AV Regimen		NCI
C64793	SY	Adriamycin-Velban Regimen		NCI
C64793	CHD	Chemotherapy Regimen Used to Treat Hodgkin Lymphoma	NCI
C64793	RO	chemotherapy regimen has component Doxorubicin	NCI
C64793	RO	chemotherapy regimen has component Vinblastine	NCI
C64793	RO	regimen has accepted use for disease Adult Hodgkin Lymphoma	NCI
C10241	STY	Therapeutic or Preventive Procedure		NCI
C10241	PT	Cytarabine/Mitoxantrone/Thioguanine/Vincristine		NCI
C10241	SY	ARA-C/DHAD/TG/VCR		NCI
C10241	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10241	RO	chemotherapy regimen has component Cytarabine	NCI
C10241	RO	chemotherapy regimen has component Thioguanine	NCI
C10241	RO	chemotherapy regimen has component Vincristine	NCI
C10241	RO	chemotherapy regimen has component Mitoxantrone Hydrochloride	NCI
C63686	STY	Therapeutic or Preventive Procedure		NCI
C63686	PT	AI Regimen		NCI
C63686	SY	Adriamycin-Ifosfamide Regimen		NCI
C63686	CHD	Chemotherapy Regimen Used to Treat Sarcoma	NCI
C63686	RO	chemotherapy regimen has component Doxorubicin	NCI
C63686	RO	chemotherapy regimen has component Ifosfamide	NCI
C63686	RO	regimen has accepted use for disease Soft Tissue Sarcoma	NCI
C12120	STY	Therapeutic or Preventive Procedure		NCI
C12120	PT	Bexarotene/Cisplatin/Vinorelbine		NCI
C12120	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C12120	RO	chemotherapy regimen has component Cisplatin	NCI
C12120	RO	chemotherapy regimen has component Vinorelbine	NCI
C12120	RO	chemotherapy regimen has component Bexarotene	NCI
C9575	STY	Therapeutic or Preventive Procedure		NCI
C9575	PT	Lomustine/Prednisone/Procarbazine/Vinblastine		NCI
C9575	SY	CCNU/PCB/PRED/VBL		NCI
C9575	SY	CVPP		NCI
C9575	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C9575	RO	chemotherapy regimen has component Lomustine	NCI
C9575	RO	chemotherapy regimen has component Prednisone	NCI
C9575	RO	chemotherapy regimen has component Vinblastine	NCI
C9575	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C10853	STY	Therapeutic or Preventive Procedure		NCI
C10853	PT	Cyclophosphamide/Etoposide/Filgrastim		NCI
C10853	SY	CTX/G-CSF/VP-16		NCI
C10853	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10853	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C10853	RO	chemotherapy regimen has component Etoposide	NCI
C10853	RO	chemotherapy regimen has component Filgrastim	NCI
C11182	STY	Therapeutic or Preventive Procedure		NCI
C11182	PT	Cisplatin/interleukin-2/Paclitaxel/Tumor Infiltrating Lymphocytes		NCI
C11182	SY	CDDP/IL-2/TAX/TIL		NCI
C11182	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11182	RO	chemotherapy regimen has component Cisplatin	NCI
C11182	RO	chemotherapy regimen has component Paclitaxel	NCI
C11182	RO	chemotherapy regimen has component Therapeutic Tumor Infiltrating Lymphocytes	NCI
C11182	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C10079	STY	Therapeutic or Preventive Procedure		NCI
C10079	PT	Bleomycin/Procarbazine/Vinblastine		NCI
C10079	SY	BLEO/PCB/VBL		NCI
C10079	SY	VPB		NCI
C10079	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10079	RO	chemotherapy regimen has component Bleomycin	NCI
C10079	RO	chemotherapy regimen has component Vinblastine	NCI
C10079	RO	chemotherapy regimen has component Procarbazine Hydrochloride	NCI
C11752	STY	Therapeutic or Preventive Procedure		NCI
C11752	PT	O6-Benzylguanine/Polifeprosan 20 With Carmustine Implant		NCI
C11752	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11752	RO	chemotherapy regimen has component O6-Benzylguanine	NCI
C11752	RO	chemotherapy regimen has component Carmustine Implant	NCI
C9555	STY	Therapeutic or Preventive Procedure		NCI
C9555	PT	Cyclophosphamide/Fluorouracil/Methotrexate/Prednisone		NCI
C9555	SY	CTX/5-FU/MTX/PRED		NCI
C9555	SY	CMFP		NCI
C9555	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9555	RO	chemotherapy regimen has component Cyclophosphamide	NCI
C9555	RO	chemotherapy regimen has component Fluorouracil	NCI
C9555	RO	chemotherapy regimen has component Methotrexate	NCI
C9555	RO	chemotherapy regimen has component Prednisone	NCI
C10374	STY	Therapeutic or Preventive Procedure		NCI
C10374	PT	Cytarabine/Etoposide/Prednisone		NCI
C10374	SY	ARA-C/PRED/VP-16		NCI
C10374	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10374	RO	chemotherapy regimen has component Cytarabine	NCI
C10374	RO	chemotherapy regimen has component Etoposide	NCI
C10374	RO	chemotherapy regimen has component Prednisone	NCI
C11471	STY	Therapeutic or Preventive Procedure		NCI
C11471	PT	gp209-2M Antigen/Incomplete Freund's Adjuvant/Interleukin-2		NCI
C11471	SY	gp209-2M/IFA/IL-2		NCI
C11471	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11471	RO	chemotherapy regimen has component Incomplete Freund's Adjuvant	NCI
C11471	RO	chemotherapy regimen has component gp209-2M Antigen	NCI
C11471	RO	chemotherapy regimen has component Recombinant Interleukin-2	NCI
C11380	STY	Therapeutic or Preventive Procedure		NCI
C11380	PT	Carboplatin/Estramustine/Filgrastim/Paclitaxel		NCI
C11380	SY	CBDCA/EM/G-CSF/TAX		NCI
C11380	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11380	RO	chemotherapy regimen has component Estramustine	NCI
C11380	RO	chemotherapy regimen has component Carboplatin	NCI
C11380	RO	chemotherapy regimen has component Paclitaxel	NCI
C11380	RO	chemotherapy regimen has component Filgrastim	NCI
C9898	STY	Therapeutic or Preventive Procedure		NCI
C9898	PT	Cisplatin/Fluorouracil/Vincristine		NCI
C9898	SY	CDDP/5-FU/VCR		NCI
C9898	CHD	Agent Combination Indexed in Open Clinical Trials	NCI
C9898	RO	chemotherapy regimen has component Cisplatin	NCI
C9898	RO	chemotherapy regimen has component Fluorouracil	NCI
C9898	RO	chemotherapy regimen has component Vincristine	NCI
C11787	STY	Therapeutic or Preventive Procedure		NCI
C11787	PT	Doxorubicin/SU5416		NCI
C11787	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C11787	RO	chemotherapy regimen has component Doxorubicin	NCI
C11787	RO	chemotherapy regimen has component Semaxanib	NCI
C10013	STY	Therapeutic or Preventive Procedure		NCI
C10013	PT	Doxorubicin/Fluoxymesterone/Mitolactol/Tamoxifen		NCI
C10013	SY	DBD/DOX/FXM/TMX		NCI
C10013	SY	DATH		NCI
C10013	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C10013	RO	chemotherapy regimen has component Doxorubicin	NCI
C10013	RO	chemotherapy regimen has component Fluoxymesterone	NCI
C10013	RO	chemotherapy regimen has component Mitolactol	NCI
C10013	RO	chemotherapy regimen has component Tamoxifen Citrate	NCI
C37636	STY	Therapeutic or Preventive Procedure		NCI
C37636	PT	Celecoxib/Gemcitabine		NCI
C37636	CHD	Agent Combination Not Indexed in Open Clinical Trials	NCI
C37636	RO	chemotherapy regimen has component Celecoxib	NCI
C37636	RO	chemotherapy regimen has component Gemcitabine Hydrochloride	NCI
C156355	STY	Therapeutic or Preventive Procedure		NCI
C156355	PT	Docetaxel/Vandetanib Regimen		NCI
C156355	SY	Vandetanib/Docetaxel Regimen		NCI
C156355	SY	Vandetanib/Docetaxel		NCI
C156355	SY	Docetaxel/Vandetanib		NCI
C156355	SY	Docetaxel-Vandetanib		NCI
C156355	SY	Docetaxel/Caprelsa		NCI
C156355	CHD	Chemotherapy Regimen Used to Treat Breast Carcinoma	NCI
C156355	CHD	Chemotherapy Regimen Used to Treat Non-Small Cell Lung Carcinoma	NCI
C156355	RO	regimen has accepted use for disease Lung Non-Small Cell Carcinoma	NCI
C156355	RO	chemotherapy regimen has component Docetaxel	NCI
C156355	RO	regimen has accepted use for disease Breast Carcinoma	NCI
C156355	RO	chemotherapy regimen has component Vandetanib	NCI
